PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Skau, CT; Courson, DS; Bestul, AJ; Winkelman, JD; Rock, RS; Sirotkin, V; Kovar, DR				Skau, Colleen T.; Courson, David S.; Bestul, Andrew J.; Winkelman, Jonathan D.; Rock, Ronald S.; Sirotkin, Vladimir; Kovar, David R.			Actin Filament Bundling by Fimbrin Is Important for Endocytosis, Cytokinesis, and Polarization in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; F-ACTIN; CAPPING PROTEIN; CONTRACTILE RING; CROSS-LINKING; SCHIZOSACCHAROMYCES-POMBE; ALPHA-ACTININ; IN-VIVO; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS	Through the coordinated action of diverse actin-binding proteins, cells simultaneously assemble actin filaments with distinct architectures and dynamics to drive different processes. Actin filament cross-linking proteins organize filaments into higher order networks, although the requirement of cross-linking activity in cells has largely been assumed rather than directly tested. Fission yeast Schizosaccharomyces pombe assembles actin into three discrete structures: endocytic actin patches, polarizing actin cables, and the cytokinetic contractile ring. The fission yeast filament cross-linker fimbrin Fim1 primarily localizes to Arp2/3 complex-nucleated branched filaments of the actin patch and by a lesser amount to bundles of linear antiparallel filaments in the contractile ring. It is unclear whether Fim1 associates with bundles of parallel filaments in actin cables. We previously discovered that a principal role of Fim1 is to control localization of tropomyosin Cdc8, thereby facilitating cofilin-mediated filament turnover. Therefore, we hypothesized that the bundling ability of Fim1 is dispensable for actin patches but is important for the contractile ring and possibly actin cables. By directly visualizing actin filament assembly using total internal reflection fluorescence microscopy, we determined that Fim1 bundles filaments in both parallel and antiparallel orientations and efficiently bundles Arp2/3 complex-branched filaments in the absence but not the presence of actin capping protein. Examination of cells exclusively expressing a truncated version of Fim1 that can bind but not bundle actin filaments revealed that bundling activity of Fim1 is in fact important for all three actin structures. Therefore, fimbrin Fim1 has diverse roles as both a filament "gatekeeper" and as a filament cross-linker.	[Skau, Colleen T.; Bestul, Andrew J.; Winkelman, Jonathan D.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Courson, David S.; Rock, Ronald S.; Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sirotkin, Vladimir] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	University of Chicago; University of Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kovar, DR (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St,Suite 915E, Chicago, IL 60637 USA.	drkovar@uchicago.edu			National Institutes of Health [RO1GM079265, RO1GM078450, T32 GM007183]; William Rainey Harper Fellowship; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM079265, R01GM078450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Rainey Harper Fellowship; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM079265 (to D. R. K.) and RO1GM078450 (to R. S. R.) and Molecular and Cellular Biology Training Grant T32 GM007183 (to C. T. S.). This work was also supported by a William Rainey Harper Fellowship (to C. T. S.) and an American Heart Association Predoctoral Fellowship (to D. S. C.).	ADAMS AEM, 1989, SCIENCE, V243, P231, DOI 10.1126/science.2643162; ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BRETSCHER A, 1980, J CELL BIOL, V86, P335, DOI 10.1083/jcb.86.1.335; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; BROWER SM, 1995, GENETICS, V140, P91; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Carlsson AE, 2004, BIOPHYS J, V86, P1074, DOI 10.1016/S0006-3495(04)74182-X; Carlsson AE, 2002, BIOPHYS J, V82, P2333, DOI 10.1016/S0006-3495(02)75579-3; Carnahan RH, 2003, J CELL BIOL, V162, P851, DOI 10.1083/jcb.200305012; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Goldsmith SC, 1997, NAT STRUCT BIOL, V4, P708, DOI 10.1038/nsb0997-708; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Goodman A, 2003, MOL BIOL CELL, V14, P2617, DOI 10.1091/mbc.E03-01-0028; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Hanein D, 1998, NAT STRUCT BIOL, V5, P787, DOI 10.1038/1828; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamasaki T, 2005, NAT CELL BIOL, V7, P916, DOI 10.1038/ncb1295; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Klein MG, 2004, STRUCTURE, V12, P999, DOI 10.1016/j.str.2004.04.010; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2001, PLANTA, V213, P390, DOI 10.1007/s004250000494; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lebart MC, 2004, BIOCHEMISTRY-US, V43, P2428, DOI 10.1021/bi030151p; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; MAEKAWA S, 1982, J BIOCHEM-TOKYO, V92, P1959, DOI 10.1093/oxfordjournals.jbchem.a134127; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; MATSUDAIRA P, 1983, NATURE, V301, P209, DOI 10.1038/301209a0; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Nakano K, 2006, MOL BIOL CELL, V17, P1933, DOI 10.1091/mbc.E05-09-0900; Nakano K, 2005, FEBS LETT, V579, P6311, DOI 10.1016/j.febslet.2005.10.011; Nakano K, 2001, MOL BIOL CELL, V12, P3515, DOI 10.1091/mbc.12.11.3515; Nakano K, 2006, GENES CELLS, V11, P893, DOI 10.1111/j.1365-2443.2006.00987.x; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; OTTO JJ, 1980, CELL MOTIL CYTOSKEL, V1, P31, DOI 10.1002/cm.970010104; Park SJ, 2007, GENES CELLS, V12, P611, DOI 10.1111/j.1365-2443.2007.01081.x; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2002, CURR OPIN STRUC BIOL, V12, P768, DOI 10.1016/S0959-440X(02)00396-2; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Skoumpla K, 2007, J CELL SCI, V120, P1635, DOI 10.1242/jcs.001115; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Takaine M, 2009, EMBO J, V28, P3117, DOI 10.1038/emboj.2009.252; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Win TZ, 2001, J CELL SCI, V114, P69; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Young ME, 2004, J CELL BIOL, V166, P629, DOI 10.1083/jcb.200404159	92	80	82	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26964	26977		10.1074/jbc.M111.239004	http://dx.doi.org/10.1074/jbc.M111.239004			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642440	Green Published, hybrid			2022-12-25	WOS:000293078200070
J	Yoshiyama-Yanagawa, T; Enya, S; Shimada-Niwa, Y; Yaguchi, S; Haramoto, Y; Matsuya, T; Shiomi, K; Sasakura, Y; Takahashi, S; Asashima, M; Kataoka, H; Niwa, R				Yoshiyama-Yanagawa, Takuji; Enya, Sora; Shimada-Niwa, Yuko; Yaguchi, Shunsuke; Haramoto, Yoshikazu; Matsuya, Takeshi; Shiomi, Kensuke; Sasakura, Yasunori; Takahashi, Shuji; Asashima, Makoto; Kataoka, Hiroshi; Niwa, Ryusuke			The Conserved Rieske Oxygenase DAF-36/Neverland Is a Novel Cholesterol-metabolizing Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ELEGANS DAUER FORMATION; LEMLI-OPITZ-SYNDROME; 3-KETOSTEROID 9-ALPHA-HYDROXYLASE; 7-DEHYDROCHOLESTEROL REDUCTASE; ECDYSTEROIDOGENIC PATHWAY; DROSOPHILA-MELANOGASTER; BIOSYNTHESIS; GENOME; HORMONE	Steroid hormones play essential roles in a wide variety of biological processes in multicellular organisms. The principal steroid hormones in nematodes and arthropods are dafachronic acids and ecdysteroids, respectively, both of which are synthesized from cholesterol as an indispensable precursor. The first critical catalytic step in the biosynthesis of these ecdysozoan steroids is the conversion of cholesterol to 7-dehydrocholesterol. However, the enzymes responsible for cholesterol 7,8-dehydrogenation remain unclear at the molecular level. Here we report that the Rieske oxygenase DAF-36/Neverland (Nvd) is a cholesterol 7,8-dehydrogenase. The daf-36/nvd genes are evolutionarily conserved, not only in nematodes and insects but also in deuterostome species that do not produce dafachronic acids or ecdysteroids, including the sea urchin Hemicentrotus pulcherrimus, the sea squirt Ciona intestinalis, the fish Danio rerio, and the frog Xenopus laevis. An in vitro enzymatic assay system reveals that all DAF-36/Nvd proteins cloned so far have the ability to convert cholesterol to 7-dehydrocholesterol. Moreover, the lethality of loss of nvd function in the fruit fly Drosophila melanogaster is rescued by the expression of daf-36/nvd genes from the nematode Caenorhabditis elegans, the insect Bombyx mori, or the vertebrates D. rerio and X. laevis. These data suggest that daf-36/nvd genes are functionally orthologous across the bilaterian phylogeny. We propose that the daf-36/nvd family of proteins is a novel conserved player in cholesterol metabolism across the animal phyla.	[Yoshiyama-Yanagawa, Takuji; Matsuya, Takeshi; Kataoka, Hiroshi] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Chiba 2778562, Japan; [Yoshiyama-Yanagawa, Takuji; Enya, Sora; Shimada-Niwa, Yuko; Yaguchi, Shunsuke; Sasakura, Yasunori; Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yaguchi, Shunsuke; Niwa, Ryusuke] Univ Tsukuba, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki 3058577, Japan; [Yaguchi, Shunsuke; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan; [Haramoto, Yoshikazu; Takahashi, Shuji] Univ Tokyo, Komaba Org Educ Excellence, Div Life Sci, Coll Arts & Sci,Meguro Ku, Tokyo 1538902, Japan; [Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Shiomi, Kensuke] Univ Tsukuba, Dept Mol Neurobiol, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Haramoto, Yoshikazu; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan	University of Tokyo; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tokyo; University of Tokyo; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST)	Kataoka, H (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwanoha 5-1-5, Chiba 2778562, Japan.	kataoka@k.u-tokyo.ac.jp; ryusuke-niwa@umin.ac.jp	Asashima, Makoto/O-8389-2018; Yaguchi, Shunsuke/H-7270-2019; Haramoto, Yoshikazu/M-1081-2018	Asashima, Makoto/0000-0002-0012-026X; Yaguchi, Shunsuke/0000-0002-8326-5762; Haramoto, Yoshikazu/0000-0002-9460-0837	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; Agricultural Chemical Research Foundation; Japan Association for Marine Biology; Japan Society for the Promotion of Science (JSPS) [19380034]; Program for Promotion of Basic Research Activities for Innovative Biosciences	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Agricultural Chemical Research Foundation(Agricultural Chemical Research Foundation, Japan); Japan Association for Marine Biology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; by grants from the Agricultural Chemical Research Foundation and the Japan Association for Marine Biology (to R. N.); and by Grant-in-Aid for Scientific Research 19380034 from the Japan Society for the Promotion of Science (JSPS) and a grant from the Program for Promotion of Basic Research Activities for Innovative Biosciences (to H. K.).	BRAND AH, 1993, DEVELOPMENT, V118, P401; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Correa-Cerro LS, 2005, MOL GENET METAB, V84, P112, DOI 10.1016/j.ymgme.2004.09.017; DECAPRIO J, 1992, J LIPID RES, V33, P441; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Glossmann HH, 2010, J INVEST DERMATOL, V130, P2139, DOI 10.1038/jid.2010.118; GRIENEISEN ML, 1993, INSECT BIOCHEM MOLEC, V23, P13, DOI 10.1016/0965-1748(93)90077-6; Griffiths WJ, 2008, CLIN CHEM, V54, P1317, DOI 10.1373/clinchem.2007.100644; Griffiths WJ, 2006, J AM SOC MASS SPECTR, V17, P341, DOI 10.1016/j.jasms.2005.10.012; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Hsu HJ, 2006, MOL CELL ENDOCRINOL, V248, P160, DOI 10.1016/j.mce.2005.10.011; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Jiang HY, 1996, J BACTERIOL, V178, P3133, DOI 10.1128/jb.178.11.3133-3139.1996; Koide T, 2006, DEVELOPMENT, V133, P2395, DOI 10.1242/dev.02393; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Lee EY, 2005, BIOCHEM BIOPH RES CO, V328, P929, DOI 10.1016/j.bbrc.2005.01.050; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Miller Walter L., 2008, V13, P1, DOI 10.1159/000134751; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2011, CHOLESTEROL, DOI 10.1155/2011/176802; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Schmidt CL, 2001, J BIOENERG BIOMEMBR, V33, P9, DOI 10.1023/A:1005616505962; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Tadjuidje E, 2006, DEV DYNAM, V235, P2095, DOI 10.1002/dvdy.20860; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	33	112	123	7	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25756	25762		10.1074/jbc.M111.244384	http://dx.doi.org/10.1074/jbc.M111.244384			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632547	Green Published, hybrid			2022-12-25	WOS:000293073000037
J	Charlton, BD; Ellis, WAH; McKinnon, AJ; Brumm, J; Nilsson, K; Fitch, WT				Charlton, Benjamin D.; Ellis, William A. H.; McKinnon, Allan J.; Brumm, Jacqui; Nilsson, Karen; Fitch, W. Tecumseh			Perception of Male Caller Identity in Koalas (Phascolarctos cinereus): Acoustic Analysis and Playback Experiments	PLOS ONE			English	Article							SOURCE-FILTER THEORY; INDIVIDUAL RECOGNITION; VOCAL RECOGNITION; RED DEER; DISCRIMINATE; FEATURES; CONSTRAINTS; PRIMATES; CONTEXTS; MOTHERS	The ability to signal individual identity using vocal signals and distinguish between conspecifics based on vocal cues is important in several mammal species. Furthermore, it can be important for receivers to differentiate between callers in reproductive contexts. In this study, we used acoustic analyses to determine whether male koala bellows are individually distinctive and to investigate the relative importance of different acoustic features for coding individuality. We then used a habituation-discrimination paradigm to investigate whether koalas discriminate between the bellow vocalisations of different male callers. Our results show that male koala bellows are highly individualized, and indicate that cues related to vocal tract filtering contribute the most to vocal identity. In addition, we found that male and female koalas habituated to the bellows of a specific male showed a significant dishabituation when they were presented with bellows from a novel male. The significant reduction in behavioural response to a final rehabituation playback shows this was not a chance rebound in response levels. Our findings indicate that male koala bellows are highly individually distinctive and that the identity of male callers is functionally relevant to male and female koalas during the breeding season. We go on to discuss the biological relevance of signalling identity in this species' sexual communication and the potential practical implications of our findings for acoustic monitoring of male population levels.	[Charlton, Benjamin D.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Ellis, William A. H.] Univ Queensland, Sch Biol Sci, Koala Ecol Grp, Brisbane, Qld, Australia; [McKinnon, Allan J.] Moggill Koala Hosp, Dept Environm & Resource Management, Bellbowrie, Qld, Australia; [Brumm, Jacqui; Nilsson, Karen] Lone Pine Koala Sanctuary, Brisbane, Qld, Australia	University of Vienna; University of Queensland	Charlton, BD (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	benjamin.charlton@univie.ac.at	Ellis, William/AAP-8955-2021	Charlton, Benjamin/0000-0002-0218-7177; Ellis, William/0000-0001-6017-4692	European Research Council [230604]	European Research Council(European Research Council (ERC)European Commission)	B.D. Charlton was supported by a European Research Council Advanced Grant SOMACCA (No. 230604) awarded to W. Tecumseh Fitch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; Blumstein DT, 2004, ANIM BEHAV, V68, P1257, DOI 10.1016/j.anbehav.2003.12.024; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, BIOL LETTERS, V5, P597, DOI 10.1098/rsbl.2009.0331; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; EAST ML, 1991, ANIM BEHAV, V42, P651, DOI 10.1016/S0003-3472(05)80247-7; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch W. Tecumseh S., 2002, P87; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Handasyde, 1999, KOALA NATURAL HIST C; Hare JF, 1998, ANIM BEHAV, V55, P451, DOI 10.1006/anbe.1997.0613; Hauser MD, 2007, ANIM BEHAV, V73, P1059, DOI 10.1016/j.anbehav.2006.11.006; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; KIMMEL HD, 1957, PSYCHOL BULL, V54, P351, DOI 10.1037/h0046737; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; Mitchell P., 1990, P151; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Reby D, 1999, ANIM BEHAV, V57, P1121, DOI 10.1006/anbe.1998.1056; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2001, ETHOLOGY, V107, P951, DOI 10.1046/j.1439-0310.2001.00732.x; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Riede T, 2003, J ACOUST SOC AM, V113, P2919, DOI 10.1121/1.1567278; Ruxton GD, 2010, METHODS ECOL EVOL, V1, P114, DOI 10.1111/j.2041-210X.2010.00014.x; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; SHIPLEY C, 1981, ANIM BEHAV, V29, P12, DOI 10.1016/S0003-3472(81)80147-9; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Swaisgood RR, 1999, ANIM BEHAV, V57, P1045, DOI 10.1006/anbe.1998.1070; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Titze IR, 1994, PRINCIPLES VOICE PRO; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; Tripovich JS, 2008, BEHAV PROCESS, V79, P74, DOI 10.1016/j.beproc.2008.04.007; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; ZIMMERMANN E, 1993, ETHOLOGY, V93, P211; [No title captured]; [No title captured]	50	33	33	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20329	10.1371/journal.pone.0020329	http://dx.doi.org/10.1371/journal.pone.0020329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633499	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500057
J	Fung, H; Weinstock, DM				Fung, Hua; Weinstock, David M.			Repair at Single Targeted DNA Double-Strand Breaks in Pluripotent and Differentiated Human Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; HUMAN ESCS; MECHANISM; PATHWAY; CULTURE; TRANSGENESIS; EXPRESSION; INHIBITOR; NUCLEASES	Differences in ex vivo cell culture conditions can drastically affect stem cell physiology. We sought to establish an assay for measuring the effects of chemical, environmental, and genetic manipulations on the precision of repair at a single DNA double-strand break (DSB) in pluripotent and somatic human cells. DSBs in mammalian cells are primarily repaired by either homologous recombination (HR) or nonhomologous end-joining (NHEJ). For the most part, previous studies of DSB repair in human cells have utilized nonspecific clastogens like ionizing radiation, which are highly nonphysiologic, or assayed repair at randomly integrated reporters. Measuring repair after random integration is potentially confounded by locus-specific effects on the efficiency and precision of repair. We show that the frequency of HR at a single DSB differs up to 20-fold between otherwise isogenic human embryonic stem cells (hESCs) based on the site of the DSB within the genome. To overcome locus-specific effects on DSB repair, we used zinc finger nucleases to efficiently target a DSB repair reporter to a safe-harbor locus in hESCs and a panel of somatic human cell lines. We demonstrate that repair at a targeted DSB is highly precise in hESCs, compared to either the somatic human cells or murine embryonic stem cells. Differentiation of hESCs harboring the targeted reporter into astrocytes reduces both the efficiency and precision of repair. Thus, the phenotype of repair at a single DSB can differ based on either the site of damage within the genome or the stage of cellular differentiation. Our approach to single DSB analysis has broad utility for defining the effects of genetic and environmental modifications on repair precision in pluripotent cells and their differentiated progeny.	[Fung, Hua; Weinstock, David M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Fung, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	dweinstock@partners.org			Harvard Stem Cell Institute; Burroughs Wellcome Fund	Harvard Stem Cell Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by a Seed Grant from the Harvard Stem Cell Institute (http://www.hsci.harvard.edu) and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (www.BWFund.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Adams Bret R, 2010, Aging (Albany NY), V2, P582; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Bennardo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000683; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Braam SR, 2008, NAT PROTOC, V3, P1435, DOI 10.1038/nprot.2008.140; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Carroll Dana, 2004, Methods Mol Biol, V262, P195; Chandrasegaran S, 1999, BIOL CHEM, V380, P841, DOI 10.1515/BC.1999.103; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Lane AA, 2010, CELL, V142, P360, DOI 10.1016/j.cell.2010.07.030; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 2005, METH MOL B, V291, P373; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Smith JR, 2008, STEM CELLS, V26, P496, DOI 10.1634/stemcells.2007-0039; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Van Hoof D, 2008, STEM CELLS, V26, P2777, DOI 10.1634/stemcells.2008-0365; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107	49	30	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20514	10.1371/journal.pone.0020514	http://dx.doi.org/10.1371/journal.pone.0020514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633706	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500067
J	Prigent, J; Panigai, L; Lamourette, P; Sauvaire, D; Devilliers, K; Plaisance, M; Volland, H; Creminon, C; Simon, S				Prigent, Julie; Panigai, Laetitia; Lamourette, Patricia; Sauvaire, Didier; Devilliers, Karine; Plaisance, Marc; Volland, Herve; Creminon, Christophe; Simon, Stephanie			Neutralising Antibodies against Ricin Toxin	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; BIOLOGICAL WARFARE; PROTECTS MICE; VACCINE; ACETYLCHOLINESTERASE; IDENTIFICATION; MANAGEMENT; TRANSPORT; LECTINS; ANTHRAX	The Centers for Disease Control and Prevention have listed the potential bioweapon ricin as a Category B Agent. Ricin is a so-called A/B toxin produced by plants and is one of the deadliest molecules known. It is easy to prepare and no curative treatment is available. An immunotherapeutic approach could be of interest to attenuate or neutralise the effects of the toxin. We sought to characterise neutralising monoclonal antibodies against ricin and to develop an effective therapy. For this purpose, mouse monoclonal antibodies (mAbs) were produced against the two chains of ricin toxin (RTA and RTB). Seven mAbs were selected for their capacity to neutralise the cytotoxic effects of ricin in vitro. Three of these, two anti-RTB (RB34 and RB37) and one anti-RTA (RA36), when used in combination improved neutralising capacity in vitro with an IC50 of 31 ng/ml. Passive administration of association of these three mixed mAbs (4.7 mu g) protected mice from intranasal challenges with ricin (5 LD50). Among those three antibodies, anti-RTB antibodies protected mice more efficiently than the anti-RTA antibody. The combination of the three antibodies protected mice up to 7.5 hours after ricin challenge. The strong in vivo neutralising capacity of this three mAbs combination makes it potentially useful for immunotherapeutic purposes in the case of ricin poisoning or possibly for prevention.	[Prigent, Julie; Lamourette, Patricia; Devilliers, Karine; Plaisance, Marc; Volland, Herve; Creminon, Christophe; Simon, Stephanie] CEA Saclay, CEA, iBiTec S, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France; [Panigai, Laetitia; Sauvaire, Didier] Unite CBR, AFSSAPS, Montpellier, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Prigent, J (corresponding author), CEA Saclay, CEA, iBiTec S, Serv Pharmacol & Immunoanal, F-91191 Gif Sur Yvette, France.	stephanie.simon@cea.fr	Simon, Stephanie/E-4289-2012	Simon, Stephanie/0000-0002-6071-8255	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables)(French Atomic Energy Commission); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	This study was supported by a grant from the PhD programme of the CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables) (Julie Prigent) and funded by the IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees) and NRBC (Nuclear Radiological Biological and Chemical Risks) programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bigalke H, 2005, TOXICOLOGY, V214, P210, DOI 10.1016/j.tox.2005.06.015; Binder P, 2003, COMP IMMUNOL MICROB, V26, P401, DOI 10.1016/S0147-9571(03)00023-7; Burnett JC, 2005, NAT REV DRUG DISCOV, V4, P281, DOI 10.1038/nrd1694; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Dokmetjian J, 2000, VACCINE, V18, P2698, DOI 10.1016/S0264-410X(00)00066-9; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; ENDO Y, 1987, J BIOL CHEM, V262, P5908; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; GRASSI J, 1988, ANAL BIOCHEM, V168, P436, DOI 10.1016/0003-2697(88)90341-7; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; LITTLE SF, 1990, INFECT IMMUN, V58, P1606, DOI 10.1128/IAI.58.6.1606-1613.1990; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NICOLSON GL, 1974, BIOCHEMISTRY-US, V13, P196, DOI 10.1021/bi00698a029; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; OLSNES S, 1973, BIOCHEMISTRY-US, V12, P3121, DOI 10.1021/bi00740a028; Olson MA, 2004, PROTEIN ENG DES SEL, V17, P391, DOI 10.1093/protein/gzh043; REIK LM, 1987, J IMMUNOL METHODS, V100, P123, DOI 10.1016/0022-1759(87)90180-3; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Sandvig K, 1999, FEBS LETT, V452, P67, DOI 10.1016/S0014-5793(99)00529-3; Schep LJ, 2009, ENVIRON INT, V35, P1267, DOI 10.1016/j.envint.2009.08.004; Smallshaw JE, 2007, VACCINE, V25, P7459, DOI 10.1016/j.vaccine.2007.08.018; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Tanaka KSE, 2001, BIOCHEMISTRY-US, V40, P6845, DOI 10.1021/bi010499p; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; Yan XJ, 1997, J MOL BIOL, V266, P1043, DOI 10.1006/jmbi.1996.0865	37	58	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20166	10.1371/journal.pone.0020166	http://dx.doi.org/10.1371/journal.pone.0020166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633505	Green Published, gold			2022-12-25	WOS:000291006500034
J	Zhang, H; Campbell, DA; Sturm, NR; Dungan, CF; Lin, SJ				Zhang, Huan; Campbell, David A.; Sturm, Nancy R.; Dungan, Christopher F.; Lin, Senjie			Spliced Leader RNAs, Mitochondrial Gene Frameshifts and Multi-Protein Phylogeny Expand Support for the Genus Perkinsus as a Unique Group of Alveolates	PLOS ONE			English	Article							SP-NOV PERKINSOZOA; CYTOCHROME-B GENE; GENOME SEQUENCE; KARENIA-BREVIS; DINOFLAGELLATE; MARINUS; AMPHIDINIUM; EVOLUTION; HETEROCAPSA; EXPRESSION	The genus Perkinsus occupies a precarious phylogenetic position. To gain a better understanding of the relationship between perkinsids, dinoflagellates and other alveolates, we analyzed the nuclear-encoded spliced-leader (SL) RNA and mitochondrial genes, intron prevalence, and multi-protein phylogenies. In contrast to the canonical 22-nt SL found in dinoflagellates (DinoSL), P. marinus has a shorter (21-nt) and a longer (22-nt) SL with slightly different sequences than DinoSL. The major SL RNA transcripts range in size between 80-83 nt in P. marinus, and similar to 83 nt in P. chesapeaki, significantly larger than the typical <= 56-nt dinoflagellate SL RNA. In most of the phylogenetic trees based on 41 predicted protein sequences, P. marinus branched at the base of the dinoflagellate clade that included the ancient taxa Oxyrrhis and Amoebophrya, sister to the clade of apicomplexans, and in some cases clustered with apicomplexans as a sister to the dinoflagellate clade. Of 104 Perkinsus spp. genes examined 69.2% had introns, a higher intron prevalence than in dinoflagellates. Examination of Perkinsus spp. mitochondrial cytochrome B and cytochrome C oxidase subunit I genes and their cDNAs revealed no mRNA editing, but these transcripts can only be translated when frameshifts are introduced at every AGG and CCC codon as if AGGY codes for glycine and CCCCU for proline. These results, along with the presence of the numerous uncharacterized 'marine alveolate group I' and Perkinsus-like lineages separating perkinsids from core dinoflagellates, expand support for the affiliation of the genus Perkinsus with an independent lineage (Perkinsozoa) positioned between the phyla of Apicomplexa and Dinoflagellata.	[Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Campbell, David A.; Sturm, Nancy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Dungan, Christopher F.] Cooperat Oxford Lab, Maryland Dept Nat Resources, Oxford, MD USA	University of Connecticut; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	zhang, yaqun/J-8478-2014; Guo, chentao/G-7320-2016; Lin, Senjie/A-7466-2011	Dungan, Christopher/0000-0001-5228-9115	NSF [EF-0629624, EF-0626678]; NOAA ECOHAB [NA05NOS4781196]; NIH [AI056034]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056034] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NOAA ECOHAB(National Oceanic Atmospheric Admin (NOAA) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NSF grants EF-0629624 (to SL) and EF-0626678 (to SL and HZ, https://www.fastlane.nsf.gov/fastlane.jsp); the NOAA ECOHAB grant NA05NOS4781196 (to SL and HZ, http://www.cop.noaa.gov/stressors/extremeevents/hab/current/abs_ECOHAB.aspx) and NIH grant AI056034 (http://nih.gov/, to DC and NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Beckenbach AT, 2005, J MOL EVOL, V60, P141, DOI 10.1007/s00239-004-0178-5; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Figueroa RI, 2008, PROTIST, V159, P563, DOI 10.1016/j.protis.2008.05.003; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gray MW, 2003, IUBMB LIFE, V55, P227, DOI 10.1080/1521654031000119425; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hearne JL, 2011, J EUKARYOT MICROBIOL, V58, P266, DOI 10.1111/j.1550-7408.2011.00538.x; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joseph SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-228; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin S., 2008, RNA DNA EDITING MOL, P280, DOI DOI 10.1002/9780470262269.CH13; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lin SJ, 2006, J PHYCOL, V42, P746, DOI 10.1111/j.1529-8817.2006.00213.x; Lin SJ, 2005, J SHELLFISH RES, V24, P733; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; MASUDA S, 2010, NUC ACID RES, P1, DOI DOI 10.1093/NAR/GKQ449; Monroe EA, 2008, PROTIST, V159, P471, DOI 10.1016/j.protis.2008.02.004; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Okamoto OK, 2001, BIOCHEMISTRY-US, V40, P15862, DOI 10.1021/bi011651q; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Saunders GW, 1997, PLANT SYST EVOL, P237; Siddall ME, 1997, PARASITOLOGY, V115, P165, DOI 10.1017/S0031182097001157; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Stelter K, 2007, PROTIST, V158, P119, DOI 10.1016/j.protis.2006.09.003; Sturm NR, 1999, MOL CELL BIOL, V19, P1595; Teles-Grilo ML, 2007, EUR J PROTISTOL, V43, P315, DOI 10.1016/j.ejop.2007.06.003; Villalba A, 2004, AQUAT LIVING RESOUR, V17, P411, DOI 10.1051/alr:2004050; Wisecaver JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-366; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2003, J PHYCOL, V39, P1160, DOI 10.1111/j.0022-3646.2003.03-055.x; Zhang H, 2008, J PHYCOL, V44, P703, DOI 10.1111/j.1529-8817.2008.00521.x; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083	46	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19933	10.1371/journal.pone.0019933	http://dx.doi.org/10.1371/journal.pone.0019933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629701	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800018
J	Lei, L; Sonabend, AM; Guarnieri, P; Soderquist, C; Ludwig, T; Rosenfeld, S; Bruce, JN; Canoll, P				Lei, Liang; Sonabend, Adam M.; Guarnieri, Paolo; Soderquist, Craig; Ludwig, Thomas; Rosenfeld, Steven; Bruce, Jeffrey N.; Canoll, Peter			Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype	PLOS ONE			English	Article							NEURAL STEM-CELLS; INTEGRATED GENOMIC ANALYSIS; MOUSE GLIOMA MODEL; GROWTH-FACTOR-B; GENE-EXPRESSION; IN-VIVO; SUBVENTRICULAR ZONE; PDGF RECEPTORS; WHITE-MATTER; OLIGODENDROCYTE DEVELOPMENT	Background: Tumor heterogeneity is a major obstacle for finding effective treatment of Glioblastoma (GBM). Based on global expression analysis, GBM can be classified into distinct subtypes: Proneural, Neural, Classical and Mesenchymal. The signatures of these different tumor subtypes may reflect the phenotypes of cells giving rise to them. However, the experimental evidence connecting any specific subtype of GBM to particular cells of origin is lacking. In addition, it is unclear how different genetic alterations interact with cells of origin in determining tumor heterogeneity. This issue cannot be addressed by studying end-stage human tumors. Methodology/Principal Findings: To address this issue, we used retroviruses to deliver transforming genetic lesions to glial progenitors in adult mouse brain. We compared the resulting tumors to human GBM. We found that different initiating genetic lesions gave rise to tumors with different growth rates. However all mouse tumors closely resembled the human Proneural GBM. Comparative analysis of these mouse tumors allowed us to identify a set of genes whose expression in humans with Proneural GBM correlates with survival. Conclusions/Significance: This study offers insights into the relationship between adult glial progenitors and Proneural GBM, and allows us to identify molecular alterations that lead to more aggressive tumor growth. In addition, we present a new preclinical model that can be used to test treatments directed at a specific type of GBM in future studies.	[Lei, Liang; Soderquist, Craig; Ludwig, Thomas; Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Sonabend, Adam M.; Bruce, Jeffrey N.] Columbia Univ, Dept Neurol Surg, New York, NY USA; [Guarnieri, Paolo] Columbia Univ, Bioinformat Div, New York, NY USA; [Rosenfeld, Steven] Columbia Univ, Dept Neurol, New York, NY USA; [Lei, Liang; Guarnieri, Paolo; Ludwig, Thomas; Rosenfeld, Steven; Bruce, Jeffrey N.; Canoll, Peter] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Lei, L (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	pc561@columbia.edu	Soderquist, Craig R/ABC-4677-2020; Bruce, Jeffrey N/AAC-5307-2022; Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585; Soderquist, Craig R/0000-0002-1454-1786	NIH/NINDS;  [1R01NS066955];  [1R56NS066992]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066955, R56NS066992] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is funded by NIH/NINDS (www.ninds.nih.gov). The grant numbers are 1R01NS066955 (P.C.) and 1R56NS066992 (S.R. and P.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; BARRES BA, 1993, DEVELOPMENT, V118, P283; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bohman LE, 2010, NEUROSURGERY, V67, P1319, DOI 10.1227/NEU.0b013e3181f556ab; Bolstad B, 2005, BIOINFORMATICS COMPU; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Canoll PD, 1996, NEURON, V17, P229, DOI 10.1016/S0896-6273(00)80155-5; Canoll P, 2008, ACTA NEUROPATHOL, V116, P465, DOI 10.1007/s00401-008-0432-9; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; COOPER LAD, 2009, PLOS ONE, V5; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Gensert JM, 2001, J NEUROBIOL, V48, P75, DOI 10.1002/neu.1043.abs; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; HAMBARDZUMYAN NMA, 2009, ONCOLOGY, V2, P89; HART IK, 1989, DEVELOPMENT, V105, P595; Hede SM, 2009, GLIA, V57, P1143, DOI 10.1002/glia.20837; Hesselager G, 2003, CANCER RES, V63, P4305; Horner PJ, 2000, J NEUROSCI, V20, P2218; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; JEAN WRI, JEFF GENTRY GERMA BA; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kappadakunnel M, 2010, J NEURO-ONCOL, V96, P359, DOI 10.1007/s11060-009-9983-4; KATAGIRI F, 2001, PATTERN DISCOVERY EX; Kesari S, 2006, NEURON, V51, P151, DOI 10.1016/j.neuron.2006.07.001; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kooperberg C, 2005, STAT MED, V24, P2281, DOI 10.1002/sim.2109; Leek JT, 2006, BIOINFORMATICS, V22, P1412, DOI 10.1093/bioinformatics/btl149; Levison SW, 1999, J NEUROSCI RES, V57, P435, DOI 10.1002/(SICI)1097-4547(19990815)57:4<435::AID-JNR3>3.0.CO;2-L; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McEntyre J, 2002, NCBI HDB; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-45; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pei YX, 2010, CANCER CELL, V18, P546, DOI 10.1016/j.ccr.2010.11.031; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Rhee W, 2009, GLIA, V57, P510, DOI 10.1002/glia.20780; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; *TEAM R, 2009, R DEV COR TEAM R LAN; Uhrbom L, 1998, CANCER RES, V58, P5275; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wright KD, 2010, CANCER CELL, V17, P419, DOI 10.1016/j.ccr.2010.04.020; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiao A, 2005, CANCER RES, V65, P5172, DOI 10.1158/0008-5472.CAN-04-3902; Xiao A, 2002, CANCER CELL, V1, P157, DOI 10.1016/S1535-6108(02)00029-6; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhu Y, 2009, MOL CELL, V36, P351, DOI 10.1016/j.molcel.2009.10.026	102	98	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20041	10.1371/journal.pone.0020041	http://dx.doi.org/10.1371/journal.pone.0020041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625383	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200027
J	Luh, C; Gierth, K; Timaru-Kast, R; Engelhard, K; Werner, C; Thal, SC				Luh, Clara; Gierth, Katharina; Timaru-Kast, Ralph; Engelhard, Kristin; Werner, Christian; Thal, Serge C.			Influence of a Brief Episode of Anesthesia during the Induction of Experimental Brain Trauma on Secondary Brain Damage and Inflammation	PLOS ONE			English	Article							INCOMPLETE CEREBRAL-ISCHEMIA; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD TRAUMA; INTRACRANIAL-PRESSURE; ARTERIAL-HYPERTENSION; RATS; INJURY; ISOFLURANE; MICE; SEVOFLURANE	It is unclear whether a single, brief, 15-minute episode of background anesthesia already modulates delayed secondary processes after experimental brain injury. Therefore, this study was designed to characterize three anesthesia protocols for their effect on molecular and histological study endpoints. Mice were randomly separated into groups that received sevoflurane (sevo), isoflurane (iso) or an intraperitoneal anesthetic combination (midazolam, fentanyl and medetomidine; comb) prior to traumatic brain injury (controlled cortical impact, CCI; 8 m/s, 1 mm impact depth, 3 mm diameter). Twenty-four hours after insult, histological brain damage, neurological function (via neurological severity score), cerebral inflammation (via real-time RT-PCR for IL6, COX-2, iNOS) and microglia (via immunohistochemical staining for Iba1) were determined. Fifteen minutes after CCI, the brain contusion volume did not differ between the anesthetic regimens (sevo = 17.9 +/- 5.5 mm 3; iso = 20.5 +/- 3.7 mm(3); comb = 19.5 +/- 4.6 mm(3)). Within 24 hours after injury, lesion size increased in all groups (sevo = 45.3 +/- 9.0 mm(3); iso = 31.5 +/- 4.0 mm(3); comb = 44.2 +/- 6.2 mm(3)). Sevo and comb anesthesia resulted in a significantly larger contusion compared to iso, which was in line with the significantly better neurological function with iso (sevo = 4.6 +/- 1.3 pts.; iso = 3.9 +/- 0.8 pts.; comb = 5.1 +/- 1.6 pts.). The expression of inflammatory marker genes was not significantly different at 15 minutes and 24 hours after CCI. In contrast, significantly more Iba1-positive cells were present in the pericontusional region after sevo compared to comb anesthesia (sevo = 181 +/- 48/mm(3); iso = 150 +/- 36/mm(3); comb = 113 +/- 40/mm(3)). A brief episode of anesthesia, which is sufficient for surgical preparations of mice for procedures such as delivering traumatic brain injury, already has a significant impact on the extent of secondary brain damage.	[Luh, Clara; Gierth, Katharina; Timaru-Kast, Ralph; Engelhard, Kristin; Werner, Christian; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany; [Luh, Clara] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Luh, C (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Dept Anesthesiol, Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729				Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Engelhard K, 1999, BRIT J ANAESTH, V83, P415, DOI 10.1093/bja/83.3.415; Friedrich DH, 2000, ACTA NEUROCHIR SUPPL, V76, P257; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HATASHITA S, 1986, J NEUROSURG, V64, P643, DOI 10.3171/jns.1986.64.4.0643; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; JANSSEN BJ, 2004, AM J PHYSL HEART CIR; Khosrovani S, 2007, P NATL ACAD SCI USA, V104, P15911, DOI 10.1073/pnas.0702727104; Kongstad L, 2001, J TRAUMA, V51, P490, DOI 10.1097/00005373-200109000-00011; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matchett GA, 2009, NEUROL RES, V31, P128, DOI 10.1179/174313209X393546; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; Solt K, 2006, ANESTH ANALG, V102, P1407, DOI 10.1213/01.ane.0000204252.07406.9f; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; WERNER C, 1995, BRIT J ANAESTH, V75, P756, DOI 10.1093/bja/75.6.756; Yurdakoc A, 2008, ACTA ANAESTH SCAND, V52, P658, DOI 10.1111/j.1399-6576.2008.01635.x; ZORNOW MH, 1992, ANESTH ANALG, V75, P232; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	31	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19948	10.1371/journal.pone.0019948	http://dx.doi.org/10.1371/journal.pone.0019948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625505	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200032
J	Muralidhara, C; Gross, AM; Gutell, RR; Alter, O				Muralidhara, Chaitanya; Gross, Andrew M.; Gutell, Robin R.; Alter, Orly			Tensor Decomposition Reveals Concurrent Evolutionary Convergences and Divergences and Correlations with Structural Motifs in Ribosomal RNA	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; INTEGRATIVE ANALYSIS; DOMAINS ARCHAEA; SEQUENCE; SUBUNIT; DNA; MICROSPORIDIA; CONSTRAINTS; BACTERIA	Evolutionary relationships among organisms are commonly described by using a hierarchy derived from comparisons of ribosomal RNA (rRNA) sequences. We propose that even on the level of a single rRNA molecule, an organism's evolution is composed of multiple pathways due to concurrent forces that act independently upon different rRNA degrees of freedom. Relationships among organisms are then compositions of coexisting pathway-dependent similarities and dissimilarities, which cannot be described by a single hierarchy. We computationally test this hypothesis in comparative analyses of 16S and 23S rRNA sequence alignments by using a tensor decomposition, i.e., a framework for modeling composite data. Each alignment is encoded in a cuboid, i.e., a third-order tensor, where nucleotides, positions and organisms, each represent a degree of freedom. A tensor mode-1 higher-order singular value decomposition (HOSVD) is formulated such that it separates each cuboid into combinations of patterns of nucleotide frequency variation across organisms and positions, i.e., "eigenpositions" and corresponding nucleotide-specific segments of "eigenorganisms," respectively, independent of a-priori knowledge of the taxonomic groups or rRNA structures. We find, in support of our hypothesis that, first, the significant eigenpositions reveal multiple similarities and dissimilarities among the taxonomic groups. Second, the corresponding eigenorganisms identify insertions or deletions of nucleotides exclusively conserved within the corresponding groups, that map out entire substructures and are enriched in adenosines, unpaired in the rRNA secondary structure, that participate in tertiary structure interactions. This demonstrates that structural motifs involved in rRNA folding and function are evolutionary degrees of freedom. Third, two previously unknown coexisting subgenic relationships between Microsporidia and Archaea are revealed in both the 16S and 23S rRNA alignments, a convergence and a divergence, conferred by insertions and deletions of these motifs, which cannot be described by a single hierarchy. This shows that mode-1 HOSVD modeling of rRNA alignments might be used to computationally predict evolutionary mechanisms.	[Muralidhara, Chaitanya; Gutell, Robin R.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Gross, Andrew M.] Univ Calif San Diego, Bioinformat & Syst Biol Program, San Diego, CA 92103 USA; [Gutell, Robin R.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Gutell, Robin R.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Alter, Orly] Univ Utah, Sci Comp & Imaging SCI Inst, Salt Lake City, UT USA; [Alter, Orly] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Alter, Orly] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	University of Texas System; University of Texas Austin; University of California System; University of California San Diego; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Muralidhara, C (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	orly@sci.utah.edu		Gutell, Robin/0000-0002-5919-0801; Alter, Orly/0000-0002-0418-1078	National Institute of General Medical Sciences [GM-067317]; National Human Genome Research Institute [HG-004302]; National Science Foundation [DMS-0847173]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067317] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0847173] Funding Source: National Science Foundation	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by National Institute of General Medical Sciences R01 Grant GM-067317 (to RRG) and National Human Genome Research Institute R01 Grant HG-004302 and National Science Foundation CAREER Award DMS-0847173 (to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter O, 2004, P NATL ACAD SCI USA, V101, P16577, DOI 10.1073/pnas.0406767101; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Alter O, 2006, P NATL ACAD SCI USA, V103, P16063, DOI 10.1073/pnas.0607650103; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BOCK WJ, 1959, EVOLUTION, V13, P194, DOI 10.2307/2405873; Cadima J, 2009, PAK J STAT, V25, P473; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; Golub GH., 2013, MATRIX COMPUTATIONS; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1992, NUCLEIC ACIDS RES, V20, P5785, DOI 10.1093/nar/20.21.5785; Gutell RR, 2000, J MOL BIOL, V304, P335, DOI 10.1006/jmbi.2000.4172; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Isaksson J, 2004, BIOCHEMISTRY-US, V43, P15996, DOI 10.1021/bi048221v; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Omberg L, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.70; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; Sagara JI, 1998, NUCLEIC ACIDS RES, V26, P1974, DOI 10.1093/nar/26.8.1974; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; VOSSBRINCK CR, 1987, NATURE, V326, P411, DOI 10.1038/326411a0; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WINKER S, 1991, SYST APPL MICROBIOL, V14, P305, DOI 10.1016/S0723-2020(11)80303-6; Woese C.R., 1967, GENETIC CODE MOL BAS; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e18768	10.1371/journal.pone.0018768	http://dx.doi.org/10.1371/journal.pone.0018768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21625625	Green Submitted, Green Published, gold			2022-12-25	WOS:000290024700024
J	Zhang, S; Wang, X; Osunkoya, AO; Iqbal, S; Wang, Y; Chen, Z; Muller, S; Chen, Z; Josson, S; Coleman, IM; Nelson, PS; Wang, YA; Wang, R; Shin, DM; Marshall, FF; Kucuk, O; Chung, LWK; Zhau, HE; Wu, D				Zhang, S.; Wang, X.; Osunkoya, A. O.; Iqbal, S.; Wang, Y.; Chen, Z.; Mueller, S.; Chen, Z.; Josson, S.; Coleman, I. M.; Nelson, P. S.; Wang, Y. A.; Wang, R.; Shin, D. M.; Marshall, F. F.; Kucuk, O.; Chung, L. W. K.; Zhau, H. E.; Wu, D.			EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis	ONCOGENE			English	Article						EPLIN; epithelial-mesenchymal transition; prostate cancer; lymph node metastasis; cytoskeleton	GENE-EXPRESSION; PROTEIN LOST; PROTEOMIC IDENTIFICATION; ACTIN-CYTOSKELETON; GROWTH; INVASION; BONE; PROGRESSION; NEOPLASM; REVEALS	Epithelial-mesenchymal transition (EMT) is a crucial mechanism for the acquisition of migratory and invasive capabilities by epithelial cancer cells. By conducting quantitative proteomics in experimental models of human prostate cancer (PCa) metastasis, we observed strikingly decreased expression of EPLIN (epithelial protein lost in neoplasm; or LIM domain and actin binding 1, LIMA-1) upon EMT. Biochemical and functional analyses demonstrated that EPLIN is a negative regulator of EMT and invasiveness in PCa cells. EPLIN depletion resulted in the disassembly of adherens junctions, structurally distinct actin remodeling and activation of beta-catenin signaling. Microarray expression analysis identified a subset of putative EPLIN target genes associated with EMT, invasion and metastasis. By immunohistochemistry, EPLIN downregulation was also demonstrated in lymph node metastases of human solid tumors including PCa, breast cancer, colorectal cancer and squamous cell carcinoma of the head and neck. This study reveals a novel molecular mechanism for converting cancer cells into a highly invasive and malignant form, and has important implications in prognosis and treating metastasis at early stages. Oncogene (2011) 30, 4941-4952; doi:10.1038/onc.2011.199; published online 30 May 2011	[Zhang, S.; Osunkoya, A. O.; Iqbal, S.; Wang, Y.; Kucuk, O.; Wu, D.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; [Zhang, S.; Osunkoya, A. O.; Iqbal, S.; Wang, Y.; Marshall, F. F.; Wu, D.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Wang, X.; Chen, Z.; Shin, D. M.; Kucuk, O.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Osunkoya, A. O.; Mueller, S.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Osunkoya, A. O.; Mueller, S.] Emory Univ, Sch Med, Lab Med, Atlanta, GA 30322 USA; [Chen, Z.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Josson, S.; Wang, R.; Chung, L. W. K.; Zhau, H. E.] Cedars Sinai Med Ctr, Dept Med, Uro Oncol Res Program, Los Angeles, CA 90048 USA; [Coleman, I. M.; Nelson, P. S.] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98195 USA; [Wang, Y. A.] Ocean NanoTech LLC, Springdale, AR USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Rollins School Public Health; Cedars Sinai Medical Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Wu, D (corresponding author), Emory Univ, Sch Med, Dept Urol, 1365 Clifton Rd,NE,Bldg B,B4108, Atlanta, GA 30322 USA.	Haiyen.Zhau@cshs.org; dwu2@emory.edu	Shin, Dong Moon/G-9649-2013; Ray, Dana M/C-3470-2013	Shin, Dong Moon/0000-0002-8245-4174; , Shareen/0000-0002-9489-7781	Department of Defense [PC060566, PC060866]; American Cancer Society [RSG-10-140-01]; Georgia Cancer Coalition Cancer Research Award; Kennedy Seed Grant; Emory University Research Committee; Winship MPB Seed Grant; National Cancer Institute [P01 CA98912, R01 CA122602, 1R43CA141870]; Georgia Cancer Coalition Distinguished Scholar Grant; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA122602, R43CA141870] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Georgia Cancer Coalition Cancer Research Award; Kennedy Seed Grant; Emory University Research Committee; Winship MPB Seed Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Scholar Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Jin-Tang Dong for critical reading of the manuscript, and Dr Anthea Hammond for editorial assistance. This work was supported by the Department of Defense PC060566, American Cancer Society RSG-10-140-01, Georgia Cancer Coalition Cancer Research Award, Kennedy Seed Grant, Emory University Research Committee Award, Winship MPB Seed Grant (DW), National Cancer Institute grants P01 CA98912, R01 CA122602 and Department of Defense PC060866 (LWKC), Georgia Cancer Coalition Distinguished Scholar Grant (OK) and National Cancer Institute grant 1R43CA141870 (YAW).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Arnold RS, 2009, PROSTATE, V69, P1, DOI 10.1002/pros.20854; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen SX, 2000, GENE, V248, P69, DOI 10.1016/S0378-1119(00)00144-X; Chircop M, 2009, CELL CYCLE, V8, P757, DOI 10.4161/cc.8.5.7878; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Larriba MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010221; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Katiyar Santosh K., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P17; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Khwaja FW, 2006, ONCOGENE, V25, P7650, DOI 10.1038/sj.onc.1209969; Khwaja FW, 2007, J PROTEOME RES, V6, P559, DOI 10.1021/pr060240z; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Koreckij TD, 2009, NEOPLASIA, V11, P1216, DOI 10.1593/neo.09960; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Lang SH, 2009, J PATHOL, V217, P299, DOI 10.1002/path.2478; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liu J, 2010, PROSTATE, V70, P1768, DOI 10.1002/pros.21213; Machesky LM, 2009, CANCER CELL, V16, P5, DOI 10.1016/j.ccr.2009.06.009; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; O'Connell PA, 2010, BLOOD, V116, P1136, DOI 10.1182/blood-2010-01-264754; Percipalle P, 2009, RNA BIOL, V6, P171, DOI 10.4161/rna.6.2.8195; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sakko AJ, 2003, CANCER RES, V63, P4786; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Song YH, 2002, MOL BIOL CELL, V13, P1408, DOI 10.1091/mbc.01-08-0414; Sung SY, 2008, CANCER RES, V68, P9996, DOI 10.1158/0008-5472.CAN-08-2492; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiolloy S, 2011, SEMIN CANCER BIOL, V21, P89, DOI 10.1016/j.semcancer.2010.12.008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wei JC, 2008, ANTICANCER RES, V28, P327; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Wong SY, 2007, P NATL ACAD SCI USA, V104, P12784, DOI 10.1073/pnas.0705499104; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1	53	54	56	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	50					4941	4952		10.1038/onc.2011.199	http://dx.doi.org/10.1038/onc.2011.199			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YJ	21625216	Green Accepted			2022-12-25	WOS:000298346500003
J	Kroken, AR; Karalewitz, APA; Fu, ZJ; Kim, JJP; Barbieri, JT				Kroken, Abby R.; Karalewitz, Andrew P. -A.; Fu, Zhuji; Kim, Jung-Ja P.; Barbieri, Joseph T.			Novel Ganglioside-mediated Entry of Botulinum Neurotoxin Serotype D into Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE; CLOSTRIDIAL-NEUROTOXINS; COMPLEX GANGLIOSIDES; STRUCTURAL-ANALYSIS; BINDING SITES; HEAVY-CHAIN; RECEPTOR; TOXIN; IDENTIFICATION; MEMBRANE	Botulinum Neurotoxins (BoNTs) are organized into seven serotypes, A-G. Although several BoNT serotypes enter neurons through synaptic vesicle cycling utilizing dual receptors (a ganglioside and a synaptic vesicle-associated protein), the entry pathway of BoNT/D is less well understood. Although BoNT/D entry is ganglioside-dependent, alignment and structural studies show that BoNT/D lacks key residues within a conserved ganglioside binding pocket that are present in BoNT serotypes A, B, E, F, and G, which indicate that BoNT/D-ganglioside interactions may be unique. In this study BoNT/D is shown to have a unique association with ganglioside relative to the other BoNT serotypes, utilizing a ganglioside binding loop (GBL, residues Tyr-1235-Ala-1245) within the receptor binding domain of BoNT/D (HCR/D) via b-series gangliosides, including GT1b, GD1b, and GD2. HCR/D bound gangliosides and entered neurons dependent upon the aromatic ring of Phe-1240 within the GBL. This is the first BoNT-ganglioside interaction that is mediated by a phenylalanine. In contrast, Trp-1238, located near the N terminus of the ganglioside binding loop, was mostly solvent-inaccessible and appeared to contribute to maintaining the loop structure. BoNT/D entry and intoxication were enhanced by membrane depolarization via synaptic vesicle cycling, where HCR/D colocalized with synaptophysin, a synaptic vesicle marker, but immunoprecipitation experiments did not detect direct association with synaptic vesicle protein 2. Thus, BoNT/D utilizes unique associations with gangliosides and synaptic vesicles to enter neurons, which may facilitate new neurotoxin therapies.	[Kroken, Abby R.; Karalewitz, Andrew P. -A.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Fu, Zhuji; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Barbieri, JT (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu		Kroken, Abby/0000-0003-1807-1125	National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases; NIAID; National Institutes of Health [GM62116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research Program and the NIAID (to J. T. B. and J. J. K.).; We acknowledge the assistance of Amanda Przedpelski for HCR production. Glycan microarray data were obtained through the Protein-Glycan Interaction Core (Core H) of the Consortium for Functional Glycomics supported by National Institutes of Health Grant GM62116.	Ando S, 1998, ANN NY ACAD SCI, V845, P232, DOI 10.1111/j.1749-6632.1998.tb09676.x; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2008, INFECT IMMUN, V76, P1314, DOI 10.1128/IAI.01025-07; Baldwin MR, 2007, BIOCHEMISTRY-US, V46, P3200, DOI 10.1021/bi602396x; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Bonanomi D, 2006, PROG NEUROBIOL, V80, P177, DOI 10.1016/j.pneurobio.2006.09.002; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Coffield JA, 1997, J PHARMACOL EXP THER, V280, P1489; Cole AA, 2010, BIOCHEM J, V427, P535, DOI 10.1042/BJ20091344; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dong M, 2007, J CELL BIOL, V179, P1511, DOI 10.1083/jcb.200707184; Dong M, 2008, MOL BIOL CELL, V19, P5226, DOI 10.1091/mbc.E08-07-0765; Eleopra R, 1997, NEUROSCI LETT, V224, P91, DOI 10.1016/S0304-3940(97)13448-6; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Karalewitz APA, 2010, BIOCHEMISTRY-US, V49, P8117, DOI 10.1021/bi100865f; KELLER JE, 2004, NAT STRUCT BIOL, V7, P693; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lazzell DR, 2004, J BIOL CHEM, V279, P52124, DOI 10.1074/jbc.M407502200; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MCPHERSON A, 1999, CRYSTALLIZATION BIOL, P188; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; OCHANDA JO, 1986, J BIOCHEM-TOKYO, V100, P27, DOI 10.1093/oxfordjournals.jbchem.a121702; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; ROUSSEL A, 1999, TURBO FRODO VERSION; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2009, J NEUROCHEM, V110, P1942, DOI 10.1111/j.1471-4159.2009.06298.x; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Strotmeier J, 2010, BIOCHEM J, V431, P207, DOI 10.1042/BJ20101042; Sugiura Y, 2005, NEUROSCIENCE, V135, P1167, DOI 10.1016/j.neuroscience.2005.07.035; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tsukamoto K, 2005, J BIOL CHEM, V280, P35164, DOI 10.1074/jbc.M507596200; Tsukamoto K, 2008, MICROB PATHOGENESIS, V44, P484, DOI 10.1016/j.micpath.2007.12.003; Woodward LA, 2003, INFECT IMMUN, V71, P2941, DOI 10.1128/IAI.71.5.2941-2944.2003; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207; Yoshinaka K, 2004, NEUROSCI LETT, V363, P168, DOI 10.1016/j.neulet.2004.04.002; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang YF, 2010, BIOCHEM BIOPH RES CO, V401, P498, DOI 10.1016/j.bbrc.2010.09.063	55	30	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26828	26837		10.1074/jbc.M111.254086	http://dx.doi.org/10.1074/jbc.M111.254086			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632541	Green Published, hybrid			2022-12-25	WOS:000293078200058
J	Hennessy, EJ; Sheedy, FJ; Santamaria, D; Barbacid, M; O'Neill, LAJ				Hennessy, Elizabeth J.; Sheedy, Frederick J.; Santamaria, David; Barbacid, Mariano; O'Neill, Luke A. J.			Toll-like Receptor-4 (TLR4) Down-regulates MicroRNA-107, Increasing Macrophage Adhesion via Cyclin-dependent Kinase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; NUCLEAR HORMONE-RECEPTORS; BREAST-CANCER CELLS; NF-KAPPA-B; IMMUNE-RESPONSES; GENE-EXPRESSION; HUMAN MONOCYTES; IN-VIVO; ACTIVATION; ENDOTOXIN	Toll-like receptors (TLRs) modulate the expression of multiple microRNAs (miRNAs). Here, we report the down-regulation of miR-107 by TLR4 in multiple cell types. The miR-107 sequence occurs in an intron within the sequence encoding the gene for pantothenate kinase 1 alpha (PanK1 alpha), which is regulated by the transcription factor peroxisome proliferator-activating receptor alpha (PPAR-alpha). PanK1 alpha is also decreased in response to lipopolysaccharide (LPS). The effect on both miR-107 and PanK1 alpha is consistent with a decrease in PPAR-alpha expression. We have found that the putative miR-107 target cyclin-dependent kinase 6 (CDK6) expression is increased by TLR4 as a result of the decrease in miR-107. This effect is required for increased adhesion of macrophages in response to LPS, and CDK6-deficient mice are resistant to the lethal effect of LPS. We have therefore identified a mechanism for LPS signaling which involves a decrease in miR-107 leading to an increase in CDK6.	[Hennessy, Elizabeth J.; Sheedy, Frederick J.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Santamaria, David; Barbacid, Mariano] Ctr Nacl Invest Oncol, Mol Oncol Programme, E-28029 Madrid, Spain	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Santamaria, David/D-3930-2011; Hennessy, Elizabeth/AAJ-4800-2021	Santamaria, David/0000-0002-4711-3569; Hennessy, Elizabeth/0000-0002-1231-5777; Sheedy, Frederick/0000-0002-4722-3135; Sheedy, Frederick/0000-0003-2645-8493; O'Neill, Luke/0000-0002-4333-2748	Science Foundation Ireland; Health Research Board Ireland [PhD/20007/9]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland	This work was supported by Science Foundation Ireland and the Health Research Board Ireland Grant PhD/20007/9.	Becker J, 2008, PULM PHARMACOL THER, V21, P324, DOI 10.1016/j.pupt.2007.08.001; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bradfield PF, 2008, INT IMMUNOL, V20, P247, DOI 10.1093/intimm/dxm136; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gantier MP, 2007, IMMUNOL CELL BIOL, V85, P458, DOI 10.1038/sj.icb.7100091; GOTO M, 1994, METABOLISM, V43, P1248, DOI 10.1016/0026-0495(94)90218-6; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; LANG CH, 1993, METABOLISM, V42, P1351, DOI 10.1016/0026-0495(93)90137-D; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Marx N, 2001, CIRCULATION, V103, P213; Mccoy CE, 2008, J BIOL CHEM, V283, P14277, DOI 10.1074/jbc.M709731200; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V275, pE64, DOI 10.1152/ajpendo.1998.275.1.E64; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pauley KM, 2008, ANN NY ACAD SCI, V1143, P226, DOI 10.1196/annals.1443.009; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Slomiany P, 2006, J CELL BIOCHEM, V99, P635, DOI 10.1002/jcb.20966; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	42	50	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25531	25539		10.1074/jbc.M111.256206	http://dx.doi.org/10.1074/jbc.M111.256206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628465	Green Published, hybrid			2022-12-25	WOS:000293073000015
J	Jacobsson, JA; Almen, MS; Benedict, C; Hedberg, LA; Michaelsson, K; Brooks, S; Kullberg, J; Axelsson, T; Johansson, L; Ahlstrom, H; Fredriksson, R; Lind, L; Schioth, HB				Jacobsson, Josefin A.; Almen, Markus Sallman; Benedict, Christian; Hedberg, Lilia A.; Michaelsson, Karl; Brooks, Samantha; Kullberg, Joel; Axelsson, Tomas; Johansson, Lars; Ahlstrom, Hakan; Fredriksson, Robert; Lind, Lars; Schioth, Helgi B.			Detailed Analysis of Variants in FTO in Association with Body Composition in a Cohort of 70-Year-Olds Suggests a Weakened Effect among Elderly	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MASS INDEX; FAT MASS; PHYSICAL-ACTIVITY; GENETIC-VARIATION; ADIPOSE-TISSUE; ENERGY-INTAKE; SAMPLE-SIZE; OBESITY; CHILDREN	Background: The rs9939609 single-nucleotide polymorphism (SNP) in the fat mass and obesity (FTO) gene has previously been associated with higher BMI levels in children and young adults. In contrast, this association was not found in elderly men. BMI is a measure of overweight in relation to the individuals' height, but offers no insight into the regional body fat composition or distribution. Objective: To examine whether the FTO gene is associated with overweight and body composition-related phenotypes rather than BMI, we measured waist circumference, total fat mass, trunk fat mass, leg fat mass, visceral and subcutaneous adipose tissue, and daily energy intake in 985 humans (493 women) at the age of 70 years. In total, 733 SNPs located in the FTO gene were genotyped in order to examine whether rs9939609 alone or the other SNPs, or their combinations, are linked to obesity-related measures in elderly humans. Design: Cross-sectional analysis of the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) cohort. Results: Neither a single SNP, such as rs9939609, nor a SNP combination was significantly linked to overweight, body composition-related measures, or daily energy intake in elderly humans. Of note, these observations hold both among men and women. Conclusions: Due to the diversity of measurements included in the study, our findings strengthen the view that the effect of FTO on body composition appears to be less profound in later life compared to younger ages and that this is seemingly independent of gender.	[Jacobsson, Josefin A.; Almen, Markus Sallman; Benedict, Christian; Brooks, Samantha; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Hedberg, Lilia A.] Royal Inst Technol KTH, Sch Biotechnol, Sci Life Lab, Solna, Sweden; [Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Axelsson, Tomas; Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Kullberg, Joel; Johansson, Lars; Ahlstrom, Hakan] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden; [Johansson, Lars] AstraZeneca R&D, Molndal, Sweden	Uppsala University; Royal Institute of Technology; Uppsala University; Uppsala University; Uppsala University; AstraZeneca	Jacobsson, JA (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	helgi.schioth@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019; Benedict, Christian/K-2190-2017; Brooks, Samantha/AAJ-2159-2020; Michaelsson, Karl/AAM-9094-2021; Johansson, Lars/AAF-4845-2019; Schioth, Helgi/AAQ-7239-2020; Kullberg, Joel/ABE-3997-2021	Fredriksson, Robert/0000-0002-2810-3226; Benedict, Christian/0000-0002-8911-4068; Brooks, Samantha/0000-0002-9146-6257; Michaelsson, Karl/0000-0003-2815-1217; Sallman Almen, Markus/0000-0001-9591-9228	Swedish Research Council; Novo Nordisk; Tore Nilsons Foundation; Ahlens Foundation; Goran Gustafsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk(Novo Nordisk); Tore Nilsons Foundation; Ahlens Foundation; Goran Gustafsson Foundation	The study was supported by the Swedish Research Council, Novo Nordisk, Tore Nilsons Foundation and Ahlens Foundation. RF was supported by the Goran Gustafsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2010, DIABETES, V59, P1549, DOI 10.2337/db09-1252; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; BARLETT HL, 1991, AM J CLIN NUTR, V53, P1112, DOI 10.1093/ajcn/53.5.1112; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker W., 1998, Scandinavian Journal of Nutrition/Naringsforskning, V42, P145; BECKER W, 1994, METHODS ANAL; Belfer I, 2004, J HUM GENET, V49, P232, DOI 10.1007/s10038-004-0140-9; Bollepalli S, 2010, OBESITY, V18, P1959, DOI 10.1038/oby.2010.82; Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5; Clasey JL, 1999, J APPL PHYSIOL, V86, P1728, DOI 10.1152/jappl.1999.86.5.1728; Coady SA, 2002, OBES RES, V10, P675, DOI 10.1038/oby.2002.91; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Hennig BJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-21; HIND K, 2010, EUR J CLIN NUTR; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hubacek JA, 2011, PHYSIOL RES, V60, P175, DOI 10.33549/physiolres.932066; Iacobellis G., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P345, DOI 10.2174/1568006054553408; JACOBSSON JA, 2008, INT J OBES LOND; Jacobsson JA, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-131; Kullberg J, 2006, J MAGN RESON IMAGING, V24, P394, DOI 10.1002/jmri.20644; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Ouyang C, 2006, PHARMACOGENET GENOM, V16, P667, DOI 10.1097/01.fpc.0000220569.82842.9b; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Schaid DJ, 2006, ANN HUM GENET, V70, P116, DOI 10.1111/j.1529-8817.2005.00215.x; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; WARDLE J, 2008, INT J OBES LOND; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Zhang J, 2005, HUM HERED, V59, P144, DOI 10.1159/000085938; Zimmermann E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004428	51	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20158	10.1371/journal.pone.0020158	http://dx.doi.org/10.1371/journal.pone.0020158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637715	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500035
J	Joseph, J; Seervi, M; Sobhan, PK; Retnabai, ST				Joseph, Jeena; Seervi, Mahendra; Sobhan, Praveen K.; Retnabai, Santhoshkumar Thankayyan			High Throughput Ratio Imaging to Profile Caspase Activity: Potential Application in Multiparameter High Content Apoptosis Analysis and Drug Screening	PLOS ONE			English	Article							CYTOCHROME-C; CELL-DEATH; FRET; VARIABILITY; ACTIVATION; GOSSYPOL; RELEASE; ORIGINS; ASSAY	Recent advancement in the area of green fluorescent protein techniques coupled with microscopic imaging has significantly contributed in defining and dissecting subcellular changes of apoptosis with high spatio-temporal resolution. Although single cell based studies using EGFP and associated techniques have provided valuable information of initiation and hierarchical changes of apoptosis, they are yet to be exploited for multiparameter cell based real time analysis for possible drug screening or pathway defining in a high throughput manner. Here we have developed multiple cancer cell lines expressing FRET sensors for active caspases and adapted them for high throughput live cell ratio imaging, enabling high content image based multiparameter analysis. Sensitivity of the system to detect live cell caspase activation was substantiated by confocal acceptor bleaching as well as wide field FRET imaging. Multiple caspase-specific activities of DEVDase, IETDase and LEHDase were analysed simultaneously with other decisive events of cell death. Through simultaneous analysis of caspase activation by FRET ratio change coupled with detection of mitochondrial membrane potential loss or superoxide generation, we identified several antitumor agents that induced caspase activation with or without membrane potential loss or superoxide generation. Also, cells that escaped the initial drug-induced caspase activation could be easily followed up for defining long term fate. Employing such a revisit imaging strategy of the same area, we have tracked the caspase surviving fractions with multiple drugs and its subsequent response to retreatment, revealing drug-dependent diverging fate of surviving cells. This thereby indicates towards a complex control of drug induced tumor resistance. The technique described here has wider application in both screening of compound libraries as well as in defining apoptotic pathways by linking multiple signaling to identify non-classical apoptosis inducing agents, the greatest advantage being that the high content information obtained are from individual cells rather than being population based.	[Joseph, Jeena; Seervi, Mahendra; Sobhan, Praveen K.; Retnabai, Santhoshkumar Thankayyan] Rajiv Gandhi Ctr Biotechnol, Integrated Canc Res Program, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Joseph, J (corresponding author), Rajiv Gandhi Ctr Biotechnol, Integrated Canc Res Program, Thycaud PO, Thiruvananthapuram, Kerala, India.	trsanthosh@rgcb.res.in	Seervi, Mahendra/K-8812-2019	Seervi, Mahendra/0000-0002-0266-2062	Dept. of Biotechnology, Govt. of India	Dept. of Biotechnology, Govt. of India	This work was supported by grants from Innovative Young Biotechnologist Award, Dept. of Biotechnology, Govt. of India to STR, CSIR SRF, Govt. of India to JJ, UGC SRF, Govt. of India to MS and ICMR SRF, and Govt. of India to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angres B, 2009, CYTOM PART A, V75A, P420, DOI 10.1002/cyto.a.20698; BATES SE, 1995, J CANCER RES CLIN, V121, P495, DOI 10.1007/BF01197759; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; DEPEYSTER A, 1984, BIOCHEM BIOPH RES CO, V118, P573, DOI 10.1016/0006-291X(84)91341-X; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GRANKVIST K, 1989, INT J BIOCHEM, V21, P853, DOI 10.1016/0020-711X(89)90283-8; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; He LS, 2004, AM J PATHOL, V164, P1901, DOI 10.1016/S0002-9440(10)63751-0; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Huitema C, 2010, J BIOMOL SCREEN, V15, P224, DOI 10.1177/1087057109357790; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jones J, 2000, J BIOMOL SCREEN, V5, P307, DOI 10.1177/108705710000500502; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tian H, 2007, BRIT J PHARMACOL, V150, P321, DOI 10.1038/sj.bjp.0706988; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	36	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20114	10.1371/journal.pone.0020114	http://dx.doi.org/10.1371/journal.pone.0020114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637712	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500031
J	Pittman, SJ; Brown, KA				Pittman, Simon J.; Brown, Kerry A.			Multi-Scale Approach for Predicting Fish Species Distributions across Coral Reef Seascapes	PLOS ONE			English	Article							REGION-WIDE DECLINES; GREAT-BARRIER-REEF; HABITAT COMPLEXITY; MARINE; COMMUNITIES; RICHNESS; MANAGEMENT; AREAS; ASSEMBLAGES; DIVERSITY	Two of the major limitations to effective management of coral reef ecosystems are a lack of information on the spatial distribution of marine species and a paucity of data on the interacting environmental variables that drive distributional patterns. Advances in marine remote sensing, together with the novel integration of landscape ecology and advanced niche modelling techniques provide an unprecedented opportunity to reliably model and map marine species distributions across many kilometres of coral reef ecosystems. We developed a multi-scale approach using three-dimensional seafloor morphology and across-shelf location to predict spatial distributions for five common Caribbean fish species. Seascape topography was quantified from high resolution bathymetry at five spatial scales (5-300 m radii) surrounding fish survey sites. Model performance and map accuracy was assessed for two high performing machine-learning algorithms: Boosted Regression Trees (BRT) and Maximum Entropy Species Distribution Modelling (MaxEnt). The three most important predictors were geographical location across the shelf, followed by a measure of topographic complexity. Predictor contribution differed among species, yet rarely changed across spatial scales. BRT provided 'outstanding' model predictions (AUC = > 0.9) for three of five fish species. MaxEnt provided 'outstanding' model predictions for two of five species, with the remaining three models considered 'excellent' (AUC = 0.8-0.9). In contrast, MaxEnt spatial predictions were markedly more accurate (92% map accuracy) than BRT (68% map accuracy). We demonstrate that reliable spatial predictions for a range of key fish species can be achieved by modelling the interaction between the geographical location across the shelf and the topographic heterogeneity of seafloor structure. This multi-scale, analytic approach is an important new cost-effective tool to accurately delineate essential fish habitat and support conservation prioritization in marine protected area design, zoning in marine spatial planning, and ecosystem-based fisheries management.	[Pittman, Simon J.] NOAA, Biogeog Branch, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA; [Pittman, Simon J.] Univ Virgin Isl, Ctr Marine Sci, St Thomas, VI USA; [Brown, Kerry A.] Kingston Univ London, Sch Geog Geol & Environm, Kingston upon Thames, Surrey, England	National Oceanic Atmospheric Admin (NOAA) - USA; University of the Virgin Islands; Kingston University	Pittman, SJ (corresponding author), NOAA, Biogeog Branch, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA.	simon.pittman@noaa.gov	Brown, Kerry/U-5082-2019	BROWN, KERRY/0000-0002-6342-8966; Pittman, Simon/0000-0002-4113-6970	National Oceanic and Atmospheric Administration	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	The field monitoring program was funded by National Oceanic and Atmospheric Administration Coral Reef Conservation Program (http://coralreef.noaa.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2010, R LANG ENV STAT COMP; BOOTH DJ, 1994, CORAL REEFS, V13, P81, DOI 10.1007/BF00300765; Brock JC, 2009, J COASTAL RES, V25, P1, DOI [10.2112/SI53-001.1, 10.2112/S153-001.1]; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Cheal AJ, 2008, MAR ECOL PROG SER, V372, P211, DOI 10.3354/meps07708; Christensen John D., 2003, Gulf and Caribbean Research, V14, P9; Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015; Douvere F, 2007, MAR POLICY, V31, P582, DOI 10.1016/j.marpol.2007.02.001; DUBIN RE, 1982, B MAR SCI, V32, P572; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Geselbracht L, 2009, AQUAT CONSERV, V19, P408, DOI 10.1002/aqc.992; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Klein CJ, 2009, BIOL CONSERV, V142, P1282, DOI 10.1016/j.biocon.2009.01.035; Knudby A, 2010, REMOTE SENS ENVIRON, V114, P1230, DOI 10.1016/j.rse.2010.01.007; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Lindeman Kenyon C., 1998, Proceedings of the Gulf and Caribbean Fisheries Institute, V50, P385; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; Mellin C, 2008, ECOL MODEL, V218, P182, DOI 10.1016/j.ecolmodel.2008.07.021; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Pittman SJ, 2007, MAR ECOL PROG SER, V348, P273, DOI 10.3354/meps07052; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Valiela I, 2001, SCI MAR, V65, P215, DOI 10.3989/scimar.2001.65s2215; Wedding LM, 2008, REMOTE SENS ENVIRON, V112, P4159, DOI 10.1016/j.rse.2008.01.025; WILLIAMS AH, 1978, J EXP MAR BIOL ECOL, V34, P197, DOI 10.1016/S0022-0981(78)80002-1; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239	51	167	169	0	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20583	10.1371/journal.pone.0020583	http://dx.doi.org/10.1371/journal.pone.0020583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637787	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000291052200079
J	Penner, RC; Knudsen, M; Wiuf, C; Andersen, JE				Penner, Robert Clark; Knudsen, Michael; Wiuf, Carsten; Andersen, Jorgen Ellegaard			An Algebro-Topological Description of Protein Domain Structure	PLOS ONE			English	Article							STRUCTURE CLASSIFICATION; SECONDARY STRUCTURE; CATH; SCOP; IDENTIFICATION; ORGANIZATION; DICTIONARY; DIVERGENCE; DATABASE; SPACE	The space of possible protein structures appears vast and continuous, and the relationship between primary, secondary and tertiary structure levels is complex. Protein structure comparison and classification is therefore a difficult but important task since structure is a determinant for molecular interaction and function. We introduce a novel mathematical abstraction based on geometric topology to describe protein domain structure. Using the locations of the backbone atoms and the hydrogen bonds, we build a combinatorial object - a so-called fatgraph. The description is discrete yet gives rise to a 2-dimensional mathematical surface. Thus, each protein domain corresponds to a particular mathematical surface with characteristic topological invariants, such as the genus (number of holes) and the number of boundary components. Both invariants are global fatgraph features reflecting the interconnectivity of the domain by hydrogen bonds. We introduce the notion of robust variables, that is variables that are robust towards minor changes in the structure/fatgraph, and show that the genus and the number of boundary components are robust. Further, we invesigate the distribution of different fatgraph variables and show how only four variables are capable of distinguishing different folds. We use local (secondary) and global (tertiary) fatgraph features to describe domain structures and illustrate that they are useful for classification of domains in CATH. In addition, we combine our method with two other methods thereby using primary, secondary, and tertiary structure information, and show that we can identify a large percentage of new and unclassified structures in CATH.	[Penner, Robert Clark; Andersen, Jorgen Ellegaard] Aarhus Univ, Ctr Topol & Quantizat Moduli Spaces, Dept Math Sci, Aarhus, Denmark; [Penner, Robert Clark] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; [Penner, Robert Clark] Univ So Calif, Dept Phys Astron, Los Angeles, CA USA; [Knudsen, Michael; Wiuf, Carsten] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Wiuf, Carsten] Aarhus Univ, Ctr Membrane Pumps Cells & Dis, Aarhus, Denmark	Aarhus University; University of Southern California; University of Southern California; Aarhus University; Aarhus University	Penner, RC (corresponding author), Aarhus Univ, Ctr Topol & Quantizat Moduli Spaces, Dept Math Sci, Aarhus, Denmark.	wiuf@birc.au.dk	Wiuf, Carsten/H-6320-2011	Wiuf, Carsten/0000-0002-1302-4445; Knudsen, Michael/0000-0002-6294-2517; Andersen, Jorgen Ellegaard/0000-0001-9721-0722	Centre for Theory in Natural Sciences; Danish Research Councils; Humboldt Foundation, Germany	Centre for Theory in Natural Sciences; Danish Research Councils(Det Frie Forskningsrad (DFF)); Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	MK is supported by the Centre for Theory in Natural Sciences; CW is supported by the Danish Research Councils and by the Humboldt Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung Z, 2005, J COMPUT BIOL, V12, P1221, DOI 10.1089/cmb.2005.12.1221; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Choi IG, 2004, P NATL ACAD SCI USA, V101, P3797, DOI 10.1073/pnas.0308656100; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; Cuff A, 2009, STRUCTURE, V17, P1051, DOI 10.1016/j.str.2009.06.015; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; Finkelstein A. V., 2002, PROTEIN PHYS COURSE; Getz G, 2002, PROTEINS, V46, P405, DOI 10.1002/prot.1176; Gramada A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-242; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim YJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-456; Knudsen Michael, 2010, Human Genomics, V4, P207; Koehl P, 1999, P NATL ACAD SCI USA, V96, P12524, DOI 10.1073/pnas.96.22.12524; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; MASSEY WS, 1997, ALGEBRAIC TOPOLOGY I; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Penner RC, 2010, COMMUN PUR APPL MATH, V63, P1249, DOI 10.1002/cpa.20340; PENNER RC, 1988, J DIFFER GEOM, V27, P35; Rackovsky S, 2009, P NATL ACAD SCI USA, V106, P14345, DOI 10.1073/pnas.0903433106; RACKOVSKY S, 2006, PROTEOMICS PROTOCOLS, P861; Rogen P, 2003, P NATL ACAD SCI USA, V100, P119, DOI 10.1073/pnas.2636460100; Rogen P, 2008, GEOMETRIAE DEDICATA, V134, P91, DOI 10.1007/s10711-008-9247-z; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zotenko E, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-12	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19670	10.1371/journal.pone.0019670	http://dx.doi.org/10.1371/journal.pone.0019670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629687	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800005
J	Sharbati, J; Lewin, A; Kutz-Lohroff, B; Kamal, E; Einspanier, R; Sharbati, S				Sharbati, Jutta; Lewin, Astrid; Kutz-Lohroff, Barbara; Kamal, Elisabeth; Einspanier, Ralf; Sharbati, Soroush			Integrated MicroRNA-mRNA-Analysis of Human Monocyte Derived Macrophages upon Mycobacterium avium subsp hominissuis Infection	PLOS ONE			English	Article							GENE-EXPRESSION; INDUCED APOPTOSIS; IMMUNE-RESPONSES; INNATE IMMUNITY; CELL-DEATH; C-MYC; TUBERCULOSIS; LIPOPOLYSACCHARIDE; RECEPTOR; STRAINS	Background: Many efforts have been made to understand basal mechanisms of mycobacterial infections. Macrophages are the first line of host immune defence to encounter and eradicate mycobacteria. Pathogenic species have evolved different mechanisms to evade host response, e. g. by influencing macrophage apoptotic pathways. However, the underlying molecular regulation is not fully understood. A new layer of eukaryotic regulation of gene expression is constituted by microRNAs. Therefore, we present a comprehensive study for identification of these key regulators and their targets in the context of host macrophage response to mycobacterial infections. Methodology/Principal Findings: We performed microRNA as well as mRNA expression analysis of human monocyte derived macrophages infected with several Mycobacterium avium hominissuis strains by means of microarrays as well as quantitative reverse transcription PCR (qRT-PCR). The data revealed the ability of all strains to inhibit apoptosis by transcriptional regulation of BCL2 family members. Accordingly, at 48 h after infection macrophages infected with all M. avium strains showed significantly decreased caspase 3 and 7 activities compared to the controls. Expression of let-7e, miR-29a and miR-886-5p were increased in response to mycobacterial infection at 48 h. The integrated analysis of microRNA and mRNA expression as well as target prediction pointed out regulative networks identifying caspase 3 and 7 as potential targets of let-7e and miR-29a, respectively. Consecutive reporter assays verified the regulation of caspase 3 and 7 by these microRNAs. Conclusions/Significance: We show for the first time that mycobacterial infection of human macrophages causes a specific microRNA response. We furthermore outlined a regulatory network of potential interactions between microRNAs and mRNAs. This study provides a theoretical concept for unveiling how distinct mycobacteria could manipulate host cell response. In addition, functional relevance was confirmed by uncovering the control of major caspases 3 and 7 by let-7e and miR-29a, respectively.	[Sharbati, Jutta; Kutz-Lohroff, Barbara; Einspanier, Ralf; Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, D-1000 Berlin, Germany; [Lewin, Astrid; Kamal, Elisabeth] Robert Koch Inst, D-1000 Berlin, Germany	Free University of Berlin; Robert Koch Institute	Sharbati, J (corresponding author), Free Univ Berlin, Inst Vet Biochem, D-1000 Berlin, Germany.	sharbati@zedat.fu-berlin.de	Sharbati, Soroush/D-2548-2014	Sharbati, Soroush/0000-0003-3338-7654	Deutsche Forschungsgemeinschaft [SFB 852, B4]; "Forschungskommission" of the Freie Universitaet Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); "Forschungskommission" of the Freie Universitaet Berlin	The study was supported by grants from Deutsche Forschungsgemeinschaft (SFB 852 project B4) and the "Forschungskommission" of the Freie Universitaet Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Balcewicz-Sablinska MK, 1999, J INFECT DIS, V180, P1230, DOI 10.1086/315011; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Barry DP, 2006, APOPTOSIS, V11, P1695, DOI 10.1007/s10495-006-9236-3; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; BEHAR SM, 2011, MUCOSAL IMMUNOL; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bermudez LE, 1999, CLIN EXP IMMUNOL, V116, P94; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corti M, 2008, EXPERT REV ANTI-INFE, V6, P351, DOI 10.1586/14787210.6.3.351; Dvorska L, 2004, VET MICROBIOL, V99, P239, DOI 10.1016/j.vetmic.2004.01.008; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Ganguly N, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-24; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Gey Van Pittius NC, 2001, GENOME BIOL, V2, DOI 10.1186/GB-2001-2-10-RESEARCH004; Greenwell-Wild T, 2002, J IMMUNOL, V169, P6286, DOI 10.4049/jimmunol.169.11.6286; Haverkamp MH, 2004, CLIN INFECT DIS, V39, P450, DOI 10.1086/422319; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Hussain S, 1999, J IMMUNOL, V163, P2041; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; Li JH, 2011, GYNECOL ONCOL, V120, P145, DOI 10.1016/j.ygyno.2010.09.009; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; McGarvey JA, 2004, CLIN EXP IMMUNOL, V136, P490, DOI 10.1111/j.1365-2249.2004.02490.x; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI 10.1099/00207713-52-5-1505; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Scholven J, 2009, CELL PHYSIOL BIOCHEM, V23, P143, DOI 10.1159/000204103; Semret M, 2004, J BACTERIOL, V186, P6332, DOI 10.1128/JB.186.18.6332-6334.2004; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sharbati-Tehrani S, 2005, MICROBIOL-SGM, V151, P2403, DOI 10.1099/mic.0.27969-0; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Wang AY, 2010, J BACTERIOL, V192, P2809, DOI 10.1128/JB.01462-09; Wittram C, 2002, BRIT J RADIOL, V75, P340, DOI 10.1259/bjr.75.892.750340; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	63	123	137	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20258	10.1371/journal.pone.0020258	http://dx.doi.org/10.1371/journal.pone.0020258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629653	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800038
J	Lalaoui, N; Morle, A; Merino, D; Jacquemin, G; Iessi, E; Morizot, A; Shirley, S; Robert, B; Solary, E; Garrido, C; Micheau, O				Lalaoui, Najoua; Morle, Aymeric; Merino, Delphine; Jacquemin, Guillaume; Iessi, Elisabetta; Morizot, Alexandre; Shirley, Sarah; Robert, Bruno; Solary, Eric; Garrido, Carmen; Micheau, Olivier			TRAIL-R4 Promotes Tumor Growth and Resistance to Apoptosis in Cervical Carcinoma HeLa Cells through AKT	PLOS ONE			English	Article							KAPPA-B; LIGAND; PROTEIN; CANCER; PROLIFERATION; RECEPTORS; ACTIVATION; COLON; OVEREXPRESSION; EXPRESSION	Background: TRAIL/Apo2L is a pro-apoptotic ligand of the TNF family that engages the apoptotic machinery through two pro-apoptotic receptors, TRAIL-R1 and TRAIL-R2. This cell death program is tightly controlled by two antagonistic receptors, TRAIL-R3 and TRAIL-R4, both devoid of a functional death domain, an intracellular region of the receptor, required for the recruitment and the activation of initiator caspases. Upon TRAIL-binding, TRAIL-R4 forms a heteromeric complex with the agonistic receptor TRAIL-R2 leading to reduced caspase-8 activation and apoptosis. Methodology/Principal Findings: We provide evidence that TRAIL-R4 can also exhibit, in a ligand independent manner, signaling properties in the cervical carcinoma cell line HeLa, through Akt. Ectopic expression of TRAIL-R4 in HeLa cells induced morphological changes, with cell rounding, loss of adherence and markedly enhanced cell proliferation in vitro and tumor growth in vivo. Disruption of the PI3K/Akt pathway using the pharmacological inhibitor LY294002, siRNA targeting the p85 regulatory subunit of phosphatidylinositol-3 kinase, or by PTEN over-expression, partially restored TRAIL-mediated apoptosis in these cells. Moreover, the Akt inhibitor, LY294002, restituted normal cell proliferation index in HeLa cells expressing TRAIL-R4. Conclusions/Significance: Altogether, these results indicate that, besides its ability to directly inhibit TRAIL-induced cell death at the membrane, TRAIL-R4 can also trigger the activation of signaling pathways leading to cell survival and proliferation in HeLa cells. Our findings raise the possibility that TRAIL-R4 may contribute to cervical carcinogenesis.	[Lalaoui, Najoua; Morle, Aymeric; Merino, Delphine; Jacquemin, Guillaume; Iessi, Elisabetta; Morizot, Alexandre; Shirley, Sarah; Garrido, Carmen; Micheau, Olivier] INSERM, U866, Dijon, France; [Lalaoui, Najoua; Morle, Aymeric; Merino, Delphine; Jacquemin, Guillaume; Iessi, Elisabetta; Morizot, Alexandre; Shirley, Sarah; Garrido, Carmen; Micheau, Olivier] Univ Bourgogne, Fac Med & Pharm, Dijon, France; [Robert, Bruno] INSERM, IRCM, U896, Montpellier, France; [Robert, Bruno] Univ Montpellier I, CRLC Val Aurelle Paul Lamarque, Montpellier, France; [Solary, Eric] INSERM, U1009, Villejuif, France; [Solary, Eric] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Garrido, Carmen] Ctr Hosp Univ Dijon, F-21004 Dijon, France; [Micheau, Olivier] Ctr Georges Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CHU Dijon Bourgogne; UNICANCER; Centre Georges-Francois Leclerc	Lalaoui, N (corresponding author), INSERM, U866, Dijon, France.	omicheau@u-bourgogne.fr	Lalaoui, Najoua/C-1410-2014; Merino, Delphine/L-9159-2017; ROBERT, Bruno/AAB-7581-2020; Garrido, Carolina/GWM-5557-2022; Iessi, Elisabetta/O-2460-2017; Garrido, carmen/G-1633-2018; micheau, olivier/C-3574-2011	Lalaoui, Najoua/0000-0002-0165-3324; Merino, Delphine/0000-0002-8075-6275; ROBERT, Bruno/0000-0001-5573-6945; Iessi, Elisabetta/0000-0001-7221-9173; Garrido, carmen/0000-0003-1368-1493; micheau, olivier/0000-0001-8499-7984; Solary, Eric/0000-0002-8629-1341	Conseil Regional de Bourgogne; INCa (Institut National du Cancer); Agence Nationale de la Recherche [ANR-06-JCJC-0103, 07-PCV-0031]; European Community (ApopTrain Marie Curie RTN); Ligue Nationale contre le Cancer; Ministry of Research and Education; ARC (Association pour la Recherche sur le Cancer); INSERM; Apoptrain Marie Curie RTN	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community (ApopTrain Marie Curie RTN)(European Commission); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministry of Research and Education; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Apoptrain Marie Curie RTN	This work is supported by grants of the Conseil Regional de Bourgogne, the INCa (Institut National du Cancer) Canceropole Grand-Est, (Agence Nationale de la Recherche, ANR-06-JCJC-0103 and 07-PCV-0031) and the European Community (ApopTrain Marie Curie RTN). NL, A. Morizot, DM, A. Morle and GJ are supported by fellowships from the Ligue Nationale contre le Cancer, the Ministry of Research and Education, the ARC (Association pour la Recherche sur le Cancer), the INSERM and the Conseil Regional de Bourgogne. EI was supported by a fellowship from the Apoptrain Marie Curie RTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Audo R, 2009, CELL DEATH DIFFER, V16, P1227, DOI 10.1038/cdd.2009.38; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bouralexis S, 2003, BRIT J CANCER, V89, P206, DOI 10.1038/sj.bjc.6601021; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Davidovich IA, 2004, CANCER LETT, V211, P189, DOI 10.1016/j.canlet.2004.03.026; Elias A, 2009, CLIN CANCER RES, V15, P5457, DOI 10.1158/1078-0432.CCR-09-1125; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Finnberg N, 2006, CLIN CANCER RES, V12, P4132, DOI 10.1158/1078-0432.CCR-06-0567; Freer-Prokop M, 2009, DIFFERENTIATION, V78, P205, DOI 10.1016/j.diff.2009.05.002; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Lee SH, 2001, ONCOGENE, V20, P399, DOI 10.1038/sj.onc.1204103; Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Morel J, 2005, J BIOL CHEM, V280, P15709, DOI 10.1074/jbc.M414469200; Morizot A, 2011, CELL DEATH DIFFER, V18, P700, DOI 10.1038/cdd.2010.144; Riccioni R, 2005, HAEMATOLOGICA, V90, P612; Rimondi E, 2006, J CELL PHYSIOL, V206, P647, DOI 10.1002/jcp.20512; Rubio-Moscardo F, 2005, BLOOD, V106, P3214, DOI 10.1182/blood-2005-05-2013; Schmidt U, 2004, J EXP MED, V199, P785, DOI 10.1084/jem.20031109; Schneider DB, 2000, ARTERIOSCL THROM VAS, V20, P298, DOI 10.1161/01.ATV.20.2.298; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2004, BLOOD, V103, P517, DOI 10.1182/blood-2003-06-2137; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simova S, 2008, APOPTOSIS, V13, P423, DOI 10.1007/s10495-007-0171-8; Sun M, 2008, CELL DEATH DIFFER, V15, P1887, DOI 10.1038/cdd.2008.124; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; Toscano F, 2008, ONCOGENE, V27, P4161, DOI 10.1038/onc.2008.52; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Vilimanovich U, 2008, CELL MOL LIFE SCI, V65, P814, DOI 10.1007/s00018-008-7513-8; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yen ML, 2008, MOL IMMUNOL, V45, P2205, DOI 10.1016/j.molimm.2007.12.003; Zauli G, 2005, J CELL PHYSIOL, V202, P900, DOI 10.1002/jcp.20202; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	41	55	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19679	10.1371/journal.pone.0019679	http://dx.doi.org/10.1371/journal.pone.0019679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625476	Green Published, gold			2022-12-25	WOS:000290793400007
J	Xue, HP; Lu, H; Zhao, X				Xue, Huping; Lu, Hong; Zhao, Xin			Sequence Diversities of Serine-Aspartate Repeat Genes among Staphylococcus aureus Isolates from Different Hosts Presumably by Horizontal Gene Transfer	PLOS ONE			English	Article							CONTINGENCY LOCI; NASAL-CARRIAGE; PROTEIN; EVOLUTION; INSIGHTS; REVEALS; STRAINS; FAMILY	Background: Horizontal gene transfer (HGT) is recognized as one of the major forces for bacterial genome evolution. Many clinically important bacteria may acquire virulence factors and antibiotic resistance through HGT. The comparative genomic analysis has become an important tool for identifying HGT in emerging pathogens. In this study, the Serine-Aspartate Repeat (Sdr) family has been compared among different sources of Staphylococcus aureus (S. aureus) to discover sequence diversities within their genomes. Methodology/Principal Findings: Four sdr genes were analyzed for 21 different S. aureus strains and 218 mastitis-associated S. aureus isolates from Canada. Comparative genomic analyses revealed that S. aureus strains from bovine mastitis (RF122 and mastitis isolates in this study), ovine mastitis (ED133), pig (ST398), chicken (ED98), and human methicillin-resistant S. aureus (MRSA) (TCH130, MRSA252, Mu3, Mu50, N315, 04-02981, JH1 and JH9) were highly associated with one another, presumably due to HGT. In addition, several types of insertion and deletion were found in sdr genes of many isolates. A new insertion sequence was found in mastitis isolates, which was presumably responsible for the HGT of sdrC gene among different strains. Moreover, the sdr genes could be used to type S. aureus. Regional difference of sdr genes distribution was also indicated among the tested S. aureus isolates. Finally, certain associations were found between sdr genes and subclinical or clinical mastitis isolates. Conclusions: Certain sdr gene sequences were shared in S. aureus strains and isolates from different species presumably due to HGT. Our results also suggest that the distributional assay of virulence factors should detect the full sequences or full functional regions of these factors. The traditional assay using short conserved regions may not be accurate or credible. These findings have important implications with regard to animal husbandry practices that may inadvertently enhance the contact of human and animal bacterial pathogens.	[Xue, Huping; Zhao, Xin] McGill Univ, Dept Anim Sci, Montreal, PQ, Canada; [Xue, Huping; Lu, Hong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	McGill University; Fudan University	Xue, HP (corresponding author), McGill Univ, Dept Anim Sci, Montreal, PQ, Canada.	xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	National Nature Science Foundation of China (NSFC) [30828026]; Natural Science and Engineering Research Council of Canada; Shanghai Municipal Science and Technology Commission [9540707400]; China Scholarship Council	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); China Scholarship Council(China Scholarship Council)	This study was supported by funding from a grant from the National Nature Science Foundation of China (NSFC Grant No. 30828026), a discovery grant from Natural Science and Engineering Research Council of Canada and a grant from Shanghai Municipal Science and Technology Commission (No 9540707400). Mr. Xue is a recipient of a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1996, ANTIMICROB AGENTS CH, V40, P924, DOI 10.1128/AAC.40.4.924; Arrecubieta C, 2007, J BIOL CHEM, V282, P18767, DOI 10.1074/jbc.M610940200; Baptiste KE, 2005, EMERG INFECT DIS, V11, P1942, DOI 10.3201/eid1112.050241; Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; Brody T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003074; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Chua K, 2010, J BACTERIOL, V192, P5556, DOI 10.1128/JB.00878-10; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lawrence JG, 1996, GENETICS, V143, P1843; Linares JA, 2001, AVIAN DIS, V45, P1068, DOI 10.2307/1592891; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McCrea KW, 2000, MICROBIOL-SGM, V146, P1535, DOI 10.1099/00221287-146-7-1535; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Rodgers JD, 1999, VET MICROBIOL, V69, P189, DOI 10.1016/S0378-1135(99)00112-1; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Said KB, 2010, J CLIN MICROBIOL, V48, P375, DOI 10.1128/JCM.01768-09; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trad S, 2004, J CLIN MICROBIOL, V42, P2054, DOI 10.1128/JCM.42.5.2054-2064.2004; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Zaneveld JR, 2008, MICROBIOL-SGM, V154, P1, DOI 10.1099/mic.0.2007/011833-0	39	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20332	10.1371/journal.pone.0020332	http://dx.doi.org/10.1371/journal.pone.0020332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625460	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400057
J	Bajardi, P; Barrat, A; Natale, F; Savini, L; Colizza, V				Bajardi, Paolo; Barrat, Alain; Natale, Fabrizio; Savini, Lara; Colizza, Vittoria			Dynamical Patterns of Cattle Trade Movements	PLOS ONE			English	Article							NETWORK ANALYSIS; MOUTH-DISEASE; LIVESTOCK MOVEMENTS; COMPLEX NETWORKS; WEIGHTED NETWORK; CENTRALITY; EPIDEMIC; RISK; PREDICTABILITY; OUTBREAKS	Despite their importance for the spread of zoonotic diseases, our understanding of the dynamical aspects characterizing the movements of farmed animal populations remains limited as these systems are traditionally studied as static objects and through simplified approximations. By leveraging on the network science approach, here we are able for the first time to fully analyze the longitudinal dataset of Italian cattle movements that reports the mobility of individual animals among farms on a daily basis. The complexity and inter-relations between topology, function and dynamical nature of the system are characterized at different spatial and time resolutions, in order to uncover patterns and vulnerabilities fundamental for the definition of targeted prevention and control measures for zoonotic diseases. Results show how the stationarity of statistical distributions coexists with a strong and non-trivial evolutionary dynamics at the node and link levels, on all timescales. Traditional static views of the displacement network hide important patterns of structural changes affecting nodes' centrality and farms' spreading potential, thus limiting the efficiency of interventions based on partial longitudinal information. By fully taking into account the longitudinal dimension, we propose a novel definition of dynamical motifs that is able to uncover the presence of a temporal arrow describing the evolution of the system and the causality patterns of its displacements, shedding light on mechanisms that may play a crucial role in the definition of preventive actions.	[Bajardi, Paolo] ISI, Computat Epidemiol Lab, Turin, Italy; [Bajardi, Paolo; Barrat, Alain] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Barrat, Alain] ISI, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Natale, Fabrizio] European Commiss, Joint Res Ctr, Inst Protect & Secur Citizen, Ispra, Italy; [Savini, Lara] Ist G Caporale, Teramo, Italy; [Colizza, Vittoria] INSERM, U707, Paris, France; [Colizza, Vittoria] Univ Paris 06, UPMC, Fac Med Pierre & Marie Curie, UMR S 707, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; European Commission Joint Research Centre; EC JRC ISPRA Site; IZS Dell'abruzzo E Del Molise Giuseppe Caporale; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bajardi, P (corresponding author), ISI, Computat Epidemiol Lab, Turin, Italy.	vittoria.colizza@inserm.fr	Bajardi, Paolo/J-6180-2012; Savini, Lara LS/C-2851-2018; Bajardi, Paolo/AAE-2416-2022	Savini, Lara LS/0000-0001-6175-7793; Bajardi, Paolo/0000-0001-8865-4495; Colizza, Vittoria/0000-0002-2113-2374	European Research Council [ERC-2007-Stg204863 (EPIFOR)]; Italian Ministry of Health [MSRCTE0108]	European Research Council(European Research Council (ERC)European Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was partially funded by the European Research Council Ideas contract no. ERC-2007-Stg204863 (EPIFOR) to VC and PB and by the MSRCTE0108 project founded by the Italian Ministry of Health to FN, LS, and VC. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Anderson I., 2002, FOOT MOUTH DIS 2001; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Brennan ML, 2008, PREV VET MED, V84, P242, DOI 10.1016/j.prevetmed.2007.12.009; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Caldarelli G., 2007, SCALE FREE NETWORKS; Castellano C, 2003, EUROPHYS LETT, V63, P153, DOI 10.1209/epl/i2003-00490-0; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Christley R. M., 2005, Society for Veterinary Epidemiology and Preventive Medicine. Proceedings of a meeting held at Nairn, Inverness, Scotland, 30th March-1st April 2005, P234; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Dall'Asta L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/P04006; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; Dorogovstev S. N., 2003, EVOLUTION NETWORKS B; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; European Parliament and European council, 2000, OFFICIAL J EUROPEA L, V204, P1; Gautreau A, 2009, P NATL ACAD SCI USA, V106, P8847, DOI 10.1073/pnas.0811113106; GOLDER SA, 2007, P 3 INT C COMM TECHN; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Green DM, 2006, P ROY SOC B-BIOL SCI, V273, P2729, DOI 10.1098/rspb.2006.3648; Guerra B, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056105; Guimera R, 2004, EUR PHYS J B, V38, P381, DOI 10.1140/epjb/e2004-00131-0; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Klemm K, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026120; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; KOSSINETS G, 2008, P 14 ACM SIGKDD INT, P38103; Kostakos V, 2009, PHYSICA A, V388, P1007, DOI 10.1016/j.physa.2008.11.021; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Lerman K., 2010, P 8 WORKSH MIN LEARN, P70, DOI DOI 10.1145/1830252.1830262; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; *MAF BIOS NZ, 2009, REV SEL CATTL ID TRA; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; *MIN HLTH CSN I G, IT NAT AN ID REG DAT; Natale F, 2011, PREV VET MED, V98, P111, DOI 10.1016/j.prevetmed.2010.11.013; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Ortiz-Pelaez A, 2006, PREV VET MED, V76, P40, DOI 10.1016/j.prevetmed.2006.04.007; PAN RV, 2011, ARXIV11015913; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; RAUTUREAU S, 2010, T BOUNDARY EMERGING, DOI DOI 10.1111/J.1865-1682.2010.01187; Robinson SE, 2007, PREV VET MED, V81, P21, DOI 10.1016/j.prevetmed.2007.04.011; Robinson SE, 2007, J R SOC INTERFACE, V4, P669, DOI 10.1098/rsif.2007.0214; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Song CM, 2010, SCIENCE, V327, P1018, DOI 10.1126/science.1177170; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; *UK DEFRA, 2002, OR UK FOOT MOUTH DIS; Vazquez A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158702; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	83	133	136	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19869	10.1371/journal.pone.0019869	http://dx.doi.org/10.1371/journal.pone.0019869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625633	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200042
J	Lohscheider, JN; Strittmatter, M; Kupper, H; Adamska, I				Lohscheider, Jens N.; Strittmatter, Martina; Kuepper, Hendrik; Adamska, Iwona			Vertical Distribution of Epibenthic Freshwater Cyanobacterial Synechococcus spp. Strains Depends on Their Ability for Photoprotection	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PHOTOSYSTEM-II; CHROMATIC ADAPTATION; LIGHT ENVIRONMENT; XANTHOPHYLL CYCLE; STATE TRANSITIONS; UP-REGULATION; CHLOROPHYLL; MUTANTS; ACCLIMATION	Background: Epibenthic cyanobacteria often grow in environments where the fluctuation of light intensity and quality is extreme and frequent. Different strategies have been developed to cope with this problem depending on the distribution of cyanobacteria in the water column. Principal Findings: Here we provide an experimental proof that the light intensity plays an important role in the vertical distribution of seven, closely related, epibenthic Synechococcus spp. strains isolated from various water depths from the littoral zone of Lake Constance in Germany and cultivated under laboratory conditions. Pigment analysis revealed that the amount of chlorophyll a and total carotenoids decreased with the time of light stress exposure in three phycoerythrin-rich strains collected from 7.0 m water depth and remained low during the recovery phase. In contrast, a constant level of chlorophyll a and either constant or enhanced levels of carotenoids were assayed in phycocyanin-rich strains collected from 1.0 and 0.5 m water depths. Protein analysis revealed that while the amount of biliproteins remained constant in all strains during light stress and recovery, the amount of D1 protein from photosystem II reaction centre was strongly reduced under light stress conditions in strains from 7.0 m and 1.0 m water depth, but not in strains collected from 0.5 m depth. Conclusion: Based on these data we propose that light intensity, in addition to light quality, is an important selective force in the vertical distribution of Synechococcus spp. strains, depending on their genetically fixed mechanisms for photoprotection.	[Lohscheider, Jens N.; Strittmatter, Martina; Kuepper, Hendrik; Adamska, Iwona] Univ Konstanz, Dept Biol, Constance, Germany; [Kuepper, Hendrik] Univ S Bohemia, Fac Biol Sci, Ceske Budejovice, Czech Republic; [Kuepper, Hendrik] Univ S Bohemia, Inst Phys Biol, Ceske Budejovice, Czech Republic	University of Konstanz; Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Lohscheider, JN (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	iwona.adamska@uni-konstanz.de	Küpper, Hendrik/J-5152-2012	Küpper, Hendrik/0000-0003-0712-7023; Strittmatter, Martina/0000-0002-1258-9751	Deutsche Forschungsgemeinschaft [SFB454, 632/04, KU 1495/4]; Konstanz University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Konstanz University	This work was supported by a research grant from Deutsche Forschungsgemeinschaft (SFB454 grant 632/04 to I. A., KU 1495/4 to H. K.) and the Konstanz University grant (to I. A. and H. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Andresen E, 2010, NEW PHYTOL, V185, P173, DOI 10.1111/j.1469-8137.2009.03068.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Becker S, 2004, FEMS MICROBIOL ECOL, V49, P181, DOI 10.1016/j.femsec.2004.03.003; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; de Marsac NT, 2003, PHOTOSYNTH RES, V76, P197; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Ernst A, 2003, MICROBIOL-SGM, V149, P217, DOI 10.1099/mic.0.25475-0; Fujita Y., 1994, MOL BIOL CYANOBACTER, P677; Gilmore AM, 2001, PHOTOSYNTH RES, V67, P89, DOI 10.1023/A:1010657000548; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Gude H, 1998, ADV LIMNOL STUTTG, V53, P85; HERBERT SK, 1992, P NATL ACAD SCI USA, V89, P8716, DOI 10.1073/pnas.89.18.8716; HOFMAN H, 2008, VERHANDL INT VEREIN, V30, P627; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Huesgen PF, 2009, RES MICROBIOL, V160, P726, DOI 10.1016/j.resmic.2009.08.005; JEWSON DH, 1984, J PLANKTON RES, V6, P259, DOI 10.1093/plankt/6.2.259; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Kupper H, 2007, ANAL CHEM, V79, P7611, DOI 10.1021/ac070236m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; McConnell MD, 2002, PLANT PHYSIOL, V130, P1201, DOI 10.1104/pp.009845; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Obinger C, 1999, FREE RADICAL RES, V31, pS243; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Postius C, 1999, ARCH MICROBIOL, V172, P69, DOI 10.1007/s002030050742; Postius C, 1998, FEMS MICROBIOL ECOL, V25, P171, DOI 10.1016/S0168-6496(97)00093-7; Postius C, 2001, FEMS MICROBIOL ECOL, V37, P117, DOI 10.1111/j.1574-6941.2001.tb00859.x; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Schafer L, 2006, PLANT CELL ENVIRON, V29, P1349, DOI 10.1111/j.1365-3040.2006.01515.x; Schafer L, 2005, J PHOTOCH PHOTOBIO B, V78, P195, DOI 10.1016/j.jphotobiol.2004.11.007; Schagerl M, 2006, J PLANT PHYSIOL, V163, P709, DOI 10.1016/j.jplph.2005.09.015; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Steiger S, 1999, J PHOTOCH PHOTOBIO B, V52, P14, DOI 10.1016/S1011-1344(99)00094-9; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; WALTERS RG, 1995, PLANTA, V197, P475, DOI 10.1007/BF00196669; WALTERS RG, 1995, PLANTA, V197, P306, DOI 10.1007/BF00202652; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623	50	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20134	10.1371/journal.pone.0020134	http://dx.doi.org/10.1371/journal.pone.0020134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625592	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200067
J	Lim, SK; Orhant-Prioux, M; Toy, W; Tan, KY; Lim, YP				Lim, Shen Kiat; Orhant-Prioux, Magali; Toy, Weiyi; Tan, Kah Yap; Lim, Yoon Pin			Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor alpha function in breast cancer via the Wnt pathway	FASEB JOURNAL			English	Article						WBP2; ER alpha; EGFR; beta-catenin; crosstalk	YES-ASSOCIATED PROTEIN; GROWTH-FACTOR RECEPTOR; NUCLEAR RECEPTORS; WNT/BETA-CATENIN; BETA-CATENIN; ACTIVATION; KINASE; SRC; CELLS; YAP	WW-binding protein 2 (WBP2) has been demonstrated in different studies to be a tyrosine kinase substrate, to activate estrogen receptor alpha (ER alpha)/progesterone receptor (PR) transcription, and to play a role in breast cancer. However, the role of WBP2 tyrosine phosphorylation in regulating ER alpha function and breast cancer biology is unknown. Here, we established WBP2 as a tyrosine phosphorylation target of estrogen signaling via EGFR crosstalk. Using dominant-negative, constitutively active mutants, RNAi, and pharmacological studies, we demonstrated that phosphorylation of WBP2 at Tyr192 and Tyr231 could be regulated by c-Src and c-Yes kinases. We further showed that abrogating WBP2 phosphorylation impaired >60% of ER alpha reporter activity, putatively by blocking nuclear entry of WBP2 and its interaction with ER alpha. Compared to vector control, overexpression of WBP2 and its phospho-mimic mutant in MCF7 cells resulted in larger tumors in mice, induced loss of cell-cell adhesion, and enhanced cell proliferation, anchorage-independent growth, migration, and invasion in both estrogen-dependent and -independent manners, events of which could be substantially abolished by overexpression of the phosphorylation-defective mutant. Hormone independence of cells expressing WBP2 phospho-mimic mutant was associated with heightened ER alpha and Wnt reporter activities. Wnt/beta-catenin inhibitor FH535 blocked phospho-WBP2-mediated cancer cell growth more pronouncedly than tamoxifen and fulvestrant, in part by reducing the expression of ER alpha. Wnt pathway is likely to be a critical component in WBP2-mediated breast cancer biology.-Lim, S. K., Orhant-Prioux, M., Toy, W., Tan, K. Y., Lim, Y. P. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor alpha function in breast cancer via the Wnt pathway. FASEB J. 25, 3004-3018 (2011). www.fasebj.org	[Lim, Shen Kiat; Toy, Weiyi; Tan, Kah Yap; Lim, Yoon Pin] Natl Univ Singapore, Fac Sci, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Lim, Shen Kiat; Orhant-Prioux, Magali; Toy, Weiyi; Tan, Kah Yap; Lim, Yoon Pin] Natl Univ Singapore, Fac Sci, Canc Sci Inst, Singapore 117597, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117597, Singapore; [Lim, Yoon Pin] Agcy Sci & Technol, Bioinformat Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII)	Lim, YP (corresponding author), Natl Univ Singapore, Fac Sci, Yong Loo Lin Sch Med, Dept Biochem, MD4A,02-05,8 Med Dr, Singapore 117597, Singapore.	bchlyp@nus.edu.sg	Toy, Weiyi/ABH-3914-2020		Singapore Biomedical Research Council; Agency for Science, Technology, and Research	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR))	The authors thank Dr. Siew Pang Chan (senior lecturer, Division of Health Sciences, La Trobe University, Melbourne, VIC, Australia; and statistics editor, Cochrane Consumers & Collaboration Group) for his assistance in statistical analysis in the xenograft studies. The work is funded by the Singapore Biomedical Research Council and Agency for Science, Technology, and Research.	Arimura A, 2004, J BIOL CHEM, V279, P31105, DOI 10.1074/jbc.M404428200; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Callige Mathilde, 2006, Nucl Recept Signal, V4, pe004; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; KARIAGINA A, HORM CANC, V1, P229; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lange CA, 2004, MOL ENDOCRINOL, V18, P269, DOI 10.1210/me.2003-0331; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lim YP, 2003, MOL CANCER THER, V2, P1369; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pirozzi G, 1997, J BIOL CHEM, V272, P14611, DOI 10.1074/jbc.272.23.14611; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1994, ONCOGENE, V9, P2145; Talukder AH, 2008, ONCOGENE, V27, P5233, DOI 10.1038/onc.2008.151; TOY W, CELL SIGNAL, V22, P437; Toy W, 2010, CELL SIGNAL, V22, P437, DOI 10.1016/j.cellsig.2009.10.015; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073	50	40	43	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3004	3018		10.1096/fj.10-169136	http://dx.doi.org/10.1096/fj.10-169136			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21642474				2022-12-25	WOS:000294435200016
J	Zhou, QY; Pardo, A; Konigshoff, M; Eickelberg, O; Budinger, GRS; Thavarajah, K; Gottardi, CJ; Jones, J; Varga, J; Selman, M; Sznajder, JI; Raj, JU; Zhou, GF				Zhou, Qiyuan; Pardo, Annie; Koenigshoff, Melanie; Eickelberg, Oliver; Budinger, G. R. Scott; Thavarajah, Krishna; Gottardi, Cara J.; Jones, Jonathan; Varga, John; Selman, Moises; Sznajder, Jacob I.; Raj, J. Usha; Zhou, Guofei			Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; extracellular matrix; integrin alpha 5 beta 1; focal adhesion kinase	GROWTH-FACTOR-BETA; PULMONARY-FIBROSIS; TGF-BETA; MATRIX DEPOSITION; HIF-ALPHA; IN-VIVO; INTEGRIN; FIBRONECTIN; ACTIVATION; INTEGRIN-ALPHA-V-BETA-6	Idiopathic pulmonary fibrosis (IPF) is characterized by exaggerated fibroblast proliferation and accumulation of collagens and fibronectin. The extracellular fibronectin and collagen network is regulated by von Hippel-Lindau protein (pVHL). However, it is unknown whether pVHL contributes to pulmonary fibrosis. We found that lungs from patients with IPF expressed increased levels of pVHL in fibroblastic foci. Bleomycin treatment also induced pVHL in lung fibroblasts, but not in alveolar type II cells. Overexpression of pVHL increased lung fibroblast proliferation, protein abundance of fibronectin and collagen, and extracellular fibronectin. In addition, overexpression of pVHL induced expression of the alpha 5 integrin subunit. Overexpression of pVHL did not alter hypoxia-inducible factor luciferase reporter activity and mRNA expression of vascular endothelial growth factor. Fibroblasts overexpressing pVHL were more sensitive to RGD peptide-mediated reduction in proliferation. Activating alpha 5 and beta 1 integrin increased proliferation of fibroblasts overexpressing pVHL and those cells were more resistant to the inhibition of alpha 5 integrin. Overexpression of pVHL also increased activation of focal adhesion kinase (FAK). Moreover, suppression of pVHL prevented TGF-beta 1-induced proliferation of mouse embryonic fibroblasts. Taken together, our results indicate that elevated expression of pVHL results in the aberrant fibronectin expression, activation of integrin/FAK signaling, fibroblast proliferation, and fibrosis.-Zhou, Q., Pardo, A., Konigshoff, M., Eickelberg, O., Budinger, G. R. S., Thavarajah, K., Gottardi, C. J., Jones, J., Varga, J., Selman, M., Sznajder, J. I., Raj, J. U., Zhou, G. Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis. FASEB J. 25, 3032-3044 (2011). www.fasebj.org	[Zhou, Qiyuan; Raj, J. Usha; Zhou, Guofei] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico; [Koenigshoff, Melanie; Eickelberg, Oliver] Univ Munich, Comprehens Pneumol Ctr, Neuherberg, Germany; [Koenigshoff, Melanie; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Budinger, G. R. Scott; Thavarajah, Krishna; Gottardi, Cara J.; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Jones, Jonathan] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL USA; [Varga, John] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Selman, Moises] Inst Nacl Enfermedades Resp, Tlalpan, Mexico	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidad Nacional Autonoma de Mexico; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zhou, GF (corresponding author), Univ Illinois, Dept Pediat, 840 S Wood St,Ste 1206,M-C 856, Chicago, IL 60612 USA.	guofei@uic.edu	Varga, John/AAK-6472-2021; Eickelberg, Oliver/A-5461-2013; Jones, Jonathan C R/T-9467-2017; Gottardi, Cara J./AAU-4691-2021	Eickelberg, Oliver/0000-0001-7170-0360; Jones, Jonathan C R/0000-0002-1496-4922; Gottardi, Cara J./0000-0003-0912-7617	U.S. National Institutes of Health [HL-071643, HL-093014, AR-042309]; Parker B. Francis foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, R01HL093014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042309, R56AR042309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by U.S. National Institutes of Health grants HL-071643, HL-093014 (J.I.S.), and AR-042309 (J.V.), and a Parker B. Francis foundation fellowship (G.Z.). The authors greatly appreciate Ms. Christine Y. Kim for her insightful reading of their manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Esteban-Barragan MA, 2002, CANCER RES, V62, P2929; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jatta K, 2009, J CLIN PATHOL, V62, P70, DOI 10.1136/jcp.2008.057190; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Tang N, 2006, MOL CELL BIOL, V26, P2519, DOI 10.1128/MCB.26.7.2519-2530.2006; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; White ES, 2003, AM J RESP CRIT CARE, V168, P436, DOI 10.1164/rccm.200301-041OC; Zhou GF, 2009, AM J PHYSIOL-LUNG C, V297, pL1120, DOI 10.1152/ajplung.00007.2009	40	18	19	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3032	3044		10.1096/fj.10-177824	http://dx.doi.org/10.1096/fj.10-177824			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21642472	Green Published			2022-12-25	WOS:000294435200018
J	Dutta, A; Zheng, ST; Jain, D; Cameron, CE; Reese, JC				Dutta, Arnob; Zheng, Suting; Jain, Deepti; Cameron, Craig E.; Reese, Joseph C.			Intermolecular Interactions within the Abundant DEAD-box Protein Dhh1 Regulate Its Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; CYTOPLASMIC PROCESSING BODIES; NONSENSE-MEDIATED DECAY; SACCHAROMYCES-CEREVISIAE; CCR4-NOT COMPLEX; HELICASE ACTIVITY; DECAPPING ENZYME; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; P-BODIES	Dhh1 is a highly conserved DEAD-box protein that has been implicated in many processes involved in mRNA regulation. At least some functions of Dhh1 may be carried out in cytoplasmic foci called processing bodies (P-bodies). Dhh1 was identified initially as a putative RNA helicase based solely on the presence of conserved helicase motifs found in the superfamily 2 (Sf2) of DEXD/H-box proteins. Although initial mutagenesis studies revealed that the signature DEAD-box motif is required for Dhh1 function in vivo, enzymatic (ATPase or helicase) or ATP binding activities of Dhh1 or those of any its many higher eukaryotic orthologues have not been described. Here we provide the first characterization of the biochemical activities of Dhh1. Dhh1 has weaker RNA-dependent ATPase activity than other well characterized DEAD-box helicases. We provide evidence that intermolecular interactions between the N- and C-terminal RecA-like helicase domains restrict its ATPase activity; mutation of residues mediating these interactions enhanced ATP hydrolysis. Interestingly, the interdomain interaction mutant displayed enhanced mRNA turnover, RNA binding, and recruitment into cytoplasmic foci in vivo compared with wild type Dhh1. Also, we demonstrate that the ATPase activity of Dhh1 is not required for it to be recruited into cytoplasmic foci, but it regulates its association with RNA in vivo. We hypothesize that the activity of Dhh1 is restricted by interdomain interactions, which can be regulated by cellular factors to impart stringent control over this very abundant RNA helicase.	[Dutta, Arnob; Zheng, Suting; Jain, Deepti; Reese, Joseph C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Reese, JC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, 463A N Frear, University Pk, PA 16802 USA.	Jcr8@psu.edu	Zheng, Suting/B-7382-2013	Dutta, Arnob/0000-0003-0061-8428	National Institutes of Health [GM58672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58672 ( to J. C. R.).	Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bergkessel M, 2004, GENETICS, V167, P21, DOI 10.1534/genetics.167.1.21; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brown CE, 1996, MOL CELL BIOL, V16, P5744; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Del Campo M, 2009, ACTA CRYSTALLOGR F, V65, P832, DOI 10.1107/S1744309109027225; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dunckley T, 2001, GENETICS, V157, P27; Dupressoir A, 2001, BMC Genomics, V2, P9, DOI 10.1186/1471-2164-2-9; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hata H, 1998, GENETICS, V148, P571; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kikuma T, 2004, J BIOL CHEM, V279, P20692, DOI 10.1074/jbc.M400231200; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Psathas JN, 2009, MOL CELL BIOL, V29, P6413, DOI 10.1128/MCB.00876-09; Reese JC, 2003, METHOD ENZYMOL, V370, P415; Reese JC, 2001, YEAST, V18, P1197, DOI 10.1002/yea.761; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; SCHMID SR, 1991, MOL CELL BIOL, V11, P3463, DOI 10.1128/MCB.11.7.3463; Selth LA, 2009, COLD SPRING HARB PRO, V2009; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; STRAHLBOLSINGER S, 1993, YEAST, V9, P429, DOI 10.1002/yea.320090414; Svitkin YV, 2001, RNA, V7, P1743; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Westmoreland TJ, 2003, J SURG RES, V113, P62, DOI 10.1016/S0022-4804(03)00155-0; Weston A, 2006, NUCLEIC ACIDS RES, V34, P3082, DOI 10.1093/nar/gkl409; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006; Zheng ST, 2010, MOL CELL BIOL, V30, P3635, DOI 10.1128/MCB.00324-10	77	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27454	27470		10.1074/jbc.M111.220251	http://dx.doi.org/10.1074/jbc.M111.220251			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21642421	Green Published, hybrid			2022-12-25	WOS:000293268700041
J	Fu, R; Gupta, R; Geng, JF; Dornevil, K; Wang, SM; Zhang, Y; Hendrich, MP; Liu, AM				Fu, Rong; Gupta, Rupal; Geng, Jiafeng; Dornevil, Kednerlin; Wang, Siming; Zhang, Yong; Hendrich, Michael P.; Liu, Aimin			Enzyme Reactivation by Hydrogen Peroxide in Heme-based Tryptophan Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C PEROXIDASE; HUMAN INDOLEAMINE 2,3-DIOXYGENASE; ELECTRON-PARAMAGNETIC-RESONANCE; CHLOROPEROXIDASE COMPOUND-II; DENSITY-FUNCTIONAL THEORY; CATALASE-PEROXIDASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; SPECTROSCOPIC PROPERTIES; MOSSBAUER-SPECTROSCOPY	An intriguing mystery about tryptophan 2,3-dioxygenase is its hydrogen peroxide-triggered enzyme reactivation from the resting ferric oxidation state to the catalytically active ferrous form. In this study, we found that such an odd Fe(III) reduction by an oxidant depends on the presence of L-Trp, which ultimately serves as the reductant for the enzyme. In the peroxide reaction with tryptophan 2,3-dioxygenase, a previously unknown catalase-like activity was detected. A ferryl species (delta = 0.055 mm/s and Delta E-Q = 1.755 mm/s) and a protein-based free radical (g = 2.0028 and 1.72 millitesla linewidth) were characterized by Mossbauer and EPR spectroscopy, respectively. This is the first compound ES-type of ferryl intermediate from a heme-based dioxygenase characterized by EPR and Mossbauer spectroscopy. Density functional theory calculations revealed the contribution of secondary ligand sphere to the spectroscopic properties of the ferryl species. In the presence of L-Trp, the reactivation was demonstrated by enzyme assays and by various spectroscopic techniques. ATrp-Trp dimer and a monooxygenated L-Trp were both observed as the enzyme reactivation by-products by mass spectrometry. Together, these results lead to the unraveling of an over 60-year old mystery of peroxide reactivation mechanism. These results may shed light on how a metalloenzyme maintains its catalytic activity in an oxidizing environment.	[Fu, Rong; Geng, Jiafeng; Dornevil, Kednerlin; Wang, Siming; Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Gupta, Rupal; Hendrich, Michael P.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Zhang, Yong] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA	University System of Georgia; Georgia State University; Carnegie Mellon University; Stevens Institute of Technology	Liu, AM (corresponding author), Georgia State Univ, Dept Chem, POB 4098, Atlanta, GA 30303 USA.	Feradical@gsu.edu	Liu, Aimin/C-1572-2017; Geng, Jiafeng/G-4948-2015; Zhang, Yong/K-2395-2014	Liu, Aimin/0000-0002-4182-8176; Geng, Jiafeng/0000-0001-9488-0974; Zhang, Yong/0000-0001-7207-6416	National Science Foundation [MCB0843537]; National Institutes of Health [GM077387, GM085774]; Georgia Cancer Coalition Distinguished Scholar Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077387, R15GM085774] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0843537] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Distinguished Scholar Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB0843537 (to A. L.) and Georgia Cancer Coalition Distinguished Scholar Program (to A. L.). This work was also supported in part by National Institutes of Health Grants GM077387 (to M. P. H.) and GM085774 (to Y. Z.).	Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Batabyal D, 2009, J AM CHEM SOC, V131, P3260, DOI 10.1021/ja807969a; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; BENDER ML, 1957, J AM CHEM SOC, V79, P116, DOI 10.1021/ja01558a030; BRADY FO, 1971, J BIOL CHEM, V246, P7119; BYRN M, 1966, J AM CHEM SOC, V88, P1916, DOI 10.1021/ja00961a013; Byrn M., 1965, UCRL16571 LAWR BERK, P1; Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; Dalosto SD, 2004, J PHYS CHEM B, V108, P6450, DOI 10.1021/jp0310697; De Laurentis W, 2007, BIOCHEMISTRY-US, V46, P12393, DOI 10.1021/bi7012189; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; Debrunner P. G., 1989, IRON PORPHYRINS, V3, P137; DEISSEROTH A, 1970, PHYSIOL REV, V50, P319, DOI 10.1152/physrev.1970.50.3.319; FEIGELSON P, 1961, BIOCHIM BIOPHYS ACTA, V50, P200, DOI 10.1016/0006-3002(61)91088-5; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Fukumura E, 2009, J BIOCHEM, V145, P505, DOI 10.1093/jb/mvp002; Garcia-Serres R, 2007, J AM CHEM SOC, V129, P1402, DOI 10.1021/ja067209i; Gerdemann C, 2001, BBA-PROTEIN STRUCT M, V1548, P94, DOI 10.1016/S0167-4838(01)00219-9; Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Guillemin GJ, 2005, NEURODEGENER DIS, V2, P166, DOI 10.1159/000089622; Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550; Gupta R, 2010, J AM CHEM SOC, V132, P1098, DOI 10.1021/ja908851e; HARAMI T, 1977, J CHEM PHYS, V67, P1164, DOI 10.1063/1.434969; HAYAISHI O, 1957, J BIOL CHEM, V229, P889; HAYAISHI O, 1993, PROTEIN SCI, V2, P472; HOFFMAN BM, 1981, J BIOL CHEM, V256, P6556; Horner O, 2007, J BIOL INORG CHEM, V12, P509, DOI 10.1007/s00775-006-0203-9; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; Jeng WY, 2004, J PEPT RES, V64, P104, DOI 10.1111/j.1399-3011.2004.00174.x; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; KNOX WE, 1950, J BIOL CHEM, V187, P419; KOPPENOL WH, 1987, BIOELECTROCH BIOENER, V18, P3, DOI 10.1016/0302-4598(87)85002-X; Kotake Y, 1936, H-S Z PHYSIOL CHEM, V243, P237, DOI 10.1515/bchm2.1936.243.6.237; KUHN H, 1981, EUR J BIOCHEM, V120, P161, DOI 10.1111/j.1432-1033.1981.tb05684.x; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; LANG G, 1976, BIOCHIM BIOPHYS ACTA, V451, P250, DOI 10.1016/0304-4165(76)90275-0; Laveille Paco, 2009, Biotechnology Journal, V4, P1460, DOI 10.1002/biot.200900100; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Li JS, 2007, ARCH INSECT BIOCHEM, V64, P74, DOI 10.1002/arch.20159; Li XH, 2008, P NATL ACAD SCI USA, V105, P8597, DOI 10.1073/pnas.0801643105; Ling Y, 2010, J PHYS CHEM LETT, V1, P2936, DOI 10.1021/jz101159x; Liu A., 2009, WILEY ENCY CHEM BIOL, V1, P591; MAEDA Y, 1967, BIOCHEM BIOPH RES CO, V29, P362, DOI 10.1016/0006-291X(67)90463-9; MEHLER AH, 1950, J BIOL CHEM, V187, P431; Mi, 1970, METHOD ENZYMOL, V17, P434, DOI 10.1016/0076-6879(71)17223-0; Munck E., 2000, PHYS METHODS BIOINOR, P287; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Paglino A, 2008, INSECT BIOCHEM MOLEC, V38, P871, DOI 10.1016/j.ibmb.2008.05.011; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Pfister TD, 2005, J BIOL CHEM, V280, P12858, DOI 10.1074/jbc.M410853200; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; PORTER TD, 1991, J BIOL CHEM, V266, P13469; Rana S.V.S., 1997, LIVER ENV XENOBIOTIC, P114; RAO SI, 1994, J BIOL CHEM, V269, P7210; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Robotka H, 2008, FUTUR NEUROL, V3, P169, DOI 10.2217/14796708.3.2.169; Ronsein GE, 2008, CHEM RES TOXICOL, V21, P1271, DOI 10.1021/tx800026g; RUTTER R, 1984, BIOCHEMISTRY-US, V23, P6809, DOI 10.1021/bi00321a082; Schulz C., 1979, Journal de Physique Colloque, V40, pC2/534, DOI 10.1051/jphyscol:19792185; SCHULZ CE, 1984, BIOCHEMISTRY-US, V23, P4743, DOI 10.1021/bi00315a033; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TANAKA T, 1959, J BIOL CHEM, V234, P1162; Thackray SJ, 2008, BIOCHEMISTRY-US, V47, P10677, DOI 10.1021/bi801202a; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; Varnado CL, 2004, ARCH BIOCHEM BIOPHYS, V421, P166, DOI 10.1016/j.abb.2003.10.020; WACHTERS AJ, 1970, J CHEM PHYS, V52, P1033, DOI 10.1063/1.1673095; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; YONETANI T, 1965, J BIOL CHEM, V240, P4509; Zhang Y, 2004, J AM CHEM SOC, V126, P4470, DOI 10.1021/ja030664j; Zhang Y, 2007, BIOCHEMISTRY-US, V46, P145, DOI 10.1021/bi0620095	87	37	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26541	26554		10.1074/jbc.M111.253237	http://dx.doi.org/10.1074/jbc.M111.253237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632548	Green Published, hybrid			2022-12-25	WOS:000293078200033
J	Zhang, YL; Xiao, MF; Horiyama, T; Zhang, YF; Li, XC; Nishino, K; Yan, AX				Zhang, Yiliang; Xiao, Minfeng; Horiyama, Tsukasa; Zhang, Yinfeng; Li, Xuechen; Nishino, Kunihiko; Yan, Aixin			The Multidrug Efflux Pump MdtEF Protects against Nitrosative Damage during the Anaerobic Respiration in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANCE; NITRIC-OXIDE; TRANSCRIPTIONAL REGULATION; ACID RESISTANCE; EXPORTER GENES; BACTERIA; EXPRESSION; REGULATOR; INDOLE; SIGNAL	Drug efflux represents an important protection mechanism in bacteria to withstand antibiotics and environmental toxic substances. Efflux genes constitute 6-18% of all transporters in bacterial genomes, yet the expression and functions of only a handful of them have been studied. Among the 20 efflux genes encoded in the Escherichia coli K-12 genome, only the AcrAB-TolC system is constitutively expressed. The expression, activities, and physiological functions of the remaining efflux genes are poorly understood. In this study we identified a dramatic up-regulation of an additional efflux pump, MdtEF, under the anaerobic growth condition of E. coli, which is independent of antibiotic exposure. We found that expression of MdtEF is up-regulated more than 20-fold under anaerobic conditions by the global transcription factor ArcA, resulting in increased efflux activity and enhanced drug tolerance in anaerobically grown E. coli. Cells lacking mdtEF display a significantly decreased survival rate under the condition of anaerobic respiration of nitrate. Deletion of the genes responsible for the biosynthesis of indole, tnaAB, or replacing nitrate with fumarate as the terminal electron acceptor during the anaerobic respiration restores the decreased survival of Delta mdtEF cells. Moreover, Delta mdtEF cells are susceptible to indole nitrosative derivatives, a class of toxic byproducts formed and accumulated within E. coli when the bacterium respires nitrate under anaerobic conditions. Taken together, we conclude that the multidrug efflux pump MdtEF is up-regulated during the anaerobic physiology of E. coli to protect the bacterium from nitrosative damage through expelling the nitrosyl indole derivatives out of the cells.	[Zhang, Yiliang; Xiao, Minfeng; Yan, Aixin] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yinfeng; Li, Xuechen] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Horiyama, Tsukasa; Nishino, Kunihiko] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	University of Hong Kong; University of Hong Kong; Osaka University	Yan, AX (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	ayan8@hku.hk		Xiao, Minfeng/0000-0002-0507-7352; Zhang, Yinfeng/0000-0002-4408-0175	Hong Kong General Research Fund [HKU 781509M]; Network Joint Research Center for Materials and Devices; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Hong Kong General Research Fund; Network Joint Research Center for Materials and Devices; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Hong Kong General Research Fund (HKU 781509M; to A. Y.) and by the Cooperative Research Program of "Network Joint Research Center for Materials and Devices" (to A. Y. and K. N.) as well as grants from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. N.).	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Astolfi P, 2006, ORG BIOMOL CHEM, V4, P3282, DOI 10.1039/b607680g; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ELLEDGE SJ, 1989, GENE DEV, V3, P185, DOI 10.1101/gad.3.2.185; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Hirakawa H, 2006, J BACTERIOL, V188, P5851, DOI 10.1128/JB.00301-06; Kawamura-Sato K, 1999, FEMS MICROBIOL LETT, V179, P345, DOI 10.1016/S0378-1097(99)00433-4; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Mettert EL, 2007, J BACTERIOL, V189, P3036, DOI 10.1128/JB.00052-07; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2008, IUBMB LIFE, V60, P569, DOI 10.1002/iub.90; Nishino K, 2008, J ANTIBIOT, V61, P120, DOI 10.1038/ja.2008.120; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K., 2008, MICROBE, V3, P179, DOI DOI 10.1128/MICR0BE.3.179.1; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Rankin LD, 2008, J BACTERIOL, V190, P6170, DOI 10.1128/JB.00508-08; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; SPIRO S, 1994, ANTON LEEUW INT J G, V66, P23, DOI 10.1007/BF00871630; Takatsuka Y, 2010, P NATL ACAD SCI USA, V107, P6559, DOI 10.1073/pnas.1001460107; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; Vanaja SK, 2009, J BACTERIOL, V191, P1868, DOI 10.1128/JB.01481-08; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Weiss B, 2001, MUTAT RES-DNA REPAIR, V461, P301, DOI 10.1016/S0921-8777(00)00062-8; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	41	51	51	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26576	26584		10.1074/jbc.M111.243261	http://dx.doi.org/10.1074/jbc.M111.243261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642439	hybrid, Green Published			2022-12-25	WOS:000293078200036
J	Guillon-Munos, A; Oikonomopoulou, K; Michel, N; Smith, CR; Petit-Courty, AS; Canepa, S; Reverdiau, P; Heuze-Vourc'h, N; Diamandis, EP; Courty, Y				Guillon-Munos, Audrey; Oikonomopoulou, Katerina; Michel, Noemie; Smith, Chistopher R.; Petit-Courty, Agne S.; Canepa, Sylvie; Reverdiau, Pascale; Heuze-Vourc'h, Nathalie; Diamandis, Eleftherios P.; Courty, Yves			Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; VEIN ENDOTHELIAL-CELLS; BREAST-CANCER CELLS; BIOLOGICAL-FLUIDS; LUNG-CANCER; TGF-BETA; SERINE PROTEASES; TERMINAL DOMAIN; FACTOR CTGF; EXPRESSION	Kallikrein-related peptidases (KLKs) are an emerging group of secreted serine proteases involved in several physiological and pathological processes. We used a degradomic approach to identify potential substrates of KLK12. MDA-MB-231cells were treated either with KLK12 or vehicle control, and the proteome of the overlying medium was analyzed by mass spectrometry. CCN1 (cyr61, ctgf, nov) was among the proteins released by the KLK12-treated cells, suggesting that KLK12 might be responsible for the shedding of this protein from the cell surface. Fragmentation of CCN1 by KLK12 was further confirmed in vitro, and the main cleavage site was localized in the hinge region between the first and second half of the recombinant protein. KLK12 can target all six members of the CCN family at different proteolytic sites. Limited proteolysis of CCNs (cyr61, ctgf, nov) was also observed in the presence of other members of the KLK family, such as KLK1, KLK5, and KLK14, whereas KLK6, KLK11, and KLK13 were unable to fragment CCNs. Because KLK12 seems to have a role in angiogenesis, we investigated the relations between KLK12, CCNs, and several factors known to be involved in angiogenesis. Solid phase binding assays showed that fragmentation of CCN1 or CCN5 by KLK12 prevents VEGF(165) binding, whereas it also triggers the release of intact VEGF and BMP2 from the CCN complexes. The KLK12-mediated release of TGF-beta 1 and FGF-2, either as intact or truncated forms, was found to be concentration-dependent. These findings suggest that KLK12 may indirectly regulate the bioavailability and activity of several growth factors through processing of their CCN binding partners.	[Guillon-Munos, Audrey; Michel, Noemie; Petit-Courty, Agne S.; Reverdiau, Pascale; Heuze-Vourc'h, Nathalie; Courty, Yves] Univ Tours, INSERM, U618, Fac Med, F-37032 Tours 1, France; [Oikonomopoulou, Katerina] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Smith, Chistopher R.; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Canepa, Sylvie] Univ Tours, CNRS, UMR INRA, Biacore Lab, F-37380 Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours	Courty, Y (corresponding author), Univ Tours, INSERM, U618, Fac Med, 10 Blvd Tonnelle, F-37032 Tours 1, France.	courty@univ-tours.fr	HEUZE-VOURC'H, Nathalie/P-8081-2016	Diamandis, Eleftherios/0000-0002-1589-820X; Heuze-Vourc'h, Nathalie/0000-0003-4929-5068; PETIT, AGNES/0000-0003-3214-807X; REVERDIAU, Pascale/0000-0002-7530-6237; Courty, Yves/0000-0003-3694-8517	INCa; Region Centre; Association pour la Recherche sur le Cancer [7935]	INCa(Institut National du Cancer (INCA) France); Region Centre(Region Centre-Val de Loire); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by INCa Grant MATRIGO, Region Centre Grant KalliCap, and Association pour la Recherche sur le Cancer Grant 7935.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Ball DK, 1998, BIOL REPROD, V59, P828, DOI 10.1095/biolreprod59.4.828; Ball DK, 2003, REPRODUCTION, V125, P271, DOI 10.1530/rep.0.1250271; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, BIOL CHEM, V388, P1215, DOI 10.1515/BC.2007.124; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Canalis E, 2007, ANN NY ACAD SCI, V1116, P50, DOI 10.1196/annals.1402.055; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Debela M, 2008, BIOL CHEM, V389, P623, DOI 10.1515/BC.2008.075; Dziadzio M, 2005, QJM-INT J MED, V98, P485, DOI 10.1093/qjmed/hci078; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Emami N, 2008, CLIN CHEM, V54, P1600, DOI 10.1373/clinchem.2008.105189; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Francischetti IMB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009356; Giusti B, 2005, ARTHRITIS RHEUM-US, V52, P3618, DOI 10.1002/art.21383; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holbourn KP, 2009, J CELL COMMUN SIGNAL, V3, P25, DOI 10.1007/s12079-009-0048-4; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Johnson SK, 2007, CANCER, V109, P1811, DOI 10.1002/cncr.22606; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KILLIAN CS, 1993, BIOCHEM BIOPH RES CO, V192, P940, DOI 10.1006/bbrc.1993.1506; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kolesnikova TV, 1998, ONCOGENE, V16, P747, DOI 10.1038/sj.onc.1201572; Komatsu N, 2007, CLIN CHIM ACTA, V377, P228, DOI 10.1016/j.cca.2006.10.009; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Memari N, 2007, BIOL CHEM, V388, P427, DOI 10.1515/BC.2007.049; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Munemasa S, 2007, BRIT J HAEMATOL, V139, P41, DOI 10.1111/j.1365-2141.2007.06721.x; Nakamura Y, 2009, J CELL COMMUN SIGNAL, V3, P105, DOI 10.1007/s12079-009-0040-z; Oikonomopoulou K, 2008, BIOL CHEM, V389, P747, DOI 10.1515/BC.2008.086; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Oikonomopoulou K, 2010, BIOL CHEM, V391, P299, DOI 10.1515/BC.2010.038; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Perbal B, 1999, P NATL ACAD SCI USA, V96, P869, DOI 10.1073/pnas.96.3.869; Perbal B, 2009, J CELL COMMUN SIGNAL, V3, P153, DOI 10.1007/s12079-009-0051-9; Planque C, 2005, BIOCHEM BIOPH RES CO, V329, P1260, DOI 10.1016/j.bbrc.2005.02.100; Roestenberg P, 2004, DIABETES CARE, V27, P1164, DOI 10.2337/diacare.27.5.1164; Sano A, 2007, INT J ONCOL, V30, P1493; Scarisbrick IA, 2008, BIOL CHEM, V389, P739, DOI 10.1515/BC.2008.085; Shaw JLV, 2008, BIOL CHEM, V389, P681, DOI 10.1515/BC.2008.069; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shi Y, 2006, TRANSPL P, V38, P2187, DOI 10.1016/j.transproceed.2006.06.093; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; Tong ZY, 2006, J ENDOCRINOL, V188, pR1, DOI 10.1677/joe.1.06719; Veveris-Lowe TL, 2007, SEMIN THROMB HEMOST, V33, P87, DOI 10.1055/s-2006-958467; Yang DH, 1998, J CLIN ENDOCR METAB, V83, P2593, DOI 10.1210/jc.83.7.2593; Yoshida K, 2007, BBA-GEN SUBJECTS, V1770, P672, DOI 10.1016/j.bbagen.2006.11.010; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346	64	51	55	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25505	25518		10.1074/jbc.M110.213231	http://dx.doi.org/10.1074/jbc.M110.213231			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628462	Green Published, hybrid			2022-12-25	WOS:000293073000013
J	Tokhtaeva, E; Sachs, G; Souda, P; Bassilian, S; Whitelegge, JP; Shoshani, L; Vagin, O				Tokhtaeva, Elmira; Sachs, George; Souda, Puneet; Bassilian, Sara; Whitelegge, Julian P.; Shoshani, Liora; Vagin, Olga			Epithelial Junctions Depend on Intercellular Trans-interactions between the Na,K-ATPase beta(1) Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; E-CADHERIN; TIGHT JUNCTIONS; ADHESION; GLYCOSYLATION; ANKYRIN; ATPASE; IDENTIFICATION; NA+,K+-ATPASE; ORGANIZATION	N-Glycans of the Na,K-ATPase beta(1) subunit are important for intercellular adhesion in epithelia, suggesting that epithelial junctions depend on N-glycan-mediated interactions between the beta(1) subunits of neighboring cells. The level of co-immunoprecipitation of the endogenous beta(1) subunit with various YFP-linked beta(1) subunits expressed in Madin-Darby canine kidney cells was used to assess beta(1)-beta(1) interactions. The amount of co-precipitated endogenous dog beta(1) was greater with dog YFP-beta(1) than with rat YFP-beta(1), showing that amino acid-mediated interactions are important for beta(1)-beta(1) binding. Co-precipitation of beta(1) was also less with the unglycosylated YFP-beta(1) than with glycosylated YFP-beta(1), indicating a role for N-glycans. Mixing cells expressing dog YFP-beta(1) with non-transfected cells increased the amount of co-precipitated beta(1), confirming the presence of intercellular (YFP-beta(1))-beta(1) complexes. Accordingly, disruption of intercellular junctions decreased the amount of co-precipitated beta(1) subunits. The decrease in beta(1) co-precipitation both with rat YFP-beta(1) and unglycosylated YFP-beta(1) was associated with decreased detergent stability of junctional proteins and increased paracellular permeability. Reducing N-glycan branching by specific inhibitors increased (YFP-beta(1))-beta(1) co-precipitation and strengthened intercellular junctions. Therefore, interactions between the beta(1) subunits of neighboring cells maintain integrity of intercellular junctions, and alterations in the beta(1) subunit N-glycan structure can regulate stability and tightness of intercellular junctions.	[Tokhtaeva, Elmira; Sachs, George; Bassilian, Sara; Vagin, Olga] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Tokhtaeva, Elmira; Sachs, George; Bassilian, Sara; Vagin, Olga] Vet Adm Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [Souda, Puneet; Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA; [Shoshani, Liora] IPN, CINVESTAV, Dept Physiol Biophys & Neurosci, Mexico City 07360, DF, Mexico	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Vagin, O (corresponding author), VAGLAHS W Los Angeles, 11301 Wilshire Blvd,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu			National Institutes of Health [DK077149, DK058333]; National Institutes of Health-NCRR [S10 RR023045]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058333, R01DK077149, R01DK058333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077149 and DK058333.; We thank Dr. Glenn Nagami (UCLA) and Dr. Ralf Jacob (Marburg University) for careful reading of the manuscript and helpful suggestions. The LTQ-FT was purchased with National Institutes of Health-NCRR support from Grant S10 RR023045.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Contreras RG, 2006, CELL MOL BIOL, V52, P31, DOI 10.1170/T758; Contreras RG, 2004, J MEMBRANE BIOL, V198, P147, DOI 10.1007/s00232-004-0670-2; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Doolittle MH, 2009, J LIPID RES, V50, P1173, DOI 10.1194/jlr.M800603-JLR200; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Laughery M, 2004, J BIOL CHEM, V279, P36339, DOI 10.1074/jbc.M402778200; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; NELSON WJ, 1991, SOC GEN PHY, V46, P77; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Padilla-Benavides T, 2010, MOL BIOL CELL, V21, P2217, DOI 10.1091/mbc.E10-01-0081; Piepenhagen PA, 1998, MOL BIOL CELL, V9, P3161, DOI 10.1091/mbc.9.11.3161; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Shin JM, 2005, BIOCHEMISTRY-US, V44, P16321, DOI 10.1021/bi051342q; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; SUN Y, 1994, BBA-PROTEIN STRUCT M, V1207, P236, DOI 10.1016/0167-4838(94)00074-3; Taniguchi K, 2001, J BIOCHEM, V129, P335, DOI 10.1093/oxfordjournals.jbchem.a002862; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; TREUHEIT MJ, 1993, J BIOL CHEM, V268, P13914; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200	31	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25801	25812		10.1074/jbc.M111.252247	http://dx.doi.org/10.1074/jbc.M111.252247			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642423	Green Published, hybrid			2022-12-25	WOS:000293073000042
J	An, XJ; Deng, ZY; Wang, T				An, Xiao Jing; Deng, Zhu Yun; Wang, Tai			OsSpo11-4, a Rice Homologue of the Archaeal TopVIA Protein, Mediates Double-Strand DNA Cleavage and Interacts with OsTopVIB	PLOS ONE			English	Article							TOPOISOMERASE-VI COMPLEX; TRANSGENIC ARABIDOPSIS PLANTS; MEIOTIC RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SYNAPSIS; MOLECULAR CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; SULFOLOBUS-SHIBATAE; STRESS TOLERANCE; GENE-EXPRESSION	DNA topoisomerase VI from Archaea, a heterotetrameric complex composed of two TopVIA and two TopVIB subunits, is involved in altering DNA topology during replication, transcription and chromosome segregation by catalyzing DNA strand transfer through transient double-strand breaks. The sequenced yeast and animal genomes encode only one homologue of the archaeal TopVIA subunit, namely Spo11, and no homologue of the archaeal TopVIB subunit. In yeast, Spo11 is essential for initiating meiotic recombination and this function appears conserved among other eukaryotes. In contrast to yeast and animals, studies in Arabidopsis and rice have identified three Spo11/TopVIA homologues and one TopVIB homologue in plants. Here, we further identified two novel Spo11/TopVIA homologues (named OsSpo11-4 and OsSpo11-5, respectively) that exist just in the monocot model plant Oryza sativa, indicating that at least five Spo11/TopVIA homologues are present in the rice genome. To reveal the biochemical function of the two novel Spo11/TopVIA homologues, we first examined the interactions among OsSpo11-1, OsSpo11-4, OsSpo11-5, and OsTopVIB by yeast two-hybrid assay. The results showed that OsSpo11-4 and OsTopVIB can self-interact strongly and among the 3 examined OsSpo11 proteins, only OsSpo11-4 interacted with OsTopVIB. Pull-down assay confirmed the interaction between OsSpo11-4 and OsTopVIB, which indicates that OsSpo11-4 may interact with OsTopVIB in vivo. Further in vitro enzymatic analysis revealed that among the above 4 proteins, only OsSpo11-4 exhibited double-strand DNA cleavage activity and its enzymatic activity appears dependent on Mg(2+) and independent of OsTopVIB, despite its interaction with OsTopVIB. We further analyzed the biological function of OsSpo11-4 by RNA interference and found that down-regulated expression of OsSpo11-4 led to defects in male meiosis, indicating OsSpo11-4 is required for meiosis.	[An, Xiao Jing; Deng, Zhu Yun; Wang, Tai] Chinese Acad Sci, Res Ctr Mol & Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing, Peoples R China; [An, Xiao Jing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	An, XJ (corresponding author), Chinese Acad Sci, Res Ctr Mol & Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing, Peoples R China.	twang@ibcas.ac.cn	Wang, Tai/G-2544-2010		Chinese Ministry of Science and Technology [2007CB947601]; Natural Science Fundation of China [30821007]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by grants from the Chinese Ministry of Science and Technology (grant Number: 2007CB947601) and Natural Science Fundation of China (grant Number: 30821007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Arencibia A, 1998, MOL BREEDING, V4, P99, DOI 10.1023/A:1009627409668; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Azumi Y, 2002, EMBO J, V21, P3081, DOI 10.1093/emboj/cdf285; BERGERAT A, 1994, J BIOL CHEM, V269, P27663; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Buhler C, 1998, NUCLEIC ACIDS RES, V26, P5157, DOI 10.1093/nar/26.22.5157; Celerin M, 2000, EMBO J, V19, P2739, DOI 10.1093/emboj/19.11.2739; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Connelly JC, 2004, MOL CELL, V13, P307, DOI 10.1016/S1097-2765(04)00056-5; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Corbett KD, 2003, EMBO J, V22, P151, DOI 10.1093/emboj/cdg008; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Ding ZJ, 2002, SEX PLANT REPROD, V15, P205, DOI 10.1007/s00497-002-0156-2; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Grelon M, 2001, EMBO J, V20, P589, DOI 10.1093/emboj/20.3.589; Grishin NV, 2000, NUCLEIC ACIDS RES, V28, P2229, DOI 10.1093/nar/28.11.2229; Hartung F, 2000, NUCLEIC ACIDS RES, V28, P1548, DOI 10.1093/nar/28.7.1548; Hartung F, 2002, CURR BIOL, V12, P1787, DOI 10.1016/S0960-9822(02)01218-6; Hartung F, 2001, GENE, V271, P81, DOI 10.1016/S0378-1119(01)00496-6; Hartung F, 2007, PLANT CELL, V19, P3090, DOI 10.1105/tpc.107.054817; Inagaki A, 2010, EPIGENETICS-US, V5, P255, DOI 10.4161/epi.5.4.11518; Jain M, 2008, PLANT CELL REP, V27, P767, DOI 10.1007/s00299-007-0491-8; Jain M, 2006, FEBS J, V273, P5245, DOI 10.1111/j.1742-4658.2006.05518.x; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kirik V, 2007, PLANT CELL, V19, P3100, DOI 10.1105/tpc.107.054361; Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049; Kuroda K, 2006, APPL MICROBIOL BIOT, V71, P127, DOI 10.1007/s00253-006-0395-5; Li WX, 2005, PLANT PHYSIOL, V138, P965, DOI 10.1104/pp.104.058347; LIN YK, 1994, GENETICS, V136, P769; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Lu Q, 1997, GENE, V200, P135, DOI 10.1016/S0378-1119(97)00393-4; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Malik SB, 2007, MOL BIOL EVOL, V24, P2827, DOI 10.1093/molbev/msm217; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Nag DK, 2006, MOL GENET GENOMICS, V276, P313, DOI 10.1007/s00438-006-0143-7; NELSON T, 1984, J CELL BIOL, V98, P558, DOI 10.1083/jcb.98.2.558; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Sasanuma H, 2007, NUCLEIC ACIDS RES, V35, P1119, DOI 10.1093/nar/gkl1162; Shannon M, 1999, FEBS LETT, V462, P329, DOI 10.1016/S0014-5793(99)01546-X; Stacey NJ, 2006, PLANT J, V48, P206, DOI 10.1111/j.1365-313X.2006.02867.x; Sugimoto-Shirasu K, 2005, P NATL ACAD SCI USA, V102, P18736, DOI 10.1073/pnas.0505883102; Sugimoto-Shirasu K, 2002, CURR BIOL, V12, P1782, DOI 10.1016/S0960-9822(02)01198-3; Tao JY, 2007, PLANT J, V51, P919, DOI 10.1111/j.1365-313X.2007.03190.x; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yin YH, 2002, P NATL ACAD SCI USA, V99, P10191, DOI 10.1073/pnas.152337599; Yu HX, 2010, CHROMOSOMA, V119, P625, DOI 10.1007/s00412-010-0284-7; Zhang LR, 2006, PLANT MOL BIOL, V60, P533, DOI 10.1007/s11103-005-4922-z	57	28	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20327	10.1371/journal.pone.0020327	http://dx.doi.org/10.1371/journal.pone.0020327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637817	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052200053
J	Chang, SS; Hsu, HL; Cheng, JC; Tseng, CP				Chang, Shy-Shin; Hsu, Hsung-Ling; Cheng, Ju-Chien; Tseng, Ching-Ping			An Efficient Strategy for Broad-Range Detection of Low Abundance Bacteria without DNA Decontamination of PCR Reagents	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; RESOLUTION MELTING ANALYSIS; RAPID IDENTIFICATION; TAQ POLYMERASE; MULTIPLEX PCR; AMPLIFICATION; DIAGNOSIS; CONTAMINATION; PATHOGENS	Background: Bacterial DNA contamination in PCR reagents has been a long standing problem that hampers the adoption of broad-range PCR in clinical and applied microbiology, particularly in detection of low abundance bacteria. Although several DNA decontamination protocols have been reported, they all suffer from compromised PCR efficiency or detection limits. To date, no satisfactory solution has been found. Methodology/Principal Findings: We herein describe a method that solves this long standing problem by employing a broad-range primer extension-PCR (PE-PCR) strategy that obviates the need for DNA decontamination. In this method, we first devise a fusion probe having a 3'-end complementary to the template bacterial sequence and a 5'-end non-bacterial tag sequence. We then hybridize the probes to template DNA, carry out primer extension and remove the excess probes using an optimized enzyme mix of Klenow DNA polymerase and exonuclease I. This strategy allows the templates to be distinguished from the PCR reagent contaminants and selectively amplified by PCR. To prove the concept, we spiked the PCR reagents with Staphylococcus aureus genomic DNA and applied PE-PCR to amplify template bacterial DNA. The spiking DNA neither interfered with template DNA amplification nor caused false positive of the reaction. Broad-range PE-PCR amplification of the 16S rRNA gene was also validated and minute quantities of template DNA (10-100 fg) were detectable without false positives. When adapting to real-time and high-resolution melting (HRM) analytical platforms, the unique melting profiles for the PE-PCR product can be used as the molecular fingerprints to further identify individual bacterial species. Conclusions/Significance: Broad-range PE-PCR is simple, efficient, and completely obviates the need to decontaminate PCR reagents. When coupling with real-time and HRM analyses, it offers a new avenue for bacterial species identification with a limited source of bacterial DNA, making it suitable for use in clinical and applied microbiology laboratories.	[Chang, Shy-Shin] Chang Gung Univ, Dept Med, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Chang, Shy-Shin] Chang Gung Mem Hosp, Dept Family Med & Emergency Med, Tao Yuan, Taiwan; [Hsu, Hsung-Ling; Tseng, Ching-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Cheng, Ju-Chien] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; China Medical University Taiwan	Chang, SS (corresponding author), Chang Gung Univ, Dept Med, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan.	ctseng@mail.cgu.edu.tw		TSENG, CHING-PING/0000-0002-2587-210X	Chang Gung Memorial Hospital [CMRPD170133, CMRPD180421]; Chang Gung Molecular Medicine Research Center [EMRPD190151]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung Molecular Medicine Research Center	This work was carried out with support from Chang Gung Memorial Hospital (CMRPD170133 and CMRPD180421) (http://www.cgmh.org.tw) and Chang Gung Molecular Medicine Research Center (EMRPD190151) (http://www.cgu.edu.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2000, J CLIN MICROBIOL, V38, P781, DOI 10.1128/JCM.38.2.781-788.2000; BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Cherkaoui A, 2009, J MICROBIOL METH, V79, P227, DOI 10.1016/j.mimet.2009.09.014; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Glushkov SA, 2009, ANAL BIOCHEM, V393, P135, DOI 10.1016/j.ab.2009.06.005; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; MAIWALD M, 1994, MOL CELL PROBE, V8, P11, DOI 10.1006/mcpr.1994.1002; Martineau F, 1998, J CLIN MICROBIOL, V36, P618, DOI 10.1128/JCM.36.3.618-623.1998; McCabe KM, 1999, MOL GENET METAB, V66, P205, DOI 10.1006/mgme.1998.2795; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; OU CY, 1991, BIOTECHNIQUES, V10, P442; Pandit L, 2005, J MED MICROBIOL, V54, P539, DOI 10.1099/jmm.0.45599-0; Philipp S, 2010, TRANSFUS MED HEMOTH, V37, P21, DOI 10.1159/000265571; RELLO J, 1993, INTENS CARE MED, V19, P22, DOI 10.1007/BF01709273; Reno WL, 2001, AM SURGEON, V67, P508; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Silkie SS, 2008, J MICROBIOL METH, V72, P275, DOI 10.1016/j.mimet.2007.12.011; Sleigh J, 2001, INTENS CARE MED, V27, P1269, DOI 10.1007/s001340100981; Sontakke S, 2009, J MICROBIOL METH, V76, P217, DOI 10.1016/j.mimet.2008.11.002; Spangler R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007010; Steinman CR, 1997, ANAL BIOCHEM, V244, P328, DOI 10.1006/abio.1996.9896; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Tajiri-Utagawa E, 2009, J CLIN MICROBIOL, V47, P435, DOI 10.1128/JCM.01247-08; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Trevini S., 2000, TXB DIAGNOSTIC MICRO, P998; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Wang Q, 2010, J CLIN MICROBIOL, V48, P2066, DOI 10.1128/JCM.02014-09; Weile J, 2009, ANAL BIOANAL CHEM, V394, P731, DOI 10.1007/s00216-009-2779-8; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; Won H, 2010, J CLIN MICROBIOL, V48, P3410, DOI 10.1128/JCM.00718-10; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Yang S, 2009, J CLIN MICROBIOL, V47, P2252, DOI 10.1128/JCM.00033-09	43	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20303	10.1371/journal.pone.0020303	http://dx.doi.org/10.1371/journal.pone.0020303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637859	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200050
J	Muhlfeld, C; Das, SK; Heinzel, FR; Schmidt, A; Post, H; Schauer, S; Papadakis, T; Kummer, W; Hoefler, G				Muehlfeld, Christian; Das, Suman Kumar; Heinzel, Frank R.; Schmidt, Albrecht; Post, Heiner; Schauer, Silvia; Papadakis, Tamara; Kummer, Wolfgang; Hoefler, Gerald			Cancer Induces Cardiomyocyte Remodeling and Hypoinnervation in the Left Ventricle of the Mouse Heart	PLOS ONE			English	Article							NEUROPEPTIDE-Y; TNF-ALPHA; STEREOLOGICAL ESTIMATION; LIPOTOXIC DISEASES; CACHEXIA; NUMBER; TUMOR; INNERVATION; ANOREXIA; MUSCLE	Cancer is often associated with cachexia, cardiovascular symptoms and autonomic dysregulation. We tested whether extracardiac cancer directly affects the innervation of left ventricular myocardium. Mice injected with Lewis lung carcinoma cells (tumor group, TG) or PBS (control group, CG) were analyzed after 21 days. Cardiac function (echocardiography), serum levels of TNF-alpha and Il-6 (ELISA), structural alterations of cardiomyocytes and their innervation (design-based stereology) and levels of innervation-related mRNA (quantitative RT-PCR) were analysed. The groups did not differ in various functional parameters. Serum levels of TNF-alpha and Il-6 were elevated in TG. The total length of axons in the left ventricle was reduced. The number of dense core vesicles per axon profile was reduced. Decreased myofibrillar volume, increased sarcoplasmic volume and increased volume of lipid droplets were indicative of metabolic alterations of TG cardiomyocytes. In the heart, the mRNA level of nerve growth factor was reduced whereas that of beta 1-adrenergic receptor was unchanged in TG. In the stellate ganglion of TG, mRNA levels of nerve growth factor and neuropeptide Y were decreased and that of tyrosine hydroxylase was increased. In summary, cancer induces a systemic pro-inflammatory state, a significant reduction in myocardial innervation and a catabolic phenotype of cardiomyocytes in the mouse. Reduced expression of nerve growth factor may account for the reduced myocardial innervation.	[Muehlfeld, Christian; Papadakis, Tamara; Kummer, Wolfgang] Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany; [Das, Suman Kumar; Schauer, Silvia; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Heinzel, Frank R.; Schmidt, Albrecht; Post, Heiner] Med Univ Graz, Div Cardiol, Graz, Austria	Justus Liebig University Giessen; Medical University of Graz; Medical University of Graz	Muhlfeld, C (corresponding author), Univ Giessen, Inst Anat & Cell Biol, Giessen, Germany.	christian.muehlfeld@anatomie.med.uni-giessen.de	Hoefler, Gerald/B-7006-2008; Hoefler, Gerald/H-1796-2016; das, suman kumar/E-1270-2015	Hoefler, Gerald/0000-0002-9056-3063; das, suman kumar/0000-0002-0539-5174; Heinzel, Frank R./0000-0002-4529-5282; Schmidt, Albrecht/0000-0003-4783-4603; Kummer, Wolfgang/0000-0002-3946-0683	Excellence Cluster Cardiopulmonary System; Verein zur Forderung der Krebsforschung in Giessen e.V.; Medical University of Graz	Excellence Cluster Cardiopulmonary System(German Research Foundation (DFG)); Verein zur Forderung der Krebsforschung in Giessen e.V.; Medical University of Graz	This study was supported by the Excellence Cluster Cardiopulmonary System (WK) and by the Verein zur Forderung der Krebsforschung in Giessen e.V. (CM). SD was funded in part by the PhD program Molecular Medicine of the Medical University of Graz. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI A, 1987, PROG CARDIOVASC DIS, V30, P45, DOI 10.1016/0033-0620(87)90010-7; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Bettermann H, 2001, CLIN PHYSIOL, V21, P411, DOI 10.1046/j.1365-2281.2001.00342.x; Brinks H, 2009, J THORAC CARDIOV SUR, V137, P742, DOI 10.1016/j.jtcvs.2008.09.020; Bruel A, 2005, BASIC RES CARDIOL, V100, P311, DOI 10.1007/s00395-005-0524-9; BRUERA E, 1986, CANCER TREAT REP, V70, P1383; BUDZYNSKI W, 1982, ARCH IMMUNOL THER EX, V30, P363; BURCH GE, 1968, CHEST, V54, P5; Carbo N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167; DONALD DE, 1974, CIRC RES, V34, P417, DOI 10.1161/01.RES.34.4.417; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x; Fukuda T, 2009, INT J ONCOL, V34, P61, DOI 10.3892/ijo_00000129; Goldberg Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1207, DOI 10.1152/ajpcell.1998.275.5.C1207; GOULD GA, 1986, THORAX, V41, P372, DOI 10.1136/thx.41.5.372; GROS D, 1982, J HISTOCHEM CYTOCHEM, V30, P193, DOI 10.1177/30.3.7061821; GULBENKIAN S, 1987, J AUTONOM NERV SYST, V18, P235, DOI 10.1016/0165-1838(87)90122-6; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Inui A, 1999, MOL MED TODAY, V5, P79, DOI 10.1016/S1357-4310(98)01395-1; Jatoi A, 2001, CANCER-AM CANCER SOC, V92, P629, DOI 10.1002/1097-0142(20010801)92:3<629::AID-CNCR1363>3.0.CO;2-M; Laviano A, 2003, LANCET ONCOL, V4, P686, DOI 10.1016/S1470-2045(03)01247-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x; McDermott BJ, 2007, CURR TOP MED CHEM, V7, P1692, DOI 10.2174/156802607782340939; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; MENDEZ J, 1960, METABOLISM, V9, P184; MILLAR BC, 1994, AM J PHYSIOL, V266, pC1271, DOI 10.1152/ajpcell.1994.266.5.C1271; Momose M, 2001, BASIC RES CARDIOL, V96, P539, DOI 10.1007/s003950170004; Muehlfeld C, 2010, CARDIOVASC PATHOL, V19, P65, DOI 10.1016/j.carpath.2008.10.015; Muhlfeld C, 2010, J APPL PHYSIOL, V108, P1402, DOI 10.1152/japplphysiol.01013.2009; Nevruz O, 2007, TOHOKU J EXP MED, V211, P121, DOI 10.1620/tjem.211.121; NYENGAARD JR, 1992, J MICROSC-OXFORD, V165, P427, DOI 10.1111/j.1365-2818.1992.tb01497.x; Pajak B, 2008, J PHYSIOL PHARMACOL, V59, P251; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; PETERS SR, 1980, CARDIOLOGY, V65, P85, DOI 10.1159/000170798; Schmidt AG, 2000, J MOL CELL CARDIOL, V32, P1735, DOI 10.1006/jmcc.2000.1209; Schuenemann M, 2008, NAT CLIN PRACT ONCOL, V5, P632, DOI 10.1038/ncponc1226; SJOSTROM M, 1987, J SURG RES, V42, P304, DOI 10.1016/0022-4804(87)90148-X; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Takei Y, 2008, TRENDS MOL MED, V14, P381, DOI 10.1016/j.molmed.2008.07.002; Takei Y, 2008, MOL BIOL CELL, V19, P855, DOI 10.1091/mbc.E07-06-0624; Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952; TESSITORE L, 1993, ARCH BIOCHEM BIOPHYS, V306, P52, DOI 10.1006/abbi.1993.1479; Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Weibel ER, 1979, PRACTICAL METHODS BI, V1; Wende AR, 2010, BBA-MOL CELL BIOL L, V1801, P311, DOI 10.1016/j.bbalip.2009.09.023; WHARTON J, 1987, EXPERIENTIA, V43, P821, DOI 10.1007/BF01945360	52	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20424	10.1371/journal.pone.0020424	http://dx.doi.org/10.1371/journal.pone.0020424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637823	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200063
J	Carlander, B; Puech-Cathala, AM; Jaussent, I; Scholz, S; Bayard, S; Cochen, V; Dauvilliers, Y				Carlander, Bertrand; Puech-Cathala, Anne Marie; Jaussent, Isabelle; Scholz, Sabine; Bayard, Sophie; Cochen, Valerie; Dauvilliers, Yves			Low Vitamin D in Narcolepsy with Cataplexy	PLOS ONE			English	Article							RECEPTOR; ONSET	Background: Narcolepsy with cataplexy (NC) is currently thought to be an autoimmune-mediated disorder in which environmental risk factors make a significant contribution to its development. It was proposed that vitamin D deficiency plays a role in autoimmune diseases. Here we investigated whether NC can be associated with 25-hydroxyvitamin D (25(OH)D) level deficiency in patients with NC compared with gender-and age-matched normal controls. Methodology: Serum level of 25 (OH)D was determined in 51 European patients with typical NC compared to 55 age-, gender-, and ethnicity-matched healthy controls. Demographic and clinical data (age at onset, duration and severity of disease at baseline, and treatment intake at time of study) and season of blood sampling were collected to control for confounding variables. Principal Findings: Serum 25(OH)D concentration was lower in NC compared to controls (median, 59.45 nmol/l [extreme values 24.05-124.03] vs. 74.73 nmol/l [26.88-167.48] p = 0.0039). Patients with NC had significantly greater vitamin D deficiency (<75 nmol/l) than controls (72.5% vs 50.9%, p = 0.0238). Division into quartiles of the whole sample revealed that the risk of being affected with NC increased with lower 25(OH)D level, with a 5.34 OR [1.65-17.27] for the lowest quartile (p = 0.0051). Further adjustment for BMI did not modify the strength of the association (OR: 3.63, 95% CI = 1.06-12.46, p = 0.0191). No between BMI and 25(OH)D interaction, and no correlation between 25(OH)D level and disease duration or severity or treatment intake were found in NC. Conclusion: We found a higher frequency of vitamin D deficiency in NC. Further studies are needed to assess the contribution of hypovitaminosis D to the risk of developing narcolepsy, and to focus on the utility of assessing vitamin D status to correct potential deficiency.	[Carlander, Bertrand; Scholz, Sabine; Bayard, Sophie; Cochen, Valerie; Dauvilliers, Yves] CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France; [Puech-Cathala, Anne Marie] CHU Montpellier, Hop Lapeyronie, Lab Hormonol, Montpellier, France; [Jaussent, Isabelle; Bayard, Sophie; Dauvilliers, Yves] Univ Montpellier 1, INSERM, U1061, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France.	ydauvilliers@yahoo.fr		Jaussent, Isabelle/0000-0002-8205-7590; Bayard, Sophie/0000-0003-0767-4924; Dauvilliers, yves/0000-0003-0683-6506				Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dauvilliers Y, 2009, NEUROLOGY, V73, P1333, DOI 10.1212/WNL.0b013e3181bd1344; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Iber C., 2007, AASM MANUAL SCORING; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; *LUNG BLOOD I, CLIN GUID ID EV TREA; Pierrot-Deseilligny C, 2010, BRAIN, V133, P1869, DOI 10.1093/brain/awq147; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851	17	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20433	10.1371/journal.pone.0020433	http://dx.doi.org/10.1371/journal.pone.0020433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633708	Green Submitted, gold, Green Published			2022-12-25	WOS:000291006500062
J	Ruzek, D; Salat, J; Singh, SK; Kopecky, J				Ruzek, Daniel; Salat, Jiri; Singh, Sunit K.; Kopecky, Jan			Breakdown of the Blood-Brain Barrier during Tick-Borne Encephalitis in Mice Is Not Dependent on CD8(+) T-Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; WEST-NILE-VIRUS; MICROVASCULAR ENDOTHELIAL-CELLS; TIGHT JUNCTION PROTEINS; MULTIPLE-SCLEROSIS; INFLAMMATORY RESPONSE; PERMEABILITY CHANGES; MOUSE MODEL; IN-VITRO; INFECTION	Tick-borne encephalitis (TBE) virus causes severe encephalitis with serious sequelae in humans. The disease is characterized by fever and debilitating encephalitis that can progress to chronic illness or fatal infection. In this study, changes in permeability of the blood-brain barrier (BBB) in two susceptible animal models (BALB/c, and C57Bl/6 mice) infected with TBE virus were investigated at various days after infection by measuring fluorescence in brain homogenates after intraperitoneal injection of sodium fluorescein, a compound that is normally excluded from the central nervous system. We demonstrate here that TBE virus infection, in addition to causing fatal encephalitis in mice, induces considerable breakdown of the BBB. The permeability of the BBB increased at later stages of TBE infection when high virus load was present in the brain (i.e., BBB breakdown was not necessary for TBE virus entry into the brain), and at the onset of the first severe clinical symptoms of the disease, which included neurological signs associated with sharp declines in body weight and temperature. The increased BBB permeability was in association with dramatic upregulation of proinflammatory cytokine/chemokine mRNA expression in the brain. Breakdown of the BBB was also observed in mice deficient in CD8(+) T-cells, indicating that these cells are not necessary for the increase in BBB permeability that occurs during TBE. These novel findings are highly relevant to the development of future therapies designed to control this important human infectious disease.	[Ruzek, Daniel; Salat, Jiri; Kopecky, Jan] Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic; [Salat, Jiri] Vet Res Inst, CS-62132 Brno, Czech Republic; [Singh, Sunit K.] Ctr Cellular & Mol Biol, Sect Infect Dis & Immunobiol, Hyderabad 500007, Andhra Pradesh, India	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Veterinary Research Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Ruzek, D (corresponding author), Acad Sci Czech Republic, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.	ruzekd@paru.cas.cz	Salát, Jiří/F-6295-2019; Růžek, Daniel/G-9275-2014; Kopecky, Jan/G-9347-2014	Salát, Jiří/0000-0002-9915-8953; Růžek, Daniel/0000-0003-4655-2380; 	Czech Science Foundation [P302/10/P438, P502/11/2116]; Ministry of Education, Youth, and Sports of the Czech Republic [Z60220518, LC06009, CZ.1.05/2.1.00/01.006 (ED006/01/01)]; Council and Industrial Research, India; Academy of Sciences of the Czech Republic [22/EU/Czech-CSIR/(18)/09-ISTAD]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Council and Industrial Research, India; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The authors acknowledge financial support by the Czech Science Foundation project No. P302/10/P438 and No. P502/11/2116, and grants Z60220518 and LC06009 from the Ministry of Education, Youth, and Sports of the Czech Republic. JS was supported by the AdmireVet project No. CZ.1.05/2.1.00/01.006 (ED006/01/01) of the Ministry of Education, Youth and Sports of the Czech Republic. SKS was supported by Science and Technology bilateral co-operation between Council and Industrial Research, India, and the Academy of Sciences of the Czech Republic (ref: 22/EU/Czech-CSIR/(18)/09-ISTAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; ANDERSEN IH, 1991, J NEUROIMMUNOL, V31, P155, DOI 10.1016/0165-5728(91)90021-X; Atrasheuskaya AV, 2003, CLIN EXP IMMUNOL, V131, P148, DOI 10.1046/j.1365-2249.2003.02050.x; Babu S, 2003, J IMMUNOL, V171, P6723, DOI 10.4049/jimmunol.171.12.6723; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Beliaeva I A, 1995, Zh Nevrol Psikhiatr Im S S Korsakova, V95, P25; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859; Chekhonin VP, 2002, CLIN CHIM ACTA, V320, P117, DOI 10.1016/S0009-8981(02)00057-8; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09; Grygorczuk Sambor, 2006, Neurol Neurochir Pol, V40, P106; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Hooper DC, 2001, J IMMUNOL, V167, P3470, DOI 10.4049/jimmunol.167.6.3470; Irani DN, 2001, ADV VIRUS RES, V56, P175, DOI 10.1016/S0065-3527(01)56007-8; Jeohn GH, 1998, J NEUROIMMUNOL, V85, P1, DOI 10.1016/S0165-5728(97)00204-X; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130; Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643; Lou JN, 1997, NEUROREPORT, V8, P629, DOI 10.1097/00001756-199702100-00010; MATHUR A, 1992, INT J EXP PATHOL, V73, P603; McMinn PC, 1996, VIROLOGY, V220, P414, DOI 10.1006/viro.1996.0329; Michalowska-Wender Grazyna, 2006, Pol Merkur Lekarski, V20, P46; MONATH TP, 1983, LAB INVEST, V48, P399; Morgan L, 2007, NEUROSCIENCE, V147, P664, DOI 10.1016/j.neuroscience.2007.04.051; Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0; Olsen AL, 2007, ANTIVIR RES, V75, P104, DOI 10.1016/j.antiviral.2006.11.013; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pulzova L, 2009, FEMS IMMUNOL MED MIC, V57, P203, DOI 10.1111/j.1574-695X.2009.00594.x; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023; Ruzek D, 2008, VIRUS RES, V137, P142, DOI 10.1016/j.virusres.2008.05.013; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; Silver NC, 2001, MULT SCLER J, V7, P75, DOI 10.1177/135245850100700201; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; SUSS J, 2008, EURO SURVEILL, V13; Thach DC, 2000, J VIROL, V74, P6156, DOI 10.1128/JVI.74.13.6156-6161.2000; Tigabu B, 2010, VIROLOGY, V408, P57, DOI 10.1016/j.virol.2010.08.021; Tigabu B, 2009, J MED VIROL, V81, P1261, DOI 10.1002/jmv.21524; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63	52	79	82	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20472	10.1371/journal.pone.0020472	http://dx.doi.org/10.1371/journal.pone.0020472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629771	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200058
J	Lyngdoh, T; Marques-Vidal, P; Paccaud, F; Preisig, M; Waeber, G; Bochud, M; Vollenweider, P				Lyngdoh, Tanica; Marques-Vidal, Pedro; Paccaud, Fred; Preisig, Martin; Waeber, Gerard; Bochud, Murielle; Vollenweider, Peter			Elevated Serum Uric Acid Is Associated with High Circulating Inflammatory Cytokines in the Population-Based Colaus Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; C-REACTIVE PROTEIN; METABOLIC SYNDROME; BLOOD-PRESSURE; HEART-FAILURE; RENAL-DISEASE; OBESITY; HYPERURICEMIA; HYPERTENSION; INTERLEUKIN-6	Background: The relation of serum uric acid (SUA) with systemic inflammation has been little explored in humans and results have been inconsistent. We analyzed the association between SUA and circulating levels of interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha) and C-reactive protein (CRP). Methods and Findings: This cross-sectional population-based study conducted in Lausanne, Switzerland, included 6085 participants aged 35 to 75 years. SUA was measured using uricase-PAP method. Plasma TNF-alpha, IL-1 beta and IL-6 were measured by a multiplexed particle-based flow cytometric assay and hs-CRP by an immunometric assay. The median levels of SUA, IL-6, TNF-alpha, CRP and IL-1 beta were 355 mu mol/L, 1.46 pg/mL, 3.04 pg/mL, 1.2 mg/L and 0.34 pg/mL in men and 262 mu mol/L, 1.21 pg/mL, 2.74 pg/mL, 1.3 mg/L and 0.45 pg/mL in women, respectively. SUA correlated positively with IL-6, TNF-alpha and CRP and negatively with IL-1 beta (Spearman r: 0.04, 0.07, 0.20 and 0.05 in men, and 0.09, 0.13, 0.30 and 0.07 in women, respectively, P < 0.05). In multivariable analyses, SUA was associated positively with CRP (beta coefficient +/- SE = 0.35 +/- 0.02, P < 0.001), TNF-alpha (0.08 +/- 0.02, P < 0.001) and IL-6 (0.10 +/- 0.03, P < 0.001), and negatively with IL-1 beta (-0.07 +/- 0.03, P = 0.027). Upon further adjustment for body mass index, these associations were substantially attenuated. Conclusions: SUA was associated positively with IL-6, CRP and TNF-alpha and negatively with IL-1 beta, particularly in women. These results suggest that uric acid contributes to systemic inflammation in humans and are in line with experimental data showing that uric acid triggers sterile inflammation.	[Lyngdoh, Tanica; Marques-Vidal, Pedro; Paccaud, Fred; Bochud, Murielle] Univ Lausanne, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Preisig, Martin] CHUV, Dept Psychiat, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHUV, Dept Med, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Lyngdoh, T (corresponding author), Univ Lausanne, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	murielle.bochud@chuv.ch	Lyngdoh, Tanica/F-3595-2011; Colaus, PsyColaus/K-6607-2013; Marques-Vidal, Pedro M/C-9449-2009; paccaud, fred/M-7516-2019; Bochud, Murielle/A-3981-2010	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bochud, Murielle/0000-0002-5727-0218; Waeber, Gerard/0000-0003-4193-788X; Preisig, Martin/0000-0001-5689-4259	GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss National Science Foundation [33CSCO-122661]	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The CoLaus study was supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, Switzerland, and the Swiss National Science Foundation (grant no: 33CSCO-122661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bonora E, 1996, INT J OBESITY, V20, P975; Bordoni Valeria, 2005, Curr Drug Discov Technol, V2, P29, DOI 10.2174/1570163053175457; Chang CH, 2009, ARCH GERONTOL GERIAT, V49, pS46, DOI 10.1016/S0167-4943(09)70013-5; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Johnson RJ, 2005, AM J HYPERTENS, V18, P431, DOI 10.1016/j.amjhyper.2004.08.035; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Leyva F, 1998, EUR HEART J, V19, P1814, DOI 10.1053/euhj.1998.1188; Manzato E, 2007, INTERN EMERG MED, V2, P1, DOI 10.1007/s11739-007-0001-6; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsuura F, 1998, METABOLISM, V47, P929, DOI 10.1016/S0026-0495(98)90346-8; Montalcini T, 2007, INTERN EMERG MED, V2, P19, DOI 10.1007/s11739-007-0004-3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Netea MG, 1997, BLOOD, V89, P577, DOI 10.1182/blood.V89.2.577; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Olexa P, 2002, WIEN KLIN WOCHENSCHR, V114, P211; RAO GN, 1991, J BIOL CHEM, V266, P8604; ROBERGE CJ, 1994, J IMMUNOL, V152, P5485; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Ruggiero C, 2007, AM J CARDIOL, V100, P115, DOI 10.1016/j.amjcard.2007.02.065; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; VON KR, 2010, NEUROIMMUNOMODULAT, V17, P39, DOI DOI 10.1159/000243084; Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	37	137	149	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19901	10.1371/journal.pone.0019901	http://dx.doi.org/10.1371/journal.pone.0019901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625475	Green Published, gold			2022-12-25	WOS:000290793400019
J	Horio, N; Yoshida, R; Yasumatsu, K; Yanagawa, Y; Ishimaru, Y; Matsunami, H; Ninomiya, Y				Horio, Nao; Yoshida, Ryusuke; Yasumatsu, Keiko; Yanagawa, Yuchio; Ishimaru, Yoshiro; Matsunami, Hiroaki; Ninomiya, Yuzo			Sour Taste Responses in Mice Lacking PKD Channels	PLOS ONE			English	Article							CHORDA TYMPANI; INTRACELLULAR PH; RECEPTOR-CELLS; ACID; RAT; SWEET; ACTIVATION; EXPRESSION; CURRENTS; COMPLEX	Background: The polycystic kidney disease-like ion channel PKD2L1 and its associated partner PKD1L3 are potential candidates for sour taste receptors. PKD2L1 is expressed in type III taste cells that respond to sour stimuli and genetic elimination of cells expressing PKD2L1 substantially reduces chorda tympani nerve responses to sour taste stimuli. However, the contribution of PKD2L1 and PKD1L3 to sour taste responses remains unclear. Methodology/Principal Findings: We made mice lacking PKD2L1 and/or PKD1L3 gene and investigated whole nerve responses to taste stimuli in the chorda tympani or the glossopharyngeal nerve and taste responses in type III taste cells. In mice lacking PKD2L1 gene, chorda tympani nerve responses to sour, but not sweet, salty, bitter, and umami tastants were reduced by 25-45% compared with those in wild type mice. In contrast, chorda tympani nerve responses in PKD1L3 knockout mice and glossopharyngeal nerve responses in single-and double-knock-out mice were similar to those in wild type mice. Sour taste responses of type III fungiform taste cells (GAD67-expressing taste cells) were also reduced by 25-45% by elimination of PKD2L1. Conclusions/Significance: These findings suggest that PKD2L1 partly contributes to sour taste responses in mice and that receptors other than PKDs would be involved in sour detection.	[Horio, Nao; Yoshida, Ryusuke; Yasumatsu, Keiko; Ninomiya, Yuzo] Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Fukuoka 812, Japan; [Yasumatsu, Keiko] Asahi Univ, Sch Dent, Dept Oral Physiol, Gifu, Japan; [Yanagawa, Yuchio] Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] CREST, JST, Tokyo, Japan; [Ishimaru, Yoshiro] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Ishimaru, Yoshiro; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Kyushu University; Asahi University; Gunma University; Japan Science & Technology Agency (JST); University of Tokyo; Duke University	Horio, N (corresponding author), Kyushu Univ, Sect Oral Neurosci, Grad Sch Dent Sci, Fukuoka 812, Japan.	yuninom@dent.kyushu-u.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020		KAKENHI [18109013, 18077004, 19880008, 20780089]; NIH; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005782] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23689076] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI 18109013, 18077004 (YN), 19880008, 20780089 (YI) and by NIH grants (HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Danilova V, 2002, J NEUROPHYSIOL, V88, P579, DOI 10.1152/jn.2002.88.2.579; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; DESIMONE JA, 2011, CHEM SENSES; Gao N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-20; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Inada H, 2008, EMBO REP, V9, P690, DOI 10.1038/embor.2008.89; Ishii S, 2009, BIOCHEM BIOPH RES CO, V385, P346, DOI 10.1016/j.bbrc.2009.05.069; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2010, FASEB J, V24, P4058, DOI 10.1096/fj.10-162925; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; Lin W, 2004, J NEUROPHYSIOL, V92, P2909, DOI 10.1152/jn.01198.2003; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Lyall V, 2006, J GEN PHYSIOL, V127, P15, DOI 10.1085/jgp.200509384; Lyall V, 2001, AM J PHYSIOL-CELL PH, V281, pC1005, DOI 10.1152/ajpcell.2001.281.3.C1005; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; NINOMIYA Y, 1988, BRAIN RES, V451, P319, DOI 10.1016/0006-8993(88)90777-9; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; Shigemura N, 2008, BIOCHEM BIOPH RES CO, V367, P356, DOI 10.1016/j.bbrc.2007.12.146; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Ugawa S, 2003, J NEUROSCI, V23, P3616; Yasumatsu K, 2009, AM J CLIN NUTR, V90, p747S, DOI 10.3945/ajcn.2009.27462J; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052; Yoshida R, 2006, J NEUROPHYSIOL, V96, P3088, DOI 10.1152/jn.00409.2006; Yoshida R, 2010, P NATL ACAD SCI USA, V107, P935, DOI 10.1073/pnas.0912048107; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075	43	84	89	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20007	10.1371/journal.pone.0020007	http://dx.doi.org/10.1371/journal.pone.0020007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625513	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200039
J	Lei, T; Liang, XD; Yang, JS; Yan, MY; Zheng, L; Walcheck, B; Ji, YD				Lei, Ting; Liang, Xudong; Yang, Junshu; Yan, Meiying; Zheng, Li; Walcheck, Bruce; Ji, Yinduo			The C-Terminal Domain of the Novel Essential Protein Gcp Is Critical for Interaction with Another Essential Protein YeaZ of Staphylococcus aureus	PLOS ONE			English	Article							SCANNING MUTAGENESIS; GENOME MAINTENANCE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ESSENTIAL GENES; KEOPS COMPLEX; GLYCOPROTEASE; IDENTIFICATION; PHENOTYPES; RESOLUTION	Previous studies have demonstrated that the novel protein Gcp is essential for the viability of various bacterial species including Staphylococcus aureus; however, the reason why it is required for bacterial growth remains unclear. In order to explore the potential mechanisms of this essentiality, we performed RT-PCR analysis and revealed that the gcp gene (sa1854) was co-transcribed with sa1855, yeaZ (sa1856) and sa1857 genes, indicating these genes are located in the same operon. Furthermore, we demonstrated that Gcp interacts with YeaZ using a yeast two-hybrid (Y2H) system and in vitro pull down assays. To characterize the Gcp-YeaZ interaction, we performed alanine scanning mutagenesis on the residues of C-terminal segment of Gcp. We found that the mutations of the C-terminal Y317-F322 region abolished the interaction of Gcp and YeaZ, and the mutations of the D324-N329 and S332-Y336 regions alleviated Gcp binding to YeaZ. More importantly, we demonstrated that these key regions of Gcp are also necessary for the bacterial survival since these mutated Gcp could not complement the depletion of endogenous Gcp. Taken together, our data suggest that the interaction of Gcp and YeaZ may contribute to the essentiality of Gcp for S. aureus survival. Our findings provide new insights into the potential mechanisms and biological functions of this novel essential protein.	[Lei, Ting; Liang, Xudong; Yang, Junshu; Yan, Meiying; Zheng, Li; Walcheck, Bruce; Ji, Yinduo] Univ Minnesota, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Lei, T (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA.	jixxx002@umn.edu			National Institutes of Health [AI065740, AI078951]; MAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078951, R21AI065740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant AI065740, AI078951, and partially by the MAES Competitive Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLAH KM, 1992, INFECT IMMUN, V60, P56, DOI 10.1128/IAI.60.1.56-62.1992; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; Fellinger K, 2008, ANAL BIOCHEM, V373, P176, DOI 10.1016/j.ab.2007.10.016; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Haussuehl K, 2009, BIOCHEM J, V423, P333, DOI 10.1042/BJ20091023; HECKER A, 2008, EMBO J; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Hecker A, 2009, BIOCHEM SOC T, V37, P29, DOI 10.1042/BST0370029; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; James P, 1996, GENETICS, V144, P1425; Jeudy S, 2005, ACTA CRYSTALLOGR F, V61, P848, DOI 10.1107/S1744309105025856; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Ji YD, 2002, PHARMACOGENOMICS, V3, P315, DOI 10.1517/14622416.3.3.315; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Loomba PS, 2010, J GLOB INFECT DIS, V2, P275, DOI 10.4103/0974-777X.68535; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nichols CE, 2006, PROTEINS, V64, P111, DOI 10.1002/prot.20982; Oberto J, 2009, NUCLEIC ACIDS RES, V37, P5343, DOI 10.1093/nar/gkp557; Schmid MB, 2004, NAT REV MICROBIOL, V2, P739, DOI 10.1038/nrmicro978; Watt MAV, 1997, FEMS MICROBIOL LETT, V147, P37, DOI 10.1111/j.1574-6968.1997.tb10217.x; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1230, DOI 10.1107/S1744309109022192; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741; Zhang L, 2000, GENE, V255, P297, DOI 10.1016/S0378-1119(00)00325-5; Zheng L, 2005, FEMS MICROBIOL LETT, V245, P279, DOI 10.1016/j.femsle.2005.03.017; Zheng L, 2007, J BACTERIOL, V189, P2734, DOI 10.1128/JB.01806-06	39	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20163	10.1371/journal.pone.0020163	http://dx.doi.org/10.1371/journal.pone.0020163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625506	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200051
J	DiAngelo, JR; Erion, R; Crocker, A; Sehgal, A				DiAngelo, Justin R.; Erion, Renske; Crocker, Amanda; Sehgal, Amita			The Central Clock Neurons Regulate Lipid Storage in Drosophila	PLOS ONE			English	Article							CIRCADIAN OSCILLATORS; RHYTHMS; NEUROPEPTIDE; GENE; METABOLISM; PACEMAKER; BEHAVIOR; NEURODEGENERATION; TRANSCRIPTION; INNERVATION	A proper balance of lipid breakdown and synthesis is essential for achieving energy homeostasis as alterations in either of these processes can lead to pathological states such as obesity. The regulation of lipid metabolism is quite complex with multiple signals integrated to control overall triglyceride levels in metabolic tissues. Based upon studies demonstrating effects of the circadian clock on metabolism, we sought to determine if the central clock cells in the Drosophila brain contribute to lipid levels in the fat body, the main nutrient storage organ of the fly. Here, we show that altering the function of the Drosophila central clock neurons leads to an increase in fat body triglycerides. We also show that although triglyceride levels are not affected by age, they are increased by expression of the amyloid-beta protein in central clock neurons. The effect on lipid storage seems to be independent of circadian clock output as changes in triglycerides are not always observed in genetic manipulations that result in altered locomotor rhythms. These data demonstrate that the activity of the central clock neurons is necessary for proper lipid storage.	[DiAngelo, Justin R.; Erion, Renske; Crocker, Amanda; Sehgal, Amita] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Sehgal, Amita] Hofstra Univ, Howard Hughes Med Inst, Hempstead, NY 11550 USA; [DiAngelo, Justin R.] Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA	University of Pennsylvania; Hofstra University; Howard Hughes Medical Institute; Hofstra University	DiAngelo, JR (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			National Institutes of Health [T32-AG000255, F31-MH080490]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH080490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants T32-AG000255, which provided support for JRD, F31-MH080490 to AC. AS is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Allada R, 2010, ANNU REV PHYSIOL, V72, P605, DOI 10.1146/annurev-physiol-021909-135815; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; Benarroch EE, 2010, NEUROLOGY, V74, P1643, DOI 10.1212/WNL.0b013e3181df0a3f; Bjorkhem I, 2010, J LIPID RES, V51, P2489, DOI 10.1194/jlr.R006338; Chatterjee A, 2010, CURR BIOL, V20, P300, DOI 10.1016/j.cub.2009.12.055; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de la Monte SM, 2009, CURR OPIN INVEST DR, V10, P1049; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hoshizaki D.K., 2005, P315; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nogueiras R, 2010, OBES REV, V11, P185, DOI 10.1111/j.1467-789X.2009.00669.x; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saeb-Parsy K, 2000, J NEUROENDOCRINOL, V12, P635; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Verleyen P, 2004, J NEUROCHEM, V88, P311, DOI 10.1046/j.1471-4159.2003.02161.x; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5	39	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19921	10.1371/journal.pone.0019921	http://dx.doi.org/10.1371/journal.pone.0019921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625640	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200048
J	Seriwatanachai, D; Densmore, MJ; Sato, T; Correa, D; Neff, L; Baron, R; Lanske, B				Seriwatanachai, Dutmanee; Densmore, Michael J.; Sato, Tadatoshi; Correa, Diego; Neff, Lynn; Baron, Roland; Lanske, Beate			Deletion of Zfp521 rescues the growth plate phenotype in a mouse model of Jansen metaphyseal chondrodysplasia	FASEB JOURNAL			English	Article						chondrocyte; endochondral bone formation; PTHrP; JMC; zinc finger protein	HORMONE-RELATED PEPTIDE; ENDOCHONDRAL BONE-FORMATION; PARATHYROID-HORMONE; PTH/PTHRP RECEPTOR; SKELETAL DEVELOPMENT; INDIAN HEDGEHOG; IN-VITRO; CHONDROCYTE MATURATION; TARGETED EXPRESSION; MICE	Jansen metaphyseal chondrodysplasia (JMC) is caused by a constitutively activating mutation of the parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor (PTHR1) and is characterized by widening of the metaphyses, reduction of long bone length, and short stature. A transgenic mouse expressing this mutation under the collagen alpha 1(II) promoter has been generated to investigate the mechanisms responsible for this chondrodysplasia. We recently identified zinc finger protein 521 (Zfp521) as a downstream target gene of PTHrP signaling. Interestingly, loss of Zfp521 from chondrocytes leads to reduced cell proliferation and increased differentiation in the growth plate. Thus, we hypothesized that specifically ablating Zfp521 from Jansen chondrocytes could sufficiently rescue the chondrodysplasia phenotype. Our results show that Zfp521 expression is up-regulated in Jansen mouse growth plate chondrocytes and that PTHR1 is required for Zfp521 expression. Its ablation from Jansen chondrocytes restored normal cell differentiation, thus initiating chondrocyte apoptosis at the chondro-osseous junction, leading to partial rescue of endochondral bone formation shown by proper bone length. This study provides the first genetic evidence that Zfp521 is required downstream of PTHR1 signaling to act on chondrocyte proliferation, differentiation, and cell death.-Seriwatanachai, D., Densmore, M. J., Sato, T., Correa, D., Neff, L., Baron, R., Lanske, B. Deletion of Zfp521 rescues the growth plate phenotype in a mouse model of Jansen metaphyseal chondrodysplasia. FASEB J. 25, 3057-3067 (2011). www.fasebj.org	[Seriwatanachai, Dutmanee; Densmore, Michael J.; Sato, Tadatoshi; Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Correa, Diego; Neff, Lynn; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Baron, Roland] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02115 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lanske, B (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, Res & Educ Bldg,Rm 303,188 Longwood Ave, Boston, MA 02115 USA.	beate_lanske@hsdm.harvard.edu	Seriwatanachai, Dutmanee/K-3423-2019	Seriwatanachai, Dutmanee/0000-0001-8955-1324; Lanske, Beate/0000-0003-4638-804X	U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR050560, AR057769]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050560, R01AR057769] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Drs. Neal G. Copeland, Soren Warming, Riku Kiviranta, and Yukiko Maeda for helpful suggestions. This work was supported by U.S. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grants AR050560 (B. L.) and AR057769 (R. B.).	Al Kaissi A, 2005, Australas Radiol, V49, P57, DOI 10.1111/j.1440-1673.2005.01395.x; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044; Jansen M, 1934, Z ORTHOP CHIR, V61, P253; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2010, BONE, V46, P472, DOI 10.1016/j.bone.2009.09.009; Minagawa M, 1997, ENDOCR J, V44, P493, DOI 10.1507/endocrj.44.493; Nakamata T, 2003, J BONE MINER RES, V18, P97, DOI 10.1359/jbmr.2003.18.1.97; Provot S, 2006, DEVELOPMENT, V133, P651, DOI 10.1242/dev.02258; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Soegiarto DW, 2001, ENDOCRINOLOGY, V142, P5303, DOI 10.1210/en.142.12.5303; VWEN SF, 2000, CANCER GENE THER, V7, P1469; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011	27	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3057	3067		10.1096/fj.11-183277	http://dx.doi.org/10.1096/fj.11-183277			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21642473	Green Published, Bronze			2022-12-25	WOS:000294435200020
J	Pentikainen, U; Jiang, PJ; Takala, H; Ruskamo, S; Campbell, ID; Ylanne, J				Pentikainen, Ulla; Jiang, Pengju; Takala, Heikki; Ruskamo, Salla; Campbell, Iain D.; Ylanne, Jari			Assembly of a Filamin Four-domain Fragment and the Influence of Splicing Variant-1 on the Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; BINDING PROTEIN HOMOLOG; X-RAY-SCATTERING; INTEGRIN BINDING; AUTO-INHIBITION; PHOSPHORYLATION; COMPETITION; DOMAINS; SYSTEM	Filamins are scaffold proteins that bind to various proteins, including the actin cytoskeleton, integrin adhesion receptors, and adaptor proteins such as migfilin. Alternative splicing of filamin, largely constructed from 24 Ig-like domains, is thought to have a role in regulating its interactions with other proteins. The filamin A splice variant-1 (FLNa var-1) lacks 41 amino acids, including the last beta-strand of domain 19, FLNa(19), and the first beta-strand of FLNa(20) that was previously shown to mask a key binding site on FLNa(21). Here, we present a structural characterization of domains 18-21, FLNa(18-21), in the FLNa var-1 as well as its nonspliced counterpart. A model of nonspliced FLNa(18-21), obtained from small angle x-ray scattering data, shows that these four domains form an L-shaped structure, with one arm composed of a pair of domains. NMR spectroscopy reveals that in the splice variant, FLNa(19) is unstructured whereas the other domains retain the same fold as in their canonical counterparts. The maximum dimensions predicted by small angle x-ray scattering data are increased upon migfilin binding in the FLNa(18-21) but not in the splice variant, suggesting that migfilin binding is able to displace the masking beta-strand and cause a rearrangement of the structure. Possible function roles for the spliced variants are discussed.	[Pentikainen, Ulla; Takala, Heikki; Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Pentikainen, Ulla; Takala, Heikki; Ruskamo, Salla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Jiang, Pengju; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Jiang, Pengju] Changzhou Sci & Technol Bur, Changzhou 213022, Peoples R China	University of Jyvaskyla; University of Jyvaskyla; University of Oxford	Pentikainen, U (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, FI-40014 Jyvaskyla, Finland.	ulla.m.pentikainen@jyu.fi	Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020	Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Pentikainen, Ulla/0000-0001-6547-1282; Ruskamo, Salla/0000-0002-9740-9077; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [121393, 114713]; National Doctoral Programme in Informational and Structural Biology; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0900052] Funding Source: researchfish; MRC [G0900052] Funding Source: UKRI	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Academy of Finland Grants 121393 (to U. P.) and 114713 (to J. Y.) and by the National Doctoral Programme in Informational and Structural Biology (to S. R.).; Supported by the Biotechnology and Biological Sciences Research Council.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jiang PJ, 2008, BIOCHEMISTRY-US, V47, P11055, DOI 10.1021/bi8011466; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xie ZW, 1998, BIOCHEM BIOPH RES CO, V251, P914, DOI 10.1006/bbrc.1998.9506; Xu WF, 1998, BLOOD, V92, P1268, DOI 10.1182/blood.V92.4.1268.416k12_1268_1276; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	40	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26921	26930		10.1074/jbc.M110.195958	http://dx.doi.org/10.1074/jbc.M110.195958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636571	Green Published, hybrid			2022-12-25	WOS:000293078200066
J	Zhu, W; Liang, G; Huang, ZP; Doty, SB; Boskey, AL				Zhu, Wei; Liang, Gang; Huang, Zhiping; Doty, Stephen B.; Boskey, Adele L.			Conditional Inactivation of the CXCR4 Receptor in Osteoprecursors Reduces Postnatal Bone Formation Due to Impaired Osteoblast Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; FACTOR-I; CHEMOKINE SDF-1; GROWTH-PLATE; OSTEOGENIC DIFFERENTIATION; MARROW; MIGRATION; EXPRESSION; MICE; PROGENITORS	Cysteine (C)-X-C motif chemokine receptor 4 (CXCR4), the primary receptor for stromal cell-derived factor-1 (SDF-1), is involved in bone morphogenic protein 2 (BMP2)-induced osteogenic differentiation of mesenchymal progenitors. To target the in vivo function of CXCR4 in bone and explore the underlying mechanisms, we conditionally inactivated CXCR4 in osteoprecursors by crossing osterix (Osx)-Cre mice with floxed CXCR4 (CXCR4(fl/fl)) mice to generate knock-outs with CXCR4 deletion driven by the Osx promoter (Osx::CXCR4(fl/fl)). The Cre-mediated excision of CXCR4 occurred exclusively in bone of Osx::CXCR4(fl/fl) mice. When compared with littermate controls, Osx::CXCR4(fl/fl) mice developed smaller osteopenic skeletons as evidenced by reduced trabecular and cortical bone mass, lower bone mineral density, and a slower mineral apposition rate. In addition, Osx::CXCR4(fl/fl) mice displayed chondrocyte disorganization in the epiphyseal growth plate associated with decreased proliferation and collagen matrix syntheses. Moreover, mature osteoblast-related expression of type I collagen alpha 1 and osteocalcin was reduced in bone of Osx::CXCR4(fl/fl) mice versus controls, suggesting that CXCR4 deficiency results in arrested osteoblast progression. Primary cultures for osteoblastic cells derived from Osx::CXCR4(fl/fl) mice also showed decreased proliferation and impaired osteoblast differentiation in response to BMP2 or BMP6 stimulation, and suppressed activation of intracellular BMP receptor-regulated Smads (R-Smads) and Erk1/2 was identified in CXCR4-deficient cells and bone tissues. These findings provide the first in vivo evidence that CXCR4 functions in postnatal bone development by regulating osteoblast development in cooperation with BMP signaling. Thus, CXCR4 acts as an endogenous signaling component necessary for bone formation.	[Zhu, Wei; Liang, Gang; Huang, Zhiping; Doty, Stephen B.; Boskey, Adele L.] Hosp Special Surg, Musculoskeletal Integr Program, New York, NY 10021 USA; [Zhu, Wei; Liang, Gang; Huang, Zhiping; Doty, Stephen B.; Boskey, Adele L.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA; [Boskey, Adele L.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University; Cornell University	Zhu, W (corresponding author), Hosp Special Surg, Musculoskeletal Integr Program, Caspary Res Bldg,Rm 624,535 E 70th St, New York, NY 10021 USA.	zhuw@hss.edu		Boskey, Adele/0000-0002-6181-2219	National Institutes of Health, NIAMS [AR046121]; Arthritis Foundation; Beatrice and Samuel A. Seaver Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; Beatrice and Samuel A. Seaver Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR046121 from the NIAMS-funded Musculoskeletal Repair and Regeneration Core Centers. This work was also supported by grants from the Arthritis Foundation and Beatrice and Samuel A. Seaver Foundation.	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO;2-B; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Majka M, 2000, STEM CELLS, V18, P128, DOI 10.1634/stemcells.18-2-128; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Wang Y, 2007, CELLS TISSUES ORGANS, V186, P192, DOI 10.1159/000105673; Wei L, 2010, DEV BIOL, V341, P236, DOI 10.1016/j.ydbio.2010.02.033; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	47	67	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26794	26805		10.1074/jbc.M111.250985	http://dx.doi.org/10.1074/jbc.M111.250985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636574	Green Published, hybrid			2022-12-25	WOS:000293078200055
J	Maier, H; Meixner, M; Hartmann, D; Sandhoff, R; Wang-Eckhardt, L; Zoller, I; Gieselmann, V; Eckhardt, M				Maier, Helena; Meixner, Marion; Hartmann, Dieter; Sandhoff, Roger; Wang-Eckhardt, Lihua; Zoeller, Inge; Gieselmann, Volkmar; Eckhardt, Matthias			Normal Fur Development and Sebum Production Depends on Fatty Acid 2-Hydroxylase Expression in Sebaceous Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; GRAM-POSITIVE BACTERIA; CATHEPSIN-L; HUMAN SKIN; BARRIER FUNCTION; ALPHA-OXIDATION; FAMILY-MEMBERS; PIG EPIDERMIS; PHYTANIC ACID; GROWTH CYCLE	2-Hydroxylated fatty acid (HFA)-containing sphingolipids are abundant in mammalian skin and are believed to play a role in the formation of the epidermal barrier. Fatty acid 2-hydroxylase (FA2H), required for the synthesis of 2-hydroxylated sphingolipids in various organs, is highly expressed in skin, and previous in vitro studies demonstrated its role in the synthesis of HFA sphingolipids in human keratinocytes. Unexpectedly, however, mice deficient in FA2H did not show significant changes in their epidermal HFA sphingolipids. Expression of FA2H in murine skin was restricted to the sebaceous glands, where it was required for synthesis of 2-hydroxylated glucosylceramide and a fraction of type II wax diesters. Absence of FA2H resulted in hyperproliferation of sebocytes and enlarged sebaceous glands during hair follicle morphogenesis and anagen (active growth phase) in adult mice. This was accompanied by a significant up-regulation of the epidermal growth factor receptor ligand epigen in sebocytes. Loss of FA2H significantly altered the composition and physicochemical properties of sebum, which often blocked the hair canal, apparently causing a delay in the hair fiber exit. Furthermore, mice lacking FA2H displayed a cycling alopecia with hair loss in telogen. These results underline the importance of the sebaceous glands and suggest a role of specific sebaceous gland or sebum lipids, synthesized by FA2H, in the hair follicle homeostasis.	[Maier, Helena; Meixner, Marion; Wang-Eckhardt, Lihua; Zoeller, Inge; Gieselmann, Volkmar; Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Hartmann, Dieter] Univ Bonn, Inst Anat, D-53115 Bonn, Germany; [Sandhoff, Roger] German Canc Res Ctr, D-69120 Heidelberg, Germany	University of Bonn; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ)	Eckhardt, M (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	eckhardt@uni-bonn.de			Deutsche Forschungsgemeinschaft from the University of Bonn [SFB645]	Deutsche Forschungsgemeinschaft from the University of Bonn(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB645 from the University of Bonn.	Alderson NL, 2009, J LIPID RES, V50, P1203, DOI 10.1194/jlr.M800666-JLR200; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Ausubel FM, 2003, CURRENT PROTOCOLS MO; Baron JM, 2008, CURR MED CHEM, V15, P2258, DOI 10.2174/092986708785747535; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Dahlhoff M, 2010, J INVEST DERMATOL, V130, P623, DOI 10.1038/jid.2009.251; Dick KJ, 2010, HUM MUTAT, V31, pE1251, DOI 10.1002/humu.21205; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; Foulon V, 2003, J LIPID RES, V44, P2349, DOI 10.1194/jlr.M300230-JLR200; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GATES AH, 1965, SCIENCE, V148, P1471, DOI 10.1126/science.148.3676.1471; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; Gu LH, 2008, AM J PATHOL, V173, P752, DOI 10.2353/ajpath.2008.071089; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Higgins CA, 2009, J INVEST DERMATOL, V129, P2100, DOI 10.1038/jid.2009.66; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mak KKL, 2003, J BIOL CHEM, V278, P26120, DOI 10.1074/jbc.M212082200; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Milner Y, 2002, J INVEST DERMATOL, V119, P639, DOI 10.1046/j.1523-1747.2002.01842.x; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Mukherji M, 2002, CHEM BIOL, V9, P597, DOI 10.1016/S1074-5521(02)00139-4; NIKKARI T, 1974, J INVEST DERMATOL, V62, P257, DOI 10.1111/1523-1747.ep12676800; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; PENNYCUIK PR, 1986, GENET RES, V48, P179, DOI 10.1017/S0016672300024988; Ponec M, 2003, J INVEST DERMATOL, V120, P581, DOI 10.1046/j.1523-1747.2003.12103.x; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Schneider MR, 2010, INT J BIOCHEM CELL B, V42, P181, DOI 10.1016/j.biocel.2009.11.017; Selleri S, 2006, J INVEST DERMATOL, V126, P711, DOI 10.1038/sj.jid.5700175; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Stenn KS, 2008, J INVEST DERMATOL, V128, P1576, DOI 10.1038/sj.jid.5701200; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Thiele JJ, 1999, J INVEST DERMATOL, V113, P1006, DOI 10.1046/j.1523-1747.1999.00794.x; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Uchida Y, 2007, J BIOL CHEM, V282, P13211, DOI 10.1074/jbc.M611562200; WATKINS PA, 1994, BBA-LIPID LIPID MET, V1214, P288, DOI 10.1016/0005-2760(94)90075-2; WERTZ PW, 1983, J LIPID RES, V24, P753; WERTZ PW, 1983, J LIPID RES, V24, P759; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhang L, 2006, PEPTIDES, V27, P413, DOI 10.1016/j.peptides.2005.05.030; Zheng Y, 1999, NAT GENET, V23, P268, DOI 10.1038/15446; Zoller I, 2008, J NEUROSCI, V28, P9741, DOI 10.1523/JNEUROSCI.0458-08.2008	55	32	32	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25922	25934		10.1074/jbc.M111.231977	http://dx.doi.org/10.1074/jbc.M111.231977			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628453	Green Published, hybrid			2022-12-25	WOS:000293073000052
J	Mateos, L; Ismail, MAM; Gil-Bea, FJ; Schule, R; Schols, L; Heverin, M; Folkesson, R; Bjorkhem, I; Cedazo-Minguez, A				Mateos, Laura; Ismail, Muhammad-Al-Mustafa; Gil-Bea, Francisco-Javier; Schuele, Rebecca; Schoels, Ludger; Heverin, Maura; Folkesson, Ronnie; Bjorkhem, Ingemar; Cedazo-Minguez, Angel			Side Chain-oxidized Oxysterols Regulate the Brain Renin-Angiotensin System through a Liver X Receptor-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNITIVE FUNCTION; APOLIPOPROTEIN-E; GENE-EXPRESSION; LXR-ALPHA; IN-VIVO; CHOLESTEROL; 27-HYDROXYCHOLESTEROL; PROTEIN; LIGAND; MICE	Disturbances in cholesterol metabolism have been associated with hypertension and neurodegenerative disorders. Because cholesterol metabolism in the brain is efficiently separated from plasma cholesterol by the blood-brain barrier (BBB), it is an unsolved paradox how high blood cholesterol can cause an effect in the brain. Here, we discuss the possibility that cholesterol metabolites permeable to the BBB might account for these effects. We show that 27-hydroxycholesterol (27-OH) and 24S-hydroxycholesterol (24S-OH) up-regulate the renin-angiotensin system (RAS) in the brain. Brains of mice on a cholesterol-enriched diet showed up-regulated angiotensin converting enzyme (ACE), angiotensinogen (AGT), and increased JAK/STAT activity. These effects were confirmed in in vitro studies with primary neurons and astrocytes exposed to 27-OH or 24S-OH, and were partially mediated by liver X receptors. In contrast, brain RAS activity was decreased in Cyp27a1-deficient mice, a model exhibiting reduced 27-OH production from cholesterol. Moreover, in humans, normocholesterolemic patients with elevated 27-OH levels, due to a CYP7B1 mutation, had markers of activated RAS in their cerebrospinal fluid. Our results demonstrate that side chain-oxidized oxysterols are modulators of brain RAS. Considering that levels of cholesterol and 27-OH correlate in the circulation and 27-OH can pass the BBB into the brain, we suggest that this cholesterol metabolite could be a link between high plasma cholesterol levels, hypertension, and neurodegeneration.	[Mateos, Laura; Ismail, Muhammad-Al-Mustafa; Gil-Bea, Francisco-Javier; Folkesson, Ronnie; Cedazo-Minguez, Angel] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimers Dis Res Ctr, Novum, SE-14186 Stockholm, Sweden; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Schuele, Rebecca; Schoels, Ludger] Univ Tubingen, Ctr Neurol, D-72076 Tubingen, Germany; [Heverin, Maura; Bjorkhem, Ingemar] Karolinska Univ Hosp, Div Clin Chem, Dept Lab Med, S-14186 Huddinge, Sweden	Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Karolinska Institutet; Karolinska University Hospital	Mateos, L (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimers Dis Res Ctr, Novum, 5th Floor, S-14186 Stockholm, Sweden.	Laura.Mateos-Montejo@ki.se; Angel.Cedazo-Minguez@ki.se	Ismail, Muhammad Al Mustafa/AAD-8555-2020; Cedazo-Minguez, Angel/C-6707-2012; Gil-Bea, Francisco J/L-5799-2014; Gil-Bea, Francisco Javier/GQY-6096-2022; Gil-Bea, Francisco J/T-8090-2017; Schöls, Ludger/ABB-2482-2021; Schüle, Rebecca/B-5763-2019; Heverin, Maura B/J-4101-2012	Cedazo-Minguez, Angel/0000-0003-4626-4864; Gil-Bea, Francisco J/0000-0002-8985-3792; Schöls, Ludger/0000-0001-7774-5025; Schüle, Rebecca/0000-0002-7781-2766; Bjorkhem, Ingemar/0000-0001-6087-9190; gil-bea, francico/0000-0002-1449-6233; Bjorkhem, Ingemar/0000-0002-0575-9425	Swedish Brain Power, Alice and Knut Wallenberg Foundation; Brain Foundation; Soderberg Foundation; Gun och Bertil Stohnes Stiftelse; Karolinska Institutet fund for Geriatric Research; Stiftelsen Gamla Tjanarinnor; Swedish Research Council; Alzheimerfonden; Stockholm County Council; Karolinska Institutet	Swedish Brain Power, Alice and Knut Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Brain Foundation; Soderberg Foundation; Gun och Bertil Stohnes Stiftelse; Karolinska Institutet fund for Geriatric Research; Stiftelsen Gamla Tjanarinnor; Swedish Research Council(Swedish Research CouncilEuropean Commission); Alzheimerfonden; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Brain Power, Alice and Knut Wallenberg Foundation, Brain Foundation, Soderberg Foundation, Gun och Bertil Stohnes Stiftelse, Karolinska Institutet fund for Geriatric Research, Stiftelsen Gamla Tjanarinnor, Swedish Research Council, Alzheimerfonden, and the regional agreement on medical training and clinical research (ALF) between the Stockholm County Council and Karolinska Institutet.	Bavner A, 2010, J LIPID RES, V51, P2722, DOI 10.1194/jlr.M008326; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I, 2010, J LIPID RES, V51, P2489, DOI 10.1194/jlr.R006338; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Cedazo-Minguez A, 2001, NEUROSCIENCE, V105, P651, DOI 10.1016/S0306-4522(01)00224-X; Dekroon RM, 2001, GLIA, V33, P298, DOI 10.1002/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N; Doulton TWR, 2009, J RENIN-ANGIO-ALDO S, V10, P185, DOI 10.1177/1470320309342733; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Ghribi O, 2008, J ALZHEIMERS DIS, V15, P673; Goldstein FC, 2008, ALZ DIS ASSOC DIS, V22, P336, DOI 10.1097/WAD.0b013e318188e80d; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Grobe JL, 2008, PHYSIOLOGY, V23, P187, DOI 10.1152/physiol.00002.2008; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Inaba S, 2009, STROKE, V40, P597, DOI 10.1161/STROKEAHA.108.519801; Inaba S, 2009, HYPERTENSION, V53, P356, DOI 10.1161/HYPERTENSIONAHA.108.123612; Iwai M, 2009, HYPERTENS RES, V32, P533, DOI 10.1038/hr.2009.74; Jansen PJ, 2009, J ALZHEIMERS DIS, V18, P319, DOI 10.3233/JAD-2009-1150; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kainu T, 1996, J MOL NEUROSCI, V7, P29, DOI 10.1007/BF02736846; KUMAR A, 1988, J NEUROSCI RES, V19, P287, DOI 10.1002/jnr.490190302; Leik CE, 2007, BRIT J PHARMACOL, V151, P450, DOI 10.1038/sj.bjp.0707241; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Ligthart SA, 2010, VASC HEALTH RISK MAN, V6, P775, DOI 10.2147/VHRM.S7343; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARRERO MB, 1995, NATURE, V375, P247, DOI 10.1038/375247a0; Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684; Mateos L., 2011, J ALZHEIMERS DIS; Mateos L, 2009, BRAIN PATHOL, V19, P69, DOI 10.1111/j.1750-3639.2008.00174.x; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Nikolova J G, 2000, Folia Med (Plovdiv), V42, P47; Nishimura Masuhiro, 2004, Drug Metab Pharmacokinet, V19, P135, DOI 10.2133/dmpk.19.135; Phillips MI, 2008, J MOL MED, V86, P715, DOI 10.1007/s00109-008-0331-5; PHILLIPS MI, 1987, ANNU REV PHYSIOL, V49, P413, DOI 10.1146/annurev.physiol.49.1.413; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Schule R, 2009, NEUROGENETICS, V10, P97, DOI 10.1007/s10048-008-0158-9; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Trousson A, 2009, J NEUROCHEM, V109, P945, DOI 10.1111/j.1471-4159.2009.06009.x; Ulven SM, 2004, J LIPID RES, V45, P2052, DOI 10.1194/jlr.M400119-JLR200; von Bohlen und Halbach O, 2006, CELL TISSUE RES, V326, P599, DOI 10.1007/s00441-006-0190-8; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wei SG, 2009, AM J PHYSIOL-HEART C, V296, pH1425, DOI 10.1152/ajpheart.00942.2008; Wright JW, 2004, PROG NEUROBIOL, V72, P263, DOI 10.1016/j.pneurobio.2004.03.003; Yang GY, 1999, BRAIN RES, V817, P123, DOI 10.1016/S0006-8993(98)01236-0; Yehuda S, 2005, NUTR NEUROSCI, V8, P309, DOI 10.1080/00268970500509972	51	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25574	25585		10.1074/jbc.M111.236877	http://dx.doi.org/10.1074/jbc.M111.236877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628469	Green Published, hybrid			2022-12-25	WOS:000293073000020
J	Dhahbi, JM; Atamna, H; Boffelli, D; Magis, W; Spindler, SR; Martin, DIK				Dhahbi, Joseph M.; Atamna, Hani; Boffelli, Dario; Magis, Wendy; Spindler, Stephen R.; Martin, David I. K.			Deep Sequencing Reveals Novel MicroRNAs and Regulation of MicroRNA Expression during Cell Senescence	PLOS ONE			English	Article							MIR-17-92 CLUSTER; GENE-EXPRESSION; CANCER; ROLES; DIFFERENTIATION; MICROARRAY; DISCOVERY; ONCOGENES; BIOMARKER; SKELETAL	In cell senescence, cultured cells cease proliferating and acquire aberrant gene expression patterns. MicroRNAs (miRNAs) modulate gene expression through translational repression or mRNA degradation and have been implicated in senescence. We used deep sequencing to carry out a comprehensive survey of miRNA expression and involvement in cell senescence. Informatic analysis of small RNA sequence datasets from young and senescent IMR90 human fibroblasts identifies many miRNAs that are regulated (either up or down) with cell senescence. Comparison with mRNA expression profiles reveals potential mRNA targets of these senescence-regulated miRNAs. The target mRNAs are enriched for genes involved in biological processes associated with cell senescence. This result greatly extends existing information on the role of miRNAs in cell senescence and is consistent with miRNAs having a causal role in the process.	[Dhahbi, Joseph M.; Boffelli, Dario; Magis, Wendy; Martin, David I. K.] Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA; [Atamna, Hani] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Dhahbi, Joseph M.; Spindler, Stephen R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Geisinger Commonwealth School of Medicine; University of California System; University of California Riverside	Dhahbi, JM (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA.	jdhahbi@chori.org; hatamna@tcmedc.org; dimartin@chori.org			NIH [ES016581, CA115768, DK080428, HL084474]; NATIONAL CANCER INSTITUTE [R01CA115768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES016581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants ES016581, CA115768, DK080428 (DM) and HL084474 (DB). JD was a Scholar of the California Institute of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Drummond MJ, 2010, PHYSL GENOMICS; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Gruber HE, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-5; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Ito T, 2010, BIOCHEM BIOPH RES CO, V398, P735, DOI 10.1016/j.bbrc.2010.07.012; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim YM, 2010, ANN NY ACAD SCI, V1201, P65, DOI 10.1111/j.1749-6632.2010.05617.x; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Laser J, 2010, FERTIL STERIL, V93, P2020, DOI 10.1016/j.fertnstert.2008.12.116; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Martins PAD, 2010, CURR DRUG TARGETS, V11, P900, DOI 10.2174/138945010791591322; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; Ortholan C, 2009, CURR MED CHEM, V16, P1047, DOI 10.2174/092986709787581833; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rizzo M, 2010, J CELL MOL MED, V14, P2633, DOI 10.1111/j.1582-4934.2010.01173.x; Ryu SJ, 2009, EXPERT OPIN THER TAR, V13, P479, DOI [10.1517/14728220902832705 , 10.1517/14728220902832705]; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Silahtaroglu A, 2010, ESSAYS BIOCHEM, V48, P165, DOI [10.1042/BSE0480165, 10.1042/bse0480165]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang XY, 2010, MOL CELL BIOCHEM, V345, P283, DOI 10.1007/s11010-010-0582-7; WANG Y, 2010, INT J RADIAT ONCOL B; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wittmann J, 2010, THESCIENTIFICWORLDJO, V10, P1239, DOI 10.1100/tsw.2010.101; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	67	66	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20509	10.1371/journal.pone.0020509	http://dx.doi.org/10.1371/journal.pone.0020509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637828	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200073
J	Bigalke, B; Schreitmuller, B; Sopova, K; Paul, A; Stransky, E; Gawaz, M; Stellos, K; Laske, C				Bigalke, Boris; Schreitmueller, Brigitte; Sopova, Kateryna; Paul, Angela; Stransky, Elke; Gawaz, Meinrad; Stellos, Konstantinos; Laske, Christoph			Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; PLASMA LEPTIN LEVELS; INDEPENDENT PREDICTOR; ADIPONECTIN LEVELS; VASCULAR REPAIR; A-BETA; ASSOCIATION; DEMENTIA; DYSFUNCTION	Background: Alzheimer's disease (AD) and atherosclerosis share common vascular risk factors such as arterial hypertension and hypercholesterolemia. Adipocytokines and CD34(+) progenitor cells are associated with the progression and prognosis of atherosclerotic diseases. Their role in AD is not adequately elucidated. Methods and Findings: In the present study, we measured in 41 patients with early AD and 37 age-and weight-matched healthy controls blood concentrations of adiponectin and leptin by enzyme linked immunoabsorbent assay and of CD34(+) progenitor cells using flow cytometry. We found significantly lower plasma levels of leptin in AD patients compared with the controls, whereas plasma levels of adiponectin did not show any significant differences (AD vs. control (mean +/- SD): leptin: 8.9 +/- 5.6 ng/mL vs. 16.3 +/- 15.5 ng/mL; P = 0.038; adiponectin: 18.5 +/- 18.1 mu g/mL vs. 16.7 +/- 8.9 mu g/mL; P = 0.641). In contrast, circulating CD34(+) cells were significantly upregulated in AD patients (mean absolute cell count +/- SD: 253 +/- 51 vs. 203 +/- 37; P = 0.02) and showed an inverse correlation with plasma levels of leptin (r = -0.248; P = 0.037). In logistic regression analysis, decreased leptin concentration (P = 0.021) and increased number of CD34(+) cells (P = 0.036) were both significantly associated with the presence of AD. According to multifactorial analysis of covariance, leptin serum levels were a significant independent predictor for the number of CD34(+) cells (P = 0.002). Conclusions: Our findings suggest that low plasma levels of leptin and increased numbers of CD34(+) progenitor cells are both associated with AD. In addition, the esults of our study provide first evidence that increased leptin plasma levels are associated with a reduced number of CD34(+) progenitor cells in AD patients. These findings point towards a combined involvement of leptin and CD34(+) progenitor cells in the pathogenesis of AD. Thus, plasma levels of leptin and circulating CD34(+) progenitor cells could represent an important molecular link between atherosclerotic diseases and AD. Further studies should clarify the pathophysiological role of both adipocytokines and progenitor cells in AD and possible diagnostic and therapeutic applications.	[Bigalke, Boris; Sopova, Kateryna; Paul, Angela; Gawaz, Meinrad; Stellos, Konstantinos] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany; [Bigalke, Boris] Kings Coll London, Sch Med, Div Imaging Sci, Rayne Inst, London WC2R 2LS, England; [Schreitmueller, Brigitte; Stransky, Elke; Laske, Christoph] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; University of London; King's College London; Eberhard Karls University of Tubingen	Bigalke, B (corresponding author), Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, Tubingen, Germany.	konstantinos.stellos@med.uni-tuebingen.de; christoph.laske@med.uni-tuebingen.de	Stellos, Konstantinos/ABH-1523-2021; Stellos, Konstantinos/AAF-2711-2020; Stellos, Konstantinos/G-8873-2011	Stellos, Konstantinos/0000-0002-0194-0825	University of Tubingen [F1331299, 1795-1-0]; German Cardiac Society (DGK); Hirnliga e.V.; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG:Li849/3-1, SFB:SFB-TR19-B8N]; Sonderforschungsbereich/Transregio-19	University of Tubingen; German Cardiac Society (DGK); Hirnliga e.V.; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Sonderforschungsbereich/Transregio-19(German Research Foundation (DFG))	The study was supported in part by Grants from the Fortune Program of the University of Tubingen F1331299 to CL and 1795-1-0 to KS (Konstantinos Stellos), from the grant of the German Cardiac Society (DGK) 'molecular imaging of atheroslerotic plaques' to BB, from Hirnliga e.V. to KS (Konstantinos Stellos) and from the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG:Li849/3-1;SFB:SFB-TR19-B8N) Sonderforschungsbereich/Transregio-19 "Inflammatory cardiomyopathy - Molecular pathogenesis and treatment'' to KS (Konstantinos Stellos) and MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atti AR, 2008, J AM GERIATR SOC, V56, P111, DOI 10.1111/j.1532-5415.2007.01458.x; Becker-Barroso E, 2005, LANCET NEUROL, V4, P598, DOI 10.1016/S1474-4422(05)70182-4; Bigalke B, 2010, PLATELETS, V21, P11, DOI 10.3109/09537100903377584; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Broedl UC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004733; Buerger K, 2009, BIOL PSYCHIAT, V65, P979, DOI 10.1016/j.biopsych.2009.01.032; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cavusoglu E, 2006, EUR HEART J, V27, P2300, DOI 10.1093/eurheartj/ehl153; Dubey L, 2008, INT J CARDIOL, V126, P183, DOI 10.1016/j.ijcard.2007.03.126; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Giordano V, 2007, NEUROCHEM RES, V32, P555, DOI 10.1007/s11064-006-9125-8; Greco SJ, 2010, J ALZHEIMERS DIS; Gunstad J, 2008, BRAIN RES, V1230, P233, DOI 10.1016/j.brainres.2008.07.045; Hara K, 2007, INT HEART J, V48, P149, DOI 10.1536/ihj.48.149; Laske C, 2008, J ALZHEIMERS DIS, V15, P83; Laske C, 2008, J PSYCHIATR RES, V42, P746, DOI 10.1016/j.jpsychires.2007.07.017; Lieb W, 2009, JAMA-J AM MED ASSOC, V302, P2565, DOI 10.1001/jama.2009.1836; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Marousi S. G., 2009, NEUROL RES; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; MCKHANN G, 1984, NEUROLOGY, V34, P30; Otsuka F, 2006, J AM COLL CARDIOL, V48, P1155, DOI 10.1016/j.jacc.2006.05.054; Salmina AB, 2010, J ALZHEIMERS DIS, V22, P17, DOI 10.3233/JAD-2010-091690; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schnabel R, 2008, EUR HEART J, V29, P649, DOI 10.1093/eurheartj/ehn009; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Shibata R, 2008, AM J CARDIOL, V101, P1712, DOI 10.1016/j.amjcard.2008.02.057; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Stellos K, 2010, J ALZHEIMERS DIS, V19, P591, DOI 10.3233/JAD-2010-1261; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Tobler K, 2010, INT J OBESITY, V34, P687, DOI 10.1038/ijo.2009.280; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wallander M, 2008, DIABETIC MED, V25, P949, DOI 10.1111/j.1464-5491.2008.02509.x; Wolk R, 2005, ATHEROSCLEROSIS, V183, P131, DOI 10.1016/j.atherosclerosis.2005.03.048; Xu QB, 2007, CURR OPIN LIPIDOL, V18, P534, DOI 10.1097/MOL.0b013e3282a66082	42	61	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20286	10.1371/journal.pone.0020286	http://dx.doi.org/10.1371/journal.pone.0020286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633502	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500051
J	Morris, SK; Bassani, DG; Awasthi, S; Kumar, R; Shet, A; Suraweera, W; Jha, P				Morris, Shaun K.; Bassani, Diego G.; Awasthi, Shally; Kumar, Rajesh; Shet, Anita; Suraweera, Wilson; Jha, Prabhat		MDS Collaborators	Diarrhea, Pneumonia, and Infectious Disease Mortality in Children Aged 5 to 14 Years in India	PLOS ONE			English	Article							VERBAL AUTOPSY; CHILDHOOD MORTALITY; ADULT DEATHS; VALIDATION; IMMUNIZATION; MORBIDITY; VALIDITY; YOUNGER; BURDEN; GENDER	Background: Little is known about the causes of death in children in India after age five years. The objective of this study is to provide the first ever direct national and sub-national estimates of infectious disease mortality in Indian children aged 5 to 14 years. Methods: A verbal autopsy based assessment of 3 855 deaths is children aged 5 to 14 years from a nationally representative survey of deaths occurring in 2001-03 in 1-1 million homes in India. Results: Infectious diseases accounted for 58% of all deaths among children aged 5 to 14 years. About 18% of deaths were due to diarrheal diseases, 10% due to pneumonia, 8% due to central nervous system infections, 4% due to measles, and 12% due to other infectious diseases. Nationally, in 2005 about 59 000 and 34 000 children aged 5 to 14 years died from diarrheal diseases and pneumonia, corresponding to mortality of 24-1 and 13-9 per 100 000 respectively. Mortality was nearly 50% higher in girls than in boys for both diarrheal diseases and pneumonia. Conclusions: Approximately 60% of all deaths in this age group are due to infectious diseases and nearly half of these deaths are due to diarrheal diseases and pneumonia. Mortality in this age group from infectious diseases, and diarrhea in particular, is much higher than previously estimated.	[Morris, Shaun K.; Bassani, Diego G.; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst,Dalla Lana Sch Publ Hl, Toronto, ON M5B 1W8, Canada; [Morris, Shaun K.] Univ Toronto, Div Infect Dis, Hosp Sick Children, Toronto, ON M5B 1W8, Canada; [Awasthi, Shally] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Kumar, Rajesh] Post Grad Inst Med Educ, Sch Publ Hlth, Chandigarh, India; [Shet, Anita] St Johns Natl Acad Hlth Sci, Dept Pediat, Bangalore, Karnataka, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); King George's Medical University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences	Morris, SK (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst,Dalla Lana Sch Publ Hl, Toronto, ON M5B 1W8, Canada.	shaun.morris@utoronto.ca	Suraweera, Wilson MG/O-8962-2014; Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Suraweera, Wilson/0000-0001-9673-5746; Shet, Anita/0000-0002-7204-8164	US National Institutes of Health; International Development Research Centre; Canadian Institutes of Health Research; Li Ka Shing Knowledge Institute; UNICEF; Canada Research Chair programme; Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Development Research Centre; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute(University of Toronto); UNICEF; Canada Research Chair programme(Canada Research Chairs); Sick Kids Foundation; Paediatric Chairs of Canada; March of Dimes(March of Dimes)	US National Institutes of Health, International Development Research Centre, Canadian Institutes of Health Research, Li Ka Shing Knowledge Institute, and US Fund for UNICEF. PJ is supported by the Canada Research Chair programme. SKM is a Fellow of the Pediatric Scientist Development Program and is supported by grants Sick Kids Foundation, Paediatric Chairs of Canada, and the March of Dimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER M, 1999, WHOCDSCSRISR994; [Anonymous], GLOBAL BURDEN DIS RI; [Anonymous], 1998, SURV CAUS DEATH RUR; ANWAR Z, 1987, Paediatrica Indonesiana, V27, P93; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Centre for Global Health Research, 2009, MILL DEATH STUD; Chandramohan D, 1998, STUD FAMILY PLANN, V29, P414, DOI 10.2307/172253; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Coldham C, 2000, TROP MED INT HEALTH, V5, P134, DOI 10.1046/j.1365-3156.2000.00505.x; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Mobley CC, 1996, J TROP PEDIATRICS, V42, P365, DOI 10.1093/tropej/42.6.365; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; *REG GEN IND, 2009, REP MED CERT CAUS DE; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Srivastava S P, 1995, Indian Pediatr, V32, P911; StataCorp L, 2007, STAT DAT AN STAT SOF; United Nations, WORLD POP PROSP 2008; Walker CLF, 2010, EPIDEMIOL INFECT, V138, P1215, DOI 10.1017/S0950268810000592; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; World Health Organisation, 2019, INT STAT CLASS DIS R; [No title captured]	34	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20119	10.1371/journal.pone.0020119	http://dx.doi.org/10.1371/journal.pone.0020119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629660	gold, Green Published			2022-12-25	WOS:000291005800027
J	Okell, LC; Griffin, JT; Kleinschmidt, I; Hollingsworth, TD; Churcher, TS; White, MJ; Bousema, T; Drakeley, CJ; Ghani, AC				Okell, Lucy C.; Griffin, Jamie T.; Kleinschmidt, Immo; Hollingsworth, T. Deirdre; Churcher, Thomas S.; White, Michael J.; Bousema, Teun; Drakeley, Chris J.; Ghani, Azra C.			The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria	PLOS ONE			English	Article							INFECTIOUS TRACHOMA; GAMETOCYTE CARRIAGE; RESISTANT MALARIA; ENDEMIC AREA; TRANSMISSION; ARTEMISININ; ELIMINATION; COMMUNITIES; PRIMAQUINE; REDUCTION	Mass treatment as a means to reducing P. falciparum malaria transmission was used during the first global malaria eradication campaign and is increasingly being considered for current control programmes. We used a previously developed mathematical transmission model to explore both the short and long-term impact of possible mass treatment strategies in different scenarios of endemic transmission. Mass treatment is predicted to provide a longer-term benefit in areas with lower malaria transmission, with reduced transmission levels for at least 2 years after mass treatment is ended in a scenario where the baseline slide-prevalence is 5%, compared to less than one year in a scenario with baseline slide-prevalence at 50%. However, repeated annual mass treatment at 80% coverage could achieve around 25% reduction in infectious bites in moderate-to-high transmission settings if sustained. Using vector control could reduce transmission to levels at which mass treatment has a longer-term impact. In a limited number of settings ( which have isolated transmission in small populations of 1000-10,000 with low-to-medium levels of baseline transmission) we find that five closely spaced rounds of mass treatment combined with vector control could make at least temporary elimination a feasible goal. We also estimate the effects of using gametocytocidal treatments such as primaquine and of restricting treatment to parasite-positive individuals. In conclusion, mass treatment needs to be repeated or combined with other interventions for long-term impact in many endemic settings. The benefits of mass treatment need to be carefully weighed against the risks of increasing drug selection pressure.	[Okell, Lucy C.; Griffin, Jamie T.; Hollingsworth, T. Deirdre; Churcher, Thomas S.; White, Michael J.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modeling, London, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Bousema, Teun; Drakeley, Chris J.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Okell, LC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modeling, London, England.	l.okell@imperial.ac.uk	Ghani, Azra/B-8560-2009; Bousema, Teun/N-3574-2014; Hollingsworth, Deirdre/D-2421-2009	Bousema, Teun/0000-0003-2666-094X; Hollingsworth, Deirdre/0000-0001-5962-4238; Churcher, Thomas/0000-0002-8442-0525; Okell, Lucy/0000-0001-7202-6873; Ghani, Azra/0000-0002-0007-4910; White, Michael/0000-0002-7472-4138	Bill and Melinda Gates Vaccine Modeling Initiative; UK Medical Research Council; TransMalariaBloc European Commission [HEALTH-F3-2008-223736]; Imperial College Junior; Wellcome Trust; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837, G0600719B] Funding Source: researchfish	Bill and Melinda Gates Vaccine Modeling Initiative; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); TransMalariaBloc European Commission(European Commission); Imperial College Junior; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Bill and Melinda Gates Vaccine Modeling Initiative, the UK Medical Research Council and the TransMalariaBloc European Commission FP7 Collaborative project (HEALTH-F3-2008-223736). TDH is funded by an Imperial College Junior Research Fellowship, and CJD by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2010, GUID TREATM MAL; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; BURGESS RW, 1961, B WORLD HEALTH ORGAN, V24, P451; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Coleman RE, 2002, AM J TROP MED HYG, V66, P379, DOI 10.4269/ajtmh.2002.66.379; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; ESCUDIE A., 1962, Medecine Tropicale, V22, P268; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ghani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004383; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Hii JLK, 1997, J MED ENTOMOL, V34, P193, DOI 10.1093/jmedent/34.2.193; Ishikawa H., 1996, Japanese Journal of Tropical Medicine and Hygiene, V24, P11; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Lakew T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000376; Lakshmanacharyulu L., 1968, B IND SOC MAL COM, P94; Lensen A, 1999, EXP PARASITOL, V91, P101, DOI 10.1006/expr.1998.4354; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; MACDONALD G, 1967, WHOMAL67615; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Naidoo I, 2010, TRENDS PARASITOL, V26, P447, DOI 10.1016/j.pt.2010.05.001; NAJERA JA, 1973, MASS DRUG ADM DDT IN; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Ray KJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000458; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Singh M, 1968, B INDIAN SOC MALARIA, V5, P207; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Smits HL, 2009, EXPERT REV ANTI-INFE, V7, P37, DOI 10.1586/14787210.7.1.37; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; STEPNIEWSKA K, 2008, ANTIMICROB AGENTS CH; von Seidlein L, 2003, T ROY SOC TROP MED H, V97, P217, DOI 10.1016/S0035-9203(03)90125-8; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; Wernsdorfer W.H., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P123; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 1996, TROP MED INT HEALTH, V1, P456, DOI 10.1046/j.1365-3156.1996.d01-88.x; Zulueta J. de., 1964, East African Medical Journal, V41, P102	50	100	100	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20179	10.1371/journal.pone.0020179	http://dx.doi.org/10.1371/journal.pone.0020179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629651	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800031
J	Sander, PM; Chen, XH; Cheng, L; Wang, XF				Sander, P. Martin; Chen, Xiaohong; Cheng, Long; Wang, Xiaofeng			Short-Snouted Toothless Ichthyosaur from China Suggests Late Triassic Diversification of Suction Feeding Ichthyosaurs	PLOS ONE			English	Article							BRITISH-COLUMBIA; BEAKED-WHALES; PARDONET FORMATION; CRANIAL OSTEOLOGY; ODONTOCETI; REPTILIA; EVOLUTION; ICHTHYOPTERYGIA; PHYLOGENY; DIVERSITY	Background: Ichthyosaurs were an important group of Mesozoic marine reptiles and existed from the Early Triassic to the early Late Cretaceous. Despite a great diversity in body shapes and feeding adaptations, all share greatly enlarged eyes, an elongated rostrum with numerous conical teeth, and a streamlined body. Methodology/Principal Findings: Based on new material from China and the restudy of Shastasaurus pacificus, we here reinterpret the classical large-bodied Late Triassic ichthyosaur genus Shastasaurus to differ greatly from the standard ichthyosaurian body plan, indicating much greater morphological diversity and range of feeding adaptations in ichthyosaurs than previously recognized. Phylogenetic analysis indicates a monophyletic clade consisting of the giant Shonisaurus sikanniensis, Guanlingsaurus liangae, and Shastasaurus pacificus to which the genus name Shastasaurus is applied. Shastasaurus liangae comb. nov. is from the Late Triassic (Carnian) Xiaowa Formation of Guizhou Province, southwestern China. The species combines a diminutive head with an entirely toothless and greatly reduced snout. The species also has by far the highest vertebral count among ichthyosaurs (86 presacral vertebrae and > 110 caudal vertebrae), a count that is also very high for tetrapods in general. A reduced toothless snout and a diminutive head is also apparently present in the giant S. sikanniensis and presumably in S. pacificus. Conclusions/Significance: In analogy to many modern odontocetes, Shastasaurus is interpreted as a specialized suction feeder on unshelled cephalopods and fish, suggesting a unique but widespread Late Triassic diversification of toothless, suction-feeding ichthyosaurs. Suction feeding has not been hypothesized for any of the other diverse marine reptiles of the Mesozoic before, but in Shastasaurus may be linked to the Late Triassic minimum in atmospheric oxygen.	[Sander, P. Martin] Univ Bonn, Div Palaeontol, Steinmann Inst, D-5300 Bonn, Germany; [Chen, Xiaohong; Cheng, Long; Wang, Xiaofeng] Wuhan Inst Geol & Mineral Resources, Wuhan, Hubei, Peoples R China	University of Bonn	Sander, PM (corresponding author), Univ Bonn, Div Palaeontol, Steinmann Inst, D-5300 Bonn, Germany.	martin.sander@uni-bonn.de			Deutsche Forschungsgemeinschaft [446 CHV 111/12/06]; Chinese Geolgical Survey [1212010611603]; University of Bonn, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Geolgical Survey; University of Bonn, Germany	Grant from Deutsche Forschungsgemeinschaft (#446 CHV 111/12/06) to PMS, Grant from the Chinese Geolgical Survey (#1212010611603) to XFW and XCH, and funds from the University of Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton M. J., 2003, LIFE NEARLY DIED GRE; Bianucci G, 2007, GEODIVERSITAS, V29, P561; Brayard A, 2009, SCIENCE, V325, P1118, DOI 10.1126/science.1174638; CALLAWAY JM, 1989, J PALEONTOL, V63, P930, DOI 10.1017/S0022336000036635; CLARKE MR, 1996, RES DOLPHINS, P281; Dal Sasso Cristiano, 1996, Paleontologia Lombarda, V4, P1; de Beer G.R, 1971, DEV VERTEBRATE SKULL; Erwin D. H., 2006, EXTINCTION LIFE EART; Heyning J. E., 1996, NATURAL HIST MUSEUM, V464, P1; Huey RB, 2005, SCIENCE, V308, P398, DOI 10.1126/science.1108019; Jiang DY, 2008, PROG NAT SCI-MATER, V18, P1315, DOI 10.1016/j.pnsc.2008.01.039; Lambert O, 2005, GEODIVERSITAS, V27, P443; Lambert O, 2009, J VERTEBR PALEONTOL, V29, P910, DOI 10.1671/039.029.0304; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; Maisch MW, 2006, J VERTEBR PALEONTOL, V26, P588, DOI 10.1671/0272-4634(2006)26[588:COOGTR]2.0.CO;2; Maisch Michael W., 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V298, P1; Maisch MW, 2000, NEUES JAHRB GEOL P-A, V217, P1; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Massare Judy A., 2005, Paludicola, V5, P20; McGowan C., 1974, Life Sci Contr R Ont Mus, VNo. 100, P1; McGowan C, 1996, CAN J EARTH SCI, V33, P24, DOI 10.1139/e96-003; MCGOWAN C, 2003, HDB PALAEOHERPETOL 8; MERRIAM JC, 1908, U CALIF MEM, V1, P1; MERRIAM JC, 1895, AM J SCI 3, V50, P55; MERRIAM JC, 1902, B DEP GEOLOGY, V3, P63; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani Ryosuke, 1999, Paludicola, V2, P174; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Muller J, 2010, P NATL ACAD SCI USA, V107, P2118, DOI 10.1073/pnas.0912622107; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Nicholls EL, 2002, J VERTEBR PALEONTOL, V22, P759, DOI 10.1671/0272-4634(2002)022[0759:NMOQLR]2.0.CO;2; Nicholls EL, 2001, CAN J EARTH SCI, V38, P983, DOI 10.1139/e00-115; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Sander P. Martin, 2000, Palaeontologische Zeitschrift, V74, P1; Sander P. Martin, 1993, Paleontologia Lombarda, V2, P145; Schmitz L, 2004, PALAEONTOGR ABT A, V270, P133; Shang Qing-Hua, 2009, Vertebrata Palasiatica, V47, P178; Wang XF, 2008, PALAEONTOLOGY, V51, P27, DOI 10.1111/j.1475-4983.2007.00735.x; Ward P., 2006, OUT THIN AIR DINOSAU; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth Alexander J., 2004, Aquatic Mammals, V30, P405, DOI 10.1578/AM.30.3.2004.405; Yin Gongzheng, 2000, Geology Geochemistry, V28, P1	46	45	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19480	10.1371/journal.pone.0019480	http://dx.doi.org/10.1371/journal.pone.0019480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625429	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005200002
J	Torres, R; Garcia, A; Paya, M; Ramirez, JC				Torres, Raul; Garcia, Aida; Paya, Monica; Ramirez, Juan C.			Non-Integrative Lentivirus Drives High-Frequency cre-Mediated Cassette Exchange in Human Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; ZINC-FINGER NUCLEASES; GENE-EXPRESSION; HUMAN ESCS; HOMOLOGOUS RECOMBINATION; TRANSGENE EXPRESSION; IN-VIVO; VECTORS; LOCUS	Recombinase mediated cassette exchange (RMCE) is a two-step process leading to genetic modification in a specific genomic target sequence. The process involves insertion of a docking genetic cassette in the genome followed by DNA transfer of a second cassette flanked by compatible recombination signals and expression of the recombinase. Major technical drawbacks are cell viability upon transfection, toxicity of the enzyme, and the ability to target efficiently cell types of different origins. To overcome such drawbacks, we developed an RMCE assay that uses an integrase-deficient lentivirus (IDLV) vector in the second step combined with promoterless trapping of double selectable markers. Additionally, recombinase expression is self-limiting as a result of the exchangeable reaction, thus avoiding toxicity. Our approach provides proof-of-principle of a simple and novel strategy with expected wide applicability modelled on a human cell line with randomly integrated copies of a genetic landing pad. This strategy does not present foreseeable limitations for application to other cell systems modified by homologous recombination. Safety, efficiency, and simplicity are the major advantages of our system, which can be applied in low-to-medium throughput strategies for screening of cDNAs, noncoding RNAs during functional genomic studies, and drug screening.	[Torres, Raul; Garcia, Aida; Paya, Monica; Ramirez, Juan C.] Fdn Ctr Nacl Invest Cardiovasc CNIC, Viral Vector Tech Unit, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Torres, R (corresponding author), Fdn Ctr Nacl Invest Cardiovasc CNIC, Viral Vector Tech Unit, Madrid, Spain.	jcramirez@cnic.es	Ramírez, Juan Carlos/B-7979-2015; Ruiz, Raul Torres/J-1649-2018	Ruiz, Raul Torres/0000-0001-9606-0398	Ministry of Health and Custom Affairs [FIS 06/0911]; Ministry of Science and Innovation [INNPACTO IPT-010000-2010-40]; Fundacion Pro-CNIC	Ministry of Health and Custom Affairs; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Pro-CNIC	This work was supported by grants of the Ministry of Health and Custom Affairs [FIS 06/0911] and Ministry of Science and Innovation [INNPACTO IPT-010000-2010-40] to J.C.R.; and National Centre for Cardiovascular Research (CNIC) institutional funding from the Fundacion Pro-CNIC to the Viral Vector Technical Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Banasik MB, 2010, GENE THER, V17, P150, DOI 10.1038/gt.2009.135; Birling Marie-Christine, 2009, Methods Mol Biol, V561, P245, DOI 10.1007/978-1-60327-019-9_16; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kolb AF, 2001, ANAL BIOCHEM, V290, P260, DOI 10.1006/abio.2000.4984; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Naldini L, 2000, ADV VIRUS RES, V55, P599, DOI 10.1016/S0065-3527(00)55020-9; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Paya M, 2006, J VIROL METHODS, V137, P95, DOI 10.1016/j.jviromet.2006.06.005; Qasim W, 2010, MOL THER, V18, P1263, DOI 10.1038/mt.2010.76; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Rodolosse A, 1998, AM J PHYSIOL-GASTR L, V274, pG931, DOI 10.1152/ajpgi.1998.274.5.G931; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Siegel RW, 2001, FEBS LETT, V505, P466, DOI 10.1016/S0014-5793(01)02805-8; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Sorrell DA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq192; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zaiss AK, 2002, J VIROL, V76, P7209, DOI 10.1128/JVI.76.14.7209-7219.2002; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	39	14	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19794	10.1371/journal.pone.0019794	http://dx.doi.org/10.1371/journal.pone.0019794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625434	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200015
J	Rather, LJ; Weinert, T; Demmer, U; Bill, E; Ismail, W; Fuchs, G; Ermler, U				Rather, Liv J.; Weinert, Tobias; Demmer, Ulrike; Bill, Eckhard; Ismail, Wael; Fuchs, Georg; Ermler, Ulrich			Structure and Mechanism of the Diiron Benzoyl-Coenzyme A Epoxidase BoxB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MULTICOMPONENT MONOOXYGENASES; AZOARCUS-EVANSII; METHANE MONOOXYGENASE; DIOXYGEN ACTIVATION; CRYSTAL-STRUCTURE; C-H; MOLECULAR-GRAPHICS; CATABOLIC PATHWAY; PROTEIN-STRUCTURE; DIAMOND CORE	The coenzyme A (CoA)-dependent aerobic benzoate metabolic pathway uses an unprecedented chemical strategy to overcome the high aromatic resonance energy by forming the nonaromatic 2,3-epoxybenzoyl-CoA. The crucial dearomatizing reaction is catalyzed by three enzymes, BoxABC, where BoxA is an NADPH-dependent reductase, BoxB is a benzoyl-CoA 2,3-epoxidase, and BoxC is an epoxide ring hydrolase. We characterized the key enzyme BoxB from Azoarcus evansii by structural and Mossbauer spectroscopic methods as a new member of class I diiron enzymes. Several family members were structurally studied with respect to the diiron center architecture, but no structure of an intact diiron enzyme with its natural substrate has been reported. X-ray structures between 1.9 and 2.5 angstrom resolution were determined for BoxB in the diferric state and with bound substrate benzoyl-CoA in the reduced state. The substrate-bound reduced state is distinguished from the diferric state by increased iron-ligand distances and the absence of directly bridging groups between them. The position of benzoyl-CoA inside a 20 angstrom long channel and the position of the phenyl ring relative to the diiron center are accurately defined. The C2 and C3 atoms of the phenyl ring are closer to one of the irons. Therefore, one oxygen of activated O-2 must be ligated predominantly to this proximate iron to be in a geometrically suitable position to attack the phenyl ring. Consistent with the observed iron/phenyl geometry, BoxB stereoselectively should form the 2S,3R-epoxide. We postulate a reaction cycle that allows a charge delocalization because of the phenyl ring and the electron-withdrawing CoA thioester.	[Weinert, Tobias; Demmer, Ulrike; Ermler, Ulrich] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Rather, Liv J.; Ismail, Wael; Fuchs, Georg] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Bill, Eckhard] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany	Max Planck Society; University of Freiburg; Max Planck Society	Ermler, U (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	ulrich.ermler@biophys.mpg.de	Ismail, Wael/X-5336-2019; Weinert, Tobias/I-4813-2013; Weinert, Tobias/J-6353-2017	Weinert, Tobias/0000-0002-0339-3722; Weinert, Tobias/0000-0002-0339-3722; Ahmed Ismail El Moslimany, Wael/0000-0002-3027-928X	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [FU 118/16-3, ER 222/5-1]; Graduiertenkolleg Biochemie der Enzyme	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg Biochemie der Enzyme	This work was supported by the Max-Planck-Gesellschaft, the Deutsche Forschungsgemeinschaft (FU 118/16-3; ER 222/5-1), and the Graduiertenkolleg Biochemie der Enzyme.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Afonine PV, 2010, J APPL CRYSTALLOGR, V43, P669, DOI 10.1107/S0021889810015608; Bains J, 2009, J BIOL CHEM, V284, P16377, DOI 10.1074/jbc.M900226200; Boll M, 2000, J BIOL CHEM, V275, P31857, DOI 10.1074/jbc.M001508200; Choi YS, 2008, P NATL ACAD SCI USA, V105, P6858, DOI 10.1073/pnas.0712073105; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gescher J, 2005, MOL MICROBIOL, V56, P1586, DOI 10.1111/j.1365-2958.2005.04637.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Grishin AM, 2011, J BIOL CHEM, V286, P10735, DOI 10.1074/jbc.M110.194423; Han WG, 2008, INORG CHEM, V47, P2975, DOI 10.1021/ic701194b; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOTZELMANN R, 1992, J AM CHEM SOC, V114, P9470, DOI 10.1021/ja00050a028; Johansson AJ, 2009, DALTON T, P6741, DOI 10.1039/b907263b; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kung JW, 2009, P NATL ACAD SCI USA, V106, P17687, DOI 10.1073/pnas.0905073106; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; Lippard SJ, 2005, PHILOS T ROY SOC A, V363, P861, DOI 10.1098/rsta.2004.1532; LIPPARD SJ, 2005, PHILOS T A, V363, P1035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Mohamed ME, 2001, J BACTERIOL, V183, P1899, DOI 10.1128/JB.183.6.1899-1908.2001; MURRAY KS, 1974, COORDIN CHEM REV, V12, P1, DOI 10.1016/S0010-8545(00)80384-7; Murray LJ, 2007, J AM CHEM SOC, V129, P14500, DOI 10.1021/ja076121h; Murray LJ, 2007, ACCOUNTS CHEM RES, V40, P466, DOI 10.1021/ar600040e; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Rinaldo D, 2007, J AM CHEM SOC, V129, P3135, DOI 10.1021/ja0654074; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Tinberg CE, 2009, BIOCHEMISTRY-US, V48, P12145, DOI 10.1021/bi901672n; Wang D, 2009, NAT CHEM, V1, P145, DOI [10.1038/nchem.162, 10.1038/NCHEM.162]; Xue GQ, 2010, NAT CHEM, V2, P400, DOI [10.1038/NCHEM.586, 10.1038/nchem.586]; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zaar A, 2001, J BIOL CHEM, V276, P24997, DOI 10.1074/jbc.M100291200	48	21	22	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29241	29248		10.1074/jbc.M111.236893	http://dx.doi.org/10.1074/jbc.M111.236893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21632537	Green Published, hybrid			2022-12-25	WOS:000293837000059
J	Anderson, DG; Mariappan, SVS; Buettner, GR; Doorn, JA				Anderson, David G.; Mariappan, S. V. Santhana; Buettner, Garry R.; Doorn, Jonathan A.			Oxidation of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopaminergic Metabolite, to a Semiquinone Radical and an ortho-Quinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; PARKINSONS-DISEASE; SUPEROXIDE-DISMUTASE; NEURODEGENERATIVE DISEASES; REACTIVE INTERMEDIATE; SUBSTANTIA NIGRA; SPIN-RESONANCE; ACTIVE-SITE; PC12 CELLS; IN-VITRO	The oxidation and toxicity of dopamine is believed to contribute to the selective neurodegeneration associated with Parkinson disease. The formation of reactive radicals and quinones greatly contributes to dopaminergic toxicity through a variety of mechanisms. The physiological metabolism of dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL) via monoamine oxidase significantly increases its toxicity. To more adequately explain this enhanced toxicity, we hypothesized that DOPAL is capable of forming radical and quinone species upon oxidation. Here, two unique oxidation products of DOPAL are identified. Several different oxidation methods gave rise to a transient DOPAL semiquinone radical, which was characterized by electron paramagnetic resonance spectroscopy. NMR identified the second oxidation product of DOPAL as the ortho-quinone. Also, carbonyl hydration of DOPAL in aqueous media was evident via NMR. Interestingly, the DOPAL quinone exists exclusively in the hydrated form. Furthermore, the enzymatic and chemical oxidation of DOPAL greatly enhance protein cross-linking, whereas auto-oxidation results in the production of superoxide. Also, DOPAL was shown to be susceptible to oxidation by cyclooxygenase-2 (COX-2). The involvement of this physiologically relevant enzyme in both oxidative stress and Parkinson disease underscores the potential importance of DOPAL in the pathogenesis of this condition.	[Anderson, David G.; Doorn, Jonathan A.] Univ Iowa, Div Med & Nat Prod Chem, Coll Pharm, Iowa City, IA 52242 USA; [Mariappan, S. V. Santhana] Univ Iowa, Cent High Field NMR Res Facil, Dept Chem, Iowa City, IA 52242 USA; [Buettner, Garry R.] Univ Iowa, Free Rad & Radiat Biol Program, ESR Facil, Dept Radiat Oncol,Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Doorn, JA (corresponding author), Univ Iowa, Div Med & Nat Prod Chem, Coll Pharm, 115 So Grand Ave, Iowa City, IA 52242 USA.	jonathan-doorn@uiowa.edu		Buettner, Garry/0000-0002-5594-1903	National Institutes of Health [R01ES15507, R01GM073929, P42ES013661]; NIGMS [T32GM 008365]; University of Iowa College of Pharmacy; American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013661, R01ES015507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, R01GM073929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Iowa College of Pharmacy; American Foundation for Pharmaceutical Education; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01ES15507 (to J. A. D.), R01GM073929 and P42ES013661 (to G. R. B.), and T32GM 008365 from NIGMS (to D. G. A.). This work was also supported by the University of Iowa College of Pharmacy and a fellowship through the American Foundation for Pharmaceutical Education (to D. G. A.).	ADAMS M, 1958, J CHEM PHYS, V28, P774, DOI 10.1063/1.1744269; Akagawa M, 2006, BIOCHEMISTRY-US, V45, P15120, DOI 10.1021/bi0614434; Asanuma M, 2004, CURR PHARM DESIGN, V10, P695, DOI 10.2174/1381612043453072; Baillet A, 2010, NEUROCHEM RES, V35, P1530, DOI 10.1007/s11064-010-0212-5; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Buettner G R, 1986, Free Radic Res Commun, V1, P349, DOI 10.3109/10715768609051638; Burke WJ, 2003, CNS NEUROL DISORD-DR, V2, P143, DOI 10.2174/1568007033482913; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Carey F. A., 2000, ADV ORG CHEM, P449; Chae SW, 2008, NEUROSCI LETT, V436, P205, DOI 10.1016/j.neulet.2008.03.031; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Collins MA, 2002, NEUROTOXICOL TERATOL, V24, P571, DOI 10.1016/S0892-0362(02)00210-6; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; EYER P, 1991, CHEM-BIOL INTERACT, V80, P159, DOI 10.1016/0009-2797(91)90022-Y; FELLMAN JH, 1958, NATURE, V182, P311, DOI 10.1038/182311a0; Feng ZH, 2003, NEUROREPORT, V14, P1927, DOI 10.1097/00001756-200310270-00009; FORNSTEDT B, 1989, J NEURAL TRANSM-PARK, V1, P279, DOI 10.1007/BF02263482; Goncalves LL, 2009, CHEM RES TOXICOL, V22, P842, DOI 10.1021/tx800423s; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; GRAHAM DG, 1978, MOL PHARMACOL, V14, P644; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hashimoto T, 2002, BRAIN RES, V931, P96, DOI 10.1016/S0006-8993(02)02233-3; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Jinsmaa Y, 2009, CHEM RES TOXICOL, V22, P835, DOI 10.1021/tx800405v; KALYANARAMAN B, 1985, ENVIRON HEALTH PERSP, V64, P185, DOI 10.2307/3430009; KALYANARAMAN B, 1982, BIOCHEM BIOPH RES CO, V106, P1119, DOI 10.1016/0006-291X(82)91228-1; Kirima K, 2001, CHEM PHARM BULL, V49, P576, DOI 10.1248/cpb.49.576; Kristal BS, 2001, FREE RADICAL BIO MED, V30, P924, DOI 10.1016/S0891-5849(01)00484-1; Lamensdorf I, 2000, EUR J PHARMACOL, V388, P147, DOI 10.1016/S0014-2999(99)00839-0; LAND EJ, 1971, BIOCHIM BIOPHYS ACTA, V226, P239, DOI 10.1016/0005-2728(71)90091-0; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Li SW, 2001, MOL BRAIN RES, V93, P1, DOI 10.1016/S0169-328X(01)00120-6; Li SW, 1998, BIOORG CHEM, V26, P45, DOI 10.1006/bioo.1998.1087; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MATTAMMAL MB, 1995, J NEUROCHEM, V64, P1645; MATTAMMAL MB, 1995, NEURODEGENERATION, V4, P271, DOI 10.1016/1055-8330(95)90016-0; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Rees JN, 2007, CHEM RES TOXICOL, V20, P1536, DOI 10.1021/tx700248y; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Song Y, 2008, CHEM RES TOXICOL, V21, P1359, DOI 10.1021/tx8000175; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Teismann P, 2003, ANN NY ACAD SCI, V991, P272; Terland O, 2006, FREE RADICAL BIO MED, V41, P1266, DOI 10.1016/j.freeradbiomed.2006.07.009; TSUKAMOTO S, 1994, TETRAHEDRON, V50, P13583, DOI 10.1016/S0040-4020(01)85673-8; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; Wangpradit O, 2010, CHEMOSPHERE, V81, P1501, DOI 10.1016/j.chemosphere.2010.08.041; Wangpradit O, 2009, CHEM RES TOXICOL, V22, P64, DOI 10.1021/tx800300t	57	72	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26978	26986		10.1074/jbc.M111.249532	http://dx.doi.org/10.1074/jbc.M111.249532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642436	hybrid, Green Published			2022-12-25	WOS:000293078200071
J	Corona, R; Larriva-Sahd, J; Paredes, RG				Corona, Rebeca; Larriva-Sahd, Jorge; Paredes, Raul G.			Paced-Mating Increases the Number of Adult New Born Cells in the Internal Cellular (Granular) Layer of the Accessory Olfactory Bulb	PLOS ONE			English	Article							NEWLY-GENERATED NEURONS; VOMERONASAL PROJECTION PATHWAY; EXPERIENCE-DEPENDENT SURVIVAL; ROSTRAL MIGRATORY STREAM; FOS EXPRESSION; FEMALE RAT; C-FOS; STIMULATED NEUROGENESIS; POSTNATAL NEUROGENESIS; SUBEPENDYMAL LAYER	The continuous production and addition of new neurons during life in the olfactory bulb is well accepted and has been extensively studied in rodents. This process could allow the animals to adapt to a changing environment. Olfactory neurogenesis begins in the subventricular zone where stem cells proliferate and give rise to young undifferentiated neuroblasts that migrate along the rostral migratory stream to the olfactory bulb ( OB). Olfaction is crucial for the expression of sexual behavior in rodents. In female rats, the ability to control the rate of sexual interactions (pacing) has important physiological and behavioral consequences. In the present experiment we evaluated if pacing behavior modifies the rate of new cells that reach the main and accessory olfactory bulb. The BrdU marker was injected before and after different behavioral tests which included: females placed in a mating cage (control), females allowed to pace the sexual interaction, females that mated but were not able to control the rate of the sexual interaction and females exposed to a sexually active male. Subjects were sacrificed fifteen days after the behavioral test. We observed a significant increase in the density of BrdU positive cells in the internal cellular layer of the accessory olfactory bulb when females paced the sexual interaction in comparison to the other 3 groups. No differences in the cell density in the main olfactory bulb were found. These results suggest that pacing behavior promotes an increase in density of the new cells in the accessory olfactory bulb.	[Corona, Rebeca; Larriva-Sahd, Jorge; Paredes, Raul G.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Corona, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Queretaro, Mexico.	rparedes@unam.mx		Corona, Rebeca/0000-0003-2005-5802	Consejo Nacional de Ciencia y Tecnologia [53547]; Direccion General de Asuntos del Personal Academico [IN213609]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico	This work was supported by grants 53547 from Consejo Nacional de Ciencia y Tecnologia and IN213609 from Direccion General de Asuntos del Personal Academico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; COROTTO FS, 1994, NEUROSCIENCE, V61, P739, DOI 10.1016/0306-4522(94)90397-2; Danilov AI, 2009, GLIA, V57, P136, DOI 10.1002/glia.20741; DAS GD, 1971, BRAIN RES, V30, P323, DOI 10.1016/0006-8993(71)90082-5; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; Doetsch F, 1997, J NEUROSCI, V17, P5046; DUDLEY CA, 1992, MOL CELL NEUROSCI, V3, P360, DOI 10.1016/1044-7431(92)90034-Y; DUDLEY CA, 1994, BRAIN RES, V642, P29, DOI 10.1016/0006-8993(94)90902-4; Erskine MS, 2004, BEHAV BRAIN RES, V153, P295, DOI 10.1016/j.bbr.2004.01.026; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; Erskine MS, 1997, J NEUROENDOCRINOL, V9, P903, DOI 10.1046/j.1365-2826.1997.00660.x; ERSKINE MS, 1995, ENDOCR REV, V16, P508, DOI 10.1210/er.16.4.508; Garcia-Horsman SP, 2008, HORM BEHAV, V54, P709, DOI 10.1016/j.yhbeh.2008.07.011; Gheusi G, 2009, BEHAV BRAIN RES, V200, P315, DOI 10.1016/j.bbr.2009.02.006; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GuevaraGuzman R, 1997, BRAIN RES BULL, V44, P141, DOI 10.1016/S0361-9230(97)00103-2; HARDY DF, 1972, J COMP PHYSIOL PSYCH, V78, P400, DOI 10.1037/h0032536; Honda N, 2008, EUR J NEUROSCI, V27, P1980, DOI 10.1111/j.1460-9568.2008.06169.x; Huang LY, 2002, HORM BEHAV, V41, P343, DOI 10.1006/hbeh.2002.1767; Hurtazo HA, 2005, NEUROSCIENCE, V135, P1035, DOI 10.1016/j.neuroscience.2005.07.012; Kang N, 2009, EUR J NEUROSCI, V29, P624, DOI 10.1111/j.1460-9568.2009.06638.x; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Laariva-Sahd J, 2008, J COMP NEUROL, V510, P309, DOI 10.1002/cne.21790; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lledo Pierre-Marie, 2008, V52, P425; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Martel KL, 2007, EUR J NEUROSCI, V26, P463, DOI 10.1111/j.1460-9568.2007.05651.x; Martinez I, 2001, HORM BEHAV, V40, P510, DOI 10.1006/hbeh.2001.1712; Matsuoka M, 2002, NEUROSCI LETT, V335, P111, DOI 10.1016/S0304-3940(02)01187-4; Matsuoka M, 2002, NEUROSCIENCE, V111, P251, DOI 10.1016/S0306-4522(01)00620-0; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P398, DOI 10.1016/S0003-3472(82)80051-1; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oboti L, 2009, EUR J NEUROSCI, V29, P679, DOI 10.1111/j.1460-9568.2009.06614.x; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Paredes RG, 1998, HORM BEHAV, V33, P48, DOI 10.1006/hbeh.1998.1435; Peretto P, 2001, CELL TISSUE RES, V306, P385, DOI 10.1007/s00441-001-0471-1; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Petreanu L, 2002, J NEUROSCI, V22, P6106; Polston EK, 2001, J NEUROSCI, V21, P4104, DOI 10.1523/JNEUROSCI.21-11-04104.2001; Portillo W, 2004, HORM BEHAV, V46, P330, DOI 10.1016/j.yhbeh.2004.03.001; SCHELLINCK HM, 1993, DEV BRAIN RES, V74, P138; Shapiro LA, 2009, EPILEPSY BEHAV, V14, P74, DOI 10.1016/j.yebeh.2008.09.011; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102	53	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19380	10.1371/journal.pone.0019380	http://dx.doi.org/10.1371/journal.pone.0019380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637743	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500004
J	Iturria-Medina, Y; Fernandez, AP; Hernandez, PV; Penton, LG; Canales-Rodriguez, EJ; Melie-Garcia, L; Castellanos, AL; Ortega, MO				Iturria-Medina, Yasser; Perez Fernandez, Alejandro; Valdes Hernandez, Pedro; Garcia Penton, Lorna; Canales-Rodriguez, Erick J.; Melie-Garcia, Lester; Lage Castellanos, Agustin; Ontivero Ortega, Marlis			Automated Discrimination of Brain Pathological State Attending to Complex Structural Brain Network Properties: The Shiverer Mutant Mouse Case	PLOS ONE			English	Article							DISTURBED FUNCTIONAL CONNECTIVITY; TEMPORAL-LOBE EPILEPSY; DIFFUSION-TENSOR; SMALL-WORLD; MULTIPLE-SCLEROSIS; CORTICAL THICKNESS; ALZHEIMERS-DISEASE; MRI; ABNORMALITIES; TRACKING	Neuroimaging classification procedures between normal and pathological subjects are sparse and highly dependent of an expert's clinical criterion. Here, we aimed to investigate whether possible brain structural network differences in the shiverer mouse mutant, a relevant animal model of myelin related diseases, can reflect intrinsic individual brain properties that allow the automatic discrimination between the shiverer and normal subjects. Common structural networks properties between shiverer (C3Fe. SWV Mbp(shi)/Mbp(shi), n = 6) and background control (C3HeB. FeJ, n = 6) mice are estimated and compared by means of three diffusion weighted MRI (DW-MRI) fiber tractography algorithms and a graph framework. Firstly, we found that brain networks of control group are significantly more clustered, modularized, efficient and optimized than those of the shiverer group, which presented significantly increased characteristic path length. These results are in line with previous structural/functional complex brain networks analysis that have revealed topologic differences and brain network randomization associated to specific states of human brain pathology. In addition, by means of network measures spatial representations and discrimination analysis, we show that it is possible to classify with high accuracy to which group each subject belongs, providing also a probability value of being a normal or shiverer subject as an individual anatomical classifier. The obtained correct predictions (e. g., around 91.6-100%) and clear spatial subdivisions between control and shiverer mice, suggest that there might exist specific network subspaces corresponding to specific brain disorders, supporting also the point of view that complex brain network analyses constitutes promising tools in the future creation of interpretable imaging biomarkers.	[Iturria-Medina, Yasser; Valdes Hernandez, Pedro; Melie-Garcia, Lester] Cuban Neurosci Ctr, Neuroimaging Dept, Havana, Cuba; [Perez Fernandez, Alejandro] Basque Ctr Cognit Brain & Language, Donostia San Sebastian, Basque Country, Spain; [Perez Fernandez, Alejandro; Garcia Penton, Lorna] Univ Diego Portales, Cognit Neurosci Lab, Santiago, Chile; [Lage Castellanos, Agustin] Cuban Neurosci Ctr, Neurostat Dept, Havana, Cuba; [Canales-Rodriguez, Erick J.] Ctr Invest Biomed Red Salud Mental CIBERSam, Madrid, Spain; [Canales-Rodriguez, Erick J.] Benito Menni Complex Assistencial Salut Mental, Barcelona, Spain; [Ontivero Ortega, Marlis] Cuban Neurosci Ctr, Neuroengn Dept, Havana, Cuba	University Diego Portales; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Iturria-Medina, Y (corresponding author), Cuban Neurosci Ctr, Neuroimaging Dept, Havana, Cuba.	iturria.medina@gmail.com	Melie-Garcia, Lester/U-5804-2019; Penton, Lorna Garcia/I-3269-2015; Canales-Rodríguez, Erick Jorge/F-7278-2010; Pérez, Alejandro/H-2202-2015; Garcia-Penton, Lorna/I-7662-2018	Penton, Lorna Garcia/0000-0001-9296-9318; Canales-Rodríguez, Erick Jorge/0000-0001-6421-2633; Pérez, Alejandro/0000-0001-6631-9653; Garcia-Penton, Lorna/0000-0001-9296-9318; Melie-Garcia, Lester/0000-0001-5602-8916; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Iturria Medina, Yasser/0000-0002-9345-0347	National Center for Research Resources at the National Institutes of Health, United States of America [U24-RR021760]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Data used for this study were downloaded from the Mouse BIRN Data Repository, supported by grants to the Mouse BIRN (U24-RR021760) Testbed funded by the National Center for Research Resources at the National Institutes of Health, United States of America. The funders and sponsors of the Mouse BIRN Data Repository, from which the authors downloaded the data, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Almendinger S, 2010, CLIN IMMUNOL, V135, pS81, DOI 10.1016/j.clim.2010.03.243; [Anonymous], THESIS; Assaf Y, 2005, MAGN RESON IMAGING, V23, P703, DOI 10.1016/j.mri.2005.04.008; Bar-Shir A, 2009, NEUROIMAGE, V48, P109, DOI 10.1016/j.neuroimage.2009.06.019; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bishop C. M., 2006, PATTERN RECOGNITION; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Commowick O, 2008, LECT NOTES COMPUT SC, V5241, P975, DOI 10.1007/978-3-540-85988-8_116; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Costa LD, 2005, EUR PHYS J B, V48, P567, DOI 10.1140/epjb/e2006-00017-1; Crofts JJ, 2009, J R SOC INTERFACE, V6, P411, DOI 10.1098/rsif.2008.0484; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Galan L, 1997, ELECTROEN CLIN NEURO, V102, P240, DOI 10.1016/S0013-4694(96)95155-3; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gross DW, 2005, EPILEPSIA, V46, P332; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; HAGMANN P, 2006, P 14 M INT SOC MAGN, P436; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; JOHNSON G, 2010, NEUROIMAGE IN PRESS; Jones CT, 2003, NEUROL CLIN, V21, P745, DOI 10.1016/S0733-8619(03)00007-0; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lori NF, 2002, NMR BIOMED, V15, P493, DOI 10.1002/nbm.779; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; ORMEROD IEC, 1987, BRAIN, V110, P1579, DOI 10.1093/brain/110.6.1579; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Savadjiev P, 2008, NEUROIMAGE, V41, P58, DOI 10.1016/j.neuroimage.2008.01.028; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wee CY, 2011, NEUROIMAGE, V54, P1812, DOI 10.1016/j.neuroimage.2010.10.026; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894	68	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19071	10.1371/journal.pone.0019071	http://dx.doi.org/10.1371/journal.pone.0019071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637753	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500002
J	Kistemaker, DA; Rozendaal, LA				Kistemaker, Dinant A.; Rozendaal, Leonard A.			In Vivo Dynamics of the Musculoskeletal System Cannot Be Adequately Described Using a Stiffness-Damping-Inertia Model	PLOS ONE			English	Article							HUMAN ELBOW JOINT; MECHANICAL-PROPERTIES; ANKLE STIFFNESS; LIMB STIFFNESS; MULTIJOINT ARM; SOLEUS MUSCLE; MOVEMENTS; REFLEX; STRETCH; FORCE	Background: Visco-elastic properties of the (neuro-)musculoskeletal system play a fundamental role in the control of posture and movement. Often, these properties are described and identified using stiffness-damping-inertia (KBI) models. In such an approach, perturbations are applied to the (neuro-)musculoskeletal system and subsequently KBI-model parameters are optimized to obtain a best fit between simulated and experimentally observed responses. Problems with this approach may arise because a KBI-model neglects critical aspects of the real musculoskeletal system. Methodology/Principal Findings: The purpose of this study was to analyze the relation between the musculoskeletal properties and the stiffness and damping estimated using a KBI-model, to analyze how this relation is affected by the nature of the perturbation and to assess the sensitivity of the estimated stiffness and damping to measurement errors. Our analyses show that the estimated stiffness and damping using KBI-models do not resemble any of the dynamical parameters of the underlying system, not even when the responses are very accurately fitted by the KBI-model. Furthermore, the stiffness and damping depend non-linearly on all the dynamical parameters of the underlying system, influenced by the nature of the perturbation and the time interval over which the KBI-model is optimized. Moreover, our analyses predict a very high sensitivity of estimated parameters to measurement errors. Conclusions/Significance: The results of this study suggest that the usage of stiffness-damping-inertia models to investigate the dynamical properties of the musculoskeletal system under control by the CNS should be reconsidered.	[Kistemaker, Dinant A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Kistemaker, Dinant A.; Rozendaal, Leonard A.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands	Western University (University of Western Ontario); Vrije Universiteit Amsterdam	Kistemaker, DA (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	dinant.kistemaker@gmail.com			Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	A. Kistemaker was supported by the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL GC, 1977, J PHYSIOL-LONDON, V268, P151, DOI 10.1113/jphysiol.1977.sp011852; BENNETT DJ, 1992, EXP BRAIN RES, V88, P433, DOI 10.1007/BF02259118; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; CAPADAY C, 1986, J NEUROSCI, V6, P1308; DESERRES SJ, 1991, EXP BRAIN RES, V86, P451, DOI 10.1007/BF00228972; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; GOTTLIEB GL, 1978, J BIOMECH, V11, P177, DOI 10.1016/0021-9290(78)90010-6; Granata KP, 2004, J ELECTROMYOGR KINES, V14, P599, DOI 10.1016/j.jelekin.2004.03.005; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Herzog W, 2000, J BIOMECH, V33, P531, DOI 10.1016/S0021-9290(99)00221-3; HOFFER JA, 1981, J NEUROPHYSIOL, V45, P267, DOI 10.1152/jn.1981.45.2.267; HOUK JC, 1979, ANNU REV PHYSIOL, V41, P99, DOI 10.1146/annurev.ph.41.030179.000531; HUNTER IW, 1982, J BIOMECH, V15, P747, DOI 10.1016/0021-9290(82)90089-6; Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756; KEARNEY RE, 1990, CRIT REV BIOMED ENG, V18, P55; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; Kistemaker DA, 2005, J BIOMECH, V38, P1816, DOI 10.1016/j.jbiomech.2004.08.025; Kistemaker DA, 2007, J NEUROPHYSIOL, V98, P1075, DOI 10.1152/jn.00287.2007; Kistemaker DA, 2007, BIOL CYBERN, V96, P341, DOI 10.1007/s00422-006-0120-6; LACQUANITI F, 1982, BIOL CYBERN, V44, P35, DOI 10.1007/BF00353954; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Milner TE, 2002, EXP BRAIN RES, V143, P406, DOI 10.1007/s00221-002-1001-4; MURRAY WM, 1995, J BIOMECH, V28, P513, DOI 10.1016/0021-9290(94)00114-J; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; Nijhof EJ, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P363; Pandy MG, 2001, ANNU REV BIOMED ENG, V3, P245, DOI 10.1146/annurev.bioeng.3.1.245; Perreault EJ, 1999, BIOL CYBERN, V80, P327, DOI 10.1007/s004220050529; Perreault EJ, 2000, IEEE T BIO-MED ENG, V47, P1413, DOI 10.1109/TBME.2000.880092; Popescu F, 2003, EXP BRAIN RES, V152, P17, DOI 10.1007/s00221-003-1507-4; Prochazka A, 1981, Int Rev Physiol, V25, P47; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; RACK PMH, 1969, J PHYSIOL-LONDON, V204, P443, DOI 10.1113/jphysiol.1969.sp008923; Rassier DE, 2005, J APPL PHYSIOL, V99, P1769, DOI 10.1152/japplphysiol.00010.2005; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; TSUJII T, 1995, MOL CELL ENDOCRINOL, V113, P123, DOI 10.1016/0303-7207(95)03613-C; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; WINTERS JM, 1988, J BIOMECH, V21, P1027, DOI 10.1016/0021-9290(88)90249-7; Wong J, 2009, J NEUROPHYSIOL, V101, P246, DOI 10.1152/jn.90371.2008; Zajac FE, 2002, J BIOMECH, V35, P1011, DOI 10.1016/S0021-9290(02)00046-5; Zinder SM, 2007, J BIOMECH, V40, P463, DOI 10.1016/j.jbiomech.2005.12.007	43	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19568	10.1371/journal.pone.0019568	http://dx.doi.org/10.1371/journal.pone.0019568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637750	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500008
J	Sharma, K; Akerstrom, S; Sharma, AK; Chow, VTK; Teow, S; Abrenica, B; Booth, SA; Booth, TF; Mirazimi, A; Lal, SK				Sharma, Kulbhushan; Akerstrom, Sara; Sharma, Anuj Kumar; Chow, Vincent T. K.; Teow, Shumein; Abrenica, Bernard; Booth, Stephanie A.; Booth, Timothy F.; Mirazimi, Ali; Lal, Sunil K.			SARS-CoV 9b Protein Diffuses into Nucleus, Undergoes Active Crm1 Mediated Nucleocytoplasmic Export and Triggers Apoptosis When Retained in the Nucleus	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; SUBCELLULAR-LOCALIZATION; SYNDROME CORONAVIRUS; BOVINE CORONAVIRUS; VIRAL REPLICATION; ACCESSORY PROTEIN; TRANSPORT; IMPORT; CELLS; APHIDICOLIN	Background: 9b is an accessory protein of the SARS-CoV. It is a small protein of 98 amino acids and its structure has been solved recently. 9b is known to localize in the extra-nuclear region and has been postulated to possess a nuclear export signal (NES), however the role of NES in 9b functioning is not well understood. Principal Findings/Methodology: In this report, we demonstrate that 9b in the absence of any nuclear localization signal (NLS) enters the nucleus by passive transport. Using various cell cycle inhibitors, we have shown that the nuclear entry of 9b is independent of the cell cycle. Further, we found that 9b interacts with the cellular protein Crm1 and gets exported out of the nucleus using an active NES. We have also revealed that this NES activity influences the half-life of 9b and affects host cell death. We found that an export signal deficient SARS-CoV 9b protein induces apoptosis in transiently transfected cells and showed elevated caspase-3 activity. Conclusion/Significance: Here, we showed that nuclear shuttling of 9b and its interaction with Crm1 are essential for the proper degradation of 9b and blocking the nuclear export of this protein induces apoptosis. This phenomenon may be critical in providing a novel role to the 9b accessory protein of SARS-CoV.	[Sharma, Kulbhushan; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Akerstrom, Sara; Mirazimi, Ali] Swedish Inst Communicable Dis Control, Solna, Sweden; [Sharma, Anuj Kumar] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Chow, Vincent T. K.] Natl Univ Singapore, YLL Sch Med, Singapore 117548, Singapore; [Teow, Shumein; Abrenica, Bernard; Booth, Stephanie A.; Booth, Timothy F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Booth, Stephanie A.; Booth, Timothy F.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Swedish Institute for Infectious Disease Control; Jawaharlal Nehru University, New Delhi; National University of Singapore; Public Health Agency of Canada; University of Manitoba	Sharma, K (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India.	sunillal@icgeb.res.in	SHARMA, KULBHUSHAN/AAD-7713-2019; Booth, Stephanie/AAX-6671-2020; Sharma, Anuj/G-3043-2011	SHARMA, KULBHUSHAN/0000-0001-5226-4209; Sharma, Anuj/0000-0001-5061-9731; Booth, Stephanie/0000-0001-8108-5955; Chow, Vincent/0000-0003-2634-6213; , Ali/0000-0003-2371-6055	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology; Department of Biotechnology at ICGEB	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology; Department of Biotechnology at ICGEB	This work was supported by internal funds from the International Centre for Genetic Engineering and Biotechnology, New Delhi, and a research grant on SARS from the Department of Biotechnology to S. K. L. The FACS facility funded by Department of Biotechnology at ICGEB was very useful and is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P97; Beswick RW, 2006, LEUKEMIA RES, V30, P427, DOI 10.1016/j.leukres.2005.08.009; Chan WS, 2005, MODERN PATHOL, V18, P1432, DOI 10.1038/modpathol.3800439; de Haan CAM, 2002, VIROLOGY, V296, P177, DOI 10.1006/viro.2002.1412; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; Depienne C, 2001, J BIOL CHEM, V276, P18102, DOI 10.1074/jbc.M009029200; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Fischer F, 1997, J VIROL, V71, P996, DOI 10.1128/JVI.71.2.996-1003.1997; Guo JP, 2004, VIROLOGY, V324, P251, DOI 10.1016/j.virol.2004.04.017; Kalatzis V, 2004, HUM MOL GENET, V13, P1361, DOI 10.1093/hmg/ddh152; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; Moshynskyy I, 2007, VIRUS RES, V127, P116, DOI 10.1016/j.virusres.2007.03.011; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; NISHI K, 1994, J BIOL CHEM, V269, P6320; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; OGURO M, 1979, EUR J BIOCHEM, V97, P603, DOI 10.1111/j.1432-1033.1979.tb13149.x; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Prieve MG, 1998, MOL CELL BIOL, V18, P4819, DOI 10.1128/MCB.18.8.4819; Qiu MF, 2005, MICROBES INFECT, V7, P882, DOI 10.1016/j.micinf.2005.02.006; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SEKI S, 1980, BIOCHIM BIOPHYS ACTA, V610, P413, DOI 10.1016/0005-2787(80)90022-2; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; SENANAYAKE SD, 1992, J VIROL, V66, P5277, DOI 10.1128/JVI.66.9.5277-5283.1992; Senanayake SD, 1997, VIRUS RES, V48, P101, DOI 10.1016/S0168-1702(96)01423-2; Sharma K, 2007, BIOCHEMISTRY-US, V46, P6488, DOI 10.1021/bi062057p; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Stauber RH, 2006, TRAFFIC, V7, P1461, DOI 10.1111/j.1600-0854.2006.00486.x; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Xu K, 2009, VIROLOGY, V388, P279, DOI 10.1016/j.virol.2009.03.032; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Yuan XL, 2005, VIRUS RES, V109, P191, DOI 10.1016/j.virusres.2005.01.001; Zhao J, 2000, J CELL SCI, V113, P4363; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005	51	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19436	10.1371/journal.pone.0019436	http://dx.doi.org/10.1371/journal.pone.0019436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637748	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500005
J	Bami, M; Episkopou, V; Gavalas, A; Gouti, M				Bami, Myrto; Episkopou, Vasso; Gavalas, Anthony; Gouti, Mina			Directed Neural Differentiation of Mouse Embryonic Stem Cells Is a Sensitive System for the Identification of Novel Hox Gene Effectors	PLOS ONE			English	Article							ACID-BINDING PROTEIN; LIM-HOMEOBOX GENES; RESPONSE ELEMENT; CRABP-I; DOWNSTREAM GENES; POOL IDENTITY; EXPRESSION; MOTOR; TARGET; TRANSFORMATION	The evolutionarily conserved Hox family of homeodomain transcription factors plays fundamental roles in regulating cell specification along the anterior posterior axis during development of all bilaterian animals by controlling cell fate choices in a highly localized, extracellular signal and cell context dependent manner. Some studies have established downstream target genes in specific systems but their identification is insufficient to explain either the ability of Hox genes to direct homeotic transformations or the breadth of their patterning potential. To begin delineating Hox gene function in neural development we used a mouse ES cell based system that combines efficient neural differentiation with inducible Hoxb1 expression. Gene expression profiling suggested that Hoxb1 acted as both activator and repressor in the short term but predominantly as a repressor in the long run. Activated and repressed genes segregated in distinct processes suggesting that, in the context examined, Hoxb1 blocked differentiation while activating genes related to early developmental processes, wnt and cell surface receptor linked signal transduction and cell-to-cell communication. To further elucidate aspects of Hoxb1 function we used loss and gain of function approaches in the mouse and chick embryos. We show that Hoxb1 acts as an activator to establish the full expression domain of CRABPI and II in rhombomere 4 and as a repressor to restrict expression of Lhx5 and Lhx9. Thus the Hoxb1 patterning activity includes the regulation of the cellular response to retinoic acid and the delay of the expression of genes that commit cells to neural differentiation. The results of this study show that ES neural differentiation and inducible Hox gene expression can be used as a sensitive model system to systematically identify Hox novel target genes, delineate their interactions with signaling pathways in dictating cell fate and define the extent of functional overlap among different Hox genes.	[Bami, Myrto; Gavalas, Anthony; Gouti, Mina] Biomed Res Fdn Acad Athens BRFAA, Dev Biol Lab, Athens, Greece; [Episkopou, Vasso] Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, London, England	Academy of Athens; Imperial College London	Bami, M (corresponding author), Biomed Res Fdn Acad Athens BRFAA, Dev Biol Lab, Athens, Greece.	mgouti@bioacademy.gr	Gavalas, Anthony/F-5817-2015; Gouti, Mina/D-3235-2018	Gouti, Mina/0000-0001-7422-1605; Gavalas, Anthony/0000-0003-4897-0359	Wellcome Trust [WT083464MA]; European Community [03ED 394]; MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by a Wellcome Trust Project Grant (WT083464MA) and by a General Secretariat for Research and Technology Grant (03ED 394, 3rd European Community Support Framework). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BOYLAN JF, 1992, J BIOL CHEM, V267, P21486; Bromleigh VC, 2000, GENE DEV, V14, P2581, DOI 10.1101/gad.817100; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chambers D, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-6; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dawid IB, 2001, NEURON, V30, P301, DOI 10.1016/S0896-6273(01)00307-5; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; DELVA L, 1993, BLOOD, V82, P2175; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Gaufo GO, 2003, DEVELOPMENT, V130, P5191, DOI 10.1242/dev.00730; Gavalas A, 2003, DEVELOPMENT, V130, P5663, DOI 10.1242/dev.00802; Gavalas A, 2001, DEVELOPMENT, V128, P3017; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Gouti M, 2008, STEM CELLS, V26, P1985, DOI 10.1634/stemcells.2008-0182; Gouti M, 2011, STEM CELLS, V29, P858, DOI 10.1002/stem.630; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grienenberger A, 2003, DEVELOPMENT, V130, P5445, DOI 10.1242/dev.00760; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; Jacob J, 2007, NAT NEUROSCI, V10, P1433, DOI 10.1038/nn1985; Joulia L, 2006, DEV GENES EVOL, V216, P431, DOI 10.1007/s00427-006-0086-3; KESSEL M, 1993, NEURON, V10, P379, DOI 10.1016/0896-6273(93)90328-O; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; Lei HY, 2005, P NATL ACAD SCI USA, V102, P2420, DOI 10.1073/pnas.0409700102; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; MARSHALL H, 1992, NATURE, V360, P737, DOI 10.1038/360737a0; Marty T, 2001, DEVELOPMENT, V128, P2833; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521; POPPERL H, 1993, MOL CELL BIOL, V13, P257; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; RUBERTE E, 1992, DEVELOPMENT, V115, P973; Samad OA, 2004, DEVELOPMENT, V131, P4071, DOI 10.1242/dev.01282; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Sun X, 2008, INT J DEV BIOL, V52, P33, DOI 10.1387/ijdb.072386xs; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Taghli-Lamallem O, 2008, DEV GENES EVOL, V218, P321, DOI 10.1007/s00427-008-0224-1; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; VAESSEN MJ, 1990, DEVELOPMENT, V110, P371; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Wagmaister JA, 2006, MECH DEVELOP, V123, P135, DOI 10.1016/j.mod.2005.11.003; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wang N, 2006, EMBO J, V25, P1469, DOI 10.1038/sj.emboj.7601037; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	62	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20197	10.1371/journal.pone.0020197	http://dx.doi.org/10.1371/journal.pone.0020197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637844	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000291052200038
J	Danino, T; Volfson, D; Bhatia, SN; Tsimring, L; Hasty, J				Danino, Tal; Volfson, Dmitri; Bhatia, Sangeeta N.; Tsimring, Lev; Hasty, Jeff			In-Silico Patterning of Vascular Mesenchymal Cells in Three Dimensions	PLOS ONE			English	Article							MATRIX GLA PROTEIN; BONE MORPHOGENETIC PROTEIN-2; MECHANISMS; COMPLEX; DIFFERENTIATION; ORGANIZATION; MIGRATION; FORM; MGP	Cells organize in complex three-dimensional patterns by interacting with proteins along with the surrounding extracellular matrix. This organization provides the mechanical and chemical cues that ultimately influence a cell's differentiation and function. Here, we computationally investigate the pattern formation process of vascular mesenchymal cells arising from their interaction with Bone Morphogenic Protein-2 (BMP-2) and its inhibitor, Matrix Gla Protein (MGP). Using a first-principles approach, we derive a reaction-diffusion model based on the biochemical interactions of BMP-2, MGP and cells. Simulations of the model exhibit a wide variety of three-dimensional patterns not observed in a two-dimensional analysis. We demonstrate the emergence of three types of patterns: spheres, tubes, and sheets, and show that the patterns can be tuned by modifying parameters in the model such as the degradation rates of proteins and chemotactic coefficient of cells. Our model may be useful for improved engineering of three-dimensional tissue structures as well as for understanding three dimensional microenvironments in developmental processes.	[Danino, Tal; Volfson, Dmitri; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tsimring, Lev; Hasty, Jeff] Univ Calif San Diego, Biocircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Bhatia, Sangeeta N.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Danino, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@ucsd.edu		Tsimring, Lev/0000-0003-0709-3548; Volfson, Dmitri/0000-0002-5167-7834	National Institutes of Health and General Medicine [GM69811]; DOE; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health and General Medicine (GM69811) and DOE CSGF fellowship (to T. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; AMBROSI D, 2006, B MATH BIOL; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Bostrom KI, 2000, Z KARDIOL, V89, P69; Brenner MP, 1998, BIOPHYS J, V74, P1677, DOI 10.1016/S0006-3495(98)77880-4; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cross MC, 1994, CHAOS, V4, P607, DOI 10.1063/1.166038; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; DIMILLA PA, 1992, AICHE J, V38, P1092, DOI 10.1002/aic.690380712; Gamba A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118101; Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101; GHOSHCHOUDHURY N, 1993, BIOCHEM BIOPH RES CO, V286, P101; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; LOESER R, 1992, BIOCHEM J, V282, P1; MURRAY JD, 1984, J MATH BIOL, V19, P265, DOI 10.1007/BF00277099; Murray JD, 2003, CR BIOL, V326, P239, DOI 10.1016/S1631-0691(03)00065-9; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Painter KJ, 1999, P NATL ACAD SCI USA, V96, P5549, DOI 10.1073/pnas.96.10.5549; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Sage A, 2009, TRENDS CARDIOVAS MED, V19, P118, DOI 10.1016/j.tcm.2009.07.002; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sweatt A, 2003, J THROMB HAEMOST, V1, P178, DOI 10.1046/j.1538-7836.2003.00023.x; TSIMRING L, 1995, PHYS REV LETT, V75, P1859, DOI 10.1103/PhysRevLett.75.1859; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Webb DJ, 2003, NAT CELL BIOL, V5, P690, DOI 10.1038/ncb0803-690; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Yochelis A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/055002; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	34	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20182	10.1371/journal.pone.0020182	http://dx.doi.org/10.1371/journal.pone.0020182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633504	gold, Green Published			2022-12-25	WOS:000291006500037
J	Kamgang, B; Brengues, C; Fontenille, D; Njiokou, F; Simard, F; Paupy, C				Kamgang, Basile; Brengues, Cecile; Fontenille, Didier; Njiokou, Flobert; Simard, Frederic; Paupy, Christophe			Genetic Structure of the Tiger Mosquito, Aedes albopictus, in Cameroon (Central Africa)	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHIKUNGUNYA-VIRUS; STATISTICAL TESTS; DIPTERA-CULICIDAE; F-STATISTICS; DENGUE; AEGYPTI; VECTOR; TIRES; DIFFERENTIATION	Background: Aedes albopictus (Skuse, 1884) (Diptera: Culicidae), a mosquito native to Asia, has recently invaded all five continents. In Central Africa it was first reported in the early 2000s, and has since been implicated in the emergence of arboviruses such as dengue and chikungunya in this region. Recent genetic studies of invasive species have shown that multiple introductions are a key factor for successful expansion in new areas. As a result, phenotypic characters such as vector competence and insecticide susceptibility may vary within invasive pest species, potentially affecting vector efficiency and pest management. Here we assessed the genetic variability and population genetics of Ae. albopictus isolates in Cameroon (Central Africa), thereby deducing their likely geographic origin. Methods and Results: Mosquitoes were sampled in 2007 in 12 localities in southern Cameroon and analyzed for polymorphism at six microsatellite loci and in two mitochondrial DNA regions (ND5 and COI). All the microsatellite markers were successfully amplified and were polymorphic, showing moderate genetic structureamong geographic populations (F-ST = 0.068, P<0.0001). Analysis of mtDNA sequences revealed four haplotypes each for the COI and ND5 genes, with a dominant haplotype shared by all Cameroonian samples. The weak genetic variation estimated from the mtDNA genes is consistent with the recent arrival of Ae. albopictus in Cameroon. Phylogeographic analysis based on COI polymorphism indicated that Ae. albopictus populations from Cameroon are related to tropical rather than temperate or subtropical outgroups. Conclusion: The moderate genetic diversity observed among Cameroonian Ae. albopictus isolates is in keeping with recent introduction and spread in this country. The genetic structure of natural populations points to multiple introductions from tropical regions.	[Kamgang, Basile; Brengues, Cecile; Fontenille, Didier; Simard, Frederic; Paupy, Christophe] IRD, CNRS IRD UM1 5290 224, Unite Mixte Rech MIVEGEC, Montpellier, France; [Kamgang, Basile] Org Coordinat Lutte Endemies Afrique Cent OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Njiokou, Flobert] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Simard, Frederic] IRSS, Bobo Dioulasso, Burkina Faso; [Paupy, Christophe] CIRMF, Unite Rech Ecol Sante, Franceville, Gabon	Institut de Recherche pour le Developpement (IRD); University of Yaounde I	Kamgang, B (corresponding author), IRD, CNRS IRD UM1 5290 224, Unite Mixte Rech MIVEGEC, Montpellier, France.	christophe.paupy@ird.fr	Kamgang, Basile/ABC-8345-2021; SIMARD, Frederic/J-9489-2016; FONTENILLE, didier/G-4091-2013; Frederic, SIMARD/AFV-5001-2022; Paupy, Christophe/I-4847-2017	Kamgang, Basile/0000-0002-8883-4557; SIMARD, Frederic/0000-0002-2871-5329; Frederic, SIMARD/0000-0002-2871-5329; Paupy, Christophe/0000-0002-7122-2079; FONTENILLE, didier/0000-0002-0544-3885	French government (Agence Nationale pour la Recherche) [ANR 05 SEST 010-01]; Institut de Recherche pour le Developpement/Departement Soutien et Formation	French government (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); Institut de Recherche pour le Developpement/Departement Soutien et Formation	This research was supported by the French government (Agence Nationale pour la Recherche) through the Epidengue project (ANR 05 SEST 010-01). Basile Kamgang was supported by an Institut de Recherche pour le Developpement/Departement Soutien et Formation PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022; Belkhir K, 2004, 5000 CNRS UMR; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bonacum J., 2001, Drosophila Information Service, V84, P201; CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107; de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318; Gubler DJ, 2003, LANCET INFECT DIS, V3, P751, DOI 10.1016/S1473-3099(03)00826-0; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; HOLM S, 1979, SCAND J STAT, V6, P65; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624; Mas-Coma S, 2009, ACTA TROP, V110, P112, DOI 10.1016/j.actatropica.2008.10.013; Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nei M., 1987, MOL EVOLUTIONARY GEN; Nei M, 1983, EVOLUTION GENES PROT; Nylander J, 2004, MRMODELTEST V2 EVOLU; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2; Smith CEG, 1956, J TROP MED HYG, V59, P3; TAJIMA F, 1989, GENETICS, V123, P597; TESH RB, 1976, AM J TROP MED HYG, V33, P176; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zalewski A, 2010, BIOL CONSERV, V143, P1355, DOI 10.1016/j.biocon.2010.03.009	58	60	67	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20257	10.1371/journal.pone.0020257	http://dx.doi.org/10.1371/journal.pone.0020257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629655	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800037
J	Lai, YL				Lai, Yinglei			On the Adaptive Partition Approach to the Detection of Multiple Change-Points	PLOS ONE			English	Article							ARRAY CGH DATA; CIRCULAR BINARY SEGMENTATION; COPY-NUMBER; REGRESSION	With an adaptive partition procedure, we can partition a "time course'' into consecutive non-overlapped intervals such that the population means/proportions of the observations in two adjacent intervals are significantly different at a given level alpha(C). However, the widely used recursive combination or partition procedures do not guarantee a global optimization. We propose a modified dynamic programming algorithm to achieve a global optimization. Our method can provide consistent estimation results. In a comprehensive simulation study, our method shows an improved performance when it is compared to the recursive combination/partition procedures. In practice, alpha(C) can be determined based on a cross-validation procedure. As an application, we consider the well-known Pima Indian Diabetes data. We explore the relationship among the diabetes risk and several important variables including the plasma glucose concentration, body mass index and age.	[Lai, Yinglei] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Lai, Yinglei] George Washington Univ, Ctr Biostat, Washington, DC USA	George Washington University; George Washington University	Lai, YL (corresponding author), George Washington Univ, Dept Stat, Washington, DC 20052 USA.	ylai@gwu.edu			National Institutes of Health [R21DK075004, R01GM092963]; Samuel W. Greenhouse Biostatistics Research Enhancement Award (GW Biostatistics Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel W. Greenhouse Biostatistics Research Enhancement Award (GW Biostatistics Center); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants R21DK075004, R01GM092963 and Samuel W. Greenhouse Biostatistics Research Enhancement Award (GW Biostatistics Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autio R, 2003, BIOINFORMATICS, V19, P1714, DOI 10.1093/bioinformatics/btg230; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S70; Braun JV, 1998, STAT SCI, V13, P142; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Efron B., 1994, INTRO BOOTSTRAP; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Good P, 2005, PERMUTATION PARAMETR; Groeneboom P, 1995, ANN STAT, V23, P1518, DOI 10.1214/aos/1176324310; Leiserson CE, 2001, INTRO ALGORITHMS; Liu J, 2007, BIOINFORMATICS, V23, P450, DOI 10.1093/bioinformatics/btl624; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Picard F, 2007, BIOMETRICS, V63, P758, DOI 10.1111/j.1541-0420.2006.00729.x; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Robertson T., 1988, ORDER RESTRICTED STA; Schell MJ, 1997, J AM STAT ASSOC, V92, P128, DOI 10.2307/2291456; SIEGMUND D, 1995, ANN STAT, V23, P255, DOI 10.1214/aos/1176324466; Silvapulle M., 2004, CONSTRAINED STAT INF; Smith J. W., 1988, Proceedings. The Twelfth Annual Symposium on Computer Applications in Medical Care (IEEE Cat. No.88CH2616-1), P261; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wu WB, 2001, BIOMETRIKA, V88, P793, DOI 10.1093/biomet/88.3.793	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19754	10.1371/journal.pone.0019754	http://dx.doi.org/10.1371/journal.pone.0019754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629694	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800008
J	McHenry, AM; Barnes, SJ; Ntumngia, FB; King, CL; Adams, JH				McHenry, Amy M.; Barnes, Samantha J.; Ntumngia, Francis B.; King, Christopher L.; Adams, John H.			Determination of the Molecular Basis for a Limited Dimorphism, N417K, in the Plasmodium vivax Duffy-Binding Protein	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; INHIBITORY ANTIBODIES; LIGAND DOMAIN; SWISS-MODEL; MALARIA; INVASION; RECOGNITION; FALCIPARUM; RESISTANCE; RESIDUES	Invasion of human red blood cells by Plasmodium merozoites is vital for replication and survival of the parasite and, as such, is an attractive target for therapeutic intervention. Merozoite invasion is mediated by specific interactions between parasite ligands and host erythrocyte receptors. The P. vivax Duffy-binding protein (PvDBP) is heavily dependent on the interaction with the human Duffy blood group antigen/receptor for chemokines (DARC) for invasion. Region II of PvDBP contains many allelic polymorphisms likely to have arisen by host immune selection. Successful vaccine development necessitates a deeper understanding of the role of these polymorphisms in both parasite function and evasion of host immunity. A 3D structure of the homologous P. knowlesi DBP predicts that most variant residues are surface-exposed, including N417K, which is a dimorphic residue change that has previously been shown to be part of a linked haplotype that alters DBP sensitivity to inhibitory antibody. In natural isolates only two residues are found at this site, asparagine (N) and lysine (K). Site-directed mutagenesis of residue 417 was used to create a panel of 20 amino acid variants that were then examined for their binding phenotype and response to immune sera. Our results suggest that the observed dimorphism likely arose due to both structural requirements and immune selection pressure. To our knowledge, this is the first exhaustive examination of this kind of the role of a single amino acid residue in antigenic character and binding ability. Our results demonstrate that a single amino acid substitution can dramatically alter both the ability of the PvDBP to bind to human erythrocytes and its antigenic character.	[McHenry, Amy M.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [McHenry, Amy M.; Barnes, Samantha J.; Ntumngia, Francis B.; Adams, John H.] Univ S Florida, Dept Global Hlth, Tampa, FL USA; [Barnes, Samantha J.] Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL USA; [King, Christopher L.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	University of Notre Dame; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Case Western Reserve University	McHenry, AM (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Ntumngia, Francis/0000-0001-9867-3534	National Institutes of Health [R01 AI33656]; Veterans Affairs Research Service; Arthur J. Schmitt Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478, R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Research Service(US Department of Veterans Affairs); Arthur J. Schmitt Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a National Institutes of Health Grant R01 AI33656 to J.H.A., Veterans Affairs Research Service Support to C.L.K. and an Arthur J. Schmitt Presidential Fellowship to A.M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Ampudia E, 1996, MOL BIOCHEM PARASIT, V78, P269, DOI 10.1016/S0166-6851(96)02611-4; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; Choe H, 2005, MOL MICROBIOL, V55, P1413, DOI 10.1111/j.1365-2958.2004.04478.x; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Crewther PE, 1996, INFECT IMMUN, V64, P3310, DOI 10.1128/IAI.64.8.3310-3317.1996; Grimberg BT, 2007, PLOS MED, V4, P1940, DOI 10.1371/journal.pmed.0040337; Hans D, 2005, MOL MICROBIOL, V55, P1423, DOI 10.1111/j.1365-2958.2005.04484.x; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Jia XL, 2000, MOL BIOCHEM PARASIT, V111, P253, DOI 10.1016/S0166-6851(00)00315-7; Kho Weon-Gyu, 2001, Korean Journal of Parasitology, V39, P143, DOI 10.3347/kjp.2001.39.2.143; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ranjan A, 1999, P NATL ACAD SCI USA, V96, P14067, DOI 10.1073/pnas.96.24.14067; Ruebush TK, 2003, AM J TROP MED HYG, V69, P548, DOI 10.4269/ajtmh.2003.69.548; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Singh SK, 2003, BIOCHEM J, V374, P193, DOI 10.1042/BJ20030622; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TSUBOI T, 1994, INFECT IMMUN, V62, P5581, DOI 10.1128/IAI.62.12.5581-5586.1994; VanBuskirk KM, 2004, P NATL ACAD SCI USA, V101, P15754, DOI 10.1073/pnas.0405421101; VanBuskirk KM, 2004, J INFECT DIS, V190, P1556, DOI 10.1086/424852; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0	36	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20192	10.1371/journal.pone.0020192	http://dx.doi.org/10.1371/journal.pone.0020192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629662	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800033
J	Minassian, AM; Ronan, EO; Poyntz, H; Hill, AVS; McShane, H				Minassian, Angela M.; Ronan, Edward O.; Poyntz, Hazel; Hill, Adrian V. S.; McShane, Helen			Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; CALMETTE-GUERIN INFECTION; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; VIRUS ANKARA; ENHANCED IMMUNOGENICITY; ANTIGEN 85A; IFN-GAMMA; MICE; CELLS	There is an urgent need for an immunological correlate of protection against tuberculosis (TB) with which to evaluate candidate TB vaccines in clinical trials. Development of a human challenge model of Mycobacterium tuberculosis (M.tb) could facilitate the detection of such correlate(s). Here we propose a novel in vivo Bacille Calmette-Guerin (BCG) challenge model using BCG immunization as a surrogate for M.tb infection. Culture and quantitative PCR methods have been developed to quantify BCG in the skin, using the mouse ear as a surrogate for human skin. Candidate TB vaccines have been evaluated for their ability to protect against a BCG skin challenge, using this model, and the results indicate that protection against a BCG skin challenge is predictive of BCG vaccine efficacy against aerosol M.tb challenge. Translation of these findings to a human BCG challenge model could enable more rapid assessment and down selection of candidate TB vaccines and ultimately the identification of an immune correlate of protection.	[Minassian, Angela M.; Ronan, Edward O.; Poyntz, Hazel; Hill, Adrian V. S.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Minassian, AM (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	minassian.angela@gmail.com		Minassian, Angela/0000-0001-7832-9824; McShane, Helen/0000-0002-2126-5142	Wellcome Trust; European Union	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	This work was funded by the Wellcome Trust and the European Union FP5 framework program project AFTBVAC. H.M. and A.V.S.H. are both Jenner Investigators. H.M. is a Wellcome Trust Senior Clinical Research Fellow, and A.V.S.H. is a Wellcome Trust Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COLLINS FM, 1971, INFECT IMMUN, V4, P688, DOI 10.1128/IAI.4.6.688-696.1971; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; Dobakhti F, 2009, MICROBES INFECT, V11, P296, DOI 10.1016/j.micinf.2008.12.003; Feng CG, 2000, J INFECT DIS, V181, P1846, DOI 10.1086/315466; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Gruppo V, 2002, TUBERCULOSIS, V82, P267, DOI 10.1054/tube.2002.0340; Hanekom WA, 2005, ANN NY ACAD SCI, V1062, P69, DOI 10.1196/annals.1358.010; Horwitz MA, 2006, VACCINE, V24, P443, DOI 10.1016/j.vaccine.2005.08.001; IZUMI T, 1971, J EXP MED, V133, P376, DOI 10.1084/jem.133.2.376; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; LADEL CH, 1995, EUR J IMMUNOL, V25, P377, DOI 10.1002/eji.1830250211; Lagranderie MRR, 1996, INFECT IMMUN, V64, P1; LEFFORD MJ, 1980, INFECT IMMUN, V28, P508; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Magdalena J, 1998, J CLIN MICROBIOL, V36, P2471, DOI 10.1128/JCM.36.9.2471-2476.1998; Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1423, DOI 10.1001/jama.279.18.1423; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Minassian Angela M, 2008, Expert Rev Respir Med, V2, P721, DOI 10.1586/17476348.2.6.721; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Talbot EA, 1997, J CLIN MICROBIOL, V35, P566, DOI 10.1128/JCM.35.3.566-569.1997; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wang J, 2004, J IMMUNOL, V173, P4590, DOI 10.4049/jimmunol.173.7.4590; Wangoo A, 2001, J IMMUNOL, V166, P3432, DOI 10.4049/jimmunol.166.5.3432	41	25	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19840	10.1371/journal.pone.0019840	http://dx.doi.org/10.1371/journal.pone.0019840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629699	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800014
J	Swarbrick, JD; Shaw, DJ; Chhabra, S; Ghai, R; Valkov, E; Norwood, SJ; Seaman, MNJ; Collins, BM				Swarbrick, James D.; Shaw, Daniel J.; Chhabra, Sandeep; Ghai, Rajesh; Valkov, Eugene; Norwood, Suzanne J.; Seaman, Matthew N. J.; Collins, Brett M.			VPS29 Is Not an Active Metallo-Phosphatase but Is a Rigid Scaffold Required for Retromer Interaction with Accessory Proteins	PLOS ONE			English	Article							MAMMALIAN RETROMER; DIPOLAR COUPLINGS; RESIDUAL DIPOLAR; SORTING NEXIN-1; IDENTIFICATION; COMPLEX; TRANSPORT; DYNAMICS; ASSOCIATION; ENDOSOMES	VPS29 is a key component of the cargo-binding core complex of retromer, a protein assembly with diverse roles in transport of receptors within the endosomal system. VPS29 has a fold related to metal-binding phosphatases and mediates interactions between retromer and other regulatory proteins. In this study we examine the functional interactions of mammalian VPS29, using X-ray crystallography and NMR spectroscopy. We find that although VPS29 can coordinate metal ions Mn2+ and Zn2+ in both the putative active site and at other locations, the affinity for metals is low, and lack of activity in phosphatase assays using a putative peptide substrate support the conclusion that VPS29 is not a functional metalloenzyme. There is evidence that structural elements of VPS29 critical for binding the retromer subunit VPS35 may undergo both metal-dependent and independent conformational changes regulating complex formation, however studies using ITC and NMR residual dipolar coupling (RDC) measurements show that this is not the case. Finally, NMR chemical shift mapping indicates that VPS29 is able to associate with SNX1 via a conserved hydrophobic surface, but with a low affinity that suggests additional interactions will be required to stabilise the complex in vivo. Our conclusion is that VPS29 is a metal ion-independent, rigid scaffolding domain, which is essential but not sufficient for incorporation of retromer into functional endosomal transport assemblies.	[Swarbrick, James D.; Chhabra, Sandeep] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Shaw, Daniel J.; Ghai, Rajesh; Norwood, Suzanne J.; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Valkov, Eugene] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Seaman, Matthew N. J.] Univ Cambridge, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge, England	Monash University; University of Queensland; University of Queensland; University of Cambridge	Swarbrick, JD (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	b.collins@imb.uq.edu.au	Valkov, Eugene/C-1554-2010; Collins, Brett/J-1563-2014; Chhabra, Sandeep/T-5468-2018; chhabra, sandeep/R-9942-2017; Ghai, Rajesh/D-5903-2012; Valkov, Eugene/AAA-1735-2020	Collins, Brett/0000-0002-6070-3774; Chhabra, Sandeep/0000-0002-5225-1333; Ghai, Rajesh/0000-0002-0919-0934; Valkov, Eugene/0000-0002-3721-1739	Australian Research Council [DP0878608, FT100100027]; NHMRC [511072]; MRC [G0701444] Funding Source: UKRI; Medical Research Council [G0701444] Funding Source: researchfish	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by funds from the Australian Research Council (DP0878608), and NHMRC (511072). BMC is supported by an ARC Future Fellowship (FT100100027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102; Bracken C, 1999, J MOL BIOL, V285, P2133, DOI 10.1006/jmbi.1998.2429; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Goddard T.D., SPARKY 3; Gokool S, 2007, BIOCHEM J, V408, P287, DOI 10.1042/BJ20070555; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Homans SW, 2005, CHEMBIOCHEM, V6, P1585, DOI 10.1002/cbic.200500010; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jackson CJ, 2008, ACTA CRYSTALLOGR F, V64, P681, DOI 10.1107/S1744309108017600; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nakada-Tsukui K, 2005, MOL BIOL CELL, V16, P5294, DOI 10.1091/mbc.E05-04-0283; NORWOOD SJ, 2010, ASSEMBLY SOLUTION ST; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; SEAMAN MN, 2009, J CELL SCI; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; Tabuchi M, 2010, J CELL SCI, V123, P756, DOI 10.1242/jcs.060574; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	71	47	49	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20420	10.1371/journal.pone.0020420	http://dx.doi.org/10.1371/journal.pone.0020420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629666	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005800050
J	Darisipudi, MN; Allam, R; Rupanagudi, KV; Anders, HJ				Darisipudi, Murthy Narayana; Allam, Ramanjaneyulu; Rupanagudi, Khader Valli; Anders, Hans-Joachim			Polyene Macrolide Antifungal Drugs Trigger Interleukin-1 beta Secretion by Activating the NLRP3 Inflammasome	PLOS ONE			English	Article							NALP3 INFLAMMASOME; IMMUNE-RESPONSES; NYSTATIN; CELLS; RECEPTORS; MECHANISM; CRYSTALS; TOXINS; ALPHA; FORMS	The use of antimycotic drugs in fungal infections is based on the concept that they suppress fungal growth by a direct killing effect. However, amphotericin and nystatin have been reported to also trigger interleukin-1 beta (IL-1 beta) secretion in monocytes but the molecular mechanism is unknown. Here we report that only the polyene macrolides amphotericin B, nystatin, and natamycin but none of the tested azole antimycotic drugs induce significant IL-1 beta secretion in-vitro in dendritic cells isolated from C57BL/6 mouse bone marrow. IL-1 beta release depended on Toll-like receptor-mediated induction of pro-IL-1 beta as well as the NLRP3 inflammasome, its adaptor ASC, and caspase-1 for enzymatic cleavage of proIL-1 beta into its mature form. All three drugs induced potassium efflux from the cells as a known mechanism for NLRP3 activation but the P2X7 receptor was not required for this process. Natamycin-induced IL-1 beta secretion also involved phagocytosis, as cathepsin activation as described for crystal-induced IL-1 beta release. Together, the polyene macrolides amphotericin B, nystatin, and natamycin trigger IL-1 beta secretion by causing potassium efflux from which activates the NLRP3-ASC-caspase-1. We conclude that beyond their effects on fungal growth, these antifungal drugs directly activate the host's innate immunity.	[Darisipudi, Murthy Narayana; Rupanagudi, Khader Valli; Anders, Hans-Joachim] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Allam, Ramanjaneyulu] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Munich; University of Lausanne	Darisipudi, MN (corresponding author), Univ Munich, Med Poliklin, Pettenkoferstr 8A, D-8000 Munich, Germany.	hjanders@med.uni-muenchen.de	Anders, Hans-Joachim/ABD-6247-2021; Allam, Ramanjaneyulu/N-4053-2016	Allam, Ramanjaneyulu/0000-0002-2789-3596; Anders, Hans-Joachim/0000-0003-2434-2956	Deutsche Forschungsgemeinschaft [GRK 1202]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft GRK 1202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allam R, 2009, J AM SOC NEPHROL, V20, P1986, DOI 10.1681/ASN.2008101067; BOLARD J, 1986, DRUG EXP CLIN RES, V12, P613; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Camacho M, 2004, J INFECT DIS, V190, P1026, DOI 10.1086/423207; Coutinho A, 2004, BIOPHYS J, V87, P3264, DOI 10.1529/biophysj.104.044883; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Ogawa Y, 2006, J INVEST DERMATOL, V126, P349, DOI 10.1038/sj.jid.5700081; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P3546, DOI 10.1128/AAC.49.8.3546-3549.2005; Rogers PD, 2002, ANTIMICROB AGENTS CH, V46, P3412, DOI 10.1128/AAC.46.11.3412-3417.2002; Sau K, 2003, J BIOL CHEM, V278, P37561, DOI 10.1074/jbc.M306137200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	26	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19588	10.1371/journal.pone.0019588	http://dx.doi.org/10.1371/journal.pone.0019588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625424	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200005
J	Palomer, X; Alvarez-Guardia, D; Davidson, MM; Chan, TO; Feldman, AM; Vazquez-Carrera, M				Palomer, Xavier; Alvarez-Guardia, David; Davidson, Mercy M.; Chan, Tung O.; Feldman, Arthur M.; Vazquez-Carrera, Manuel			The Interplay between NF-kappaB and E2F1 Coordinately Regulates Inflammation and Metabolism in Human Cardiac Cells (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							PYRUVATE-DEHYDROGENASE; HEART-FAILURE; CYCLE PROGRESSION; GLUCOSE-OXIDATION; DOWN-REGULATION; B ACTIVITY; TRANSCRIPTION; EXPRESSION; PGC-1-ALPHA; INHIBITION	Pyruvate dehydrogenase kinase 4 (PDK4) inhibition by nuclear factor-kappa B (NF-kappa B) is related to a shift towards increased glycolysis during cardiac pathological processes such as cardiac hypertrophy and heart failure. The transcription factors estrogen-related receptor-alpha (ERR alpha) and peroxisome proliferator-activated receptor (PPAR) regulate PDK4 expression through the potent transcriptional coactivator PPAR gamma coactivator-1 alpha (PGC-1 alpha). NF-kappa B activation in AC16 cardiac cells inhibit ERR alpha and PPAR beta/delta transcriptional activity, resulting in reduced PGC-1 alpha and PDK4 expression, and an enhanced glucose oxidation rate. However, addition of the NF-kappa B inhibitor parthenolide to these cells prevents the downregulation of PDK4 expression but not ERR alpha and PPAR beta/delta DNA binding activity, thus suggesting that additional transcription factors are regulating PDK4. Interestingly, a recent study has demonstrated that the transcription factor E2F1, which is crucial for cell cycle control, may regulate PDK4 expression. Given that NF-kappa B may antagonize the transcriptional activity of E2F1 in cardiac myocytes, we sought to study whether inflammatory processes driven by NF-kappa B can downregulate PDK4 expression in human cardiac AC16 cells through E2F1 inhibition. Protein coimmunoprecipitation indicated that PDK4 downregulation entailed enhanced physical interaction between the p65 subunit of NF-kappa B and E2F1. Chromatin immunoprecipitation analyses demonstrated that p65 translocation into the nucleus prevented the recruitment of E2F1 to the PDK4 promoter and its subsequent E2F1-dependent gene transcription. Interestingly, the NF-kappa B inhibitor parthenolide prevented the inhibition of E2F1, while E2F1 overexpression reduced interleukin expression in stimulated cardiac cells. Based on these findings, we propose that NF-kappa B acts as a molecular switch that regulates E2F1-dependent PDK4 gene transcription.	[Palomer, Xavier; Alvarez-Guardia, David; Vazquez-Carrera, Manuel] Univ Barcelona, Dept Pharmacol & Therapeut Chem, Fac Pharm, IBUB, Barcelona, Spain; [Palomer, Xavier; Alvarez-Guardia, David; Vazquez-Carrera, Manuel] Univ Barcelona, CIBERDEM, Fac Pharm, Barcelona, Spain; [Davidson, Mercy M.] Columbia Univ, Dept Radiat Oncol, New York, NY USA; [Chan, Tung O.; Feldman, Arthur M.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Columbia University; Jefferson University	Palomer, X (corresponding author), Univ Barcelona, Dept Pharmacol & Therapeut Chem, Fac Pharm, IBUB, Barcelona, Spain.	mvazquezcarrera@ub.edu	Vázquez-Carrera, Manuel/H-2612-2015; Tarridas, Xavier Palomer/H-1494-2015	Vázquez-Carrera, Manuel/0000-0001-7138-8207; Chan, Tung/0000-0001-6574-9555	Ministerio de Ciencia e Innovacion of the Spanish Government [SAF2006-01475, SAF2009-06939]	Ministerio de Ciencia e Innovacion of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the Ministerio de Ciencia e Innovacion of the Spanish Government (SAF2006-01475 and SAF2009-06939). CIBERDEM is an Instituto de Salud Carlos III project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Araki K, 2008, ONCOGENE, V27, P5696, DOI 10.1038/onc.2008.184; Bergman MR, 1999, AM J PHYSIOL-HEART C, V277, pH543, DOI 10.1152/ajpheart.1999.277.2.H543; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2002, CIRCULATION, V106, P2707, DOI 10.1161/01.CIR.0000038706.30661.86; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Darville MI, 1997, NUCLEIC ACIDS RES, V25, P2759, DOI 10.1093/nar/25.14.2759; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hlaing M, 2004, J BIOL CHEM, V279, P43625, DOI 10.1074/jbc.M408391200; Hsieh MCF, 2008, J BIOL CHEM, V283, P27410, DOI 10.1074/jbc.M802418200; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Li YY, 2001, CIRCULATION, V104, P2492, DOI 10.1161/hc4501.098944; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lydell CP, 2002, CARDIOVASC RES, V53, P841, DOI 10.1016/S0008-6363(01)00560-0; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shaw J, 2008, P NATL ACAD SCI USA, V105, P20734, DOI 10.1073/pnas.0807735105; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tu Z, 2006, J BIOL CHEM, V281, P6699, DOI 10.1074/jbc.M512439200; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Vara D, 2003, J BIOL CHEM, V278, P21388, DOI 10.1074/jbc.M212612200; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	33	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19724	10.1371/journal.pone.0019724	http://dx.doi.org/10.1371/journal.pone.0019724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625432	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200010
J	Salajegheh, M; Lam, T; Greenberg, SA				Salajegheh, Mohammad; Lam, Theresa; Greenberg, Steven A.			Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis	PLOS ONE			English	Article							CLINICALLY AMYOPATHIC DERMATOMYOSITIS; INFLAMMATORY MYOPATHIES; POLYMYOSITIS; PATHOGENESIS; DIAGNOSIS; PROFILES; DISEASE; CELLS	Background: Inclusion body myositis (IBM) is a poorly understood and refractory autoimmune muscle disease. Though widely believed to have no significant humoral autoimmunity, we sought to identify novel autoantibodies with high specificity for this disease. Methodology/Principal Findings: Plasma autoantibodies from 65 people, including 25 with IBM, were analyzed by immunoblots against normal human muscle. Thirteen of 25 (52%) IBM patient samples recognized an approximately 43 kDa muscle protein. No other disease (N = 25) or healthy volunteer (N = 15) samples recognized this protein. Conclusions: Circulating antibodies against a 43-kDa muscle autoantigen may lead to the discovery of a novel biomarker for IBM. Its high specificity for IBM among patients with autoimmune myopathies furthermore suggests a relationship to disease pathogenesis.	[Salajegheh, Mohammad; Greenberg, Steven A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Salajegheh, Mohammad; Lam, Theresa; Greenberg, Steven A.] Childrens Hosp Boston, Childrens Hosp Informat Program, Boston, MA USA; [Salajegheh, Mohammad; Greenberg, Steven A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Salajegheh, M (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	msalajegheh@partners.org			Muscular Dystrophy Association [MDA92561, MDA4353]	Muscular Dystrophy Association(Muscular Dystrophy Association)	This study was sponsored by the Muscular Dystrophy Association (grants MDA92561 to Dr. Salajegheh and MDA4353 to Dr. Greenberg) URL: http://www.mdausa.org/. No additional external funding was received for this study. The named funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Salajegheh, Ms. Lam and Dr. Greenberg report no further financial disclosures in regards to this study.	Bradshaw EM, 2007, J IMMUNOL, V178, P547, DOI 10.4049/jimmunol.178.1.547; Brouwer R, 2001, ANN RHEUM DIS, V60, P116, DOI 10.1136/ard.60.2.116; Dalakas MC, 1997, ANN NEUROL, V41, P100, DOI 10.1002/ana.410410116; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Ghirardello A, 2010, RHEUMATOLOGY, V49, P2370, DOI 10.1093/rheumatology/keq281; Greenberg SA, 2005, NEUROLOGY, V65, P1782, DOI 10.1212/01.wnl.0000187124.92826.20; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; Greenberg SA, 2001, NEUROLOGY, V57, P755, DOI 10.1212/WNL.57.5.755; Greenberg SA, 2007, NEUROLOGY, V69, P2008, DOI 10.1212/01.WNL.0000291619.17160.b8; Gunawardena H, 2008, CURR OPIN RHEUMATOL, V20, P675, DOI 10.1097/BOR.0b013e328313bff4; Hengstman GJD, 2002, J NEUROL, V249, P69, DOI 10.1007/PL00007850; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Koffman BM, 1998, MUSCLE NERVE, V21, P115, DOI 10.1002/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.3.CO;2-G; Limaye V, 2010, RHEUMATOL INT; Mammen AL, 2010, ANN NY ACAD SCI, V1184, P134, DOI 10.1111/j.1749-6632.2009.05119.x; Salaiegheh M, 2010, ANN NEUROL, V67, P53, DOI 10.1002/ana.21805; Salajegheh M, 2010, MUSCLE NERVE, V42, P576, DOI 10.1002/mus.21739; Sato S, 2005, ARTHRITIS RHEUM-US, V52, P1571, DOI 10.1002/art.21023; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sordet C, 2006, JOINT BONE SPINE, V73, P646, DOI 10.1016/j.jbspin.2006.04.005	20	73	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20266	10.1371/journal.pone.0020266	http://dx.doi.org/10.1371/journal.pone.0020266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629782	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200045
J	Druzin, M; Malinina, E; Grimsholm, O; Johansson, S				Druzin, Michael; Malinina, Evgenya; Grimsholm, Ola; Johansson, Staffan			Mechanism of Estradiol-Induced Block of Voltage-Gated K+ Currents in Rat Medial Preoptic Neurons	PLOS ONE			English	Article							OPEN-CHANNEL BLOCK; POTASSIUM CHANNELS; ESTROGEN-RECEPTORS; STEROID-HORMONES; SEXUAL-BEHAVIOR; BRAIN; 17-BETA-ESTRADIOL; NUCLEUS; PREGNENOLONE; ANTIESTROGEN	The present study was conducted to characterize possible rapid effects of 17-beta-estradiol on voltage-gated K+ channels in preoptic neurons and, in particular, to identify the mechanisms by which 17-beta-estradiol affects the K+ channels. Whole-cell currents from dissociated rat preoptic neurons were studied by perforated-patch recording. 17-beta-estradiol rapidly (within seconds) and reversibly reduced the K+ currents, showing an EC50 value of 9.7 mu M. The effect was slightly voltage dependent, but independent of external Ca2+, and not sensitive to an estrogen-receptor blocker. Although 17-alpha-estradiol also significantly reduced the K+ currents, membrane-impermeant forms of estradiol did not reduce the K+ currents and other estrogens, testosterone and cholesterol were considerably less effective. The reduction induced by estradiol was overlapping with that of the K-V-2-channel blocker r-stromatoxin-1. The time course of K+ current in 17-beta-estradiol, with a time-dependent inhibition and a slight dependence on external K+, suggested an open-channel block mechanism. The properties of block were predicted from a computational model where 17-beta-estradiol binds to open K+ channels. It was concluded that 17-beta-estradiol rapidly reduces voltage-gated K+ currents in a way consistent with an open-channel block mechanism. This suggests a new mechanism for steroid action on ion channels.	[Druzin, Michael; Malinina, Evgenya; Grimsholm, Ola; Johansson, Staffan] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden	Umea University	Druzin, M (corresponding author), Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden.	staffan.johansson@physiol.umu.se	Druzin, Michael/G-1273-2014; Grimsholm, Ola/Q-7995-2019; Johansson, Staffan/Q-4736-2018; Grimsholm, Ola/O-9187-2017; Grimsholm, Ola/U-6779-2019	Grimsholm, Ola/0000-0003-2064-2556; Johansson, Staffan/0000-0003-1022-5097; Grimsholm, Ola/0000-0003-2064-2556; 	Swedish Research Council [21401]; Royal Swedish Academy of Sciences; Stiftelsen J C Kempes Minnes Stipendiefond; Umea University; Gunvor och Josef Aners stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences; Stiftelsen J C Kempes Minnes Stipendiefond; Umea University; Gunvor och Josef Aners stiftelse	This work was supported by the Swedish Research Council (http://www.vr.se/) (Project 21401); the Royal Swedish Academy of Sciences (http://www.kva.se/); Stiftelsen J C Kempes Minnes Stipendiefond (http://medicinska.se/sv/lankar/stipendier_jc_kempe_/); Umea University (http://www.umu.se); and Gunvor och Josef Aners stiftelse (http://www.anerstiftelsen.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1965, J GEN PHYSIOL, V48, P859, DOI 10.1085/jgp.48.5.859; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Balthazart J, 2004, PHYSIOL BEHAV, V83, P247, DOI 10.1016/j.physbeh.2004.08.025; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Baum MJ, 2003, SCAND J PSYCHOL, V44, P213, DOI 10.1111/1467-9450.00338; Biewenga E, 2005, NEUROSCI LETT, V373, P179, DOI 10.1016/j.neulet.2004.09.067; Brock MW, 2001, J GEN PHYSIOL, V118, P113, DOI 10.1085/jgp.118.1.113; Carrer HF, 2003, J NEUROSCI, V23, P6338; Clancy AN, 2000, HORM BEHAV, V38, P86, DOI 10.1006/hbeh.2000.1602; Clarke R, 2001, PHARMACOL REV, V53, P25; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cross E, 1999, AM J PHYSIOL-REG I, V276, pR1346, DOI 10.1152/ajpregu.1999.276.5.R1346; Drake EB, 2000, NEUROLOGY, V54, P599, DOI 10.1212/WNL.54.3.599; Druzin M, 2004, NEUROPHARMACOLOGY, V46, P285, DOI 10.1016/j.neuropharm.2003.09.003; Fatehi M, 2005, NEUROSCIENCE, V135, P1075, DOI 10.1016/j.neuroscience.2005.07.024; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Hille B., 2001, ION CHANNELS EXCITAB, P814; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; JOHANSSON S, 1992, J PHYSIOL-LONDON, V445, P141, DOI 10.1113/jphysiol.1992.sp018916; Johansson S, 2001, J PHYSIOL-LONDON, V532, P625, DOI 10.1111/j.1469-7793.2001.0625e.x; Karlsson U, 1997, BRAIN RES, V759, P270, DOI 10.1016/S0006-8993(97)00262-X; KELLY MJ, 1977, EXP BRAIN RES, V30, P43; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Liu YC, 2003, BIOCHEM PHARMACOL, V66, P2053, DOI 10.1016/S0006-2952(03)00584-7; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Moller C, 2006, EUR J PHARMACOL, V532, P44, DOI 10.1016/j.ejphar.2006.01.006; Oren I, 2004, BIOPHYS J, V87, P768, DOI 10.1529/biophysj.103.035527; Paredes RG, 2003, SCAND J PSYCHOL, V44, P203, DOI 10.1111/1467-9450.00337; Philp KL, 2006, BRIT J PHARMACOL, V149, P233, DOI 10.1038/sj.bjp.0706850; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Romano N, 2008, ENDOCRINOLOGY, V149, P5335, DOI 10.1210/en.2008-0424; Roselli CE, 2001, J STEROID BIOCHEM, V79, P247, DOI 10.1016/S0960-0760(01)00141-8; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Serra M, 2000, J NEUROCHEM, V75, P732, DOI 10.1046/j.1471-4159.2000.0750732.x; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Sundgren-Andersson AK, 1998, BRAIN RES, V783, P194, DOI 10.1016/S0006-8993(97)01342-5; Taziaux M, 2007, J NEUROSCI, V27, P6563, DOI 10.1523/JNEUROSCI.1797-07.2007; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Valverde MA, 1999, SCIENCE, V285, P1929, DOI 10.1126/science.285.5435.1929; VOROBJEV VS, 1991, J NEUROSCI METH, V38, P145, DOI 10.1016/0165-0270(91)90164-U; WAKELING AE, 1991, CANCER RES, V51, P3867	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20213	10.1371/journal.pone.0020213	http://dx.doi.org/10.1371/journal.pone.0020213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625454	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400046
J	Hedegaard, CJ; Enevold, C; Sellebjerg, F; Bendtzen, K; Nielsen, CH				Hedegaard, Chris Juul; Enevold, Christian; Sellebjerg, Finn; Bendtzen, Klaus; Nielsen, Claus Henrik			Variation in NOD2 Augments Th2-and Th17 Responses to Myelin Basic Protein in Multiple Sclerosis	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; T-CELLS; CROHNS-DISEASE; INTERLEUKIN-17 PRODUCTION; HEALTHY-INDIVIDUALS; CARD15 MUTATIONS; BLAU-SYNDROME; KAPPA-B; INFLAMMATION; DISTINCT	Variations in the gene for the nucleotide-binding oligomerisation domain (NOD) 2 have been associated with Crohn's disease but not multiple sclerosis (MS). Here we investigate the effect of three polymorphisms in the NOD2 gene (rs5743277, rs2066842 and rs5743291) on cytokine production and CD4+ T cell proliferation elicited by human myelin basic protein (MBP) in blood mononuclear cell (MNC) cultures from 29 patients with MS. No polymorphism was observed at rs5743277. No associations with the rs2066842 polymorphism were found. Concerning rs5743291, none were homozygous for the minor allele. Seven of 29 (24%) patients were heterozygous, and five of these (71%) exhibited increased MBP-induced CD4+ T cell proliferation versus four of 22 (18%), who were homozygous for the major allele (p < 0.04). Interleukin (IL)-5 was induced by MBP in MNC from the same five carriers versus two (9%) homozygotes (p < 0.004); four carriers (57%) versus three non-carriers (14%) exhibited IL-17 responses to MBP (p < 0.04). By contrast, we found no association between the polymorphisms investigated and interferon-gamma-, tumor necrosis factor-alpha-, IL-2, -4- or IL-10 responses to MBP. These results indicate that the rs5743291 polymorphism influences T helper (Th) cell 2- and Th17 cell responses in MNC from MS patients.	[Hedegaard, Chris Juul; Enevold, Christian; Bendtzen, Klaus; Nielsen, Claus Henrik] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Dept Rheumatol, Copenhagen, Denmark; [Sellebjerg, Finn] Copenhagen Univ Hosp, Dept Neurol, Danish MS Res Ctr, Rigshosp, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hedegaard, CJ (corresponding author), Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Dept Rheumatol, Copenhagen, Denmark.	claus.henrik.nielsen@rh.regionh.dk		Enevold, Christian/0000-0002-2748-1997; Nielsen, Claus Henrik/0000-0001-7543-9016; Hedegaard, Chris Juul/0000-0003-1333-8687; Sellebjerg, Finn/0000-0002-1333-9623	Warwara Larsen's Foundation [J. 2008-7306]; Aase & Ejnar Danielsen's Foundation [107163]; Research committee of Rigshospitalet; Danish Biotechnology Program	Warwara Larsen's Foundation; Aase & Ejnar Danielsen's Foundation; Research committee of Rigshospitalet; Danish Biotechnology Program	This study was supported by Warwara Larsen's Foundation (J. 2008-7306), Aase & Ejnar Danielsen's Foundation (107163), the Research committee of Rigshospitalet and the Danish Biotechnology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hedegaard CJ, 2008, IMMUNOLOGY, V125, P161, DOI 10.1111/j.1365-2567.2008.02837.x; Hedegaard CJ, 2009, IMMUNOLOGY, V128, pe451, DOI 10.1111/j.1365-2567.2008.02999.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Mathews RJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2525; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nielsen CH, 2001, EUR J IMMUNOL, V31, P2660, DOI 10.1002/1521-4141(200109)31:9<2660::AID-IMMU2660>3.0.CO;2-E; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ochi H, 2002, J NEUROL SCI, V201, P45, DOI 10.1016/S0022-510X(02)00189-2; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Philpott DJ, 2009, NAT IMMUNOL, V10, P455, DOI 10.1038/ni0509-455; Sawcer S, 2003, J NEUROL NEUROSUR PS, V74, P1157, DOI 10.1136/jnnp.74.8.1157; Sorensen TL, 2001, NEUROLOGY, V57, P1371, DOI 10.1212/WNL.57.8.1371; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	31	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20253	10.1371/journal.pone.0020253	http://dx.doi.org/10.1371/journal.pone.0020253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625457	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400050
J	Iwai, Y; Murakami, K; Gomi, Y; Hashimoto, T; Asakawa, Y; Okuno, Y; Ishikawa, T; Hatakeyama, D; Echigo, N; Kuzuhara, T				Iwai, Yuma; Murakami, Kouki; Gomi, Yasuyuki; Hashimoto, Toshihiro; Asakawa, Yoshinori; Okuno, Yoshinobu; Ishikawa, Toyokazu; Hatakeyama, Dai; Echigo, Noriko; Kuzuhara, Takashi			Anti-Influenza Activity of Marchantins, Macrocyclic Bisbibenzyls Contained in Liverworts	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; RNA-POLYMERASE; CHEMICAL-CONSTITUENTS; PA SUBUNIT; ENDONUCLEASE; GENES; CHEMOSYSTEMATICS; BIS(BIBENZYLS); OSELTAMIVIR; BRYOPHYTES	The H1N1 influenza A virus of swine-origin caused pandemics throughout the world in 2009 and the highly pathogenic H5N1 avian influenza virus has also caused epidemics in Southeast Asia in recent years. The threat of influenza A thus remains a serious global health issue and novel drugs that target these viruses are highly desirable. Influenza A possesses an endonuclease within its RNA polymerase which comprises PA, PB1 and PB2 subunits. To identify potential new anti-influenza compounds in our current study, we screened 33 different types of phytochemicals using a PA endonuclease inhibition assay in vitro and an anti-influenza A virus assay. The marchantins are macrocyclic bisbibenzyls found in liverworts, and plagiochin A and perrottetin F are marchantin-related phytochemicals. We found from our screen that marchantin A, B, E, plagiochin A and perrottetin F inhibit influenza PA endonuclease activity in vitro. These compounds have a 3,4-dihydroxyphenethyl group in common, indicating the importance of this moiety for the inhibition of PA endonuclease. Docking simulations of marchantin E with PA endonuclease suggest a putative "fitting and chelating model" as the mechanism underlying PA endonuclease inhibition. The docking amino acids are well conserved between influenza A and B. In a cultured cell system, marchantin E was further found to inhibit the growth of both H3N2 and H1N1 influenza A viruses, and marchantin A, E and perrotein F showed inhibitory properties towards the growth of influenza B. These marchantins also decreased the viral infectivity titer, with marchantin E showing the strongest activity in this assay. We additionally identified a chemical group that is conserved among different anti-influenza chemicals including marchantins, green tea catechins and dihydroxy phenethylphenylphthalimides. Our present results indicate that marchantins are candidate anti-influenza drugs and demonstrate the utility of the PA endonuclease assay in the screening of phytochemicals for anti-influenza characteristics.	[Iwai, Yuma; Hatakeyama, Dai; Echigo, Noriko; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 770, Japan; [Murakami, Kouki; Gomi, Yasuyuki; Okuno, Yoshinobu; Ishikawa, Toyokazu] Osaka Univ, Res Fdn Microbial Dis, Kanonji Inst, Res Grp,Res & Prod Technol Div, Kagawa, Japan; [Hashimoto, Toshihiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Pharmacognosy, Tokushima 770, Japan; [Asakawa, Yoshinori] Tokushima Bunri Univ, Fac Pharmaceut Sci, Lab Pharmacognosy, Tokushima 770, Japan	Tokushima Bunri University; Osaka University; Tokushima Bunri University; Tokushima Bunri University	Iwai, Y (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Yamashiro Cho, Tokushima 770, Japan.	kuzuhara@ph.bunri-u.ac.jp	ハタケヤマ, ダイ/HHS-5095-2022	ハタケヤマ, ダイ/0000-0001-6047-7124; Kuzuhara, Takashi/0000-0003-0565-6060	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Tokushima Bunri University	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University	The influenza virus (A/PR/8/34) RNA polymerase PA plasmid, pBMSA-PA, was provided by the DNA Bank, RIKEN BioResource Center (Tsukuba, Japan; originally deposited by Dr. Susumu Nakada) with the support of National Bio-Resources Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).; This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS), and funding from Tokushima Bunri University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa Y, 2008, CURR PHARM DESIGN, V14, P3067, DOI 10.2174/138161208786404272; Asakawa Y, 2004, PHYTOCHEMISTRY, V65, P623, DOI 10.1016/j.phytochem.2004.01.003; Asakawa Y., 1999, Phytochemicals in human health protection, nutrition, and plant defense., P319; ASAKAWA Y, 1982, PROG CH ORG NAT PROD, V42, P1; Asakawa Y., 1990, BRYOPHYTES THEIR CHE, P369; Asakawa Y, 1995, PROG CH ORG NAT PROD, V65, P1; Asakawa Y, 2009, HETEROCYCLES, V77, P99, DOI 10.3987/REV-08-SR(F)3; BUCHANAN MS, 1995, PHYTOCHEMISTRY, V40, P1251, DOI 10.1016/0031-9422(95)00467-L; *CHEM COMP GROUP C, 2004, MOL OP ENV MOE; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Harinantenaina L, 2005, J NAT PROD, V68, P1779, DOI 10.1021/np0502589; HASHIMOTO T, 1994, CHEM PHARM BULL, V42, P1376; Hashimoto T, 2003, PHYTOMEDICINE, V10, P309, DOI 10.1078/094471103322004802; HASHIMOTO T, 1994, CHEM PHARM BULL, V42, P2397; HASHIMOTO T, 1994, TETRAHEDRON LETT, V35, P2559, DOI 10.1016/S0040-4039(00)77170-X; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Honda A, 1997, BIOL CHEM, V378, P483; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwai Y, 2010, BIOORGAN MED CHEM, V18, P5379, DOI 10.1016/j.bmc.2010.05.035; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Kuzuhara T., 2009, PLOS CURR INFLUENZA; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; MAHY BWJ, VIROLOGY METHODS MAN, P35; Morita H, 2009, BIOORG MED CHEM LETT, V19, P493, DOI 10.1016/j.bmcl.2008.11.036; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Morse SS, 2007, NAT MED, V13, P681, DOI 10.1038/nm1597; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA Y, 1991, J BIOCHEM-TOKYO, V110, P395, DOI 10.1093/oxfordjournals.jbchem.a123592; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OKUNO Y, 1990, J CLIN MICROBIOL, V28, P1308, DOI 10.1128/JCM.28.6.1308-1313.1990; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suzuki T, 2008, J PHARMACOL SCI, V107, P285, DOI 10.1254/jphs.08006FP; TAIRA Z, 1994, CHEM PHARM BULL, V42, P52; Taub M, 1979, Methods Enzymol, V58, P552; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; THOMPSON, 1997, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	47	66	73	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19825	10.1371/journal.pone.0019825	http://dx.doi.org/10.1371/journal.pone.0019825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625478	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400014
J	Wei, YC; Huan, YJ; Shi, YQ; Liu, ZF; Bou, G; Luo, YB; Zhang, L; Yang, CR; Kong, QR; Tian, JT; Xia, P; Sun, QY; Liu, ZH				Wei, Yanchang; Huan, Yanjun; Shi, Yongqian; Liu, Zhongfeng; Bou, Gerelchimeg; Luo, Yibo; Zhang, Li; Yang, Cairong; Kong, Qingran; Tian, Jiangtian; Xia, Ping; Sun, Qing-Yuan; Liu, ZhongHua			Unfaithful Maintenance of Methylation Imprints Due to Loss of Maternal Nuclear Dnmt1 during Somatic Cell Nuclear Transfer	PLOS ONE			English	Article							DNA METHYLATION; EXPRESSION; GENES; MICE; ABERRANT; LOCALIZATION; INACTIVATION; DISRUPTION; PATTERNS; REGIONS	The low success rate of somatic cell nuclear transfer (SCNT) in mammalian cloning is largely due to imprinting problems. However, little is known about the mechanisms of reprogramming imprinted genes during SCNT. Parental origin-specific DNA methylation regulates the monoallelic expression of imprinted genes. In natural fertilization, methylation imprints are established in the parental germline and maintained throughout embryonic development. However, it is unclear whether methylation imprints are protected from global changes of DNA methylation in cloned preimplantation embryos. Here, we demonstrate that cloned porcine preimplantation embryos exhibit demethylation at differentially methylated regions (DMRs) of imprinted genes; in particular, demethylation occurs during the first two cell cycles. By RNAi-mediated knockdown, we found that Dnmt1 is required for the maintenance of methylation imprints in porcine preimplantation embryos. However, no clear signals were detected in the nuclei of oocytes and preimplantation embryos by immunofluorescence. Thus, Dnmt1 is present at very low levels in the nuclei of porcine oocytes and preimplantation embryos and maintains methylation imprints. We further showed that methylation imprints were rescued in nonenucleated metaphase II (MII) oocytes. Our results indicate that loss of Dnmt1 in the maternal nucleus during SCNT significantly contributes to the unfaithful maintenance of methylation imprints in cloned embryos.	[Wei, Yanchang; Huan, Yanjun; Shi, Yongqian; Liu, Zhongfeng; Bou, Gerelchimeg; Luo, Yibo; Zhang, Li; Kong, Qingran; Tian, Jiangtian; Liu, ZhongHua] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Wei, Yanchang; Yang, Cairong; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Xia, Ping] Univ Calif Davis, Dept Obstet & Gynecol, Sch Med, Sacramento, CA 95817 USA	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Zoology, CAS; University of California System; University of California Davis	Wei, YC (corresponding author), NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China.	sunqy@ioz.ac.cn; liu086@yahoo.com	Yang, Cairong/AAB-1440-2021; Liu, Zhunghua/F-2485-2010	Yang, Cairong/0000-0001-9594-0529; Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	National Natural Science Foundation of China, NSFC [30871431]; Talent Youth Foundation of Heilongjiang Province [JC200905]	National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); Talent Youth Foundation of Heilongjiang Province	This work was supported by National Natural Science Foundation of China, NSFC (30871431), and the Talent Youth Foundation of Heilongjiang Province(JC200905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Chang G, 2009, GENOMICS, V93, P112, DOI 10.1016/j.ygeno.2008.09.011; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Han DW, 2008, MOL REPROD DEV, V75, P777, DOI 10.1002/mrd.20802; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Jeong YS, 2009, DEV DYNAM, V238, P1666, DOI 10.1002/dvdy.21975; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Miki H, 2005, GENESIS, V41, P81, DOI 10.1002/gene.20100; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wei YC, 2010, CELL REPROGRAM, V12, P213, DOI 10.1089/cell.2009.0090; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yamazaki Y, 2005, P NATL ACAD SCI USA, V102, P11361, DOI 10.1073/pnas.0504943102; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Yang L, 2005, MOL REPROD DEV, V71, P431, DOI 10.1002/mrd.20311; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155	40	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20154	10.1371/journal.pone.0020154	http://dx.doi.org/10.1371/journal.pone.0020154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625467	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400042
J	Bozoky, Z; Rona, G; Klement, E; Medzihradszky, KF; Merenyi, G; Vertessy, BG; Friedrich, P				Bozoky, Zoltan; Rona, Gergely; Klement, Eva; Medzihradszky, Katalin F.; Merenyi, Gabor; Vertessy, Beata G.; Friedrich, Peter			Calpain-Catalyzed Proteolysis of Human dUTPase Specifically Removes the Nuclear Localization Signal Peptide	PLOS ONE			English	Article							ACTIVE-SITE; ESCHERICHIA-COLI; CELL-CYCLE; IN-VIVO; DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; APOPTOSIS; CLEAVAGE; URACIL; DNA	Background: Calpain proteases drive intracellular signal transduction via specific proteolysis of multiple substrates upon Ca2+-induced activation. Recently, dUTPase, an enzyme essential to maintain genomic integrity, was identified as a physiological calpain substrate in Drosophila cells. Here we investigate the potential structural/functional significance of calpain-activated proteolysis of human dUTPase. Methodology/Principal Findings: Limited proteolysis of human dUTPase by mammalian m-calpain was investigated in the presence and absence of cognate ligands of either calpain or dUTPase. Significant proteolysis was observed only in the presence of Ca(II) ions, inducing calpain action. The presence or absence of the dUTP-analogue alpha,beta-imido-dUTP did not show any effect on Ca2+-calpain-induced cleavage of human dUTPase. The catalytic rate constant of dUTPase was unaffected by calpain cleavage. Gel electrophoretic analysis showed that Ca2+-calpain-induced cleavage of human dUTPase resulted in several distinctly observable dUTPase fragments. Mass spectrometric identification of the calpain-cleaved fragments identified three calpain cleavage sites (between residues (SE5)-S-4; (TP8)-T-7; and (LS32)-L-31). The cleavage between the (LS32)-L-31 peptide bond specifically removes the flexible N-terminal nuclear localization signal, indispensable for cognate localization. Conclusions/Significance: Results argue for a mechanism where Ca2+-calpain may regulate nuclear availability and degradation of dUTPase.	[Bozoky, Zoltan; Rona, Gergely; Merenyi, Gabor; Vertessy, Beata G.; Friedrich, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Klement, Eva; Medzihradszky, Katalin F.] Hungarian Acad Sci, Biol Res Ctr, Prote Res Grp, H-6701 Szeged, Hungary; [Medzihradszky, Katalin F.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of California System; University of California San Francisco; Budapest University of Technology & Economics	Bozoky, Z (corresponding author), Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary.	vertessy@enzim.hu; friedric@enzim.hu	Róna, Gergely/AAB-8411-2020; Vertessy, Beata G/H-6202-2012	Róna, Gergely/0000-0003-3222-7261; Vertessy, Beata G./0000-0002-1288-2982	Hungarian Scientific Research Fund [OTKA NK 60723, OTKA K68229, CK-78646]; Howard Hughes Medical Institutes [55000342]; Alexander von Humboldt Foundation; National Office for Research and Technology, Hungary [TAMOP-4.2.1/B-09/1/KMR-2010-0002];  [ADDMAL09 TET-09-1-2010-001]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Office for Research and Technology, Hungary(National Office for Research and Technology); 	This work was supported by grants from Hungarian Scientific Research Fund (OTKA NK 60723 to PF, OTKA K68229 and CK-78646 to BGV), the Howard Hughes Medical Institutes (#55000342), Alexander von Humboldt Foundation, the ADDMAL09 TET-09-1-2010-001 project and the New Hungary Development Plan (TAMOP-4.2.1/B-09/1/KMR-2010-0002) from the National Office for Research and Technology, Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2004, J BIOL CHEM, V279, P20118, DOI 10.1074/jbc.M311969200; Barabas O, 2003, J BIOL CHEM, V278, P38803, DOI 10.1074/jbc.M306967200; Bekesi A, 2004, J BIOL CHEM, V279, P22362, DOI 10.1074/jbc.M313647200; Bozoky Z, 2009, ARCH BIOCHEM BIOPHYS, V481, P219, DOI 10.1016/j.abb.2008.11.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; Cheng ZX, 2008, J ETHNOPHARMACOL, V120, P129, DOI 10.1016/j.jep.2008.07.030; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Fiser A, 2000, BIOCHEM BIOPH RES CO, V279, P534, DOI 10.1006/bbrc.2000.3994; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Gong J, 2010, ARCH VIROL, V155, P1069, DOI 10.1007/s00705-010-0684-2; HORVATH A, 2010, J BACTERIOL, V170, P1069; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Huang CJ, 2010, J BIOL CHEM, V285, P339, DOI 10.1074/jbc.M109.024190; Janossy J, 2004, BIOCHEM PHARMACOL, V67, P1513, DOI 10.1016/j.bcp.2003.12.021; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kovari J, 2004, J BIOL CHEM, V279, P17932, DOI 10.1074/jbc.M313643200; Ladner RD, 1997, J BIOL CHEM, V272, P19072, DOI 10.1074/jbc.272.30.19072; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Larsson G, 1996, NAT STRUCT BIOL, V3, P532, DOI 10.1038/nsb0696-532; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; MELLGREN RL, 1991, J BIOL CHEM, V266, P13920; Merenyi G, 2010, FEBS J, V277, P2142, DOI 10.1111/j.1742-4658.2010.07630.x; Muha V, 2009, BIOCHEM BIOPH RES CO, V381, P271, DOI 10.1016/j.bbrc.2009.02.036; Mustafi D, 2003, P NATL ACAD SCI USA, V100, P5670, DOI 10.1073/pnas.1031504100; Pineiro D, 2007, EXP CELL RES, V313, P369, DOI 10.1016/j.yexcr.2006.10.020; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; SHERWOOD SW, 1993, P NATL ACAD SCI USA, V90, P3353, DOI 10.1073/pnas.90.8.3353; SHLOMAI J, 1978, J BIOL CHEM, V253, P3305; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Tinkelenberg BA, 2003, EXP CELL RES, V287, P39, DOI 10.1016/S0014-4827(03)00048-X; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015; Williams D, 2011, BBA-MOL CELL RES, V1813, P315, DOI 10.1016/j.bbamcr.2010.11.021; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	46	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19546	10.1371/journal.pone.0019546	http://dx.doi.org/10.1371/journal.pone.0019546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625588	Green Submitted, gold, Green Published			2022-12-25	WOS:000290771200009
J	Braun, S; Humphreys, C; Fraser, E; Brancale, A; Bochtler, M; Dale, TC				Braun, Sebastian; Humphreys, Christine; Fraser, Elizabeth; Brancale, Andrea; Bochtler, Matthias; Dale, Trevor C.			Amyloid-Associated Nucleic Acid Hybridisation	PLOS ONE			English	Article							BETA-SHEET PROTEINS; PRION PROTEIN; MOLECULAR-DYNAMICS; DNA HYBRIDIZATION; FIBRIL FORMATION; IN-VITRO; PEPTIDES; AGGREGATION; CYTOCHROME; CONVERSION	Nucleic acids promote amyloid formation in diseases including Alzheimer's and Creutzfeldt-Jakob disease. However, it remains unclear whether the close interactions between amyloid and nucleic acid allow nucleic acid secondary structure to play a role in modulating amyloid structure and function. Here we have used a simplified system of short basic peptides with alternating hydrophobic and hydrophilic amino acid residues to study nucleic acid - amyloid interactions. Employing biophysical techniques including X-ray fibre diffraction, circular dichroism spectroscopy and electron microscopy we show that the polymerized charges of nucleic acids concentrate and enhance the formation of amyloid from short basic peptides, many of which would not otherwise form fibres. In turn, the amyloid component binds nucleic acids and promotes their hybridisation at concentrations below their solution K-d, as shown by time-resolved FRET studies. The self-reinforcing interactions between peptides and nucleic acids lead to the formation of amyloid nucleic acid (ANA) fibres whose properties are distinct from their component polymers. In addition to their importance in disease and potential in engineering, ANA fibres formed from prebiotically-produced peptides and nucleic acids may have played a role in early evolution, constituting the first entities subject to Darwinian evolution.	[Braun, Sebastian; Humphreys, Christine; Fraser, Elizabeth; Bochtler, Matthias; Dale, Trevor C.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Brancale, Andrea] Cardiff Univ, Sch Pharm, Cardiff, S Glam, Wales; [Bochtler, Matthias] Cardiff Univ, Sch Chem, Cardiff, S Glam, Wales; [Bochtler, Matthias] Int Inst Mol & Cell Biol, Warsaw, Poland	Cardiff University; Cardiff University; Cardiff University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Braun, S (corresponding author), Cardiff Univ, Sch Biosci, Redwood Bldg, Cardiff, S Glam, Wales.	daletc@cardiff.ac.uk	Fraser, Elizabeth/M-7049-2015; Dale, Trevor C/D-3749-2009; Brancale, Andrea/N-9445-2014	Fraser, Elizabeth/0000-0001-8420-3208; Dale, Trevor C/0000-0002-4880-9963; Brancale, Andrea/0000-0002-9728-3419; Bochtler, Matthias/0000-0001-7884-4463	Alzheimer's Research Trust [ART4/PHD20084/1]; Leverhulme Trust [F4/00 4074/AX]; Alzheimers Research UK [ART-PhD2008-1] Funding Source: researchfish	Alzheimer's Research Trust; Leverhulme Trust(Leverhulme Trust); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was funded by the Alzheimer's Research Trust (ART4/PHD20084/1) (http://www.alzheimersresearchuk.org) and the Leverhulme Trust (F4/00 4074/AX) (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bian W, 2006, J APPL CRYSTALLOGR, V39, P752, DOI 10.1107/S0021889806025386; BRACK A, 1990, ORIGINS LIFE EVOL B, V20, P139, DOI 10.1007/BF01808274; Brazier SP, 1998, BIOCHEM J, V335, P375, DOI 10.1042/bj3350375; Cairns-Smith A.G., 1982, GENETIC TAKEOVER MIN; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Chan V, 1995, BIOPHYS J, V69, P2243, DOI 10.1016/S0006-3495(95)80095-0; Cherny D, 2004, J MOL BIOL, V344, P929, DOI 10.1016/j.jmb.2004.09.096; Dale T, 2006, J THEOR BIOL, V240, P337, DOI 10.1016/j.jtbi.2005.09.027; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Franchi M, 2003, ORIGINS LIFE EVOL B, V33, P1, DOI 10.1023/A:1023982008714; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Lewis RNAH, 1999, BIOCHEMISTRY-US, V38, P15193, DOI 10.1021/bi9912342; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; MAKIN OS, 2002, XRAY DIFFRACTION STU, P67; MASKOS U, 1993, NUCLEIC ACIDS RES, V21, P4663, DOI 10.1093/nar/21.20.4663; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Milner-White E. J., 2010, J COSMOL, V10, P3217; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Pertinhez TA, 2001, FEBS LETT, V495, P184, DOI 10.1016/S0014-5793(01)02384-5; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rasband W.S., 1997, IMAGE J; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang WX, 2002, P NATL ACAD SCI USA, V99, P2760, DOI 10.1073/pnas.052706199; Wu LL, 2008, SOFT MATTER, V4, P744, DOI 10.1039/b717478k; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92	44	24	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19125	10.1371/journal.pone.0019125	http://dx.doi.org/10.1371/journal.pone.0019125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625537	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000290771200005
J	Brouard, O; Le Jeune, AH; Leroy, C; Cereghino, R; Roux, O; Pelozuelo, L; Dejean, A; Corbara, B; Carrias, JF				Brouard, Olivier; Le Jeune, Anne-Helene; Leroy, Celine; Cereghino, Regis; Roux, Olivier; Pelozuelo, Laurent; Dejean, Alain; Corbara, Bruno; Carrias, Jean-Francois			Are Algae Relevant to the Detritus-Based Food Web in Tank-Bromeliads?	PLOS ONE			English	Article							PITCHER-PLANT; COMMUNITY STRUCTURE; MOSQUITO LARVAE; CARBON; PHYTOPLANKTON; POPULATIONS; BACTERIA; GROWTH; FOREST; FRESH	We assessed the occurrence of algae in five species of tank-bromeliads found in contrasting environmental sites in a Neotropical, primary rainforest around the Nouragues Research Station, French Guiana. The distributions of both algal abundance and biomass were examined based on physical parameters, the morphological characteristics of bromeliad species and with regard to the structure of other aquatic microbial communities held in the tanks. Algae were retrieved in all of the bromeliad species with mean densities ranging from similar to 10(2) to 10(4) cells/mL. Their biomass was positively correlated to light exposure and bacterial biomass. Algae represented a tiny component of the detrital food web in shaded bromeliads but accounted for up to 30 percent of the living microbial carbon in the tanks of Catopsis berteroniana, located in a highly exposed area. Thus, while nutrient supplies are believed to originate from wind-borne particles and trapped insects (i.e., allochtonous organic matter), our results indicate that primary producers (i.e., autochtonous organic matter) are present in this insectivorous bromeliad. Using a 24-h incubation of size-fractionated and manipulated samples from this plant, we evaluated the impact of mosquito foraging on algae, other microorganisms and rotifers. The prey assemblages were greatly altered by the predation of mosquito larvae. Grazing losses indicated that the dominant algal taxon, Bumilleriopsis sp., like protozoa and rotifers, is a significant part of the diet of mosquito larvae. We conclude that algae are a relevant functional community of the aquatic food web in C. berteroniana and might form the basis of a complementary non-detrital food web.	[Brouard, Olivier; Le Jeune, Anne-Helene; Corbara, Bruno; Carrias, Jean-Francois] Univ Blaise Pascal, CNRS, Lab Microorganismes Genome & Environm, LMGE,UMR 6023, Aubiere, France; [Leroy, Celine; Roux, Olivier; Dejean, Alain] CNRS, UMR 8172, Kourou, France; [Cereghino, Regis; Pelozuelo, Laurent] Univ Toulouse 3, CNRS, EcoLab, Lab Ecol Fonct & Environm,UMR 5245, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse	Brouard, O (corresponding author), Univ Blaise Pascal, CNRS, Lab Microorganismes Genome & Environm, LMGE,UMR 6023, Aubiere, France.	j-francois.carrias@univ-bpclermont.fr	CEREGHINO, Regis/G-9500-2011; Carrias, Jean-François/AAT-2738-2021; Roux, Olivier/A-1181-2011; Carrias, Jean-françois/E-6952-2011; Leroy, Celine/I-4857-2016; Roux, Olivier/I-5675-2016	Carrias, Jean-François/0000-0002-6201-1544; Leroy, Celine/0000-0003-4859-8040; Cereghino, Regis/0000-0003-3981-3159; CORBARA, Bruno/0000-0003-4232-8234; Roux, Olivier/0000-0001-5440-0219; Dejean, Alain/0000-0002-3561-2248	Programme Amazonie II of the French Centre National de la Recherche Scientifique [2ID]	Programme Amazonie II of the French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (Project 2ID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; ALY C, 1988, ENTOMOL EXP APPL, V46, P55, DOI 10.1007/BF00187000; AMBLARD C, 1991, ANN BIOL-PARIS, V30, P6; BATEMAN LE, 1987, HYDROBIOLOGIA, V147, P129, DOI 10.1007/BF00025735; BENZING DH, 2000, BROMELIACEAE PROFILE; BIRD DF, 1984, CAN J FISH AQUAT SCI, V41, P1015, DOI 10.1139/f84-118; Bledzki LA, 1998, HYDROBIOLOGIA, V385, P193, DOI 10.1023/A:1003566729588; BORSHEIM KY, 1987, MAR ECOL PROG SER, V36, P171, DOI 10.3354/meps036171; BRADSHAW WE, 1986, NATL GEOGR RES, V2, P167; BRATBAK G, 1985, MAR ECOL PROG SER, V25, P23, DOI 10.3354/meps025023; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491, DOI 10.1128/AEM.46.2.491-498.1983; Carrias JF, 1998, ARCH HYDROBIOL, V143, P227; Carrias JF, 2001, J TROP ECOL, V17, P611, DOI 10.1017/S0266467401001456; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Fish D., 1983, P1; Frank J.H., 1983, P101; Frank J.H., 2009, Terrestrial Arthropod Reviews, V1, P125; Frazer G.W., 1999, GAP LIGHT ANAL GLA 2, DOI DOI 10.1038/ismej.2015.171; Gebuhr C, 2006, PLANT BIOLOGY, V8, P849, DOI 10.1055/s-2006-924474; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; Gurung TB, 1999, AQUAT MICROB ECOL, V17, P27, DOI 10.3354/ame017027; Jabiol J, 2009, FOREST ECOL MANAG, V257, P351, DOI 10.1016/j.foreco.2008.09.010; Kalff J, 2002, LIMNOLOGY INLAND WAT; Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2; KIKKAWA J, 2001, TRENDS ECOL EVOL, V16, P322; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; LAESSLE AM, 1961, ECOLOGY, V42, P499, DOI 10.2307/1932236; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; McNeely C, 2007, ECOLOGY, V88, P391, DOI 10.1890/0012-9658(2007)88[391:GTCACS]2.0.CO;2; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; NEILSON AH, 1980, PHYSIOL PLANTARUM, V48, P542, DOI 10.1111/j.1399-3054.1980.tb03302.x; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; Richardson BA, 1999, BIOTROPICA, V31, P321, DOI 10.1111/j.1744-7429.1999.tb00144.x; Richardson BA, 2000, J TROP ECOL, V16, P167, DOI 10.1017/S0266467400001346; Richardson BA, 2000, ECOL ENTOMOL, V25, P348, DOI 10.1046/j.1365-2311.2000.00255.x; Sarthou C, 2003, J VEG SCI, V14, P645, DOI 10.1658/1100-9233(2003)014[0645:SVOTGI]2.0.CO;2; Sigee D. C., 2005, FRESHWATER MICROBIOL; Srivastava DS, 2006, OECOLOGIA, V149, P493, DOI 10.1007/s00442-006-0467-3; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Trzcinski MK, 2005, OIKOS, V110, P146, DOI 10.1111/j.0030-1299.2005.13633.x; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x	50	50	53	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20129	10.1371/journal.pone.0020129	http://dx.doi.org/10.1371/journal.pone.0020129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625603	Green Submitted, gold, Green Published			2022-12-25	WOS:000290720200066
J	Li, L; Qiao, D; Fu, XY; Lao, SH; Zhang, XL; Wu, CY				Li, Li; Qiao, Dan; Fu, Xiaoying; Lao, Suihua; Zhang, Xianlan; Wu, Changyou			Identification of Mycobacterium tuberculosis-Specific Th1, Th17 and Th22 Cells Using the Expression of CD40L in Tuberculous Pleurisy	PLOS ONE			English	Article							CD4(+) T-CELLS; ANTIGEN-SPECIFIC CD4(+); FLOW-CYTOMETRIC METHOD; POLYFUNCTIONAL CD4(+); IMMUNE-RESPONSES; INFECTION; IL-4; ACTIVATION; MOLECULES; DIAGNOSIS	Important advances have been made in the immunodiagnosis of tuberculosis (TB) based on the detection of Mycobacterium tuberculosis (MTB)-specific T cells. However, the sensitivity and specificity of the immunological approach are relatively low because there are no specific markers for antigen-specific Th cells, and some of the Th cells that do not produce cytokines can be overlooked using this approach. In this study, we found that MTB-specific peptides of ESAT-6/CFP-10 can stimulate the expression of CD40L specifically in CD4(+) T cells but not other cells from pleural fluid cells (PFCs) in patients with tuberculous pleurisy (TBP). CD4(+)CD40L(+) but not CD4(+)CD40L(-) T cells express IFN-gamma, IL-2, TNF-alpha, IL-17 or IL-22 after stimulation with MTB-specific peptides. In addition, CD4(+)CD40L(+) T cells were found to be mostly polyfunctional T cells that simultaneously produce IFN-gamma, IL-2 and TNF-alpha and display an effector or effector memory phenotype (CD45RA(-)CD45RO(+)CCR7(-)CD62L(-)ICOS(-)). To determine the specificity of CD4(+)CD40L(+) T cells, we incubated PFCs with ESTA-6/CFP-10 peptides and sorted live CD4(+)CD40L(+) and CD4(+)CD40L(-) T cells by flow cytometry. We further demonstrated that sorted CD4(+)CD40L(+), but not CD4(+)CD40L(-) fractions, principally produced IFN-gamma, IL-2, TNF-alpha, IL-17 and IL-22 following restimulation with ESTA-6/CFP-10 peptides. Taken together, our data indicate that the expression of CD40L on MTB-specific CD4(+) T cells could be a good marker for the evaluation and isolation of MTB-specific Th cells and might also be useful in the diagnosis of TB.	[Li, Li; Qiao, Dan; Fu, Xiaoying; Wu, Changyou] Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lao, Suihua; Zhang, Xianlan] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, L (corresponding author), Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			National Nature Science Foundation of China [30872300]; university basic scientific research expense; Youth Development Project [09YKPY76]; China Postdoctoral Science Foundation [20090460804]; National Key Basic Research Program of China (973) [2007CB512404];  [115];  [2008ZX10003011]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); university basic scientific research expense; Youth Development Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Basic Research Program of China (973)(National Basic Research Program of China); ; 	This work was supported by grant 115 (no. 2008ZX10003011), the National Nature Science Foundation of China (no. 30872300), university basic scientific research expense, the Youth Development Project (no. 09YKPY76), the China Postdoctoral Science Foundation (no. 20090460804) and the National Key Basic Research Program of China (973; no. 2007CB512404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; BRINES RD, 1993, INT IMMUNOL, V5, P1445, DOI 10.1093/intimm/5.11.1445; Brosterhus H, 1999, EUR J IMMUNOL, V29, P4053, DOI 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.3.CO;2-3; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Erb KJ, 1998, IMMUNOL CELL BIOL, V76, P41, DOI 10.1046/j.1440-1711.1998.00719.x; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Jafari C, 2008, INFECTION, V36, P510, DOI 10.1007/s15010-008-8089-9; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Kahi S, 1998, CLIN DIAGN LAB IMMUN, V5, P745, DOI 10.1128/CDLI.5.6.745-748.1998; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; MAINO VC, 1995, CYTOMETRY, V20, P127, DOI 10.1002/cyto.990200205; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Michalek J, 2003, P NATL ACAD SCI USA, V100, P1180, DOI 10.1073/pnas.0337543100; Prabha C, 2007, Indian J Med Microbiol, V25, P18; Richeldi L, 2006, AM J RESP CRIT CARE, V174, P736, DOI 10.1164/rccm.200509-1516PP; ROY M, 1993, J IMMUNOL, V151, P2497; Salgame P, 2005, CURR OPIN IMMUNOL, V17, P374, DOI 10.1016/j.coi.2005.06.006; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Sugawara I, 2000, MICROBIOL IMMUNOL, V44, P971, DOI 10.1111/j.1348-0421.2000.tb02592.x; Suni MA, 1998, J IMMUNOL METHODS, V212, P89, DOI 10.1016/S0022-1759(98)00004-0; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yew WW, 2007, AM J RESP CRIT CARE, V175, P541, DOI 10.1164/rccm.200611-1653UP	36	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20165	10.1371/journal.pone.0020165	http://dx.doi.org/10.1371/journal.pone.0020165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625607	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200069
J	Zheng, YS; Zhang, H; Zhang, XJ; Feng, DD; Luo, XQ; Zeng, CW; Lin, KY; Zhou, H; Qu, LH; Zhang, P; Chen, YQ				Zheng, Y-S; Zhang, H.; Zhang, X-J; Feng, D-D; Luo, X-Q; Zeng, C-W; Lin, K-Y; Zhou, H.; Qu, L-H; Zhang, P.; Chen, Y-Q			MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia	ONCOGENE			English	Article						microRNA; acute myeloblastic leukemia; granulocyte/monocyte differentiation; RBSP3-pRB-E2F1 pathway	RETINOBLASTOMA PROTEIN PATHWAY; FREQUENT ALTERATIONS; BINDING PROTEIN; CANCER; MICRORNAS; CYCLE; E2F1; KARYOTYPE; APOPTOSIS; PATTERNS	Acute myeloblastic leukemia (AML) is characterized by the accumulation of abnormal myeloblasts (mainly granulocyte or monocyte precursors) in the bone marrow and blood. Though great progress has been made for improvement in clinical treatment during the past decades, only minority with AML achieve long-term survival. Therefore, further understanding mechanisms of leukemogenesis and exploring novel therapeutic strategies are still crucial for improving disease outcome. MicroRNA-100 (miR-100), a small non-coding RNA molecule, has been reported as a frequent event aberrantly expressed in patients with AML; however, the molecular basis for this phenotype and the statuses of its downstream targets have not yet been elucidated. In the present study, we found that the expression level of miR-100 in vivo was related to the stage of the maturation block underlying the subtypes of myeloid leukemia. In vitro experiments further demonstrated that miR-100 was required to promote the cell proliferation of promyelocytic blasts and arrest them differentiated to granulocyte/monocyte lineages. Significantly, we identified RBSP3, a phosphatase-like tumor suppressor, as a bona fide target of miR-100 and validated that RBSP3 was involved in cell differentiation and survival in AML. Moreover, we revealed a new pathway that miR-100 regulates G1/S transition and S-phase entry and blocks the terminal differentiation by targeting RBSP3, which partly in turn modulates the cell cycle effectors pRB/E2F1 in AML. These events promoted cell proliferation and blocked granulocyte/monocyte differentiation. Our data highlight an important role of miR-100 in the molecular etiology of AML, and implicate the potential application of miR-100 in cancer therapy. Oncogene (2012) 31, 80-92; doi: 10.1038/onc.2011.208; published online 6 June 2011	[Chen, Y-Q] Sun Yat Sen Univ, Minist Educ, Biotechnol Res Ctr, Key Lab Gene Engn,State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Y-S] Hainan Univ, Dept Biotechnol, Hainan, Peoples R China; [Luo, X-Q] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, P.] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Zhang, P.] Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China	Sun Yat Sen University; Hainan University; Sun Yat Sen University; Army Medical University; Army Medical University	Chen, YQ (corresponding author), Sun Yat Sen Univ, Minist Educ, Biotechnol Res Ctr, Key Lab Gene Engn,State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsscyq@mail.sysu.edu.cn	Lin, Kangyu/I-8050-2016; Zhang, Hua/AAF-3999-2020; Zeng, Chengwu/AAA-8920-2019; Zhang, Hua/AAA-2164-2022	Lin, Kangyu/0000-0003-0140-2557; Zhang, Hua/0000-0001-9731-2737; Zhang, Xingju/0000-0003-0717-2510; Zhou, Hui/0000-0001-9157-3792; Zeng, Chengwu/0000-0002-1333-3918	National Science and Technology Department [2011CBA01105, 2011CB811301, 2009ZX09103-641]; National Natural Science Foundation of China [30872784, 81070440]; Fundamental Research Funds for the Central Universities	National Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank the following investigators and hospitals that provided samples for the analysis: Dr Hai-Xia Guo at the Second Affiliated Hospital of Sun Yat-sen University; Li-Bing Huang at the First Affiliated Hospital of Sun Yat-sen University; This work was supported by National Science and Technology Department (2011CBA01105, 2011CB811301 and 2009ZX09103-641) and the funds from National Natural Science Foundation of China (No 30872784 and 81070440), as well as supported by 'the Fundamental Research Funds for the Central Universities'. We thank Nature Publishing Group Language Editing, LLC for editing the text of the manuscript.	Anedchenko EA, 2008, MOL BIOL+, V42, P859, DOI 10.1134/S0026893308060058; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bousquet M, 2008, J EXP MED, V205, P2499, DOI 10.1084/jem.20080285; Careccia S, 2009, ONCOGENE, V28, P4034, DOI 10.1038/onc.2009.255; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Estey E, 2007, J CLIN ONCOL, V25, P1908, DOI 10.1200/JCO.2006.10.2731; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Farag SS, 2005, J CLIN ONCOL, V23, P482, DOI 10.1200/JCO.2005.06.090; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Ghosh A, 2010, CANCER SCI, V101, P1511, DOI 10.1111/j.1349-7006.2010.01551.x; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Ji Y, 2004, CANCER RES, V64, P370, DOI 10.1158/0008-5472.CAN-03-3029; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kashuba VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005231; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Leite KR, 2009, UROL ONCOL, V29, P265; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Senchenko VN, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-75; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Sinha S, 2008, CANCER SCI, V99, P1984, DOI 10.1111/j.1349-7006.2008.00952.x; STRAUSS M, 1995, NAT MED, V1, P1245, DOI 10.1038/nm1295-1245; Strom DK, 1998, CELL GROWTH DIFFER, V9, P59; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang JR, 2009, EUR J CELL BIOL, V88, P103, DOI 10.1016/j.ejcb.2008.05.003; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	48	94	107	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	1					80	92		10.1038/onc.2011.208	http://dx.doi.org/10.1038/onc.2011.208			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21643017	Green Published, hybrid			2022-12-25	WOS:000299176200008
J	Saunders, EC; Ng, WW; Chambers, JM; Ng, M; Naderer, T; Kromer, JO; Likic, VA; McConville, MJ				Saunders, Eleanor C.; Ng, William W.; Chambers, Jennifer M.; Ng, Milica; Naderer, Thomas; Kroemer, Jens O.; Likic, Vladimir A.; McConville, Malcolm J.			Isotopomer Profiling of Leishmania mexicana Promastigotes Reveals Important Roles for Succinate Fermentation and Aspartate Uptake in Tricarboxylic Acid Cycle (TCA) Anaplerosis, Glutamate Synthesis, and Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCYCLIC TRYPANOSOMA-BRUCEI; PHOSPHOGLYCERATE KINASE GENES; CARBON METABOLISM; ENERGY-METABOLISM; CARBOHYDRATE-METABOLISM; GLUCOSE-METABOLISM; KREBS CYCLE; VIRULENCE; AMASTIGOTES; PARASITES	Leishmania parasites proliferate within nutritionally complex niches in their sandfly vector and mammalian hosts. However, the extent to which these parasites utilize different carbon sources remains poorly defined. In this study, we have followed the incorporation of various C-13-labeled carbon sources into the intracellular and secreted metabolites of Leishmania mexicana promastigotes using gas chromatography-mass spectrometry and C-13 NMR. [U-C-13] Glucose was rapidly incorporated into intermediates in glycolysis, the pentose phosphate pathway, and the cytoplasmic carbohydrate reserve material, mannogen. Enzymes involved in the upper glycolytic pathway are sequestered within glycosomes, and the ATP and NAD(+) consumed by these reactions were primarily regenerated by the fermentation of phosphoenolpyruvate to succinate( glycosomal succinate fermentation). The initiating enzyme in this pathway, phosphoenolpyruvate carboxykinase, was exclusively localized to the glycosome. Although some of the glycosomal succinate was secreted, most of the C4 dicarboxylic acids generated during succinate fermentation were further catabolized in the TCA cycle. A high rate of TCA cycle anaplerosis was further suggested by measurement of [U-C-13] aspartate and [U-C-13] alanine uptake and catabolism. TCA cycle anaplerosis is apparently needed to sustain glutamate production under standard culture conditions. Specifically, inhibition of mitochondrial aconitase with sodium fluoroacetate resulted in the rapid depletion of intracellular glutamate pools and growth arrest. Addition of high concentrations of exogenous glutamate alleviated this growth arrest. These findings suggest that glycosomal and mitochondrial metabolism in Leishmania promastigotes is tightly coupled and that, in contrast to the situation in some other trypanosomatid parasites, the TCA cycle has crucial anabolic functions.	[Saunders, Eleanor C.; Ng, William W.; Chambers, Jennifer M.; Ng, Milica; Naderer, Thomas; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Saunders, Eleanor C.; Ng, William W.; Chambers, Jennifer M.; Ng, Milica; Naderer, Thomas; Likic, Vladimir A.; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Parkville, Vic 3010, Australia; [Kroemer, Jens O.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia	University of Melbourne; University of Melbourne; University of Queensland	McConville, MJ (corresponding author), 30 Flemington Rd, Parkville, Vic 3010, Australia.	malcolmm@unimelb.edu.au	Krömer, Jens O./C-5958-2009	Krömer, Jens O./0000-0001-5006-0819; Saunders, Eleanor/0000-0002-3247-8522; Naderer, Thomas/0000-0003-2691-0283	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council.	Adje CA, 1997, MOL BIOCHEM PARASIT, V90, P155, DOI 10.1016/S0166-6851(97)00152-7; BALOGUN RA, 1974, COMP BIOCHEM PHYSIOL, V49, P215, DOI 10.1016/0300-9629(74)90110-8; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; De Souza DP, 2006, BIOINFORMATICS, V22, P1391, DOI 10.1093/bioinformatics/btl085; Dey R, 2010, MOL MICROBIOL, V77, P399, DOI 10.1111/j.1365-2958.2010.07214.x; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Doyle MA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-57; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Eylert E, 2010, J BIOL CHEM, V285, P22232, DOI 10.1074/jbc.M110.128678; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Guerra DG, 2006, MOL BIOCHEM PARASIT, V149, P155, DOI 10.1016/j.molbiopara.2006.05.006; HANNAERT V, 1992, MOL BIOCHEM PARASIT, V55, P115, DOI 10.1016/0166-6851(92)90132-4; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Leroux AE, 2011, MOL BIOCHEM PARASIT, V177, P61, DOI 10.1016/j.molbiopara.2011.01.010; Lutz NW, 1996, MAGNET RESON MED, V36, P788, DOI 10.1002/mrm.1910360519; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Mazareb S, 1999, EXP PARASITOL, V91, P341, DOI 10.1006/expr.1998.4391; McKoy G, 1997, MOL BIOCHEM PARASIT, V90, P169, DOI 10.1016/S0166-6851(97)00172-2; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MOTTRAM JC, 1985, EXP PARASITOL, V59, P265, DOI 10.1016/0014-4894(85)90081-5; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Naderer T, 2008, MOL MICROBIOL, V69, P858, DOI 10.1111/j.1365-2958.2008.06314.x; Naderer T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001245; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Paes LS, 2008, J EUKARYOT MICROBIOL, V55, P382, DOI 10.1111/j.1550-7408.2008.00346.x; RAINEY PM, 1991, MOL BIOCHEM PARASIT, V45, P307, DOI 10.1016/0166-6851(91)90099-R; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Saunders EC, 2010, PARASITOLOGY, V137, P1303, DOI 10.1017/S0031182010000077; SCHLEIN Y, 1994, AM J TROP MED HYG, V50, P20, DOI 10.4269/ajtmh.1994.50.1.TM0500010020; Sernee MF, 2006, P NATL ACAD SCI USA, V103, P9458, DOI 10.1073/pnas.0603539103; terKuile BH, 1997, J BACTERIOL, V179, P4699, DOI 10.1128/jb.179.15.4699-4705.1997; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Uboldi AD, 2006, INT J PARASITOL, V36, P1499, DOI 10.1016/j.ijpara.2006.08.006; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; VanHellemond JJ, 1997, MOL BIOCHEM PARASIT, V85, P135, DOI 10.1016/S0166-6851(97)02828-4; Vernal J, 1998, MOL BIOCHEM PARASIT, V96, P83, DOI 10.1016/S0166-6851(98)00117-0; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	56	64	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27706	27717		10.1074/jbc.M110.213553	http://dx.doi.org/10.1074/jbc.M110.213553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21636575	Green Published, hybrid			2022-12-25	WOS:000293268700063
J	Shin, SY; Kim, CG; Lim, Y; Lee, YH				Shin, Soon Young; Kim, Chang Gun; Lim, Yoongho; Lee, Young Han			The ETS Family Transcription Factor ELK-1 Regulates Induction of the Cell Cycle-regulatory Gene p21(Waf1)Cip1 and the BAX Gene in Sodium Arsenite-exposed Human Keratinocyte HaCaT Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAPK SIGNALING PATHWAYS; BRCA1 SPLICE VARIANTS; SERUM RESPONSE FACTOR; CARCINOMA A431 CELLS; MOLECULAR-MECHANISMS; DNA-DAMAGE; P21(WAF1/CIP1) EXPRESSION; P21 WAF1/CIP1; INHIBITOR P21	Cyclin-dependent kinase inhibitor (CDKN1A), often referred to as p21(Waf1/Cip1) (p21), is induced by a variety of environmental stresses. Transcription factor ELK-1 is a member of the ETS oncogene superfamily. Here, we show that ELK-1 directly trans-activates the p21 gene, independently of p53 and EGR-1, in sodium arsenite (NaASO(2))-exposed HaCaT cells. Promoter deletion analysis and site-directed mutagenesis identified the presence of an ELK-1-binding core motif between -190 and -170 bp of the p21 promoter that confers inducibility by NaASO(2). Chromatin immunoprecipitation and electrophoretic mobility shift analyses confirmed the specific binding of ELK-1 to its putative binding sequence within the p21 promoter. In addition, NaASO(2)-induced p21 promoter activity was enhanced by exogenous expression of ELK-1 and reduced by expression of siRNA targeted to ELK-1 mRNA. The importance of ELK-1 in response to NaASO(2) was further confirmed by the observation that stable expression of ELK-1 siRNA in HaCaT cells resulted in the attenuation of NaASO(2)-induced p21 expression. Although ELK-1 was activated by ERK, JNK, and p38 MAPK in response toNaASO(2), ELK-1-mediated activation of the p21 promoter was largely dependent on ERK. In addition, EGR-1 induced by ELK-1 seemed to be involved in NaASO2-induced expression of BAX. This supports the view that the ERK/ELK-1 cascade is involved in p53-independent induction of p21 and BAX gene expression.	[Shin, Soon Young] Konkuk Univ, SMART Inst Adv Biomed Sci, Dept Biomed Sci & Technol, Res Ctr Transcript Control, Seoul 143701, South Korea; [Lim, Yoongho] Konkuk Univ, Div Biosci & Biotechnol, BMIC, Seoul 143701, South Korea	Konkuk University; Konkuk University	Shin, SY (corresponding author), Konkuk Univ, SMART Inst Adv Biomed Sci, Dept Biomed Sci & Technol, Res Ctr Transcript Control, 1 Hwayang Dong, Seoul 143701, South Korea.	shinsy@konkuk.ac.kr; yhlee58@konkuk.ac.kr			Ministry of Education, Science and Technology, Republic of Korea [20090084181, KRF-2008-314-C00290, NRF-2010-0014208]; Konkuk University	Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Konkuk University	This work was supported by Disease Network Research Program Grant 20090084181 and Basic Research Promotion Fund Grants KRF-2008-314-C00290 and NRF-2010-0014208 from the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology, Republic of Korea. This work was also supported by the SMART Research Professor Program of Konkuk University.	Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Al-Sarraj A, 2004, J MOL MED, V82, P530, DOI 10.1007/s00109-004-0545-0; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Beier F, 1999, J BIOL CHEM, V274, P30273, DOI 10.1074/jbc.274.42.30273; BETTLEY FR, 1975, BRIT J DERMATOL, V92, P563; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; Chan TA, 2000, GENE DEV, V14, P1584; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Chou RH, 2002, BIOCHEM BIOPH RES CO, V293, P298, DOI 10.1016/S0006-291X(02)00212-7; Ciccarelli C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-41; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; Della Ragione F, 2003, J BIOL CHEM, V278, P23360, DOI 10.1074/jbc.M300771200; Dong ZG, 2002, ENVIRON HEALTH PERSP, V110, P757, DOI 10.1289/ehp.02110s5757; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Facchinetti MM, 2004, CANCER RES, V64, P3629, DOI 10.1158/0008-5472.CAN-03-3741; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gillis LD, 2009, CELL CYCLE, V8, P253, DOI 10.4161/cc.8.2.7550; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; HARPER JW, 1993, CELL, V75, P805; Huang CS, 2004, MOL CELL BIOCHEM, V255, P57, DOI 10.1023/B:MCBI.0000007261.04684.78; Huang CS, 1999, J BIOL CHEM, V274, P14595, DOI 10.1074/jbc.274.21.14595; Huang HS, 2002, FREE RADICAL BIO MED, V33, P864, DOI 10.1016/S0891-5849(02)00983-8; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim JY, 2002, J CELL PHYSIOL, V190, P29, DOI 10.1002/jcp.10049; Kivinen L, 1999, ONCOGENE, V18, P6252, DOI 10.1038/sj.onc.1203000; Kweon MH, 2007, ONCOGENE, V26, P3559, DOI 10.1038/sj.onc.1210135; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Lincet H, 2000, CANCER LETT, V161, P17, DOI 10.1016/S0304-3835(00)00586-3; Liu ZM, 2006, CELL SIGNAL, V18, P244, DOI 10.1016/j.cellsig.2005.04.006; Lu ML, 2000, ONCOGENE, V19, P6351, DOI 10.1038/sj.onc.1204025; Nuntharatanapong N, 2005, AM J PHYSIOL-HEART C, V289, pH99, DOI 10.1152/ajpheart.00901.2004; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Qian Y, 2003, J INORG BIOCHEM, V96, P271, DOI 10.1016/S0162-0134(03)00235-6; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Sidhu JS, 2006, TOXICOL SCI, V89, P475, DOI 10.1093/toxsci/kfj032; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Tchounwou PB, 2003, CELL MOL BIOL, V49, P1071; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Yamazaki Y, 2003, J BIOL CHEM, V278, P30642, DOI 10.1074/jbc.M212242200; Yan GZ, 1997, J NEUROSCI, V17, P6122; Yang SH, 2006, BIOCHEM SOC SYMP, V73, P121, DOI 10.1042/bss0730121; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690; Zagurovskaya M, 2009, ONCOGENE, V28, P1121, DOI 10.1038/onc.2008.461; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhang CL, 2003, J BIOL CHEM, V278, P27903, DOI 10.1074/jbc.M304328200	73	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26860	26872		10.1074/jbc.M110.216721	http://dx.doi.org/10.1074/jbc.M110.216721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642427	Green Published, hybrid			2022-12-25	WOS:000293078200061
J	Kuo, CL; Oyler, GA; Shoemaker, CB				Kuo, Chueh-Ling; Oyler, George A.; Shoemaker, Charles B.			Accelerated Neuronal Cell Recovery from Botulinum Neurotoxin Intoxication by Targeted Ubiquitination	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; NEUROTRANSMITTER RELEASE; CHIMERIC MOLECULES; ANTIBODY FRAGMENTS; SEROTYPE-A; SCF; BINDING; PROTEINS; PEPTIDE; DEGRADATION	Botulinum neurotoxin (BoNT), a Category A biodefense agent, delivers a protease to motor neuron cytosol that cleaves one or more soluble NSF attachment protein receptors (SNARE) proteins involved in neurotransmission to cause a flaccid paralysis. No antidotes exist to reverse symptoms of BoNT intoxication so severely affected patients require artificial respiration with prolonged intensive care. Time to recovery depends on toxin serotype because the intraneuronal persistence of the seven known BoNT serotypes varies widely from days to many months. Our therapeutic antidote strategy is to develop 'targeted F-box' (TFB) agents that target the different intraneuronal BoNT proteases for accelerated degradation by the ubiquitin proteasome system (UPS), thus promoting rapid recovery from all serotypes. These agents consist of a camelid heavy chain-only V-H (VHH) domain specific for a BoNT protease fused to an F-box domain recognized by an intraneuronal E3-ligase. A fusion protein containing the 14 kDa anti-BoNT/A protease VHH, ALcB8, joined to a 15 kDa F-box domain region of TrCP (D5) was sufficient to cause increased ubiquitination and accelerate turnover of the targeted BoNT/A protease within neurons. Neuronal cells expressing this TFB, called D5-B8, were also substantially resistant to BoNT/A intoxication and recovered from intoxication at least 2.5 fold quicker than control neurons. Fusion of D5 to a VHH specific for BoNT/B protease (BLcB10) led to accelerated turnover of the targeted protease within neurons, thus demonstrating the modular nature of these therapeutic agents and suggesting that development of similar therapeutic agents specific to all botulinum serotypes should be readily achievable.	[Kuo, Chueh-Ling; Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Oyler, George A.] Synapt Res LLC, Baltimore, MD 21218 USA		Kuo, CL (corresponding author), Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu			NIAID; NIH; DHHS [U54 AI057159, R21 AI088489, N01-AI-30050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088489, R29AI030050, U54AI057159] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part with federal funds from the NIAID, NIH, DHHS, under Award Numbers U54 AI057159 and R21 AI088489, and Contract No. N01-AI-30050. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID and NIH. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GO is an employee of Synaptic Research LLC and contributed to the original concept and the data analysis.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Fahrer J, 2010, BIOCONJUGATE CHEM, V21, P130, DOI 10.1021/bc900365b; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gibbs WW, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican0805-78; Ho MF, 2011, PROTEIN ENG DES SEL, V24, P247, DOI 10.1093/protein/gzq093; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; KOZAKI S, 1989, INFECT IMMUN, V57, P2634, DOI 10.1128/IAI.57.9.2634-2639.1989; Kuo CL, 2010, TOXICON, V55, P619, DOI 10.1016/j.toxicon.2009.10.019; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lalli G, 1999, J CELL SCI, V112, P2715; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Sakamoto KM, 2005, METHOD ENZYMOL, V399, P833, DOI 10.1016/S0076-6879(05)99054-X; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; Tsai YC, 2010, P NATL ACAD SCI USA, V107, P16554, DOI 10.1073/pnas.1008302107; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Webb RP, 2009, VACCINE, V27, P4490, DOI 10.1016/j.vaccine.2009.05.030; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; Zhang Peng, 2009, BMC Pharmacology, V9, P12, DOI 10.1186/1471-2210-9-12; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	41	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20352	10.1371/journal.pone.0020352	http://dx.doi.org/10.1371/journal.pone.0020352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629663	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800044
J	Lee, AP; Brenner, S; Venkatesh, B				Lee, Alison P.; Brenner, Sydney; Venkatesh, Byrappa			Mouse Transgenesis Identifies Conserved Functional Enhancers and cis-Regulatory Motif in the Vertebrate LIM Homeobox Gene Lhx2 Locus	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DNA METHYLATION PATTERNS; IN-VIVO; DENN DOMAIN; HOX GENE; EXPRESSION; PROTEIN; HOMEODOMAIN; ELEMENTS; CONNECDENN	The vertebrate Lhx2 is a member of the LIM homeobox family of transcription factors. It is essential for the normal development of the forebrain, eye, olfactory system and liver as well for the differentiation of lymphoid cells. However, despite the highly restricted spatio-temporal expression pattern of Lhx2, nothing is known about its transcriptional regulation. In mammals and chicken, Crb2, Dennd1a and Lhx2 constitute a conserved linkage block, while the intervening Dennd1a is lost in the fugu Lhx2 locus. To identify functional enhancers of Lhx2, we predicted conserved noncoding elements (CNEs) in the human, mouse and fugu Crb2-Lhx2 loci and assayed their function in transgenic mouse at E11.5. Four of the eight CNE constructs tested functioned as tissue-specific enhancers in specific regions of the central nervous system and the dorsal root ganglia (DRG), recapitulating partial and overlapping expression patterns of Lhx2 and Crb2 genes. There was considerable overlap in the expression domains of the CNEs, which suggests that the CNEs are either redundant enhancers or regulating different genes in the locus. Using a large set of CNEs (810 CNEs) associated with transcription factor-encoding genes that express predominantly in the central nervous system, we predicted four over-represented 8-mer motifs that are likely to be associated with expression in the central nervous system. Mutation of one of them in a CNE that drove reporter expression in the neural tube and DRG abolished expression in both domains indicating that this motif is essential for expression in these domains. The failure of the four functional enhancers to recapitulate the complete expression pattern of Lhx2 at E11.5 indicates that there must be other Lhx2 enhancers that are either located outside the region investigated or divergent in mammals and fishes. Other approaches such as sequence comparison between multiple mammals are required to identify and characterize such enhancers.	[Lee, Alison P.; Brenner, Sydney; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Lee, AP (corresponding author), ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore.	mcbbv@imcb.a-star.edu.sg	Lee, Alison/HCH-1286-2022	Lee, Alison/0000-0002-3773-1021; Venkatesh, Byrappa/0000-0003-3620-0277	Biomedical Research Council of A*STAR, Singapore	Biomedical Research Council of A*STAR, Singapore(Agency for Science Technology & Research (A*STAR))	The project was funded by the Biomedical Research Council of A*STAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; ASP J, 2006, NONRADIOACTIVE SITU, pR11; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Bendall AJ, 1998, DIFFERENTIATION, V63, P151, DOI 10.1046/j.1432-0436.1998.6330151.x; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Gruber CA, 1997, MOL CELL BIOL, V17, P2391, DOI 10.1128/MCB.17.5.2391; Guazzi S, 1998, J BIOL CHEM, V273, P11092, DOI 10.1074/jbc.273.18.11092; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Joksimovic M, 2005, GENE EXPR PATTERNS, V5, P792, DOI 10.1016/j.modgep.2005.03.008; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Kolterud A, 2004, GENE EXPR PATTERNS, V4, P521, DOI 10.1016/j.modgep.2004.03.001; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lee AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-441; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; NAGY A, 2003, MANIPULATING MOUSE E, pR10; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; ODENWALD WF, 1989, GENE DEV, V3, P158, DOI 10.1101/gad.3.2.158; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Ovcharenko I, 2008, MOL BIOL EVOL, V25, P1668, DOI 10.1093/molbev/msn116; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Porter FD, 1997, DEVELOPMENT, V124, P2935; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Rahmatpanah FB, 2006, LEUKEMIA, V20, P1855, DOI 10.1038/sj.leu.2404345; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rhee JM, 1998, J BIOL CHEM, V273, P34196, DOI 10.1074/jbc.273.51.34196; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Sironi M, 2005, HUM MOL GENET, V14, P2533, DOI 10.1093/hmg/ddi257; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; van den Hurk JAJM, 2005, MOL VIS, V11, P263; Wandzioch E, 2004, P NATL ACAD SCI USA, V101, P16549, DOI 10.1073/pnas.0404678101; Wang HF, 2001, NEUROSCIENCE, V103, P999, DOI 10.1016/S0306-4522(00)00590-X; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wu HK, 1997, BIOCHEM BIOPH RES CO, V234, P742, DOI 10.1006/bbrc.1997.6592; Wu HK, 1996, ONCOGENE, V12, P1205; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhao YG, 2010, DEV BIOL, V337, P313, DOI 10.1016/j.ydbio.2009.11.002; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	68	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20088	10.1371/journal.pone.0020088	http://dx.doi.org/10.1371/journal.pone.0020088			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629789	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200034
J	Talman, V; Tuominen, RK; af Gennas, GB; Yli-Kauhaluoma, J; Ekokoski, E				Talman, Virpi; Tuominen, Raimo K.; af Gennas, Gustav Boije; Yli-Kauhaluoma, Jari; Ekokoski, Elina			C1 Domain-Targeted Isophthalate Derivatives Induce Cell Elongation and Cell Cycle Arrest in HeLa Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; DIACYLGLYCEROL; ACTIVATION; ISOZYMES; BINDING; DEATH; IDENTIFICATION; BRYOSTATIN-1; EPSILON; DISEASE	Diacylglycerol (DAG)-mediated signaling pathways, such as those mediated by protein kinase C (PKC), are central in regulating cell proliferation and apoptosis. DAG-responsive C1 domains are therefore considered attractive drug targets. Our group has designed a novel class of compounds targeted to the DAG binding site within the C1 domain of PKC. We have previously shown that these 5-(hydroxymethyl)isophthalates modulate PKC activation in living cells. In this study we investigated their effects on HeLa human cervical cancer cell viability and proliferation by using standard cytotoxicity tests and an automated imaging platform with machine vision technology. Cellular effects and their mechanisms were further characterized with the most potent compound, HMI-1a3. Isophthalate derivatives with high affinity to the PKC C1 domain exhibited antiproliferative and non-necrotic cytotoxic effects on HeLa cells. The anti-proliferative effect was irreversible and accompanied by cell elongation. HMI-1a3 induced down-regulation of retinoblastoma protein and cyclins A, B1, D1, and E. Effects of isophthalates on cell morphology, cell proliferation and expression of cell cycle-related proteins were different from those induced by phorbol 12-myristate-13-acetate (PMA) or bryostatin 1, but correlated closely to binding affinities. Therefore, the results strongly indicate that the effect is C1 domain-mediated.	[Talman, Virpi; Tuominen, Raimo K.; Ekokoski, Elina] Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland; [af Gennas, Gustav Boije; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland	University of Helsinki; University of Helsinki	Talman, V (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmacol & Toxicol, Helsinki, Finland.	virpi.talman@helsinki.fi	Talman, Virpi/AAP-5146-2020; Boije af Gennäs, Gustav/N-4545-2015	Boije af Gennäs, Gustav/0000-0002-0099-6085; Talman, Virpi/0000-0002-2702-6505; Yli-Kauhaluoma, Jari/0000-0003-0370-7653	EU [503467]; Finnish Cultural Foundation; Magnus Ehrnrooth Foundation; Finnish Pharmaceutical Society; Alfred Kordelin Foundation	EU(European Commission); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Magnus Ehrnrooth Foundation; Finnish Pharmaceutical Society; Alfred Kordelin Foundation	This work was partially supported by grants from the EU (Pro-Kinase Research project no. 503467), the Finnish Cultural Foundation, the Magnus Ehrnrooth Foundation, the Finnish Pharmaceutical Society, and the Alfred Kordelin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	af Gennas GB, 2009, J MED CHEM, V52, P3969, DOI 10.1021/jm900229p; AFGENNAS GB, 2011, CURR TOP ME IN PRESS; BASU A, 1992, CANCER RES, V52, P3119; Blomen VA, 2007, CELL MOL LIFE SCI, V64, P3084, DOI 10.1007/s00018-007-7271-z; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Cameron AJ, 2008, INT J CANCER, V123, P769, DOI 10.1002/ijc.23560; Cameron AJM, 2010, ADV ENZYME REGUL, V50, P169, DOI 10.1016/j.advenzreg.2009.10.004; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Du W, 2009, J BIOL CHEM, V284, P26315, DOI 10.1074/jbc.M109.046904; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gonelli A, 2009, MINI-REV MED CHEM, V9, P498, DOI 10.2174/138955709787847967; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; Khan TK, 2009, NEUROBIOL DIS, V34, P332, DOI 10.1016/j.nbd.2009.02.003; Kim H, 2009, TOXICOL LETT, V184, P13, DOI 10.1016/j.toxlet.2008.10.006; Kim YT, 2005, YONSEI MED J, V46, P597, DOI 10.3349/ymj.2005.46.5.597; Kortmansky J, 2003, CANCER INVEST, V21, P924, DOI 10.1081/CNV-120025095; Kozikowski AP, 1997, J MED CHEM, V40, P1316, DOI 10.1021/jm960875h; Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130; Ling M, 2005, J BIOL CHEM, V280, P17910, DOI 10.1074/jbc.M412036200; Martinez-Ramos I, 2005, J CELL BIOCHEM, V96, P79, DOI 10.1002/jcb.20428; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sun MK, 2010, PHARMACOL THERAPEUT, V127, P66, DOI 10.1016/j.pharmthera.2010.03.001; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Toker A, 2005, EMBO REP, V6, P310, DOI 10.1038/sj.embor.7400378; Truman JP, 2009, CANCER BIOL THER, V8, P54, DOI 10.4161/cbt.8.1.7119; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713	40	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20053	10.1371/journal.pone.0020053	http://dx.doi.org/10.1371/journal.pone.0020053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629792	Green Published, gold			2022-12-25	WOS:000291005200029
J	Blonder, B; Dornhaus, A				Blonder, Benjamin; Dornhaus, Anna			Time-Ordered Networks Reveal Limitations to Information Flow in Ant Colonies	PLOS ONE			English	Article							SOCIAL NETWORK; BEHAVIOR; ORGANIZATION; DYNAMICS; PATTERNS; MODELS; SIZE	Background: An important function of many complex networks is to inhibit or promote the transmission of disease, resources, or information between individuals. However, little is known about how the temporal dynamics of individual-level interactions affect these networks and constrain their function. Ant colonies are a model comparative system for understanding general principles linking individual-level interactions to network-level functions because interactions among individuals enable integration of multiple sources of information to collectively make decisions, and allocate tasks and resources. Methodology/Findings: Here we show how the temporal and spatial dynamics of such individual interactions provide upper bounds to rates of colony-level information flow in the ant Temnothorax rugatulus. We develop a general framework for analyzing dynamic networks and a mathematical model that predicts how information flow scales with individual mobility and group size. Conclusions/Significance: Using thousands of time-stamped interactions between uniquely marked ants in four colonies of a range of sizes, we demonstrate that observed maximum rates of information flow are always slower than predicted, and are constrained by regulation of individual mobility and contact rate. By accounting for the ordering and timing of interactions, we can resolve important difficulties with network sampling frequency and duration, enabling a broader understanding of interaction network functioning across systems and scales.	[Blonder, Benjamin; Dornhaus, Anna] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona	Blonder, B (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	bblonder@email.arizona.edu			NSF [IOS 0841756]	NSF(National Science Foundation (NSF))	B.B. was supported by a NSF graduate research fellowship. A.D. was supported by NSF grant IOS 0841756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Cao TT, 2008, BIOL LETTERS, V4, P613, DOI 10.1098/rsbl.2008.0381; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cole BJ, 1996, AM NAT, V148, P1, DOI 10.1086/285908; COLE BJ, 1991, AM NAT, V137, P244, DOI 10.1086/285156; Dornhaus A, 2006, INSECT SOC, V53, P420, DOI 10.1007/s00040-006-0887-4; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GORDON DM, 1993, ANIM BEHAV, V45, P1083, DOI 10.1006/anbe.1993.1134; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; HATCHER MJ, 1992, NATURWISSENSCHAFTEN, V79, P32, DOI 10.1007/BF01132279; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Kossinets G., 2008, SIGKDD, P435; Kostakos V, 2009, PHYSICA A, V388, P1007, DOI 10.1016/j.physa.2008.11.021; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Naug D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1023, DOI 10.1007/s00265-009-0721-x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pacala SW, 1996, EVOL ECOL, V10, P127, DOI 10.1007/BF01241782; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; PINTERWOLLMAN N, 2011, J R SOC INT IN PRESS; Pratt SC, 2005, BEHAV ECOL, V16, P488, DOI 10.1093/beheco/ari020; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; ROMANO CM, 2010, PLOS ONE, V5; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Sendova-Franks AB, 2010, ANIM BEHAV, V79, P473, DOI 10.1016/j.anbehav.2009.11.035; SENDOVAFRANKS AB, 1995, ANIM BEHAV, V50, P121, DOI 10.1006/anbe.1995.0226; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; SOLE RV, 1993, J THEOR BIOL, V161, P343, DOI 10.1006/jtbi.1993.1060; Valverde S, 2006, IEEE INTELL SYST, V21, P36, DOI 10.1109/MIS.2006.34; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	34	74	78	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20298	10.1371/journal.pone.0020298	http://dx.doi.org/10.1371/journal.pone.0020298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625450	Green Published, gold			2022-12-25	WOS:000290793400053
J	Yepes, A; Rico, S; Rodriguez-Garcia, A; Santamaria, RI; Diaz, M				Yepes, Ana; Rico, Sergio; Rodriguez-Garcia, Antonio; Santamaria, Ramon I.; Diaz, Margarita			Novel Two-Component Systems Implied in Antibiotic Production in Streptomyces coelicolor	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; ATYPICAL RESPONSE REGULATOR; MORPHOLOGICAL-DIFFERENTIATION; SECONDARY METABOLISM; ESCHERICHIA-COLI; HISTIDINE KINASE; HALSTEDII JM8; GROWTH-PHASE; A3(2); GENE	The abundance of two-component systems (TCSs) in Streptomyces coelicolor A3(2) genome indicates their importance in the physiology of this soil bacteria. Currently, several TCSs have been related to antibiotic regulation, and the purpose in this study was the characterization of five TCSs, selected by sequence homology with the well-known absA1A2 system, that could also be associated with this important process. Null mutants of the five TCSs were obtained and two mutants (Delta SCO1744/1745 and Delta SCO4596/4597/4598) showed significant differences in both antibiotic production and morphological differentiation, and have been renamed as abr (antibiotic regulator). No detectable changes in antibiotic production were found in the mutants in the systems that include the ORFs SCO3638/3639, SCO3640/3641 and SCO2165/2166 in any of the culture conditions assayed. The system SCO1744/1745 (AbrA1/A2) was involved in negative regulation of antibiotic production, and acted also as a negative regulator of the morphological differentiation. By contrast, the system SCO4596/4597/4598 (AbrC1/C2/C3), composed of two histidine kinases and one response regulator, had positive effects on both morphological development and antibiotic production. Microarray analyses of the Delta abrC1/C2/C3 and wild-type transcriptomes revealed downregulation of actII-ORF4 and cdaR genes, the actinorhodin and calcium-dependent antibiotic pathway-specific regulators respectively. These results demonstrated the involvement of these new two-component systems in antibiotic production and morphological differentiation by different approaches. One is a pleiotropic negative regulator: abrA1/A2. The other one is a positive regulator composed of three elements, two histidine kinases and one response regulator: abrC1/C2/C3.	[Yepes, Ana; Rico, Sergio; Santamaria, Ramon I.; Diaz, Margarita] Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Rodriguez-Garcia, Antonio] Inst Biotecnol Leon, Leon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Yepes, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Dept Genet & Microbiol, Edificio Dept,Campus Miguel de Unamuno, E-37008 Salamanca, Spain.	mardi@usal.es	Rodríguez-García, Antonio/A-9461-2011; Santamaria, Ramon I/K-2870-2014; Santamaria, Ramon I/M-9069-2019; Martínez, Margarita Díaz/L-3069-2014	Rodríguez-García, Antonio/0000-0001-8118-9762; Santamaria, Ramon I/0000-0002-2181-6776; Santamaria, Ramon I/0000-0002-2181-6776; Martínez, Margarita Díaz/0000-0003-4286-1506	Comision Interministerial de Ciencia y Tecnologia (CICYT) [GEN2003-20245-C09-02]; Junta de Castilla y Leon [SA072A07]; Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-17551]; Junta de Castilla y Leon; Consejo Superior de Investigaciones Cientificas (CSIC)	Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Consejo Superior de Investigaciones Cientificas (CSIC)	This work has been supported by grants GEN2003-20245-C09-02 from the Comision Interministerial de Ciencia y Tecnologia (CICYT) to R. Santamaria, SA072A07 from the Junta de Castilla y Leon to M. Diaz and BFU2010-17551 from Ministerio de Ciencia e Innovacion (MICINN) to M. Diaz. A. Y. was a holder of a predoctoral grant from the Junta de Castilla y Leon, S.R. has a predoctoral grant from the Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham SAI, 2001, APPL ENVIRON MICROB, V67, P5425, DOI 10.1128/AEM.67.12.5425-5430.2001; Anderson TB, 2001, MOL MICROBIOL, V39, P553, DOI 10.1046/j.1365-2958.2001.02240.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Chang HM, 1996, MOL MICROBIOL, V21, P1075; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diaz M, 2005, MICROBIOL-SGM, V151, P2583, DOI 10.1099/mic.0.27983-0; Fernandez-Abalos JM, 2003, MICROBIOL-SGM, V149, P1623, DOI 10.1099/mic.0.26113-0; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; Gadgil M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-66; GRAMAJO HC, 1993, MOL MICROBIOL, V7, P837, DOI 10.1111/j.1365-2958.1993.tb01174.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hopwood D. A., 1985, GENETIC MANIPULATION; Hosaka T, 2006, MOL MICROBIOL, V61, P883, DOI 10.1111/j.1365-2958.2006.05285.x; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Kato H, 2008, BIOSCI BIOTECH BIOCH, V72, P1072, DOI 10.1271/bbb.70816; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim D, 2001, MICROBIOL-SGM, V147, P1197, DOI 10.1099/00221287-147-5-1197; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; LI L, 2010, J IND MICROBIOL BIOT; Li YH, 2004, PRO BIOMED OPT IMAG, V5, P1, DOI 10.1117/12.533347; Lu YH, 2007, APPL MICROBIOL BIOT, V77, P625, DOI 10.1007/s00253-007-1184-5; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McKenzie NL, 2007, J BACTERIOL, V189, P5284, DOI 10.1128/JB.00305-07; McKenzie NL, 2010, J ANTIBIOT, V63, P177, DOI 10.1038/ja.2010.13; McKenzie NL, 2009, MICROBIOL-SGM, V155, P1812, DOI 10.1099/mic.0.028431-0; Paget MSB, 1999, MOL MICROBIOL, V33, P97, DOI 10.1046/j.1365-2958.1999.01452.x; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Ryding NJ, 2002, J BACTERIOL, V184, P794, DOI 10.1128/JB.184.3.794-805.2002; Sambrook J., 2002, MOL CLONING LAB MANU; Scaramozzino F, 2009, J BACTERIOL, V191, P687, DOI 10.1128/JB.01184-08; Sheeler NL, 2005, J BACTERIOL, V187, P687, DOI 10.1128/JB.187.2.687-696.2005; Shu D, 2009, APPL MICROBIOL BIOT, V81, P1149, DOI 10.1007/s00253-008-1738-1; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; TAKANO E, 1992, MOL MICROBIOL, V6, P2797, DOI 10.1111/j.1365-2958.1992.tb01459.x; Tanaka Y, 2009, APPL ENVIRON MICROB, V75, P4919, DOI 10.1128/AEM.00681-09; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Wang G, 2009, ANTIMICROB AGENTS CH, V53, P1019, DOI 10.1128/AAC.00388-08; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; XU D, 2010, APPL ENV MICROBIOL; Xu WJ, 2010, MOL MICROBIOL, V75, P781, DOI 10.1111/j.1365-2958.2009.07023.x	47	36	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19980	10.1371/journal.pone.0019980	http://dx.doi.org/10.1371/journal.pone.0019980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625497	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400027
J	Zhaoping, L; Geisler, WS; May, KA				Zhaoping, Li; Geisler, Wilson S.; May, Keith A.			Human Wavelength Discrimination of Monochromatic Light Explained by Optimal Wavelength Decoding of Light of Unknown Intensity	PLOS ONE			English	Article							VISUAL DISCRIMINATIONS; SPECTRAL SENSITIVITIES; QUANTUM EFFICIENCY; COLOR-VISION; CONES; RETINA	We show that human ability to discriminate the wavelength of monochromatic light can be understood as maximum likelihood decoding of the cone absorptions, with a signal processing efficiency that is independent of the wavelength. This work is built on the framework of ideal observer analysis of visual discrimination used in many previous works. A distinctive aspect of our work is that we highlight a perceptual confound that observers should confuse a change in input light wavelength with a change in input intensity. Hence a simple ideal observer model which assumes that an observer has a full knowledge of input intensity should over-estimate human ability in discriminating wavelengths of two inputs of unequal intensity. This confound also makes it difficult to consistently measure human ability in wavelength discrimination by asking observers to distinguish two input colors while matching their brightness. We argue that the best experimental method for reliable measurement of discrimination thresholds is the one of Pokorny and Smith, in which observers only need to distinguish two inputs, regardless of whether they differ in hue or brightness. We mathematically formulate wavelength discrimination under this wavelength-intensity confound and show a good agreement between our theoretical prediction and the behavioral data. Our analysis explains why the discrimination threshold varies with the input wavelength, and shows how sensitively the threshold depends on the relative densities of the three types of cones in the retina (and in particular predict discriminations in dichromats). Our mathematical formulation and solution can be applied to general problems of sensory discrimination when there is a perceptual confound from other sensory feature dimensions.	[Zhaoping, Li; May, Keith A.] UCL, Dept Comp Sci, London, England; [Geisler, Wilson S.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA	University of London; University College London; University of Texas System; University of Texas Austin	Zhaoping, L (corresponding author), UCL, Dept Comp Sci, London, England.	z.li@ucl.ac.uk	May, Keith/F-8686-2011	May, Keith/0000-0001-8114-5989; Geisler, Wilson/0000-0003-4630-6614	Gatsby Charitable Foundation; BBSRC [GR/E002536/01]	Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Gatsby Charitable Foundation and a Cognitive Science Foresight grant BBSRC #GR/E002536/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1987, J COMP NEUROL, V255, P18, DOI 10.1002/cne.902550103; BANKS MS, 1987, VISION RES, V27, P1915, DOI 10.1016/0042-6989(87)90057-5; Barlow H. B., 1977, VERTEBRATE PHOTORECE, P337; BARLOW HB, 1962, J PHYSIOL-LONDON, V160, P155, DOI 10.1113/jphysiol.1962.sp006838; BARLOW HB, 1962, J PHYSIOL-LONDON, V160, P169, DOI 10.1113/jphysiol.1962.sp006839; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BEDFORD RE, 1958, J OPT SOC AM, V48, P129, DOI 10.1364/JOSA.48.000129; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; CICERONE CM, 1989, VISION RES, V29, P1587, DOI 10.1016/0042-6989(89)90140-5; Dayan P., 2001, THEORETICAL NEUROSCI; DEVALOIS RL, 1968, SCIENCE, V162, P533, DOI 10.1126/science.162.3853.533; GEISLER WS, 1989, PSYCHOL REV, V96, P267, DOI 10.1037/0033-295X.96.2.267; KNOBLAUCH K, 1993, J OPT SOC AM A, V10, P378, DOI 10.1364/JOSAA.10.000378; Li ZP, 2010, PERCEPTION, V39, P1148; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; Packer O., 2003, SCI COLOR, P41, DOI 10.1016/B978-044451251-2/50003-9; Pelli D. G., 1990, VISION CODING EFFICI, P3; POKORNY J, 1970, J OPT SOC AM, V60, P562, DOI 10.1364/JOSA.60.000562; Ripamonti C, 2009, J VISION, V9, DOI 10.1167/9.3.10; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; VOS JJ, 1971, VISION RES, V11, P799, DOI 10.1016/0042-6989(71)90003-4; WRIGHT WD, 1952, J OPT SOC AM, V42, P509, DOI 10.1364/JOSA.42.000509; Wright WD, 1934, P PHYS SOC, V46, P459, DOI 10.1088/0959-5309/46/3/317	25	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19248	10.1371/journal.pone.0019248	http://dx.doi.org/10.1371/journal.pone.0019248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625482	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400002
J	Arthaud, L; Ben Rokia-Mille, S; Raad, H; Dombrovsky, A; Prevost, N; Capovilla, M; Robichon, A				Arthaud, Laury; Ben Rokia-Mille, Selim; Raad, Hussein; Dombrovsky, Aviv; Prevost, Nicolas; Capovilla, Maria; Robichon, Alain			Trade-Off between Toxicity and Signal Detection Orchestrated by Frequency- and Density-Dependent Genes	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENE; ARYL-HYDROCARBON RECEPTOR; DROSOPHILA-MELANOGASTER; INTRASPECIFIC COMPETITION; ENVIRONMENT INTERACTIONS; BEHAVIOR POLYMORPHISM; EPIGENETIC REGULATION; OLFACTORY BEHAVIOR; LIPID-PEROXIDATION; LOCUSTA-MIGRATORIA	Behaviors in insects are partly highly efficient Bayesian processes that fulfill exploratory tasks ending with the colonization of new ecological niches. The foraging (for) gene in Drosophila encodes a cGMP-dependent protein kinase (PKG). It has been extensively described as a frequency-dependent gene and its transcripts are differentially expressed between individuals, reflecting the population density context. Some for transcripts, when expressed in a population at high density for many generations, concomitantly trigger strong dispersive behavior associated with foraging activity. Moreover, genotype-by-environment interaction (GEI) analysis has highlighted a dormant role of for in energetic metabolism in a food deprivation context. In our current report, we show that alleles of for encoding different cGMP-dependent kinase isoforms influence the oxidation of aldehyde groups of aromatic molecules emitted by plants via Aldh-III and a phosphorylatable adaptor. The enhanced efficiency of oxidation of aldehyde odorants into carboxyl groups by the action of for lessens their action and toxicity, which should facilitate exploration and guidance in a complex odor environment. Our present data provide evidence that optimal foraging performance requires the fast metabolism of volatile compounds emitted by plants to avoid neurosensory saturation and that the frequency-dependent genes that trigger dispersion influence these processes.	[Arthaud, Laury; Ben Rokia-Mille, Selim; Raad, Hussein; Prevost, Nicolas; Robichon, Alain] Univ Nice Sophia Antipolis, INRA, CNRS, UMR 6243, Sophia Antipolis, France; [Dombrovsky, Aviv] Agr Res Org, Volcani Ctr, IL-50250 Bet Dagan, Israel; [Capovilla, Maria] Univ Ferrara, Dept Biol & Evolut, Dulbecco Telethon Inst, I-44100 Ferrara, Italy	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Ferrara	Arthaud, L (corresponding author), Univ Nice Sophia Antipolis, INRA, CNRS, UMR 6243, Sophia Antipolis, France.	alain.robichon@sophia.inra.fr	Capovilla, Maria/O-8483-2016	robichon, alain/0000-0003-1075-9646; Capovilla, Maria/0000-0002-1308-7964	ANR [blan-0186-01]; CNRS [PEPS 2437]; Maria Capovilla's Telethon [S03021]; Fondazione Telethon Funding Source: Custom	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Maria Capovilla's Telethon; Fondazione Telethon(Fondazione Telethon)	This work was supported by ANR blan-0186-01, a CNRS grant PEPS 2437, and Maria Capovilla's Telethon grant n. S03021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTAD DN, 1983, SCIENCE, V220, P93, DOI 10.1126/science.220.4592.93; ASMAN DC, 1993, J BIOL CHEM, V268, P12530; ASMUSSEN MA, 1983, GENETICS, V103, P335; AYYUB C, 1990, J NEUROGENET, V6, P243, DOI 10.3109/01677069009107114; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Boesch JS, 1999, ARCH BIOCHEM BIOPHYS, V361, P223, DOI 10.1006/abbi.1998.0989; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Chapuis MP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-37; Chapuis MP, 2009, MOL ECOL, V18, P792, DOI 10.1111/j.1365-294X.2008.04072.x; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; FEANY MB, 1990, P NATL ACAD SCI USA, V87, P2795, DOI 10.1073/pnas.87.7.2795; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goldman D, 2010, BIOL PSYCHIAT, V67, P295, DOI 10.1016/j.biopsych.2009.12.005; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; GURU SC, 1990, ALCOHOL, V7, P397, DOI 10.1016/0741-8329(90)90022-5; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; HADDAD GG, 1997, J INSECT PHYSL, V43, P203; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hempel J, 2001, EUR J BIOCHEM, V268, P722, DOI 10.1046/j.1432-1327.2001.01926.x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; JORDE PE, 1995, GENETICS, V139, P1077; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Kopp M, 2006, EVOLUTION, V60, P1537; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Mable BK, 1998, BIOESSAYS, V20, P453, DOI 10.1002/(SICI)1521-1878(199806)20:6<453::AID-BIES3>3.0.CO;2-N; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; O'Farrell PH, 2001, J CLIN INVEST, V107, P671, DOI 10.1172/JCI12562; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PENG TX, 1991, GENETICS, V128, P381; Perozich J, 2000, EUR J BIOCHEM, V267, P6197, DOI 10.1046/j.1432-1327.2000.01697.x; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Reisdorph R, 2007, DRUG METAB DISPOS, V35, P386, DOI 10.1124/dmd.106.012393; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rizzo WB, 2005, HUM MUTAT, V26, P1, DOI 10.1002/humu.20181; RKHA S, 1991, P NATL ACAD SCI USA, V88, P1835, DOI 10.1073/pnas.88.5.1835; Rokia-Mille SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002395; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schneider KA, 2006, J MATH BIOL, V52, P483, DOI 10.1007/s00285-005-0355-1; Simpson SJ, 2006, P NATL ACAD SCI USA, V103, P4152, DOI 10.1073/pnas.0508915103; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Stagos D, 2010, BRAIN RES BULL, V81, P211, DOI 10.1016/j.brainresbull.2009.08.017; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; TOSIC M, 1981, GENETICS, V97, P679; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Wymore T, 2003, CHEM-BIOL INTERACT, V143, P75, DOI 10.1016/S0009-2797(02)00175-8; Zhang LX, 2002, J CELL BIOCHEM, V85, P392, DOI 10.1002/jcb.10146	61	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19805	10.1371/journal.pone.0019805	http://dx.doi.org/10.1371/journal.pone.0019805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625551	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200024
J	Stewart, JE; Kawabe, M; Abdo, Z; Arie, T; Peever, TL				Stewart, Jane E.; Kawabe, Masato; Abdo, Zaid; Arie, Tsutomu; Peever, Tobin L.			Contrasting Codon Usage Patterns and Purifying Selection at the Mating Locus in Putatively Asexual Alternaria Fungal Species	PLOS ONE			English	Article							AMINO-ACID SITES; PATHOGEN ASPERGILLUS-FUMIGATUS; TRANSFER-RNA GENES; POSITIVE SELECTION; DIVERSIFYING SELECTION; SUBSTITUTION RATES; ESCHERICHIA-COLI; DNA POLYMORPHISM; CRYPTIC SEX; EVOLUTION	Sexual reproduction in heterothallic ascomycete fungi is controlled by a single mating-type locus called MAT1 with two alternate alleles or idiomorphs, MAT1-1 and MAT1-2. These alleles lack sequence similarity and encode different transcriptional regulators. A large number of phytopathogenic fungi including Alternaria spp. are considered asexual, yet still carry expressed MAT1 genes. The molecular evolution of Alternaria MAT1 was explored using nucleotide diversity, nonsynonymous vs. synonymous substitution (dn/ds) ratios and codon usage statistics. Likelihood ratio tests of site-branch models failed to detect positive selection on MAT1-1-1 or MAT1-2-1. Codon-site models demonstrated that both MAT1-1-1 and MAT1-2-1 are under purifying selection and significant differences in codon usage were observed between MAT1-1-1 and MAT1-2-1. Mean GC content at the third position (GC3) and effective codon usage (ENC) were significantly different between MAT1-1-1 and MAT1-2-1 with values of 0.57 and 48 for MAT1-1-1 and 0.62 and 46 for MAT1-2-1, respectively. In contrast, codon usage of Pleospora spp. (anamorph Stemphylium), a closely related Dothideomycete genus, was not significantly different between MAT1-1-1 and MAT1-2-1. The purifying selection and biased codon usage detected at the MAT1 locus in Alternaria spp. suggest a recent sexual past, cryptic sexual present and/or that MAT1 plays important cellular role(s) in addition to mating.	[Stewart, Jane E.; Kawabe, Masato; Peever, Tobin L.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Abdo, Zaid] Univ Idaho, Dept Math, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Initiat Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Arie, Tsutomu] Tokyo Univ Agr & Technol, Inst Symbiot Sci & Technol, Tokyo, Japan	Washington State University; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Tokyo University of Agriculture & Technology	Stewart, JE (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	jestewart@wsu.edu	Abdo, Zaid/E-5176-2017; ARIE, Tsutomu/C-2831-2013	Abdo, Zaid/0000-0002-8272-7734; ARIE, Tsutomu/0000-0002-4604-6608	NIH [P20RR16448]; ARCS Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; Division Of Environmental Biology [0918668] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [22405018] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	ZA is partially funded by NIH P20RR16448. JS received partial financial support from the ARCS Foundation (www.arcsfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Andersson SGE, 1996, MICROBIOL-UK, V142, P915, DOI 10.1099/00221287-142-4-915; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Barbour L, 2006, MOL MICROBIOL, V59, P637, DOI 10.1111/j.1365-2958.2005.04965.x; Berbee ML, 2003, MYCOL RES, V107, P169, DOI 10.1017/S0953756203007263; BULMER M, 1991, GENETICS, V129, P897; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; Civetta A, 2006, MOL BIOL EVOL, V23, P655, DOI 10.1093/molbev/msj074; Debuchy R, 1999, FUNGAL GENET BIOL, V27, P218, DOI 10.1006/fgbi.1999.1142; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; FU Y, 1993, GENETICS, V155, P1405; GENEREUX D, 2002, GENOME BIOL, V3, P58; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Grocock RJ, 2002, GENE, V289, P131, DOI 10.1016/S0378-1119(02)00503-6; Groenewald M, 2006, FUNGAL GENET BIOL, V43, P813, DOI 10.1016/j.fgb.2006.05.008; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Higgs PG, 2008, MOL BIOL EVOL, V25, P2279, DOI 10.1093/molbev/msn173; Hollander M, 1973, NONPARAMETRIC STAT M; Inderbitzin P, 2005, P NATL ACAD SCI USA, V102, P11390, DOI 10.1073/pnas.0501918102; Innan H, 2000, GENETICS, V155, P2015; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lafay B, 2000, MICROBIOL-UK, V146, P851, DOI 10.1099/00221287-146-4-851; Liu ZY, 2005, MOL BIOL EVOL, V22, P659, DOI 10.1093/molbev/msi049; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; NEUHAUSER C, 2003, HDB STAT GENETICS, P577; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; PEDEN JF, 1999, THESIS U NOTTINGHAM; Peever TL, 1999, PHYTOPATHOLOGY, V89, P851, DOI 10.1094/PHYTO.1999.89.10.851; Rau D, 2007, CURR GENET, V51, P377, DOI 10.1007/s00294-007-0126-1; Rehmeyer CJ, 2009, CURR GENET, V55, P253, DOI 10.1007/s00294-009-0240-3; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Sharon A, 1996, MOL GEN GENET, V251, P60, DOI 10.1007/BF02174345; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; SIMMONS EG, 1986, MYCOTAXON, V25, P287; Staats M, 2007, FUNGAL GENET BIOL, V44, P52, DOI 10.1016/j.fgb.2006.07.003; Stukenbrock EH, 2007, MOL PLANT PATHOL, V8, P321, DOI 10.1111/J.1364-3703.2007.00396.X; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; TAJIMA F, 1989, GENETICS, V123, P585; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wirsel S, 1998, MOL GEN GENET, V259, P272, DOI 10.1007/s004380050813; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yamagishi D, 2006, MOL PLANT MICROBE IN, V19, P1280, DOI 10.1094/MPMI-19-1280; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yun SH, 1999, P NATL ACAD SCI USA, V96, P5592, DOI 10.1073/pnas.96.10.5592; Zhan JS, 2007, FUNGAL GENET BIOL, V44, P339, DOI 10.1016/j.fgb.2006.10.008	69	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20083	10.1371/journal.pone.0020083	http://dx.doi.org/10.1371/journal.pone.0020083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625561	gold, Green Published, Green Submitted			2022-12-25	WOS:000290771200048
J	Trikic, MZ; Monk, P; Roehl, H; Partridge, LJ				Trikic, Michael Z.; Monk, Pete; Roehl, Henry; Partridge, Lynda J.			Regulation of Zebrafish Hatching by Tetraspanin cd63	PLOS ONE			English	Article							CATHEPSIN-L; SECRETORY LYSOSOMES; GENE-EXPRESSION; DENDRITIC CELLS; PROTEIN CD63; WILD-TYPE; DIFFERENTIATION; MEMBRANE; VESICLES; BIOSYNTHESIS	Tetraspanins cause the clustering of membrane proteins into a level of organisation essential for cellular function. Given the importance and complicated nature of this mechanism, we attempted a novel approach to identify the function of a single component in a biologically relevant context. A morpholino knockdown strategy was used to investigate the role of cd63, a membrane protein associated with intracellular transport and a melanoma marker, in embryonic zebrafish. By using three separate morpholinos targeting cd63, we were able to identify a specific phenotype. Strikingly, morphant fish failed to hatch due to the lack of secreted proteolytic enzymes required for chorion-softening. The morphology of the hatching gland at both the cellular and intracellular levels was disorganised, suggesting a role for cd63 in the functioning of this organ. This work identifies a specific role for cd63 in the zebrafish embryo and provides evidence for the suitability of zebrafish as a model system for the investigation of tetraspanin enriched microdomains.	[Trikic, Michael Z.; Monk, Pete] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Roehl, Henry] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Trikic, MZ (corresponding author), Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England.	m.trikic@shef.ac.uk	Monk, Peter/C-6155-2008	Monk, Peter/0000-0003-4637-3059; Trikic, Michael/0000-0001-5580-5402	University of Sheffield, in the department of Molecular Biology and Biotechnology; Medical Research Council [G0700091B] Funding Source: researchfish	University of Sheffield, in the department of Molecular Biology and Biotechnology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a University of Sheffield Krebs Studentship grant, in the department of Molecular Biology and Biotechnology. The funding source no longer exists, however the link to the source of funding follows: http://www.shef.ac.uk/mbb/prospectivepg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; Amano T, 2001, J BIOCHEM-TOKYO, V129, P739, DOI 10.1093/oxfordjournals.jbchem.a002914; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Biswas N, 2009, ENDOCRINOLOGY, V150, P3547, DOI 10.1210/en.2008-1613; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Crosier PS, 2001, DEV DYNAM, V222, P637, DOI 10.1002/dvdy.1218; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Gardiner MR, 2005, DEV DYNAM, V234, P992, DOI 10.1002/dvdy.20571; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gritsman K, 2000, DEVELOPMENT, V127, P921; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hiroi J, 2004, DEV GENES EVOL, V214, P176, DOI 10.1007/s00427-004-0397-1; HOTTA H, 1988, CANCER RES, V48, P2955; INOHAYA K, 1995, DEV BIOL, V171, P374, DOI 10.1006/dbio.1995.1289; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kallquist L, 2008, BLOOD, V112, P3444, DOI 10.1182/blood-2007-10-116285; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lettau M, 2007, IMMUNOL LETT, V108, P10, DOI 10.1016/j.imlet.2006.10.001; Leung YF, 2007, INVEST OPHTH VIS SCI, V48, P881, DOI 10.1167/iovs.06-0723; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Mangos S, 2000, MOL CELL BIOCHEM, V215, P93, DOI 10.1023/A:1026598516681; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Muller WEG, 1999, MAR BIOTECHNOL, V1, P569, DOI 10.1007/PL00011812; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rauch GJ, 2003, SUBMISSION CURATION; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; Schafer T, 2010, ALLERGY, V65, P1242, DOI 10.1111/j.1398-9995.2010.02350.x; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Thisse B, 2004, ZFIN DIRECT DATA SUB; THISSE C, 1993, DEVELOPMENT, V119, P1203; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; Vogel AM, 1997, DEV GENES EVOL, V206, P477, DOI 10.1007/s004270050078; Wu M, 2007, J CELL SCI, V120, P3147, DOI 10.1242/jcs.007260; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang Z, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-8; Yoshida T, 2008, TRAFFIC, V9, P540, DOI [10.1111/j.1600-0854.2007.00700.x, 10.1111/j.1600-0854.2008.00700.x]	49	35	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19683	10.1371/journal.pone.0019683	http://dx.doi.org/10.1371/journal.pone.0019683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625559	Green Published, Green Accepted, gold			2022-12-25	WOS:000290771200015
J	Skennerton, CT; Angly, FE; Breitbart, M; Bragg, L; He, SM; McMahon, KD; Hugenholtz, P; Tyson, GW				Skennerton, Connor T.; Angly, Florent E.; Breitbart, Mya; Bragg, Lauren; He, Shaomei; McMahon, Katherine D.; Hugenholtz, Philip; Tyson, Gene W.			Phage Encoded H-NS: A Potential Achilles Heel in the Bacterial Defence System	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; STREPTOCOCCUS-THERMOPHILUS BACTERIOPHAGES; NUCLEOID-ASSOCIATED PROTEIN; ESCHERICHIA-COLI; GENE-EXPRESSION; DNA; GENOME; VIRUSES; TRANSCRIPTION; COMMUNITY	The relationship between phage and their microbial hosts is difficult to elucidate in complex natural ecosystems. Engineered systems performing enhanced biological phosphorus removal (EBPR), offer stable, lower complexity communities for studying phage-host interactions. Here, metagenomic data from an EBPR reactor dominated by Candidatus Accumulibacter phosphatis (CAP), led to the recovery of three complete and six partial phage genomes. Heat-stable nucleoid structuring (H-NS) protein, a global transcriptional repressor in bacteria, was identified in one of the complete phage genomes (EPV1), and was most similar to a homolog in CAP. We infer that EPV1 is a CAP-specific phage and has the potential to repress up to 6% of host genes based on the presence of putative H-NS binding sites in the CAP genome. These genes include CRISPR associated proteins and a Type III restriction-modification system, which are key host defense mechanisms against phage infection. Further, EPV1 was the only member of the phage community found in an EBPR microbial metagenome collected seven months prior. We propose that EPV1 laterally acquired H-NS from CAP providing it with a means to reduce bacterial defenses, a selective advantage over other phage in the EBPR system. Phage encoded H-NS could constitute a previously unrecognized weapon in the phage-host arms race.	[Skennerton, Connor T.; Angly, Florent E.; Bragg, Lauren; Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia; [Skennerton, Connor T.; Angly, Florent E.; Bragg, Lauren; Hugenholtz, Philip; Tyson, Gene W.] Univ Queensland, Australian Ctr Ecogenom, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Skennerton, Connor T.; Angly, Florent E.; Bragg, Lauren; Hugenholtz, Philip; Tyson, Gene W.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Bragg, Lauren] CSIRO Math Informat & Stat, St Lucia, Qld, Australia; [He, Shaomei] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [He, Shaomei] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [McMahon, Katherine D.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA	University of Queensland; University of Queensland; University of Queensland; State University System of Florida; University of South Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Skennerton, CT (corresponding author), Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia.	g.tyson@uq.edu.au	Breitbart, Mya/B-1366-2009; Tyson, Gene W/C-6558-2013; Hugenholtz, Philip/AAD-9138-2019; Angly, Florent E/A-7717-2011; Bragg, Lauren/B-8554-2009; McMahon, Katherine D/I-3651-2012	Breitbart, Mya/0000-0003-3210-2899; Tyson, Gene W/0000-0001-8559-9427; Hugenholtz, Philip/0000-0001-5386-7925; Angly, Florent E/0000-0002-8999-0738; Skennerton, Connor/0000-0003-1320-4873; McMahon, Katherine D./0000-0002-7038-026X	Australian Research Council [DP1093175]; US National Science Foundation [BES-0332136]; Directorate For Engineering [0967646] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); US National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the Australian Research Council (www.arc.gov.au/), 265 grant DP1093175, and US National Science Foundation (www.nsf.gov/) grant BES-0332136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Barr JJ, 2010, FEMS MICROBIOL ECOL, V74, P631, DOI 10.1111/j.1574-6941.2010.00967.x; Brussow H, 1998, VIRUS GENES, V16, P95, DOI 10.1023/A:1007957911848; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dillon SC, 2010, MOL MICROBIOL, V76, P1250, DOI 10.1111/j.1365-2958.2010.07173.x; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Doyle M, 2007, SCIENCE, V315, P251, DOI 10.1126/science.1137550; Drummond AJ, 2010, GENEIOUS; Duplessis M, 2005, VIROLOGY, V340, P192, DOI 10.1016/j.virol.2005.05.033; Eppley JM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-398; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Ghedin E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-62; Gordon BRG, 2010, P NATL ACAD SCI USA, V107, P5154, DOI 10.1073/pnas.0913551107; He SM, 2010, APPL ENVIRON MICROB, V76, P5479, DOI 10.1128/AEM.00370-10; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; KRUGER D, 2005, FEMS MICROBIOL REV, V1, P177; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIU QY, 1993, P NATL ACAD SCI USA, V90, P1761, DOI 10.1073/pnas.90.5.1761; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; MEDINAAPARICIO L, 2011, J BACTERIOL, P1410; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Neethling J., 2006, FACTORS INFLUENCING; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Sette M, 2009, J BIOL CHEM, V284, P30453, DOI 10.1074/jbc.M109.044313; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; SUN S, NUCL ACIDS RES; Tendeng C, 2003, TRENDS MICROBIOL, V11, P511, DOI 10.1016/j.tim.2003.09.005; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wichman HA, 2010, PHILOS T R SOC B, V365, P2495, DOI 10.1098/rstb.2010.0053; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	36	41	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20095	10.1371/journal.pone.0020095	http://dx.doi.org/10.1371/journal.pone.0020095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625595	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200063
J	Singh, P; Wedeken, L; Waters, LC; Carr, MD; Klempnauer, KH				Singh, P.; Wedeken, L.; Waters, L. C.; Carr, M. D.; Klempnauer, K-H			Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation	ONCOGENE			English	Article						Pdcd4; c-myb; translation; RNA binding	PROTEIN PDCD4; EUKARYOTIC TRANSLATION; STRUCTURAL BASIS; GENE-EXPRESSION; C/EBP-BETA; V-MYB; TRANSFORMATION; INITIATION; CELLS; MA-3	Pdcd4 is a novel tumor suppressor protein that functions in the nucleus and the cytoplasm, and appears to be involved in the regulation of transcription and translation. In the cytoplasm, Pdcd4 has been implicated in the suppression of translation of mRNAs containing structured 5'-untranslated regions; however, the mechanisms that recruit Pdcd4 to specific target mRNAs and the identities of these mRNAs are mostly unknown. In this study, we have identified c-myb mRNA as the first natural translational target mRNA of Pdcd4. We have found that translational suppression of c-myb mRNA by Pdcd4 is dependent on sequences located within the c-myb-coding region. Furthermore, we have found that the N-terminal domain of Pdcd4 has an important role in targeting Pdcd4 to c-myb RNA by mediating preferential RNA binding to the Pdcd4-responsive region of c-myb mRNA. Overall, our work demonstrates for the first time that Pdcd4 is directly involved in translational suppression of a natural mRNA and provides the first evidence for a key role of the RNA-binding domain in targeting Pdcd4 to a specific mRNA. Oncogene (2011) 30, 4864-4873; doi:10.1038/onc.2011.202; published online 6 June 2011	[Singh, P.; Wedeken, L.; Klempnauer, K-H] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Waters, L. C.; Carr, M. D.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Munster; University of Leicester	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de	Singh, Priyanka/N-1372-2018; Singh, Priyanka/GRF-6098-2022	Singh, Priyanka/0000-0003-0841-1544; Singh, Priyanka/0000-0002-5928-6280; Wedeken, Lena/0000-0003-1061-9459; Carr, Mark/0000-0002-3939-0996	Deutsche Krebshilfe [10-1716]; Wilhelm-Sander-Stiftung [2004.088.1]; Wellcome Trust; Graduate School of Chemistry (GSC-MS) at the University of Munster	Deutsche Krebshilfe(Deutsche Krebshilfe); Wilhelm-Sander-Stiftung; Wellcome Trust(Wellcome TrustEuropean Commission); Graduate School of Chemistry (GSC-MS) at the University of Munster	We thank M Hentze and D Ostareck for providing plasmids. This work was supported by the Deutsche Krebshilfe (10-1716), the Wilhelm-Sander-Stiftung (2004.088.1) and the Wellcome Trust. PS and LW were supported by the Graduate School of Chemistry (GSC-MS) at the University of Munster.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Appl H, 2002, ONCOGENE, V21, P3076, DOI 10.1038/sj.onc.1205427; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; ErcikanAbali EA, 1997, BIOCHEMISTRY-US, V36, P12317, DOI 10.1021/bi971026e; EVAN GI, 1984, MOL CELL BIOL, V4, P2843, DOI 10.1128/MCB.4.12.2843; FOOS G, 1992, EMBO J, V11, P4619, DOI 10.1002/j.1460-2075.1992.tb05564.x; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; LaRonde-LeBlanc N, 2007, MOL CELL BIOL, V27, P147, DOI 10.1128/MCB.00867-06; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Prechtel AT, 2006, J BIOL CHEM, V281, P10912, DOI 10.1074/jbc.M510306200; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Schlichter U, 2001, BBA-GENE STRUCT EXPR, V1520, P99, DOI 10.1016/S0167-4781(01)00252-4; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; SLEEMAN JP, 1993, ONCOGENE, V8, P1931; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Wedeken Lena, 2010, Genes Cancer, V1, P293, DOI 10.1177/1947601910364227; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010618	43	36	37	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	49					4864	4873		10.1038/onc.2011.202	http://dx.doi.org/10.1038/onc.2011.202			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21643008				2022-12-25	WOS:000298346400003
J	Salin-Cantegrel, A; Riviere, JB; Shekarabi, M; Rasheed, S; DaCal, S; Laganiere, J; Gaudet, R; Rochefort, D; Lesca, G; Gaspar, C; Dion, PA; Lapointe, JY; Rouleau, GA				Salin-Cantegrel, Adele; Riviere, Jean-Baptiste; Shekarabi, Masoud; Rasheed, Sarah; DaCal, Sandra; Laganiere, Janet; Gaudet, Rebecca; Rochefort, Daniel; Lesca, Gaetan; Gaspar, Claudia; Dion, Patrick A.; Lapointe, Jean-Yves; Rouleau, Guy A.			Transit Defect of Potassium-Chloride Co-transporter 3 Is a Major Pathogenic Mechanism in Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CHANNEL ACTIVITY; CURCUMIN; KCC3; CL; EXPRESSION; TRUNCATION; MUTATIONS; CFTR	Missense and protein-truncating mutations of the human potassium-chloride co-transporter 3 gene (KCC3) cause hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), which is a severe neurodegenerative disease characterized by axonal dysfunction and neurodevelopmental defects. We previously reported that KCC3-truncating mutations disrupt brain-type creatine kinase-dependent activation of the co-transporter through the loss of its last 140 amino acids. Here, we report a novel and more distal HMSN/ACC-truncating mutation (3402C -> T; R1134X) that eliminates only the last 17 residues of the protein. This small truncation disrupts the interaction with brain-type creatine kinase in mammalian cells but also affects plasma membrane localization of the mutant transporter. Although it is not truncated, the previously reported HMSN/ACC-causing 619C -> T (R207C) missense mutation also leads to KCC3 loss of function in Xenopus oocyte flux assay. Immunodetection in Xenopus oocytes and in mammalian cultured cells revealed a decreased amount of R207C at the plasma membrane, with significant retention of the mutant proteins in the endoplasmic reticulum. In mammalian cells, curcumin partially corrected these mutant protein mislocalizations, with more protein reaching the plasma membrane. These findings suggest that mis-trafficking of mutant protein is an important pathophysiological feature of HMSN/ACC causative KCC3 mutations.	[Salin-Cantegrel, Adele; Riviere, Jean-Baptiste; Shekarabi, Masoud; Rasheed, Sarah; Laganiere, Janet; Gaudet, Rebecca; Rochefort, Daniel; Gaspar, Claudia; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, CHUM, Res Ctr, Ctr Excellence Neur, Montreal, PQ H2L 4M1, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [DaCal, Sandra; Lapointe, Jean-Yves] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Lesca, Gaetan] Hop Edouard Herriot, Serv Genet Mol & Clin, F-69003 Lyon, France	Universite de Montreal; Universite de Montreal; Universite de Montreal; CHU Lyon	Rouleau, GA (corresponding author), 2099 Rue Alexandre de Seve,Off Y-3633, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	Lesca, Gaetan/C-6111-2019	Lesca, Gaetan/0000-0001-7691-9492	Canadian Institutes of Health Research; Fondation des Jumelles Coude	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation des Jumelles Coude	This work was supported by a grant from the Canadian Institutes of Health Research and a grant by the Fondation des Jumelles Coude.	Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Dupre N, 2003, ANN NEUROL, V54, P9, DOI 10.1002/ana.77777; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Harada K, 2007, BIOCHEM BIOPH RES CO, V353, P351, DOI 10.1016/j.bbrc.2006.12.036; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Lu M, 2006, J CLIN INVEST, V116, P797, DOI 10.1172/JCI26961; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Salin-Cantegrel A, 2007, NEUROLOGY, V69, P1350, DOI 10.1212/01.wnl.0000291779.35643.15; Salin-Cantegrel A, 2008, HUM MOL GENET, V17, P2703, DOI 10.1093/hmg/ddn172; Shen MR, 2003, J BIOL CHEM, V278, P39941, DOI 10.1074/jbc.M308232200; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; SMIT LS, 1995, HUM MOL GENET, V4, P269, DOI 10.1093/hmg/4.2.269; Uyanik G, 2006, NEUROLOGY, V66, P1044, DOI 10.1212/01.wnl.0000204181.31175.8b; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443	17	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28456	28465		10.1074/jbc.M111.226894	http://dx.doi.org/10.1074/jbc.M111.226894			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21628467	Green Published, hybrid			2022-12-25	WOS:000293557800061
J	Dasgupta, S; Cushman, I; Kpetemey, M; Casey, PJ; Vishwanatha, JK				Dasgupta, Subhamoy; Cushman, Ian; Kpetemey, Marilyne; Casey, Patrick J.; Vishwanatha, Jamboor K.			Prenylated C17orf37 Induces Filopodia Formation to Promote Cell Migration and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; GERANYLGERANYLTRANSFERASE-I; 17Q12 AMPLICON; LIPID RAFTS; MICE; RAS; FARNESYLTRANSFERASE; PROTEINS; GENE; MICRODOMAINS	Post-translational modification by covalent attachment of isoprenoid lipids (prenylation) regulates the functions and biological activities of several proteins implicated in the oncogenic transformation and metastatic progression of cancer. The largest group of prenylated proteins contains a CAAX motif at the C-terminal that serves as a substrate for a series of post-translational modifications that convert these otherwise hydrophilic proteins to lipidated proteins, thus facilitating membrane association. C17orf37 (chromosome 17 open reading frame 37), also known as C35/Rdx12/MGC14832, located in the 17q12 amplicon, is overexpressed in human cancer, and its expression correlates with the migratory and invasive phenotype of cancer cells. Here we show that C17orf37 contains a functional CAAX motif and is post-translationally modified by protein geranylgeranyltransferase-I (GGTase-I). Geranylgeranylation of C17orf37 at the CAAX motif facilitates association of the protein to the inner leaflet of plasma membrane, enhances migratory phenotype of cells by inducing increased filopodia formation, and potentiates directional migration. A prenylation-deficient mutant of C17orf37 is functionally inactive and fails to trigger dissemination of tail vein-injected cells in a mouse model of metastasis. These findings demonstrate that prenylation is required for the function of the C17orf37 protein in cancer cells and imply that the post-translational modification may functionally regulate metastatic progression of disease.	[Dasgupta, Subhamoy; Kpetemey, Marilyne; Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX 76107 USA; [Dasgupta, Subhamoy; Kpetemey, Marilyne; Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA; [Cushman, Ian; Casey, Patrick J.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Cushman, Ian; Casey, Patrick J.] Duke Natl Univ Singapore Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Duke University	Vishwanatha, JK (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	jamboor.vishwanatha@unthsc.edu	Dasgupta, Subhamoy/I-6022-2015	Dasgupta, Subhamoy/0000-0001-7167-908X; Casey, Patrick/0000-0002-7366-9309; Vishwanatha, Jamboor/0000-0002-0266-6020	National Institutes of Health [MD 001633]; Department of Defense [PC081282]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant MD 001633 (to J. K. V.). This work was also supported by Department of Defense Grant PC081282 (to S. D.).	Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Axelrod D, 2001, J BIOMED OPT, V6, P6, DOI 10.1117/1.1335689; Bergo MO, 2004, J BIOL CHEM, V279, P4729, DOI 10.1074/jbc.M310081200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Carrico D, 2004, BIOORGAN MED CHEM, V12, P6517, DOI 10.1016/j.bmc.2004.09.020; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; DER CJ, 1991, CANCER CELL-MON REV, V3, P331; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Kauraniemi P, 2003, AM J PATHOL, V163, P1979, DOI 10.1016/S0002-9440(10)63556-0; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lin X, 2002, GASTROENTEROLOGY, V123, P345, DOI 10.1053/gast.2002.34279; Magdalena J, 2003, MOL BIOL CELL, V14, P670, DOI 10.1091/mbc.e02-06-0345; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Magee Anthony I, 2003, Biochem J, V376, pe3, DOI 10.1042/BJ20031531; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Maqani N, 2006, MOL CANCER RES, V4, P449, DOI 10.1158/1541-7786.MCR-06-0058; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Ostrom Rennolds S., 2007, V400, P459; Pei ZT, 2003, J BIOL CHEM, V278, P47070, DOI 10.1074/jbc.M310075200; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Prior IA, 2001, J CELL SCI, V114, P1603; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rothermund Christy A, 2005, BMC Urol, V5, P5, DOI 10.1186/1471-2490-5-5; Shaikh SR, 2006, CHEM PHYS LIPIDS, V144, P1, DOI 10.1016/j.chemphyslip.2006.06.017; Sun JZ, 1999, CANCER RES, V59, P4919; Thissen JA, 1996, ANAL BIOCHEM, V243, P80, DOI 10.1006/abio.1996.0484; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Meer G, 2002, SCIENCE, V296, P855, DOI 10.1126/science.1071491; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Woo JT, 2005, BIOCHEM PHARMACOL, V69, P87, DOI 10.1016/j.bcp.2004.08.036; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZHANG FL, 1994, J BIOL CHEM, V269, P23465; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	42	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25935	25946		10.1074/jbc.M111.254599	http://dx.doi.org/10.1074/jbc.M111.254599			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628459	Green Published, hybrid			2022-12-25	WOS:000293073000053
J	Leung, GP; Lee, L; Schmidt, TI; Shirahige, K; Kobor, MS				Leung, Grace P.; Lee, Linda; Schmidt, Thorsten I.; Shirahige, Katsuhiko; Kobor, Michael S.			Rtt107 Is Required for Recruitment of the SMC5/6 Complex to DNA Double Strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE RESPONSE; REPAIR; GENES; YEAST; RECOMBINATION; CHECKPOINT; REVEALS; MODULES	Genome integrity is maintained by a network of DNA damage response pathways, including checkpoints and DNA repair processes. In Saccharomyces cerevisiae, the BRCT domain-containing protein Rtt107/Esc4 is required for the restart of DNA replication after successful repair of DNA damage and for cellular resistance to DNA-damaging agents. In addition to its well characterized interaction with the endonuclease Slx4, Rtt107 interacts with a number of other DNA repair and recombination proteins. These include the evolutionarily conserved SMC5/6 complex, which is involved in numerous chromosome maintenance activities, such as DNA repair, chromosome segregation, and telomere function. The interaction between Rtt107 and the SMC5/6 complex was mediated through the N-terminal BRCT domains of Rtt107 and the Nse6 subunit of SMC5/6 and was independent of methyl methane sulfonate-induced damage and Slx4. Supporting a shared function in the DNA damage response, Rtt107 was required for recruitment of SMC5/6 to DNA double strand breaks. However, this functional relationship did not extend to other types of DNA lesions such as protein-bound nicks. Interestingly, Rtt107 was phosphorylated when SMC5/6 function was compromised in the absence of DNA-damaging agents, indicating a connection beyond the DNA damage response. Genetic analyses revealed that, although a subset of Rtt107 and SMC5/6 functions was shared, these proteins also contributed independently to maintenance of genome integrity.	[Leung, Grace P.; Lee, Linda; Schmidt, Thorsten I.; Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [Shirahige, Katsuhiko] Univ Tokyo, Lab Genome Struct & Funct, Ctr Epigenet Dis, Inst Mol & Cellular Biosci,Bunkyo Ku, Tokyo 1130032, Japan	Child & Family Research Institute; University of British Columbia; University of Tokyo	Kobor, MS (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	msk@cmmt.ubc.ca		Kobor, Michael/0000-0003-4140-1743; Shirahige, Katsuhiko/0000-0002-7862-1144	Canadian Institutes of Health Research [MOP-79442]; Natural Sciences and Engineering Research Council of Canada; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Child and Family Research Institute	This work was supported in part by Canadian Institutes of Health Research Grant MOP-79442 (to M. S. K.).; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a fellowship from the Child and Family Research Institute.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; AMBERG DC, 2005, METHODS YEAST GENETI, P155; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Duan XY, 2009, J BIOL CHEM, V284, P8507, DOI 10.1074/jbc.M809139200; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Haber JE, 2002, METHOD ENZYMOL, V350, P141, DOI 10.1016/S0076-6879(02)50961-7; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; James P, 1996, GENETICS, V144, P1425; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nielsen I, 2009, NAT METHODS, V6, P753, DOI [10.1038/NMETH.1372, 10.1038/nmeth.1372]; OGAWA H, 1995, ADV BIOPHYS, V31, P67, DOI 10.1016/0065-227X(95)99383-Z; Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	35	32	32	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26250	26257		10.1074/jbc.M111.235200	http://dx.doi.org/10.1074/jbc.M111.235200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642432	Green Published, hybrid			2022-12-25	WOS:000293073000082
J	Zhang, NY; Jacobson, AD; MacFadden, A; Liu, CW				Zhang, Nan-Yan; Jacobson, Andrew D.; MacFadden, Andrea; Liu, Chang-Wei			Ubiquitin Chain Trimming Recycles the Substrate Binding Sites of the 26 S Proteasome and Promotes Degradation of Lysine 48-linked Polyubiquitin Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; PROTEIN; SUBUNIT; RPN13; UCH37; RECOGNITION; ACTIVATION; RECEPTOR; REVEALS; ANALOGS	The 26 S proteasome possesses two distinct deubiquitinating activities. The ubiquitin (Ub) chain amputation activity removes the entire polyUb chain from the substrates. The Ub chain trimming activity progressively cleaves a polyUb chain from the distal end. The Ub chain amputation activity mediates degradation-coupled deubiquitination. The Ub chain trimming activity can play a supportive or an inhibitory role in degradation, likely depending on features of the substrates. How Ub chain trimming assists degradation is not clear. We find that inhibition of the chain trimming activity of the 26 S proteasome with Ub aldehyde significantly inhibits degradation of Ub(4) (Lys-48)-UbcH10 and causes accumulation of free Ub(4) (generated from chain amputation) that can be retained on the proteasome. Also, a non-trimmable Lys-48-mimic Ub(4) efficiently targets UbcH10 to the 26 S proteasome, but it cannot support efficient degradation of UbcH10 compared with regular Lys-48 Ub(4). These results indicate that polyUb chain trimming promotes proteasomal degradation of Lys-48-linked substrates. Mechanistically, we propose that Ub chain trimming cleaves the proteasome-bound Lys-48-linked polyUb chains, which vacates the Ub binding sites of the 26 S proteasome, thus allowing continuous substrate loading.	[Zhang, Nan-Yan; Jacobson, Andrew D.; MacFadden, Andrea; Liu, Chang-Wei] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Liu, CW (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu			American Heart Association; American Cancer Society	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society)	This work was supported in part by grants from the American Heart Association and the American Cancer Society (to C. W. L.).	Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Park KC, 1997, ARCH BIOCHEM BIOPHYS, V347, P78, DOI 10.1006/abbi.1997.0311; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Raasi Shahri, 2005, V301, P47; Russell NS, 2004, BIOCHEMISTRY-US, V43, P4844, DOI 10.1021/bi035626r; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095	38	11	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25540	25546		10.1074/jbc.M111.260505	http://dx.doi.org/10.1074/jbc.M111.260505			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632534	hybrid, Green Published			2022-12-25	WOS:000293073000016
J	Chavez, JD; Hoopmann, MR; Weisbrod, CR; Takara, K; Bruce, JE				Chavez, Juan D.; Hoopmann, Michael R.; Weisbrod, Chad R.; Takara, Kohji; Bruce, James E.			Quantitative Proteomic and Interaction Network Analysis of Cisplatin Resistance in HeLa Cells	PLOS ONE			English	Article							RNA EXPRESSION LEVELS; DRUG-RESISTANCE; MESSENGER-RNA; CANCER-CELLS; MASS-SPECTROMETRY; ALDOSE REDUCTASE; DNA-DAMAGE; PROTEIN; COMPLEX; IDENTIFICATION	Cisplatin along with other platinum based drugs are some of the most widely used chemotherapeutic agents. However drug resistance is a major problem for the successful chemotherapeutic treatment of cancer. Current evidence suggests that drug resistance is a multifactorial problem due to changes in the expression levels and activity of a wide number of proteins. A majority of the studies to date have quantified mRNA levels between drug resistant and drug sensitive cell lines. Unfortunately mRNA levels do not always correlate with protein expression levels due to post-transcriptional changes in protein abundance. Therefore global quantitative proteomics screens are needed to identify the protein targets that are differentially expressed in drug resistant cell lines. Here we employ a quantitative proteomics technique using stable isotope labeling with amino acids in cell culture (SILAC) coupled with mass spectrometry to quantify changes in protein levels between cisplatin resistant (HeLa/CDDP) and sensitive HeLa cells in an unbiased fashion. A total of 856 proteins were identified and quantified, with 374 displaying significantly altered expression levels between the cell lines. Expression level data was then integrated with a network of protein-protein interactions, and biological pathways to obtain a systems level view of proteome changes which occur with cisplatin resistance. Several of these proteins have been previously implicated in resistance towards platinum-based and other drugs, while many represent new potential markers or therapeutic targets.	[Chavez, Juan D.; Hoopmann, Michael R.; Weisbrod, Chad R.; Bruce, James E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Takara, Kohji] Himeji Dokkyo Univ, Dept Pharmaceut Sci, Himeji, Hyogo, Japan	University of Washington; University of Washington Seattle; Himeji Dokkyo University	Chavez, JD (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jimbruce@u.washington.edu		Hoopmann, Michael/0000-0001-7029-7792; Chavez, Juan/0000-0001-8849-0304	US National Institutes of Health [R01GM086688, R01RR023334, S10RR025107]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023334, S10RR025107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086688] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the US National Institutes of Health through grants: R01GM086688, R01RR023334, and S10RR025107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Chung YM, 2001, ANTICANCER RES, V21, P1129; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deutsch E. W., PROTEOMICS, V10, P1150; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Florczyk U, 2011, CANCER LETT, V300, P40, DOI 10.1016/j.canlet.2010.09.003; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Han EKH, 2000, BRIT J CANCER, V83, P83; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; Hoopmann MR, 2007, ANAL CHEM, V79, P5620, DOI 10.1021/ac0700833; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jordan P, 1998, NUCLEIC ACIDS RES, V26, P2831, DOI 10.1093/nar/26.12.2831; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Lee EK, 2002, ANTI-CANCER DRUG, V13, P859, DOI 10.1097/00001813-200209000-00012; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Mencia N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-250; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Nomura M, 2005, ANTICANCER RES, V25, P2729; PAK JH, CANC INVESTIGATION, V29, P21; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; ROHWER N, PLOS ONE, V5; ROSENBERG JM, 1993, MOL PHARMACOL, V43, P491; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santos JSD, 2000, BBA-MOL CELL RES, V1498, P181, DOI 10.1016/S0167-4889(00)00095-1; Saraswat M, 2006, MED SCI MONITOR, V12, pCR525; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stewart JJ, 2006, MOL CELL PROTEOMICS, V5, P433, DOI 10.1074/mcp.M500140-MCP200; Takara K, 2006, CANCER CHEMOTH PHARM, V58, P785, DOI 10.1007/s00280-006-0226-5; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Toshimitsu H, 2004, CANCER LETT, V211, P69, DOI 10.1016/j.canlet.2004.01.038; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; VIDAL M, CELL, V144, P986; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P19, DOI 10.1001/archotol.132.1.19; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113; Xu RH, 2005, CANCER RES, V65, P613; Xu Y, CANC RES, V70, P2455; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang JT, 2007, CANCER TREAT REV, V33, P741, DOI 10.1016/j.ctrv.2007.07.018	57	31	33	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19892	10.1371/journal.pone.0019892	http://dx.doi.org/10.1371/journal.pone.0019892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637840	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200018
J	Guo, L; Liang, TM; Gu, WJ; Xu, YM; Bai, YF; Lu, ZH				Guo, Li; Liang, Tingming; Gu, Wanjun; Xu, Yuming; Bai, Yunfei; Lu, Zuhong			Cross-Mapping Events in miRNAs Reveal Potential miRNA-Mimics and Evolutionary Implications	PLOS ONE			English	Article							TINY RNAS; MICRORNA; IDENTIFICATION; BIOMARKERS; SIRNAS; CANCER; SITES	MicroRNAs (miRNAs) have important roles in various biological processes. miRNA cross-mapping is a prevalent phenomenon where miRNA sequence originating from one genomic region is mapped to another location. To have a better understanding of this phenomenon in the human genome, we performed a detailed analysis in this paper using public miRNA high-throughput sequencing data and all known human miRNAs. We observed widespread cross-mapping events between miRNA precursors (pre-miRNAs), other non-coding RNAs (ncRNAs) and the opposite strands of pre-miRNAs by analyzing the high-throughput sequencing data. Computational analysis on all known human miRNAs also confirmed that many of them could be involved in cross-mapping events. The processing or decay of both ncRNAs and pre-miRNA opposite strand transcripts may contribute to miRNA enrichment, although some might be miRNA-mimics due to miRNA mis-annotation. Comparing to canonical miRNAs, miRNAs involved in cross-mapping events between pre-miRNAs and other ncRNAs normally had shorter lengths (17-19 nt), lower prediction scores and were classified as pseudo miRNA precursors. Notably, 4.9% of all human miRNAs could be accurately mapped to the opposite strands of pre-miRNAs, which showed that both strands of the same genomic region had the potential to produce mature miRNAs and simultaneously implied some potential miRNA precursors. We proposed that the cross-mapping events are more complex than we previously thought. Sequence similarity between other ncRNAs and pre-miRNAs and the specific stem-loop structures of pre-miRNAs may provide evolutionary implications.	[Guo, Li; Xu, Yuming; Bai, Yunfei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Liang, Tingming] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Peoples R China; [Liang, Tingming] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Aquat Crustacean Dis, Nanjing, Peoples R China; [Gu, Wanjun; Lu, Zuhong] Southeast Univ, Key Lab Child Dev & Learning Sci, Minist Educ, Nanjing, Peoples R China	Southeast University - China; Nanjing Normal University; Nanjing Normal University; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	zhlu@seu.edu.cn	Gu, Wanjun/B-3998-2010; Lu, Zuhong/A-5448-2013; Gu, Wanjun/P-5389-2019; Liang, Tingming/ACL-6141-2022	Gu, Wanjun/0000-0003-4501-0539; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393, 30900836, 60971021]; Innovation Project for Graduate Students of Jiangsu Province [CX10B_081Z]; Scientific Research Foundation of Graduate School of Southeast University; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project for Graduate Students of Jiangsu Province; Scientific Research Foundation of Graduate School of Southeast University; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation	This work was supported by projects 30871393, 30900836 and 60971021 of the National Natural Science Foundation of China and funded by Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-Discipline Foundation. The work was also supported by a research grant from the Innovation Project for Graduate Students of Jiangsu Province (No. CX10B_081Z) and the Scientific Research Foundation of Graduate School of Southeast University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Contu R, 2010, CIRC RES, V107, P573, DOI 10.1161/CIRCRESAHA.110.227983; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guo L, 2011, BIOSYSTEMS, V104, P87, DOI 10.1016/j.biosystems.2011.01.004; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Wang JB, 2010, CANCER LETT, V297, P137, DOI 10.1016/j.canlet.2010.07.018; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352	36	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20517	10.1371/journal.pone.0020517	http://dx.doi.org/10.1371/journal.pone.0020517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637827	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200075
J	Zheng, AJ; Li, JK; Begna, D; Fang, Y; Feng, M; Song, FF				Zheng, Aijuan; Li, Jianke; Begna, Desalegn; Fang, Yu; Feng, Mao; Song, Feifei			Proteomic Analysis of Honeybee (Apis mellifera L.) Pupae Head Development	PLOS ONE			English	Article							IN-SITU LOCALIZATION; CELL-DEATH; HYPOPHARYNGEAL GLAND; PROTEIN EXPRESSION; GENE-EXPRESSION; DROSOPHILA; BEE; BRAIN; SHOCK; STORAGE	The honeybee pupae development influences its future adult condition as well as honey and royal jelly productions. However, the molecular mechanism that regulates honeybee pupae head metamorphosis is still poorly understood. To further our understand of the associated molecular mechanism, we investigated the protein change of the honeybee pupae head at 5 time-points using 2-D electrophoresis, mass spectrometry, bioinformatics, quantitative real-time polymerase chain reaction and Western blot analysis. Accordingly, 58 protein spots altered their expression across the 5 time points (13-20 days), of which 36 proteins involved in the head organogenesis were upregulated during early stages (13-17 days). However, 22 proteins involved in regulating the pupae head neuron and gland development were upregulated at later developmental stages (19-20 days). Also, the functional enrichment analysis further suggests that proteins related to carbohydrate metabolism and energy production, development, cytoskeleton and protein folding were highly involved in the generation of organs and development of honeybee pupal head. Furthermore, the constructed protein interaction network predicted 33 proteins acting as key nodes of honeybee pupae head growth of which 9 and 4 proteins were validated at gene and protein levels, respectively. In this study, we uncovered potential protein species involved in the formation of honeybee pupae head development along with their specific temporal requirements. This first proteomic result allows deeper understanding of the proteome profile changes during honeybee pupae head development and provides important potential candidate proteins for future reverse genetic research on honeybee pupae head development to improve the performance of related organs.	[Zheng, Aijuan; Li, Jianke; Begna, Desalegn; Fang, Yu; Feng, Mao; Song, Feifei] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing, Peoples R China; [Zheng, Aijuan] Chinese Acad Agr Sci, Feed Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS	Zheng, AJ (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing, Peoples R China.	apislijk@126.com	Li, Jianke/K-8139-2013	Begna, Desalegn/0000-0001-6792-2630	Modern Agro-industry Technology Research System [CARS-45]; National Natural Science Foundation of China [30972148]	Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-45) and the National Natural Science Foundation of China (No. 30972148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Babcock M, 2004, J NEUROSCI, V24, P3964, DOI 10.1523/JNEUROSCI.5259-03.2004; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boeddeker N, 2010, P ROY SOC B-BIOL SCI, V277, P1899, DOI 10.1098/rspb.2009.2326; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao CK, 2007, J CELL BIOL, V176, P843, DOI 10.1083/jcb.200611155; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; *CONS THGS, 2006, NATURE, V444, P512; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; De Moraes RLMS, 2000, CELL BIOL INT, V24, P737, DOI 10.1006/cbir.2000.0534; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Garcia L, 2009, J PROTEOME RES, V8, P1464, DOI 10.1021/pr800823r; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goel M, 2001, J BIOL CHEM, V276, P38762, DOI 10.1074/jbc.M104125200; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gregorc A, 1999, CELL BIOL INT, V23, P211, DOI 10.1006/cbir.1999.0344; Gregorc A, 1998, CELL BIOL INT, V22, P137, DOI 10.1006/cbir.1998.0232; Gregorc A, 2000, CELL BIOL INT, V24, P319, DOI 10.1006/cbir.1999.0490; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hasegawa M, 2009, INSECT BIOCHEM MOLEC, V39, P661, DOI 10.1016/j.ibmb.2009.08.001; Haslbeck M, 2006, INT J BIOL MACROMOL, V38, P107, DOI 10.1016/j.ijbiomac.2006.01.013; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; JAY S. CAMERON, 1962, BEE WORLD, V43, P119; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; KLOPPENBURG P, 1995, J COMP NEUROL, V363, P333, DOI 10.1002/cne.903630213; Kucharski R, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0007; LEVENBOOK IS, 1985, J BIOL STAND, V13, P135, DOI 10.1016/S0092-1157(85)80019-6; Li J, 2009, INSECT MOL BIOL, V18, P1, DOI 10.1111/j.1365-2583.2008.00849.x; Li J, 2007, APIDOLOGIE, V38, P545, DOI 10.1051/apido:2007047; LIN HF, 1994, DEVELOPMENT, V120, P947; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martins JR, 2008, J INSECT PHYSIOL, V54, P867, DOI 10.1016/j.jinsphys.2008.03.009; MILNE CP, 1984, J HERED, V75, P509, DOI 10.1093/oxfordjournals.jhered.a110003; NEUKIRCH A, 1982, J COMP PHYSIOL, V146, P35, DOI 10.1007/BF00688714; PATERSON J, 1991, GENETICS, V129, P1073; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pinter M, 1998, INSECT BIOCHEM MOLEC, V28, P91, DOI 10.1016/S0965-1748(97)00095-7; Pinto LZ, 2002, J INSECT PHYSIOL, V48, P783, DOI 10.1016/S0022-1910(02)00103-8; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Scharlaken B, 2008, DEV COMP IMMUNOL, V32, P883, DOI 10.1016/j.dci.2008.01.010; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; SEVERSON DW, 1990, EXPERIENTIA, V46, P737, DOI 10.1007/BF01939951; Shao R., 1992, Journal of Fujian Agricultural College, V21, P101; Silva-Zacarin ECM, 2006, APIDOLOGIE, V37, P507, DOI 10.1051/apido:2006030; Smith P D, 1980, Basic Life Sci, V15, P175; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; TAYLOR DJ, 1992, J COMP PHYSIOL A, V170, P715, DOI 10.1007/BF00198982; Trieselmann N, 2002, CURR BIOL, V12, P1124, DOI 10.1016/S0960-9822(02)00934-X; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; WANG Z, 1993, UPTAKE METABOLISM ST, P1; WARN RM, 1985, EXP CELL RES, V157, P355, DOI 10.1016/0014-4827(85)90120-X; Wulfkuhle JD, 1998, CELL MOTIL CYTOSKEL, V40, P119, DOI 10.1002/(SICI)1097-0169(1998)40:2<119::AID-CM2>3.0.CO;2-A	63	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20428	10.1371/journal.pone.0020428	http://dx.doi.org/10.1371/journal.pone.0020428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637821	Green Submitted, gold, Green Published			2022-12-25	WOS:000291052200064
J	Kotlarchyk, MA; Shreim, SG; Alvarez-Elizondo, MB; Estrada, LC; Singh, R; Valdevit, L; Kniazeva, E; Gratton, E; Putnam, AJ; Botvinick, EL				Kotlarchyk, Maxwell A.; Shreim, Samir G.; Alvarez-Elizondo, Martha B.; Estrada, Laura C.; Singh, Rahul; Valdevit, Lorenzo; Kniazeva, Ekaterina; Gratton, Enrico; Putnam, Andrew J.; Botvinick, Elliot L.			Concentration Independent Modulation of Local Micromechanics in a Fibrin Gel	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX MIMICS; MECHANICAL-PROPERTIES; ENDOTHELIAL-CELLS; PARTICLE TRACKING; STRESS FIBERS; MESH SIZE; HYDROGELS; ELASTICITY; MIGRATION; BEHAVIOR	Methods for tuning extracellular matrix (ECM) mechanics in 3D cell culture that rely on increasing the concentration of either protein or cross-linking molecules fail to control important parameters such as pore size, ligand density, and molecular diffusivity. Alternatively, ECM stiffness can be modulated independently from protein concentration by mechanically loading the ECM. We have developed a novel device for generating stiffness gradients in naturally derived ECMs, where stiffness is tuned by inducing strain, while local mechanical properties are directly determined by laser tweezers based active microrheology (AMR). Hydrogel substrates polymerized within 35 mm diameter Petri dishes are strained non-uniformly by the precise rotation of an embedded cylindrical post, and exhibit a position-dependent stiffness with little to no modulation of local mesh geometry. Here we present the device in the context of fibrin hydrogels. First AMR is used to directly measure local micromechanics in unstrained hydrogels of increasing fibrin concentration. Changes in stiffness are then mapped within our device, where fibrin concentration is held constant. Fluorescence confocal imaging and orbital particle tracking are used to quantify structural changes in fibrin on the micro and nano levels respectively. The micromechanical strain stiffening measured by microrheology is not accompanied by ECM microstructural changes under our applied loads, as measured by confocal microscopy. However, super-resolution orbital tracking reveals nanostructural straightening, lengthening, and reduced movement of fibrin fibers. Furthermore, we show that aortic smooth muscle cells cultured within our device are morphologically sensitive to the induced mechanical gradient. Our results demonstrate a powerful cell culture tool that can be used in the study of mechanical effects on cellular physiology in naturally derived 3D ECM tissues.	[Kotlarchyk, Maxwell A.; Shreim, Samir G.; Alvarez-Elizondo, Martha B.; Estrada, Laura C.; Kniazeva, Ekaterina; Gratton, Enrico; Putnam, Andrew J.; Botvinick, Elliot L.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA; [Alvarez-Elizondo, Martha B.; Botvinick, Elliot L.] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA; [Estrada, Laura C.; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92715 USA; [Singh, Rahul; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Valdevit, Lorenzo] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA; [Valdevit, Lorenzo] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92717 USA; [Botvinick, Elliot L.] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Kotlarchyk, MA (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	elliot.botvinick@uci.edu	Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377; Valdevit, Lorenzo/0000-0001-9525-7148; Alvarez Elizondo, Martha Beatriz/0000-0002-3632-5224	National Science Foundation [DMR-0805164]; National Institutes of Health [P41-RR001192, R01-HL085339]; UCMEXUS-CONACYT; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085339] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCMEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this research was provided by the National Science Foundation (DMR-0805164) and the National Institutes of Health (P41-RR001192 and R01-HL085339), and UCMEXUS-CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behravesh E, 2003, BIOMATERIALS, V24, P4365, DOI 10.1016/S0142-9612(03)00338-7; Bereczky Z, 2003, PATHOPHYSIOL HAEMO T, V33, P430, DOI 10.1159/000083841; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; BRAU RR, 2007, J OPT A-PURE APPL OP, pS103; Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Germain S, 2010, CURR OPIN HEMATOL, V17, P245, DOI 10.1097/MOH.0b013e32833865b9; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333; Hellriegel C, 2009, J R SOC INTERFACE, V6, pS3, DOI 10.1098/rsif.2008.0313.focus; Hudson NE, 2010, BIOPHYS J, V98, P1632, DOI 10.1016/j.bpj.2009.12.4312; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Humphrey JD, 2008, CELL BIOCHEM BIOPHYS, V50, P53, DOI 10.1007/s12013-007-9002-3; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005; Kim PD, 2009, BIOMATERIALS, V30, P3854, DOI 10.1016/j.biomaterials.2009.04.013; Kis-Petikova K, 2004, MICROSC RES TECHNIQ, V63, P34, DOI 10.1002/jemt.10417; Kotlarchyk MA, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194121; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Liao HM, 2008, ACTA BIOMATER, V4, P1161, DOI 10.1016/j.actbio.2008.04.013; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; MIZUNO D, 2008, MACROMOLECULES; MOCKROS LF, 1974, BIOPHYS CHEM, V2, P164, DOI 10.1016/0301-4622(74)80037-2; Munoz-Pinto DJ, 2009, J BIOMED MATER RES A, V90A, P303, DOI 10.1002/jbm.a.32492; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040; Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012; Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006; Russell RJ, 2009, BIOPHYS J, V97, P1578, DOI 10.1016/j.bpj.2009.07.017; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Silveira A, 2006, ARTERIOSCL THROM VAS, V26, P2419, DOI 10.1161/01.ATV.0000245798.26855.88; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382	40	66	66	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20201	10.1371/journal.pone.0020201	http://dx.doi.org/10.1371/journal.pone.0020201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629793	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200043
J	Msyamboza, KP; Ngwira, B; Dzowela, T; Mvula, C; Kathyola, D; Harries, AD; Bowie, C				Msyamboza, Kelias P.; Ngwira, Bagrey; Dzowela, Titha; Mvula, Chimwemwe; Kathyola, Damson; Harries, Anthony D.; Bowie, Cameron			The Burden of Selected Chronic Non-Communicable Diseases and Their Risk Factors in Malawi: Nationwide STEPS Survey	PLOS ONE			English	Article							DIABETES-MELLITUS; RESEARCH AGENDA; BLOOD-PRESSURE; AFRICA; TUBERCULOSIS; COUNTRIES; POLICY; CARE	Background: Chronic non-communicable diseases (NCDs) are becoming significant causes of morbidity and mortality, particularly in sub-Saharan African countries, although local, high-quality data to inform evidence-based policies are lacking. Objectives: To determine the magnitude of NCDs and their risk factors in Malawi. Methods: Using the WHO STEPwise approach to chronic disease risk factor surveillance, a population-based, nationwide cross-sectional survey was conducted between July and September 2009 on participants aged 25-64 years. Socio-demographic and behaviour risk factors were collected in Step 1. Physical anthropometric measurements and blood pressure were documented in Step 2. Blood cholesterol and fasting blood glucose were measured in Step 3. Results and Conclusion: A total of 5,206 adults (67% females) were surveyed. Tobacco smoking, alcohol drinking and raised blood pressure (BP) were more frequent in males than females, 25% vs 3%, 30% vs 4% and 37% vs 29%. Overweight, physical inactivity and raised cholesterol were more common in females than males, 28% vs 16%, 13% vs 6% and 11% vs 6%. Tobacco smoking was more common in rural than urban areas 11% vs 7%, and overweight and physical inactivity more common in urban than rural areas 39% vs 22% and 24% vs 9%, all with p < 0.05. Overall (both sexes) prevalence of tobacco smoking, alcohol consumption, overweight and physical inactivity was 14%, 17%, 22%, 10% and prevalence of raised BP, fasting blood sugar and cholesterol was 33%, 6% and 9% respectively. These data could be useful in the formulation and advocacy of NCD policy and action plan in Malawi.	[Msyamboza, Kelias P.] World Hlth Org, Malawi Country Off, Lilongwe, Malawi; [Ngwira, Bagrey; Bowie, Cameron] Univ Malawi, Coll Med, Dept Community Hlth, Blantyre, Malawi; [Dzowela, Titha; Mvula, Chimwemwe; Kathyola, Damson] Minist Hlth, Lilongwe, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	World Health Organization; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Msyamboza, KP (corresponding author), World Hlth Org, Malawi Country Off, Lilongwe, Malawi.	msyambozak@mw.afro.who.int		Bowie, Cam/0000-0002-6956-3691	Malawi Ministry of Health; World Health Organisation	Malawi Ministry of Health; World Health Organisation(World Health Organization)	The study was co-funded by the Malawi Ministry of Health and World Health Organisation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2010, LANCET; Belghazi J, 2007, VASC HEALTH RISK MAN, V3, P389; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bowie Cameron, 2006, Malawi Med J, V18, P103; Cohen DB, 2010, AM J TROP MED HYG, V83, P575, DOI 10.4269/ajtmh.2010.10-0104; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Harries AD, 2010, TROP MED INT HEALTH, V15, P659, DOI 10.1111/j.1365-3156.2010.02523.x; Harries AD, 2009, T ROY SOC TROP MED H, V103, P1, DOI 10.1016/j.trstmh.2008.08.008; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Lins Nancy E, 2010, Glob Health Promot, V17, P27, DOI 10.1177/1757975910363927; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Maher D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-355; McCarthy M, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-13; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Mufunda J, 2006, ETHNIC DIS, V16, P521; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Organization W. H, 2009, 2008 2013 ACT PLAN G; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Unwin N, 2006, ANN TROP MED PARASIT, V100, P455, DOI 10.1179/136485906X97453; Unwin N, 2001, B WORLD HEALTH ORGAN, V79, P947; Wan Y, 2010, J HUM HYPERTENS, V24, P431, DOI 10.1038/jhh.2010.37; *WHO DEP CHRON DIS, 2005, PREV CHRON DIS VIT I; *WHO REG OFF S E A, 2009, RES PRIOR NONC DIS; *WHO REG OFF S E A, 2007, REG FRAM PREV CONTR; World Health Organization, 2005, WHO STEPS SURV MAN W; [No title captured]	32	119	122	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20316	10.1371/journal.pone.0020316	http://dx.doi.org/10.1371/journal.pone.0020316			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629735	Green Accepted, Green Published, gold			2022-12-25	WOS:000291005200053
J	Tao, R; Li, J; Xin, JJ; Wu, J; Guo, J; Zhang, LY; Jiang, LY; Zhang, W; Yang, Z; Li, LJ				Tao, Ran; Li, Jun; Xin, Jiaojiao; Wu, Jian; Guo, Jing; Zhang, Liyuan; Jiang, Longyan; Zhang, Wu; Yang, Zhe; Li, Lanjuan			Methylation Profile of Single Hepatocytes Derived from Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC INACTIVATION; PROTEOMIC ANALYSIS; CANCER; GENE; LIVER; EXPRESSION; BREAST; CELLS; HYPERMETHYLATION	Background: With the development of high-throughput screening, a variety of genetic alterations has been found in hepatocellular carcinoma (HCC). Although previous studies on HCC methylation profiles have focused on liver tissue, studies using isolated hepatocytes are rare. The heterogeneity of liver composition may impact the genuine methylation status of HCC; therefore, it is important to clarify the methylation profile of hepatocytes to aid in understanding the process of tumorigenesis. Methods and Findings: The global methylation profile of single hepatocytes isolated from liver tissue of hepatitis B virus (HBV) related HCC (HBHC) was analyzed using Illumina Infinium Human Methylation27 BeadChips, and combined bisulfite restriction analysis (COBRA) and bisulfite sequencing were used to validate the 20 significant hypermethylated genes identified. In this study, we found many noteworthy differences in the genome-wide methylation profiles of single hepatocytes of HBHC. Unsupervised hierarchical clustering analysis showed that hepatocyte methylation profiles could be classified according to three cell types: hepatocytes of HCC, adjacent hepatocytes and normal hepatocytes. Among the 20 most hypermethylated genes in the hepatocytes of HBHC, 7 novel genes (WNK2, EMILIN2, TLX3, TM6SF1, TRIM58, HIST1H4F and GRASP) were found to be hypermethylated in HBHC and hypomethylated in paired adjacent liver tissues; these findings have not been reported in previous studies on tissue samples. Conclusion: The genome-wide methylation profile of purified single hepatocytes of HBHC was aided in understanding the process of tumorigenesis, and a series of novel methylated genes found in this study have the potential to be biomarkers for the diagnosis and prognosis of HBHC.	[Tao, Ran; Li, Jun; Xin, Jiaojiao; Guo, Jing; Zhang, Liyuan; Jiang, Longyan; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Jian; Zhang, Wu; Yang, Zhe] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Tao, R (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Li, Jun/E-4744-2012	Li, Jun/0000-0002-7236-8088	National ST Major Project [2008ZX10002-005]; National Natural Science Foundation of China [30970747]; Zhejiang Provincial Natural Science Foundation [Y2090010]; Ministry of Health of PRC Science Foundation [WKJ2010-2-006]; Qianjiang Excellent Talent Project [2010R10076]	National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Ministry of Health of PRC Science Foundation; Qianjiang Excellent Talent Project	This work was supported by the National S&T Major Project (2008ZX10002-005), the National Natural Science Foundation of China (30970747), the Zhejiang Provincial Natural Science Foundation (Y2090010), the Ministry of Health of PRC Science Foundation (WKJ2010-2-006) and the Qianjiang Excellent Talent Project (2010R10076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JH, 2006, PROTEOMICS, V6, P538, DOI 10.1002/pmic.200500257; Archer KJ, 2010, MOL GENET GENOMICS, V283, P341, DOI 10.1007/s00438-010-0522-y; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Blumberg Baruch S, 2010, Front Biosci (Schol Ed), V2, P756; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Capiod T., 2007, V45, P405; Cronier L, 2009, ANTIOXID REDOX SIGN, V11, P323, DOI 10.1089/ars.2008.2153; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Galli A, 2010, HEPATOLOGY, V52, P493, DOI 10.1002/hep.23669; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERLYNG P, 1992, CARCINOGENESIS, V13, P1795, DOI 10.1093/carcin/13.10.1795; Guedj N, 2006, LAB INVEST, V86, P951, DOI 10.1038/labinvest.3700450; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Harrell JC, 2008, CLIN EXP METASTAS, V25, P81, DOI 10.1007/s10585-007-9105-7; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Jeong JS, 2003, EXP MOL PATHOL, V74, P74, DOI 10.1016/S0014-4800(03)80011-4; LAMBERT MP, 2010, J HEPATOLOGY; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Li BK, 2010, ANN SURG ONCOL, V17, P1917, DOI 10.1245/s10434-010-0921-7; Li J, 2006, ASAIO J, V52, P321, DOI 10.1097/01.mat.0000217794.35830.4a; Li J, 2010, DIFFERENTIATION, V80, P166, DOI 10.1016/j.diff.2010.04.002; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Lou C, 2009, CANCER SCI, V100, P996, DOI 10.1111/j.1349-7006.2009.01138.x; Ma XD, 2000, WORLD J GASTROENTERO, V6, P66; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Qiu GH, 2008, J HEPATOL, V48, P433, DOI 10.1016/j.jhep.2007.11.015; RESCAN PY, 1990, AM J PATHOL, V137, P701; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tischoff I, 2005, INT J CANCER, V115, P684, DOI 10.1002/ijc.20944; UM TH, 2010, J HEPATOLOGY; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wu LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014460; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yang ZF, 2008, LIVER INT, V28, P622, DOI 10.1111/j.1478-3231.2008.01687.x; Yuan YF, 2006, CLIN CANCER RES, V12, P6687, DOI 10.1158/1078-0432.CCR-06-0921; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang W, 2000, CANCER RES, V60, P5395; Zhong S, 2002, CLIN CANCER RES, V8, P1087	49	49	53	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19862	10.1371/journal.pone.0019862	http://dx.doi.org/10.1371/journal.pone.0019862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625442	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005200017
J	Canesi, L; Negri, A; Barmo, C; Banni, M; Gallo, G; Viarengo, A; Dondero, F				Canesi, Laura; Negri, Alessandro; Barmo, Cristina; Banni, Mohamed; Gallo, Gabriella; Viarengo, Aldo; Dondero, Francesco			The Organophosphate Chlorpyrifos Interferes with the Responses to 17 beta-Estradiol in the Digestive Gland of the Marine Mussel Mytilus galloprovincialis	PLOS ONE			English	Article							DEVELOPMENTAL NEUROTOXICITY; CELL-DEVELOPMENT; GENE-EXPRESSION; IN-VITRO; EXPOSURE; PESTICIDES; POLLUTION; BIVALVE; PROTEIN; MECHANISMS	Background: Many pesticides have been shown to act as endocrine disrupters. Although the potencies of currently used pesticides as hormone agonists/antagonists are low compared with those of natural ligands, their ability to act via multiple mechanisms might enhance the biological effect. The organophosphate Chlorpyrifos (CHP) has been shown to be weakly estrogenic and cause adverse neurodevelopmental effects in mammals. However, no information is available on the endocrine effects of CHP in aquatic organisms. In the digestive gland of the bivalve Mytilus galloprovincialis, a target tissue of both estrogens and pesticides, the possible effects of CHP on the responses to the natural estrogen 17 beta-estradiol (E-2) were investigated. Methodology/Principal Findings: Mussels were exposed to CHP (4.5 mg/l, 72 hrs) and subsequently injected with E-2 (6.75 ng/g dw). Responses were evaluated in CHP, E-2 and CHP/E-2 treatment groups at 24 h p.i. by a biomarker/transcriptomic approach. CHP and E-2 induced additive, synergistic, and antagonistic effects on lysosomal biomarkers (lysosomal membrane stability, lysosome/cytoplasm volume ratio, lipofuscin and neutral lipid accumulation). Additive and synergistic effects were also observed on the expression of estrogen-responsive genes (GST pi, catalase, 5-HTR) evaluated by RT-Q-PCR. The use of a 1.7K cDNA Mytilus microarray showed that CHP, E-2 and CHP/E-2, induced 81, 44, and 65 Differentially Expressed Genes (DEGs), respectively. 24 genes were exclusively shared between CHP and CHP/E-2, only 2 genes between E-2 and CHP/E-2. Moreover, 36 genes were uniquely modulated by CHP/E-2. Gene ontology annotation was used to elucidate the putative mechanisms involved in the responses elicited by different treatments. Conclusions: The results show complex interactions between CHP and E-2 in the digestive gland, indicating that the combination of certain pesticides and hormones may give rise to unexpected effects at the molecular/cellular level. Overall, these data demonstrate that CHP can interfere with the mussel responses to natural estrogens.	[Canesi, Laura; Barmo, Cristina; Gallo, Gabriella] Univ Genoa, Dipartimento Biol, Genoa, Italy; [Negri, Alessandro; Banni, Mohamed; Viarengo, Aldo; Dondero, Francesco] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Ambiente & Vita, Alessandria, Italy; [Banni, Mohamed] ISA, Lab Biochem & Environm Toxicol, Chott Mariem, Sousse, Tunisia	University of Genoa; University of Eastern Piedmont Amedeo Avogadro; Universite de Tunis-El-Manar; Institut Salah Azaiez	Canesi, L (corresponding author), Univ Genoa, Dipartimento Biol, Genoa, Italy.	Laura.Canesi@unige.it	; Dondero, Francesco/J-1528-2012; Banni, Mohamed/M-2144-2014	Viarengo, Aldo/0000-0002-1557-6526; Dondero, Francesco/0000-0001-7945-3712; Banni, Mohamed/0000-0001-9764-0343; Canesi, Laura/0000-0003-2061-3819	Italian Ministry of Research [20079FELYB]; Fondazione CARIGE (Cassa di Risparmio di Genova e Imperia) [2009.0659-42]; UE [FP6-2003-Global-2, 003956]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE (Cassa di Risparmio di Genova e Imperia)(Fondazione Carige); UE	This work was supported by the Italian Ministry of Research (PRIN2007), prot. 20079FELYB http://prin.miur.it/, Fondazione CARIGE (Cassa di Risparmio di Genova e Imperia)(prot. 2009.0659-42) http://www.fondazionecarige.it, and partly supported by the UE FP6-2003-Global-2 Program, NoMiracle, IP Contract n. 003956 http://nomiracle.jrc.ec.europa.eu/default.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HR, 2002, TOXICOL APPL PHARM, V179, P1, DOI 10.1006/taap.2001.9347; Bagchi D, 1997, TOXICOL LETT, V91, P31, DOI 10.1016/S0378-4274(97)03868-X; Banni M, 2011, PLOSONE IN PRESS; Bejarano AC, 2003, ENVIRON TOXICOL CHEM, V22, P2100, DOI 10.1897/02-293; Bretveld RW, 2006, REPROD BIOL ENDOCRIN, V31, P4; Burlando B, 2002, AM J PHYSIOL-CELL PH, V283, pC1461, DOI 10.1152/ajpcell.00429.2001; Campbell CG, 1997, BRAIN RES BULL, V43, P179, DOI 10.1016/S0361-9230(96)00436-4; Canesi L, 2004, GEN COMP ENDOCR, V136, P58, DOI 10.1016/j.ygcen.2003.12.003; Canesi L, 2008, AQUAT TOXICOL, V87, P272, DOI 10.1016/j.aquatox.2008.02.007; Canesi L, 2007, MOL CELL ENDOCRINOL, V276, P36, DOI 10.1016/j.mce.2007.06.002; Canesi L, 2007, GEN COMP ENDOCR, V153, P40, DOI 10.1016/j.ygcen.2007.02.005; Canesi L, 2006, AM J PHYSIOL-REG I, V291, pR664, DOI 10.1152/ajpregu.00139.2006; Canesi L, 2010, COMP BIOCHEM PHYS C, V152, P399, DOI 10.1016/j.cbpc.2010.06.008; Caughlan A, 2004, TOXICOL SCI, V78, P125, DOI 10.1093/toxsci/kfh038; Choi HJ, 2009, AM J RESP CELL MOL, V40, P168, DOI 10.1165/rcmb.2007-0377OC; Ciocan CM, 2010, ENVIRON POLLUT, V158, P2977, DOI 10.1016/j.envpol.2010.05.025; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cubero-Leon E, 2010, AQUAT TOXICOL, V98, P178, DOI 10.1016/j.aquatox.2010.02.007; Dam K, 1998, DEV BRAIN RES, V108, P39, DOI 10.1016/S0165-3806(98)00028-5; Degen GH, 2000, INT ARCH OCC ENV HEA, V73, P433, DOI 10.1007/s004200000163; Dondero F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-195; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Doran WJ, 2001, ECOTOX ENVIRON SAFE, V49, P91, DOI 10.1006/eesa.2000.2036; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Gosling E., 1992, DEV AQUACULTURE FISH, V25; Grunfeld HT, 2004, TOXICOL LETT, V151, P467, DOI 10.1016/j.toxlet.2004.03.021; Hagger JA, 2010, ECOTOXICOLOGY, V19, P953, DOI 10.1007/s10646-010-0477-0; Hoarau P, 2006, COMP BIOCHEM PHYS C, V143, P196, DOI 10.1016/j.cbpc.2006.02.007; Iguchi T, 2007, GEN COMP ENDOCR, V153, P25, DOI 10.1016/j.ygcen.2007.01.013; Itziou A, 2009, CHEMOSPHERE, V76, P1315, DOI 10.1016/j.chemosphere.2009.06.032; Janer G, 2005, AQUAT TOXICOL, V75, P32, DOI 10.1016/j.aquatox.2005.01.012; Jones OAH, 2008, MAR ECOL PROG SER, V369, P169, DOI 10.3354/meps07654; Joshi SC, 2007, TOXICOL IND HEALTH, V23, P439, DOI 10.1177/0748233707080908; Kang HG, 2004, TOXICOLOGY, V199, P219, DOI 10.1016/j.tox.2004.02.025; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Lluri G, 2008, EXP CELL RES, V314, P11, DOI 10.1016/j.yexcr.2007.06.007; McKinlay R, 2008, ENVIRON INT, V34, P168, DOI 10.1016/j.envint.2007.07.013; Moore MN, 2008, METHOD ENZYMOL, V451, P581, DOI 10.1016/S0076-6879(08)03233-3; MOORE MN, 1976, CELL TISSUE RES, V175, P279; MOORE MN, 1988, MAR ECOL PROG SER, V46, P81, DOI 10.3354/meps046081; MOORE MN, 1982, HISTOCHEM J, V14, P713, DOI 10.1007/BF01033620; Odenkirchen E. W., 1988, 85 US FISH WILDL SER; Paszkiewicz-Gadek A, 2003, GYNECOL ENDOCRINOL, V17, P37; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao D, 2005, TOXICOL APPL PHARM, V206, P17, DOI 10.1016/j.taap.2004.11.003; Recchia FM, 2010, INVEST OPHTH VIS SCI, V51, P1098, DOI 10.1167/iovs.09-4006; Scheil V, 2010, ENVIRON TOXICOL, V25, P83, DOI 10.1002/tox.20477; Schuh RA, 2002, TOXICOL APPL PHARM, V182, P176, DOI 10.1006/taap.2002.9445; Schulz R, 2004, J ENVIRON QUAL, V33, P419, DOI 10.2134/jeq2004.0419; Serrano R, 1997, ARCH ENV CONTAM TOXI, V29, P284; Sherman JD, 1996, ARCH ENVIRON HEALTH, V51, P5, DOI 10.1080/00039896.1996.9935986; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Slotkin TA, 2009, BRAIN RES, V1263, P23, DOI 10.1016/j.brainres.2009.01.049; Slotkin TA, 2009, ENVIRON HEALTH PERSP, V117, P587, DOI 10.1289/ehp.0800251; Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020; Song SM, 2005, GASTROENTEROLOGY, V129, P1581, DOI 10.1053/j.gastro.2005.09.002; USEPA, 2000, CHLORPYRIFOS REVISED; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; WHITNEY KD, 1995, TOXICOL APPL PHARM, V134, P53, DOI 10.1006/taap.1995.1168; Wright JP, 2002, J AGR FOOD CHEM, V50, P235, DOI 10.1021/jf0108664	62	45	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19803	10.1371/journal.pone.0019803	http://dx.doi.org/10.1371/journal.pone.0019803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625485	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400012
J	Pavelko, KD; Girtman, MA; Mitsunaga, Y; Mendez-Fernandez, YV; Bell, MP; Hansen, MJ; Allen, KS; Rodriguez, M; Pease, LR				Pavelko, Kevin D.; Girtman, Megan A.; Mitsunaga, Yoshihiro; Mendez-Fernandez, Yanice V.; Bell, Michael P.; Hansen, Michael J.; Allen, Kathleen S.; Rodriguez, Moses; Pease, Larry R.			Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy	PLOS ONE			English	Article							IMMUNE-RESPONSES; LEADER PROTEIN; DANIELS STRAIN; C57BL/6 MICE; SIALIC-ACID; IN-VITRO; T-CELLS; INFECTION; BINDING; EPITOPE	The induction of sterilizing T-cell responses to tumors is a major goal in the development of T-cell vaccines for treating cancer. Although specific components of anti-viral CD8+ immunity are well characterized, we still lack the ability to mimic viral CD8+ T-cell responses in therapeutic settings for treating cancers. Infection with the picornavirus Theiler's murine encephalomyelitis virus (TMEV) induces a strong sterilizing CD8+ T-cell response. In the absence of sterilizing immunity, the virus causes a persistent infection. We capitalized on the ability of TMEV to induce strong cellular immunity even under conditions of immune deficiency by modifying the virus to evaluate its potential as a T-cell vaccine. The introduction of defined CD8+ T-cell epitopes into the leader sequence of the TMEV genome generates an attenuated vaccine strain that can efficiently drive CD8+ T-cell responses to the targeted antigen. This virus activates T-cells in a manner that is capable of inducing targeted tissue damage and glucose dysregulation in an adoptive T-cell transfer model of diabetes mellitus. As a therapeutic vaccine for the treatment of established melanoma, epitope-modified TMEV can induce strong cytotoxic T-cell responses and promote infiltration of the T-cells into established tumors, ultimately leading to a delay in tumor growth and improved survival of vaccinated animals. We propose that epitope-modified TMEV is an excellent candidate for further development as a human T-cell vaccine for use in immunotherapy.	[Pavelko, Kevin D.; Girtman, Megan A.; Mitsunaga, Yoshihiro; Mendez-Fernandez, Yanice V.; Bell, Michael P.; Hansen, Michael J.; Allen, Kathleen S.; Rodriguez, Moses; Pease, Larry R.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Rodriguez, Moses] Mayo Clin, Dept Neurol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Pavelko, KD (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	pease.larry@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315; Rodriguez, Moses/0000-0001-6328-6497	Mayo Clinic, National Institutes of Health (NIH) [5R01CA104996, 5R01NS32129]; Richard M. Schulze Family Foundation; NATIONAL CANCER INSTITUTE [R01CA104996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032129] Funding Source: NIH RePORTER	Mayo Clinic, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard M. Schulze Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by Mayo Clinic, National Institutes of Health (NIH) grants 5R01CA104996 and 5R01NS32129, and a generous gift from the Richard M. Schulze Family Foundation. The funders have no role in study design, data collection and anaylsis, decision to publish, or preparation of the manuscript.	Amato RJ, 2010, EXPERT OPIN BIOL TH, V10, P281, DOI 10.1517/14712590903586213; Au GG, 2007, BRIT J HAEMATOL, V137, P133, DOI 10.1111/j.1365-2141.2007.06550.x; Badshah C, 2000, J VIROL, V74, P875, DOI 10.1128/JVI.74.2.875-882.2000; Block MS, 2005, J IMMUNOL, V174, P2756, DOI 10.4049/jimmunol.174.5.2756; BORROW P, 1992, J GEN VIROL, V73, P1861, DOI 10.1099/0022-1317-73-7-1861; Borson ND, 1997, J VIROL, V71, P5244, DOI 10.1128/JVI.71.7.5244-5250.1997; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Delhaye S, 2004, J VIROL, V78, P4357, DOI 10.1128/JVI.78.8.4357-4362.2004; Dethlefs S, 1997, J VIROL, V71, P5361, DOI 10.1128/JVI.71.7.5361-5365.1997; Dunlop LR, 2003, MICROBES INFECT, V5, P1049, DOI 10.1016/S1286-4579(03)00194-1; Gallo P, 2005, GENE THER, V12, pS84, DOI 10.1038/sj.gt.3302619; Goetz C, 2010, CYTOKINE GROWTH F R, V21, P197, DOI 10.1016/j.cytogfr.2010.02.005; Hales LM, 2008, J GEN VIROL, V89, P1265, DOI 10.1099/vir.0.83570-0; HEMMI S, 1988, J EXP MED, V168, P2319, DOI 10.1084/jem.168.6.2319; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hwang C, 1999, CURR OPIN MOL THER, V1, P471; Jnaoui K, 2002, J VIROL, V76, P8138, DOI 10.1128/JVI.76.16.8138-8147.2002; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Jones MS, 2007, J CLIN MICROBIOL, V45, P2144, DOI 10.1128/JCM.00174-07; Kang MH, 2008, GLIA, V56, P942, DOI 10.1002/glia.20668; Kumar ASM, 2003, J VIROL, V77, P2709, DOI 10.1128/JVI.77.4.2709-2716.2003; Lin XQ, 1998, J VIROL, V72, P1262, DOI 10.1128/JVI.72.2.1262-1269.1998; LINDSLEY MD, 1991, J VIROL, V65, P6612, DOI 10.1128/JVI.65.12.6612-6620.1991; Lipton HL, 2001, VIRUS RES, V76, P79, DOI 10.1016/S0168-1702(01)00256-8; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Myoung J, 2007, VIROLOGY, V360, P159, DOI 10.1016/j.virol.2006.09.045; NITAYAPHAN S, 1985, J VIROL, V56, P887, DOI 10.1128/JVI.56.3.887-895.1985; Olson JK, 2002, J IMMUNOL, V169, P2719, DOI 10.4049/jimmunol.169.5.2719; Parish Christopher R, 2009, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0409s84; Reddi HV, 2003, J GEN VIROL, V84, P845, DOI 10.1099/vir.0.18746-0; Reiman JM, 2007, SEMIN CANCER BIOL, V17, P275, DOI 10.1016/j.semcancer.2007.06.009; RODRIGUEZ M, 1983, LAB INVEST, V49, P672; RODRIGUEZ M, 1986, J EXP MED, V163, P620, DOI 10.1084/jem.163.3.620; RODRIGUEZ M, 1983, ANN NEUROL, V13, P426, DOI 10.1002/ana.410130409; ROOS RP, 1989, J VIROL, V63, P5492, DOI 10.1128/JVI.63.12.5492-5496.1989; Rossi CP, 1998, J VIROL, V72, P4515; Schagen FHE, 2004, CRIT REV ONCOL HEMAT, V50, P51, DOI 10.1016/S1040-8428(03)00172-0; van Pesch V, 2001, J VIROL, V75, P7811, DOI 10.1128/JVI.75.17.7811-7817.2001; Zhang G, 1999, J GEN VIROL, V80, P639, DOI 10.1099/0022-1317-80-3-639; Zoll J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000416	40	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20217	10.1371/journal.pone.0020217	http://dx.doi.org/10.1371/journal.pone.0020217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625449	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400047
J	Grabherr, MG; Pontiller, J; Mauceli, E; Ernst, W; Baumann, M; Biagi, T; Swofford, R; Russell, P; Zody, MC; Di Palma, F; Lindblad-Toh, K; Grabherr, RM				Grabherr, Manfred G.; Pontiller, Jens; Mauceli, Evan; Ernst, Wolfgang; Baumann, Martina; Biagi, Tara; Swofford, Ross; Russell, Pamela; Zody, Michael C.; Di Palma, Federica; Lindblad-Toh, Kerstin; Grabherr, Reingard M.			Exploiting Nucleotide Composition to Engineer Promoters	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; TRANSCRIPTION; CPG; EVOLUTION; ISLANDS; GENOME	The choice of promoter is a critical step in optimizing the efficiency and stability of recombinant protein production in mammalian cell lines. Artificial promoters that provide stable expression across cell lines and can be designed to the desired strength constitute an alternative to the use of viral promoters. Here, we show how the nucleotide characteristics of highly active human promoters can be modelled via the genome-wide frequency distribution of short motifs: by overlapping motifs that occur infrequently in the genome, we constructed contiguous sequence that is rich in GC and CpGs, both features of known promoters, but lacking homology to real promoters. We show that snippets from this sequence, at 100 base pairs or longer, drive gene expression in vitro in a number of mammalian cells, and are thus candidates for use in protein production. We further show that expression is driven by the general transcription factors TFIIB and TFIID, both being ubiquitously present across cell types, which results in less tissue-and species-specific regulation compared to the viral promoter SV40. We lastly found that the strength of a promoter can be tuned up and down by modulating the counts of GC and CpGs in localized regions. These results constitute a "proof-of-concept" for custom-designing promoters that are suitable for biotechnological and medical applications.	[Grabherr, Manfred G.; Mauceli, Evan; Biagi, Tara; Swofford, Ross; Russell, Pamela; Zody, Michael C.; Di Palma, Federica; Lindblad-Toh, Kerstin] Broad Inst, Cambridge, MA USA; [Pontiller, Jens; Ernst, Wolfgang; Baumann, Martina; Grabherr, Reingard M.] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Zody, Michael C.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Natural Resources & Life Sciences, Vienna; Uppsala University	Grabherr, MG (corresponding author), Broad Inst, Cambridge, MA USA.	evan@broadinstitute.org		Swofford, Ross/0000-0003-3676-8479; Grabherr, Reingard/0000-0002-4501-927X; Di-Palma, Federica/0000-0002-4394-0102; Russell, Pamela/0000-0003-2997-6392; Ernst, Wolfgang/0000-0003-1625-0103; Grabherr, Manfred/0000-0001-8792-6508	National Human Genome Research Institute (Large Scale Sequencing and Analysis of Genomes) [NIH 1 U54 HG03067]; Department of Biotechnology, University of Natural Resources and Life Sciences Vienna; ESF EURYI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute (Large Scale Sequencing and Analysis of Genomes)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Biotechnology, University of Natural Resources and Life Sciences Vienna; ESF EURYI(European Science Foundation (ESF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was in part supported by a grant from the National Human Genome Research Institute (Large Scale Sequencing and Analysis of Genomes, Grant No. NIH 1 U54 HG03067, Lander), and by the Department of Biotechnology, University of Natural Resources and Life Sciences Vienna. KLT is an ESF EURYI award recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; BERNARDI G, 1993, MOL BIOL EVOL, V10, P186; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Haseloff J, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0176.focus; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Munteanu A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-66; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233, DOI 10.2174/138920110791111960; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stegmaier Philip, 2004, Genome Inform, V15, P276; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	31	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20136	10.1371/journal.pone.0020136	http://dx.doi.org/10.1371/journal.pone.0020136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625601	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200068
J	Lehikoinen, A				Lehikoinen, Aleksi			Advanced Autumn Migration of Sparrowhawk Has Increased the Predation Risk of Long-Distance Migrants in Finland	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; PHENOLOGICAL CHANGES; POPULATION DECLINES; HABITAT SELECTION; ACCIPITER-NISUS; SPRING ARRIVAL; BIRDS DEPENDS; PREY; SHIFTS; CONSEQUENCES	Predation affects life history traits of nearly all organisms and the population consequences of predator avoidance are often larger than predation itself. Climate change has been shown to cause phenological changes. These changes are not necessarily similar between species and may cause mismatches between prey and predator. Eurasian sparrowhawk Accipiter nisus, the main predator of passerines, has advanced its autumn phenology by about ten days in 30 years due to climate change. However, we do not know if sparrowhawk migrate earlier in response to earlier migration by its prey or if earlier sparrowhawk migration results in changes to predation risk on its prey. By using the median departure date of 41 passerine species I was able to show that early migrating passerines tend to advance, and late migrating species delay their departure, but none of the species have advanced their departure times as much as the sparrowhawk. This has lead to a situation of increased predation risk on early migrating long-distance migrants (LDM) and decreased the overlap of migration season with later departing short-distance migrants (SDM). Findings highlight the growing list of problems of declining LDM populations caused by climate change. On the other hand it seems that the autumn migration may become safer for SDM whose populations are growing. Results demonstrate that passerines show very conservative response in autumn phenology to climate change, and thus phenological mismatches caused by global warming are not necessarily increasing towards the higher trophic levels.	Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland	University of Helsinki	Lehikoinen, A (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland.	aleksi.lehikoinen@helsinki.fi	Lehikoinen, Aleksi/O-5444-2016	Lehikoinen, Aleksi/0000-0002-1989-277X	Finnish Museum of Natural History; Finnish Cultural Foundation	Finnish Museum of Natural History; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	The salary of AL comes from the Finnish Museum of Natural History. The observatory received economic support from the Finnish Cultural Foundation to cover the food costs of the observers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CP, 2010, AUK, V127, P411, DOI 10.1525/auk.2009.09108; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brommer JE, 2008, ORNIS FENNICA, V85, P109; Caro Tim, 2005, pXIII; Cramp S., 1988, BIRDS W PALEARCTIC; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Cresswell W, 2010, J ANIM ECOL, V79, P556, DOI 10.1111/j.1365-2656.2010.01671.x; Elewa Ashraf M. T., 2007, P1, DOI 10.1007/978-3-540-46046-6_1; Filippi-Codaccioni O, 2010, J ORNITHOL, V151, P687, DOI 10.1007/s10336-010-0500-5; Forsman JT, 2001, ECOLOGY, V82, P232, DOI 10.1890/0012-9658(2001)082[0232:EOPOCA]2.0.CO;2; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; KJELLEN N, 1992, ORNIS SCAND, V23, P420, DOI 10.2307/3676673; Lehikoinen A., 2008, TRINGA, V35, P146; Lehikoinen A, 1979, TRINGA, V27, P150; Lehikoinen A, 2010, J AVIAN BIOL, V41, P627, DOI 10.1111/j.1600-048X.2010.05080.x; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; Newson SE, 2010, J APPL ECOL, V47, P244, DOI 10.1111/j.1365-2664.2010.01771.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I., 1998, POPULATION LIMITATIO; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearce-Higgins JW, 2009, OECOLOGIA, V159, P649, DOI 10.1007/s00442-008-1242-4; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Saino N, 2009, BIOL LETTERS, V5, P539, DOI 10.1098/rsbl.2009.0312; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Saurola P., 1981, LINTUMIES, V16, P10; SOLONEN T, 1990, HOLARCTIC ECOL, V13, P229; SOLONEN T, 1985, SUOMEN LINNUSTO; Thomson RL, 2006, OIKOS, V113, P325, DOI 10.1111/j.2006.0030-1299.14376.x; Thomson RL, 2006, ECOGRAPHY, V29, P507; Thomson RL, 2010, ECOLOGY, V91, P1832, DOI 10.1890/09-0989.1; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8; Vahatalo AV, 2004, J AVIAN BIOL, V35, P210; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713	42	24	24	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20001	10.1371/journal.pone.0020001	http://dx.doi.org/10.1371/journal.pone.0020001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625604	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200057
J	Badgwell, DB; Lu, Z; Le, K; Gao, F; Yang, M; Suh, GK; Bao, JJ; Das, P; Andreeff, M; Chen, W; Yu, Y; Ahmed, AA; Liao, WSL; Bast, RC				Badgwell, D. B.; Lu, Z.; Le, K.; Gao, F.; Yang, M.; Suh, G. K.; Bao, J-J; Das, P.; Andreeff, M.; Chen, W.; Yu, Y.; Ahmed, A. A.; Liao, W. S-L; Bast, R. C., Jr.			The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways	ONCOGENE			English	Article						tumor-suppressor gene ARHI; migration suppression; Stat3; RhoA GTPase; cytoskeleton	EPIDERMAL-GROWTH-FACTOR; FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; RHO-GTPASES; G-PROTEIN; BREAST; ACTIVATION; FAK; LOCALIZATION; FIBROBLASTS	Ovarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be particularly important in the pathogenesis of the disease. ARHI is an imprinted tumor-suppressor gene that is downregulated in >60% of ovarian cancers, and its loss is associated with decreased progression-free survival. ARHI encodes a 26-kDa GTPase with homology to Ras. In contrast to Ras, ARHI inhibits cell growth, but whether it also regulates cell motility has not been studied previously. Here we report that re-expression of ARHI decreases the motility of IL-6-and epidermal growth factor (EGF)-stimulated SKOv3 and Hey ovarian cancer cells, inhibiting both chemotaxis and haptotaxis. ARHI binds to and sequesters Stat3 in the cytoplasm, preventing its translocation to the nucleus and localization in focal adhesion complexes. Stat3 siRNA or the JAK2 inhibitor AG490 produced similar inhibition of motility. However, the combination of ARHI expression with Stat3 knockdown or inhibition produced greatest inhibition in ovarian cancer cell migration, consistent with Stat3-dependent and Stat3-independent mechanisms. Consistent with two distinct signaling pathways, knockdown of Stat3 selectively inhibited IL-6-stimulated migration, whereas knockdown of focal adhesion kinase (FAK) preferentially inhibited EGF-stimulated migration. In EGF-stimulated ovarian cancer cells, re-expression of ARHI inhibited FAK(Y397) and Src(Y416) phosphorylation, disrupted focal adhesions, and blocked FAK-mediated RhoA signaling, resulting in decreased levels of GTP-RhoA. Re-expression of ARHI also disrupted the formation of actin stress fibers in a FAK- and RhoA-dependent manner. Thus, ARHI has a critical and previously uncharacterized role in the regulation of ovarian cancer cell migration, exerting inhibitory effects on two distinct signaling pathways. Oncogene (2012) 31, 68-79; doi: 10.1038/onc.2011.213; published online 6 June 2011	[Badgwell, D. B.; Lu, Z.; Le, K.; Gao, F.; Yang, M.; Suh, G. K.; Bao, J-J; Das, P.; Chen, W.; Yu, Y.; Ahmed, A. A.; Liao, W. S-L; Bast, R. C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Andreeff, M.] Univ Texas MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bast, RC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd,Box 355, Houston, TX 77030 USA.	rbast@mdanderson.org	Lu, Zhen/E-5221-2015; Bast, Robert C/E-6585-2011	Bast, Robert C/0000-0003-4621-8462	NCI from the National Institutes of Health [P01 CA064602, 1RO1 CA135354-01]; MD Anderson SPORE in Ovarian Cancer [5P50 CA83639]; CCSG shared resources [CA 5 P30 CA016672]; Ovarian Cancer Research Fund; Cancer Research UK Clinician Scientist fellowship; MD Anderson Cancer Center CCSG NCI [P30 CA16672]; MRC [G0902418] Funding Source: UKRI; Medical Research Council [G0902418] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA064602, P30CA016672, P50CA083639, R01CA135354, T32CA009666] Funding Source: NIH RePORTER	NCI from the National Institutes of Health; MD Anderson SPORE in Ovarian Cancer; CCSG shared resources; Ovarian Cancer Research Fund; Cancer Research UK Clinician Scientist fellowship(Cancer Research UK); MD Anderson Cancer Center CCSG NCI; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants NCI P01 CA064602 and 1RO1 CA135354-01 from the National Institutes of Health. We also acknowledge the support of the MD Anderson SPORE in Ovarian Cancer 5P50 CA83639 and the CCSG shared resources funded, in part, by CA 5 P30 CA016672. Support was also provided by the Ovarian Cancer Research Fund through a Program Project Award. DBB was supported by an Excellence Award from the Ovarian Cancer Research Fund. AAA was supported by a Cancer Research UK Clinician Scientist fellowship. We thank Jodie Polan for excellent technical support with confocal microscopy and Jared Burks from the Flow Cytometry and Cell Imaging core laboratory for the live-cell time-lapse microscopy partially supported by the MD Anderson Cancer Center CCSG NCI P30 CA16672.	Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bongard M, 2005, VISUAL GUIDE; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Colomiere M, 2009, INT J BIOCHEM CELL B, V41, P1034, DOI 10.1016/j.biocel.2008.09.018; Debidda M, 2005, J BIOL CHEM, V280, P17275, DOI 10.1074/jbc.M413187200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Ferreira T, 2011, IMAGEJ USER GUIDE, P144; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Jang ACC, 2007, J MAMMARY GLAND BIOL, V12, P103, DOI 10.1007/s10911-007-9042-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Katabuchi Hidetaka, 2003, Medical Electron Microscopy, V36, P74; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; LIDOR YJ, 1993, EXP CELL RES, V207, P332, DOI 10.1006/excr.1993.1200; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; LIOTTA LA, 1987, ANTI-CANCER DRUG DES, V2, P195; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Luo RZ, 2003, ONCOGENE, V22, P2897, DOI 10.1038/sj.onc.1206380; Marcoux N, 2005, CELL SIGNAL, V17, P1449, DOI 10.1016/j.cellsig.2005.03.001; MARTINEZ-MAZA O, 1991, In Vivo (Attiki), V5, P583; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nishimoto A, 2005, CANCER RES, V65, P6701, DOI 10.1158/0008-5472.CAN-05-0130; Okamura H, 2005, INT REV CYTOL, V242, P1; Orr F W, 2001, Surg Oncol Clin N Am, V10, P357; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Rosen DG, 2004, CLIN CANCER RES, V10, P6559, DOI 10.1158/1078-0432.CCR-04-0698; RUSTIN GJS, 1993, ANN ONCOL, V4, P71; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vij N, 2008, MOL VIS, V14, P1020; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Yu YH, 2006, METHOD ENZYMOL, V407, P455, DOI 10.1016/S0076-6879(05)07037-0; Zhai JB, 2003, J BIOL CHEM, V278, P24865, DOI 10.1074/jbc.M302381200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	52	68	74	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	1					68	79		10.1038/onc.2011.213	http://dx.doi.org/10.1038/onc.2011.213			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21643014	Green Accepted			2022-12-25	WOS:000299176200007
J	Borgeson, E; Docherty, NG; Murphy, M; Rodgers, K; Ryan, A; O'Sullivan, TP; Guiry, PJ; Goldschmeding, R; Higgins, DF; Godson, C				Boergeson, Emma; Docherty, Neil G.; Murphy, Madeline; Rodgers, Karen; Ryan, Aidan; O'Sullivan, Tim P.; Guiry, Patrick J.; Goldschmeding, Roel; Higgins, Debra F.; Godson, Catherine			Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis	FASEB JOURNAL			English	Article						eicosanoids; unilateral ureteric obstruction; TGF-beta; tubulointerstial fibrosis	UNILATERAL URETERAL OBSTRUCTION; IN-VIVO; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; MESENCHYMAL TRANSITION; INTERSTITIAL FIBROSIS; APOPTOTIC NEUTROPHILS; SYNTHETIC ANALOG; LIPID MEDIATORS; GENE-EXPRESSION	Unresolved inflammation underlies the development of fibrosis and organ failure. Here, we investigate the potential of the proresolving eicosanoid lipoxinA(4) (LXA(4)) and its synthetic analog benzo-LXA(4) to prophylactically modulate fibrotic and inflammatory responses in a model of early renal fibrosis, unilateral ureteric obstruction (UUO). Male Wistar rats (Animalia, Chordata, Rattus norvegicus) were injected intravenously with vehicle (0.1% ethanol), LXA(4) (45 mu g/250-g rat), or benzo-LXA(4) (15 mu g/250-g rat) 15 min prior to surgery and sacrificed 3 d postligation. Renal gene and protein expression, collagen deposition, macrophage infiltration, and apoptosis were analyzed using manipulated kidneys from sham operations as control. Lipoxins (LXs) attenuated collagen deposition and renal apoptosis (P<0.05) and shifted the inflammatory milieu toward resolution, inhibiting TNF-alpha and IFN-gamma expression, while stimulating proresolving IL-10. LXs attenuated UUO-induced activation of MAP kinases, Akt, and Smads (P<0.05) in injured kidneys. We explored whether the underlying mechanism reflected LX-induced modulation of fibroblast activation. Using cultured rat renal NRK-49F fibroblasts, we report that LXA(4) (1 nM) inhibits TGF-beta 1 (10 ng/ml)-induced activation of Smad2 and MAP-kinases (P<0.05), and furthermore, LXA(4) reduced TGF-beta 1-stimulated PAI-1 luciferase activation (P<0.05) relative to vehicle-stimulated cells. We propose that LXs may represent a potentially useful and novel therapeutic strategy for consideration in the context of renal fibrosis.-Borgeson, E., Docherty, N. G., Murphy, M., Rodgers, K., Ryan, A., O'Sullivan, T. P., Guiry, P. J., Goldschmeding, R., Higgins, D. F., Godson, C. Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis. FASEB J. 25, 2967-2979 (2011). www.fasebj.org	[Boergeson, Emma; Murphy, Madeline; Rodgers, Karen; Ryan, Aidan; Higgins, Debra F.; Godson, Catherine] Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst, Diabet Res Ctr, Dublin 2, Ireland; [O'Sullivan, Tim P.; Guiry, Patrick J.] Univ Coll Dublin, Ctr Synth & Chem Biol, Dublin 2, Ireland; [Docherty, Neil G.] Trinity Coll Dublin, Sch Med, Dept Physiol, Dublin, Ireland; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	University College Dublin; University College Dublin; Trinity College Dublin; Utrecht University; Utrecht University Medical Center	Godson, C (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst, UCD Diabet Res Ctr, Dublin 2, Ireland.	catherine.godson@ucd.ie	Borgeson, Emma/O-3128-2017; O'Sullivan, Timothy/ABF-6865-2021; O'Sullivan, Timothy/J-1710-2012; Goldschmeding, Roel/I-1723-2014	Borgeson, Emma/0000-0002-2290-9472; O'Sullivan, Timothy/0000-0001-6649-331X; O'Sullivan, Timothy/0000-0001-6649-331X; Docherty, Neil/0000-0002-0961-2607; Godson, Catherine/0000-0003-0655-1041	Irish Research Council for Science, Engineering, and Technology; Science Foundation Ireland; Health Research Board; Government of Ireland Programme for Research in Third-Level Institutions	Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Government of Ireland Programme for Research in Third-Level Institutions	The authors thank Prof. Finian Martin for helpful suggestions during the work. E. B. is a recipient of an Irish Research Council for Science, Engineering, and Technology Embark postgraduate research scholarship. Work in C. G.'s laboratory is supported by Science Foundation Ireland, the Health Research Board, and the Government of Ireland Programme for Research in Third-Level Institutions. The authors acknowledge the excellent support of Andrew Gaffney, technical help of the UCD Conway Institute Transcriptomics Core facility and staff at the UCD Biomedical animal facility, Dionne van der Gizel (University of Utrecht), and Dr. Simon Curran (UCD Diabetes Research Centre).	BADR KF, 1989, P NATL ACAD SCI USA, V86, P3438, DOI 10.1073/pnas.86.9.3438; Baker N, 2009, J IMMUNOL, V182, P3819, DOI 10.4049/jimmunol.0803175; Borgeson E, 2010, THESCIENTIFICWORLDJO, V10, P1370, DOI 10.1100/tsw.2010.120; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Cheng S, 2006, FASEB J, V20, P1898, DOI 10.1096/fj.06-5898fje; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chiang N, 2003, BRIT J PHARMACOL, V139, P89, DOI 10.1038/sj.bjp.0705220; de Vries WB, 2010, PEDIATR RES, V67, P72, DOI 10.1203/PDR.0b013e3181bf570d; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docherty NG, 2009, KIDNEY INT, V75, P205, DOI 10.1038/ki.2008.482; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Duffield JS, 2011, J AM SOC NEPHROL, V22, P199, DOI 10.1681/ASN.2010121301; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Duffy CD, 2010, CHEMMEDCHEM, V5, P517, DOI 10.1002/cmdc.200900533; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Grumbach Y, 2009, AM J PHYSIOL-LUNG C, V296, pL101, DOI 10.1152/ajplung.00018.2008; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Kieran NE, 2003, KIDNEY INT, V64, P480, DOI 10.1046/j.1523-1755.2003.00106.x; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Leonard MO, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015795.74094.91; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma FY, 2009, AM J PHYSIOL-RENAL, V296, pF177, DOI 10.1152/ajprenal.90498.2008; Maderna P, 2005, PROSTAG LEUKOTR ESS, V73, P179, DOI 10.1016/j.plefa.2005.05.004; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Martins V, 2009, J IMMUNOL, V182, P5374, DOI 10.4049/jimmunol.0802259; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy M, 2008, BIOCHEM SOC T, V36, P941, DOI 10.1042/BST0360941; Murphy M, 2008, J AM SOC NEPHROL, V19, P1672, DOI 10.1681/ASN.2007101080; O'Sullivan TP, 2007, J MED CHEM, V50, P5894, DOI 10.1021/jm060270d; Okada H, 2005, CURR MOL MED, V5, P467, DOI 10.2174/1566524054553478; PAPAYIANNI A, 1995, KIDNEY INT, V47, P1295, DOI 10.1038/ki.1995.184; Petasis NA, 2008, BIOORG MED CHEM LETT, V18, P1382, DOI 10.1016/j.bmcl.2008.01.013; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Rodriguez-Pena AB, 2008, KIDNEY INT, V74, P196, DOI 10.1038/ki.2008.160; Rooney B, 2011, FEBS LETT, V585, P531, DOI 10.1016/j.febslet.2011.01.004; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; SERHAN CN, 1995, BIOCHEMISTRY-US, V34, P14609, DOI 10.1021/bi00044a041; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; Sun YP, 2009, PROSTAG LEUKOTR ESS, V81, P357, DOI 10.1016/j.plefa.2009.09.004; Sung SA, 2007, NEPHRON EXP NEPHROL, V105, pE1, DOI 10.1159/000096859; Suzuki Hitoe, 2004, Clin Exp Nephrol, V8, P188; Wada T, 2004, J AM SOC NEPHROL, V15, P940, DOI 10.1097/01.ASN.0000120371.09769.80; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Willoughby DA, 2000, INT J IMMUNOPHARMACO, V22, P1131, DOI 10.1016/S0192-0561(00)00064-3; Wu SH, 2010, AM J NEPHROL, V32, P122, DOI 10.1159/000315121; Xia Z, 2008, AM J NEPHROL, V28, P34, DOI 10.1159/000108759; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yanagita M, 2006, KIDNEY INT, V70, P989, DOI 10.1038/sj.ki.5001731; Yoo KH, 2006, KIDNEY INT, V70, P1735, DOI 10.1038/sj.ki.5000357	63	86	95	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					2967	2979		10.1096/fj.11-185017	http://dx.doi.org/10.1096/fj.11-185017			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21628447				2022-12-25	WOS:000294435200012
J	Wu, H; Teng, PN; Jayaraman, T; Onishi, S; Li, JH; Bannon, L; Huang, HZ; Close, J; Sfeir, C				Wu, Hong; Teng, Pang-Ning; Jayaraman, Thottala; Onishi, Shinsuke; Li, Jinhua; Bannon, Leslie; Huang, Hongzhang; Close, John; Sfeir, Charles			Dentin Matrix Protein 1 (DMP1) Signals via Cell Surface Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; GENE-TRANSCRIPTION; MESENCHYMAL CELLS; STEM-CELLS; KINASE; DIFFERENTIATION; BIOMINERALIZATION; ACTIVATION; PATHWAY; ROLES	Dentin matrix phosphoprotein 1 (DMP1) is a non-collagenous, acidic extracellular matrix protein expressed chiefly in bone and dentin. We examined the DMP1 ability to engage cell-surface receptors and subsequently activate intracellular signaling pathways. Our data indeed show that the presence of extracellular DMP1 triggers focal adhesion point formation in human mesenchymal stem cells and osteoblast-like cells. We determine that DMP1 acts via interaction with alpha v beta 3 integrin and stimulates phosphorylation of focal adhesion kinase. Further biochemical characterization confirms the activation of downstream effectors of the MAPK pathways, namely ERK and JNK, after DMP1 treatment. This activation is specifically inhibitable and can also be blocked by the addition of anti-alpha v beta 3 integrin antibody. Furthermore, we show that extracellular treatment with DMP1 stimulates the translocation of phosphorylated JNK to the nucleus and a concomitant up-regulation of transcriptional activation by phosphorylated c-Jun. The evidence presented here indicates that DMP1 is specifically involved in signaling via extracellular matrix-cell surface interaction. Combined with the published DMP1-null data (Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., Rios, H., Drezner, M. K., Quarles, L. D., Bonewald, L. F., and White, K. E. (2006) Nat. Genet. 38, 1310-1315) it can be hypothesized that DMP1 could be a key effector of ECM-osteocyte signaling.	[Wu, Hong; Huang, Hongzhang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Stomotol, Guangzhou 51025, Guangdong, Peoples R China; [Wu, Hong; Teng, Pang-Ning; Jayaraman, Thottala; Onishi, Shinsuke; Li, Jinhua; Bannon, Leslie; Close, John; Sfeir, Charles] Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA; [Teng, Pang-Ning; Sfeir, Charles] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sfeir, C (corresponding author), 552 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	csfeir@pitt.edu			National Tissue Engineering Center [DAMD17-02-1-0717]; Center for Craniofacial Regeneration at the University of Pittsburgh	National Tissue Engineering Center; Center for Craniofacial Regeneration at the University of Pittsburgh	This work was supported by National Tissue Engineering Center Grant DAMD17-02-1-0717 and the Center for Craniofacial Regeneration at the University of Pittsburgh for supporting this research.	Almushayt A, 2006, GENE THER, V13, P611, DOI 10.1038/sj.gt.3302687; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Caverzasio J, 2007, ENDOCRINOLOGY, V148, P5323, DOI 10.1210/en.2007-0520; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Jayaraman T, 1996, SCIENCE, V272, P1492, DOI 10.1126/science.272.5267.1492; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kulkarni GV, 2000, ARCH ORAL BIOL, V45, P475, DOI 10.1016/S0003-9969(00)00010-8; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nemoto S, 1998, MOL CELL BIOL, V18, P3518, DOI 10.1128/MCB.18.6.3518; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin CL, 2006, J BIOL CHEM, V281, P8034, DOI 10.1074/jbc.M512964200; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Robinson CJM, 2001, CELL SIGNAL, V13, P29, DOI 10.1016/S0898-6568(00)00121-2; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2; Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441	38	41	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29462	29469		10.1074/jbc.M110.194746	http://dx.doi.org/10.1074/jbc.M110.194746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21642437	Green Published, hybrid			2022-12-25	WOS:000294046600003
J	Wang, YH; Wang, YC; Xu, Y; Tong, WY; Pan, TT; Li, JH; Sun, SH; Shao, JJ; Ding, HP; Toyoda, T; Yuan, ZH				Wang, Yaohui; Wang, Yuchan; Xu, Yan; Tong, Wenyan; Pan, TingTing; Li, Jianhua; Sun, Shuhui; Shao, Junjie; Ding, Huanping; Toyoda, Tetsuya; Yuan, Zhenghong			Hepatitis C Virus NS5B Protein Delays S Phase Progression in Human Hepatocyte-derived Cells by Relocalizing Cyclin-dependent Kinase 2-interacting Protein (CINP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; DNA-DAMAGE RESPONSE; RNA-POLYMERASE; HEPATOCELLULAR-CARCINOMA; GENOMIC INSTABILITY; CDC25 PHOSPHATASES; REACTIVE OXYGEN; INTERFERON-BETA; DOWN-REGULATION; BINDING MOTIF	Cell cycle dysregulation is a critical event in virus infection-associated tumorigenesis. Previous studies have suggested that hepatitis C virus NS5B modulates cell cycle progression in addition to participating in RNA synthesis as an RNA-dependent RNA polymerase. However, the molecular mechanisms have thus far remained unclear. In this study, a HepG2 Tet-On NS5B stable cell line was generated to confirm the effect of NS5B on the cell cycle. To better understand the role of NS5B in cell cycle regulation, yeast two-hybrid assays were performed using a human liver cDNA library. The cyclin-dependent kinase 2-interacting protein (CINP) was identified. The interaction between NS5B and CINP was further demonstrated by in vivo and in vitro assays, and their association was found to be indispensable for S phase delay and cell proliferation suppression. Further experiments indicated that NS5B relocalized CINP from the nucleus to the cytoplasm. Directly knocking down CINP by specific siRNA resulted in a significant alteration in the DNA damage response and expression of cell cycle checkpoint proteins, including an increase in p21 and a decrease in phosphorylated Retinoblastoma and Chk1. Similar results were observed in cells expressing NS5B, and the effects were partially reversed upon ectopic overexpression of CINP. These studies suggest that the DNA damage response might be exploited by NS5B to hinder cell cycle progression. Taken together, our data demonstrate that NS5B delays cells in S phase through interaction with CINP and relocalization of the protein from the nucleus to the cytoplasm. Such effects might contribute to hepatitis C virus persistence and pathogenesis.	[Wang, Yaohui; Wang, Yuchan; Xu, Yan; Tong, Wenyan; Pan, TingTing; Li, Jianhua; Sun, Shuhui; Yuan, Zhenghong] Shanghai Med Coll, Key Lab Med Mol Virol, Shanghai 200032, Peoples R China; [Ding, Huanping; Yuan, Zhenghong] Fudan Univ, Inst Med Microbiol, Shanghai 200032, Peoples R China; [Ding, Huanping; Yuan, Zhenghong] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Yuan, Zhenghong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Res Unit, Shanghai 201508, Peoples R China; [Shao, Junjie] Shanghai Ctr Dis Prevent & Control, Shanghai 200332, Peoples R China; [Toyoda, Tetsuya] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Unit Viral Genome Regulat, Shanghai 200025, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Yuan, ZH (corresponding author), Shanghai Med Coll, Key Lab Med Mol Virol, POB 228,138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	zhyuan@shmu.edu.cn	Wang, Yaohui/ABD-4904-2021	Wang, Yaohui/0000-0003-0165-6573	National Megaprojects [2008ZX10203]; Program for Outstanding Medical Academic Leader of Shanghai	National Megaprojects; Program for Outstanding Medical Academic Leader of Shanghai	This work was supported in part by National Megaprojects for Infectious Diseases Grant 2008ZX10203 and the Program for Outstanding Medical Academic Leader of Shanghai.	Aressy B, 2008, ANTI-CANCER AGENT ME, V8, P818, DOI 10.2174/187152008786847756; Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Ariumi Y, 2008, J VIROL, V82, P9639, DOI 10.1128/JVI.00351-08; Baek KH, 2006, J MOL BIOL, V359, P22, DOI 10.1016/j.jmb.2006.03.020; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Bowen DG, 2005, J HEPATOL, V42, P408, DOI 10.1016/j.jhep.2004.12.013; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chisari FV, 2005, NATURE, V436, P930, DOI 10.1038/nature04076; Choi BH, 2001, DNA CELL BIOL, V20, P75, DOI 10.1089/104454901750070274; Deore RR, 2010, CURR MED CHEM, V17, P3806; Einav S, 2008, HEPATOLOGY, V47, P827, DOI 10.1002/hep.22108; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Grishina I, 2005, CELL CYCLE, V4, P1120; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Hirano M, 2003, J BIOL CHEM, V278, P5109, DOI 10.1074/jbc.M207629200; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hu BC, 2001, J BIOL CHEM, V276, P17693, DOI 10.1074/jbc.M009340200; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jakobs A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm617; Jirmanova L, 2005, CELL CYCLE, V4, P1428, DOI 10.4161/cc.4.10.2055; Kerkvliet J, 2011, J VIROL, V85, P621, DOI 10.1128/JVI.01626-10; Kitay-Cohen Y, 2000, BLOOD, V96, P2910; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Machida K, 2004, J VIROL, V78, P8835, DOI 10.1128/JVI.78.16.8835-8843.2004; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; Machida K, 2010, HEPATOLOGY, V52, P480, DOI 10.1002/hep.23697; McGivern DR, 2009, J VIROL, V83, P7422, DOI 10.1128/JVI.00262-09; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Naka K, 2006, VIROLOGY, V346, P348, DOI 10.1016/j.virol.2005.10.023; Naruyama H, 2008, BIOCHEM BIOPH RES CO, V374, P79, DOI 10.1016/j.bbrc.2008.06.112; Ohkawa K, 2004, J BIOL CHEM, V279, P11719, DOI 10.1074/jbc.M308560200; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Radkov SA, 2000, NAT MED, V6, P1121, DOI 10.1038/80459; SAKAMURO D, 1995, J VIROL, V69, P3893, DOI 10.1128/JVI.69.6.3893-3896.1995; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shimakami T, 2006, J VIROL, V80, P3332, DOI 10.1128/JVI.80.7.3332-3340.2006; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Siavoshian S, 2004, ARCH VIROL, V149, P323, DOI 10.1007/s00705-003-0205-7; Srinivasan SV, 2007, J BIOL CHEM, V282, P23867, DOI 10.1074/jbc.M700542200; van Harn T, 2010, GENE DEV, V24, P1377, DOI 10.1101/gad.580710; Vannucchi S, 2000, ONCOGENE, V19, P5041, DOI 10.1038/sj.onc.1203883; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; von dem Bussche A, 2010, J HEPATOL, V53, P797, DOI 10.1016/j.jhep.2010.05.022; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Weng LY, 2009, ARCH VIROL, V154, P765, DOI 10.1007/s00705-009-0366-0; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhu YH, 2004, MOL CELL BIOL, V24, P6268, DOI 10.1128/MCB.24.14.6268-6277.2004; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	74	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26603	26615		10.1074/jbc.M111.225672	http://dx.doi.org/10.1074/jbc.M111.225672			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628470	Green Published, hybrid			2022-12-25	WOS:000293078200039
J	Matsushita, H; Endo, S; Kobayashi, E; Sakamoto, Y; Kobayashi, K; Kitaguchi, K; Kuroki, K; Soderhall, A; Maenaka, K; Nakamura, A; Strittmatter, SM; Takai, T				Matsushita, Haruka; Endo, Shota; Kobayashi, Eiji; Sakamoto, Yuzuru; Kobayashi, Keisuke; Kitaguchi, Kohji; Kuroki, Kimiko; Soderhall, Arvid; Maenaka, Katsumi; Nakamura, Akira; Strittmatter, Stephen M.; Takai, Toshiyuki			Differential but Competitive Binding of Nogo Protein and Class I Major Histocompatibility Complex (MHCI) to the PIR-B Ectodomain Provides an Inhibition of Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; MYELIN-ASSOCIATED GLYCOPROTEIN; OCULAR-DOMINANCE PLASTICITY; NEURITE OUTGROWTH; AXONAL REGENERATION; MICE; RECOGNITION; SHP-1; IDENTIFICATION; ASSOCIATION	Binding of class I MHC molecules (MHCI) to an inhibitory receptor, PIR-B, expressed on B cells and myeloid cells provides constitutive cellular inhibition, thus ensuring peripheral tolerance. Recent unexpected findings pointed to a novel inhibitory role of PIR-B in neuritere generation through binding to three axonal outgrowth inhibitors of myelin, including Nogo. Thus, it becomes interesting to determine whether the actions of the inhibitory myelin proteins and MHCI could coexist independently or be mutually exclusive as to the PIR-B-mediated immune and neural cell inhibition. Here, we present data supporting the competition of Nogo-and MHCI-mediated inhibition where they coexist. Kinetic analyses of Nogo and MHCI binding to the whole or a part of the recombinant PIR-B ectodomain revealed that PIR-B binds with higher affinity to Nogo than MHCI and that the MHCI binding only occurred with the N-terminal domains of PIR-B, whereas Nogo binding occurred with either the N- or C-terminal ectodomains. Importantly, kinetic tests indicated that the binding to PIR-B of Nogo and MHCI was competitive. Both endogenous and exogenous Nogo intensified the PIR-B-mediated suppression of interleukin-6 release from lipopolysaccharide-stimulated wildtype, but not PIR-B-deficient, cultured mast cells, indicating that PIR-B mediates Nogo-induced inhibition. Thus, we propose a novel mechanism by which PIR-B-mediated regulation is achieved differentially but competitively via MHCI and Nogo in cells of the immune system.	[Matsushita, Haruka; Endo, Shota; Kobayashi, Eiji; Sakamoto, Yuzuru; Kobayashi, Keisuke; Kitaguchi, Kohji; Nakamura, Akira; Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Sakamoto, Yuzuru] Tohoku Inst Technol, Ctr Gen Educ, Div Human Sci, Sendai, Miyagi 9828577, Japan; [Kuroki, Kimiko; Maenaka, Katsumi] Kyushu Univ, Div Struct Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Soderhall, Arvid] Sidec Technol AB, SE-16440 Stockholm, Sweden; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06536 USA	Tohoku University; Tohoku Institute Technology; Kyushu University; Yale University	Takai, T (corresponding author), Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	tostakai@idac.tohoku.ac.jp	Kuroki, Kimiko/F-6906-2012; Sakamoto, Yuzuru/L-7690-2019; Strittmatter, Stephen/F-5739-2011	Sakamoto, Yuzuru/0000-0002-4863-3179; Strittmatter, Stephen/0000-0001-8188-3092; Kobayashi, Eiji/0000-0002-7303-2797	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; 21st Century Center of Excellence (COE); Grants-in-Aid for Scientific Research [22659057, 22121007] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042304, R37NS033020] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Agency, a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the 21st Century Center of Excellence (COE) Program "Center for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases" and Global COE Program "Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine".	Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Allen RL, 2001, J IMMUNOL, V167, P5543, DOI 10.4049/jimmunol.167.10.5543; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Endo S, 2008, P NATL ACAD SCI USA, V105, P14515, DOI 10.1073/pnas.0804571105; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; Kanehira M, 2006, J BIOCHEM, V140, P211, DOI 10.1093/jb/mvj140; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kubagawa H, 1999, J EXP MED, V189, P309, DOI 10.1084/jem.189.2.309; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Maeda A, 1998, J EXP MED, V188, P991, DOI 10.1084/jem.188.5.991; Masuda A, 2007, J EXP MED, V204, P907, DOI 10.1084/jem.20060631; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Taylor LS, 1999, BLOOD, V94, P1790, DOI 10.1182/blood.V94.5.1790.417k16_1790_1796; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867	34	32	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25739	25747		10.1074/jbc.M110.157859	http://dx.doi.org/10.1074/jbc.M110.157859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636572	Green Published, hybrid			2022-12-25	WOS:000293073000035
J	Brilli, F; Ruuskanen, TM; Schnitzhofer, R; Muller, M; Breitenlechner, M; Bittner, V; Wohlfahrt, G; Loreto, F; Hansel, A				Brilli, Federico; Ruuskanen, Taina M.; Schnitzhofer, Ralf; Mueller, Markus; Breitenlechner, Martin; Bittner, Vinzenz; Wohlfahrt, Georg; Loreto, Francesco; Hansel, Armin			Detection of Plant Volatiles after Leaf Wounding and Darkening by Proton Transfer Reaction "Time-of-Flight" Mass Spectrometry (PTR-TOF)	PLOS ONE			English	Article							DIFFERENT ENVIRONMENTAL-CONDITIONS; ORGANIC-COMPOUND EMISSIONS; DIMETHYLALLYL DIPHOSPHATE; LIPOXYGENASE PATHWAY; ISOPRENE EMISSION; GREEN LEAVES; SIGNALS; MAIZE; INDUCTION; PRODUCTS	Proton transfer reaction-time of flight (PTR-TOF) mass spectrometry was used to improve detection of biogenic volatiles organic compounds (BVOCs) induced by leaf wounding and darkening. PTR-TOF measurements unambiguously captured the kinetic of the large emissions of green leaf volatiles (GLVs) and acetaldehyde after wounding and darkening. GLVs emission correlated with the extent of wounding, thus confirming to be an excellent indicator of mechanical damage. Transient emissions of methanol, C5 compounds and isoprene from plant species that do not emit isoprene constitutively were also detected after wounding. In the strong isoprene-emitter Populus alba, light-dependent isoprene emission was sustained and even enhanced for hours after photosynthesis inhibition due to leaf cutting. Thus isoprene emission can uncouple from photosynthesis and may occur even after cutting leaves or branches, e. g., by agricultural practices or because of abiotic and biotic stresses. This observation may have important implications for assessments of isoprene sources and budget in the atmosphere, and consequences for tropospheric chemistry.	[Brilli, Federico; Schnitzhofer, Ralf; Mueller, Markus] Ionicon Analyt GmbH, Innsbruck, Austria; [Ruuskanen, Taina M.; Schnitzhofer, Ralf; Breitenlechner, Martin; Bittner, Vinzenz; Hansel, Armin] Univ Innsbruck, Inst Ion Phys & Appl Phys, A-6020 Innsbruck, Austria; [Wohlfahrt, Georg] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Loreto, Francesco] CNR, IPP, Florence, Italy; [Ruuskanen, Taina M.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Mueller, Markus] Inst Rech Catalyse & Environm Lyon IRCELYON, CNRS, Villeurbanne, France	University of Innsbruck; University of Innsbruck; Consiglio Nazionale delle Ricerche (CNR); University of Helsinki; Centre National de la Recherche Scientifique (CNRS)	Brilli, F (corresponding author), Ionicon Analyt GmbH, Innsbruck, Austria.	armin.hansel@uibk.ac.at	Brilli, Federico/O-6475-2015; Mueller, Markus/L-1699-2014; Wohlfahrt, Georg/D-2409-2009; Breitenlechner, Martin/AAA-3402-2021; Loreto, Francesco/B-7477-2015; Hansel, Armin/F-3915-2010	Brilli, Federico/0000-0002-2563-6086; Mueller, Markus/0000-0003-4110-8950; Wohlfahrt, Georg/0000-0003-3080-6702; Loreto, Francesco/0000-0002-9171-2681; Hansel, Armin/0000-0002-1062-2394; Breitenlechner, Martin/0000-0002-2382-6660	Austrian National Science Fund [L518-N20]; company Ionicon Analytik; European Commission [218065]; Austrian Science Fund (FWF) [L 518, P 23267] Funding Source: researchfish	Austrian National Science Fund(Austrian Science Fund (FWF)); company Ionicon Analytik; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian National Science Fund by the Translational Research-Programme (L518-N20) and partly by the company Ionicon Analytik as one of the partners involved in the Marie Curie Industry-Academia Partnership and Pathways (IAPP) project 218065 "PTR-TOF" funded by the European Commission within the Seventh Framework Programme (FP7 - People). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Beauchamp J, 2005, PLANT CELL ENVIRON, V28, P1334, DOI 10.1111/j.1365-3040.2005.01383.x; Behnke K, 2009, TREE PHYSIOL, V29, P725, DOI 10.1093/treephys/tpp009; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Capitani D, 2009, PLANT PHYSIOL, V149, P1638, DOI 10.1104/pp.108.128884; Charron CS, 1996, J AM SOC HORTIC SCI, V121, P483, DOI 10.21273/JASHS.121.3.483; CROFT KPC, 1993, PLANT PHYSIOL, V101, P13, DOI 10.1104/pp.101.1.13; De Gouw JA, 2000, ENVIRON SCI TECHNOL, V34, P2640, DOI 10.1021/es991219k; DIEUAIDE M, 1992, PLANT PHYSIOL, V99, P595, DOI 10.1104/pp.99.2.595; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Fall R, 2001, ATMOS ENVIRON, V35, P3905, DOI 10.1016/S1352-2310(01)00141-8; Fall R, 1999, J GEOPHYS RES-ATMOS, V104, P15963, DOI 10.1029/1999JD900144; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; Farag MA, 2002, PHYTOCHEMISTRY, V61, P545, DOI 10.1016/S0031-9422(02)00240-6; Farmer EE, 2001, NATURE, V411, P854, DOI 10.1038/35081189; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fisher AJ, 2003, PHYTOCHEMISTRY, V62, P159, DOI 10.1016/S0031-9422(02)00521-6; Graus M, 2004, PLANT PHYSIOL, V135, P1967, DOI 10.1104/pp.104.043240; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; Guenther A., 2006, ATMOS CHEM PHYS, V6, P3181, DOI [10.5194/acp-6-3181-2006, DOI 10.5194/ACP-6-3181-2006, DOI 10.5194/ACPD-6-107-2006]; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; HATANAKA A, 1987, CHEM PHYS LIPIDS, V44, P341, DOI 10.1016/0009-3084(87)90057-0; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; Heiden AC, 2003, J ATMOS CHEM, V45, P143, DOI 10.1023/A:1024069605420; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Higgins R, 2007, PLANTA, V225, P1535, DOI 10.1007/s00425-006-0440-8; Holzinger R, 2000, J GEOPHYS RES-ATMOS, V105, P20573, DOI 10.1029/2000JD900296; Jardine K, 2009, PLANT BIOLOGY, V11, P591, DOI 10.1111/j.1438-8677.2008.00155.x; Jia WS, 2007, PLANT PHYSIOL, V143, P68, DOI 10.1104/pp.106.089110; Karl T, 2002, PLANT CELL ENVIRON, V25, P1121, DOI 10.1046/j.1365-3040.2002.00889.x; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; LORETO F, 1993, PLANTA, V189, P420, DOI 10.1007/BF00194440; Loreto F, 2006, PLANT CELL ENVIRON, V29, P1820, DOI 10.1111/j.1365-3040.2006.01561.x; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Milburn J. A., 1979, WATER FLOW IN PLANTS; Muller M, 2010, ATMOS MEAS TECH, V3, P387, DOI 10.5194/amt-3-387-2010; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Nogues I, 2006, PLANT PHYSIOL, V141, P721, DOI 10.1104/pp.105.073213; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Sharkey TD, 1996, TRENDS PLANT SCI, V1, P78, DOI 10.1016/S1360-1385(96)80038-0; SILVER GM, 1991, PLANT PHYSIOL, V97, P1588, DOI 10.1104/pp.97.4.1588; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9	56	132	134	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20419	10.1371/journal.pone.0020419	http://dx.doi.org/10.1371/journal.pone.0020419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637822	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200062
J	Cooper, TF; Lai, M; Ulstrup, KE; Saunders, SM; Flematti, GR; Radford, B; van Oppen, MJH				Cooper, Timothy F.; Lai, Michael; Ulstrup, Karin E.; Saunders, Sandra M.; Flematti, Gavin R.; Radford, Ben; van Oppen, Madeleine J. H.			Symbiodinium Genotypic and Environmental Controls on Lipids in Reef Building Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; STYLOPHORA-PISTILLATA; ALGAL ENDOSYMBIONTS; LIGHT REGIMES; ZOOXANTHELLAE; GROWTH; PHOTOBIOLOGY; FLEXIBILITY; IRRADIANCE; DIVERSITY	Background: Lipids in reef building corals can be divided into two classes; non-polar storage lipids, e. g. wax esters and triglycerides, and polar structural lipids, e. g. phospholipids and cholesterol. Differences among algal endosymbiont types are known to have important influences on processes including growth and the photobiology of scleractinian corals yet very little is known about the role of symbiont types on lipid energy reserves. Methodology/Principal Findings: The ratio of storage lipid and structural lipid fractions of Scott Reef corals were determined by thin layer chromatography. The lipid fraction ratio varied with depth and depended on symbiont type harboured by two corals (Seriatopora hystrix and Pachyseris speciosa). S. hystrix colonies associated with Symbiodinium C1 or C1/C# at deep depths (<23 m) had lower lipid fraction ratios (i.e. approximately equal parts of storage and structural lipids) than those with Symbiodinium D1 in shallow depths (<23 m), which had higher lipid fraction ratios (i.e. approximately double amounts of storage relative to structural lipid). Further, there was a non-linear relationship between the lipid fraction ratio and depth for S. hystrix with a modal peak at similar to 23 m coinciding with the same depth as the shift from clade D to C types. In contrast, the proportional relationship between the lipid fraction ratio and depth for P. speciosa, which exhibited high specificity for Symbiodinium C3 like across the depth gradient, was indicative of greater amounts of storage lipids contained in the deep colonies. Conclusions/Significance: This study has demonstrated that Symbiodinium exert significant controls over the quality of coral energy reserves over a large-scale depth gradient. We conclude that the competitive advantages and metabolic costs that arise from flexible associations with divergent symbiont types are offset by energetic trade-offs for the coral host.	[Cooper, Timothy F.; Radford, Ben] UWA Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia; [Lai, Michael; Saunders, Sandra M.; Flematti, Gavin R.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA, Australia; [Ulstrup, Karin E.] DHI Water & Environm, Perth, WA, Australia; [van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; University of Western Australia; Australian Institute of Marine Science	Cooper, TF (corresponding author), UWA Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia.	t.cooper@aims.gov.au	van Oppen, Madeleine JH/C-3261-2008; Cooper, Timothy/B-8168-2008; Flematti, Gavin R/J-2018-2012	Flematti, Gavin/0000-0003-2545-6939; van Oppen, Madeleine/0000-0003-4607-0744	Woodside Energy Ltd	Woodside Energy Ltd	This study was funded by Woodside Energy Ltd (as operator of the Browse LNG Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; Anthony KRN, 2000, CORAL REEFS, V19, P59, DOI 10.1007/s003380050227; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; BRINKMAN R, 2009, SRRPRPRT025 AIMS; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Frade PR, 2008, MOL ECOL, V17, P691, DOI 10.1111/j.1365-294X.2007.03612.x; HARLAND AD, 1992, MAR BIOL, V112, P253, DOI 10.1007/BF00702469; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2010, J EXP MAR BIOL ECOL, V391, P143, DOI 10.1016/j.jembe.2010.06.019; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Leathwick JR, 2005, FRESHWATER BIOL, V50, P2034, DOI 10.1111/j.1365-2427.2005.01448.x; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; Muscatine L, 1980, PRIMARY PRODUCTIVITY, P381; Oku H, 2003, CORAL REEFS, V22, P83, DOI 10.1007/s00338-003-0279-4; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; PORTER JW, 1974, ZOOPLANKTON FEEDING; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Saunders SM, 2005, ENVIRON CHEM, V2, P331, DOI 10.1071/EN05043; TOMASCIK T, 1985, MAR BIOL, V87, P143, DOI 10.1007/BF00539422; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P2617, DOI 10.1098/rspb.2001.2007; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Zhu M, 2005, ECOL MODEL, V187, P524, DOI 10.1016/j.ecolmodel.2005.01.049	45	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20434	10.1371/journal.pone.0020434	http://dx.doi.org/10.1371/journal.pone.0020434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637826	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200065
J	Zong, ZY; Peng, CH; Lu, XJ				Zong, Zhiyong; Peng, Chunhong; Lue, Xiaoju			Diversity of SCCmec Elements in Methicillin-Resistant Coagulase-Negative Staphylococci Clinical Isolates	PLOS ONE			English	Article							CASSETTE-CHROMOSOME-MEC; GENETIC DIVERSITY; AUREUS; EPIDERMIDIS; SAPROPHYTICUS; STRAINS; PSEUDINTERMEDIUS; IDENTIFICATION; HAEMOLYTICUS; INFECTIONS	Background: Methicillin-resistant coagulase-negative staphylococci (MR-CoNS) are opportunistic pathogens and serve as a large reservoir of staphylococcal cassette chromosome mec (SCCmec). Characterization of SCCmec in MR-CoNS can generate useful information on the mobilization and evolution of this element. Methodology/Principal Findings: Non-repetitive MR-CoNS clinical isolates (n=84; 39 S. epidermidis, 19 S. haemolyticus, 9 S. hominis, 6 S. capitis, 4 S. warneri, 2 S. cohnii, 2 S. saprophyticus, 1 S. kloosii, 1 S. simulans and 1 S. massiliensis) were collected. All isolates could grow on plates with 4 mg/L cefoxitin and all had mecA as detected by PCR. Strain typing using RAPD and ERIC-PCR revealed that almost all isolates were of different strains. SCCmec typing was performed using multiplex PCR published previously. For isolates in which SCCmec could not be typed, the mec complex classes were determined by additional PCR and the ccr genes were amplified with published or newly-designed primers and then sequenced. SCCmec types were assigned for 63 isolates by multiplex PCR and were assigned for 14 other isolates by PCR targeting mec and ccr. Among 77 isolates with determined SCCmec types, 54 had a single type, including type III (n = 19), IV (n = 14), V (n = 10), II (n = 2), I (n = 1), VIII (n = 1) and five unnamed types (n = 7), while 23 isolates had two types, III+V (n = 12), II+V (n = 8), II+IV (n = 2) or IV+V (n = 1). The five unnamed types were assigned UT1 (class A mec, ccrA1/ccrB4), UT2 (class C1 mec, ccrA4/ccrB4), UT3 (class A mec, ccrA5/ccrB3), UT4 (class C2 mec, ccrA2/ccrB2 plus ccrC1) and UT5 (class A mec, ccrA1/ccrB1 plus ccrC1). Conclusions/Significance: SCCmec types III, IV and V were prevalent in MR-CoNS and many isolates could harbor more than one type. Several new types of SCCmec were identified, highlighting the great genetic diversity and the need of developing classification schemes for SCCmec in MR-CoNS.	[Zong, Zhiyong; Lue, Xiaoju] Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China; [Peng, Chunhong] Sichuan Univ, W China Hosp, Dept Resp Med, Chengdu 610064, Peoples R China; [Zong, Zhiyong] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Peoples R China; [Peng, Chunhong] Peoples Hosp Guizhou Prov, Dept Emergence, Guiyang, Peoples R China	Sichuan University; Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China.	zongzhiy@scu.edu.cn	Zong, Zhiyong/C-6142-2013	ZONG, ZHIYONG/0000-0002-7675-260X	National Natural Science Foundation of China [30900052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by a grant from the National Natural Science Foundation of China (project no. 30900052). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Masalma M, 2010, INT J SYST EVOL MICR, V60, P1066, DOI 10.1099/ijs.0.006486-0; BARBIER F, 2010, J ANTIMICROB CHEMOTH; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Casey AL, 2006, J INFECTION, V52, P282, DOI 10.1016/j.jinf.2005.06.005; Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Ender M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-62; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; Hanssen AM, 2007, ANTIMICROB AGENTS CH, V51, P1671, DOI 10.1128/AAC.00978-06; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Higashide M, 2008, ANTIMICROB AGENTS CH, V52, P2061, DOI 10.1128/AAC.01150-07; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Ibrahem S, 2008, CLIN MICROBIOL INFEC, V14, P1020, DOI 10.1111/j.1469-0691.2008.02080.x; Ibrahem S, 2009, J CLIN MICROBIOL, V47, P32, DOI 10.1128/JCM.01085-08; Ishihara K, 2010, APPL ENVIRON MICROB, V76, P5165, DOI 10.1128/AEM.02780-09; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Soderquist B, 2009, CLIN MICROBIOL INFEC, V15, P1176, DOI 10.1111/j.1469-0691.2009.02771.x; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang Y, 2009, J APPL MICROBIOL, V107, P1375, DOI 10.1111/j.1365-2672.2009.04322.x; Zong ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014016	34	90	94	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20191	10.1371/journal.pone.0020191	http://dx.doi.org/10.1371/journal.pone.0020191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637845	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200037
J	Chen, JM; Sun, YX				Chen, Jiming; Sun, Yingxue			Variation in the Analysis of Positively Selected Sites Using Nonsynonymous/Synonymous Rate Ratios: An Example Using Influenza Virus	PLOS ONE			English	Article							AMINO-ACID SITES; MOLECULAR EVOLUTION; HEMAGGLUTININ; MODELS; TRENDS; GENE	Sites in a gene showing the nonsynonymous/synonymous rate ratio (omega) >1 have been frequently identified to be under positive selection. To examine the performance of such analysis, sites of the omega ratio >1 in the HA1 gene of H3N2 subtype human influenza viruses were identified from seven overlapping sequence data sets in this study. Our results showed that the sites of the omega ratio >1 were of significant variation among the data sets even though they targeted similar clusters, indicating that the analysis is likely to be either of low sensitivity or of low specificity in identifying sites under positive selection. Most (43/45) of the sites showing omega >1 calculated from at least one data set are involved in B-cell epitopes which cover less than a half sites in the protein, suggesting that the analysis is likely to be of low sensitivity rather than of low specificity. It was further found that the analysis sensitivity could not be enhanced by including more sequences or covering longer time intervals. Previously some reports also likely identified only a portion of the sites under positive selection in the viral gene using the omega ratio. Low sensitivity of the analysis may result from that some sites under positive selection in the gene are also under negative (purifying) selection simultaneously for functional constrains, and so their omega ratios could be <1. Theoretically, the sites under the two opposite selection forces at the same time favor only certain nonsynonymous changes, e.g. those changing the antigenicity of the gene and maintaining the gene function. This study also suggested that sometimes we can identify more sites under positive selection using the omega ratio by integrating the positively selected sites estimated from multiple data sets.	[Chen, Jiming; Sun, Yingxue] China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China	China Animal Health & Epidemiology Center	Chen, JM (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Ji-Ming/AHD-7398-2022; Chen, Jiming/AAA-3575-2020	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Ministry of Agriculture of P. R. China	Ministry of Agriculture of P. R. China	This work was supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture of P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Crandall KA, 1999, MOL BIOL EVOL, V16, P372, DOI 10.1093/oxfordjournals.molbev.a026118; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Hao DC, 2010, J PLANT RES, V123, P241, DOI 10.1007/s10265-009-0261-5; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li W. H, 1997, MOL EVOLUTION; Nielsen R, 1998, GENETICS, V148, P929; Perry GH, 2006, MOL BIOL EVOL, V23, P644, DOI 10.1093/molbev/msj072; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2006, MOL BIOL EVOL, V23, P1902, DOI 10.1093/molbev/msl050; Van der Merwe MM, 2009, P ROY SOC B-BIOL SCI, V276, P2913, DOI 10.1098/rspb.2009.0328; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wolf JBW, 2009, GENOME BIOL EVOL, V1, P308, DOI 10.1093/gbe/evp030; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, J MOL EVOL, V51, P423, DOI 10.1007/s002390010105; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077	31	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19996	10.1371/journal.pone.0019996	http://dx.doi.org/10.1371/journal.pone.0019996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629696	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005800021
J	Robinson, EJH; Franks, NR; Ellis, S; Okuda, S; Marshall, JAR				Robinson, Elva J. H.; Franks, Nigel R.; Ellis, Samuel; Okuda, Saki; Marshall, James A. R.			A Simple Threshold Rule Is Sufficient to Explain Sophisticated Collective Decision-Making	PLOS ONE			English	Article							NEST-SITE SELECTION; DIVISION-OF-LABOR; COLONIES CHOOSE; ANT COLONIES; MATE CHOICE; HONEY-BEES; EXPERIENCE; ORGANIZATION; EVOLUTION; SWARMS	Decision-making animals can use slow-but-accurate strategies, such as making multiple comparisons, or opt for simpler, faster strategies to find a 'good enough' option. Social animals make collective decisions about many group behaviours including foraging and migration. The key to the collective choice lies with individual behaviour. We present a case study of a collective decision-making process (house-hunting ants, Temnothorax albipennis), in which a previously proposed decision strategy involved both quality-dependent hesitancy and direct comparisons of nests by scouts. An alternative possible decision strategy is that scouting ants use a very simple quality-dependent threshold rule to decide whether to recruit nest-mates to a new site or search for alternatives. We use analytical and simulation modelling to demonstrate that this simple rule is sufficient to explain empirical patterns from three studies of collective decision-making in ants, and can account parsimoniously for apparent comparison by individuals and apparent hesitancy (recruitment latency) effects, when available nests differ strongly in quality. This highlights the need to carefully design experiments to detect individual comparison. We present empirical data strongly suggesting that best-of-n comparison is not used by individual ants, although individual sequential comparisons are not ruled out. However, by using a simple threshold rule, decision-making groups are able to effectively compare options, without relying on any form of direct comparison of alternatives by individuals. This parsimonious mechanism could promote collective rationality in group decision-making.	[Robinson, Elva J. H.; Franks, Nigel R.; Ellis, Samuel; Okuda, Saki] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Robinson, Elva J. H.] Univ York, Dept Biol, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Marshall, James A. R.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England	University of Bristol; University of York - UK; University of Sheffield; University of Sheffield	Robinson, EJH (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Elva.Robinson@yccsa.org	Franks, Nigel/AAG-8207-2019; Robinson, Elva J H/AAC-9785-2019; Ellis, Sam/AGH-4882-2022	Franks, Nigel/0000-0001-8139-9604; Ellis, Samuel/0000-0001-9019-6040; Robinson, Elva/0000-0003-4914-9327; Marshall, James/0000-0002-1506-167X	EPSRC [EP/D076226/1]; Nuffield; University of Bristol; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02166X/2, BB/G02166X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D076226/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Nuffield; University of Bristol; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EJHR and NRF acknowledge support from EPSRC grant EP/D076226/1 http://www.epsrc.ac.uk/Pages/default.aspx. SO was supported by a Nuffield Undergraduate Bursary http://users.ecs.soton.ac.uk/saw/nuffield.html; SE was supported by a University of Bristol Summer Studentship http://www.bristol.ac.uk/biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; BURNS JG, 2007, ANIM BEHAV, V70, pE1; CALDERONE NW, 1989, EXPERIENTIA, V45, P765, DOI 10.1007/BF01974583; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; de Biseau J.C., 1992, Psyche (Cambridge), V98, P323, DOI 10.1155/1991/38402; Dhar R, 1997, J CONSUM RES, V24, P215, DOI 10.1086/209506; DOWDS BM, 1983, BEHAVIOUR, V85, P1, DOI 10.1163/156853983X00011; Doyle JR, 1999, PSYCHOL MARKET, V16, P225, DOI 10.1002/(SICI)1520-6793(199905)16:3<225::AID-MAR3>3.0.CO;2-X; Edwards SC, 2009, P ROY SOC B-BIOL SCI, V276, P3655, DOI 10.1098/rspb.2009.0981; FEWELL JH, 1992, OECOLOGIA, V92, P542, DOI 10.1007/BF00317846; Franks NR, 2006, ANIM BEHAV, V72, P611, DOI 10.1016/j.anbehav.2005.11.019; Franks NR, 2008, ANIM BEHAV, V76, P323, DOI 10.1016/j.anbehav.2008.02.009; Franks NR, 2006, P ROY SOC B-BIOL SCI, V273, P165, DOI 10.1098/rspb.2005.3312; Franks NR, 2003, ANIM BEHAV, V65, P215, DOI 10.1006/anbe.2002.2032; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; FREEMAN PR, 1983, INT STAT REV, V51, P189, DOI 10.2307/1402748; Healey CIM, 2008, ANIM BEHAV, V76, P893, DOI 10.1016/j.anbehav.2008.02.016; Hutchinson JMC, 2005, BIOL REV, V80, P73, DOI 10.1017/S1464793104006554; Kacelnik A, 2011, BEHAV ECOL SOCIOBIOL, V65, P547, DOI 10.1007/s00265-010-1101-2; Kay LM, 2006, NEURON, V51, P277, DOI 10.1016/j.neuron.2006.07.015; Langen Tom A., 1999, Animal Cognition, V2, P223, DOI 10.1007/s100710050043; Leuteritz T., 2008, IUCN RED LIST THREAT; Levin S, 2010, PHILOS T R SOC B, V365, P13, DOI 10.1098/rstb.2009.0197; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; Mabry KE, 2008, AM NAT, V172, P625, DOI 10.1086/591682; Mallon EB, 2000, P ROY SOC B-BIOL SCI, V267, P765, DOI 10.1098/rspb.2000.1069; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; Marshall JAR, 2009, CURR BIOL, V19, pR395, DOI 10.1016/j.cub.2009.03.011; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; MOORE AJ, 1988, EVOLUTION, V42, P387, DOI [10.2307/2409241, 10.1111/j.1558-5646.1988.tb04141.x]; *NAT CTR FOR THE R, 2010, RESP US AN BIOSC RES; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Papoulis A., 2001, PROBABILITY RANDOM V, V4th ed.; Passino KM, 2006, BEHAV ECOL SOCIOBIOL, V59, P427, DOI 10.1007/s00265-005-0067-y; Planque R, 2007, BEHAV ECOL SOCIOBIOL, V61, P347, DOI 10.1007/s00265-006-0263-4; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P4373, DOI 10.1098/rspb.2009.1244; Robinson EJH, 2009, P ROY SOC B-BIOL SCI, V276, P2635, DOI 10.1098/rspb.2009.0350; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; SASAKI T, 2011, BEHAV ECOL IN PRESS; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Seeley TD, 1999, BEHAV ECOL SOCIOBIOL, V45, P19, DOI 10.1007/s002650050536; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Seeley TD, 2001, BEHAV ECOL SOCIOBIOL, V49, P416, DOI 10.1007/s002650000299; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V30, P59, DOI 10.1007/BF00168595; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Seeley TD, 2008, J EXP BIOL, V211, P3691, DOI 10.1242/jeb.021071; SHAFIR S, 1994, ANIM BEHAV, V48, P55, DOI 10.1006/anbe.1994.1211; Stroeymeyt N, 2011, BEHAV ECOL, V22, P535, DOI 10.1093/beheco/arr007; SVENSSON BG, 1989, J INSECT BEHAV, V2, P387, DOI 10.1007/BF01068063; The ABC Research Group, 1999, SIMPLE HEURISTICS MA, P287, DOI DOI 10.1111/.1745-9125.2010.00223.X; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Visscher PK, 1999, NATURE, V397, P400, DOI 10.1038/17047; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0	74	54	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19981	10.1371/journal.pone.0019981	http://dx.doi.org/10.1371/journal.pone.0019981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629645	Green Published, gold, Green Accepted			2022-12-25	WOS:000291005800020
J	Chew, KCM; Matsuda, N; Saisho, K; Lim, GGY; Chai, C; Tan, HM; Tanaka, K; Lim, KL				Chew, Katherine C. M.; Matsuda, Noriyuki; Saisho, Keiko; Lim, Grace G. Y.; Chai, Chou; Tan, Hui-Mei; Tanaka, Keiji; Lim, Kah-Leong			Parkin Mediates Apparent E2-Independent Monoubiquitination In Vitro and Contains an Intrinsic Activity That Catalyzes Polyubiquitination	PLOS ONE			English	Article							UBIQUITIN-PROTEIN LIGASE; CARRIER PROTEIN; CHAIN SYNTHESIS; DISEASE; PINK1; PHOSPHORYLATION; MITOCHONDRIA; MUTATIONS; DEGRADATION; ACTIVATION	Background: Mutations in the parkin gene, which encodes a ubiquitin ligase (E3), are a major cause of autosomal recessive parkinsonism. Although parkin-mediated ubiquitination was initially linked to protein degradation, accumulating evidence suggests that the enzyme is capable of catalyzing multiple forms of ubiquitin modifications including monoubiquitination, K48- and K63-linked polyubiquitination. In this study, we sought to understand how a single enzyme could exhibit such multifunctional catalytic properties. Methods and Findings: By means of in vitro ubiquitination assays coupled with mass spectrometry analysis, we were surprised to find that parkin is apparently capable of mediating E2-independent protein ubiquitination in vitro, an unprecedented activity exhibited by an E3 member. Interestingly, whereas full length parkin catalyzes solely monoubiquitination regardless of the presence or absence of E2, a truncated parkin mutant containing only the catalytic moiety supports both E2-independent and E2-dependent assembly of ubiquitin chains. Conclusions: Our results here suggest a complex regulation of parkin's activity and may help to explain how a single enzyme like parkin could mediate diverse forms of ubiquitination.	[Chew, Katherine C. M.; Lim, Grace G. Y.; Lim, Kah-Leong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Matsuda, Noriyuki; Saisho, Keiko; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 113, Japan; [Chai, Chou; Lim, Kah-Leong] A STAR Duke NUS Neurosci Res Partnership, Singapore, Singapore; [Tan, Hui-Mei; Lim, Kah-Leong] Natl Inst Neurosci, Singapore, Singapore	National University of Singapore; Tokyo Metropolitan Institute of Medical Science; National Neuroscience Institute (NNI)	Chew, KCM (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.	phslkl@nus.edu.sg	Matsuda, Noriyuki/AAI-3156-2020; Lim, Kah/L-5426-2019; Lim, Kah-Leong/AAY-3308-2020	Matsuda, Noriyuki/0000-0001-8199-952X; Chew, Katherine C. M./0000-0003-2051-4386; Lim, Kah-Leong/0000-0002-5440-2588	Singapore Biomedical Research Council; Singapore Millennium Foundation; Ministry of Education, Science, Sports, Culture and Technology	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Millennium Foundation(Singapore Millennium Foundation); Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Singapore Biomedical Research Council (LKL), http://www.a-star.edu.sg/AboutASTAR/BiomedicalResearchCouncil/tabid/64/Default.aspx; the Singapore Millennium Foundation (LKL and GL), http://www.smf-scholar.org/, and the Ministry of Education, Science, Sports, Culture and Technology (NM and KT), http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Huzil JT, 2007, J BIOL CHEM, V282, P37454, DOI 10.1074/jbc.M705242200; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lim KL, 2006, NEUROBIOL AGING, V27, P524, DOI 10.1016/j.neurobiolaging.2005.07.023; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Rubio de la Torre E, 2009, HUM MOL GENET, V18, P809, DOI 10.1093/hmg/ddn407; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; VANNOCKER S, 1991, P NATL ACAD SCI USA, V88, P10297, DOI 10.1073/pnas.88.22.10297; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; YOSHII SR, 2011, J BIOL CHEM; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	35	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19720	10.1371/journal.pone.0019720	http://dx.doi.org/10.1371/journal.pone.0019720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625422	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200009
J	Lai, KM; Bottomley, C; McNerney, R				Lai, Ka-Man; Bottomley, Christian; McNerney, Ruth			Propagation of Respiratory Aerosols by the Vuvuzela	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PULMONARY-FUNCTION; PILGRIMAGE HAJJ; TUBERCULOSIS; INFECTION; INFLUENZA; DISEASE; DISSEMINATION; PARTICLES; CONTAGION	Vuvuzelas, the plastic blowing horns used by sports fans, recently achieved international recognition during the FIFA World Cup soccer tournament in South Africa. We hypothesised that vuvuzelas might facilitate the generation and dissemination of respiratory aerosols. To investigate the quantity and size of aerosols emitted when the instrument is played, eight healthy volunteers were asked to blow a vuvuzela. For each individual the concentration of particles in expelled air was measured using a six channel laser particle counter and the duration of blowing and velocity of air leaving the vuvuzela were recorded. To allow comparison with other activities undertaken at sports events each individual was also asked to shout and the measurements were repeated while using a paper cone to confine the exhaled air. Triplicate measurements were taken for each individual. The mean peak particle counts were 658x10(3) per litre for the vuvuzela and 3.7x10(3) per litre for shouting, representing a mean log(10) difference of 2.20 (95% CI: 2.03,2.36; p<0.001). The majority (>97%) of particles captured from either the vuvuzela or shouting were between 0.5 and 5 microns in diameter. Mean peak airflows recorded for the vuvuzela and shouting were 6.1 and 1.8 litres per second respectively. We conclude that plastic blowing horns (vuvuzelas) have the capacity to propel extremely large numbers of aerosols into the atmosphere of a size able to penetrate the lower lung. Some respiratory pathogens are spread via contaminated aerosols emitted by infected persons. Further investigation is required to assess the potential of the vuvuzela to contribute to the transmission of aerosol borne diseases. We recommend, as a precautionary measure, that people with respiratory infections should be advised not to blow their vuvuzela in enclosed spaces and where there is a risk of infecting others.	[Lai, Ka-Man] UCL, Dept Civil Environm & Geomat Engn, Healthy Infrastruct Res Ctr, London, England; [Bottomley, Christian] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England; [McNerney, Ruth] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lai, KM (corresponding author), UCL, Dept Civil Environm & Geomat Engn, Healthy Infrastruct Res Ctr, London, England.	ruth.mcnerney@lshtm.ac.uk	Lai, Ka Man/C-3259-2015	Lai, Ka Man/0000-0002-0037-792X; MCNERNEY, Ruth/0000-0002-1957-443X; Bottomley, Christian/0000-0002-5241-8412	Engineering and Physical Science Research Council [EPSRC EP/G029881/1]; Department for International Development, UK; Medical Research Council (UK); Engineering and Physical Sciences Research Council [EP/G029881/1] Funding Source: researchfish; Medical Research Council [G0700837] Funding Source: researchfish; EPSRC [EP/G029881/1] Funding Source: UKRI; MRC [G0700837] Funding Source: UKRI	Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department for International Development, UK; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Engineering and Physical Science Research Council grant EPSRC EP/G029881/1 (K-ML) and the Department for International Development, UK (RM). CB received salary support from the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Al-Ghamdi SM, 2003, SAUDI MED J, V24, P1073; BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403; Biellik RJ, 1997, B WORLD HEALTH ORGAN, V75, P367; BLUMBERG L, 2010, 2010 FIFA SOCCER WOU, P63; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; DUGUID J P, 1947, Rep Dep Health Scotl, V46, P62; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; DUGUID JP, 1946, BRIT MED J, V1, P265, DOI 10.1136/bmj.1.4442.265; EHRESMANN KR, 1995, J INFECT DIS, V171, P679, DOI 10.1093/infdis/171.3.679; El-Sheikh SM, 1998, TROP MED INT HEALTH, V3, P205; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; HALL WJ, 1980, ANNU REV MED, V31, P233, DOI 10.1146/annurev.me.31.020180.001313; HATCH TF, 1961, BACTERIOL REV, V25, P237, DOI 10.1128/MMBR.25.3.237-240.1961; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Knight V, 1980, Ann N Y Acad Sci, V353, P147, DOI 10.1111/j.1749-6632.1980.tb18917.x; LECLAIR JM, 1980, NEW ENGL J MED, V302, P450, DOI 10.1056/NEJM198002213020807; LOUDON RG, 1968, AM REV RESPIR DIS, V98, P297; Moloney A, 2009, LANCET, V373, P1591, DOI 10.1016/S0140-6736(09)60868-0; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; National Institute for Communicable Diseases, 2011, SEV AC RESP ILLN SAR; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; ROBERTS F, 2000, RESP PHYSL UPDATE AN; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Schwarz K, 2010, J AEROSOL MED PULM D, V23, P371, DOI 10.1089/jamp.2009.0809; Serisier DJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-63; Swanepoel D, 2010, SAMJ S AFR MED J, V100, P192, DOI 10.7196/SAMJ.4098; Swanepoel DW, 2010, SAMJ S AFR MED J, V100, P99, DOI 10.7196/SAMJ.3697; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; WELLS WF, 1948, AM J HYG, V47, P11, DOI 10.1093/oxfordjournals.aje.a119179; World Health Organization, 2010, GLOB TUB CONTR WHO R	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20086	10.1371/journal.pone.0020086	http://dx.doi.org/10.1371/journal.pone.0020086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629778	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000291005200033
J	Cimica, V; Chen, HC; Iyer, JK; Reich, NC				Cimica, Velasco; Chen, Hui-Chen; Iyer, Janaki K.; Reich, Nancy C.			Dynamics of the STAT3 Transcription Factor: Nuclear Import Dependent on Ran and Importin-beta 1	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; COILED-COIL DOMAIN; NF-KAPPA-B; UNPHOSPHORYLATED STAT3; LIVING CELLS; TYROSINE PHOSPHORYLATION; MITOCHONDRIAL STAT3; SIGNAL TRANSDUCER; CRYSTAL-STRUCTURE; PROTEIN	The signal transducer and activator of transcription-3 (STAT3) induces transcription of genes that control differentiation, inflammation, proliferation, and tumor cell invasion. Cytokines such as interleukin-6 and interferon stimulate the specific tyrosine phosphorylation of STAT3, which confers its ability to bind consensus DNA targets. In addition, unphosphorylated STAT3 has been demonstrated to induce specific gene expression. STAT3 must gain entrance to the nucleus to impact transcription, however access to the nucleus is a tightly regulated process. Because nuclear trafficking is critical to the function of STAT3, we investigated the molecular mechanisms by which STAT3 is imported to the nucleus. Live cell imaging techniques were used with STAT3 tagged with green fluorescence protein (GFP) or photoactivatable GFP to follow the cellular dynamics of both unphosphorylated and tyrosine phosphorylated forms. Cytokine activation did not alter the rate of STAT3 nuclear import or nuclear export. In addition, Forster resonance energy transfer experiments revealed homomeric interaction of unphosphorylated STAT3 dependent on its amino terminus, but this dimerization is not necessary for its nuclear import. Previous work demonstrated the adapter importin-alpha 3 binds to STAT3 and is required for nuclear import. To determine whether STAT3 nuclear import is mediated by the importin-alpha/importin-beta 1 heterodimer, the effects of siRNA to importin-beta 1 were evaluated. Results indicate STAT3 nuclear import is dependent on the function of importin-beta 1. Since the Ran GTPase is necessary to bind importin-beta 1 in the nucleus for release of importin-alpha-cargo, the effect of a GTPase deficient mutant of Ran was tested. Expression of the Ran interfering mutant inhibited STAT3 nuclear import. This study defines importin-alpha/importin-beta 1/Ran as the molecular mechanism by which STAT3 traffics to the nucleus.	[Cimica, Velasco; Chen, Hui-Chen; Iyer, Janaki K.; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cimica, V (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu	Cimica, Velasco/H-2656-2014	Cimica, Velasco/0000-0001-7489-3145	National Institutes of Health [RO1CA122910]; NATIONAL CANCER INSTITUTE [R01CA122910] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant RO1CA122910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhattacharya S, 2003, J CLIN INVEST, V111, P553, DOI 10.1172/JCI200315372; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen HC, 2010, J IMMUNOL, V185, P64, DOI 10.4049/jimmunol.0903323; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Dingwall C, 1998, METHOD CELL BIOL, V53, P517; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Herrmann A, 2004, J CELL SCI, V117, P339, DOI 10.1242/jcs.00833; Herrmann A, 2007, J CELL SCI, V120, P3249, DOI 10.1242/jcs.03482; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang Y, 2007, J BIOL CHEM, V282, P34958, DOI 10.1074/jbc.M704548200; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kawashima T, 2009, MOL CELL BIOL, V29, P1796, DOI 10.1128/MCB.01423-08; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kretzschmar AK, 2004, BIOCHEM J, V377, P289, DOI 10.1042/BJ20030708; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Palacios I, 1996, J CELL BIOL, V133, P485, DOI 10.1083/jcb.133.3.485; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Phillips D, 2010, J BIOL CHEM, V285, P23532, DOI 10.1074/jbc.C110.152652; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Pranada AL, 2004, J BIOL CHEM, V279, P15114, DOI 10.1074/jbc.M312530200; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Reich NC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290pe61; Ren ZY, 2008, BIOCHEM BIOPH RES CO, V374, P1, DOI 10.1016/j.bbrc.2008.04.049; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schroder M, 2004, J LEUKOCYTE BIOL, V75, P792, DOI 10.1189/jlb.1003496; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Ushijima R, 2005, BIOCHEM BIOPH RES CO, V330, P880, DOI 10.1016/j.bbrc.2005.03.063; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Wente SR, 2010, COLD SPRING HARB PER; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	69	83	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20188	10.1371/journal.pone.0020188	http://dx.doi.org/10.1371/journal.pone.0020188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625522	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200053
J	Eitel, M; Guidi, L; Hadrys, H; Balsamo, M; Schierwater, B				Eitel, Michael; Guidi, Loretta; Hadrys, Heike; Balsamo, Maria; Schierwater, Bernd			New Insights into Placozoan Sexual Reproduction and Development	PLOS ONE			English	Article							ADHAERENS FE SCHULZE; ANTIGEN 8 SPAG8; TRICHOPLAX-ADHAERENS; CORTICAL GRANULES; CELL-DIFFERENTIATION; ASEXUAL REPRODUCTION; METAZOAN EVOLUTION; HOX GENES; FERTILIZATION; OOGENESIS	Unraveling animal life cycles and embryonic development is basic to understanding animal biology and often sheds light on phylogenetic relationships. A key group for understanding the evolution of the Metazoa is the early branching phylum Placozoa, which has attracted rapidly increasing attention. Despite over a hundred years of placozoan research the life cycle of this enigmatic phylum remains unknown. Placozoa are a unique model system for which the nuclear genome was published before the basic biology (i.e. life cycle and development) has been unraveled. Four organismal studies have reported the development of oocytes and one genetic study has nourished the hypothesis of sexual reproduction in natural populations at least in the past. Here we report new observations on sexual reproduction and embryonic development in the Placozoa and support the hypothesis of current sexual reproduction. The regular observation of oocytes and expressed sperm markers provide support that placozoans reproduce sexually in the field. Using whole genome and EST sequences and additional cDNA cloning we identified five conserved sperm markers, characteristic for different stages in spermatogenesis. We also report details on the embryonic development up to a 128-cell stage and new ultrastructural features occurring during early development. These results suggest that sperm and oocyte generation and maturation occur in different placozoans and that clonal lineages reproduce bisexually in addition to the standard mode of vegetative reproduction. The sum of observations is best congruent with the hypothesis of a simple life cycle with an alternation of reproductive modes between bisexual and vegetative reproduction.	[Eitel, Michael; Hadrys, Heike; Schierwater, Bernd] ITZ, Stiftung Tierarztliche Hsch Hannover, Hannover, Germany; [Guidi, Loretta; Balsamo, Maria] Dept Earth Life & Environm Sci, Urbino, Italy; [Hadrys, Heike; Schierwater, Bernd] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA	University of Veterinary Medicine Hannover, Foundation; Yale University	Eitel, M (corresponding author), ITZ, Stiftung Tierarztliche Hsch Hannover, Hannover, Germany.	michael.eitel@ecolevol.de	Balsamo, Maria/AAW-3205-2020	Balsamo, Maria/0000-0002-7947-0632; Eitel, Michael/0000-0002-0531-0732; Guidi, loretta/0000-0002-9009-9520	German Science Foundation (DFG) [Schi-227/20-2, Schi-227/20-3, Schi-227/26-1]; Italian Ministry of Education, University and Research; Evangelische Studienwerk e.V. scholarship; Stiftung Tierarztliche Hochschule Hannover	German Science Foundation (DFG)(German Research Foundation (DFG)); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Evangelische Studienwerk e.V. scholarship; Stiftung Tierarztliche Hochschule Hannover	The study was supported by the German Science Foundation (DFG grants Schi-227/20-2, -3 and Schi-227/26-1 to BS) and by the Italian Ministry of Education, University and Research (PRIN 2007 grant to MB). ME acknowledges funding by an Evangelische Studienwerk e.V. scholarship and an "Otto Butschli" scholarship from the Stiftung Tierarztliche Hochschule Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2008, AQUAT BIOL, V1, P291, DOI 10.3354/ab00032; ADIYODI KG, 1994, REPROD BIOL INVERTEB; ANDERSON E, 1968, J CELL BIOL, V37, P514, DOI 10.1083/jcb.37.2.514; Bavestrello G, 2006, CHEM ECOL, V22, P197, DOI 10.1080/02757540600670810; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Blackstone NW, 2009, PLOS BIOL, V7, P29, DOI 10.1371/journal.pbio.1000007; CHEN CLA, 1995, ZOOL STUD, V34, P29; Cheng GY, 2007, ASIAN J ANDROL, V9, P23, DOI 10.1111/j.1745-7262.2007.00247.x; Chiaverano L, 2004, HYDROBIOLOGIA, V530, P373, DOI 10.1007/s10750-004-2666-4; Cran D.G., 1989, Journal of Reproduction and Fertility Supplement, P49; DANDEKAR P, 1992, MOL REPROD DEV, V31, P135, DOI 10.1002/mrd.1080310208; de Putron SJ, 2009, INVERTEBR BIOL, V128, P213, DOI 10.1111/j.1744-7410.2009.00170.x; DeSalle R, 2008, BIOESSAYS, V30, P1043, DOI 10.1002/bies.20842; Eckelbarger KJ, 2005, INVERTEBR REPROD DEV, V47, P167, DOI 10.1080/07924259.2005.9652157; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Furukawa K, 1994, CHROMOSOME RES, V2, P99, DOI 10.1007/BF01553489; Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P2614, DOI 10.1021/es8024484; Grell K.G., 1984, Advances in Invertebrate Reproduction, V3, P541; GRELL K G, 1971, Naturwissenschaftliche Rundschau, V24, P160; Grell K.G., 1991, P13; GRELL K G, 1971, Cytobiologie, V4, P216; Grell K.G., 1981, TRICHOPLAX ADHAERENS, P107; GRELL KG, 1981, ZOOMORPHOLOGY, V98, P47, DOI 10.1007/BF00310320; GRELL KG, 1971, NATURWISSENSCHAFTEN, V58, P570, DOI 10.1007/BF00598728; GRELL KG, 1972, Z MORPHOL TIERE, V73, P297, DOI 10.1007/BF00391925; GRELL KG, 1974, Z MORPHOL TIERE, V79, P295; Guan J, 2010, REPROD DOMEST ANIM, V45, P992, DOI 10.1111/j.1439-0531.2009.01473.x; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; Hamel JF, 2007, BIOL BULL-US, V213, P101, DOI 10.2307/25066626; HOTTA Y, 1995, ADV BIOPHYS, V31, P101, DOI 10.1016/0065-227X(95)99386-4; Hwang KC, 2003, BIOCHEM BIOPH RES CO, V306, P198, DOI 10.1016/S0006-291X(03)00916-1; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; JENNISON BL, 1979, CAN J ZOOL, V57, P403, DOI 10.1139/z79-047; Kuhn K, 1999, J EXP ZOOL, V285, P63, DOI 10.1002/(SICI)1097-010X(19990415)285:1<63::AID-JEZ8>3.0.CO;2-X; Li R, 2009, CELL BIOCHEM FUNCT, V27, P264, DOI 10.1002/cbf.1574; Liu G, 2004, ACTA BIOCH BIOPH SIN, V36, P93, DOI 10.1093/abbs/36.2.93; Lucas CH, 1998, MAR BIOL, V131, P629, DOI 10.1007/s002270050355; Mei J, 2008, MOL CELL ENDOCRINOL, V289, P67, DOI 10.1016/j.mce.2008.02.016; Mercurio M, 2007, MAR BIOL, V151, P1491, DOI 10.1007/s00227-006-0584-x; MILLER FP, 2009, EVOLUTION SEXUAL REP; NOSEK J, 1984, HISTOCHEM J, V16, P435, DOI 10.1007/BF01002871; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Perovic-Ottstadt S, 2004, INT J DEV BIOL, V48, P293, DOI 10.1387/ijdb.041813sp; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; RUTHMANN A, 1981, Z NATURFORSCH C, V36, P564; RUTHMANN A, 1975, CYTOBIOLOGIE, V10, P421; Salzberg Y, 2010, DEV BIOL, V338, P158, DOI 10.1016/j.ydbio.2009.11.028; Schierwater B, 1998, MOL PHYLOGENET EVOL, V9, P375, DOI 10.1006/mpev.1998.0489; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; SCHIERWATER B, 2009, COMMUNICATIVE INTEGR, V2, P1; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; Schierwater B, 2009, INT J BIOCHEM CELL B, V41, P370, DOI 10.1016/j.biocel.2008.09.023; SCHULSINGER F, 1991, Acta Psychiatrica Scandinavica Supplementum, P1; Schulze FE, 1883, ZOOL ANZ, V6, P92; Schwab K, 2003, KIDNEY INT, V64, P1588, DOI 10.1046/j.1523-1755.2003.00276.x; Shakib K, 2005, PROTEOMICS, V5, P2819, DOI 10.1002/pmic.200401108; Siddall ME, 2010, CLADISTICS, V26, P444, DOI 10.1111/j.1096-0031.2009.00295.x; Signorovitch AY, 2006, BIOL BULL-US, V211, P149, DOI 10.2307/4134589; Signorovitch AY, 2005, P NATL ACAD SCI USA, V102, P15518, DOI 10.1073/pnas.0504031102; Simpson T., 1984, CELL BIOL SPONGES; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Steiner R, 1999, DEV BIOL, V216, P635, DOI 10.1006/dbio.1999.9520; Swiatek P, 2006, TISSUE CELL, V38, P263, DOI 10.1016/j.tice.2006.06.005; Syed T, 2002, VIE MILIEU, V52, P177; THIEMANN M, 1988, Z NATURFORSCH C, V43, P955; THIEMANN M, 1990, ZOOMORPHOLOGY, V110, P37, DOI 10.1007/BF01632810; THIEMANN M, 1991, ZOOMORPHOLOGY, V110, P165, DOI 10.1007/BF01632872; Velilla E, 2004, MOL REPROD DEV, V68, P507, DOI 10.1002/mrd.20111; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; von der Chevallerie K., 2010, CAH BIOL MAR, V51, P212; Whalan S, 2007, CORAL REEFS, V26, P655, DOI 10.1007/s00338-007-0236-8; WITTE U, 1994, J EXP MAR BIOL ECOL, V183, P41, DOI 10.1016/0022-0981(94)90155-4; Wong Julian L., 2008, V440, P61, DOI 10.1007/978-1-59745-178-9_5; Wu HY, 2010, FEBS LETT, V584, P2807, DOI 10.1016/j.febslet.2010.05.016; Zhang TT, 2010, MICRON, V41, P59, DOI 10.1016/j.micron.2009.08.004; Zhang ZB, 2009, P NATL ACAD SCI USA, V106, P17055, DOI 10.1073/pnas.0906414106	78	46	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19639	10.1371/journal.pone.0019639	http://dx.doi.org/10.1371/journal.pone.0019639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625556	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200012
J	Watson, MJ; Worthington, EN; Clunes, LA; Rasmussen, JE; Jones, L; Tarran, R				Watson, Michael J.; Worthington, Erin N.; Clunes, Lucy A.; Rasmussen, Julia E.; Jones, Lisa; Tarran, Robert			Defective adenosine-stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling	FASEB JOURNAL			English	Article						chloride; ion channel; G protein-coupled receptor; 2nd messenger	TRANSMEMBRANE CONDUCTANCE REGULATOR; PLASMA-MEMBRANE; 2B RECEPTOR; TRAFFICKING; EXPRESSION; SECRETION; COMPLEXES; DOMAIN; LUNGS	Adenosine (ADO) is an extracellular signaling molecule that is an important regulator of innate lung defense. On binding ADO, the A2B receptor (A2BR) stimulates cAMP production to activate the CFTR Cl- channel, increase ciliary beating, and initiate cytokine secretion. We tested the hypothesis that CFTR served as a positive regulator of the A2BRs. We found that A2BR and CFTR coimmunoprecipitated. They also underwent ADO-dependent Forster resonance energy transfer (FRET), which increased from 5% in the absence of agonist to 18% with 100 mu M ADO (EC50 1.7 mu M), suggesting that they dynamically associate in the plasma membrane. In contrast, despite colocalization, no FRET was observed between CFTR and GAP43. The interaction between A2BR and CFTR had some specificity: A2BR-stimulated but not forskolin-stimulated cAMP production was similar to 50% greater in the presence of CFTR, due to a CFTR-dependent increase in plasma membrane A2BR levels. These CFTR-dependent increases in A2BR levels and cAMP production resulted in significantly enhanced ciliary beating and increased cytokine secretion in normal compared to cystic fibrosis airway epithelia. Thus, we hypothesize that CFTR regulates A2BR levels in the plasma membrane to modulate cell signaling and to enhance selective components of the innate lung defense system.-Watson, M. J., Worthington, E. N., Clunes, L. A., Rasmussen, J. E., Jones, L., Tarran, R. Defective adenosine-stimulated cAMP production in cystic fibrosis airway epithelia: a novel role for CFTR in cell signaling. FASEB J. 25, 2996-3003 (2011). www.fasebj.org	[Watson, Michael J.; Worthington, Erin N.; Clunes, Lucy A.; Rasmussen, Julia E.; Jones, Lisa; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7125 Thurston Bowles Bldg, Chapel Hill, NC 27599 USA.	tarran@med.unc.edu		Watson, Michael/0000-0002-3715-3153	U.S. National Institutes of Health [P50HL084934, R01HL74158-3, P30DK34987]; British American Tobacco; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934, R01HL074158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British American Tobacco; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Claire Brown (McGill University, Montreal, QC, Canada) for the GAP43 construct and Drs. Tamas Hegudus, Martina Gentzsch and Jack Riordan [University of North Carolina (UNC)-Chapel Hill] for providing the CFTRcfp construct and the BHK cell lines. The authors also thank Drs. Eduardo Lazarowski and Jack Stutts for critical reading of this manuscript. The help of the UNC Immunotechnology Core and the UNC CF Center Molecular and Tissue Culture Cores is gratefully acknowledged. This study was supported by U.S. National Institutes of Health grants P50HL084934, R01HL74158-3, and P30DK34987, by British American Tobacco, and by the Cystic Fibrosis Foundation.	ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; Antonioli L, 2008, PHARMACOL THERAPEUT, V120, P233, DOI 10.1016/j.pharmthera.2008.08.010; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; BRUNTON LL, 2003, SCI STKE, pPE44; Bucheimer RE, 2004, J PHYSIOL-LONDON, V555, P311, DOI 10.1113/jphysiol.2003.056697; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; CHOLON DM, AM J PHYSL LUNG CELL, V298, pL304; Cobb BR, 2002, AM J PHYSIOL-LUNG C, V282, pL12, DOI 10.1152/ajplung.2002.282.1.L12; Com Gulnur, 2009, Handb Exp Pharmacol, P363, DOI 10.1007/978-3-540-89615-9_12; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Guggino William B, 2004, Proc Am Thorac Soc, V1, P28, DOI 10.1513/pats.2306011; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Harris A, 1993, Semin Cell Biol, V4, P37, DOI 10.1006/scel.1993.1005; Ho K, 1998, CURR OPIN NEPHROL HY, V7, P49, DOI 10.1097/00041552-199801000-00009; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Nichols D, 2008, CLIN REV ALLERG IMMU, V34, P146, DOI 10.1007/s12016-007-8039-9; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitaraman SV, 2000, AM J PHYSIOL-CELL PH, V278, pC1230, DOI 10.1152/ajpcell.2000.278.6.C1230; Skach WR, 2000, KIDNEY INT, V57, P825, DOI 10.1046/j.1523-1755.2000.00921.x; Sun Y, 2008, J IMMUNOL, V180, P4173, DOI 10.4049/jimmunol.180.6.4173; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Wang LX, 2004, AM J PHYSIOL-GASTR L, V287, pG1100, DOI 10.1152/ajpgi.00164.2004	44	19	19	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					2996	3003		10.1096/fj.11-186080	http://dx.doi.org/10.1096/fj.11-186080			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21628448	Green Published			2022-12-25	WOS:000294435200015
J	Gravel, D; Canard, E; Guichard, F; Mouquet, N				Gravel, Dominique; Canard, Elsa; Guichard, Frederic; Mouquet, Nicolas			Persistence Increases with Diversity and Connectance in Trophic Metacommunities	PLOS ONE			English	Article							FOOD-WEB COMPLEXITY; FORAGING ADAPTATION; NETWORK STRUCTURE; STABILITY; MODELS; COMMUNITY; DYNAMICS; DISPERSAL; BALANCE; CHAOS	Background: We are interested in understanding if metacommunity dynamics contribute to the persistence of complex spatial food webs subject to colonization-extinction dynamics. We study persistence as a measure of stability of communities within discrete patches, and ask how do species diversity, connectance, and topology influence it in spatially structured food webs. Methodology/Principal Findings: We answer this question first by identifying two general mechanisms linking topology of simple food web modules and persistence at the regional scale. We then assess the robustness of these mechanisms to more complex food webs with simulations based on randomly created and empirical webs found in the literature. We find that linkage proximity to primary producers and food web diversity generate a positive relationship between complexity and persistence in spatial food webs. The comparison between empirical and randomly created food webs reveal that the most important element for food web persistence under spatial colonization-extinction dynamics is the degree distribution: the number of prey species per consumer is more important than their identity. Conclusions/Significance: With a simple set of rules governing patch colonization and extinction, we have predicted that diversity and connectance promote persistence at the regional scale. The strength of our approach is that it reconciles the effect of complexity on stability at the local and the regional scale. Even if complex food webs are locally prone to extinction, we have shown their complexity could also promote their persistence through regional dynamics. The framework we presented here offers a novel and simple approach to understand the complexity of spatial food webs.	[Gravel, Dominique] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Gravel, Dominique] Univ Quebec, Ctr Etud Foret, Rimouski, PQ G5L 3A1, Canada; [Gravel, Dominique] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Canard, Elsa; Mouquet, Nicolas] Univ Montpellier 2, Inst Sci Evolut, Montpellier, France; [Guichard, Frederic] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University; University of Quebec; University of Quebec; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; McGill University	Gravel, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	dominique_gravel@uqar.qc.ca	MOUQUET, Nicolas/AAL-1440-2021	Mouquet, Nicolas/0000-0003-1840-6984	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair program; James S. McDonnell Foundation; NSERC; le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); CRNS;  [ANR-BACH-09-JCJC-0110-01]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair program(Canada Research Chairs); James S. McDonnell Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT); CRNS; 	D. Gravel was supported by a post-doctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chair program. This work was also supported by research grants from the James S. McDonnell Foundation, NSERC, and le Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) to F. Guichard. N. Mouquet is supported by the CRNS and research grant ANR-BACH-09-JCJC-0110-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Amarasekare P, 2008, ANNU REV ECOL EVOL S, V39, P479, DOI 10.1146/annurev.ecolsys.39.110707.173434; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; CALCAGNO V, 2011, P ROY SOC IN PRESS B; Cohen J.E., 1990, COMMUNITY FOOD WEBS; COHEN JE, 1984, ANN PROBAB, V12, P283, DOI 10.1214/aop/1176993291; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Cuddington K, 2005, ECOLOGICAL PARADIGMS; DEANGELIS DL, 1975, ECOLOGY, V56, P238; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dunne JA, 2006, SFI S SCI C, P27; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fussmann GF, 2002, ECOL LETT, V5, P394, DOI 10.1046/j.1461-0248.2002.00329.x; Gouhier TC, 2010, AM NAT, V175, pE16, DOI 10.1086/649579; GRAVEL D, BIOGEOGRAPH IN PRESS; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; HAYDON D, 1994, AM NAT, V144, P14, DOI 10.1086/285658; Holt Robert D., 1997, P149, DOI 10.1016/B978-012323445-2/50010-9; Hoopes MF, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P35; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUTCHINSON GE, 1959, AM NAT, V93, P149; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jansen VAA, 2003, ECOL LETT, V6, P498, DOI 10.1046/j.1461-0248.2003.00464.x; Jansen VAA, 1995, OIKOS, V74, P384, DOI 10.2307/3545983; Jansen Vincent A.A., 2000, P183, DOI 10.1017/CBO9780511525537.013; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Koelle K, 2005, ECOL LETT, V8, P167, DOI 10.1111/j.1461-0248.2004.00703.x; Kondoh M, 2006, J THEOR BIOL, V238, P646, DOI 10.1016/j.jtbi.2005.06.028; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; LAWLOR LR, 1978, AM NAT, V112, P445, DOI 10.1086/283286; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; May R. M., 1973, STABILITY COMPLEXITY; May RM, 2001, STABILITY COMPLEXITY; May RM, 2009, PHILOS T R SOC B, V364, P1643, DOI 10.1098/rstb.2008.0280; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2002, ECOL LETT, V5, P37, DOI 10.1046/j.1461-0248.2002.00280.x; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; MOUQUET N, 2005, METACOMMUNITIES FRAM; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Odum E. P., 1953, FUNDAMENTALS ECOLOGY; PACALA SW, 1990, NATURE, V344, P150, DOI 10.1038/344150a0; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Pillai P, 2010, THEOR ECOL-NETH, V3, P223, DOI 10.1007/s12080-009-0065-1; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; PIMM SL, 1982, FOOD WEBS; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; SOLE RV, 1992, PHYS LETT A, V166, P123, DOI 10.1016/0375-9601(92)90546-X; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; SOLE RV, 2006, SELF ORG COMPLEX ECO; Stouffer DB, 2010, ECOL LETT, V13, P154, DOI 10.1111/j.1461-0248.2009.01407.x; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Winemiller K. O., 2005, DYNAMIC FOOD WEBS MU	77	69	70	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19374	10.1371/journal.pone.0019374	http://dx.doi.org/10.1371/journal.pone.0019374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637749	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500003
J	Elberse, KEM; van de Pol, I; Witteveen, S; van der Heide, HGJ; Schot, CS; van Dijk, A; van der Ende, A; Schouls, LM				Elberse, Karin E. M.; van de Pol, Ingrid; Witteveen, Sandra; van der Heide, Han G. J.; Schot, Corrie S.; van Dijk, Anita; van der Ende, Arie; Schouls, Leo M.			Population Structure of Invasive Streptococcus pneumoniae in the Netherlands in the Pre-Vaccination Era Assessed by MLVA and Capsular Sequence Typing	PLOS ONE			English	Article							PNEUMOCOCCAL DISEASE; MULTIPLEX PCR; UNITED-STATES; SEROTYPES; DIVERSITY; CPSB; ASSOCIATIONS; CHILDREN; 6C	The introduction of nationwide pneumococcal vaccination may lead to serotype replacement and the emergence of new variants that have expanded their genetic repertoire through recombination. To monitor alterations in the pneumococcal population structure, we have developed and utilized Capsular Sequence Typing (CST) in addition to Multiple-Locus Variable number tandem repeat Analysis (MLVA). To assess the serotype of each isolate CST was used. Based on the determination of the partial sequence of the capsular wzh gene, this method assigns a capsular type of an isolate within a single PCR reaction using multiple primersets. The genetic background of pneumococcal isolates was assessed by MLVA. MLVA and CST were used to create a snapshot of the Dutch pneumococcal population causing invasive disease before the introduction of the 7-valent pneumococcal conjugate vaccine in the Netherlands in 2006. A total of 1154 clinical isolates collected and serotyped by the Netherlands Reference Laboratory for Bacterial Meningitis were included in the snapshot. The CST was successful in discriminating most serotypes present in our collection. MLVA demonstrated that isolates belonging to some serotypes had a relatively high genetic diversity whilst other serotypes had a very homogeneous genetic background. MLVA and CST appear to be valuable tools to determine the population structure of pneumococcal isolates and are useful in monitoring the effects of pneumococcal vaccination.	[Elberse, Karin E. M.; van de Pol, Ingrid; Witteveen, Sandra; van der Heide, Han G. J.; Schot, Corrie S.; van Dijk, Anita; Schouls, Leo M.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Elberse, KEM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands.	Karin.Elberse@RIVM.nl	van der Ende, Arie/A-4346-2012	van der Ende, Arie/0000-0003-1298-3086				AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Borrow R, 2008, INFECT IMMUN, V76, P5305, DOI 10.1128/IAI.00796-08; BRATCHER PE, 2009, MICROBIOLOGY; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Hall LMC, 1996, J CLIN MICROBIOL, V34, P853, DOI 10.1128/JCM.34.4.853-859.1996; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jefferies JMC, 2004, J CLIN MICROBIOL, V42, P5681, DOI 10.1128/JCM.42.12.5681-5688.2004; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; Kong FR, 2003, J MED MICROBIOL, V52, P1047, DOI 10.1099/jmm.0.05277-0; LUND E, 1960, Bull World Health Organ, V23, P5; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784	33	37	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20390	10.1371/journal.pone.0020390	http://dx.doi.org/10.1371/journal.pone.0020390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637810	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200059
J	Voolstra, CR; Sunagawa, S; Matz, MV; Bayer, T; Aranda, M; Buschiazzo, E; DeSalvo, MK; Lindquist, E; Szmant, AM; Coffroth, MA; Medina, M				Voolstra, Christian R.; Sunagawa, Shinichi; Matz, Mikhail V.; Bayer, Till; Aranda, Manuel; Buschiazzo, Emmanuel; DeSalvo, Michael K.; Lindquist, Erika; Szmant, Alina M.; Coffroth, Mary Alice; Medina, Monica			Rapid Evolution of Coral Proteins Responsible for Interaction with the Environment	PLOS ONE			English	Article							GENE-EXPRESSION; NUCLEOTIDE SUBSTITUTION; INNATE IMMUNITY; TEMPERATURE; STRESS; MECHANISM; HISTORY; IDENTIFICATION; GENERATION; EUKARYOTES	Background: Corals worldwide are in decline due to climate change effects (e. g., rising seawater temperatures), pollution, and exploitation. The ability of corals to cope with these stressors in the long run depends on the evolvability of the underlying genetic networks and proteins, which remain largely unknown. A genome-wide scan for positively selected genes between related coral species can help to narrow down the search space considerably. Methodology/Principal Findings: We screened a set of 2,604 putative orthologs from EST-based sequence datasets of the coral species Acropora millepora and Acropora palmata to determine the fraction and identity of proteins that may experience adaptive evolution. 7% of the orthologs show elevated rates of evolution. Taxonomically-restricted (i.e. lineage-specific) genes show a positive selection signature more frequently than genes that are found across many animal phyla. The class of proteins that displayed elevated evolutionary rates was significantly enriched for proteins involved in immunity and defense, reproduction, and sensory perception. We also found elevated rates of evolution in several other functional groups such as management of membrane vesicles, transmembrane transport of ions and organic molecules, cell adhesion, and oxidative stress response. Proteins in these processes might be related to the endosymbiotic relationship corals maintain with dinoflagellates in the genus Symbiodinium. Conclusion/Relevance: This study provides a birds-eye view of the processes potentially underlying coral adaptation, which will serve as a foundation for future work to elucidate the rates, patterns, and mechanisms of corals' evolutionary response to global climate change.	[Voolstra, Christian R.; Bayer, Till; Aranda, Manuel] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sunagawa, Shinichi] European Mol Biol Lab, Heidelberg, Germany; [Matz, Mikhail V.] Univ Texas Austin, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA; [Buschiazzo, Emmanuel; Medina, Monica] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [DeSalvo, Michael K.] Univ Calif San Francisco, Dept Anesthesia, UCSF Sch Med, San Francisco, CA 94143 USA; [Lindquist, Erika] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Szmant, Alina M.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Coffroth, Mary Alice] SUNY Buffalo, Grad Program Evolut Ecol & Behav, Buffalo, NY 14260 USA; [Coffroth, Mary Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA	King Abdullah University of Science & Technology; European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Austin; University of California System; University of California Merced; University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of North Carolina; University of North Carolina Wilmington; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Voolstra, CR (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	christian.voolstra@kaust.edu.sa; mmedina@ucmerced.edu	Buschiazzo, Emmanuel/B-5126-2011; Matz, Mikhail V/K-4392-2017; Bayer, Till/H-6826-2016; Voolstra, Christian R/H-7158-2014; Sunagawa, Shinichi/Q-5950-2019; Aranda Lastra, Manuel/D-9530-2011	Matz, Mikhail V/0000-0001-5453-9819; Bayer, Till/0000-0002-4704-2449; Voolstra, Christian R/0000-0003-4555-3795; Sunagawa, Shinichi/0000-0003-3065-0314; Aranda Lastra, Manuel/0000-0001-6673-016X	National Science Foundation [IOS-0644438, OCE-0313708]; Collaborative Travel Fund; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231];  [DEB-1054766]; Direct For Biological Sciences [1402065] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Collaborative Travel Fund; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by DEB-1054766 to M. V. M. and National Science Foundation grants IOS-0644438 and OCE-0313708 to M. M., and by a Collaborative Travel Fund to C. R. V. made by King Abdullah University of Science and Technology (KAUST). The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Asada K., 1987, PHOTOINHIBITION, P227; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; BARTLETT CY, 2009, CONSERV BIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Chen MC, 2003, BIOCHEM BIOPH RES CO, V308, P586, DOI 10.1016/S0006-291X(03)01428-1; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MOL ECOL, V19, P1174, DOI 10.1111/j.1365-294X.2010.04534.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Downs CA, 2009, AUTOPHAGY, V5, P211, DOI 10.4161/auto.5.2.7405; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2009, ENVIRON MICROBIOL, V11, P268, DOI 10.1111/j.1462-2920.2008.01774.x; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Foret S, 2010, TRENDS GENET, V26, P154, DOI 10.1016/j.tig.2010.01.003; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; GAME ET, 2009, ECOL LETT; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Hayes ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-150; Heinen TJAJ, 2009, CURR BIOL, V19, P1527, DOI 10.1016/j.cub.2009.07.049; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES TP, 1992, TRENDS ECOL EVOL, V7, P292, DOI 10.1016/0169-5347(92)90225-Z; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Portune KJ, 2010, MAR GENOM, V3, P51, DOI 10.1016/j.margen.2010.03.002; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Reyes-Bermudez A, 2009, MAR GENOM, V2, P149, DOI 10.1016/j.margen.2009.07.002; Reynolds WS, 2000, COMP BIOCHEM PHYS A, V126, P33, DOI 10.1016/S0742-8413(00)00099-2; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Sunagawa S, 2008, COMP BIOCHEM PHYS B, V151, P133, DOI 10.1016/j.cbpb.2008.06.007; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Sunagawa S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004865; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tautz D, 1998, PHILOS T ROY SOC B, V353, P231, DOI 10.1098/rstb.1998.0205; Team RDC, 2019, R LANG ENV STAT COMP; Telford MJ, 2007, CURR BIOL, V17, pR945, DOI 10.1016/j.cub.2007.09.023; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; VOOLSTRA CR, 2008, COMP BIOCH PHYSL D; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; WEEKS R, 2009, CONSERV BIOL; Wilkinson C., 2004, STATUS CORAL REEFS W; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wilson GA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000324; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	79	67	67	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20392	10.1371/journal.pone.0020392	http://dx.doi.org/10.1371/journal.pone.0020392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633702	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500059
J	Liang, YJ; Luo, J; Yuan, Q; Zheng, D; Liu, YP; Shi, L; Zhou, Y; Chen, AL; Ren, YY; Sun, KY; Sun, Y; Wang, Y; Zhang, ZS				Liang, Yue-Jin; Luo, Jie; Yuan, Quan; Zheng, Dan; Liu, Ya-Ping; Shi, Lei; Zhou, Ying; Chen, Ai-Ling; Ren, Yong-Ya; Sun, Ke-Yi; Sun, Yan; Wang, Yong; Zhang, Zhao-Song			New Insight into the Antifibrotic Effects of Praziquantel on Mice in Infection with Schistosoma japonicum	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER FIBROSIS; MATRIX METALLOPROTEINASES; TH2 CYTOKINES; RAT-LIVER; ACTIVATION; EXPRESSION; INHIBITORS; BETA; MECHANISMS	Background: Schistosomiasis is a parasitic disease infecting more than 200 million people in the world. Although chemotherapy targeting on killing schistosomes is one of the main strategies in the disease control, there are few effective ways of dealing with liver fibrosis caused by the parasite infection in the chronic and advanced stages of schistosomiasis. For this reason, new strategies and prospective drugs, which exert antifibrotic effects, are urgently required. Methods and Findings: The antifibrotic effects of praziquantel were assessed in the murine models of schistosomiasis japonica. Murine fibrosis models were established by cutaneous infection with 14 +/- 2 Schistosoma japonicum cercariae. Then, the mice of both chronic (8 weeks post-infection) and advanced (15 weeks post-infection) schistosomiasis were treated by gavage of praziquantel (250 mg/kg, once daily for 3 days) to eliminate worms, and followed by praziquantel anti-fibrosis treatment (300 mg/kg, twice daily for 30 days). The fibrosis-related parameters assessed were areas of collagen deposition, content of hydroxyproline and mRNA expressions of Col1 alpha 1, Col3 alpha 1, alpha-SMA, TGF-beta, MMP9, TIMP1, IL-4, IL-10, IL-13 and IFN-gamma of liver. Spleen weight index, alanine aminotransferase activity and liver portal venous pressure were also measured. The results showed that anti-fibrosis treatment improved liver fibrosis, splenomegaly, hepatic function, as well as liver portal hypertension. In order to confirm the anti-fibrotic properties of praziquantel, we established a CCL4-induced model and revealed that CCL4-induced liver fibrosis was inhibited by PZQ treatment for 30 days. Furthermore, we analyzed the effects of praziquantel on mouse primary hepatic stellate cells (HSCs). It is indicated that mRNA expressions of Col1 alpha 1, Col3 alpha 1, alpha-SMA, TGF-beta, MMP9 and TIMP1 of HSCs were all inhibited after praziquantel anti-parasite treatments. Conclusions: The significant amelioration of hepatic fibrosis by praziquantel treatment validates it as a promising drug of anti-fibrosis and offers potential of a new chemotherapy for hepatic fibrosis resulting from schistosomiasis.	[Liang, Yue-Jin; Luo, Jie; Yuan, Quan; Zheng, Dan; Liu, Ya-Ping; Shi, Lei; Zhou, Ying; Chen, Ai-Ling; Sun, Yan; Wang, Yong; Zhang, Zhao-Song] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Ren, Yong-Ya] Nanjing Med Univ, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Sun, Ke-Yi] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Liang, YJ (corresponding author), Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	yongwsh@njmu.edu.cn	Liang, Yuejin/X-5250-2019; yuan, quan/GZM-5597-2022	Liang, Yuejin/0000-0002-9557-1847	National Basic Research Program of China (973 Program) [2007CB513102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) (No. 2007CB513102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani RA, 2010, PARASITOL RES, V107, P1, DOI 10.1007/s00436-010-1855-5; Andersson Karin L, 2007, Curr Treat Options Gastroenterol, V10, P504, DOI 10.1007/s11938-007-0050-y; Andrade ZA, 2008, ACTA TROP, V108, P79, DOI 10.1016/j.actatropica.2008.04.003; Arnaud V, 2008, J INFECT DIS, V198, P418, DOI 10.1086/588826; Arthur MJP, 1998, J GASTROEN HEPATOL, V13, pS33; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Berhe N, 2008, AM J TROP MED HYG, V78, P228, DOI 10.4269/ajtmh.2008.78.228; BIEMPICA L, 1983, AM J TROP MED HYG, V32, P316, DOI 10.4269/ajtmh.1983.32.316; Breitkopf K, 2005, ALCOHOL CLIN EXP RES, V29, p121S, DOI 10.1097/01.alc.0000189284.98684.22; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; CHEEVER AW, 1994, J IMMUNOL, V153, P753; Cheever AW, 1997, MEM I OSWALDO CRUZ, V92, P689, DOI 10.1590/S0074-02761997000500024; CHRISTIAN J, 2010, GUT, P827; Chu D, 2007, PARASITOLOGY, V134, P1611, DOI 10.1017/S0031182007002946; Constandinou C, 2005, METH MOLEC MED, V117, P237; Cortez-Pinto H, 2001, HEPATO-GASTROENTEROL, V48, P87; Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313; DUNN MA, 1977, J CLIN INVEST, V59, P666, DOI 10.1172/JCI108685; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Freitas CRL, 1999, MEM I OSWALDO CRUZ, V94, P815, DOI 10.1590/S0074-02761999000600019; Frenzel K, 1999, AM J TROP MED HYG, V60, P927, DOI 10.4269/ajtmh.1999.60.927; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Giannelli G, 2006, J INTERF CYTOK RES, V26, P301, DOI 10.1089/jir.2006.26.301; Gomez DE, 1999, AM J TROP MED HYG, V61, P9, DOI 10.4269/ajtmh.1999.61.9; Gonzalez-Forero D, 2004, J PHYSIOL-LONDON, V557, P991, DOI 10.1113/jphysiol.2003.059972; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Han YP, 2004, J BIOL CHEM, V279, P4820, DOI 10.1074/jbc.M310999200; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; HOMEIDA MA, 1991, AM J TROP MED HYG, V45, P360, DOI 10.4269/ajtmh.1991.45.360; Huang XR, 2008, AM J PHYSIOL-RENAL, V295, pF118, DOI 10.1152/ajprenal.00021.2008; Jacobs W, 1998, CELL TISSUE RES, V292, P101, DOI 10.1007/s004410051039; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Maia MD, 2007, ACTA TROP, V101, P183, DOI 10.1016/j.actatropica.2007.01.004; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; MORCOS SH, 1985, AM J TROP MED HYG, V34, P314, DOI 10.4269/ajtmh.1985.34.314; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; Olds G. Richard, 2001, Curr Infect Dis Rep, V3, P59, DOI 10.1007/s11908-001-0060-1; Parsons CJ, 2007, J GASTROEN HEPATOL, V22, pS79, DOI 10.1111/j.1440-1746.2006.04659.x; Peterson TC, 1998, BIOCHEM PHARMACOL, V55, P703, DOI 10.1016/S0006-2952(97)00593-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinlaor S, 2006, INT J CANCER, V119, P1067, DOI 10.1002/ijc.21893; Rakotonirina E J, 2010, Sante, V20, P15, DOI 10.1684/san.2009.0175; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Ross AGP, 1997, PARASITOL TODAY, V13, P152, DOI 10.1016/S0169-4758(97)01026-0; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; STELMA FF, 1995, AM J TROP MED HYG, V53, P167, DOI 10.4269/ajtmh.1995.53.167; Takemura Y, 1998, AM J TROP MED HYG, V59, P551, DOI 10.4269/ajtmh.1998.59.551; Tao FF, 2009, VACCINE, V27, P4110, DOI 10.1016/j.vaccine.2009.04.073; Tomanovic NR, 2009, J GASTROINTEST LIVER, V18, P163; Watson M, 2009, J EXOT PET MED, V18, P229, DOI 10.1053/j.jepm.2009.06.005; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; *WHO, 2002, WHOCDSCPEPVC20024; Wu J, 2008, EXP BIOL MED, V233, P377, DOI 10.3181/0710-RM-269; Xu YongLiang, 2007, Chinese Journal of Schistosomiasis Control, V19, P357; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zhang L, 2008, MICROBES INFECT, V10, P251, DOI 10.1016/j.micinf.2007.11.009	67	46	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20247	10.1371/journal.pone.0020247	http://dx.doi.org/10.1371/journal.pone.0020247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629648	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005800035
J	Coleman, MA; Chambers, J; Knott, NA; Malcolm, HA; Harasti, D; Jordan, A; Kelaher, BP				Coleman, Melinda A.; Chambers, Justine; Knott, Nathan A.; Malcolm, Hamish A.; Harasti, David; Jordan, Alan; Kelaher, Brendan P.			Connectivity within and among a Network of Temperate Marine Reserves	PLOS ONE			English	Article							HABITAT-FORMING ALGA; PHYLLOSPORA-COMOSA PHAEOPHYCEAE; GENETIC-STRUCTURE; MACROCYSTIS-PYRIFERA; POPULATION-STRUCTURE; ECKLONIA-RADIATA; LIFE-HISTORY; GIANT-KELP; DISPERSAL; PATTERNS	Networks of marine reserves are increasingly being promoted as a means of conserving marine biodiversity. One consideration in designing systems of marine reserves is the maintenance of connectivity to ensure the long-term persistence and resilience of populations. Knowledge of connectivity, however, is frequently lacking during marine reserve design and establishment. We characterise patterns of genetic connectivity of 3 key species of habitat-forming macroalgae across an established network of temperate marine reserves on the east coast of Australia and the implications for adaptive management and marine reserve design. Connectivity varied greatly among species. Connectivity was high for the subtidal macroalgae Ecklonia radiata and Phyllospora comosa and neither species showed any clear patterns of genetic structuring with geographic distance within or among marine parks. In contrast, connectivity was low for the intertidal, Hormosira banksii, and there was a strong pattern of isolation by distance. Coastal topography and latitude influenced small scale patterns of genetic structure. These results suggest that some species are well served by the current system of marine reserves in place along this temperate coast but it may be warranted to revisit protection of intertidal habitats to ensure the long-term persistence of important habitat-forming macroalgae. Adaptively managing marine reserve design to maintain connectivity may ensure the long-term persistence and resilience of marine habitats and the biodiversity they support.	[Coleman, Melinda A.; Kelaher, Brendan P.] New S Wales Marine Pk Author, Narooma, Australia; [Coleman, Melinda A.; Knott, Nathan A.; Malcolm, Hamish A.; Harasti, David; Jordan, Alan; Kelaher, Brendan P.] New S Wales Marine Pk Author, Sydney, NSW, Australia; [Chambers, Justine] Australian Genome Res Facil Ltd, Plant Genom Ctr, Glen Osmond, SA, Australia		Coleman, MA (corresponding author), New S Wales Marine Pk Author, Batemans Marine Pk, Narooma, Australia.	Melinda.coleman@environment.nsw.gov.au	Harasti, David/I-1266-2019; Knott, Nathan/AAA-8888-2019; Kelaher, Brendan/P-3647-2017; Coleman, Melinda A/R-5563-2016	Harasti, David/0000-0002-2851-9838; Knott, Nathan/0000-0002-7873-0412; Kelaher, Brendan/0000-0002-7505-4412; Coleman, Melinda A/0000-0003-2623-633X				Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson MJ, 2005, J ANIM ECOL, V74, P636, DOI 10.1111/j.1365-2656.2005.00959.x; Andrew NL, 2000, MAR FRESHWATER RES, V51, P255, DOI 10.1071/MF99008; [Anonymous], ALGAE AUSTR INTRO; Araujo MB, 2001, CONSERV BIOL, V15, P1710, DOI 10.1046/j.1523-1739.2001.99450.x; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; BELKHIR K, 2000, GENETIX WINDOWS BASE; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Cai W, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024701; Coleman MA, 2009, MAR FRESHWATER RES, V60, P802, DOI 10.1071/MF08268; Coleman MA, 2005, J PHYCOL, V41, P753, DOI 10.1111/j.0022-3646.2005.04136.x; Coleman MA, 2008, J PHYCOL, V44, P897, DOI 10.1111/j.1529-8817.2008.00541.x; Coleman MA, 2008, CONSERV GENET, V9, P1015, DOI 10.1007/s10592-007-9437-5; Coleman MA, 2007, MAR FRESHWATER RES, V58, P589, DOI 10.1071/MF06216; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coleman MA, 2009, MAR ECOL PROG SER, V381, P63, DOI 10.3354/meps07977; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Curley BG, 2009, MAR BIOL, V156, P381, DOI 10.1007/s00227-008-1090-0; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Dolman G, 2009, CONSERV GENET, V10, P657, DOI 10.1007/s10592-008-9603-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Goodsell PJ, 2002, MAR ECOL PROG SER, V239, P37, DOI 10.3354/meps239037; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Halpern BS, 2003, ECOL APPL, V13, pS117; HATCHER BG, 1987, MAR BIOL, V95, P63, DOI 10.1007/BF00447486; HUNT A, 1989, MAR BIOL, V102, P537, DOI 10.1007/BF00438356; Irving AD, 2004, MAR BIOL, V144, P361, DOI 10.1007/s00227-003-1202-9; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Keough MJ, 1998, ECOL APPL, V8, P141, DOI 10.1890/1051-0761(1998)008[0141:EOPDFT]2.0.CO;2; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; Lubchenco J, 2003, ECOL APPL, V13, pS3; Mata MM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003592; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McKenzie PF, 2008, J PHYCOL, V44, P1108, DOI 10.1111/j.1529-8817.2008.00563.x; Millar Alan J. K., 1994, Australian Systematic Botany, V7, P1, DOI 10.1071/SB9940001; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pearson GA, 2006, INTEGR COMP BIOL, V46, P587, DOI 10.1093/icb/icl030; Piggott MP, 2008, MAR ECOL PROG SER, V365, P127, DOI 10.3354/meps07478; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reed DC, 2004, J PHYCOL, V40, P275, DOI 10.1046/j.1529-8817.2004.03119.x; REED DC, 1990, ECOLOGY, V71, P776, DOI 10.2307/1940329; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roughan M, 2011, DEEP-SEA RES PT II, V58, P628, DOI 10.1016/j.dsr2.2010.06.004; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Shanks AL, 2003, ECOL APPL, V13, pS159; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Sherman CDH, 2008, BIOL J LINN SOC, V95, P106, DOI 10.1111/j.1095-8312.2008.01044.x; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; UNDERWOOD AJ, 1990, HYDROBIOLOGIA, V192, P3, DOI 10.1007/BF00006224; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker DI, 1998, BOT MAR, V41, P105, DOI 10.1515/botm.1998.41.1-6.105; Ward RD, 2001, MAR FRESHWATER RES, V52, P563, DOI 10.1071/MF99184; Watts RJ, 2004, MAR FRESHWATER RES, V55, P641, DOI 10.1071/MF04051; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WOMERSLEY H.B.S, 1987, MARINE BENTHIC FLO 2; ZIMMERMAN RC, 1985, LIMNOL OCEANOGR, V30, P1298, DOI 10.4319/lo.1985.30.6.1298	68	55	56	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20168	10.1371/journal.pone.0020168	http://dx.doi.org/10.1371/journal.pone.0020168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625388	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200041
J	Mak, IWY; Cowan, RW; Turcotte, RE; Singh, G; Ghert, M				Mak, Isabella W. Y.; Cowan, Robert W.; Turcotte, Robert E.; Singh, Gurmit; Ghert, Michelle			PTHrP Induces Autocrine/Paracrine Proliferation of Bone Tumor Cells through Inhibition of Apoptosis	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; PARATHYROID-HORMONE; IN-VITRO; CANCER; EXPRESSION; CARCINOMA; PEPTIDE; DEATH; DIFFERENTIATION; HYPERCALCEMIA	Giant Cell Tumor of Bone (GCT) is an aggressive skeletal tumor characterized by local bone destruction, high recurrence rates and metastatic potential. Previous work in our lab has shown that the neoplastic cell of GCT is a proliferating pre-osteoblastic stromal cell in which the transcription factor Runx2 plays a role in regulating protein expression. One of the proteins expressed by these cells is parathryroid hormone-related protein (PTHrP). The objectives of this study were to determine the role played by PTHrP in GCT of bone with a focus on cell proliferation and apoptosis. Primary stromal cell cultures from 5 patients with GCT of bone and one lung metastsis were used for cell-based experiments. Control cell lines included a renal cell carcinoma (RCC) cell line and a human fetal osteoblast cell line. Cells were exposed to optimized concentrations of a PTHrP neutralizing antibody and were analyzed with the use of cell proliferation and apoptosis assays including mitochondrial dehydrogenase assays, crystal violet assays, APO-1 ELISAs, caspase activity assays, flow cytometry and immunofluorescent immunohistochemistry. Neutralization of PTHrP in the cell environment inhibited cell proliferation in a consistent manner and induced apoptosis in the GCT stromal cells, with the exception of those obtained from a lung metastasis. Cell cycle progression was not significantly affected by PTHrP neutralization. These findings indicate that PTHrP plays an autocrine/paracrine neoplastic role in GCT by allowing the proliferating stromal cells to evade apoptosis, possibly through non-traditional caspase-independent pathways. Thus PTHrP neutralizing immunotherapy is an intriguing potential therapeutic strategy for this tumor.	[Mak, Isabella W. Y.; Ghert, Michelle] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Cowan, Robert W.] McMaster Univ, Dept Med Sci, Hamilton, ON, Canada; [Turcotte, Robert E.] Montreal Gen Hosp, McGill Univ Hlth Ctr, Dept Orthopaed Surg, Montreal, PQ H3G 1A4, Canada; [Singh, Gurmit] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Mak, Isabella W. Y.; Cowan, Robert W.; Singh, Gurmit; Ghert, Michelle] Hamilton Hlth Sci, Juravinski Canc Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; McGill University; McMaster University; McMaster University	Mak, IWY (corresponding author), McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada.	michelle.ghert@jcc.hhsc.ca	Singh, Gurmit/C-6744-2014; Ghert, Michelle/AAQ-1745-2021; Ghert, Michelle/CAH-4578-2022; Mak, Isabella/E-1777-2012	Ghert, Michelle/0000-0002-4778-4522; Mak, Isabella/0000-0002-7861-4200; Cowan, Robert/0000-0001-7415-7156	Canadian Institutes of Health Research (CIHR); Hamilton Health Science; Juravinski Cancer Centre Foundation; McMaster University	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Hamilton Health Science; Juravinski Cancer Centre Foundation; McMaster University	The work was funded by Canadian Institutes of Health Research (CIHR) Grant, Hamilton Health Science New Investigator Fund, Juravinski Cancer Centre Foundation Grant, and McMaster University Surgical Associates Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke M, 2008, J CANCER RES CLIN, V134, P969, DOI 10.1007/s00432-008-0370-x; Balke M, 2009, J CANCER RES CLIN, V135, P149, DOI 10.1007/s00432-008-0427-x; Betea D, 2004, J CLIN ENDOCR METAB, V89, P3413, DOI 10.1210/jc.2003-031911; Blank M, 2007, CELL CYCLE, V6, P686, DOI 10.4161/cc.6.6.3990; Bradwell AR, 1999, LANCET, V353, P370, DOI 10.1016/S0140-6736(98)06469-1; BURTIS WJ, 1992, CLIN CHEM, V38, P2171; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Cowan RW, 2011, BONE, V48, pS48, DOI 10.1016/j.bone.2010.10.135; Cowan RW, 2009, BONE, V44, P865, DOI 10.1016/j.bone.2009.01.393; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Ghert M, 2007, CLIN ORTHOP RELAT R, P8, DOI 10.1097/BLO.0b013e31804856a1; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Iwamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P6, DOI 10.1053/joca.2002.0860; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kanduc D, 2002, INT J ONCOL, V21, P165; Kartsogiannis V, 1998, BONE, V22, P189, DOI 10.1016/S8756-3282(97)00278-0; Klein G, 2004, CELL DEATH DIFFER, V11, P13, DOI 10.1038/sj.cdd.4401342; Knochentumoren A, 2008, J BONE JOINT SURG AM, V90A, P1060, DOI 10.2106/JBJS.D.02771; Liao JH, 2006, CANCER METAST REV, V25, P559, DOI 10.1007/s10555-006-9033-z; Luparello C, 2001, J BONE MINER RES, V16, P2173, DOI 10.1359/jbmr.2001.16.12.2173; Mak IWY, 2010, HUM PATHOL, V41, P1320, DOI 10.1016/j.humpath.2010.03.001; Mak IWY, 2009, BONE, V45, P377, DOI 10.1016/j.bone.2009.04.253; Mak IY, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/164197; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Nakashima M, 2003, PATHOL RES PRACT, V199, P85, DOI 10.1078/0344-0338-00359; NISHIDA S, 1994, BONE, V15, P717, DOI 10.1016/8756-3282(94)90322-0; Nishihara M, 2007, ANN NY ACAD SCI, V1117, P385, DOI 10.1196/annals.1402.046; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Talon I, 2006, CARCINOGENESIS, V27, P73, DOI 10.1093/carcin/bgi203; THIEDE MA, 1988, P NATL ACAD SCI USA, V85, P4605, DOI 10.1073/pnas.85.13.4605; Thomas DM, 2009, CURR OPIN ONCOL, V21, P338, DOI 10.1097/CCO.0b013e32832c951d; Tse LF, 2008, BONE, V42, P68, DOI 10.1016/j.bone.2007.08.038; Turcotte RE, 2006, ORTHOP CLIN N AM, V37, P35, DOI 10.1016/j.ocl.2005.08.005; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Yamada T, 2009, MOL CANCER THER, V8, P119, DOI 10.1158/1535-7163.MCT-08-0874	40	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19975	10.1371/journal.pone.0019975	http://dx.doi.org/10.1371/journal.pone.0019975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625386	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200021
J	Sanchez, K; Papelard, A; Nguyen, C; Bendeddouche, I; Jousse, M; Rannou, F; Revel, M; Poiraudeau, S				Sanchez, Katherine; Papelard, Agathe; Nguyen, Christelle; Bendeddouche, Imad; Jousse, Marylene; Rannou, Francois; Revel, Michel; Poiraudeau, Serge			McMaster-Toronto Arthritis Patient Preference Disability Questionnaire Sensitivity to Change in Low Back Pain: Influence of Shifts in Priorities	PLOS ONE			English	Article							COPING STRATEGIES QUESTIONNAIRE; FEAR-AVOIDANCE BELIEFS; CROSS-SECTIONAL SURVEY; RHEUMATOID-ARTHRITIS; SYSTEMIC-SCLEROSIS; CLINICAL-TRIALS; HEALTH; VALIDITY; SCORES; VALIDATION	Objective: To assess the sensitivity to change of the McMaster Toronto Arthritis Patient Preference Disability Questionnaire (MACTAR) in chronic low back pain (CLBP) and shifts in patients' priorities of disabling activities over time. Methods: A prospective longitudinal survey of 100 patients (38 males) with CLBP in a tertiary care teaching hospital. Evaluation at baseline and 6 months by the MACTAR, Quebec Back Pain Disability Questionnaire (QUEBEC), Hospital Anxiety and Depression scale (HAD), Fear-Avoidance Beliefs Questionnaire (FABQ), Coping Strategies Questionnaire (CSQ), and pain and handicap visual analogue scales (VASs). Patients' perceived improvement or worsening of condition was assessed at 6 months. Effect size (ES) and Standardized response mean (SRM) and effect size (ES) were used to evaluate sensitivity to change of the MACTAR. Results: The MACTAR SRM and ES values (SRM = 0.25; ES = 0.37) were among the highest for the instruments evaluated. For patients considering their condition as improved, the SRM was 0.66 and the ES 1. The 3 disability domains, classified by the International Classification of Functioning, Disability and Health (ICF), most often cited as priorities at baseline remained the most cited at follow-up: mobility (40.9% of patients); community, social and civic life (22.7%); and domestic life (22.4%). At 6 months, 48 patients shifted their priorities, for a decrease in MACTAR SRM and ES values for patients considering their condition improved and an increase in these values for those considering their condition deteriorated. Conclusions: Although the MACTAR has similar sensitivity to change as other outcome measures widely used in CLBP, shifts in patient priorities over time are common and influence scores and sensitivity to change.	[Sanchez, Katherine; Papelard, Agathe; Nguyen, Christelle; Bendeddouche, Imad; Jousse, Marylene; Rannou, Francois; Revel, Michel; Poiraudeau, Serge] Univ Paris 05, Hop Cochin, AP HP, Serv Med Phys & Readaptat, Paris, France; [Rannou, Francois; Poiraudeau, Serge] INSERM, Inst Federatif Rech Handicap, IFR 25, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sanchez, K (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Serv Med Phys & Readaptat, Paris, France.	serge.poiraudeau@cch.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016	Nguyen, MD, PhD, Christelle/0000-0001-7141-3230; Poiraudeau, Serge/0000-0002-1988-9124				ALARCOSCIEZA, 2002, J REHABIL MED, V34, P205; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; CAMELS P, 2005, ANN READAPT MED PHYS, V48, P288; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Chaory K, 2004, SPINE, V29, P908, DOI 10.1097/00007632-200404150-00018; CO YY, 1993, J MANIP PHYSIOL THER, V16, P14; DEYO RA, 1986, SPINE, V11, P951, DOI 10.1097/00007632-198611000-00017; Ehrlich GE, 2003, B WORLD HEALTH ORGAN, V81, P671; Fairbank J C, 1980, Physiotherapy, V66, P271; FERMANIAN J, 1984, REV EPIDEMIOL SANTE, V32, P408; FORTIN PR, 1995, ARTHRITIS RHEUM, V38, P1027, DOI 10.1002/art.1780380802; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Hewlett S, 2001, ANN RHEUM DIS, V60, P928, DOI 10.1136/ard.60.10.928; Irachabal S, 2008, ENCEPHALE, V34, P47, DOI 10.1016/j.encep.2006.11.002; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Lester N, 1996, CLIN J PAIN, V12, P291, DOI 10.1097/00002508-199612000-00008; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; MAIN CJ, 1991, PAIN, V46, P287, DOI 10.1016/0304-3959(91)90112-B; Mouthon L, 2008, ARTHRIT RHEUM-ARTHR, V59, P968, DOI 10.1002/art.23819; Nguyen C, 2010, J RHEUMATOL, V37, P359, DOI 10.3899/jrheum.090632; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Pfingsten M, 2000, EUR J PAIN-LONDON, V4, P259, DOI 10.1053/eujp.2000.0178; Riley JL, 1997, CLIN J PAIN, V13, P156, DOI 10.1097/00002508-199706000-00010; Robinson ME, 1997, CLIN J PAIN, V13, P43, DOI 10.1097/00002508-199703000-00007; Rocchi M B L, 2005, Eura Medicophys, V41, P275; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Sanchez K, 2009, SPINE, V34, P1052, DOI 10.1097/BRS.0b013e31819c093b; Stratford PW, 1996, PHYS THER, V76, P1109, DOI 10.1093/ptj/76.10.1109; TUGWELL P, 1987, J RHEUMATOL, V14, P446; TUGWELL P, 1990, ARCH INTERN MED, V150, P59, DOI 10.1001/archinte.150.1.59; TULEY MR, 1991, J CLIN EPIDEMIOL, V44, P471; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Verhoeven AC, 2000, J RHEUMATOL, V27, P2801; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; YVANESTHOMAS M, 2002, REV RHUM ED FR, V69, P737; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20274	10.1371/journal.pone.0020274	http://dx.doi.org/10.1371/journal.pone.0020274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629777	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005200046
J	Bapat, D; Huang, XM; Gunalan, K; Preiser, PR				Bapat, Devaki; Huang, Ximei; Gunalan, Karthigayan; Preiser, Peter R.			Changes in Parasite Virulence Induced by the Disruption of a Single Member of the 235 kDa Rhoptry Protein Multigene Family of Plasmodium yoelii	PLOS ONE			English	Article							RODENT MALARIA PARASITE; ERYTHROCYTE INVASION PHENOTYPES; HIGH-EFFICIENCY TRANSFECTION; HOST-CELL SELECTION; BINDING-PROTEIN; MEROZOITE PROTEINS; AVIRULENT LINES; IMMUNE EVASION; FALCIPARUM; RECEPTOR	Invasion of the erythrocyte by the merozoites of the malaria parasite is a complex process involving a range of receptor-ligand interactions. Two protein families termed Erythrocyte Binding Like (EBL) proteins and Reticulocyte Binding Protein Homologues (RH) play an important role in host cell recognition by the merozoite. In the rodent malaria parasite, Plasmodium yoelii, the 235 kDa rhoptry proteins (Py235) are coded for by a multigene family and are members of the RH. In P. yoelii Py235 as well as a single member of EBL have been shown to be key mediators of virulence enabling the parasite to invade a wider range of host erythrocytes. One member of Py235, PY01365 is most abundantly transcribed in parasite populations and the protein specifically binds to erythrocytes and is recognized by the protective monoclonal antibody 25.77, suggesting a key role of this particular member in virulence. Recent studies have indicated that overall levels of Py235 expression are essential for parasite virulence. Here we show that disruption of PY01365 in the virulent YM line directly impacts parasite virulence. Furthermore the disruption of PY01365 leads to a reduction in the number of schizonts that express members of Py235 that react specifically with the mcAb 25.77. Erythrocyte binding assays show reduced binding of Py235 to red blood cells in the PY01365 knockout parasite as compared to YM. While our results identify PY01365 as a mediator of parasite virulence, they also confirm that other members of Py235 are able to substitute for PY01365.	[Bapat, Devaki; Huang, Ximei; Gunalan, Karthigayan; Preiser, Peter R.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bapat, D (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	prpreiser@ntu.edu.sg	Gunalan, Karthigayan/AAE-5893-2021; Preiser, Peter R/A-2201-2011	, Peter/0000-0003-4331-7000	Biomedical Research Council of Singapore (BMRC) [08/1/22/19/581]	Biomedical Research Council of Singapore (BMRC)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of Singapore (BMRC Grant No: 08/1/22/19/581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; FAHEY JR, 1984, INFECT IMMUN, V44, P151, DOI 10.1128/IAI.44.1.151-156.1984; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; Gao X, 2008, PLOS PATHOG IN PRESS; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2006, MOL BIOCHEM PARASIT, V150, P186, DOI 10.1016/j.molbiopara.2006.07.012; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Kappe SHI, 1997, MOL BIOCHEM PARASIT, V89, P137, DOI 10.1016/S0166-6851(97)00113-8; Kappe SHI, 1998, P NATL ACAD SCI USA, V95, P1230, DOI 10.1073/pnas.95.3.1230; KEEN J, 1990, MOL BIOCHEM PARASIT, V42, P241, DOI 10.1016/0166-6851(90)90167-K; Khan SM, 2001, MOL BIOCHEM PARASIT, V114, P197, DOI 10.1016/S0166-6851(01)00253-5; Khan SM, 2001, MOL BIOCHEM PARASIT, V117, P1, DOI 10.1016/S0166-6851(01)00333-4; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DC, 2004, P NATL ACAD SCI US; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; Ogun SA, 2000, EXP PARASITOL, V95, P187, DOI 10.1006/expr.2000.4535; Ogun SA, 2006, MOL BIOCH PARASITOL; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Otsuki H, 2009, P NATL ACAD SCI USA, V106, P7167, DOI 10.1073/pnas.0811313106; Pattaradilokrat S, 2009, P NATL ACAD SCI USA, V106, P7161, DOI 10.1073/pnas.0811430106; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Prasad CD, 2003, MOL BIOCHEM PARASIT, V128, P101, DOI 10.1016/S0166-6851(03)00040-9; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Preiser PR, 1998, EXP PARASITOL, V89, P50, DOI 10.1006/expr.1998.4259; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Ramalingam JK, 2008, J BIOL CHEM, V283, P36386, DOI 10.1074/jbc.M803102200; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998	51	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20170	10.1371/journal.pone.0020170	http://dx.doi.org/10.1371/journal.pone.0020170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625465	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400043
J	Delrieu, I; Yaro, S; Tamekloe, TAS; Njanpop-Lafourcade, BM; Tall, H; Jaillard, P; Ouedraogo, MS; Badziklou, K; Sanou, O; Drabo, A; Gessner, BD; Kambou, JL; Mueller, JE				Delrieu, Isabelle; Yaro, Seydou; Tamekloe, Tsidi A. S.; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Jaillard, Philippe; Ouedraogo, Macaire S.; Badziklou, Kossi; Sanou, Oumarou; Drabo, Aly; Gessner, Bradford D.; Kambou, Jean L.; Mueller, Judith E.			Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso	PLOS ONE			English	Article							MENINGOCOCCAL MENINGITIS; CARRIAGE; IMPACT; NIGER; BELT; W135	Serogroup X meningococci (NmX) historically have caused sporadic and clustered meningitis cases in sub-Saharan Africa. To study recent NmX epidemiology, we analyzed data from population-based, sentinel and passive surveillance, and outbreak investigations of bacterial meningitis in Togo and Burkina Faso during 2006-2010. Cerebrospinal fluid specimens were analyzed by PCR. In Togo during 2006-2009, NmX accounted for 16% of the 702 confirmed bacterial meningitis cases. Kozah district experienced an NmX outbreak in March 2007 with an NmX seasonal cumulative incidence of 33/100,000. In Burkina Faso during 2007-2010, NmX accounted for 7% of the 778 confirmed bacterial meningitis cases, with an increase from 2009 to 2010 (4% to 35% of all confirmed cases, respectively). In 2010, NmX epidemics occurred in northern and central regions of Burkina Faso; the highest district cumulative incidence of NmX was estimated as 130/100,000 during March-April. Although limited to a few districts, we have documented NmX meningitis epidemics occurring with a seasonal incidence previously only reported in the meningitis belt for NmW135 and NmA, which argues for development of an NmX vaccine.	[Delrieu, Isabelle; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Jaillard, Philippe; Sanou, Oumarou; Gessner, Bradford D.; Mueller, Judith E.] Agence Med Prevent, Paris, France; [Yaro, Seydou; Drabo, Aly] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Tamekloe, Tsidi A. S.] Minist Hlth, Lome, Togo; [Ouedraogo, Macaire S.] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Badziklou, Kossi] Natl Inst Hyg, Lome, Togo; [Kambou, Jean L.] Minist Hlth, Ouagadougou, Burkina Faso	Agence de Medecine Preventive; Centre Muraz	Delrieu, I (corresponding author), Agence Med Prevent, Paris, France.	jmueller@aamp.org			Sanofi Pasteur; French Foreign Ministry (Fonds de Solidarite Prioritaire); Institut Pasteur de Paris	Sanofi Pasteur; French Foreign Ministry (Fonds de Solidarite Prioritaire); Institut Pasteur de Paris	The surveillance in Togo and Burkina Faso 2006-09 was supported by Sanofi Pasteur. Surveillance in Burkina Faso 2009-10 was supported by the French Foreign Ministry (Fonds de Solidarite Prioritaire) with the Institut Pasteur de Paris. The Mobile Laboratory has received a donation from Mrs. Claude Lardy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjogble KLS, 2007, VACCINE, V25, pA47, DOI 10.1016/j.vaccine.2007.04.040; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P294; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Collard JM, 2010, EMERG INFECT DIS, V16, P1496, DOI 10.3201/eid1609.100510; Dellicour S, 2007, TROP MED INT HEALTH, V12, P1409, DOI 10.1111/j.1365-3156.2007.01929.x; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Etienne J, 1990, Med Trop (Mars), V50, P227; Gagneux SP, 2002, J INFECT DIS, V185, P618, DOI 10.1086/339010; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lewis R., 2006, WHO HLTH ACTION CRIS, V1, P6; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Materu S, 2007, EMERG INFECT DIS, V13, P944, DOI 10.3201/eid1306.070042; McSweeney C., 2008, CLIMATE CHANGE COUNT; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Mueller JE, 2008, TROP MED INT HEALTH, V13, P1543, DOI 10.1111/j.1365-3156.2008.02165.x; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Ouedraogo RT, 2008, MOBILE LAB IMPROVE R; Traore Y, 2006, CLIN INFECT DIS, V43, P817, DOI 10.1086/507339; WHO-AFRO, 2009, STANDARD OPERATING P	24	97	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19513	10.1371/journal.pone.0019513	http://dx.doi.org/10.1371/journal.pone.0019513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625480	Green Published, gold, Green Submitted			2022-12-25	WOS:000290793400005
J	Guan, HY; Song, LB; Cai, JC; Huang, YB; Wu, JH; Yuan, J; Li, J; Li, MF				Guan, Hongyu; Song, Libing; Cai, Junchao; Huang, Yongbo; Wu, Jueheng; Yuan, Jie; Li, Jun; Li, Mengfeng			Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; HUMAN GLIOBLASTOMA CELLS; BCL-2 FAMILY-MEMBERS; BREAST-CANCER; AKT ACTIVATION; UP-REGULATION; LUNG-CANCER; EXPRESSION; SURVIVAL; BIM	The aim of this study was to investigate the mechanism through which Sphingosine kinase-1 (SPHK1) exerts its antiapoptosis activity in glioma cancer cells. We here report that dysregulation of SPHK1 alters the sensitivity of glioma to apoptosis both in vitro and in vivo. Further mechanistic study examined the expression of Bcl-2 family members, including Bcl-2, Mcl-1, Bax and Bim, in SPHK1-overexpressing glioma cells and revealed that only pro-apoptotic Bim was downregulated by SPHK1. Moreover, the transcriptional level of Bim was also altered by SPHK1 in glioma cells. We next confirmed the correlation between SPHK1 and Bim expression in primary glioma specimens. Importantly, increasing SPHK1 expression in glioma cells markedly elevated Akt activity and phosphorylated inactivation of FOXO3a, which led to downregulation of Bim. A pharmacological approach showed that these effects of SPHK1 were dependent on phosphatidylinositol 3-kinase (PI3K). Furthermore, effects of SPHK1 on Akt/FOXO3a/Bim pathway could be reversed by SPHK1 specific RNA interference or SPHK1 inhibitor. Collectively, our results indicate that regulation of the Akt/FOXO3a/Bim pathway may be a novel mechanism by which SPHK1 protects glioma cells from apoptosis, thereby involved in glioma tumorigenesis.	[Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Guan, Hongyu] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Diabet, Guangzhou 510275, Guangdong, Peoples R China; [Song, Libing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Junchao; Huang, Yongbo; Wu, Jueheng; Yuan, Jie; Li, Jun; Li, Mengfeng] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Junchao; Huang, Yongbo; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou 510275, Guangdong, Peoples R China; [Yuan, Jie] Sun Yat Sen Univ, Key Lab Funct Mol Ocean Microorganisms, Dept Educ Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Guan, HY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China.	limf@mail.sysu.edu.cn	meng, li/GVT-2063-2022; Song, LB/AAL-1968-2020	Huang, Yongbo/0000-0001-6798-0451	Ministry of Science and Technology of China [2005CB724605]; Natural Science Foundation of China [30771110, 30870963, U0632002, 30831160517, 40806059, 81030048, 81001190]; Fundamental Research Funds for the Central Universities [10ykzd03]; Program for New Century Excellent Talents in Universities [NCET-07-0877]; Science and Technology Department of Guangdong Province, China [8251008901000006]; Ministry of Education of China [(2008)890, 200805580047]; Guangdong Provincial Natural Science Foundation [06201946]; National High-Tech R&D Program (863 Program) [2007AA09Z431, 2007AA09Z448]; National Science and Technique Major Project [2009ZX09103-041, 201005022-2, 2009ZX10004-213]; Key Science and Technique Research Project of Guangdong Province [2007A03260001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Science and Technology Department of Guangdong Province, China; Ministry of Education of China(Ministry of Education, China); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Science and Technique Major Project; Key Science and Technique Research Project of Guangdong Province	The work was funded by the Ministry of Science and Technology of China (973) 2005CB724605; The Natural Science Foundation of China (No. 30771110, 30870963, U0632002, 30831160517, 40806059, 81030048, 81001190); The Fundamental Research Funds for the Central Universities (No. 10ykzd03); Program for New Century Excellent Talents in Universities (No. NCET-07-0877); The Science and Technology Department of Guangdong Province, China (No. 8251008901000006); Ministry of Education of China [No. (2008)890 and No. 200805580047]; Guangdong Provincial Natural Science Foundation (No. 06201946); National High-Tech R&D Program (863 Program) (2007AA09Z431, 2007AA09Z448); National Science and Technique Major Project (2009ZX09103-041, 201005022-2, 2009ZX10004-213); and The Key Science and Technique Research Project of Guangdong Province (2007A03260001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Andre F, 2008, ANN ONCOL, V19, P315, DOI 10.1093/annonc/mdm429; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dean EJ, 2007, CANCER TREAT REV, V33, P203, DOI 10.1016/j.ctrv.2006.11.002; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; French KJ, 2003, CANCER RES, V63, P5962; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Jiang ZH, 2004, J NEUROCHEM, V89, P168, DOI 10.1111/j.1471-4159.2004.02319.x; Jin HO, 2006, J CELL PHYSIOL, V206, P477, DOI 10.1002/jcp.20488; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; KLEIHUES P, WHO CLASSIFICATION T; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sonoda Y, 2001, CANCER RES, V61, P6674; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4	47	66	68	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19946	10.1371/journal.pone.0019946	http://dx.doi.org/10.1371/journal.pone.0019946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625639	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200050
J	Bhandari, RK; Sadler-Riggleman, I; Clement, TM; Skinner, MK				Bhandari, Ramji K.; Sadler-Riggleman, Ingrid; Clement, Tracy M.; Skinner, Michael K.			Basic Helix-Loop-Helix Transcription Factor TCF21 Is a Downstream Target of the Male Sex Determining Gene SRY	PLOS ONE			English	Article							TESTICULAR SERTOLI-CELLS; FETAL LEYDIG-CELLS; TESTIS DEVELOPMENT; EMBRYONIC TESTIS; DIFFERENTIATION; MICE; ACTIVATION; EXPRESSION; PROTEINS; SOX9	The cascade of molecular events involved in mammalian sex determination has been shown to involve the SRY gene, but specific downstream events have eluded researchers for decades. The current study identifies one of the first direct downstream targets of the male sex determining factor SRY as the basic-helix-loop-helix (bHLH) transcription factor TCF21. SRY was found to bind to the Tcf21 promoter and activate gene expression. Mutagenesis of SRY/SOX9 response elements in the Tcf21 promoter eliminated the actions of SRY. SRY was found to directly associate with the Tcf21 promoter SRY/SOX9 response elements in vivo during fetal rat testis development. TCF21 was found to promote an in vitro sex reversal of embryonic ovarian cells to induce precursor Sertoli cell differentiation. TCF21 and SRY had similar effects on the in vitro sex reversal gonadal cell transcriptomes. Therefore, SRY acts directly on the Tcf21 promoter to in part initiate a cascade of events associated with Sertoli cell differentiation and embryonic testis development.	[Bhandari, Ramji K.; Sadler-Riggleman, Ingrid; Clement, Tracy M.; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA	Washington State University	Bhandari, RK (corresponding author), Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA.	skinner@wsu.edu			National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a National Institutes of Health (NIH) grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsoum IB, 2010, J ANDROL, V31, P11, DOI 10.2164/jandrol.109.008318; Barsoum IB, 2009, DEV BIOL, V329, P96, DOI 10.1016/j.ydbio.2009.02.025; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Candiani G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013430; Chaudhary J, 2002, ENDOCRINOLOGY, V143, P426, DOI 10.1210/en.143.2.426; Chaudhary J, 1999, BIOL REPROD, V60, P1244, DOI 10.1095/biolreprod60.5.1244; Chaudhary J, 1999, ENDOCRINOLOGY, V140, P1262, DOI 10.1210/en.140.3.1262; CLEMENT TM, 2010, BIOL REPROD UNPUB; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Clement TM, 2010, REPROD TOXICOL, V30, P353, DOI 10.1016/j.reprotox.2010.05.086; Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; Cupp AS, 2003, BIOL REPROD, V68, P2033, DOI 10.1095/biolreprod.102.012617; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; KADESCH T, 1993, CELL GROWTH DIFFER, V4, P49; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kitajima S, 2000, DEVELOPMENT, V127, P3215; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Levine E, 2000, BIOL REPROD, V62, P132, DOI 10.1095/biolreprod62.1.132; Levine E, 2000, BIOL REPROD, V62, P477, DOI 10.1095/biolreprod62.3.477; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SHIMA JE, 2004, BIOL REPROD; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SKINNER MK, 2010, BASIC HELIX LOOP HEL; Stevens JD, 2008, DIFFERENTIATION, V76, P1006, DOI 10.1111/j.1432-0436.2008.00285.x; Tamura M, 2001, MECH DEVELOP, V102, P135, DOI 10.1016/S0925-4773(01)00298-2; Tien JCY, 2009, INT J BIOL SCI, V5, P256; Uzumcu M, 2002, BIOL REPROD, V66, P745, DOI 10.1095/biolreprod66.3.745; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	43	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e19935	10.1371/journal.pone.0019935	http://dx.doi.org/10.1371/journal.pone.0019935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21637323	Green Submitted, gold, Green Published			2022-12-25	WOS:000290657500034
J	Bottegoni, G; Rocchia, W; Rueda, M; Abagyan, R; Cavalli, A				Bottegoni, Giovanni; Rocchia, Walter; Rueda, Manuel; Abagyan, Ruben; Cavalli, Andrea			Systematic Exploitation of Multiple Receptor Conformations for Virtual Ligand Screening	PLOS ONE			English	Article							PROTEIN FLEXIBILITY; SCORING FUNCTIONS; ENSEMBLE DOCKING; DRUG DISCOVERY; ENRICHMENT; OPTIMIZATION; RECOGNITION; PERFORMANCE; VALIDATION; STRATEGIES	The role of virtual ligand screening in modern drug discovery is to mine large chemical collections and to prioritize for experimental testing a comparatively small and diverse set of compounds with expected activity against a target. Several studies have pointed out that the performance of virtual ligand screening can be improved by taking into account receptor flexibility. Here, we systematically assess how multiple crystallographic receptor conformations, a powerful way of discretely representing protein plasticity, can be exploited in screening protocols to separate binders from non-binders. Our analyses encompass 36 targets of pharmaceutical relevance and are based on actual molecules with reported activity against those targets. The results suggest that an ensemble receptor-based protocol displays a stronger discriminating power between active and inactive molecules as compared to its standard single rigid receptor counterpart. Moreover, such a protocol can be engineered not only to enrich a higher number of active compounds, but also to enhance their chemical diversity. Finally, some clear indications can be gathered on how to select a subset of receptor conformations that is most likely to provide the best performance in a real life scenario.	[Bottegoni, Giovanni; Rocchia, Walter; Cavalli, Andrea] Ist Italiano Tecnol, Dept Drug Discovery & Dev D3, Genoa, Italy; [Rueda, Manuel; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Cavalli, Andrea] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy	Istituto Italiano di Tecnologia - IIT; University of California System; University of California San Diego; University of Bologna	Bottegoni, G (corresponding author), Ist Italiano Tecnol, Dept Drug Discovery & Dev D3, Genoa, Italy.	andrea.cavalli@iit.it	Rocchia, Walter/H-3784-2012	Rocchia, Walter/0000-0003-2480-7151; Rueda, Manuel/0000-0001-9280-058X; CAVALLI, ANDREA/0000-0002-6370-1176; Bottegoni, Giovanni/0000-0003-1251-583X	Fondazione Istituto Italiano di Tecnologia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071872] Funding Source: NIH RePORTER	Fondazione Istituto Italiano di Tecnologia; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by Fondazione Istituto Italiano di Tecnologia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, PROTEINS, V19, P132, DOI 10.1002/prot.340190206; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Abagyan R, 2001, CURR OPIN CHEM BIOL, V5, P375, DOI 10.1016/S1367-5931(00)00217-9; Abagyan R., 2010, ICM MANUAL 3 7; Abagyan R, 2009, METHODS MOL BIOL, V575, P249, DOI 10.1007/978-1-60761-274-2_11; Barril X, 2005, J MED CHEM, V48, P4432, DOI 10.1021/jm048972v; Bissantz C, 2000, J MED CHEM, V43, P4759, DOI 10.1021/jm001044l; Bisson WH, 2007, P NATL ACAD SCI USA, V104, P11927, DOI 10.1073/pnas.0609752104; Bolstad ESD, 2008, PROTEINS, V73, P566, DOI 10.1002/prot.22081; Bottegoni G, 2008, J COMPUT AID MOL DES, V22, P311, DOI 10.1007/s10822-008-9188-5; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Carlson HA, 2000, MOL PHARMACOL, V57, P213; Cavasotto CN, 2004, J MOL BIOL, V337, P209, DOI 10.1016/j.jmb.2004.01.003; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Corbeil CR, 2007, J CHEM INF MODEL, V47, P435, DOI 10.1021/ci6002637; Craig IR, 2010, J CHEM INF MODEL, V50, P511, DOI 10.1021/ci900407c; Damm KL, 2007, J AM CHEM SOC, V129, P8225, DOI 10.1021/ja0709728; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; FERRARA P, 2007, J MOL MODEL; Good AC, 2008, J COMPUT AID MOL DES, V22, P169, DOI 10.1007/s10822-007-9167-2; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Jahn A, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-14; Jain AN, 2008, J COMPUT AID MOL DES, V22, P133, DOI 10.1007/s10822-008-9196-5; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kirchmair J, 2008, CURR MED CHEM, V15, P2040, DOI 10.2174/092986708785132843; Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; Lorber DM, 1998, PROTEIN SCI, V7, P938; Mayr LM, 2008, J BIOMOL SCREEN, V13, P443, DOI 10.1177/1087057108319644; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; McCammon JA, 2005, BBA-PROTEINS PROTEOM, V1754, P221, DOI 10.1016/j.bbapap.2005.07.041; Moitessier N, 2008, BRIT J PHARMACOL, V153, pS7, DOI 10.1038/sj.bjp.0707515; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Park SJ, 2010, J COMPUT AID MOL DES, V24, P459, DOI 10.1007/s10822-010-9362-4; Polgar T, 2005, J MED CHEM, V48, P7946, DOI 10.1021/jm050504d; Polgar T, 2006, J CHEM INF MODEL, V46, P1795, DOI 10.1021/ci050412x; Rao S, 2008, J COMPUT AID MOL DES, V22, P621, DOI 10.1007/s10822-008-9182-y; Rueda M, 2010, J CHEM INF MODEL, V50, P186, DOI 10.1021/ci9003943; Rueda M, 2009, J CHEM INF MODEL, V49, P716, DOI 10.1021/ci8003732; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; Sheridan RP, 2008, J COMPUT AID MOL DES, V22, P257, DOI 10.1007/s10822-008-9168-9; Sheridan RP, 2001, J CHEM INF COMP SCI, V41, P1395, DOI 10.1021/ci0100144; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sperandio O, 2010, EUR BIOPHYS J BIOPHY, V39, P1365, DOI 10.1007/s00249-010-0592-0; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Teodoro ML, 2003, CURR PHARM DESIGN, V9, P1635, DOI 10.2174/1381612033454595; TOTROV M, 1999, DERIVATION SENSITIVE, P37; Totrov M., 2001, DRUG RECEPTOR THERMO, P603; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Verdonk ML, 2008, J CHEM INF MODEL, V48, P2214, DOI 10.1021/ci8002254; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Wei BQ, 2004, J MOL BIOL, V337, P1161, DOI 10.1016/j.jmb.2004.02.015; Zhao Y, 2007, PROTEINS, V68, P726, DOI 10.1002/prot.21423	65	65	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2011	6	5							e18845	10.1371/journal.pone.0018845	http://dx.doi.org/10.1371/journal.pone.0018845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TX	21625529	gold, Green Published, Green Submitted			2022-12-25	WOS:000290657500002
J	Hargrove, TY; Wawrzak, Z; Liu, JL; Nes, WD; Waterman, MR; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Liu, Jialin; Nes, W. David; Waterman, Michael R.; Lepesheva, Galina I.			Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14 alpha-Demethylase (CYP51) from Leishmania infantum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							14 ALPHA-DEMETHYLASE; OBTUSIFOLIOL 14-ALPHA-DEMETHYLASE; CHOLESTEROL-BIOSYNTHESIS; CYTOCHROME-P450 3A4; C-32 DEMETHYLATION; TRYPANOSOMA-BRUCEI; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; EXPRESSION; LANOSTEROL	Leishmaniasis is a major health problem that affects populations of similar to 90 countries worldwide, with no vaccine and only a few moderately effective drugs. Here we report the structure/function characterization of sterol 14 alpha-demethylase (CYP51) from Leishmania infantum. The enzyme catalyzes removal of the 14 alpha-methyl group from sterol precursors. The reaction is essential for membrane biogenesis and therefore has great potential to become a target for antileishmanial chemotherapy. Although L. infantum CYP51 prefers C4-monomethylated sterol substrates such as C4-norlanosterol and obtusifoliol (V-max of similar to 10 and 8min(-1), respectively), it is also found to 14 alpha-demethylate C4-dimethylated lanosterol (V-max = 0.9 min(-1)) and C4-desmethylated 14 alpha-methylzymosterol (V-max = 1.9 min(-1)). Binding parameters with six sterols were tested, with K-d values ranging from 0.25 to 1.4 mu M. Thus, L. infantum CYP51 is the first example of a plant-like sterol 14 alpha-demethylase, where requirements toward the composition of the C4 atom substituents are not strict, indicative of possible branching in the postsqualene portion of sterol biosynthesis in the parasite. Comparative analysis of three CYP51 substrate binding cavities (Trypanosoma brucei, Trypanosoma cruzi, and L. infantum) suggests that substrate preferences of plant- and fungal-like protozoan CYP51s largely depend on the differences in the enzyme active site topology. These minor structural differences are also likely to underlie CYP51 catalytic rates and drug susceptibility and can be used to design potent and specific inhibitors.	[Hargrove, Tatiana Y.; Waterman, Michael R.; Lepesheva, Galina I.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Ctr Synchrotron Res, Argonne, IL 60439 USA; [Liu, Jialin; Nes, W. David] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA	Vanderbilt University; Northwestern University; Texas Tech University System; Texas Tech University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 622 RRB,23rd Pierce, Nashville, TN 37232 USA.	galina.i.lepesheva@vanderbilt.edu			National Institutes of Health [GM 067871]; Vanderbilt Institute of Chemical Biology; National Science Foundation [MCB-0929212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute of Chemical Biology; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067871 (to M. R. W. and G. I. L.). This work was also supported by Vanderbilt Institute of Chemical Biology Pilot Project Grant 2011 (to G. I. L.) and National Science Foundation Grant MCB-0929212 (to W. D. N.).	Alrajhi AA, 2002, NEW ENGL J MED, V346, P891, DOI 10.1056/NEJMoa011882; Bak S, 1997, PLANT J, V11, P191, DOI 10.1046/j.1365-313X.1997.11020191.x; Balana-Fouce R, 1998, GEN PHARMACOL-VASC S, V30, P435, DOI 10.1016/S0306-3623(97)00268-1; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; BEACH DH, 1988, MOL BIOCHEM PARASIT, V31, P149, DOI 10.1016/0166-6851(88)90166-1; Cabello-Hurtado F, 1999, EUR J BIOCHEM, V262, P435, DOI 10.1046/j.1432-1327.1999.00376.x; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOTOH O, 1992, J BIOL CHEM, V267, P83; Haughan P.A., 1991, P312; Jackson CJ, 2002, J BIOL CHEM, V277, P46959, DOI 10.1074/jbc.M203523200; Kahn RA, 1996, J BIOL CHEM, V271, P32944, DOI 10.1074/jbc.271.51.32944; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Lepesheva GI, 2006, BIOCHEM SOC T, V34, P1161, DOI 10.1042/BST0341161; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama K, 2001, J BIOL CHEM, V276, P31459, DOI 10.1074/jbc.M103943200; Nes W. R., 1977, BIOCH STEROIDS OTHER; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; OMURA T, 1964, J BIOL CHEM, V239, P2370; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Petrikkos G, 2007, INT J ANTIMICROB AG, V30, P108, DOI 10.1016/j.ijantimicag.2007.03.009; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Rodrigues JCF, 2002, ANTIMICROB AGENTS CH, V46, P487, DOI 10.1128/AAC.46.2.487-499.2002; Rodriguez NE, 2006, CELL MICROBIOL, V8, P1106, DOI 10.1111/j.1462-5822.2006.00695.x; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Singh Sarman, 2004, Journal of Infection and Chemotherapy, V10, P307, DOI 10.1007/s10156-004-0348-9; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; TABACIK C, 1981, BIOCHEM BIOPH RES CO, V101, P1087, DOI 10.1016/0006-291X(81)91559-X; TATON M, 1991, BIOCHEM J, V277, P483, DOI 10.1042/bj2770483; TRZASKOS JM, 1986, J BIOL CHEM, V261, P6937; TRZASKOS JM, 1984, J BIOL CHEM, V259, P3402; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4225, DOI 10.1128/AAC.00316-10; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YOSHIDA Y, 1984, J BIOL CHEM, V259, P1655; Yoshida Y, 2000, BIOCHEM BIOPH RES CO, V273, P799, DOI 10.1006/bbrc.2000.3030; Zonios DI, 2008, SEMIN RESP CRIT CARE, V29, P198, DOI 10.1055/s-2008-1063858	51	78	82	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26838	26848		10.1074/jbc.M111.237099	http://dx.doi.org/10.1074/jbc.M111.237099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632531	Green Published, hybrid			2022-12-25	WOS:000293078200059
J	Bacchetti, P; Boylan, R; Astemborski, J; Shen, H; Mehta, SH; Thomas, DL; Terrault, NA; Monto, A				Bacchetti, Peter; Boylan, Ross; Astemborski, Jacquie; Shen, Hui; Mehta, Shruti H.; Thomas, David L.; Terrault, Norah A.; Monto, Alexander			Progression of Biopsy-Measured Liver Fibrosis in Untreated Patients with Hepatitis C Infection: Non-Markov Multistate Model Analysis	PLOS ONE			English	Article							INJECTION-DRUG USERS; UNITED-STATES; VIRUS-INFECTION; DISEASE; CLASSIFICATION; IMPUTATION; DIAGNOSIS; SEVERITY; RISKS; AGE	Background: Fibrosis stages from liver biopsies reflect liver damage from hepatitis C infection, but analysis is challenging due to their ordered but non-numeric nature, infrequent measurement, misclassification, and unknown infection times. Methods: We used a non-Markov multistate model, accounting for misclassification, with multiple imputation of unknown infection times, applied to 1062 participants of whom 159 had multiple biopsies. Odds ratios (OR) quantified the estimated effects of covariates on progression risk at any given time. Results: Models estimated that progression risk decreased the more time participants had already spent in the current stage, African American race was protective (OR 0.75, 95% confidence interval 0.60 to 0.95, p = 0.018), and older current age increased risk (OR 1.33 per decade, 95% confidence interval 1.15 to 1.54, p = 0.0002). When controlled for current age, older age at infection did not appear to increase risk (OR 0.92 per decade, 95% confidence interval 0.47 to 1.79, p = 0.80). There was a suggestion that co-infection with human immunodeficiency virus increased risk of progression in the era of highly active antiretroviral treatment beginning in 1996 (OR 2.1, 95% confidence interval 0.97 to 4.4, p = 0.059). Other examined risk factors may influence progression risk, but evidence for or against this was weak due to wide confidence intervals. The main results were essentially unchanged using different assumed misclassification rates or imputation of age of infection. Discussion: The analysis avoided problems inherent in simpler methods, supported the previously suspected protective effect of African American race, and suggested that current age rather than age of infection increases risk. Decreasing risk of progression with longer time already spent in a stage was also previously found for post-transplant progression. This could reflect varying disease activity, with recent progression indicating active disease and high risk, while longer time already spent in a stage indicates quiescent disease and low risk.	[Bacchetti, Peter; Boylan, Ross] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Astemborski, Jacquie; Thomas, David L.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Astemborski, Jacquie; Mehta, Shruti H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shen, Hui; Terrault, Norah A.; Monto, Alexander] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Shen, Hui; Monto, Alexander] San Francisco VA Med Ctr, Div Gastroenterol, San Francisco, CA USA; [Terrault, Norah A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Bacchetti, P (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	peter@biostat.ucsf.edu			United States National Institutes of Health [R01AI069952, R01DA016078, R01DA004334, R01DA012568, R01AA012879, P30DK26743, M01RR00079, U19AI40034]; Veterans Administration [CX000295]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069952, U19AI040034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078, R01DA004334, R01DA012568] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000295] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grant R01AI069952 from the United States National Institutes of Health. The studies providing data were supported by grants R01DA016078, R01DA004334, R01DA012568, R01AA012879, P30DK26743, M01RR00079, and U19AI40034 from the United States NIH and by Veterans Administration Merit grant CX000295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacchetti P, 2003, EMERG INFECT DIS, V9, P1611, DOI 10.3201/eid0912.030361; Bacchetti P, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-145; Bacchetti P, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1213; Bacchetti P, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1139; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Cross T, 2008, HEPATOL RES, V38, P762, DOI 10.1111/j.1872-034X.2008.00364.x; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Deuffic-Burban S, 2002, J VIRAL HEPATITIS, V9, P114, DOI 10.1046/j.1365-2893.2002.00340.x; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ishida JH, 2008, CLIN GASTROENTEROL H, V6, P69, DOI 10.1016/j.cgh.2007.10.021; Jackson CH, 2003, J ROY STAT SOC D-STA, V52, P193, DOI 10.1111/1467-9884.00351; Jackson CH, 2002, STAT MED, V21, P113, DOI 10.1002/sim.886; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; Monto A, 2004, HEPATOLOGY, V39, P826, DOI 10.1002/hep.20127; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Okafor O, 2004, REV ESP PATOL, V37, P269; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rai R, 2002, HEPATOLOGY, V35, P1247, DOI 10.1053/jhep.2002.33151; Rid A, 2010, JAMA-J AM MED ASSOC, V304, P1472, DOI 10.1001/jama.2010.1414; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012; Terrault NA, 2008, CLIN GASTROENTEROL H, V6, P1403, DOI 10.1016/j.cgh.2008.08.006; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wilson LE, 2006, HEPATOLOGY, V43, P788, DOI 10.1002/hep.21091	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20104	10.1371/journal.pone.0020104	http://dx.doi.org/10.1371/journal.pone.0020104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637766	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500029
J	Lech, M; Rommele, C; Kulkarni, OP; Susanti, HE; Migliorini, A; Garlanda, C; Mantovani, A; Anders, HJ				Lech, Maciej; Roemmele, Christoph; Kulkarni, Onkar P.; Susanti, Heni Eka; Migliorini, Adriana; Garlanda, Cecilia; Mantovani, Alberto; Anders, Hans-Joachim			Lack of the Long Pentraxin PTX3 Promotes Autoimmune Lung Disease but not Glomerulonephritis in Murine Systemic Lupus Erythematosus	PLOS ONE			English	Article							SERUM-AMYLOID-P; C-REACTIVE PROTEIN; APOPTOTIC CELLS; PULMONARY INFLAMMATION; INNATE IMMUNITY; COMPLEMENT ACTIVATION; MRL-(FAS)LPR MICE; DENDRITIC CELLS; PRONE MICE; LPR MICE	The long pentraxin PTX3 has multiple roles in innate immunity. For example, PTX3 regulates C1q binding to pathogens and dead cells and regulates their uptake by phagocytes. It also inhibits P-selectin-mediated recruitment of leukocytes. Both of these mechanisms are known to be involved in autoimmunity and autoimmune tissue injury, e. g. in systemic lupus erythematosus, but a contribution of PTX3 is hypothetical. To evaluate a potential immunoregulatory role of PTX3 in autoimmunity we crossed Ptx3-deficient mice with Fas-deficient (lpr) C57BL/6 (B6) mice with mild lupus-like autoimmunity. PTX3 was found to be increasingly expressed in kidneys and lungs of B6lpr along disease progression. Lack of PTX3 impaired the phagocytic uptake of apoptotic T cells into peritoneal macrophages and selectively expanded CD4/CD8 double negative T cells while other immune cell subsets and lupus autoantibody production remained unaffected. Lack of PTX3 also aggravated autoimmune lung disease, i.e. peribronchial and perivascular CD3+ T cell and macrophage infiltrates of B6lpr mice. In contrast, histomorphological and functional parameters of lupus nephritis remained unaffected by the Ptx3 genotype. Together, PTX3 specifically suppresses autoimmune lung disease that is associated with systemic lupus erythematosus. Vice versa, loss-of-function mutations in the Ptx3 gene might represent a genetic risk factor for pulmonary (but not renal) manifestations of systemic lupus or other autoimmune diseases.	[Lech, Maciej; Roemmele, Christoph; Kulkarni, Onkar P.; Susanti, Heni Eka; Migliorini, Adriana; Anders, Hans-Joachim] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Garlanda, Cecilia; Mantovani, Alberto] IRCCS, Ist Clin Humanitas, Rozzano, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Rozzano, Italy	University of Munich; IRCCS Humanitas Research Hospital; University of Milan	Lech, M (corresponding author), Univ Munich, Med Poliklin, Pettenkoferstr 8A, D-8000 Munich, Germany.	hjanders@med.uni-muenchen.de	Römmele, Christoph/GLN-4996-2022; Lech, Maciej/AAJ-7899-2021; Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022; Anders, Hans-Joachim/ABD-6247-2021	Römmele, Christoph/0000-0002-8745-8510; Lech, Maciej/0000-0002-4293-2733; Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X; Susanti, Eka/0000-0003-3713-3707; Migliorini, Adriana/0000-0002-1024-6042; Anders, Hans-Joachim/0000-0003-2434-2956	Deutsche Forschungsgemeinschaft [AN372/11-1, GRK 1202]; European Commission	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was supported by a grant from the Deutsche Forschungsgemeinschaft (AN372/11-1 and GRK 1202) to H.J.A. and European Commission (ERC project HIIS to A. Montovani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2008, EUR J IMMUNOL, V38, P3487, DOI 10.1002/eji.200838604; Anders HJ, 2009, TRENDS MOL MED, V15, P553, DOI 10.1016/j.molmed.2009.10.004; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Bassi N, 2010, ANN RHEUM DIS, V69, P1704, DOI 10.1136/ard.2009.117804; BECKER GJ, 1980, ANN RHEUM DIS, V39, P50, DOI 10.1136/ard.39.1.50; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; DEGUCHI Y, 1991, CLIN EXP IMMUNOL, V85, P392; Enocsson H, 2009, ARTHRITIS RHEUM, V60, P3755, DOI 10.1002/art.25042; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; GUTIERREZRAMOS JC, 1990, NATURE, V346, P271, DOI 10.1038/346271a0; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Harari OA, 2001, RHEUMATOLOGY, V40, P889, DOI 10.1093/rheumatology/40.8.889; Hollan I, 2010, ARTHRIT CARE RES, V62, P378, DOI 10.1002/acr.20094; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Jaillon S, 2009, CELL DEATH DIFFER, V16, P465, DOI 10.1038/cdd.2008.173; KAKKANAIAH VN, 1990, J AUTOIMMUN, V3, P271, DOI 10.1016/0896-8411(90)90146-J; Kanta H, 2009, GENES IMMUN, V10, P390, DOI 10.1038/gene.2009.6; Kim N, 2002, J AUTOIMMUN, V19, P215, DOI 10.1006/jaut.2002.0617; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Kulkarni O, 2008, FRONT BIOSCI-LANDMRK, V13, P3312; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Kulkarni O, 2009, J PHARMACOL EXP THER, V328, P371, DOI 10.1124/jpet.108.142711; Kulkarni OP, 2010, AM J PATHOL, V176, P2840, DOI 10.2353/ajpath.2010.091227; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lech M, 2010, J PATHOL, V220, P596, DOI 10.1002/path.2678; Lloyd CM, 1997, J CLIN INVEST, V100, P963, DOI 10.1172/JCI119647; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Patole PS, 2007, J AUTOIMMUN, V29, P52, DOI 10.1016/j.jaut.2007.04.004; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rovere P, 2000, BLOOD, V96, P4300; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Shiozawa F, 2004, ARTHRITIS RES THER, V6, pR78, DOI 10.1186/ar1029; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; SINGER PA, 1990, J AUTOIMMUN, V3, P123, DOI 10.1016/0896-8411(90)90136-G; SUNDERRAJAN EV, 1986, AM J PATHOL, V124, P353; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; Voss A, 2008, J RHEUMATOL, V35, P625	53	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20118	10.1371/journal.pone.0020118	http://dx.doi.org/10.1371/journal.pone.0020118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637713	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500033
J	Mongin, E; Auer, TO; Bourrat, F; Gruhl, F; Dewar, K; Blanchette, M; Wittbrodt, J; Ettwiller, L				Mongin, Emmanuel; Auer, Thomas O.; Bourrat, Franck; Gruhl, Franziska; Dewar, Ken; Blanchette, Mathieu; Wittbrodt, Joachim; Ettwiller, Laurence			Combining Computational Prediction of Cis-Regulatory Elements with a New Enhancer Assay to Efficiently Label Neuronal Structures in the Medaka Fish	PLOS ONE			English	Article							GENOME; GENE; IDENTIFICATION; TRANSGENESIS; DOWNSTREAM; SEQUENCES; ALIGNMENT; CIRCUITS; INSIGHTS; REVEALS	The developing vertebrate nervous system contains a remarkable array of neural cells organized into complex, evolutionarily conserved structures. The labeling of living cells in these structures is key for the understanding of brain development and function, yet the generation of stable lines expressing reporter genes in specific spatio-temporal patterns remains a limiting step. In this study we present a fast and reliable pipeline to efficiently generate a set of stable lines expressing a reporter gene in multiple neuronal structures in the developing nervous system in medaka. The pipeline combines both the accurate computational genome-wide prediction of neuronal specific cis-regulatory modules (CRMs) and a newly developed experimental setup to rapidly obtain transgenic lines in a cost-effective and highly reproducible manner. 95% of the CRMs tested in our experimental setup show enhancer activity in various and numerous neuronal structures belonging to all major brain subdivisions. This pipeline represents a significant step towards the dissection of embryonic neuronal development in vertebrates.	[Mongin, Emmanuel; Blanchette, Mathieu] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Auer, Thomas O.; Gruhl, Franziska; Wittbrodt, Joachim; Ettwiller, Laurence] Heidelberg Univ, Ctr Organismal Studies COS, Heidelberg, Germany; [Bourrat, Franck] CNRS, DEPSN Inst Fessard, MSNC INRA Grp, UPR2197, Gif Sur Yvette, France; [Dewar, Ken] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Wittbrodt, Joachim] Inst Toxicol & Genet, KIT, Eggenstein Leopoldshafen, Germany	McGill University; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Karlsruhe Institute of Technology	Mongin, E (corresponding author), McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada.	blanchem@mcb.mcgill.ca; Jochen.Wittbrodt@COS.uni-Heidelberg.de; Laurence.Ettwiller@cos.uni-heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377; Auer, Thomas Oliver/0000-0003-3442-0567; Ettwiller, Laurence/0000-0002-3957-6539; Gruhl, Franziska/0000-0002-2613-7211	genome Quebec/Canada; European Community [FP7/2007-2013]; EMBO;  [DFG-SFB488 TP17-TP8]	genome Quebec/Canada; European Community(European Commission); EMBO(European Molecular Biology Organization (EMBO)); 	EM is supported by funding from genome Quebec/Canada. LE and JW are supported by the European Community's Seventh Framework Programme (FP7/2007-2013) CISSTEM and DFG-SFB488 TP17-TP8. This work was also supported in part by the EMBO Short-term Fellowships program (EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cooke JE, 2001, DEVELOPMENT, V128, P571; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Haudry Y, 2008, NUCLEIC ACIDS RES, V36, pD847, DOI 10.1093/nar/gkm797; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez RE, 2004, DEVELOPMENT, V131, P4511, DOI 10.1242/dev.01297; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loosli F, 2001, DEVELOPMENT, V128, P4035; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moens CB, 1996, DEVELOPMENT, V122, P3981; MONTEILHET C, 1990, NUCLEIC ACIDS RES, V18, P1407, DOI 10.1093/nar/18.6.1407; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Paten B, 2009, BIOINFORMATICS, V25, P295, DOI 10.1093/bioinformatics/btn630; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Philippakis AA, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P519; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Rohrschneider MR, 2007, DEV BIOL, V309, P358, DOI 10.1016/j.ydbio.2007.06.012; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19747	10.1371/journal.pone.0019747	http://dx.doi.org/10.1371/journal.pone.0019747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637758	Green Published, gold			2022-12-25	WOS:000291052500011
J	Venn, A; Tambutte, E; Holcomb, M; Allemand, D; Tambutte, S				Venn, Alexander; Tambutte, Eric; Holcomb, Michael; Allemand, Denis; Tambutte, Sylvie			Live Tissue Imaging Shows Reef Corals Elevate pH under Their Calcifying Tissue Relative to Seawater	PLOS ONE			English	Article							SCLERACTINIAN CORALS; CARBONIC-ACID; CALCIFICATION; PHOTOSYNTHESIS; SKELETON; DISSOCIATION; MECHANISMS; BIOMINERALIZATION; ULTRASTRUCTURE; LOCALIZATION	The threat posed to coral reefs by changes in seawater pH and carbonate chemistry (ocean acidification) raises the need for a better mechanistic understanding of physiological processes linked to coral calcification. Current models of coral calcification argue that corals elevate extracellular pH under their calcifying tissue relative to seawater to promote skeleton formation, but pH measurements taken from the calcifying tissue of living, intact corals have not been achieved to date. We performed live tissue imaging of the reef coral Stylophora pistillata to determine extracellular pH under the calcifying tissue and intracellular pH in calicoblastic cells. We worked with actively calcifying corals under flowing seawater and show that extracellular pH (pHe) under the calicoblastic epithelium is elevated by similar to 0.5 and similar to 0.2 pH units relative to the surrounding seawater in light and dark conditions respectively. By contrast, the intracellular pH (pHi) of the calicoblastic epithelium remains stable in the light and dark. Estimates of aragonite saturation states derived from our data indicate the elevation in subcalicoblastic pHe favour calcification and may thus be a critical step in the calcification process. However, the observed close association of the calicoblastic epithelium with the underlying crystals suggests that the calicoblastic cells influence the growth of the coral skeleton by other processes in addition to pHe modification. The procedure used in the current study provides a novel, tangible approach for future investigations into these processes and the impact of environmental change on the cellular mechanisms underpinning coral calcification.	[Venn, Alexander; Tambutte, Eric; Holcomb, Michael; Allemand, Denis; Tambutte, Sylvie] CSM, Monaco, Monaco; [Venn, Alexander; Tambutte, Eric; Allemand, Denis; Tambutte, Sylvie] LEA CSM CNRS BIOSENSIB, Monaco, Monaco		Venn, A (corresponding author), CSM, Monaco, Monaco.	alex@centrescientifique.mc			government of the Principality of Monaco; NSF	government of the Principality of Monaco; NSF(National Science Foundation (NSF))	Research was funded by the government of the Principality of Monaco. Michael Holcomb received support from an NSF international research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Allemand D, 1998, CAN J BOT, V76, P925, DOI 10.1139/b98-086; Allison N, 2010, GEOCHIM COSMOCHIM AC, V74, P1790, DOI 10.1016/j.gca.2009.12.030; [Anonymous], 2007, CO2SYS XLS CALCULATO; BARNES DJ, 1970, SCIENCE, V170, P1305, DOI 10.1126/science.170.3964.1305; BARNES DJ, 1972, PROC R SOC SER B-BIO, V182, P331, DOI 10.1098/rspb.1972.0083; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; Clode PL, 2002, TISSUE CELL, V34, P187, DOI 10.1016/S0040-8166(02)00031-9; COHEN A, 2009, OCEANOGRAPHY, V0022; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; CONSTANTZ B R, 1986, Palaios, V1, P152, DOI 10.2307/3514508; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; de Nooijer LJ, 2009, P NATL ACAD SCI USA, V106, P15374, DOI 10.1073/pnas.0904306106; Dewitt S, 2011, J MICROSC-OXFORD, V241, P221, DOI 10.1111/j.1365-2818.2010.03451.x; DICKSON AG, 1990, J PHYS CHEM-US, V94, P7978, DOI 10.1021/j100383a042; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Furla P, 2000, J EXP BIOL, V203, P3445; Gaillardet J, 1995, EARTH PLANET SC LETT, V136, P665, DOI 10.1016/0012-821X(95)00180-K; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holcomb M, 2009, GEOCHIM COSMOCHIM AC, V73, P4166, DOI 10.1016/j.gca.2009.04.015; Honisch B, 2004, GEOCHIM COSMOCHIM AC, V68, P3675, DOI 10.1016/j.gca.2004.03.002; IP YK, 1991, MAR BIOL, V111, P191, DOI 10.1007/BF01319700; ISA Y, 1986, MAR BIOL, V93, P91, DOI 10.1007/BF00428658; Johnston I.S., 1980, International Review of Cytology, V67, P171; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; LETISSIER MDA, 1988, MAR BIOL, V98, P493, DOI 10.1007/BF00391540; Marshall AT, 2007, J EXP BIOL, V210, P2453, DOI 10.1242/jeb.003343; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; McConnaughey TA, 1997, EARTH-SCI REV, V42, P95, DOI 10.1016/S0012-8252(96)00036-0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; Pelejero C, 2005, SCIENCE, V309, P2204, DOI 10.1126/science.1113692; Raz-Bahat M, 2006, CELL TISSUE RES, V325, P361, DOI 10.1007/s00441-006-0182-8; Reynaud S, 2004, CORAL REEFS, V23, P539, DOI 10.1007/s00338-004-0399-5; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Sinclair DJ, 2006, GEOCHIM COSMOCHIM AC, V70, P3855, DOI 10.1016/j.gca.2006.05.019; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; Venn AA, 2009, P NATL ACAD SCI USA, V106, P16574, DOI 10.1073/pnas.0902894106; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; WHITAKER JE, 1991, ANAL BIOCHEM, V194, P330, DOI 10.1016/0003-2697(91)90237-N; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010; [No title captured]	50	183	186	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20013	10.1371/journal.pone.0020013	http://dx.doi.org/10.1371/journal.pone.0020013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637757	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500024
J	Crabtree-Ramirez, B; Caro-Vega, Y; Shepherd, BE; Wehbe, F; Cesar, C; Cortes, C; Padgett, D; Koenig, S; Gotuzzo, E; Cahn, P; McGowan, C; Masys, D; Sierra-Madero, J				Crabtree-Ramirez, Brenda; Caro-Vega, Yanink; Shepherd, Bryan E.; Wehbe, Firas; Cesar, Carina; Cortes, Claudia; Padgett, Denis; Koenig, Serena; Gotuzzo, Eduardo; Cahn, Pedro; McGowan, Catherine; Masys, Daniel; Sierra-Madero, Juan		CCASAnet Team	Cross-Sectional Analysis of Late HAART Initiation in Latin America and the Caribbean: Late Testers and Late Presenters	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LATE DIAGNOSIS; HIV-INFECTION; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; AIDS; CONSEQUENCES; MORTALITY; ENGLAND; ACCESS	Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initiation in HIV-infected subjects in developing countries. Data from Latin America and the Caribbean is still lacking. Our main objective was to determine the frequency, risk factors and trends in time for being late HAART initiator (LHI) in this region. Methodology: Cross-sectional analysis from 9817 HIV-infected treatment-naive patients initiating HAART at 6 sites (Argentina, Chile, Haiti, Honduras, Peru and Mexico) from October 1999 to July 2010. LHI had CD4(+) count <= 200cells/mm(3) prior to HAART. Late testers (LT) were those LHI who initiated HAART within 6 months of HIV diagnosis. Late presenters (LP) initiated after 6 months of diagnosis. Prevalence, risk factors and trends over time were analyzed. Principal Findings: Among subjects starting HAART (n = 9817) who had baseline CD4+ available (n = 8515), 76% were LHI: Argentina (56%[95% CI: 52-59]), Chile (80%[95% CI: 77-82]), Haiti (76%[95% CI: 74-77]), Honduras (91%[95% CI: 87-94]), Mexico (79%[95% CI: 75-83]), Peru (86%[95% CI: 84-88]). The proportion of LHI statistically changed over time (except in Honduras) (p <= 0.02; Honduras p=0.7), with a tendency towards lower rates in recent years. Males had increased risk of LHI in Chile, Haiti, Peru, and in the combined site analyses (CSA). Older patients were more likely LHI in Argentina and Peru (OR 1.21 per +10-year of age, 95% CI: 1.02-1.45; OR 1.20, 95% CI: 1.02-1.43; respectively), but not in CSA (OR 1.07, 95% CI: 0.94-1.21). Higher education was associated with decreased risk for LHI in Chile (OR 0.92 per +1-year of education, 95% CI: 0.87-0.98) (similar trends in Mexico, Peru, and CSA). LHI with date of HIV-diagnosis available, 55% were LT and 45% LP. Conclusion: LHI was highly prevalent in CCASAnet sites, mostly due to LT; the main risk factors associated were being male and older age. Earlier HIV-diagnosis and earlier treatment initiation are needed to maximize benefits from HAART in the region.	[Crabtree-Ramirez, Brenda; Caro-Vega, Yanink; Sierra-Madero, Juan] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Shepherd, Bryan E.; Wehbe, Firas; McGowan, Catherine; Masys, Daniel] Vanderbilt Univ, Nashville, TN USA; [Cortes, Claudia] Univ Chile, Fdn Arriaran, Santiago, Chile; [Padgett, Denis] Inst Honduren Seguro Social & Hosp Escuela, Tegucigalpa, Honduras; [Koenig, Serena] Cornell Univ, GHESKIO Weill Med Coll, Port Au Prince, Haiti; [Koenig, Serena] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Gotuzzo, Eduardo] Inst Med Trop Alexander von Humboldt, Lima, Peru	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Vanderbilt University; Universidad de Chile; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidad Peruana Cayetano Heredia	Crabtree-Ramirez, B (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico.	jsmadero@yahoo.com	Wehbe, Firas/Q-6176-2019; Cesar, Carina/H-2831-2019; Cortes, Claudia P/AAF-7326-2020; Sierra Madero, Juan/AAW-8825-2021	Wehbe, Firas/0000-0002-3984-9584; Cortes, Claudia P/0000-0001-9101-9783; Caro-Vega, Yanink/0000-0003-3806-5806; Crabtree-Ramirez, Brenda/0000-0002-2587-1123	National Institutes of Health [1-U01-AI069923]; Pfizer; MSD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); MSD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Cooperative Agreement (1-U01-AI069923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BCR: speaker for BMS and MSD and grant for clinical trial of MSD; C. Cortes: speaker for MSD and GSK; EG: received grants from Pfizer and MSD; PC: board membership of MSD, GSK, Pfizer, Tibotec, Shering Plough, and speaker for Abbot, Tibotec, BMS, GSK, MSD, Pfizer and Boeringer Ingelheim; JSM: speaker for ViiV and Stendahl and has received grant for research from Pfizer. Authors YCV, BES, FW, C. Cesar, DP, SK, CM, and DM have no conflict of interest.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Bonjour Maeva A, 2008, AIDS Res Ther, V5, P6, DOI 10.1186/1742-6405-5-6; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; *CENSIDA, 2008, GUIA MAN ANT PERS CO; Cesar C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010490; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; *EACS, 2009, CLIN MAN TREATM HIV; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fisher M, 2008, CURR OPIN INFECT DIS, V21, P1, DOI 10.1097/QCO.0b013e3282f2d8fb; Friedman J H, 1984, 1 STANF U LAB COMP S; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Harrell FE, 2001, REGRESSION MODELING; Hocking JS, 2000, INT J STD AIDS, V11, P503, DOI 10.1258/0956462001916407; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Mills EJ, 2011, AIDS, V25, P851, DOI 10.1097/QAD.0b013e32834564e9; *MIN SAL, 2005, GUI CLIN SINDR INM A; *MIN SAL, 2007, REC TRAT ANT 2007; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; *OARAC, 2009, GUID US ANT AG HIV 1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Sabin CA, 2010, AIDS, V24, P723, DOI 10.1097/QAD.0b013e328333fa0f; *SADI, 2007, REC SEG TRAT INF HIV; Schwarcz S, 2006, JAIDS-J ACQ IMM DEF, V43, P491, DOI 10.1097/01.qai.0000243114.37035.de; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2010, ANT THER HIV INF AD; WHO, 2004, SCAL ANT THER RES LI; World Health Organization, 2006, ANT THER HIV INF AD; Zala Carlos, 2008, Medscape J Med, V10, P78, DOI 10.1186/1758-2652-10-4-78	45	57	57	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20272	10.1371/journal.pone.0020272	http://dx.doi.org/10.1371/journal.pone.0020272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637802	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200046
J	Hamidi, H; Gustafason, D; Pellegrini, M; Gasson, J				Hamidi, Habib; Gustafason, Derek; Pellegrini, Matteo; Gasson, Judith			Identification of Novel Targets of CSL-Dependent Notch Signaling in Hematopoiesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VITRO DIFFERENTIATION; FACTOR-BINDING SITES; MODEL-BASED ANALYSIS; ZONE B-CELLS; RBP-J-KAPPA; T-CELLS; TRANSCRIPTION FACTORS; GENE-EXPRESSION	Somatic activating mutations in the Notch1 receptor result in the overexpression of activated Notch1, which can be tumorigenic. The goal of this study is to understand the molecular mechanisms underlying the phenotypic changes caused by the overexpression of ligand independent Notch 1 by using a tetracycline inducible promoter in an in vitro embryonic stem (ES) cells/OP9 stromal cells coculture system, recapitulating normal hematopoiesis. First, an in silico analysis of the promoters of Notch regulated genes (previously determined by microarray analysis) revealed that the motifs recognized by regulatory proteins known to mediate hematopoiesis were overrepresented. Notch 1 does not bind DNA but instead binds the CSL transcription factor to regulate gene expression. The in silico analysis also showed that there were putative CSL binding sites observed in the promoters of 28 out of 148 genes. A custom ChIP-chip array was used to assess the occupancy of CSL in the promoter regions of the Notch1 regulated genes in vivo and showed that 61 genes were bound by activated Notch responsive CSL. Then, comprehensive mapping of the CSL binding sites genome-wide using ChIP-seq analysis revealed that over 10,000 genes were bound within 10 kb of the TSS (transcription start site). The majority of the targets discovered by ChIP-seq belong to pathways that have been shown by others to crosstalk with Notch signaling. Finally, 83 miRNAs were significantly differentially expressed by greater than 1.5-fold during the course of in vitro hematopoiesis. Thirty one miRNA were up-regulated and fifty two were down-regulated. Overexpression of Notch1 altered this pattern of expression of microRNA: six miRNAs were up-regulated and four were down regulated as a result of activated Notch1 overexpression during the course of hematopoiesis. Time course analysis of hematopoietic development revealed that cells with Notch 1 overexpression mimic miRNA expression of cells in a less mature stage, which is consistent with our previous biological characterization.	[Hamidi, Habib; Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gustafason, Derek; Pellegrini, Matteo] Univ Calif Los Angeles, DOE Inst Genom & Prote, Los Angeles, CA USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Gasson, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hamidi, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jgasson@mednet.ucla.edu	Hamidi, Habib/H-8030-2016	Hamidi, Habib/0000-0003-0196-9852; Pellegrini, Matteo/0000-0001-9355-9564				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Binor E, 2005, DEV NEUROSCI-BASEL, V27, P306, DOI 10.1159/000086710; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boggs K, 2009, CELL BIOL INT, V33, P318, DOI 10.1016/j.cellbi.2008.12.005; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Di Marcotullio L, 2006, MOL NEUROBIOL, V34, P193, DOI 10.1385/MN:34:3:193; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Era T, 2000, BLOOD, V95, P870, DOI 10.1182/blood.V95.3.870.003k44_870_878; Erkeland SJ, 2003, BLOOD, V101, P1111, DOI 10.1182/blood-2002-04-1207; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Ganapati U, 2007, STEM CELLS, V25, P1872, DOI 10.1634/stemcells.2006-0547; Gardiner MR, 2007, MECH DEVELOP, V124, P762, DOI 10.1016/j.mod.2007.06.005; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hertzog P, 2008, IMMUNITY, V29, P663, DOI 10.1016/j.immuni.2008.10.006; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; HROMAS R, 1995, CANCER RES, V55, P3610; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Iida S, 2008, GENES CELLS, V13, P313, DOI 10.1111/j.1365-2443.2008.01173.x; ISHIGAKI T, 2009, ADV HEMATOL; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kitajima K, 2003, METHOD ENZYMOL, V365, P72; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu J, 2008, DEV CELL, V14, P843, DOI 10.1016/j.devcel.2008.03.012; Lubman OY, 2007, J MOL BIOL, V365, P577, DOI 10.1016/j.jmb.2006.09.071; Lugus JJ, 2007, DEVELOPMENT, V134, P393, DOI 10.1242/dev.02731; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui T, 2007, GENE DEV, V21, P2629, DOI 10.1101/gad.1575207; MEIERSTIEGEN F, PLOS ONE, V5; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; Olsen AL, 2006, BLOOD, V107, P1265, DOI 10.1182/blood-2005-09-3621; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rasmussen KJ, 2008, AM J MED GENET A, V146A, P261, DOI 10.1002/ajmg.a.32110; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santos MA, 2007, P NATL ACAD SCI USA, V104, P15454, DOI 10.1073/pnas.0702891104; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Shawber CJ, 2007, J CLIN INVEST, V117, P3369, DOI 10.1172/JCI24311; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; Small D, 2003, J BIOL CHEM, V278, P16405, DOI 10.1074/jbc.M300464200; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Vincentz JW, 2008, DEV DYNAM, V237, P3809, DOI 10.1002/dvdy.21803; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wang JF, 2004, DEV BIOL, V266, P178, DOI 10.1016/j.ydbio.2003.10.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102	118	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20022	10.1371/journal.pone.0020022	http://dx.doi.org/10.1371/journal.pone.0020022			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637838	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200027
J	Heymans, JJ; Mackinson, S; Sumaila, UR; Dyck, A; Little, A				Heymans, Johanna Jacomina; Mackinson, Steven; Sumaila, Ussif Rashid; Dyck, Andrew; Little, Alyson			The Impact of Subsidies on the Ecological Sustainability and Future Profits from North Sea Fisheries	PLOS ONE			English	Article							ECOSYSTEM; MANAGEMENT; ECOSIM; ECOPATH; MODELS; GULF	Background: This study examines the impact of subsidies on the profitability and ecological stability of the North Sea fisheries over the past 20 years. It shows the negative impact that subsidies can have on both the biomass of important fish species and the possible profit from fisheries. The study includes subsidies in an ecosystem model of the North Sea and examines the possible effects of eliminating fishery subsidies. Methodology/Principal Findings: Hindcast analysis between 1991 and 2003 indicates that subsidies reduced the profitability of the fishery even though gross revenue might have been high for specific fisheries sectors. Simulations seeking to maximise the total revenue between 2004 and 2010 suggest that this can be achieved by increasing the effort of Nephrops trawlers, beam trawlers, and the pelagic trawl-and-seine fleet, while reducing the effort of demersal trawlers. Simulations show that ecological stability can be realised by reducing the effort of the beam trawlers, Nephrops trawlers, pelagic- and demersal trawl-and-seine fleets. This analysis also shows that when subsidies are included, effort will always be higher for all fleets, because it effectively reduces the cost of fishing. Conclusions/Significance: The study found that while removing subsidies might reduce the total catch and revenue, it increases the overall profitability of the fishery and the total biomass of commercially important species. For example, cod, haddock, herring and plaice biomass increased over the simulation when optimising for profit, and when optimising for ecological stability, the biomass for cod, plaice and sole also increased. When subsidies are eliminated, the study shows that rather than forcing those involved in the fishery into the red, fisheries become more profitable, despite a decrease in total revenue due to a loss of subsidies from the government.	[Heymans, Johanna Jacomina] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Mackinson, Steven; Little, Alyson] Cefas, Lowestoft, Suffolk, England; [Sumaila, Ussif Rashid; Dyck, Andrew] UBC Fisheries Ctr, Vancouver, BC, Canada; [Little, Alyson] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	UHI Millennium Institute; Centre for Environment Fisheries & Aquaculture Science; University of British Columbia; University of Aberdeen	Heymans, JJ (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland.	sheilaheymans@yahoo.com	Sumaila, U. Rashid/ABE-6475-2020; Heymans, Johanna J/H-4848-2012	Heymans, Johanna J/0000-0002-7290-8988; Mackinson, Steven/0000-0002-0262-1180; Barratt, Alyson/0000-0002-7663-7070	Oak Foundation; European Research Development Fund; Scottish Association for Marine Science; European Union [226675]; Pew Charitable Trusts, Philadelphia; United Kingdom Department for Environment Food and Rural Affairs [M1202]; NERC [dml010007] Funding Source: UKRI; Natural Environment Research Council [dml010007] Funding Source: researchfish	Oak Foundation; European Research Development Fund; Scottish Association for Marine Science; European Union(European Commission); Pew Charitable Trusts, Philadelphia; United Kingdom Department for Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was fifty percent funded by the Oak Foundation. Match funding for J.J. Heymans was obtained from the European Research Development Fund, the Scottish Association for Marine Science, and the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP> 226675. U.R. Sumaila and A. Dyck were match funded by the Global Ocean Economics Project funded by the Pew Charitable Trusts, Philadelphia. S. Mackinson was match funded from the United Kingdom Department for Environment Food and Rural Affairs project M1202. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christensen V, 2004, B MAR SCI, V74, P549; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V., 2005, ECOPATH ECOSIM USERS; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Cotter J, 2010, FISH FISH, V11, P210, DOI 10.1111/j.1467-2979.2009.00351.x; ENGELHARD CH, 2011, ICES J MARI IN PRESS, DOI DOI 10.1093/ICESJMS/FSR1031; *EU, 2008, 0802 SGECA EU; Heymans JJ, 2007, ECOSYSTEMS, V10, P488, DOI 10.1007/s10021-007-9034-y; Heymans JJ, 2009, PROG OCEANOGR, V83, P417, DOI 10.1016/j.pocean.2009.07.013; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Knudsen S, 2010, OCEAN COAST MANAGE, V53, P252, DOI 10.1016/j.ocecoaman.2010.04.008; MACKINSON S, 2007, CEFAS SCI SERIES TEC, V142; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; Milazzo M, 1998, WTP406; Moxnes E, 2000, SYST DYNAM REV, V16, P325, DOI 10.1002/sdr.201; NICOLSON JR, 1999, SHETLAND FISHERMEN C; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; *OECD, 2006, REV FISH OECD COUNTR; *OECD, 2003, LIBERALISING FISHERI; Pascoe S, 2008, AQUAT LIVING RESOUR, V21, P223, DOI 10.1051/alr:2008041; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Stouten H, 2008, AQUAT LIVING RESOUR, V21, P247, DOI 10.1051/alr:2008037; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Sumaila UR, 2007, FISH RES, V88, P1, DOI 10.1016/j.fishres.2007.08.017; Tinch R., 2009, SINK SWIM EC WHALING; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Walters C, 2008, B MAR SCI, V83, P251; WALTERS CJ, 2002, USE ECOSYSTEM MODELS, V10, P11	33	21	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20239	10.1371/journal.pone.0020239	http://dx.doi.org/10.1371/journal.pone.0020239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637848	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200041
J	Mirzasoleiman, B; Jalili, M				Mirzasoleiman, Baharan; Jalili, Mahdi			Failure Tolerance of Motif Structure in Biological Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; ORGANIZATION; ROBUSTNESS; ERROR; TOOL	Complex networks serve as generic models for many biological systems that have been shown to share a number of common structural properties such as power-law degree distribution and small-worldness. Real-world networks are composed of building blocks called motifs that are indeed specific subgraphs of (usually) small number of nodes. Network motifs are important in the functionality of complex networks, and the role of some motifs such as feed-forward loop in many biological networks has been heavily studied. On the other hand, many biological networks have shown some degrees of robustness in terms of their efficiency and connectedness against failures in their components. In this paper we investigated how random and systematic failures in the edges of biological networks influenced their motif structure. We considered two biological networks, namely, protein structure network and human brain functional network. Furthermore, we considered random failures as well as systematic failures based on different strategies for choosing candidate edges for removal. Failure in the edges tipping to high degree nodes had the most destructive role in the motif structure of the networks by decreasing their significance level, while removing edges that were connected to nodes with high values of betweenness centrality had the least effect on the significance profiles. In some cases, the latter caused increase in the significance levels of the motifs.	[Mirzasoleiman, Baharan; Jalili, Mahdi] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology	Mirzasoleiman, B (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.	mjalili@sharif.edu		Jalili, Mahdi/0000-0002-0517-9420	Sharif University of Technology	Sharif University of Technology	This work was funded by Sharif University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G., 2006, RHYTHMS BRAIN; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; ERDOS P, 1960, B INT STATIST INST, V38, P343; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jalili M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001059; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; KNYAZEVA MG, 2008, NEUROBIOLOGY AGING; Lodato I, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/28001; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salehi M, 2010, PHYSICA A, V389, P5521, DOI 10.1016/j.physa.2010.08.001; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang Lan V, 2005, J Biol, V4, P6, DOI 10.1186/jbiol23	54	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20512	10.1371/journal.pone.0020512	http://dx.doi.org/10.1371/journal.pone.0020512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637829	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200074
J	Tootle, TL; Williams, D; Hubb, A; Frederick, R; Spradling, A				Tootle, Tina L.; Williams, Dianne; Hubb, Alexander; Frederick, Rebecca; Spradling, Allan			Drosophila Eggshell Production: Identification of New Genes and Coordination by Pxt	PLOS ONE			English	Article							OVARIAN FOLLICULAR DEVELOPMENT; ECDYSONE-RECEPTOR ECR; STEROIDOGENIC GENES; REPRODUCTIVE-TRACT; PROSTAGLANDIN E-2; OOCYTE MATURATION; BREAST-CANCER; BOMBYX-MORI; OOGENESIS; EXPRESSION	Drosophila ovarian follicles complete development using a spatially and temporally controlled maturation process in which they resume meiosis and secrete a multi-layered, protective eggshell before undergoing arrest and/or ovulation. Microarray analysis revealed more than 150 genes that are expressed in a stage-specific manner during the last 24 hours of follicle development. These include all 30 previously known eggshell genes, as well as 19 new candidate chorion genes and 100 other genes likely to participate in maturation. Mutations in pxt, encoding a putative Drosophila cyclooxygenase, cause many transcripts to begin expression prematurely, and are associated with eggshell defects. Somatic activity of Pxt is required, as RNAi knockdown of pxt in the follicle cells recapitulates both the temporal expression and eggshell defects. One of the temporally regulated genes, cyp18a1, which encodes a cytochromome P450 protein mediating ecdysone turnover, is downregulated in pxt mutant follicles, and cyp18a1 mutation itself alters eggshell gene expression. These studies further define the molecular program of Drosophila follicle maturation and support the idea that it is coordinated by lipid and steroid hormonal signals.	[Tootle, Tina L.; Hubb, Alexander] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Williams, Dianne; Frederick, Rebecca; Spradling, Allan] Carnegie Inst, Howard Hughes Med Inst, Dept Embryol, Baltimore, MD USA	University of Iowa; Carnegie Institution for Science; Howard Hughes Medical Institute	Tootle, TL (corresponding author), Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA.	tina-tootle@uiowa.edu	Tootle, Tina/AAE-1220-2019	Tootle, Tina/0000-0002-1515-9538	Howard Hughes Medical Institute; NRSA through the National Cancer Institute; Anatomy and Cell Biology Department, University of Iowa	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NRSA through the National Cancer Institute; Anatomy and Cell Biology Department, University of Iowa	The project was funded by Howard Hughes Medical Institute, a NRSA through the National Cancer Institute, and start-up funds from the Anatomy and Cell Biology Department, University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; Attar E, 2009, J CLIN ENDOCR METAB, V94, P623, DOI 10.1210/jc.2008-1180; Berg CA, 2008, TISSUE ENG PT A, V14, P1479, DOI 10.1089/ten.tea.2008.0124; Bernardi F, 2007, DEV GENES EVOL, V217, P529, DOI 10.1007/s00427-007-0164-1; Bernardi F, 2009, DEV BIOL, V328, P541, DOI 10.1016/j.ydbio.2009.01.013; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Brodie AMH, 2001, J STEROID BIOCHEM, V79, P41, DOI 10.1016/S0960-0760(01)00131-5; Bulin C, 2005, ARTERIOSCL THROM VAS, V25, P84, DOI 10.1161/01.ATV.0000146814.81581.68; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; Cavaliere V, 2008, DEV DYNAM, V237, P2061, DOI 10.1002/dvdy.21625; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; DOWNS SM, 1983, J EXP ZOOL, V228, P99, DOI 10.1002/jez.1402280111; Ebert AD, 2005, EUR J OBSTET GYN R B, V122, P144, DOI 10.1016/j.ejogrb.2005.04.017; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Fakhouri M, 2006, DEV BIOL, V293, P127, DOI 10.1016/j.ydbio.2006.01.028; FUCHS AR, 1987, J STEROID BIOCHEM, V27, P1073, DOI 10.1016/0022-4731(87)90192-0; Gaziova I, 2004, DEVELOPMENT, V131, P2715, DOI 10.1242/dev.01143; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Hackney JF, 2007, DEV DYNAM, V236, P1213, DOI 10.1002/dvdy.21140; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Jonchere V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-57; Karuppu D, 2002, BREAST CANCER RES TR, V76, P103, DOI 10.1023/A:1020531329686; Kolahi KS, 2009, DEV BIOL, V331, P129, DOI 10.1016/j.ydbio.2009.04.028; Konstandi OA, 2005, INSECT BIOCHEM MOLEC, V35, P1043, DOI 10.1016/j.ibmb.2005.04.005; Lagow E, 1999, HUM REPROD UPDATE, V5, P280, DOI 10.1093/humupd/5.4.280; LeMosy EK, 2000, DEV BIOL, V217, P352, DOI 10.1006/dbio.1999.9562; Li JY, 1996, INSECT BIOCHEM MOLEC, V26, P309, DOI 10.1016/0965-1748(95)00099-2; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lister AL, 2008, GEN COMP ENDOCR, V159, P46, DOI 10.1016/j.ygcen.2008.07.017; Machado E, 2007, INSECT BIOCHEM MOLEC, V37, P876, DOI 10.1016/j.ibmb.2007.04.003; Nogueron MI, 2000, DEV BIOL, V225, P459, DOI 10.1006/dbio.2000.9805; PARKS S, 1987, GENE DEV, V1, P497, DOI 10.1101/gad.1.5.497; Pascucci T, 1996, DEV BIOL, V177, P590, DOI 10.1006/dbio.1996.0188; PETRI WH, 1976, DEV BIOL, V49, P185, DOI 10.1016/0012-1606(76)90266-9; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Prosperi JR, 2006, PROSTAG OTH LIPID M, V81, P55, DOI 10.1016/j.prostaglandins.2006.07.003; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; ROBINSON DS, 1968, HISTOCHEMISTRY, V13, P97; Slonina D, 2009, PROSTAG OTH LIPID M, V90, P69, DOI 10.1016/j.prostaglandins.2009.08.006; SPRADLING AC, 1979, CELL, V16, P589, DOI 10.1016/0092-8674(79)90032-1; Spradling Allan C., 1993, P1; Stevens LM, 2003, CURR BIOL, V13, P1058, DOI 10.1016/S0960-9822(03)00379-8; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Szafer-Glusman E, 2008, CURR BIOL, V18, P1426, DOI 10.1016/j.cub.2008.08.061; Takahashi T, 2006, J BIOL CHEM, V281, P37117, DOI 10.1074/jbc.M608202200; TOLIAS PP, 1993, MOL CELL BIOL, V13, P5898, DOI 10.1128/MCB.13.9.5898; Tootle TL, 2008, DEVELOPMENT, V135, P839, DOI 10.1242/dev.017590; Waring GL, 2000, INT REV CYTOL, V198, P67; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004; Yakoby N, 2008, DEV CELL, V15, P725, DOI 10.1016/j.devcel.2008.09.008; Yakoby N, 2008, DEVELOPMENT, V135, P343, DOI 10.1242/dev.008920; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739	59	75	78	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19943	10.1371/journal.pone.0019943	http://dx.doi.org/10.1371/journal.pone.0019943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637834	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200021
J	Dobson, RCJ; Giron, I; Hudson, AO				Dobson, Renwick C. J.; Giron, Irma; Hudson, Andre O.			L,L-Diaminopimelate Aminotransferase from Chlamydomonas reinhardtii: A Target for Algaecide Development	PLOS ONE			English	Article							LL-DIAMINOPIMELATE AMINOTRANSFERASE; CIRCULAR-DICHROISM SPECTRA; SIZE-DISTRIBUTION ANALYSIS; DIHYDRODIPICOLINATE SYNTHASE; CRYSTAL-STRUCTURE; BIOSYNTHESIS PATHWAY; LYSINE BIOSYNTHESIS; ESCHERICHIA-COLI; EVOLUTION; ANALOGS	In some bacterial species and photosynthetic cohorts, including algae, the enzyme L, L-diaminopimelate aminotransferase (DapL) (E.C. 2.6.1.83) is involved in the anabolism of the essential amino acid L-lysine. DapL catalyzes the conversion of tetrahydrodipicolinate (THDPA) to L,L-diaminopimelate (L,L-DAP), in one step bypassing the DapD, DapC and DapE enzymatic reactions present in the acyl DAP pathways. Here we present an in vivo and in vitro characterization of the DapL ortholog from the alga Chlamydomonas reinhardtii (Cr-DapL). The in vivo analysis illustrated that the enzyme is able to functionally complement the E. coli dap auxotrophs and was essential for plant development in Arabidopsis. In vitro, the enzyme was able to inter-convert THDPA and L,L-DAP, showing strong substrate specificity. Cr-DapL was dimeric in both solution and when crystallized. The structure of Cr-DapL was solved in its apo form, showing an overall architecture of a a/b protein with each monomer in the dimer adopting a pyridoxal phosphate-dependent transferase-like fold in a V-shaped conformation. The active site comprises residues from both monomers in the dimer and shows some rearrangement when compared to the apo-DapL structure from Arabidopsis. Since animals do not possess the enzymatic machinery necessary for the de novo synthesis of the amino acid L-lysine, enzymes involved in this pathway are attractive targets for the development of antibiotics, herbicides and algaecides.	[Dobson, Renwick C. J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Biomol Interact Ctr, Christchurch 1, New Zealand; [Giron, Irma; Hudson, Andre O.] Rochester Inst Technol, Sch Biol Sci, Rochester, NY 14623 USA	University of Melbourne; University of Canterbury; Rochester Institute of Technology	Dobson, RCJ (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.	rdobson@unimelb.edu.au; aohsbi@rit.edu	Dobson, Renwick/AAZ-7020-2021	Dobson, Renwick/0000-0002-5506-4939; Hudson, Andre/0000-0001-5690-4322	C.R. Roper Bequest for fellowship; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	C.R. Roper Bequest for fellowship; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	R.C.J.D. acknowledges the C.R. Roper Bequest for fellowship support. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baizman ER, 2000, MICROBIOL-SGM, V146, P3129, DOI 10.1099/00221287-146-12-3129; BERGES DA, 1986, J BIOL CHEM, V261, P6160; Boughton BA, 2008, BIOORGAN MED CHEM, V16, P9975, DOI 10.1016/j.bmc.2008.10.026; Boughton BA, 2008, BIOORG MED CHEM LETT, V18, P460, DOI 10.1016/j.bmcl.2007.11.108; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan CG, 2010, BIOORGAN MED CHEM, V18, P2141, DOI 10.1016/j.bmc.2010.02.001; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hudson AO, 2008, J BACTERIOL, V190, P3256, DOI 10.1128/JB.01381-07; Hudson AO, 2011, ACTA CRYSTALLOGR F, V67, P140, DOI 10.1107/S174430911004844X; Hudson AO, 2006, PLANT PHYSIOL, V140, P292, DOI 10.1104/pp.105.072629; Hudson AO, 2005, BBA-GEN SUBJECTS, V1721, P27, DOI 10.1016/j.bbagen.2004.09.008; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; LAM LKP, 1988, J BIOL CHEM, V263, P11814; Laue T.M., 1992, COMPUTER AIDED INTER; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu YC, 2010, J BACTERIOL, V192, P3304, DOI 10.1128/JB.00172-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mccoy AJ, 2006, P NATL ACAD SCI USA, V103, P17909, DOI 10.1073/pnas.0608643103; McElver J, 2001, GENETICS, V159, P1751; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; MISONO H, 1976, BIOCHEM BIOPH RES CO, V72, P89, DOI 10.1016/0006-291X(76)90964-5; Mitsakos V, 2008, BIOORG MED CHEM LETT, V18, P842, DOI 10.1016/j.bmcl.2007.11.026; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Rupp B, 2010, BIOMOLECULAR CRYSTALLOGRAPHY: PRINCIPLES, PRACTICE, AND APPLICATION TO STRUCTURAL BIOLOGY, P1; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Turner JJ, 2005, BIOORG MED CHEM LETT, V15, P995, DOI 10.1016/j.bmcl.2004.12.043; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Watanabe N, 2008, J MOL BIOL, V384, P1314, DOI 10.1016/j.jmb.2008.10.022; Watanabe N, 2007, J MOL BIOL, V371, P685, DOI 10.1016/j.jmb.2007.05.061; Weyand S, 2007, J MOL BIOL, V367, P825, DOI 10.1016/j.jmb.2007.01.023	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20439	10.1371/journal.pone.0020439	http://dx.doi.org/10.1371/journal.pone.0020439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633707	Green Published, gold			2022-12-25	WOS:000291006500063
J	Ganichkin, OM; Anedchenko, EA; Wahl, MC				Ganichkin, Oleg M.; Anedchenko, Ekaterina A.; Wahl, Markus C.			Crystal Structure Analysis Reveals Functional Flexibility in the Selenocysteine-Specific tRNA from Mouse	PLOS ONE			English	Article							PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI; SELENOPROTEIN SYNTHESIS; ELONGATION-FACTOR; WATER; ANTICODON; MECHANISM; SELENIUM; BINDING; KINASE	Background: Selenocysteine tRNAs (tRNA(Sec)) exhibit a number of unique identity elements that are recognized specifically by proteins of the selenocysteine biosynthetic pathways and decoding machineries. Presently, these identity elements and the mechanisms by which they are interpreted by tRNA(Sec)-interacting factors are incompletely understood. Methodology/Principal Findings: We applied rational mutagenesis to obtain well diffracting crystals of murine tRNA(Sec). tRNA(Sec) lacking the single-stranded 3'-acceptor end ((Delta GCCA)RNA(Sec)) yielded a crystal structure at 2.0 angstrom resolution. The global structure of (Delta GCCA)RNA(Sec) resembles the structure of human tRNA(Sec) determined at 3.1 angstrom resolution. Structural comparisons revealed flexible regions in tRNA(Sec) used for induced fit binding to selenophosphate synthetase. Water molecules located in the present structure were involved in the stabilization of two alternative conformations of the anticodon stem-loop. Modeling of a 2'-O-methylated ribose at position U34 of the anticodon loop as found in a sub-population of tRNA(Sec) in vivo showed how this modification favors an anticodon loop conformation that is functional during decoding on the ribosome. Soaking of crystals in Mn2+-containing buffer revealed eight potential divalent metal ion binding sites but the located metal ions did not significantly stabilize specific structural features of tRNA(Sec). Conclusions/Significance: We provide the most highly resolved structure of a tRNA(Sec) molecule to date and assessed the influence of water molecules and metal ions on the molecule's conformation and dynamics. Our results suggest how conformational changes of tRNA(Sec) support its interaction with proteins.	[Ganichkin, Oleg M.; Anedchenko, Ekaterina A.; Wahl, Markus C.] Free Univ Berlin, Abt Strukturbiochem, D-1000 Berlin, Germany	Free University of Berlin	Ganichkin, OM (corresponding author), Free Univ Berlin, Abt Strukturbiochem, D-1000 Berlin, Germany.	mwahl@chemie.fu-berlin.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307	Deutsche Forschungsgemeinschaft [WA 1126/2-3]; Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Zentrum Berlin fur Materialien und Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Supported by a grant from the Deutsche Forschungsgemeinschaft (grant WA 1126/2-3) in the priority program 1087. http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Roger Scherrers, Wyatt Technology Europe GmbH, for analyzing our mouse tRNA<SUP>Sec</SUP> preparation by multi-angle static light scattering. We thank Azat Gabdulkhakov (Freie Universitat Berlin, AG Kristallographie) for help in solving the structure of mouse tRNA<SUP>Sec</SUP>. We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien und Energie, the Freie Universitat Berlin, the Humboldt-Universitat zu Berlin, the Max-Delbruck Centrum and the Leibniz-Institut fur Molekulare Pharmakologie. We thank the team of Uwe Muller for support during diffraction data collection.	Alexander RW, 2010, FEBS LETT, V584, P376, DOI 10.1016/j.febslet.2009.11.061; Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; Araiso Y, 2009, P NATL ACAD SCI USA, V106, P16215, DOI 10.1073/pnas.0908861106; BARON C, 1993, J MOL BIOL, V231, P274, DOI 10.1006/jmbi.1993.1282; Biswas R, 1997, J MOL BIOL, V267, P1149, DOI 10.1006/jmbi.1997.0936; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Cabello-Villegas J, 2002, J MOL BIOL, V319, P1015, DOI 10.1016/S0022-2836(02)00382-0; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Cate JH, 1996, STRUCTURE, V4, P1221, DOI 10.1016/S0969-2126(96)00129-3; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Chiba S, 2010, MOL CELL, V39, P410, DOI 10.1016/j.molcel.2010.07.018; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Correll CC, 1999, J MOL BIOL, V292, P275, DOI 10.1006/jmbi.1999.3072; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; GUERON M, 1982, BIOPHYS J, V38, P231, DOI 10.1016/S0006-3495(82)84553-0; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; HOLBROOK SR, 1991, NATURE, V353, P579, DOI 10.1038/353579a0; Hubert N, 1998, RNA, V4, P1029, DOI 10.1017/S1355838298980888; Ioudovitch A, 1998, RNA, V4, P365; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; JOACHIMIAK A, 1994, EMBO J, V13, P367, DOI 10.1002/j.1460-2075.1994.tb06270.x; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; KENNARD O, 1986, J BIOMOL STRUCT DYN, V3, P623, DOI 10.1080/07391102.1986.10508452; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Lodmell JS, 2001, J MOL BIOL, V311, P475, DOI 10.1006/jmbi.2001.4879; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHAMA T, 1994, ARCH BIOCHEM BIOPHYS, V315, P293, DOI 10.1006/abbi.1994.1503; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sherlin LD, 2001, RNA, V7, P1671; Sherrer RL, 2011, NUCLEIC ACIDS RES, V39, P1034, DOI 10.1093/nar/gkq845; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steitz TA, 2008, NAT REV MOL CELL BIO, V9, P242, DOI 10.1038/nrm2352; Stock T, 2010, MOL MICROBIOL, V75, P149, DOI 10.1111/j.1365-2958.2009.06970.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vendeix FAP, 2008, BIOCHEMISTRY-US, V47, P6117, DOI 10.1021/bi702356j; Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9; Wahl MC, 1996, NAT STRUCT BIOL, V3, P24, DOI 10.1038/nsb0196-24; Walczak R, 1996, RNA, V2, P367; Walter NG, 2007, MOL CELL, V28, P923, DOI 10.1016/j.molcel.2007.12.001; Warner GJ, 2000, J BIOL CHEM, V275, P28110; WESTHOF E, 1988, ANNU REV BIOPHYS BIO, V17, P125; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	65	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20032	10.1371/journal.pone.0020032	http://dx.doi.org/10.1371/journal.pone.0020032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629646	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800023
J	Dobo, J; Major, B; Kekesi, KA; Szabo, I; Megyeri, M; Hajela, K; Juhasz, G; Zavodszky, P; Gal, P				Dobo, Jozsef; Major, Balazs; Kekesi, Katalin A.; Szabo, Istvan; Megyeri, Marton; Hajela, Krishnan; Juhasz, Gabor; Zavodszky, Peter; Gal, Peter			Cleavage of Kininogen and Subsequent Bradykinin Release by the Complement Component: Mannose-Binding Lectin-Associated Serine Protease (MASP)-1	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; HUMAN-PLASMA KALLIKREIN; HEREDITARY ANGIOEDEMA; FACTOR-XII; CATALYTIC REGION; C1 INHIBITOR; ACTIVATION; PATHWAY; MASP-1; IDENTIFICATION	Bradykinin (BK), generated from high-molecular-weight kininogen (HK) is the major mediator of swelling attacks in hereditary angioedema (HAE), a disease associated with C1-inhibitor deficiency. Plasma kallikrein, activated by factor XIIa, is responsible for most of HK cleavage. However other proteases, which activate during episodes of angioedema, might also contribute to BK production. The lectin pathway of the complement system activates after infection and oxidative stress on endothelial cells generating active serine proteases: MASP-1 and MASP-2. Our aim was to study whether activated MASPs are able to digest HK to release BK. Initially we were trying to find potential new substrates of MASP-1 in human plasma by differential gel electrophoresis, and we identified kininogen cleavage products by this proteomic approach. As a control, MASP-2 was included in the study in addition to MASP-1 and kallikrein. The proteolytic cleavage of HK by MASPs was followed by SDS-PAGE, and BK release was detected by HPLC. We showed that MASP-1 was able to cleave HK resulting in BK production. MASP-2 could also cleave HK but could not release BK. The cleavage pattern of MASPs is similar but not strictly identical to that of kallikrein. The catalytic efficiency of HK cleavage by a recombinant version of MASP-1 and MASP-2 was about 4.0 x 10(2) and 2.7 x 10(2) M(-1) s(-1), respectively. C1-inhibitor, the major inhibitor of factor XIIa and kallikrein, also prevented the cleavage of HK by MASPs. In all, a new factor XII- and kallikrein-independent mechanism of bradykinin production by MASP-1 was demonstrated, which may contribute to the pro-inflammatory effect of the lectin pathway of complement and to the elevated bradykinin levels in HAE patients.	[Dobo, Jozsef; Major, Balazs; Szabo, Istvan; Megyeri, Marton; Zavodszky, Peter; Gal, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Kekesi, Katalin A.] Eotvos Lorand Univ, Dept Physiol & Neurobiol, Budapest, Hungary; [Kekesi, Katalin A.; Juhasz, Gabor] Eotvos Lorand Univ, Inst Biol, Lab Prote, Budapest, Hungary; [Hajela, Krishnan] Devi Ahilya Univ, Sch Life Sci, Indore, Madhya Pradesh, India	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; Eotvos Lorand University; Devi Ahilya University	Dobo, J (corresponding author), Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary.	dobo@enzim.hu; gal@enzim.hu	Juhász, Gábor/I-7781-2017; Gal, Peter/B-5886-2011; Kékesi, Katalin Adrienna A/H-3484-2017; Dobo, Jozsef/C-7331-2014	Juhász, Gábor/0000-0002-0849-6931; Kékesi, Katalin Adrienna A/0000-0003-3042-4878; Dobo, Jozsef/0000-0001-9187-8502	Anyos Jedlik [NKFP_07_1-MASPOK07]; Hungarian Scientific Research Fund (OTKA) [NK77978]; NDA [KMOP-1.1.2-07/1-2008 0003]; GVOP-3.2.1; EGIS; TAMOP [4.2.1./B-09/1/KMR-2010 0003]	Anyos Jedlik; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NDA; GVOP-3.2.1; EGIS; TAMOP	This work was funded by the Anyos Jedlik grant NKFP_07_1-MASPOK07, the Hungarian Scientific Research Fund (OTKA) grant NK77978, the NDA grant KMOP-1.1.2-07/1-2008 0003, the GVOP-3.2.1 grant, the EGIS PSYCH grant and the TAMOP 4.2.1./B-09/1/KMR-2010 0003 grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Beinrohr L, 2008, TRENDS MOL MED, V14, P511, DOI 10.1016/j.molmed.2008.09.009; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Davis AE, 2005, CLIN IMMUNOL, V114, P3, DOI 10.1016/j.clim.2004.05.007; Dobo J, 2008, ACTA CRYSTALLOGR F, V64, P781, DOI 10.1107/S174430910802294X; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Joseph K, 1996, P NATL ACAD SCI USA, V93, P8552, DOI 10.1073/pnas.93.16.8552; Joseph K, 2002, P NATL ACAD SCI USA, V99, P896, DOI 10.1073/pnas.022626899; Joseph K, 2008, ANN ALLERG ASTHMA IM, V101, P279, DOI 10.1016/S1081-1206(10)60493-0; Joseph K, 2009, J ALLERGY CLIN IMMUN, V124, P143, DOI 10.1016/j.jaci.2009.02.006; Kaplan AP, 2010, J ALLERGY CLIN IMMUN, V126, P918, DOI 10.1016/j.jaci.2010.08.012; Kaplan AP, 2010, MOL IMMUNOL, V47, P2161, DOI 10.1016/j.molimm.2010.05.010; Kaplan AP, 2002, J ALLERGY CLIN IMMUN, V109, P195, DOI 10.1067/mai.2002.121316; Keleman Z, 2010, CLIN IMMUNOL, V134, P354, DOI 10.1016/j.clim.2009.11.002; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Montalto MC, 2001, J IMMUNOL, V166, P4148, DOI 10.4049/jimmunol.166.6.4148; MORI K, 1981, J BIOCHEM-TOKYO, V89, P1465, DOI 10.1093/oxfordjournals.jbchem.a133339; NARTIKOVA V F, 1986, Biokhimiya, V51, P463; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; PERKINS SJ, 1990, J MOL BIOL, V214, P751, DOI 10.1016/0022-2836(90)90290-3; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Santos-Gonzalez M, 2007, EXP GERONTOL, V42, P798, DOI 10.1016/j.exger.2007.04.013; SCHIFFMAN S, 1980, J BIOL CHEM, V255, P6433; Szego EM, 2010, EUR NEUROPSYCHOPHARM, V20, P96, DOI 10.1016/j.euroneuro.2009.11.003; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; TANS G, 1987, J BIOL CHEM, V262, P11308; TAYEH MA, 1994, J BIOL CHEM, V269, P16318; Terai I, 1997, CLIN EXP IMMUNOL, V110, P317; Varga L, 2008, CLIN EXP IMMUNOL, V153, P68, DOI 10.1111/j.1365-2249.2008.03671.x; Wong NKH, 1999, MOL IMMUNOL, V36, P853, DOI 10.1016/S0161-5890(99)00106-6	42	86	88	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20036	10.1371/journal.pone.0020036	http://dx.doi.org/10.1371/journal.pone.0020036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625439	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005200025
J	Poirier, C; Boumans, T; Vellema, M; De Groof, G; Charlier, TD; Verhoye, M; Van der Linden, A; Balthazart, J				Poirier, Colline; Boumans, Tiny; Vellema, Michiel; De Groof, Geert; Charlier, Thierry D.; Verhoye, Marleen; Van der Linden, Annemie; Balthazart, Jacques			Own Song Selectivity in the Songbird Auditory Pathway: Suppression by Norepinephrine	PLOS ONE			English	Article							VOCAL CONTROL NUCLEI; MALE ZEBRA FINCHES; NORADRENERGIC NEUROTOXIN; CATECHOLAMINE LEVELS; MONOAMINE LEVELS; SEX-DIFFERENCES; TURNOVER RATES; CONTROL-SYSTEM; BRAIN; DSP-4	Background: Like human speech, birdsong is a learned behavior that supports species and individual recognition. Norepinephrine is a catecholamine suspected to play a role in song learning. The goal of this study was to investigate the role of norepinephrine in bird's own song selectivity, a property thought to be important for auditory feedback processes required for song learning and maintenance. Methodology/Principal Findings: Using functional magnetic resonance imaging, we show that injection of DSP-4, a specific noradrenergic toxin, unmasks own song selectivity in the dorsal part of NCM, a secondary auditory region. Conclusions/Significance: The level of norepinephrine throughout the telencephalon is known to be high in alert birds and low in sleeping birds. Our results suggest that norepinephrine activity can be further decreased, giving rise to a strong own song selective signal in dorsal NCM. This latent own song selective signal, which is only revealed under conditions of very low noradrenergic activity, might play a role in the auditory feedback and/or the integration of this feedback with the motor circuitry for vocal learning and maintenance.	[Poirier, Colline; Boumans, Tiny; Vellema, Michiel; De Groof, Geert; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2020 Antwerp, Belgium; [Vellema, Michiel] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany; [Charlier, Thierry D.; Balthazart, Jacques] Univ Liege, GIGA Neurosci, Res Unit Behav Neuroendocrinol, Liege, Belgium	University of Antwerp; Max Planck Society; University of Liege	Poirier, C (corresponding author), Univ Antwerp, Dept Biomed Sci, Bioimaging Lab, B-2020 Antwerp, Belgium.	colline.poirier@ua.ac.be	Charlier, Thierry/J-4668-2015; De Groof, Geert/D-8251-2013; Balthazart, Jacques/H-6865-2019; Van der Linden, Annemie/L-7855-2017	Balthazart, Jacques/0000-0001-9492-2126; Van der Linden, Annemie/0000-0003-2941-6520; Poirier, Colline/0000-0001-9793-4907; Vellema, Michiel/0000-0001-7172-4776; Verhoye, Marleen/0000-0002-6267-0611	University of Antwerp; NINDS [NS035467]; Research Foundation - Flanders (FWO) [G.0420.02]; EC [LSHB-CT-2005-512146, EMIL LSHC-CT-2004-503569]; FRS-FNRS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035467] Funding Source: NIH RePORTER	University of Antwerp; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Foundation - Flanders (FWO)(FWO); EC(European CommissionEuropean Commission Joint Research Centre); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Francqui grant and a BOF-KP grant from the University of Antwerp to C.P., a grant from the NINDS (NS035467) to J.B., and grants from the Research Foundation - Flanders (FWO, project Nr G.0420.02), Concerted Research Actions (GOA funding) from the University of Antwerp, by EC - FP6 project DiMI, LSHB-CT-2005-512146 and EC - FP6 project EMIL LSHC-CT-2004-503569 to A.VdL. T.D.C. was an FRS-FNRS Postdoctoral Researcher and T. B. a doctoral fellow of the Research Foundation - Flanders (FWO). G. D. G. and C. P. are post-doctoral fellows of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2005, BEHAV PROCESS, V69, P331, DOI 10.1016/j.beproc.2005.01.010; Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; BALL GF, 1994, PSYCHONEUROENDOCRINO, V19, P485, DOI 10.1016/0306-4530(94)90035-3; BALTHAZART J, 1989, BRAIN RES, V492, P163, DOI 10.1016/0006-8993(89)90899-8; BARCLAY SR, 1990, BRAIN RES, V523, P251, DOI 10.1016/0006-8993(90)91494-2; BARCLAY SR, 1988, BRAIN RES, V459, P333, DOI 10.1016/0006-8993(88)90649-X; Barclay SR, 1996, PHARMACOL BIOCHEM BE, V53, P213, DOI 10.1016/0091-3057(95)00183-2; BARCLAY SR, 1992, PHARMACOL BIOCHEM BE, V41, P195, DOI 10.1016/0091-3057(92)90082-Q; BENNETT C, 1984, IRCS MED SCI-BIOCHEM, V12, P181; BERNARD DJ, 1995, J COMP NEUROL, V360, P726, DOI 10.1002/cne.903600415; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Boumans T, 2007, EUR J NEUROSCI, V26, P2613, DOI 10.1111/j.1460-9568.2007.05865.x; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Cardin JA, 2004, J NEUROPHYSIOL, V91, P2148, DOI 10.1152/jn.00918.2003; Cardin JA, 2003, J NEUROPHYSIOL, V90, P2884, DOI 10.1152/jn.00391.2003; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Castelino CB, 2010, J CHEM NEUROANAT, V39, P96, DOI 10.1016/j.jchemneu.2009.08.003; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; FRITSCHY JM, 1990, J CHEM NEUROANAT, V3, P309; HALLMAN H, 1984, J NEURAL TRANSM, V60, P89, DOI 10.1007/BF01245027; Harding CF, 1998, J NEUROBIOL, V34, P329, DOI 10.1002/(SICI)1097-4695(199803)34:4<329::AID-NEU4>3.0.CO;2-8; Janata P, 1999, J NEUROSCI, V19, P5108; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; Keller GB, 2009, NATURE, V457, P187, DOI 10.1038/nature07467; Lei HM, 2010, NEURON, V65, P122, DOI 10.1016/j.neuron.2009.12.008; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; Margoliash D, 2010, BRAIN LANG, V115, P45, DOI 10.1016/j.bandl.2009.09.005; Mello CV, 1998, J COMP NEUROL, V400, P207; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Poirier C, 2010, NMR BIOMED, V23, P1027, DOI 10.1002/nbm.1525; Poirier C, 2009, J NEUROSCI, V29, P2252, DOI 10.1523/JNEUROSCI.4650-08.2009; Prather JF, 2004, CURR OPIN NEUROBIOL, V14, P496, DOI 10.1016/j.conb.2004.06.004; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Riters LV, 2007, BRAIN RES, V1149, P127, DOI 10.1016/j.brainres.2007.02.059; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Riters LV, 2002, J CHEM NEUROANAT, V23, P269, DOI 10.1016/S0891-0618(02)00005-4; Sockman KW, 2008, DEV NEUROBIOL, V68, P656, DOI 10.1002/dneu.20611; Theunissen FE, 2004, ANN NY ACAD SCI, V1016, P222, DOI 10.1196/annals.1298.023; Vyas A, 2008, BEHAV NEUROSCI, V122, P1148, DOI 10.1037/0735-7044.122.5.1148; Waterman SA, 2008, BEHAV BRAIN RES, V188, P271, DOI 10.1016/j.bbr.2007.11.004	43	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20131	10.1371/journal.pone.0020131	http://dx.doi.org/10.1371/journal.pone.0020131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625389	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005200036
J	Mersmann, N; Tkachev, D; Jelinek, R; Roth, PT; Mobius, W; Ruhwedel, T; Ruhle, S; Weber-Fahr, W; Sartorius, A; Klugmann, M				Mersmann, Nadine; Tkachev, Dmitri; Jelinek, Ruth; Roeth, Philipp Thomas; Moebius, Wiebke; Ruhwedel, Torben; Ruehle, Sabine; Weber-Fahr, Wolfgang; Sartorius, Alexander; Klugmann, Matthias			Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACETYL-L-ASPARTATE; SPONGY DEGENERATION; N-ACETYLASPARTYLGLUTAMATE; ELECTRON-MICROSCOPY; TREMOR RAT; BRAIN; CNS; EXPRESSION; MOUSE	Canavan Disease (CD) is a recessive leukodystrophy caused by loss of function mutations in the gene encoding aspartoacylase (ASPA), an oligodendrocyte-enriched enzyme that hydrolyses N-acetylaspartate (NAA) to acetate and aspartate. The neurological phenotypes of different rodent models of CD vary considerably. Here we report on a novel targeted aspa mouse mutant expressing the bacterial beta-Galactosidase (lacZ) gene under the control of the aspa regulatory elements. X-Gal staining in known ASPA expression domains confirms the integrity of the modified locus in heterozygous aspa lacZ-knockin (aspa(lacZ/+)) mice. In addition, abundant ASPA expression was detected in Schwann cells. Homozygous (aspa(lacZ/lacZ)) mutants are ASPA-deficient, show CD-like histopathology and moderate neurological impairment with behavioural deficits that are more pronounced in aspa(lacZ/lacZ) males than females. Non-invasive ultrahigh field proton magnetic resonance spectroscopy revealed increased levels of NAA, myo-inositol and taurine in the aspa(lacZ/lacZ) brain. Spongy degeneration was prominent in hippocampus, thalamus, brain stem, and cerebellum, whereas white matter of optic nerve and corpus callosum was spared. Intracellular vacuolisation in astrocytes coincides with axonal swellings in cerebellum and brain stem of aspa(lacZ/lacZ) mutants indicating that astroglia may act as an osmolyte buffer in the aspa-deficient CNS. In summary, the aspa(lacZ) mouse is an accurate model of CD and an important tool to identify novel aspects of its complex pathology.	[Mersmann, Nadine; Tkachev, Dmitri; Jelinek, Ruth; Roeth, Philipp Thomas; Ruehle, Sabine; Klugmann, Matthias] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany; [Moebius, Wiebke; Ruhwedel, Torben] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Weber-Fahr, Wolfgang; Sartorius, Alexander] Cent Inst Mental Hlth, Neuroimaging Dept, D-6800 Mannheim, Germany; [Klugmann, Matthias] Univ New S Wales, Dept Physiol, Translat Neurosci Facil, Sydney, NSW, Australia	Johannes Gutenberg University of Mainz; Max Planck Society; Central Institute of Mental Health; University of New South Wales Sydney	Mersmann, N (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med Ctr, Mainz, Germany.	m.klugmann@unsw.edu.au	Sartorius, Alexander/E-3061-2012	Ruhwedel, Torben/0000-0002-9535-9395; Sartorius, Alexander/0000-0002-1243-3693; /0000-0002-2902-7165	European Leukodystrophy Association [ELA 2006-032C5]; Mainz University Medical Center [Forschungsfoerderung Stufe 1]	European Leukodystrophy Association; Mainz University Medical Center	This work was supported by the European Leukodystrophy Association (grant number: ELA 2006-032C5), and a grant in aid (Forschungsfoerderung Stufe 1) of the Mainz University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1973, HUM PATHOL, V4, P331, DOI 10.1016/S0046-8177(73)80098-X; Arun P, 2010, J INHERIT METAB DIS, V33, P195, DOI 10.1007/s10545-010-9100-z; Assadi M, 2010, EUR J PAEDIATR NEURO, V14, P354, DOI 10.1016/j.ejpn.2009.11.006; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Blum S, 1999, J MAGN RESON, V136, P219, DOI 10.1006/jmre.1998.1618; Cakmakci H, 2010, EUR J RADIOL, V74, pE162, DOI 10.1016/j.ejrad.2009.05.048; Canavan MM, 1931, ARCH NEURO PSYCHIATR, V25, P299, DOI 10.1001/archneurpsyc.1931.02230020085005; Cerghet M, 2009, J NEUROL SCI, V286, P76, DOI 10.1016/j.jns.2009.06.039; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Hershfield JR, 2006, FASEB J, V20, P2139, DOI 10.1096/fj.05-5358fje; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008; KAMOSHIT.S, 1967, NEUROLOGY, V17, P895, DOI 10.1212/WNL.17.9.895; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; Kirmani BF, 2003, DEV BRAIN RES, V140, P105, DOI 10.1016/S0165-3806(02)00592-8; Kitada K, 2000, J NEUROCHEM, V74, P2512, DOI 10.1046/j.1471-4159.2000.0742512.x; Klugmann M, 2005, MOL THER, V11, P745, DOI 10.1016/j.ymthe.2005.01.006; Klugmann M, 2003, NEUROREPORT, V14, P1837, DOI 10.1097/00001756-200310060-00016; Klugmann Matthias, 2006, P303, DOI 10.1016/B978-012397632-1/50024-1; KONDO A, 1991, BRAIN, V114, P979, DOI 10.1093/brain/114.2.979; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Madhavarao CN, 2004, J COMP NEUROL, V472, P318, DOI 10.1002/cne.20080; Matalon R, 2000, J GENE MED, V2, P165; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; Mobius W, 2010, METHOD CELL BIOL, V96, P475, DOI 10.1016/S0091-679X(10)96020-2; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; Pederzolli CD, 2009, METAB BRAIN DIS, V24, P283, DOI 10.1007/s11011-009-9137-6; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Surendran S, 2004, BRAIN RES, V1016, P268, DOI 10.1016/j.brainres.2004.05.035; Surendran S, 2006, BIOCHEM BIOPH RES CO, V11, P11; SUZUKI K, 1968, ACTA NEUROPATHOL, V10, P95, DOI 10.1007/BF00690515; Tacke U, 2005, NEUROPEDIATRICS, V36, P252, DOI 10.1055/s-2005-865865; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; Uldry M, 2001, EMBO J, V20, P4467, DOI 10.1093/emboj/20.16.4467; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x	44	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20336	10.1371/journal.pone.0020336	http://dx.doi.org/10.1371/journal.pone.0020336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625469	Green Published, gold, Green Submitted			2022-12-25	WOS:000290793400058
J	Luciani, MG; Seok, J; Sayeed, A; Champion, S; Goodson, WH; Jeffrey, SS; Xiao, WZ; Mindrinos, M; Davis, RW; Dairkee, SH				Luciani, Maria Gloria; Seok, Junhee; Sayeed, Aejaz; Champion, Stacey; Goodson, William H.; Jeffrey, Stefanie S.; Xiao, Wenzhong; Mindrinos, Michael; Davis, Ronald W.; Dairkee, Shanaz H.			Distinctive Responsiveness to Stromal Signaling Accompanies Histologic Grade Programming of Cancer Cells	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; TUMOR MICROENVIRONMENT; POOR-PROGNOSIS; GROWTH-FACTOR; IN-SITU; EXPRESSION; FIBROBLASTS; CARCINOMA; PROGRESSION; ASSOCIATION	Whether stromal components facilitate growth, invasion, and dissemination of cancer cells or suppress neoplastic lesions from further malignant progression is a continuing conundrum in tumor biology. Conceptualizing a dynamic picture of tumorigenesis is complicated by inter-individual heterogeneity. In the post genomic era, unraveling such complexity remains a challenge for the cancer biologist. Towards establishing a functional association between cellular crosstalk and differential cancer aggressiveness, we identified a signature of malignant breast epithelial response to stromal signaling. Proximity to fibroblasts resulted in gene transcript alterations of > 2-fold for 107 probes, collectively designated as Fibroblast Triggered Gene Expression in Tumor (FTExT). The hazard ratio predicted by the FTExT classifier for distant relapse in patients with intermediate and high grade breast tumors was significant compared to routine clinical variables (dataset 1, n = 258, HR - 2.11, 95% CI 1.17-3.80, p-value 0.01; dataset 2, n = 171, HR - 3.07, 95% CI 1.21-7.83, p-value 0.01). Biofunctions represented by FTExT included inflammatory signaling, free radical scavenging, cell death, and cell proliferation. Unlike genes of the 'proliferation cluster', which are overexpressed in aggressive primary tumors, FTExT genes were uniquely repressed in such cases. As proof of concept for our correlative findings, which link stromal-epithelial crosstalk and tumor behavior, we show a distinctive differential in stromal impact on prognosis-defining functional endpoints of cell cycle progression, and resistance to therapy-induced growth arrest and apoptosis in low vs. high grade cancer cells. Our experimental data thus reveal aspects of 'paracrine cooperativity' that are exclusively contingent upon the histopathologically defined grade of interacting tumor epithelium, and demonstrate that epithelial responsiveness to the tumor microenvironment is a deterministic factor underlying clinical outcome. In this light, early attenuation of epithelial-stromal crosstalk could improve the management of cases prone to be clinically challenging.	[Luciani, Maria Gloria; Sayeed, Aejaz; Champion, Stacey; Goodson, William H.; Dairkee, Shanaz H.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Seok, Junhee; Xiao, Wenzhong; Mindrinos, Michael; Davis, Ronald W.] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Jeffrey, Stefanie S.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; Stanford University; Stanford University	Luciani, MG (corresponding author), Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA.	dairkes@cpmcri.org	Dairkee, Shanaz Hashmi/D-6743-2012	Dairkee, Shanaz/0000-0002-2073-9684; GOODSON, WILLIAM/0000-0001-7489-3188; Jeffrey, Stefanie/0000-0003-4478-2764; xiao, wenzhong/0000-0003-4944-6380	National Institutes of Health [R01CA109325]; NATIONAL CANCER INSTITUTE [R01CA109325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health under grant R01CA109325. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; CAMP JT, 2010, MOL CANC RES    1203; Cardone A, 1997, PANMINERVA MED, V39, P174; CORNIL I, 1991, P NATL ACAD SCI USA, V88, P6028, DOI 10.1073/pnas.88.14.6028; Dairkee SH, 2007, ONCOGENE, V26, P6269, DOI 10.1038/sj.onc.1210452; Dairkee SH, 2008, CANCER RES, V68, P2076, DOI 10.1158/0008-5472.CAN-07-6526; Dairkee SH, 2009, CANCER RES, V69, P7826, DOI 10.1158/0008-5472.CAN-09-1564; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kleer CG, 2008, CLIN CANCER RES, V14, P5357, DOI 10.1158/1078-0432.CCR-08-0732; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Makretsov NA, 2007, MODERN PATHOL, V20, P84, DOI 10.1038/modpathol.3800713; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stuelten CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009832; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	45	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20016	10.1371/journal.pone.0020016	http://dx.doi.org/10.1371/journal.pone.0020016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625507	gold, Green Published, Green Submitted			2022-12-25	WOS:000290771200040
J	Maekawa, T; Takahashi, N; Tabeta, K; Aoki, Y; Miyashita, H; Miyauchi, S; Miyazawa, H; Nakajima, T; Yamazaki, K				Maekawa, Tomoki; Takahashi, Naoki; Tabeta, Koichi; Aoki, Yukari; Miyashita, Hirotaka; Miyauchi, Sayuri; Miyazawa, Haruna; Nakajima, Takako; Yamazaki, Kazuhisa			Chronic Oral Infection with Porphyromonas gingivalis Accelerates Atheroma Formation by Shifting the Lipid Profile	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; CHLAMYDIA-PNEUMONIAE; UP-REGULATION; X-RECEPTOR; ATHEROSCLEROSIS; METABOLISM; RISK; LXR; INFLAMMATION	Background: Recent studies have suggested that periodontal disease increases the risk of atherothrombotic disease. Atherosclerosis has been characterized as a chronic inflammatory response to cholesterol deposition in the arteries. Although several studies have suggested that certain periodontopathic bacteria accelerate atherogenesis in apolipoprotein E-deficient mice, the mechanistic link between cholesterol accumulation and periodontal infection-induced inflammation is largely unknown. Methodology/Principal Findings: We orally infected C57BL/6 and C57BL/6. KOR-Apoe(shl) (B6.Apoeshl) mice with Porphyromonas gingivalis, which is a representative periodontopathic bacterium, and evaluated atherogenesis, gene expression in the aorta and liver and systemic inflammatory and lipid profiles in the blood. Furthermore, the effect of lipopolysaccharide (LPS) from P. gingivalis on cholesterol transport and the related gene expression was examined in peritoneal macrophages. Alveolar bone resorption and elevation of systemic inflammatory responses were induced in both strains. Despite early changes in the expression of key genes involved in cholesterol turnover, such as liver X receptor and ATP-binding cassette A1, serum lipid profiles did not change with short-term infection. Long-term infection was associated with a reduction in serum high-density lipoprotein (HDL) cholesterol but not with the development of atherosclerotic lesions in wild-type mice. In B6.Apoeshl mice, long-term infection resulted in the elevation of very low-density lipoprotein (VLDL), LDL and total cholesterols in addition to the reduction of HDL cholesterol. This shift in the lipid profile was concomitant with a significant increase in atherosclerotic lesions. Stimulation with P. gingivalis LPS induced the change of cholesterol transport via targeting the expression of LDL receptor-related genes and resulted in the disturbance of regulatory mechanisms of the cholesterol level in macrophages. Conclusions/Significance: Periodontal infection itself does not cause atherosclerosis, but it accelerates it by inducing systemic inflammation and deteriorating lipid metabolism, particularly when underlying hyperlidemia or susceptibility to hyperlipidemia exists, and it may contribute to the development of coronary heart disease.	[Maekawa, Tomoki; Takahashi, Naoki; Tabeta, Koichi; Aoki, Yukari; Miyashita, Hirotaka; Miyauchi, Sayuri; Miyazawa, Haruna; Nakajima, Takako; Yamazaki, Kazuhisa] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan; [Maekawa, Tomoki; Takahashi, Naoki; Aoki, Yukari; Miyashita, Hirotaka; Miyauchi, Sayuri; Miyazawa, Haruna; Yamazaki, Kazuhisa] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Sci Hlth Promot, Lab Periodontol & Immunol, Niigata, Japan; [Nakajima, Takako] Niigata Univ, Med & Dent Hosp, Gen Dent & Clin Educ Unit, Niigata, Japan	Niigata University; Niigata University; Niigata University	Maekawa, T (corresponding author), Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan.	kaz@dent.niigata-u.ac.jp	Maekawa, Tomoki/AAA-4673-2020; TABTA, KOICHI/AAG-6481-2020	TABTA, KOICHI/0000-0002-7019-1872; Maekawa, Tomoki/0000-0002-4597-1316	Ministry of Education, Science, Sports and Culture of Japan [19390536, 19592384, 19791610, 20592426]; Promotion of Niigata University Research Project; Grants-in-Aid for Scientific Research [23390476, 21390555] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Niigata University Research Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (19390536, 19592384, 19791610, and 20592426)(http://www.jsps.go.jp/) and the Promotion of Niigata University Research Project (http://www.niigata-u.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; BAKER PJ, 1994, ARCH ORAL BIOL, V39, P1035, DOI 10.1016/0003-9969(94)90055-8; Blessing E, 2001, ATHEROSCLEROSIS, V158, P13, DOI 10.1016/S0021-9150(00)00758-9; Buhlin K, 2009, ATHEROSCLEROSIS, V206, P518, DOI 10.1016/j.atherosclerosis.2009.03.035; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chiu B, 1997, CIRCULATION, V96, P2144; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; Domon H, 2008, J LEUKOCYTE BIOL, V83, P672, DOI 10.1189/jlb.0607432; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Feingold KR, 2008, BIOCHEM BIOPH RES CO, V374, P341, DOI 10.1016/j.bbrc.2008.07.023; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Gonzalez-Baro MR, 2007, AM J PHYSIOL-GASTR L, V292, pG1195, DOI 10.1152/ajpgi.00553.2006; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Li L, 2008, J LIPID RES, V49, P1782, DOI 10.1194/jlr.M800172-JLR200; Liao HL, 2002, ARTERIOSCL THROM VAS, V22, P127, DOI 10.1161/hq1201.101772; Maekawa T, 2010, J VASC RES, V47, P346, DOI 10.1159/000265568; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; Matsushima Y, 1999, MAMM GENOME, V10, P352, DOI 10.1007/s003359901000; MENDALL MA, 1994, BRIT HEART J, V71, P437; Nakajima T, 2010, J PERIODONTAL RES, V45, P116, DOI 10.1111/j.1600-0765.2009.01209.x; Norata GD, 2005, INT J MOL MED, V16, P717; O'Connor S, 2001, EMERG INFECT DIS, V7, P780; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Ramirez-Tortosa MC, 2010, NUTR METAB CARDIOVAS, V20, P133, DOI 10.1016/j.numecd.2009.03.003; Rufail ML, 2007, J PERIODONTAL RES, V42, P495, DOI 10.1111/j.1600-0765.2007.00973.x; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; SEYMOUR GJ, 1993, J PERIODONTAL RES, V28, P478, DOI 10.1111/j.1600-0765.1993.tb02108.x; Shimazaki Y, 2007, J DENT RES, V86, P271, DOI 10.1177/154405910708600314; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Yamazaki K, 2007, CLIN EXP IMMUNOL, V149, P445, DOI 10.1111/j.1365-2249.2007.03450.x; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	40	94	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20240	10.1371/journal.pone.0020240	http://dx.doi.org/10.1371/journal.pone.0020240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625524	Green Submitted, gold, Green Published			2022-12-25	WOS:000290771200054
J	Butturini, E; Cavalieri, E; de Prati, AC; Darra, E; Rigo, A; Shoji, K; Murayama, N; Yamazaki, H; Watanabe, Y; Suzuki, H; Mariotto, S				Butturini, Elena; Cavalieri, Elisabetta; de Prati, Alessandra Carcereri; Darra, Elena; Rigo, Antonella; Shoji, Kazuo; Murayama, Norie; Yamazaki, Hiroshi; Watanabe, Yasuo; Suzuki, Hisanori; Mariotto, Sofia			Two Naturally Occurring Terpenes, Dehydrocostuslactone and Costunolide, Decrease Intracellular GSH Content and Inhibit STAT3 Activation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; SERINE PHOSPHORYLATION; SESQUITERPENE LACTONE; S-GLUTATHIONYLATION; MEDIATED APOPTOSIS; OXIDATIVE STRESS; HEME OXYGENASE-1; MEDICINAL-PLANT; CANCER CELLS	The main purpose of the present study is to envisage the molecular mechanism of inhibitory action of dehydrocostuslactone (DCE) andcostunolide (CS), two naturally occurring sesquiterpene lactones, towards the activation of signal transducer and activator of transcription 3 (STAT3). We report that, in human THP-1 cell line, they inhibit IL-6-elicited tyrosine phosphorylation of STAT3 and its DNA binding activity with EC50 of 10 mu M with concomitantdown-regulation of the phosphorylation of the tyrosine Janus kinases JAK1, JAK2 and Tyk2. Furthermore, these compounds that contain an alpha-beta-unsatured carbonyl moiety and function as potent Michael reaction acceptor, induce a rapid drop in intracellular glutathione (GSH) concentration by direct interaction with it, thereby triggering S-glutathionylation of STAT3. Dehydrocostunolide (HCS), the reduced form of CS lacking only the alpha-beta-unsaturated carbonyl group, fails to exert any inhibitory action. Finally, the glutathione ethylene ester (GEE), the cell permeable GSH form, reverts the inhibitory action of DCE and CS on STAT3 tyrosine phosphorylation. We conclude that these two sesquiterpene lactones are able to induce redox-dependent post-translational modification of cysteine residues of STAT3 protein in order to regulate its function.	[Butturini, Elena; Cavalieri, Elisabetta; de Prati, Alessandra Carcereri; Darra, Elena; Shoji, Kazuo; Suzuki, Hisanori; Mariotto, Sofia] Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy; [Butturini, Elena; Shoji, Kazuo; Watanabe, Yasuo] Showa Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan; [Rigo, Antonella] Univ Verona, Dept Med, I-37100 Verona, Italy; [Murayama, Norie; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Dept Pharmacokinet, Tokyo, Japan	University of Verona; Showa Pharmaceutical University; University of Verona; Showa Pharmaceutical University	Butturini, E (corresponding author), Univ Verona, Dept Life & Reprod Sci, I-37100 Verona, Italy.	sofiamariotto@hotmail.it	mariotto, sofia/AAH-5473-2019; Yamazaki, Hiroshi/A-6081-2011	Yamazaki, Hiroshi/0000-0002-1068-4261; Butturini, Elena/0000-0001-6612-8945; Watanabe, Yasuo/0000-0003-2232-0091; Darra, Elena/0000-0002-4684-4351	University of Verona	University of Verona	This work was partly supported by JointProject (HS). EB was financed by a Ph.D. fellowship (University of Verona). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2008, CURR DRUG TARGETS, V9, P369, DOI 10.2174/138945008784221116; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buettner R, 2002, CLIN CANCER RES, V8, P945; Choi JH, 2002, JPN J CANCER RES, V93, P1327, DOI 10.1111/j.1349-7006.2002.tb01241.x; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Paola R, 2005, SHOCK, V24, P255, DOI 10.1097/01.shk.0000175428.57769.34; de Prati AC, 2005, CURR MED CHEM, V12, P1819, DOI 10.2174/0929867054546645; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Hsu YL, 2009, J PHARMACOL EXP THER, V329, P808, DOI 10.1124/jpet.108.148395; Hung JY, 2010, LUNG CANCER, V68, P355, DOI 10.1016/j.lungcan.2009.07.017; Jeong GS, 2007, EUR J PHARMACOL, V565, P37, DOI 10.1016/j.ejphar.2007.02.053; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Koo TH, 2001, PLANTA MED, V67, P103, DOI 10.1055/s-2001-11503; KUO PL, 2009, MOL CANC THER; Lee HJ, 1999, PLANTA MED, V65, P104, DOI 10.1055/s-1999-13968; Lee MG, 2001, BIOL PHARM BULL, V24, P303, DOI 10.1248/bpb.24.303; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Mariotto S, 2008, PHARMACOL RES, V57, P110, DOI 10.1016/j.phrs.2007.12.005; Menegazzi M, 2008, INT J BIOCHEM CELL B, V40, P1509, DOI 10.1016/j.biocel.2007.11.019; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pae HO, 2007, INFLAMM RES, V56, P520, DOI 10.1007/s00011-007-7015-4; Pandey MM, 2007, J ETHNOPHARMACOL, V110, P379, DOI 10.1016/j.jep.2006.12.033; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schmidt TJ, 1997, BIOORGAN MED CHEM, V5, P645, DOI 10.1016/S0968-0896(97)00003-5; SITIA R, 2004, SCI STKE, pPE27; Townsend PA, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1716fje; Wedge DE, 2000, PHYTOCHEMISTRY, V53, P747, DOI 10.1016/S0031-9422(00)00008-X; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	40	75	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20174	10.1371/journal.pone.0020174	http://dx.doi.org/10.1371/journal.pone.0020174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625597	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200070
J	Choe, CU; Lardong, K; Gelderblom, M; Ludewig, P; Leypoldt, F; Koch-Nolte, F; Gerloff, C; Magnus, T				Choe, Chi-un; Lardong, Kerstin; Gelderblom, Mathias; Ludewig, Peter; Leypoldt, Frank; Koch-Nolte, Friedrich; Gerloff, Christian; Magnus, Tim			CD38 Exacerbates Focal Cytokine Production, Postischemic Inflammation and Brain Injury after Focal Cerebral Ischemia	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; T-CELLS; EXPERIMENTAL STROKE; IMMUNE-RESPONSES; MESSENGER-RNA; EXPRESSION; CHEMOKINES; MICE; RAT; ACTIVATION	Background: Converging evidence suggests that inflammatory processes significantly influence brain injury and clinical impairment in ischemic stroke. Although early studies suggested a key role of lymphocytes, recent data has emphasized the orchestrating function of innate immunity, i.e., macrophages and microglia. The bifunctional receptor and ectoenzyme CD38 synthesizes calcium-mobilizing second messengers (e.g., cyclic ADP-ribose), which have been shown to be necessary for activation and migration of myeloid immune cells. Therefore, we investigated the dynamics of CD38 in stroke and the impact of CD38-deficiency on cytokine production, inflammation and cerebral damage in a mouse model of cerebral ischemia-reperfusion. Methodology/Principal Findings: We show that the local expression of the chemokine MCP-1 was attenuated in CD38-deficient mice compared with wildtype mice after focal cerebral ischemia and reperfusion. In contrast, no significant induction of MCP-1 expression was observed in peripheral blood after 6 hours. Flow cytometry analysis revealed less infiltrating macrophages and lymphocytes in the ischemic hemisphere of CD38-deficient mice, whereas the amount of resident microglia was unaltered. An up-regulation of CD38 expression was observed in macrophages and CD8(+) cells after focal cerebral ischemia in wildtype mice, whereas CD38 expression was unchanged in microglia. Finally, we demonstrate that CD38-deficiency decreases the cerebral ischemic injury and the persistent neurological deficit after three days of reperfusion in this murine temporary middle cerebral artery occlusion (tMCAO) model. Conclusion/Significance: CD38 is differentially regulated following stroke and its deficiency attenuates the postischemic chemokine production, the immune cell infiltration and the cerebral injury after temporary ischemia and reperfusion. Therefore CD38 might prove a therapeutic target in ischemic stroke.	[Choe, Chi-un; Lardong, Kerstin; Gelderblom, Mathias; Ludewig, Peter; Leypoldt, Frank; Gerloff, Christian; Magnus, Tim] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Koch-Nolte, Friedrich] Univ Hosp Hamburg Eppendorf, Dept Immunol, Hamburg, Germany; [Ludewig, Peter] Univ Hosp Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Choe, CU (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	cchoe@uke.de; t.magnus@uke.de	Leypoldt, Frank/ABC-3186-2021	Gerloff, Christian/0000-0002-6484-8882; Koch-Nolte, Friedrich/0000-0003-1730-6674; Leypoldt, Frank/0000-0002-8972-515X	Universitatsklinik Hamburg-Eppendorf [NWF-09/02]; Werner-Otto-Foundation; Novartis Foundation; Deutsche Forschungsgemeinschaft [310/6-3]	Universitatsklinik Hamburg-Eppendorf; Werner-Otto-Foundation; Novartis Foundation(Novartis); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Forschungsforderungsfonds NWF-09/02 (C.-u.C.) of the Universitatsklinik Hamburg-Eppendorf, the Werner-Otto-Foundation (C.-u.C., T.M.), the Novartis Foundation (C.-u.C.) and the Deutsche Forschungsgemeinschaft (No 310/6-3 to F.K.-N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KJ, 2010, STROKE, V41, pS75, DOI 10.1161/STROKEAHA.110.592881; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Choe CU, 2009, J NEUROCHEM, V110, P1766, DOI 10.1111/j.1471-4159.2009.06266.x; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gourmala NG, 1997, J NEUROIMMUNOL, V74, P35, DOI 10.1016/S0165-5728(96)00203-2; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Losy J, 2001, STROKE, V32, P2695, DOI 10.1161/hs1101.097380; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; WANG XK, 1995, STROKE, V26, P661, DOI 10.1161/01.STR.26.4.661; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046	28	61	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19046	10.1371/journal.pone.0019046	http://dx.doi.org/10.1371/journal.pone.0019046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21625615	Green Published, gold, Green Submitted			2022-12-25	WOS:000290558500003
J	Rowh, MAW; DeMicco, A; Horowitz, JE; Yin, B; Yang-Iott, KS; Fusello, AM; Hobeika, E; Reth, M; Bassing, CH				Rowh, M. A. W.; DeMicco, A.; Horowitz, J. E.; Yin, B.; Yang-Iott, K. S.; Fusello, A. M.; Hobeika, E.; Reth, M.; Bassing, C. H.			Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations	ONCOGENE			English	Article						p53; B lineage lymphomas; Igh/c-myc translocations	DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; V(D)J RECOMBINATION; TRANSGENIC MICE; DNA BREAKS; GENE AMPLIFICATION; CRE RECOMBINASE; HISTONE H2AX; P53; MYC	Inactivating Tp53 mutations are frequent genetic lesions in human tumors that harbor genomic instability, including B lineage lymphomas with IG translocations. Antigen receptor genes are assembled and modified in developing lymphocytes by RAG/AID-initiated genomic rearrangements that involve the induction of DNA double strand breaks (DSBs). Although TP53 inhibits the persistence of DSBs and induces apoptosis to protect cells from genomic instability and transformation, the development of spontaneous tumors harboring clonal translocations has not been reported in mice that only lack wild-type Tp53 protein or express Tp53 mutants. Tp53-deficient (Tp53(-/-)) mice succumb to T lineage lymphomas lacking clonal translocations but develop B lymphoid tumors containing immunoglobulin (Ig) translocations upon combined inactivation of DSB repair factors, RAG mutation or AID overexpression; mice expressing apoptosis-defective Tp53 mutants develop B cell lymphomas that have not been characterized for potential genomic instability. As somatic rather than germline inactivating mutations of TP53 are typically associated with human cancers and Tp53 deletion has cellular context dependent effects upon lymphocyte transformation, we generated mice with conditional Tp53 deletion in lineage-committed B lymphocytes to avoid complications associated with defective Tp53 responses during embryogenesis and/or in multilineage potential cells and, thereby, directly evaluate the potential physiological role of Tp53 in suppressing translocations in differentiated cells. These mb1-cre: Tp53(flox)/(flox) mice succumbed to lymphoid tumors containing Ig gene rearrangements and immunophenotypes characteristic of B cells from various developmental stages. Most mb1-cre: Tp53(flox)/(flox) tumors harbored clonal translocations, including Igh/c-myc or other oncogenic translocations generated by the aberrant repair of RAG/AID-generated DSBs. Our data indicate that Tp53 serves critical functions in B lineage lymphocytes to prevent transformation caused by translocations in cell populations experiencing physiological levels of RAG/AID-initiated DSB intermediates, and provide evidence that the somatic TP53 mutations found in diffuse large B-cell lymphoma and Burkitt's lymphoma may contribute to the development of these human malignancies. Oncogene (2011) 30, 4757-4764; doi:10.1038/onc.2011.191; published online 30 May 2011	[Bassing, C. H.] Univ Penn, Dept Pathol, CHOP, Immunol Grad Grp,Sch Med, Philadelphia, PA 19104 USA; [Rowh, M. A. W.; DeMicco, A.; Horowitz, J. E.; Yin, B.; Yang-Iott, K. S.; Fusello, A. M.; Bassing, C. H.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Dept Pathol & Lab Med, Div Canc Pathobiol, Philadelphia, PA 19104 USA; [Rowh, M. A. W.; DeMicco, A.; Horowitz, J. E.; Yin, B.; Yang-Iott, K. S.; Fusello, A. M.; Bassing, C. H.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [DeMicco, A.; Yin, B.; Bassing, C. H.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Hobeika, E.; Reth, M.] Univ Freiburg, BIOSS, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Hobeika, E.; Reth, M.] Max Planck Inst Immunobiol, Freiburg, Germany	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Freiburg; Max Planck Society	Bassing, CH (corresponding author), Univ Penn, Dept Pathol, CHOP, Immunol Grad Grp,Sch Med, 4054 Colket Translat Res Bldg,421 Curie Blvd,3501, Philadelphia, PA 19104 USA.	bassing@email.chop.edu	hobeika, elias/AAV-6663-2021	Rowh, Marta/0000-0001-9584-7826	University of Pennsylvania [5T32-AR007442-23, GM-07229]; Cancer Research Institute; Department of Pathology and Laboratory Medicine; Center for Childhood Cancer Research of the Children's Hospital of Philadelphia Research Institute; Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine; Pennsylvania Department of Health; Leukemia and Lymphoma Society; National Institutes of Health [R01 CA125195]; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007442] Funding Source: NIH RePORTER	University of Pennsylvania; Cancer Research Institute; Department of Pathology and Laboratory Medicine; Center for Childhood Cancer Research of the Children's Hospital of Philadelphia Research Institute; Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine; Pennsylvania Department of Health; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Training Program Rheumatic Disease of the University of Pennsylvania (5T32-AR007442-23 to MAWR), the Training Grant TG GM-07229 of the University of Pennsylvania (AD), the Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Training Grant awarded to the University of Pennsylvania (BY); the Department of Pathology and Laboratory Medicine and the Center for Childhood Cancer Research of the Children's Hospital of Philadelphia Research Institute, the Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine, a grant from the Pennsylvania Department of Health, a Leukemia and Lymphoma Society Scholar Award (CHB), and the National Institutes of Health Grant R01 CA125195 (CHB).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2008, BLOOD, V111, P2163, DOI 10.1182/blood-2007-08-104760; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Cheung AMY, 2002, CANCER RES, V62, P6194; Cheung KJJ, 2009, BRIT J HAEMATOL, V146, P257, DOI 10.1111/j.1365-2141.2009.07739.x; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dujka ME, 2010, ONCOGENE, V29, P957, DOI 10.1038/onc.2009.394; Fishler T, 2010, ONCOGENE, V29, P4007, DOI 10.1038/onc.2010.163; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Giblin W, 2009, BLOOD, V113, P2965, DOI 10.1182/blood-2008-07-165167; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Rooney S, 2004, P NATL ACAD SCI USA, V101, P2410, DOI 10.1073/pnas.0308757101; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Wu C, 2003, IMMUNITY, V18, P75, DOI 10.1016/S1074-7613(02)00515-0; Yin B, 2010, BLOOD OCT, V117, P175; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	39	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	47					4757	4764		10.1038/onc.2011.191	http://dx.doi.org/10.1038/onc.2011.191			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	861QG	21625223				2022-12-25	WOS:000298033700008
J	Jankowski, V; Tolle, M; Santos, RAS; Gunthner, T; Krause, E; Beyermann, M; Welker, P; Bader, M; Pinheiro, SVB; Sampaio, WO; Lautner, R; Kretschmer, A; van der Giet, M; Zidek, W; Jankowski, J				Jankowski, Vera; Toelle, Markus; Santos, Robson A. S.; Guenthner, Thomas; Krause, Eberhard; Beyermann, Michael; Welker, Pia; Bader, Michael; Brant Pinheiro, Sergio Veloso; Sampaio, Walkyria O.; Lautner, Roberto; Kretschmer, Axel; van der Giet, Markus; Zidek, Walter; Jankowski, Joachim			Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects	FASEB JOURNAL			English	Article						amino acid exchange; vascular tone	HUMAN ENDOTHELIAL-CELLS; RECEPTOR MAS; PROTEIN; EXPRESSION; MOUSE; GENE; RAT	The family of angiotensin peptides has been steadily growing in recent years. Most are fragments of angiotensin II (Ang II) with different affinities to the known angiotensin receptors. Here, we describe a novel endogenous Ang II-like octapeptide in plasma from healthy humans and patients with end-stage renal failure, which acts as a stronger agonist at Mas receptors than Ang 1-7. Chromatographic purification and structural analysis by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF) revealed an Ang II-like octapeptide, angioprotectin, with the sequence Pro-Glu-Val-Tyr-Ile-His-Pro-Phe, which differs from Ang II in Pro(1) and Glu(2) instead of Asp(1) and Arg(2). Pro-Glu-Val-Tyr-Ile-His-Pro-Phe in angioprotectin is most likely generated enzymatically from Ang II. Angioprotectin antagonized the contractile actions of Ang II on rat aortic rings. The physiological antagonism of vasoconstrictor actions of Ang II by angioprotectin is mediated by the Mas receptor. Angioprotectin has a stronger affinity to the Mas receptor than Ang-1-7. Plasma concentrations were similar to 15% of plasma Ang II concentrations in healthy volunteers and up to 50% in patients with renal failure. A commercially available Ang II antibody did not discriminate between angioprotectin and Ang II; thus, angioprotectin can contribute to Ang II concentrations measured by antibody-based assays. This novel peptide is likely to be a relevant component of the human renin-angiotensin-system.-Jankowski, V., Tolle, M., Santos, R. A. S., Gunthner, T., Krause, E., Beyermann, M., Welker, P., Bader, M., Pinheiro, S. V. B., Sampaio, W. O., Lautner, R., Kretschmer, A., van der Giet, M., Zidek, W., Jankowski, J. Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. FASEB J. 25, 2987-2995 (2011). www.fasebj.org	[Jankowski, Vera; Toelle, Markus; Guenthner, Thomas; van der Giet, Markus; Zidek, Walter; Jankowski, Joachim] Charite, Med Klin 4, D-12200 Berlin, Germany; [Welker, Pia] Charite, Inst Vegetat Anat, D-12200 Berlin, Germany; [Santos, Robson A. S.; Brant Pinheiro, Sergio Veloso; Sampaio, Walkyria O.; Lautner, Roberto] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Krause, Eberhard; Beyermann, Michael] Forschungsinst Mol Pharmakol, Berlin, Germany; [Bader, Michael] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Kretschmer, Axel] Bayer Schering Pharma, Wuppertal, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidade Federal de Minas Gerais; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Bayer AG; Bayer Healthcare Pharmaceuticals	Jankowski, J (corresponding author), Charite, Med Klin 4, Hindenburgdamm 30, D-12200 Berlin, Germany.	joachim.jankowski@charite.de	Tölle, Markus/GPP-7157-2022; Bader, Michael/K-2124-2013; PINHEIRO, SERGIO V B/T-8307-2019; Santos, Robson A S/C-9336-2011; Lautner, Roberto/G-9503-2012	Santos, Robson A S/0000-0001-8738-5852; van der Giet, Markus/0000-0003-3590-5451; Bader, Michael/0000-0003-4780-4164	German Federal Ministry of Education and Research [NGFN/01GR0807]; Sonnenfeld Foundation; European Union [FP7-HEALTH-2009-2.4.5-2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Sonnenfeld Foundation; European Union(European Commission)	The authors thank M. Witt (Bruker-Daltonics, Bremen, Germany) for accumulation of FT-mass spectra. The authors were supported by a grant from the German Federal Ministry of Education and Research (NGFN/01GR0807 to J.J.), a grant from the Sonnenfeld Foundation (to J.J.), and grant FP7-HEALTH-2009-2.4.5-2 from the European Union to the SysKid Consortium.	AMBROZ C, 1991, BIOCHIM BIOPHYS ACTA, V1133, P107, DOI 10.1016/0167-4889(91)90248-V; Ardaillou R, 1999, J AM SOC NEPHROL, V10, pS30; Beyermann M, 1996, J MED CHEM, V39, P3324, DOI 10.1021/jm960116z; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Douglas SA, 2000, BRIT J PHARMACOL, V131, P1262, DOI 10.1038/sj.bjp.0703690; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; Jankowski V, 2005, HYPERTENSION, V46, P591, DOI 10.1161/01.HYP.0000177436.09733.d4; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Orzechowski HD, 2001, MOL PHARMACOL, V60, P1332, DOI 10.1124/mol.60.6.1332; PESQUERO JB, 1994, J BIOL CHEM, V269, P26920; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Santos RAS, 2000, REGUL PEPTIDES, V91, P45, DOI 10.1016/S0167-0115(00)00138-5; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; van Kats JP, 2001, KIDNEY INT, V60, P2311, DOI 10.1046/j.1523-1755.2001.00049.x; Walther T, 1998, J BIOL CHEM, V273, P11867, DOI 10.1074/jbc.273.19.11867; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	22	31	31	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					2987	2995		10.1096/fj.11-185470	http://dx.doi.org/10.1096/fj.11-185470			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21628446				2022-12-25	WOS:000294435200014
J	Singh, SK; Baumgart, S; Singh, G; Konig, AO; Reutlinger, K; Hofbauer, LC; Barth, P; Gress, TM; Lomberk, G; Urrutia, R; Fernandez-Zapico, ME; Ellenrieder, V				Singh, Shiv K.; Baumgart, Sandra; Singh, Garima; Koenig, Alexander O.; Reutlinger, Kristina; Hofbauer, Lorenz C.; Barth, Peter; Gress, Thomas M.; Lomberk, Gwen; Urrutia, Raul; Fernandez-Zapico, Martin E.; Ellenrieder, Volker			Disruption of a Nuclear NFATc2 Protein Stabilization Loop Confers Breast and Pancreatic Cancer Growth Suppression by Zoledronic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; C-MYC; SIGNALING PATHWAY; CARCINOMA CELLS; TUMOR-GROWTH; SURVIVAL; BISPHOSPHONATES; INHIBITION; APOPTOSIS; INVASION	The aminobisphosphonate zoledronic acid has elicited significant attention due to its remarkable anti-tumoral activity, although its detailed mechanism of action remains unclear. Here, we demonstrate the existence of a nuclear GSK-3 beta-NFATc2 stabilization pathway that promotes breast and pancreatic cancer growth in vitro and in vivo and serves as a bona fide target of zoledronic acid. Specifically, the serine/threonine kinase GSK-3 beta stabilizes nuclear NFATc2 through phosphorylation of the serine-rich SP2 domain, thus protecting the transcription factor from E3-ubiquitin ligase HDM2-mediated proteolysis. Zoledronic acid disrupts this NFATc2 stabilization pathway through two mechanisms, namely GSK-3 beta inhibition and induction of HDM2 activity. Upon nuclear accumulation, HDM2 targets unphosphorylated NFATc2 for ubiquitination at acceptor lysine residues Lys-684/Lys-897 and hence labels the factor for subsequent proteasomal degradation. Conversely, mutagenesis-induced constitutive serine phosphorylation (Ser-215, Ser-219, and Ser-223) of the SP2 domain prevents NFATc2 from HDM2-mediated ubiquitination and degradation and consequently rescues cancer cells from growth suppression by zoledronic acid. In conclusion, this study demonstrates a critical role of the GSK-3 beta-HDM2 signaling loop in the regulation of NFATc2 protein stability and growth promotion and suggests that double targeting of this pathway is responsible, at least to a significant part, for the potent and reliable anti-tumoral effects of zoledronic acid.	[Singh, Shiv K.; Baumgart, Sandra; Singh, Garima; Koenig, Alexander O.; Reutlinger, Kristina; Gress, Thomas M.; Ellenrieder, Volker] Univ Marburg, Signaling & Transcript Lab, Dept Gastroenterol, D-35043 Marburg, Germany; [Hofbauer, Lorenz C.] Tech Univ Dresden, Div Endocrinol Diabet & Bone Dis, Dept Med 3, D-01307 Dresden, Germany; [Barth, Peter] Univ Marburg, Dept Pathol, D-35043 Marburg, Germany; [Lomberk, Gwen; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Dept Biochem, Rochester, MN 55905 USA; [Lomberk, Gwen; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Dept Mol Biol, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55904 USA	Philipps University Marburg; Technische Universitat Dresden; Philipps University Marburg; Mayo Clinic; Mayo Clinic; Mayo Clinic	Ellenrieder, V (corresponding author), Univ Marburg, Signaling & Transcript Lab, Dept Gastroenterol, D-35043 Marburg, Germany.	ellenrie@med.uni-marburg.de	Hofbauer, Lorenz C/G-2490-2010; Lomberk, Gwen/AAL-8490-2020	Hofbauer, Lorenz C/0000-0002-8691-8423; Lomberk, Gwen/0000-0001-5463-789X; Singh, Shiv K./0000-0002-5725-4058; Gress, Thomas/0000-0002-9333-5461	Deutsche Forschungsgemeinschaft [KFO210, SFB-TR17]; LOEWE-Schwerpunkt "Tumor and Inflammation"; German Cancer Research Foundation [70-3022-El I]; Novartis Foundation; Wilhelm Sander Foundation; National Institutes of Health [DK 52913]; Mayo Clinic [P50 CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [NIDDK P30 DK084567]; NATIONAL CANCER INSTITUTE [P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052913, P30DK084567, R01DK052913] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE-Schwerpunkt "Tumor and Inflammation"; German Cancer Research Foundation; Novartis Foundation(Novartis); Wilhelm Sander Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was generously supported by the Deutsche Forschungsgemeinschaft (Grant KFO210, SFB-TR17) (to V. E.), the LOEWE-Schwerpunkt "Tumor and Inflammation" (to V. E.) and the Max-Eder program of the German Cancer Research Foundation (Grant 70-3022-El I) (to V. E.), the Novartis Foundation (to V. E. and L. C. H.), the Wilhelm Sander Foundation (to L. C. H.), National Institutes of Health Grant DK 52913 (to R. U.), Mayo Clinic Pancreatic SPORE Grant P50 CA102701 (to M. E. F. Z.), and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant NIDDK P30 DK084567 (to M. E. F. Z.).	Bertoldo F, 2009, NAT REV CLIN ONCOL, V6, P191, DOI 10.1038/nrclinonc.2009.24; Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003; Boissier S, 2000, CANCER RES, V60, P2949; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chuah C, 2005, LEUKEMIA, V19, P1896, DOI 10.1038/sj.leu.2403949; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Li YY, 2008, LUNG CANCER, V59, P180, DOI 10.1016/j.lungcan.2007.08.026; Lyseng-Williamson KA, 2008, DRUGS, V68, P2661, DOI 10.2165/0003495-200868180-00010; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ottewell PD, 2010, INT J CANCER, V126, P522, DOI 10.1002/ijc.24756; Ougolkov AV, 2007, BLOOD, V110, P735, DOI 10.1182/blood-2006-12-060947; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Peng HJ, 2007, CANCER RES, V67, P9346, DOI 10.1158/0008-5472.CAN-06-4508; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Szuhai K, 2009, CLIN CANCER RES, V15, P2259, DOI 10.1158/1078-0432.CCR-08-2184; Tanvetyanon T, 2006, ANN ONCOL, V17, P897, DOI 10.1093/annonc/mdj105; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; Tenta R, 2008, HORM METAB RES, V40, P737, DOI 10.1055/s-2008-1078753; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Winter MC, 2009, CURR OPIN ONCOL, V21, P499, DOI 10.1097/CCO.0b013e328331c794; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoeli-Lerner M, 2009, MOL CANCER RES, V7, P425, DOI 10.1158/1541-7786.MCR-08-0342	36	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28761	28771		10.1074/jbc.M110.197533	http://dx.doi.org/10.1074/jbc.M110.197533			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21628454	hybrid, Green Published			2022-12-25	WOS:000293837000014
J	Kim, YC; DeMartino, GN				Kim, Young-Chan; DeMartino, George N.			C Termini of Proteasomal ATPases Play Nonequivalent Roles in Cellular Assembly of Mammalian 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE; 20S PROTEASOME; SUBSTRATE ENTRY; CORE PARTICLE; AAA SUBUNITS; COMPLEX; DEGRADATION; PA700; ACTIVATION; PATHWAY	The 26 S proteasome comprises two multisubunit subcomplexes as follows: 20 S proteasome and PA700/19 S regulatory particle. The cellular mechanisms by which these subcomplexes assemble into 26 S proteasome and the molecular determinants that govern the assembly process are poorly defined. Here, we demonstrate the nonequivalent roles of the C termini of six AAA subunits (Rpt1-Rpt6) of PA700 in 26 S proteasome assembly in mammalian cells. The C-terminal HbYX motif (where Hb is a hydrophobic residue, Y is tyrosine, and X is any amino acid) of each of two subunits, Rpt3 and Rpt5, but not that of a third subunit Rpt2, was essential for assembly of 26 S proteasome. The C termini of none of the three non-HbYX motif Rpt subunits were essential for cellular 26 S proteasome assembly, although deletion of the last three residues of Rpt6 destabilized the 20 S-PA700 interaction. Rpt subunits defective for assembly into 26 S proteasome due to C-terminal truncations were incorporated into intact PA700. Moreover, intact PA700 accumulated as an isolated subcomplex when cellular 20 S proteasome content was reduced by RNAi. These results indicate that 20 S proteasome is not an obligatory template for assembly of PA700. Collectively, these results identify specific structural elements of two Rpt subunits required for 26 S proteasome assembly, demonstrate that PA700 can be assembled independently of the 20 S proteasome, and suggest that intact PA700 is a direct intermediate in the cellular pathway of 26 S proteasome assembly.	[Kim, Young-Chan; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by Welch Foundation Grant I-500 (to G. N. D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Adams GM, 1997, J MOL BIOL, V273, P646, DOI 10.1006/jmbi.1997.1334; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; MA CP, 1994, J BIOL CHEM, V269, P3539; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tanaka K., 2009, CELL, V137, P914; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382	54	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26652	26666		10.1074/jbc.M111.246793	http://dx.doi.org/10.1074/jbc.M111.246793			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628461	Green Published, hybrid			2022-12-25	WOS:000293078200043
J	Korytowski, W; Basova, LV; Pilat, A; Kernstock, RM; Girotti, AW				Korytowski, Witold; Basova, Liana V.; Pilat, Anna; Kernstock, Robert M.; Girotti, Albert W.			Permeabilization of the Mitochondrial Outer Membrane by Bax/Truncated Bid (tBid) Proteins as Sensitized by Cardiolipin Hydroperoxide Translocation MECHANISTIC IMPLICATIONS FOR THE INTRINSIC PATHWAY OF OXIDATIVE APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; 5-AMINOLEVULINATE-TREATED TUMOR-CELLS; CATHODE ELECTROCHEMICAL DETECTION; LIPID-PEROXIDATION; INTERMEMBRANE TRANSFER; MEDIATED APOPTOSIS; YEAST MITOCHONDRIA; BCL-2 FAMILY; CONTACT SITE	Cytochrome c (cyt c) release upon oxidation of cardiolipin (CL) in the mitochondrial inner membrane (IM) under oxidative stress occurs early in the intrinsic apoptotic pathway. We postulated that CL oxidation mobilizes not only cyt c but also CL itself in the form of hydroperoxide (CLOOH) species. Relatively hydrophilic CLOOHs could assist in apoptotic signaling by translocating to the outer membrane (OM), thus promoting recruitment of the pro-apoptotic proteins truncated Bid (tBid) and Bax for generation of cyt c-traversable pores. Initial testing of these possibilities showed that CLOOH-containing liposomes were permeabilized more readily by tBid plus Ca2+ than CL-containing counterparts. Moreover, CLOOH translocated more rapidly from IM-mimetic to OM-mimetic liposomes than CL and permitted more extensive OM permeabilization. We found that tBid bound more avidly to CLOOH-containing membranes than to CL counterparts, and binding increased with increasing CLOOH content. Permeabilization of CLOOH-containing liposomes in the presence of tBid could be triggered by monomeric Bax, consistent with tBid/Bax cooperation in pore formation. Using CL-null mitochondria from a yeast mutant, we found that tBid binding and cyt c release were dramatically enhanced by transfer acquisition of CLOOH. Additionally, we observed a pre-apoptotic IM-to-OM transfer of oxidized CL in cardiomyocytes treated with the Complex III blocker, antimycin A. These findings provide new mechanistic insights into the role of CL oxidation in the intrinsic pathway of oxidative apoptosis.	[Korytowski, Witold; Basova, Liana V.; Pilat, Anna; Kernstock, Robert M.; Girotti, Albert W.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Korytowski, Witold] Jagiellonian Univ, Inst Mol Biol, PL-30387 Krakow, Poland	Medical College of Wisconsin; Jagiellonian University	Girotti, AW (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	agirotti@mcw.edu	Girotti, Albert/AAF-6910-2020		National Institutes of Health [HL85677, CA72630 (USPHS)]; Polish Ministry of Science [3P05A-5523]; NATIONAL CANCER INSTITUTE [R01CA072630] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL85677 and CA72630 (USPHS). This work was also supported by Polish Ministry of Science Grant 3P05A-5523.	Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Cristea IM, 2004, CHEM PHYS LIPIDS, V129, P133, DOI 10.1016/j.chemphyslip.2004.02.002; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Epand RF, 2007, BIOPHYS J, V92, P126, DOI 10.1529/biophysj.106.092353; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Esposti MD, 2002, CELL DEATH DIFFER, V9, P234, DOI 10.1038/sj.cdd.4400997; Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Girotti AW, 2008, FREE RADICAL BIO MED, V44, P956, DOI 10.1016/j.freeradbiomed.2007.12.004; Girotti AW, 2000, METHOD ENZYMOL, V319, P85; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; ITOH YH, 1986, ANAL BIOCHEM, V154, P200, DOI 10.1016/0003-2697(86)90515-4; Iverson SL, 2004, J BIOL CHEM, V279, P1100, DOI 10.1074/jbc.M305020200; Jiang YJ, 2004, J LIPID RES, V45, P244, DOI 10.1194/jlr.M300314-JLR200; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Korytowski W, 1999, METHOD ENZYMOL, V300, P23; Korytowski W, 2005, ANAL BIOCHEM, V343, P136, DOI 10.1016/j.ab.2005.04.005; Kriska T, 2005, ARCH BIOCHEM BIOPHYS, V433, P435, DOI 10.1016/j.abb.2004.09.025; Kriska T, 2002, FREE RADICAL BIO MED, V33, P1389, DOI 10.1016/S0891-5849(02)01078-X; Kriska T, 2004, ANAL BIOCHEM, V327, P97, DOI 10.1016/j.ab.2003.12.021; Kriska T, 2006, J BIOL CHEM, V281, P23643, DOI 10.1074/jbc.M600744200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lesnefsky EJ, 2000, ANAL BIOCHEM, V285, P246, DOI 10.1006/abio.2000.4783; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Liu JH, 2008, BIOCHEMISTRY-US, V47, P4518, DOI 10.1021/bi701962c; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Mari M, 2008, GASTROENTEROLOGY, V134, P1507, DOI 10.1053/j.gastro.2008.01.073; McIntyre JA, 2003, PROG LIPID RES, V42, P176, DOI 10.1016/S0163-7827(02)00048-6; Montessuit S, 1999, PROTEIN EXPRES PURIF, V15, P202, DOI 10.1006/prep.1998.1010; Morin C, 2003, BIOCHEM BIOPH RES CO, V307, P477, DOI 10.1016/S0006-291X(03)01203-8; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9; Polcic P, 2005, CELL DEATH DIFFER, V12, P310, DOI 10.1038/sj.cdd.4401566; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1992, J BIOL CHEM, V267, P22243; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; SPECK SH, 1983, FEBS LETT, V164, P379, DOI 10.1016/0014-5793(83)80321-4; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; Thomson M, 2003, BIOESSAYS, V25, P252, DOI 10.1002/bies.10243; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; VANKUIJK FJGM, 1987, TRENDS BIOCHEM SCI, V12, P31, DOI 10.1016/0968-0004(87)90014-4; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; Vila A, 2004, BIOCHEMISTRY-US, V43, P12592, DOI 10.1021/bi0491200; Vila A, 2001, BIOCHEMISTRY-US, V40, P14715, DOI 10.1021/bi011408r; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	71	72	78	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26334	26343		10.1074/jbc.M110.188516	http://dx.doi.org/10.1074/jbc.M110.188516			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642428	Green Published, hybrid			2022-12-25	WOS:000293078200010
J	Bonner, C; Farrelly, AM; Concannon, CG; Dussmann, H; Baquie, M; Virard, I; Wobser, H; Kogel, D; Wollheim, CB; Rupnik, M; Byrne, MM; Konig, HG; Prehn, JHM				Bonner, Caroline; Farrelly, Angela M.; Concannon, Caoimhin G.; Dussmann, Heiko; Baquie, Mathurin; Virard, Isabelle; Wobser, Hella; Koegel, Donat; Wollheim, Claes B.; Rupnik, Marjan; Byrne, Maria M.; Koenig, Hans-Georg; Prehn, Jochen H. M.			Bone Morphogenetic Protein 3 Controls Insulin Gene Expression and Is Down-regulated in INS-1 Cells Inducibly Expressing a Hepatocyte Nuclear Factor 1A-Maturity-onset Diabetes of the Young Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; PANCREAS DEVELOPMENT; SIGNAL-TRANSDUCTION; ENDOCRINE PANCREAS; BETA-CELLS; SECRETION; GLUCOSE; TRANSCRIPTION; DYSFUNCTION; APOPTOSIS	Inactivating mutations in the transcription factor hepatocyte nuclear factor (HNF) 1A cause HNF1A-maturity-onset diabetes of the young (HNF1A-MODY), the most common monogenic form of diabetes. To examine HNF1A-MODY-induced defects in gene expression, we performed a microarray analysis of the transcriptome of rat INS-1 cells inducibly expressing the common hot spot HNF1A frameshift mutation, Pro291fsinsC-HNF1A. Real-time quantitative PCR (qPCR), Western blotting, immunohistochemistry, reporter assays, and chromatin immunoprecipitation (ChIP) were used to validate alterations in gene expression and to explore biological activities of target genes. Twenty-four hours after induction of the mutant HNF1A protein, we identified a prominent down-regulation of the bone morphogenetic protein 3 gene (Bmp-3) mRNA expression. Reporter assays, qPCR, and Western blot analysis validated these results. In contrast, inducible expression of wild-type HNF1A led to a time-dependent increase in Bmp-3 mRNA and protein levels. Moreover, reduced protein levels of BMP-3 and insulin were detected in islets of transgenic HNF1A-MODY mice. Interestingly, treatment of naive INS-1 cells or murine organotypic islet cultures with recombinant human BMP-3 potently increased their insulin levels and restored the decrease in SMAD2 phosphorylation and insulin gene expression induced by the HNF1A frameshift mutation. Our study suggests a critical link between HNF1A-MODY-induced alterations in Bmp-3 expression and insulin gene levels in INS-1 cells and indicates that the reduced expression of growth factors involved in tissue differentiation may play an important role in the pathophysiology of HNF1A-MODY.	[Bonner, Caroline; Farrelly, Angela M.; Concannon, Caoimhin G.; Dussmann, Heiko; Virard, Isabelle; Wobser, Hella; Koenig, Hans-Georg; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Farrelly, Angela M.; Byrne, Maria M.] Mater Misericordiae Univ Hosp, Dublin 7, Ireland; [Baquie, Mathurin; Wollheim, Claes B.] Univ Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 1211, Switzerland; [Koegel, Donat] Goethe Univ Hosp, Ctr Neurol & Neurosurg, D-60590 Frankfurt, Germany; [Rupnik, Marjan] Univ Maribor, Fac Med, Inst Physiol, SLO-2000 Maribor, Slovenia	Royal College of Surgeons - Ireland; Mater Misericordiae University Hospital; University College Dublin; University of Geneva; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Maribor	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, 123 St Stephens Green, Dublin 2, Ireland.	prehn@rcsi.ie	Concannon, Caoimhin/B-2075-2010; Rupnik, Marjan Slak/R-4738-2019; Slak Rupnik, Marjan/E-6246-2015; Byrne, Maria/A-8310-2017; Pattou, Francois/O-6151-2017; Prehn, Jochen HM/A-3928-2010; Bonner, Caroline/A-9819-2015; Farrelly, Angela/E-8010-2017	Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882; Byrne, Maria/0000-0002-9394-8698; Pattou, Francois/0000-0001-8388-3766; Prehn, Jochen HM/0000-0003-3479-7794; Bonner, Caroline/0000-0002-4430-8280; Virard, Isabelle/0000-0002-3980-0078; Dussmann, Heiko/0000-0002-3582-8057; Kogel, Donat/0000-0003-1209-0210; Farrelly, Angela/0000-0002-1242-5693	Health Research Board [RP/2008/14, RP/2004/220, RP/2007/316]; Science Foundation Ireland [08/IN1/1949]	Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Health Research Board Grant RP/2008/14 and Science Foundation Ireland Grant 08/IN1/1949 (to J. H. M. P.) and Health Research Board Grants RP/2004/220 and RP/2007/316 (to M. M. B.).	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56; Ball EMA, 2001, DEV BIOL, V238, P1, DOI 10.1006/dbio.2001.0399; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bonner C, 2010, DIABETES, V59, P2799, DOI 10.2337/db09-1478; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; Farrelly AM, 2009, DIABETOLOGIA, V52, P136, DOI 10.1007/s00125-008-1168-8; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frayling TM, 2001, DIABETES, V50, pS94, DOI 10.2337/diabetes.50.2007.S94; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Jiang FX, 2002, J CELL SCI, V115, P753; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; Rane SG, 2006, CYTOKINE GROWTH F R, V17, P107, DOI 10.1016/j.cytogfr.2005.09.003; Rozen S, 2000, Methods Mol Biol, V132, P365; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; SANVITO F, 1994, DEVELOPMENT, V120, P3451; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wang HY, 2002, J BIOL CHEM, V277, P17564, DOI 10.1074/jbc.M111037200; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wobser H, 2006, DIABETOLOGIA, V49, P519, DOI 10.1007/s00125-005-0119-x; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamaoka T, 1998, J CLIN INVEST, V102, P294, DOI 10.1172/JCI2769	41	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25719	25728		10.1074/jbc.M110.215525	http://dx.doi.org/10.1074/jbc.M110.215525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628466	Green Published, hybrid			2022-12-25	WOS:000293073000033
J	Welin, A; Eklund, D; Stendahl, O; Lerm, M				Welin, Amanda; Eklund, Daniel; Stendahl, Olle; Lerm, Maria			Human Macrophages Infected with a High Burden of ESAT-6-Expressing M. tuberculosis Undergo Caspase-1-and Cathepsin B-Independent Necrosis	PLOS ONE			English	Article							INTERNUCLEOSOMAL DNA CLEAVAGE; NECROTIC CELL-DEATH; MYCOBACTERIUM-TUBERCULOSIS; CALMETTE-GUERIN; PORE FORMATION; APOPTOSIS; INFLAMMASOME; VIRULENCE; ACTIVATION; SECRETION	Mycobacterium tuberculosis (Mtb) infects lung macrophages, which instead of killing the pathogen can be manipulated by the bacilli, creating an environment suitable for intracellular replication and spread to adjacent cells. The role of host cell death during Mtb infection is debated because the bacilli have been shown to be both anti-apoptotic, keeping the host cell alive to avoid the antimicrobial effects of apoptosis, and pro-necrotic, killing the host macrophage to allow infection of neighboring cells. Since mycobacteria activate the NLRP3 inflammasome in macrophages, we investigated whether Mtb could induce one of the recently described inflammasome-linked cell death modes pyroptosis and pyronecrosis. These are mediated through caspase-1 and cathepsin-B, respectively. Human monocyte-derived macrophages were infected with virulent (H37Rv) Mtb at a multiplicity of infection (MOI) of 1 or 10. The higher MOI resulted in strongly enhanced release of IL-1 beta, while a low MOI gave no IL-1 beta response. The infected macrophages were collected and cell viability in terms of the integrity of DNA, mitochondria and the plasma membrane was determined. We found that infection with H37Rv at MOI 10, but not MOI 1, over two days led to extensive DNA fragmentation, loss of mitochondrial membrane potential, loss of plasma membrane integrity, and HMGB1 release. Although we observed plasma membrane permeabilization and IL-1 beta release from infected cells, the cell death induced by Mtb was not dependent on caspase-1 or cathepsin B. It was, however, dependent on mycobacterial expression of ESAT-6. We conclude that as virulent Mtb reaches a threshold number of bacilli inside the human macrophage, ESAT-6-dependent necrosis occurs, activating caspase-1 in the process.	[Welin, Amanda; Eklund, Daniel; Stendahl, Olle; Lerm, Maria] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lerm, Maria] Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden	Linkoping University; Karolinska Institutet	Welin, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	daniel.eklund@liu.se	Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Lerm, Maria/0000-0002-5092-9892; Eklund, Daniel/0000-0002-6045-4800	Swedish Research Council [529-2003-5994, 2005-7046, 2006-5968]; SIDA/SAREC; ULF; Ekhaga Foundation; Carl Trygger Foundation; King Gustaf V 80-Year Memorial Foundation; County Council of Ostergotland; Swedish Heart Lung Foundation; Oskar II Jubilee Foundation; Clas Groschinsky Foundation; Soderbergs Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); SIDA/SAREC; ULF; Ekhaga Foundation; Carl Trygger Foundation; King Gustaf V 80-Year Memorial Foundation; County Council of Ostergotland; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Oskar II Jubilee Foundation; Clas Groschinsky Foundation; Soderbergs Foundation	This work was supported by grants from the Swedish Research Council (#529-2003-5994, #2005-7046, #2006-5968), SIDA/SAREC, ULF, Ekhaga Foundation, Carl Trygger Foundation, King Gustaf V 80-Year Memorial Foundation, County Council of Ostergotland, Swedish Heart Lung Foundation, Oskar II Jubilee Foundation, Clas Groschinsky Foundation, and the Soderbergs Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; BARNES PF, 1992, J IMMUNOL, V149, P541; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; COLLINS RJ, 1992, INT J RADIAT BIOL, V61, P451, DOI 10.1080/09553009214551201; Danelishvili L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010474; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Dong Z, 1997, AM J PATHOL, V151, P1205; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Fratazzi C, 1999, J LEUKOCYTE BIOL, V66, P763, DOI 10.1002/jlb.66.5.763; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gan HX, 2005, J INFECT DIS, V191, P1292, DOI 10.1086/428906; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee Jinhee, 2010, J Cell Death, V3, P1; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mihalik R, 2004, CELL DEATH DIFFER, V11, P1357, DOI 10.1038/sj.cdd.4401493; Mishra BB, 2010, CELL MICROBIOL; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Poot M, 1997, CYTOMETRY, V27, P358, DOI 10.1002/(SICI)1097-0320(19970401)27:4<358::AID-CYTO7>3.0.CO;2-8; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Welin A, 2008, INFECT IMMUN, V76, P2882, DOI 10.1128/IAI.01549-07; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079	60	96	104	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20302	10.1371/journal.pone.0020302	http://dx.doi.org/10.1371/journal.pone.0020302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637850	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200049
J	Anderson, I; Scheuner, C; Goker, M; Mavromatis, K; Hooper, SD; Porat, I; Klenk, HP; Ivanova, N; Kyrpides, N				Anderson, Iain; Scheuner, Carmen; Goeker, Markus; Mavromatis, Kostas; Hooper, Sean D.; Porat, Iris; Klenk, Hans-Peter; Ivanova, Natalia; Kyrpides, Nikos			Novel Insights into the Diversity of Catabolic Metabolism from Ten Haloarchaeal Genomes	PLOS ONE			English	Article							ENTNER-DOUDOROFF PATHWAY; UNIVERSAL STRESS-PROTEIN; SP-NOV; GEN. NOV.; HALOQUADRATUM-WALSBYI; HALOPHILIC BACTERIUM; HALOFERAX-VOLCANII; SEQUENCE; HALOBACTERIUM; ARCHAEA	Background: The extremely halophilic archaea are present worldwide in saline environments and have important biotechnological applications. Ten complete genomes of haloarchaea are now available, providing an opportunity for comparative analysis. Methodology/Principal Findings: We report here the comparative analysis of five newly sequenced haloarchaeal genomes with five previously published ones. Whole genome trees based on protein sequences provide strong support for deep relationships between the ten organisms. Using a soft clustering approach, we identified 887 protein clusters present in all halophiles. Of these core clusters, 112 are not found in any other archaea and therefore constitute the haloarchaeal signature. Four of the halophiles were isolated from water, and four were isolated from soil or sediment. Although there are few habitat-specific clusters, the soil/sediment halophiles tend to have greater capacity for polysaccharide degradation, siderophore synthesis, and cell wall modification. Halorhabdus utahensis and Haloterrigena turkmenica encode over forty glycosyl hydrolases each, and may be capable of breaking down naturally occurring complex carbohydrates. H. utahensis is specialized for growth on carbohydrates and has few amino acid degradation pathways. It uses the non-oxidative pentose phosphate pathway instead of the oxidative pathway, giving it more flexibility in the metabolism of pentoses. Conclusions: These new genomes expand our understanding of haloarchaeal catabolic pathways, providing a basis for further experimental analysis, especially with regard to carbohydrate metabolism. Halophilic glycosyl hydrolases for use in biofuel production are more likely to be found in halophiles isolated from soil or sediment.	[Anderson, Iain; Mavromatis, Kostas; Hooper, Sean D.; Ivanova, Natalia; Kyrpides, Nikos] US DOE, Genome Biol Program, Joint Genome Inst, Walnut Creek, CA USA; [Scheuner, Carmen; Goeker, Markus; Klenk, Hans-Peter] Deutsch Sammlung Mikroorganismen & Zellkulturen, D-3300 Braunschweig, Germany; [Porat, Iris] INEOS Bio, Fayetteville, AR USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Anderson, I (corresponding author), US DOE, Genome Biol Program, Joint Genome Inst, Walnut Creek, CA USA.	IJAnderson@lbl.gov	Göker, Markus/AAX-6258-2021; Kyrpides, Nikos C./A-6305-2014	Göker, Markus/0000-0002-5144-6200; Kyrpides, Nikos C./0000-0002-6131-0462; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ivanova, Natalia/0000-0002-5802-9485	Office of Science of the United States Department of Energy [DE-AC02-05CH112]	Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Science of the United States Department of Energy (http://www.er.doe.gov/) under Contract No. DE-AC02-05CH112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 2009, STAND GENOMIC SCI, V1, P218, DOI 10.4056/sigs.31864; Baker RH, 1998, MOL PHYLOGENET EVOL, V9, P427, DOI 10.1006/mpev.1998.0519; Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Bardavid RE, 2008, EXTREMOPHILES, V12, P125, DOI 10.1007/s00792-007-0114-x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Brewer ML, 2007, J CHEM INF MODEL, V47, P1727, DOI 10.1021/ci600565r; Bucknam J, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-26; Burns DG, 2007, INT J SYST EVOL MICR, V57, P387, DOI 10.1099/ijs.0.64690-0; Burns DG, 2004, FEMS MICROBIOL LETT, V238, P469, DOI 10.1016/j.femsle.2004.08.016; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chivian D, 2008, SCIENCE, V322, P275, DOI 10.1126/science.1155495; Dadi AP, 2006, BIOTECHNOL BIOENG, V95, P904, DOI 10.1002/bit.21047; DELEY J, 1957, J BIOL CHEM, V227, P745; Di Bonaventura MP, 2010, MOL PHYLOGENET EVOL, V54, P950, DOI 10.1016/j.ympev.2009.08.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; FRANZMANN PD, 1988, SYST APPL MICROBIOL, V11, P20, DOI 10.1016/S0723-2020(88)80044-4; Galtier N, 2007, SYSTEMATIC BIOL, V56, P633, DOI 10.1080/10635150701546231; GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Graham DE, 2002, J BIOL CHEM, V277, P23500, DOI 10.1074/jbc.M203467200; Grant W.D., 2001, BERGEYS MANUAL SYSTE, V2nd ed., P294; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Huang JL, 2005, MOL BIOL EVOL, V22, P2142, DOI 10.1093/molbev/msi221; Hugouvieux-Cotte-Pattat N, 2004, MOL MICROBIOL, V51, P1361, DOI 10.1046/j.1365-2958.2003.03908.x; Ihara K, 1997, INT J SYST BACTERIOL, V47, P73, DOI 10.1099/00207713-47-1-73; Johnsen U, 2001, ARCH MICROBIOL, V175, P52, DOI 10.1007/s002030000237; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; Klenk HP, 2010, SYST APPL MICROBIOL, V33, P175, DOI 10.1016/j.syapm.2010.03.003; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIENAU EK, 2009, CLADISTICS, V25, P1; Litzinger S, 2010, J BACTERIOL, V192, P3132, DOI 10.1128/JB.01256-09; Malfatti S, 2009, STAND GENOMIC SCI, V1, P150, DOI 10.4056/sigs.23264; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Meskys R, 2001, EUR J BIOCHEM, V268, P3390, DOI 10.1046/j.1432-1327.2001.02239.x; Montalvo-Rodriguez R, 1998, INT J SYST BACTERIOL, V48, P1305, DOI 10.1099/00207713-48-4-1305; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OREN A, 1990, INT J SYST BACTERIOL, V40, P209, DOI 10.1099/00207713-40-2-209; OREN A, 1994, FEMS MICROBIOL REV, V13, P415, DOI 10.1111/j.1574-6976.1994.tb00060.x; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; PORTALIER R, 1980, J BACTERIOL, V143, P1095, DOI 10.1128/JB.143.3.1095-1107.1980; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Purdy KJ, 2004, ENVIRON MICROBIOL, V6, P591, DOI 10.1111/j.1462-2920.2004.00592.x; RANGASWAMY V, 1994, J BACTERIOL, V176, P5505, DOI 10.1128/JB.176.17.5505-5512.1994; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sarkar IN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-103; Saunders E, 2010, STAND GENOMIC SCI, V2, P107, DOI 10.4056/sigs.681272; Savage KN, 2007, INT J SYST EVOL MICR, V57, P19, DOI 10.1099/ijs.0.64464-0; Schroder I, 2004, J BACTERIOL, V186, P7680, DOI 10.1128/JB.186.22.7680-7689.2004; Schweikhard ES, 2010, BIOCHEMISTRY-US, V49, P2194, DOI 10.1021/bi9017522; Sisignano M, 2010, MICROBIOL-SGM, V156, P521, DOI 10.1099/mic.0.033449-0; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; SOLIMAN GSH, 1982, ZBL BAKT MIK HYG I C, V3, P318, DOI 10.1016/S0721-9571(82)80045-8; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tanaka T, 2004, J BIOL CHEM, V279, P30021, DOI 10.1074/jbc.M314187200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Tindall BJ, 2009, STAND GENOMIC SCI, V1, P270, DOI 10.4056/sigs.42644; TOMLINSON GA, 1974, CAN J MICROBIOL, V20, P1085, DOI 10.1139/m74-170; Tsujibo H, 1998, APPL ENVIRON MICROB, V64, P2920; Wagner GK, 2010, CHEMBIOCHEM, V11, P1939, DOI 10.1002/cbic.201000201; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Waino M, 2003, EXTREMOPHILES, V7, P87, DOI 10.1007/s00792-002-0299-y; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Zvyagintseva IS, 1987, MIKROBIOLOGIYA, V56, P839	90	51	52	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20237	10.1371/journal.pone.0020237	http://dx.doi.org/10.1371/journal.pone.0020237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633497	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500046
J	Armstrong, PC; Kirkby, NS; Zain, ZN; Emerson, M; Mitchell, JA; Warner, TD				Armstrong, Paul C.; Kirkby, Nicholas S.; Zain, Zetty N.; Emerson, Michael; Mitchell, Jane A.; Warner, Timothy D.			Thrombosis Is Reduced by Inhibition of COX-1, but Unaffected by Inhibition of COX-2, in an Acute Model of Platelet Activation in the Mouse	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; CYCLOOXYGENASE SELECTIVITY; GASTROINTESTINAL TOXICITY; PROSTANOID FORMATION; RANDOMIZED-TRIALS; AGGREGATION; ATHEROTHROMBOSIS; PROSTACYCLIN; VIVO	Background: Clinical use of selective inhibitors of cyclooxygenase (COX)-2 appears associated with increased risk of thrombotic events. This is often hypothesised to reflect reduction in anti-thrombotic prostanoids, notably PGI2, formed by COX-2 present within endothelial cells. However, whether COX-2 is actually expressed to any significant extent within endothelial cells is controversial. Here we have tested the effects of acute inhibition of COX on platelet reactivity using a functional in vivo approach in mice. Methodology/Principal Findings: A non-lethal model of platelet-driven thromboembolism in the mouse was used to assess the effects of aspirin (7 days orally as control) diclofenac (1 mg.kg(-1), i.v.) and parecoxib (0.5 mg.kg(-1), i.v.) on thrombus formation induced by collagen or the thromboxane (TX) A(2)-mimetic, U46619. The COX inhibitory profiles of the drugs were confirmed in mouse tissues ex vivo. Collagen and U46619 caused in vivo thrombus formation with the former, but not latter, sensitive to oral dosing with aspirin. Diclofenac inhibited COX-1 and COX-2 ex vivo and reduced thrombus formation in response to collagen, but not U46619. Parecoxib inhibited only COX-2 and had no effect upon thrombus formation caused by either agonist. Conclusions/Significance: Inhibition of COX-1 by diclofenac or aspirin reduced thrombus formation induced by collagen, which is partly dependent upon platelet-derived TXA(2), but not that induced by U46619, which is independent of platelet TXA(2). These results are consistent with the model demonstrating the effects of COX-1 inhibition in platelets, but provide no support for the hypothesis that acute inhibition of COX-2 in the circulation increases thrombosis.	[Armstrong, Paul C.; Kirkby, Nicholas S.; Zain, Zetty N.; Warner, Timothy D.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Emerson, Michael] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Platelet Biol Grp, London, England	University of London; Queen Mary University London; Imperial College London	Armstrong, PC (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.	t.d.warner@qmul.ac.uk	Armstrong, Paul/Z-1408-2019; Warner, Timothy D/A-1980-2009	Warner, Timothy D/0000-0003-3988-4408; MOHD ZAIN, ZETTY NADIA/0000-0002-6299-7796; Armstrong, Paul/0000-0003-0904-677X; Kirkby, Nicholas/0000-0003-3509-8549	European Community [LSHM-CT-2004-0050333]; British Heart Foundation [PG/07/098/23757]; Wellcome Trust [085255/Z/08/Z]; National Institute of Health Research	European Community(European Commission); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR))	This research was supported by European Community FP6 funding ("Eicosanox"; LSHM-CT-2004-0050333), the British Heart Foundation (PG/07/098/23757) and the Wellcome Trust (085255/Z/08/Z). This publication reflects only the authors' views. The European Community is not liable for any use that may be made of information herein. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Armstrong PCJ, 2008, J THROMB HAEMOST, V6, P1933, DOI 10.1111/j.1538-7836.2008.03133.x; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; CRONBERG S, 1984, SCAND J HAEMATOL, V33, P155; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Giuliano F, 1999, BRIT J PHARMACOL, V126, P1824, DOI 10.1038/sj.bjp.0702518; Giuliano F, 2001, EUR J PHARMACOL, V426, P95, DOI 10.1016/S0014-2999(01)01207-9; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; GRYGLEWSKI RJ, 1978, NATURE, V273, P765, DOI 10.1038/273765a0; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jennings LK, 2009, AM J CARDIOL, V103, p4A, DOI 10.1016/j.amjcard.2008.11.017; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KRISHNAMURTHI S, 1984, BIOCHEM PHARMACOL, V33, P3025, DOI 10.1016/0006-2952(84)90604-X; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MONCADA S, 1978, NATURE, V273, P767, DOI 10.1038/273767a0; Moore C, 2010, THROMB HAEMOSTASIS, V104, P342, DOI 10.1160/TH09-11-0764; Niemi TT, 1997, ACTA ANAESTH SCAND, V41, P1353, DOI 10.1111/j.1399-6576.1997.tb04657.x; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Patrono C, 2009, MOL INTERV, V9, P31, DOI 10.1124/mi.9.1.8; Potter CMF, 2011, ARTERIOSCL THROM VAS, V31, P384, DOI 10.1161/ATVBAHA.110.214031; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Talley JJ, 2000, J MED CHEM, V43, P1661, DOI 10.1021/jm000069h; Tymvios C, 2008, THROMB HAEMOSTASIS, V99, P435, DOI 10.1160/TH07-07-0479; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2008, LANCET, V371, P270, DOI 10.1016/S0140-6736(08)60137-3; White WB, 2007, HYPERTENSION, V49, P408, DOI 10.1161/01.HYP.0000258106.74139.25; WHITTLE BJR, 1980, PROSTAGLANDINS, V19, P605, DOI 10.1016/S0090-6980(80)80010-4; Zidar N, 2008, J CELL MOL MED	37	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20062	10.1371/journal.pone.0020062	http://dx.doi.org/10.1371/journal.pone.0020062			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629780	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200030
J	Kaschner, K; Tittensor, DP; Ready, J; Gerrodette, T; Worm, B				Kaschner, Kristin; Tittensor, Derek P.; Ready, Jonathan; Gerrodette, Tim; Worm, Boris			Current and Future Patterns of Global Marine Mammal Biodiversity	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT SELECTION; SPECIES-DIVERSITY; CETACEAN HABITATS; RIGHT WHALE; CONSERVATION; ECOSYSTEM; IMPACTS; MODELS; OCEAN	Quantifying the spatial distribution of taxa is an important prerequisite for the preservation of biodiversity, and can provide a baseline against which to measure the impacts of climate change. Here we analyse patterns of marine mammal species richness based on predictions of global distributional ranges for 115 species, including all extant pinnipeds and cetaceans. We used an environmental suitability model specifically designed to address the paucity of distributional data for many marine mammal species. We generated richness patterns by overlaying predicted distributions for all species; these were then validated against sightings data from dedicated long-term surveys in the Eastern Tropical Pacific, the Northeast Atlantic and the Southern Ocean. Model outputs correlated well with empirically observed patterns of biodiversity in all three survey regions. Marine mammal richness was predicted to be highest in temperate waters of both hemispheres with distinct hotspots around New Zealand, Japan, Baja California, the Galapagos Islands, the Southeast Pacific, and the Southern Ocean. We then applied our model to explore potential changes in biodiversity under future perturbations of environmental conditions. Forward projections of biodiversity using an intermediate Intergovernmental Panel for Climate Change (IPCC) temperature scenario predicted that projected ocean warming and changes in sea ice cover until 2050 may have moderate effects on the spatial patterns of marine mammal richness. Increases in cetacean richness were predicted above 40 degrees latitude in both hemispheres, while decreases in both pinniped and cetacean richness were expected at lower latitudes. Our results show how species distribution models can be applied to explore broad patterns of marine biodiversity worldwide for taxa for which limited distributional data are available.	[Kaschner, Kristin] Univ Freiburg, Inst Zool, Evolutionary Biol & Ecol Lab, Freiburg, Germany; [Tittensor, Derek P.; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Ready, Jonathan] Fed Univ Para, Inst Estuarine & Coastal Studies, Braganca, Para, Brazil; [Gerrodette, Tim] Natl Marine Fisheries Serv, Protected Resources Div, SW Fisheries Sci Ctr, La Jolla, CA 92038 USA	University of Freiburg; Dalhousie University; Universidade Federal do Para; National Oceanic Atmospheric Admin (NOAA) - USA	Kaschner, K (corresponding author), Univ Freiburg, Inst Zool, Evolutionary Biol & Ecol Lab, Freiburg, Germany.	Kristin.Kaschner@biologie.uni-freiburg.de	Ready, Jonathan S/J-2964-2012; Kaschner, Kristin/GQQ-6475-2022; Tittensor, Derek P./AAV-1117-2021	Ready, Jonathan S/0000-0002-9374-8661; Tittensor, Derek P./0000-0002-9550-3123; Worm, Boris/0000-0002-5742-8716; Kaschner, Kristin/0000-0002-4061-626X	Sloan Foundation; Future Oceans Cluster Project [D 1067/88]; IFM-Geomar Kiel	Sloan Foundation(Alfred P. Sloan Foundation); Future Oceans Cluster Project; IFM-Geomar Kiel	This research was supported by the Sloan Foundation (Census of Marine Life, Future of Marine Animal Populations Project). Partial funding for the main author was provided through the Future Oceans Cluster Project D 1067/88 "Winners and Losers in the Future Oceans'' project, IFM-Geomar Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; AU DWK, 1985, FISH B-NOAA, V83, P623; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; Bivand R., 2009, SPDEP SPATIAL DEPEND; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cotte C, 2007, DEEP-SEA RES PT I, V54, P243, DOI 10.1016/j.dsr.2006.11.001; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Grech A, 2008, CONSERV BIOL, V22, P711, DOI 10.1111/j.1523-1739.2008.00923.x; Greene CH, 2004, FRONT ECOL ENVIRON, V2, P29, DOI 10.1890/1540-9295(2004)002[0029:CATCBO]2.0.CO;2; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; Harwood J, 2001, J MAMMAL, V82, P630, DOI 10.1644/1545-1542(2001)082<0630:MMATEI>2.0.CO;2; HOYT E, 2005, MARINE PROTECTED ARE, P492; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; *IWC, 2001, IDCR DESS SOWER SURV; JUNGHAUS J, 2006, IPCCAR4 WORLD DAT CT; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K., 2007, SEAMOUNTS ECOLOGY FI, P230; Kaschner K, 2004, MODELLING MAPPING RE; Kaschner K., 2008, AQUAMAPS PREDICTED R; KATONA S, 1988, OCEANOGR MAR BIOL, V26, P553; KINZEY D, 2000, LJ0008 NOAA NMFS SWF; Kovacs Kit M., 2008, Science Progress, V91, P117, DOI 10.3184/003685008X324010; Krafft BA, 2006, ICES J MAR SCI, V63, P1136, DOI 10.1016/j.icesjms.2006.04.001; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; Lunn NJ, 1997, CAN J FISH AQUAT SCI, V54, P914, DOI 10.1139/cjfas-54-4-914; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; MacLeod Colin D., 2009, Endangered Species Research, V7, P125, DOI 10.3354/esr00197; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moore SE, 2000, ARCTIC, V53, P432; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Moore Sue E., 1997, Journal of Northwest Atlantic Fishery Science, V22, P55; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; *NAMMCO, 2001, N ATL SIGHT SURV NAS; Nicol S, 2008, MAR FRESHWATER RES, V59, P361, DOI 10.1071/MF07161; *NOAA NODC, 1998, WORLD OC ATL 1998; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; PAYNE PM, 1993, BIOL NO HEMISPHERE P, P51; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; READ J, OBIS SEAMAP MAPPING; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; RIBIC CA, 1991, ANTARCT SCI, V3, P181, DOI 10.1017/S0954102091000214; Rice D. W., 1998, SOC MARINE MAMMALOGY, V4, P1; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanjit L, 2005, J BIOSCIENCES, V30, P557, DOI 10.1007/BF02703552; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Simmonds MP, 2007, ORYX, V41, P19, DOI 10.1017/S0030605307001524; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Team RDC, 2009, R LANG ENV STAT COMP; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P263, DOI 10.1016/B978-0-444-53301-2.00014-2; Zacharias Mark A., 2006, Journal of Cetacean Research and Management, V8, P1	76	141	144	5	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19653	10.1371/journal.pone.0019653	http://dx.doi.org/10.1371/journal.pone.0019653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625431	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200008
J	Matz, C; Nouri, B; McCarter, L; Martinez-Urtaza, J				Matz, Carsten; Nouri, Bianka; McCarter, Linda; Martinez-Urtaza, Jaime			Acquired Type III Secretion System Determines Environmental Fitness of Epidemic Vibrio parahaemolyticus in the Interaction with Bacterivorous Protists	PLOS ONE			English	Article							ACANTHAMOEBA-CASTELLANII; INFECTIOUS-DISEASE; GENOMIC ISLANDS; COASTAL WATERS; CHESAPEAKE BAY; CHOLERAE; O3-K6; STRAINS; PATHOGENICITY; EMERGENCE	Genome analyses of marine microbial communities have revealed the widespread occurrence of genomic islands (GIs), many of which encode for protein secretion machineries described in the context of bacteria-eukaryote interactions. Yet experimental support for the specific roles of such GIs in aquatic community interactions remains scarce. Here, we test for the contribution of type III secretion systems (T3SS) to the environmental fitness of epidemic Vibrio parahaemolyticus. Comparisons of V. parahaemolyticus wild types and T3SS-defective mutants demonstrate that the T3SS encoded on genome island VPaI-7 (T3SS-2) promotes survival of V. parahaemolyticus in the interaction with diverse protist taxa. Enhanced persistence was found to be due to T3SS-2 mediated cytotoxicity and facultative parasitism of V. parahaemolyticus on coexisting protists. Growth in the presence of bacterivorous protists and the T3SS-2 genotype showed a strong correlation across environmental and clinical isolates of V. parahaemolyticus. Short-term microcosm experiments provide evidence that protistan hosts facilitate the invasion of T3SS-2 positive V. parahaemolyticus into a coastal plankton community, and that water temperature and productivity further promote enhanced survival of T3SS-2 positive V. parahaemolyticus. This study is the first to describe the fitness advantage of GI-encoded functions in a microbial food web, which may provide a mechanistic explanation for the global spread and the seasonal dynamics of V. parahaemolyticus pathotypes, including the pandemic serotype cluster O3:K6, in aquatic environments.	[Matz, Carsten; Nouri, Bianka] Helmholtz Ctr Infect Res, Braunschweig, Germany; [McCarter, Linda] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Martinez-Urtaza, Jaime] Univ Santiago de Compostela, Inst Acuicultura, Santiago De Compostela, Spain	Helmholtz Association; Helmholtz-Center for Infection Research; University of Iowa; Universidade de Santiago de Compostela	Matz, C (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	jaime.martinez.urtaza@usc.es	Martinez-Urtaza, Jaime/A-5528-2015; Martinez-Urtaza, Jaime/ABG-5429-2020	Martinez-Urtaza, Jaime/0000-0001-6219-0418	University of Iowa Carver College of Medicine Initiative; German Science Foundation (DFG) [Ma 2491/4-1]; Spanish Ministry of Science and Innovation [CGL2009-10488]	University of Iowa Carver College of Medicine Initiative; German Science Foundation (DFG)(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Work supporting the construction of the T3SS-2 mutants in LM5674 was supported by The University of Iowa Carver College of Medicine Initiative Grant (to Linda McCarter). This work was supported by the German Science Foundation (DFG) grant Ma 2491/4-1 (to Carsten Matz) and by the Spanish Ministry of Science and Innovation grant CGL2009-10488 (to Jaime Martinez-Urtaza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers U, 2005, MICROBIOL-SGM, V151, P167, DOI 10.1099/mic.0.27563-0; Baffone W, 2006, ENVIRON MICROBIOL, V8, P1299, DOI 10.1111/j.1462-2920.2006.01011.x; Baker-Austin C, 2010, ENV MICROBIOL REP, V2, P7, DOI 10.1111/j.1758-2229.2009.00096.x; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Boyd EF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-110; Burek KA, 2008, ECOL APPL, V18, pS126, DOI 10.1890/06-0553.1; Cabello FC, 2007, EMERG INFECT DIS, V13, P655, DOI 10.3201/eid1304.06-1152; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Han HH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-570; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5498, DOI 10.1128/AEM.68.11.5498-5507.2002; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Jaques S, 2006, J BACTERIOL, V188, P2625, DOI 10.1128/JB.188.7.2625-2635.2006; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Laskowski-Arce MA, 2008, APPL ENVIRON MICROB, V74, P7183, DOI 10.1128/AEM.01332-08; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Martinez-Urtaza J, 2005, EMERG INFECT DIS, V11, P1319, DOI 10.3201/eid1108.050322; Martinez-Urtaza J, 2008, EPIDEMIOLOGY, V19, P829, DOI 10.1097/EDE.0b013e3181883d43; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2001, APPL ENVIRON MICROB, V67, P814, DOI 10.1128/AEM.67.2.814-820.2001; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; McCarter Linda, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P51; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; Meador CE, 2007, J CLIN MICROBIOL, V45, P1133, DOI 10.1128/JCM.00042-07; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Mourino-Perez RR, 2003, APPL ENVIRON MICROB, V69, P6923, DOI 10.1128/AEM.69.11.6923-6931.2003; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; Okuda Jun, 1997, Journal of Clinical Microbiology, V35, P3150; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Persson OP, 2009, ENVIRON MICROBIOL, V11, P1348, DOI 10.1111/j.1462-2920.2008.01861.x; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Rodriguez-Castro A, 2010, ENV MICROBIOL REP, V2, P58, DOI 10.1111/j.1758-2229.2009.00064.x; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Weitere M, 2005, ENVIRON MICROBIOL, V7, P1593, DOI 10.1111/j.1462-2920.2005.00851.x; Worden AZ, 2006, ENVIRON MICROBIOL, V8, P21, DOI 10.1111/j.1462-2920.2005.00863.x; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594	61	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20275	10.1371/journal.pone.0020275	http://dx.doi.org/10.1371/journal.pone.0020275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629787	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200047
J	Oakland, M; Jeon, B; Sahin, O; Shen, ZQ; Zhang, QJ				Oakland, Mayumi; Jeon, Byeonghwa; Sahin, Orhan; Shen, Zhangqi; Zhang, Qijing			Functional Characterization of a Lipoprotein-Encoding Operon in Campylobacter jejuni	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; STREPTOCOCCUS-MUTANS; EPITHELIAL-CELLS; GENOME SEQUENCE; BINDING PROTEIN; CLONING VECTORS; CMER FUNCTIONS; EFFLUX PUMP; COLONIZATION; ADHERENCE	Background: Bacterial lipoproteins have important functions in bacterial pathogenesis and physiology. In Campylobacter jejuni, a major foodborne pathogen causing gastroenteritis in humans, the majority of lipoproteins have not been functionally characterized. Previously, we showed by DNA microarray that CmeR, a transcriptional regulator repressing the expression of the multidrug efflux pump CmeABC, modulates the expression of a three-gene operon (cj0089, cj0090, and cj0091) encoding a cluster of lipoproteins in C. jejuni. Methodology/Principal Findings: In this work, we characterized the function and regulation of the cj0089-cj0090-cj0091 operon. In contrast to the repression of cmeABC, CmeR activates the expression of the lipoprotein genes and the regulation is confirmed by immunoblotting using anti-Cj0089 and anti-Cj0091 antibodies. Gel mobility shift assay showed that CmeR directly binds to the promoter of the lipoprotein operon, but the binding is much weaker compared with the promoter of cmeABC. Analysis of different cellular fractions indicated that Cj0089 was associated with the inner membrane, while Cj0091 was located on the outer membrane. Inactivation of cj0091, but not cj0089, significantly reduced the adherence of C. jejuni to INT 407 cells in vitro, indicating that Cj0091 has a function in adherence. When inoculated into chickens, the Cj0091 mutant also showed a defect in early colonization of the intestinal tract, suggesting that Cj0091 contributes to Campylobacter colonization in vivo. It was also shown that Cj0091 was produced and immunogenic in chickens that were naturally infected by C. jejuni. Conclusion/Significance: These results indicate that the lipoprotein operon is subject to direct regulation by CmeR and that Cj0091 functions as an adhesion mechanism in C. jejuni and contributes to Campylobacter colonization of the intestinal tract in animal hosts.	[Oakland, Mayumi; Jeon, Byeonghwa; Sahin, Orhan; Shen, Zhangqi; Zhang, Qijing] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA	Iowa State University	Oakland, M (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	zhang123@iastate.edu	Zhang, Qijing/B-7530-2012; Jeon, Byeonghwa/AAB-6806-2020; Shen, Zhangqi/HCI-5736-2022	Jeon, Byeonghwa/0000-0002-6665-5558; Shen, Zhangqi/0000-0003-4789-7540; Sahin, Orhan/0000-0003-0262-4581	United States Department of Agriculture National Research Initiative [RO1DK063008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063008] Funding Source: NIH RePORTER	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (www.nih.gov/) grant RO1DK063008 and the Food Safety Research and Response Network (http://www.fsrrn.net/), funded by the United States Department of Agriculture National Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen M, 1998, AVIAN DIS, V42, P732, DOI 10.2307/1592708; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; Amako K, 1997, MICROBIOL IMMUNOL, V41, P855, DOI 10.1111/j.1348-0421.1997.tb01940.x; Ashgar SSA, 2007, J BACTERIOL, V189, P1856, DOI 10.1128/JB.01427-06; ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P241, DOI 10.1021/bi00167a032; BABAKHANI FK, 1993, INFECT IMMUN, V61, P3466, DOI 10.1128/IAI.61.8.3466-3475.1993; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOLLA JM, 1995, J BACTERIOL, V177, P4266, DOI 10.1128/jb.177.15.4266-4271.1995; CALDWELL MB, 1983, INFECT IMMUN, V42, P1176, DOI 10.1128/IAI.42.3.1176-1182.1983; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Clench MH, 1999, J EXP ZOOL, V283, P441, DOI 10.1002/(SICI)1097-010X(19990301/01)283:4/5&lt;441::AID-JEZ13&gt;3.0.CO;2-8; De E, 2000, FEBS LETT, V469, P93, DOI 10.1016/S0014-5793(00)01244-8; DOUGLAS CWI, 1984, FEMS MICROBIOL LETT, V25, P211; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; FORESTER H, 1983, J GEN MICROBIOL, V129, P2779; Friedman C.R., 2000, CAMPYLOBACTER, P121; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Guo BQ, 2008, J BACTERIOL, V190, P1879, DOI 10.1128/JB.01796-07; Hu L, 2000, CAMPYLOBACTER, V2nd, P191; HUYER M, 1986, FEMS MICROBIOL LETT, V37, P247, DOI 10.1111/j.1574-6968.1986.tb01803.x; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; JHUANG J, 1997, EUR J BIOCHEM, V224, P575; Jin SM, 2003, CELL MICROBIOL, V5, P165, DOI 10.1046/j.1462-5822.2003.00265.x; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Konkel ME, 2010, J BACTERIOL, V192, P68, DOI 10.1128/JB.00969-09; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Luo N, 2003, ANTIMICROB AGENTS CH, V47, P390, DOI 10.1128/AAC.47.1.390-394.2003; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Petersen L, 2003, J MOL BIOL, V326, P1361, DOI 10.1016/S0022-2836(03)00034-2; Pickett C.L., 2000, CAMPYLOBACTER, P179; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL RG, 1993, J INFECT DIS, V168, P210, DOI 10.1093/infdis/168.1.210; Sahin O, 2001, APPL ENVIRON MICROB, V67, P3951, DOI 10.1128/AEM.67.9.3951-3957.2001; Skirrow M.B., 2000, CAMPYLOBACTER, V2nd ed., P69; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Vandamme P., 2000, CAMPYLOBACTER, P3; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Wosten MMSM, 1998, J BACTERIOL, V180, P594; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; Yan MG, 2006, J ANTIMICROB CHEMOTH, V58, P1154, DOI 10.1093/jac/dkl412; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	58	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20084	10.1371/journal.pone.0020084	http://dx.doi.org/10.1371/journal.pone.0020084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625391	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200032
J	Ramsgaard, L; Englert, JM; Manni, ML; Milutinovic, PS; Gefter, J; Tobolewski, J; Crum, L; Coudriet, GM; Piganelli, J; Zamora, R; Vodovotz, Y; Enghild, JJ; Oury, TD				Ramsgaard, Lasse; Englert, Judson M.; Manni, Michelle L.; Milutinovic, Pavle S.; Gefter, Julia; Tobolewski, Jacob; Crum, Lauren; Coudriet, Gina M.; Piganelli, Jon; Zamora, Ruben; Vodovotz, Yoram; Enghild, Jan J.; Oury, Tim D.			Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; MOBILITY GROUP BOX-1; PULMONARY-FIBROSIS; NEURITE OUTGROWTH; SOLUBLE RECEPTOR; CELL-SURFACE; HOST-DEFENSE; RAGE; PROTEIN	Background: The receptor for advanced glycation end-products (RAGE) has been suggested to modulate lung injury in models of acute pulmonary inflammation. To study this further, model systems utilizing wild type and RAGE knockout (KO) mice were used to determine the role of RAGE signaling in lipopolysaccharide (LPS) and E. coli induced acute pulmonary inflammation. The effect of intraperitoneal (i.p.) and intratracheal (i.t.) administration of mouse soluble RAGE on E. coli injury was also investigated. Methodology/Principal Findings: C57BL/6 wild type and RAGE KO mice received an i.t. instillation of LPS, E. coli, or vehicle control. Some groups also received i.p. or i.t. administration of mouse soluble RAGE. After 24 hours, the role of RAGE expression on inflammation was assessed by comparing responses in wild type and RAGE KO. RAGE protein levels decreased in wild type lung homogenates after treatment with either LPS or bacteria. In addition, soluble RAGE and HMGB1 increased in the BALF after E. coli instillation. RAGE KO mice challenged with LPS had the same degree of inflammation as wild type mice. However, when challenged with E. coli, RAGE KO mice had significantly less inflammation when compared to wild type mice. Most cytokine levels were lower in the BALF of RAGE KO mice compared to wild type mice after E. coli injury, while only monocyte chemotactic protein-1, MCP-1, was lower after LPS challenge. Neither i.p. nor i.t. administration of mouse soluble RAGE attenuated the severity of E. coli injury in wild type mice. Conclusions/Significance: Lack of RAGE in the lung does not protect against LPS induced acute pulmonary inflammation, but attenuates injury following live E. coli challenge. These findings suggest that RAGE mediates responses to E. coli-associated pathogen-associated molecular pattern molecules other than LPS or other bacterial specific signaling responses. Soluble RAGE treatment had no effect on inflammation.	[Ramsgaard, Lasse; Englert, Judson M.; Manni, Michelle L.; Milutinovic, Pavle S.; Gefter, Julia; Tobolewski, Jacob; Crum, Lauren; Coudriet, Gina M.; Oury, Tim D.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Piganelli, Jon] Childrens Hosp Pittsburgh, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; [Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Zamora, Ruben; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Remodeling, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark; [Ramsgaard, Lasse; Enghild, Jan J.] Univ Aarhus, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Aarhus University	Ramsgaard, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	tdoury@pitt.edu		Enghild, Jan Johannes/0000-0001-9292-9172	NIH [R21ES013986, F30ES016973, R33-HL-089082]; Lundbeck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295, R33HL089082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013986, F30ES016973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH R21ES013986 to Tim D. Oury; NIH F30ES016973 to Judson M. Englert; NIH R33-HL-089082, The Lundbeck Foundation grant to Lasse Ramsgaard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Blackwell TS, 1999, AM J RESP CRIT CARE, V159, P1644, DOI 10.1164/ajrccm.159.5.9806166; BRETT J, 1993, AM J PATHOL, V143, P1699; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Demling N, 2006, CELL TISSUE RES, V323, P475, DOI 10.1007/s00441-005-0069-0; ENGLERT JM, 2011, INT J CLIN EXP PATHO, V4; Englert JM, 2008, PROTEIN EXPRES PURIF, V61, P99, DOI 10.1016/j.pep.2008.05.004; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Feng YK, 2008, EXP MOL PATHOL, V85, P214, DOI 10.1016/j.yexmp.2008.09.002; FREEMAN B A, 1984, Environmental Health Perspectives, V56, P51, DOI 10.2307/3429835; Gefter JV, 2009, CELL TISSUE RES, V337, P79, DOI 10.1007/s00441-009-0791-0; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; He M, 2007, AM J PHYSIOL-LUNG C, V293, pL1427, DOI 10.1152/ajplung.00075.2007; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Liu R, 2009, ACTA MED OKAYAMA, V63, P203; Lizotte PP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-15; LONGMUIR IS, 1960, BIOCHEM J, V76, P225, DOI 10.1042/bj0760225; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Pachydaki SI, 2006, EXP EYE RES, V82, P807, DOI 10.1016/j.exer.2005.09.022; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Queisser MA, 2008, AM J RESP CELL MOL, V39, P337, DOI 10.1165/rcmb.2007-0244OC; Ramsgaard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009604; Renard C, 1997, MOL PHARMACOL, V52, P54, DOI 10.1124/mol.52.1.54; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; SU X, 2009, AM J PHYSL LUNG CELL; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhou ZM, 2003, CIRCULATION, V107, P2238, DOI 10.1161/01.CIR.0000063577.32819.23	49	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20132	10.1371/journal.pone.0020132	http://dx.doi.org/10.1371/journal.pone.0020132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629785	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005200037
J	Shaheen, FS; Znojek, P; Fisher, A; Webster, M; Plummer, R; Gaughan, L; Smith, GCM; Leung, HY; Curtin, NJ; Robson, CN				Shaheen, Fadhel S.; Znojek, Pawel; Fisher, Ann; Webster, Martin; Plummer, Ruth; Gaughan, Luke; Smith, Graeme C. M.; Leung, Hing Y.; Curtin, Nicola J.; Robson, Craig N.			Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer	PLOS ONE			English	Article							CELL-CYCLE; ATM; GAMMA-H2AX; MECHANISMS; INHIBITOR; RADIATION; PATHWAYS	Regardless of the achievable remissions with first line hormone therapy in patients with prostate cancer (CaP), the disease escapes the hormone dependent stage to a more aggressive status where chemotherapy is the only effective treatment and no treatment is curative. This makes it very important to identify new targets that can improve the outcome of treatment. ATM and DNA-PK are the two kinases responsible for signalling and repairing double strand breaks (DSB). Thus, both kinases are pertinent targets in CaP treatment to enhance the activity of the numerous DNA DSB inducing agents used in CaP treatment such as ionizing radiation (IR). Colony formation assay was used to assess the sensitivity of hormone dependent, p53 wt (LNCaP) and hormone independent p53 mutant (PC3) CaP cell lines to the cytotoxic effect of IR and Doxorubicin in the presence or absence of Ku55933 and NU7441 which are small molecule inhibitors of ATM and DNA-PK, respectively. Flow cytometry based methods were used to assess the effect of the two inhibitors on cell cycle, apoptosis and H2AX foci formation. Neutral comet assay was used to assess the induction of DNA DSBs. Ku55933 or NU7441 alone increased the sensitivity of CaP cell lines to the DNA damaging agents, however combining both inhibitors together resulted in further enhancement of sensitivity. The cell cycle profile of both cell lines was altered with increased cell death, DNA DSBs and H2AX foci formation. This study justifies further evaluation of the ATM and DNA-PK inhibitors for clinical application in CaP patients. Additionally, the augmented effect resulting from combining both inhibitors may have a significant implication for the treatment of CaP patients who have a defect in one of the two DSB repair pathways.	[Shaheen, Fadhel S.; Znojek, Pawel; Fisher, Ann; Webster, Martin; Plummer, Ruth; Gaughan, Luke; Curtin, Nicola J.; Robson, Craig N.] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Smith, Graeme C. M.] KuDOS Pharmaceut Ltd, Cambridge, England; [Leung, Hing Y.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Newcastle University - UK; AstraZeneca; Beatson Institute	Shaheen, FS (corresponding author), Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	C.N.Robson@ncl.ac.uk		Leung, Hing Y./0000-0002-3933-3975; Curtin, Nicola/0000-0003-1369-1843	Aga Khan Foundation; CRUK, CancerResearchUK.org; MRC; AICR; MRC [G0900871, G0800889] Funding Source: UKRI; Cancer Research UK [15151] Funding Source: researchfish; Medical Research Council [G0900871, G0800889] Funding Source: researchfish	Aga Khan Foundation; CRUK, CancerResearchUK.org(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Aga Khan Foundation, www.akdn.org/AKF, CRUK, CancerResearchUK.org, MRC, www.mrc.ac.uk, and AICR, www.aicr.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Collis SJ, 2003, CANCER RES, V63, P1550; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Khanna KK, 2001, CELL DEATH DIFFER, V8, P1052, DOI 10.1038/sj.cdd.4400874; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Melia J, 2005, BJU INT, V95, P1; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	22	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20311	10.1371/journal.pone.0020311	http://dx.doi.org/10.1371/journal.pone.0020311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629734	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000291005200052
J	Aviello, G; Canadanovic-Brunet, JM; Milic, N; Capasso, R; Fattorusso, E; Taglialatela-Scafati, O; Fasolino, I; Izzo, AA; Borrelli, F				Aviello, Gabriella; Canadanovic-Brunet, Jasna M.; Milic, Natasa; Capasso, Raffaele; Fattorusso, Ernesto; Taglialatela-Scafati, Orazio; Fasolino, Ines; Izzo, Angelo A.; Borrelli, Francesca			Potent Antioxidant and Genoprotective Effects of Boeravinone G, a Rotenoid Isolated from Boerhaavia diffusa	PLOS ONE			English	Article							OXYGEN-FREE-RADICALS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; GASTROINTESTINAL-TRACT; HYDROGEN-PEROXIDE; BOERHAVIA-DIFFUSA; GLUTATHIONE; ISCHEMIA; DAMAGE; ASSAY	Background and Aims: Free radicals are implicated in the aetiology of some gastrointestinal disorders such as gastric ulcer, colorectal cancer and inflammatory bowel disease. In the present study we investigated the antioxidant and genoprotective activity of some rotenoids (i.e. boeravinones) isolated from the roots of Boerhaavia diffusa, a plant used in the Ayurvedic medicine for the treatment of diseases affecting the gastrointestinal tract. Methods/Principal Findings: Antioxidant activity has been evaluated using both chemical (Electron Spin Resonance spectroscopy, ESR) and Caco-2 cells-based (TBARS and ROS) assays. DNA damage was evaluated by Comet assay, while pERK(1/2) and phospho-NF-kB p65 levels were estimated by western blot. Boeravinones G, D and H significantly reduced the signal intensity of ESR induced by hydroxyl radicals, suggesting a scavenging activity. Among rotenoids tested, boeravinone G exerted the most potent effect. Boeravinone G inhibited both TBARS and ROS formation induced by Fenton's reagent, increased SOD activity and reduced H2O2-induced DNA damage. Finally, boeravinone G reduced the levels of pERK(1) and phospho-NF-kB p65 (but not of pERK(2)) increased by Fenton's reagent. Conclusions: It is concluded that boeravinone G exhibits an extraordinary potent antioxidant activity (significant effect in the nanomolar range). The MAP kinase and NF-kB pathways seem to be involved in the antioxidant effect of boeravinone G. Boeravinone G might be considered as lead compound for the development of drugs potentially useful against those pathologies whose aetiology is related to ROS-mediated injuries.	[Aviello, Gabriella; Milic, Natasa; Capasso, Raffaele; Fasolino, Ines; Izzo, Angelo A.; Borrelli, Francesca] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Canadanovic-Brunet, Jasna M.] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia; [Fattorusso, Ernesto; Taglialatela-Scafati, Orazio] Univ Naples Federico II, Dept Nat Prod Chem, Naples, Italy	University of Naples Federico II; University of Novi Sad; University of Naples Federico II	Aviello, G (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy.	franborr@unina.it	Borrelli, Francesca/AAC-6715-2022	Izzo, Angelo/0000-0002-8557-2133; Borrelli, Francesca/0000-0002-2695-3294; Capasso, Raffaele/0000-0002-3335-1822	Enrico ed Enrica Sovena Foundation	Enrico ed Enrica Sovena Foundation	This work was supported by the Enrico ed Enrica Sovena Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2004, J ENVIRON BIOL, V25, P307; Ahmed-Belkacem A, 2007, J MED CHEM, V50, P1933, DOI 10.1021/jm061450q; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anderson D, 1999, FOOD CHEM TOXICOL, V37, P1015, DOI 10.1016/S0278-6915(99)00089-7; Aviello G, 2010, J CELL MOL MED, V14, P2006, DOI 10.1111/j.1582-4934.2009.00815.x; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Borrelli F, 2005, PLANTA MED, V71, P928, DOI 10.1055/s-2005-871282; Borrelli F, 2006, J NAT PROD, V69, P903, DOI 10.1021/np060073h; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canadanovic-Brunet JM, 2005, J SCI FOOD AGR, V85, P265, DOI 10.1002/jsfa.1950; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; CROMBIE L, 1992, BIOORG MED CHEM LETT, V2, P13, DOI 10.1016/S0960-894X(00)80645-9; DHAR ML, 1968, INDIAN J EXP BIOL, V6, P232; Dryden Gerald W Jr, 2005, Curr Gastroenterol Rep, V7, P308, DOI 10.1007/s11894-005-0024-y; Dryden GW, 2006, CURR OPIN GASTROEN, V22, P165, DOI 10.1097/01.mog.0000208463.69266.8c; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Gatof D, 2002, GASTROENTEROL CLIN N, V31, P587, DOI 10.1016/S0889-8553(02)00011-0; Goldstone AB, 2006, FREE RADICAL BIO MED, V41, P1860, DOI 10.1016/j.freeradbiomed.2006.09.015; GUTMAN M, 1970, J BIOL CHEM, V245, P1992; Halliwell B, 2000, FREE RADICAL RES, V33, P819, DOI 10.1080/10715760000301341; Hiruma-Lima CA, 2000, J ETHNOPHARMACOL, V71, P267, DOI 10.1016/S0378-8741(00)00178-1; Holmes EW, 1998, DIGEST DIS SCI, V43, P1088, DOI 10.1023/A:1018899222258; Ishihara T, 2009, J PHARMACOL EXP THER, V328, P152, DOI 10.1124/jpet.108.144451; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Ji LL, 2007, APPL PHYSIOL NUTR ME, V32, P930, DOI 10.1139/H07-098; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Kapoor LD., 1990, HDB AYURVEDIC MED PL; Karihtala P, 2007, APMIS, V115, P81, DOI 10.1111/j.1600-0463.2007.apm_514.x; Karp SM, 2006, DM-DIS MON, V52, P199, DOI 10.1016/j.disamonth.2006.05.005; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim Hyeyoung, 2005, Inflammopharmacology, V13, P63, DOI 10.1163/156856005774423962; Kulich SM, 2003, J BIOSCIENCES, V28, P83, DOI 10.1007/BF02970136; KUPCHAN SM, 1973, J ORG CHEM, V38, P178, DOI 10.1021/jo00941a049; KUTHAN H, 1986, BIOCHEM J, V237, P175, DOI 10.1042/bj2370175; LAMI N, 1991, CHEM PHARM BULL, V39, P1863, DOI 10.1248/cpb.39.1863; Leyon PV, 2005, LIFE SCI, V76, P1339, DOI 10.1016/j.lfs.2004.06.031; Liu LN, 2005, WORLD J GASTROENTERO, V11, P1503, DOI 10.3748/wjg.v11.i10.1503; Mehrotra S, 2002, INT IMMUNOPHARMACOL, V2, P987, DOI 10.1016/S1567-5769(02)00031-0; Miralles-Barrachina O, 1999, CLIN NUTR, V18, P313, DOI 10.1016/S0261-5614(98)80030-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Olaleye MT, 2010, FOOD CHEM TOXICOL, V48, P2200, DOI 10.1016/j.fct.2010.05.047; Opara EC, 2006, DM-DIS MON, V52, P183, DOI 10.1016/j.disamonth.2006.05.003; OTAMIRI T, 1991, DIGEST DIS, V9, P133, DOI 10.1159/000171299; Pari L, 2004, J MED FOOD, V7, P472, DOI 10.1089/jmf.2004.7.472; PARKS DA, 1983, SURGERY, V94, P428; Piquet MA, 2006, GASTROEN CLIN BIOL, V30, P262, DOI 10.1016/S0399-8320(06)73163-3; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Rego AC, 1999, FREE RADICAL BIO MED, V26, P1405, DOI 10.1016/S0891-5849(98)00337-2; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Sachidanandam K, 2005, CARDIOVASC DRUG REV, V23, P115; Satheesh M. Amarnath, 2004, Indian Journal of Experimental Biology, V42, P989; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Shi MJ, 2004, AM J HYPERTENS, V17, P450, DOI 10.1016/j.amjhyper.2003.12.019; Sido B, 1998, GUT, V42, P485, DOI 10.1136/gut.42.4.485; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Yokomizo A, 2006, BIOSCI BIOTECH BIOCH, V70, P1317, DOI 10.1271/bbb.50604; ZIMMERMAN BJ, 1994, HEPATO-GASTROENTEROL, V41, P337	61	44	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19628	10.1371/journal.pone.0019628	http://dx.doi.org/10.1371/journal.pone.0019628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625488	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400006
J	Natarajan, C; Jiang, XB; Fago, A; Weber, RE; Moriyama, H; Storz, JF				Natarajan, Chandrasekhar; Jiang, Xiaoben; Fago, Angela; Weber, Roy E.; Moriyama, Hideaki; Storz, Jay F.			Expression and Purification of Recombinant Hemoglobin in Escherichia coli	PLOS ONE			English	Article							HUMAN NORMAL ADULT; PROTEIN; ADAPTATION; SUBSTITUTIONS; GLOBIN; INSIGHTS; AFFINITY; ACID; GENE	Background: Recombinant DNA technologies have played a pivotal role in the elucidation of structure-function relationships in hemoglobin (Hb) and other globin proteins. Here we describe the development of a plasmid expression system to synthesize recombinant Hbs in Escherichia coli, and we describe a protocol for expressing Hbs with low intrinsic solubilities. Since the alpha- and beta-chain Hbs of different species span a broad range of solubilities, experimental protocols that have been optimized for expressing recombinant human HbA may often prove unsuitable for the recombinant expression of wildtype and mutant Hbs of other species. Methodology/Principal Findings: As a test case for our expression system, we produced recombinant Hbs of the deer mouse (Peromyscus maniculatus), a species that has been the subject of research on mechanisms of Hb adaptation to hypoxia. By experimentally assessing the combined effects of induction temperature, induction time and E. coli expression strain on the solubility of recombinant deer mouse Hbs, we identified combinations of expression conditions that greatly enhanced the yield of recombinant protein and which also increased the efficiency of post-translational modifications. Conclusion/Significance: Our protocol should prove useful for the experimental study of recombinant Hbs in many non-human animals. One of the chief advantages of our protocol is that we can express soluble recombinant Hb without co-expressing molecular chaperones, and without the need for additional reconstitution or heme-incorporation steps. Moreover, our plasmid construct contains a combination of unique restriction sites that allows us to produce recombinant Hbs with different alpha- and beta-chain subunit combinations by means of cassette mutagenesis.	[Natarajan, Chandrasekhar; Jiang, Xiaoben; Moriyama, Hideaki; Storz, Jay F.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Fago, Angela; Weber, Roy E.] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Nebraska System; University of Nebraska Lincoln; Aarhus University	Natarajan, C (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu	Fago, Angela/J-5946-2013; Natarajan, Chandrasekhar/D-3144-2012; Natarajan, Chandrasekar/ABG-5195-2020	Fago, Angela/0000-0001-7315-2628; Natarajan, Chandrasekhar/0000-0002-4841-0426; 	National Science Foundation [DEB-0614342]; National Institutes of Health/National Heart, Lung, and Blood Institute [R01 HL087216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Science Foundation Grant DEB-0614342 (http://www.nsf.gov/); and National Institutes of Health/National Heart, Lung, and Blood Institute Grant R01 HL087216 (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brittain T, 2002, MOL ASPECTS MED, V23, P293, DOI 10.1016/S0098-2997(02)00004-3; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Chang CK, 2002, BIOCHEMISTRY-US, V41, P5644, DOI 10.1021/bi011919d; CHANG SYP, 1989, J BACTERIOL, V171, P4071, DOI 10.1128/jb.171.7.4071-4072.1989; Cheng Y, 2002, BIOCHEMISTRY-US, V41, P11901, DOI 10.1021/bi0202880; Dickerson R.E., 1983, HEMOGLOBIN; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; HERNAN RA, 1992, BIOCHEMISTRY-US, V31, P8619, DOI 10.1021/bi00151a032; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; Ho C, 2000, ENCY LIFE SCI; HOFFMAN SJ, 1990, P NATL ACAD SCI USA, V87, P8521, DOI 10.1073/pnas.87.21.8521; JESSEN TH, 1994, METHOD ENZYMOL, V231, P347; JONES PG, 1987, J BACTERIOL, V169, P2092, DOI 10.1128/jb.169.5.2092-2095.1987; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KIM HW, 1995, J MOL BIOL, V248, P867, DOI 10.1006/jmbi.1995.0267; KIM HW, 1994, P NATL ACAD SCI USA, V91, P11547, DOI 10.1073/pnas.91.24.11547; KOMIYAMA NH, 1995, NATURE, V373, P244, DOI 10.1038/373244a0; LEE SJ, 1994, MOL MICROBIOL, V11, P833, DOI 10.1111/j.1365-2958.1994.tb00361.x; NAGAI K, 1984, NATURE, V309, P810, DOI 10.1038/309810a0; Olins Peter O., 1993, Current Opinion in Biotechnology, V4, P520, DOI 10.1016/0958-1669(93)90071-4; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; Pieragostini E, 2005, COMP BIOCHEM PHYS B, V142, P18, DOI 10.1016/j.cbpc.2005.05.005; Sambrook J, 2001, MOL CLONING LAB MANU; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Storz JF, 2007, J MAMMAL, V88, P24, DOI 10.1644/06-MAMM-S-199R1.1; Storz JF, 2010, J EXP BIOL, V213, P2565, DOI 10.1242/jeb.042598; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Tsai CH, 1999, BIOCHEMISTRY-US, V38, P8751, DOI 10.1021/bi990286o; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; WEBER RE, 1981, NATURE, V292, P386, DOI 10.1038/292386a0; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; WEBER RE, 1993, J APPL PHYSIOL, V75, P2646, DOI 10.1152/jappl.1993.75.6.2646; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443	40	32	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20176	10.1371/journal.pone.0020176	http://dx.doi.org/10.1371/journal.pone.0020176			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625463	Green Submitted, gold, Green Published			2022-12-25	WOS:000290793400044
J	Liu, YF; Zhang, N; Yao, HW; Pan, XM; Ge, M				Liu, Yan-Feng; Zhang, Nan; Yao, Hong-Wei; Pan, Xian-Ming; Ge, Meng			Mth10b, a Unique Member of the Sac10b Family, Does Not Bind Nucleic Acid	PLOS ONE			English	Article							ARCHAEAL CHROMATIN PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL-ANALYSIS; DNA; SSH10B; ALBA; STABILITY; SIR2; MECHANISM	The Sac10b protein family is regarded as a group of nucleic acid-binding proteins that are highly conserved and widely distributed within archaea. All reported members of this family are basic proteins that exist as homodimers in solution and bind to DNA and/or RNA without apparent sequence specificity in vitro. Here, we reported a unique member of the family, Mth10b from Methanobacterium thermoautotrophicum Delta H, whose amino acid sequence shares high homology with other Sac10b family proteins. However, unlike those proteins, Mth10b is an acidic protein; its potential isoelectric point is only 4.56, which is inconsistent with the characteristics of a nucleic acid-binding protein. In this study, Mth10b was expressed in Escherichia coli and purified using a three-column chromatography purification procedure. Biochemical characterization indicated that Mth10b should be similar to typical Sac10b family proteins with respect to its secondary and tertiary structure and in its preferred oligomeric forms. However, an electrophoretic mobility shift analysis (EMSA) showed that neither DNA nor RNA bound to Mth10b in vitro, indicating that either Mth10b likely has a physiological function that is distinct from those of other Sac10b family members or nucleic acid-binding ability may not be a fundamental factor to the actual function of the Sac10b family.	[Liu, Yan-Feng; Zhang, Nan; Yao, Hong-Wei; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ge, Meng] Chinese Acad Sci, Inst Biophys, Ctr Struct & Mol Biol, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Liu, YF (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn; gem@moon.ibp.ac.cn	, 0000-0003-2383-1942/B-1483-2015; Yao, Hongwei/B-1483-2015	, 0000-0003-2383-1942/0000-0003-2383-1942; Yao, Hongwei/0000-0001-8518-7019	Natural Science Foundation of China [30870475]; Ministry of Science and Technology of China [2009CB918801]; China Postdoctoral Science Foundation [20100470567]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants 30870475 from the Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm), 2009CB918801 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), and 20100470567 from China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Biyani K, 2005, BIOCHEMISTRY-US, V44, P14217, DOI 10.1021/bi051266r; BOHRMANN B, 1994, J STRUCT BIOL, V112, P70, DOI 10.1006/jsbi.1994.1008; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; Fang XY, 2008, BIOCHEMISTRY-US, V47, P11212, DOI 10.1021/bi8007593; Fang XY, 2009, ARCH BIOCHEM BIOPHYS, V481, P52, DOI 10.1016/j.abb.2008.08.025; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Ge M, 2009, EXTREMOPHILES, V13, P481, DOI 10.1007/s00792-009-0233-7; Ge M, 2009, EXTREMOPHILES, V13, P131, DOI 10.1007/s00792-008-0204-4; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Hada K, 2008, BIOSCI BIOTECH BIOCH, V72, P749, DOI 10.1271/bbb.70639; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Xuan JS, 2009, PROTEIN EXPRES PURIF, V64, P162, DOI 10.1016/j.pep.2008.11.003; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	30	5	5	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19977	10.1371/journal.pone.0019977	http://dx.doi.org/10.1371/journal.pone.0019977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625642	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200053
J	Zhang, Y; Matkovich, SJ; Duan, XJ; Diwan, A; Kang, MY; Dorn, GW				Zhang, Yan; Matkovich, Scot J.; Duan, Xiujun; Diwan, Abhinav; Kang, Min-Young; Dorn, Gerald W., II			Receptor-independent Protein Kinase C alpha (PKC alpha) Signaling by Calpain-generated Free Catalytic Domains Induces HDAC5 Nuclear Export and Regulates Cardiac Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEART-FAILURE; GENE-EXPRESSION; HISTONE DEACETYLASE-5; HYPERTROPHY; CONTRACTILITY; INHIBITORS; GROWTH; PHOSPHORYLATION; ACTIVATION	Receptor-mediated activation of protein kinase (PK) C is a central pathway regulating cell growth, homeostasis, and programmed death. Recently, we showed that calpain-mediated proteolytic processing of PKC alpha in ischemic myocardium activates PKC signaling in a receptor-independent manner by releasing a persistent and constitutively active free catalytic fragment, PKC alpha-CT. This unregulated kinase provokes cardiomyopathy, but the mechanisms remain unclear. Here, we demonstrate that PKC alpha-CT is a potent regulator of pathological cardiac gene expression. PKC alpha-CT constitutively localizes to nuclei and directly promotes nucleo-cytoplasmic shuttling of HDAC5, inducing expression of apoptosis and other deleterious genes. Whereas PKD activation is required for HDAC5 nuclear export induced by unprocessed PKCs activated by phorbol ester, PKC alpha-CT directly drives HDAC cytosolic relocalization. Activation of MEF2-dependent inflammatory pathway genes by PKC alpha-CT can induce a cell-autonomous transcriptional response that mimics, but anticipates, actual inflammation. Because calpain-mediated processing of PKC isoforms occurs in many tissues wherein calcium is increased by stress or injury, our observation that the catalytically active product of this interaction is a constitutively active transcriptional regulator has broad ramifications for understanding and preventing the pathological transcriptional stress response.	[Zhang, Yan; Matkovich, Scot J.; Duan, Xiujun; Diwan, Abhinav; Kang, Min-Young; Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogen, Dept Med, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Dorn, GW (corresponding author), Washington Univ, Ctr Pharmacogen, Dept Med, Sch Med, 660 S Euclid Ave,Campus Box 8220, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu	Matkovich, Scot J/AFP-0908-2022; Matkovich, Scot J/B-9077-2009	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857	National Institutes of Health [R01 HL080008, R01 HL059888]; National Center for Research Resources [UL1 RR024992]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888, R01HL080008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL080008 and R01 HL059888 and by UL1 RR024992 from the National Center for Research Resources (to G. W. D. II).	Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Clerk A, 1999, AM J CARDIOL, V83, p64H; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hahn HS, 2003, CIRC RES, V93, P1111, DOI 10.1161/01.RES.0000105087.79373.17; Hambleton M, 2007, AM J PHYSIOL-HEART C, V293, pH3768, DOI 10.1152/ajpheart.00486.2007; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mann D L, 2001, Heart Fail Rev, V6, P71, DOI 10.1023/A:1011449708842; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mochly-Rosen D, 2000, CIRC RES, V86, P1173; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Olson Eric N, 2006, Novartis Found Symp, V274, P3; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; SIMPSON PC, 1991, MOL CELL BIOCHEM, V104, P35; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775	46	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26943	26951		10.1074/jbc.M111.234757	http://dx.doi.org/10.1074/jbc.M111.234757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642422	Green Published, hybrid			2022-12-25	WOS:000293078200068
J	Perez, T; Garcia, GC; Eguiluz, VM; Vicente, R; Pipa, G; Mirasso, C				Perez, Toni; Garcia, Guadalupe C.; Eguiluz, Victor M.; Vicente, Raul; Pipa, Gordon; Mirasso, Claudio			Effect of the Topology and Delayed Interactions in Neuronal Networks Synchronization	PLOS ONE			English	Article							LONG	As important as the intrinsic properties of an individual nervous cell stands the network of neurons in which it is embedded and by virtue of which it acquires great part of its responsiveness and functionality. In this study we have explored how the topological properties and conduction delays of several classes of neural networks affect the capacity of their constituent cells to establish well-defined temporal relations among firing of their action potentials. This ability of a population of neurons to produce and maintain a millisecond-precise coordinated firing (either evoked by external stimuli or internally generated) is central to neural codes exploiting precise spike timing for the representation and communication of information. Our results, based on extensive simulations of conductance-based type of neurons in an oscillatory regime, indicate that only certain topologies of networks allow for a coordinated firing at a local and long-range scale simultaneously. Besides network architecture, axonal conduction delays are also observed to be another important factor in the generation of coherent spiking. We report that such communication latencies not only set the phase difference between the oscillatory activity of remote neural populations but determine whether the interconnected cells can set in any coherent firing at all. In this context, we have also investigated how the balance between the network synchronizing effects and the dispersive drift caused by inhomogeneities in natural firing frequencies across neurons is resolved. Finally, we show that the observed roles of conduction delays and frequency dispersion are not particular to canonical networks but experimentally measured anatomical networks such as the macaque cortical network can display the same type of behavior.	[Perez, Toni] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Garcia, Guadalupe C.] Jacobs Univ Bremen, Sch Sci & Engn, Bremen, Germany; [Eguiluz, Victor M.; Mirasso, Claudio] Inst Fis Interdisciplinar Sistemas Complejos CSIC, Palma de Mallorca, Spain; [Vicente, Raul] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Vicente, Raul] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Pipa, Gordon] Univ Osnabrueck, Inst Cognit Sci, Osnabruck, Germany	Lehigh University; Jacobs University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Max Planck Society; University Osnabruck	Perez, T (corresponding author), Lehigh Univ, Dept Phys, Bldg 16, Bethlehem, PA 18015 USA.	amp609@lehigh.edu	Perez, Toni/G-6815-2011; Mirasso, Claudio R/B-8661-2008; Eguíluz, Víctor M./B-9655-2008; Vicente, Raul/E-1566-2011; Pipa, Gordon/M-1813-2014	Eguíluz, Víctor M./0000-0003-1133-1289; Vicente, Raul/0000-0002-2497-0007; Pipa, Gordon/0000-0002-3416-2652; Mirasso, Claudio/0000-0003-2980-7038; Garcia, Guadalupe Clara/0000-0002-2227-2483	MEC Ministerio de Educacion y Ciencia (Spain) [FIS2007-60327]; Hertie Foundation (Germany); Mathers Foundation (USA)	MEC Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Hertie Foundation (Germany); Mathers Foundation (USA)	MEC Ministerio de Educacion y Ciencia (Spain) through project FISICOS (FIS2007-60327), the Hertie Foundation (Germany) and the Mathers Foundation (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Atay FM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.144101; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Buzsaki G., 2006, RHYTHMS BRAIN; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Dayan P., 2001, THEORETICAL NEUROSCI; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Eguiluz VM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056113; Ermentrout GB, 1998, P NATL ACAD SCI USA, V95, P1259, DOI 10.1073/pnas.95.3.1259; Ernst U, 1998, PHYS REV E, V57, P2150, DOI 10.1103/PhysRevE.57.2150; ERNST U, 1995, PHYS REV LETT, V74, P1570, DOI 10.1103/PhysRevLett.74.1570; GUTTMAN S, 1980, J PHYSL, V305, P377; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; LAKSHMANAN M, 2011, SPRINGER SER SYNERG; Liang XM, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066202; MANRUBIA SC, 2004, EMERGENCE DYNAMICAL; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Pikovsky AS, 1997, PHYSICA D, V104, P219, DOI 10.1016/S0167-2789(96)00301-6; Reddy DVR, 2000, PHYS REV LETT, V85, P3381, DOI 10.1103/PhysRevLett.85.3381; RINZEL J, 1980, MATH BIOSCI, V49, P27, DOI 10.1016/0025-5564(80)90109-1; Roxin A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238103; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Stepan G, 2009, PHILOS T R SOC A, V367, P1059, DOI 10.1098/rsta.2008.0279; Strogatz S. H., 2003, SYNC; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; Vicente R, 2008, P NATL ACAD SCI USA, V105, P17157, DOI 10.1073/pnas.0809353105; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang QY, 2010, PHYSICA A, V389, P3299, DOI 10.1016/j.physa.2010.03.031; Wang QY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026206; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Wang QY, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50008; Wang XJ, 1996, J NEUROSCI, V16, P6402; WATTS D, 1998, NATURE, V393, P40910; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040	39	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19900	10.1371/journal.pone.0019900	http://dx.doi.org/10.1371/journal.pone.0019900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637767	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500015
J	Khaidakov, M; Mitra, S; Kang, BY; Wang, XW; Kadlubar, S; Novelli, G; Raj, V; Winters, M; Carter, WC; Mehta, JL				Khaidakov, Magomed; Mitra, Sona; Kang, Bum-Yong; Wang, Xianwei; Kadlubar, Susan; Novelli, Giuseppe; Raj, Vinay; Winters, Maria; Carter, Weleetka C.; Mehta, Jawahar L.			Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; DENSITY-LIPOPROTEIN RECEPTOR-1; ARTERY ENDOTHELIAL-CELLS; STEAROYL-COA DESATURASE; LECTIN-LIKE; BREAST-CANCER; CYCLIN D2; EXPRESSION; LOX-1; ABROGATION	Recent studies have linked expression of lectin-like ox-LDL receptor 1 (OLR1) to tumorigenesis. We analyzed microarray data from Olr1 knockout (KO) and wild type (WT) mice for genes involved in cellular transformation and evaluated effects of OLR1 over-expression in normal mammary epithelial cells (MCF10A) and breast cancer cells (HCC1143) in terms of gene expression, migration, adhesion and transendothelial migration. Twenty-six out of 238 genes were inhibited in tissues of OLR1 KO mice; the vast majority of OLR1 sensitive genes contained NF-kB binding sites in their promoters. Further studies revealed broad inhibition of NF-kB target genes outside of the transformation-associated gene pool, with enrichment themes of defense response, immune response, apoptosis, proliferation, and wound healing. Transcriptome of Olr1 KO mice also revealed inhibition of de novo lipogenesis, rate-limiting enzymes fatty acid synthase (Fasn), stearoyl-CoA desaturase (Scd1) and ELOVL family member 6 (Elovl6), as well as lipolytic phospholipase A2 group IVB (Pla2g4b). In studies comparing MCF10A and HCC1143, the latter displayed 60% higher OLR1 expression. Forced over-expression of OLR1 resulted in upregulation of NF-kB (p65) and its target pro-oncogenes involved in inhibition of apoptosis (BCL2, BCL2A1, TNFAIP3) and regulation of cell cycle (CCND2) in both cell lines. Basal expression of FASN, SCD1 and PLA2G4B, as well as lipogenesis transcription factors PPARA, SREBF2 and CREM, was higher in HCC1143 cells. Over-expression of OLR1 in HCC1143 cells also enhanced cell migration, without affecting their adherence to TNF alpha-activated endothelium or transendothelial migration. On the other hand, OLR1 neutralizing antibody inhibited both adhesion and transmigration of untreated HCC1143 cells. We conclude that OLR1 may act as an oncogene by activation of NF-kB target genes responsible for proliferation, migration and inhibition of apoptosis and de novo lipogenesis genes.	[Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Winters, Maria; Carter, Weleetka C.; Mehta, Jawahar L.] Coll Med, Dept Internal Med, Little Rock, AR USA; [Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Winters, Maria; Carter, Weleetka C.; Mehta, Jawahar L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Kadlubar, Susan; Raj, Vinay] Univ Arkansas Med Sci, Coll Med, Div Med Genet, Little Rock, AR 72205 USA; [Kang, Bum-Yong] Emory Univ, Atlanta, GA 30322 USA; [Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Genet, Rome, Italy	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; Emory University; University of Rome Tor Vergata	Khaidakov, M (corresponding author), Coll Med, Dept Internal Med, Little Rock, AR USA.	mkhaidakov@uams.edu; Mehtajl@uams.edu	Mehta, jl/AAB-8832-2019; Novelli, Giuseppe/A-5195-2013; Mehta, JL/AAG-7572-2020; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/T-8822-2019; Wang, Xianwei/AAN-8915-2020	Mehta, jl/0000-0003-0384-2097; Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Wang, Xianwei/0000-0002-1490-8736				Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Brinkley TE, 2008, OBESITY, V16, P1454, DOI 10.1038/oby.2008.213; Chen MY, 2000, ARTERIOSCL THROM VAS, V20, P1107, DOI 10.1161/01.ATV.20.4.1107; Cleary MP, 2010, VET PATHOL, V47, P202, DOI 10.1177/0300985809357753; Evron E, 2001, CANCER RES, V61, P2782; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319; Hu CP, 2008, HYPERTENSION, V52, P556, DOI 10.1161/HYPERTENSIONAHA.108.115287; Hu C, 2008, J MOL CELL CARDIOL, V44, P76, DOI 10.1016/j.yjmcc.2007.10.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaattela M, 1996, J IMMUNOL, V156, P1166; Kang BY, 2010, PHYSIOL GENOMICS, V42, P42, DOI 10.1152/physiolgenomics.00009.2010; Kobayashi T, 2009, BIOCHEM BIOPH RES CO, V387, P196, DOI 10.1016/j.bbrc.2009.06.146; Li DY, 2000, CIRCULATION, V102, P1970, DOI 10.1161/01.CIR.102.16.1970; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Romieu I, 2009, SALUD PUBLICA MEXICO, V51, pS172, DOI 10.1590/S0036-36342009000800007; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; UTSUGI T, 1991, CANCER RES, V51, P3062; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wang R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-120; Xie QH, 2004, DNA CELL BIOL, V23, P111, DOI 10.1089/104454904322759920; Yamanaka S, 1998, GENOMICS, V54, P191, DOI 10.1006/geno.1998.5561; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464	31	75	80	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20277	10.1371/journal.pone.0020277	http://dx.doi.org/10.1371/journal.pone.0020277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637860	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052200047
J	Raju, HB; Hu, Y; Vedula, A; Dubovy, SR; Goldberg, JL				Raju, Hemalatha B.; Hu, Ying; Vedula, Anil; Dubovy, Sander R.; Goldberg, Jeffrey L.			Evaluation of Magnetic Micro- and Nanoparticle Toxicity to Ocular Tissues	PLOS ONE			English	Article							CELLS; RABBIT; MODEL; RATS	Purpose: Magnetic nanoparticles (MNPs) may be used for focal delivery of plasmids, drugs, cells, and other applications. Here we ask whether such particles are toxic to ocular structures. Methods: To evaluate the ocular toxicity of MNPs, we asked if either 50 nm or 4 mu m magnetic particles affect intraocular pressure, corneal endothelial cell count, retinal morphology including both cell counts and glial activation, or photoreceptor function at different time points after injection. Sprague-Dawley rats (n = 44) were injected in the left eye with either 50 nm (3 mu l, 1.65 mg) or 4 mu m (3 mu l, 1.69 mg) magnetic particles, and an equal volume of PBS into the right eye. Electroretinograms (ERG) were used to determine if MNPs induce functional changes to the photoreceptor layers. Enucleated eyes were sectioned for histology and immunofluorescence. Results: Compared to control-injected eyes, MNPs did not alter IOP measurements. ERG amplitudes for a-waves were in the 100-250 mu V range and b-waves were in the 500-600 mu V range, with no significant differences between injected and non-injected eyes. Histological sectioning and immunofluorescence staining showed little difference in MNP-injected animals compared to control eyes. In contrast, at 1 week, corneal endothelial cell numbers were significantly lower in the 4 mu m magnetic particle-injected eyes compared to either 50 nm MNP- or PBS-injected eyes. Furthermore, iron deposition was detected after 4 mu m magnetic particle but not 50 nm MNP injection. Conclusions: Intravitreal or anterior chamber injections of MNPs showed little to no signs of toxicity on retinal structure, photoreceptor function or aqueous drainage in the eye. Our results suggest that MNPs are safe for intraocular use.	[Raju, Hemalatha B.; Hu, Ying; Vedula, Anil; Dubovy, Sander R.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Raju, HB (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jgoldberg@med.miami.edu		Goldberg, Jeffrey/0000-0002-1390-7360	NEI [R21-EY017971, P30 EY014801]; NATIONAL EYE INSTITUTE [P30EY014801, R21EY017971] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors gratefully acknowledge funding from the NEI R21-EY017971 (JLG) and P30 EY014801 (Miami), the Hope for Vision Foundation (JLG), and an unrestricted grant from Research to Prevent Blindness to the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakri SJ, 2008, RETINA-J RET VIT DIS, V28, P147, DOI 10.1097/IAE.0b013e3180dc9360; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5; Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t; DECLERCQ SS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1051, DOI 10.1001/archopht.1977.04450060138014; Gallo JM, 1997, CANCER RES, V57, P3063; HAFELI UO, 2009, MOL PHARM; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; KNAVE, 1969, ACTA OPHTHALMOL S, V100; Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0; Lacava ZGM, 2004, SPECTROSC-INT J, V18, P597, DOI 10.1155/2004/186521; Lattuada M, 2007, LANGMUIR, V23, P2158, DOI 10.1021/la062092x; Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030; MEYER LA, 1988, INVEST OPHTH VIS SCI, V29, P940; Oweida AJ, 2004, MOL IMAGING, V3, P85, DOI 10.1162/1535350041464856; PETER PA, 1957, AM J OPHTHALMOL, V44, P198, DOI 10.1016/0002-9394(57)90448-8; POTTS, 1972, ASSESSMENT VISUAL FU; Raju HB, 2008, EXPERT REV OPHTHALMO, V3, P431, DOI 10.1586/17469899.3.4.431; Sappington RM, 2010, INVEST OPHTH VIS SCI, V51, P207, DOI 10.1167/iovs.09-3947; Schutt W, 1997, HYBRIDOMA, V16, P109, DOI 10.1089/hyb.1997.16.109; Sha O., 2006, Neuroembryology and Aging, V4, P183, DOI 10.1159/000118928	22	62	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e17452	10.1371/journal.pone.0017452	http://dx.doi.org/10.1371/journal.pone.0017452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637340	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200003
J	Vrana, NE; Dupret, A; Coraux, C; Vautier, D; Debry, C; Lavalle, P				Vrana, Nihal Engin; Dupret, Agnes; Coraux, Christelle; Vautier, Dominique; Debry, Christian; Lavalle, Philippe			Hybrid Titanium/Biodegradable Polymer Implants with an Hierarchical Pore Structure as a Means to Control Selective Cell Movement	PLOS ONE			English	Article							TISSUE ENGINEERING SCAFFOLDS; POLYELECTROLYTE MULTILAYERS; TRACHEAL PROSTHESIS; FREEZE-EXTRACTION; EPITHELIAL-CELLS; PHASE-SEPARATION; POROUS TITANIUM; REPAIR; BIOMATERIALS; PEPTIDE	In order to improve implant success rate, it is important to enhance their responsiveness to the prevailing conditions following implantation. Uncontrolled movement of inflammatory cells and fibroblasts is one of these in vivo problems and the porosity properties of the implant have a strong effect on these. Here, we describe a hybrid system composed of a macroporous titanium structure filled with a microporous biodegradable polymer. This polymer matrix has a distinct porosity gradient to accommodate different cell types (fibroblasts and epithelial cells). The main clinical application of this system will be the prevention of restenosis due to excessive fibroblast migration and proliferation in the case of tracheal implants. Methodology/Principal Findings: A microbead-based titanium template was filled with a porous Poly (L-lactic acid) (PLLA) body by freeze-extraction method. A distinct porosity difference was obtained between the inner and outer surfaces of the implant as characterized by image analysis and Mercury porosimetry (9.8 +/- 2.2 mu m vs. 36.7 +/- 11.4 mu m, p <= 0.05). On top, a thin PLLA film was added to optimize the growth of epithelial cells, which was confirmed by using human respiratory epithelial cells. To check the control of fibroblast movement, PKH26 labeled fibroblasts were seeded onto Titanium and Titanium/PLLA implants. The cell movement was quantified by confocal microscopy: in one week cells moved deeper in Ti samples compared to Ti/PLLA. Conclusions: In vitro experiments showed that this new implant is effective for guiding different kind of cells it will contact upon implantation. Overall, this system would enable spatial and temporal control over cell migration by a gradient ranging from macroporosity to nanoporosity within a tracheal implant. Moreover, mechanical properties will be dependent mainly on the titanium frame. This will make it possible to create a polymeric environment which is suitable for cells without the need to meet mechanical requirements with the polymeric structure.	[Vrana, Nihal Engin; Dupret, Agnes; Vautier, Dominique; Debry, Christian; Lavalle, Philippe] INSERM, Inst Natl Sante & Rech Med, U977, Strasbourg, France; [Vautier, Dominique; Lavalle, Philippe] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Dupret, Agnes; Debry, Christian] Hop Univ Strasbourg, Hop Hautepierre, Serv Otorhinolaryngol & Chirurg Cervicofaciale, Strasbourg, France; [Coraux, Christelle] INSERM, Inst Natl Sante & Rech Med, U903, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne	Vrana, NE (corresponding author), INSERM, Inst Natl Sante & Rech Med, U977, Strasbourg, France.	philippe.lavalle@inserm.fr	Vrana, Nihal Engin/A-2029-2010; Lavalle, Philippe/E-6328-2016; Dupret-Bories, Agnes/O-6327-2014; CORAUX, Christelle/P-5668-2016	Vrana, Nihal Engin/0000-0002-5398-6710; Lavalle, Philippe/0000-0001-8798-912X; Dupret-Bories, Agnes/0000-0002-7068-3500; CORAUX, Christelle/0000-0001-5345-5074	Region Alsace; Pole Materiaux et Nanosciences d'Alsace (PMNA); CNRS; INSERM; Louis Pasteur University; Alsace Region	Region Alsace(Region Grand-Est); Pole Materiaux et Nanosciences d'Alsace (PMNA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Louis Pasteur University; Alsace Region(Region Grand-Est)	The study was funded by Region Alsace and Pole Materiaux et Nanosciences d'Alsace (PMNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. A. Walder for providing titanium samples, to Dr. M. Erhardt for his help with SEM images (IBMP, Strasbourg Esplanade Cellular Imaging Facility, funded by CNRS, INSERM, Louis Pasteur University and Alsace Region). We thank K. Benmlih for the build-up of the Teflon molds.	Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321; Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446; Budyanto L, 2009, J MATER SCI-MATER M, V20, P105, DOI 10.1007/s10856-008-3545-8; Coraux C, 2005, M S-MED SCI, V21, P1063; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; Fuchs JR, 2003, J PEDIATR SURG, V38, P984, DOI 10.1016/S0022-3468(03)00139-8; Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6; GROSSIN L, 2009, ADV MAT, V21; Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6; Kanzaki M, 2006, TISSUE ENG, V12, P1275, DOI 10.1089/ten.2006.12.1275; Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008; Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388; Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048; Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com; Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015; Moroni L, 2007, TISSUE ENG, V13, P2483, DOI 10.1089/ten.2006.0385; Muller S, 2008, ADV FUNCT MATER, V18, P1767, DOI 10.1002/adfm.200701233; Papenburg BJ, 2010, ACTA BIOMATER, V6, P2477, DOI 10.1016/j.actbio.2009.12.051; Pavia FC, 2008, J BIOMED MATER RES A, V86A, P459, DOI 10.1002/jbm.a.31621; Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012; Schultz P, 2007, EUR ARCH OTO-RHINO-L, V264, P433, DOI 10.1007/s00405-006-0195-7; Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049; Schultz P, 2004, EUR ARCH OTO-RHINO-L, V261, P484, DOI 10.1007/s00405-003-0717-5; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Skowron-Zwarg M, 2007, EXP CELL RES, V313, P2695, DOI 10.1016/j.yexcr.2007.02.035; WOLF MH, 2008, EUROPEAN CELLS MAT, V15, P1; Zani BG, 2008, P NATL ACAD SCI USA, V105, P7046, DOI 10.1073/pnas.0802463105	31	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20480	10.1371/journal.pone.0020480	http://dx.doi.org/10.1371/journal.pone.0020480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637824	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200070
J	Goodman, BA; Johnson, PTJ				Goodman, Brett A.; Johnson, Pieter T. J.			Disease and the Extended Phenotype: Parasites Control Host Performance and Survival through Induced Changes in Body Plan	PLOS ONE			English	Article							TROPHICALLY TRANSMITTED PARASITE; RHABDIAS-BUFONIS NEMATODA; TREMATODE INFECTION; WILLAMETTE RIVER; LIMB DEVELOPMENT; LIFE-HISTORY; MANIPULATION; BEHAVIOR; MALFORMATIONS; DEFORMITIES	Background: By definition, parasites harm their hosts. However, some forms of parasite-induced alterations increase parasite transmission between hosts, such that manipulated hosts can be considered extensions of the parasite's phenotype. While well accepted in principle, surprisingly few studies have quantified how parasite manipulations alter host performance and survival under field and laboratory conditions. Methodology/Principal Findings: By interfering with limb development, the trematode Ribeiroia ondatrae causes particularly severe morphological alterations within amphibian hosts that provide an ideal system to evaluate parasite-induced changes in phenotype. Here, we coupled laboratory performance trials with a capture-mark-recapture study of 1388 Pacific chorus frogs (Pseudacris regilla) to quantify the effects of parasite-induced malformations on host locomotion, foraging, and survival. Malformations, which affected similar to 50% of metamorphosing frogs in nature, caused dramatic reductions in all measures of organismal function. Malformed frogs exhibited significantly shorter jumping distances (41% reduction), slower swimming speeds (37% reduction), reduced endurance (66% reduction), and lower foraging success relative to infected hosts without malformations. Furthermore, while normal and malformed individuals had comparable survival within predator-free exclosures, deformed frogs in natural populations had 22% lower biweekly survival than normal frogs and rarely recruited to the adult population over a two-year period. Conclusions/Significance: Our results highlight the ability of parasites to deeply alter multiple dimensions of host phenotype with important consequences for performance and survival. These patterns were best explained by malformation status, rather than infection per se, helping to decouple the direct and indirect effects of parasitism on host fitness.	[Goodman, Brett A.; Johnson, Pieter T. J.] Univ Colorado, Boulder, CO 80309 USA; [Goodman, Brett A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University of Colorado System; University of Colorado Boulder; University of Adelaide	Goodman, BA (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pieter.johnson@colorado.edu	Goodman, Brett/F-4717-2013	Goodman, Brett/0000-0001-6457-081X; JOHNSON, PIETER/0000-0002-7997-5390	National Science Foundation [DEB-0841758]; David and Lucile Packard Foundation	National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	The work was completed as part of a grant from the National Science Foundation (DEB-0841758) and a fellowship to PJ from the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Arnott SA, 2000, P ROY SOC B-BIOL SCI, V267, P657, DOI 10.1098/rspb.2000.1052; BEAVER PAUL C., 1939, JOUR PARASITOL, V25, P383, DOI 10.2307/3272305; Bernot RJ, 2008, FRESHWATER BIOL, V53, P322, DOI 10.1111/j.1365-2427.2007.01896.x; Blanchet S, 2009, TRENDS PARASITOL, V25, P364, DOI 10.1016/j.pt.2009.05.005; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cunningham ME, 2005, ENVIRON BIOL FISH, V73, P9, DOI 10.1007/s10641-004-3153-5; DALY EW, 2011, OECOLOGIA IN PRESS; Dawkins R., 1982, pi; DOBSON AP, 1988, Q REV BIOL, V63, P139, DOI 10.1086/415837; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; FERNER JW, 2009, AMPHIBIAN ECOLOGY CO, pCH8; Fryxell J. M., 2008, SERENGETI; GOATER CP, 1992, PARASITOLOGY, V104, P179, DOI 10.1017/S0031182000060923; GOATER CP, 1992, OECOLOGIA, V89, P161, DOI 10.1007/BF00317213; GOATER CP, 1993, OIKOS, V66, P129, DOI 10.2307/3545205; GOODMAN BA, 2011, ECOLOGY IN PRESS; Heemeyer Jennifer L., 2007, Herpetological Review, V38, P425; Hudson P., 2002, ECOLOGY WILDLIFE DIS; Hughes DP, 2008, CURR BIOL, V18, pR294, DOI 10.1016/j.cub.2008.02.001; Jameson D. L., 1956, Copeia, P25; JAMESON DL, 1957, COPEIA, P221; Johnson PTJ, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P511, DOI 10.1201/EBK1420064162-c16; Johnson PTJ, 2009, J ANIM ECOL, V78, P191, DOI 10.1111/j.1365-2656.2008.01455.x; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Johnson PTJ, 2002, ECOL MONOGR, V72, P151, DOI 10.1890/0012-9615(2002)072[0151:PROILT]2.0.CO;2; Johnson PTJ, 2001, HERPETOLOGICA, V57, P336; JOHNSON PTJ, 2011, FUNCT ECOL IN PRESS; Kaldonski N, 2009, P ROY SOC B-BIOL SCI, V276, P169, DOI 10.1098/rspb.2008.0798; Kelehear C, 2009, PARASITOLOGY, V136, P919, DOI 10.1017/S0031182009006325; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 1996, ECOLOGY, V77, P1390, DOI 10.2307/2265536; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Laland KN, 2004, BIOL PHILOS, V19, P313, DOI 10.1023/B:BIPH.0000036113.38737.d8; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; MOORE J, 1984, AM NAT, V123, P572, DOI 10.1086/284224; Moore J., 2002, PARASITES BEHAV ANIM; Mouritsen KN, 2003, OECOLOGIA, V135, P131, DOI 10.1007/s00442-003-1183-x; Nauwelaerts Sandra, 2000, Herpetological Review, V31, P154; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Ouellet M, 2000, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, P617; Parker GA, 2009, EVOLUTION, V63, P448, DOI 10.1111/j.1558-5646.2008.00565.x; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; ROMANSIC JM, 2011, OECOLOGIA IN PRESS; Rorabaugh JC, 2005, AMPHIBIAN DECLINES C, P478; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Seppala O, 2008, P ROY SOC B-BIOL SCI, V275, P1611, DOI 10.1098/rspb.2008.0152; SESSIONS SK, 1990, J EXP ZOOL, V254, P38, DOI 10.1002/jez.1402540107; Shaw JC, 2009, P ROY SOC B-BIOL SCI, V276, P1137, DOI 10.1098/rspb.2008.1597; Stopper GF, 2002, J EXP ZOOL, V294, P252, DOI 10.1002/jez.10173; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; Thomas F, 1998, PARASITOLOGY, V116, P431, DOI 10.1017/S003118209800239X; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x; Villeneuve DL, 2005, ENVIRON SCI TECHNOL, V39, P3495, DOI 10.1021/es048570c; WASSERSUG RJ, 1977, ECOLOGY, V58, P830, DOI 10.2307/1936218; Watkins TB, 2001, EVOLUTION, V55, P1668; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wood CL, 2007, P NATL ACAD SCI USA, V104, P9335, DOI 10.1073/pnas.0700062104; Wright KM., 2001, AMPHIBIAN MED CAPTIV; Yanoviak SP, 2008, AM NAT, V171, P536, DOI 10.1086/528968	70	59	60	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20193	10.1371/journal.pone.0020193	http://dx.doi.org/10.1371/journal.pone.0020193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633498	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500039
J	Yamakuchi, M; Yagi, S; Ito, T; Lowenstein, CJ				Yamakuchi, Munekazu; Yagi, Shusuke; Ito, Takashi; Lowenstein, Charles J.			MicroRNA-22 Regulates Hypoxia Signaling in Colon Cancer Cells	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GENE-EXPRESSION; VEGF; PREDICTION; MECHANISMS; ORIGINS; HIF-1; RNAS	MicroRNAs (MiRNAs) are short, non-coding RNA that regulate a variety of cellular functions by suppressing target protein expression. We hypothesized that a set of microRNA regulate tumor responses to hypoxia by inhibiting components of the hypoxia signaling pathway. We found that miR-22 expression in human colon cancer is lower than in normal colon tissue. We also found that miR-22 controls hypoxia inducible factor 1 alpha (HIF-1 alpha) expression in the HCT116 colon cancer cell line. Over-expression of miR-22 inhibits HIF-1 alpha expression, repressing vascular endothelial growth factor (VEGF) production during hypoxia. Conversely, knockdown of endogenous miR-22 enhances hypoxia induced expression of HIF-1 alpha and VEGF. The conditioned media from cells over-expressing miR-22 contain less VEGF protein than control cells, and also induce less endothelial cell growth and invasion, suggesting miR-22 in adjacent cells influences endothelial cell function. Taken together, our data suggest that miR-22 might have an anti-angiogenic effect in colon cancer.	[Yamakuchi, Munekazu; Yagi, Shusuke; Ito, Takashi; Lowenstein, Charles J.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	University of Rochester	Yamakuchi, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	Munekazu_Yamakuchi@urmc.rochester.edu		Lowenstein, Charles/0000-0003-0485-7514	American Heart Association [0835446N]; NIH	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by American Heart Association grant (0835446N) (MY) and NIH grant (CJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA Y, AM J PATHOL, V176; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cascio S, J CELL PHYSL, V224, P242; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; KROL J, NAT REV GENET; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LIU L, TOXICOL IN VITRO, V24, P1168; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rasheed S, 2009, BRIT J CANCER, V100, P1666, DOI 10.1038/sj.bjc.6605026; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; SEMENZA GL, ARTERIOSCLER THROMB, V30, P648; TING Y, BIOCH BIOPHYS RES CO, V394, P606; Xiong J, FEBS J, V277, P1684; XIONG J, ONCOGENE; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107	37	108	121	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20291	10.1371/journal.pone.0020291	http://dx.doi.org/10.1371/journal.pone.0020291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629773	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200048
J	Jurjanz, L; Donix, M; Amanatidis, EC; Meyer, S; Poettrich, K; Huebner, T; Baeumler, D; Smolka, MN; Holthoff, VA				Jurjanz, Luisa; Donix, Markus; Amanatidis, Eva C.; Meyer, Shirin; Poettrich, Katrin; Huebner, Thomas; Baeumler, Damaris; Smolka, Michael N.; Holthoff, Vjera A.			Visual Personal Familiarity in Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							EARLY ALZHEIMERS-DISEASE; METABOLIC-CHANGES; FRONTAL-CORTEX; FAMOUS PEOPLE; OLDER-ADULTS; MEMORY; DEMENTIA; FMRI; ACTIVATION; MATTER	Background: Patients with amnestic mild cognitive impairment are at high risk for developing Alzheimer's disease. Besides episodic memory dysfunction they show deficits in accessing contextual knowledge that further specifies a general concept or helps to identify an object or a person. Methodology/Principal Findings: Using functional magnetic resonance imaging, we investigated the neural networks associated with the perception of personal familiar faces and places in patients with amnestic mild cognitive impairment and healthy control subjects. Irrespective of stimulus type, patients compared to control subjects showed lower activity in right prefrontal brain regions when perceiving personally familiar versus unfamiliar faces and places. Both groups did not show different neural activity when perceiving faces or places irrespective of familiarity. Conclusions/Significance: Our data highlight changes in a frontal cortical network associated with knowledge-based personal familiarity among patients with amnestic mild cognitive impairment. These changes could contribute to deficits in social cognition and may reduce the patients' ability to transition from basic to complex situations and tasks.	[Jurjanz, Luisa; Donix, Markus; Amanatidis, Eva C.; Meyer, Shirin; Poettrich, Katrin; Huebner, Thomas; Baeumler, Damaris; Smolka, Michael N.; Holthoff, Vjera A.] Tech Univ Dresden, Div Old Age Psychiat, Dept Psychiat & Psychotherapy, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Donix, Markus; Holthoff, Vjera A.] German Ctr Neurodegenerat Dis, Dresden, Germany; [Huebner, Thomas; Smolka, Michael N.] Tech Univ Dresden, Dept Psychol, Neuroimaging Ctr, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Technische Universitat Dresden	Jurjanz, L (corresponding author), Tech Univ Dresden, Div Old Age Psychiat, Dept Psychiat & Psychotherapy, Univ Hosp Carl Gustav Carus, Dresden, Germany.	luisa.jurjanz@uniklinikum-dresden.de; markus.donix@uniklinikum-dresden.de	Smolka, Michael/B-4865-2011	Smolka, Michael/0000-0001-5398-5569; Holthoff, Vjera/0000-0001-7803-1091	Hirnliga eV	Hirnliga eV	This study was funded by Hirnliga eV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ally BA, 2009, BRAIN COGNITION, V69, P504, DOI 10.1016/j.bandc.2008.11.003; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson ND, 2008, NEUROPSYCHOLOGY, V22, P177, DOI 10.1037/0894-4105.22.2.177; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burgener S, 2002, ALZ DIS ASSOC DIS, V16, P88, DOI 10.1097/00002093-200204000-00006; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Choi SJ, 2005, J GERIATR PSYCH NEUR, V18, P12, DOI 10.1177/0891988704271763; Clough JS, 2010, SOC NEUROSCI, P1; DAVIS S, 2007, CEREB CORTEX; Delis DC., 2000, CALIFORNIA VERBAL LE; Devanand DP, 2010, J GERIATR PSYCH NEUR, V23, P185, DOI 10.1177/0891988710363715; Donix M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015790; Donix M, 2010, ARCH CLIN NEUROPSYCH, V25, P22, DOI 10.1093/arclin/acp098; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Estevez-Gonzalez A, 2004, DEMENT GERIATR COGN, V17, P188, DOI 10.1159/000076355; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Giovannetti T, 2006, ARCH CLIN NEUROPSYCH, V21, P607, DOI 10.1016/j.acn.2006.05.005; Gobbini MI, 2006, BRAIN RES BULL, V71, P76, DOI 10.1016/j.brainresbull.2006.08.003; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hong GRS, 2009, J CLIN NURS, V18, P1365, DOI 10.1111/j.1365-2702.2008.02566.x; Huber W, 1984, Adv Neurol, V42, P291; Hurting C., 2000, WMS R WECHSLER GEDAC; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KESSELS RP, 2010, NEUROPSYCHOL DEV C B, P1; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; LIU L, 1991, AM J OCCUP THER, V45, P67, DOI 10.5014/ajot.45.1.67; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mandzia JL, 2009, NEUROBIOL AGING, V30, P717, DOI 10.1016/j.neurobiolaging.2007.08.024; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Nestor PJ, 2003, EUR J NEUROSCI, V18, P2663, DOI 10.1046/j.1460-9568.2003.02999.x; Norton MC, 2009, J GERONTOL B-PSYCHOL, V64, P560, DOI 10.1093/geronb/gbp052; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petrella JR, 2006, RADIOLOGY, V240, P177, DOI 10.1148/radiol.2401050739; Poettrich K, 2009, NEUROBIOL AGING, V30, P284, DOI 10.1016/j.neurobiolaging.2007.05.027; Ries ML, 2006, NEUROIMAGE, V29, P485, DOI 10.1016/j.neuroimage.2005.07.030; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Serra L, 2010, NEUROPSYCHOLOGY, V24, P316, DOI 10.1037/a0017654; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Trivedi MA, 2008, DEMENT GERIATR COGN, V26, P123, DOI 10.1159/000148190; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Werner P, 2009, DEMENT GERIATR COGN, V27, P301, DOI 10.1159/000204915; Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193; WESTMAN E, 2010, NEUROIMAGE; Woodard JL, 2009, BRAIN, V132, P2068, DOI 10.1093/brain/awp157	61	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20030	10.1371/journal.pone.0020030	http://dx.doi.org/10.1371/journal.pone.0020030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766OI	21625502	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400032
J	Christoffels, IK; van de Ven, V; Waldorp, LJ; Formisano, E; Schiller, NO				Christoffels, Ingrid K.; van de Ven, Vincent; Waldorp, Lourens J.; Formisano, Elia; Schiller, Niels O.			The Sensory Consequences of Speaking: Parametric Neural Cancellation during Speech in Auditory Cortex	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; ASSOCIATION CORTEX; NEURONAL-ACTIVITY; FEEDBACK CONTROL; FMRI; ACTIVATIONS; MODULATION; RESPONSES; MODEL	When we speak, we provide ourselves with auditory speech input. Efficient monitoring of speech is often hypothesized to depend on matching the predicted sensory consequences from internal motor commands ( forward model) with actual sensory feedback. In this paper we tested the forward model hypothesis using functional Magnetic Resonance Imaging. We administered an overt picture naming task in which we parametrically reduced the quality of verbal feedback by noise masking. Presentation of the same auditory input in the absence of overt speech served as listening control condition. Our results suggest that a match between predicted and actual sensory feedback results in inhibition of cancellation of auditory activity because speaking with normal unmasked feedback reduced activity in the auditory cortex compared to listening control conditions. Moreover, during self-generated speech, activation in auditory cortex increased as the feedback quality of the self-generated speech decreased. We conclude that during speaking early auditory cortex is involved in matching external signals with an internally generated model or prediction of sensory consequences, the locus of which may reside in auditory or higher order brain areas. Matching at early auditory cortex may provide a very sensitive monitoring mechanism that highlights speech production errors at very early levels of processing and may efficiently determine the self-agency of speech input.	[Christoffels, Ingrid K.; Schiller, Niels O.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Christoffels, Ingrid K.; Schiller, Niels O.] Leiden Univ, Leiden Inst Psychol Res, Leiden, Netherlands; [van de Ven, Vincent; Formisano, Elia] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Waldorp, Lourens J.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Schiller, Niels O.] Netherlands Inst Adv Study Humanities & Social Sc, Wassenaar, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Maastricht University; University of Amsterdam	Christoffels, IK (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	ichristoffels@fsw.leidenuniv.nl	Schiller, Niels O./A-9481-2008; van de Ven, Vincent/D-3003-2009	Schiller, Niels O./0000-0002-0392-7608; van de Ven, Vincent/0000-0001-8735-3711; Formisano, Elia/0000-0001-5008-2460	Netherlands Organization for Scientific Research (NWO) [451-06-009, 451-07-014, 452-04-337, 453-02-006]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	IKC, VV, EF, and NOS were supported by grants from the Netherlands Organization for Scientific Research (NWO) (respectively 451-06-009, 451-07-014, 452-04-337; and 453-02-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; BORDEN GJ, 1979, BRAIN LANG, V7, P307, DOI 10.1016/0093-934X(79)90025-7; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Ford JM, 2005, INT J PSYCHOPHYSIOL, V57, P143, DOI 10.1016/j.ijpsycho.2005.03.002; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Frith C, 2005, CR BIOL, V328, P169, DOI 10.1016/j.crvi.2004.10.012; Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Shergill SS, 2001, PSYCHOL MED, V31, P241, DOI 10.1017/S003329170100335X; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Talairach J., 1988, COPLANAR STEREOTAXIC; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Toyomura A, 2007, NEUROSCIENCE, V146, P499, DOI 10.1016/j.neuroscience.2007.02.023; van de Ven VG, 2005, NEUROIMAGE, V27, P644, DOI 10.1016/j.neuroimage.2005.04.041; van de Ven V, 2009, NEUROIMAGE, V47, P1982, DOI 10.1016/j.neuroimage.2009.05.057; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324	38	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e18307	10.1371/journal.pone.0018307	http://dx.doi.org/10.1371/journal.pone.0018307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766HI	21625532	Green Published, gold			2022-12-25	WOS:000290771200003
J	Guckel, E; Frey, S; Zaiss, MM; Schett, G; Ghosh, S; Voll, RE				Gueckel, Eva; Frey, Silke; Zaiss, Mario M.; Schett, Georg; Ghosh, Sankar; Voll, Reinhard E.			Cell-Intrinsic NF-kappa B Activation Is Critical for the Development of Natural Regulatory T Cells in Mice	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; FOXP3 TRANSCRIPTION-FACTOR; GROWTH-FACTOR-BETA; NUCLEAR-FACTOR; C-REL; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; DIFFERENTIAL REQUIREMENT; LYMPHOCYTE-PROLIFERATION; INTESTINAL INFLAMMATION	Background: Naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells develop in the thymus and represent a mature T cell subpopulation critically involved in maintaining peripheral tolerance. The differentiation of Treg cells in the thymus requires T cell receptor (TCR)/CD28 stimulation along with cytokine-promoted Foxp3 induction. TCR-mediated nuclear factor kappa B (NF-kappa B) activation seems to be involved in differentiation of Treg cells because deletion of components of the NF-kappa B signaling pathway, as well as of NF-kB transcription factors, leads to markedly decreased Treg cell numbers in thymus and periphery. Methodology/ Principal Findings: To investigate if Treg cell-intrinsic NF-kappa B activation is required for thymic development and peripheral homeostasis of Treg cells we used transgenic (Tg) mice with thymocyte-specific expression of a stable I kappa B alpha mutant to inhibit NF-kappa B activation solely within the T cell lineage. Here we show that Treg cell-intrinsic NF-kappa B activation is important for the generation of cytokine-responsive Foxp3(-) thymic Treg precursors and their further differentiation into mature Treg cells. Treg cell development could neither be completely rescued by the addition of exogenous Interleukin 2 (IL-2) nor by the presence of wild-type derived cells in adoptive transfer experiments. However, peripheral NF-kappa B activation appears to be required for IL-2 production by conventional T cells, thereby participating in Treg cell homeostasis. Moreover, pharmacological NF-kappa B inhibition via the I kappa B kinase beta (IKK beta) inhibitor AS602868 led to markedly diminished thymic and peripheral Treg cell frequencies. Conclusion/Significance: Our results indicate that Treg cell-intrinsic NF-kappa B activation is essential for thymic Treg cell differentiation, and further suggest pharmacological NF-kappa B inhibition as a potential therapeutic approach for manipulating this process.	[Gueckel, Eva; Frey, Silke; Voll, Reinhard E.] Univ Erlangen Nurnberg, Dept Internal Med, Nikolaus Fiebiger Ctr Mol Med, Clin Res Grp, Erlangen, Germany; [Zaiss, Mario M.; Schett, Georg] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Internal Med Rheumatol & Clin Immunol 3, Erlangen, Germany; [Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Voll, Reinhard E.] Univ Med Ctr Freiburg, Dept Rheumatol & Clin Immunol, Ctr Chron Immunodeficiency, Freiburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Columbia University; University of Freiburg	Guckel, E (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med, Nikolaus Fiebiger Ctr Mol Med, Clin Res Grp, Erlangen, Germany.	reinhard.voll@uniklinik-freiburg.de	Zaiss, Mario M./ABE-7125-2021	Zaiss, Mario M./0000-0003-3844-1664; Frey, Silke/0000-0001-9411-8357	German Research Society [SFB 643, B3]; Interdisciplinary Center for Clinical Research (IZKF) [N2]; ELAN; German Research Community (DFG) [GK592]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER	German Research Society(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF); ELAN; German Research Community (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the German Research Society (Collaborative Research Centers SFB 643; project B3) and the Interdisciplinary Center for Clinical Research (IZKF, project number N2). Parts of this work were also funded by an intramural grant from the ELAN fund and the Training Grant GK592, from the German Research Community (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Antov A, 2003, J IMMUNOL, V171, P3435, DOI 10.4049/jimmunol.171.7.3435; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, IMMUNOL LETT, V114, P1, DOI 10.1016/j.imlet.2007.08.005; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Frelin C, 2003, ONCOGENE, V22, P8187, DOI 10.1038/sj.onc.1206963; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Greve B, 2007, J IMMUNOL, V179, P179, DOI 10.4049/jimmunol.179.1.179; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2008, EUR J IMMUNOL, V38, P928, DOI 10.1002/eji.200838147; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Itoh M, 1999, J IMMUNOL, V162, P5317; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; LAI JH, 1995, MOL CELL BIOL, V15, P4260; Lee AJ, 2010, J BIOL CHEM, V285, P15696, DOI 10.1074/jbc.M109.095190; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu HY, 2006, CLIN EXP PHARMACOL P, V33, P519, DOI 10.1111/j.1440-1681.2006.04401.x; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lounnas N, 2009, INT J CANCER, V125, P308, DOI 10.1002/ijc.24294; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Mora AL, 2001, J IMMUNOL, V166, P2218, DOI 10.4049/jimmunol.166.4.2218; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nishioka T, 2006, J IMMUNOL, V176, P6586, DOI 10.4049/jimmunol.176.11.6586; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhao L, 2007, J LEUKOCYTE BIOL, V81, P1386, DOI 10.1189/jlb.0506364; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610; Zhou P, 2005, J IMMUNOL, V174, P3447, DOI 10.4049/jimmunol.174.6.3447	82	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20003	10.1371/journal.pone.0020003	http://dx.doi.org/10.1371/journal.pone.0020003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625598	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200058
J	Crespo, MD; Rubini, M				Crespo, Maria D.; Rubini, Marina			Rational Design of Protein Stability: Effect of (2S,4R)-4-Fluoroproline on the Stability and Folding Pathway of Ubiquitin	PLOS ONE			English	Article							COLLAGEN TRIPLE-HELIX; PROLINE RESIDUES; CONFORMATIONAL STABILITY; SYNTHETIC BIOLOGY; IN-VIVO; PEPTIDES; 4-FLUOROPROLINE; INSIGHTS; MODEL; STABILIZATION	Background: Many strategies have been employed to increase the conformational stability of proteins. The use of 4-substituted proline analogs capable to induce pre-organization in target proteins is an attractive tool to deliver an additional conformational stability without perturbing the overall protein structure. Both, peptides and proteins containing 4-fluorinated proline derivatives can be stabilized by forcing the pyrrolidine ring in its favored puckering conformation. The fluorinated pyrrolidine rings of proline can preferably stabilize either a C-gamma-exo or a C-gamma-endo ring pucker in dependence of proline chirality (4R/4S) in a complex protein structure. To examine whether this rational strategy can be generally used for protein stabilization, we have chosen human ubiquitin as a model protein which contains three proline residues displaying C-gamma-exo puckering. Methodology/Principal Findings: While (2S, 4R)-4-fluoroproline ((4R)-FPro) containing ubiquitinin can be expressed in related auxotrophic Escherichia coli strain, all attempts to incorporate (2S, 4S)-4-fluoroproline ((4S)-FPro) failed. Our results indicate that (4R)-FPro is favoring the C-gamma-exo conformation present in the wild type structure and stabilizes the protein structure due to a pre-organization effect. This was confirmed by thermal and guanidinium chloride-induced denaturation profile analyses, where we observed an increase in stability of -4.71 kJ.mol(-1) in the case of (4R)-FPro containing ubiquitin ((4R)-FPro-ub) compared to wild type ubiquitin (wt-ub). Expectedly, activity assays revealed that (4R)-FPro-ub retained the full biological activity compared to wt-ub. Conclusions/Significance: The results fully confirm the general applicability of incorporating fluoroproline derivatives for improving protein stability. In general, a rational design strategy that enforces the natural occurring proline puckering conformation can be used to stabilize the desired target protein.	[Crespo, Maria D.] ETH Honggerberg, Inst Mol Biol & Biophys, Zurich, Switzerland; [Rubini, Marina] Univ Konstanz, Dept Organ Chem, Constance, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Konstanz	Crespo, MD (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, Zurich, Switzerland.	marina.rubini@uni-konstanz.de		Rubini, Marina/0000-0002-3102-2558	University of Konstanz	University of Konstanz	This work was supported by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth D, 2004, CHEMBIOCHEM, V5, P79, DOI 10.1002/cbic.200300702; Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918; Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; BRIGGS MS, 1992, P NATL ACAD SCI USA, V89, P2017, DOI 10.1073/pnas.89.6.2017; Crespo MD, 2006, J MOL BIOL, V360, P1053, DOI 10.1016/j.jmb.2006.05.061; Crespo MD, 2004, EUR J BIOCHEM, V271, P4474, DOI 10.1111/j.1432-1033.2004.04392.x; DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904; Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v; Gladwin ST, 1996, FOLD DES, V1, P407, DOI 10.1016/S1359-0278(96)00057-0; Golbik R, 2005, BIOCHEMISTRY-US, V44, P16026, DOI 10.1021/bi051442w; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Hodges JA, 2003, J AM CHEM SOC, V125, P9262, DOI 10.1021/ja035881z; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; Jackson SE, 2006, ORG BIOMOL CHEM, V4, P1845, DOI 10.1039/b600829c; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; KIEFHABER T, 2005, PROTEIN FOLDING HDB, V1; Kim W, 2005, J AM CHEM SOC, V127, P18121, DOI 10.1021/ja054105j; Kim W, 2006, ANGEW CHEM INT EDIT, V45, P8141, DOI 10.1002/anie.200603227; Kim WY, 2004, CHEMBIOCHEM, V5, P928, DOI 10.1002/cbic.200400052; Lee HY, 2006, J AM CHEM SOC, V128, P337, DOI 10.1021/ja0563410; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; Marsh ENG, 2000, CHEM BIOL, V7, pR153, DOI 10.1016/S1074-5521(00)00139-3; Montclare JK, 2009, CHEMBIOCHEM, V10, P84, DOI 10.1002/cbic.200800164; Moroder L, 2010, CHEMPHYSCHEM, V11, P1181, DOI 10.1002/cphc.201000035; Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; PANASIK N, 1994, INT J PEPT PROT RES, V44, P262; Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Shoulders MD, 2010, P NATL ACAD SCI USA, V107, P559, DOI 10.1073/pnas.0909592107; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Shoulders MD, 2009, ADV EXP MED BIOL, V611, P251, DOI 10.1007/978-0-387-73657-0_115; Son S, 2006, CHEMBIOCHEM, V7, P1251, DOI 10.1002/cbic.200500420; Steiner T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001680; Tang Y, 2001, BIOCHEMISTRY-US, V40, P2790, DOI 10.1021/bi0022588; Tang Y, 2001, ANGEW CHEM INT EDIT, V40, P1494, DOI 10.1002/1521-3773(20010417)40:8<1494::AID-ANIE1494>3.0.CO;2-X; Vallee-Belisle A, 2007, J MOL BIOL, V374, P791, DOI 10.1016/j.jmb.2007.09.018; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang P, 2003, J AM CHEM SOC, V125, P6900, DOI 10.1021/ja0298287; Went HM, 2004, FEBS LETT, V567, P333, DOI 10.1016/j.febslet.2004.04.089; WINTRODE PL, 1994, PROTEINS, V18, P246, DOI 10.1002/prot.340180305; WOOLFSON DN, 1993, J MOL BIOL, V229, P502, DOI 10.1006/jmbi.1993.1049	51	32	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2011	6	5							e19425	10.1371/journal.pone.0019425	http://dx.doi.org/10.1371/journal.pone.0019425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	764TP	21625626	Green Published, Green Submitted, gold			2022-12-25	WOS:000290656300008
J	Giovinazzi, S; Lindsay, CR; Morozov, VM; Escobar-Cabrera, E; Summers, MK; Han, HS; McIntosh, LP; Ishov, AM				Giovinazzi, S.; Lindsay, C. R.; Morozov, V. M.; Escobar-Cabrera, E.; Summers, M. K.; Han, H. S.; McIntosh, L. P.; Ishov, A. M.			Regulation of mitosis and taxane response by Daxx and Rassf1	ONCOGENE			English	Article						Daxx; Rassf1A/C; taxane chemotherapy; mitosis; SAC; APC	TUMOR-SUPPRESSOR RASSF1A; TRANSCRIPTION REPRESSOR DAXX; SPINDLE ASSEMBLY CHECKPOINT; BREAST-CANCER PATIENTS; BETA-TUBULIN; PACLITAXEL RESISTANCE; INTERACTING PROTEIN; MITOTIC CHECKPOINT; NUCLEAR-STRUCTURE; DOWN-REGULATION	Current theories suggest that mitotic checkpoint proteins are essential for proper cellular response to taxanes, a widely used family of chemotherapeutic compounds. We recently showed that absence or depletion of protein Daxx increases cellular taxol (paclitaxel) resistance-a common trait of patients diagnosed with several malignancies, including breast cancer. Further investigation of Daxx-mediated taxol response revealed that Daxx is important for the proper timing of mitosis progression and cyclin B stability. Daxx interacts with mitotic checkpoint protein RAS-association domain family protein 1 (Rassf1) and partially colocalizes with this protein during mitosis. Rassf1/Daxx depletion or expression of Daxx-binding domain of Rassf1 elevates cyclin B stability and increases taxol resistance in cells and mouse xenograft models. In breast cancer patients, we observed the inverse correlation between Daxx and clinical response to taxane-based chemotherapy. These data suggest that Daxx and Rassf1 define a mitotic stress checkpoint that enables cells to exit mitosis as micronucleated cells (and eventually die) when encountered with specific mitotic stress stimuli, including taxol. Surprisingly, depletion of Daxx or Rassf1 does not change the activity of E3 ubiquitin ligase anaphase promotion complex/C in in vitro settings, suggesting the necessity of mitotic cellular environment for proper activation of this checkpoint. Daxx and Rassf1 may become useful predictive markers for the proper selection of patients for taxane chemotherapy. Oncogene (2012) 31, 13-26; doi: 10.1038/onc.2011.211; published online 6 June 2011	[Giovinazzi, S.; Lindsay, C. R.; Morozov, V. M.; Ishov, A. M.] Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Escobar-Cabrera, E.; McIntosh, L. P.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Escobar-Cabrera, E.; McIntosh, L. P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Summers, M. K.] Genentech Inc, Dept Cellular Regulat, San Francisco, CA 94080 USA; [Han, H. S.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of Florida; University of British Columbia; University of British Columbia; Roche Holding; Genentech; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Ishov, AM (corresponding author), Univ Florida, Shands Canc Ctr, Dept Anat & Cell Biol, 2033 Mowry Rd,Room 358, Gainesville, FL 32610 USA.	ishov@ufl.edu		Morozov, Viacheslav/0000-0002-4901-7722	NIH/NCI [R01 CA127378-01A1]; Canadian Cancer Society [017308]; NATIONAL CANCER INSTITUTE [R01CA127378] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Gerd Pfeifer, Beckman Research Institute, for the generous gift of anti-Rassf1 antibodies and Dr Frank Rauscher, The Wistar Institute, for HP1 antibodies. This work was supported by NIH/NCI R01 CA127378-01A1 for CRL, SG, VMM and AMI, by the Canadian Cancer Society (017308) for EE and LPM. NMR spectroscopy support was provided by the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the British Columbia Knowledge Development Fund (BCKDF), the UBC Blusson Fund and the Michael Smith Foundation for Health Research (MSFHR).	Aapro MS, 2001, ONCOLOGIST, V6, P36, DOI 10.1634/theoncologist.6-4-376; Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Amaar YG, 2005, J BONE MINER RES, V20, P1430, DOI 10.1359/JBMR.050311; Bonneterre J, 1999, EUR J CANCER, V35, P1431, DOI 10.1016/S0959-8049(99)00174-4; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Crown J, 2004, ONCOLOGIST, V9, P24, DOI 10.1634/theoncologist.9-suppl_2-24; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; De Mulder P H, 1999, Acta Otorhinolaryngol Belg, V53, P247; Escobar-Cabrera E, 2010, STRUCTURE, V18, P1642, DOI 10.1016/j.str.2010.09.016; Estrabaud E, 2007, CANCER RES, V67, P1054, DOI 10.1158/0008-5472.CAN-06-2530; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; Hari M, 2003, MOL CANCER THER, V2, P597; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Iwao-Koizumi K, 2005, J CLIN ONCOL, V23, P422, DOI 10.1200/JCO.2005.09.078; Kitagawa D, 2006, EMBO J, V25, P3286, DOI 10.1038/sj.emboj.7601212; Kubota T, 1997, J SURG ONCOL, V64, P115, DOI 10.1002/(SICI)1096-9098(199702)64:2<115::AID-JSO5>3.3.CO;2-1; Lee EA, 2004, MOL CANCER THER, V3, P661; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Lindsay CR, 2007, CELL CYCLE, V6, P1200, DOI 10.4161/cc.6.10.4244; Lindsay CR, 2009, CELL CYCLE, V8, P1544, DOI 10.4161/cc.8.10.8379; Liu L, 2007, CELL CYCLE, V6, P1663, DOI 10.4161/cc.6.13.4435; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Mantel C, 2008, CELL CYCLE, V7, P484, DOI 10.4161/cc.7.4.5316; Mauriac L, 2005, BREAST, V14, P617, DOI 10.1016/j.breast.2005.08.013; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michaelson JS, 2000, APOPTOSIS, V5, P217, DOI 10.1023/A:1009696227420; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Miyoshi Y, 2004, CLIN CANCER RES, V10, P8163, DOI 10.1158/1078-0432.CCR-04-1310; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; RAVDIN P, 2003, EJC SUPPL, V1, P32; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Saffert RT, 2008, FUTURE VIROL, V3, P265, DOI 10.2217/17460794.3.3.265; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Wang YQ, 2005, BBA-MOL CELL RES, V1744, P245, DOI 10.1016/j.bbamcr.2004.12.003; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Wysong DR, 2009, CELL CYCLE, V8, P876, DOI 10.4161/cc.8.6.7897; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322	55	22	23	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	1					13	26		10.1038/onc.2011.211	http://dx.doi.org/10.1038/onc.2011.211			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21643015	Green Accepted, Bronze			2022-12-25	WOS:000299176200002
J	Couturier, J; Stroher, E; Albetel, AN; Roret, T; Muthuramalingam, M; Tarrago, L; Seidel, T; Tsan, P; Jacquot, JP; Johnson, MK; Dietz, KJ; Didierjean, C; Rouhier, N				Couturier, Jeremy; Stroeher, Elke; Albetel, Angela-Nadia; Roret, Thomas; Muthuramalingam, Meenakumari; Tarrago, Lionel; Seidel, Thorsten; Tsan, Pascale; Jacquot, Jean-Pierre; Johnson, Michael K.; Dietz, Karl-Josef; Didierjean, Claude; Rouhier, Nicolas			Arabidopsis Chloroplastic Glutaredoxin C5 as a Model to Explore Molecular Determinants for Iron-Sulfur Cluster Binding into Glutaredoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI GLUTAREDOXIN; MIXED DISULFIDE; ACTIVE-SITE; MONOTHIOL GLUTAREDOXINS; NMR STRUCTURE; THIOREDOXIN; PROTEIN; GLUTATHIONE; EXPRESSION; GRX5	Unlike thioredoxins, glutaredoxins are involved in iron-sulfur cluster assembly and in reduction of specific disulfides (i.e. protein-glutathione adducts), and thus they are also important redox regulators of chloroplast metabolism. Using GFP fusion, AtGrxC5 isoform, present exclusively in Brassicaceae, was shown to be localized in chloroplasts. A comparison of the biochemical, structural, and spectroscopic properties of Arabidopsis GrxC5 (WCSYC active site) with poplar GrxS12 (WCSYS active site), a chloroplastic paralog, indicated that, contrary to the solely apomonomeric GrxS12 isoform, AtGrxC5 exists as two forms when expressed in Escherichia coli. The monomeric apoprotein possesses deglutathionylation activity mediating the recycling of plastidial methionine sulfoxide reductase B1 and peroxiredoxin IIE, whereas the dimeric holoprotein incorporates a [2Fe-2S] cluster. Site-directed mutagenesis experiments and resolution of the x-ray crystal structure of AtGrxC5 in its holoform revealed that, although not involved in its ligation, the presence of the second active site cysteine (Cys(32)) is required for cluster formation. In addition, thiol titrations, fluorescence measurements, and mass spectrometry analyses showed that, despite the presence of a dithiol active site, AtGrxC5 does not form any inter-or intramolecular disulfide bond and that its activity exclusively relies on a monothiol mechanism.	[Roret, Thomas; Tsan, Pascale; Didierjean, Claude] Nancy Univ, Univ Henri Poincare, Fac Sci & Technol, Equipe Biocristallog,CNRS,UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Tarrago, Lionel; Jacquot, Jean-Pierre; Rouhier, Nicolas] Nancy Univ, Inst Federatif Rech Ecosyst Forestiers Agroressou, Inst Natl Rech Agron, UMR 1136, F-54506 Vandoeuvre Les Nancy, France; [Couturier, Jeremy; Stroeher, Elke; Muthuramalingam, Meenakumari; Seidel, Thorsten; Dietz, Karl-Josef] Univ Bielefeld, Fac Biol W5 134, D-33501 Bielefeld, Germany; [Albetel, Angela-Nadia; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Albetel, Angela-Nadia; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; INRAE; Universite de Lorraine; University of Bielefeld; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Didierjean, C (corresponding author), Nancy Univ, Univ Henri Poincare, Fac Sci & Technol, Equipe Biocristallog,CNRS,UMR 7036, BP 239, F-54506 Vandoeuvre Les Nancy, France.	Claude.Didierjean@crm2.uhp-nancy.fr; nrouhier@scbiol.uhp-nancy.fr	DIDIERJEAN, Claude/L-1493-2013; Couturier, Jérémy/AAF-6588-2020; Tarrago, Lionel/N-3534-2016; Tarrago, Lionel/CAH-1308-2022; Jacquot, Jean-Pierre/A-1571-2012; Dietz, Karl-Josef/B-6029-2009	DIDIERJEAN, Claude/0000-0002-3176-8974; Couturier, Jérémy/0000-0003-3127-2669; Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Jacquot, Jean-Pierre/0000-0003-4975-8587; Dietz, Karl-Josef/0000-0003-0311-2182; tsan, pascale/0000-0002-0218-0258; Rouhier, Nicolas/0000-0002-2036-7884	National Institutes of Health [GM62524]; Alexander von Humboldt Foundation; Agence Nationale de la Recherche [JC07_204825]; Deutsche Forschungsgemeinschaft [DI346-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062524, R37GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Agence Nationale de la Recherche(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62524 (to M. K. J.). This work was also supported by the Alexander von Humboldt Foundation (to J. P. J.), Agence Nationale de la Recherche Grant JC07_204825 (to J. C. and N. R.), and Deutsche Forschungsgemeinschaft Grant DI346-14 (to K. J. D.).	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Behm M, 2000, PLANT PHYSIOL BIOCH, V38, P363, DOI 10.1016/S0981-9428(00)00760-9; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Ceylan S, 2010, J BIOL CHEM, V285, P35224, DOI 10.1074/jbc.M110.165860; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Couturier J, 2010, BIOCHEM BIOPH RES CO, V403, P435, DOI 10.1016/j.bbrc.2010.11.050; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng YG, 2006, BIOCHEMISTRY-US, V45, P7998, DOI 10.1021/bi060444t; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gama F, 2008, PHYSIOL PLANTARUM, V133, P599, DOI 10.1111/j.1399-3054.2008.01097.x; Gao XH, 2010, FEBS LETT, V584, P2242, DOI 10.1016/j.febslet.2010.04.034; Greetham D, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-3; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horling F, 2003, PLANT PHYSIOL, V131, P317, DOI 10.1104/pp.010017; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Johansson C, 2007, J BIOL CHEM, V282, P3077, DOI 10.1074/jbc.M608179200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Molina-Navarro MM, 2006, FEBS LETT, V580, P2273, DOI 10.1016/j.febslet.2006.03.037; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIKKOLA M, 1991, J BIOL CHEM, V266, P16105; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2001, PLANT PHYSIOL, V127, P1299, DOI 10.1104/pp.010586; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Saaranen MJ, 2009, ANTIOXID REDOX SIGN, V11, P1819, DOI [10.1089/ars.2008.2387, 10.1089/ARS.2008.2387]; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Seidel T, 2005, FEBS LETT, V579, P4374, DOI 10.1016/j.febslet.2005.06.077; Stroher E, 2009, MOL PLANT, V2, P357, DOI 10.1093/mp/ssn084; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wormuth D, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-15; XIA TH, 1992, PROTEIN SCI, V1, P310; YANG YF, 1991, J BIOL CHEM, V266, P12759; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200	62	63	66	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27515	27527		10.1074/jbc.M111.228726	http://dx.doi.org/10.1074/jbc.M111.228726			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21632542	Green Published, hybrid			2022-12-25	WOS:000293268700046
J	Jha, BK; Polyakova, I; Kessler, P; Dong, BH; Dickerman, B; Sen, GC; Silverman, RH				Jha, Babal Kant; Polyakova, Irina; Kessler, Patricia; Dong, Beihua; Dickerman, Benjamin; Sen, Ganes C.; Silverman, Robert H.			Inhibition of RNase L and RNA-dependent Protein Kinase (PKR) by Sunitinib Impairs Antiviral Innate Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; 2-5A-DEPENDENT RNASE; 2',5'-OLIGOADENYLATE SYNTHETASE; INTERFERON ACTION; ACTIVATION; IRE1; CLEAVAGE; DOMAIN; 2-5A; OLIGOADENYLATES	RNase L and RNA-dependent protein kinase (PKR) are effectors of the interferon antiviral response that share homology in their pseudokinase and protein kinase domains, respectively. Sunitinib is an orally available, ATP-competitive inhibitor of VEGF andPDGFreceptors used clinically to suppress angiogenesis and tumor growth. Sunitinib also impacts IRE1, an endoplasmic reticulum protein involved in the unfolded protein response that is closely related to RNase L. Here, we report that sunitinib is a potent inhibitor of both RNase L and PKR with IC50 values of 1.4 and 0.3 mu M, respectively. In addition, flavonol activators of IRE1 inhibited RNase L. Sunitinib treatment of wild type (WT) mouse embryonic fibroblasts resulted in about a 12-fold increase in encephalomyocarditis virus titers. However, sunitinib had no effect on encephalomyocarditis virus growth in cells lacking both PKR and RNase L. Furthermore, oral delivery of sunitinib inWTmice resulted in 10-fold higher viral titers in heart tissues while suppressing by about 2-fold the IFN-beta levels. In contrast, sunitinib had no effect on viral titers in mice deficient in both RNase L and PKR. Also, sunitinib reduced mean survival times from 12 to 6 days in virus-infectedWTmice while having no effect on survival of mice lacking both RNase L and PKR. Results indicate that sunitinib treatments prevent antiviral innate immune responses mediated by RNase L and PKR.	[Jha, Babal Kant; Polyakova, Irina; Kessler, Patricia; Dong, Beihua; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Dickerman, Benjamin; Sen, Ganes C.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Silverman, RH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.	silverr@ccf.org	jha, babal k/B-1803-2010	jha, babal k/0000-0002-7660-5255	National Institutes of Health, NCI [CA044059, CA062220]; NATIONAL CANCER INSTITUTE [R01CA068782, R01CA044059, P01CA062220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073303] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA044059 (to R. H. S.) and CA062220 (to G. S.) from NCI.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; BAUMAL R, 1986, CANCER RES, V46, P3994; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Carroll SS, 1997, J BIOL CHEM, V272, P19193, DOI 10.1074/jbc.272.31.19193; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 1997, J BIOL CHEM, V272, P22236, DOI 10.1074/jbc.272.35.22236; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; DONG BH, 1994, J BIOL CHEM, V269, P14153; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813; Luthra P, 2011, P NATL ACAD SCI USA, V108, P2118, DOI 10.1073/pnas.1012409108; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Molinaro RJ, 2006, NUCLEIC ACIDS RES, V34, P6684, DOI 10.1093/nar/gkl968; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nakanishi M, 2005, PROTEINS, V60, P131, DOI 10.1002/prot.20474; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Silverman RH, 2000, METHOD ENZYMOL, V313, P522; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Sun L, 2003, J MED CHEM, V46, P1116, DOI 10.1021/jm0204183; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Thakur CS, 2007, P NATL ACAD SCI USA, V104, P9585, DOI 10.1073/pnas.0700590104; Thakur CS, 2005, METH MOLEC MED, V116, P103; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; WRESCHNER DH, 1982, EUR J BIOCHEM, V124, P261; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	40	61	63	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26319	26326		10.1074/jbc.M111.253443	http://dx.doi.org/10.1074/jbc.M111.253443			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636578	Green Published, hybrid			2022-12-25	WOS:000293078200008
J	Lee, J; Arvan, P				Lee, Jaemin; Arvan, Peter			Repeat Motif-containing Regions within Thyroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINESTERASE-LIKE DOMAIN; CONGENITAL GOITER; THYROID PEROXIDASE; HORMONE FORMATION; PROTEIN; GENE; ACETYLCHOLINESTERASE; HYPOTHYROIDISM; MUTATIONS; SECRETION	Thyroglobulin (precursor for thyroid hormone synthesis) is a large secreted glycoprotein comprising contiguous region I (multiple type-1 repeating units engaging the first similar to 1,191 residues, followed by a similar to 245-residue hinge region), regions II-III (multiple type-2 and 3 repeating units, comprising similar to 720 residues), and the C-terminal cholinesterase-like (ChEL) domain (similar to 570 residues). A signal peptide attached to ChEL makes an independent secretory protein that binds to I-II-III, stabilizing it and rescuing the secretion of I-II-III that would otherwise be trapped in the endoplasmic reticulum (ER). In this study, we found that a signal peptide attached to regions II-III also makes for an efficient secretory protein that neither demonstrably interacts nor has its secretion enhanced by the presence of secretory ChEL. By contrast, region I, either with or without the hinge region, cannot be secreted on its own and remains in the ER where it is bound to ER chaperones BiP and GRP94. Whereas ChEL can rescue secretion of I-II-III, it can rescue I-II only very weakly, and region I not at all. Yet, ChEL begins to rescue region I in cells that also co-express secretory II-III. The data suggest that conformational maturation of region I is a limiting step in the thyroglobulin maturation process, and this step is facilitated by the presence of both regions II-III and ChEL. Mutations causing hypothyroidism might induce solely local/regional misfolding or may interfere more globally by impeding interactions between regions that are required for thyroglobulin secretion.	[Lee, Jaemin; Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	National Institutes of Health [R01-DK40344]; University of Michigan Diabetes Research and Training Center [NIH5P60-DK20572, P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Diabetes Research and Training Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK40344 (to P. A.). This work was also supported by University of Michigan Diabetes Research and Training Center Grant NIH5P60-DK20572 for the Molecular Biology and Sequencing Cores and University of Michigan Cancer Center Core Laboratories Grant P30 CA46592.	Aryan P, 2004, THYROID, P77; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Gutnisky VJ, 2004, J CLIN ENDOCR METAB, V89, P646, DOI 10.1210/jc.2003-030587; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Hishinuma A, 1999, J CLIN ENDOCR METAB, V84, P1438, DOI 10.1210/jc.84.4.1438; Hishinuma A, 2006, J CLIN ENDOCR METAB, V91, P3100, DOI 10.1210/jc.2005-2702; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; Lee J, 2009, J BIOL CHEM, V284, P12752, DOI 10.1074/jbc.M806898200; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; MONACO F, 1981, COMP BIOCHEM PHYS B, V70, P341, DOI 10.1016/0305-0491(81)90054-7; MORI N, 1987, P NATL ACAD SCI USA, V84, P2813, DOI 10.1073/pnas.84.9.2813; Pardo V, 2009, J CLIN ENDOCR METAB, V94, P2938, DOI 10.1210/jc.2009-0150; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Peteiro-Gonzalez D, 2010, J CLIN ENDOCR METAB, V95, P3522, DOI 10.1210/jc.2009-2109; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SWILLENS S, 1986, BIOCHEM BIOPH RES CO, V137, P142, DOI 10.1016/0006-291X(86)91187-3; Targovnik HM, 2010, MOL CELL ENDOCRINOL, V322, P44, DOI 10.1016/j.mce.2010.01.009; TARGOVNIK HM, 1993, J CLIN ENDOCR METAB, V77, P210, DOI 10.1210/jc.77.1.210; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	28	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26327	26333		10.1074/jbc.M111.242099	http://dx.doi.org/10.1074/jbc.M111.242099			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636579	Green Published, hybrid			2022-12-25	WOS:000293078200009
J	Sadlova, J; Yeo, M; Seblova, V; Lewis, MD; Mauricio, I; Volf, P; Miles, MA				Sadlova, Jovana; Yeo, Matthew; Seblova, Veronika; Lewis, Michael D.; Mauricio, Isabel; Volf, Petr; Miles, Michael A.			Visualisation of Leishmania donovani Fluorescent Hybrids during Early Stage Development in the Sand Fly Vector	PLOS ONE			English	Article							PARASITIC PROTOZOA; GENETIC EXCHANGE; CLONAL THEORY; CUTANEOUS LEISHMANIASIS; PHLEBOTOMUS-PAPATASI; TRYPANOSOMA-BRUCEI; V. GUYANENSIS; TRANSMISSION; BRAZILIENSIS; VIANNIA	Background: The Leishmania protozoan parasites cause devastating human diseases. Leishmania have been considered to replicate clonally, without genetic exchange. However, an accumulation of evidence indicates that there are inter-specific and intra-specific hybrids among natural populations. The first and so far only experimental proof of genetic exchange was obtained in 2009 when double drug resistant Leishmania major hybrids were produced by co-infecting sand flies with two strains carrying different drug resistance markers. However, the location and timing of hybridisation events in sand flies has not been described. Methodology/Principal Findings: Here we have co-infected Phlebotomus perniciosus and Lutzomyia longipalpis with transgenic promastigotes of Leishmania donovani strains carrying hygromycin or neomycin resistance genes and red or green fluorescent markers. Fed females were dissected at different times post bloodmeal (PBM) and examined by fluorescent microscopy or fluorescent activated cell sorting (FACS) followed by confocal microscopy. In mixed infections strains LEM3804 and Gebre-1 reached the cardia and stomodeal valves more rapidly than strains LEM4265 and LV9. Hybrids unequivocally expressing both red and green fluorescence were seen in single flies of both vectors tested, co-infected with LEM4265 and Gebre-1. The hybrids were present as short (procyclic) promastigotes 2 days PBM in the semi-digested blood in the endoperitrophic space. Recovery of a clearly co-expressing hybrid was also achieved by FACS. However, hybrids could not sustain growth in vitro. Conclusions/Significance: For the first time, we observed L. donovani hybrids in the sand fly vector, 2 days PBM and described the morphological stages involved. Fluorescence microscopy in combination with FACS allows visualisation and recovery of the progeny of experimental crosses but on this occasion the hybrids were not viable in vitro. Nevertheless, genetic exchange in L. donovani has profound epidemiological significance, because it facilitates the emergence and spread of new phenotypic traits.	[Sadlova, Jovana; Seblova, Veronika; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic; [Yeo, Matthew; Lewis, Michael D.; Miles, Michael A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1, England; [Mauricio, Isabel] Inst Higiene & Med, Lisbon, Portugal	Charles University Prague; University of London; London School of Hygiene & Tropical Medicine	Sadlova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Parasitol, Prague, Czech Republic.	Matthew.yeo@lshtm.ac.uk	Sadlova, Jovana/C-1327-2012; Seblova, Veronika/C-5029-2014; Mauricio, Isabel/H-5272-2011; Volf, Petr/C-4300-2012	Sadlova, Jovana/0000-0002-0432-2707; Mauricio, Isabel/0000-0002-7748-4643; Volf, Petr/0000-0003-1790-1123; Lewis, Michael/0000-0001-9540-3280	Wellcome Trust; Ministry of Education [LC06009, MSM0021620828]	Wellcome Trust(Wellcome TrustEuropean Commission); Ministry of Education	The work was financed by Wellcome Trust and JS, VS and PV were also funded by Ministry of Education (projects LC06009, MSM0021620828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Banuls AL, 1999, AM J TROP MED HYG, V61, P838, DOI 10.4269/ajtmh.1999.61.838; Bates PA, 2004, CURR MOL MED, V4, P601, DOI 10.2174/1566524043360285; BELLI AA, 1994, PARASITOLOGY, V109, P435, DOI 10.1017/S0031182000080689; Benkova I, 2007, J MED ENTOMOL, V44, P150, DOI 10.1603/0022-2585(2007)44[150:EOTOMO]2.0.CO;2; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Cihakova J, 1997, ANN TROP MED PARASIT, V91, P267, DOI 10.1080/00034989761120; Delgado O, 1997, MEM I OSWALDO CRUZ, V92, P581, DOI 10.1590/S0074-02761997000500002; DUJARDIN JC, 1995, ACTA TROP, V59, P293, DOI 10.1016/0001-706X(95)00094-U; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; GIBSON W, 1994, MOL BIOCHEM PARASIT, V64, P241, DOI 10.1016/0166-6851(94)00017-4; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; Miles MA, 2009, SCIENCE, V324, P187, DOI 10.1126/science.1172789; Myskova J, 2008, J MED ENTOMOL, V45, P133, DOI 10.1603/0022-2585(2008)45[133:LISFCO]2.0.CO;2; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439; Rougeron V, 2009, P NATL ACAD SCI USA, V106, P10224, DOI 10.1073/pnas.0904420106; Sadlova J, 2009, CELL TISSUE RES, V337, P313, DOI 10.1007/s00441-009-0802-1; Schwenkenbecher JM, 2006, INT J PARASITOL, V36, P237, DOI 10.1016/j.ijpara.2005.09.010; Tibayrenc M, 2002, TRENDS PARASITOL, V18, P405, DOI 10.1016/S1471-4922(02)02357-7; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1991, BIOSCIENCE, V41, P767, DOI 10.2307/1311726; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Volf P, 2007, TRENDS PARASITOL, V23, P91, DOI 10.1016/j.pt.2006.12.010; Volf P, 2009, SCIENCE, V324, P1644, DOI 10.1126/science.324_1644b; WALTERS LL, 1993, J EUKARYOT MICROBIOL, V40, P196, DOI 10.1111/j.1550-7408.1993.tb04904.x; Yeo M, 2007, INT J PARASITOL, V37, P111, DOI 10.1016/j.ijpara.2006.08.002	32	55	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19851	10.1371/journal.pone.0019851	http://dx.doi.org/10.1371/journal.pone.0019851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637755	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500014
J	Tellier, A; Pfaffelhuber, P; Haubold, B; Naduvilezhath, L; Rose, LE; Stadler, T; Stephan, W; Metzler, D				Tellier, Aurelien; Pfaffelhuber, Peter; Haubold, Bernhard; Naduvilezhath, Lisha; Rose, Laura E.; Staedler, Thomas; Stephan, Wolfgang; Metzler, Dirk			Estimating Parameters of Speciation Models Based on Refined Summaries of the Joint Site-Frequency Spectrum	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-GENETICS; WILD TOMATOES; DIVERGENCE; MIGRATION; SELECTION; POLYMORPHISM; HISTORY; SAMPLES; NUMBER	Understanding the processes and conditions under which populations diverge to give rise to distinct species is a central question in evolutionary biology. Since recently diverged populations have high levels of shared polymorphisms, it is challenging to distinguish between recent divergence with no (or very low) inter-population gene flow and older splitting events with subsequent gene flow. Recently published methods to infer speciation parameters under the isolation-migration framework are based on summarizing polymorphism data at multiple loci in two species using the joint site-frequency spectrum (JSFS). We have developed two improvements of these methods based on a more extensive use of the JSFS classes of polymorphisms for species with high intra-locus recombination rates. First, using a likelihood based method, we demonstrate that taking into account low-frequency polymorphisms shared between species significantly improves the joint estimation of the divergence time and gene flow between species. Second, we introduce a local linear regression algorithm that considerably reduces the computational time and allows for the estimation of unequal rates of gene flow between species. We also investigate which summary statistics from the JSFS allow the greatest estimation accuracy for divergence time and migration rates for low (around 10) and high (around 100) numbers of loci. Focusing on cases with low numbers of loci and high intra-locus recombination rates we show that our methods for the estimation of divergence time and migration rates are more precise than existing approaches.	[Tellier, Aurelien; Naduvilezhath, Lisha; Rose, Laura E.; Stephan, Wolfgang; Metzler, Dirk] LMU Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany; [Pfaffelhuber, Peter] Univ Freiburg, Fac Math & Phys, Freiburg, Germany; [Haubold, Bernhard] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Poln, Germany; [Staedler, Thomas] ETH, Inst Integrat Biol, Zurich, Switzerland	University of Munich; University of Freiburg; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tellier, A (corresponding author), LMU Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany.	tellier@biologie.uni-muenchen.de	Stephan, Wolfgang/GOV-6503-2022; Städler, Thomas/B-7286-2009; Metzler, Dirk/K-2797-2014; Tellier, Aurelien/C-3852-2017	Städler, Thomas/0000-0003-4513-8583; Metzler, Dirk/0000-0003-1027-135X; Tellier, Aurelien/0000-0002-8895-0785	DFG Forschergruppe [1078]; DFG [STE 325/9, STE 325/13]; Swiss National Science Foundation [31003A_130702]; Volkswagen Foundation [I/82752]	DFG Forschergruppe(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Volkswagen Foundation(Volkswagen)	This work was supported by grants of the DFG Forschergruppe 1078, "Natural selection in structured populations", to D. M., P. P., and L. E. R.; DFG grants STE 325/9 and STE 325/13 to W. S.; Swiss National Science Foundation grant 31003A_130702 to T. S.; and Volkswagen Foundation grant I/82752 to A.T.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2003, GENETICS, V165, P1289; Arunyawat U, 2007, MOL BIOL EVOL, V24, P2310, DOI 10.1093/molbev/msm162; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Coyne JA, 2004, SPECIATION, V37; EFRON B, 1985, BIOMETRIKA, V72, P45, DOI 10.1093/biomet/72.1.45; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Garrigan D, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-72; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen JD, 2008, MOL BIOL EVOL, V25, P438, DOI 10.1093/molbev/msm273; Joyce P, 2008, STAT APPL GENET MOL, V7; Karlis D, 2005, STAT COMPUT, V15, P255, DOI 10.1007/s11222-005-4069-4; KIMURA M, 1969, GENETICS, V61, P893; Lopes JS, 2009, BIOINFORMATICS, V25, P2747, DOI 10.1093/bioinformatics/btp487; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McCullagh P, 1989, GEN LINEAR MODELS; Nielsen R, 2001, GENETICS, V158, P885; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nunes MA, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1576; Pawitan Y, 2001, ALL LIKELIHOOD STAT; R Development Core Team, 2005, R LANG ENV STAT COMP; Roselius K, 2005, GENETICS, V171, P753, DOI 10.1534/genetics.105.043877; Stadler T, 2005, EVOLUTION, V59, P1268, DOI 10.1111/j.0014-3820.2005.tb01777.x; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephan W, 1998, GENETICS, V150, P1585; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TELLIER A, 2011, HEREDITY IN PRESS, DOI DOI 10.1038/HDY.2010.2175; Thornton KR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-35; Wakeley J, 1997, GENETICS, V145, P847; Wang Y, 2010, GENETICS, V184, P363, DOI 10.1534/genetics.109.110528; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017	38	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e18155	10.1371/journal.pone.0018155	http://dx.doi.org/10.1371/journal.pone.0018155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637331	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200006
J	Viana-Pereira, M; Lee, A; Popov, S; Bax, DA; Al-Sarraj, S; Bridges, LR; Stavale, JN; Hargrave, D; Jones, C; Reis, RM				Viana-Pereira, Marta; Lee, Alicia; Popov, Sergey; Bax, Dorine A.; Al-Sarraj, Safa; Bridges, Leslie R.; Stavale, Joao N.; Hargrave, Darren; Jones, Chris; Reis, Rui M.			Microsatellite Instability in Pediatric High Grade Glioma Is Associated with Genomic Profile and Differential Target Gene Inactivation	PLOS ONE			English	Article							DNA MISMATCH REPAIR; 5 MONONUCLEOTIDE REPEATS; ENDOMETRIAL TUMORS; COLORECTAL CANCERS; LYNCH-SYNDROME; CELL-LINES; MUTATION; DAMAGE; TEMOZOLOMIDE; METHYLATION	High grade gliomas (HGG) are one of the leading causes of cancer-related deaths in children, and there is increasing evidence that pediatric HGG may harbor distinct molecular characteristics compared to adult tumors. We have sought to clarify the role of microsatellite instability (MSI) in pediatric versus adult HGG. MSI status was determined in 144 patients (71 pediatric and 73 adults) using a well established panel of five quasimonomorphic mononucleotide repeat markers. Expression of MLH1, MSH2, MSH6 and PMS2 was determined by immunohistochemistry, MLH1 was assessed for mutations by direct sequencing and promoter methylation using MS-PCR. DNA copy number profiles were derived using array CGH, and mutations in eighteen MSI target genes studied by multiplex PCR and genotyping. MSI was found in 14/71 (19.7%) pediatric cases, significantly more than observed in adults (5/73, 6.8%; p = 0.02, Chi-square test). MLH1 expression was downregulated in 10/13 cases, however no mutations or promoter methylation were found. MSH6 was absent in one pediatric MSI-High tumor, consistent with an inherited mismatch repair deficiency associated with germline MSH6 mutation. MSI was classed as Type A, and associated with a remarkably stable genomic profile. Of the eighteen classic MSI target genes, we identified mutations only in MSH6 and DNAPKcs and described a polymorphism in MRE11 without apparent functional consequences in DNA double strand break detection and repair. This study thus provides evidence for a potential novel molecular pathway in a proportion of gliomas associated with the presence of MSI.	[Viana-Pereira, Marta; Reis, Rui M.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Viana-Pereira, Marta; Lee, Alicia; Popov, Sergey; Bax, Dorine A.; Jones, Chris] Inst Canc Res, Sect Paediat Oncol, Surrey, England; [Popov, Sergey; Hargrave, Darren; Jones, Chris] Royal Marsden Hosp, Surrey, England; [Al-Sarraj, Safa] Kings Coll Hosp London, Dept Clin Neuropathol, London, England; [Bridges, Leslie R.] St George Hosp, London, England; [Stavale, Joao N.] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Reis, Rui M.] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil	Universidade do Minho; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; St Georges University London; Universidade Federal de Sao Paulo (UNIFESP); Hospital de Cancer de Barretos	Viana-Pereira, M (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	chris.jones@icr.ac.uk; rreis@ecsaude.uminho.pt	Hargrave, Darren R/H-1066-2014; Viana-Pereira, Marta/E-1317-2014; Reis, Rui M/C-2859-2009; Jones, Chris/ABE-6059-2021; Reis, Rui Manuel/B-1744-2018; Reis, Rui Manuel/AAD-6470-2020	Hargrave, Darren R/0000-0001-8219-9807; Viana-Pereira, Marta/0000-0003-3087-0624; Reis, Rui M/0000-0002-9639-7940; Jones, Chris/0000-0001-8118-2296; Reis, Rui Manuel/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940	British Council; Portuguese Council of Rectors; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/29145/2006]	British Council(The British Council in India); Portuguese Council of Rectors; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The authors acknowledge the British Council and the Portuguese Council of Rectors, Treaty of Windsor Anglo-Portuguese Joint Research Programme (R.M. Reis, C. Jones). M. Viana-Pereira is funded by a PhD fellowship '[SFRH/BD/29145/2006]' of Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu A, 2007, EUR J HUM GENET, V15, P922, DOI 10.1038/sj.ejhg.5201858; Alonso M, 2001, CANCER RES, V61, P2124; Amariglio N, 1995, CANCER GENET CYTOGEN, V84, P56, DOI 10.1016/0165-4608(95)00085-2; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Cheng Y, 1999, HUM PATHOL, V30, P1284, DOI 10.1016/S0046-8177(99)90057-6; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DAMS E, 1995, CANCER RES, V55, P1547; de Leeuw WJF, 2000, J PATHOL, V192, P328, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH701>3.0.CO;2-2; Duval A, 2002, CANCER RES, V62, P1609; Duval A, 2002, CANCER RES, V62, P2447; Eckert A, 2007, BRAIN PATHOL, V17, P146, DOI 10.1111/j.1750-3639.2007.00049.x; Fallik D, 2003, CANCER RES, V63, P5738; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Giunti L, 2009, EUR J HUM GENET, V17, P919, DOI 10.1038/ejhg.2008.271; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Ham MF, 2006, CANCER SCI, V97, P226, DOI 10.1111/j.1349-7006.2006.00165.x; Hegde M, 2005, J MOL DIAGN, V7, P525, DOI 10.1016/S1525-1578(10)60584-3; Hegde MR, 2005, CLIN CANCER RES, V11, P4689, DOI 10.1158/1078-0432.CCR-04-2025; Izumoto S, 1997, CANCER LETT, V112, P251, DOI 10.1016/S0304-3835(96)04583-1; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Kanamori M, 2000, ONCOGENE, V19, P1564, DOI 10.1038/sj.onc.1203454; Karran P, 1996, SEMIN CANCER BIOL, V7, P15, DOI 10.1006/scbi.1996.0003; Lee HS, 2007, INT J ONCOL, V31, P859; Leung SY, 1998, AM J PATHOL, V153, P1181, DOI 10.1016/S0002-9440(10)65662-3; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li HR, 2004, CANCER RES, V64, P4760, DOI 10.1158/0008-5472.CAN-04-0975; Martinez R, 2005, J CANCER RES CLIN, V131, P87, DOI 10.1007/s00432-004-0592-5; Maxwell JA, 2008, CLIN CANCER RES, V14, P4859, DOI 10.1158/1078-0432.CCR-07-4807; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mori Y, 2002, CANCER RES, V62, P3641; Oda S, 2005, NUCLEIC ACIDS RES, V33, P1628, DOI 10.1093/nar/gki303; Park SJ, 2003, AM J PATHOL, V162, P815, DOI 10.1016/S0002-9440(10)63878-3; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Pollack IF, 2010, PEDIATR BLOOD CANCER, V55, P1066, DOI 10.1002/pbc.22634; REMVIKOS Y, 1995, GENE CHROMOSOME CANC, V12, P272, DOI 10.1002/gcc.2870120406; Sobrido MJ, 2000, J NEUROL NEUROSUR PS, V69, P369, DOI 10.1136/jnnp.69.3.369; The WHO, 2020, CLASSIFICATION TUMOU; Thorstensen L, 2005, NEOPLASIA, V7, P99, DOI 10.1593/neo.04448; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Viana-Pereira M, 2009, NEURO-ONCOLOGY, V11, P458, DOI 10.1215/15228517-2008-115; Vladimirova V, 2008, NEUROPATH APPL NEURO, V34, P547, DOI 10.1111/j.1365-2990.2007.00919.x; Wong YF, 2006, CARCINOGENESIS, V27, P951, DOI 10.1093/carcin/bgi333; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20588	10.1371/journal.pone.0020588	http://dx.doi.org/10.1371/journal.pone.0020588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637783	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200081
J	Yu, W; Hegarty, JP; Berg, A; Chen, X; West, G; Kelly, AA; Wang, YH; Poritz, LS; Koltun, WA; Lin, ZW				Yu, Wei; Hegarty, John P.; Berg, Arthur; Chen, Xi; West, Gail; Kelly, Ashley A.; Wang, Yunhua; Poritz, Lisa S.; Koltun, Walter A.; Lin, Zhenwu			NKX2-3 Transcriptional Regulation of Endothelin-1 and VEGF Signaling in Human Intestinal Microvascular Endothelial Cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; GROWTH-FACTOR; DIFFERENTIAL EXPRESSION; LEUKOCYTE ADHESION; IMMUNE; GENES; IMMUNOREACTIVITY; ANGIOGENESIS; HEART	Background: NKX2-3 is associated with inflammatory bowel disease (IBD). NKX2-3 is expressed in microvascular endothelial cells and the muscularis mucosa of the gastrointestinal tract. Human intestinal microvascular endothelial cells (HIMECs) are actively involved in the pathogenesis of IBD and IBD-associated microvascular dysfunction. To understand the cellular function of NKX2-3 and its potential role underlying IBD pathogenesis, we investigated the genes regulated by NKX2-3 in HIMEC using cDNA microarray. Methodology/Principal Findings: NKX2-3 expression was suppressed by shRNA in two HIMEC lines and gene expression was profiled by cDNA microarray. Pathway Analysis was used to identify gene networks according to biological functions and associated pathways. Validation of microarray and genes expression in intestinal tissues was assessed by RT-PCR. NKX2-3 regulated genes are involved in immune and inflammatory response, cell proliferation and growth, metabolic process, and angiogenesis. Several inflammation and angiogenesis related signaling pathways that play important roles in IBD were regulated by NKX2-3, including endothelin-1 and VEGF-PI3K/AKT-eNOS. Expression levels of NKX2-3, VEGFA, PI3K, AKT, and eNOS are increased in intestinal tissues from IBD patients and expression levels of EDN1 are decreased in intestinal tissues from IBD patients. These results demonstrated the important roles of NKX2-3, VEGF, PI3K, AKT, eNOS, and EDN1 in IBD pathogenesis. Correlation analysis showed a positive correlation between mRNA expression of NKX2-3 and VEGFA and a negative correlation between mRNA expression of NKX2-3 and EDN1 in intestinal tissues from IBD patients. Conclusion/Relevance: NKX2-3 may play an important role in IBD pathogenesis by regulating endothelin-1 and VEGF signaling in HIMECs.	[Yu, Wei; Hegarty, John P.; Kelly, Ashley A.; Wang, Yunhua; Poritz, Lisa S.; Koltun, Walter A.; Lin, Zhenwu] Penn State Univ, Dept Surg, Hershey, PA 17033 USA; [Berg, Arthur] Penn State Univ, Ctr Stat Genet, Dept Publ Hlth Sci, Hershey, PA USA; [Poritz, Lisa S.] Penn State Univ, Dept Cellular & Mol Physiol, Hershey, PA USA; [Chen, Xi] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [West, Gail] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Vanderbilt University; Cleveland Clinic Foundation	Yu, W (corresponding author), Penn State Univ, Dept Surg, Hershey, PA 17033 USA.	wkoltun@hmc.psu.edu; zlin@hmc.psu.edu	yu, wei/B-5859-2011	Hegarty, John/0000-0003-3401-848X; Berg, Arthur/0000-0002-4097-7348	Philadelphia Health Care Trust; Milton S. Hershey Medical Center; Penn State College of Medicine; Milton S. Hershey Penn State College of Medicine Surgery Research Feasibility [942-82HY, 1940]	Philadelphia Health Care Trust; Milton S. Hershey Medical Center; Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Milton S. Hershey Penn State College of Medicine Surgery Research Feasibility	This work was supported by a grant from the Philadelphia Health Care Trust (WAK), the Carlino fund for IBD research at the Milton S. Hershey Medical Center (WAK), Penn State College of Medicine, and the Milton S. Hershey Penn State College of Medicine Surgery Research Feasibility Grant (WY). Budget: 942-82HY, Fund: 1940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2006, MOL PHARMACOL, V69, P975, DOI 10.1124/mol.105.018846; Binion DG, 1997, GASTROENTEROLOGY, V112, P1895, DOI 10.1053/gast.1997.v112.pm9178682; Boros M, 1998, GASTROENTEROLOGY, V114, P103, DOI 10.1016/S0016-5085(98)70638-9; Buchberger A, 1996, MECH DEVELOP, V56, P151, DOI 10.1016/0925-4773(96)00521-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Danese S, 2007, CURR OPIN GASTROEN, V23, P384, DOI 10.1097/MOG.0b013e32810c8de3; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Deban L, 2008, AM J PATHOL, V172, P1457, DOI 10.2353/ajpath.2008.070593; Fiocchi C, 1997, AM J PHYSIOL-GASTR L, V273, pG769, DOI 10.1152/ajpgi.1997.273.4.G769; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Fu YC, 1998, DEVELOPMENT, V125, P4439; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Hatoum OA, 2005, INFLAMM BOWEL DIS, V11, P304, DOI 10.1097/01.MIB.0000160772.78951.61; Kang YS, 2006, J MOL ENDOCRINOL, V36, P377, DOI 10.1677/jme.1.02033; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kocher AA, 2006, J MOL CELL CARDIOL, V40, P455, DOI 10.1016/j.yjmcc.2005.11.013; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; Lee Yong C, 2005, Curr Opin Investig Drugs, V6, P1124; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; McCartney SA, 2002, LIFE SCI, V71, P1893, DOI 10.1016/S0024-3205(02)01923-9; MURCH SH, 1992, LANCET, V339, P381, DOI 10.1016/0140-6736(92)90077-G; OIKONOMOU KA, INFLAMM BOWEL DIS; Oktar BK, 2000, AM J PHYSIOL-GASTR L, V279, pG483, DOI 10.1152/ajpgi.2000.279.3.G483; Pabst O, 1997, DEV DYNAM, V209, P29; Pabst O, 1999, DEVELOPMENT, V126, P2215; RACHMILEWITZ D, 1992, LANCET, V339, P1062, DOI 10.1016/0140-6736(92)90589-U; Ramsauer M, 2002, J CLIN INVEST, V110, P1615, DOI 10.1172/JCI200217326; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tarlinton D, 2003, J IMMUNOL, V170, P4002, DOI 10.4049/jimmunol.170.8.4002; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; VILLARREAL G, BIOCH BIOPHYS RES CO, V391, P984; Wang CC, 2000, DEV BIOL, V224, P152, DOI 10.1006/dbio.2000.9749; Yu W, 2010, DIGEST DIS SCI, V55, P3171, DOI 10.1007/s10620-010-1138-0; Yu W, 2010, MOL GENET METAB, V100, P88, DOI 10.1016/j.ymgme.2010.02.001; Yu W, 2009, J CROHNS COLITIS, V3, P189, DOI 10.1016/j.crohns.2009.04.003	40	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20454	10.1371/journal.pone.0020454	http://dx.doi.org/10.1371/journal.pone.0020454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637825	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200066
J	Salloum, M; van der Mee-Marquet, N; Valentin-Domelier, AS; Quentin, R				Salloum, Mazen; van der Mee-Marquet, Nathalie; Valentin-Domelier, Anne-Sophie; Quentin, Roland			Diversity of Prophage DNA Regions of Streptococcus agalactiae Clonal Lineages from Adults and Neonates with Invasive Infectious Disease	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; NONPREGNANT ADULTS; MOLECULAR CHARACTERIZATION; SEROTYPE-V; TYPING SYSTEM; STRAINS; SEQUENCE; BACTERIOPHAGE; EMERGENCE; GENOME	The phylogenetic position and prophage DNA content of the genomes of 142 S. agalactiae (group-B streptococcus, GBS) isolates responsible for bacteremia and meningitis in adults and neonates were studied and compared. The distribution of the invasive isolates between the various serotypes, sequence types (STs) and clonal complexes (CCs) differed significantly between adult and neonatal isolates. Use of the neighbor-net algorithm with the PHI test revealed evidence for recombination in the population studied (PHI, P = 2.01 x 10(-6)), and the recombination-mutation ratio (R/M) was 6:7. Nevertheless, the estimated R/M ratio differed between CCs. Analysis of the prophage DNA regions of the genomes of the isolates assigned 90% of the isolates to five major prophage DNA groups: A to E. The mean number of prophage DNA fragments amplified per isolate varied from 2.6 for the isolates of prophage DNA group E to 4.0 for the isolates of prophage DNA group C. The isolates from adults and neonates with invasive diseases were distributed differently between the various prophage DNA groups (P<0.00001). Group C prophage DNA fragments were found in 52% of adult invasive isolates, whereas 74% of neonatal invasive isolates had prophage DNA fragments of groups A and B. Differences in prophage DNA content were also found between serotypes, STs and CCs (P<0.00001). All the ST-1 and CC1 isolates, mostly of serotype V, belonged to the prophage DNA group C, whereas 84% of the ST-17 and CC17 isolates, all of serotype III, belonged to prophage DNA groups A and B. These data indicate that the transduction mechanisms, i.e., gene transfer from one bacterium to another by a bacteriophage, underlying genetic recombination in S. agalactiae species, are specific to each intraspecies lineage and population of strains responsible for invasive diseases in adults and neonates.	[Salloum, Mazen; van der Mee-Marquet, Nathalie; Valentin-Domelier, Anne-Sophie; Quentin, Roland] Univ Tours, EA Bacteries & Risque Maternofoetal 3854, Inst Federat Rech Agents Transmissibles & Infecti, UFR Med, Tours, France; [van der Mee-Marquet, Nathalie; Valentin-Domelier, Anne-Sophie] CHRU, Hop Trousseau, Serv Bacteriol & Hyg Hosp, Tours, France	Universite de Tours; CHU Tours	Salloum, M (corresponding author), Univ Tours, EA Bacteries & Risque Maternofoetal 3854, Inst Federat Rech Agents Transmissibles & Infecti, UFR Med, Tours, France.	n.vandermee@chu-tours.fr		Valentin, Anne-Sophie/0000-0001-8662-097X	University National research source for EA 3854 (University of Tours, France) [IFR136]	University National research source for EA 3854 (University of Tours, France)	Funding was received from University National research source for EA 3854 of IFR136 (University of Tours, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Safadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010794; ANTHONY BF, 1979, J PEDIATR-US, V95, P431, DOI 10.1016/S0022-3476(79)80530-2; ANTHONY BF, 1977, ANNU REV MED, V28, P355, DOI 10.1146/annurev.me.28.020177.002035; BAND JD, 1981, AM J DIS CHILD, V135, P355, DOI 10.1001/archpedi.1981.02130280045015; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Blancas D, 2004, EUR J CLIN MICROBIOL, V23, P168, DOI 10.1007/s10096-003-1098-9; Blumberg HM, 1996, J INFECT DIS, V173, P365, DOI 10.1093/infdis/173.2.365; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; BOYER KM, 1980, AM J DIS CHILD, V134, P964, DOI 10.1001/archpedi.1980.02130220042013; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chen Y, 2005, PLOS BIOL, V3, P1276, DOI 10.1371/journal.pbio.0030229; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; COLEMAN D, 1991, MOL MICROBIOL, V5, P933, DOI 10.1111/j.1365-2958.1991.tb00768.x; Domelier AS, 2008, J ANTIMICROB CHEMOTH, V62, P1227, DOI 10.1093/jac/dkn388; Domelier AS, 2009, J BACTERIOL, V191, P4776, DOI 10.1128/JB.00426-09; EICKHOFF TC, 1964, NEW ENGL J MED, V271, P1221, DOI 10.1056/NEJM196412102712401; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Feil EJ, 2000, GENETICS, V154, P1439; HARRISON LH, 1995, J INFECT DIS, V171, P513, DOI 10.1093/infdis/171.2.513; Hery-Arnaud G, 2007, APPL ENVIRON MICROB, V73, P4668, DOI 10.1128/AEM.02604-06; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Kong FR, 2002, J CLIN MICROBIOL, V40, P216, DOI 10.1128/JCM.40.1.216-226.2002; LEE CY, 1986, P NATL ACAD SCI USA, V83, P5474, DOI 10.1073/pnas.83.15.5474; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; NOYA FJD, 1987, J INFECT DIS, V155, P1135, DOI 10.1093/infdis/155.6.1135; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; QUENTIN R, 2006, B EPIDEMIOL HEBDO, V45, P352; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; RUSSELL H, 1969, J GEN VIROL, V5, P315, DOI 10.1099/0022-1317-5-2-315; Salloum M, 2010, J CLIN MICROBIOL, V48, P1261, DOI 10.1128/JCM.01820-09; SCHWARTZ B, 1991, JAMA-J AM MED ASSOC, V266, P1112, DOI 10.1001/jama.266.8.1112; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; STRINGER J, 1980, J MED MICROBIOL, V13, P133, DOI 10.1099/00222615-13-1-133; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Takahashi S, 1998, J INFECT DIS, V177, P1116, DOI 10.1086/517408; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; van der Mee-Marquet N, 2006, J CLIN MICROBIOL, V44, P1049, DOI 10.1128/JCM.44.3.1049-1058.2006; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08	50	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20256	10.1371/journal.pone.0020256	http://dx.doi.org/10.1371/journal.pone.0020256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633509	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500049
J	Dimayuga, PC; Chyu, KY; Kirzner, J; Yano, J; Zhao, XN; Zhou, JC; Shah, PK; Cercek, B				Dimayuga, Paul C.; Chyu, Kuang-Yuh; Kirzner, Jonathan; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Shah, Prediman K.; Cercek, Bojan			Enhanced Neointima Formation Following Arterial Injury in Immune Deficient Rag-1-/- Mice Is Attenuated by Adoptive Transfer of CD8(+) T cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMOOTH-MUSCLE-CELLS; DRUG-ELUTING STENTS; VASCULAR INJURY; APOLIPOPROTEIN-E; KNOCKOUT MICE; FACTOR 1-ALPHA; LYMPHOCYTES; CD4(+); INFLAMMATION	T cells modulate neointima formation after arterial injury but the specific T cell population that is activated in response to arterial injury remains unknown. The objective of the study was to identify the T cell populations that are activated and modulate neointimal thickening after arterial injury in mice. Arterial injury in wild type C57Bl6 mice resulted in T cell activation characterized by increased CD4(+) CD44(hi) and CD8(+) CD44(hi) T cells in the lymph nodes and spleens. Splenic CD8(+) CD25(+) T cells and CD8(+) CD28(+) T cells, but not CD4(+) CD25(+) and CD4(+) CD28(+) T cells, were also significantly increased. Adoptive cell transfer of CD4(+) or CD8(+) T cells from donor CD8-/- or CD4-/- mice, respectively, to immune-deficient Rag-1-/- mice was performed to determine the T cell subtype that inhibits neointima formation after arterial injury. Rag-1-/- mice that received CD8(+) T cells had significantly reduced neointima formation compared with Rag-1-/- mice without cell transfer. CD4(+) T cell transfer did not reduce neointima formation. CD8(+) T cells from CD4-/- mice had cytotoxic activity against syngeneic smooth muscle cells in vitro. The study shows that although both CD8(+) T cells and CD4(+) T cells are activated in response to arterial injury, adoptive cell transfer identifies CD8(+) T cells as the specific and selective cell type involved in inhibiting neointima formation.	[Dimayuga, Paul C.; Chyu, Kuang-Yuh; Kirzner, Jonathan; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Shah, Prediman K.; Cercek, Bojan] Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Dimayuga, PC (corresponding author), Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA.	DimayugaP@cshs.org			Spielberg Family Cardiovascular Research Fund; Heart Foundation, Cedars-Sinai Medical Center	Spielberg Family Cardiovascular Research Fund; Heart Foundation, Cedars-Sinai Medical Center	This work was supported by the Spielberg Family Cardiovascular Research Fund and the Heart Foundation, Cedars-Sinai Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunetti ND, 2008, CORONARY ARTERY DIS, V19, P133, DOI 10.1097/MCA.0b013e3282f3fbcb; Chyu KY, 1999, CIRC RES, V85, P1192; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2010, CURR OPIN LIPIDOL, V21, P416, DOI 10.1097/MOL.0b013e32833cacbe; Dimayuga PC, 2009, AM J PHYSIOL-REG I, V297, pR1593, DOI 10.1152/ajpregu.00114.2009; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; HART MN, 1985, AM J PATHOL, V119, P448; Karshovska E, 2007, ARTERIOSCL THROM VAS, V27, P2540, DOI 10.1161/ATVBAHA.107.151050; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kurobe H, 2010, ARTERIOSCL THROM VAS, V30, P210, DOI 10.1161/ATVBAHA.109.192666; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Lukashev D, 2001, J BIOL CHEM, V276, P48754, DOI 10.1074/jbc.M104782200; Lukashev D, 2006, J IMMUNOL, V177, P4962, DOI 10.4049/jimmunol.177.8.4962; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nakazawa G, 2007, HERZ, V32, P274, DOI 10.1007/s00059-007-2997-9; Navarro-Lopez F, 2003, REV ESP CARDIOL, V56, P465, DOI 10.1157/13047011; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Remskar M, 2001, CIRC RES, V88, P390; Richard DE, 2000, J BIOL CHEM, V275, P26765; Sardella G, 2005, IMMUNOL LETT, V96, P85, DOI 10.1016/j.imlet.2004.08.001; Schoneveld AH, 2005, CARDIOVASC RES, V66, P162, DOI 10.1016/j.cardiores.2004.12.016; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Shishido T, 2006, BIOCHEM BIOPH RES CO, V345, P1446, DOI 10.1016/j.bbrc.2006.05.056; Steffel J, 2007, HERZ, V32, P268, DOI 10.1007/s00059-007-3000-5; Stroem A, 2007, CIRC RES, V101, pE83, DOI 10.1161/CIRCRESAHA.107.160705; Tanaka T, 2004, AM J CARDIOL, V93, P1547, DOI 10.1016/j.amjcard.2004.02.070; TURKA LA, 1990, J IMMUNOL, V144, P1646; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhu BH, 2002, ARTERIOSCL THROM VAS, V22, P450, DOI 10.1161/hq0302.105377	41	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20214	10.1371/journal.pone.0020214	http://dx.doi.org/10.1371/journal.pone.0020214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629656	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005800034
J	Donati, C; Marseglia, G; Magi, A; Serrati, S; Cencetti, F; Bernacchioni, C; Nannetti, G; Benelli, M; Brunelli, S; Torricelli, F; Cossu, G; Bruni, P				Donati, Chiara; Marseglia, Giuseppina; Magi, Alberto; Serrati, Simona; Cencetti, Francesca; Bernacchioni, Caterina; Nannetti, Genni; Benelli, Matteo; Brunelli, Silvia; Torricelli, Francesca; Cossu, Giulio; Bruni, Paola			Sphingosine 1-Phosphate Induces Differentiation of Mesoangioblasts towards Smooth Muscle. A Role for GATA6	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TGF-BETA; SPHINGOSINE-1-PHOSPHATE; RECEPTOR; PROLIFERATION; MULTIPOTENT; APOPTOSIS	Different cells can contribute to repair following vascular injury by differentiating into smooth muscle (SM) cells; however the extracellular signals involved are presently poorly characterized. Mesoangioblasts are progenitor cells capable of differentiating into various mesoderm cell types including SM cells. In this study the biological action exerted by the pleiotropic sphingolipid sphingosine 1-phosphate (S1P) in human mesoangioblasts has been initially investigated by cDNA microarray analysis. Obtained data confirmed the anti-apoptotic action of this sphingolipid and identified for the first time a strong differentiating action toward SM cells. Quantitative mRNA and protein analysis corroborated the microarray results demonstrating enhanced expression of myogenic marker proteins and regulation of the expression of transcription factor GATA6 and its co-regulator, LMCD1. Importantly, GATA6 up-regulation induced by S1P was responsible for the enhanced expression of SM-specific contractile proteins. Moreover, by specific gene silencing experiments GATA6 was critical in the pro-differentiating activity of the cytokine TGF beta. Finally, the pharmacological inhibition of endogenous S1P formation in response to TGFb abrogated GATA6 up-regulation, supporting the view that the S1P pathway plays a physiological role in mediating the pro-myogenic effect of TGFb. This study individuates GATA6 as novel player in the complex transcriptional regulation of mesoangioblast differentiation into SM cells and highlights a role for S1P to favour vascular regeneration.	[Donati, Chiara; Cencetti, Francesca; Bernacchioni, Caterina; Bruni, Paola] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Donati, Chiara; Cencetti, Francesca; Bernacchioni, Caterina; Bruni, Paola] IIM, Rome, Italy; [Marseglia, Giuseppina; Magi, Alberto; Nannetti, Genni; Benelli, Matteo; Torricelli, Francesca] Azienda Osped Univ, SOD Diagnost Genet, Florence, Italy; [Serrati, Simona] Univ Florence, Dipartimento Oncol & Patol Sperimentali, Florence, Italy; [Brunelli, Silvia; Cossu, Giulio] Ist Sci H San Raffaele, Div Med Rigenerat, Milan, Italy; [Brunelli, Silvia] Univ Milano Bicocca, Dipartimento Med Sperimentale, Monza, Italy; [Cossu, Giulio] Univ Milan, Dipartimento Biol, Milan, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; University of Milan	Donati, C (corresponding author), Univ Florence, Dipartimento Sci Biochim, Florence, Italy.		Brunelli, Silvia/P-3853-2019; Bruni, Paola/A-1151-2008; Serrati, Simona/B-2520-2013; Magi, Alberto/M-6773-2015; cencetti, francesca/J-8372-2018; Benelli, Matteo/I-2497-2018; Brunelli, Silvia/J-3248-2014; donati, chiara/AAN-2682-2021	Brunelli, Silvia/0000-0003-1753-5346; Serrati, Simona/0000-0002-4015-5205; Magi, Alberto/0000-0001-7393-4283; Benelli, Matteo/0000-0003-1227-356X; Brunelli, Silvia/0000-0003-1753-5346; donati, chiara/0000-0003-2224-4199; Cencetti, Francesca/0000-0003-4351-2965; Bruni, Paola/0000-0002-1151-3413; Bernacchioni, Caterina/0000-0002-1023-0067; Cossu, Giulio/0000-0001-5863-9593	University of Florence; Ente Cassa di Risparmio di Firenze; Fondazione Cassa di Risparmio di Lucca	University of Florence; Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Fondazione Cassa di Risparmio di Lucca	This work was supported by funds from University of Florence (ex-60%) to P. Bruni and C. Donati, www.unifi.it, Ente Cassa di Risparmio di Firenze to F. Torricelli, www.crf.it, Fondazione Cassa di Risparmio di Lucca to P. Bruni, www.fondazionecarilucca.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbuti A, 2010, J MOL CELL CARDIOL, V48, P415, DOI 10.1016/j.yjmcc.2009.10.006; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Brunelli S, 2005, TRENDS CARDIOVAS MED, V15, P96, DOI 10.1016/j.tcm.2005.04.004; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Donati C, 2004, FASEB J, V18, P449, DOI 10.1096/fj.04-1780fje; Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725; Donati C, 2009, CELL SIGNAL, V21, P228, DOI 10.1016/j.cellsig.2008.10.007; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grabski AD, 2009, ARTERIOSCL THROM VAS, V29, P1644, DOI 10.1161/ATVBAHA.109.191965; Han CL, 2001, J VASC RES, V38, P113, DOI 10.1159/000051038; Kanematsu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1093, DOI 10.1152/ajpcell.00225.2007; Krenning G, 2008, TRENDS CARDIOVAS MED, V18, P312, DOI 10.1016/j.tcm.2009.01.004; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Medlin MD, 2010, ARTERIOSCL THROM VAS, V30, P1779, DOI 10.1161/ATVBAHA.110.209395; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Narita N, 1996, GENOMICS, V36, P345, DOI 10.1006/geno.1996.0472; Nincheri P, 2009, CELL MOL LIFE SCI, V66, P1741, DOI 10.1007/s00018-009-9181-8; Nincheri P, 2010, CELL SIGNAL, V22, P1688, DOI 10.1016/j.cellsig.2010.06.009; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Radeke HH, 2005, J IMMUNOL, V174, P2778, DOI 10.4049/jimmunol.174.5.2778; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Sachinidis A, 2003, CELL PHYSIOL BIOCHEM, V13, P423, DOI 10.1159/000075130; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Tagliafico E, 2004, J CELL SCI, V117, P4377, DOI 10.1242/jcs.01291; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wamhoff BR, 2008, ARTERIOSCL THROM VAS, V28, P1454, DOI 10.1161/ATVBAHA.107.159392; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200	47	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20389	10.1371/journal.pone.0020389	http://dx.doi.org/10.1371/journal.pone.0020389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629665	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800047
J	Greene, TA; Alarcon, S; Thomas, A; Berdougo, E; Doranz, BJ; Breslin, PAS; Rucker, JB				Greene, Tiffani A.; Alarcon, Suzanne; Thomas, Anu; Berdougo, Eli; Doranz, Benjamin J.; Breslin, Paul A. S.; Rucker, Joseph B.			Probenecid Inhibits the Human Bitter Taste Receptor TAS2R16 and Suppresses Bitter Perception of Salicin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MULTIDRUG-RESISTANCE PROTEINS; CELLS; FAMILY; PHENYLTHIOCARBAMIDE; SENSITIVITY; SENSATIONS; DIVERSITY; SACCHARIN; TRANSPORT	Bitter taste stimuli are detected by a diverse family of G protein-coupled receptors (GPCRs) expressed in gustatory cells. Each bitter taste receptor (TAS2R) responds to an array of compounds, many of which are toxic and can be found in nature. For example, human TAS2R16 (hTAS2R16) responds to beta-glucosides such as salicin, and hTAS2R38 responds to thiourea-containing molecules such as glucosinolates and phenylthiocarbamide (PTC). While many substances are known to activate TAS2Rs, only one inhibitor that specifically blocks bitter receptor activation has been described. Here, we describe a new inhibitor of bitter taste receptors, p-(dipropylsulfamoyl) benzoic acid (probenecid), that acts on a subset of TAS2Rs and inhibits through a novel, allosteric mechanism of action. Probenecid is an FDA-approved inhibitor of the Multidrug Resistance Protein 1 (MRP1) transporter and is clinically used to treat gout in humans. Probenecid is also commonly used to enhance cellular signals in GPCR calcium mobilization assays. We show that probenecid specifically inhibits the cellular response mediated by the bitter taste receptor hTAS2R16 and provide molecular and pharmacological evidence for direct interaction with this GPCR using a non-competitive (allosteric) mechanism. Through a comprehensive analysis of hTAS2R16 point mutants, we define amino acid residues involved in the probenecid interaction that result in decreased sensitivity to probenecid while maintaining normal responses to salicin. Probenecid inhibits hTAS2R16, hTAS2R38, and hTAS2R43, but does not inhibit the bitter receptor hTAS2R31 or non-TAS2R GPCRs. Additionally, structurally unrelated MRP1 inhibitors, such as indomethacin, fail to inhibit hTAS2R16 function. Finally, we demonstrate that the inhibitory activity of probenecid in cellular experiments translates to inhibition of bitter taste perception of salicin in humans. This work identifies probenecid as a pharmacological tool for understanding the cell biology of bitter taste and as a lead for the development of broad specificity bitter blockers to improve nutrition and medical compliance.	[Greene, Tiffani A.; Thomas, Anu; Berdougo, Eli; Doranz, Benjamin J.; Rucker, Joseph B.] Integral Mol Inc, Philadelphia, PA 19104 USA; [Alarcon, Suzanne; Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Breslin, Paul A. S.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Monell Chemical Senses Center	Greene, TA (corresponding author), Integral Mol Inc, Philadelphia, PA 19104 USA.	jrucker@integralmolecular.com		Breslin, Paul/0000-0001-5988-8401	National Institutes of Health [DC002995, DC010105, GM072379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM072379, R44GM072379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002995, R44DC010105, R01DC002995, R43DC010105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health: DC002995 to P.A.S.B., DC010105 to J.B.R., and GM072379 to B.J.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DAYTON PG, 1966, J MED CHEM, V9, P941, DOI 10.1021/jm00324a034; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Egan JM, 2008, MOL INTERV, V8, P78, DOI 10.1124/mi.8.2.5; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Hayes JE, 2011, CHEM SENSES, V36, P311, DOI 10.1093/chemse/bjq132; Hinrichs AL, 2006, AM J HUM GENET, V78, P103, DOI 10.1086/499253; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; JANSSEN S, 2011, P NATL ACAD SCI US; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mennella JA, 2005, PEDIATRICS, V115, pE216, DOI 10.1542/peds.2004-1582; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Mundell SJ, 2000, J BIOL CHEM, V275, P12900, DOI 10.1074/jbc.275.17.12900; Paes C, 2009, J AM CHEM SOC, V131, P6952, DOI 10.1021/ja900186n; Pronin AN, 2007, CURR BIOL, V17, P1403, DOI 10.1016/j.cub.2007.07.046; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; SIROTNAK FM, 1991, CANCER RES, V51, P1412; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Sohi H, 2004, DRUG DEV IND PHARM, V30, P429, DOI 10.1081/DDC-120037477; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Stocker SL, 2008, CLIN PHARMACOKINET, V47, P111, DOI 10.2165/00003088-200847020-00004; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Wang JC, 2007, ALCOHOL CLIN EXP RES, V31, P209, DOI 10.1111/j.1530-0277.2006.00297.x	52	91	97	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20123	10.1371/journal.pone.0020123	http://dx.doi.org/10.1371/journal.pone.0020123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629661	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005800028
J	Nazer, E; Verdun, RE; Sanchez, DO				Nazer, Ezequiel; Verdun, Ramiro E.; Sanchez, Daniel O.			Nucleolar Localization of RNA Binding Proteins Induced by Actinomycin D and Heat Shock in Trypanosoma cruzi	PLOS ONE			English	Article							SR SPLICING FACTORS; STRESS GRANULES; LIFE-CYCLE; POLY(A)-BINDING PROTEIN; NUCLEAR-ORGANIZATION; DOMAIN PROTEINS; GENE-EXPRESSION; MESSENGER-RNAS; BRUCEI; PHOSPHORYLATION	In this work we show that under Actinomycin D (ActD) treatment, several RNA Binding Proteins (RBPs) involved in mRNA metabolism are relocalized into the nucleolus in Trypanosoma cruzi as a specific stress response. ATP depletion as well as kinase inhibition markedly reduced the nucleolar localization response, suggesting that an energy-dependent transport modulated by the phosphorylation status of the parasite might be required. Deletion analyses in one of such proteins, TcSR62, showed that a domain bearing basic amino acids located in the COOH terminal region was sufficient to promote its nucleolar relocalization. Interestingly, we showed that in addition to RBPs, poly(A)+ RNA is also accumulated into the nucleolus in response to ActD treatment. Finally, we found out that nucleolar relocalization of RBPs is also triggered by severe heat shock in a reversible way. Together, these results suggest that the nucleolus of an early divergent eukaryote is either able to sequester key factors related to mRNA metabolism in response to transcriptional stress or behaves as a RBP processing center, arguing in favour to the hypothesis that the non-traditional features of the nucleolus could be acquired early during evolution.	[Nazer, Ezequiel; Sanchez, Daniel O.] UNSAM CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, San Martin, Buenos Aires, Argentina; [Verdun, Ramiro E.] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Miami	Nazer, E (corresponding author), UNSAM CONICET, Inst Invest Biotecnol, Inst Tecnol Chascomus, San Martin, Buenos Aires, Argentina.	dsanchez@unsam.edu.ar		sanchez, daniel/0000-0002-5427-7764	National Agency for promotion of Science and Technology, (ANPCyT, Argentina) [PICT 2007-624]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)	National Agency for promotion of Science and Technology, (ANPCyT, Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by National Agency for promotion of Science and Technology, (ANPCyT, Argentina, PICT 2007-624 to D.O.S.) and by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2003, PLANT J, V36, P883, DOI 10.1046/j.1365-313X.2003.01932.x; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Avila ML, 2007, BIOCHEM BIOPH RES CO, V364, P26, DOI 10.1016/j.bbrc.2007.09.090; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barth S, 2008, EUKARYOT CELL, V7, P86, DOI 10.1128/EC.00215-07; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; Bercovich N, 2009, BIOCHEM BIOPH RES CO, V380, P850, DOI 10.1016/j.bbrc.2009.01.182; Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brown JWS, 2005, NUCLEIC ACIDS RES, V33, pD633, DOI 10.1093/nar/gki052; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; De Carvalho Elizeu F., 1994, Biological Research, V27, P225; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Durand-Dubief M, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-2; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Foldynova-Trantirkova S, 2005, INT J PARASITOL, V35, P359, DOI 10.1016/j.ijpara.2004.12.012; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gluenz E, 2007, INT J PARASITOL, V37, P617, DOI 10.1016/j.ijpara.2006.11.016; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Karni-Schmidt O, 2008, J CELL SCI, V121, P4098, DOI 10.1242/jcs.030098; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; LAIRD PW, 1987, NUCLEIC ACIDS RES, V15, P10087, DOI 10.1093/nar/15.24.10087; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Lee MGS, 1997, ANNU REV MICROBIOL, V51, P463, DOI 10.1146/annurev.micro.51.1.463; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lopez-Velazquez G, 2005, MICROSC MICROANAL, V11, P293, DOI 10.1017/S1431927605050233; Marchetti MA, 2000, J CELL SCI, V113, P899; MARTIN F, 1993, BIOCHEM BIOPH RES CO, V196, P1155, DOI 10.1006/bbrc.1993.2372; MCNALLY KP, 1992, MOL CELL BIOL, V12, P4844, DOI 10.1128/MCB.12.11.4844; Metz A, 2004, J CELL SCI, V117, P4551, DOI 10.1242/jcs.01329; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Nepomuceno-Mejia T, 2010, FEMS MICROBIOL LETT, V313, P41, DOI 10.1111/j.1574-6968.2010.02117.x; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Savaldi-Goldstein S, 2000, PLANT J, V21, P91, DOI 10.1046/j.1365-313x.2000.00657.x; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Tillemans V, 2005, PLANT J, V41, P567, DOI 10.1111/j.1365-313X.2004.02321.x; Tillemans V, 2006, PLANT CELL, V18, P3218, DOI 10.1105/tpc.106.044529; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Weighardt F, 1999, J CELL SCI, V112, P1465; Weingartner M, 2001, PLANT CELL, V13, P1929, DOI 10.1105/tpc.13.8.1929; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Yeakley JM, 1999, J CELL BIOL, V145, P447, DOI 10.1083/jcb.145.3.447; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	65	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19920	10.1371/journal.pone.0019920	http://dx.doi.org/10.1371/journal.pone.0019920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629693	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005800016
J	Udelnow, A; Kreyes, A; Ellinger, S; Landfester, K; Walther, P; Klapperstueck, T; Wohlrab, J; Henne-Bruns, D; Knippschild, U; Wurl, P				Udelnow, Andrej; Kreyes, Andreas; Ellinger, Stefan; Landfester, Katharina; Walther, Paul; Klapperstueck, Thomas; Wohlrab, Johannes; Henne-Bruns, Doris; Knippschild, Uwe; Wuerl, Peter			Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; CHOLINE PHOSPHOLIPID-METABOLISM; MAGNETIC-RESONANCE-SPECTROSCOPY; BREAST-CANCER; IN-VITRO; MALIGNANT-TRANSFORMATION; EPITHELIAL-CELLS; TUMOR RESISTANCE; APOPTOTIC DEATH; DOSE-RESPONSES	Background: Omeprazole has recently been described as a modulator of tumour chemoresistance, although its underlying molecular mechanisms remain controversial. Since pancreatic tumours are highly chemoresistant, a logical step would be to investigate the pharmacodynamic, morphological and biochemical effects of omeprazole on pancreatic cancer cell lines. Methodology/Principal Findings: Dose-effect curves of omeprazole, pantoprazole, gemcitabine, 5-fluorouracil and the combinations of omeprazole and 5-fluorouracil or gemcitabine were generated for the pancreatic cancer cell lines MiaPaCa-2, ASPC-1, Colo357, PancTu-1, Panc1 and Panc89. They revealed that omeprazole inhibited proliferation at probably nontoxic concentrations and reversed the hormesis phenomena of 5-fluorouracil. Electron microscopy showed that omeprazole led to accumulation of phagophores and early autophagosomes in ASPC-1 and MiaPaCa-2 cells. Signal changes indicating inhibited proliferation and programmed cell death were found by proton NMR spectroscopy of both cell lines when treated with omeprazole which was identified intracellularly. Omeprazole modulates the lysosomal transport pathway as shown by Western blot analysis of the expression of LAMP-1, Cathepsin-D and beta-COP in lysosome-and Golgi complex containing cell fractions. Acridine orange staining revealed that the pump function of the vATPase was not specifically inhibited by omeprazole. Gene expression of the autophagy-related LC3 gene as well as of Bad, Mdr-1, Atg12 and the vATPase was analysed after treatment of cells with 5-fluorouracil and omeprazole and confirmed the above mentioned results. Conclusions: We hypothesise that omeprazole interacts with the regulatory functions of the vATPase without inhibiting its pump function. A modulation of the lysosomal transport pathway and autophagy is caused in pancreatic cancer cells leading to programmed cell death. This may circumvent common resistance mechanisms of pancreatic cancer. Since omeprazole use has already been established in clinical practice these results could lead to new clinical applications.	[Udelnow, Andrej; Henne-Bruns, Doris; Knippschild, Uwe; Wuerl, Peter] Univ Hosp Ulm, Dept Gen Visceral & Transplantat Surg, Ulm, Germany; [Kreyes, Andreas; Ellinger, Stefan] Univ Ulm, Inst Organ Chem Macromol Chem & Organ Mat, Ulm, Germany; [Landfester, Katharina] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Walther, Paul] Univ Ulm, Dept Elect Microscopy, Ulm, Germany; [Klapperstueck, Thomas; Wohlrab, Johannes] Univ Halle Wittenberg, Dept Dermatol & Venereol, Halle, Germany	Ulm University; Ulm University; Max Planck Society; Ulm University; Martin Luther University Halle Wittenberg	Udelnow, A (corresponding author), St Franziskus Hosp, Dept Surg, Flensburg, Germany.	oberiu2@googlemail.com	Landfester, Katharina/F-9449-2011	Landfester, Katharina/0000-0001-9591-4638				Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aboagye EO, 1999, CANCER RES, V59, P80; Ackerstaff E, 2001, CANCER RES, V61, P3599; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bold RJ, 1999, ANN SURG ONCOL, V6, P279, DOI 10.1007/s10434-999-0279-x; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Breedveld P, 2004, CANCER RES, V64, P5804, DOI 10.1158/0008-5472.CAN-03-4062; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Calabrese EJ, 2008, BRIT J CLIN PHARMACO, V66, P594, DOI 10.1111/j.1365-2125.2008.03243.x; Calabrese EJ, 2010, DOSE-RESPONSE, V8, P80, DOI 10.2203/dose-response.09-063.Calabrese; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Chinni SR, 1999, BIOCHEM J, V339, P599, DOI 10.1042/0264-6021:3390599; Chou T C, 1994, Contrib Gynecol Obstet, V19, P91; COWIE FJ, 1995, BRIT J CANCER, V71, P877, DOI 10.1038/bjc.1995.169; De Milito A, 2005, EXPERT OPIN PHARMACO, V6, P1049, DOI 10.1517/14656566.6.7.1049; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; ESPINA V, 2010, ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0010240; Fischbach W, 2004, GUT, V53, P34, DOI 10.1136/gut.53.1.34; FRUCHT H, 1991, DIGEST DIS SCI, V36, P394, DOI 10.1007/BF01298865; Garcea G, 2008, J PANCREAS, V9, P99; GENTRY J, 2004, R NEWS, V4, P14; Gjoen T, 1997, SUBCELLULAR FRACTION, P169; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2004, CANCER RES, V64, P4270, DOI 10.1158/0008-5472.CAN-03-3829; GRECO WR, 1990, CANCER RES, V50, P5318; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Griffin JL, 2003, CANCER RES, V63, P3195; Grochola LF, 2010, PANCREAS, V39, P76, DOI 10.1097/MPA.0b013e3181b9f105; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hettiarachchi KD, 2006, FOOD CHEM TOXICOL, V44, P1966, DOI 10.1016/j.fct.2006.06.023; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; KALTHOFF H, 1993, ONCOGENE, V8, P289; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Katagiri F, 2005, BIOL PHARM BULL, V28, P370, DOI 10.1248/bpb.28.370; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KLIONSKY DJ, 2003, AUTOPHAGY AUTOPHAGY, P1; Klotz U, 2004, BASIC CLIN PHARMACOL, V95, P2, DOI 10.1111/j.1600-0773.2004.pto950102.x; Kohler T, 2002, LEUKEMIA, V16, P22, DOI 10.1038/sj.leu.2402340; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; Liu F, 2007, BIOL PHARM BULL, V30, P2279, DOI 10.1248/bpb.30.2279; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; MATTSSON JP, 1991, BIOCHIM BIOPHYS ACTA, V1065, P261, DOI 10.1016/0005-2736(91)90238-4; Mirossay L, 1999, PHYSIOL RES, V48, P135; Moka D, 1998, J PHARMACEUT BIOMED, V17, P125, DOI 10.1016/S0731-7085(97)00176-3; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Mori N, 2007, CANCER RES, V67, P11284, DOI 10.1158/0008-5472.CAN-07-2728; Nascarella MA, 2009, DOSE-RESPONSE, V7, P160, DOI 10.2203/dose-response.08-025.Nascarella; OKABE T, 1983, CANCER, V51, P662, DOI 10.1002/1097-0142(19830215)51:4<662::AID-CNCR2820510419>3.0.CO;2-X; Pardo R, 2010, PANCREATOLOGY, V10, P19, DOI 10.1159/000264680; Pauli-Magnus C, 2001, N-S ARCH PHARMACOL, V364, P551, DOI 10.1007/s00210-001-0489-7; R Development Core Team, 2009, R FDN STAT COMP; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; RENBERG L, 1989, DRUG METAB DISPOS, V17, P69; Ritz C, 2005, J STAT SOFTWARE, V12; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Sobota JA, 2009, J CELL SCI, V122, P3542, DOI 10.1242/jcs.034298; Thomson ABR, 2010, WORLD J GASTROENTERO, V16, P2323, DOI 10.3748/wjg.v16.i19.2323; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; Trauzold A, 2003, BRIT J CANCER, V89, P1714, DOI 10.1038/sj.bjc.6601330; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yeo M, 2004, CLIN CANCER RES, V10, P8687, DOI 10.1158/1078-0432.CCR-04-1065; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; YUNIS AA, 1977, INT J CANCER, V19, P128, DOI 10.1002/ijc.2910190118	70	82	85	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20143	10.1371/journal.pone.0020143	http://dx.doi.org/10.1371/journal.pone.0020143			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629657	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800029
J	Si, YH; Liu, XY; Cheng, M; Wang, MR; Gong, QL; Yang, Y; Wang, TY; Yang, W				Si, Youhui; Liu, Xiuying; Cheng, Min; Wang, Maorong; Gong, Qiaoling; Yang, Yang; Wang, Tianyi; Yang, Wei			Growth Differentiation Factor 15 Is Induced by Hepatitis C Virus Infection and Regulates Hepatocellular Carcinoma-Related Genes	PLOS ONE			English	Article							MACROPHAGE INHIBITORY CYTOKINE-1; ACUTE CORONARY SYNDROME; TGF-BETA SUPERFAMILY; MESSENGER-RNA; CANCER; EXPRESSION; CELLS; LIVER; SEVERITY; PATHWAYS	Liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) are commonly induced by chronic hepatitis C virus (HCV) infection. We aimed to identify and characterize the involvement of previously screened cytokine GDF15 in HCV pathogenesis. We examined the GDF15 expression after HCV infection both in vitro and in vivo. Cultured JFH-1 HCV was used to determine the GDF15 function on virus propagation. GDF15 overexpression and RNA interference were employed to profile the GDF15-regulated genes, signaling pathways and cell biology phenotypes. The mRNA expression and protein secretion of GDF15 was dramatically increased in HCV-infected hepatoma cells, which maybe a host response to viral proteins or infection-induced cell stress. Patients infected with HCV had an average 15-fold higher blood GDF15 level than that of healthy volunteers. Three HCC individuals in the HCV cohort showed extremely high GDF15 concentrations. Transfection or exogenously supplied GDF15 enhanced HCV propagation, whereas knockdown of endogenous GDF15 resulted in inhibition of virus replication. Overexpressed GDF15 led to Akt activation and the phosphorylation of Akt downstream targeted GSK-3 beta and Raf. Several HCC-related molecules, such as E-cadherin, beta-catenin, Cyclin A2/B1/D1, were up-regulated by GDF15 stimulation in vitro. Overexpression of GDF15 in hepatoma cells resulted in increased DNA synthesis, promoted cell proliferation, and importantly enhanced invasiveness of the cells. In conclusion, these results suggest that an elevated serum GDF15 level is a potential diagnostic marker for viral hepatitis, and GDF15 may contribute to HCV pathogenesis by altering the signaling and growth of host cells.	[Si, Youhui; Liu, Xiuying; Cheng, Min; Gong, Qiaoling; Yang, Yang; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China; [Si, Youhui; Liu, Xiuying; Cheng, Min; Gong, Qiaoling; Yang, Yang; Yang, Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Maorong] 81st Hosp PLA, Liver Dis Ctr PLA, Nanjing, Peoples R China; [Wang, Tianyi] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Si, YH (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100037, Peoples R China.	wyang@ipb.pumc.edu.cn	Si, Youhui/O-6274-2017	Si, Youhui/0000-0001-8909-221X	Chinese Science and Technology Key Project [2008ZX10002-014, 2009ZX10004-303]; National Basic Research Program of China [2011CB504804]; National Natural Science Foundation of China [30970156]; Institute of Pathogen Biology [2010IPB102]	Chinese Science and Technology Key Project; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Pathogen Biology	This work was supported by grants from the Chinese Science and Technology Key Project (2008ZX10002-014, 2009ZX10004-303), the National Basic Research Program of China (2011CB504804), National Natural Science Foundation of China (30970156) and an intramural grant from the Institute of Pathogen Biology (2010IPB102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Boyle GM, 2009, J INVEST DERMATOL, V129, P383, DOI 10.1038/jid.2008.270; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; He X, 2008, CANCER RES, V68, P5591, DOI 10.1158/0008-5472.CAN-08-0025; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kim WR, 2002, MICROBES INFECT, V4, P1219, DOI 10.1016/S1286-4579(02)01649-0; Komurian-Pradel F, 2001, J VIROL METHODS, V95, P111, DOI 10.1016/S0166-0934(01)00300-7; Lee DH, 2003, CANCER RES, V63, P4648; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; ROULOT D, 1995, HEPATOLOGY, V21, P298, DOI 10.1002/hep.1840210206; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Subramaniam S, 2003, J BIOL CHEM, V278, P8904, DOI 10.1074/jbc.M210037200; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Tsai JF, 1997, HEPATOLOGY, V25, P1141, DOI 10.1002/hep.510250516; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; von Wichert T, 2005, ONCOGENE, V24, P1284, DOI 10.1038/sj.onc.1208264; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Welsh JB, 2001, CANCER RES, V61, P5974; Wollert KC, 2007, CIRCULATION, V116, P1540, DOI 10.1161/CIRCULATIONAHA.107.697714; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Yang W, 2008, J BIOL CHEM, V283, P8643, DOI 10.1074/jbc.M709824200	33	36	38	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19967	10.1371/journal.pone.0019967	http://dx.doi.org/10.1371/journal.pone.0019967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625435	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000291005200020
J	Yu, J; Li, X; Wang, Y; Li, B; Li, HY; Li, YP; Zhou, WH; Zhang, CZ; Wang, YY; Rao, ZH; Bartlam, M; Cao, YJ				Yu, Jia; Li, Xin; Wang, Yu; Li, Bo; Li, Hongyue; Li, Yapeng; Zhou, Weihong; Zhang, Cuizhu; Wang, Yingying; Rao, Zihe; Bartlam, Mark; Cao, Youjia			PDlim2 Selectively Interacts with the PDZ Binding Motif of Highly Pathogenic Avian H5N1 Influenza A Virus NS1	PLOS ONE			English	Article							NF-KAPPA-B; STRUCTURAL BASIS; INFECTED-CELLS; PROTEIN; DOMAIN; GENE; DETERMINANTS; RECOGNITION; ACTIVATION; SEQUENCE	The multi-functional NS1 protein of influenza A virus is a viral virulence determining factor. The last four residues at the C-terminus of NS1 constitute a type I PDZ domain binding motif (PBM). Avian influenza viruses currently in circulation carry an NS1 PBM with consensus sequence ESEV, whereas human influenza viruses bear an NS1 PBM with consensus sequence RSKV or RSEV. The PBM sequence of the influenza A virus NS1 is reported to contribute to high viral pathogenicity in animal studies. Here, we report the identification of PDlim2 as a novel binding target of the highly pathogenic avian influenza virus H5N1 strain with an NS1 PBM of ESEV (A/Chicken/Henan/12/2004/H5N1, HN12-NS1) by yeast two-hybrid screening. The interaction was confirmed by in vitro GST pull-down assays, as well as by in vivo mammalian two-hybrid assays and bimolecular fluorescence complementation assays. The binding was also confirmed to be mediated by the interaction of the PDlim2 PDZ domain with the NS1 PBM motif. Interestingly, our assays showed that PDlim2 bound specifically with HN12-NS1, but exhibited no binding to NS1 from a human influenza H1N1 virus bearing an RSEV PBM (A/Puerto Rico/8/34/H1N1, PR8-NS1). A crystal structure of the PDlim2 PDZ domain fused with the C-terminal hexapeptide from HN12-NS1, together with GST pull-down assays on PDlim2 mutants, reveals that residues Arg16 and Lys31 of PDlim2 are critical for the binding between PDlim2 and HN12-NS1. The identification of a selective binding target of HN12-NS1 (ESEV), but not PR8-NS1 (RSEV), enables us to propose a structural mechanism for the interaction between NS1 PBM and PDlim2 or other PDZ-containing proteins.	[Yu, Jia; Li, Xin; Wang, Yu; Li, Bo; Li, Hongyue; Li, Yapeng; Zhou, Weihong; Zhang, Cuizhu; Rao, Zihe; Bartlam, Mark; Cao, Youjia] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Wang, Yingying] Nankai Univ, Coll Environm Sci & Engn, Key Lab Pollut Proc & Environm Criteria, Minist Educ, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Yu, J (corresponding author), Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China.	bartlam@nankai.edu.cn; caoyj@nankai.edu.cn	Rao, Zihe/HCH-6944-2022; wang, yingying/GRS-3058-2022	Bartlam, Mark/0000-0001-5173-5080	National Natural Science Foundation of China [30599432, 31000345, 30870128]; National S&T Major Project on Major Infectious Diseases [2008ZX10001-010]; Ministry of Science and Technology 973 Project [2007CB914301, 2007CB914800, 2010CB530304]; Tianjin Municipal Science and Technology Commission [08SYSYTC00200, 08QTPTJC28200]; 111 Project [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project on Major Infectious Diseases; Ministry of Science and Technology 973 Project(National Basic Research Program of China); Tianjin Municipal Science and Technology Commission; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (grant numbers 30599432, 31000345 and 30870128) to Y. C., the National S&T Major Project on Major Infectious Diseases (grant numbers 2008ZX10001-010), the Ministry of Science and Technology 973 Project (grant numbers 2007CB914301, 2007CB914800, 2010CB530304), and the Tianjin Municipal Science and Technology Commission (grant numbers 08SYSYTC00200, 08QTPTJC28200). This work is also supported by the 111 Project, B08011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Dong W, 2006, ACTA BIOCH BIOPH SIN, V38, P780, DOI 10.1111/j.1745-7270.2006.00220.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Healy NC, 2009, J LEUKOCYTE BIOL, V85, P481, DOI 10.1189/jlb.0408238; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Katz A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-187; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; [Li Bo 李博], 2010, [南开大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Nankaiensis], V43, P29; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Thomas M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-25; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Tomarev SL, 2004, INVEST OPHTH VIS SCI, V45, pU314; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; Wakita K, 2001, CANCER RES, V61, P854; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	38	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19511	10.1371/journal.pone.0019511	http://dx.doi.org/10.1371/journal.pone.0019511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625420	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200003
J	Szabo, NE; Zhao, TY; Cankaya, M; Stoykova, A; Zhou, XL; Alvarez-Bolado, G				Szabo, Nora-Emoeke; Zhao, Tianyu; Cankaya, Murat; Stoykova, Anastassia; Zhou, Xunlei; Alvarez-Bolado, Gonzalo			Interaction between Axons and Specific Populations of Surrounding Cells Is Indispensable for Collateral Formation in the Mammillary System	PLOS ONE			English	Article							EMBRYONIC MOUSE FOREBRAIN; IN-SITU HYBRIDIZATION; MILK-EJECTION REFLEX; WINGED HELIX GENE; PAX6 MUTANT MICE; TARGET RECOGNITION; MAMMILLOTHALAMIC TRACT; BOUNDARY FORMATION; ADHESION MOLECULE; RAT HYPOTHALAMUS	Background: An essential phenomenon during brain development is the extension of long collateral branches by axons. How the local cellular environment contributes to the initial sprouting of these branches in specific points of an axonal shaft remains unclear. Methodology/Principal Findings: The principal mammillary tract (pm) is a landmark axonal bundle connecting ventral diencephalon to brainstem (through the mammillotegmental tract, mtg). Late in development, the axons of the principal mammillary tract sprout collateral branches at a very specific point forming a large bundle whose target is the thalamus. Inspection of this model showed a number of distinct, identified cell populations originated in the dorsal and the ventral diencephalon and migrating during development to arrange themselves into several discrete groups around the branching point. Further analysis of this system in several mouse lines carrying mutant alleles of genes expressed in defined subpopulations (including Pax6, Foxb1, Lrp6 and Gbx2) together with the use of an unambiguous genetic marker of mammillary axons revealed: 1) a specific group of Pax6-expressing cells in close apposition with the prospective branching point is indispensable to elicit axonal branching in this system; and 2) cooperation of transcription factors Foxb1 and Pax6 to differentially regulate navigation and fasciculation of distinct branches of the principal mammillary tract. Conclusions/Significance: Our results define for the first time a model system where interaction of the axonal shaft with a specific group of surrounding cells is essential to promote branching. Additionally, we provide insight on the cooperative transcriptional regulation necessary to promote and organize an intricate axonal tree.	[Szabo, Nora-Emoeke; Zhao, Tianyu; Zhou, Xunlei; Alvarez-Bolado, Gonzalo] Max Planck Inst Biophys Chem, Brain Dev Grp, D-37077 Gottingen, Germany; [Cankaya, Murat] Erzincan Univ, Fac Sci & Art, Dept Biol, Erzincan, Turkey; [Stoykova, Anastassia] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Max Planck Society; Erzincan Binali Yildirim University; Max Planck Society	Szabo, NE (corresponding author), IRCM, Montreal, PQ, Canada.	alvarez@ana.uni-heidelberg.de		Alvarez-Bolado, Gonzalo/0000-0002-3044-1603	Max Planck Society; Deutsche Forschungsgemeinschaft [AL 603]; NICHD [IA 52242]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Work was supported by the Max Planck Society and by the Deutsche Forschungsgemeinschaft Grant AL 603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Andrea Wizenmann (University of Tubingen) and Herbert Hildebrandt (University of Hannover) made valuable comments on the text. Michael Heide (University of Heidelberg) assisted with the confocal microscopy. The anti-Pax6 antibody, developed by A. Kawakami, was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Alpeeva EV, 2009, BRAIN RES, V1248, P1, DOI 10.1016/j.brainres.2008.10.060; ALTMAN J, 1986, ADV ANAT EMBRYOL CEL, V100, P1; Alvarez-Bolado G, 2000, DEV NEUROSCI-BASEL, V22, P197, DOI 10.1159/000017442; Alvarez-Bolado G, 2000, DEVELOPMENT, V127, P1029; Andrews GL, 2003, J NEUROSCI, V23, P9873; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bastmeyer M, 1998, J COMP NEUROL, V392, P1, DOI 10.1002/(SICI)1096-9861(19980302)392:1<1::AID-CNE1>3.0.CO;2-6; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Bayer Shirley A., 1995, P1041; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; CANTERAS NS, 1992, P NATL ACAD SCI USA, V89, P10089, DOI 10.1073/pnas.89.21.10089; Daston MM, 1996, J NEUROSCI, V16, P5488; Dottori M, 2001, DEVELOPMENT, V128, P4127; Duncan MK, 2000, J CELL SCI, V113, P3173; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; EASTER SS, 1993, J NEUROSCI, V13, P285; Gallo G, 1999, J NEUROSCI, V19, P3860; Gibson DA, 2011, DEVELOPMENT, V138, P183, DOI 10.1242/dev.046441; Grinchuk O, 2005, J BIOL CHEM, V280, P35228, DOI 10.1074/jbc.M506195200; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HAYAKAWA T, 1989, J COMP NEUROL, V284, P1, DOI 10.1002/cne.902840102; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JEANNETEAU F, 2010, NAT NEUROSCI, DOI DOI 10.1242/DEV.046441; Jelsing J, 2008, NEUROSCIENCE, V154, P641, DOI 10.1016/j.neuroscience.2008.03.051; Jones L, 2002, DEVELOPMENT, V129, P5041; Kaestner KH, 1996, MECH DEVELOP, V55, P221, DOI 10.1016/0925-4773(96)00507-2; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kloetzli JM, 2001, GENESIS, V29, P60, DOI 10.1002/1526-968X(200102)29:2<60::AID-GENE1006>3.0.CO;2-L; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Labosky PA, 1997, DEVELOPMENT, V124, P1263; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Mastick GS, 1997, DEVELOPMENT, V124, P1985; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; Meech R, 1999, P NATL ACAD SCI USA, V96, P2420, DOI 10.1073/pnas.96.5.2420; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nural HF, 2004, J COMP NEUROL, V479, P399, DOI 10.1002/cne.20317; OLEARY DDM, 1990, COLD SH Q B, V55, P453; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Pinon MC, 2008, J NEUROSCI, V28, P8724, DOI 10.1523/JNEUROSCI.2565-08.2008; Pratt T, 2000, DEVELOPMENT, V127, P5167; Puelles L., 2004, RAT NERVOUS SYSTEM, P3, DOI [10.1016/b978-012547638-6/50002-x, DOI 10.1016/B978-012547638-6/50002-X]; SATO M, 1994, NEURON, V13, P791, DOI 10.1016/0896-6273(94)90246-1; Scholpp S, 2010, TRENDS NEUROSCI, V33, P373, DOI 10.1016/j.tins.2010.05.003; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Tsuchiya R, 2009, J NEUROSCI RES, V87, P1620, DOI 10.1002/jnr.21966; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Valverde F, 2000, J COMP NEUROL, V419, P485; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Vitalis T, 2000, J NEUROSCI, V20, P6501, DOI 10.1523/JNEUROSCI.20-17-06501.2000; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Wehr R, 1997, DEVELOPMENT, V124, P4447; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Zhao TY, 2008, EUR J NEUROSCI, V28, P1941, DOI 10.1111/j.1460-9568.2008.06503.x; Zhao TY, 2007, GENESIS, V45, P781, DOI 10.1002/dvg.20356; Zhou CJ, 2004, J NEUROSCI, V24, P7632, DOI 10.1523/JNEUROSCI.2123-04.2004; Zhou LB, 2008, SCIENCE, V320, P946, DOI 10.1126/science.1155244	69	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20315	10.1371/journal.pone.0020315	http://dx.doi.org/10.1371/journal.pone.0020315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625468	gold, Green Published			2022-12-25	WOS:000290793400055
J	Bai, QF; Shen, YL; Yao, XJ; Wang, F; Du, YP; Wang, Q; Jin, NZ; Hai, J; Hu, TJ; Yang, JB				Bai, Qifeng; Shen, Yulin; Yao, Xiaojun; Wang, Fang; Du, Yuping; Wang, Qin; Jin, Nengzhi; Hai, Jun; Hu, Tiejun; Yang, Jinbo			Modeling a New Water Channel That Allows SET9 to Dimethylate p53	PLOS ONE			English	Article							LYSINE METHYLTRANSFERASE SET7/9; COVALENT HISTONE MODIFICATIONS; MOLECULAR-DYNAMICS SIMULATION; FULL-LENGTH INTEGRASE; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; ACTIVE-SITE; DNA COMPLEX; METHYLATION; TRANSCRIPTION	SET9, a protein lysine methyltransferase, has been thought to be capable of transferring only one methyl group to target lysine residues. However, some reports have pointed out that SET9 can dimethylate Lys372 of p53 (p53-K372) and Lys4 of histone H3 (H3-K4). In order to understand how p53 can be dimethylated by SET9, we measured the radius of the channel that surrounds p53-K372, first on the basis of the crystal structure of SET9, and we show that the channel is not suitable for water movement. Second, molecular dynamic (MD) simulations were carried out for 204 ns on the crystal structure of SET9. The results show that water leaves the active site of SET9 through a new channel, which is made of G292, A295, Y305 and Y335. In addition, the results of molecular docking and MD simulations indicate that the new water channel continues to remain open when S-adenosyl-L-methionine (AdoMet) or S-adenosyl-L-homocysteine (AdoHcy) is bound to SET9. The changes in the radii of these two channels were measured in the equilibrium phase at the constant temperature of 300 K. The results indicate that the first channel still does not allow water to get into or out of the active site, but the new channel is large enough to allow this water to circulate. Our results indicate that water can be removed from the active site, an essential process for allowing the dimethylation reaction to occur.	[Bai, Qifeng; Wang, Fang; Du, Yuping; Wang, Qin; Hai, Jun; Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China; [Shen, Yulin; Jin, Nengzhi; Hu, Tiejun] Gansu Comp Ctr, Lanzhou, Gansu, Peoples R China; [Yao, Xiaojun] Lanzhou Univ, Sch Chem, Lanzhou 730000, Gansu, Peoples R China; [Yang, Jinbo] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44106 USA	Lanzhou University; Lanzhou University; Cleveland Clinic Foundation	Bai, QF (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Gansu, Peoples R China.	htj@mail.gspcc.com; yangjb@lzu.edu.cn	Yang, Jinbo/AAM-9580-2020; Bai, Qifeng/A-2950-2019	Bai, Qifeng/0000-0001-7296-6187	Ministry of Education [NCET-08-0260]; Ministry of Science and Technology of the People's Republic of China [2009DFA30990]; Gansu Provincial Science and Technology [0708WCGA149]; China's Ministry of Science; Innovative Team-Building Program of Gansu Province [098TTCA007]	Ministry of Education; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Gansu Provincial Science and Technology; China's Ministry of Science; Innovative Team-Building Program of Gansu Province	This work was supported by grants NCET-08-0260 from Ministry of Education and 2009DFA30990 from Ministry of Science and Technology of the People's Republic of China; 0708WCGA149 from the Gansu Provincial Science and Technology to J.Y.; 2009AA01A130 from China's Ministry of Science 863 and 098TTCA007 from Innovative Team-Building Program of Gansu Province to T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Chakrabarti SK, 2003, J BIOL CHEM, V278, P23617, DOI 10.1074/jbc.M303423200; *CHEMAXON, 2009, MARV WAS US DRAW DIS; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Luca L, 2005, BIOCHEM BIOPH RES CO, V336, P1010, DOI 10.1016/j.bbrc.2005.08.211; De Luca L, 2003, BIOCHEM BIOPH RES CO, V310, P1083, DOI 10.1016/j.bbrc.2003.09.120; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; FRISCH MJ, 1998, GAUSSIAN98 REVISION; Garcia-Fandino R, 2009, J AM CHEM SOC, V131, P15678, DOI 10.1021/ja903400n; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lang PT, 2009, RNA, V15, P1219, DOI 10.1261/rna.1563609; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Nicholls P, 2000, CELL MOL LIFE SCI, V57, P987, DOI 10.1007/PL00000751; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ruiz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003230; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang SL, 2007, J PHYS CHEM B, V111, P3758, DOI 10.1021/jp067147i; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107	39	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19856	10.1371/journal.pone.0019856	http://dx.doi.org/10.1371/journal.pone.0019856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625555	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200027
J	Kang, YS; Kim, W; Huh, YH; Bae, J; Kim, JS; Song, WK				Kang, Yong Seok; Kim, Wook; Huh, Yun Hyun; Bae, Jeomil; Kim, Jin Soo; Song, Woo Keun			P130Cas Attenuates Epidermal Growth Factor (EGF) Receptor Internalization by Modulating EGF-Triggered Dynamin Phosphorylation	PLOS ONE			English	Article							ADAPTER PROTEIN CAS; TYROSINE PHOSPHORYLATION; C-SRC; SIGNAL-TRANSDUCTION; ERBB RECEPTORS; ENDOCYTOSIS; CELLS; ACTIVATION; KINASE; CANCER	Background: Endocytosis controls localization-specific signal transduction via epidermal growth factor receptor (EGFR), as well as downregulation of that receptor. Extracellular matrix (ECM)-integrin coupling induces formation of macromolecular complexes that include EGFR, integrin, Src kinase and p130Cas, resulting in EGFR activation. In addition, cell adhesion to ECM increases EGFR localization at the cell surface and reduces EGFR internalization. The molecular mechanisms involved are not yet well understood. Methodology/Principal Findings: We investigated the molecular mechanism by which p130Cas affects the endocytic regulation of EGFR. Biochemical quantification revealed that cell adhesion to fibronectin (FN) increases total EGFR levels and its phosphorylation, and that p130Cas is required for this process. Measurements of Texas Red-labeled EGF uptake and cell surface EGFR revealed that p130Cas overexpression reduces EGF-induced EGFR internalization, while p130Cas depletion enhances it. In addition, both FN-mediated cell adhesion and p130Cas overexpression reduce EGF-stimulated dynamin phosphorylation, which is necessary for EGF-induced EGFR internalization. Coimmunoprecipitation and GST pull-down assays confirmed the interaction between p130Cas and dynamin. Moreover, a SH3-domain-deleted form of p130Cas, which shows diminished binding to dynamin, inhibits dynamin phosphorylation and EGF uptake less effectively than wild-type p130Cas. Conclusions/Significance: Our results show that p130Cas plays an inhibitory role in EGFR internalization via its interaction with dynamin. Given that the EGFR internalization process determines signaling density and specificity in the EGFR pathway, these findings suggest that the interaction between p130Cas and dynamin may regulate EGFR trafficking and signaling in the same manner as other endocytic regulatory proteins related to EGFR endocytosis.	[Kang, Yong Seok; Huh, Yun Hyun; Bae, Jeomil; Kim, Jin Soo; Song, Woo Keun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea; [Kang, Yong Seok; Huh, Yun Hyun; Bae, Jeomil; Kim, Jin Soo; Song, Woo Keun] Gwangju Inst Sci & Technol, Bio Imaging & Cell Dynam Res Ctr, Kwangju, South Korea; [Kim, Wook] NIA, Diabet Sect, NIH, Baltimore, MD 21224 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kang, YS (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju, South Korea.	wksong@gist.ac.kr		Bae, Jeomil/0000-0001-9374-6802	Bio Imaging Research Center at GIST; Cell Dynamic Research Center [20100001616]; Korea Foundation for Cancer Research [KFCR-2009-001]; Mid-career Researcher Program [20100000344]; Korean Government (MEST) [2010K001181]	Bio Imaging Research Center at GIST; Cell Dynamic Research Center; Korea Foundation for Cancer Research; Mid-career Researcher Program; Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Bio Imaging Research Center at GIST, the Cell Dynamic Research Center (20100001616), the Korea Foundation for Cancer Research (KFCR-2009-001), the Mid-career Researcher Program (20100000344), and the Converging Research Center Program (2010K001181) funded by the Korean Government (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Johannessen LE, 2001, BIOCHEM J, V356, P87, DOI 10.1042/0264-6021:3560087; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Kook S, 2000, MOL BIOL CELL, V11, P929, DOI 10.1091/mbc.11.3.929; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lee JW, 2004, MOL CELLS, V17, P188; Lie PPY, 2006, J ENDOCRINOL, V191, P571, DOI 10.1677/joe.1.06996; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Liu NS, 2009, EMBO J, V28, P3485, DOI 10.1038/emboj.2009.282; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nyati MK, 2006, NAT REV CANCER, V6, P876, DOI 10.1038/nrc1953; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Thalappilly S, 2010, ONCOGENE, V29, P2528, DOI 10.1038/onc.2010.1; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97	45	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20125	10.1371/journal.pone.0020125	http://dx.doi.org/10.1371/journal.pone.0020125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625594	Green Submitted, gold, Green Published			2022-12-25	WOS:000290720200065
J	Coutts, AS; Pires, IM; Weston, L; Buffa, FM; Milani, M; Li, JL; Harris, AL; Hammond, EM; La Thangue, NB				Coutts, A. S.; Pires, I. M.; Weston, L.; Buffa, F. M.; Milani, M.; Li, J-L; Harris, A. L.; Hammond, E. M.; La Thangue, N. B.			Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1 alpha	ONCOGENE			English	Article						JMY; HIF-1; actin; hypoxia; motility	INDUCIBLE FACTOR-I; P53; COFACTOR; P300; MDM2	Junction-mediating and regulatory protein (JMY) is a novel p53 cofactor that regulates p53 activity during stress. JMY interacts with p300/CBP, which are ubiquitous transcriptional co-activators that interact with a variety of sequence-specific transcription factors, including hypoxia-inducible factor-1 alpha (HIF-1 alpha). In addition, JMY is an actin-nucleating protein, which, through its WH2 domains, stimulates cell motility. In this study, we show that JMY is upregulated during hypoxia in a HIF-1 alpha-dependent manner. The JMY gene contains HIF-responsive elements in its promoter region and HIF-1 alpha is recruited to its promoter during hypoxia. HIF-1 alpha drives transcription of JMY, which accounts for its induction under hypoxia. Moreover, the enhanced cell motility and invasion that occurs during hypoxia requires JMY, as depleting JMY under hypoxic conditions causes decreased cell motility. Our results establish the interplay between JMY and HIF-1 alpha as a new mechanism that controls cell motility under hypoxic stress. Oncogene (2011) 30, 4835-4842; doi: 10.1038/onc.2011.188; published online 30 May 2011	[Coutts, A. S.; Weston, L.; La Thangue, N. B.] Univ Oxford, Dept Oncol, Canc Biol Lab, Oxford OX3 7DQ, Oxon, England; [Pires, I. M.; Hammond, E. M.] Univ Oxford, Dept Oncol, Canc Res UK MRC Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, Oxon, England; [Buffa, F. M.; Milani, M.; Li, J-L; Harris, A. L.] Univ Oxford, Dept Oncol, Canc Res UK Mol Oncol Labs, Weatherall Inst Mol Med, Oxford OX3 7DQ, Oxon, England	University of Oxford; Cancer Research UK; University of Oxford; University of Oxford	La Thangue, NB (corresponding author), Univ Oxford, Dept Oncol, Canc Biol Lab, Old Rd Campus,Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, Oxon, England.	nick.lathangue@clinpharm.ox.ac.uk	Harris, Adrian L/ABA-3343-2020; Buffa, Francesca/D-2574-2013	Harris, Adrian L/0000-0003-1376-8409; Buffa, Francesca/0000-0003-0409-406X; Hammond, Ester/0000-0002-2335-3146; Coutts, Amanda/0000-0002-5005-1864; Pires, Isabel/0000-0002-0417-2710	MRC; CRUK [C300/6731, C6415/A9321]; LRF; AICR; MRC [G1000807, G0500905, G9400953] Funding Source: UKRI; Cancer Research UK [13058] Funding Source: researchfish; Medical Research Council [G0500905, G9400953, G1000807] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); LRF; AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the MRC, CRUK, LRF and AICR for support. ASC and LW are funded by MRC and CRUK (grant # C300/6731). IMP and EMH are funded by CRUK (grant # C6415/A9321). We also thank Long Dang, Peter Ratcliffe and Shoumo Bhattacharya for providing invaluable reagents.	Biswas S, 2010, J ONCOL, V2010, DOI 10.1155/2010/757908; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rapisarda A, 2009, CELL CYCLE, V8, P4040, DOI 10.4161/cc.8.24.10145; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zalmas LP, 2008, EMBO REP, V9, P252, DOI 10.1038/sj.embor.7401158; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	25	24	24	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	48					4835	4842		10.1038/onc.2011.188	http://dx.doi.org/10.1038/onc.2011.188			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21625218	Green Published			2022-12-25	WOS:000298134700007
J	Taniuchi, K; Cerny, RL; Tanouchi, A; Kohno, K; Kotani, N; Honke, K; Saibara, T; Hollingsworth, MA				Taniuchi, K.; Cerny, R. L.; Tanouchi, A.; Kohno, K.; Kotani, N.; Honke, K.; Saibara, T.; Hollingsworth, M. A.			Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth	ONCOGENE			English	Article						polypeptide N-acetylgalactosaminyl-transferase; GalNAc-T3; pancreatic cancer; O-glycosylation; cell growth; apoptosis	ALPHA-D-GALACTOSAMINE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; CDNA CLONING; EXPRESSION; METASTASIS; MUCIN; IDENTIFICATION; GLYCANS; TARGETS; ANTIGEN	O-linked glycans of secreted and membrane-bound proteins have an important role in the pathogenesis of pancreatic cancer by modulating immune responses, inflammation and tumorigenesis. A critical aspect of O-glycosylation, the position at which proteins are glycosylated with N-acetyl-galactosamine on serine and threonine residues, is regulated by the substrate specificity of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases (GalNAc-Ts). Thus, GalNAc-Ts regulate the first committed step in O-glycosylated protein biosynthesis, determine sites of O-glycosylation on proteins and are important for understanding normal and carcinoma-associated O-glycosylation. We have found that one of these enzymes, GalNAc-T3, is overexpressed in human pancreatic cancer tissues and suppression of GalNAc-T3 significantly attenuates the growth of pancreatic cancer cells in vitro and in vivo. In addition, suppression of GalNAc-T3 induces apoptosis of pancreatic cancer cells. Our results indicate that GalNAc-T3 is likely involved in pancreatic carcinogenesis. Modification of cellular glycosylation occurs in nearly all types of cancer as a result of alterations in the expression levels of glycosyltransferases. We report guanine the nucleotide-binding protein, a-transducing activity polypeptide-1 (GNAT1) as a possible substrate protein of GalNAc-T3. GalNAc-T3 is associated with O-glycosylation of GNAT1 and affects the subcellular distribution of GNAT1. Knocking down endogenous GNAT1 significantly suppresses the growth/survival of PDAC cells. Our results imply that GalNAc-T3 contributes to the function of O-glycosylated proteins and thereby affects the growth and survival of pancreatic cancer cells. Thus, substrate proteins of GalNAc-T3 should serve as important therapeutic targets for pancreatic cancers. Oncogene (2011) 30, 4843-4854; doi:10.1038/onc.2011.194; published online 30 May 2011	[Taniuchi, K.] Kochi Univ, Sch Med, Dept Gastroenterol & Hepatol, Nanko Ku, Kochi 7838505, Japan; [Taniuchi, K.; Hollingsworth, M. A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Taniuchi, K.; Hollingsworth, M. A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Cerny, R. L.] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; [Kohno, K.] Univ Occupat & Environm Hlth, Sch Med, Dept Biol Mol, Fukuoka, Japan; [Kotani, N.; Honke, K.] Kochi Univ, Sch Med, Dept Biochem, Kochi 7838505, Japan	Kochi University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; University of Occupational & Environmental Health - Japan; Kochi University	Taniuchi, K (corresponding author), Kochi Univ, Sch Med, Dept Gastroenterol & Hepatol, Nanko Ku, Kochi 7838505, Japan.	jm-ktaniuchi@kochi-u.ac.jp		Kotani, Norihiro/0000-0003-3739-6478	Tamotsu Takeuchi; NIH [U01CA111294, R01CA057362]; NATIONAL CANCER INSTITUTE [U01CA128437, P50CA127297, R01CA057362, U01CA111294, P30CA036727] Funding Source: NIH RePORTER	Tamotsu Takeuchi; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Michel Ouellette for providing the HPNE cells and Tamotsu Takeuchi for supporting pathological experiments and helpful discussion. We also thank Janice Taylor and James Talaska for excellent technical assistance. This work was funded by the NIH with grants to MAH (U01CA111294; R01CA057362).	Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P1; Andersen MH, 2005, NAT REV DRUG DISCOV, V4, P399, DOI 10.1038/nrd1717; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; BRAGA VMM, 1992, DEVELOPMENT, V115, P427; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; CATTORETTI G, 1992, J PATHOL, V168, P357, DOI 10.1002/path.1711680404; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GRAY JW, 1980, ANNU REV BIOPHYS BIO, V9, P509, DOI 10.1146/annurev.bb.09.060180.002453; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Joshi S. S., 2001, Current Pharmaceutical Biotechnology, V2, P187, DOI 10.2174/1389201013378725; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kondo A, 2006, BBA-PROTEINS PROTEOM, V1764, P1881, DOI 10.1016/j.bbapap.2006.10.011; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Li M, 2010, J BIOSCIENCES, V35, P665, DOI 10.1007/s12038-010-0073-8; Mayoral MA, 2008, CANCER INVEST, V26, P615, DOI 10.1080/07357900701837051; MELLORS A, 1995, METHOD ENZYMOL, V248, P728; Merighi Stefania, 2006, Purinergic Signal, V2, P627, DOI 10.1007/s11302-006-9020-4; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Nomoto M, 1999, CANCER RES, V59, P6214; Reis CA, 1999, CANCER RES, V59, P1003; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Sutherlin ME, 1997, CANCER RES, V57, P4744; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Wray CJ, 2005, GASTROENTEROLOGY, V128, P1626, DOI 10.1053/j.gastro.2005.03.035	32	63	66	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	49					4843	4854		10.1038/onc.2011.194	http://dx.doi.org/10.1038/onc.2011.194			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21625220	Green Accepted, Green Published			2022-12-25	WOS:000298346400001
J	Theesfeld, CL; Pourmand, D; Davis, T; Garza, RM; Hampton, RY				Theesfeld, Chandra L.; Pourmand, Deeba; Davis, Talib; Garza, Renee M.; Hampton, Randolph Y.			The Sterol-sensing Domain (SSD) Directly Mediates Signal-regulated Endoplasmic Reticulum-associated Degradation (ERAD) of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Isozyme Hmg2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA REDUCTASE; MEMBRANE-PROTEIN; CHOLESTEROL HOMEOSTASIS; UBIQUITIN LIGASE; SCAP PROTEIN; YEAST; INSIG; REQUIRES; PATHWAY; BINDING	The sterol-sensing domain (SSD) is a conserved motif in membrane proteins responsible for sterol regulation. Mammalian proteins SREBP cleavage-activating protein (SCAP) and HMG-CoA reductase (HMGR) both possess SSDs required for feedback regulation of sterol-related genes and sterol synthetic rate. Although these two SSD proteins clearly sense sterols, the range of signals detected by this eukaryotic motif is not clear. The yeastHMG-CoAreductase isozyme Hmg2, like its mammalian counterpart, undergoes endoplasmic reticulum (ER)-associated degradation that is subject to feedback control by the sterol pathway. The primary degradation signal for yeast Hmg2 degradation is the 20-carbon isoprene geranylgeranyl pyrophosphate, rather than a sterol. Nevertheless, the Hmg2 protein possesses an SSD, leading us to test its role in feedback control of Hmg2 stability. We mutated highly conserved SSD residues of Hmg2 and evaluated regulated degradation. Our results indicated that the SSD was required for sterol pathway signals to stimulate Hmg2 ER-associated degradation and was employed for detection of both geranylgeranyl pyrophosphate and a secondary oxysterol signal. Our data further indicate that the SSD allows a signal-dependent structural change in Hmg2 that promotes entry into the ER degradation pathway. Thus, the eukaryotic SSD is capable of significant plasticity in signal recognition or response. We propose that the harnessing of cellular quality control pathways to bring about feedback regulation of normal proteins is a unifying theme for the action of all SSDs.	[Theesfeld, Chandra L.; Pourmand, Deeba; Davis, Talib; Garza, Renee M.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [NRSA 5F32GM82195, 5R01DK051996]; National Institutes of Health through NIGMS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NRSA 5F32GM82195 (to C. L. T.) and 5R01DK051996 to R. Y. H.) through the NIGMS.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Peng ZL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-420; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SENGSTAG C, 1990, MOL CELL BIOL, V10, P672, DOI 10.1128/MCB.10.2.672; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	38	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26298	26307		10.1074/jbc.M111.244798	http://dx.doi.org/10.1074/jbc.M111.244798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628456	Green Published, hybrid			2022-12-25	WOS:000293078200006
J	Guimaraes, BG; Barbosa, RL; Soprano, AS; Campos, BM; de Souza, TA; Tonoli, CCC; Leme, AFP; Murakami, MT; Benedetti, CE				Guimaraes, Beatriz G.; Barbosa, Rosicler L.; Soprano, Adriana S.; Campos, Bruna M.; de Souza, Tiago A.; Tonoli, Celisa C. C.; Leme, Adriana F. P.; Murakami, Mario T.; Benedetti, Celso E.			Plant Pathogenic Bacteria Utilize Biofilm Growth-associated Repressor (BigR), a Novel Winged-helix Redox Switch, to Control Hydrogen Sulfide Detoxification under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; AGROBACTERIUM-TUMEFACIENS; XYLELLA-FASTIDIOSA; ESCHERICHIA-COLI; INTERNAL OXYGEN; ZINC SENSOR; PROTEIN; RHODANESE; OPERON; FAMILY	Winged-helix transcriptional factors play important roles in the control of gene expression in many organisms. In the plant pathogens Xylella fastidiosa and Agrobacterium tumefaciens, the winged-helix protein BigR, a member of the ArsR/SmtB family of metal sensors, regulates transcription of the bigR operon involved in bacterial biofilm growth. Previous studies showed that BigR represses transcription of its own operon through the occupation of the RNA polymerase-binding site; however, the signals that modulate its activity and the biological function of its operon are still poorly understood. Here we show that although BigR is a homodimer similar to metal sensors, it functions as a novel redox switch that derepresses transcription upon oxidation. Crystal structures of reduced and oxidized BigR reveal that formation of a disulfide bridge involving two critical cysteines induces conformational changes in the dimer that remarkably alter the topography of the winged-helix DNA-binding interface, precluding DNA binding. This structural mechanism of DNA association-dissociation is novel among winged-helix factors. Moreover, we demonstrate that the bigR operon is required for hydrogen sulfide detoxification through the action of a sulfur dioxygenase (Blh) and sulfite exporter. As hydrogen sulfide strongly inhibits cytochrome c oxidase, it must be eliminated to allow aerobic growth under low oxygen tension, an environmental condition found in bacterial bio-films, xylem vessels, and root tissues. Accordingly, we show that the bigR operon is critical to sustain bacterial growth under hypoxia. These results suggest that BigR integrates the transcriptional regulation of a sulfur oxidation pathway to an oxidative signal through a thiol-based redox switch.	[Guimaraes, Beatriz G.; Barbosa, Rosicler L.; Soprano, Adriana S.; Campos, Bruna M.; de Souza, Tiago A.; Tonoli, Celisa C. C.; Leme, Adriana F. P.; Murakami, Mario T.; Benedetti, Celso E.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil		Benedetti, CE (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, CP6192, Sao Paulo, Brazil.	celso.benedetti@lnbio.org.br	Murakami, Mario T/F-5640-2016; Leme, Adriana F Paes/C-9679-2012; Murakami, Mario T/C-2087-2012; Guimarães, Beatriz Gomes/Z-6242-2019; de Souza, Tiago Antonio/C-1039-2012; Guimarães, Beatriz G/D-3858-2014; Citros, Inct/I-2442-2013	Murakami, Mario T/0000-0002-0405-8010; Leme, Adriana F Paes/0000-0001-7959-147X; Guimarães, Beatriz Gomes/0000-0002-8546-2460; de Souza, Tiago Antonio/0000-0001-6283-4359; Benedetti, Celso/0000-0002-4602-0256; Santos Soprano, Adriana/0000-0001-7117-927X; Tonoli, Celisa/0000-0003-2580-5588	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Armstrong W, 2009, ANN BOT-LONDON, V103, P281, DOI 10.1093/aob/mcn177; Arunkumar AI, 2009, P NATL ACAD SCI USA, V106, P18177, DOI 10.1073/pnas.0905558106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbosa RL, 2007, J BACTERIOL, V189, P6185, DOI 10.1128/JB.00331-07; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Bricogne G., 2009, BUSTER VERSION 2 9 1; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eklund L, 2000, TREES-STRUCT FUNCT, V14, P177, DOI 10.1007/PL00009761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gueune H, 2008, APPL ENVIRON MICROB, V74, P1954, DOI 10.1128/AEM.02294-07; Hanzelmann P, 2009, PROTEIN SCI, V18, P2480, DOI 10.1002/pro.260; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KANVINDE L, 1990, APPL ENVIRON MICROB, V56, P2087, DOI 10.1128/AEM.56.7.2087-2092.1990; Krishna SS, 2007, PROTEINS, V69, P415, DOI 10.1002/prot.21314; Lazaro Barbosa R, 2007, ACTA CRYSTALLOGR F, V63, P596, DOI 10.1107/S1744309107028722; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Liu T, 2008, BIOCHEMISTRY-US, V47, P10564, DOI 10.1021/bi801313y; Lloyd D, 2006, TRENDS MICROBIOL, V14, P456, DOI 10.1016/j.tim.2006.08.003; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mandal S, 2007, MICROBIOL-SGM, V153, P80, DOI 10.1099/mic.0.29197-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy JG, 2006, ACTA CRYSTALLOGR D, V62, P964, DOI 10.1107/S0907444906020592; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pavlovkin J, 2002, J EXP BOT, V53, P1143, DOI 10.1093/jexbot/53.371.1143; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Spicer R, 2007, J EXP BOT, V58, P1313, DOI 10.1093/jxb/erl296; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; THOMSON CJ, 1991, PLANT PHYSIOL, V96, P1294, DOI 10.1104/pp.96.4.1294; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Vonrhein C., 2006, MACROMOLECULAR CRYST, V2, P215; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wilson K, 2008, DIGEST DIS SCI, V53, P277, DOI 10.1007/s10620-007-9854-9	54	54	55	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26148	26157		10.1074/jbc.M111.234039	http://dx.doi.org/10.1074/jbc.M111.234039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632538	Green Published, hybrid			2022-12-25	WOS:000293073000072
J	Vetrivel, KS; Barman, A; Chen, Y; Nguyen, PD; Wagner, SL; Prabhakar, R; Thinakaran, G				Vetrivel, Kulandaivelu S.; Barman, Arghya; Chen, Ying; Nguyen, Phuong D.; Wagner, Steven L.; Prabhakar, Rajeev; Thinakaran, Gopal			Loss of Cleavage at beta '-Site Contributes to Apparent Increase in beta-Amyloid Peptide (A beta) Secretion by beta-Secretase (BACE1)-Glycosylphosphatidylinositol (GPI) Processing of Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; LIPID RAFTS; GAMMA-SECRETASE; CLEAVING ENZYME; BACE1; GOLGI; TRAFFICKING; METABOLISM; SUBSTRATE; COMPLEX	Several lines of evidence implicate lipid raft microdomains in Alzheimer disease-associated beta-amyloid peptide (A beta) production. Notably, targeting beta-secretase (beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)) exclusively to lipid rafts by the addition of a glycosylphosphatidylinositol (GPI) anchor to its ectodomain has been reported to elevate A beta secretion. Paradoxically, A beta secretion is not reduced by the expression of non-raft resident S-palmitoylation-deficient BACE1 (BACE1-4C/A (C474A/C478A/C482A/C485A)). We addressed this apparent discrepancy in raft microdomain-associated BACE1 processing of APP in this study. As previously reported, we found that expression of BACE1-GPI elevated A beta secretion as compared with wild-type BACE1 (WTBACE1) or BACE1-4C/A. However, this increase occurred without any difference in the levels of APP ectodomain released following BACE1 cleavage (soluble APP beta), arguing against an overall increase in BACE1 processing of APP per se. Further analysis revealed that WTBACE1 cleaves APP at beta- and beta'-sites, generating +1 and +11 beta-C-terminal fragments and secreting intact as well as N-terminally truncated A beta. In contrast, three different BACE1-GPI chimeras preferentially cleaved APP at the beta-site, mainly generating +1 beta-C-terminal fragment and secreting intact A beta. As a consequence, cells expressing BACE1-GPI secreted relatively higher levels of intact A beta without an increase in BACE1 processing of APP. Markedly reduced cleavage at beta'-site exhibited by BACE1-GPI was cell type-independent and insensitive to subcellular localization of APP or the pathogenic KM/NL mutant. We conclude that the apparent elevation in A beta secretion by BACE1-GPI is mainly attributed to preferential cleavage at the beta-site and failure to detect +11 A beta species secreted by cells expressing WTBACE1.	[Vetrivel, Kulandaivelu S.; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Vetrivel, Kulandaivelu S.; Chen, Ying; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Barman, Arghya; Prabhakar, Rajeev] Univ Miami, Dept Chem, Coral Gables, FL 33146 USA; [Nguyen, Phuong D.; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA	University of Chicago; University of Chicago; University of Chicago; University of Miami; University of California System; University of California San Diego	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu		Prabhakar, Rajeev/0000-0003-1137-1272	National Institutes of Health [AG021495, AG019070]; Alzheimer's Association; Department of Health of the Florida State Health Department [08KN-11]; NATIONAL INSTITUTE ON AGING [R01AG021495, R01AG019070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Department of Health of the Florida State Health Department; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 and AG019070 (to G. T.). This work was also supported by grants from the Alzheimer's Association (to G. T. and to K. S. V.) and Department of Health Grant 08KN-11 from the James and Esther King Biomedical Research Program of the Florida State Health Department (to R. P.).	Barman A, 2011, BIOCHEMISTRY-US, V50, P4337, DOI 10.1021/bi200081h; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; Gorfe AA, 2005, STRUCTURE, V13, P1487, DOI 10.1016/j.str.2005.06.015; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Koo EH, 1996, J CELL SCI, V109, P991; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Onishi M, 1996, EXP HEMATOL, V24, P324; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Qahwash I, 2004, J BIOL CHEM, V279, P39010, DOI 10.1074/jbc.M407101200; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Steinhilb ML, 2002, J NEUROCHEM, V80, P1019, DOI 10.1046/j.0022-3042.2002.00764.x; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Xiong B, 2004, ACTA PHARMACOL SIN, V25, P705; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	46	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26166	26177		10.1074/jbc.M111.260471	http://dx.doi.org/10.1074/jbc.M111.260471			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642424	hybrid, Green Published			2022-12-25	WOS:000293073000074
J	Mih, JD; Sharif, AS; Liu, F; Marinkovic, A; Symer, MM; Tschumperlin, DJ				Mih, Justin D.; Sharif, Asma S.; Liu, Fei; Marinkovic, Aleksandar; Symer, Matthew M.; Tschumperlin, Daniel J.			A Multiwell Platform for Studying Stiffness-Dependent Cell Biology	PLOS ONE			English	Article							SUBSTRATE FLEXIBILITY; CREASING INSTABILITY; MATRIX STIFFNESS; SOFT; MORPHOLOGY; HYDROGELS; FIBROSIS; CULTURE	Adherent cells are typically cultured on rigid substrates that are orders of magnitude stiffer than their tissue of origin. Here, we describe a method to rapidly fabricate 96 and 384 well platforms for routine screening of cells in tissue-relevant stiffness contexts. Briefly, polyacrylamide (PA) hydrogels are cast in glass-bottom plates, functionalized with collagen, and sterilized for cell culture. The Young's modulus of each substrate can be specified from 0.3 to 55 kPa, with collagen surface density held constant over the stiffness range. Using automated fluorescence microscopy, we captured the morphological variations of 7 cell types cultured across a physiological range of stiffness within a 384 well plate. We performed assays of cell number, proliferation, and apoptosis in 96 wells and resolved distinct profiles of cell growth as a function of stiffness among primary and immortalized cell lines. We found that the stiffness-dependent growth of normal human lung fibroblasts is largely invariant with collagen density, and that differences in their accumulation are amplified by increasing serum concentration. Further, we performed a screen of 18 bioactive small molecules and identified compounds with enhanced or reduced effects on soft versus rigid substrates, including blebbistatin, which abolished the suppression of lung fibroblast growth at 1 kPa. The ability to deploy PA gels in multiwell plates for high throughput analysis of cells in tissue-relevant environments opens new opportunities for the discovery of cellular responses that operate in specific stiffness regimes.	[Mih, Justin D.; Sharif, Asma S.; Liu, Fei; Marinkovic, Aleksandar; Symer, Matthew M.; Tschumperlin, Daniel J.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mih, JD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dtschump@hsph.harvard.edu		Symer, Matthew/0000-0003-2722-8155	U.S. National Institutes of Health [GM-073628, HL-092961]; Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM073628] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the U.S. National Institutes of Health (GM-073628 and HL-092961) and the Scleroderma Foundation to D.J.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARATYNSCHAUS Y, PREPARATION COMPLAIN; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Chen WLK, 2010, BIOMATERIALS, V31, P2489, DOI 10.1016/j.biomaterials.2009.12.002; CRETU A, 2010, STUDYING EFFECTS MAT; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Jachowicz J, 2007, SKIN RES TECHNOL, V13, P299, DOI 10.1111/j.1600-0846.2007.00229.x; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saha K, 2010, BIOPHYS J, V99, pL94, DOI 10.1016/j.bpj.2010.09.045; Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328; Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Trujillo V, 2008, SOFT MATTER, V4, P564, DOI 10.1039/b713263h; Tse JR, 2010, CURR PROTOC CELL BIO, V47, DOI [10.1002/0471143030.cb1016-47, DOI 10.1002/0471143030.CB1016-47]; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; 6846881	34	118	118	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19929	10.1371/journal.pone.0019929	http://dx.doi.org/10.1371/journal.pone.0019929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637769	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500018
J	Nilsson, EE; Schindler, R; Savenkova, MI; Skinner, MK				Nilsson, Eric E.; Schindler, Ryan; Savenkova, Marina I.; Skinner, Michael K.			Inhibitory Actions of Anti-Mullerian Hormone (AMH) on Ovarian Primordial Follicle Assembly	PLOS ONE			English	Article							DIFFERENTIAL SUBCELLULAR-LOCALIZATION; NECROSIS-FACTOR-ALPHA; FGF ANTISENSE GENE; GERM-CELLS; NEST BREAKDOWN; TGF-BETA; IN-VITRO; MOUSE; GROWTH; PROGESTERONE	The current study was designed to investigate the actions of Anti-Mullerian Hormone (AMH) on primordial follicle assembly. Ovarian primordial follicles develop from the breakdown of oocyte nests during fetal development for the human and immediately after birth in rodents. AMH was found to inhibit primordial follicle assembly and decrease the initial primordial follicle pool size in a rat ovarian organ culture. The AMH expression was found to be primarily in the stromal tissue of the ovaries at this period of development, suggesting a stromal-epithelial cell interaction for primordial follicle assembly. AMH was found to promote alterations in the ovarian transcriptome during primordial follicle assembly with over 200 genes with altered expression. A gene network was identified suggesting a potential central role for the Fgf2/Nudt6 antisense transcript in the follicle assembly process. A number of signal transduction pathways are regulated by AMH actions on the ovarian transcriptome, in particular the transforming growth factor - beta (TGF beta) signaling process. AMH is the first hormone/protein shown to have an inhibitory action on primordial follicle assembly. Due to the critical role of the primordial follicle pool size for female reproduction, elucidation of factors, such as AMH, that regulate the assembly process will provide insights into potential therapeutics to manipulate the pool size and female reproduction.	[Nilsson, Eric E.; Schindler, Ryan; Savenkova, Marina I.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Nilsson, EE (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020; Savenkova, Marina/AAN-9927-2021		National Institutes of Health, NICHD	National Institutes of Health, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a National Institutes of Health, NICHD grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguma-Nibasheka M, 2007, MOL CELL ENDOCRINOL, V267, P127, DOI 10.1016/j.mce.2007.01.008; BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chen Y, 2007, ENDOCRINOLOGY, V148, P3580, DOI 10.1210/en.2007-0088; Coulson-Thomas VJ, 2010, EXP CELL RES, V316, P3207, DOI 10.1016/j.yexcr.2010.08.005; de Bruin JP, 2002, BIOL REPROD, V66, P1151, DOI 10.1095/biolreprod66.4.1151; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Erickson Gregory F, 2003, Reprod Biol Endocrinol, V1, P9, DOI 10.1186/1477-7827-1-9; Faddy MJ, 1996, HUM REPROD, V11, P1484; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; GONDOS B, 1973, Z ZELLFORSCH MIK ANA, V138, P23, DOI 10.1007/BF00307075; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Gougeon A, 2000, MOL CELL ENDOCRINOL, V163, P33, DOI 10.1016/S0303-7207(00)00220-3; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Klattig J, 2007, SEX DEV, V1, P271, DOI 10.1159/000108929; Knee R, 1997, P NATL ACAD SCI USA, V94, P4943, DOI 10.1073/pnas.94.10.4943; KONISHI I, 1986, J ANAT, V148, P121; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; LEE MM, 1993, ENDOCR REV, V14, P152, DOI 10.1210/er.14.2.152; Mark-Kappeler CJ, 2010, TOXICOL APPL PHARM, V249, P1, DOI 10.1016/j.taap.2010.08.024; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Morrison LJ, 2002, BIOL REPROD, V66, P450, DOI 10.1095/biolreprod66.2.450; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; Nilsson EE, 2006, REPRODUCTION, V132, P877, DOI 10.1530/REP-06-0045; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Nilsson EE, 2009, MOL CELL ENDOCRINOL, V313, P9, DOI 10.1016/j.mce.2009.09.004; ODOR DL, 1969, AM J ANAT, V124, P163, DOI 10.1002/aja.1001240204; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; Piprek RP, 2009, FOLIA BIOL-KRAKOW, V57, P105, DOI 10.3409/fb57_3-4.105-113; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; SAKAI T, 1955, JAPANESE J VET RES, V3, P183; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; Schlessinger D, 2010, J ANDROL, V31, P16, DOI 10.2164/jandrol.109.008201; Sforza C, 1998, MARC MALPIG SYMP SER, V6, P51; SHIMA JE, 2004, BIOL REPROD; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Tanaka Y, 2001, REPRODUCTION, V121, P777, DOI 10.1530/rep.0.1210777; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Trombly DJ, 2009, ENDOCRINOLOGY, V150, P1014, DOI 10.1210/en.2008-0213; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Visser JA, 2005, MOL CELL ENDOCRINOL, V234, P81, DOI 10.1016/j.mce.2004.09.008; Visser JA, 2003, MOL CELL ENDOCRINOL, V211, P65, DOI 10.1016/j.mce.2003.09.012; Wenner CE, 2003, J CELL PHYSIOL, V196, P42, DOI 10.1002/jcp.10243; Yang MY, 2008, BIOL REPROD, V78, P1153, DOI 10.1095/biolreprod.107.066688; Zhang SC, 2007, J MOL MED, V85, P1215, DOI 10.1007/s00109-007-0219-9; Zhang SC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-10; Zhao P, 2008, ENDOCRINOLOGY, V149, P2782, DOI 10.1210/en.2007-1662	67	76	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20087	10.1371/journal.pone.0020087	http://dx.doi.org/10.1371/journal.pone.0020087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637711	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500028
J	Hommais, F; Zghidi-Abouzid, O; Oger-Desfeux, C; Pineau-Chapelle, E; Van Gijsegem, F; Nasser, W; Reverchon, S				Hommais, Florence; Zghidi-Abouzid, Ouafa; Oger-Desfeux, Christine; Pineau-Chapelle, Emilie; Van Gijsegem, Frederique; Nasser, William; Reverchon, Sylvie			lpxC and yafS are the Most Suitable Internal Controls to Normalize Real Time RT-qPCR Expression in the Phytopathogenic Bacteria Dickeya dadantii	PLOS ONE			English	Article							HOUSEKEEPING GENES; GLOBAL REGULATOR; PLANT PATHOGEN; VIRULENCE; PCR; TRANSCRIPTION; PHASE; FIS	Background: Quantitative RT-PCR is the method of choice for studying, with both sensitivity and accuracy, the expression of genes. A reliable normalization of the data, using several reference genes, is critical for an accurate quantification of gene expression. Here, we propose a set of reference genes, of the phytopathogenic bacteria Dickeya dadantii and Pectobacterium atrosepticum, which are stable in a wide range of growth conditions. Results: We extracted, from a D. dadantii micro-array transcript profile dataset comprising thirty-two different growth conditions, an initial set of 49 expressed genes with very low variation in gene expression. Out of these, we retained 10 genes representing different functional categories, different levels of expression (low, medium, and high) and with no systematic variation in expression correlating with growth conditions. We measured the expression of these reference gene candidates using quantitative RT-PCR in 50 different experimental conditions, mimicking the environment encountered by the bacteria in their host and directly during the infection process in planta. The two most stable genes (ABF-0017965 (lpxC) and ABF-0020529 (yafS) were successfully used for normalization of RT-qPCR data. Finally, we demonstrated that the ortholog of lpxC and yafS in Pectobacterium atrosepticum also showed stable expression in diverse growth conditions. Conclusions: We have identified at least two genes, lpxC (ABF-0017965) and yafS (ABF-0020509), whose expressions are stable in a wide range of growth conditions and during infection. Thus, these genes are considered suitable for use as reference genes for the normalization of real-time RT-qPCR data of the two main pectinolytic phytopathogenic bacteria D. dadantii and P. atrosepticum and, probably, of other Enterobacteriaceae. Moreover, we defined general criteria to select good reference genes in bacteria.	[Hommais, Florence; Zghidi-Abouzid, Ouafa; Nasser, William; Reverchon, Sylvie] Univ Lyon 1, Unite Microbiol, Pathogenie CNRS INSA UCBL UMR 5240, F-69622 Villeurbanne, France; [Hommais, Florence; Zghidi-Abouzid, Ouafa; Nasser, William; Reverchon, Sylvie] Univ Lyon, Lyon, France; [Hommais, Florence; Zghidi-Abouzid, Ouafa; Nasser, William; Reverchon, Sylvie] INSA Lyon, Villeurbanne, France; [Oger-Desfeux, Christine] Univ Lyon 1, IFR41, F-69622 Villeurbanne, France; [Pineau-Chapelle, Emilie; Van Gijsegem, Frederique] UMR 217 INRA AgroParisTech UPMC P6, Lab Interact Plantes Pathogenes, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; AgroParisTech; INRAE; UDICE-French Research Universities; Sorbonne Universite	Hommais, F (corresponding author), Univ Lyon 1, Unite Microbiol, Pathogenie CNRS INSA UCBL UMR 5240, F-69622 Villeurbanne, France.	hommais@univ-lyon1.fr	Van Gijsegem, Frederique/D-1103-2017; Hommais, Florence/D-2785-2019; NASSER, William/C-9611-2019; Sylvie, Reverchon/P-7932-2016	Hommais, Florence/0000-0003-2151-3545; NASSER, William/0000-0001-9848-3597; Sylvie, Reverchon/0000-0002-0478-3474	French ANR [ANR-07-BLAN-0212]; Centre National de la Recherche Scientifique	French ANR(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the French ANR Blanc Regupath 2007 Program, N<SUP>o</SUP>ANR-07-BLAN-0212, and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Dorman CJ, 2009, NUCLEIC ACIDS RES, V37, P672, DOI 10.1093/nar/gkn996; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; HINTON JCD, 1989, MOL GEN GENET, V217, P141, DOI 10.1007/BF00330953; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; HUGOUVIEUXCOTTEPATTAT N, 1992, J BACTERIOL, V174, P7807, DOI 10.1128/JB.174.23.7807-7818.1992; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kepseu WD, 2010, J BIOL CHEM, V285, P28565, DOI 10.1074/jbc.M110.114710; Lautier T, 2007, MOL MICROBIOL, V66, P1474, DOI 10.1111/j.1365-2958.2007.06012.x; Lautier T, 2007, MOL MICROBIOL, V66, P1491, DOI 10.1111/j.1365-2958.2007.06010.x; Lebeau A, 2008, ENVIRON MICROBIOL, V10, P545, DOI 10.1111/j.1462-2920.2007.01473.x; Perombelon MCM, 2002, PLANT PATHOL, V51, P1, DOI 10.1046/j.0032-0862.2001.Short title.doc.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reverchon S, 2010, MOL MICROBIOL, V78, P1018, DOI 10.1111/j.1365-2958.2010.07388.x; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sepulchre JA, 2007, J THEOR BIOL, V244, P239, DOI 10.1016/j.jtbi.2006.08.010; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100; Wisniewski JP, 2004, PLANT MOL BIOL, V56, P325, DOI 10.1007/s11103-004-3414-x	27	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20269	10.1371/journal.pone.0020269	http://dx.doi.org/10.1371/journal.pone.0020269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637857	Green Submitted, gold, Green Published			2022-12-25	WOS:000291052200045
J	Ope, MO; Katz, MA; Aura, B; Gikunju, S; Njenga, MK; Ng'ang'a, Z; Vulule, J; Breiman, RF; Feikin, DR				Ope, Maurice O.; Katz, Mark A.; Aura, Barrack; Gikunju, Stella; Njenga, M. Kariuki; Ng'ang'a, Zipporah; Vulule, John; Breiman, Robert F.; Feikin, Daniel R.			Risk Factors for Hospitalized Seasonal Influenza in Rural Western Kenya	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; TYPE-1 INFECTION; SWINE INFLUENZA; HIGH PREVALENCE; MORTALITY; MORBIDITY; HUMANS; EPIDEMIOLOGY	Background: Risk factors for influenza hospitalization in Africa are unknown, including the role of HIV. Methods: We conducted a case-control study of risk factors for hospitalized seasonal influenza among persons in rural western Kenya, a high HIV prevalence area, from March 2006-August 2008. Eligible cases were >= five years old, admitted to health facilities with respiratory symptoms, and had nasopharyngeal/oropharyngeal swab specimens that tested positive for influenza A or B by real-time reverse transcription-PCR. Three randomly selected age- ,sex-and neighborhood-matched controls were enrolled per case. A structured questionnaire was administered and home-based HIV testing was performed. Risk factors were evaluated using conditional logistic regression. Results: A total of 64 cases (38 with influenza A and 26 with influenza B) and 190 controls were enrolled. The median age was 16 years (range 5-69 years). Among cases, 24.5% were HIV-infected versus 12.5% of controls (p = 0.004). Among persons >= 18 years old, 13 (59%) of 22 tested cases were HIV-positive compared with 15 (24%) of 62 tested controls (p = 0.005). In multivariable analysis, HIV-infection was associated with hospitalization due to influenza [adjusted Odds Ratio (aOR) 3.56, 95% CI 1.25-10.1]. The mean CD4 count among HIV-infected cases and controls was similar (399 vs. 387, respectively, p = 0.89). Chronic lung disease (aOR 6.83, 95% CI 1.37-34.0) was also associated with influenza hospitalization in multivariable analysis. Active pulmonary tuberculosis was associated with influenza hospitalization in bivariate, but not multivariable, analysis. Conclusions: People with HIV infection and chronic lung disease were at increased risk of hospitalized influenza in rural Kenya. HIV infection is common in many parts of sub-Saharan Africa. Influenza vaccine might prevent severe influenza in these risk groups.	[Ope, Maurice O.] Minist Publ Hlth & Sanitat, Dept Dis Surveillance & Response, Nairobi, Kenya; [Ope, Maurice O.] Ctr Dis Control & Prevent, Field Epidemiol & Lab Management Training Program, Nairobi, Kenya; [Ope, Maurice O.; Ng'ang'a, Zipporah] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Katz, Mark A.] Ctr Dis Control & Prevent, Global Dis Detect Div, Influenza Program, Nairobi, Kenya; [Aura, Barrack; Gikunju, Stella; Njenga, M. Kariuki; Breiman, Robert F.; Feikin, Daniel R.] Ctr Dis Control & Prevent, Int Emerging Infect Program, Nairobi, Kenya; [Aura, Barrack; Gikunju, Stella; Vulule, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya	Jomo Kenyatta University of Agriculture & Technology; Kenya Medical Research Institute	Ope, MO (corresponding author), Minist Publ Hlth & Sanitat, Dept Dis Surveillance & Response, Nairobi, Kenya.	dfeikin@cdc.gov			U.S. Centers for Disease Control and Prevention	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The project was funded by funding from the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Anema A, 2008, HIV MED, V9, P57, DOI 10.1111/j.1468-1293.2008.00515.x; Bender JM, 2009, PEDIATR EMERG CARE, V25, P369, DOI 10.1097/PEC.0b013e3181a792a9; Boschini A, 2006, J MED VIROL, V78, P1218, DOI 10.1002/jmv.20684; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; *IFPMA, 2010, P 7 C OPT CONTR INFL; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Li GX, 2009, J CLIN VIROL, V46, P275, DOI 10.1016/j.jcv.2009.07.015; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Madhi SA, 2007, PEDIATR INFECT DIS J, V26, P693, DOI 10.1097/INF.0b013e3180621192; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; National AIDS and STI Control Programme, 2008, KEN AIDS IND SURV 20; Neuzil KM, 2003, JAIDS-J ACQ IMM DEF, V34, P304, DOI 10.1097/00126334-200311010-00008; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Tasker SA, 1999, ANN INTERN MED, V131, P430, DOI 10.7326/0003-4819-131-6-199909210-00006; World Health Organization, 2008, HIV AIDS EP SURV REP; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; 2002, WKLY EPIDEMIOL REC, V77, P350	29	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20111	10.1371/journal.pone.0020111	http://dx.doi.org/10.1371/journal.pone.0020111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637856	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200033
J	Kolluru, B; Hawizy, L; Murray-Rust, P; Tsujii, J; Ananiadou, S				Kolluru, BalaKrishna; Hawizy, Lezan; Murray-Rust, Peter; Tsujii, Junichi; Ananiadou, Sophia			Using Workflows to Explore and Optimise Named Entity Recognition for Chemistry	PLOS ONE			English	Article							BIOINFORMATICS; TOOLS; WEB	Chemistry text mining tools should be interoperable and adaptable regardless of system-level implementation, installation or even programming issues. We aim to abstract the functionality of these tools from the underlying implementation via reconfigurable workflows for automatically identifying chemical names. To achieve this, we refactored an established named entity recogniser (in the chemistry domain), OSCAR and studied the impact of each component on the net performance. We developed two reconfigurable workflows from OSCAR using an interoperable text mining framework, U-Compare. These workflows can be altered using the drag-&-drop mechanism of the graphical user interface of U-Compare. These workflows also provide a platform to study the relationship between text mining components such as tokenisation and named entity recognition (using maximum entropy Markov model (MEMM) and pattern recognition based classifiers). Results indicate that, for chemistry in particular, eliminating noise generated by tokenisation techniques lead to a slightly better performance than others, in terms of named entity recognition (NER) accuracy. Poor tokenisation translates into poorer input to the classifier components which in turn leads to an increase in Type I or Type II errors, thus, lowering the overall performance. On the Sciborg corpus, the workflow based system, which uses a new tokeniser whilst retaining the same MEMM component, increases the F-score from 82.35% to 84.44%. On the PubMed corpus, it recorded an F-score of 84.84% as against 84.23% by OSCAR.	[Kolluru, BalaKrishna; Tsujii, Junichi; Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Hawizy, Lezan; Murray-Rust, Peter] Univ Cambridge, Unilever Ctr Mol Informat, Cambridge, England	University of Manchester; University of Cambridge	Kolluru, B (corresponding author), Univ Manchester, Natl Ctr Text Min, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	balakrishna.kolluru@manchester.ac.uk		Hawizy, Lezan/0000-0002-0932-3135; Murray-Rust, Peter/0000-0003-3386-3972	UK Joint Information Systems Committee (JISC); Biotechnology and Biological Sciences Research Council [BB/F006039/1]; BBSRC [BB/G53025X/1, BB/F006012/1, BB/F006039/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G53025X/1, BB/F006012/1] Funding Source: researchfish	UK Joint Information Systems Committee (JISC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research has been supported by the UK Joint Information Systems Committee (JISC) (CheTA project) and the Biotechnology and Biological Sciences Research Council (ONDEX project, BB/F006039/1). The National Centre for Text Mining is supported by JISC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, 2010, PIP PIL; Banville DL, 2006, DRUG DISCOV TODAY, V11, P35, DOI 10.1016/S1359-6446(05)03682-2; COPESTAKE A, 2010, EXTRACTING SCI SCI P; Corbett P, 2006, LECT NOTES COMPUT SC, V4216, P107; Corbett P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S4; *EBI, 2010, CHEM ENT BIOL INT CH; FERRUCCI D, 2006, INTEROPERABILITYSTAN; FLORIAN B, 2008, CICLING, P334; Hassan M, 2006, MOL DIVERS, V10, P283, DOI 10.1007/s11030-006-9041-5; Hettne KM, 2010, J CHEMINFORMATICS, V2, DOI [10.1186/1758-2946-2-3, 10.1186/1758-2946-2-4]; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Jiao DZ, 2009, J CHEM INF MODEL, V49, P263, DOI 10.1021/ci800332w; KANO Y, 2010, BIOINFORMATICS; KANO Y, 2008, P 1 INT C GLOB INT L, P122; KANO Y, 2009, SETQA NLP 09, P22; Kano Y, 2009, BIOINFORMATICS, V25, P1997, DOI 10.1093/bioinformatics/btp289; Kemp N, 1998, J CHEM INF COMP SCI, V38, P544, DOI 10.1021/ci980324v; KLINGER R, 2009, CHEM NAMES TERMINOLO; Klinger R, 2008, BIOINFORMATICS, V24, pI268, DOI 10.1093/bioinformatics/btn181; Kolarik C., 2008, WORKSH BUILD EV RES; KOLRIK C, 2007, BIOINFORMATICS, V13, P264; KUHN T, 2009, CHEM CENTRAL J, V3, P42; Kuhn T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-159; Ludascher B, 2006, CONCURR COMP-PRACT E, V18, P1039, DOI 10.1002/cpe.994; MELLEBEEK B, 2009, NATURE PRECEDINGS; MIYAO Y, 2005, ACL 05 P 43 ANN M AS, P83; Muller B, 2010, LECT NOTES COMPUT SC, V6107, P152, DOI 10.1007/978-3-642-13084-7_12; Murray-Rust P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-141; Murray-Rust P, 1999, J CHEM INF COMP SCI, V39, P928, DOI 10.1021/ci990052b; *NIH, 2010, PUBM; NOBATA C, 2009, INT C DIG LIB SEM WE; Oinn T, 2004, BIOINFORMATICS, V20, P3045, DOI 10.1093/bioinformatics/bth361; RUPP CJ, 2006, P 4 UK E SCI ALL HAN; RUPP CJ, 2007, INTEGRATING GEN PURP; Shon J, 2008, CURR OPIN DRUG DISC, V11, P381; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; TAYLOR I, 2007, WORKFLOWS E SCI WORK; TIWARI A, 2008, COMPUTATIONAL BIOL C, V31, P306; Townsend Joseph A., 2009, Proceedings of the 2009 5th IEEE International Conference on e-Science (e-Science 2009), P337, DOI 10.1109/e-Science.2009.54; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y., 2009, P 12 C EUR CHAPT ACL, P790; Vellay S. G. P., 2009, Infectious Disorders - Drug Targets, V9, P366; WILBUR W, 1999, AMIA S 1999, P176; Wren JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S3; 2010, OPENNLP; 2010, MEDLINE	46	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20181	10.1371/journal.pone.0020181	http://dx.doi.org/10.1371/journal.pone.0020181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633495	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500036
J	Zhang, FB; Shang, DH; Zhang, YH; Tian, Y				Zhang, Fengbo; Shang, Donghao; Zhang, Yuhai; Tian, Ye			Interleukin-22 Suppresses the Growth of A498 Renal Cell Carcinoma Cells via Regulation of STAT1 Pathway	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; INTERFERON-ALPHA; INDUCIBLE FACTOR; CANCER; IL-22; EXPRESSION; CYTOKINE; SURVIVAL; IL-10; COLON	Background: Renal cell carcinoma (RCC) is one of the most common kidney cancers and is highly resistant to chemotherapy. Accumulating evidence suggests that interleukin-22 (IL-22) may mediate host defense against varietal pathogens as a proinflammatory and anti-inflammatory cytokine. The purpose of this study is to assess the inhibitory effects of IL-22 on human RCC cell line A498 and to investigate the possible mechanisms underlying the anti-tumor effects of this cytokine. Methodology: A498 cells, a RCC cell line, were used to assess the inhibitory growth effects of IL-22 using the MTT assay and flow cytometric analysis in vitro. BALB/C nude mice bearing A498 cell xenografts were used to examine the antitumor efficacy of IL-22 in vivo. Western blotting assay was performed to detect the regulation of the intracellular signaling pathway of IL-22. Principal Findings: We found that IL-22 suppressed the growth of A498 cells in a dose-dependent manner and inhibited the growth of A498 xenografts. We also observed that IL-22 produced a dose-dependent inhibitory effect on A498 cells that involved the induction of G2/M cell cycle arrest without cell apoptosis. Moreover, we showed that the phosphorylation of STAT1 was increased and the phosphorylation of ERK1/2 was attenuated in A498 cells exposed to IL-22. The growth inhibition of A498 cells was partially revised after IL-22 treatment as the expression of STAT1 was knocked down. And inflammatory cytokines, interferon-alpha and tumor necrosis factor-alpha (TNF-alpha) were barely involved in the suppression of A498 cell xenografts treated with IL-22. Conclusions: IL-22 dose-dependently suppresses RCC cell line A498 cells in vitro and induces growth inhibition of A498 cell-bearing mouse xenografts. These results suggest that the anti-RCC effects of IL-22 are at least partially mediated through regulation of STAT1 signaling pathways and G2/M cell cycle arrest, rather than by inducing apoptosis and inflammatory cytokines.	[Zhang, Fengbo; Shang, Donghao; Zhang, Yuhai; Tian, Ye] Capital Med Univ, Beijing Friendship Hosp, Dept Urol Surg, Beijing, Peoples R China	Capital Medical University	Zhang, FB (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Urol Surg, Beijing, Peoples R China.	Fengbo_zhang@hotmail.com						Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Anderson GM, 2004, CURR OPIN PHARMACOL, V4, P314, DOI 10.1016/j.coph.2004.04.004; Arias JF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-15; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; DeCastro GJ, 2008, UROL CLIN N AM, V35, P581, DOI 10.1016/j.ucl.2008.07.005; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Hartmann JT, 1999, ANTICANCER RES, V19, P1541; Hernberg M, 1999, J IMMUNOTHER, V22, P145, DOI 10.1097/00002371-199903000-00006; Ikeuchi H, 2005, ARTHRITIS RHEUM-US, V52, P1037, DOI 10.1002/art.20965; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Krop I, 2005, CANCER RES, V65, P9659, DOI 10.1158/0008-5472.CAN-05-1663; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li J, 2004, INT IMMUNOPHARMACOL, V4, P693, DOI 10.1016/j.intimp.2004.01.010; McDermott DF, 2005, J CLIN ONCOL, V23, P133, DOI 10.1200/JCO.2005.03.206; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Nagakawa H, 2004, SCAND J IMMUNOL, V60, P449, DOI 10.1111/j.0300-9475.2004.01504.x; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Nanus DM, 2004, CANCER-AM CANCER SOC, V101, P1545, DOI 10.1002/cncr.20541; O'Brien MF, 2004, EUR UROL, V45, P613, DOI 10.1016/j.eururo.2003.11.002; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pantuck AJ, 2001, J UROLOGY, V166, P1611, DOI 10.1016/S0022-5347(05)65640-6; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Roos FC, 2009, CURR OPIN UROL, V19, P459, DOI 10.1097/MOU.0b013e32832f0c7d; Schnyder B, 2010, CYTOKINE, V50, P220, DOI 10.1016/j.cyto.2010.02.003; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Thompson CL, 2010, CANCER CAUSE CONTROL, V21, P1165, DOI 10.1007/s10552-010-9542-5; Veiga-Fernandes H, 2010, J EXP MED, V207, P269, DOI 10.1084/jem.20100105; Vuky J, 2000, UROL ONCOL, V5, P249, DOI 10.1016/S1078-1439(00)00068-5; Weber GF, 2006, J IMMUNOL, V177, P8266, DOI 10.4049/jimmunol.177.11.8266; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yao SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000789; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401; Zhu ZZ, 2010, ONCOLOGY-BASEL, V78, P382, DOI 10.1159/000320521; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	43	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20382	10.1371/journal.pone.0020382	http://dx.doi.org/10.1371/journal.pone.0020382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625390	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005200057
J	Alexandrov, BS; Valtchinov, VI; Alexandrov, LB; Gelev, V; Dagon, Y; Bock, J; Kohane, IS; Rasmussen, KO; Bishop, AR; Usheva, A				Alexandrov, Boian S.; Valtchinov, Vlad I.; Alexandrov, Ludmil B.; Gelev, Vladimir; Dagon, Yossi; Bock, Jonathan; Kohane, Isaac S.; Rasmussen, Kim O.; Bishop, Alan R.; Usheva, Anny			DNA Dynamics Is Likely to Be a Factor in the Genomic Nucleotide Repeats Expansions Related to Diseases	PLOS ONE			English	Article							BASAL TRANSCRIPTION; INSTABILITY; GENE; MECHANISMS; ATAXIA; REPLICATION; PROMOTER; SEQUENCE; BINDING; COMMON	Trinucleotide repeats sequences (TRS) represent a common type of genomic DNA motif whose expansion is associated with a large number of human diseases. The driving molecular mechanisms of the TRS ongoing dynamic expansion across generations and within tissues and its influence on genomic DNA functions are not well understood. Here we report results for a novel and notable collective breathing behavior of genomic DNA of tandem TRS, leading to propensity for large local DNA transient openings at physiological temperature. Our Langevin molecular dynamics (LMD) and Markov Chain Monte Carlo (MCMC) simulations demonstrate that the patterns of openings of various TRSs depend specifically on their length. The collective propensity for DNA strand separation of repeated sequences serves as a precursor for outsized intermediate bubble states independently of the G/C-content. We report that repeats have the potential to interfere with the binding of transcription factors to their consensus sequence by altered DNA breathing dynamics in proximity of the binding sites. These observations might influence ongoing attempts to use LMD and MCMC simulations for TRS-related modeling of genomic DNA functionality in elucidating the common denominators of the dynamic TRS expansion mutation with potential therapeutic applications.	[Alexandrov, Boian S.; Rasmussen, Kim O.; Bishop, Alan R.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Valtchinov, Vlad I.; Kohane, Isaac S.] Natl Ctr Biomed Comp Informat Integrating Biol &, Boston, MA USA; [Alexandrov, Ludmil B.; Gelev, Vladimir; Dagon, Yossi; Bock, Jonathan; Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Alexandrov, BS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA.	ausheva@bidmc.harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Dagon, Yossi/AAI-5882-2020; Alexandrov, Ludmil/AAS-1454-2021; Alexandrov, Boian/D-2488-2010; Rasmussen, Kim O/B-5464-2009; Alexandrov, Ludmil/B-6582-2014	Kohane, Isaac Kohane/0000-0003-2192-5160; Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Boian/0000-0001-8636-4603; Rasmussen, Kim O/0000-0002-4029-4723; Alexandrov, Ludmil/0000-0003-3596-4515	New Atlantic Technology Group, LLC, Newton, MA [0246, 02468]; National Institute of Health [GM073911]; ARRA supplement [GM073911-04S]; National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory [DE-AC52-06NA25396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073911] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010125] Funding Source: NIH RePORTER	New Atlantic Technology Group, LLC, Newton, MA; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA supplement; National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory(National Nuclear Security Administration); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank New Atlantic Technology Group, LLC, Newton, MA 0246 for support.; This research was supported by grants from the National Institute of Health Grant GM073911, ARRA supplement GM073911-04S to AU, Contract DE-AC52-06NA25396 National Nuclear Security Administration of the US Department of Energy at Los Alamos National Laboratory, New Atlantic Technology Group, LLC, Newton, MA 02468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2010, NUCLEIC ACIDS RES, V38, P1790, DOI 10.1093/nar/gkp1084; Alexandrov BS, 2009, NUCLEIC ACIDS RES, V37, P2405, DOI 10.1093/nar/gkp016; Ares S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.035504; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Cannella M, 2005, AM J MED GENET B, V133B, P127, DOI 10.1002/ajmg.b.30125; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cheli Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008743; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; De Biase I, 2007, GENOMICS, V90, P1, DOI 10.1016/j.ygeno.2007.04.001; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kornberg A, 2005, DNA REPLICATION, P41; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pandolfo M., 2006, GENETIC INSTABILITIE, P277; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Potaman VN, 2003, J MOL BIOL, V326, P1095, DOI 10.1016/S0022-2836(03)00037-8; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rindler PM, 2011, NUCLEIC ACIDS RES, V39, P526, DOI 10.1093/nar/gkq788; Schmid R, 1995, N ENGL J MED, V333, P1217; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Zeng Y, 2004, J MOL BIOL, V339, P67, DOI 10.1016/j.jmb.2004.02.072	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19800	10.1371/journal.pone.0019800	http://dx.doi.org/10.1371/journal.pone.0019800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625483	Green Published, gold, Green Submitted			2022-12-25	WOS:000290793400011
J	Glendorf, T; Stidsen, CE; Norrman, M; Nishimura, E; Sorensen, AR; Kjeldsen, T				Glendorf, Tine; Stidsen, Carsten E.; Norrman, Mathias; Nishimura, Erica; Sorensen, Anders R.; Kjeldsen, Thomas			Engineering of Insulin Receptor Isoform-Selective Insulin Analogues	PLOS ONE			English	Article							IGF-II; STRUCTURAL SWITCH; HYBRID RECEPTORS; BINDING EPITOPES; LIGAND-BINDING; ALPHA-SUBUNIT; B-ISOFORM; A-ISOFORM; CHAIN; RESIDUES	Background: The insulin receptor (IR) exists in two isoforms, A and B, and the isoform expression pattern is tissue-specific. The C-terminus of the insulin B chain is important for receptor binding and has been shown to contact the IR just adjacent to the region where the A and B isoforms differ. The aim of this study was to investigate the importance of the C-terminus of the B chain in IR isoform binding in order to explore the possibility of engineering tissue-specific/liver-specific insulin analogues. Methodology/Principal Findings: Insulin analogue libraries were constructed by total amino acid scanning mutagenesis. The relative binding affinities for the A and B isoform of the IR were determined by competition assays using scintillation proximity assay technology. Structural information was obtained by X-ray crystallography. Introduction of B25A or B25N mutations resulted in analogues with a 2-fold preference for the B compared to the A isoform, whereas the opposite was observed with a B25Y substitution. An acidic amino acid residue at position B27 caused an additional 2-fold selective increase in affinity for the receptor B isoform for analogues bearing a B25N mutation. Furthermore, the combination of B25H with either B27D or B27E also resulted in B isoform-preferential analogues (2-fold preference) even though the corresponding single mutation analogues displayed no differences in relative isoform binding affinity. Conclusions/Significance: We have discovered a new class of IR isoform-selective insulin analogues with 2-4-fold differences in relative binding affinities for either the A or the B isoform of the IR compared to human insulin. Our results demonstrate that a mutation at position B25 alone or in combination with a mutation at position B27 in the insulin molecule confers IR isoform selectivity. Isoform-preferential analogues may provide new opportunities for developing insulin analogues with improved clinical benefits.	[Glendorf, Tine; Stidsen, Carsten E.; Norrman, Mathias; Nishimura, Erica; Sorensen, Anders R.; Kjeldsen, Thomas] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark	Novo Nordisk	Glendorf, T (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	tgle@novonordisk.com		Nishimura, Erica/0000-0001-5741-3648; Kjeldsen, Thomas/0000-0003-0094-9286	Danish Ministry of Science, Technology and Innovation; Novo Nordisk; Novo Nordisk A/S	Danish Ministry of Science, Technology and Innovation; Novo Nordisk(Novo Nordisk); Novo Nordisk A/S(Novo Nordisk)	This work was supported by the Danish Ministry of Science, Technology and Innovation, the Novo Nordisk CORA Training and Research Program, and Novo Nordisk A/S. Novo Nordisk A/S had a role in the decision to publish. The work was carried out as part of T.G.'s Ph.D. studies and was funded by the Danish Ministry of Science, Technology and Innovation and Novo Nordisk A/S (the ministry paid part of T. G.'s salary and Novo Nordisk paid the rest of T.G.'s salary and for the experimental work T.G. performed in the laboratories. T.G. is a Novo Nordisk employee now and designed the study, collected the data, analyzed it and wrote the manuscript so T.G. definitely had a role in decision to publish. Novo Nordisk also paid the publication fee.	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; DEMEYTS P, 1978, NATURE, V273, P504; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frayn K, 2010, METABOLIC REGULATION; Giudice J, 2011, J CELL SCI, V124, P801, DOI 10.1242/jcs.076869; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; Kalli KR, 2002, ENDOCRINOLOGY, V143, P3259, DOI 10.1210/en.2001-211408; KELLERER M, 1992, BIOCHEMISTRY-US, V31, P4588, DOI 10.1021/bi00134a008; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KOSAKI A, 1995, J BIOL CHEM, V270, P20816, DOI 10.1074/jbc.270.35.20816; Kristensen C, 2002, J BIOL CHEM, V277, P18340, DOI 10.1074/jbc.M112249200; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MCCLAIN DA, 1991, MOL ENDOCRINOL, V5, P734, DOI 10.1210/mend-5-5-734; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; NAKAGAWA SH, 1987, J BIOL CHEM, V262, P12054; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Serrano R, 2005, J MOL ENDOCRINOL, V34, P153, DOI 10.1677/jme.1.01635; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w	50	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20288	10.1371/journal.pone.0020288	http://dx.doi.org/10.1371/journal.pone.0020288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625452	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400052
J	Hagita, S; Osaka, M; Shimokado, K; Yoshida, M				Hagita, Sumihiko; Osaka, Mizuko; Shimokado, Kentaro; Yoshida, Masayuki			Adipose Inflammation Initiates Recruitment of Leukocytes to Mouse Femoral Artery: Role of Adipo-Vascular Axis in Chronic Inflammation	PLOS ONE			English	Article							HIGH-FAT-DIET; MACROPHAGE POLARIZATION; DENDRITIC CELLS; TISSUE INFLAMMATION; INSULIN-RESISTANCE; INDUCED OBESITY; MICE; EXPRESSION; ACTIVATION; ACCUMULATION	Background: Although inflammation within adipose tissues is known to play a role in metabolic syndrome, the causative connection between inflamed adipose tissue and atherosclerosis is not fully understood. In the present study, we examined the direct effects of adipose tissue on macro-vascular inflammation using intravital microscopic analysis of the femoral artery after adipose tissue transplantation. Methods and Results: We obtained subcutaneous (SQ) and visceral (VIS) adipose tissues from C57BL/6 mice fed normal chow (NC) or a high fat diet (HF), then transplanted the tissues into the perivascular area of the femoral artery of recipient C57/BL6 mice. Quantitative intravital microscopic analysis revealed an increase in adherent leukocytes after adipose tissue transplantation, with VIS found to induce significantly more leukocyte accumulation as compared to SQ. Moreover, adipose tissues from HF fed mice showed significantly more adhesion to the femoral artery. Simultaneous flow cytometry demonstrated upregulation of CD11b on peripheral granulocyte and monocytes after adipose tissue transplantation. We also observed dominant expressions of the inflammatory cytokine IL-6, and chemokines MCP-1 and MIP-1 beta in the stromal vascular fraction (SVF) of these adipose tissues as well as sera of recipient mice after transplantation. Finally, massive accumulations of pro-inflammatory and dendritic cells were detected in mice with VIS transplantation as compared to SQ, as well as in HF mice as compared to those fed NC. Conclusion: Our in vivo findings indicate that adipose tissue stimulates leukocyte accumulation in the femoral artery. The underlying mechanisms involve upregulation of CD11b in leukocytes, induction of cytokines and chemokines, and accumulation of pro-inflammatory cells in the SVF.	[Hagita, Sumihiko; Osaka, Mizuko; Yoshida, Masayuki] Tokyo Med & Dent Univ, Life Sci & Bioeth Res Ctr, Bunkyo Ku, Tokyo, Japan; [Hagita, Sumihiko; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Vasc Med, Bunkyo Ku, Tokyo, Japan; [Hagita, Sumihiko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Society for the Promotion of Science	Hagita, S (corresponding author), Tokyo Med & Dent Univ, Life Sci & Bioeth Res Ctr, Bunkyo Ku, Tokyo, Japan.	masa.vasc@tmd.ac.jp	王, 强/F-4212-2011		Mitsubishi Pharma Research Foundation;  [18590805]	Mitsubishi Pharma Research Foundation; 	This study was supported in part by a Grant-in-Aid for Scientific Research (no. 18590805) and a research grant from the Mitsubishi Pharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Bedford PA, 2006, J LEUKOCYTE BIOL, V80, P546, DOI 10.1189/jlb.0905501; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Cui J, 2009, CELL IMMUNOL, V260, P44, DOI 10.1016/j.cellimm.2009.08.001; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Gomez-Ruiz A, 2010, J CELL PHYSIOL, V225, P206, DOI 10.1002/jcp.22241; Hagita S, 2008, HYPERTENSION, V51, P797, DOI 10.1161/HYPERTENSIONAHA.107.098855; Ito A, 2008, J BIOL CHEM, V283, P35715, DOI 10.1074/jbc.M804220200; Jabs A, 2007, ATHEROSCLEROSIS, V192, P75, DOI 10.1016/j.atherosclerosis.2006.05.050; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kim CS, 2008, OBESITY, V16, P1261, DOI 10.1038/oby.2008.55; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; KURAHARA H, 2009, J SURG RES; Lazarus AH, 1998, CYTOMETRY, V32, P206, DOI 10.1002/(SICI)1097-0320(19980701)32:3<206::AID-CYTO7>3.0.CO;2-H; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MARTINEZNUNEZ RT, 2010, J BIOL CHEM; Mullerad J, 2000, CYTOKINE, V12, P1683, DOI 10.1006/cyto.2000.0775; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ohman MK, 2010, ARTERIOSCL THROM VAS, V30, P1151, DOI 10.1161/ATVBAHA.110.205914; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Ritter U, 2003, J LEUKOCYTE BIOL, V74, P216, DOI 10.1189/jlb.1202587; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Upham JW, 2000, CYTOMETRY, V40, P50, DOI 10.1002/(SICI)1097-0320(20000501)40:1<50::AID-CYTO7>3.0.CO;2-P; Watanabe S, 2003, J IMMUNOL, V171, P5828, DOI 10.4049/jimmunol.171.11.5828; WEBSTER GA, 1995, CLIN EXP IMMUNOL, V100, P536; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044	37	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19871	10.1371/journal.pone.0019871	http://dx.doi.org/10.1371/journal.pone.0019871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625491	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400017
J	Espinosa, O; Hancock, JM				Espinosa, Octavio; Hancock, John M.			A Gene-Phenotype Network for the Laboratory Mouse and Its Implications for Systematic Phenotyping	PLOS ONE			English	Article							R-PACKAGE; DATABASE; ONTOLOGIES; REPOSITORY; DISCOVERY; MODELS; TOOL	The laboratory mouse is the pre-eminent model organism for the dissection of human disease pathways. With the advent of a comprehensive panel of gene knockouts, projects to characterise the phenotypes of all knockout lines are being initiated. The range of genotype-phenotype associations can be represented using the Mammalian Phenotype ontology. Using publicly available data annotated with this ontology we have constructed gene and phenotype networks representing these associations. These networks show a scale-free, hierarchical and modular character and community structure. They also exhibit enrichment for gene coexpression, protein-protein interactions and Gene Ontology annotation similarity. Close association between gene communities and some high-level ontology terms suggests that systematic phenotyping can provide a direct insight into underlying pathways. However some phenotypes are distributed more diffusely across gene networks, likely reflecting the pleiotropic roles of many genes. Phenotype communities show a many-to-many relationship to human disease communities, but stronger overlap at more granular levels of description. This may suggest that systematic phenotyping projects should aim for high granularity annotations to maximise their relevance to human disease.	[Espinosa, Octavio; Hancock, John M.] MRC Mammalian Genet Unit, Bioinformat Grp, Harwell, Oxon, England; [Espinosa, Octavio] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	MRC Harwell; University of Oxford	Espinosa, O (corresponding author), Inst Canc Res, Chester Beattie Labs, London SW3 6JB, England.	j.hancock@har.mrc.ac.uk	Hancock, John/A-2442-2009	Hancock, John/0000-0003-2991-2217	UK Medical Research Council; MRC [MC_U142684171] Funding Source: UKRI; Medical Research Council [MC_U142684171] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beck T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S5-S2; Brown SDM, 2009, ANNU REV GENET, V43, P305, DOI 10.1146/annurev-genet-102108-134143; Bult CJ, 2010, NUCLEIC ACIDS RES, V38, pD586, DOI 10.1093/nar/gkp880; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Groth P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-136; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hancock JM, 2009, MAMM GENOME, V20, P457, DOI 10.1007/s00335-009-9208-3; Hancock John M., 2007, Briefings in Functional Genomics & Proteomics, V6, P292, DOI 10.1093/bfgp/elm033; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; JIANG JQ, 2010, J INTEGR BIOINFORM, V7, DOI DOI 10.2390/BIECOLL-JIB-2010-2149; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Morgan H, 2010, NUCLEIC ACIDS RES, V38, pD577, DOI 10.1093/nar/gkp1007; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Ringwald M, 2000, NUCLEIC ACIDS RES, V28, P115, DOI 10.1093/nar/28.1.115; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; SCHAEFER E, 2010, EUR J MED GENET; Schofield PN, 2010, DIS MODEL MECH, V3, P281, DOI 10.1242/dmm.002790; Shimodaira H, 2008, J STAT PLAN INFER, V138, P1227, DOI 10.1016/j.jspi.2007.04.001; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vinogradov AE, 2010, P ROY SOC B-BIOL SCI, V277, P1403, DOI 10.1098/rspb.2009.1865; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19693	10.1371/journal.pone.0019693	http://dx.doi.org/10.1371/journal.pone.0019693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625554	gold, Green Submitted, Green Published			2022-12-25	WOS:000290771200016
J	Huang, JQ; Zheng, ZL; Andersson, AF; Engstrand, L; Ye, WM				Huang, Jiaqi; Zheng, Zongli; Andersson, Anders F.; Engstrand, Lars; Ye, Weimin			Rapid Screening of Complex DNA Samples by Single-Molecule Amplification and Sequencing	PLOS ONE			English	Article								Microbial cloning makes Sanger sequencing of complex DNA samples possible but is labor intensive. We present a simple, rapid and robust method that enables laboratories without special equipment to perform single-molecule amplicon sequencing, although in a low-throughput manner, from sub-picogram quantities of DNA. The method can also be used for quick quality control of next-generation sequencing libraries, as was demonstrated for a metagenomic sample.	[Huang, Jiaqi; Zheng, Zongli; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Zheng, Zongli; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Stockholm, Sweden; [Engstrand, Lars] Swedish Inst Communicable Infect Dis Control, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Swedish Institute for Infectious Disease Control	Huang, JQ (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	zhengzongli@gmail.com	Huang, Jiaqi/AGG-3698-2022; Andersson, Anders/J-9310-2019; Huang, Jiaqi/AAK-8658-2020; zheng, zongli/C-7309-2008; huang, jiaqi/HCI-2563-2022; zheng, zongli/B-2917-2011	Huang, Jiaqi/0000-0002-7808-9477; Andersson, Anders/0000-0002-3627-6899; Huang, Jiaqi/0000-0002-7808-9477; zheng, zongli/0000-0003-4849-4903	European Union [LSHC-CT-2005-018704]; Swedish Cancer Society; Karolinska Institutet (KID); Swedish Research Council FORMAS	European Union(European Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet (KID); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Sixth Research Framework Program of the European Union, project INCA (LSHC-CT-2005-018704) to Olof Nyren and LE, and Swedish Cancer Society to Olof Nyren, WY, and LE. JH and ZZ were also supported by scholarships from the Karolinska Institutet (KID). AA was funded by a grant from the Swedish Research Council FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Fredlake CP, 2008, P NATL ACAD SCI USA, V105, P476, DOI 10.1073/pnas.0705093105; *ILL INC, 2007, PREP SAMPL SEQ GEN D; Karger BL, 2009, ELECTROPHORESIS, V30, pS196, DOI 10.1002/elps.200900218; Kraytsberg Y, 2009, METHODS MOL BIOL, V554, P329, DOI 10.1007/978-1-59745-521-3_21; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	6	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19723	10.1371/journal.pone.0019723	http://dx.doi.org/10.1371/journal.pone.0019723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625543	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200019
J	Shulse, CN; Allen, EE				Shulse, Christine N.; Allen, Eric E.			Widespread Occurrence of Secondary Lipid Biosynthesis Potential in Microbial Lineages	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; III POLYKETIDE SYNTHASES; TO-HEAD HYDROCARBON; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; ESCHERICHIA-COLI; GENOME SEQUENCE; PSYCHROMONAS-INGRAHAMII; HETEROCYST GLYCOLIPIDS; FACULTATIVE ANAEROBE	Bacterial production of long-chain omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), is constrained to a narrow subset of marine gamma-proteobacteria. The genes responsible for de novo bacterial PUFA biosynthesis, designated pfaEABCD, encode large, multi-domain protein complexes akin to type I iterative fatty acid and polyketide synthases, herein referred to as "Pfa synthases". In addition to the archetypal Pfa synthase gene products from marine bacteria, we have identified homologous type I FAS/PKS gene clusters in diverse microbial lineages spanning 45 genera representing 10 phyla, presumed to be involved in long-chain fatty acid biosynthesis. In total, 20 distinct types of gene clusters were identified. Collectively, we propose the designation of "secondary lipids" to describe these biosynthetic pathways and products, a proposition consistent with the "secondary metabolite" vernacular. Phylogenomic analysis reveals a high degree of functional conservation within distinct biosynthetic pathways. Incongruence between secondary lipid synthase functional clades and taxonomic group membership combined with the lack of orthologous gene clusters in closely related strains suggests horizontal gene transfer has contributed to the dissemination of specialized lipid biosynthetic activities across disparate microbial lineages.	[Shulse, Christine N.; Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Allen, Eric E.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Shulse, CN (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eallen@ucsd.edu	PONNERASSERY, Sudheesh/C-4589-2014	Shulse, Christine/0000-0001-9320-4384				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Auman AJ, 2006, INT J SYST EVOL MICR, V56, P1001, DOI 10.1099/ijs.0.64068-0; Bauersachs T, 2009, PHYTOCHEMISTRY, V70, P2034, DOI 10.1016/j.phytochem.2009.08.014; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bowman JP, 1998, MICROBIOL-UK, V144, P1601, DOI 10.1099/00221287-144-6-1601; Campbell EL, 1997, ARCH MICROBIOL, V167, P251, DOI 10.1007/s002030050440; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLARKE K, 2001, PLYMOUTH PRIMER E; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hantash FM, 1997, MICROBIOL-UK, V143, P147, DOI 10.1099/00221287-143-1-147; Herlemann DPR, 2009, APPL ENVIRON MICROB, V75, P2841, DOI 10.1128/AEM.02698-08; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lippmeier JC, 2009, LIPIDS, V44, P621, DOI 10.1007/s11745-009-3311-9; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Miller M. A., 2010, CIPRES PORTALS; Miyanaga A, 2008, P NATL ACAD SCI USA, V105, P871, DOI 10.1073/pnas.0709819105; Moser DP, 1996, APPL ENVIRON MICROB, V62, P2100, DOI 10.1128/AEM.62.6.2100-2105.1996; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; Nichols DS, 2002, J MICROBIOL METH, V48, P161, DOI 10.1016/S0167-7012(01)00320-7; Nishida T, 2006, FEBS LETT, V580, P2731, DOI 10.1016/j.febslet.2006.04.032; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2009, FEMS MICROBIOL LETT, V295, P170, DOI 10.1111/j.1574-6968.2009.01582.x; PERRY KA, 1993, SCIENCE, V259, P801, DOI 10.1126/science.259.5096.801; Raghukumar S, 2002, EUR J PROTISTOL, V38, P127, DOI 10.1078/0932-4739-00832; Riley M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-210; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANGKHOBOL V, 1981, INT J SYST BACTERIOL, V31, P285, DOI 10.1099/00207713-31-3-285; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Singh A, 1996, J IND MICROBIOL, V16, P370, DOI 10.1007/BF01570118; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Starkey RL, 1939, SOIL SCI, V47, P329, DOI 10.1097/00010694-193904000-00007; Sugihara S, 2008, BIOTECHNOL LETT, V30, P411, DOI 10.1007/s10529-007-9579-z; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3850, DOI 10.1128/AEM.00436-10; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Wang F, 2009, J BACTERIOL, V191, P2574, DOI 10.1128/JB.00498-08; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wiens GD, 2008, J BACTERIOL, V190, P6970, DOI 10.1128/JB.00721-08; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Yokochi T, 1998, APPL MICROBIOL BIOT, V49, P72, DOI 10.1007/s002530051139; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	62	60	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20146	10.1371/journal.pone.0020146	http://dx.doi.org/10.1371/journal.pone.0020146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21629834	gold, Green Published			2022-12-25	WOS:000290771200050
J	Hansen, LH; Bentzon-Tilia, M; Bentzon-Tilia, S; Norman, A; Rafty, L; Sorensen, SJ				Hansen, Lars H.; Bentzon-Tilia, Mikkel; Bentzon-Tilia, Sara; Norman, Anders; Rafty, Louise; Sorensen, Soren J.			Design and Synthesis of a Quintessential Self-Transmissible IncX1 Plasmid, pX1.0	PLOS ONE			English	Article							ESCHERICHIA-COLI; CONFERRING RESISTANCE; VIRULENCE PLASMID; BIOFILM FORMATION; MULTIDRUG EFFLUX; DNA SEGMENTS; GENE; GENOME; CONSTRUCTION; REPLICATION	DNA exchange in bacteria via conjugative plasmids is believed to be among the most important contributing factors to the rapid evolution- and diversification rates observed in bacterial species. The IncX1 plasmids are particularly interesting in relation to enteric bacteria, and typically carry genetic loads like antibiotic resistance genes and virulence factors. So far, however, a "pure" version of these molecular parasites, without genetic loads, has yet to be isolated from the environment. Here we report the construction of pX1.0, a fully synthesized IncX1 plasmid capable of horizontal transfer between different enteric bacteria. The designed pX1.0 sequence was derived from the consensus gene content of five IncX1 plasmids and three other, more divergent, members of the same phylogenetic group. The pX1.0 plasmid was shown to replicate stably in E. coli with a plasmid DNA per total DNA ratio corresponding to approximately 3-9 plasmids per chromosome depending on the growth phase of the host. Through conjugation, pX1.0 was able to self-transfer horizontally into an isogenic strain of E. coli as well as into two additional species belonging to the family Enterobacteriaceae. Our results demonstrate the immediate applicability of recent advances made within the field of synthetic biology for designing and constructing DNA systems, previously existing only in silica.	[Hansen, Lars H.; Bentzon-Tilia, Mikkel; Bentzon-Tilia, Sara; Norman, Anders; Sorensen, Soren J.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Rafty, Louise] DNA2 0, Menlo Pk, CA USA	University of Copenhagen	Hansen, LH (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	hestbjerg@bio.ku.dk	Hansen, Lars/G-3236-2011; Norman, Anders/E-2515-2011; Bentzon-Tilia, Mikkel/C-4319-2013; Bentzon-Tilia, Mikkel/AAW-2341-2021; Sørensen, Søren Johannes/N-2120-2019; Sørensen, Søren J/J-5015-2014	Norman, Anders/0000-0002-1282-394X; Bentzon-Tilia, Mikkel/0000-0002-7888-9845; Sørensen, Søren Johannes/0000-0001-6227-9906; Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Danish Research Council for Independent Research; Natural Sciences (FNU) [09-065940]	Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Sciences (FNU)(Danish Natural Science Research Council)	The project was partly funded by The Danish Research Council for Independent Research vertical bar Natural Sciences (FNU). FNU homepage: http://fi.dk, grant number: 09-065940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BAHL MI, 2007, MULTIPLE ANTIBIOTIC; BRADLEY DE, 1978, PLASMID, V1, P376, DOI 10.1016/0147-619X(78)90053-7; Burian J, 1997, PLASMID, V37, P2, DOI 10.1006/plas.1996.1273; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; DILLON PJ, 1991, J VIROL, V65, P4490, DOI 10.1128/JVI.65.8.4490-4493.1991; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hansen LH, 2004, ANTIMICROB AGENTS CH, V48, P3332, DOI 10.1128/AAC.48.9.3332-3337.2004; Harada KM, 2006, PLASMID, V56, P11, DOI 10.1016/j.plasmid.2005.12.002; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251; Kamachi K, 2006, MICROBIOL-SGM, V152, P3477, DOI 10.1099/mic.0.29056-0; Kodumal SJ, 2004, P NATL ACAD SCI USA, V101, P15573, DOI 10.1073/pnas.0406911101; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Olsen JE, 2004, MICROB PATHOGENESIS, V36, P337, DOI 10.1016/j.micpath.2004.02.005; RYAN MJ, 1979, J BIOL CHEM, V254, P5817; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Sorensen AH, 2003, ANTIMICROB AGENTS CH, V47, P798, DOI 10.1128/AAC.47.2.798-799.2003; STALKER DM, 1985, PLASMID, V14, P245, DOI 10.1016/0147-619X(85)90008-3; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19912	10.1371/journal.pone.0019912	http://dx.doi.org/10.1371/journal.pone.0019912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625636	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200047
J	Xu, WM; Chen, J; Chen, H; Diao, RY; Fok, KL; Dong, JD; Sun, TT; Chen, WY; Yu, MK; Zhang, XH; Tsang, LL; Lau, A; Shi, QX; Shi, QH; Huang, PB; Chan, HC				Xu, Wen Ming; Chen, Jing; Chen, Hui; Diao, Rui Ying; Fok, Kin Lam; Dong, Jian Da; Sun, Ting Ting; Chen, Wen Ying; Yu, Mei Kuen; Zhang, Xiao Hu; Tsang, Lai Ling; Lau, Ann; Shi, Qi Xian; Shi, Qing Hua; Huang, Ping Bo; Chan, Hsiao Chang			Defective CFTR-Dependent CREB Activation Results in Impaired Spermatogenesis and Azoospermia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SOLUBLE ADENYLYL-CYCLASE; CYSTIC-FIBROSIS GENE; TRANSCRIPTION FACTORS; CONGENITAL ABSENCE; INFERTILE MEN; SPERM QUALITY; VAS-DEFERENS; HEALTHY-MEN; GERM-CELLS	Cystic fibrosis (CF) is the most common life-limiting recessive genetic disease among Caucasians caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) with over 95% male patients infertile. However, whether CFTR mutations could affect spermatogenesis and result in azoospermia remains an open question. Here we report compromised spermatogenesis, with significantly reduced testicular weight and sperm count, and decreased cAMP-responsive element binding protein (CREB) expression in the testes of CFTR knockout mice. The involvement of CFTR in HCO3- transport and the expression of the HCO3- sensor, soluble adenylyl cyclase (sAC), are demonstrated for the first time in the primary culture of rat Sertoli cells. Inhibition of CFTR or depletion of HCO3- could reduce FSH-stimulated, sAC-dependent cAMP production and phosphorylation of CREB, the key transcription factor in spermatogenesis. Decreased CFTR and CREB expression are also observed in human testes with azoospermia. The present study reveals a previously undefined role of CFTR and sAC in regulating the cAMP-CREB signaling pathway in Sertoli cells, defect of which may result in impaired spermatogenesis and azoospermia. Altered CFTR-sAC-cAMP-CREB functional loop may also underline the pathogenesis of various CF-related diseases.	[Xu, Wen Ming; Chan, Hsiao Chang] Sichuan Univ, Chinese Univ Hong Kong, W China Inst Women & Childrens Hlth, Joint Lab Reprod Med,W China Univ Hosp 2, Chengdu 610064, Peoples R China; [Xu, Wen Ming; Chen, Jing; Chen, Hui; Diao, Rui Ying; Fok, Kin Lam; Dong, Jian Da; Sun, Ting Ting; Chen, Wen Ying; Yu, Mei Kuen; Zhang, Xiao Hu; Tsang, Lai Ling; Lau, Ann; Chan, Hsiao Chang] Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Diao, Rui Ying] Peking Univ, Shenzhen Key Lab Male Reprod & Genet, Shenzhen Hosp, Shenzhen, Peoples R China; [Chen, Wen Ying; Shi, Qi Xian] Zhejiang Acad Med Sci, Dept Reprod Physiol, Hangzhou, Zhejiang, Peoples R China; [Shi, Qing Hua] Univ Sci & Technol China, Lab Mol & Cell Genet, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230026, Peoples R China; [Huang, Ping Bo] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Sichuan University; Chinese University of Hong Kong; Peking University; Zhejiang Academy of Medical Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Hong Kong University of Science & Technology	Xu, WM (corresponding author), Sichuan Univ, Chinese Univ Hong Kong, W China Inst Women & Childrens Hlth, Joint Lab Reprod Med,W China Univ Hosp 2, Chengdu 610064, Peoples R China.	hsiaocchan@cuhk.edu.hk	Fok, Kin Lam/G-2757-2017; Chan, Hsiao Chang/E-1507-2016; Fok, Ellis/M-2784-2019; Dong, Jianda/C-3338-2018; Huang, Pingbo/I-1127-2019; Shi, Qinghua/N-2950-2013	Fok, Kin Lam/0000-0003-3038-1337; Fok, Ellis/0000-0003-3038-1337; Dong, Jianda/0000-0001-5583-0210; Huang, Pingbo/0000-0002-4560-8760; 	National Natural Science Foundation of China [30770817]; South China National Research Center for Integrated Biosciences; Sun Yat-sen University; National 973 projects [2006CB504002]; Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong; Morningside Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South China National Research Center for Integrated Biosciences; Sun Yat-sen University; National 973 projects(National Basic Research Program of China); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong(Chinese University of Hong Kong); Morningside Foundation	The work was supported by the National Natural Science Foundation of China (No. 30770817), the South China National Research Center for Integrated Biosciences in collaboration with Sun Yat-sen University, the National 973 projects (2006CB504002), the Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong, and the Morningside Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Ashby J, 2003, TOXICOL SCI, V74, P129, DOI 10.1093/toxsci/kfg093; Boockfor FR, 1998, AM J PHYSIOL-CELL PH, V274, pC922, DOI 10.1152/ajpcell.1998.274.4.C922; BUNDEY RA, 2004, SCI STKE, pPE19; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; De Cesare D, 2000, J ENDOCRINOL INVEST, V23, P592, DOI 10.1007/BF03343781; Dohle GR, 2002, HUM REPROD, V17, P13, DOI 10.1093/humrep/17.1.13; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; DORRINGTON JH, 1975, MOL CELL ENDOCRINOL, V3, P57, DOI 10.1016/0303-7207(75)90031-3; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hihnala S, 2006, MOL HUM REPROD, V12, P107, DOI 10.1093/molehr/gal009; Jakubiczka S, 1999, HUM REPROD, V14, P1833, DOI 10.1093/humrep/14.7.1833; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Larriba S, 2005, INT J ANDROL, V28, P284, DOI 10.1111/j.1365-2605.2005.00544.x; Larriba S, 1998, HUM MOL GENET, V7, P1739, DOI 10.1093/hmg/7.11.1739; Mak JCW, 2002, EUR J PHARMACOL, V436, P165, DOI 10.1016/S0014-2999(01)01625-9; Mak V, 2000, HUM REPROD, V15, P436, DOI 10.1093/humrep/15.2.436; Marquez B, 2008, REPROD FERT DEVELOP, V20, P247, DOI 10.1071/RD07146; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mruk DD, 1999, J BIOL CHEM, V274, P27056, DOI 10.1074/jbc.274.38.27056; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Pallares-Ruiz N, 1999, HUM REPROD, V14, P3035, DOI 10.1093/humrep/14.12.3035; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Ravnik-Glavac M, 2001, GENET TEST, V5, P243, DOI 10.1089/10906570152742308; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schulz S, 2006, FERTIL STERIL, V85, P135, DOI 10.1016/j.fertnstert.2005.07.1282; Scobey MJ, 2001, ENDOCRINOLOGY, V142, P948, DOI 10.1210/en.142.2.948; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Song GJ, 2000, FERTIL STERIL, V73, P1104, DOI 10.1016/S0015-0282(00)00520-3; TINDALL DJ, 1981, ENVIRON HEALTH PERSP, V38, P5, DOI 10.2307/3429353; TIZZANO EF, 1994, AM J PATHOL, V144, P906; Tuerlings JHAM, 1998, FERTIL STERIL, V69, P899, DOI 10.1016/S0015-0282(98)00050-8; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Walker WH, 1996, TRENDS ENDOCRIN MET, V7, P133, DOI 10.1016/1043-2760(96)00035-5; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104	44	94	101	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2011	6	5							e19120	10.1371/journal.pone.0019120	http://dx.doi.org/10.1371/journal.pone.0019120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	761GX	21625623	Green Submitted, Green Published, gold			2022-12-25	WOS:000290386800008
J	Dentelli, P; Rosso, A; Olgasi, C; Camussi, G; Brizzi, MF				Dentelli, P.; Rosso, A.; Olgasi, C.; Camussi, G.; Brizzi, M. F.			IL-3 is a novel target to interfere with tumor vasculature	ONCOGENE			English	Article						IL-3; tumor angiogenesis; Akt; inflammatory cells; mbKitL	ENDOTHELIAL PROGENITOR CELLS; POTENTIAL ROLE; C-KIT; ANGIOGENESIS; EXPRESSION; BETA-1-INTEGRIN; PROLIFERATION; RECRUITMENT; MACROPHAGES; ACTIVATION	Angiogenesis inhibiting agents are currently integral component of anticancer therapy. However, tumors, initially responsive to anti-angiogenic drugs or vascular targeting agents, can acquire resistance. The limited clinical efficacy might result from the heterogeneous nature of tumors or alternatively from the unique phenotype of tumor vascular cells, widely diverse from so-called 'normal' endothelium. Hence, defining the molecular mechanisms driving this diversity might provide a rational basis to design combinatory therapies that should be more effective in avoiding resistance. Herein, we demonstrated that tumor-derived endothelial cells (TECs) isolated from breast and kidney carcinomas retained an endothelial phenotype, but outspread independently of growth factors. Applying small interfering RNA approach, we demonstrated that interleukin (IL)-3, but not vascular endothelial growth factor, released by TECs, supports their autocrine growth and promotes in vivo vessel formation and tumor angiogenesis. Meanwhile, we found that the expression of the membrane-bound kit ligand (mbKitL) depends on IL-3, and it is crucial for adhesion of endothelial progenitor cells (EPCs) and inflammatory cells to TECs. These events required Akt activation. Finally, the finding that depletion of the mbKitL prevented EPC and inflammatory cell trafficking into vascular microenvironment, indicates that, as in bone marrow, the mbKitL can act as a membrane/adhesion molecule for c-Kit-expressing cells. These data provide evidences that an IL-3 autocrine loop can drive a tumor endothelial switch and that targeting IL-3 might confer a significant therapeutic advantage to hamper tumor angiogenesis. Oncogene (2011) 30, 4930-4940; doi:10.1038/onc.2011.204; published online 6 June 2011	[Dentelli, P.; Rosso, A.; Olgasi, C.; Camussi, G.; Brizzi, M. F.] Univ Turin, Dept Internal Med, I-10126 Turin, Italy	University of Turin	Brizzi, MF (corresponding author), Univ Turin, Dept Internal Med, Corso Dogliotti 14, I-10126 Turin, Italy.	mariafelice.brizzi@unito.it	Brizzi, Maria Felice/J-7882-2016; Camussi, Giovanni/J-7624-2016; olgasi, cristina/J-2934-2018	Camussi, Giovanni/0000-0003-2795-232X; olgasi, cristina/0000-0002-5738-213X	Italian Association for Cancer Research (AIRC); MIUR (Ministero dell'Universita e Ricerca Scientifica)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministero dell'Universita e Ricerca Scientifica)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants of the Italian Association for Cancer Research (AIRC) to MFB and GC and by MIUR (Ministero dell'Universita e Ricerca Scientifica) to MFB and GC.	AVANZI GC, 1990, J CELL PHYSIOL, V145, P458, DOI 10.1002/jcp.1041450310; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Biancone L, 2004, J IMMUNOL, V173, P5268, DOI 10.4049/jimmunol.173.8.5268; BRIZZI MF, 1993, J CLIN INVEST, V91, P2887, DOI 10.1172/JCI116534; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Bussolati B, 2006, J MOL MED-JMM, V84, P852, DOI 10.1007/s00109-006-0075-z; Bussolati B, 2010, CURR VASC PHARMACOL, V8, P220, DOI 10.2174/157016110790887036; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; Dentelli P, 2004, ONCOGENE, V23, P1681, DOI 10.1038/sj.onc.1207290; Dentelli P, 1999, J IMMUNOL, V163, P2151; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Grange C, 2006, ONCOL REP, V15, P381; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MATSUDA R, 1993, AM J PATHOL, V142, P339; Nishie A, 1999, CLIN CANCER RES, V5, P1107; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Ribatti D, 2007, CANCER LETT, V248, P18, DOI 10.1016/j.canlet.2006.06.007; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Sica A, 2007, EXPERT OPIN THER TAR, V11, P1219, DOI 10.1517/14728222.11.9.1219; St Croix B, 2000, SCIENCE, V289, P1197; Takakura N, 2006, CANCER SCI, V97, P568, DOI 10.1111/j.1349-7006.2006.00223.x; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Uberti B, 2010, ONCOGENE, V29, P6581, DOI 10.1038/onc.2010.384; Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659; van Beijnum Judy R, 2009, Front Biosci (Schol Ed), V1, P216; Verfaillie CM, 2008, CANCER CELL, V14, P193, DOI 10.1016/j.ccr.2008.08.005; Weber C, 2006, TRENDS IMMUNOL, V27, P268, DOI 10.1016/j.it.2006.04.002; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2009, BBA-REV CANCER, V1796, P50, DOI 10.1016/j.bbcan.2009.04.002; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215	45	42	44	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	50					4930	4940		10.1038/onc.2011.204	http://dx.doi.org/10.1038/onc.2011.204			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YJ	21643009				2022-12-25	WOS:000298346500002
J	Han, SE; Sundararajan, J; Bowling, DL; Lake, J; Purves, D				Han, Shui' Er; Sundararajan, Janani; Bowling, Daniel Liu; Lake, Jessica; Purves, Dale			Co-Variation of Tonality in the Music and Speech of Different Cultures	PLOS ONE			English	Article							ENGLISH; RHYTHM	Whereas the use of discrete pitch intervals is characteristic of most musical traditions, the size of the intervals and the way in which they are used is culturally specific. Here we examine the hypothesis that these differences arise because of a link between the tonal characteristics of a culture's music and its speech. We tested this idea by comparing pitch intervals in the traditional music of three tone language cultures (Chinese, Thai and Vietnamese) and three non-tone language cultures (American, French and German) with pitch intervals between voiced speech segments. Changes in pitch direction occur more frequently and pitch intervals are larger in the music of tone compared to non-tone language cultures. More frequent changes in pitch direction and larger pitch intervals are also apparent in the speech of tone compared to non-tone language cultures. These observations suggest that the different tonal preferences apparent in music across cultures are closely related to the differences in the tonal characteristics of voiced speech.	[Han, Shui' Er; Sundararajan, Janani; Bowling, Daniel Liu; Purves, Dale] Duke NUS Grad Med Sch, A STAR Neurosci Res Partnership, Neurosci & Behav Disorders Program, Singapore, Singapore; [Bowling, Daniel Liu; Purves, Dale] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Bowling, Daniel Liu; Lake, Jessica; Purves, Dale] Duke Univ, Levine Sci Res Ctr, Ctr Cognit Neurosci, Durham, NC USA; [Lake, Jessica; Purves, Dale] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	National University of Singapore; Duke University; Duke University; Duke University	Han, SE (corresponding author), Duke NUS Grad Med Sch, A STAR Neurosci Res Partnership, Neurosci & Behav Disorders Program, Singapore, Singapore.	purves@neuro.duke.edu		Bowling, Daniel/0000-0002-5303-5472	National Science Foundation; Duke-NUS Graduate Medical School; Division Of Behavioral and Cognitive Sci [0924181] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Duke-NUS Graduate Medical School(National University of Singapore); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work has been supported by grants from the National Science Foundation (http://www.nsf. gov/) and Duke-NUS Graduate Medical School (http://www.duke-nus.edu.sg/web/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry Phillips, 1909, J AM FOLK LORE, V22, P72; Bowling DL, 2010, J ACOUST SOC AM, V127, P491, DOI 10.1121/1.3268504; Brazil D., 1997, COMMUNICATIVE VALUE; Brown Keith, 2008, CONCISE ENCY LANGUAG; Crystal D., 1997, CAMBRIDGE ENCY LANGU; DEAN B, 1985, MONUM NIPPON, V40, P147, DOI 10.2307/2384717; Dowling W. J., 1986, MUSIC COGNITION; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Gill KZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008144; Haviland William, 2007, CULTURAL ANTHR HUMAN; HIRST D, 1999, INTONATION SYSTEMS S; HO LT, 1983, ASIAN MUSIC, V14, P132; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; KEEFE DH, 1991, MUSIC PERCEPT, V8, P449; McGowan RW, 2011, MUSIC PERCEPT, V28, P307, DOI 10.1525/MP.2011.28.3.307; Morton David, 1976, TRADITIONAL MUSIC TH; Patel AD, 2006, J ACOUST SOC AM, V119, P3034, DOI 10.1121/1.2179657; Schwartz DA, 2003, J NEUROSCI, V23, P7160, DOI 10.1523/JNEUROSCI.23-18-07160.2003; Thompson WF, 2005, SEMIOTICA, V156, P203, DOI 10.1515/semi.2005.2005.156.203; von Hippel P, 2000, MUSIC PERCEPT, V18, P59; VONHELMHOLTZ H. L. F., 1954, SENSATIONS TONE; VOS PG, 1989, MUSIC PERCEPT, V6, P383; [No title captured]	23	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20160	10.1371/journal.pone.0020160	http://dx.doi.org/10.1371/journal.pone.0020160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	769XV	21637716	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500036
J	Peng, H; Sun, LJ; Jia, BB; Lan, XQ; Zhu, B; Wu, YM; Zheng, JL				Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin			HIV-1-Infected and Immune-Activated Macrophages Induce Astrocytic Differentiation of Human Cortical Neural Progenitor Cells via the STAT3 Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEUKEMIA INHIBITORY FACTOR; CENTRAL-NERVOUS-SYSTEM; ADULT BRAIN; STEM/PROGENITOR CELLS; PRECURSOR CELLS; STEM-CELLS; NEUROGENESIS; MICROGLIA; INFLAMMATION	Diminished adult neurogenesis is considered a potential mechanism in the pathogenesis of HIV-1-associated dementia (HAD). In HAD, HIV-1-infected and immune-activated brain mononuclear phagocytes (MP; perivascular macrophages and microglia) drive central nervous system (CNS) inflammation and may alter normal neurogenesis. We previously demonstrated HIV-1-infected and lipopolysaccharide (LPS) activated monocyte-derived macrophages (MDM) inhibit human neural progenitor cell (NPC) neurogenesis, while enhancing astrogliogenesis through the secretion of the inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), in vitro and in vivo. Here we further test the hypothesis that HIV-1-infected/activated MDM promote NPC astrogliogenesis via activation of the transcription factor signal transducer and activator of transcription 3 (STAT3), a critical factor for astrogliogenesis. Our results show that LPS-activated MDM-conditioned medium (LPS-MCM) and HIV-infected/LPS-activated MDM-conditioned medium (LPS+HIV-MCM) induced Janus kinase 1 (Jak1) and STAT3 activation. Induction of the Jak-STAT3 activation correlated with increased glia fibrillary acidic protein (GFAP) expression, demonstrating an induction of astrogliogenesis. Moreover, STAT3-targeting siRNA (siSTAT3) decreased MCM-induced STAT3 activation and NPC astrogliogenesis. Furthermore, inflammatory cytokines (including IL-6, IL-1 beta and TNF-alpha) produced by LPS-activated and/or HIV-1-infected MDM may contribute to MCM-induced STAT3 activation and astrocytic differentiation. These observations were confirmed in severe combined immunodeficient (SCID) mice with HIV-1 encephalitis (HIVE). In HIVE mice, siRNA control (without target sequence, sicon) pre-transfected NPCs injected with HIV-1-infected MDM showed more astrocytic differentiation and less neuronal differentiation of NPCs as compared to NPC injection alone. siSTAT3 abrogated HIV-1-infected MDM-induced astrogliogenesis of injected NPCs. Collectively, these observations demonstrate that HIV-1-infected/activated MDM induces NPC astrogliogenesis through the STAT3 pathway. This study generates important data elucidating the role of brain inflammation in neurogenesis and may provide insight into new therapeutic strategies for HAD.	[Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin] Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA; [Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol, Omaha, NE USA; [Peng, Hui; Sun, Lijun; Jia, Beibei; Lan, Xiqian; Zhu, Bing; Wu, Yumei; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Expt Neurosci, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Peng, H (corresponding author), Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA.	hpeng@unmc.edu; jzheng@unmc.edu			National Institutes of Health [R21 NS066841, R01 NS41858, R01NS61642, P20RR15635, P01NS43985]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041858, R01NS061642, P01NS043985, R21NS066841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants by the National Institutes of Health: R21 NS066841 to HP; R01 NS41858, R01NS61642, P20RR15635 and P01NS43985 to JZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; CAO F, BIOCH BIOPHYS RES CO, V394, P843; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gendelman H. E, 1997, NEUROLOGY AIDS, P1; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Kolson DL, 2000, J CLIN INVEST, V106, P11, DOI 10.1172/JCI10553; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lipton SA, 1997, CURR OPIN NEUROL, V10, P247, DOI 10.1097/00019052-199706000-00014; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 2002, MOL NEUROBIOL, V25, P233; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; OKAMOTO S, 2007, CELL STEM CELL, V1, P1; Peng H, 2005, J NEUROSCI RES, V82, P295, DOI 10.1002/jnr.20629; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Persidsky Y, 1996, AM J PATHOL, V149, P1027; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; Rajan P, 1998, J NEUROSCI, V18, P3620; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Schwartz L, 2006, CURR HIV RES, V4, P319, DOI 10.2174/157016206777709438; Strizki JM, 1996, J VIROL, V70, P7654, DOI 10.1128/JVI.70.11.7654-7662.1996; Taupin Philippe, 2008, Int J Med Sci, V5, P127; Zheng JL, 2001, NEUROTOX RES, V3, P461, DOI 10.1007/BF03033204; Zhu PX, 2008, FASEB J, V22, P3866, DOI 10.1096/fj.08-105908	41	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19439	10.1371/journal.pone.0019439	http://dx.doi.org/10.1371/journal.pone.0019439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637744	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500006
J	Anthony, KG; Strych, U; Yeung, KR; Shoen, CS; Perez, O; Krause, KL; Cynamon, MH; Aristoff, PA; Koski, RA				Anthony, Karen G.; Strych, Ulrich; Yeung, Kacheong R.; Shoen, Carolyn S.; Perez, Oriana; Krause, Kurt L.; Cynamon, Michael H.; Aristoff, Paul A.; Koski, Raymond A.			New Classes of Alanine Racemase Inhibitors Identified by High-Throughput Screening Show Antimicrobial Activity against Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; SALMONELLA-TYPHIMURIUM; CYCLOSERINE; INACTIVATION; DERIVATIVES; MECHANISM; ENZYMES; DESIGN; GROWTH; DRUGS	Background: In an effort to discover new drugs to treat tuberculosis (TB) we chose alanine racemase as the target of our drug discovery efforts. In Mycobacterium tuberculosis, the causative agent of TB, alanine racemase plays an essential role in cell wall synthesis as it racemizes L-alanine into D-alanine, a key building block in the biosynthesis of peptidoglycan. Good antimicrobial effects have been achieved by inhibition of this enzyme with suicide substrates, but the clinical utility of this class of inhibitors is limited due to their lack of target specificity and toxicity. Therefore, inhibitors that are not substrate analogs and that act through different mechanisms of enzyme inhibition are necessary for therapeutic development for this drug target. Methodology/Principal Findings: To obtain non-substrate alanine racemase inhibitors, we developed a high-throughput screening platform and screened 53,000 small molecule compounds for enzyme-specific inhibitors. We examined the 'hits' for structural novelty, antimicrobial activity against M. tuberculosis, general cellular cytotoxicity, and mechanism of enzyme inhibition. We identified seventeen novel non-substrate alanine racemase inhibitors that are structurally different than any currently known enzyme inhibitors. Seven of these are active against M. tuberculosis and minimally cytotoxic against mammalian cells. Conclusions/Significance: This study highlights the feasibility of obtaining novel alanine racemase inhibitor lead compounds by high-throughput screening for development of new anti-TB agents.	[Anthony, Karen G.; Yeung, Kacheong R.; Perez, Oriana; Aristoff, Paul A.; Koski, Raymond A.] L2 Diagnost LLC, New Haven, CT USA; [Strych, Ulrich] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Shoen, Carolyn S.; Cynamon, Michael H.] Vet Affairs Med Ctr, Syracuse, NY USA; [Krause, Kurt L.] Univ Otago, Dept Biochem, Dunedin, New Zealand	University of Houston System; University of Houston; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Otago	Anthony, KG (corresponding author), L2 Diagnost LLC, New Haven, CT USA.	Karen.Anthony@L2dx.com	Krause, Kurt/N-4886-2014	Krause, Kurt/0000-0002-3525-1112; Strych, Ulrich/0000-0001-9455-7683	National Institute of Allergy and Infectious Diseases [R43AI068161]; University of Otago; Robert A. Welch Foundation; National Institutes of Health; Thrash Foundation; Foundation for the Centers for Molecular Research in Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082081, R43AI068161, U54AI057159] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Otago; Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrash Foundation; Foundation for the Centers for Molecular Research in Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R43AI068161 from the National Institute of Allergy and Infectious Diseases as well as the University of Otago, the Robert A. Welch Foundation, the National Institutes of Health, the Thrash Foundation, and the Foundation for the Centers for Molecular Research in Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADET B, 1984, BIOCHEMISTRY-US, V23, P5188, DOI 10.1021/bi00317a016; Blondal K, 2007, B WORLD HEALTH ORGAN, V85, P387, DOI 10.2471/BLT.06.035345; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; Chakrabarti B, 2007, FUTURE MICROBIOL, V2, P51, DOI 10.2217/17460913.2.1.51; COPIE V, 1988, BIOCHEMISTRY-US, V27, P4966, DOI 10.1021/bi00414a002; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; ERION MD, 1987, BIOCHEMISTRY-US, V26, P3417, DOI 10.1021/bi00386a025; ESAKI N, 1986, BIOCHEMISTRY-US, V25, P3261, DOI 10.1021/bi00359a027; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Ginsberg AM, 2010, DRUGS, V70, P2201, DOI 10.2165/11538170-000000000-00000; Ginsberg AM, 2010, TUBERCULOSIS, V90, P162, DOI 10.1016/j.tube.2010.03.003; Heijenoort J.V, 1994, NEW COMPR BIOCH, V27, P39, DOI 10.1016/S0167-7306(08)60406-8; Kim MG, 2003, MED CHEM RES, V12, P130; Kim MG, 2003, J ANTIBIOT, V56, P160, DOI 10.7164/antibiotics.56.160; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; Laughon BE, 2007, CURR TOP MED CHEM, V7, P463, DOI 10.2174/156802607780059736; LeMagueres P, 2005, BIOCHEMISTRY-US, V44, P1471, DOI 10.1021/bi0486583; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; Mustata GI, 2003, BIOPOLYMERS, V70, P186, DOI 10.1002/bip.10425; Mustata GI, 2002, J COMPUT AID MOL DES, V16, P935, DOI 10.1023/A:1023875514454; Neuhaus F, 1967, D CYCLOSERINE O CARB; NEUHAUS F, 1967, ANTIBIOTICS MECH ACT; NEUHAUS FC, 1981, PHARMACOL THERAPEUT, V14, P265, DOI 10.1016/0163-7258(81)90030-9; Ondrechen MJ, 2001, J AM CHEM SOC, V123, P2830, DOI 10.1021/ja0029679; *ORG WH, 2007, WHO FACT SHEET TUB 2; Pucci MJ, 2010, ANTIMICROB AGENTS CH, V54, P3478, DOI 10.1128/AAC.00287-10; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Strych U, 2001, FEMS MICROBIOL LETT, V196, P93, DOI 10.1016/S0378-1097(01)00045-3; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Viskum K, 1997, INT J TUBERC LUNG D, V1, P299; WALSH CT, 1989, J BIOL CHEM, V264, P2393; YEW WW, 1993, CLIN INFECT DIS, V17, P288, DOI 10.1093/clinids/17.2.288; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	30	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20374	10.1371/journal.pone.0020374	http://dx.doi.org/10.1371/journal.pone.0020374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637807	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052200057
J	Iwabuchi, KA; Yamakawa, T; Sato, Y; Ichisaka, T; Takahashi, K; Okita, K; Yamanaka, S				Iwabuchi, Kumiko A.; Yamakawa, Tatsuya; Sato, Yoshiko; Ichisaka, Tomoko; Takahashi, Kazutoshi; Okita, Keisuke; Yamanaka, Shinya			ECAT11/L1td1 Is Enriched in ESCs and Rapidly Activated During iPSCGeneration, but It Is Dispensable for the Maintenance and Induction of Pluripotency	PLOS ONE			English	Article							SELF-RENEWAL; CHAPERONE ACTIVITY; ORF1 PROTEIN; STEM-CELLS; MOUSE; LINE-1; EXPRESSION; RETROTRANSPOSITION; GENERATION; ROLES	The principal factors that lead to proliferation and pluripotency in embryonic stem cells (ESCs) have been vigorously investigated. However, the global network of factors and their full signaling cascade is still unclear. In this study, we found that ECAT11 (L1td1) is one of the ESC-associated transcripts harboring a truncated fragment of ORF-1, a component of theL1 retrotransposable element. We generated an ECAT11 knock-in mouse by replacing its coding region with green fluorescent protein. In the early stage of development, the fluorescence was observed at the inner cell mass of blastocysts and epiblasts. Despite this specific expression, ECAT11-null mice grow normally and are fertile. In addition, ECAT11 was dispensable for both the proliferation and pluripotency of ESCs. We found rapid and robust activation of ECAT11 in fibroblasts after the forced expression of transcription factors that can give rise pluripotency in somatic cells. However, iPS cells could be established from ECAT11-null fibroblasts. Our data demonstrate thedispensability of ECAT11/L1td1 in pluripotency, despite its specific expression.	[Iwabuchi, Kumiko A.; Yamakawa, Tatsuya; Sato, Yoshiko; Ichisaka, Tomoko; Takahashi, Kazutoshi; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Iwabuchi, Kumiko A.; Yamakawa, Tatsuya; Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto, Japan; [Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Iwabuchi, KA (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	yamanaka@cira.kyoto-u.ac.jp	Takahashi, Kazutoshi/ABE-5504-2020	Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090	NIBIO; MEXT; JSPS	NIBIO(National Institute of Biomedical Innovation); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO, a grant from the Leading Project of MEXT, a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of JSPS, Grants-in-Aid for Scientific Research of JSPS and MEXT (to SY). KI was supported by Research Fellowships for Young Scientists from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Benihoud K, 2002, ONCOGENE, V21, P5593, DOI 10.1038/sj.onc.1205730; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Januszyk K, 2007, J BIOL CHEM, V282, P24893, DOI 10.1074/jbc.M702023200; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kroutter EN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000458; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; PACKER AI, 1993, DEV BIOL, V157, P281, DOI 10.1006/dbio.1993.1133; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	34	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20461	10.1371/journal.pone.0020461	http://dx.doi.org/10.1371/journal.pone.0020461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637830	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200067
J	Zhang, Y; Ma, CJ; Wang, JM; Ji, XJ; Wu, XY; Jia, ZS; Moorman, JP; Yao, ZQ				Zhang, Ying; Ma, Cheng J.; Wang, Jia M.; Ji, Xiao J.; Wu, Xiao Y.; Jia, Zhan S.; Moorman, Jonathan P.; Yao, Zhi Q.			Tim-3 Negatively Regulates IL-12 Expression by Monocytes in HCV Infection	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; T-CELL IMMUNOGLOBULIN; CONTAINING MOLECULE-3 TIM-3; CORE PROTEIN; ELEVATED FREQUENCIES; PD-1 EXPRESSION; DENDRITIC CELLS; GENE FAMILY; CD4(+); ACTIVATION	T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) is a newly identified negative immunomodulator that is up-regulated on dysfunctional T cells during viral infections. The expression and function of Tim-3 on human innate immune responses during HCV infection, however, remains poorly characterized. In this study, we report that Tim-3 is constitutively expressed on human resting CD14(+) monocyte/macrophages (M/M-circle divide) and functions as a cap to block IL-12, a key pro-inflammatory cytokine linking innate and adaptive immune responses. Tim-3 expression is significantly reduced and IL-12 expression increased upon stimulation with Toll-like receptor 4 (TLR4) ligand - lipopolysaccharide (LPS) and TLR7/8 ligand - R848. Notably, Tim-3 is over-expressed on un-stimulated as well as TLR-stimulated M/M-circle divide, which is inversely associated with the diminished IL-12 expression in chronically HCV-infected individuals when compared to healthy subjects. Up-regulation of Tim-3 and inhibition of IL-12 are also observed in M/M-circle divide incubated with HCV-expressing hepatocytes, as well as in primary M/M-circle divide or monocytic THP-1 cells incubated with HCV core protein, an effect that mimics the function of complement C1q and is reversible by blocking the HCV core/gC1qR interaction. Importantly, blockade of Tim-3 signaling significantly rescues HCV-mediated inhibition of IL-12, which is primarily expressed by Tim-3 negative M/M-circle divide. Tim-3 blockade reduces HCV core-mediated expression of the negative immunoregulators PD-1 and SOCS-1 and increases STAT-1 phosphorylation. Conversely, blocking PD-1 or silencing SOCS-1 gene expression also decreases Tim-3 expression and enhances IL-12 secretion and STAT-1 phosphorylation. These findings suggest that Tim-3 plays a crucial role in negative regulation of innate immune responses, through crosstalk with PD-1 and SOCS-1 and limiting STAT-1 phosphorylation, and may be a novel target for immunotherapy to HCV infection.	[Zhang, Ying; Ma, Cheng J.; Wang, Jia M.; Ji, Xiao J.; Wu, Xiao Y.; Moorman, Jonathan P.; Yao, Zhi Q.] E Tennessee State Univ, James H Quillen Coll Med, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA; [Moorman, Jonathan P.; Yao, Zhi Q.] James H Quillen VA Med Ctr, Dept Vet Affairs, Med Serv, Johnson City, TN USA; [Zhang, Ying; Jia, Zhan S.; Yao, Zhi Q.] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Peoples R China	East Tennessee State University; Air Force Military Medical University	Zhang, Y (corresponding author), E Tennessee State Univ, James H Quillen Coll Med, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA.	Yao@etsu.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health/National Institute of Allergy and Infectious Diseases grant to ZQY/JPM (1R15A1084057-01). This publication is the result of work supported with resources and the use of facilities at the James H. Quillen Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bohnenkamp HR, 2007, CELL IMMUNOL, V247, P72, DOI 10.1016/j.cellimm.2007.07.008; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cho HY, 2009, IMMUNOL LETT, V127, P39, DOI 10.1016/j.imlet.2009.08.011; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Eisen-Vandervelde AL, 2004, J BIOL CHEM, V279, P43479, DOI 10.1074/jbc.M407640200; Eisen-Vandervelde AL, 2004, CLIN IMMUNOL, V111, P16, DOI 10.1016/j.clim.2003.12.003; Eyles JL, 2002, J BIOL CHEM, V277, P43735, DOI 10.1074/jbc.M208586200; Frazier AD, 2010, VIRAL IMMUNOL, V23, P487, DOI 10.1089/vim.2010.0010; Frisancho-Kiss S, 2006, J IMMUNOL, V176, P6411, DOI 10.4049/jimmunol.176.11.6411; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hafler DA, 2008, J EXP MED, V205, P2699, DOI 10.1084/jem.20082429; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Kato T, 2007, J VIROL, V81, P4405, DOI 10.1128/JVI.02334-06; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Ma CJ, 2011, IMMUNOLOGY, V132, P421, DOI 10.1111/j.1365-2567.2010.03382.x; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Moorman J, 2009, IMMUNOLOGY, V128, P227, DOI 10.1111/j.1365-2567.2009.03106.x; Moorman JP, 2011, VACCINE, V29, P3169, DOI 10.1016/j.vaccine.2011.02.052; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; NI L, 2010, IMMUNOLOGY CELL BIOL; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Vali B, 2010, EUR J IMMUNOL, V40, P2493, DOI 10.1002/eji.201040340; Wakita Takaji, 2009, V510, P305, DOI 10.1007/978-1-59745-394-3_23; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Yao ZQ, 2007, VIRAL IMMUNOL, V20, P276, DOI 10.1089/vim.2006.0096; Yao ZQ, 2011, IMMUNOL INVEST, V40, P243, DOI 10.3109/08820139.2010.534218; Yao ZQ, 2008, IMMUNOLOGY, V125, P197, DOI 10.1111/j.1365-2567.2008.02829.x; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yao ZQ, 2003, VIROLOGY, V314, P271, DOI 10.1016/S0042-6822(03)00419-7; Yao ZQ, 2001, VIRAL IMMUNOL, V14, P277, DOI 10.1089/08828240152716547; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Zhang Y, 2011, J IMMUNOL, V186, P3093, DOI 10.4049/jimmunol.1002006; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	56	66	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19664	10.1371/journal.pone.0019664	http://dx.doi.org/10.1371/journal.pone.0019664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637332	Green Submitted, gold, Green Published			2022-12-25	WOS:000291052200010
J	Rezaei-Ghaleh, N; Andreetto, E; Yan, LM; Kapurniotu, A; Zweckstetter, M				Rezaei-Ghaleh, Nasrollah; Andreetto, Erika; Yan, Li-Mei; Kapurniotu, Aphrodite; Zweckstetter, Markus			Interaction between Amyloid Beta Peptide and an Aggregation Blocker Peptide Mimicking Islet Amyloid Polypeptide	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; DIABETES-MELLITUS; CHEMICAL-EXCHANGE; AQUEOUS-SOLUTION; STATE NMR; IN-VITRO; PROTEIN; IAPP; OLIGOMERS	Assembly of amyloid-beta peptide (A beta) into cytotoxic oligomeric and fibrillar aggregates is believed to be a major pathologic event in Alzheimer's disease (AD) and interfering with A beta aggregation is an important strategy in the development of novel therapeutic approaches. Prior studies have shown that the double N-methylated analogue of islet amyloid polypeptide (IAPP) IAPP-GI, which is a conformationally constrained IAPP analogue mimicking a non-amyloidogenic IAPP conformation, is capable of blocking cytotoxic self-assembly of A beta. Here we investigate the interaction of IAPP-GI with A beta 40 and A beta 42 using NMR spectroscopy. The most pronounced NMR chemical shift changes were observed for residues 13-20, while residues 7-9, 15-16 as well as the C-terminal half of A beta - that is both regions of the A beta sequence that are converted into beta-strands in amyloid fibrils - were less accessible to solvent in the presence of IAPP-GI. At the same time, interaction of IAPP-GI with A beta resulted in a concentration-dependent co-aggregation of A beta and IAPP-GI that was enhanced for the more aggregation prone A beta 42 peptide. On the basis of the reduced toxicity of the A beta peptide in the presence of IAPP-GI, our data are consistent with the suggestion that IAPP-GI redirects A beta into nontoxic "off-pathway'' aggregates.	[Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany; [Andreetto, Erika; Yan, Li-Mei; Kapurniotu, Aphrodite] Tech Univ Munich, Div Peptide Biochem, D-8050 Freising Weihenstephan, Germany; [Zweckstetter, Markus] DFG Res Ctr Mol Physiol Brain, Gottingen, Germany	Max Planck Society; Technical University of Munich; German Research Foundation (DFG)	Rezaei-Ghaleh, N (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	mzwecks@gwdg.de	Rezaei-Ghaleh, Nasrollah/B-9443-2008	Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Zweckstetter, Markus/0000-0002-2536-6581	Max Planck Society; DFG [ZW 71/2-2, 3-2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	This work was supported by the Max Planck Society and the DFG through a Heisenberg scholarship (ZW 71/2-2 and 3-2) to M.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BLOMBERG F, 1977, J AM CHEM SOC, V99, P8149, DOI 10.1021/ja00467a005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Kapurniotu A, 2002, J MOL BIOL, V315, P339, DOI 10.1006/jmbi.2001.5244; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Narayanan S, 2005, BIOCHEMISTRY-US, V44, P1444, DOI 10.1021/bi048264b; Nicolls MR, 2004, CURR ALZHEIMER RES, V1, P47, DOI 10.2174/1567205043480555; PELTON JG, 1993, PROTEIN SCI, V2, P543; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Rhoades E, 2000, BBA-PROTEIN STRUCT M, V1476, P230, DOI 10.1016/S0167-4838(99)00248-4; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Schmitz O, 2004, DIABETES, V53, pS233, DOI 10.2337/diabetes.53.suppl_3.S233; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Vaiana SM, 2008, BIOPHYS J, V94, pL45, DOI 10.1529/biophysj.107.125146; Velkova A, 2008, ANGEW CHEM INT EDIT, V47, P7114, DOI 10.1002/anie.200801499; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288	40	39	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20289	10.1371/journal.pone.0020289	http://dx.doi.org/10.1371/journal.pone.0020289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633500	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500052
J	Nair, D; Dayyat, EA; Zhang, SX; Wang, Y; Gozal, D				Nair, Deepti; Dayyat, Ehab A.; Zhang, Shelley X.; Wang, Yang; Gozal, David			Intermittent Hypoxia-Induced Cognitive Deficits Are Mediated by NADPH Oxidase Activity in a Murine Model of Sleep Apnea	PLOS ONE			English	Article							SPATIAL-LEARNING DEFICITS; CHRONIC GRANULOMATOUS-DISEASE; OXIDATIVE STRESS; CORTICAL-NEURONS; NITRIC-OXIDE; MOUSE MODEL; ACTIVATION; MICE; MAZE; RATS	Background: In rodents, exposure to intermittent hypoxia (IH), a hallmark of obstructive sleep apnea (OSA), is associated with neurobehavioral impairments, increased apoptosis in the hippocampus and cortex, as well as increased oxidant stress and inflammation. Excessive NADPH oxidase activity may play a role in IH-induced CNS dysfunction. Methods and Findings: The effect of IH during light period on two forms of spatial learning in the water maze and well as markers of oxidative stress was assessed in mice lacking NADPH oxidase activity (gp91phox(_/Y)) and wild-type littermates. On a standard place training task, gp91phox(_/Y) displayed normal learning, and were protected from the spatial learning deficits observed in wild-type littermates exposed to IH. Moreover, anxiety levels were increased in wild-type mice exposed to IH as compared to room air (RA) controls, while no changes emerged in gp91phox(_/Y) mice. Additionally, wild-type mice, but not gp91phox(_/Y) mice had significantly elevated levels of NADPH oxidase expression and activity, as well as MDA and 8-OHDG in cortical and hippocampal lysates following IH exposures. Conclusions: The oxidative stress responses and neurobehavioral impairments induced by IH during sleep are mediated, at least in part, by excessive NADPH oxidase activity, and thus pharmacological agents targeting NADPH oxidase may provide a therapeutic strategy in sleep-disordered breathing.	[Nair, Deepti; Dayyat, Ehab A.; Zhang, Shelley X.; Wang, Yang; Gozal, David] Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Nair, D (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA.	dgozal@uchicago.edu	Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020	Nair, Deepti/0000-0002-0491-717X	National Institutes of Health [HL-086662]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grant HL-086662. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005; Akashiba T, 2002, CHEST, V122, P861, DOI 10.1378/chest.122.3.861; Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Angermuller S, 2009, HISTOCHEM CELL BIOL, V131, P459, DOI 10.1007/s00418-009-0563-7; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Baran AS, 2003, CNS SPECTR, V8, P128, DOI 10.1017/S1092852900018356; Bardwell WA, 2001, SLEEP, V24, P905, DOI 10.1093/sleep/24.8.905; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Borak J, 1996, J SLEEP RES, V5, P123, DOI 10.1046/j.1365-2869.1996.d01-60.x; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Bruce-Keller AJ, 2010, ANTIOXID REDOX SIGN, V12, P1371, DOI 10.1089/ars.2009.2823; Burckhardt IC, 2008, AM J RESP CRIT CARE, V177, P1135, DOI 10.1164/rccm.200701-110OC; Carpagnano GE, 2002, CHEST, V122, P1162, DOI 10.1378/chest.122.4.1162; Chen H, 2009, J CEREB BLOOD FLOW M; Day R, 1999, PROG CARDIOVASC DIS, V41, P341, DOI 10.1053/pcad.1999.0410341; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Droge W, 2002, AGEING RES REV, V1, P257, DOI 10.1016/S1568-1637(01)00008-3; Eckeli AL, 2000, NEUROREPORT, V11, P1839, DOI 10.1097/00001756-200006260-00008; El-Sheikh M, 2010, CHILD DEV, V81, P870, DOI 10.1111/j.1467-8624.2010.01439.x; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; FILE SE, 1992, BIOL COUN S, P25; FUKUI T, 1995, BBA-BIOENERGETICS, V1231, P215, DOI 10.1016/0005-2728(95)00098-4; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Girouard H, 2009, J NEUROSCI, V29, P2545, DOI 10.1523/JNEUROSCI.0133-09.2009; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Goldbart AD, 2006, BRAIN RES, V1090, P190, DOI 10.1016/j.brainres.2006.03.046; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gozal D, 2007, AM J RESP CRIT CARE, V176, P188, DOI 10.1164/rccm.200610-1519OC; Gozal D, 2010, AM J RESP CRIT CARE, V182, P104, DOI 10.1164/rccm.201001-0108OC; Gozal D, 2008, CURR OPIN PEDIATR, V20, P654, DOI 10.1097/MOP.0b013e328316ec2d; Gozal E, 2002, SLEEP, V25, pA333; Gozal E, 2001, NEUROSCI LETT, V305, P197, DOI 10.1016/S0304-3940(01)01853-5; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Ha JS, 2010, EXP CELL RES, V316, P1651, DOI 10.1016/j.yexcr.2010.03.021; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jang HJ, 2008, NEUROSCI LETT, V443, P17, DOI 10.1016/j.neulet.2008.07.049; Jun J, 2008, AM J PHYSIOL-REG I, V295, pR1274, DOI 10.1152/ajpregu.90346.2008; KAPLAN R, 1992, AUST NZ J PSYCHIAT, V26, P586, DOI 10.3109/00048679209072093; Kaster MP, 2007, EUR J PHARMACOL, V565, P119, DOI 10.1016/j.ejphar.2007.03.003; Kheirandish L, 2005, SLEEP, V28, P1412, DOI 10.1093/sleep/28.11.1412; Kishida KT, 2005, J NEUROCHEM, V94, P299, DOI 10.1111/j.1471-4159.2005.03189.x; Kubota H, 2010, ANN THORAC SURG, V90, P1692, DOI 10.1016/j.athoracsur.2010.04.097; Li JG, 2007, J APPL PHYSIOL, V102, P557, DOI 10.1152/japplphysiol.01081.2006; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; Li RC, 2003, AM J RESP CRIT CARE, V168, P469, DOI 10.1164/rccm.200211-1264OC; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Maneen MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1042, DOI 10.1152/ajpheart.00800.2006; Miller FJ, 2002, METHOD ENZYMOL, V353, P220; MONTPLAISIR J, 1992, SLEEP, V15, pS17, DOI 10.1093/sleep/15.suppl_6.S17; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MURALIKRISHNA AR, 2006, FREE RADIC BIOL MED, V40, P376, DOI DOI 10.1016/J.FREERADBIOMED.2005.08.044; Nanetti L, 2007, MOL CELL BIOCHEM, V303, P19, DOI 10.1007/s11010-007-9451-4; Noh KM, 2000, J NEUROSCI, V20; Ohayon MM, 2003, J CLIN PSYCHIAT, V64, P1195, DOI 10.4088/JCP.v64n1009; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Ramanathan L, 2005, J NEUROCHEM, V93, P47, DOI 10.1111/j.1471-4159.2004.02988.x; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Row BW, 2007, BEHAV BRAIN RES, V177, P308, DOI 10.1016/j.bbr.2006.11.028; Row BW, 2004, J NEUROCHEM, V89, P189, DOI 10.1111/j.1471-4159.2004.02352.x; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Row BW, 2002, PEDIATR RES, V52, P449, DOI 10.1203/01.PDR.0000030718.77598.A4; ROYERPOKORA B, 1987, DIS MARKERS, V5, P57; Sanchez AI, 2001, PSYCHIAT CLIN NEUROS, V55, P641, DOI 10.1046/j.1440-1819.2001.00918.x; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Serrano F, 2003, BRAIN RES, V988, P193, DOI 10.1016/S0006-8993(03)03364-X; Shan XY, 2007, NEUROBIOL DIS, V28, P206, DOI 10.1016/j.nbd.2007.07.013; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Sumimoto H, 2004, JPN J INFECT DIS, V57, pS24; Tammariello SP, 2000, J NEUROSCI, V20; Tejada-Simon MV, 2005, MOL CELL NEUROSCI, V29, P97, DOI 10.1016/j.mcn.2005.01.007; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yasui Hiroyuki, 2005, Drug Metab Pharmacokinet, V20, P1, DOI 10.2133/dmpk.20.1; Zhan GX, 2005, AM J RESP CRIT CARE, V172, P921, DOI 10.1164/rccm.200504-581OC; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zomkowski ADE, 2004, BRAIN RES, V1023, P253, DOI 10.1016/j.brainres.2004.07.041	90	124	131	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19847	10.1371/journal.pone.0019847	http://dx.doi.org/10.1371/journal.pone.0019847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625437	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200016
J	Fong, MY; McDunn, J; Kakar, SS				Fong, Miranda Y.; McDunn, Jonathan; Kakar, Sham S.			Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer	PLOS ONE			English	Article							N-ACETYLASPARTATE; BREAST-CANCER; PROSTATE-CANCER; AEROBIC GLYCOLYSIS; VITAMIN-E; TAURINE; ACID; RESONANCE; GROWTH; PROFILES	In this study, we characterized the metabolome of the human ovary and identified metabolic alternations that coincide with primary epithelial ovarian cancer (EOC) and metastatic tumors resulting from primary ovarian cancer (MOC) using three analytical platforms: gas chromatography mass spectrometry (GC/MS) and liquid chromatography tandem mass spectrometry (LC/MS/MS) using buffer systems and instrument settings to catalog positive or negative ions. The human ovarian metabolome was found to contain 364 biochemicals and upon transformation of the ovary caused changes in energy utilization, altering metabolites associated with glycolysis and beta-oxidation of fatty acids-such as carnitine (1.79 fold in EOC, p < 0.001; 1.88 fold in MOC, p < 0.001), acetylcarnitine (1.75 fold in EOC, p < 0.001; 2.39 fold in MOC, p < 0.001), and butyrylcarnitine (3.62 fold, p < 0.0094 in EOC; 7.88 fold, p < 0.001 in MOC). There were also significant changes in phenylalanine catabolism marked by increases in phenylpyruvate (4.21 fold; p = 0.0098) and phenyllactate (195.45 fold; p < 0.0023) in EOC. Ovarian cancer also displayed an enhanced oxidative stress response as indicated by increases in 2-aminobutyrate in EOC (1.46 fold, p = 0.0316) and in MOC (2.25 fold, p < 0.001) and several isoforms of tocopherols. We have also identified novel metabolites in the ovary, specifically N-acetylasparate and N-acetyl-aspartyl-glutamate, whose role in ovarian physiology has yet to be determined. These data enhance our understanding of the diverse biochemistry of the human ovary and demonstrate metabolic alterations upon transformation. Furthermore, metabolites with significant changes between groups provide insight into biochemical consequences of transformation and are candidate biomarkers of ovarian oncogenesis. Validation studies are warranted to determine whether these compounds have clinical utility in the diagnosis or clinical management of ovarian cancer patients.	[Fong, Miranda Y.; Kakar, Sham S.] Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA; [Kakar, Sham S.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [McDunn, Jonathan] Metabolon Inc, Durham, NC USA	University of Louisville; University of Louisville; Metabolon	Fong, MY (corresponding author), Univ Louisville, Dept Physiol & Biophys, Louisville, KY 40292 USA.	sskaka01@louisville.edu		McDunn, Jonathan/0000-0001-8792-828X	NIH/NCI [CA124630]; Metabolon, Inc.; NATIONAL CANCER INSTITUTE [R01CA124630] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Metabolon, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funds used to perform this work were supported by a NIH/NCI CA124630 research Grant to SSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon was paid for the service peformed in metabolites profiling according to signed contract.; JM is an employee of Metabolon, Inc. and was responsible for preliminary analysis of the data and final editing of the manuscript. However, as part of the University of Louisville's contract with Metabolon, Inc., he does not have any financial benefit or retention of invention or ownership rights, patentable or not. This does not affect adherence to PLoS ONE policies on sharing data and material.	ATEN RF, 1994, ENDOCRINOLOGY, V135, P533, DOI 10.1210/en.135.2.533; Baslow MH, 2010, AMINO ACIDS, V38, P51, DOI 10.1007/s00726-009-0232-0; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; BHOSALE P, INT J GYNECOL CANC, V20, P936; CASSLEN BG, 1987, J REPROD MED, V32, P181; CESARIO S, NURS WOMENS HLTH, V14, P222; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Chen JL, 2010, WORLD J GASTROENTERO, V16, P5874, DOI 10.3748/wjg.v16.i46.5874; CHEN X, J SEP SCI; Cheng LL, 2005, CANCER RES, V65, P3030, DOI 10.1158/0008-5472.CAN-04-4106; Clark JF, 2006, MED HYPOTHESES, V67, P506, DOI 10.1016/j.mehy.2006.02.047; COLLIER VU, 1980, AM J PHYSIOL, V238, pE450, DOI 10.1152/ajpendo.1980.238.5.E450; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Debier C, 2005, BRIT J NUTR, V93, P153, DOI 10.1079/BJN20041308; DELRIO RM, 1990, PROG CLIN BIOL RES, V351, P357; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fernandes CG, 2010, CELL MOL NEUROBIOL, V30, P317, DOI 10.1007/s10571-009-9455-6; Frickenschmidt A, 2008, BIOMARKERS, V13, P435, DOI [10.1080/13547500802012858, 10.1080/13547500802012858 ]; Galarreta M, 1996, ADV EXP MED BIOL, V403, P463; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; GUERIN P, 1995, HUM REPROD, V10, P866, DOI 10.1093/oxfordjournals.humrep.a136052; HAM EA, 1963, BIOCHIM BIOPHYS ACTA, V71, P208, DOI 10.1016/0006-3002(63)91008-4; Hascalik S, 2006, INT J GYNECOL CANCER, V16, P423, DOI 10.1111/j.1525-1438.2006.00200.x; Hellstrom I, 2008, ADV EXP MED BIOL, V622, P15, DOI 10.1007/978-0-387-68969-2_2; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; HUXTABLE RJ, 1989, PROG NEUROBIOL, V32, P471, DOI 10.1016/0301-0082(89)90019-1; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; JHIANG SM, 1993, FEBS LETT, V318, P139, DOI 10.1016/0014-5793(93)80008-I; Kikuchi H, 2009, CANCER RES, V69, P8499, DOI 10.1158/0008-5472.CAN-09-2213; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kolwijck E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010293; Kondoh H, 2005, CANCER RES, V65, P177; KOTHANDARAMAN N, BMC CANC, V10, P64; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin BY, 2009, PROTEOM CLIN APPL, V3, P853, DOI 10.1002/prca.200800141; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2003, ANTICANCER RES, V23, P1149; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Melichar B, 1998, CLIN CANCER RES, V4, P3069; MEYDANI SN, 1992, VITAMIN E HLTH DIS, P549; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Monleon D, 2009, NMR BIOMED, V22, P342, DOI 10.1002/nbm.1345; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; *NAT CANC I, STAT FACT SHEET; Neesham D, 2007, AUST FAM PHYSICIAN, V36, P126; Nolen B, 2010, GYNECOL ONCOL, V117, P440, DOI 10.1016/j.ygyno.2010.02.005; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Odin AP, 1997, MUTAT RES-REV MUTAT, V386, P39, DOI 10.1016/S1383-5742(96)00044-0; Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; OPPENHEIMER L, 1979, J BIOL CHEM, V254, P5184; ORENSANZ LM, 1986, ADV BIOCHEM PSYCHOPH, V42, P265; Osl M, 2008, BIOINFORMATICS, V24, P2908, DOI 10.1093/bioinformatics/btn506; Pangalos MN, 1999, J BIOL CHEM, V274, P8470, DOI 10.1074/jbc.274.13.8470; PHOENIX J, 1994, EXP PHYSIOL, V79, P601, DOI 10.1113/expphysiol.1994.sp003794; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rimpi S, 2007, BIOCHEM SOC T, V35, P305, DOI 10.1042/BST0350305; ROBINSON MB, 1986, EUR J PHARMACOL, V130, P345, DOI 10.1016/0014-2999(86)90291-8; Rosca MG, 2009, ADV DRUG DELIVER REV, V61, P1332, DOI 10.1016/j.addr.2009.06.009; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sager TN, 1997, J NEUROCHEM, V68, P675; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; SLUPSKY CM, CLIN CANC RES, V16, P5835; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; SOLIS JM, 1988, NEUROSCI LETT, V91, P53, DOI 10.1016/0304-3940(88)90248-0; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STRUYS EA, ANN CLIN BIOCH, V47, P282; Szelag Adam, 2002, Ginekol Pol, V73, P627; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; VANDERHEIDEN MG, SCIENCE, V329, P1492; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEI J, INT J CANC; Wong DA, 2004, J BIOL CHEM, V279, P41302, DOI 10.1074/jbc.M406766200; Woo HM, 2009, CLIN CHIM ACTA, V400, P63, DOI 10.1016/j.cca.2008.10.014; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Yang CS, 1997, BIOCHEM PHARMACOL, V53, P357, DOI 10.1016/S0006-2952(96)00729-0; Zagouri F, 2010, EUR J GYNAECOL ONCOL, V31, P268; ZHEN H, INT J GYNECOL CANC, V20, P316	94	115	119	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19963	10.1371/journal.pone.0019963	http://dx.doi.org/10.1371/journal.pone.0019963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625518	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200034
J	Li, GT; Zhou, XY; Kong, LG; Wang, YL; Zhang, H; Zhu, H; Mitchell, TK; Dean, RA; Xu, JR				Li, Guotian; Zhou, Xiaoying; Kong, Lingan; Wang, Yuling; Zhang, Haifeng; Zhu, Heng; Mitchell, Thomas K.; Dean, Ralph A.; Xu, Jin-Rong			MoSfl1 Is Important for Virulence and Heat Tolerance in Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; INFECTION-RELATED MORPHOGENESIS; CANDIDA-ALBICANS SFL1; TRANSCRIPTION FACTOR; ZINC-FINGER; APPRESSORIUM FORMATION; USTILAGO-MAYDIS; MAP KINASE; SACCHAROMYCES-CEREVISIAE; TURGOR GENERATION	The formation of appressoria, specialized plant penetration structures of Magnaporthe oryzae, is regulated by the MST11-MST7-PMK1 MAP kinase cascade. One of its downstream transcription factor, MST12, is important for penetration and invasive growth but dispensable for appressorium formation. To identify additional downstream targets that are regulated by Pmk1, in this study we performed phosphorylation assays with a protein microarray composed of 573 M. oryzae transcription factor (TF) genes. Three of the TF genes phosphorylated by Pmk1 in vitro were further analyzed by coimmunoprecipitation assays. One of them, MoSFL1, was found to interact with Pmk1 in vivo. Like other Sfl1 orthologs, the MoSfl1 protein has the HSF-like domain. When expressed in yeast, MoSFL1 functionally complemented the flocculation defects of the sfl1 mutant. In M. oryzae, deletion of MoSFl1 resulted in a significant reduction in virulence on rice and barley seedlings. Consistent with this observation, the Mosfl1 mutant was defective in invasive growth in penetration assays with rice leaf sheaths. In comparison with that of vegetative hyphae, the expression level of MoSFL1 was increased in appressoria and infected rice leaves. The Mosfl1 mutant also had increased sensitivity to elevated temperatures. In CM cultures of the Mosfl1 and pmk1 mutants grown at 30 degrees C, the production of aerial hyphae and melanization were reduced but their growth rate was not altered. When assayed by qRT-PCR, the transcription levels of the MoHSP30 and MoHSP98 genes were reduced 10- and 3-fold, respectively, in the Mosfl1 mutant. SFL1 orthologs are conserved in filamentous ascomycetes but none of them have been functionally characterized in non-Saccharomycetales fungi. MoSfl1 has one putative MAPK docking site and three putative MAPK phosphorylation sites. Therefore, it may be functionally related to Pmk1 in the regulation of invasive growth and stress responses in M. oryzae.	[Li, Guotian; Zhou, Xiaoying; Kong, Lingan; Zhang, Haifeng; Xu, Jin-Rong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Wang, Yuling] NW A&F Univ, Coll Plant Protect, Yangling, Shanxi, Peoples R China; [Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Mitchell, Thomas K.] Ohio State Univ, Dept Plant Pathol, Columbia, OH USA; [Dean, Ralph A.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwest A&F University - China; Johns Hopkins University; University System of Ohio; Ohio State University; University of North Carolina; North Carolina State University	Li, GT (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	jinrong@purdue.edu			USDA [2007-35319-102681]; China Scholarship Council via Northwest A F University [2008630021]	USDA(United States Department of Agriculture (USDA)); China Scholarship Council via Northwest A F University(China Scholarship Council)	This work was supported by a grant from the USDA Integrated Research Program (#2007-35319-102681). Guotian Li was partially supported by a China Scholarship Council fellowship, #2008630021, via Northwest A & F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Bourett TM, 2002, FUNGAL GENET BIOL, V37, P211, DOI 10.1016/S1087-1845(02)00524-8; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; CHAO CCT, 1991, CAN J BOT, V69, P2130, DOI 10.1139/b91-267; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ding SL, 2010, PLANT CELL, V22, P2495, DOI 10.1105/tpc.110.074302; Flor-Parra I, 2006, PLANT CELL, V18, P2369, DOI 10.1105/tpc.106.042754; FUJITA A, 1989, GENE, V85, P321; Galeote VA, 2007, CURR GENET, V52, P55, DOI 10.1007/s00294-007-0136-z; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grunler A, 2010, FUNGAL GENET BIOL, V47, P619, DOI 10.1016/j.fgb.2010.04.001; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hartmann HA, 1999, PLANT CELL, V11, P1293, DOI 10.1105/tpc.11.7.1293; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Kaffarnik F, 2003, EMBO J, V22, P5817, DOI 10.1093/emboj/cdg554; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; Kim TS, 2004, MOL CELL BIOL, V24, P7695, DOI 10.1128/MCB.24.17.7695-7706.2004; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu WD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001261; Liu WD, 2010, MOL PLANT MICROBE IN, V23, P366, DOI 10.1094/MPMI-23-4-0366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masloff S, 1999, GENETICS, V152, P191; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Mitchell TK, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P73, DOI 10.1007/978-1-4020-9500-9_8; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Mok J, 2009, NAT PROTOC, V4, P1820, DOI 10.1038/nprot.2009.194; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Nishimura M, 2009, BIOSCI BIOTECH BIOCH, V73, P1779, DOI 10.1271/bbb.90146; Odenbach D, 2007, MOL MICROBIOL, V64, P293, DOI 10.1111/j.1365-2958.2007.05643.x; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Park G, 2004, MOL MICROBIOL, V53, P1695, DOI 10.1111/j.1365-2958.2004.04220.x; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Park G, 2006, PLANT CELL, V18, P2822, DOI 10.1105/tpc.105.038422; Patzold AJ, 2001, FEBS LETT, V494, P64, DOI 10.1016/S0014-5793(01)02312-2; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Shi ZX, 1995, MOL PLANT MICROBE IN, V8, P949, DOI 10.1094/MPMI-8-0949; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; TABA MRM, 1991, GENE DEV, V5, P2000, DOI 10.1101/gad.5.11.2000; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Tsuji G, 2000, MOL MICROBIOL, V38, P940, DOI 10.1046/j.1365-2958.2000.02181.x; VALENT B, 1990, PHYTOPATHOLOGY, V80, P33, DOI 10.1094/Phyto-80-33; VALENT B, 1991, GENETICS, V127, P87; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang TT, 2008, CHINESE SCI BULL, V53, P2624, DOI 10.1007/s11434-008-0302-9; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhou XY, 2011, MOL MICROBIOL, V80, P33, DOI 10.1111/j.1365-2958.2011.07556.x; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	71	37	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19951	10.1371/journal.pone.0019951	http://dx.doi.org/10.1371/journal.pone.0019951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625508	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200033
J	Xue, XL; Sztajer, H; Buddruhs, N; Petersen, J; Rohde, M; Talay, SR; Wagner-Dobler, I				Xue, Xiaoli; Sztajer, Helena; Buddruhs, Nora; Petersen, Joern; Rohde, Manfred; Talay, Susanne R.; Wagner-Doebler, Irene			Lack of the Delta Subunit of RNA Polymerase Increases Virulence Related Traits of Streptococcus mutans	PLOS ONE			English	Article							WALL-ASSOCIATED PROTEIN; BIOFILM FORMATION; DENTAL BIOFILM; BACTERIAL INTERACTIONS; MICROARRAY ANALYSIS; ORAL STREPTOCOCCI; STRESS TOLERANCE; MATRIX MOLECULES; HEART-VALVE; SURFACE	The delta subunit of the RNA polymerase, RpoE, maintains the transcriptional specificity in Gram-positive bacteria. Lack of RpoE results in massive changes in the transcriptome of the human dental caries pathogen Streptococcus mutans. In this study, we analyzed traits of the Delta rpoE mutant which are important for biofilm formation and interaction with oral microorganisms and human cells and performed a global phenotypic analysis of its physiological functions. The Delta rpoE mutant showed higher self-aggregation compared to the wild type and coaggregated with other oral bacteria and Candida albicans. It formed a biofilm with a different matrix structure and an altered surface attachment. The amount of the cell surface antigens I/II SpaP and the glucosyltransferase GtfB was reduced. The Delta rpoE mutant displayed significantly stronger adhesion to human extracellular matrix components, especially to fibronectin, than the wild type. Its adhesion to human epithelial cells HEp-2 was reduced, probably due to the highly aggregated cell mass. The analysis of 1248 physiological traits using phenotype microarrays showed that the Delta rpoE mutant metabolized a wider spectrum of carbon sources than the wild type and had acquired resistance to antibiotics and inhibitory compounds with various modes of action. The reduced antigenicity, increased aggregation, adherence to fibronection, broader substrate spectrum and increased resistance to antibiotics of the Delta rpoE mutant reveal the physiological potential of S. mutans and show that some of its virulence related traits are increased.	[Xue, Xiaoli; Sztajer, Helena; Wagner-Doebler, Irene] Helmholtz Ctr Infect Res GmbH, Div Cell Biol, Res Grp Microbial Commun, Braunschweig, Germany; [Buddruhs, Nora; Petersen, Joern] German Collect Microorganisms & Cell Cultures Gmb, Res Grp Roseobacter Mol Systemat, Braunschweig, Germany; [Rohde, Manfred; Talay, Susanne R.] Helmholtz Ctr Infect Res GmbH, Dept Med Microbiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research	Xue, XL (corresponding author), Helmholtz Ctr Infect Res GmbH, Div Cell Biol, Res Grp Microbial Commun, Braunschweig, Germany.	iwd@gbf.de	Wagner-Döbler, Irene/Y-1685-2019	Wagner-Dobler, Irene/0000-0001-5883-2502	Chinese Academy of Science (CSC); German State Ministry for Research and Education (BMBF) [FK 0315411A]; German Research Organisation (DFG) [DFG TRR 51]; European Community [FP7/2007-2013, 222886-2]; Helmholtz-Centre for Infection Research (HZI) GmbH; German Collection of Microorganisms and Cell Cultures (DSMZ) GmbH	Chinese Academy of Science (CSC)(Chinese Academy of Sciences); German State Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Organisation (DFG)(German Research Foundation (DFG)); European Community(European Commission); Helmholtz-Centre for Infection Research (HZI) GmbH; German Collection of Microorganisms and Cell Cultures (DSMZ) GmbH	Xiaoli Xue was supported by a Chinese Academy of Science (CSC)-Helmholtz Joint Fellowship. IWD acknowledges the support of the German State Ministry for Research and Education (BMBF), grant FK 0315411A, and the support of the German Research Organisation (DFG) for the Special Research Program (SFB), grant DFG TRR 51. The research leading to the Phenotype Microarray (PM) results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 222886-2 (Microme project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HSZ, MR, ST and IWD are employees of the Helmholtz-Centre for Infection Research (HZI) GmbH. NB and JP are employees of the German Collection of Microorganisms and Cell Cultures (DSMZ) GmbH. Both institutions are govenment funded research organizations. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abranches J, 2009, ORAL MICROBIOL IMMUN, V24, P141, DOI 10.1111/j.1399-302X.2008.00487.x; ACHBERGER EC, 1981, J BIOL CHEM, V256, P7424; Ahn SJ, 2009, APPL ENVIRON MICROB, V75, P2517, DOI 10.1128/AEM.02367-08; Aires CP, 2008, CARIES RES, V42, P380, DOI 10.1159/000154783; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Beg AM, 2002, BIOCHEM BIOPH RES CO, V298, P75, DOI 10.1016/S0006-291X(02)02390-2; Biswas S, 2005, INFECT IMMUN, V73, P6923, DOI 10.1128/IAI.73.10.6923-6934.2005; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Burne RA, 1996, J DENT RES, V75, P1572, DOI 10.1177/00220345960750080801; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; CROWLEY PJ, 1987, INFECT IMMUN, V55, P2695, DOI 10.1128/IAI.55.11.2695-2700.1987; Cury JA, 2000, CARIES RES, V34, P491, DOI 10.1159/000016629; Eberhard J, 2009, ORAL MICROBIOL IMMUN, V24, P325, DOI 10.1111/j.1399-302X.2009.00518.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Garcia-Godoy F, 2008, J AM DENT ASSOC, V139, p25S, DOI 10.14219/jada.archive.2008.0352; Han TK, 2006, BIOCHEM BIOPH RES CO, V343, P787, DOI 10.1016/j.bbrc.2006.03.025; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; HONDA O, 1990, J GEN MICROBIOL, V136, P2099, DOI 10.1099/00221287-136-10-2099; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jarosz LM, 2009, EUKARYOT CELL, V8, P1658, DOI 10.1128/EC.00070-09; JENKINSON HF, 1990, INFECT IMMUN, V58, P1429, DOI 10.1128/IAI.58.5.1429-1436.1990; Jiang YL, 2002, J ENDODONT, V28, P279, DOI 10.1097/00004770-200204000-00005; Jones AL, 2003, INFECT IMMUN, V71, P4011, DOI 10.1128/IAI.71.7.4011-4017.2003; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kaur SJ, 2010, J BIOL CHEM, V285, P27798, DOI 10.1074/jbc.M109.098053; Kelemen L, 2004, FEBS LETT, V566, P190, DOI 10.1016/j.febslet.2004.04.029; Kinney KK, 2010, AM J MED SCI, V340, P209, DOI 10.1097/MAJ.0b013e3181e99aa4; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Nakano K, 2006, MICROBES INFECT, V8, P114, DOI 10.1016/j.micinf.2005.06.005; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nomura R, 2006, J MED MICROBIOL, V55, P1135, DOI 10.1099/jmm.0.46609-0; Ogawa A, 2011, APPL ENVIRON MICROB, V77, P1572, DOI 10.1128/AEM.02066-10; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Periasamy S, 2009, APPL ENVIRON MICROB, V75, P3250, DOI 10.1128/AEM.02901-08; Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x; RIIHINEN K, 2010, PHYTOTHER RES; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Senadheera D, 2008, ADV EXP MED BIOL, V631, P178, DOI 10.1007/978-0-387-78885-2_12; Shun CT, 2005, INFECT IMMUN, V73, P3261, DOI 10.1128/IAI.73.6.3261-3270.2005; SKLAVOUNOU A, 1980, INFECT IMMUN, V27, P686, DOI 10.1128/IAI.27.2.686-689.1980; TAKAHASHI N, 2010, J DENT RES; TAO L, 1993, J DENT RES, V72, P1386, DOI 10.1177/00220345930720100701; Vilchez R, 2010, CHEMBIOCHEM, V11, P1552, DOI 10.1002/cbic.201000086; Vollmer T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-78; von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018; Wang W, 2003, BIOTECHNOL BIOENG, V83, P525, DOI 10.1002/bit.10701; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10; Zhang JQ, 2009, MICROBIOL-SGM, V155, P61, DOI 10.1099/mic.0.023077-0; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zhu L, 2006, MICROBIOL-SGM, V152, P2395, DOI 10.1099/mic.0.28883-0; Zhu M, 2009, APPL ENVIRON MICROB, V75, P7037, DOI 10.1128/AEM.01015-09; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	69	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20075	10.1371/journal.pone.0020075	http://dx.doi.org/10.1371/journal.pone.0020075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625504	Green Submitted, Green Published, gold			2022-12-25	WOS:000290771200045
J	Stein, SJ; Baldwin, AS				Stein, S. J.; Baldwin, A. S.			NF-kappa B suppresses ROS levels in BCR-ABL(+) cells to prevent activation of JNK and cell death	ONCOGENE			English	Article						IKK beta inhibitor; BCR-ABL; ROS; NF-kappa B; JNK	ALPHA-INDUCED APOPTOSIS; REACTIVE OXYGEN; OXIDATIVE STRESS; C-JUN; TRANSFORMED FIBROBLASTS; IMATINIB RESISTANCE; MEDIATED MECHANISM; SIGNALING PATHWAY; CANCER-CELLS; CML CELLS	Elevated levels of reactive oxygen species (ROS) are found in most oncogenically transformed cells and are proposed to promote cellular transformation through mechanisms such as inhibition of phosphatases. BCR-ABL, the oncoprotein associated with the majority of chronic myeloid leukemias (CMLs), induces accumulation of intracellular ROS, causing enhanced signaling down-stream of PI3K. Previously we have shown that the transcription factor nuclear factor-kappa B (NF-kappa B) is activated by BCR-ABL expression and is required for BCR-ABL-mediated cellular transformation. Inhibition of I kappa B kinase (IKK beta) and NF-kappa B leads to cell death through an unknown mechanism. Here, we analyze the potential involvement of NF-kappa B in moderating BCR-ABL-induced ROS levels to protect from death. The data confirm that BCR-ABL promotes ROS and demonstrate that NF-kappa B prevents excessive levels. Inhibition of NF-kappa B leads to an increase in ROS levels and to cell death, which is at least partially controlled through ROS-induced c-Jun N-terminal kinase activity. The data demonstrate that one function for NF-kappa B in oncogenesis is the suppression of oncoprotein-induced ROS levels and that inhibition of NF-jB in some cancers, including CML, will increase ROS levels and promote cell death. Oncogene (2011) 30, 4557-4566; doi: 10.1038/onc.2011.156; published online 30 May 2011	[Baldwin, A. S.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Baldwin, A. S.] Univ N Carolina, Sch Med, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Baldwin, AS (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, 22-000 LCCC,CB 7295, Chapel Hill, NC 27599 USA.	abaldwin@med.unc.edu			Leukemia and Lymphoma Society; NIH [CA73756, CA75080]; Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA075080, R01CA073756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI035098] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Justina Chen for technical support and members of the Baldwin lab for advice and discussion. We acknowledge grant support from the Leukemia and Lymphoma Society, from the NIH (CA73756 and CA75080), and from the Samuel Waxman Cancer Research Foundation.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Braun T, 2006, CELL DEATH DIFFER, V13, P748, DOI 10.1038/sj.cdd.4401874; Chandra J, 2006, BLOOD, V107, P2501, DOI 10.1182/blood-2005-07-2966; Cilloni D, 2006, LEUKEMIA, V20, P61, DOI 10.1038/sj.leu.2403998; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Duncan EA, 2008, MOL CANCER THER, V7, P391, DOI 10.1158/1535-7163.MCT-07-0305; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hamdane M, 1997, ONCOGENE, V15, P2267, DOI 10.1038/sj.onc.1201411; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schimmel M, 2002, ONCOGENE, V21, P5886, DOI 10.1038/sj.onc.1205740; Senthil K, 2004, CLIN CHIM ACTA, V339, P27, DOI 10.1016/j.cccn.2003.08.017; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zhang H, 2008, LEUKEMIA, V22, P1191, DOI 10.1038/leu.2008.74; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	50	25	26	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 10	2011	30	45					4557	4566		10.1038/onc.2011.156	http://dx.doi.org/10.1038/onc.2011.156			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	21625221	Green Accepted, Green Submitted			2022-12-25	WOS:000296890700003
J	Bellinzoni, M; Bastard, K; Perret, A; Zaparucha, A; Perchat, N; Vergne, C; Wagner, T; de Melo-Minardi, RC; Artiguenave, F; Cohen, GN; Weissenbach, J; Salanoubat, M; Alzari, PM				Bellinzoni, Marco; Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; Wagner, Tristan; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Cohen, Georges N.; Weissenbach, Jean; Salanoubat, Marcel; Alzari, Pedro M.			3-Keto-5-aminohexanoate Cleavage Enzyme A COMMON FOLD FOR AN UNCOMMON CLAISEN-TYPE CONDENSATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMUM-LIKELIHOOD; DEGRADATION; REFINEMENT; FAMILIES; GENOMICS; DOCKING; PATHWAY; GENES	The exponential increase in genome sequencing output has led to the accumulation of thousands of predicted genes lacking a proper functional annotation. Among this mass of hypothetical proteins, enzymes catalyzing new reactions or using novel ways to catalyze already known reactions might still wait to be identified. Here, we provide a structural and biochemical characterization of the 3-keto-5-aminohexanoate cleavage enzyme (Kce), an enzymatic activity long known as being involved in the anaerobic fermentation of lysine but whose catalytic mechanism has remained elusive so far. Although the enzyme shows the ubiquitous triose phosphate isomerase (TIM) barrel fold and a Zn2+ cation reminiscent of metal-dependent class II aldolases, our results based on a combination of x-ray snapshots and molecular modeling point to an unprecedented mechanism that proceeds through deprotonation of the 3-keto-5-aminohexanoate substrate, nucleophilic addition onto an incoming acetyl-CoA, intramolecular transfer of the CoA moiety, and final retro-Claisen reaction leading to acetoacetate and 3-aminobutyryl-CoA. This model also accounts for earlier observations showing the origin of carbon atoms in the products, as well as the absence of detection of any covalent acyl-enzyme intermediate. Kce is the first representative of a large family of prokaryotic hypothetical proteins, currently annotated as the "domain of unknown function" DUF849.	[Bellinzoni, Marco; Wagner, Tristan; Alzari, Pedro M.] Inst Pasteur, Unite Microbiol Struct, F-75724 Paris 15, France; [Bellinzoni, Marco; Wagner, Tristan; Alzari, Pedro M.] CNRS, URA2185, F-75724 Paris 15, France; [Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Weissenbach, Jean; Salanoubat, Marcel] Inst Genom, CEA, Direct Sci Vivant, F-91057 Evry, France; [Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Weissenbach, Jean; Salanoubat, Marcel] CNRS, UMR8030, F-91057 Evry, France; [Bastard, Karine; Perret, Alain; Zaparucha, Anne; Perchat, Nadia; Vergne, Carine; de Melo-Minardi, Raquel C.; Artiguenave, Francois; Weissenbach, Jean; Salanoubat, Marcel] Univ Evry Val Essonne, F-91057 Evry, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Zaparucha, A (corresponding author), IG Genoscope, Lab Chim Organ & Biocatalyse, 2 Rue Gaston Cremieux, F-91057 Evry, France.	azaparuc@genoscope.cns.fr; pedro.alzari@pasteur.fr	Zaparucha, Anne/ADO-0726-2022; InWeb, Inct/J-9839-2013	Zaparucha, Anne/0000-0003-2531-4148; Alzari, Pedro/0000-0002-4233-1903; C. de Melo-Minardi, Raquel/0000-0001-5190-100X; PERRET, Alain/0000-0002-8896-1978; Karine, Bastard/0000-0003-4898-7871; Bellinzoni, Marco/0000-0002-8887-6917	Institut Pasteur; CEA; CNRS; University of Evry	Institut Pasteur(European Commission); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Evry	This work was supported by grants from the Institut Pasteur, the CEA, the CNRS, and the University of Evry.	Anstrom DM, 2003, PROTEIN SCI, V12, P1822, DOI 10.1110/ps.03174303; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER HA, 1980, J BACTERIOL, V143, P1165, DOI 10.1128/JB.143.3.1165-1170.1980; BARKER HA, 1982, J BACTERIOL, V152, P201; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis FA, 1999, J ORG CHEM, V64, P1403, DOI 10.1021/jo9820622; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kreimeyer A, 2007, J BIOL CHEM, V282, P7191, DOI 10.1074/jbc.M609829200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YORIFUJI T, 1977, J BIOL CHEM, V252, P20; Zhang C, 2003, CURR OPIN CHEM BIOL, V7, P28, DOI 10.1016/S1367-5931(02)00015-7	32	11	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27399	27405		10.1074/jbc.M111.253260	http://dx.doi.org/10.1074/jbc.M111.253260			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21632536	Green Published, hybrid			2022-12-25	WOS:000293268700035
J	Watanabe, M; Horai, Y; Houten, SM; Morimoto, K; Sugizaki, T; Arita, E; Mataki, C; Sato, H; Tanigawara, Y; Schoonjans, K; Itoh, H; Auwerx, J				Watanabe, Mitsuhiro; Horai, Yasushi; Houten, Sander M.; Morimoto, Kohkichi; Sugizaki, Taichi; Arita, Eri; Mataki, Chikage; Sato, Hiroyuki; Tanigawara, Yusuke; Schoonjans, Kristina; Itoh, Hiroshi; Auwerx, Johan			Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK-REGULATION; ORPHAN-NUCLEAR-RECEPTOR; INSULIN SENSITIVITY; IN-VIVO; MICE; METABOLISM; EXPRESSION; SIGNAL; SHP; IDENTIFICATION	We evaluated the metabolic impact of farnesoid X receptor (FXR) activation by administering a synthetic FXR agonist (GW4064) to mice in which obesity was induced by a high fat diet. Administration of GW4064 accentuated body weight gain and glucose intolerance induced by the high fat diet and led to a pronounced worsening of the changes in liver and adipose tissue. Mechanistically, treatment with GW4064 decreased bile acid (BA) biosynthesis, BA pool size, and energy expenditure, whereas reconstitution of the BA pool in these GW4064-treated animals by BA administration dose-dependently reverted the metabolic abnormalities. Our data therefore suggest that activation of FXR with synthetic agonists is not useful for long term management of the metabolic syndrome, as it reduces the BA pool size and subsequently decreases energy expenditure, translating as weight gain and insulin resistance. In contrast, expansion of the BA pool size, which can be achieved by BA administration, could be an interesting strategy to manage the metabolic syndrome.	[Watanabe, Mitsuhiro; Horai, Yasushi; Morimoto, Kohkichi; Sugizaki, Taichi; Arita, Eri; Itoh, Hiroshi] Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Mataki, Chikage; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Sato, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Biosci, Ehime 7910295, Japan; [Tanigawara, Yusuke] Keio Univ, Dept Pharm, Sch Med, Tokyo 1608582, Japan	Keio University; University of Amsterdam; Academic Medical Center Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Ehime University; Keio University	Watanabe, M (corresponding author), Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan.	wmitsu@sc.itc.keio.ac.jp; johan.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houten, Sander/Y-3599-2019	Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393; Schoonjans, Kristina/0000-0003-1247-4265	National Institutes of Health; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; Uehara Memorial Foundation; Takeda Science Foundation; Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science; Japan Health Foundation; Kowa Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Ono Medical Foundation; Astellas Foundation for Research on Metabolic Disorders; Novartis Foundation (Japan) for Promotion of Science(Novartis); Japan Health Foundation(Japan Health Foundation); Kowa Life Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by National Institutes of Health grants. This work was also supported by grants from the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the Uehara Memorial Foundation, Takeda Science Foundation, the Sumitomo Foundation, Ono Medical Foundation, Astellas Foundation for Research on Metabolic Disorders, the Novartis Foundation (Japan) for Promotion of Science, the Japan Health Foundation, Kowa Life Science Foundation and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Houten SM, 2007, MOL ENDOCRINOL, V21, P1312, DOI 10.1210/me.2007-0113; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Houten SM, 2004, ANN MED, V36, P482, DOI 10.1080/07853890410018790; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qiao L, 2003, MOL CELL BIOL, V23, P3052, DOI 10.1128/MCB.23.9.3052-3066.2003; Rizzo G, 2006, MOL PHARMACOL, V70, P1164, DOI 10.1124/mol.106.023820; SAKAKURA H, 1993, J CHROMATOGR-BIOMED, V621, P123, DOI 10.1016/0378-4347(93)80087-K; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stayrook KR, 2005, ENDOCRINOLOGY, V146, P984, DOI 10.1210/en.2004-0965; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	41	187	198	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26913	26920		10.1074/jbc.M111.248203	http://dx.doi.org/10.1074/jbc.M111.248203			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632533	Green Published, hybrid			2022-12-25	WOS:000293078200065
J	Aguda, BD; Marsh, CB; Thacker, M; Crouser, ED				Aguda, Baltazar D.; Marsh, Clay B.; Thacker, Michael; Crouser, Elliott D.			An In Silico Modeling Approach to Understanding the Dynamics of Sarcoidosis	PLOS ONE			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; DISEASE; INFLIXIMAB; CANCER; CD8	Background: Sarcoidosis is a polygenic disease with diverse phenotypic presentations characterized by an abnormal antigen-mediated Th1 type immune response. At present, progress towards understanding sarcoidosis disease mechanisms and the development of novel treatments is limited by constraints attendant to conducting human research in a rare disease in the absence of relevant animal models. We sought to develop a computational model to enhance our understanding of the pathological mechanisms of and predict potential treatments of sarcoidosis. Methodology/Results: Based upon the literature, we developed a computational model of known interactions between essential immune cells (antigen-presenting macrophages, effector and regulatory T cells) and cytokine mediators (IL-2, TNF alpha, IFN gamma) of granulomatous inflammation during sarcoidosis. The dynamics of these interactions are described by a set of ordinary differential equations. The model predicts bistable switching behavior which is consistent with normal (self-limited) and "sarcoidosis-like'' (sustained) activation of the inflammatory components of the system following a single antigen challenge. By perturbing the influence of model components using inhibitors of the cytokine mediators, distinct clinically relevant disease phenotypes were represented. Finally, the model was shown to be useful for pre-clinical testing of therapies based upon molecular targets and dose-effect relationships. Conclusions/Significance: Our work illustrates a dynamic computer simulation of granulomatous inflammation scenarios that is useful for the investigation of disease mechanisms and for pre-clinical therapeutic testing. In lieu of relevant in vitro or animal surrogates, our model may provide for the screening of potential therapies for specific sarcoidosis disease phenotypes in advance of expensive clinical trials.	[Aguda, Baltazar D.] NCI, Ctr Canc Res, Neurooncol Branch, Bethesda, MD 20892 USA; [Marsh, Clay B.; Crouser, Elliott D.] Ohio State Univ, Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Thacker, Michael] Ohio State Univ, Med Ctr, Dept Elect & Comp Engn, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Aguda, BD (corresponding author), NCI, Ctr Canc Res, Neurooncol Branch, Bethesda, MD 20892 USA.	Elliott.Crouser@osumc.edu	Crouser, Elliott/ABC-2602-2021; Crouser, Elliott/E-2933-2011		American Thoracic Society/Foundation for Sarcoidosis Research (EDC)	American Thoracic Society/Foundation for Sarcoidosis Research (EDC)	Funding was provided by the American Thoracic Society/Foundation for Sarcoidosis Research (EDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2007, PLOS COMPUT BIOL, V3, P1674, DOI 10.1371/journal.pcbi.0030152; Alencar AM, 2002, NATURE, V417, P809, DOI 10.1038/417809b; Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; Arazi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008447; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Bilate AM, 2010, J CLIN INVEST, V120, P4190, DOI 10.1172/JCI45262; Correale P, 2001, EUR J CANCER, V37, P892, DOI 10.1016/S0959-8049(01)00063-6; Crouser ED, 2010, CHEST, V137, P1432, DOI 10.1378/chest.09-2576; DELEN CI, 2009, RHEUMATOLOGY, V48, P883; Dhaille F, 2010, DERMATOLOGY, V220, P234, DOI 10.1159/000275676; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Idali F, 2008, CLIN EXP IMMUNOL, V152, P127, DOI 10.1111/j.1365-2249.2008.03609.x; Izbicki G, 2007, CHEST, V131, P1414, DOI 10.1378/chest.06-2114; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Judson MA, 2008, EUR RESPIR J, V31, P1189, DOI 10.1183/09031936.00051907; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Mariani L, 2004, PROG BIOPHYS MOL BIO, V86, P45, DOI 10.1016/j.pbiomolbio.2004.02.007; Mendoza L, 2006, BIOSYSTEMS, V84, P101, DOI 10.1016/j.biosystems.2005.10.004; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Nagar M, 2010, J IMMUNOL, V184, P3570, DOI 10.4049/jimmunol.0902070; Noor A, 2007, CLIN DERMATOL, V25, P250, DOI 10.1016/j.clindermatol.2007.03.002; Safirstein BH, 2003, CHEST, V123, P301, DOI 10.1378/chest.123.1.301; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009088; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19544	10.1371/journal.pone.0019544	http://dx.doi.org/10.1371/journal.pone.0019544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637752	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500007
J	Hida, K; Lai, SK; Suk, JS; Won, SY; Boyle, MP; Hanes, J				Hida, Kaoru; Lai, Samuel K.; Suk, Jung Soo; Won, Sang Y.; Boyle, Michael P.; Hanes, Justin			Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients	PLOS ONE			English	Article							CILIATED AIRWAY EPITHELIUM; ADENOASSOCIATED VIRUS; IN-VITRO; RECOMBINANT ADENOVIRUS; INTRACELLULAR TRAFFICKING; POLYMER NANOPARTICLES; DIRECTED EVOLUTION; NONHUMAN-PRIMATES; IMMUNE-RESPONSES; RAPID-TRANSPORT	Norwalk virus and human papilloma virus, two viruses that infect humans at mucosal surfaces, have been found capable of rapidly penetrating human mucus secretions. Viral vectors for gene therapy of Cystic Fibrosis (CF) must similarly penetrate purulent lung airway mucus (sputum) to deliver DNA to airway epithelial cells. However, surprisingly little is known about the rates at which gene delivery vehicles penetrate sputum, including viral vectors used in clinical trials for CF gene therapy. We find that sputum spontaneously expectorated by CF patients efficiently traps two viral vectors commonly used in CF gene therapy trials, adenovirus (d similar to 80 nm) and adeno-associated virus (AAV serotype 5; d similar to 20 nm), leading to average effective diffusivities that are similar to 3,000-fold and 12,000-fold slower than their theoretical speeds in water, respectively. Both viral vectors are slowed by adhesion, as engineered muco-inert nanoparticles with diameters as large as 200 nm penetrate the same sputum samples at rates only similar to 40-fold reduced compared to in pure water. A limited fraction of AAV exhibit sufficiently fast mobility to penetrate physiologically thick sputum layers, likely because of the lower viscous drag and smaller surface area for adhesion to sputum constituents. Nevertheless, poor penetration of CF sputum is likely a major contributor to the ineffectiveness of viral vector based gene therapy in the lungs of CF patients observed to date.	[Hida, Kaoru; Suk, Jung Soo; Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Lai, Samuel K.; Won, Sang Y.; Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD USA; [Lai, Samuel K.; Boyle, Michael P.; Hanes, Justin] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Baltimore, MD USA; [Boyle, Michael P.] Johns Hopkins Univ, Sch Med, Johns Hopkins Adult Cyst Fibrosis Program, Div Pulm & Crit Care Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Hida, K (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hanes@jhu.edu		Boyle, Michael/0000-0002-9740-1630; Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [NIH EB003558, P01 HL051811-16]; Cystic Fibrosis Foundation [CFF HANES08G0]; Croucher Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Croucher Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by National Institutes of Health grants to J.H. (NIH EB003558, P01 HL051811-16), the Cystic Fibrosis Foundation (CFF HANES08G0) and to S. K. L. (Croucher Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher RC, 1999, J CLIN INVEST, V103, P441, DOI 10.1172/JCI6330; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clunes Mark T, 2007, Drug Discov Today Dis Mech, V4, P63, DOI 10.1016/j.ddmec.2007.09.001; Cone R., 1999, MUCOSAL IMMUNOLOGY, P43; Conrad CK, 1996, GENE THER, V3, P658; Dasgupta B, 1996, PEDIATR PULM, V22, P161, DOI 10.1002/(SICI)1099-0496(199609)22:3<161::AID-PPUL4>3.0.CO;2-S; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Duan DS, 1998, HUM GENE THER, V9, P2761, DOI 10.1089/hum.1998.9.18-2761; Ferrari S, 2002, ADV DRUG DELIVER REV, V54, P1373, DOI 10.1016/S0169-409X(02)00145-X; GaherySegard H, 1997, J CLIN INVEST, V100, P2218, DOI 10.1172/JCI119759; Griesenbach U, 2006, GENE THER, V13, P1061, DOI 10.1038/sj.gt.3302809; Griesenbach U, 2004, GENE THER, V11, pS43, DOI 10.1038/sj.gt.3302368; Grubb BR, 1999, PHYSIOL REV, V79, P193; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hansen J, 2000, J VIROL, V74, P992, DOI 10.1128/JVI.74.2.992-996.2000; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; Joseph PM, 2001, HUM GENE THER, V12, P1369, DOI 10.1089/104303401750298535; Kaplan JM, 1996, GENE THER, V3, P117; KONSTAN MW, 1994, AM J RESP CRIT CARE, V150, P448, DOI 10.1164/ajrccm.150.2.8049828; Lai SK, 2008, J CONTROL RELEASE, V125, P107, DOI 10.1016/j.jconrel.2007.10.015; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Li WP, 2009, MOL THER, V17, P2067, DOI 10.1038/mt.2009.155; Limberis MP, 2009, MOL THER, V17, P294, DOI 10.1038/mt.2008.261; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Moss RB, 2007, HUM GENE THER, V18, P726, DOI 10.1089/hum.2007.022; Mueller C, 2008, CLIN REV ALLERG IMMU, V35, P164, DOI 10.1007/s12016-008-8080-3; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Perricone MA, 2000, HUM GENE THER, V11, P1997, DOI 10.1089/10430340050143426; Rooney CP, 2002, J VIROL, V76, P10437, DOI 10.1128/JVI.76.20.10437-10443.2002; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103; SHEEHAN JK, 1986, BIOCHEM J, V239, P147, DOI 10.1042/bj2390147; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stern M, 1998, GENE THER, V5, P91, DOI 10.1038/sj.gt.3300556; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Suh J, 2007, INT J NANOMED, V2, P735; Suk JS, 2007, EXP BIOL MED, V232, P461; Suk JS, 2011, NANOMEDICINE-UK, V6, P365, DOI 10.2217/NNM.10.123; Suk JS, 2009, BIOMATERIALS, V30, P2591, DOI 10.1016/j.biomaterials.2008.12.076; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Virella-Lowell I, 2000, GENE THER, V7, P1783, DOI 10.1038/sj.gt.3301268; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wagner JA, 1998, LANCET, V351, P1702, DOI 10.1016/S0140-6736(05)77740-0; Walters RW, 2002, J BIOL CHEM, V277, P23709, DOI 10.1074/jbc.M200292200; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; Yan ZY, 2006, J BIOL CHEM, V281, P29684, DOI 10.1074/jbc.M604099200; YANG YP, 1995, NAT MED, V1, P890, DOI 10.1038/nm0995-890; Zahm JM, 2001, AM J RESP CRIT CARE, V163, P1153, DOI 10.1164/ajrccm.163.5.2005002; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	60	48	56	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19919	10.1371/journal.pone.0019919	http://dx.doi.org/10.1371/journal.pone.0019919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637751	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052500017
J	Lin, A; Jimenez, J; Derr, J; Vera, P; Manapat, ML; Esvelt, KM; Villanueva, L; Liu, DR; Chen, IA				Lin, Abraham; Jimenez, Jose; Derr, Julien; Vera, Pedro; Manapat, Michael L.; Esvelt, Kevin M.; Villanueva, Laura; Liu, David R.; Chen, Irene A.			Inhibition of Bacterial Conjugation by Phage M13 and Its Protein g3p: Quantitative Analysis and Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHANGING EPIDEMIOLOGY; RESISTANCE; PLASMID; INFECTION; KINETICS; BACTERIOPHAGES; PENETRATION; PNEUMONIAE; EVOLUTION	Conjugation is the main mode of horizontal gene transfer that spreads antibiotic resistance among bacteria. Strategies for inhibiting conjugation may be useful for preserving the effectiveness of antibiotics and preventing the emergence of bacterial strains with multiple resistances. Filamentous bacteriophages were first observed to inhibit conjugation several decades ago. Here we investigate the mechanism of inhibition and find that the primary effect on conjugation is occlusion of the conjugative pilus by phage particles. This interaction is mediated primarily by phage coat protein g3p, and exogenous addition of the soluble fragment of g3p inhibited conjugation at low nanomolar concentrations. Our data are quantitatively consistent with a simple model in which association between the pili and phage particles or g3p prevents transmission of an F plasmid encoding tetracycline resistance. We also observe a decrease in the donor ability of infected cells, which is quantitatively consistent with a reduction in pili elaboration. Since many antibiotic-resistance factors confer susceptibility to phage infection through expression of conjugative pili (the receptor for filamentous phage), these results suggest that phage may be a source of soluble proteins that slow the spread of antibiotic resistance genes.	[Lin, Abraham; Jimenez, Jose; Derr, Julien; Vera, Pedro; Villanueva, Laura; Chen, Irene A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Esvelt, Kevin M.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Esvelt, Kevin M.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Manapat, Michael L.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	Lin, A (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	ichen@post.harvard.edu	Villanueva, Laura/N-3598-2014; Vera, Pedro/AAE-1514-2021; Liu, David R./HCH-3132-2022	Villanueva, Laura/0000-0001-5659-8599; Jimenez, Jose/0000-0002-2700-9473; Esvelt, Kevin/0000-0001-8797-3945; Lin, Abraham/0000-0003-1659-3026; Chen, Irene/0000-0001-6040-7927	Harvard College; Human Frontiers Science Program; Fannie and John Hertz Foundation; NSF; Howard Hughes Medical Institute; NIH [R01GM065400, GM068763]; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400, P50GM068763] Funding Source: NIH RePORTER	Harvard College; Human Frontiers Science Program(Human Frontier Science Program); Fannie and John Hertz Foundation; NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AL received support from the Harvard College Research Program (http://www.seo.harvard.edu). JJ and MLM are fellows of the Foundational Questions in Evolutionary Biology at Harvard University sponsored by the John Templeton Foundation (http://www.fas.harvard.edu/similar to fqeb/). JD received a fellowship from the Human Frontiers Science Program (http://www.hfsp.org/). KME received graduate fellowships from the Fannie and John Hertz Foundation (http://www.hertzfoundation.org/) and the NSF (http://www.nsf.gov/). DRL acknowledges support from the Howard Hughes Medical Institute (http://www.hhmi.org/) and NIH grant R01GM065400 (http://www.nih.gov/). This work was supported by NIH grant GM068763 to the National Centers of Systems Biology. IAC is a Bauer Fellow at Harvard University (http://www.sysbio.harvard.edu/csb). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrup L, 1999, MICROBIOL-UK, V145, P2001, DOI 10.1099/13500872-145-8-2001; Andrup L, 1998, PLASMID, V40, P30, DOI 10.1006/plas.1998.1346; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; BOEKE JD, 1982, MOL GEN GENET, V186, P185, DOI 10.1007/BF00331849; CULLUM J, 1978, PLASMID, V1, P536, DOI 10.1016/0147-619X(78)90010-0; Daehnel K, 2005, MICROBIOL-SGM, V151, P3541, DOI 10.1099/mic.0.28159-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng LW, 1999, VIROLOGY, V253, P271, DOI 10.1006/viro.1998.9509; Frost LS., 1993, BACTERIAL CONJUGATIO, P189; GUINEY DG, 1982, J MOL BIOL, V162, P699, DOI 10.1016/0022-2836(82)90397-7; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Holliger P, 1999, J MOL BIOL, V288, P649, DOI 10.1006/jmbi.1999.2720; INGRAM LC, 1973, ANTIMICROB AGENTS CH, V3, P279, DOI 10.1128/AAC.3.2.279; JACOBSON A, 1972, J VIROL, V10, P835, DOI 10.1128/JVI.10.4.835-843.1972; Kim BC, 2005, J BACTERIOL, V187, P4505, DOI 10.1128/JB.187.13.4505-4513.2005; LEVIN BR, 1979, PLASMID, V2, P247, DOI 10.1016/0147-619X(79)90043-X; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; MAPLE P, 1990, J CHEMOTHERAPY, V2, P280, DOI 10.1080/1120009X.1990.11739031; MARVIN DA, 1969, BACTERIOL REV, V33, P172, DOI 10.1007/BF02702778; May T, 2010, ISME J; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; MEYNELL E, 1968, BACTERIOL REV, V32, P55, DOI 10.1128/MMBR.32.1.55-83.1968; MEYNELL GG, 1968, NATURE, V217, P1184, DOI 10.1038/2171184a0; NOVOTNY C, 1968, J BACTERIOL, V95, P314, DOI 10.1128/JB.95.2.314-326.1968; OU JT, 1973, J BACTERIOL, V114, P1108, DOI 10.1128/JB.114.3.1108-1115.1973; PALCHOUDHURY SR, 1969, MOL GEN GENET, V105, P131, DOI 10.1007/BF00445683; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rozinov MN, 1998, CHEM BIOL, V5, P713, DOI 10.1016/S1074-5521(98)90664-0; RUSSEL M, 2006, BACTERIOPHAGES, P146; RUSSELL SE, 1972, J BACTERIOL, V11, P7; SALIVAR WO, 1964, VIROLOGY, V24, P359, DOI 10.1016/0042-6822(64)90173-4; Sambrook J, 2001, MOL CLONING LAB MANU; SUN TP, 1986, J BACTERIOL, V165, P107, DOI 10.1128/jb.165.1.107-115.1986; TOLMASKY ME, 1986, ANTIMICROB AGENTS CH, V30, P315, DOI 10.1128/AAC.30.2.315; TZAGOLOFF H, 1964, VIROLOGY, V24, P372, DOI 10.1016/0042-6822(64)90174-6; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; Webster R, 2001, PHAGE DISPLAY LAB MA, V1st; Williams JJ, 2008, CURR OPIN CHEM BIOL, V12, P389, DOI 10.1016/j.cbpa.2008.06.015; Zhu WM, 2008, ANTIMICROB AGENTS CH, V52, P452, DOI 10.1128/AAC.00908-07	46	51	55	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19991	10.1371/journal.pone.0019991	http://dx.doi.org/10.1371/journal.pone.0019991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637841	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200024
J	Weyman, PD; Vargas, WA; Tong, YK; Yu, JP; Maness, PC; Smith, HO; Xu, Q				Weyman, Philip D.; Vargas, Walter A.; Tong, Yingkai; Yu, Jianping; Maness, Pin-Ching; Smith, Hamilton O.; Xu, Qing			Heterologous Expression of Alteromonas macleodii and Thiocapsa roseopersicina [NiFe] Hydrogenases in Synechococcus elongatus	PLOS ONE			English	Article							BIDIRECTIONAL HYDROGENASE; ACCESSORY GENES; MUTAGENESIS; MATURATION; OXIDATION; CLONING; BBS; CYANOBACTERIA; BIOSYNTHESIS; ALCALIGENES	Oxygen-tolerant [NiFe] hydrogenases may be used in future photobiological hydrogen production systems once the enzymes can be heterologously expressed in host organisms of interest. To achieve heterologous expression of [NiFe] hydrogenases in cyanobacteria, the two hydrogenase structural genes from Alteromonas macleodii Deep ecotype (AltDE), hynS and hynL, along with the surrounding genes in the gene operon of HynSL were cloned in a vector with an IPTG-inducible promoter and introduced into Synechococcus elongatus PCC7942. The hydrogenase protein was expressed at the correct size upon induction with IPTG. The heterologously-expressed HynSL hydrogenase was active when tested by in vitro H-2 evolution assay, indicating the correct assembly of the catalytic center in the cyanobacterial host. Using a similar expression system, the hydrogenase structural genes from Thiocapsa roseopersicina (hynSL) and the entire set of known accessory genes were transferred to S. elongatus. A protein of the correct size was expressed but had no activity. However, when the 11 accessory genes from AltDE were co-expressed with hynSL, the T. roseopersicina hydrogenase was found to be active by in vitro assay. This is the first report of active, heterologously-expressed [NiFe] hydrogenases in cyanobacteria.	[Weyman, Philip D.; Vargas, Walter A.; Tong, Yingkai; Smith, Hamilton O.; Xu, Qing] J Craig Venter Inst, Dept Synthet Biol & Bioenergy, Rockville, MD USA; [Yu, Jianping; Maness, Pin-Ching] Natl Renewable Energy Lab, Golden, CO USA	J. Craig Venter Institute; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Weyman, PD (corresponding author), J Craig Venter Inst, Dept Synthet Biol & Bioenergy, Rockville, MD USA.	qxu2019@gmail.com		Yu, Jianping/0000-0003-0466-3197; Weyman, Philip/0000-0001-5787-0291	U.S. Department of Energy [DE-FG36-05GO15027]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, the Hydrogen, Fuel Cells, and Infrastructure Technology Program (DE-FG36-05GO15027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananyev G, 2008, APPL ENVIRON MICROB, V74, P6102, DOI 10.1128/AEM.01078-08; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; Bascones E, 2000, APPL ENVIRON MICROB, V66, P4292, DOI 10.1128/AEM.66.10.4292-4299.2000; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BOGOROV LV, 1974, MIKROBIOLOGIYA, V43, P326; Boison G, 1996, FEBS LETT, V394, P153, DOI 10.1016/0014-5793(96)00936-2; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CASTENHOLZ RW, 1988, METHOD ENZYMOL, V167, P68; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; COLBEAU A, 1994, GENE, V140, P25, DOI 10.1016/0378-1119(94)90726-9; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Fodor B, 2001, APPL ENVIRON MICROB, V67, P2476, DOI 10.1128/AEM.67.6.2476-2483.2001; FRIEDRICH B, 1984, J BACTERIOL, V158, P331, DOI 10.1128/JB.158.1.331-333.1984; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Kovacs KL, 2002, INT J HYDROGEN ENERG, V27, P1463, DOI 10.1016/S0360-3199(02)00097-6; Maness PC, 2002, APPL ENVIRON MICROB, V68, P2633, DOI 10.1128/AEM.68.6.2633-2636.2002; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Maroti G, 2010, INT J HYDROGEN ENERG, V35, P3358, DOI 10.1016/j.ijhydene.2009.10.059; Maroti G, 2009, APPL ENVIRON MICROB, V75, P5821, DOI 10.1128/AEM.00580-09; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Rakhely G, 1998, J BACTERIOL, V180, P1460, DOI 10.1128/JB.180.6.1460-1465.1998; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; Sambrook J, 2001, MOL CLONING LAB MANU; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vargas WA, 2011, APPL ENVIRON MICROB, V77, P1990, DOI 10.1128/AEM.01559-10; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Weyman PD, 2011, MICROBIOL-SGM, V157, P1363, DOI 10.1099/mic.0.044834-0; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; YAGI K, 1986, BIOCHEM BIOPH RES CO, V137, P114, DOI 10.1016/0006-291X(86)91183-6	39	30	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20126	10.1371/journal.pone.0020126	http://dx.doi.org/10.1371/journal.pone.0020126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637846	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200035
J	Polakof, S; Panserat, S; Craig, PM; Martyres, DJ; Plagnes-Juan, E; Savari, S; Aris-Brosou, S; Moon, TW				Polakof, Sergio; Panserat, Stephane; Craig, Paul M.; Martyres, David J.; Plagnes-Juan, Elisabeth; Savari, Sharareh; Aris-Brosou, Stephane; Moon, Thomas W.			The Metabolic Consequences of Hepatic AMP-Kinase Phosphorylation in Rainbow Trout	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; SKELETAL-MUSCLE; METFORMIN; INSULIN; EXPRESSION; LIVER; MODEL; GLUCONEOGENESIS	AMP-activated protein kinase (AMPK), a phylogenetically conserved serine/threonine protein kinase, is proposed to function as a "fuel gauge'' to monitor cellular energy status in response to nutritional environmental variations. However, in fish, few studies have addressed the metabolic consequences related to the activation of this kinase. This study demonstrates that the rainbow trout (Oncorhynchus mykiss) possesses paralogs of the three known AMPK subunits that co-diversified, that the AMPK protein is present in the liver and in isolated hepatocytes, and it does change in response to physiological (fasting-re-feeding cycle) and pharmacological (AICAR and metformin administration and incubations) manipulations. Moreover, the phosphorylation of AMPK results in the phosphorylation of acetyl-CoA carboxylase, a main downstream target of AMPK in mammals. Other findings include changes in hepatic glycogen levels and several molecular actors involved in hepatic glucose and lipid metabolism, including mRNA transcript levels for glucokinase, glucose-6-phosphatase and fatty acid synthase both in vivo and in vitro. The fact that most results presented in this study are consistent with the recognized role of AMPK as a master regulator of energy homeostasis in living organisms supports the idea that these functions are conserved in this piscine model.	[Polakof, Sergio; Panserat, Stephane; Plagnes-Juan, Elisabeth] INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France; [Polakof, Sergio] Univ Vigo, Lab Fisiol Anim, Dept Biol Func & Ciencias Saude, Fac Biol, Vigo 36310, Spain; [Craig, Paul M.; Martyres, David J.; Savari, Sharareh; Aris-Brosou, Stephane; Moon, Thomas W.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Craig, Paul M.; Martyres, David J.; Savari, Sharareh; Aris-Brosou, Stephane; Moon, Thomas W.] Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON, Canada	INRAE; Universite de Pau et des Pays de l'Adour; Universidade de Vigo; University of Ottawa; University of Ottawa	Polakof, S (corresponding author), CRNH Auvergne, INRA, UMR 1019, UNH, Clermont Ferrand, France.	spolakof@st-pee.inra.fr	Craig, Paul/G-4248-2011; Craig, Paul/J-4058-2015; Polakof, Sergio/V-1132-2017	Polakof, Sergio/0000-0002-0976-8732; Panserat, Stephane/0000-0002-4479-9868; Aris-Brosou, Stephane/0000-0003-4987-0296	Xunta de Galicia; NSERC Canada; France-Canada Research Fund; Natural Sciences & Engineering Research Council (NSERC) of Canada	Xunta de Galicia(Xunta de GaliciaEuropean Commission); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); France-Canada Research Fund; Natural Sciences & Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	S. Polakof was the recipient of a postdoctoral fellowship from the Xunta de Galicia (Program Angeles Alvarino), P. Craig was supported by a postdoctoral fellowship from NSERC Canada, and D.J. Martyres by an undergraduate scholarship from NSERC Canada. This study was supported by research grants from a France-Canada Research Fund grant to T.W. Moon and S. Panserat, and Natural Sciences & Engineering Research Council (NSERC) of Canada grants to S. Aris-Brosou and T.W. Moon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F.W., 1984, P1; Aris-Brosou S., 2008, INT J PLANT GENOMICS, V2008; Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Diamanti-Kandarakis E, 2010, EUR J ENDOCRINOL, V162, P193, DOI 10.1530/EJE-09-0733; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; HERTZ Y, 1989, AQUACULTURE, V80, P175, DOI 10.1016/0044-8486(89)90283-4; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jibb LA, 2008, J EXP BIOL, V211, P3111, DOI 10.1242/jeb.019117; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Magallon S., 2009, TIMETREE LIFE, P133; Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581; Mommsen Thomas P., 1994, Biochemistry and Molecular Biology of Fishes, V3, P355; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Navarro I., 1995, BIOCH MOL BIOL FISHE, p394 ; Otto M, 2003, DIABETES OBES METAB, V5, P189, DOI 10.1046/j.1463-1326.2003.00263.x; PANSERAT S, 2009, AM J PHYSIOL-REG I, V293, P707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plagnes-Juan E, 2008, J EXP BIOL, V211, P2510, DOI 10.1242/jeb.018374; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2009, AM J PHYSIOL-REG I, V297, pR1769, DOI 10.1152/ajpregu.00369.2009; Polakof S, 2010, J EXP BIOL, V213, P1443, DOI 10.1242/jeb.037689; Posada D., 2003, CURRENT PROTOCOLS BI; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Stenslokken KO, 2008, AM J PHYSIOL-REG I, V295, pR1803, DOI 10.1152/ajpregu.90590.2008; Tomita K, 2005, ALCOHOL CLIN EXP RES, V29, p240S, DOI 10.1097/01.alc.0000191126.11479.69; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Walter I, 2010, J EXP BIOL, V213, P3167, DOI 10.1242/jeb.043349; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1	49	54	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20228	10.1371/journal.pone.0020228	http://dx.doi.org/10.1371/journal.pone.0020228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625448	Green Published, gold			2022-12-25	WOS:000290793400048
J	Prabhu, VS; Farnham, PG; Hutchinson, AB; Soorapanth, S; Heffelfinger, JD; Golden, MR; Brooks, JT; Rimland, D; Sansom, SL				Prabhu, Vimalanand S.; Farnham, Paul G.; Hutchinson, Angela B.; Soorapanth, Sada; Heffelfinger, James D.; Golden, Matthew R.; Brooks, John T.; Rimland, David; Sansom, Stephanie L.			Cost-Effectiveness of HIV Screening in STD Clinics, Emergency Departments, and Inpatient Units: A Model-Based Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; INFECTED PERSONS; MEDICAL-CARE; STATES; TRANSMISSION; PREVENTION; DIAGNOSIS; LIFE; GUIDELINES	Background: Identifying and treating persons with human immunodeficiency virus (HIV) infection early in their disease stage is considered an effective means of reducing the impact of the disease. We compared the cost-effectiveness of HIV screening in three settings, sexually transmitted disease (STD) clinics serving men who have sex with men, hospital emergency departments (EDs), settings where patients are likely to be diagnosed early, and inpatient diagnosis based on clinical manifestations. Methods and Findings: We developed the Progression and Transmission of HIV/AIDS model, a health state transition model that tracks index patients and their infected partners from HIV infection to death. We used program characteristics for each setting to compare the incremental cost per quality-adjusted life year gained from early versus late diagnosis and treatment. We ran the model for 10,000 index patients for each setting, examining alternative scenarios, excluding and including transmission to partners, and assuming HAART was initiated at a CD4 count of either 350 or 500 cells/mu L. Screening in STD clinics and EDs was cost-effective compared with diagnosing inpatients, even when including only the benefits to the index patients. Screening patients in STD clinics, who have less-advanced disease, was cost-effective compared with ED screening when treatment with HAART was initiated at a CD4 count of 500 cells/mu L. When the benefits of reduced transmission to partners from early diagnosis were included, screening in settings with less-advanced disease stages was cost-saving compared with screening later in the course of infection. The study was limited by a small number of observations on CD4 count at diagnosis and by including transmission only to first generation partners of the index patients. Conclusions: HIV prevention efforts can be advanced by screening in settings where patients present with less-advanced stages of HIV infection and by initiating treatment with HAART earlier in the course of infection.	[Prabhu, Vimalanand S.] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Farnham, Paul G.; Hutchinson, Angela B.; Heffelfinger, James D.; Brooks, John T.; Sansom, Stephanie L.] Ctr Dis Control & Prevent CDC, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, Atlanta, GA USA; [Soorapanth, Sada] San Francisco State Univ, San Francisco, CA 94132 USA; [Golden, Matthew R.] Univ Washington, Publ Health Seattle & King Cty STD Clin, Seattle, WA 98195 USA; [Golden, Matthew R.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Rimland, David] Vet Affairs Med Ctr, Med Specialty Serv Line RIM 111, Decatur, GA 30033 USA; [Rimland, David] Emory Univ, Sch Med, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California State University System; San Francisco State University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University	Prabhu, VS (corresponding author), Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA.	pgf1@cdc.gov	Golden, Matthew/AAE-4314-2020	Soorapanth, Sada/0000-0002-0644-9082				Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; CDC, 2003, MMWR-MORBID MORTAL W, V52, P329; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Freeman HP, 1995, NATL VITAL STAT REPO, V3, P19; Gold MR, 1996, COST EFFECTIVENESS H; Golden MR, 2009, MONTR CAN 16 C RETR; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Helms DJ, 2009, JAIDS-J ACQ IMM DEF, V50, P320, DOI 10.1097/QAI.0b013e3181945f03; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holtgrave DR, 2010, PUBLIC HEALTH REP, V125, P372, DOI 10.1177/003335491012500305; Jean-Jacques M, 2008, AIDS CARE, V20, P977, DOI 10.1080/09540120701767257; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lyons MS, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-220; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mauskopf J, 2005, JAIDS-J ACQ IMM DEF, V39, P562; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Merito Monica, 2006, Eur J Health Econ, V7, P30, DOI 10.1007/s10198-005-0327-9; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Raboud JM, 1998, AIDS, V12, P1619, DOI 10.1097/00002030-199813000-00008; Reed JB, 2009, AIDS PATIENT CARE ST, V23, P765, DOI 10.1089/apc.2008.0213; Sabin CA, 2008, AIDS, V22, P1943, DOI 10.1097/QAD.0b013e32830e4cf3; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Sculpher Mark, 2006, DECISION MODELLING H; Sterne JAC, 2007, JAIDS-J ACQ IMM DEF, V46, P607, DOI 10.1097/QAI.0b013e31815b7dba; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; TURNER BJ, 1994, ARCH INTERN MED, V154, P1561, DOI 10.1001/archinte.154.14.1561; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Walensky RP, 2002, ARCH INTERN MED, V162, P887, DOI 10.1001/archinte.162.8.887; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; Weinstein MC, 2008, MED CARE, V46, P343, DOI 10.1097/MLR.0b013e31816a7144; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027; Zetola NM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-17	53	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19936	10.1371/journal.pone.0019936	http://dx.doi.org/10.1371/journal.pone.0019936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766OI	21625489	Green Published, gold			2022-12-25	WOS:000290793400020
J	Sorci, M; Silkworth, W; Gehan, T; Belfort, G				Sorci, Mirco; Silkworth, Whitney; Gehan, Timothy; Belfort, Georges			Evaluating Nuclei Concentration in Amyloid Fibrillation Reactions Using Back-Calculation Approach	PLOS ONE			English	Article							PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; MOLECULAR-BASIS; EARLY EVENTS; INSULIN; MECHANISM; OLIGOMERS; PATHWAYS; KINETICS; STATES	Background: In spite of our extensive knowledge of the more than 20 proteins associated with different amyloid diseases, we do not know how amyloid toxicity occurs or how to block its action. Recent contradictory reports suggest that the fibrils and/or the oligomer precursors cause toxicity. An estimate of their temporal concentration may broaden understanding of the amyloid aggregation process. Methodology/Principal Findings: Assuming that conversion of folded protein to fibril is initiated by a nucleation event, we back-calculate the distribution of nuclei concentration. The temporal in vitro concentration of nuclei for the model hormone, recombinant human insulin, is estimated to be in the picomolar range. This is a conservative estimate since the back-calculation method is likely to overestimate the nuclei concentration because it does not take into consideration fibril fragmentation, which would lower the amount of nuclei Conclusions: Because of their propensity to form aggregates (non-ordered) and fibrils (ordered), this very low concentration could explain the difficulty in isolating and blocking oligomers or nuclei toxicity and the long onset time for amyloid diseases.	[Sorci, Mirco] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Sorci, M (corresponding author), Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA.	belfog@rpi.edu	Gehan, Timothy/U-6630-2018	Gehan, Timothy/0000-0003-0143-791X	NSF [CTS-94-00610]; DOE [DE-FE02-90ER14114, DE-FE02001ER46429]	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	This work was supported by NSF (CTS-94-00610) and DOE (DE-FE02-90ER14114 and DE-FE02001ER46429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; [Anonymous], 2001, NATURE STRUCTURAL BI, V8, P281; [Anonymous], GOODNESS FIT TESTS; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; Chiang PK, 2008, CURR MOL MED, V8, P580, DOI 10.2174/156652408785747951; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Grudzielanek S, 2007, J MOL BIOL, V370, P372, DOI 10.1016/j.jmb.2007.04.053; Heldt CL, 2011, PROTEINS, V79, P92, DOI 10.1002/prot.22861; Hoppener JWM, 2000, NEW ENGL J MED, V343, P411; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Librizzi F, 2005, PROTEIN SCI, V14, P3129, DOI 10.1110/ps.051692305; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Meng GN, 2010, SCIENCE, V327, P560, DOI 10.1126/science.1181263; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nayak A, 2009, PROTEINS, V74, P556, DOI 10.1002/prot.22169; Nettleton EJ, 2000, BIOPHYS J, V79, P1053, DOI 10.1016/S0006-3495(00)76359-4; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Oosawa F., 1975, THERMODYNAMICS POLYM; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pease LF, 2010, BIOPHYS J, V99, P3979, DOI 10.1016/j.bpj.2010.10.010; Podesta A, 2006, BIOPHYS J, V90, P589, DOI 10.1529/biophysj.105.068833; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Sipe JD, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P1, DOI 10.1002/9783527619344; Sorci M, 2009, PROTEINS, V77, P62, DOI 10.1002/prot.22417; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; WAUGH DAVID F., 1957, J CELL AND COMP PHYSIOL, V49, P145, DOI 10.1002/jcp.1030490415; WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20072	10.1371/journal.pone.0020072	http://dx.doi.org/10.1371/journal.pone.0020072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625464	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400038
J	Zhang, YZ; Handley, D; Kaplan, T; Yu, HY; Bais, AS; Richards, T; Pandit, KV; Zeng, QL; Benos, PV; Friedman, N; Eickelberg, O; Kaminski, N				Zhang, Yingze; Handley, Daniel; Kaplan, Tommy; Yu, Haiying; Bais, Abha S.; Richards, Thomas; Pandit, Kusum V.; Zeng, Qilu; Benos, Panayiotis V.; Friedman, Nir; Eickelberg, Oliver; Kaminski, Naftali			High Throughput Determination of TGF beta 1/SMAD3 Targets in A549 Lung Epithelial Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SURFACTANT PROTEIN-B; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR-I; GENE-EXPRESSION DATA; TGF-BETA; MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; CONFERS RESISTANCE	Background: Transforming growth factor beta 1 (TGF beta 1) plays a major role in many lung diseases including lung cancer, pulmonary hypertension, and pulmonary fibrosis. TGF beta 1 activates a signal transduction cascade that results in the transcriptional regulation of genes in the nucleus, primarily through the DNA-binding transcription factor SMAD3. The objective of this study is to identify genome-wide scale map of SMAD3 binding targets and the molecular pathways and networks affected by the TGF beta 1/SMAD3 signaling in lung epithelial cells. Methodology: We combined chromatin immunoprecipitation with human promoter region microarrays (ChIP-on-chip) along with gene expression microarrays to study global transcriptional regulation of the TGF beta 1/SMAD3 pathway in human A549 alveolar epithelial cells. The molecular pathways and networks associated with TGF beta 1/SMAD3 signaling were identified using computational approaches. Validation of selected target gene expression and direct binding of SMAD3 to promoters were performed by quantitative real time RT-PCR and electrophoretic mobility shift assay on A549 and human primary lung epithelial cells. Results and Conclusions: Known TGF beta 1 target genes such as SERPINE1, SMAD6, SMAD7, TGFB1 and LTBP3, were found in both ChIP-on-chip and gene expression analyses as well as some previously unrecognized targets such as FOXA2. SMAD3 binding of FOXA2 promoter and changed expression were confirmed. Computational approaches combining ChIP-on-chip and gene expression microarray revealed multiple target molecular pathways affected by the TGF beta 1/SMAD3 signaling. Identification of global targets and molecular pathways and networks associated with TGF beta 1/SMAD3 signaling allow for a better understanding of the mechanisms that determine epithelial cell phenotypes in fibrogenesis and carcinogenesis as does the discovery of the direct effect of TGF beta 1 on FOXA2.	[Zhang, Yingze; Handley, Daniel; Richards, Thomas; Pandit, Kusum V.; Zeng, Qilu; Kaminski, Naftali] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Richard P & Dorothy P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA; [Kaplan, Tommy] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Friedman, Nir] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Sch Comp Sci & Engn, Jerusalem, Israel; [Yu, Haiying; Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Asklepios Hosp Gauting, Munich, Germany; [Yu, Haiying; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Bais, Abha S.; Benos, Panayiotis V.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; Hebrew University of Jerusalem; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, YZ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Richard P & Dorothy P Simmons Ctr Interstitial Lu, Pittsburgh, PA 15260 USA.	zhangy@upmc.edu	Kaplan, Tommy/T-2528-2017; Friedman, Nir/H-9692-2012; Eickelberg, Oliver/A-5461-2013; Pandit, Kusum/E-7265-2018	Kaplan, Tommy/0000-0002-1892-5461; Friedman, Nir/0000-0002-9678-3550; Eickelberg, Oliver/0000-0001-7170-0360; Kaminski, Naftali/0000-0001-5917-4601; Pandit, Kusum/0000-0001-7458-4705; Benos, Panayiotis/0000-0003-3172-3132	Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research; National Institutes of Health [HL0894932, HL095397, LM009657]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008949, R01HL095397] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009657] Funding Source: NIH RePORTER	Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Dorothy P. and Richard P. Simmons Endowed Chair for Pulmonary Research and National Institutes of Health grants HL0894932, HL095397, and LM009657 (to Dr. Kaminski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Bonewald LF, 1999, CRIT REV EUKAR GENE, V9, P33, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.30; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Dave NB, 2005, METH MOLEC MED, V117, P333; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Ekins S, 2006, XENOBIOTICA, V36, P877, DOI 10.1080/00498250600861660; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; *GENEGO M, 2008, GENEGO IS LEAD PROV; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; *ING SYST, 2008, ING PATHW AN; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kaminski N, 2003, AM J RESP CELL MOL, V29, pS32; Khoor A, 2004, HUM PATHOL, V35, P560, DOI 10.1016/j.humpath.2004.01.017; Kim JH, 2007, J KOREAN MED SCI, V22, P898, DOI 10.3346/jkms.2007.22.5.898; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konishi K, 2009, AM J RESP CRIT CARE, V180, P167, DOI 10.1164/rccm.200810-1596OC; Latella G, 2009, EUR J CLIN INVEST, V39, P145, DOI 10.1111/j.1365-2362.2008.02076.x; Latella G, 2009, LIVER INT, V29, P997, DOI 10.1111/j.1478-3231.2009.02011.x; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Li CG, 2002, J BIOL CHEM, V277, P38399, DOI 10.1074/jbc.M203188200; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Maitra M, 2010, J BIOL CHEM, V285, P22103, DOI 10.1074/jbc.M110.121467; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Minoo P, 2008, NUCLEIC ACIDS RES, V36, P179, DOI 10.1093/nar/gkm871; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; RAHMANN S, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1032; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Selman M, 2004, SARCOIDOSIS VASC DIF, V21, P165; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Whitsett JA, 2006, PEDIATR CLIN N AM, V53, P873, DOI 10.1016/j.pcl.2006.08.009; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; WINGENDER E, 2004, IN SILICO BIOL, V4, P55; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yoshimi T, 2005, EUR J CELL BIOL, V84, P555, DOI 10.1016/j.ejcb.2004.12.026; YU H, 2008, FASEB J; Yu HY, 2008, FASEB J, V22, P1778, DOI 10.1096/fj.07-083857; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; ZHONG Q, 2010, AM J RESP CELL MOL B; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	72	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20319	10.1371/journal.pone.0020319	http://dx.doi.org/10.1371/journal.pone.0020319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625455	Green Published, Green Accepted, gold			2022-12-25	WOS:000290793400056
J	Liu, PC; Wang, JX; Song, QS; Zhao, XF				Liu, Peng-Cheng; Wang, Jin-Xing; Song, Qi-Sheng; Zhao, Xiao-Fan			The Participation of Calponin in the Cross Talk between 20-Hydroxyecdysone and Juvenile Hormone Signaling Pathways by Phosphorylation Variation	PLOS ONE			English	Article							PROTEIN-KINASE-C; DROSOPHILA-MELANOGASTER; HELICOVERPA-ARMIGERA; ECDYSONE RECEPTOR; METHOPRENE-TOLERANT; BROAD-COMPLEX; INSECT DEVELOPMENT; VAV PROTOONCOGENE; NUCLEAR RECEPTOR; GENE-EXPRESSION	20-hydroxyecdysone (20E) and juvenile hormone (JH) signaling pathways interact to mediate insect development, but the mechanism of this interaction is poorly understood. Here, a calponin homologue domain (Chd) containing protein (HaCal) is reported to play a key role in the cross talk between 20E and JH signaling by varying its phosphorylation. Chd is known as an actin binding domain present in many proteins including some signaling proteins. Using an epidermal cell line (HaEpi), HaCal was found to be up-regulated by either 20E or the JH analog methoprene (JHA). 20E induced rapid phosphorylation of HaCal whereas no phosphorylation occurred with JHA. HaCal could be quickly translocated into the nuclei through 20E or JH signaling but interacted with USP1 only under the mediation of JHA. Knockdown of HaCal by RNAi blocked the 20E inducibility of USP1, PKC and HR3, and also blocked the JHA inducibility of USP1, PKC and JHi. After gene silencing of HaCal by ingestion of dsHaCal expressed by Escherichia coli, the larval development was arrested and the gene expression of USP1, PKC, HR3 and JHi were blocked. These composite data suggest that HaCal plays roles in hormonal signaling by quickly transferring into nucleus to function as a phosphorylated form in the 20E pathway and as a non-phosphorylated form interacting with USP1 in the JH pathway to facilitate 20E or JH signaling cascade, in short, by switching its phosphorylation status to regulate insect development.	[Liu, Peng-Cheng; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Peoples R China; [Song, Qi-Sheng] Univ Missouri, Div Plant Sci, Columbia, MO USA	Shandong University; University of Missouri System; University of Missouri Columbia	Liu, PC (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021	Liu, Pengcheng/0000-0003-1179-2296; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [30710103901, 30970404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No: 30710103901 and 30970404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95; Dekel I, 2000, FEBS LETT, V472, P99, DOI 10.1016/S0014-5793(00)01413-7; DIANA E, 2003, BIOESSAYS, V25, P994; DONG DJ, 2010, AMINO ACIDS; Dong DJ, 2012, AMINO ACIDS, V42, P1297, DOI 10.1007/s00726-010-0824-8; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Ferjani I, 2010, BBA-PROTEINS PROTEOM, V1804, P1760, DOI 10.1016/j.bbapap.2010.05.012; Fu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-600; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Henrich VC, 1999, VITAM HORM, V55, P73; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; Hou L, 2011, AMINO ACIDS, V40, P953, DOI 10.1007/s00726-010-0720-2; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; Kethidi DR, 2006, MOL CELL ENDOCRINOL, V247, P127, DOI 10.1016/j.mce.2005.12.016; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KOELLE MR, 1992, P NATL ACAD SCI USA, V89, P6167, DOI 10.1073/pnas.89.13.6167; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu Y, 2009, ARCH INSECT BIOCHEM, V72, P74, DOI 10.1002/arch.20324; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; ORO AE, 1992, DEVELOPMENT, V115, P449; Ozlu N, 2010, WIRES SYST BIOL MED, V2, P255, DOI 10.1002/wsbm.41; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Sasorith Souphatta, 2002, Journal of Insect Science (Tucson), V2, pUnpaginated; SEVALA VL, 1989, EXPERIENTIA, V45, P355, DOI 10.1007/BF01957476; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Soin T, 2008, J INSECT PHYSIOL, V54, P429, DOI 10.1016/j.jinsphys.2007.11.001; Song Q, 2003, INSECT BIOCHEM MOLEC, V33, P1211, DOI 10.1016/j.ibmb.2003.06.005; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Sui YP, 2009, INSECT MOL BIOL, V18, P353, DOI 10.1111/j.1365-2583.2009.00879.x; Sun XP, 2006, ARCH INSECT BIOCHEM, V62, P116, DOI 10.1002/arch.20130; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; WILLIAMS CM, 1961, TRENDS ENDOCRIN MET, V16, P6; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; XU Y, 2002, EUR J BIOCH; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhao XF, 2004, INSECT MOL BIOL, V13, P407, DOI 10.1111/j.0962-1075.2004.00499.x; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zheng WW, 2010, MOL CELL ENDOCRINOL, V315, P282, DOI 10.1016/j.mce.2009.10.018; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259	59	30	39	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19776	10.1371/journal.pone.0019776	http://dx.doi.org/10.1371/journal.pone.0019776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625546	gold, Green Published, Green Submitted			2022-12-25	WOS:000290771200021
J	Tayebi, M; Jones, DR; Taylor, WA; Stileman, BF; Chapman, C; Zhao, DM; David, M				Tayebi, Mourad; Jones, Daryl Rhys; Taylor, William Alexander; Stileman, Benjamin Frederick; Chapman, Charlotte; Zhao, Deming; David, Monique			PrPSc-Specific Antibodies with the Ability to Immunodetect Prion Oligomers	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; TRANSMISSIBLE MINK ENCEPHALOPATHY; MONOCLONAL-ANTIBODIES; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; COMMON MECHANISM; PROTEIN PRPSC; HUMAN PLASMA; CELL-LINES; IN-VIVO	The development of antibodies with binding capacity towards soluble oligomeric forms of PrPSc recognised in the aggregation process in early stage of the disease would be of paramount importance in diagnosing prion diseases before extensive neuropathology has ensued. As blood transfusion appears to be efficient in the transmission of the infectious prion agent, there is an urgent need to develop reagents that would specifically recognize oligomeric forms of the abnormally folded prion protein, PrPSc. To that end, we show that anti-PrP monoclonal antibodies (called PRIOC mAbs) derived from mice immunised with native PrP-coated microbeads are able to immunodetect oligomers/multimers of PrPSc. Oligomer-specific immunoreactivity displayed by these PRIOC mAbs was demonstrated as large aggregates of immunoreactive deposits in prion-permissive neuroblastoma cell lines but not in equivalent non-infected or prn-p(0/0) cell lines. In contrast, an anti-monomer PrP antibody displayed diffuse immunoreactivity restricted to the cell membrane. Furthermore, our PRIOC mAbs did not display any binding with monomeric recombinant and cellular prion proteins but strongly detected PrPSc oligomers as shown by a newly developed sensitive and specific ELISA. Finally, PrioC antibodies were also able to bind soluble oligomers formed of Ab and a-synuclein. These findings demonstrate the potential use of anti-prion antibodies that bind PrPSc oligomers, recognised in early stage of the disease, for the diagnosis of prion diseases in blood and other body fluids.	[Tayebi, Mourad; Jones, Daryl Rhys; Taylor, William Alexander; Stileman, Benjamin Frederick; Chapman, Charlotte; David, Monique] Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim TSE Lab, Beijing 100094, Peoples R China	University of London; University of London Royal Veterinary College; China Agricultural University	Tayebi, M (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England.	mtayebi@rvc.ac.uk		TAYEBI, MOURAD/0000-0001-8664-6918	United Kingdom Royal Society; Royal Veterinary College	United Kingdom Royal Society(Royal Society of London); Royal Veterinary College	This work was supported by the United Kingdom Royal Society and The Royal Veterinary College Internal Grant Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Cordes H, 2008, J IMMUNOL METHODS, V337, P106, DOI 10.1016/j.jim.2008.07.004; CURIN S, 2004, J BIOL CHEM, V279, P3694; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Jones DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009804; Jones M, 2009, BRAIN PATHOL, V19, P293, DOI 10.1111/j.1750-3639.2008.00181.x; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Kim JI, 2003, J NEUROIMMUNOL, V140, P137, DOI 10.1016/S0165-5728(03)00181-4; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nakamura N, 2003, HYBRIDOMA HYBRIDOM, V22, P263, DOI 10.1089/153685903322328992; Nishimura T, 2008, BIOCHEM BIOPH RES CO, V377, P1047, DOI 10.1016/j.bbrc.2008.10.087; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PORTER DD, 1973, J IMMUNOL, V111, P1407; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Rubenstein R, 1999, J NEUROVIROL, V5, P401, DOI 10.3109/13550289909029481; Soto C, 1999, J MOL MED-JMM, V77, P412, DOI 10.1007/s001090050371; SPINNER DS, J LEUKOC BIOL, V81, P1374; Tayebi M, 2004, MOL MED, V10, P104, DOI 10.2119/2004-00027.Tayebi; Tayebi M, 2009, J GEN VIROL, V90, P777, DOI 10.1099/vir.0.005041-0; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yokoyama T, 1996, ARCH VIROL, V141, P763, DOI 10.1007/BF01718334; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19998	10.1371/journal.pone.0019998	http://dx.doi.org/10.1371/journal.pone.0019998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625515	Green Published, gold			2022-12-25	WOS:000290771200038
J	Nather, FC; Bueno, JLO; Bigand, E; Droit-Volet, S				Nather, Francisco C.; Bueno, Jose L. O.; Bigand, Emmanuel; Droit-Volet, Sylvie			Time Changes with the Embodiment of Another's Body Posture	PLOS ONE			English	Article							INTERNAL CLOCK; APPARENT MOTION; SPEEDING-UP; PERCEPTION; BISECTION; REPRESENTATIONS; DURATION; MOVEMENT; CHILDREN; EMOTION	The aim of the present study was to investigate whether the perception of presentation durations of pictures of different body postures was distorted as function of the embodied movement that originally produced these postures. Participants were presented with two pictures, one with a low-arousal body posture judged to require no movement and the other with a high-arousal body posture judged to require considerable movement. In a temporal bisection task with two ranges of standard durations (0.4/1.6 s and 2/8 s), the participants had to judge whether the presentation duration of each of the pictures was more similar to the short or to the long standard duration. The results showed that the duration was judged longer for the posture requiring more movement than for the posture requiring less movement. However the magnitude of this overestimation was relatively greater for the range of short durations than for that of longer durations. Further analyses suggest that this lengthening effect was mediated by an arousal effect of limited duration on the speed of the internal clock system.	[Nather, Francisco C.; Bueno, Jose L. O.] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil; [Bigand, Emmanuel] Univ Bourgogne, Inst Univ France, CNRS, LEAD, Dijon, France; [Droit-Volet, Sylvie] Univ Blaise Pascal, CNRS, LAPSCO, Clermont Ferrand, France	Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Nather, FC (corresponding author), Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.	f.nather@hotmail.com; sylvie.droit-volet@univ-bpclermont.fr	Bueno, José Lino Oliveira/F-3200-2015		CAPES; CAPES-COFECUB Program (Brazil-France); CNPq; French National Research Agency [ANR Blan06-2-145908]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-COFECUB Program (Brazil-France)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); French National Research Agency(French National Research Agency (ANR))	This research was supported by a Post-Doctoral Scholarship from CAPES to F. C. Nather, and a CAPES-COFECUB Program (Brazil-France) to J.L.O. Bueno, E. Bigand and S. Droit-Volet. The work was also funded by grants from CNPq to J.L.O. Bueno and from the French National Research Agency (ANR Blan06-2-145908 FaceExpress). The funders paid for the travels of France-Brazil for the researchers, but had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALLAN LG, 1991, LEARN MOTIV, V22, P39, DOI 10.1016/0023-9690(91)90016-2; Angrilli A, 1997, PERCEPT PSYCHOPHYS, V59, P972, DOI 10.3758/BF03205512; Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Block R. A., 1990, COGNITIVE MODELS PSY, P1; Bonnet C, 2005, PERCEPTION, V34, P835, DOI 10.1068/p5039; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Chambon M, 2008, J EXP SOC PSYCHOL, V44, P672, DOI 10.1016/j.jesp.2007.04.014; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Droit-Volet S, 2002, Q J EXP PSYCHOL-B, V55, P193, DOI 10.1080/02724990143000252; Droit-Volet S, 2001, J EXP CHILD PSYCHOL, V80, P142, DOI 10.1006/jecp.2001.2631; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2007, BEHAV PROCESS, V74, P244, DOI 10.1016/j.beproc.2006.09.012; Droit-Volet S, 2009, PHILOS T R SOC B, V364, P1943, DOI 10.1098/rstb.2009.0013; DROITVOLET S, SUBJECTIVE IN PRESS; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; Fraisse, 1967, PSYCHOL TEMPS; FRAISSE P, 1984, ANNU REV PSYCHOL, V35, P1, DOI 10.1146/annurev.ps.35.020184.000245; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; Garbarini F, 2004, BRAIN COGNITION, V56, P100, DOI 10.1016/j.bandc.2004.06.003; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GROWE B, 2001, DEGAS; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; MARICQ AV, 1981, J EXP PSYCHOL ANIM B, V7, P18, DOI 10.1037/0097-7403.7.1.18; MARQUES L, 1999, DEGAS MOVIMENTO; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; NATHER FC, J STUDY TIM IN PRESS; NATHER FC, 2008, P 24 ANN M SOC PSYCH, P185; Nather Francisco Carlos, 2006, Psicol. Reflex. Crit., V19, P217, DOI 10.1590/S0102-79722006000200007; Penney T.B., 2003, METH NE FRO NEUROSCI, P209, DOI 10.1080/17470218.2015.1023735; Penney TB, 1998, TIMING OF BEHAVIOR, P165; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; SHIFFRAR M, 1993, PSYCHOL SCI, V4, P379, DOI 10.1111/j.1467-9280.1993.tb00585.x; SHIFFRAR M, 1990, PSYCHOL SCI, V1, P257, DOI 10.1111/j.1467-9280.1990.tb00210.x; Strickland C., 2004, ARTE COMENTADA PREHI; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; Verfaillie K, 2002, VIS COGN, V9, P217, DOI 10.1080/13506280143000403; WEARDEN JH, 1991, Q J EXP PSYCHOL-B, V43, P59; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wittmann M, 2009, PHILOS T R SOC B, V364, P1955, DOI 10.1098/rstb.2009.0003; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319	50	44	47	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19818	10.1371/journal.pone.0019818	http://dx.doi.org/10.1371/journal.pone.0019818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XV	21637759	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500012
J	Goes, FS; Rongione, M; Chen, YC; Karchin, R; Elhaik, E; Potash, JB				Goes, Fernando S.; Rongione, Michael; Chen, Yun-Ching; Karchin, Rachel; Elhaik, Eran; Potash, James B.		Bipolar Genome Study	Exonic DNA Sequencing of ERBB4 in Bipolar Disorder	PLOS ONE			English	Article							TRADITIONAL DIAGNOSTIC BOUNDARIES; GENOME-WIDE ASSOCIATION; SCHIZOPHRENIA; GENES; SUSCEPTIBILITY; VARIANTS; NRG1; NEUREGULIN-1; POPULATION; NETWORK	The Neuregulin-ErbB4 pathway plays a crucial role in brain development and constitutes one of the most biologically plausible signaling pathways implicated in schizophrenia and, to a lesser extent, in bipolar disorder (BP). However, recent genome-wide association analyses have not provided evidence for common variation in NRG1 or ERBB4 influencing schizophrenia or bipolar disorder susceptibility. In this study, we investigate the role of rare coding variants in ERBB4 in BP cases with mood-incongruent psychotic features, a form of BP with arguably the greatest phenotypic overlap with schizophrenia. We performed Sanger sequencing of all 28 exons in ERBB4, as well as part of the promoter and part of the 3'UTR sequence, hypothesizing that rare deleterious variants would be found in 188 cases with mood-incongruent psychosis from the GAIN BP study. We found 42 variants, of which 16 were novel, although none were non-synonymous or clearly deleterious. One of the novel variants, present in 11.2% of cases, is located next to an alternative stop codon, which is associated with a shortened transcript of ERBB4 that is not translated. We genotyped this variant in the GAIN BP case-control samples and found a marginally significant association with mood-incongruent psychotic BP compared with controls (additive model: OR = 1.64, P-value = 0.055; dominant model: OR = 1.73. P-value = 0.039). In conclusion, we found no rare variants of clear deleterious effect, but did uncover a modestly associated novel variant that could affect alternative splicing of ERBB4. However, the modest sample size in this study cannot definitively rule out a role for rare variants in bipolar disorder and studies with larger sample sizes are needed to confirm the observed association.	[Goes, Fernando S.; Rongione, Michael; Potash, James B.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Chen, Yun-Ching; Karchin, Rachel] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Chen, Yun-Ching; Karchin, Rachel] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD USA; [Elhaik, Eran] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Goes, FS (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA.	fgoes1@jhmi.edu	Elhaik, Eran/H-6838-2019; Karchin, Rachel/A-3385-2010; Greenwood, Tiffany/F-6356-2012; Smith, Erin/E-5933-2011; Zhang, Peng/N-2920-2014; McMahon, Francis J/A-7290-2009; Mahon, Pamela Belmonte/O-9806-2018	Elhaik, Eran/0000-0003-4795-1084; Greenwood, Tiffany/0000-0002-6080-6503; Zhang, Peng/0000-0003-1182-1392; McMahon, Francis J/0000-0002-9469-305X; Mahon, Pamela Belmonte/0000-0002-3947-441X; Karchin, Rachel/0000-0002-5069-1239	NIMH [K99 MH086049]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014592, K99MH086049] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by my NIMH grant (K99 MH086049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Benzel I, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-31; Bindewald E, 2006, RNA, V12, P342, DOI 10.1261/rna.2164906; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Goes FS, 2007, AM J PSYCHIAT, V164, P236, DOI 10.1176/appi.ajp.164.2.236; Green EK, 2005, ARCH GEN PSYCHIAT, V62, P642, DOI 10.1001/archpsyc.62.6.642; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Nicodemus KK, 2010, ARCH GEN PSYCHIAT, V67, P991, DOI 10.1001/archgenpsychiatry.2010.117; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Potash JB, 2007, AM J PSYCHIAT, V164, P1229, DOI 10.1176/appi.ajp.2007.06122045; Potash JB, 2009, NAT REV NEUROL, V5, P299, DOI 10.1038/nrneurol.2009.71; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sanders AR, 2010, AM J PSYCHIAT, V167, P854, DOI 10.1176/appi.ajp.2010.09071050; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shiota S, 2008, J HUM GENET, V53, P929, DOI 10.1007/s10038-008-0332-9; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471	31	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20242	10.1371/journal.pone.0020242	http://dx.doi.org/10.1371/journal.pone.0020242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637803	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000291052200042
J	Hennessey, PT; Ochs, MF; Mydlarz, WW; Hsueh, W; Cope, L; Yu, WN; Califano, JA				Hennessey, Patrick T.; Ochs, Michael F.; Mydlarz, Wojciech W.; Hsueh, Wayne; Cope, Leslie; Yu, Wayne; Califano, Joseph A.			Promoter Methylation in Head and Neck Squamous Cell Carcinoma Cell Lines Is Significantly Different than Methylation in Primary Tumors and Xenografts	PLOS ONE			English	Article							DNA METHYLATION; CPG ISLAND; IN-VIVO; LUNG-CANCER; HYPERMETHYLATION; CHEMOTHERAPY; REVEALS; GENES; MODEL	Studies designed to identify novel methylation events related to cancer often employ cancer cell lines in the discovery phase of the experiments and have a relatively low rate of discovery of cancer-related methylation events. An alternative algorithm for discovery of novel methylation in cancer uses primary tumor-derived xenografts instead of cell lines as the primary source of nucleic acid for evaluation. We evaluated DNA extracted from primary head and neck squamous cell carcinomas (HNSCC), xenografts grown from these primary tumors in nude mice, HNSCC-derived cell lines, normal oral mucosal samples, and minimally transformed oral keratinocyte-derived cell lines using Illumina Infinum Humanmethylation 27 genome-wide methylation microarrays. We found > 2,200 statistically significant methylation differences between cancer cell lines and primary tumors and when comparing normal oral mucosa to keratinocyte cell lines. We found no statistically significant promoter methylation differences between primary tumor xenografts and primary tumors. This study demonstrates that tumor-derived xenografts are highly accurate representations of promoter methylation in primary tumors and that cancer derived cell lines have significant drawbacks for discovery of promoter methylation alterations in primary tumors. These findings also support use of primary tumor xenografts for the study of methylation in cancer, drug discovery, and the development of personalized cancer treatments.	[Hennessey, Patrick T.; Mydlarz, Wojciech W.; Califano, Joseph A.] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Ochs, Michael F.; Cope, Leslie] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Ochs, Michael F.; Cope, Leslie] Johns Hopkins Med Inst, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Hsueh, Wayne] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Yu, Wayne] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Califano, Joseph A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Hennessey, PT (corresponding author), Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	jcalifa@jhmi.edu			National Cancer Institute [5P50CA096784-05, RC1DE020324]; NIH [T32DC000027]; Hopkins [CCSG P30CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA096784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000027] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The following funding sources supported this research: Dr. Califano is supported by a National Cancer Institute SPORE (5P50CA096784-05) and Challenge Grant (RC1DE020324). Drs. Hennessey and Mydlarz are funded in part by a NIH T32 Research Training Grant (T32DC000027). Drs. Ochs and Cope are partially funded by the Hopkins CCSG P30CA006973. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang JC, 2010, MOL CANCER THER, V9, P1443, DOI 10.1158/1535-7163.MCT-09-1048; DONG X, CLIN CANC RES, V16, P1442; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001; Houshdaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009359; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KAWAI J, 1994, MOL CELL BIOL, V14, P7421, DOI 10.1128/MCB.14.11.7421; Kim MM, 2006, ORAL ONCOL, V42, P201, DOI 10.1016/j.oraloncology.2005.07.004; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Koizume S, 2002, NUCLEIC ACIDS RES, V30, P4770, DOI 10.1093/nar/gkf593; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Merk J, 2009, EUR J CARDIO-THORAC, V36, P454, DOI 10.1016/j.ejcts.2009.03.054; Milne ANA, 2007, HUM PATHOL, V38, P903, DOI 10.1016/j.humpath.2006.12.010; Paz MF, 2003, CANCER RES, V63, P1114; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; STRATTON JA, 1986, GYNECOL ONCOL, V25, P302, DOI 10.1016/0090-8258(86)90081-8; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5	32	50	50	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20584	10.1371/journal.pone.0020584	http://dx.doi.org/10.1371/journal.pone.0020584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637785	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200080
J	Tahir, MN; Amin, I; Briddon, RW; Mansoor, S				Tahir, Muhammad Nouman; Amin, Imran; Briddon, Rob W.; Mansoor, Shahid			The Merging of Two Dynasties-Identification of an African Cotton Leaf Curl Disease-Associated Begomovirus with Cotton in Pakistan	PLOS ONE			English	Article							PCR-MEDIATED AMPLIFICATION; DNA-BETA SATELLITE; UNIVERSAL PRIMERS; PALAMPUR VIRUS; 1ST REPORT; GEMINIVIRUS; PROTEIN; BETASATELLITE; SUPPRESSOR; DIVERSITY	Cotton leaf curl disease (CLCuD) is a severe disease of cotton that occurs in Africa and Pakistan/northwestern India. The disease is caused by begomoviruses in association with specific betasatellites that differ between Africa and Asia. During survey of symptomatic cotton in Sindh (southern Pakistan) Cotton leaf curl Gezira virus (CLCuGV), the begomovirus associated with CLCuD in Africa, was identified. However, the cognate African betasatellite (Cotton leaf curl Gezira betasatellite) was not found. Instead, two Asian betasatellites, the CLCuD-associated Cotton leaf curl Multan betasatellite (CLCuMB) and Chilli leaf curl betasatellite (ChLCB) were identified. Inoculation of the experimental plant species Nicotiana benthamiana showed that CLCuGV was competent to maintain both CLCuMB and ChLCB. Interestingly, the enations typical of CLCuD were only induced by CLCuGV in the presence of CLCuMB. Also in infections involving both CLCuMB and ChLCB the enations typical of CLCuMB were less evident. This is the first time an African begomovirus has been identified on the Indian sub-continent, highlight the growing threat of begomoviruses and particularly the threat of CLCuD causing viruses to cotton cultivation in the rest of the world.	[Tahir, Muhammad Nouman; Amin, Imran; Briddon, Rob W.; Mansoor, Shahid] Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan	Pakistan Institute of Engineering & Applied Science	Tahir, MN (corresponding author), Natl Inst Biotechnol & Genet Engn, Agr Biotechnol Div, Faisalabad, Pakistan.	shahidmansoor7@gmail.com	Briddon, Rob W./I-5921-2012	Briddon, Rob W./0000-0001-8738-0365; Mansoor, Shahid/0000-0001-7418-1826	Higher Education Commission (HEC), Pakistan; HEC; NIBGE; Donald Danforth Plant Science Center, St. Louis, USA	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); HEC; NIBGE; Donald Danforth Plant Science Center, St. Louis, USA	MNT is supported by a Ph.D Fellowship from Higher Education Commission (HEC), Pakistan. RWB is supported by the HEC under the "Foreign Faculty Hiring Program". The work is supported by a collaborative project between NIBGE and the Donald Danforth Plant Science Center, St. Louis, USA under the "Pak-USA linkage program". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahmed MZ, 2011, PEST MANAG SCI, V67, P307, DOI 10.1002/ps.2067; Ali I, 2010, PLANT DIS, V94, P276, DOI 10.1094/PDIS-94-2-0276A; Amin I, 2006, ARCH VIROL, V151, P2055, DOI 10.1007/s00705-006-0773-4; Amrao L, 2010, VIRUS RES, V153, P161, DOI 10.1016/j.virusres.2010.07.003; Amrao L, 2010, VIRUS RES, V152, P153, DOI 10.1016/j.virusres.2010.06.019; Azhar MT, 2010, VIRUS GENES, V41, P417, DOI 10.1007/s11262-010-0521-4; Briddon RW, 2008, ARCH VIROL, V153, P763, DOI 10.1007/s00705-007-0013-6; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon RW, 2003, MOL PLANT PATHOL, V4, P427, DOI [10.1046/j.1364-3703.2003.00188.x, 10.1046/J.1364-3703.2003.00188.X]; Briddon RW, 2003, VIROLOGY, V312, P106, DOI 10.1016/S0042-6822(03)00200-9; Briddon RW, 2002, MOL BIOTECHNOL, V20, P315, DOI 10.1385/MB:20:3:315; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Bull SE, 2003, MOL BIOTECHNOL, V23, P83, DOI 10.1385/MB:23:1:83; Cai JH, 2010, PLANT PATHOL, V59, P794, DOI 10.1111/j.1365-3059.2010.02266.x; Cui XF, 2005, J VIROL, V79, P10764, DOI 10.1128/JVI.79.16.10764-10775.2005; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Halley-Stott RP, 2007, ARCH VIROL, V152, P1237, DOI 10.1007/s00705-006-0933-6; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Heydarnejad J, 2009, ARCH VIROL, V154, P1015, DOI 10.1007/s00705-009-0389-6; Hussain M, 2005, J VIROL, V79, P4434, DOI 10.1128/JVI.79.7.4434-4439.2005; Hussain M, 2009, J PHYTOPATHOL, V157, P576, DOI 10.1111/j.1439-0434.2008.01523.x; Idris AM, 2005, VIRUS RES, V109, P19, DOI 10.1016/j.virusres.2004.10.002; Idris AM, 2004, PHYTOPATHOLOGY, V94, P1068, DOI 10.1094/PHYTO.2004.94.10.1068; Idris AM, 2002, VIRUS GENES, V24, P249, DOI 10.1023/A:1015380600089; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; KIRKPATRICK T. W., 1931, BULL ENT RES [LONDON], V22, P323, DOI 10.1017/S0007485300029862; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Liu L, 1997, J GEN VIROL, V78, P2113, DOI 10.1099/0022-1317-78-8-2113; Mansoor S, 2003, PLANT PATHOL, V52, P784, DOI 10.1111/j.1365-3059.2003.00893.x; Mansoor S, 2003, ARCH VIROL, V148, P1969, DOI 10.1007/s00705-003-0149-y; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; MAYO MA, 2005, 8 REPORT INT COMMITT, P1163; Nahid N, 2008, ARCH VIROL, V153, P1441, DOI 10.1007/s00705-008-0133-7; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Qazi J, 2007, VIRUS RES, V128, P135, DOI 10.1016/j.virusres.2007.04.002; Saeed M, 2005, MOL PLANT MICROBE IN, V18, P7, DOI 10.1094/MPMI-18-0007; Saeed M, 2010, AUSTRALAS PLANT DIS, V5, P55, DOI 10.1071/DN10021; Saunders K, 2004, VIROLOGY, V324, P37, DOI 10.1016/j.virol.2004.03.018; STANLEY J, 2005, VIRUS TAXONOMY, P301; Stonor J, 2003, PLANT PATHOL, V52, P379, DOI 10.1046/j.1365-3059.2003.00854.x; Tahir M, 2010, AUSTRALAS PLANT DIS, V5, P21, DOI 10.1071/DN10009; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915	46	51	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20366	10.1371/journal.pone.0020366	http://dx.doi.org/10.1371/journal.pone.0020366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637815	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200056
J	Seligman, BJ; Cullen, MR; Horwitz, RI				Seligman, Benjamin J.; Cullen, Mark R.; Horwitz, Ralph I.			Aging, Transition, and Estimating the Global Burden of Disease	PLOS ONE			English	Article								Background: The World Health Organization's Global Burden of Disease (GBD) reports are an important tool for global health policy makers, however the accuracy of estimates for countries undergoing an epidemiologic transition is unclear. We attempted to validate the life table model used to generate estimates for all-cause mortality in developing countries. Methods and Results: Data were obtained for males and females from the Human Mortality Database for all countries with available data every ten years from 1900 to 2000. These provided inputs for the GBD life table model and served as comparison observed data. Above age sixty model estimates of survival for both sexes differed substantially from those observed. Prior to the year 1960 for males and 1930 for females, estimated survival tended to be greater than observed; following 1960 for both males and females estimated survival tended to be less than observed. Viewing observed and estimated survival separately, observed survival past sixty increased over the years considered. For males, the increase was from a mean (sd) probability of 0.22 (0.06) to 0.46 (0.1). For females, the increase was from 0.26 (0.06) to 0.65 (0.08). By contrast, estimated survival past sixty decreased over the same period. Among males, estimated survival probability declined from 0.54 (0.2) to 0.09 (0.06). Among females, the decline was from 0.36 (0.12) to 0.15 (0.08). Conclusions: These results show that the GBD mortality model did not accurately estimate survival at older ages as developed countries transitioned in the twentieth century and may be similarly flawed in developing countries now undergoing transition. Estimates of the size of older-age populations and their attributable disease burden should be reconsidered.	[Seligman, Benjamin J.; Cullen, Mark R.] Stanford Univ Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Horwitz, Ralph I.] GlaxoSmithKline, Philadelphia, PA USA	Stanford University; GlaxoSmithKline	Seligman, BJ (corresponding author), Stanford Univ Sch Med, Dept Med, Palo Alto, CA 94304 USA.	bensel1@stanford.edu		cullen, mark/0000-0001-7996-1864; Seligman, Benjamin/0000-0002-8223-5924	Stanford Medical Scholars Program; Stanford NIH/NCCR [TLI RR025742]	Stanford Medical Scholars Program; Stanford NIH/NCCR(Swiss National Science Foundation (SNSF))	This publication was supported by the Stanford Medical Scholars Program and by the Stanford NIH/NCCR CTSA grant number TLI RR025742. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], HUM MORT DAT; [Anonymous], PLOS MED; [Anonymous], POPULATION STUDIES; [Anonymous], GLOBAL BURDEN DIS RI; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; R Core Team, 2022, R LANG ENV STAT COMP; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; World Health Organization, 2008, The global burden of disease: 2004 update	10	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20264	10.1371/journal.pone.0020264	http://dx.doi.org/10.1371/journal.pone.0020264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629652	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800039
J	Duan, YK; Zhu, Z; Cai, K; Tan, XM; Lu, XF				Duan, Yangkai; Zhu, Zhi; Cai, Ke; Tan, Xiaoming; Lu, Xuefeng			De novo Biosynthesis of Biodiesel by Escherichia coli in Optimized Fed-Batch Cultivation	PLOS ONE			English	Article							BIOMASS; OVERPRODUCTION; BIOFUELS; ALKANES	Biodiesel is a renewable alternative to petroleum diesel fuel that can contribute to carbon dioxide emission reduction and energy supply. Biodiesel is composed of fatty acid alkyl esters, including fatty acid methyl esters (FAMEs) and fatty acid ethyl esters (FAEEs), and is currently produced through the transesterification reaction of methanol (or ethanol) and triacylglycerols (TAGs). TAGs are mainly obtained from oilseed plants and microalgae. A sustainable supply of TAGs is a major bottleneck for current biodiesel production. Here we report the de novo biosynthesis of FAEEs from glucose, which can be derived from lignocellulosic biomass, in genetically engineered Escherichia coli by introduction of the ethanol-producing pathway from Zymomonas mobilis, genetic manipulation to increase the pool of fatty acyl-CoA, and heterologous expression of acyl-coenzyme A: diacylglycerol acyltransferase from Acinetobacter baylyi. An optimized fed-batch microbial fermentation of the modified E. coli strain yielded a titer of 922 mg L(-1) FAEEs that consisted primarily of ethyl palmitate, -oleate, -myristate and -palmitoleate.	[Duan, Yangkai; Zhu, Zhi; Cai, Ke; Tan, Xiaoming; Lu, Xuefeng] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Duan, YK (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao, Peoples R China.	lvxf@qibebt.ac.cn	zheng, yonghong/H-3700-2012; Duan, Yangkai/C-4166-2018; Tan, Xiaoming/E-6571-2013	Duan, Yangkai/0000-0002-0995-333X; Tan, Xiaoming/0000-0002-7375-3674	Chinese Academy of Sciences foundation [O91001110A]	Chinese Academy of Sciences foundation	This study was supported by the "100-Talent Program of the Chinese Academy of Sciences" foundation (Grant O91001110A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Liu TG, 2010, METAB ENG, V12, P378, DOI 10.1016/j.ymben.2010.02.003; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Somerville C, 2007, CURR BIOL, V17, pR115, DOI 10.1016/j.cub.2007.01.010; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	14	50	66	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20265	10.1371/journal.pone.0020265	http://dx.doi.org/10.1371/journal.pone.0020265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629774	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005200044
J	Yu, H; He, YH; Zhang, X; Peng, ZH; Yang, YT; Zhu, R; Bai, JY; Tian, Y; Li, XH; Chen, WS; Fang, DC; Wang, RQ				Yu, Hao; He, Yonghong; Zhang, Xin; Peng, Zhihong; Yang, Yongtao; Zhu, Rong; Bai, Jianying; Tian, Yin; Li, Xiaohuan; Chen, Wensheng; Fang, Dianchun; Wang, Rongquan			The Rat IgGFc gamma BP and Muc2 C-Terminal Domains and TFF3 in Two Intestinal Mucus Layers Bind Together by Covalent Interaction	PLOS ONE			English	Article							DIMER FORMATION; PROTEIN; BARRIER; THICKNESS; CLEAVAGE; COLITIS; CELLS; COLON	Background: The secreted proteins from goblet cells compose the intestinal mucus. The aims of this study were to determine how they exist in two intestinal mucus layers. Methodology/Principal Findings: The intestinal mucosa was fixed with Carnoy solution and immunostained. Mucus from the loose layer, the firm layer was gently suctioned or scraped, respectively, lysed in SDS sample buffer with or without DTT, then subjected to the western blotting of rTFF3, rIgGFc gamma BP or rMuc2. The non-reduced or reduced soluble mucus samples in RIPA buffer were co-immunoprecipitated to investigate their possible interactions. Polyclonal antibodies for rTFF3, the rIgGFc gamma BP C-terminal domain and the rMuc2 C-terminal domain confirmed their localization in the mucus layer and in the mucus collected from the rat intestinal loose layer or firm layer in both western blot and immunoprecipitation experiments. A complex of rTFF3, which was approximately 250 kDa, and a monomer of 6 kDa were present in both layers of the intestinal mucus; rIgGFc gamma BP was present in the complex (250-280 kDa) under non-reducing conditions, but shifted to 164 kDa under reducing conditions in both of the layers. rMuc2 was found mainly in a complex of 214-270 kDa under non-reducing conditions, but it shifted to 140 kDa under reducing conditions. The co-immunoprecipitation experiments showed that binding occurs among rTFF3, rIgGFc gamma BP and rMuc2 in the RIPA buffer soluble intestinal mucus. Blocking the covalent interaction by 100 mM DTT in the RIPA buffer soluble intestinal mucus disassociated their binding. Conclusions/Significance: Rat goblet cell-secreted TFF3, IgGFc gamma BP and Muc2, existing in the two intestinal mucus layers, are bound together by covalent interactions in the soluble fraction of intestinal mucus and form heteropolymers to be one of the biochemical mechanisms of composing the net-like structure of mucus.	[Yu, Hao; He, Yonghong; Zhang, Xin; Peng, Zhihong; Yang, Yongtao; Zhu, Rong; Bai, Jianying; Tian, Yin; Li, Xiaohuan; Chen, Wensheng; Fang, Dianchun; Wang, Rongquan] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China	Army Medical University	Yu, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing, Peoples R China.	rongquanw@hotmail.com		Wang, Rongquan/0000-0001-5307-0086	NSFC; Natural Science Foundation of CQ CSTC [2008BA5034]	NSFC(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by a NSFC grant (Y.H.) and the Natural Science Foundation Project of CQ CSTC 2008BA5034 (R. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TK, 2010, J PROTEOME RES, V9, P3108, DOI 10.1021/pr100020c; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bell SL, 1998, EUR J BIOCHEM, V253, P123, DOI 10.1046/j.1432-1327.1998.2530123.x; Bell SL, 2003, BIOCHEM J, V373, P893, DOI 10.1042/BJ20030096; Bell SL, 2001, BIOCHEM J, V357, P203, DOI 10.1042/0264-6021:3570203; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Feng ZM, 2007, DIGEST DIS SCI, V52, P2104, DOI 10.1007/s10620-006-9711-2; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gindzienski A, 2003, J Physiol Pharmacol, V54 Suppl 3, P127; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; Hasnain SZ, 2010, GASTROENTEROLOGY, V138, P1763, DOI 10.1053/j.gastro.2010.01.045; Hoffmann W, 2009, J MED CHEM, V52, P6505, DOI 10.1021/jm9008136; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Khatri IA, 1998, BIOCHEM J, V331, P323, DOI 10.1042/bj3310323; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Kobayashi K, 2001, IMMUNOL LETT, V79, P229, DOI 10.1016/S0165-2478(01)00288-7; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; MCCORMICK DA, 1990, J CLIN PATHOL, V43, P143, DOI 10.1136/jcp.43.2.143; Phillipson M, 2008, AM J PHYSIOL-GASTR L, V295, pG806, DOI 10.1152/ajpgi.90252.2008; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Poulsen SS, 2005, REGUL PEPTIDES, V126, P163, DOI 10.1016/j.regpep.2004.09.007; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P963, DOI 10.1002/ibd.20163; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Xu GQ, 2000, EUR J BIOCHEM, V267, P2998, DOI 10.1046/j.1432-1327.2000.01319.x; XU GQ, 1992, J BIOL CHEM, V267, P5401	31	24	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20334	10.1371/journal.pone.0020334	http://dx.doi.org/10.1371/journal.pone.0020334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629776	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005200055
J	Ohashi, E; Tanabe, K; Henmi, Y; Mesaki, K; Kobayashi, Y; Takei, K				Ohashi, Emiko; Tanabe, Kenji; Henmi, Yuji; Mesaki, Kumi; Kobayashi, Yuka; Takei, Kohji			Receptor Sorting within Endosomal Trafficking Pathway Is Facilitated by Dynamic Actin Filaments	PLOS ONE			English	Article							ENDOCYTIC RECYCLING COMPARTMENT; PLASMA-MEMBRANE; IN-VIVO; F-ACTIN; PROTEIN; TRANSPORT; MYOSIN; CLATHRIN; POLYMERIZATION; LYSOSOMES	Early endosomes (EEs) are known to be a sorting station for internalized molecules destined for degradation, recycling, or other intracellular organelles. Segregation is an essential step in such sorting, but the molecular mechanism of this process remains to be elucidated. Here, we show that actin is required for efficient recycling and endosomal maturation by producing a motile force. Perturbation of actin dynamics by drugs induced a few enlarged EEs containing several degradative vacuoles and also interfered with their transporting ability. Actin repolymerization induced by washout of the drug caused the vacuoles to dissociate and individually translocate toward the perinuclear region. We further elucidated that cortactin, an actin-nucleating factor, was required for transporting contents from within EEs. Actin filaments regulated by cortactin may provide a motile force for efficient sorting within early endosomes. These data suggest that actin filaments coordinate with microtubules to mediate segregation in EEs.	[Ohashi, Emiko; Tanabe, Kenji; Henmi, Yuji; Mesaki, Kumi; Kobayashi, Yuka; Takei, Kohji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Okayama, Japan	Okayama University	Ohashi, E (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurosci, Okayama, Japan.	kt0911@gmail.com	TANABE, Kenji/B-2319-2011	Tanabe, Kenji/0000-0003-2645-9429; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Science, Sports, Culture and Technology of Japan [23113721, 15079206]; Okayama Medical Foundation; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okayama Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan, (23113721) http://kaken.nii.ac.jp/en/p/23113721, (15079206) http://kaken.nii.ac.jp/en/p/15079206; and by the Okayama Medical Foundation, http://omf.umin.ac.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Drengk A, 2003, CURR BIOL, V13, P1814, DOI 10.1016/j.cub.2003.09.037; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kaksonen M, 2000, J CELL SCI, V113, P4421; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Llado A, 2008, MOL BIOL CELL, V19, P17, DOI 10.1091/mbc.E07-05-0411; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Semenova I, 2008, CURR BIOL, V18, P1581, DOI 10.1016/j.cub.2008.08.070; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Shinozaki-Narikawa N, 2006, TRAFFIC, V7, P1539, DOI 10.1111/j.1600-0854.2006.00480.x; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014	49	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19942	10.1371/journal.pone.0019942	http://dx.doi.org/10.1371/journal.pone.0019942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625493	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400021
J	Teismann, IK; Warnecke, T; Suntrup, S; Steinstrater, O; Kronenberg, L; Ringelstein, EB; Dengler, R; Petri, S; Pantev, C; Dziewas, R				Teismann, Inga K.; Warnecke, Tobias; Suntrup, Sonja; Steinstraeter, Olaf; Kronenberg, Linda; Ringelstein, E. Bernd; Dengler, Reinhard; Petri, Susanne; Pantev, Christo; Dziewas, Rainer			Cortical Processing of Swallowing in ALS Patients with Progressive Dysphagia - A Magnetoencephalographic Study	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR CORTEX; CEREBRAL-CORTEX; REORGANIZATION; COMPENSATION; STIMULATION; ACTIVATION; POWER; MRI; PET	Amyotrophic lateral sclerosis (ALS) is a rare disease causing degeneration of the upper and lower motor neuron. Involvement of the bulbar motor neurons often results in fast progressive dysphagia. While cortical compensation of dysphagia has been previously shown in stroke patients, this topic has not been addressed in patients suffering from ALS. In the present study, we investigated cortical activation during deglutition in two groups of ALS patients with either moderate or severe dysphagia. Whole-head MEG was employed on fourteen patients with sporadic ALS using a self-paced swallowing paradigm. Data were analyzed by means of time-frequency analysis and synthetic aperture magnetometry (SAM). Group analysis of individual SAM data was performed using a permutation test. We found a reduction of cortical swallowing related activation in ALS patients compared to healthy controls. Additionally a disease-related shift of hemispheric lateralization was observed. While healthy subjects showed bilateral cortical activation, the right sensorimotor cortex was predominantly involved in ALS patients. Both effects were even stronger in the group of patients with severe dysphagia. Our results suggest that bilateral degeneration of the upper motor neuron in the primary motor areas also impairs further adjusted motor areas, which leads to a strong reduction of 'swallowing related' cortical activation. While both hemispheres are affected by the degeneration a relatively stronger activation is seen in the right hemisphere. This right hemispheric lateralization of volitional swallowing observed in this study may be the only sign of cortical plasticity in dysphagic ALS patients. It may demonstrate compensational mechanisms in the right hemisphere which is known to predominantly coordinate the pharyngeal phase of deglutition. These results add new aspects to our understanding of the pathophysiology of dysphagia in ALS patients and beyond. The compensational mechanisms observed could be relevant for future research in swallowing therapies.	[Teismann, Inga K.; Warnecke, Tobias; Suntrup, Sonja; Ringelstein, E. Bernd; Dziewas, Rainer] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Teismann, Inga K.; Suntrup, Sonja; Steinstraeter, Olaf; Kronenberg, Linda; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany	University of Munster; University of Munster; Hannover Medical School	Teismann, IK (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	i.teismann@uni-muenster.de	Dziewas, Rainer/AAX-9505-2020; Petri, Susanne/AID-7665-2022	Dziewas, Rainer/0000-0003-1592-8461; 	DFG [PA-392/9-2]	DFG(German Research Foundation (DFG))	This study was supported by DFG (PA-392/9-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks BR, 1996, NEUROL CLIN, V14, P399, DOI 10.1016/S0733-8619(05)70264-4; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Butman JA, 2007, AM J NEURORADIOL, V28, P87; Chau W, 2004, NEUROIMAGE, V23, P983, DOI 10.1016/j.neuroimage.2004.07.007; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; Daniels S K, 1996, J Stroke Cerebrovasc Dis, V6, P30, DOI 10.1016/S1052-3057(96)80023-1; Daniels SK, 2006, DYSPHAGIA, V21, P21, DOI 10.1007/s00455-005-9007-2; Dziewas R, 2003, NEUROIMAGE, V20, P135, DOI 10.1016/S1053-8119(03)00285-4; Dziewas R, 2007, DYSPHAGIA, V22, P63, DOI 10.1007/s00455-006-9032-9; Dziewas R, 2009, HUM BRAIN MAPP, V30, P1352, DOI 10.1002/hbm.20603; Ertekin C, 2000, BRAIN, V123, P125, DOI 10.1093/brain/123.1.125; Furlong PL, 2004, NEUROIMAGE, V22, P1447, DOI 10.1016/j.neuroimage.2004.02.041; Hamalainen Matti S., 1992, Brain Topography, V5, P95, DOI 10.1007/BF01129036; Hamdy S, 1999, J NEUROPHYSIOL, V81, P1917, DOI 10.1152/jn.1999.81.4.1917; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Higo R, 2004, AURIS NASUS LARYNX, V31, P247, DOI 10.1016/j.anl.2004.05.009; Hillel A, 1999, NEUROLOGY, V53, pS22; HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176; Hughes TAT, 1996, QJM-MON J ASSOC PHYS, V89, P109; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; KEW JJM, 1994, NEUROLOGY, V44, P1101, DOI 10.1212/WNL.44.6.1101; Konrad C, 2006, EXP BRAIN RES, V172, P361, DOI 10.1007/s00221-006-0352-7; Konrad C, 2002, EXP BRAIN RES, V143, P51, DOI 10.1007/s00221-001-0981-9; Kuipers-Upmeijer J, 2001, J NEUROL NEUROSUR PS, V71, P615, DOI 10.1136/jnnp.71.5.615; LANGMORE SE, 1991, ANN OTO RHINOL LARYN, V100, P678; Le Forestier N, 2001, J NEUROL SCI, V185, P95, DOI 10.1016/S0022-510X(01)00469-5; Leder SB, 2004, DYSPHAGIA, V19, P177, DOI 10.1007/s00455-004-0009-2; Li SS, 2009, AMYOTROPH LATERAL SC, V10, P280, DOI 10.3109/17482960902893342; LUIS MLS, 1990, J NEUROL, V237, P471; Mohammadi B, 2009, J NEUROL, V256, P1263, DOI 10.1007/s00415-009-5112-8; Mosier KM, 1999, AM J NEURORADIOL, V20, P1520; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Robbins J, 1988, Dysphagia, V3, P11, DOI 10.1007/BF02406275; ROBBINS JA, 1993, ARCH PHYS MED REHAB, V74, P1295, DOI 10.1016/0003-9993(93)90082-L; ROBINSON S, 1999, SENDAI RECENT ADV BI, P232; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Smith CD, 2002, NEUROLOGY, V58, P647, DOI 10.1212/WNL.58.4.647; Steinstraeter O, 2009, EXP BRAIN RES, V193, P387, DOI 10.1007/s00221-008-1634-z; Tanaka M, 2003, NEUROL RES, V25, P351, DOI 10.1179/016164103101201670; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Teismann IK, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-62; Teismann IK, 2010, NEUROBIOL AGING, V31, P1044, DOI 10.1016/j.neurobiolaging.2008.07.001; Teismann IK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-71; Teismann IK, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-13; Teismann IK, 2009, HUM BRAIN MAPP, V30, P92, DOI 10.1002/hbm.20488; Vaiman M, 2004, OTOLARYNG HEAD NECK, V131, P548, DOI 10.1016/j.otohns.2004.03.013; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; YETKIN FZ, 1995, AM J NEURORADIOL, V16, P1087	51	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19987	10.1371/journal.pone.0019987	http://dx.doi.org/10.1371/journal.pone.0019987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625445	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400028
J	Weber, E; Gruetzner, R; Werner, S; Engler, C; Marillonnet, S				Weber, Ernst; Gruetzner, Ramona; Werner, Stefan; Engler, Carola; Marillonnet, Sylvestre			Assembly of Designer TAL Effectors by Golden Gate Cloning	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; III EFFECTORS; ONE-POT; GENE; RECOGNITION; EXPRESSION; NUCLEASES; PATHOGEN; AVRBS3	Generation of customized DNA binding domains targeting unique sequences in complex genomes is crucial for many biotechnological applications. The recently described DNA binding domain of the transcription activator-like effectors (TALEs) from Xanthomonas consists of a series of repeats arranged in tandem, each repeat binding a nucleotide of the target sequence. We present here a strategy for engineering of TALE proteins with novel DNA binding specificities based on the 17.5 repeat-containing AvrBs3 TALE as a scaffold. For each of the 17 full repeats, four module types were generated, each with a distinct base preference. Using this set of 68 repeat modules, recognition domains for any 17 nucleotide DNA target sequence of choice can be constructed by assembling selected modules in a defined linear order. Assembly is performed in two successive one-pot cloning steps using the Golden Gate cloning method that allows seamless fusion of multiple DNA fragments. Applying this strategy, we assembled designer TALEs with new target specificities and tested their function in vivo.	[Weber, Ernst; Gruetzner, Ramona; Werner, Stefan; Engler, Carola; Marillonnet, Sylvestre] Icon Genet GmbH, Halle, Saale, Germany	ICON plc	Weber, E (corresponding author), Icon Genet GmbH, Halle, Saale, Germany.	marillonnet@icongenetics.de		Werner, Stefan/0000-0002-4932-1441	Icon Gentics GmbH	Icon Gentics GmbH	This work was funded by Icon Gentics GmbH. As all authors are employed by the funder, the funder played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; FELENBOK B, 1991, J BIOTECHNOL, V17, P11, DOI 10.1016/0168-1656(91)90023-O; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; LEBEDENKO EN, 1991, NUCLEIC ACIDS RES, V19, P6757, DOI 10.1093/nar/19.24.6757; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LI T, 2010, NUCL ACIDS RES; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; MILLER JC, 2010, NAT BIOTECHNOL; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WEBER E, 2011, PLOS ONE; ZHANG F, 2011, NAT BIOTECHNOL	24	146	241	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19722	10.1371/journal.pone.0019722	http://dx.doi.org/10.1371/journal.pone.0019722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625552	Green Submitted, Green Published, gold			2022-12-25	WOS:000290771200018
J	Ingels, J; Tchesunov, AV; Vanreusel, A				Ingels, Jeroen; Tchesunov, Alexei V.; Vanreusel, Ann			Meiofauna in the Gollum Channels and the Whittard Canyon, Celtic Margin-How Local Environmental Conditions Shape Nematode Structure and Function	PLOS ONE			English	Article							NEAR-BOTTOM FLOW; DEEP-SEA; CONTINENTAL-SLOPE; METAZOAN MEIOFAUNA; SPECIES-DIVERSITY; MARINE NEMATODES; SHELF BREAK; ASTOMONEMA-SOUTHWARDORUM; SEDIMENT TRANSPORT; PORCUPINE-SEABIGHT	The Gollum Channels and Whittard Canyon (NE Atlantic) are two areas that receive high input of organic matter and phytodetritus from euphotic layers, but they are typified by different trophic and hydrodynamic conditions. Sediment biogeochemistry was analysed in conjunction with structure and diversity of the nematode community and differences were tested between study areas, water depths (700 m vs 1000 m), stations, and sediment layers. The Gollum Channels and Whittard Canyon harboured high meiofauna abundances (1054-1426 ind. 10 cm(-2)) and high nematode diversity (total of 181 genera). Next to enhanced meiofauna abundance and nematode biomass, there were signs of high levels of organic matter deposition leading to reduced sedimentary conditions, which in turn structured the nematode community. Striking in this respect was the presence of large numbers of 'chemosynthetic' Astomonema nematodes (Astomonema southwardorum, Order Monhysterida, Family Siphonolaimidae). This genus lacks a mouth, buccal cavity and pharynx and possesses a rudimentary gut containing internal, symbiotic prokaryotes which have been recognised as sulphur-oxidising bacteria. Dominance of Astomonema may indicate the presence of reduced environments in the study areas, which is partially confirmed by the local biogeochemical environment. The nematode communities were mostly affected by sediment layer differences and concomitant trophic conditions rather than other spatial gradients related to study area, water depth or station differences, pointing to small-scale heterogeneity as the main source of variation in nematode structure and function. Furthermore, the positive relation between nematode standing stocks, and quantity and quality of the organic matter was stronger when hydrodynamic disturbance was greater. Analogically, this study also suggests that structural diversity can be positively correlated with trophic conditions and that this relation is tighter when hydrodynamic disturbance is greater.	[Ingels, Jeroen; Vanreusel, Ann] Univ Ghent, Dept Marine Biol, B-9000 Ghent, Belgium; [Tchesunov, Alexei V.] Moscow MV Lomonosov State Univ, Dept Invertebrate Zool, Fac Biol, Moscow, Russia	Ghent University; Lomonosov Moscow State University	Ingels, J (corresponding author), Univ Ghent, Dept Marine Biol, B-9000 Ghent, Belgium.	jeroen.ingels@ugent.be	Ingels, Jeroen/A-1691-2008	Ingels, Jeroen/0000-0001-8342-2222; Tchesunov, Alexei/0000-0003-2365-910X	European Commission [GOCE511234, 2263541]; Russian Fund for Basic Research [09-04-01212]	European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR))	This research was funded by the European Commission's Sixth Framework Programme HERMES project (http://www.eu-hermes.net, EC contract GOCE511234) and the European Commission's Seventh Framework Programme HERMIONE project (http://www.eu-hermione.net, grant agreement number 2263541). Participation of AVT in this research was supported by the Russian Fund for Basic Research (grant number 09-04-01212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero A, 2003, CONT SHELF RES, V23, P79, DOI 10.1016/S0278-4343(02)00168-1; Anderson M., 2005, PERMANOVA PERMUTATIO; Anderson M.J., 2008, PERMANOVA PRIMER GUI; ANDERSON M. J., 2007, PERMANOVA PRIMER GUI; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; AUSTEN MC, 1993, J MAR BIOL ASSOC UK, V73, P627, DOI 10.1017/S0025315400033166; Bianchelli S, 2008, CHEM ECOL, V24, P101, DOI 10.1080/02757540801963386; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; BILLETT DSM, 1983, NATURE, V302, P520, DOI 10.1038/302520a0; BONGERS T, 1991, MAR ECOL PROG SER, V76, P135, DOI 10.3354/meps076135; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cunningham MJ, 2005, SEDIMENT GEOL, V179, P99, DOI 10.1016/j.sedgeo.2005.04.014; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Deprez T, 2005, NEMYS WORLD WIDE WEB; Duineveld G, 2001, OCEANOL ACTA, V24, P69, DOI 10.1016/S0399-1784(00)01129-4; Duros P, 2011, DEEP-SEA RES PT I, V58, P128, DOI 10.1016/j.dsr.2010.11.008; Gage JD, 1992, DEEP SEA BIOL NATURA; Gallucci F, 2008, MAR ECOL PROG SER, V367, P173, DOI 10.3354/meps07537; Garcia R, 2007, MAR ECOL PROG SER, V340, P207, DOI 10.3354/meps340207; GIERE O, 1995, J MAR BIOL ASSOC UK, V75, P153, DOI 10.1017/S0025315400015265; HEIP C, 1990, NETH J SEA RES, V26, P333, DOI 10.1016/0077-7579(90)90095-X; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Heip Carlo H. R., 1998, Oceanis, V24, P61; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; Hill AE, 1998, J MAR RES, V56, P87, DOI 10.1357/002224098321836127; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hope WD, 1977, Mikrofauna Meeresbodens, VNo. 61, P307; HOSTE E, 2006, TEMPORAL SPATIAL VAR; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUSTON MA, 1994, BIOLOGICAL DIVERSITY; INGELS J, DEEP SEA 2 IN PRESS; Ingels J., 2006, HERMES RV BELGICA 20; Ingels J, 2009, DEEP-SEA RES PT I, V56, P1521, DOI 10.1016/j.dsr.2009.04.010; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Joint I, 2001, DEEP-SEA RES PT II, V48, P3049, DOI 10.1016/S0967-0645(01)00032-7; Jorissen FJ, 1995, MAR MICROPALEONTOL, V26, P3, DOI 10.1016/0377-8398(95)00047-X; KENYON NH, 1978, OCEANOL ACTA, V1, P369; KENYON NH, 1987, MAR GEOL, V74, P57, DOI 10.1016/0025-3227(87)90005-3; Kito K, 2006, ZOOTAXA, P39; Lampitt RS, 1997, DEEP-SEA RES PT I, V44, P1377, DOI 10.1016/S0967-0637(97)00020-4; Lampitt RS, 1995, DEEP-SEA RES PT I, V42, P1865, DOI 10.1016/0967-0637(95)00084-4; Lee HJ, 2001, POLAR BIOL, V24, P926; Levin LA, 2003, ECOSY WORLD, V28, P111; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MCLAREN P, 1985, J SEDIMENT PETROL, V55, P457; Mokievskii VO, 2007, OCEANOLOGY+, V47, P797, DOI 10.1134/S0001437007060057; Musat N, 2007, ENVIRON MICROBIOL, V9, P1345, DOI 10.1111/j.1462-2920.2006.01232.x; Oliveira A, 2007, MAR GEOL, V246, P105, DOI 10.1016/j.margeo.2007.04.017; Ott J, 2004, SYMBIOSIS, V36, P103; Pfannkuche O, 2000, DEEP-SEA RES PT II, V47, P2805, DOI 10.1016/S0967-0645(00)00050-3; PFANNKUCHE O, 1985, OCEANOL ACTA, V8, P343; PINGREE RD, 1989, PROG OCEANOGR, V23, P303, DOI 10.1016/0079-6611(89)90003-7; Raes M, 2006, DEEP-SEA RES PT I, V53, P1880, DOI 10.1016/j.dsr.2006.08.012; REID GS, 1990, MAR GEOL, V92, P69, DOI 10.1016/0025-3227(90)90027-H; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schmidt S, 2001, MAR GEOL, V173, P55, DOI 10.1016/S0025-3227(00)00163-8; Schratzberger M, 1998, MAR BIOL, V130, P643, DOI 10.1007/s002270050286; Schratzberger M, 2009, MAR BIOL, V156, P709, DOI 10.1007/s00227-008-1122-9; SHERMAN KM, 1981, AM ZOOL, V21, P1035; Smith C. R., 2010, P ROYAL SOC B; SOETAERT K, 1995, MAR ECOL PROG SER, V125, P171, DOI 10.3354/meps125171; Soetaert K, 2002, MAR ECOL PROG SER, V242, P179, DOI 10.3354/meps242179; Soetaert K, 2009, MAR ECOL PROG SER, V392, P123, DOI 10.3354/meps08202; Soltwedel T, 2003, VIE MILIEU, V53, P1; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Thiel H, 1983, DEEP SEA BIOL, P167; Thiel H., 1978, UPWELLING ECOSYSTEMS, p124?138; Thistle D, 1998, DEEP-SEA RES PT I, V45, P625, DOI 10.1016/S0967-0637(97)00101-5; Thistle D, 1998, DEEP-SEA RES PT II, V45, P13, DOI 10.1016/S0967-0645(97)00044-1; Thistle D, 1999, DEEP-SEA RES PT I, V46, P2041, DOI 10.1016/S0967-0637(99)00040-0; Thomsen L, 2002, PROG OCEANOGR, V52, P315, DOI 10.1016/S0079-6611(02)00013-7; Tyler P, 2009, OCEANOGRAPHY, V22, P46, DOI 10.5670/oceanog.2009.05; Van Rooij D., 2004, INTEGRATED STUDY QUA; Vanaverbeke J, 1997, J SEA RES, V38, P93, DOI 10.1016/S1385-1101(97)00038-5; VANREUSEL A, 1995, INT REV GES HYDROBIO, V80, P313, DOI 10.1002/iroh.19950800218; Vanreusel A, 2010, MAR ECOL-EVOL PERSP, V31, P6, DOI 10.1111/j.1439-0485.2009.00352.x; VIDAKOVIC J, 1987, CAH BIOL MAR, V28, P111; VINCX M, 1994, ADV MAR BIOL, V30, P1, DOI 10.1016/S0065-2881(08)60061-9; Vincx M., 1996, METHODS EXAMINATION, P214; Warwick R.M., 1998, FREE LIVING MARINE N; WHITE M, 2008, HERMES DELIVERABLE 1; White M, 2006, HERMES DELIVERABLE 4; WIESER W., 1953, ARKIV ZOOL, V4, P439; Wright S., 1997, PHYTOPLANKTON PIGMEN, P327	87	62	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20094	10.1371/journal.pone.0020094	http://dx.doi.org/10.1371/journal.pone.0020094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21629829	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200062
J	Kim, DS; Choi, YB; Han, BG; Park, SY; Jeon, Y; Kim, DH; Ahn, ER; Shin, JE; Lee, BI; Lee, H; Hong, KM; Kim, SY				Kim, D-S; Choi, Y-B; Han, B-G; Park, S-Y; Jeon, Y.; Kim, D-H; Ahn, E-R; Shin, J-E; Lee, B. I.; Lee, H.; Hong, K-M; Kim, S-Y			Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking	ONCOGENE			English	Article						transglutaminase 2; NF-kappa B; von Hippel-Lindau; IGF-1R; HIF-1 alpha; EPO	KAPPA-B ACTIVATION; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TISSUE TRANSGLUTAMINASE; NECROSIS-FACTOR; DRUG-RESISTANT; FACTOR-I; PATHWAY; EXPRESSION; CARCINOMA	Nuclear factor-kappa B (NF-kappa B) and insulin-like growth factor-1 (IGF-1)-mediated signaling is associated with different tumors including renal cell carcinoma. NF-kappa B- and IGF-1-mediated signaling is found to be inhibited in the presence of wild-type von Hippel-Lindau (VHL) tumor suppresser gene. Therefore, negative regulator of VHL may be a good target for regulating NF-kappa B and IGF-1R. In this study, we found that VHL, a tumor suppressor protein that downregulates the NF-kappa B activity and the stability of IGF-1R was depleted by TGase 2 through polymerization via crosslinking and proteasomal degradation in kidney, breast and ovary cancer cell lines. We also found that TGase 2 knockdown promotes hypoxia-inducible factor 1 alpha (HIF-1 alpha) degradation, and thereby decrease HIF-1 alpha transcriptional activity. Importantly, VHL expression was decreased in vivo in TGase-2-transgenic mice, and this was associated with increased NF-kappa B activity and the levels of expression of IGF-1R, HIF-1 alpha and erythropoietin in kidney tissue. These results suggest a novel mechanism of regulation of the VHL tumor suppressor by TGase 2 that appears to be independent of the known cancer regulatory mechanisms. Oncogene (2011) 30, 4780-4790; doi: 10.1038/onc.2011.183; published online 30 May 2011	[Kim, D-S; Choi, Y-B; Han, B-G; Park, S-Y; Kim, D-H; Ahn, E-R; Shin, J-E; Lee, B. I.; Hong, K-M; Kim, S-Y] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Div Canc Biol, Res Inst, Goyang 410769, Kyunggi Do, South Korea; [Jeon, Y.; Lee, H.] Res Inst, Div Canc Biol, Canc Resources Branch, Goyang, South Korea	National Cancer Center - Korea (NCC)	Kim, SY (corresponding author), Natl Canc Ctr, Canc Cell & Mol Biol Branch, Div Canc Biol, Res Inst, 323 Ilsan Ro, Goyang 410769, Kyunggi Do, South Korea.	kimsooyoul@gmail.com			National Cancer Center in Korea [NCC0810180-1, NCC1110011-1]; National Research Foundation of Korea; Ministry of Education, Science and Technology [20090086078]	National Cancer Center in Korea; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a research grant (NCC0810180-1 and NCC1110011-1) from the National Cancer Center in Korea and by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (no. 20090086078).	Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Curtis CD, 2005, METH MOLEC MED, V103, P123; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kim DS, 2010, BIOCHEM BIOPH RES CO, V399, P300, DOI 10.1016/j.bbrc.2010.07.078; Kim DS, 2009, FRONT BIOSCI-LANDMRK, V14, P2514, DOI 10.2741/3394; Kim JM, 2008, J MOL BIOL, V384, P756, DOI 10.1016/j.jmb.2008.10.010; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Maiuri L, 2008, J IMMUNOL, V180, P7697, DOI 10.4049/jimmunol.180.11.7697; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Otrock ZK, 2009, CRIT REV ONCOL HEMAT, V70, P93, DOI 10.1016/j.critrevonc.2009.01.001; Park KS, 2009, FRONT BIOSCI-LANDMRK, V14, P1945, DOI 10.2741/3354; Park SS, 2006, J BIOL CHEM, V281, P34965, DOI 10.1074/jbc.M604150200; Qi H, 2003, CANCER RES, V63, P7076; Seo JS, 2010, J ETHNOPHARMACOL, V130, P578, DOI 10.1016/j.jep.2010.05.055; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Tischoff I, 2008, Z GASTROENTEROL, V46, P1202, DOI 10.1055/s-2008-1027406; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Yuen JSP, 2007, ONCOGENE, V26, P6499, DOI 10.1038/sj.onc.1210474; Yuen JSP, 2009, MOL CANCER THER, V8, P1448, DOI 10.1158/1535-7163.MCT-09-0101	28	21	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2011	30	48					4780	4790		10.1038/onc.2011.183	http://dx.doi.org/10.1038/onc.2011.183			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21625219				2022-12-25	WOS:000298134700002
J	Lasiglie, D; Traggiai, E; Federici, S; Alessio, M; Buoncompagni, A; Accogli, A; Chiesa, S; Penco, F; Martini, A; Gattorno, M				Lasiglie, Denise; Traggiai, Elisabetta; Federici, Silvia; Alessio, Maria; Buoncompagni, Antonella; Accogli, Andrea; Chiesa, Sabrina; Penco, Federica; Martini, Alberto; Gattorno, Marco			Role of IL-1 Beta in the Development of Human T(H)17 Cells: Lesson from NLPR3 Mutated Patients	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; GENE-EXPRESSION PROFILES; GROWTH-FACTOR-BETA; HELPER T-CELLS; TGF-BETA; AUTOIMMUNE INFLAMMATION; PERIPHERAL-BLOOD; CIAS1 MUTATIONS; DENDRITIC CELLS	Background: T helper 17 cells (T-H-17) represent a lineage of effector T cells critical in host defence and autoimmunity. In both mouse and human IL-1 beta has been indicated as a key cytokine for the commitment to T-H-17 cells. Cryopyrin-associated periodic syndromes (CAPS) are a group of inflammatory diseases associated with mutations of the NLRP3 gene encoding the inflammasome component cryopyrin. In this work we asked whether the deregulated secretion of IL-1 beta secondary to mutations characterizing these patients could affect the IL-23/IL-17 axis. Methodology/Principal Findings: A total of 11 CAPS, 26 systemic onset juvenile idiopathic arthritis (SoJIA) patients and 20 healthy controls were analyzed. Serum levels of IL-17 and IL-6 serum were assessed by ELISA assay. Frequency of T(H)17 cells was quantified upon staphylococcus enterotoxin B (SEB) stimulation. Secretion of IL-1 beta, IL-23 and IL-6 by monocyte derived dendritic cells (MoDCs), were quantified by ELISA assay. A total of 8 CAPS and 11 SoJIA patients were also analysed before and after treatment with IL-1 beta blockade. Untreated CAPS patients showed significantly increased IL-17 serum levels as well as a higher frequency of T(H)17 compared to control subjects. On the contrary, SoJIA patients displayed a frequency of T(H)17 similar to normal donors, but were found to have significantly increased serum level of IL-6 when compared to CAPS patients or healthy donors. Remarkably, decreased IL-17 serum levels and T(H)17 frequency were observed in CAPS patients following in vivo IL-1 beta blockade. On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1 beta and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. Conclusion/Significance: These findings further support the central role of IL-1 beta in the differentiation of T(H)17 in human inflammatory conditions.	[Lasiglie, Denise; Traggiai, Elisabetta; Federici, Silvia; Buoncompagni, Antonella; Accogli, Andrea; Chiesa, Sabrina; Penco, Federica; Gattorno, Marco] G Gaslini Inst Children, Div Pediat 2, Rheumatol Unit, Genoa, Italy; [Lasiglie, Denise; Martini, Alberto] Univ Genoa, Lab Immunol Rheumat Dis, Dept Pediat, Genoa, Italy; [Alessio, Maria] Federico II Hosp, Dept Pediat, Naples, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Lasiglie, D (corresponding author), G Gaslini Inst Children, Div Pediat 2, Rheumatol Unit, Genoa, Italy.	marcogattorno@ospedale-gaslini.ge.it	Gattorno, Marco/AAL-2974-2020; Chiesa, Sabrina/AAN-7877-2020; Penco, Federica/L-1013-2016	Gattorno, Marco/0000-0003-0704-1916; Penco, Federica/0000-0002-8437-3466; MARTINI, Alberto/0000-0001-7642-1459; Accogli, Andrea/0000-0001-8724-6721; Chiesa, Sabrina/0000-0002-0392-1927	Telethon Italia [NGGP09127]; Ricerca Corrente Ministeriale	Telethon Italia(Fondazione Telethon); Ricerca Corrente Ministeriale	The work was partially supported by Telethon Italia (Grant NGGP09127) and Ricerca Corrente Ministeriale. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Benedetti F, 2005, ARTHRITIS RHEUM-US, V52, P687, DOI 10.1002/art.20946; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; Dinarello CA, 2009, MAYO CLIN PROC, V84, P105, DOI 10.4065/84.2.105; El-Osta H, 2010, MOL CANCER THER, V9, P1485, DOI 10.1158/1535-7163.MCT-10-0156; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Frosch M, 2009, ARTHRITIS RHEUM-US, V60, P883, DOI 10.1002/art.24349; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Harris KM, 2008, J IMMUNOL, V181, P4457, DOI 10.4049/jimmunol.181.7.4457; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hirota K, 2010, SEMIN IMMUNOPATHOL, V32, P3, DOI 10.1007/s00281-009-0187-y; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Lepore L, 2010, J PEDIATR-US, V157, P310, DOI 10.1016/j.jpeds.2010.02.040; Lequerre T, 2008, ANN RHEUM DIS, V67, P302, DOI 10.1136/ard.2007.076034; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Matsubara T, 2006, ARTHRITIS RHEUM-US, V54, P2314, DOI 10.1002/art.21965; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Nowak EC, 2010, IMMUNOLOGY, V131, P169, DOI 10.1111/j.1365-2567.2010.03332.x; O'Garra A, 2008, NAT IMMUNOL, V9, P588, DOI 10.1038/ni0608-588; Ogilvie EM, 2007, ARTHRITIS RHEUM-US, V56, P1954, DOI 10.1002/art.22644; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woo P, 2005, ARTHRITIS RES THER, V7, pR1281, DOI 10.1186/ar1826; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7	56	91	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20014	10.1371/journal.pone.0020014	http://dx.doi.org/10.1371/journal.pone.0020014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637346	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200026
J	Niers, TMH; Richel, DJ; Meijers, JCM; Schlingemann, RO				Niers, Tatjana M. H.; Richel, Dick J.; Meijers, Joost C. M.; Schlingemann, Reinier O.			Vascular Endothelial Growth Factor in the Circulation in Cancer Patients May Not Be a Relevant Biomarker	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; RENAL-CELL CARCINOMA; FACTOR VEGF; PLASMA-LEVELS; ANGIOGENESIS; PLATELETS; ACTIVATION; ANTIBODY; LEUKOCYTES; RECEPTORS	Background: Levels of circulating vascular endothelial growth factor (VEGF) have widely been used as biomarker for angiogenic activity in cancer. For this purpose, non-standardized measurements in plasma and serum were used, without correction for artificial VEGF release by platelets activated ex vivo. We hypothesize that "true" circulating (c) VEGF levels in most cancer patients are low and unrelated to cancer load or tumour angiogenesis. Methodology: We determined VEGF levels in PECT, a medium that contains platelet activation inhibitors, in citrate plasma, and in isolated platelets in 16 healthy subjects, 18 patients with metastatic non-renal cancer (non-RCC) and 12 patients with renal cell carcinoma (RCC). In non-RCC patients, circulating plasma VEGF levels were low and similar to VEGF levels in controls if platelet activation was minimized during the harvest procedure by PECT medium. In citrate plasma, VEGF levels were elevated in non-RCC patients, but this could be explained by a combination of increased platelet activation during blood harvesting, and by a two-fold increase in VEGF content of individual platelets (controls: 3.4 IU/10(6), non-RCC: 6.2 IU/10(6) platelets, p = 0.001). In contrast, cVEGF levels in RCC patients were elevated (PECT plasma: 64 pg/ml vs. 21 pg/ml, RCC vs. non-RCC, p, 0.0001), and not related to platelet VEGF concentration. Conclusions: Our findings suggest that "true" freely cVEGF levels are not elevated in the majority of cancer patients. Previously reported elevated plasma VEGF levels in cancer appear to be due to artificial release from activated platelets, which in cancer have an increased VEGF content, during the blood harvest procedure. Only in patients with RCC, which is characterized by excessive VEGF production due to a specific genetic defect, were cVEGF levels elevated. This observation may be related to limited and selective success of anti-VEGF agents, such as bevacizumab and sorafenib, as monotherapy in RCC compared to other forms of cancer.	[Niers, Tatjana M. H.; Richel, Dick J.] Univ Amsterdam, Acad Med Ctr, Dept Oncol, NL-1105 AZ Amsterdam, Netherlands; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Niers, TMH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.schlingemann@amc.uva.nl	Meijers, J.C.M./S-5981-2019	Meijers, J.C.M./0000-0002-4198-6780				Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Caine GJ, 2004, ANN MED, V36, P273, DOI 10.1080/07853890410026098; Davies MM, 2000, BRIT J CANCER, V82, P1004; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; George ML, 2000, CLIN CANCER RES, V6, P3147; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; Grothey A, 2008, CANCER J, V14, P170, DOI 10.1097/PPO.0b013e318178d9de; Gunsilius E, 2000, ONCOLOGY-BASEL, V58, P169, DOI 10.1159/000012095; Hyodo I, 1998, EUR J CANCER, V34, P2041, DOI 10.1016/S0959-8049(98)00282-2; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; KAPLAN KL, 1986, CRIT REV ONCOL HEMAT, V5, P235, DOI 10.1016/S1040-8428(86)80040-3; KAPLAN KL, 1981, BLOOD, V57, P199; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Longo R, 2007, CANCER CHEMOTH PHARM, V60, P151, DOI 10.1007/s00280-006-0403-6; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Motzer RJ, 1999, J CLIN ONCOL, V17, P2530, DOI 10.1200/JCO.1999.17.8.2530; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Nyhan MJ, 2008, BIOCHEM SOC T, V36, P472, DOI 10.1042/BST0360472; Presta LG, 1997, CANCER RES, V57, P4593; Rini BI, 2005, J CLIN ONCOL, V23, P1028, DOI 10.1200/JCO.2005.01.186; Salgado R, 1999, BRIT J CANCER, V80, P892, DOI 10.1038/sj.bjc.6690437; Salven P, 1999, CLIN CANCER RES, V5, P487; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Veikkola T, 1999, SEMIN CANCER BIOL, V9, P211, DOI 10.1006/scbi.1998.0091; VERHEUL HM, 1998, ONCOLOGIST, V3, P2; Verheul HMW, 2000, BLOOD, V96, P4216, DOI 10.1182/blood.V96.13.4216; Verheul HMW, 2000, CLIN CANCER RES, V6, P166; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Werther K, 2002, SCAND J CLIN LAB INV, V62, P343, DOI 10.1080/00365510260296492; Witmer AN, 2002, J HISTOCHEM CYTOCHEM, V50, P767, DOI 10.1177/002215540205000603; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yoshikawa T, 2000, CANCER LETT, V153, P7, DOI 10.1016/S0304-3835(99)00426-7	36	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19873	10.1371/journal.pone.0019873	http://dx.doi.org/10.1371/journal.pone.0019873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637343	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200017
J	Peattie, AM; Dirks, JH; Henriques, S; Federle, W				Peattie, Anne M.; Dirks, Jan-Henning; Henriques, Sergio; Federle, Walter			Arachnids Secrete a Fluid over Their Adhesive Pads	PLOS ONE			English	Article							SUCTORIAL ORGAN; COLEOPTERA; ULTRASTRUCTURE; MORPHOLOGY; SOLIFUGAE; FORCE; WET	Background: Many arachnids possess adhesive pads on their feet that help them climb smooth surfaces and capture prey. Spider and gecko adhesives have converged on a branched, hairy structure, which theoretically allows them to adhere solely by dry (solid-solid) intermolecular interactions. Indeed, the consensus in the literature is that spiders and their smooth-padded relatives, the solifugids, adhere without the aid of a secretion. Methodology and Principal Findings: We investigated the adhesive contact zone of living spiders, solifugids and mites using interference reflection microscopy, which allows the detection of thin liquid films. Like insects, all the arachnids we studied left behind hydrophobic fluid footprints on glass (mean refractive index: 1.48-1.50; contact angle: 3.7-11.2 degrees). Fluid was not always secreted continuously, suggesting that pads can function in both wet and dry modes. We measured the attachment forces of single adhesive setae from tarantulas (Grammostola rosea) by attaching them to a bending beam with a known spring constant and filming the resulting deflection. Individual spider setae showed a lower static friction at rest (26% +/- 2.8 SE of the peak friction) than single gecko setae (Thecadactylus rapicauda; 96% +/- 1.7 SE). This may be explained by the fact that spider setae continued to release fluid after isolation from the animal, lubricating the contact zone. Significance: This finding implies that tarsal secretions occur within all major groups of terrestrial arthropods with adhesive pads. The presence of liquid in an adhesive contact zone has important consequences for attachment performance, improving adhesion to rough surfaces and introducing rate-dependent effects. Our results leave geckos and anoles as the only known representatives of truly dry adhesive pads in nature. Engineers seeking biological inspiration for synthetic adhesives should consider whether model species with fluid secretions are appropriate to their design goals.	[Peattie, Anne M.; Dirks, Jan-Henning; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England; [Henriques, Sergio] Univ Evora, Dept Biol, Evora, Portugal	University of Cambridge; University of Evora	Peattie, AM (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	apeattie@gmail.com	Federle, Walter/K-8263-2014; Dirks, Jan-Henning/B-9706-2011	Federle, Walter/0000-0002-6375-3005; 	Royal Society; German National Academic Foundation; Biotechnology and Biological Sciences Research Council [BB/E004156/1]; Cambridge Isaac Newton Trust; Biotechnology and Biological Sciences Research Council [BB/I008667/1] Funding Source: researchfish; BBSRC [BB/E004156/1, BB/I008667/1] Funding Source: UKRI	Royal Society(Royal Society of London); German National Academic Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Isaac Newton Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by fellowships from the Royal Society (to AMP; http://royalsociety.org/Funding/) and the German National Academic Foundation (to J-HD; http://www.studienstiftung.de/), and grants from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/; Grant ID: BB/E004156/1) and the Cambridge Isaac Newton Trust (to WF; http://www.newtontrust.cam.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, FUNCTION EVOLUTION G; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Betz O, 2003, J MORPHOL, V255, P24, DOI 10.1002/jmor.10044; Cushing PE, 2005, ARTHROPOD STRUCT DEV, V34, P397, DOI 10.1016/j.asd.2005.02.002; Dirks JH, 2011, J R SOC INTERFACE, V8, P952, DOI 10.1098/rsif.2010.0575; Dirks JH, 2010, J R SOC INTERFACE, V7, P587, DOI 10.1098/rsif.2009.0308; Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5; Dunlop JA, 2002, EUROPEAN ARACHNOLOGY 2000, P345; EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Federle W, 2006, J EXP BIOL, V209, P2611, DOI 10.1242/jeb.02323; Geiselhardt SF, 2010, J COMP PHYSIOL A, V196, P369, DOI 10.1007/s00359-010-0522-8; Gorb SN, 1998, P ROY SOC B-BIOL SCI, V265, P747, DOI 10.1098/rspb.1998.0356; Gorb SN, 2006, NATURE, V443, P407, DOI 10.1038/443407a; HASENFUSS I, 1977, ZOOMORPHOLOGIE, V87, P51, DOI 10.1007/BF02568741; HILL DE, 1977, ZOOL J LINN SOC-LOND, V60, P319, DOI 10.1111/j.1096-3642.1977.tb00838.x; HOMANN H, 1957, NATURWISSENSCHAFTEN, V44, P318, DOI 10.1007/BF00630926; Kesel AB, 2003, J EXP BIOL, V206, P2733, DOI 10.1242/jeb.00478; Klann AE, 2008, ARTHROPOD STRUCT DEV, V37, P3, DOI 10.1016/j.asd.2007.04.001; LIU TP, 1990, EXP APPL ACAROL, V8, P105, DOI 10.1007/BF01193385; MCFARLANE JS, 1950, PROC R SOC LON SER-A, V202, P224, DOI 10.1098/rspa.1950.0096; Mizutani K, 2006, JSME INT J C-MECH SY, V49, P539, DOI 10.1299/jsmec.49.539; Nachtigall W., 1974, BIOL MECH ATTACHMENT; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Peattie AM, 2009, J COMP PHYSIOL B, V179, P231, DOI 10.1007/s00360-008-0310-8; Perez-Miles F, 2009, NATURE, V461, pE9, DOI 10.1038/nature08404; RADLER J, 1993, J PHYS II, V3, P727; Riskin DK, 2010, BIOL J LINN SOC, V99, P233; Roscoe D.T., 1991, Bulletin of the British Arachnological Society, V8, P224; STORK NE, 1980, J EXP BIOL, V88, P91; Votsch W, 2002, INSECT BIOCHEM MOLEC, V32, P1605, DOI 10.1016/S0965-1748(02)00098-X; Welbourn WC, 2003, EXP APPL ACAROL, V30, P107, DOI 10.1023/B:APPA.0000006545.40017.a0; Weygoldt Peter, 2000, P1; Wilms J, 2008, NATURWISSENSCHAFTEN, V95, P149, DOI 10.1007/s00114-007-0298-z	35	32	34	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20485	10.1371/journal.pone.0020485	http://dx.doi.org/10.1371/journal.pone.0020485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637774	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200071
J	Roxby, AC; Drake, AL; John-Stewart, G; Brown, ER; Matemo, D; Otieno, PA; Farquhar, C				Roxby, Alison C.; Drake, Alison L.; John-Stewart, Grace; Brown, Elizabeth R.; Matemo, Daniel; Otieno, Phelgona A.; Farquhar, Carey			Herpes Simplex Virus Type 2, Genital Ulcers and HIV-1 Disease Progression in Postpartum Women	PLOS ONE			English	Article							CONTROLLED-TRIAL; DOUBLE-BLIND; VIRAL LOAD; RNA LEVELS; INFECTION; ACYCLOVIR; TRANSMISSION; THERAPY; PLASMA; RISK	Background: Co-infection with herpes simplex virus type 2 (HSV-2) has been associated with increased HIV-1 RNA levels and immune activation, two predictors of HIV-1 progression. The impact of HSV-2 on clinical outcomes among HIV-1 infected pregnant women is unclear. Methods: HIV-1 infected pregnant women in Nairobi were enrolled antenatally and HSV-2 serology was obtained. HIV-1 RNA and CD4 count were serially measured for 12-24 months postpartum. Survival analysis using endpoints of death, opportunistic infection (OI), and CD4,200 cells mu L, and linear mixed models estimating rate of change of HIV-1 RNA and CD4, were used to determine associations between HSV-2 serostatus and HIV-1 progression. Results: Among 296 women, 254 (86%) were HSV-2-seropositive. Only 30 (10%) women had prior or current genital ulcer disease (GUD); median baseline CD4 count was 422 cells mu L. Adjusting for baseline CD4, women with GUD were significantly more likely to have incident OIs (adjusted hazard ratio (aHR) 2.79, 95% Cl: 1.33-5.85), and there was a trend for association between HSV-2-seropositivity and incident OIs (aHR 3.83, 95% Cl: 0.93-15.83). Rate of change in CD4 count and HIV-1 RNA did not differ by HSV-2 status or GUD, despite a trend toward higher baseline HIV-1 RNA in HSV-2-seropositive women (4.73 log10 copies/ml vs. 4.47 log10 copies/ml, P = 0.07). Conclusions: HSV-2 was highly prevalent and pregnant HIV-1 infected women with GUD were significantly more likely to have incident OIs than women without GUD, suggesting that clinically evident HSV-2 is a more important predictor of HIV-1 disease progression than asymptomatic HSV-2.	[Roxby, Alison C.; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Drake, Alison L.; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA USA; [John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Brown, Elizabeth R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Matemo, Daniel] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Otieno, Phelgona A.] Kenya Govt Med Res Ctr, Clin Res Ctr, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Kenya Medical Research Institute	Roxby, AC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	aroxby@u.washington.edu	John-Stewart, Grace/U-3351-2019; Brown, Elizabeth/A-8984-2008; John-Stewart, Grace/L-3650-2019	Roxby, Alison/0000-0001-9449-8062	US National Institutes of Health (NIH) [RO1 HD 23412, K24 HD054314-04]; University of Washington Center for AIDS Research (CFAR) [P30 AI027757]; Fogarty International Center; NIH [D43 TW00007]; NIH Fogarty International Center [5 R24 TW007988]; University of Washington CFAR [T32 AI07140-32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023412, K24HD054314] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, P30AI027757] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of Washington CFAR; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by US National Institutes of Health (NIH) research grants RO1 HD 23412 and K24 HD054314-04 and the University of Washington Center for AIDS Research (CFAR) P30 AI027757. ACR was a scholar in the International AIDS Research and Training Program, supported by the Fogarty International Center, NIH (D43 TW00007), and is a Fogarty International Clinical Research Fellow funded under NIH Fogarty International Center grant 5 R24 TW007988. ALD is supported by a University of Washington CFAR Training Grant (T32 AI07140-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumakhan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009973; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Bollen LJM, 2008, AIDS, V22, P1169, DOI 10.1097/QAD.0b013e3282fec42a; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502; COOPER DA, 1993, AIDS, V7, P197, DOI 10.1097/00002030-199302000-00007; Cowan FA, 2008, AIDS, V22, P193, DOI 10.1097/QAD.0b013e3282f2a939; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Drake AL, 2007, OBSTET GYNECOL, V109, P403, DOI 10.1097/01.AOG.0000251511.27725.5c; Duffus WA, 2005, INT J STD AIDS, V16, P733, DOI 10.1258/095646205774763298; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Hitti J, 1997, AM J OBSTET GYNECOL, V177, P450, DOI 10.1016/S0002-9378(97)70214-X; Ioannidis JPA, 1998, J INFECT DIS, V178, P349, DOI 10.1086/515621; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Otieno PA, 2007, J INFECT DIS, V195, P220, DOI 10.1086/510245; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; Schacker T, 2001, Herpes, V8, P46; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; STEIN DS, 1994, ANN INTERN MED, V121, P100, DOI 10.7326/0003-4819-121-2-199407150-00004; Walson JL, 2007, JAIDS-J ACQ IMM DEF, V46, P208, DOI 10.1097/QAI.0b013e318141fcc0; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19947	10.1371/journal.pone.0019947	http://dx.doi.org/10.1371/journal.pone.0019947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637835	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200022
J	Xiong, J; Yuan, DX; Fillingham, JS; Garg, J; Lu, XY; Chang, Y; Liu, YF; Fu, CJ; Pearlman, RE; Miao, W				Xiong, Jie; Yuan, Dongxia; Fillingham, Jeffrey S.; Garg, Jyoti; Lu, Xingyi; Chang, Yue; Liu, Yifan; Fu, Chengjie; Pearlman, Ronald E.; Miao, Wei			Gene Network Landscape of the Ciliate Tetrahymena thermophila	PLOS ONE			English	Article							RETINOBLASTOMA PROTEIN FAMILY; DNA ELIMINATION; GENOME REARRANGEMENT; BIOLOGICAL NETWORKS; CELL-CYCLE; COEXPRESSION NETWORK; FUNCTIONAL MODULES; MICROARRAY DATA; HUMAN CDC2; SMALL RNAS	Background: Genome-wide expression data of gene microarrays can be used to infer gene networks. At a cellular level, a gene network provides a picture of the modules in which genes are densely connected, and of the hub genes, which are highly connected with other genes. A gene network is useful to identify the genes involved in the same pathway, in a protein complex or that are co-regulated. In this study, we used different methods to find gene networks in the ciliate Tetrahymena thermophila, and describe some important properties of this network, such as modules and hubs. Methodology/Principal Findings: Using 67 single channel microarrays, we constructed the Tetrahymena gene network (TGN) using three methods: the Pearson correlation coefficient (PCC), the Spearman correlation coefficient (SCC) and the context likelihood of relatedness (CLR) algorithm. The accuracy and coverage of the three networks were evaluated using four conserved protein complexes in yeast. The CLR network with a Z-score threshold 3.49 was determined to be the most robust. The TGN was partitioned, and 55 modules were found. In addition, analysis of the arbitrarily determined 1200 hubs showed that these hubs could be sorted into six groups according to their expression profiles. We also investigated human disease orthologs in Tetrahymena that are missing in yeast and provide evidence indicating that some of these are involved in the same process in Tetrahymena as in human. Conclusions/Significance: This study constructed a Tetrahymena gene network, provided new insights to the properties of this biological network, and presents an important resource to study Tetrahymena genes at the pathway level.	[Xiong, Jie; Yuan, Dongxia; Lu, Xingyi; Chang, Yue; Fu, Chengjie; Miao, Wei] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Xiong, Jie; Lu, Xingyi; Chang, Yue] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Yuan, Dongxia] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Fillingham, Jeffrey S.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Garg, Jyoti; Pearlman, Ronald E.] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Garg, Jyoti; Pearlman, Ronald E.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Liu, Yifan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Toronto Metropolitan University; York University - Canada; York University - Canada; University of Michigan System; University of Michigan	Xiong, J (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	miaowei530@yeah.net	Fu, Cheng-Jie/B-3679-2008	Fu, Cheng-Jie/0000-0001-9357-9661; Xiong, Jie/0000-0001-8923-0424; Liu, Yifan/0000-0002-3896-0002; miao, wei/0000-0003-3440-8322	National Natural Science Foundation of China [31071993]; CAS [KSCX2-YW-G-072]; Canadian Institutes of Health Research [MOP 97799]; Ryerson University; National Institutes of Health [GM087343]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087343] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ryerson University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China (No. 31071993), and Knowledge Innovation Program of CAS (No. KSCX2-YW-G-072) to WM. Funding from the Canadian Institutes of Health Research (MOP 97799) to REP is gratefully acknowledged as is start-up funding from Ryerson University to JSF. The microarray work of YF was supported by National Institutes of Health grant (GM087343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Bowman GR, 2005, J EUKARYOT MICROBIOL, V52, P291, DOI 10.1111/j.1550-7408.2005.00045.x; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Butte A J, 2000, Pac Symp Biocomput, P418; CassidyHanley D, 1997, GENETICS, V146, P135; Cerulo L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-228; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Collins K, 2005, CURR BIOL, V15, pR317, DOI 10.1016/j.cub.2005.04.039; Collins K, 1998, P NATL ACAD SCI USA, V95, P8485, DOI 10.1073/pnas.95.15.8485; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elati M., 2011, UNSUPERVISED LEARNIN, P955, DOI DOI 10.1002/9780470892107.CH41; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; EWEN ME, 1994, CANCER METAST REV, V13, P45, DOI 10.1007/BF00690418; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fillingham JS, 2002, J EUKARYOT MICROBIOL, V49, P99, DOI 10.1111/j.1550-7408.2002.tb00350.x; Foster I, 2002, SCIENCE, V297, P1124, DOI 10.1126/science.1074392; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; HU Q, 1992, MOL CELL BIOL, V12, P971, DOI 10.1128/MCB.12.3.971; Huynen MA, 1999, TRENDS MICROBIOL, V7, P281, DOI 10.1016/S0966-842X(99)01539-5; Kashima H, 2009, BIOINFORMATICS, V25, P2962, DOI 10.1093/bioinformatics/btp494; Khanin R, 2007, METHODS OF MICROARRAY DATA ANALYSIS V, P75, DOI 10.1007/978-0-387-34569-7_6; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; Li JL, 1996, NUCLEIC ACIDS RES, V24, P1943, DOI 10.1093/nar/24.10.1943; Liang S, 1998, Pac Symp Biocomput, P18; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Matsuda A, 2010, EUKARYOT CELL, V9, P1087, DOI 10.1128/EC.00379-09; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mohan A, 2006, BRIT J OPHTHALMOL, V90, P889, DOI 10.1136/bjo.2005.089219; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Nina PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000418; Noto T, 2010, CELL, V140, P692, DOI 10.1016/j.cell.2010.02.010; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Paggi MG, 1996, J CELL BIOCHEM, V62, P418; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Seoane M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003632; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; van den Berg RA, 2010, FUNGAL GENET BIOL, V47, P539, DOI 10.1016/j.fgb.2010.03.005; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Wang JYJ, 2001, ACTA ONCOL, V40, P689; Wille A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r92; WIMAN KG, 1993, FASEB J, V7, P841, DOI 10.1096/fasebj.7.10.8393817; Witkin KL, 2007, MOL CELL BIOL, V27, P2074, DOI 10.1128/MCB.02105-06; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Zhang SH, 2007, PROTEOMICS, V7, P2856, DOI 10.1002/pmic.200700095; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	80	21	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20124	10.1371/journal.pone.0020124	http://dx.doi.org/10.1371/journal.pone.0020124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637855	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200034
J	Jha, AR; Nixon, DF; Rosenberg, MG; Martin, JN; Deeks, SG; Hudson, RR; Garrison, KE; Pillai, SK				Jha, Aashish R.; Nixon, Douglas F.; Rosenberg, Michael G.; Martin, Jeffrey N.; Deeks, Steven G.; Hudson, Richard R.; Garrison, Keith E.; Pillai, Satish K.			Human Endogenous Retrovirus K106 (HERV-K106) Was Infectious after the Emergence of Anatomically Modern Humans	PLOS ONE			English	Article							HUMAN GENOME; INSERTIONAL POLYMORPHISMS; RECOMBINATION RATE; HUMAN-POPULATIONS; DNA POLYMORPHISM; EVOLUTION; ELEMENTS; IDENTIFICATION; PERSISTENCE; FAMILIES	HERV-K113 and HERV-K115 have been considered to be among the youngest HERVs because they are the only known full-length proviruses that are insertionally polymorphic and maintain the open reading frames of their coding genes. However, recent data suggest that HERV-K113 is at least 800,000 years old, and HERV-K115 even older. A systematic study of HERV-K HML2 members to identify HERVs that may have infected the human genome in the more recent evolutionary past is lacking. Therefore, we sought to determine how recently HERVs were exogenous and infectious by examining sequence variation in the long terminal repeat (LTR) regions of all full-length HERV-K loci. We used the traditional method of inter-LTR comparison to analyze all full length HERV-Ks and determined that two insertions, HERV-K106 and HERV-K116 have no differences between their 5' and 3' LTR sequences, suggesting that these insertions were endogenized in the recent evolutionary past. Among these insertions with no sequence differences between their LTR regions, HERV-K106 had the most intact viral sequence structure. Coalescent analysis of HERV-K106 3' LTR sequences representing 51 ethnically diverse individuals suggests that HERV-K106 integrated into the human germ line approximately 150,000 years ago, after the emergence of anatomically modern humans.	[Jha, Aashish R.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Nixon, Douglas F.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Rosenberg, Michael G.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Martin, Jeffrey N.; Deeks, Steven G.] Univ Calif San Francisco, Div HIV AIDS, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA; [Hudson, Richard R.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Garrison, Keith E.] St Marys Coll Calif, Dept Biol, Moraga, CA USA; [Pillai, Satish K.] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA	University of Chicago; University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Chicago; Saint Mary's College of California; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Jha, AR (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	nepaliaashish@gmail.com; satish.pillai@ucsf.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Jha, Aashish/0000-0003-3227-1086	National Institutes of Health [AI076059, AI060379, AI084113]; UCSF CFAR [P-30 AI27763]; UCSF CTSI [UL1 RR024131]; CNICS [R24 AI067039]; NIAID [K24AI069994];  [1K01DA024654]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI060379, R01AI060379, R24AI067039, R01AI076059, R56AI084113, P30AI027763, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA024654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF CFAR; UCSF CTSI; CNICS; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants AI076059, AI060379, AI084113, UCSF CFAR (P-30 AI27763), UCSF CTSI (UL1 RR024131), CNICS (R24 AI067039), NIAID (K24AI069994), and 1K01DA024654 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; CHRISTENSEN T, 2010, J NEUROIMMUNE PHARM; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DANGEL AW, 1995, IMMUNOGENETICS, V42, P41, DOI 10.1007/BF00164986; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Dolgin ES, 2008, GENETICS, V178, P2169, DOI 10.1534/genetics.107.082743; FU YX, 1993, GENETICS, V133, P693; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Glazko GV, 2003, MOL BIOL EVOL, V20, P424, DOI 10.1093/molbev/msg050; Heslin DJ, 2009, J VIROL, V83, P1105, DOI 10.1128/JVI.01439-08; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hughes JF, 2004, P NATL ACAD SCI USA, V101, P1668, DOI 10.1073/pnas.0307885100; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Jha AR, 2009, MOL BIOL EVOL, V26, P2617, DOI 10.1093/molbev/msp180; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Katzourakis A, 2007, J VIROL, V81, P10712, DOI 10.1128/JVI.00410-07; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lebedev YB, 2000, GENE, V247, P265, DOI 10.1016/S0378-1119(00)00062-7; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macfarlane C, 2004, J MOL EVOL, V59, P642, DOI 10.1007/s00239-004-2656-1; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Moyes D, 2007, TRENDS GENET, V23, P326, DOI 10.1016/j.tig.2007.05.004; Moyes DL, 2005, GENOMICS, V86, P337, DOI 10.1016/j.ygeno.2005.06.004; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Paces J, 2002, NUCLEIC ACIDS RES, V30, P205, DOI 10.1093/nar/30.1.205; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; TAJIMA F, 1989, GENETICS, V123, P585; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669	41	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20234	10.1371/journal.pone.0020234	http://dx.doi.org/10.1371/journal.pone.0020234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633511	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500044
J	Morello, N; Bianchi, FT; Marmiroli, P; Tonoli, E; Menendez, VR; Silengo, L; Cavaletti, G; Vercelli, A; Altruda, F; Tolosano, E				Morello, Noemi; Bianchi, Federico Tommaso; Marmiroli, Paola; Tonoli, Elisabetta; Menendez, Virginia Rodriguez; Silengo, Lorenzo; Cavaletti, Guido; Vercelli, Alessandro; Altruda, Fiorella; Tolosano, Emanuela			A Role for Hemopexin in Oligodendrocyte Differentiation and Myelin Formation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR-RELATED PROTEIN-1; PLASMA HEMOPEXIN; ALZHEIMERS-DISEASE; PERIPHERAL-NERVES; IN-VITRO; MICE; HEME; BRAIN; EXPRESSION	Myelin formation and maintenance are crucial for the proper function of the CNS and are orchestrated by a plethora of factors including growth factors, extracellular matrix components, metalloproteases and protease inhibitors. Hemopexin (Hx) is a plasma protein with high heme binding affinity, which is also locally produced in the CNS by ependymal cells, neurons and glial cells. We have recently reported that oligodendrocytes (OLs) are the type of cells in the brain that are most susceptible to lack of Hx, as the number of iron-overloaded OLs increases in Hx-null brain, leading to oxidative tissue damage. In the current study, we found that the expression of the Myelin Basic Protein along with the density of myelinated fibers in the basal ganglia and in the motor and somatosensory cortex of Hx-null mice were strongly reduced starting at 2 months and progressively decreased with age. Myelin abnormalities were confirmed by electron microscopy and, at the functional level, resulted in the inability of Hx-null mice to perform efficiently on the Rotarod. It is likely that the poor myelination in the brain of Hx-null mice was a consequence of defective maturation of OLs as we demonstrated that the number of mature OLs was significantly reduced in mutant mice whereas that of precursor cells was normal. Finally, in vitro experiments showed that Hx promotes OL differentiation. Thus, Hx may be considered a novel OL differentiation factor and the modulation of its expression in CNS may be an important factor in the pathogenesis of human neurodegenerative disorders.	[Morello, Noemi; Bianchi, Federico Tommaso; Silengo, Lorenzo; Altruda, Fiorella; Tolosano, Emanuela] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Marmiroli, Paola; Menendez, Virginia Rodriguez; Cavaletti, Guido] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy; [Tonoli, Elisabetta; Vercelli, Alessandro] Univ Turin, Neurosci Inst Turin, Dept Anat Pharmacol & Forens Med, Turin, Italy	University of Turin; University of Milano-Bicocca; University of Turin	Morello, N (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	emanuela.tolosano@unito.it	Tolosano, Emanuela/A-4684-2015; Tolosano, Emanuela/L-8080-2019; marmiroli, paola/AAB-6077-2022; Cavaletti, Guido/AAA-7063-2022; Vercelli, Alessandro E/A-1926-2012	Tolosano, Emanuela/0000-0002-1622-2340; Tolosano, Emanuela/0000-0002-1622-2340; Cavaletti, Guido/0000-0003-4128-2406; Vercelli, Alessandro E/0000-0002-5909-2128; Bianchi, Federico Tommaso/0000-0002-8385-3310	Italian Ministry of University and Research; Regione Piemonte; Compagnia di San Paolo	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte); Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by the Italian Ministry of University and Research to E.T. and F.A., by "Regione Piemonte" to F.A. and by "Compagnia di San Paolo" to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker WW, 2005, PEDIATR NEPHROL, V20, P1410, DOI 10.1007/s00467-005-1936-3; Bakker WW, 2005, KIDNEY INT, V68, P603, DOI 10.1111/j.1523-1755.2005.00438.x; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bauer Nina G., 2009, Journal of Biology (London), V8, P78, DOI 10.1186/jbiol169; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Camborieux L, 1998, NEUROSCIENCE, V82, P1039; CHEN L, 2010, J NEUROSURG; Cheung PK, 2000, KIDNEY INT, V57, P1512, DOI 10.1046/j.1523-1755.2000.00996.x; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Dedieu S, 2008, CELL ADHES MIGR, V2, P77, DOI 10.4161/cam.2.2.6374; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Dyer CA, 2002, NEUROCHEM RES, V27, P1279, DOI 10.1023/A:1021611430052; Ferreira AA, 2004, J NEUROCYTOL, V33, P225, DOI 10.1023/B:NEUR.0000030697.78488.63; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; HARDY R, 1993, J NEUROSCI RES, V36, P121, DOI 10.1002/jnr.490360202; HARDY R, 1991, DEVELOPMENT, V111, P1061; Hunt RC, 1996, J CELL PHYSIOL, V168, P71, DOI 10.1002/(SICI)1097-4652(199607)168:1<71::AID-JCP9>3.0.CO;2-5; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kapojos JJ, 2003, KIDNEY INT, V63, P1681, DOI 10.1046/j.1523-1755.2003.00907.x; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Lees M B, 1984, Prog Clin Biol Res, V146, P257; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Li ZZ, 2000, J NEUROSCI, V20, P4944; LIEM HH, 1975, ACTA HAEMATOL-BASEL, V53, P219; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; MACKLIN WB, 1991, J NEUROCHEM, V56, P163, DOI 10.1111/j.1471-4159.1991.tb02576.x; MADORE N, 1994, J NEUROSCI RES, V39, P186, DOI 10.1002/jnr.490390209; Madore N, 1999, J NEUROCHEM, V72, P708, DOI 10.1046/j.1471-4159.1999.0720708.x; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Roher AE, 2009, BIOMARKERS, V14, P493, DOI 10.3109/13547500903108423; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; SKOFF RP, 1976, NATURE, V264, P560, DOI 10.1038/264560a0; Spiller F, 2011, AM J RESP CRIT CARE, V183, P922, DOI 10.1164/rccm.201002-0223OC; SWERTS JP, 1992, J BIOL CHEM, V267, P10596; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Younes-Rapozo V, 2009, INT J DEV NEUROSCI, V27, P757, DOI 10.1016/j.ijdevneu.2009.08.014; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	49	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20173	10.1371/journal.pone.0020173	http://dx.doi.org/10.1371/journal.pone.0020173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633699	Green Published, gold			2022-12-25	WOS:000291006500035
J	Thaler, L; Arnott, SR; Goodale, MA				Thaler, Lore; Arnott, Stephen R.; Goodale, Melvyn A.			Neural Correlates of Natural Human Echolocation in Early and Late Blind Echolocation Experts	PLOS ONE			English	Article							SENSORY SUBSTITUTION; HUMAN CEREBELLUM; AUDITORY MOTION; CORTEX ACTIVITY; VISUAL-CORTEX; PLASTICITY; PERCEPTION; CONNECTIVITY; RESPONDS; VISION	Background: A small number of blind people are adept at echolocating silent objects simply by producing mouth clicks and listening to the returning echoes. Yet the neural architecture underlying this type of aid-free human echolocation has not been investigated. To tackle this question, we recruited echolocation experts, one early-and one late-blind, and measured functional brain activity in each of them while they listened to their own echolocation sounds. Results: When we compared brain activity for sounds that contained both clicks and the returning echoes with brain activity for control sounds that did not contain the echoes, but were otherwise acoustically matched, we found activity in calcarine cortex in both individuals. Importantly, for the same comparison, we did not observe a difference in activity in auditory cortex. In the early-blind, but not the late-blind participant, we also found that the calcarine activity was greater for echoes reflected from surfaces located in contralateral space. Finally, in both individuals, we found activation in middle temporal and nearby cortical regions when they listened to echoes reflected from moving targets. Conclusions: These findings suggest that processing of click-echoes recruits brain regions typically devoted to vision rather than audition in both early and late blind echolocation experts.	[Thaler, Lore; Goodale, Melvyn A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Arnott, Stephen R.] Rotman Res Inst, Toronto, ON, Canada	Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Baycrest	Thaler, L (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	mgoodale@uwo.ca	Goodale, Melvyn A/M-5907-2013	Goodale, Melvyn A/0000-0001-6748-0561	Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by the Canadian Institutes of Health Research (MAG) and the Ontario Ministry of Research and Innovation (LT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann O, 2010, J NEUROSCI, V30, P4489, DOI 10.1523/JNEUROSCI.5661-09.2010; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beauchamp MS, 2007, J NEUROSCI, V27, P8261, DOI 10.1523/JNEUROSCI.0754-07.2007; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bridge H, 2009, BRAIN, V132, P3467, DOI 10.1093/brain/awp279; Burton H, 2003, J NEUROSCI, V23, P4005; CISELET V, 1982, ARCH INT PHYSIOL BIO, V90, pP47; De Volder AG, 1999, BRAIN RES, V826, P128, DOI 10.1016/S0006-8993(99)01275-5; Dufour A, 2005, EXP BRAIN RES, V165, P515, DOI 10.1007/s00221-005-2329-3; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Glickstein M, 2009, NEUROSCIENCE, V162, P549, DOI 10.1016/j.neuroscience.2009.02.054; Glickstein M, 2011, CORTEX, V47, P59, DOI 10.1016/j.cortex.2009.09.001; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Haarmeier T, 2007, CEREBELLUM, V6, P177, DOI 10.1080/14734220701286187; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; HEYES T, 1984, ELECTRON WIRELESS W, V90, P26; Hughes B, 2001, HUM MOVEMENT SCI, V20, P371, DOI 10.1016/S0167-9457(01)00059-8; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Jones G, 2005, CURR BIOL, V15, pR484, DOI 10.1016/j.cub.2005.06.051; Kay L., 1964, ULTRASONICS, V2, P53, DOI 10.1016/0041-624X(64)90382-8; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; KISH D, 1995, THESIS CALIFORNIA ST; Langers DRM, 2005, NEUROIMAGE, V28, P490, DOI 10.1016/j.neuroimage.2005.06.024; Lepore N, 2010, NEUROIMAGE, V49, P134, DOI 10.1016/j.neuroimage.2009.07.048; Lipschutz B, 2002, NEUROIMAGE, V17, P643, DOI 10.1006/nimg.2002.1184; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Rojas JAM, 2009, ACTA ACUST UNITED AC, V95, P325, DOI 10.3813/AAA.918155; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Noppeney U, 2005, CURR BIOL, V15, pR488, DOI 10.1016/j.cub.2005.06.053; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Saenz M, 2008, J NEUROSCI, V28, P5141, DOI 10.1523/JNEUROSCI.0803-08.2008; SAMUELS ML, 1992, AM STAT, V46, P228, DOI 10.2307/2685222; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Stoffregen TA, 1995, ECOL PSYCHOL, V7, P181; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Talairach J., 1988, COPLANAR STEREOTAXIC; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A	49	145	145	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20162	10.1371/journal.pone.0020162	http://dx.doi.org/10.1371/journal.pone.0020162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21633496	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000291006500033
J	Luedeling, E; Girvetz, EH; Semenov, MA; Brown, PH				Luedeling, Eike; Girvetz, Evan H.; Semenov, Mikhail A.; Brown, Patrick H.			Climate Change Affects Winter Chill for Temperate Fruit and Nut Trees	PLOS ONE			English	Article							PHENOLOGICAL RESPONSE; HYDROGEN CYANAMIDE; DORMANCY BREAKING; DEPENDENCE; RELEASE; PLANTS; LEAF	Background: Temperate fruit and nut trees require adequate winter chill to produce economically viable yields. Global warming has the potential to reduce available winter chill and greatly impact crop yields. Methodology/Principal Findings: We estimated winter chill for two past (1975 and 2000) and 18 future scenarios (mid and end 21st century; 3 Global Climate Models [GCMs]; 3 greenhouse gas emissions [GHG] scenarios). For 4,293 weather stations around the world and GCM projections, Safe Winter Chill (SWC), the amount of winter chill that is exceeded in 90% of all years, was estimated for all scenarios using the "Dynamic Model" and interpolated globally. We found that SWC ranged between 0 and about 170 Chill Portions (CP) for all climate scenarios, but that the global distribution varied across scenarios. Warm regions are likely to experience severe reductions in available winter chill, potentially threatening production there. In contrast, SWC in most temperate growing regions is likely to remain relatively unchanged, and cold regions may even see an increase in SWC. Climate change impacts on SWC differed quantitatively among GCMs and GHG scenarios, with the highest GHG leading to losses up to 40 CP in warm regions, compared to 20 CP for the lowest GHG. Conclusions/Significance: The extent of projected changes in winter chill in many major growing regions of fruits and nuts indicates that growers of these commodities will likely experience problems in the future. Mitigation of climate change through reductions in greenhouse gas emissions can help reduce the impacts, however, adaption to changes will have to occur. To better prepare for likely impacts of climate change, efforts should be undertaken to breed tree cultivars for lower chilling requirements, to develop tools to cope with insufficient winter chill, and to better understand the temperature responses of tree crops.	[Luedeling, Eike] World Agroforestry Ctr ICRAF, Nairobi, Kenya; [Girvetz, Evan H.] Nature Conservancy, Seattle, WA USA; [Semenov, Mikhail A.] Rothamsted Res, Harpenden, Herts, England; [Brown, Patrick H.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	CGIAR; World Agroforestry (ICRAF); Nature Conservancy; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of California System; University of California Davis	Luedeling, E (corresponding author), World Agroforestry Ctr ICRAF, Nairobi, Kenya.	e.luedeling@cgiar.org	Luedeling, Eike/I-3269-2019; Luedeling, Eike/A-5662-2012; Brown, Patrick/E-4085-2012; Semenov, Mikhail/HCI-8667-2022; Semenov, Mikhail/W-8060-2019	Luedeling, Eike/0000-0002-7316-3631; Luedeling, Eike/0000-0002-7316-3631; Brown, Patrick/0000-0001-6857-8608; Semenov, Mikhail/0000-0002-1561-7113; 	Biotechnology and Biological Sciences Research Council of the UK (BBSRC); BBSRC [BBS/E/C/00004938] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004938] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council of the UK (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council of the UK (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan P, 1997, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.1997.444.2; Almorox J, 2005, ENERG CONVERS MANAGE, V46, P1465, DOI 10.1016/j.enconman.2004.07.007; BALANDIER P, 1993, AGR FOREST METEOROL, V67, P95, DOI 10.1016/0168-1923(93)90052-J; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Blanke M, 2009, ERWERBS-OBSTBAU, V51, P101, DOI 10.1007/s10341-009-0086-3; Chandler WH, 1942, DECIDUOUS ORCHARDS; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; *CIA, 2006, CIA WORLD FACTB; DOZIER WA, 1990, HORTSCIENCE, V25, P1573, DOI 10.21273/HORTSCI.25.12.1573; Erez A, 1995, ACTA HORTIC, P81, DOI 10.17660/ActaHortic.1995.395.7; Erez A, 2000, TEMPERATE FRUIT CROPS IN WARM CLIMATES, P17; EREZ A, 1966, PHYSIOL PLANTARUM, V19, P650, DOI 10.1111/j.1399-3054.1966.tb07049.x; Evans N, 2010, FOOD SECUR, V2, P143, DOI 10.1007/s12571-010-0058-3; FAOSTAT, 2009, STAT DAT FOOD AGR OR; FISHMAN S, 1987, J THEOR BIOL, V126, P309, DOI 10.1016/S0022-5193(87)80237-0; FISHMAN S, 1987, J THEOR BIOL, V124, P473, DOI 10.1016/S0022-5193(87)80221-7; GEORGE AP, 1992, AUST J EXP AGR, V32, P89, DOI 10.1071/EA9920089; Girvetz EH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008320; GRIESBACH J., 2007, GROWING TEMPERATE FR; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Knight T. A., 1801, PHILOS T R SOC LOND, V91, P333; Lazzarotto P, 2010, CLIM RES, V41, P221, DOI 10.3354/cr00847; LINVILL DE, 1990, HORTSCIENCE, V25, P14, DOI 10.21273/HORTSCI.25.1.14; Luedeling E, 2011, INT J BIOMETEOROL, V55, P411, DOI 10.1007/s00484-010-0352-y; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; Luedeling E, 2009, AGR FOREST METEOROL, V149, P1854, DOI 10.1016/j.agrformet.2009.06.013; Luedeling E, 2009, ERWERBS-OBSTBAU, V51, P81, DOI 10.1007/s10341-009-0085-4; Luedeling E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006166; Luedeling E, 2009, CLIMATIC CHANGE, V96, P219, DOI 10.1007/s10584-009-9581-7; Luedeling E, 2009, AGR ECOSYST ENVIRON, V133, P23, DOI 10.1016/j.agee.2009.04.016; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Nakicenovic N., 2000, SPECIAL REPORT EMISS; *NCDC, 2008, DAT NAT CLIM DAT CTR; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Petri JL, 2004, ACTA HORTIC, P53, DOI 10.17660/ActaHortic.2004.662.4; RICHARDSON E A, 1974, Hortscience, V9, P331; Ruiz D, 2007, ENVIRON EXP BOT, V61, P254, DOI 10.1016/j.envexpbot.2007.06.008; SAMISH RM, 1954, ANNU REV PLANT PHYS, V5, P183, DOI 10.1146/annurev.pp.05.060154.001151; Saure M. C., 1985, Horticultural Reviews, V7, P239, DOI 10.1002/9781118060735.ch6; SEMENOV MA, CLIMATE RES IN PRESS; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; Semenov MA, 2009, J EXP BOT, V60, P2791, DOI 10.1093/jxb/erp164; Semenov MA, 2009, J R SOC INTERFACE, V6, P343, DOI 10.1098/rsif.2008.0285; Spencer J.W., 1971, SEARCH, V2, P172; Vegis A., 1961, HDB PFLANZENPHYSIOLO, V16, P168; Vennetier M, 2009, FOREST ECOL MANAG, V258, pS56, DOI 10.1016/j.foreco.2009.09.015; Wilks DS, 1999, PROG PHYS GEOG, V23, P329, DOI 10.1177/030913339902300302; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107	48	196	204	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20155	10.1371/journal.pone.0020155	http://dx.doi.org/10.1371/journal.pone.0020155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629649	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800030
J	Siarkou, VI; Stamatakis, A; Kappas, I; Hadweh, P; Laroucau, K				Siarkou, Victoria I.; Stamatakis, Alexandros; Kappas, Ilias; Hadweh, Paul; Laroucau, Karine			Evolutionary Relationships among Chlamydophila abortus Variant Strains Inferred by rRNA Secondary Structure-Based Phylogeny	PLOS ONE			English	Article							HIGHER-ORDER STRUCTURE; MEMBRANE PROTEIN GENE; ET-AL. 1989; CHLAMYDIA-PSITTACI; BINDING-SITE; INCLUSION MORPHOLOGY; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; PROVIDES EVIDENCE; STRUCTURE MODEL	The evolutionary relationships among known Chlamydophila abortus variant strains including the LLG and POS, previously identified as being highly distinct, were investigated based on rRNA secondary structure information. PCR-amplified overlapping fragments of the 16S, 16S-23S intergenic spacer (IS), and 23S domain I rRNAs were subjected to cloning and sequencing. Secondary structure analysis revealed the presence of transitional single nucleotide variations (SNVs), two of which occurred in loops, while seven in stem regions that did not result in compensatory substitutions. Notably, only two SNVs, in 16S and 23S, occurred within evolutionary variable regions. Maximum likelihood and Bayesian phylogeny reconstructions revealed that C. abortus strains could be regarded as representing two distinct lineages, one including the "classical'' C. abortus strains and the other the "LLG/POS variant'', with the type strain B577(T) possibly representing an intermediate of the two lineages. The two C. abortus lineages shared three unique (apomorphic) characters in the 23S domain I and 16S-23S IS, but interestingly lacked synapomorphies in the 16S rRNA. The two lineages could be distinguished on the basis of eight positions; four of these comprised residues that appeared to be signature or unique for the "classical'' lineage, while three were unique for the "LLG/POS variant''. The U277 (E. coli numbering) signature character, corresponding to a highly conserved residue of the 16S molecule, and the unique G681 residue, conserved in a functionally strategic region also of 16S, are the most pronounced attributes (autapomorphies) of the "classical'' and the "LLG/POS variant'' lineages, respectively. Both lineages were found to be descendants of a common ancestor with the Prk/Daruma C. psittaci variant. Compared with the "classical'', the "LLG/POS variant'' lineage has retained more ancestral features. The current rRNA secondary structure-based analysis and phylogenetic inference reveal new insights into how these two C. abortus lineages have differentiated during their evolution.	[Siarkou, Victoria I.] Aristotle Univ Thessaloniki, Lab Microbiol & Infect Dis, Fac Vet Med, GR-54006 Thessaloniki, Greece; [Stamatakis, Alexandros] Heidelberg Inst Theoret Studies, Exelixis Lab, Sci Comp Grp, Heidelberg, Germany; [Kappas, Ilias; Hadweh, Paul] Aristotle Univ Thessaloniki, Dept Genet Dev & Mol Biol, Sch Biol, GR-54006 Thessaloniki, Greece; [Laroucau, Karine] French Agcy Food Environm & Occupat Hlth & Safety, Bacterial Zoonoses Unit, Maisons Alfort, France	Aristotle University of Thessaloniki; Heidelberg Institute for Theoretical Studies; Aristotle University of Thessaloniki; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Siarkou, VI (corresponding author), Aristotle Univ Thessaloniki, Lab Microbiol & Infect Dis, Fac Vet Med, GR-54006 Thessaloniki, Greece.	vickysi@vet.auth.gr	Stamatakis, Alexandros/B-8740-2009; Laroucau, Karine/GSO-1980-2022; Kappas, Ilias/AAB-5286-2021; Kappas, Ilias/H-9973-2013	Stamatakis, Alexandros/0000-0003-0353-0691; Laroucau, Karine/0000-0001-7605-8602; Kappas, Ilias/0000-0002-8564-7035; Hadweh, Paul/0000-0001-8418-9987				Aitken I. D., 2000, Diseases of sheep, P81; ALLMANG C, 1994, NUCLEIC ACIDS RES, V22, P3708, DOI 10.1093/nar/22.18.3708; Anton AI, 1999, J BACTERIOL, V181, P2703; Bouakane A, 2005, VET REC, V157, P771, DOI 10.1136/vr.157.24.771; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Boumedine KS, 1998, RES MICROBIOL, V149, P735, DOI 10.1016/S0923-2508(99)80020-5; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Bush RM, 2001, INT J SYST EVOL MICR, V51, P203, DOI 10.1099/00207713-51-1-203; Cannone Jamie J., 2002, BMC Bioinformatics, V3, P1; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CORMACK RS, 1991, J BIOL CHEM, V266, P18525; DAMMEL CS, 1993, GENE DEV, V7, P660, DOI 10.1101/gad.7.4.660; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Elgavish T, 2001, J MOL BIOL, V310, P735, DOI 10.1006/jmbi.2001.4807; ENGEL JN, 1987, J BACTERIOL, V169, P5678, DOI 10.1128/jb.169.12.5678-5685.1987; Everett KDE, 2000, VET MICROBIOL, V75, P109, DOI 10.1016/S0378-1135(00)00213-3; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Everett KDE, 1997, INT J SYST BACTERIOL, V47, P461, DOI 10.1099/00207713-47-2-461; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P803, DOI 10.1099/00207713-49-2-803; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; GAUTHERET D, 1995, RNA, V1, P807; GRIFFITHS PC, 1992, VET MICROBIOL, V30, P165, DOI 10.1016/0378-1135(92)90111-6; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Gutell RR, 2000, J MOL BIOL, V304, P335, DOI 10.1006/jmbi.2000.4172; HOPFL P, 1989, EUR J BIOCHEM, V185, P355, DOI 10.1111/j.1432-1033.1989.tb15123.x; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kerr K, 2005, RES VET SCI, V78, P1, DOI 10.1016/j.rvsc.2004.08.004; Laroucau K, 2010, VACCINE, V28, P5653, DOI 10.1016/j.vaccine.2010.06.064; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; LUDWIG W, 1994, FEMS MICROBIOL REV, V15, P155, DOI 10.1111/j.1574-6976.1994.tb00132.x; Ludwig W, 2005, BERGEYS MANUAL SYSTE, V2, P49, DOI DOI 10.1007/978-0-387-21609-6_8; MARKEY BK, 1993, VET MICROBIOL, V35, P141, DOI 10.1016/0378-1135(93)90122-N; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; MOUGEL M, 1988, NUCLEIC ACIDS RES, V16, P2825, DOI 10.1093/nar/16.7.2825; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; OLSEN GJ, 1993, FASEB J, V7, P113, DOI 10.1096/fasebj.7.1.8422957; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Peplies J, 2008, SYST APPL MICROBIOL, V31, P251, DOI 10.1016/j.syapm.2008.08.003; Pettersson B, 1997, J BACTERIOL, V179, P4195, DOI 10.1128/jb.179.13.4195-4205.1997; Pettersson B, 2001, INT J SYST EVOL MICR, V51, P633, DOI 10.1099/00207713-51-2-633; Pettersson B, 2000, INT J SYST EVOL MICR, V50, P291, DOI 10.1099/00207713-50-1-291; POWERS T, 1995, RNA, V1, P194; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Ramaswamy P, 2009, J MOL BIOL, V392, P666, DOI 10.1016/j.jmb.2009.07.032; Recht MI, 2004, J MOL BIOL, V344, P395, DOI 10.1016/j.jmb.2004.09.009; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALINAS J, 1995, VET MICROBIOL, V43, P219, DOI 10.1016/0378-1135(94)00100-B; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Siarkou V, 2002, VET MICROBIOL, V85, P145, DOI 10.1016/S0378-1135(01)00506-5; Smit S, 2007, NUCLEIC ACIDS RES, V35, P3339, DOI 10.1093/nar/gkm101; Smith TF, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-16; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1986, J MOL BIOL, V192, P101, DOI 10.1016/0022-2836(86)90467-5; STERN S, 1988, J MOL BIOL, V201, P683, DOI 10.1016/0022-2836(88)90467-6; STERN S, 1988, J MOL BIOL, V200, P291, DOI 10.1016/0022-2836(88)90241-0; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Van Loock M, 2003, INT J SYST EVOL MICR, V53, P761, DOI 10.1099/ijs.0.02329-0; VANCAMP G, 1993, CURR MICROBIOL, V27, P147, DOI 10.1007/BF01576012; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Vretou E, 2001, INFECT IMMUN, V69, P607, DOI 10.1128/IAI.69.1.607-612.2001; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Young JM, 2000, INT J SYST EVOL MICR, V50, P1687, DOI 10.1099/00207713-50-4-1687; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	78	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19813	10.1371/journal.pone.0019813	http://dx.doi.org/10.1371/journal.pone.0019813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629695	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005800011
J	Andonian, K; Hierro, JL; Khetsuriani, L; Becerra, P; Janoyan, G; Villarreal, D; Cavieres, L; Fox, LR; Callaway, RM				Andonian, Krikor; Hierro, Jose L.; Khetsuriani, Liana; Becerra, Pablo; Janoyan, Grigor; Villarreal, Diego; Cavieres, Lohengrin; Fox, Laurel R.; Callaway, Ragan M.			Range-Expanding Populations of a Globally Introduced Weed Experience Negative Plant-Soil Feedbacks	PLOS ONE			English	Article							STARTHISTLE CENTAUREA-SOLSTITIALIS; INVASIVE TREE; RELEASE; BIOTA; PATHOGENS; EXPLAIN; ACCUMULATION; DIVERSITY; SUCCESS; FITNESS	Background: Biological invasions are fundamentally biogeographic processes that occur over large spatial scales. Interactions with soil microbes can have strong impacts on plant invasions, but how these interactions vary among areas where introduced species are highly invasive vs. naturalized is still unknown. In this study, we examined biogeographic variation in plant-soil microbe interactions of a globally invasive weed, Centaurea solstitialis (yellow starthistle). We addressed the following questions (1) Is Centaurea released from natural enemy pressure from soil microbes in introduced regions? and (2) Is variation in plant-soil feedbacks associated with variation in Centaurea's invasive success? Methodology/Principal Findings: We conducted greenhouse experiments using soils and seeds collected from native Eurasian populations and introduced populations spanning North and South America where Centaurea is highly invasive and noninvasive. Soil microbes had pervasive negative effects in all regions, although the magnitude of their effect varied among regions. These patterns were not unequivocally congruent with the enemy release hypothesis. Surprisingly, we also found that Centaurea generated strong negative feedbacks in regions where it is the most invasive, while it generated neutral plant-soil feedbacks where it is noninvasive. Conclusions/Significance: Recent studies have found reduced below-ground enemy attack and more positive plant-soil feedbacks in range-expanding plant populations, but we found increased negative effects of soil microbes in range-expanding Centaurea populations. While such negative feedbacks may limit the long-term persistence of invasive plants, such feedbacks may also contribute to the success of invasions, either by having disproportionately negative impacts on competing species, or by yielding relatively better growth in uncolonized areas that would encourage lateral spread. Enemy release from soil-borne pathogens is not sufficient to explain the success of this weed in such different regions. The biogeographic variation in soil-microbe effects indicates that different mechanisms may operate on this species in different regions, thus establishing geographic mosaics of species interactions that contribute to variation in invasion success.	[Andonian, Krikor; Fox, Laurel R.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hierro, Jose L.; Villarreal, Diego] Univ Nacl La Pampa, Fac Ciencias Exactas & Nat, Santa Rosa, Argentina; [Hierro, Jose L.] Consejo Nacl Invest Cient & Tecn, La Pampa, Santa Rosa, Argentina; [Khetsuriani, Liana] Georgian Acad Sci, Inst Bot, GE-380060 Tbilisi, Georgia; [Becerra, Pablo] Catholic Univ Chile, Fac Agron & Ingn Forestal, Dept Ecosistemas & Medio Ambiente, Santiago, Chile; [Janoyan, Grigor] Amer Univ Armenia, Acopian Ctr Environm, Yerevan, Armenia; [Cavieres, Lohengrin] Univ Concepcion, Dept Bot, Concepcion, Chile; [Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of California System; University of California Santa Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National Academy of Sciences of Georgia; Pontificia Universidad Catolica de Chile; American University of Armenia; Universidad de Concepcion; University of Montana System; University of Montana	Andonian, K (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	andonian@biology.ucsc.edu	Cavieres, Lohengrin/A-9542-2010	Cavieres, Lohengrin/0000-0001-9122-3020	U.S. Fulbright Student Fellowship; STEPS; Langenheim Plant Ecology Fellowship; CRDF [GEB1-2833]; NSF; Andrew W. Mellon Foundation; DoD SERDP; University of Montana; Rocky Mountain Research Station; CONICET; Institute of Ecology and Biodiversity [ICM P05-002]	U.S. Fulbright Student Fellowship; STEPS; Langenheim Plant Ecology Fellowship; CRDF; NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation; DoD SERDP; University of Montana; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute of Ecology and Biodiversity	This research was funded by a U.S. Fulbright Student Fellowship, a STEPS Institute Graduate Student Fellowship, and a Langenheim Plant Ecology Fellowship to K.A., CRDF grant #GEB1-2833 to R.M.C. and J.L.H. Additional support was provided from NSF, the Andrew W. Mellon Foundation, DoD SERDP, the University of Montana Sponsored Research Office, and the Rocky Mountain Research Station to R. M. C., from CONICET to J.L.H., and from the Institute of Ecology and Biodiversity (ICM P05-002) to P.B. and L.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilasha D, 2009, J PLANT ECOL, V2, P77, DOI 10.1093/jpe/rtp008; Andonian K, 2011, BIOL INVASIONS, V13, P2957, DOI 10.1007/s10530-011-9978-x; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Beckstead J, 2003, ECOLOGY, V84, P2824, DOI 10.1890/02-0517; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Brandt AJ, 2009, ECOLOGY, V90, P1063, DOI 10.1890/08-0054.1; Callaway RM, 2006, BIOL INVASIONS, V8, P1389, DOI 10.1007/s10530-006-0003-8; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; ELTON CS, 1958, ECOLOGY INVASIONS PL; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Eppinga MB, 2006, OIKOS, V114, P168, DOI 10.1111/j.2006.0030-1299.14625.x; Gerlach JD, 1997, P CALIF WEED SCI SOC, V49, P136; Grosholz ED, 2003, ECOL LETT, V6, P700, DOI 10.1046/j.1461-0248.2003.00495.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hierro JL, 2006, AM NAT, V168, P144, DOI 10.1086/505767; Hierro JL, 2009, OIKOS, V118, P529, DOI [10.1111/j.1600-0706.2009.17283.x, 10.1111/j.1600-0706.2008.17283.x]; Hijano E., 1995, ALFALFA ARGENTINA; Ji BM, 2010, ECOLOGY, V91, P3037, DOI 10.1890/09-1451.1; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; KULMATISKI A, 2008, ECOL LETT, P980; Lambrinos JG, 2002, ECOLOGY, V83, P518, DOI 10.1890/0012-9658(2002)083[0518:TVISOC]2.0.CO;2; MADDOX DM, 1985, WEED SCI, V33, P315, DOI 10.1017/S0043174500082357; MADDOX MD, 1981, ARRW20 USDA ARS; Mangla S, 2008, J ECOL, V96, P58, DOI 10.1111/j.1365-2745.2007.01312.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Nijjer S, 2007, P ROY SOC B-BIOL SCI, V274, P2621, DOI 10.1098/rspb.2007.0804; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pitcairn M. J., 2006, California Agriculture, V60, P83, DOI 10.3733/ca.v060n02p83; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Reinhart KO, 2004, ECOL APPL, V14, P1737, DOI 10.1890/03-5204; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Shea K, 2005, ECOLOGY, V86, P3174, DOI 10.1890/05-0195; Siemann E, 2001, ECOL LETT, V4, P514, DOI 10.1046/j.1461-0248.2001.00274.x; Springer YP, 2009, ECOLOGY, V90, P1852, DOI 10.1890/08-0740.1; Swope SM, 2010, ECOLOGY, V91, P2284, DOI 10.1890/09-0855.1; te Beest M, 2009, J ECOL, V97, P1281, DOI 10.1111/j.1365-2745.2009.01574.x; Thompson J. N., 2005, INTERSPEC INTERACT; Uygur S, 2004, WEED SCI, V52, P746, DOI 10.1614/WS-03-150R1; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van Kleunen M, 2009, J ECOL, V97, P385, DOI 10.1111/j.1365-2745.2009.01483.x; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	52	37	37	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20117	10.1371/journal.pone.0020117	http://dx.doi.org/10.1371/journal.pone.0020117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629781	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200035
J	Bryan, SJ; Burroughs, NJ; Evered, C; Sacharz, J; Nenninger, A; Mullineaux, CW; Spence, EM				Bryan, Samantha J.; Burroughs, Nigel J.; Evered, Carol; Sacharz, Joanna; Nenninger, Anja; Mullineaux, Conrad W.; Spence, Edward M.			Loss of the SPHF Homologue Slr1768 Leads to a Catastrophic Failure in the Maintenance of Thylakoid Membranes in Synechocystis sp PCC 6803	PLOS ONE			English	Article							ESCHERICHIA-COLI; SP PCC-6803; ARABIDOPSIS-THALIANA; DELETION MUTANT; PLASMA-MEMBRANE; NUCLEAR GENE; BIOGENESIS; PROTEINS; CYANOBACTERIA; ALBINO3	Background: In cyanobacteria the photosystems are localised to, and maintained in, specialist membranes called the thylakoids. The mechanism driving the biogenesis of the thylakoid membranes is still an open question, with only two potential biogenesis factors, Vipp1 and Alb3 currently identified. Methodology/Principal Findings: We generated a slr1768 knockout using the pGEM T-easy vector and REDIRECT. By comparing growth and pigment content (chlorophyll a fluoresence) of the Delta slr1768 mutant with the wild-type, we found that Dslr1768 has a conditional phenotype; specifically under high light conditions (130 mu mol m(-2) s(-1)) thylakoid biogenesis is disrupted leading to cell death on a scale of days. The thylakoids show considerable disruption, with loss of both structure and density, while chlorophyll a density decreases with the loss of thylakoids, although photosynthetic efficiency is unaffected. Under low light (30 mu mol m(-2) s(-1)) the phenotype is significantly reduced, with a growth rate similar to the wildtype and only a low frequency of cells with evident thylakoid disruption. Conclusions/Significance: This is the first example of a gene that affects the maintenance of the thylakoid membranes specifically under high light, and which displays a phenotype dependent on light intensity. Our results demonstrate that Slr1768 has a leading role in acclimatisation, linking light damage with maintenance of the thylakoids.	[Bryan, Samantha J.; Sacharz, Joanna; Nenninger, Anja; Mullineaux, Conrad W.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Burroughs, Nigel J.] Univ Warwick, Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Evered, Carol] Warwick HRI, Wellesbourne, Warwick, England; [Spence, Edward M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of London; Queen Mary University London; University of Warwick; University of Warwick	Bryan, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	edward.spence@kcl.ac.uk			University of Warwick; BBSRC [BB/G021856/1]; Biotechnology and Biological Sciences Research Council [BB/G021856/1] Funding Source: researchfish	University of Warwick; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	University of Warwick (www2.warwick.ac.uk), BBSRC grant no. BB/G021856/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Aseeva E, 2007, PLANT PHYSIOL BIOCH, V45, P119, DOI 10.1016/j.plaphy.2007.01.005; BELFORT M, 1973, J BACTERIOL, V115, P299, DOI 10.1128/JB.115.1.299-306.1973; Bellafiore S, 2002, PLANT CELL, V14, P2303, DOI 10.1105/tpc.003442; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; CHENG HH, 1988, P NATL ACAD SCI USA, V85, P7882, DOI 10.1073/pnas.85.21.7882; Fuhrmann E, 2009, PLANT PHYSIOL, V149, P735, DOI 10.1104/pp.108.132373; GAUTSCH JW, 1974, GENETICS, V77, P435; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gerdes L, 2006, J BIOL CHEM, V281, P16632, DOI 10.1074/jbc.M513623200; GOLDEN SS, 1988, METHOD ENZYMOL, V167, P714; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2002, STREPTOMYCES COELICO; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; HINTERSTOISSER B, 1993, J PLANT PHYSIOL, V142, P407, DOI 10.1016/S0176-1617(11)81245-9; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; MacKinney G, 1941, J BIOL CHEM, V140, P315; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mullineaux CW, 1999, AUST J PLANT PHYSIOL, V26, P671, DOI 10.1071/PP99027; Nickelsen J, 2011, FEMS MICROBIOL LETT, V315, P1, DOI 10.1111/j.1574-6968.2010.02096.x; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Vothknecht UC, 2001, BBA-MOL CELL RES, V1541, P91, DOI 10.1016/S0167-4889(01)00153-7; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898	39	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19625	10.1371/journal.pone.0019625	http://dx.doi.org/10.1371/journal.pone.0019625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625427	Green Published, gold			2022-12-25	WOS:000291005200006
J	Malhotra, S; Lapointe, J; Salari, K; Higgins, JP; Ferrari, M; Montgomery, K; van de Rijn, M; Brooks, JD; Pollack, JR				Malhotra, Sameer; Lapointe, Jacques; Salari, Keyan; Higgins, John P.; Ferrari, Michelle; Montgomery, Kelli; van de Rijn, Matt; Brooks, James D.; Pollack, Jonathan R.			A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; TOPOISOMERASE-II-ALPHA; BREAST-CANCER; RADICAL PROSTATECTOMY; RB/E2F PATHWAY; CELL-CYCLE; BIOMARKERS; SURVIVAL; KI-67; KI67	Prostate cancer exhibits tremendous variability in clinical behavior, ranging from indolent to lethal disease. Better prognostic markers are needed to stratify patients for appropriately aggressive therapy. By expression profiling, we can identify a proliferation signature variably expressed in prostate cancers. Here, we asked whether one or more tissue biomarkers might capture that information, and provide prognostic utility. We assayed three proliferation signature genes: MKI67 (Ki-67; also a classic proliferation biomarker), TOP2A (DNA topoisomerase II, alpha), and E2F1 (E2F transcription factor 1). Immunohistochemical staining was evaluable on 139 radical prostatectomy cases (in tissue microarray format), with a median clinical follow-up of eight years. Each of the three proliferation markers was by itself prognostic. Notably, combining the three markers together as a "proliferation index" (0 or 1, vs. 2 or 3 positive markers) provided superior prognostic performance (hazard ratio = 2.6 (95% CI: 1.4-4.9); P = 0.001). In a multivariate analysis that included preoperative serum prostate specific antigen (PSA) levels, Gleason grade and pathologic tumor stage, the composite proliferation index remained a significant predictor (P = 0.005). Analysis of receiver-operating characteristic (ROC) curves confirmed the improved prognostication afforded by incorporating the proliferation index (compared to the clinicopathologic data alone). Our findings highlight the potential value of a multi-gene signature-based diagnostic, and define a tri-marker proliferation index with possible utility for improved prognostication and treatment stratification in prostate cancer.	[Malhotra, Sameer; Ferrari, Michelle; Brooks, James D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Lapointe, Jacques] McGill Univ, Dept Surg, Div Urol, Montreal, PQ H3A 2T5, Canada; [Salari, Keyan; Higgins, John P.; Montgomery, Kelli; van de Rijn, Matt; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Salari, Keyan] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; McGill University; Stanford University; Stanford University	Malhotra, S (corresponding author), Stanford Univ, Dept Urol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu; pollack1@stanford.edu		van de Rijn, Matt/0000-0002-1909-9739	National Institutes of Health [CA111782, CA122246]; CTSA [UL1 RR025744]; Burroughs Wellcome Fund [1007519]; NATIONAL CANCER INSTITUTE [R01CA111782, R01CA122246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health: CA111782 (JDB), CA122246 (JRP), CTSA grant UL1 RR025744 (Stanford Spectrum); and from the Burroughs Wellcome Fund: #1007519 (JRP, JDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian PJ, 2009, EUR UROL, V55, P1321, DOI 10.1016/j.eururo.2009.02.028; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brustmann H, 2004, GYNECOL ONCOL, V95, P16, DOI 10.1016/j.ygyno.2004.07.040; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Cowen D, 2002, CLIN CANCER RES, V8, P1148; D'Amico AV, 2005, J CLIN ONCOL, V23, P4975, DOI 10.1200/JCO.2005.08.904; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Gerdes J, 1990, Semin Cancer Biol, V1, P199; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Gunia S, 2008, WORLD J UROL, V26, P243, DOI 10.1007/s00345-008-0257-0; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Hartmann EM, 2009, FUTURE ONCOL, V5, P63, DOI 10.2217/14796694.5.1.63; Inoue T, 2005, UROLOGY, V66, P332, DOI 10.1016/j.urology.2005.02.028; Jamali M, 2008, ENDOCR PATHOL, V19, P282, DOI 10.1007/s12022-008-9044-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; Keshgegian AA, 1998, AM J CLIN PATHOL, V110, P443; Kosari F, 2008, CLIN CANCER RES, V14, P1734, DOI 10.1158/1078-0432.CCR-07-1494; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lowrance William T, 2009, Rev Urol, V11, P117; Mazhar D, 2008, NAT CLIN PRACT UROL, V5, P486, DOI 10.1038/ncpuro1204; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; O'Connor JK, 2006, INT J RADIAT ONCOL, V65, P1411, DOI 10.1016/j.ijrobp.2006.02.045; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Shariat SF, 2008, CURR OPIN UROL, V18, P279, DOI 10.1097/MOU.0b013e3282f9b3e5; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WATT PM, 1994, BIOCHEM J, V303, P681, DOI 10.1042/bj3030681; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174	51	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20293	10.1371/journal.pone.0020293	http://dx.doi.org/10.1371/journal.pone.0020293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629784	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200049
J	Pignatelli, M; Moya, A				Pignatelli, Miguel; Moya, Andres			Evaluating the Fidelity of De Novo Short Read Metagenomic Assembly Using Simulated Data	PLOS ONE			English	Article							SHORT DNA-SEQUENCES; PHYLOGENETIC CLASSIFICATION; TAXONOMIC CLASSIFICATION; DATA SETS; COMMUNITY; GENOMES; RESOURCE; MILLIONS; ARACHNE	A frequent step in metagenomic data analysis comprises the assembly of the sequenced reads. Many assembly tools have been published in the last years targeting data coming from next-generation sequencing (NGS) technologies but these assemblers have not been designed for or tested in multi-genome scenarios that characterize metagenomic studies. Here we provide a critical assessment of current de novo short reads assembly tools in multi-genome scenarios using complex simulated metagenomic data. With this approach we tested the fidelity of different assemblers in metagenomic studies demonstrating that even under the simplest compositions the number of chimeric contigs involving different species is noticeable. We further showed that the assembly process reduces the accuracy of the functional classification of the metagenomic data and that these errors can be overcome raising the coverage of the studied metagenome. The results presented here highlight the particular difficulties that de novo genome assemblers face in multi-genome scenarios demonstrating that these difficulties, that often compromise the functional classification of the analyzed data, can be overcome with a high sequencing effort.	[Pignatelli, Miguel; Moya, Andres] UVEG Inst Cavanilles, Ctr Super Invest Salut Publ, Unitat Mixta Invest Genom & Salut, Valencia, Spain; [Pignatelli, Miguel; Moya, Andres] CIBERESP, Barcelona, Spain; [Pignatelli, Miguel] European Bioinformat Inst, Hinxton, England	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; European Molecular Biology Laboratory (EMBL)	Pignatelli, M (corresponding author), UVEG Inst Cavanilles, Ctr Super Invest Salut Publ, Unitat Mixta Invest Genom & Salut, Valencia, Spain.	mp@ebi.ac.uk	Moya, Andrés/A-8190-2008	Moya, Andrés/0000-0002-2867-1119	Ministerio de Ciencia y Educacion, Spain [SAF2009-13032-C02-01]; Generalitat Valenciana, Spain [Prometeo/2009/092]; CIBER of Epidemiology and Public Health (CIBERESP, Ministerio de Ciencia e Innovacion, Spain)	Ministerio de Ciencia y Educacion, Spain(Spanish Government); Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); CIBER of Epidemiology and Public Health (CIBERESP, Ministerio de Ciencia e Innovacion, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been funded by grants SAF2009-13032-C02-01 from Ministerio de Ciencia y Educacion, Spain, as well as Prometeo/2009/092 from Generalitat Valenciana, Spain. M.P. is the recipient of a contract from the CIBER of Epidemiology and Public Health (CIBERESP, Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; CHARUVAKA A, 2010, EVALUATION SHORT REA; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; HUANG X, 2005, CURR PROTOC BIOINFOR, pCH11; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Laserson J, 2011, J COMPUT BIOL, V18, P429, DOI 10.1089/cmb.2010.0244; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; SUTTON GG, 1995, GENOME SCI TECHNOLOG, V1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Ye Yuzhen, 2009, Journal of Bioinformatics and Computational Biology, V7, P455, DOI 10.1142/S0219720009004151; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19984	10.1371/journal.pone.0019984	http://dx.doi.org/10.1371/journal.pone.0019984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625384	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200022
J	Yang, QS; He, H; Li, HY; Tian, H; Zhang, JJ; Zhai, LG; Chen, JD; Wu, H; Yi, GJ; He, ZH; Peng, XX				Yang, Qiaosong; He, Han; Li, Heying; Tian, Hua; Zhang, Jianjun; Zhai, Liguang; Chen, Jiandong; Wu, Hong; Yi, Ganjun; He, Zheng-Hui; Peng, Xinxiang			NOA1 Functions in a Temperature-Dependent Manner to Regulate Chlorophyll Biosynthesis and Rubisco Formation in Rice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ARABIDOPSIS-THALIANA; ORYZA-SATIVA; RNA-BINDING; MUTANT; IDENTIFICATION; LIGHT; PORB; PROTOCHLOROPHYLLIDE; TRANSCRIPTION	NITRIC OXIDE-ASSOCIATED1 (NOA1) encodes a circularly permuted GTPase (cGTPase) known to be essential for ribosome assembly in plants. While the reduced chlorophyll and Rubisco phenotypes were formerly noticed in both NOA1-supressed rice and Arabidopsis, a detailed insight is still necessary. In this study, by using RNAi transgenic rice, we further demonstrate that NOA1 functions in a temperature-dependent manner to regulate chlorophyll and Rubisco levels. When plants were grown at 30 degrees C, the chlorophyll and Rubisco levels in OsNOA1-silenced plants were only slightly lower than those in WT. However, at 22 degrees C, the silenced plants accumulated far less chlorophyll and Rubisco than WT. It was further revealed that the regulation of chlorophyll and Rubisco occurs at the anabolic level. Etiolated WT seedlings restored chlorophyll and Rubisco accumulations readily once returned to light, at either 30 degrees C or 15 degrees C. Etiolated OsNOA1-silenced plants accumulated chlorophyll and Rubisco to normal levels only at 30 degrees C, and lost this ability at low temperature. On the other hand, de-etiolated OsNOA1-silenced seedlings maintained similar levels of chlorophyll and Rubisco as WT, even after being shifted to 15 degrees C for various times. Further expression analyses identified several candidate genes, including OsPorA (NADPH: protochlorophyllide oxidoreductase A), OsrbcL (Rubisco large subunit), OsRALyase (Ribosomal RNA apurinic site specific lyase) and OsPuf4 (RNA-binding protein of the Puf family), which may be involved in OsNOA1-regulated chlorophyll biosynthesis and Rubisco formation. Overall, our results suggest OsNOA1 functions in a temperature-dependent manner to regulate chlorophyll biosynthesis, Rubisco formation and plastid development in rice.	[Yang, Qiaosong; He, Han; Li, Heying; Zhang, Jianjun; Zhai, Liguang; Chen, Jiandong; Wu, Hong; Peng, Xinxiang] S China Agr Univ, Educ Dept Guangdong Prov, Key Lab Plant Funct Genom & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Yang, Qiaosong; Yi, Ganjun] Guangdong Acad Agr Sci, Inst Fruit Tree Res, Guangzhou, Guangdong, Peoples R China; [Tian, Hua] S China Agr Univ, Coll Agr, Guangzhou, Guangdong, Peoples R China; [He, Zheng-Hui] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	South China Agricultural University; Guangdong Academy of Agricultural Sciences; South China Agricultural University; California State University System; San Francisco State University	Peng, XX (corresponding author), S China Agr Univ, Educ Dept Guangdong Prov, Key Lab Plant Funct Genom & Biotechnol, Guangzhou, Guangdong, Peoples R China.	xpeng@scau.edu.cn	Yang, Qiaosong/AAX-4986-2020	He, Zheng-Hui/0000-0002-0075-4983	National Natural Science Foundation of China [30870184, 30971710]; Post-doctoral Science Foundation of China [200801256]; National Basic Research Program of China [2009CB118504]; National Institutes of Health [S06 GM52588]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM052588] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Post-doctoral Science Foundation of China(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (30870184, 30971710, http://www.nsfc.gov.cn), Post-doctoral Science Foundation of China (200801256, http://www.chinapostdoctor.org.cn) and National Basic Research Program of China (2009CB118504, http://www.973.gov.cn). This work was also partially supported by the National Institutes of Health (SCORE award no. S06 GM52588) to Z.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; An SJ, 2011, THEOR APPL GENET, V122, P459, DOI 10.1007/s00122-010-1460-0; Anand B, 2006, NUCLEIC ACIDS RES, V34, P2196, DOI 10.1093/nar/gkl178; Araki N, 2000, PHYSIOL PLANTARUM, V108, P19, DOI 10.1034/j.1399-3054.2000.108001019x./; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; BEVINS MA, 1993, PLANT PHYSIOL, V103, P1123, DOI 10.1104/pp.103.4.1123; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Cui JX, 2011, PLANT CELL ENVIRON, V34, P347, DOI 10.1111/j.1365-3040.2010.02248.x; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Ito Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2727, DOI 10.1271/bbb.66.2727; Koeda S, 2009, J PLANT RES, V122, P623, DOI 10.1007/s10265-009-0250-8; Kolbert Z, 2008, J PLANT PHYSIOL, V165, P967, DOI 10.1016/j.jplph.2007.07.019; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu HJ, 2010, NEW PHYTOL, V187, P83, DOI 10.1111/j.1469-8137.2010.03264.x; Liu WZ, 2007, PLANTA, V226, P785, DOI 10.1007/s00425-007-0525-z; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Nakano R, 2006, PLANT CELL PHYSIOL, V47, P270, DOI 10.1093/pcp/pci245; Nishiyama I., 1977, Agriculture and Horticulture (Nogyo oyobi Engei), V52, P1480; NISHIYAMA I, 1977, AGR HORTIC, V53, P30; NISHIYAMA I, 1977, AGR HORTIC, V52, P1353; NISHIYAMA I, 1977, AGR HORTIC, V53, P263; Ogasawara T, 1999, EMBO J, V18, P6522, DOI 10.1093/emboj/18.22.6522; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Philippar K, 2007, P NATL ACAD SCI USA, V104, P678, DOI 10.1073/pnas.0610062104; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Samuelsen AI, 1997, PLANTA, V201, P303, DOI 10.1007/s004250050071; Schoefs B, 1999, PHOTOSYNTHETICA, V36, P481, DOI 10.1023/A:1007002101856; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tamaki H, 2009, PLANT J, V57, P1027, DOI 10.1111/j.1365-313X.2008.03750.x; Tun NN, 2008, NEW PHYTOL, V178, P515, DOI 10.1111/j.1469-8137.2008.02383.x; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996; Zhou YH, 2007, ANN BOT-LONDON, V100, P839, DOI 10.1093/aob/mcm181; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	49	24	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20015	10.1371/journal.pone.0020015	http://dx.doi.org/10.1371/journal.pone.0020015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625436	gold, Green Published, Green Submitted			2022-12-25	WOS:000291005200024
J	Zhou, GF; Afrane, YA; Vardo-Zalik, AM; Atieli, H; Zhong, DB; Wamae, P; Himeidan, YE; Minakawa, N; Githeko, AK; Yan, GY				Zhou, Guofa; Afrane, Yaw A.; Vardo-Zalik, Anne M.; Atieli, Harrysone; Zhong, Daibin; Wamae, Peter; Himeidan, Yousif E.; Minakawa, Noboru; Githeko, Andrew K.; Yan, Guiyun			Changing Patterns of Malaria Epidemiology between 2002 and 2010 in Western Kenya: The Fall and Rise of Malaria	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ANOPHELES-GAMBIAE; TRANSMISSION; COVERAGE; ELIMINATION; IMPACT; VARIABILITY; ARABIENSIS; MANAGEMENT; MORTALITY	Background: The impact of insecticide treated nets (ITNs) on reducing malaria incidence is shown mainly through data collection from health facilities. Routine evaluation of long-term epidemiological and entomological dynamics is currently unavailable. In Kenya, new policies supporting the provision of free ITNs were implemented nationwide in June 2006. To evaluate the impacts of ITNs on malaria transmission, we conducted monthly surveys in three sentinel sites with different transmission intensities in western Kenya from 2002 to 2010. Methods and Findings: Longitudinal samplings of malaria parasite prevalence in asymptomatic school children and vector abundance in randomly selected houses were undertaken monthly from February 2002. ITN ownership and usage surveys were conducted annually from 2004 to 2010. Asymptomatic malaria parasite prevalence and vector abundances gradually decreased in all three sites from 2002 to 2006, and parasite prevalence reached its lowest level from late 2006 to early 2007. The abundance of the major malaria vectors, Anopheles funestus and An. gambiae, increased about 5-10 folds in all study sites after 2007. However, the resurgence of vectors was highly variable between sites and species. By 2010, asymptomatic parasite prevalence in Kombewa had resurged to levels recorded in 2004/2005, but the resurgence was smaller in magnitude in the other sites. Household ITN ownership was at 50-70% in 2009, but the functional and effective bed net coverage in the population was estimated at 40.3%, 49.4% and 28.2% in 2010 in Iguhu, Kombewa, and Marani, respectively. Conclusion: The resurgence in parasite prevalence and malaria vectors has been observed in two out of three sentinel sites in western Kenya despite a high ownership of ITNs. The likely factors contributing to malaria resurgence include reduced efficacy of ITNs, insecticide resistance in mosquitoes and lack of proper use of ITNs. These factors should be targeted to avoid further resurgence of malaria transmission.	[Zhou, Guofa; Vardo-Zalik, Anne M.; Zhong, Daibin; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA; [Afrane, Yaw A.; Atieli, Harrysone; Wamae, Peter; Himeidan, Yousif E.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Climate & Human Hlth Res Unit, Kisumu, Kenya; [Minakawa, Noboru] Nagasaki Univ, Inst Trop Med, Dept Med Entomol, Nagasaki 852, Japan	University of California System; University of California Irvine; Kenya Medical Research Institute; Nagasaki University	Zhou, GF (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA.	zhoug@uci.edu	Zhong, Daibin/GRF-0564-2022	, Noboru/0000-0003-3664-9605	National Institute of Health [D43 TW01505, R01 A1050243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was funded by the National Institute of Health (D43 TW01505 and R01 A1050243). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2009, AM J TROP MED HYG, V81, P195; [Anonymous], 2009, LANCET, V374, P266, DOI 10.1016/S0140-6736(09)61346-5; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2005, GUIDELINES LAB FIELD; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 2008, GLOB MAL CONTR EL RE; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brooker S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-231; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chaves LF, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-100; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; GILLIES MT, 1987, 55 S AFR I MED RES; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; Githinji S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-250; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; GREENWOOD B, 2009, T ROY SOC TROP MED H, V103, P2; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hamilton J.D., 2020, TIME SERIES ANAL, DOI 10.2307/j.ctv14jx6sm; Hsiang MS, 2010, LANCET, V375, P1586, DOI 10.1016/S0140-6736(10)60350-9; Kamau L, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.1101; Knols BGJ, 2010, AM J TROP MED HYG, V82, P174, DOI 10.4269/ajtmh.2010.09-0787; Kouyate B, 2007, PLOS MED, V4, P997, DOI 10.1371/journal.pmed.0040127; Lengeler C, 2007, LANCET, V370, P1009, DOI 10.1016/S0140-6736(07)61454-8; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Mathenge EM, 2001, J MED ENTOMOL, V38, P531, DOI 10.1603/0022-2585-38.4.531; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Maxwell CA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-44; Minakawa N, 2002, J MED ENTOMOL, V39, P833, DOI 10.1603/0022-2585-39.6.833; Muller O, 2009, LANCET, V373, P122, DOI 10.1016/S0140-6736(09)60033-7; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-209; Shah NK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000312; Slutsker L, 2009, LANCET, V373, P11, DOI 10.1016/S0140-6736(08)61597-4; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Whitty CJM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S7; *WHO, 1975, 13 WHO; WHO, 2009, WHOHTMNTDWHOPES20095; *WHO, 2009, RBMEXD2009STATE2 WHO; WHO GMP, 2005, INS TREAT MOSQ NETS; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	60	88	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20318	10.1371/journal.pone.0020318	http://dx.doi.org/10.1371/journal.pone.0020318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629783	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200054
J	Monsey, MS; Ota, KT; Akingbade, IF; Hong, ES; Schafe, GE				Monsey, Melissa S.; Ota, Kristie T.; Akingbade, Irene F.; Hong, Ellie S.; Schafe, Glenn E.			Epigenetic Alterations Are Critical for Fear Memory Consolidation and Synaptic Plasticity in the Lateral Amygdala	PLOS ONE			English	Article							LONG-TERM-MEMORY; DNA METHYLATION; HISTONE ACETYLATION; CONDITIONED FEAR; ERK/MAP KINASE; MECHANISMS; ACQUISITION; ACTIVATION; TRANSCRIPTION; POTENTIATION	Epigenetic mechanisms, including histone acetylation and DNA methylation, have been widely implicated in hippocampal-dependent learning paradigms. Here, we have examined the role of epigenetic alterations in amygdala-dependent auditory Pavlovian fear conditioning and associated synaptic plasticity in the lateral nucleus of the amygdala (LA) in the rat. Using Western blotting, we first show that auditory fear conditioning is associated with an increase in histone H3 acetylation and DNMT3A expression in the LA, and that training-related alterations in histone acetylation and DNMT3A expression in the LA are downstream of ERK/MAPK signaling. Next, we show that intra-LA infusion of the histone deacetylase (HDAC) inhibitor TSA increases H3 acetylation and enhances fear memory consolidation; that is, long-term memory (LTM) is enhanced, while short-term memory (STM) is unaffected. Conversely, intra-LA infusion of the DNA methyltransferase (DNMT) inhibitor 5-AZA impairs fear memory consolidation. Further, intra-LA infusion of 5-AZA was observed to impair training-related increases in H3 acetylation, and pre-treatment with TSA was observed to rescue the memory consolidation deficit induced by 5-AZA. In our final series of experiments, we show that bath application of either 5-AZA or TSA to amygdala slices results in significant impairment or enhancement, respectively, of long-term potentiation (LTP) at both thalamic and cortical inputs to the LA. Further, the deficit in LTP following treatment with 5-AZA was observed to be rescued at both inputs by co-application of TSA. Collectively, these findings provide strong support that histone acetylation and DNA methylation work in concert to regulate memory consolidation of auditory fear conditioning and associated synaptic plasticity in the LA.	[Monsey, Melissa S.; Ota, Kristie T.; Akingbade, Irene F.; Hong, Ellie S.; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	Yale University; Yale University	Monsey, MS (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	glenn.schafe@yale.edu			National Institutes of Health [MH 073949]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health Grant MH 073949 (to GES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; CHAPMAN PF, 1990, SYNAPSE, V6, P271, DOI 10.1002/syn.890060306; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Miller CA, 2008, NEUROBIOL LEARN MEM, V89, P599, DOI 10.1016/j.nlm.2007.07.016; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Ota KT, 2008, LEARN MEMORY, V15, P792, DOI 10.1101/lm.1114808; PAUL S, 2006, BIOL PSYCHIAT; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Ploski JE, 2010, J NEUROCHEM, V112, P636, DOI 10.1111/j.1471-4159.2009.06491.x; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Schafe GE, 2000, J NEUROSCI, V20, P8177; Schafe GE, 1999, LEARN MEMORY, V6, P97; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286	40	150	157	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19958	10.1371/journal.pone.0019958	http://dx.doi.org/10.1371/journal.pone.0019958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	766OI	21625500	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400023
J	Nekouzadeh, A; Rudy, Y				Nekouzadeh, Ali; Rudy, Yoram			Continuum Molecular Simulation of Large Conformational Changes during Ion-Channel Gating	PLOS ONE			English	Article							DIELECTRIC-CONSTANT; DYNAMICS SIMULATION; PROTEIN; COOPERATIVITY; LINKING; ENERGY; MOTION; MODEL; STATE; GO	A modeling framework was developed to simulate large and gradual conformational changes within a macromolecule (protein) when its low amplitude high frequency vibrations are not concerned. Governing equations were derived as alternative to Langevin and Smoluchowski equations and used to simulate gating conformational changes of the Kv7.1 ion-channel over the time scale of its gating process (tens of milliseconds). The alternative equations predict the statistical properties of the motion trajectories with good accuracy and do not require the force field to be constant over the diffusion length, as assumed in Langevin equation. The open probability of the ion-channel was determined considering cooperativity of four subunits and solving their concerted transition to the open state analytically. The simulated open probabilities for a series of voltage clamp tests produced current traces that were similar to experimentally recorded currents.	[Nekouzadeh, Ali] Washington Univ, Cardiac Bioelect & Arrhythmia Ctr, St Louis, MO 63130 USA; Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Nekouzadeh, A (corresponding author), Washington Univ, Cardiac Bioelect & Arrhythmia Ctr, St Louis, MO 63130 USA.	nekouzadeh@wustl.edu; rudy@wustl.edu	nekouzadeh, ali/E-1290-2011		National Institutes of Health-National Heart, Lung and Blood Institute [R01-HL 049054-18, R01-HL 033343-26]; Children's Discovery Institute Fellowship [CH-F-2008-121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033343, R01HL049054] Funding Source: NIH RePORTER	National Institutes of Health-National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Children's Discovery Institute Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health-National Heart, Lung and Blood Institute grants R01-HL 049054-18 and R01-HL 033343-26 (to Y.R.) and a Children's Discovery Institute Fellowship No. CH-F-2008-121 (to A.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CF, 2010, P NATL ACAD SCI US; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Chen A, 2000, BIOPHYS J, V78, P2814, DOI 10.1016/S0006-3495(00)76824-X; Coffey W.T., 2004, LANGEVIN EQUATION AP, DOI 10.1142/5343; DILGER JP, 1979, SCIENCE, V206, P1196, DOI 10.1126/science.228394; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P463, DOI 10.1098/rspa.1924.0082; Karp DA, 2007, BIOPHYS J, V92, P2041, DOI 10.1529/biophysj.106.090266; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Koehorst RBM, 2004, BIOPHYS J, V87, P1445, DOI 10.1529/biophysj.104.043208; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Lange OF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2199530; Lecar H, 2003, BIOPHYS J, V85, P2854, DOI 10.1016/S0006-3495(03)74708-0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; NAKAMURA H, 1988, PROTEIN ENG, V2, P177, DOI 10.1093/protein/2.3.177; Nekouzadeh A, 2011, 3 RESIDUE LOOP CLOSU; Nekouzadeh A, 2008, BIOPHYS J, V95, P3510, DOI 10.1529/biophysj.108.136721; Paci E, 2002, BIOPHYS J, V83, P3032, DOI 10.1016/S0006-3495(02)75308-3; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; RAUDINO A, 1986, BIOPHYS J, V50, P441, DOI 10.1016/S0006-3495(86)83480-4; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; Silva JR, 2010, J GEN PHYSIOL, V135, P575, DOI 10.1085/jgp.200910358; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Sprik M, 1998, J CHEM PHYS, V109, P7737, DOI 10.1063/1.477419; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; WOOLF TB, 1994, P NATL ACAD SCI USA, V91, P11631, DOI 10.1073/pnas.91.24.11631; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20186	10.1371/journal.pone.0020186	http://dx.doi.org/10.1371/journal.pone.0020186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625456	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400045
J	Strange, A; Li, P; Lister, C; Anderson, J; Warthmann, N; Shindo, C; Irwin, J; Nordborg, M; Dean, C				Strange, Amy; Li, Peijin; Lister, Clare; Anderson, Jillian; Warthmann, Norman; Shindo, Chikako; Irwin, Judith; Nordborg, Magnus; Dean, Caroline			Major-Effect Alleles at Relatively Few Loci Underlie Distinct Vernalization and Flowering Variation in Arabidopsis Accessions	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED LINE POPULATIONS; NATURAL VARIATION; FT PROTEIN; FLORAL INDUCTION; TIME-VARIATION; THALIANA; RECOMBINANT; FRIGIDA; GENE	We have explored the genetic basis of variation in vernalization requirement and response in Arabidopsis accessions, selected on the basis of their phenotypic distinctiveness. Phenotyping of F2 populations in different environments, plus fine mapping, indicated possible causative genes. Our data support the identification of FRI and FLC as candidates for the major-effect QTL underlying variation in vernalization response, and identify a weak FLC allele, caused by a Mutator-like transposon, contributing to flowering time variation in two N. American accessions. They also reveal a number of additional QTL that contribute to flowering time variation after saturating vernalization. One of these was the result of expression variation at the FT locus. Overall, our data suggest that distinct phenotypic variation in the vernalization and flowering response of Arabidopsis accessions is accounted for by variation that has arisen independently at relatively few major-effect loci.	[Strange, Amy; Li, Peijin; Lister, Clare; Anderson, Jillian; Shindo, Chikako; Irwin, Judith; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich, Norfolk, England; [Warthmann, Norman] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Nordborg, Magnus] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; University of Southern California	Strange, A (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	caroline.dean@bbsrc.ac.uk	Li, Peijin/D-5764-2016; Warthmann, Norman/E-1069-2011; Li, Peijin/AAT-6978-2021	Warthmann, Norman/0000-0002-1178-8409; Li, Peijin/0000-0003-1579-7553; Dean, Caroline/0000-0002-6555-3525; Nordborg, Magnus/0000-0001-7178-9748	BBSRC [BB/E009662/1]; DuPont; BBSRC [BB/I007857/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009662/1, BB/I007857/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); DuPont; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a BBSRC CASE studentship (partnered with DuPont), BBSRC grant BB/E009662/1 and BBSRC Strategic Grant to The John Innes Centre. We thank Detlef Weigel for funding the verification by Genaissance of unpublished data, on all the markers used for the genetic mapping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; BERNIER G, 1988, ANNU REV PLANT PHYS, V39, P175, DOI 10.1146/annurev.arplant.39.1.175; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; Caicedo AL, 2009, MOL BIOL EVOL, V26, P699, DOI 10.1093/molbev/msn300; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jorgensen S, 2004, MOL ECOL, V13, P3403, DOI 10.1111/j.1365-294X.2004.02329.x; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Larsson AS, 1998, GENETICS, V149, P597; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; LI Y, 2010, P NATL ACAD SCI US; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2004, P NATL ACAD SCI USA, V101, P3281, DOI 10.1073/pnas.0306778101; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; O'Neill CM, 2008, THEOR APPL GENET, V116, P623, DOI 10.1007/s00122-007-0696-9; Osterberg MK, 2002, GENETICS, V161, P299; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Rouse DT, 2002, PLANT J, V29, P183, DOI 10.1046/j.0960-7412.2001.01210.x; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Schlappi MR, 2006, PLANT PHYSIOL, V142, P1728, DOI 10.1104/pp.106.085571; Schwartz C, 2009, GENETICS, V183, P723, DOI 10.1534/genetics.109.104984; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Ungerer MC, 2002, GENETICS, V160, P1133; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102	49	63	65	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19949	10.1371/journal.pone.0019949	http://dx.doi.org/10.1371/journal.pone.0019949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625501	Green Published, gold			2022-12-25	WOS:000290793400022
J	Andrecut, M; Halley, JD; Winkler, DA; Huang, S				Andrecut, Mircea; Halley, Julianne D.; Winkler, David A.; Huang, Sui			A General Model for Binary Cell Fate Decision Gene Circuits with Degeneracy: Indeterminacy and Switch Behavior in the Absence of Cooperativity	PLOS ONE			English	Article							TRANSCRIPTION FACTORS GATA-1; STEM-CELL; C/EBP-ALPHA; LINEAGE-COMMITMENT; PU.1; EXPRESSION; MOUSE; TROPHECTODERM; LANDSCAPE; STATE	Background: The gene regulatory circuit motif in which two opposing fate-determining transcription factors inhibit each other but activate themselves has been used in mathematical models of binary cell fate decisions in multipotent stem or progenitor cells. This simple circuit can generate multistability and explains the symmetric "poised" precursor state in which both factors are present in the cell at equal amounts as well as the resolution of this indeterminate state as the cell commits to either cell fate characterized by an asymmetric expression pattern of the two factors. This establishes the two alternative stable attractors that represent the two fate options. It has been debated whether cooperativity of molecular interactions is necessary to produce such multistability. Principal Findings: Here we take a general modeling approach and argue that this question is not relevant. We show that non-linearity can arise in two distinct models in which no explicit interaction between the two factors is assumed and that distinct chemical reaction kinetic formalisms can lead to the same (generic) dynamical system form. Moreover, we describe a novel type of bifurcation that produces a degenerate steady state that can explain the metastable state of indeterminacy prior to cell fate decision-making and is consistent with biological observations. Conclusion: The general model presented here thus offers a novel principle for linking regulatory circuits with the state of indeterminacy characteristic of multipotent (stem) cells.	[Andrecut, Mircea; Halley, Julianne D.; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Winkler, David A.] CSIRO, Clayton, Vic 3168, Australia; [Winkler, David A.] Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	University of Calgary; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Andrecut, M (corresponding author), Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada.	Dave.Winkler@csiro.au; sui.huang@ucalgary.ca	Winkler, David A/A-3774-2008	Winkler, David A/0000-0002-7301-6076; Winkler, David Alan/0000-0003-2423-674X	Alberta Innovates/iCore; National Sciences and Engineering Research Council of Canada [372012-2009]; Victoria Fellowship; CSIRO	Alberta Innovates/iCore; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Victoria Fellowship; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Alberta Innovates/iCore (M.A., S.H.); National Sciences and Engineering Research Council of Canada (S.H.), grant number: 372012-2009; Victoria Fellowship (J.D.H.); CSIRO Newton Turner Award (D.A.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrecut M, 2008, J THEOR BIOL, V250, P468, DOI 10.1016/j.jtbi.2007.10.035; Andrecut M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/148; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bar-Yam Y, 1997, STUDIES NONLINEARITY; Bokes P, 2009, MATH MED BIOL, V26, P117, DOI 10.1093/imammb/dqn026; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHEN HM, 1995, ONCOGENE, V11, P1549; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; DELBRUCK M, 1949, C INT CTR NAT RECH S; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; HALLEY JD, 2009, STEM CELL RES; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; HUANG S, 2009, ENCY COMPLEXITY SYST; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huang S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000380; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Liew CW, 2006, J BIOL CHEM, V281, P28296, DOI 10.1074/jbc.M602830200; Lipshtat A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.188101; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Morceau F, 2004, ANN NY ACAD SCI, V1030, P537, DOI 10.1196/annals.1329.064; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; NICOLIS G, 1986, REP PROG PHYS, V49, P873, DOI 10.1088/0034-4885/49/8/002; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Rangatia J, 2002, MOL CELL BIOL, V22, P8681, DOI 10.1128/MCB.22.24.8681-8694.2002; Reddy VA, 2002, BLOOD, V100, P483, DOI 10.1182/blood.V100.2.483; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; SAVAGEAU MA, 1995, J THEOR BIOL, V176, P115, DOI 10.1006/jtbi.1995.0181; Sneppen K., 2005, PHYS MOL BIOL; Sternman J., 2000, BUSINESS DYNAMICS SY; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; WANG J, BIOPHYS J IN PRESS; Wang J, 2010, BIOPHYS J, V99, P29, DOI 10.1016/j.bpj.2010.03.058; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; ZHOU JX, 2010, TRENDS GENE IN PRESS; ZHOU JX, 2010, TRANDS GENE IN PRESS	59	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19358	10.1371/journal.pone.0019358	http://dx.doi.org/10.1371/journal.pone.0019358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625586	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200006
J	Dahlin, JS; Ivarsson, MA; Heyman, B; Hallgren, J				Dahlin, Joakim S.; Ivarsson, Martin A.; Heyman, Birgitta; Hallgren, Jenny			IgE Immune Complexes Stimulate an Increase in Lung Mast Cell Progenitors in a Mouse Model of Allergic Airway Inflammation	PLOS ONE			English	Article							FC-GAMMA-RIV; IMMUNOGLOBULIN-E; IN-VIVO; ASTHMA; ANTIBODY; RECEPTOR; MICE; RECRUITMENT; RESPONSES; ANTIGEN	Mast cell numbers and allergen specific IgE are increased in the lungs of patients with allergic asthma and this can be reproduced in mouse models. The increased number of mast cells is likely due to recruitment of mast cell progenitors that mature in situ. We hypothesized that formation of IgE immune complexes in the lungs of sensitized mice increase the migration of mast cell progenitors to this organ. To study this, a model of allergic airway inflammation where mice were immunized with ovalbumin (OVA) in alum twice followed by three daily intranasal challenges of either OVA coupled to trinitrophenyl (TNP) alone or as immune complexes with IgE-anti-TNP, was used. Mast cell progenitors were quantified by a limiting dilution assay. IgE immune complex challenge of sensitized mice elicited three times more mast cell progenitors per lung than challenge with the same dose of antigen alone. This dose of antigen challenge alone did not increase the levels of mast cell progenitors compared to unchallenged mice. IgE immune complex challenge of sensitized mice also enhanced the frequency of mast cell progenitors per 10 6 mononuclear cells by 2.1-fold. The enhancement of lung mast cell progenitors by IgE immune complex challenge was lost in FcR gamma deficient mice but not in CD23 deficient mice. Our data show that IgE immune complex challenge enhances the number of mast cell progenitors in the lung through activation of an Fc receptor associated with the FcR gamma chain. This most likely takes place via activation of Fc epsilon RI, although activation via Fc gamma RIV or a combination of the two receptors cannot be excluded. IgE immune complex-mediated enhancement of lung MCp numbers is a new reason to target IgE in therapies against allergic asthma.	[Dahlin, Joakim S.; Ivarsson, Martin A.; Heyman, Birgitta; Hallgren, Jenny] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Dahlin, JS (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	jenny.hallgren@imbim.uu.se	Ivarsson, Martin/AAE-2406-2020; Dahlin, Joakim/J-1057-2019; Hallgren Martinsson, Jenny/AAZ-5937-2021; Hallgren Martinsson, Jenny/AAZ-6356-2021	Ivarsson, Martin/0000-0002-7745-1331; Dahlin, Joakim/0000-0003-3007-9875; Hallgren Martinsson, Jenny/0000-0002-3685-5364; Heyman, Birgitta/0000-0003-0869-0483	Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Swedish Research Council; Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation	Linne Foundation; Ake Wiberg Foundation; Magnus Bergvall Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Ellen, Walter and Lennart Hesselman's Foundation; Hans von Kantzow's Foundation; King Gustaf V:s 80 Years Foundation; Ollie and Elof Ericsson's Foundation	This work was supported by grants to J. Hallgren from the Linne Foundation, Ake Wiberg Foundation (www.ake-wiberg.com/), Magnus Bergvall Foundation (www.magnbergvallsstiftelse.nu/) and the Swedish Research Council (www.vr.se/) and grants to B. Heyman from the Swedish Research Council, Ellen, Walter and Lennart Hesselman's Foundation, Hans von Kantzow's Foundation, King Gustaf V:s 80 Years Foundation (ams.orbelon.com/gv80/), Ollie and Elof Ericsson's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonia JP, 2006, BLOOD, V108, P1588, DOI 10.1182/blood-2005-12-012781; Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Chvatchko Y, 1996, J EXP MED, V184, P2353, DOI 10.1084/jem.184.6.2353; Collington SJ, 2010, J IMMUNOL, V184, P6114, DOI 10.4049/jimmunol.0904177; CRAPPER RM, 1983, J IMMUNOL, V131, P923; FUJIWARA H, 1994, P NATL ACAD SCI USA, V91, P6835, DOI 10.1073/pnas.91.15.6835; Getahun A, 2005, J IMMUNOL, V175, P1473, DOI 10.4049/jimmunol.175.3.1473; Getahun A, 2006, IMMUNOL LETT, V104, P38, DOI 10.1016/j.imlet.2005.11.005; GOOD A, 1980, PREPARATIONS HAPTEN; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hallgren J, 2007, P NATL ACAD SCI USA, V104, P20478, DOI 10.1073/pnas.0709651104; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; Heyman B, 2002, ALLERGY, V57, P577, DOI 10.1034/j.1398-9995.2002.02159.x; Hirano M, 2007, NAT IMMUNOL, V8, P762, DOI 10.1038/ni1477; Hjelm F, 2008, J IMMUNOL, V180, P6604, DOI 10.4049/jimmunol.180.10.6604; Holgate S, 2009, ALLERGY, V64, P1728, DOI 10.1111/j.1398-9995.2009.02201.x; Jones TG, 2009, J IMMUNOL, V183, P5251, DOI 10.4049/jimmunol.0901471; Karasuyama H, 1988, Tanpakushitsu Kakusan Koso, V33, P2527; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Mathias CB, 2009, J IMMUNOL, V182, P2416, DOI 10.4049/jimmunol.0801569; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; STERK AR, 1982, J IMMUNOL, V128, P838; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; TEUSCHER C, 1985, INFECT IMMUN, V48, P474, DOI 10.1128/IAI.48.2.474-479.1985; VANHERWERDEN L, 1995, LANCET, V346, P1262, DOI 10.1016/S0140-6736(95)91863-9; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zuberi RI, 2000, J IMMUNOL, V164, P2667, DOI 10.4049/jimmunol.164.5.2667	32	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20261	10.1371/journal.pone.0020261	http://dx.doi.org/10.1371/journal.pone.0020261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625525	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200055
J	Gao, Y; Chung, T; Zou, X; Pike, HM; Brown, RE				Gao, Yongguang; Chung, Taeowan; Zou, Xianqiong; Pike, Helen M.; Brown, Rhoderick E.			Human Glycolipid Transfer Protein (GLTP) Expression Modulates Cell Shape	PLOS ONE			English	Article							DELTA-CATENIN; DOWN-REGULATION; GROWTH; GLYCOSPHINGOLIPIDS; ADHESION; PROLIFERATION; MOTILITY; PATHWAY; GENE	Glycolipid transfer protein (GLTP) accelerates glycosphingolipid (GSL) intermembrane transfer via a unique lipid transfer/binding fold (GLTP-fold) that defines the GLTP superfamily and is the prototype for GLTP-like domains in larger proteins, i.e. phosphoinositol 4-phosphate adaptor protein-2 (FAPP2). Although GLTP-folds are known to play roles in the nonvesicular intracellular trafficking of glycolipids, their ability to alter cell phenotype remains unexplored. In the present study, overexpression of human glycolipid transfer protein (GLTP) was found to dramatically alter cell phenotype, with cells becoming round between 24 and 48 h after transfection. By 48 h post transfection, similar to 70% conversion to the markedly round shape was evident in HeLa and HEK-293 cells, but not in A549 cells. In contrast, overexpression of W96A-GLTP, a liganding-site point mutant with abrogated ability to transfer glycolipid, did not alter cell shape. The round adherent cells exhibited diminished motility in wound healing assays and an inability to endocytose cholera toxin but remained viable and showed little increase in apoptosis as assessed by poly(ADP-ribose) polymerase cleavage. A round cell phenotype also was induced by overexpression of FAPP2, which binds/transfers glycolipid via its C-terminal GLTP-like fold, but not by a plant GLTP ortholog (ACD11), which is incapable of glycolipid binding/transfer. Screening for human protein partners of GLTP by yeast two hybrid screening and by immuno-pulldown analyses revealed regulation of the GLTP-induced cell rounding response by interaction with delta-catenin. Remarkably, while delta-catenin overexpression alone induced dendritic outgrowths, coexpression of GLTP along with delta-catenin accelerated transition to the rounded phenotype. The findings represent the first known phenotypic changes triggered by GLTP overexpression and regulated by direct interaction with a p120-catenin protein family member.	[Gao, Yongguang; Zou, Xianqiong; Pike, Helen M.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Chung, Taeowan] Yeungnam Univ, Sch Biotechnol, Kyeongsan, South Korea	University of Minnesota System; Yeungnam University	Gao, Y (corresponding author), Univ Calif Meced, Sch Nat Sci, Merced, CA USA.	reb@umn.edu	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252; Brown, Rhoderick/0000-0002-7337-3604	Hormel Foundation;  [NIH GM45928];  [NIH CA121493]; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	Hormel Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We express our gratitude for financial support by NIH GM45928, NIH CA121493, and The Hormel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Bektas M, 2003, GLYCOCONJUGATE J, V20, P39, DOI 10.1023/B:GLYC.0000016741.88476.8b; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Kamlekar RK, 2010, BIOPHYS J, V99, P2626, DOI 10.1016/j.bpj.2010.08.038; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lu Q, 2009, PROSTATE, V69, P411, DOI 10.1002/pros.20902; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; Neumann S, 2008, BIOL CHEM, V389, P1349, DOI 10.1515/BC.2008.154; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Reynolds AB, 2010, CELL, V141, P20, DOI 10.1016/j.cell.2010.03.022; Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang T, 2009, ONCOGENE, V28, P555, DOI 10.1038/onc.2008.399; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeng Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-19	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19990	10.1371/journal.pone.0019990	http://dx.doi.org/10.1371/journal.pone.0019990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625605	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200055
J	Singh, RR; Kunkalla, K; Qu, C; Schlette, E; Neelapu, SS; Samaniego, F; Vega, F				Singh, R. R.; Kunkalla, K.; Qu, C.; Schlette, E.; Neelapu, S. S.; Samaniego, F.; Vega, F.			ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma	ONCOGENE			English	Article						ABCG2; ATP-binding cassettes; hedgehog pathway; GLI; diffuse large B-cell lymphoma	CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; SONIC-HEDGEHOG; P-GLYCOPROTEIN; POOR RESPONSE; EXPRESSION; GENE; TRANSPORTER; SURVIVAL; PATHWAY	Successful treatment of diffuse large B-cell lymphoma (DLBCL) is frequently hindered by the development of resistance to conventional chemotherapy resulting in disease relapse and high mortality. High expression of antiapoptotic and/or drug transporter proteins induced by oncogenic signaling pathways has been implicated in the development of chemoresistance in cancer. Previously, our studies showed that high expression of adenosine triphosphate-binding cassette drug transporter ABCG2 in DLBCL correlated inversely with disease-and failure-free survival. In this study, we have implicated activated hedgehog (Hh) signaling pathway as a key factor behind high ABCG2 expression in DLBCL through direct upregulation of ABCG2 gene transcription. We have identified a single binding site for GLI transcription factors in the ABCG2 promoter and established its functionality using luciferase reporter, site-directed mutagenesis and chromatin-immunoprecipitation assays. Furthermore, in DLBCL tumor samples, significantly high ABCG2 and GLI1 levels were found in DLBCL tumors with lymph node involvement in comparison with DLBCL tumor cells collected from pleural and/or peritoneal effusions. This suggests a role for the stromal microenvironment in maintaining high levels of ABCG2 and GLI1. Accordingly, in vitro co-culture of DLBCL cells with HS-5 stromal cells increased ABCG2 mRNA and protein levels by paracrine activation of Hh signaling. In addition to ABCG2, co-culture of DLBCL cells with HS-5 cells also resulted in increase expression of the antiapoptotic proteins BCL2, BCL-xL and BCL2A1 and in induced chemotolerance to doxorubicin and methotrexate, drugs routinely used for the treatment of DLBCL. Similarly, activation of Hh signaling in DLBCL cell lines with recombinant Shh N-terminal peptide resulted in increased expression of BCL2 and ABCG2 associated with increased chemotolerance. Finally, functional inhibition of ABCG2 drug efflux activity with fumitremorgin C or inhibition of Hh signaling with cyclopamine-KAAD abrogated the stroma-induced chemotolerance suggesting that targeting ABCG2 and Hh signaling may have therapeutic value in overcoming chemoresistance in DLBCL. Oncogene (2011) 30, 4874-4886; doi:10.1038/onc.2011.195; published online 30 May 2011	[Singh, R. R.; Kunkalla, K.; Qu, C.; Schlette, E.; Vega, F.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Neelapu, S. S.; Samaniego, F.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Singh, RR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Unit 72,1515 Holcombe Blvd, Houston, TX 77030 USA.	rsingh@mdanderson.org; fvegava@mdanderson.org	Vega, Francisco/AGY-4571-2022	Vega, Francisco/0000-0001-5956-452X	NCI/NIH [CA16672]; Leukemia and Lymphoma Society; NIH [1 K08 CA143151-01]; UT MD Anderson Cancer Center Lymphoma SPORE [1P50CA136411-01A1]; Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTE [P50CA136411, P30CA016672, K08CA143151] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT MD Anderson Cancer Center Lymphoma SPORE; Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Susan E Bates (NIH) for providing the ABCG2 promoter luciferase constructs. We also thank Professor Michael G Rosenblum, Department of Experimental Therapeutics, MD Anderson Cancer Center for providing OCI-LY3 and OCI-LY10 cell lines. The primary tumor samples were provided by the Hematopathology and Lymphoma Tissue Banks of the UT MD Anderson Cancer Center (supported by the NCI/NIH Grant CA16672). This research was supported by funds from The Translational Grant of The Leukemia and Lymphoma Society (to RRS and FV), K08 Physician-Scientist Award 1 K08 CA143151-01 (NIH) (to FV), SPORE Lymphoma Grant UT MD Anderson Cancer Center Lymphoma SPORE 1P50CA136411-01A1 (to FV) and Lauri Strauss Leukemia Foundation Grant award (to RRS and FV).	Abbott BL, 2002, BLOOD, V100, P4594, DOI 10.1182/blood-2002-01-0271; Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Allikmets R, 1998, CANCER RES, V58, P5337; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Andreadis C, 2007, BLOOD, V109, P3409, DOI 10.1182/blood-2006-09-047621; Armitage JO, 2007, BLOOD, V110, P29, DOI 10.1182/blood-2007-01-041871; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Barnes EA, 2005, ONCOGENE, V24, P902, DOI 10.1038/sj.onc.1208240; Baumann P, 2009, MOL CANCER THER, V8, P366, DOI 10.1158/1535-7163.MCT-08-0664; Benderra Z, 2004, CLIN CANCER RES, V10, P7896, DOI 10.1158/1078-0432.CCR-04-0795; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bleau AM, 2009, CELL CYCLE, V8, P2936; Candeil L, 2004, INT J CANCER, V109, P848, DOI 10.1002/ijc.20032; Damiani D, 2010, LEUKEMIA RES, V34, P942, DOI 10.1016/j.leukres.2010.01.008; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Desch P, 2010, ONCOGENE, V29, P4885, DOI 10.1038/onc.2010.243; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fernandez M, 2010, J CELL BIOCHEM, V111, P130, DOI 10.1002/jcb.22676; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grigorieva I, 1998, EXP HEMATOL, V26, P597; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Honjo Y, 2001, CANCER RES, V61, P6635; Hu LL, 2007, CARCINOGENESIS, V28, P1740, DOI 10.1093/carcin/bgm113; Jerkeman M, 2004, ANN HEMATOL, V83, P414, DOI 10.1007/s00277-004-0855-x; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kawabata S, 2003, CLIN CANCER RES, V9, P3052; Kim JE, 2009, MODERN PATHOL, V22, P1312, DOI 10.1038/modpathol.2009.98; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Lwin T, 2009, LEUKEMIA, V23, P170, DOI 10.1038/leu.2008.266; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Miyake K, 1999, CANCER RES, V59, P8; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Ohsawa M, 2005, ONCOLOGY-BASEL, V68, P422, DOI 10.1159/000086984; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Queiroz KCS, 2010, ONCOGENE, V29, P6314, DOI 10.1038/onc.2010.375; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Rocchi E, 2000, BIOCHEM BIOPH RES CO, V271, P42, DOI 10.1006/bbrc.2000.2590; RODRIGUEZ C, 1993, LEUKEMIA RES, V17, P149, DOI 10.1016/0145-2126(93)90060-X; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Sauerbrey A, 2002, BRIT J HAEMATOL, V118, P147, DOI 10.1046/j.1365-2141.2002.03550.x; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Singh RR, 2010, LEUKEMIA, V24, P1025, DOI 10.1038/leu.2010.35; Singh RR, 2009, CANCER RES, V69, P2550, DOI 10.1158/0008-5472.CAN-08-1808; Stam RW, 2004, LEUKEMIA, V18, P78, DOI 10.1038/sj.leu.2403168; Steinbach D, 2002, LEUKEMIA, V16, P1443, DOI 10.1038/sj.leu.2402541; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; To KKW, 2006, MOL CELL BIOL, V26, P8572, DOI 10.1128/MCB.00650-06; Tsunoda S, 2006, ONCOLOGY-BASEL, V71, P251, DOI 10.1159/000106787; Uggla B, 2005, LEUKEMIA RES, V29, P141, DOI 10.1016/j.leukres.2004.06.004; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Yasuda S, 2009, MOL BIOL REP, V36, P1889, DOI 10.1007/s11033-008-9395-0; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; YUEN AR, 1994, J CLIN ONCOL, V12, P2453, DOI 10.1200/JCO.1994.12.11.2453	66	122	126	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	49					4874	4886		10.1038/onc.2011.195	http://dx.doi.org/10.1038/onc.2011.195			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21625222	Green Accepted			2022-12-25	WOS:000298346400004
J	Li, XF; Ji, WD; Zhang, R; Folta-Stogniew, E; Min, W; Boggon, TJ				Li, Xiaofeng; Ji, Weidong; Zhang, Rong; Folta-Stogniew, Ewa; Min, Wang; Boggon, Titus J.			Molecular Recognition of Leucine-Aspartate Repeat (LD) Motifs by the Focal Adhesion Targeting Homology Domain of Cerebral Cavernous Malformation 3 (CCM3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20-LIKE KINASE-3 MST3; CELL-MIGRATION; BINDING DOMAIN; 4-HELIX BUNDLE; RHO-GTPASES; PAXILLIN; PROTEIN; MUTATIONS; GENE; VINCULIN	Cerebral cavernous malformation (CCM) is a disease that affects between 0.1 and 0.5% of the human population, with mutations in CCM3 accounting for similar to 15% of the autosomal dominant form of the disease. We recently reported that CCM3 contains an N-terminal dimerization domain (CCM3D) and a C-terminal focal adhesion targeting (FAT) homology domain. Intermolecular protein-protein interactions of CCM3 are mediated by a highly conserved surface on the FAT homology domain and are affected by CCM3 truncations in the human disease. Here we report the crystal structures of CCM3 in complex with three different leucine-aspartate repeat (LD) motifs (LD1, LD2, and LD4) from the scaffolding protein paxillin, at 2.8, 2.7, and 2.5 angstrom resolution. We show that CCM3 binds LD motifs using the highly conserved hydrophobic patch 1 (HP1) and that this binding is similar to the binding of focal adhesion kinase and Pyk2 FAT domains to paxillin LD motifs. We further show by surface plasmon resonance that CCM3 binds paxillin LD motifs with affinities in the micromolar range, similar to FAK family FAT domains. Finally, we show that endogenous CCM3 and paxillin co-localize in mouse cerebral pericytes. These studies provide a molecular-level framework to investigate the protein-protein interactions of CCM3.	[Boggon, Titus J.] Yale Univ Sch Med, Dept Pharmacol, SHM B316A, New Haven, CT 06520 USA; [Ji, Weidong; Min, Wang] Yale Univ Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Folta-Stogniew, Ewa] Yale Univ Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ Sch Med, Dept Pharmacol, SHM B316A, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu	Li, Xiaofeng/F-3735-2011; ji, weidong/AAX-7397-2020		National Institutes of Health [HL077357, HL085789, RR026992, AI075133, GM088240, DK087844]; Yale University; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077357, R01HL085789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077357 and HL085789 (to W. M.), RR026992 (to E. F.-S.), and AI075133, GM088240, and DK087844 (to T. J. B.). This work was also supported by startup funds to T. J. B. from Yale University.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Davenport WJ, 2001, NEUROLOGY, V56, P540, DOI 10.1212/WNL.56.4.540; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Ding JJ, 2010, BIOCHEM BIOPH RES CO, V399, P587, DOI 10.1016/j.bbrc.2010.07.119; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; Pozzati E, 1996, NEUROSURGERY, V38, P662, DOI 10.1227/00006123-199604000-00006; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	55	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26138	26147		10.1074/jbc.M110.211250	http://dx.doi.org/10.1074/jbc.M110.211250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632544	Green Published, hybrid			2022-12-25	WOS:000293073000071
J	Gareau, C; Fournier, MJ; Filion, C; Coudert, L; Martel, D; Labelle, Y; Mazroui, R				Gareau, Cristina; Fournier, Marie-Josee; Filion, Christine; Coudert, Laetitia; Martel, David; Labelle, Yves; Mazroui, Rachid			p21(WAF1/CIP1) Upregulation through the Stress Granule-Associated Protein CUGBP1 Confers Resistance to Bortezomib-Mediated Apoptosis	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA STABILIZATION; MENTAL-RETARDATION PROTEIN; PANCREATIC-CANCER CELLS; 3/P21 COMPLEX-FORMATION; BINDING PROTEIN; MYOTONIC-DYSTROPHY; GENE-EXPRESSION; CYTOPLASMIC GRANULES; SIGNALING PATHWAYS	Background: p21(WAF1/CIP1) is a well known cyclin-dependent kinase inhibitor induced by various stress stimuli. Depending on the stress applied, p21 upregulation can either promote apoptosis or prevent against apoptotic injury. The stress-mediated induction of p21 involves not only its transcriptional activation but also its posttranscriptional regulation, mainly through stabilization of p21 mRNA levels. We have previously reported that the proteasome inhibitor MG132 induces the stabilization of p21 mRNA, which correlates with the formation of cytoplasmic RNA stress granules. The mechanism underlying p21 mRNA stabilization, however, remains unknown. Methodology/Principal Findings: We identified the stress granules component CUGBP1 as a factor required for p21 mRNA stabilization following treatment with bortezomib (= PS-341/Velcade). This peptide boronate inhibitor of the 26S proteasome is very efficient for the treatment of myelomas and other hematological tumors. However, solid tumors are sometimes refractory to bortezomib treatment. We found that depleting CUGBP1 in cancer cells prevents bortezomib-mediated p21 upregulation. FISH experiments combined to mRNA stability assays show that this effect is largely due to a mistargeting of p21 mRNA in stress granules leading to its degradation. Altering the expression of p21 itself, either by depleting CUGBP1 or p21, promotes bortezomib-mediated apoptosis. Conclusions/Significance: We propose that one key mechanism by which apoptosis is inhibited upon treatment with chemotherapeutic drugs might involve upregulation of the p21 protein through CUGBP1.	[Gareau, Cristina; Fournier, Marie-Josee; Filion, Christine; Coudert, Laetitia; Martel, David; Labelle, Yves; Mazroui, Rachid] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, CHUQ Res Ctr,St Francois Assise Res Ctr CRCHUQ CR, Quebec City, PQ G1K 7P4, Canada	Laval University	Gareau, C (corresponding author), Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, CHUQ Res Ctr,St Francois Assise Res Ctr CRCHUQ CR, Quebec City, PQ G1K 7P4, Canada.	rachid.mazroui@crsfa.ulaval.ca			Canadian Institutes of Health Research grants (CIHR) [MOP-IC093226, MOP-096454]; Canadian Foundation for Inovation (CFI) [MOP-GF091050]; Faculty of Medicine at Laval University; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research grants (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Inovation (CFI)(Canada Foundation for Innovation); Faculty of Medicine at Laval University; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes of Health Research grants (CIHR) (MOP-IC093226 and MOP-096454) and a Canadian Foundation for Inovation (CFI) grant (MOP-GF091050) to R. Mazroui. C. Gareau is recipient of a scholarship from the Faculty of Medicine at Laval University. R. Mazroui is a recipient of a Fonds de la Recherche en Sante du Quebec (FRSQ) research Scholars-Junior 1, and is a new investigator of CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Adnane J, 2000, ONCOGENE, V19, P5338, DOI 10.1038/sj.onc.1203956; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Codony-Servat J, 2006, MOL CANCER THER, V5, P665, DOI 10.1158/1535-7163.MCT-05-0147; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Cusack JC, 2001, CANCER RES, V61, P3535; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Ferrandiz N, 2010, CANCER LETT, V292, P133, DOI 10.1016/j.canlet.2009.11.017; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; HARPER JW, 1993, CELL, V75, P805; Hideshima T, 2001, CANCER RES, V61, P3071; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lazzarini R, 2008, CLIN CANCER RES, V14, P5099, DOI 10.1158/1078-0432.CCR-08-0255; Lee JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011201; Lenz HJ, 2003, CANCER TREAT REV, V29, P41, DOI 10.1016/S0305-7372(03)00082-3; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Lin WJ, 2007, J BIOL CHEM, V282, P19958, DOI 10.1074/jbc.M702281200; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; de Silanes IL, 2009, NUCLEIC ACIDS RES, V37, P2658, DOI 10.1093/nar/gkp123; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; Richardson Paul G, 2003, Clin Adv Hematol Oncol, V1, P596; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018; Salomons FA, 2005, ESSAYS BIOCHEM, V41, P113, DOI 10.1042/EB0410113; Seomun Y, 2005, MOL VIS, V11, P764; Sloss CM, 2008, CLIN CANCER RES, V14, P5116, DOI 10.1158/1078-0432.CCR-07-4506; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Suzuki A, 2000, ONCOGENE, V19, P1346, DOI 10.1038/sj.onc.1203429; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Tang ZY, 2008, J SURG RES, V145, P111, DOI 10.1016/j.jss.2007.03.061; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06; Zhang LB, 2008, J BIOL CHEM, V283, P22457, DOI 10.1074/jbc.M802803200; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	89	81	86	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20254	10.1371/journal.pone.0020254	http://dx.doi.org/10.1371/journal.pone.0020254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637851	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200044
J	Jawara, M; Awolola, TS; Pinder, M; Jeffries, D; Smallegange, RC; Takken, W; Conway, DJ				Jawara, Musa; Awolola, Taiwo S.; Pinder, Margaret; Jeffries, David; Smallegange, Renate C.; Takken, Willem; Conway, David J.			Field Testing of Different Chemical Combinations as Odour Baits for Trapping Wild Mosquitoes in The Gambia	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; MALARIA MOSQUITO; CARBON-DIOXIDE; SENSU-STRICTO; CULICIDAE; DIPTERA; RESPONSES; BEHAVIOR; YEAST	Odour baited traps have potential use in population surveillance of insect vectors of disease, and in some cases for vector population reduction. Established attractants for human host-seeking mosquitoes include a combination of CO(2) with L-lactic acid and ammonia, on top of which additional candidate compounds are being tested. In this field study in rural Gambia, using Latin square experiments with thorough randomization and replication, we tested nine different leading candidate combinations of chemical odorants for attractiveness to wild mosquitoes including anthropophilic malaria vectors, using modified Mosquito Magnet-X (MM-X) counterflow traps outside experimental huts containing male human sleepers. Highest catches of female mosquitoes, particularly of An. gambiae s.l. and Mansonia species, were obtained by incorporation of tetradecanoic acid. As additional carboxylic acids did not increase the trap catches further, this 'reference blend' (tetradecanoic acid with L-lactic acid, ammonia and CO(2)) was used in subsequent experiments. MM-X traps with this blend caught similar numbers of An. gambiae s.l. and slightly more Mansonia and Culex mosquitoes than a standard CDC light trap, and these numbers were not significantly affected by the presence or absence of human sleepers in the huts. Experiments with CO(2) produced from overnight yeast cultures showed that this organic source was effective in enabling trap attractiveness for all mosquito species, although at a slightly lower efficiency than obtained with use of CO(2) gas cylinders. Although further studies are needed to discover additional chemicals that increase attractiveness, as well as to optimise trap design and CO(2) source for broader practical use, the odour-baited traps described here are safe and effective for sampling host-seeking mosquitoes outdoors and can be incorporated into studies of malaria vector ecology.	[Jawara, Musa; Awolola, Taiwo S.; Pinder, Margaret; Jeffries, David; Conway, David J.] MRC Labs, Banjul, Gambia; [Awolola, Taiwo S.] Nigerian Inst Med Res, Lagos, Nigeria; [Smallegange, Renate C.; Takken, Willem] Wageningen Univ, Entomol Lab, Wageningen, Netherlands; [Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	MRC Laboratory Molecular Biology; Wageningen University & Research; University of London; London School of Hygiene & Tropical Medicine	Jawara, M (corresponding author), MRC Labs, Banjul, Gambia.	david.conway@lshtm.ac.uk	Smallegange, Renate C./L-1566-2019	Smallegange, Renate C./0000-0002-6946-9777; Conway, David/0000-0002-8711-3037	Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative (GCGH) [121]; Medical Research Council of the United Kingdom	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation through the Grand Challenges in Global Health Initiative (GCGH)(Bill & Melinda Gates Foundation); Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Foundation for the National Institutes of Health and the Bill and Melinda Gates Foundation, through the Grand Challenges in Global Health Initiative (GCGH# 121 grant co-ordinated by Dr. Larry Zwiebel), and by the Medical Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167; Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Oli K., 2005, Tropical Biomedicine, V22, P249; Pickett JA, 2010, J CHEM ECOL, V36, P113, DOI 10.1007/s10886-010-9739-9; QIU YT, 2010, MED VET ENTOMOL; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Saitoh Y, 2004, J AM MOSQUITO CONTR, V20, P261; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7	22	31	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19676	10.1371/journal.pone.0019676	http://dx.doi.org/10.1371/journal.pone.0019676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637337	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000291052200012
J	Mulckhuyse, M; Belopolsky, AV; Heslenfeld, D; Talsma, D; Theeuwes, J				Mulckhuyse, Manon; Belopolsky, Artem V.; Heslenfeld, Dirk; Talsma, Durk; Theeuwes, Jan			Distribution of Attention Modulates Salience Signals in Early Visual Cortex	PLOS ONE			English	Article							STIMULUS-DRIVEN; SELECTIVE ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; CORTICAL AREAS; CAPTURE; SEARCH; VOLUNTARY; COLOR; INHIBITION	Previous research has shown that the extent to which people spread attention across the visual field plays a crucial role in visual selection and the occurrence of bottom-up driven attentional capture. Consistent with previous findings, we show that when attention was diffusely distributed across the visual field while searching for a shape singleton, an irrelevant salient color singleton captured attention. However, while using the very same displays and task, no capture was observed when observers initially focused their attention at the center of the display. Using event-related fMRI, we examined the modulation of retinotopic activity related to attentional capture in early visual areas. Because the sensory display characteristics were identical in both conditions, we were able to isolate the brain activity associated with exogenous attentional capture. The results show that spreading of attention leads to increased bottom-up exogenous capture and increased activity in visual area V3 but not in V2 and V1.	[Mulckhuyse, Manon; Belopolsky, Artem V.; Heslenfeld, Dirk; Theeuwes, Jan] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Mulckhuyse, Manon; Talsma, Durk] Univ Ghent, B-9000 Ghent, Belgium	Vrije Universiteit Amsterdam; Ghent University	Mulckhuyse, M (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	Manon.Mulckhuyse@UGent.be	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721; Belopolsky, Artem/0000-0003-3606-2134; Talsma, Durk/0000-0002-3435-2317	Human Frontier Science Program [HSFP-RGP39/2005]	Human Frontier Science Program(Human Frontier Science Program)	This research was funded by a grant from Human Frontier Science Program (HSFP-RGP39/2005) to Jan Theeuwes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fecteau JH, 2005, J COGNITIVE NEUROSCI, V17, P1714, DOI 10.1162/089892905774589235; Fecteau JH, 2004, J NEUROPHYSIOL, V92, P1728, DOI 10.1152/jn.00184.2004; FOLK CL, 1994, J EXP PSYCHOL HUMAN, V20, P317, DOI 10.1037/0096-1523.20.2.317; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; GIBSON BS, 2001, ATTRACTION DISTRACTI, P51, DOI DOI 10.1016/S0166-4115(01)80005-4; Hernandez M, 2010, ATTEN PERCEPT PSYCHO, V72, P963, DOI 10.3758/APP.72.4.963; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Liu TS, 2005, NEURON, V45, P469, DOI 10.1016/j.neuron.2004.12.039; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Muller NG, 2007, J COGNITIVE NEUROSCI, V19, P587, DOI 10.1162/jocn.2007.19.4.587; Mulckhuyse M, 2008, EXP BRAIN RES, V186, P225, DOI 10.1007/s00221-007-1226-3; Munneke J, 2008, BRAIN RES, V1222, P184, DOI 10.1016/j.brainres.2008.05.039; Ogawa T, 2004, J NEUROSCI, V24, P6371, DOI 10.1523/JNEUROSCI.0569-04.2004; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Talsma D, 2010, J COGNITIVE NEUROSCI, V22, P761, DOI 10.1162/jocn.2009.21223; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; THEEUWES J, 1994, PERCEPTION, V23, P429, DOI 10.1068/p230429; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Theeuwes J, 2010, ACTA PSYCHOL, V135, P133, DOI 10.1016/j.actpsy.2010.07.006; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Van der Stigchel S, 2009, ACTA PSYCHOL, V132, P201, DOI 10.1016/j.actpsy.2009.07.001; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121	54	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20379	10.1371/journal.pone.0020379	http://dx.doi.org/10.1371/journal.pone.0020379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XS	21637812	Green Published, gold			2022-12-25	WOS:000291052200058
J	Wassenberg, MWM; de Wit, GA; Bonten, MJM				Wassenberg, Marjan W. M.; de Wit, G. Ardine; Bonten, Marc J. M.			Cost-Effectiveness of Preoperative Screening and Eradication of Staphylococcus aureus Carriage	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; NASAL CARRIAGE; PERITONEAL-DIALYSIS; MORTALITY; SURGERY; GENES; RISK	Background: Preoperative screening for nasal S. aureus carriage, followed by eradication treatment of identified carriers with nasal mupirocine ointment and chlorhexidine soap was highly effective in preventing deep-seated S. aureus infections. It is unknown how cost-effectiveness of this intervention is affected by suboptimal S. aureus screening. We determined cost-effectiveness of different preoperative S. aureus screening regimes. Methods: We compared different screening scenarios (ranging from treating all patients without screening to treating only identified S. aureus carriers) to the base case scenario without any screening and treatment. Screening and treatment costs as well as costs and mortality due to deep-seated S. aureus infection were derived from hospital databases and prospectively collected data, respectively. Results: As compared to the base case scenario, all scenarios are associated with improved health care outcomes at reduced costs. Treating all patients without screening is most cost-beneficial, saving (sic)7339 per life year gained, as compared to (sic)3330 when only identified carriers are treated. In sensitivity analysis, outcomes are susceptible to the sensitivity of the screening test and the efficacy of treatment. Reductions in these parameters would reduce the cost-effectiveness of scenarios in which treatment is based on screening. When only identified S. aureus carriers are treated costs of screening should be less than (sic)6.23 to become the dominant strategy. Conclusions: Preoperative screening and eradication of S. aureus carriage to prevent deep-seated S. aureus infections saves both life years and medical costs at the same time, although treating all patients without screening is the dominant strategy, resulting in most health gains and largest savings.	[Wassenberg, Marjan W. M.; Bonten, Marc J. M.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Wassenberg, Marjan W. M.] Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [de Wit, G. Ardine; Bonten, Marc J. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Wassenberg, MWM (corresponding author), Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands.	mbonten@umcutrecht.nl		de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	M.J.M.B. was supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriesse GI, 2009, EUR J CLIN MICROBIOL, V28, P1223, DOI 10.1007/s10096-009-0770-0; Batra R, 2010, CLIN INFECT DIS, V50, P210, DOI 10.1086/648717; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Choudhurry RSR, 2006, J MICROBIOL METH, V65, P354, DOI 10.1016/j.mimet.2005.08.009; *COLL ZORGV, 2010, FARM KOMP 2010; *DUTCH HEALTHC AUT, CI1094B2 DUTCH HEALT; Gold MR, 1996, COST EFFECTIVENESS H; Hacek DM, 2008, CLIN ORTHOP RELAT R, V466, P1349, DOI 10.1007/s11999-008-0210-y; Karra R, 2006, J THORAC CARDIOV SUR, V132, P537, DOI 10.1016/j.jtcvs.2006.04.037; Kluytmans JAJW, 1996, INFECT CONT HOSP EP, V17, P780; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Nouwen J, 2006, J CLIN MICROBIOL, V44, P2233, DOI 10.1128/JCM.02083-05; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Smith K, 2008, J ANTIMICROB CHEMOTH, V61, P78, DOI 10.1093/jac/dkm395; Vali L, 2008, J ANTIMICROB CHEMOTH, V61, P524, DOI 10.1093/jac/dkm520; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; White A, 1963, ANTIMICROB AGENTS CH, V161, P667	18	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e14815	10.1371/journal.pone.0014815	http://dx.doi.org/10.1371/journal.pone.0014815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637333	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200002
J	Nadendla, SK; Hazan, A; Ward, M; Harper, LJ; Moutasim, K; Bianchi, LS; Naase, M; Ghali, L; Thomas, GJ; Prowse, DM; Philpott, MP; Neill, GW				Nadendla, Sandeep K.; Hazan, Allon; Ward, Matt; Harper, Lisa J.; Moutasim, Karwan; Bianchi, Lucia S.; Naase, Mahmoud; Ghali, Lucy; Thomas, Gareth J.; Prowse, David M.; Philpott, Michael P.; Neill, Graham W.			GLI1 Confers Profound Phenotypic Changes upon LNCaP Prostate Cancer Cells That Include the Acquisition of a Hormone Independent State	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; STEM-CELLS; TRANSCRIPTIONAL ACTIVITY; CLAUDIN EXPRESSION; DRUG-RESISTANCE; LIPOCALIN NGAL; BREAST-CANCER; NUDE-MICE; IN-VITRO	The GLI (GLI1/GLI2) transcription factors have been implicated in the development and progression of prostate cancer although our understanding of how they actually contribute to the biology of these common tumours is limited. We observed that GLI reporter activity was higher in normal (PNT-2) and tumourigenic (DU145 and PC-3) androgen-independent cells compared to androgen-dependent LNCaP prostate cancer cells and, accordingly, GLI mRNA levels were also elevated. Ectopic expression of GLI1 or the constitutively active Delta NGLI2 mutant induced a distinct cobblestone-like morphology in LNCaP cells that, regarding the former, correlated with increased GLI2 as well as expression of the basal/stem-like markers CD44, beta 1-integrin, Delta Np63 and BMI1, and decreased expression of the luminal marker AR (androgen receptor). LNCaP-GLI1 cells were viable in the presence of the AR inhibitor bicalutamide and gene expression profiling revealed that the transcriptome of LNCaP-GLI1 cells was significantly closer to DU145 and PC-3 cells than to control LNCaP-pBP (empty vector) cells, as well as identifying LCN2/NGAL as a highly induced transcript which is associated with hormone independence in breast and prostate cancer. Functionally, LNCaP-GLI1 cells displayed greater clonal growth and were more invasive than control cells but they did not form colonies in soft agar or prostaspheres in suspension suggesting that they do not possess inherent stem cell properties. Moreover, targeted suppression of GLI1 or GLI2 with siRNA did not reverse the transformed phenotype of LNCaP-GLI1 cells nor did double GLI1/GLI2 knockdowns activate AR expression in DU145 or PC-3 cells. As such, early targeting of the GLI oncoproteins may hinder progression to a hormone independent state but a more detailed understanding of the mechanisms that maintain this phenotype is required to determine if their inhibition will enhance the efficacy of anti-hormonal therapy through the induction of a luminal phenotype and increased dependency upon AR function.	[Nadendla, Sandeep K.; Hazan, Allon; Ward, Matt; Harper, Lisa J.; Bianchi, Lucia S.; Philpott, Michael P.; Neill, Graham W.] Queen Mary Univ London, Ctr Cutaneous Res, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England; [Nadendla, Sandeep K.; Naase, Mahmoud; Ghali, Lucy] Middlesex Univ, Dept Biomed Sci, Sch Hlth & Social Sci, Enfield, Middx, England; [Moutasim, Karwan; Thomas, Gareth J.] Univ Southampton, Canc Sci Div, Sch Med, Southampton, Hants, England; [Prowse, David M.] Queen Mary Univ London, Ctr Mol Oncol & Imaging, Inst Canc, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London; Middlesex University; University of Southampton; University of London; Queen Mary University London	Nadendla, SK (corresponding author), Queen Mary Univ London, Ctr Cutaneous Res, Blizard Inst Cell & Mol Sci, Barts & London Sch Med & Dent, London, England.	g.w.neill@qmul.ac.uk	Neill, Graham/C-9008-2012	Philpott, Michael/0000-0002-1255-4612	Middlesex University; Prostate Action [G2007/55, G2008/07, G2009/30]; Barts; The London Charity	Middlesex University; Prostate Action; Barts; The London Charity	This work was principally (and generously) supported by the Middlesex University Matched Funding Scheme (SKN), Prostate Action http://www.prostateaction.org.uk/ (SKN and AH: Grant codes G2007/55, G2008/07 and G2009/30) and Barts and The London Charity http://www.bartsandthelondoncharity.org.uk/ (GWN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay S, 2008, J PATHOL, V216, P460, DOI 10.1002/path.2427; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Chen BY, 2007, BIOCHEM BIOPH RES CO, V357, P1084, DOI 10.1016/j.bbrc.2007.04.091; Chen GC, 2011, BIOCHEM BIOPH RES CO, V404, P809, DOI 10.1016/j.bbrc.2010.12.065; Chen MQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-89; Chen M, 2009, CELL CYCLE, V8, P149, DOI 10.4161/cc.8.1.7532; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Creighton CJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-199; Datta S, 2006, CELL MOL LIFE SCI, V63, P435, DOI 10.1007/s00018-005-5389-4; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Gruvberger S, 2001, CANCER RES, V61, P5979; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Jarrard DF, 1998, CANCER RES, V58, P5310; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kinoshita H, 2000, CANCER RES, V60, P3623; Kise Y, 2006, BIOCHEM BIOPH RES CO, V351, P78, DOI 10.1016/j.bbrc.2006.10.036; KLARMANN GJ, 2009, CLIN EXP METASTASIS; Krajewska M, 2007, PROSTATE, V67, P907, DOI 10.1002/pros.20578; Lang SH, 2000, BRIT J CANCER, V82, P990, DOI 10.1054/bjoc.1999.1029; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; LEE EK, 2010, J PROTEOME RES; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu AY, 1999, PROSTATE, V40, P192; Liu AY, 2002, PROSTATE, V50, P92, DOI 10.1002/pros.10036; Lu S, 2007, CLIN CANCER RES, V13, P5692, DOI 10.1158/1078-0432.CCR-07-1078; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Moses MA, 1998, CANCER RES, V58, P1395; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Nadiminty N, 2010, PROSTATE, V70, P276, DOI 10.1002/pros.21062; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Neill GW, 2008, CARCINOGENESIS, V29, P738, DOI 10.1093/carcin/bgn037; Neill GW, 2003, CANCER RES, V63, P4692; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Prasad PD, 2010, CELL TISSUE RES, V339, P337, DOI 10.1007/s00441-009-0902-y; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Shaw G, 2008, EUR UROL, V54, P1333, DOI 10.1016/j.eururo.2008.01.070; Sheehan GM, 2007, HUM PATHOL, V38, P564, DOI 10.1016/j.humpath.2006.11.007; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Sikand K, 2010, INT J CANC; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; SINGH A, 2010, ONCOGENE; Speek M, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-13; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stoesz SP, 1998, INT J CANCER, V79, P565, DOI 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.3.CO;2-6; Sun RP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-93; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Szasz AM, 2010, BJU INT, V105, P716, DOI 10.1111/j.1464-410X.2009.08808.x; Tanimura A, 1998, J VIROL, V72, P3958, DOI 10.1128/JVI.72.5.3958-3964.1998; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tessel MA, 2010, CURR OPIN ONCOL, V22, P592, DOI 10.1097/CCO.0b013e32833ea80c; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; Vare P, 2008, ONCOL REP, V19, P25; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang XQ, 2001, J BIOL CHEM, V276, P1311, DOI 10.1074/jbc.M005191200; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang FH, 2005, CLIN CANCER RES, V11, P4512, DOI 10.1158/1078-0432.CCR-04-2571; Zhang YM, 2009, NEOPLASIA, V11, P96, DOI 10.1593/neo.81264; ZHAO J, 2009, BREAST CANC RES TREA	88	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20271	10.1371/journal.pone.0020271	http://dx.doi.org/10.1371/journal.pone.0020271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633508	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000291006500050
J	Singhmar, P; Kumar, A				Singhmar, Pooja; Kumar, Arun			Angelman Syndrome Protein UBE3A Interacts with Primary Microcephaly Protein ASPM, Localizes to Centrosomes and Regulates Chromosome Segregation	PLOS ONE			English	Article							TRUNCATING MUTATIONS; NEURONAL PROGENITORS; CITRON-KINASE; BRAIN SIZE; GENE; IDENTIFICATION; CYTOKINESIS; CDK5RAP2; FAMILIES; CELL	Many proteins associated with the phenotype microcephaly have been localized to the centrosome or linked to it functionally. All the seven autosomal recessive primary microcephaly (MCPH) proteins localize at the centrosome. Microcephalic osteodysplastic primordial dwarfism type II protein PCNT and Seckel syndrome (also characterized by severe microcephaly) protein ATR are also centrosomal proteins. All of the above findings show the importance of centrosomal proteins as the key players in neurogenesis and brain development. However, the exact mechanism as to how the loss-of-function of these proteins leads to microcephaly remains to be elucidated. To gain insight into the function of the most commonly mutated MCPH gene ASPM, we used the yeast two-hybrid technique to screen a human fetal brain cDNA library with an ASPM bait. The analysis identified Angelman syndrome gene product UBE3A as an ASPM interactor. Like ASPM, UBE3A also localizes to the centrosome. The identification of UBE3A as an ASPM interactor is not surprising as more than 80% of Angelman syndrome patients have microcephaly. However, unlike in MCPH, microcephaly is postnatal in Angelman syndrome patients. Our results show that UBE3A is a cell cycle regulated protein and its level peaks in mitosis. The shRNA knockdown of UBE3A in HEK293 cells led to many mitotic abnormalities including chromosome missegregation, abnormal cytokinesis and apoptosis. Thus our study links Angelman syndrome protein UBE3A to ASPM, centrosome and mitosis for the first time. We suggest that a defective chromosome segregation mechanism is responsible for the development of microcephaly in Angelman syndrome.	[Singhmar, Pooja; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Singhmar, P (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219	Department of Biotechnology, New Delhi [BT/PR5914/Med/14/715/2005]; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was financially supported by a grant (number BT/PR5914/Med/14/715/2005) from the Department of Biotechnology, New Delhi to AK, and a Junior Research Fellowship from the Council of Scientific and Industrial Research, New Delhi to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; GONZALEZ C, 1990, J CELL SCI, V96, P605; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Gul A, 2007, J NEUROGENET, V21, P153, DOI 10.1080/01677060701508594; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar A, 2004, CLIN GENET, V66, P341, DOI 10.1111/j.1399-0004.2004.00304.x; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Nicholas AK, 2009, J MED GENET, V46, P249, DOI 10.1136/jmg.2008.062380; Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682; Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Sarkisian MR, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-08-j0001.2002; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Yang YZ, 2007, J CELL BIOCHEM, V101, P167, DOI 10.1002/jcb.21164; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683; Zhang XY, 2009, CELL CYCLE, V8, P1206, DOI 10.4161/cc.8.8.8205; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481	39	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20397	10.1371/journal.pone.0020397	http://dx.doi.org/10.1371/journal.pone.0020397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633703	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500060
J	Laffray, S; Pages, S; Dufour, H; De Koninck, P; De Koninck, Y; Cote, D				Laffray, Sophie; Pages, Stephane; Dufour, Hugues; De Koninck, Paul; De Koninck, Yves; Cote, Daniel			Adaptive Movement Compensation for In Vivo Imaging of Fast Cellular Dynamics within a Moving Tissue	PLOS ONE			English	Article							MOUSE SPINAL-CORD; LONG-TERM; MICROSCOPY; BRAIN; RESOLUTION; AXONS; MICE	In vivo non-linear optical microscopy has been essential to advance our knowledge of how intact biological systems work. It has been particularly enabling to decipher fast spatiotemporal cellular dynamics in neural networks. The power of the technique stems from its optical sectioning capability that in turn also limits its application to essentially immobile tissue. Only tissue not affected by movement or in which movement can be physically constrained can be imaged fast enough to conduct functional studies at high temporal resolution. Here, we show dynamic two-photon Ca(2+) imaging in the spinal cord of a living rat at millisecond time scale, free of motion artifacts using an optical stabilization system. We describe a fast, non-contact adaptive movement compensation approach, applicable to rough and weakly reflective surfaces, allowing real-time functional imaging from intrinsically moving tissue in live animals. The strategy involves enslaving the position of the microscope objective to that of the tissue surface in real-time through optical monitoring and a closed feedback loop. The performance of the system allows for efficient image locking even in conditions of random or irregular movements.	[Laffray, Sophie; Pages, Stephane; Dufour, Hugues; De Koninck, Paul; De Koninck, Yves; Cote, Daniel] Univ Laval, CRULRG, Quebec City, PQ, Canada; [De Koninck, Yves; Cote, Daniel] Univ Laval, Ctr Opt Photon & Laser, Quebec City, PQ G1K 7P4, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ, Canada; [De Koninck, Yves] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Cote, Daniel] Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Laffray, S (corresponding author), Univ Laval, CRULRG, Quebec City, PQ, Canada.	Yves.Dekoninck@crulrg.ulaval.ca	Côté, Daniel/D-5185-2011; De Koninck, Yves/C-2659-2008; Laffray, Sophie/AAA-4792-2019	De Koninck, Yves/0000-0002-5779-9330; Laffray, Sophie/0000-0002-1562-0304	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada; Fonds de la recherche en sante du Quebec; CIPI TEN	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); CIPI TEN	Canadian Institute of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html), The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca/fr/index.shtml), CIPI TEN (http://www.cipi.ulaval.ca/programs/ten_program/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asatryan K, 2010, OPT EXPRESS, V18, P13981, DOI 10.1364/OE.18.013981; Chaigneau E, 2007, J NEUROSCI, V27, P6452, DOI 10.1523/JNEUROSCI.3141-06.2007; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; JOHANNSSEN HC, 2010, J PHYSL; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kreft M, 2005, ANN NY ACAD SCI, V1048, P321, DOI 10.1196/annals.1342.029; LEWIS CE, 1986, RADIOLOGY, V160, P803, DOI 10.1148/radiology.160.3.3737921; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Rajadhyaksha M, 1999, APPL OPTICS, V38, P2105, DOI 10.1364/AO.38.002105; Rochefort NL, 2008, TRENDS MOL MED, V14, P389, DOI 10.1016/j.molmed.2008.07.005; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751	21	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19928	10.1371/journal.pone.0019928	http://dx.doi.org/10.1371/journal.pone.0019928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629702	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005800017
J	Nauwelaers, D; Van Houtte, M; Winters, B; Steegen, K; Van Baelen, K; Chi, E; Zhou, MM; Steiner, D; Bonesteel, R; Aston, C; Stuyver, LJ				Nauwelaers, David; Van Houtte, Margriet; Winters, Bart; Steegen, Kim; Van Baelen, Kurt; Chi, Ellen; Zhou, Mimi; Steiner, Derek; Bonesteel, Rachelle; Aston, Colin; Stuyver, Lieven J.			A Synthetic HIV-1 Subtype C Backbone Generates Comparable PR and RT Resistance Profiles to a Subtype B Backbone in a Recombinant Virus Assay	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; GENETIC SUBTYPES; IN-VITRO; TYPE-1; INHIBITORS; SELECTION	In order to determine phenotypic protease and reverse transcriptase inhibitor-associated resistance in HIV subtype C virus, we have synthetically constructed an HIV-1 subtype C (HIV-1-C) viral backbone for use in a recombinant virus assay. The in silico designed viral genome was divided into 4 fragments, which were chemically synthesized and joined together by conventional subcloning. Subsequently, gag-protease-reverse-transcriptase (GPRT) fragments from 8 HIV-1 subtype C-infected patient samples were RT-PCR-amplified and cloned into the HIV-1-C backbone (deleted for GPRT) using In-Fusion reagents. Recombinant viruses (1 to 5 per patient sample) were produced in MT4-eGFP cells where cyto-pathogenic effect (CPE), p24 and Viral Load (VL) were monitored. The resulting HIV-1-C recombinant virus stocks (RVS) were added to MT4-eGFP cells in the presence of serial dilutions of antiretroviral drugs (PI, NNRTI, NRTI) to determine the fold-change in IC50 compared to the IC50 of wild-type HIV-1 virus. Additionally, viral RNA was extracted from the HIV-1-C RVS and the amplified GPRT products were used to generate recombinant virus in a subtype B backbone. Phenotypic resistance profiles in a subtype B and subtype C backbone were compared. The following observations were made: i) functional, infectious HIV-1 subtype C viruses were generated, confirmed by VL and p24 measurements; ii) their rate of infection was slower than viruses generated in the subtype B backbone; iii) they did not produce clear CPE in MT4 cells; and iv) drug resistance profiles generated in both backbones were very similar, including re-sensitizing effects like M184V on AZT.	[Nauwelaers, David; Van Houtte, Margriet; Winters, Bart; Steegen, Kim; Van Baelen, Kurt; Stuyver, Lieven J.] Virco BVBA, Beerse, Belgium; [Chi, Ellen; Zhou, Mimi; Steiner, Derek; Bonesteel, Rachelle; Aston, Colin] Centocor Inc, Centocor Res & Discovery, San Diego, CA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Nauwelaers, D (corresponding author), Biocartis NV, Generaal De Wittelaan L11 B3, Mechelen, Belgium.	lstuyver@its.jnj.com	Steegen, K/AAF-6512-2020; Steegen, Kim/ABH-4471-2020	Steegen, Kim/0000-0003-3226-7685	Virco BVBA; Centocor	Virco BVBA; Centocor	The following commercial companies are funders for this study: Virco BVBA (employees DN, MVH, KS, BW, KVB, LJS) and its affiliate Centocor (employees EC, MZ, DS, RB, CA). There were no external funding sources for this study. This research was conducted in the course of the authors' employment. The funders had no direct or indirect influence on the results of the research or on the presentation of the results in the paper.	Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; BORROTOESODA K, 2001, ANTIVIR THER, V6; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Cello J, 2002, NATURE, V418, P915, DOI 10.1038/418915a; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Church G, 2005, NATURE, V438, P423, DOI 10.1038/438423a; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; EVANS GA, 2001, Patent No. 6670127; EVANS GA, 1998, Patent No. 6521427; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; GIBSON DG, SCIENCE; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Iordanskiy S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-85; Jackson JH, 2008, BMC SYST BIOL, V2, DOI [10.1186/1752-0509-2-62, 10.1007/s11693-008-9018-z]; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KUSUMI K, 1992, J VIROL, V66, P875, DOI 10.1128/JVI.66.2.875-885.1992; Luisi PL, 2007, CHEM BIODIVERS, V4, P603, DOI 10.1002/cbdv.200790053; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Quinones-Mateu ME, 1999, AIDS RES HUM RETROV, V15, P85, DOI 10.1089/088922299311763; Rabinow Paul, 2009, Syst Synth Biol, V3, P99, DOI 10.1007/s11693-009-9042-7; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Wainberg MA, 2005, ANTIMICROB AGENTS CH, V49, P1671, DOI 10.1128/AAC.49.5.1671-1678.2005; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19643	10.1371/journal.pone.0019643	http://dx.doi.org/10.1371/journal.pone.0019643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629677	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005800004
J	Popa, I; Therville, N; Carpentier, S; Levade, T; Cuvillier, O; Portoukalian, J				Popa, Iuliana; Therville, Nicole; Carpentier, Stephane; Levade, Thierry; Cuvillier, Olivier; Portoukalian, Jacques			Production of Multiple Brain-Like Ganglioside Species Is Dispensable for Fas-Induced Apoptosis of Lymphoid Cells	PLOS ONE			English	Article							ACIDIC SPHINGOMYELINASE; MEDIATED APOPTOSIS; GD3 GANGLIOSIDE; LYSOSOMAL SPHINGOMYELINASE; T-LYMPHOCYTES; CERAMIDE; DEATH; MICE; MITOCHONDRIA; SPHINGOSINE	Activation of an acid sphingomyelinase (aSMase) leading to a biosynthesis of GD3 disialoganglioside has been associated with Fas-induced apoptosis of lymphoid cells. The present study was undertaken to clarify the role of this enzyme in the generation of gangliosides during apoptosis triggered by Fas ligation. The issue was addressed by using aSMase-deficient and aSMase-corrected cell lines derived from Niemann-Pick disease (NPD) patients. Fas cross-linking elicited a rapid production of large amounts of complex a-and b-series species of gangliosides with a pattern and a chromatographic behavior as single bands reminiscent of brain gangliosides. The gangliosides were synthesized within the first ten minutes and completely disappeared within thirty minutes after stimulation. Noteworthy is the observation that GD3 was not the only ganglioside produced. The production of gangliosides and the onset of apoptotic hallmarks occurred similarly in both aSMase-deficient and aSMase-corrected NPD lymphoid cells, indicating that aSMase activation is not accountable for ganglioside generation. Hampering ganglioside production by inhibiting the key enzyme glucosylceramide synthase did not abrogate the apoptotic process. In addition, GM3 synthase-deficient lymphoid cells underwent Fas-induced apoptosis, suggesting that gangliosides are unlikely to play an indispensable role in transducing Fas-induced apoptosis of lymphoid cells.	[Popa, Iuliana; Portoukalian, Jacques] Univ Lyon 1, Hop Edouard Herriot, Lab Rech Dermatol, EA4169, F-69365 Lyon, France; [Therville, Nicole; Carpentier, Stephane; Levade, Thierry] Fac Med Toulouse, INSERM, UMR1037, F-31073 Toulouse, France; [Therville, Nicole; Carpentier, Stephane; Levade, Thierry] Univ Toulouse, Ctr Rech Cancerol Toulouse, Toulouse, France; [Levade, Thierry] CHU Purpan, Inst Federatif Biol, Lab Biochim Metab, Toulouse, France; [Cuvillier, Olivier] CNRS, IPBS, Toulouse, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Popa, I (corresponding author), Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France.	thierry.levade@inserm.fr; olivier.cuvillier@ipbs.fr; jacques.portoukalian@univ-lyon1.fr	Levade, Thierry/O-8948-2014; CUVILLIER, Olivier/B-2567-2009; CUVILLIER, Olivier/S-1631-2019; Therville, Nicole/P-2371-2014	CUVILLIER, Olivier/0000-0003-3346-375X; CUVILLIER, Olivier/0000-0003-3346-375X; Therville, Nicole/0000-0002-7068-1361; portoukalian, jacques/0000-0001-6584-3234	INSERM; Vaincre les Maladies Lysosomales Foundation; Universite Paul Sabatier	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Vaincre les Maladies Lysosomales Foundation; Universite Paul Sabatier	This work was supported by INSERM, Universite Paul Sabatier, and Vaincre les Maladies Lysosomales Foundation (to OC and TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezombes C, 2001, FASEB J, V15, P297; Bodennec J, 2000, J LIPID RES, V41, P1524; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; BOUCHON B, 1990, BIOCHIM BIOPHYS ACTA, V1051, P1, DOI 10.1016/0167-4889(90)90166-B; Chen HY, 2002, J EXP MED, V196, P1529, DOI 10.1084/jem.20021915; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Cuvillier O, 2000, J BIOL CHEM, V275, P15691, DOI 10.1074/jbc.M000280200; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Giammarioli AM, 2001, FEBS LETT, V506, P45, DOI 10.1016/S0014-5793(01)02776-4; GILL BM, 1994, IMMUNOL REV, V142, P113, DOI 10.1111/j.1600-065X.1994.tb00885.x; GRABER D, 1994, J NEUROCHEM, V63, P1060; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; KISIC A, 1974, J LIPID RES, V15, P179; Lin T, 2000, J BIOL CHEM, V275, P8657, DOI 10.1074/jbc.275.12.8657; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; NAGATA Y, 1992, J BIOL CHEM, V267, P12082; Okada M, 2002, J BIOL CHEM, V277, P1633, DOI 10.1074/jbc.C100395200; OKADA Y, 1988, FEBS LETT, V235, P25, DOI 10.1016/0014-5793(88)81227-4; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Popa I, 2002, J LIPID RES, V43, P1335, DOI 10.1194/jlr.D20005-JLR200; PORTOUKALIAN J, 1986, J CHROMATOGR, V380, P386, DOI 10.1016/S0378-4347(00)83668-3; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Sabourdy F, 2008, BBA-MOL CELL BIOL L, V1781, P145, DOI 10.1016/j.bbalip.2008.01.004; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Shimizu M, 1999, J IMMUNOL, V162, P7350; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; TEPPER CG, 1995, P NATL ACAD SCI USA, V92, P8443, DOI 10.1073/pnas.92.18.8443; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19974	10.1371/journal.pone.0019974	http://dx.doi.org/10.1371/journal.pone.0019974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629700	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800019
J	Mausberg, TB; Wess, G; Simak, J; Keller, L; Drogemuller, M; Drogemuller, C; Webster, MT; Stephenson, H; Dukes-McEwan, J; Leeb, T				Mausberg, Theresa-Bernadette; Wess, Gerhard; Simak, Julia; Keller, Lisa; Droegemueller, Michaela; Droegemueller, Cord; Webster, Matthew T.; Stephenson, Hannah; Dukes-McEwan, Joanna; Leeb, Tosso			A Locus on Chromosome 5 Is Associated with Dilated Cardiomyopathy in Doberman Pinschers	PLOS ONE			English	Article							CANDIDATE GENE; DOGS	Dilated cardiomyopathy (DCM) is a heterogeneous group of heart diseases with a strong genetic background. Currently, many human DCM cases exist where no causative mutation can be identified. DCM also occurs with high prevalence in several large dog breeds. In the Doberman Pinscher a specific DCM form characterized by arrhythmias and/or echocardiographic changes has been intensively studied by veterinary cardiologists. We performed a genome-wide association study in Doberman Pinschers. Using 71 cases and 70 controls collected in Germany we identified a genome-wide significant association to DCM on chromosome 5. We validated the association in an independent cohort collected in the United Kingdom. There is no known DCM candidate gene under the association signal. Therefore, DCM in Doberman Pinschers offers the chance of identifying a novel DCM gene that might also be relevant for human health.	[Mausberg, Theresa-Bernadette; Droegemueller, Michaela; Droegemueller, Cord; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Wess, Gerhard; Simak, Julia; Keller, Lisa] LMU Univ, Clin Small Anim Med, Munich, Germany; [Webster, Matthew T.] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Stephenson, Hannah; Dukes-McEwan, Joanna] Univ Liverpool, Small Anim Teaching Hosp, Liverpool L69 3BX, Merseyside, England	University of Bern; University of Munich; Uppsala University; University of Liverpool	Mausberg, TB (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	tosso.leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014	Leeb, Tosso/0000-0003-0553-4880; Dukes-McEwan, Joanna/0000-0002-0326-8251; Webster, Matthew/0000-0003-1141-2863; Wess, Gerhard/0000-0002-6634-8072; Drogemuller, Cord/0000-0001-9773-522X	European Commission [LUPA-GA.201270]; Albert-Heim Foundation; Boehringer Ingelheim Vetemedica	European Commission(European CommissionEuropean Commission Joint Research Centre); Albert-Heim Foundation; Boehringer Ingelheim Vetemedica(Boehringer Ingelheim)	This work was funded thanks to grants from the European Commission (LUPA-GA.201270), the Albert-Heim Foundation, and Boehringer Ingelheim Vetemedica (PROTECT study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Calvert CA, 2000, J AM VET MED ASSOC, V217, P1328, DOI 10.2460/javma.2000.217.1328; Calvert CA, 2004, J AM ANIM HOSP ASSOC, V40, P24, DOI 10.5326/0400024; CALVERT CA, 1982, J AM VET MED ASSOC, V181, P598; Calvert CA, 1997, J AM VET MED ASSOC, V210, P505; CALVERT CA, 2000, CURRENT VET THERAPY, V13, P756; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; Meurs KM, 2008, AM J VET RES, V69, P1050, DOI 10.2460/ajvr.69.8.1050; Meurs KM, 2007, J VET INTERN MED, V21, P1016, DOI 10.1892/0891-6640(2007)21[1016:APGEOF]2.0.CO;2; Meurs KM, 2001, AM J VET RES, V62, P33, DOI 10.2460/ajvr.2001.62.33; Minors SL, 1998, J VET INTERN MED, V12, P369, DOI 10.1111/j.1939-1676.1998.tb02137.x; O'Grady MR, 2008, J VET INTERN MED, V22, P897, DOI 10.1111/j.1939-1676.2008.0116.x; O'Grady MR, 2004, VET CLIN N AM-SMALL, V34, P1187, DOI 10.1016/j.cvsm.2004.05.009; RABER H, 1993, ENZYKLOPADIE HUNDERA, V1, P467; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Stabej P, 2005, CYTOGENET GENOME RES, V111, P140, DOI 10.1159/000086383; Stabej P, 2005, AM J VET RES, V66, P432, DOI 10.2460/ajvr.2005.66.432; Stabej P, 2004, GENE, V340, P241, DOI 10.1016/j.gene.2004.06.050; Stark K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001167; Tidholm A, 1997, J AM ANIM HOSP ASSOC, V33, P544, DOI 10.5326/15473317-33-6-544; Wess G, 2010, J VET INTERN MED, V24, P533, DOI 10.1111/j.1939-1676.2010.0479.x; WIERSMA AC, 2007, BMC VET RES, V3; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525	29	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20042	10.1371/journal.pone.0020042	http://dx.doi.org/10.1371/journal.pone.0020042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625443	gold, Green Published, Green Submitted			2022-12-25	WOS:000290793400035
J	Opitz, CA; Litzenburger, UM; Opitz, U; Sahm, F; Ochs, K; Lutz, C; Wick, W; Platten, M				Opitz, Christiane A.; Litzenburger, Ulrike M.; Opitz, Uta; Sahm, Felix; Ochs, Katharina; Lutz, Christian; Wick, Wolfgang; Platten, Michael			The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; TRYPTOPHAN DEGRADATION; INTERFERON-GAMMA; DENDRITIC CELLS; OVARIAN-CANCER; PROTEIN-KINASE; HEPATOCELLULAR-CARCINOMA; ENDOMETRIAL CANCER; MECHANISM; SURVIVAL	1-methyl-D-tryptophan (1-D-MT) is currently being used in clinical trials in patients with relapsed or refractory solid tumors with the aim of inhibiting indoleamine-2,3-dioxygenase (IDO)-mediated tumor immune escape. IDO is expressed in tumors and tumor-draining lymph nodes and degrades tryptophan (trp) to create an immunsuppressive micromilieu both by depleting trp and by accumulating immunosuppressive metabolites of the kynurenine (kyn) pathway. Here we show that proliferation of alloreactive T-cells cocultured with IDO1-positive human cancer cells paradoxically was inhibited by 1-D-MT. Surprisingly incubation with 1-D-MT increased kyn production of human cancer cells. Cell-free assays revealed that 1-D-MT did not alter IDO1 enzymatic activity. Instead, 1-D-MT induced IDO1 mRNA and protein expression through pathways involving p38 MAPK and JNK signalling. Treatment of cancer patients with 1-D-MT has transcriptional effects that may promote rather than suppress anti-tumor immune escape by increasing IDO1 in the cancer cells. These off-target effects should be carefully analyzed in the ongoing clinical trials with 1-D-MT.	[Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ochs, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Dept Neurooncol, Neurol Clin, Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ochs, Katharina; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ochs, Katharina; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-6900 Heidelberg, Germany; [Opitz, Uta; Lutz, Christian] Heidelberg Pharma AG, Ladenburg, Germany; [Sahm, Felix] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Sahm, Felix] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-6900 Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Opitz, CA (corresponding author), Univ Heidelberg Hosp, Dept Neurooncol, Neurol Clin, Heidelberg, Germany.	m.platten@dkfz-heidelberg.de	Wick, Wolfgang/AAA-2545-2020; Sahm, Felix/GQY-8202-2022; Opitz, Christiane A/I-9507-2012; Platten, Michael/F-2902-2013	Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Opitz, Christiane A/0000-0001-5575-9821; Platten, Michael/0000-0002-4746-887X	Helmholtz Association [VH-NG-306]; Hertie Foundation; Heidelberg University	Helmholtz Association(Helmholtz Association); Hertie Foundation; Heidelberg University	This work was supported by a grant from the Helmholtz Association (VH-NG-306) to MP and the Hertie Foundation to WW. CAO is supported by a Heidelberg University Medical Faculty Postdoctoral Fellowship. As Uta Opitz and Christian Lutz are employees of Heidelberg Pharma, Heidelberg Pharma had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boasso A, 2009, J IMMUNOL, V182, P4313, DOI 10.4049/jimmunol.0803314; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Corrigall VM, 2009, IMMUNOLOGY, V128, P218, DOI 10.1111/j.1365-2567.2009.03103.x; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; Giannopoulos A, 2003, CLIN CANCER RES, V9, P5550; Herve C, 1996, J CHROMATOGR B, V675, P157, DOI 10.1016/0378-4347(95)00341-X; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Ino K, 2006, BRIT J CANCER, V95, P1555, DOI 10.1038/sj.bjc.6603477; Ino K, 2008, CLIN CANCER RES, V14, P2310, DOI 10.1158/1078-0432.CCR-07-4144; Ishio T, 2004, J GASTROEN HEPATOL, V19, P319, DOI 10.1111/j.1440-1746.2003.03259.x; LANZ T, 2009, STEM CELLS DEV; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Marth C, 2006, INT J GYNECOL CANCER, V16, P1522, DOI 10.1111/j.1525-1438.2006.00622.x; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Okamoto T, 2007, CYTOTECHNOLOGY, V54, P107, DOI 10.1007/s10616-007-9081-4; Opitz CA, 2007, CELL MOL LIFE SCI, V64, P2542, DOI 10.1007/s00018-007-7140-9; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; OZAKI Y, 1988, P NATL ACAD SCI USA, V85, P1242, DOI 10.1073/pnas.85.4.1242; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Riesenberg R, 2007, CLIN CANCER RES, V13, P6993, DOI 10.1158/1078-0432.CCR-07-0942; Schmitt M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp581; Schroecksnadel K, 2007, J CANCER RES CLIN, V133, P477, DOI 10.1007/s00432-007-0191-3; Sharma MD, 2009, BLOOD, V113, P6102, DOI 10.1182/blood-2008-12-195354; Takao M, 2007, ONCOL REP, V17, P1333; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang Y, 2009, BRAIN BEHAV IMMUN; Windbichler GH, 2000, BRIT J CANCER, V82, P1138; YOSHIDA R, 1988, J IMMUNOL, V141, P2819; Yu WG, 1996, INT IMMUNOL, V8, P855, DOI 10.1093/intimm/8.6.855; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007	41	107	115	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19823	10.1371/journal.pone.0019823	http://dx.doi.org/10.1371/journal.pone.0019823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625531	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400013
J	Heron-Delaney, M; Anzures, G; Herbert, JS; Quinn, PC; Slater, AM; Tanaka, JW; Lee, K; Pascalis, O				Heron-Delaney, Michelle; Anzures, Gizelle; Herbert, Jane S.; Quinn, Paul C.; Slater, Alan M.; Tanaka, James W.; Lee, Kang; Pascalis, Olivier			Perceptual Training Prevents the Emergence of the Other Race Effect during Infancy	PLOS ONE			English	Article							FACE RECOGNITION; OWN-RACE; 3-MONTH-OLD INFANTS; PLASTICITY; EXPERIENCE; CHILDHOOD; MEMORY; BIAS	Experience plays a crucial role in the development of the face processing system. At 6 months of age infants can discriminate individual faces from their own and other races. By 9 months of age this ability to process other-race faces is typically lost, due to minimal experience with other-race faces, and vast exposure to own-race faces, for which infants come to manifest expertise [1]. This is known as the Other Race Effect. In the current study, we demonstrate that exposing Caucasian infants to Chinese faces through perceptual training via picture books for a total of one hour between 6 and 9 months allows Caucasian infants to maintain the ability to discriminate Chinese faces at 9 months of age. The development of the processing of face race can be modified by training, highlighting the importance of early experience in shaping the face representation.	[Heron-Delaney, Michelle; Herbert, Jane S.] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Anzures, Gizelle] Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada; [Quinn, Paul C.] Univ Delaware, Dept Psychol, Newark, DE USA; [Slater, Alan M.] Univ Exeter, Dept Psychol, Exeter EX4 4RJ, Devon, England; [Tanaka, James W.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Lee, Kang] Univ Toronto, Inst Child Study, Toronto, ON, Canada; [Pascalis, Olivier] Univ Pierre Mendes France, Lab Psychol & Neurocognit, Grenoble, France	University of Sheffield; University of Toronto; University of Delaware; University of Exeter; University of Victoria; University of Toronto; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Heron-Delaney, M (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	michelle.delaney@uq.edu.au	Herbert, Jane/GNP-3396-2022; Heron-Delaney, Michelle/M-7540-2014	Herbert, Jane/0000-0002-8762-4531; pascalis, olivier/0000-0003-4609-3233; Heron-Delaney, Michelle/0000-0003-1332-9385	Economic and Social Research Council [RES-000-22-3246]; National Institutes of Health [R01 HD046526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/G027188/1] Funding Source: researchfish; ESRC [ES/G027188/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an Economic and Social Research Council grant (RES-000-22-3246)(http://www.esrc.ac.uk/funding-and-guidance/funding-opportunities/) awarded to MH-D, JSH, and OP, and by National Institutes of Health grant R01 HD046526 (http://grants.nih.gov/grants/oer.htm) awarded to PCQ, AMS, JWT, KL, and OP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; de Heering A, 2010, DEVELOPMENTAL SCI, V13, P181, DOI 10.1111/j.1467-7687.2009.00876.x; ELLIOTT ES, 1973, B PSYCHONOMIC SOC, V2, P71, DOI 10.3758/BF03327717; FAGAN JF, 1974, CHILD DEV, V45, P351; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Ferguson KT, 2009, INFANCY, V14, P263, DOI 10.1080/15250000902839369; GOLDSTEIN AG, 1985, B PSYCHONOMIC SOC, V23, P211; Hunter M.A., 1988, ADV INFANCY RES, V5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Lebrecht S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004215; MALPASS RS, 1973, PERCEPT PSYCHOPHYS, V14, P285, DOI 10.3758/BF03212392; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Scott LS, 2009, PSYCHOL SCI, V20, P676, DOI 10.1111/j.1467-9280.2009.02348.x; SLATER AM, 1975, J EXP CHILD PSYCHOL, V20, P240, DOI 10.1016/0022-0965(75)90101-0; Tanaka JW, 2009, COGN AFFECT BEHAV NE, V9, P122, DOI 10.3758/CABN.9.1.122	23	99	100	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19858	10.1371/journal.pone.0019858	http://dx.doi.org/10.1371/journal.pone.0019858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765PE	21625638	gold, Green Published, Green Accepted			2022-12-25	WOS:000290720200040
J	Park, J; Lee, HJ; Cheon, CI; Kim, SH; Hur, YS; Auh, CK; Im, KH; Yun, DJ; Lee, S; Davis, KR				Park, Jungan; Lee, Hyun-Ju; Cheon, Choong-Ill; Kim, Sung-Han; Hur, Yoon-Sun; Auh, Chung-Kyun; Im, Kyung-Hwan; Yun, Dae-Jin; Lee, Sukchan; Davis, Keith R.			The Arabidopsis thaliana Homeobox Gene ATHB12 Is Involved in Symptom Development Caused by Geminivirus Infection	PLOS ONE			English	Article							CURLY-TOP-VIRUS; HD-ZIP PROTEIN; VIRION-SENSE GENES; TRANSCRIPTIONAL ANALYSIS; WATER-DEFICIT; EXPRESSION; INTERACTS; MOVEMENT; GROWTH; CELLS	Background: Geminiviruses are single-stranded DNA viruses that infect a number of monocotyledonous and dicotyledonous plants. Arabidopsis is susceptible to infection with the Curtovirus, Beet severe curly top virus (BSCTV). Infection of Arabidopsis with BSCTV causes severe symptoms characterized by stunting, leaf curling, and the development of abnormal inflorescence and root structures. BSCTV-induced symptom development requires the virus-encoded C4 protein which is thought to interact with specific plant-host proteins and disrupt signaling pathways important for controlling cell division and development. Very little is known about the specific plant regulatory factors that participate in BSCTV-induced symptom development. This study was conducted to identify specific transcription factors that are induced by BSCTV infection. Methodology/Principal Findings: Arabidopsis plants were inoculated with BSCTV and the induction of specific transcription factors was monitored using quantitative real-time polymerase chain reaction assays. We found that the ATHB12 and ATHB7 genes, members of the homeodomain-leucine zipper family of transcription factors previously shown to be induced by abscisic acid and water stress, are induced in symptomatic tissues of Arabidopsis inoculated with BSCTV. ATHB12 expression is correlated with an array of morphological abnormalities including leaf curling, stunting, and callus-like structures in infected Arabidopsis. Inoculation of plants with a BSCTV mutant with a defective c4 gene failed to induce ATHB12. Transgenic plants expressing the BSCTV C4 gene exhibited increased ATHB12 expression whereas BSCTV-infected ATHB12 knock-down plants developed milder symptoms and had lower ATHB12 expression compared to the wild-type plants. Reporter gene studies demonstrated that the ATHB12 promoter was responsive to BSCTV infection and the highest expression levels were observed in symptomatic tissues where cell cycle genes also were induced. Conclusions/Significance: These results suggest that ATHB7 and ATHB12 may play an important role in the activation of the abnormal cell division associated with symptom development during geminivirus infection.	[Park, Jungan; Lee, Hyun-Ju; Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Cheon, Choong-Ill; Kim, Sung-Han; Hur, Yoon-Sun] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Auh, Chung-Kyun] Mokpo Natl Univ, Div Life Sci, Muan, South Korea; [Im, Kyung-Hwan] Univ Incheon, Dept Biol, Inchon, South Korea; [Yun, Dae-Jin] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju, South Korea; [Yun, Dae-Jin] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju, South Korea; [Yun, Dae-Jin] Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju, South Korea; [Davis, Keith R.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Owensboro Canc Res Program,James Graham Brown Can, Louisville, KY 40292 USA	Sungkyunkwan University (SKKU); Sookmyung Women's University; Mokpo National University; Incheon National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; University of Louisville	Park, J (corresponding author), Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea.	sukchan@skku.ac.kr; keith.davis@omhs.org	Davis, Keith/H-3242-2019; Kim, Sunghan/ABH-3874-2020; Davis, Keith R/C-5623-2009	Davis, Keith/0000-0002-7432-8610; Davis, Keith R/0000-0002-7432-8610; Yun, Dae-Jin/0000-0002-3638-6043; Kim, Sunghan/0000-0002-4955-8780	Rural Development Administration (RDA) in Korea [PJ006325]	Rural Development Administration (RDA) in Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by a grant of the BioGreen21 Agenda program (No. PJ006325) from the Rural Development Administration (RDA) in Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G. N., 2005, PLANT PATHOL; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Baliji S, 2007, MOL PLANT MICROBE IN, V20, P194, DOI 10.1094/MPMI-20-2-0194; Baliji S, 2010, VIROLOGY, V402, P238, DOI 10.1016/j.virol.2010.03.023; BRIDDON RW, 1989, VIROLOGY, V172, P628, DOI 10.1016/0042-6822(89)90205-5; CARABELLI M, 1993, PLANT J, V4, P469, DOI 10.1046/j.1365-313X.1993.04030469.x; CHAN RL, 1994, PLANT PHYSIOL, V106, P1687, DOI 10.1104/pp.106.4.1687; DAVIS KR, 1989, MOL PLANT MICROBE IN, V2, P363, DOI 10.1094/MPMI-2-363; Desvoyes B, 2002, PLANT PHYSIOL, V129, P1521, DOI 10.1104/pp.004754; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Egelkrout EM, 2001, PLANT CELL, V13, P1437, DOI 10.1105/tpc.13.6.1437; Egelkrout EM, 2002, PLANT CELL, V14, P3225, DOI 10.1105/tpc.006403; Engler JD, 1999, PLANT CELL, V11, P793, DOI 10.1105/tpc.11.5.793; FRISCHMUTH S, 1993, VIROLOGY, V197, P312, DOI 10.1006/viro.1993.1592; Gutierrez C, 2000, PLANT MOL BIOL, V43, P763, DOI 10.1023/A:1006462028363; Hao LH, 2003, PLANT CELL, V15, P1034, DOI 10.1105/tpc.009530; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; HORMUZDI SG, 1995, VIROLOGY, V206, P1044, DOI 10.1006/viro.1995.1027; HORMUZDI SG, 1993, VIROLOGY, V193, P900, DOI 10.1006/viro.1993.1199; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; JEFFERSON RA, 1987, EMBO J, V6, P3901; JEFFERSON RA, 1989, NATURE, V342, P837, DOI 10.1038/342837a0; KAWAHARA R, 1995, PLANT MOL BIOL, V27, P155, DOI 10.1007/BF00019187; Lai JB, 2009, PLANT J, V57, P905, DOI 10.1111/j.1365-313X.2008.03737.x; Latham JR, 1997, PLANT J, V11, P1273, DOI 10.1046/j.1365-313X.1997.11061273.x; LEE S, 1994, PLANT J, V6, P525, DOI 10.1046/j.1365-313X.1994.6040525.x; Lee Sukchan, 1996, Journal of Plant Biology, V39, P249; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Lee YH, 1998, PLANT MOL BIOL, V37, P377, DOI 10.1023/A:1006084305012; Lucas WJ, 1996, J EXP BOT, V47, P1119, DOI 10.1093/jxb/47.Special_Issue.1119; MATTHEWS R, 2001, PLANT VIROLOGY; Mattsson J, 2003, PLANT PHYSIOL, V131, P1327, DOI 10.1104/pp.013623; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; MEISSNER R, 1995, PLANTA, V195, P541, DOI 10.1007/BF00195713; Mills-Lujan K, 2010, PROTOPLASMA, V239, P95, DOI 10.1007/s00709-009-0086-z; Moon YH, 1996, MOL CELLS, V6, P366; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Park J, 2004, MOL CELLS, V17, P117; Park J, 2010, PLANT CELL REP, V29, P1377, DOI 10.1007/s00299-010-0923-8; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SCHENA M, 1994, P NATL ACAD SCI USA, V91, P8393, DOI 10.1073/pnas.91.18.8393; Shen W, 2006, PLANT PHYSIOL, V142, P1642, DOI 10.1104/pp.106.088476; Shin D, 2004, BIOCHEM BIOPH RES CO, V323, P534, DOI 10.1016/j.bbrc.2004.08.127; SMITH SH, 1968, PHYTOPATHOLOGY, V58, P1669; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Son O, 2010, PLANT CELL PHYSIOL, V51, P1537, DOI 10.1093/pcp/pcq108; STANLEY J, 1992, VIROLOGY, V191, P396, DOI 10.1016/0042-6822(92)90201-Y; Steindler C, 1999, DEVELOPMENT, V126, P4235; STENGER DC, 1992, J GEN VIROL, V73, P237, DOI 10.1099/0022-1317-73-2-237; STENGER DC, 1990, J GEN VIROL, V71, P2211, DOI 10.1099/0022-1317-71-10-2211; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Ware DH, 1997, PLANT PHYSIOL, V114, P1163; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yang JY, 2008, GENE DEV, V22, P2564, DOI 10.1101/gad.1682208	60	18	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20054	10.1371/journal.pone.0020054	http://dx.doi.org/10.1371/journal.pone.0020054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625602	Green Published, gold, Green Submitted			2022-12-25	WOS:000290720200059
J	Shatnyeva, OM; Kubarenko, AV; Weber, CEM; Pappa, A; Schwartz-Albiez, R; Weber, ANR; Krammer, PH; Lavrik, IN				Shatnyeva, Olga M.; Kubarenko, Andriy V.; Weber, Claudia E. M.; Pappa, Alexander; Schwartz-Albiez, Reinhard; Weber, Alexander N. R.; Krammer, Peter H.; Lavrik, Inna N.			Modulation of the CD95-Induced Apoptosis: The Role of CD95 N-Glycosylation	PLOS ONE			English	Article							SIGNALING COMPLEX; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; DEATH; RECEPTOR; FAS; LIGAND; DOMAIN; SIALYLATION; REQUIREMENT	Protein modifications of death receptor pathways play a central role in the regulation of apoptosis. It has been demonstrated that O-glycosylation of TRAIL-receptor (R) is essential for sensitivity and resistance towards TRAIL-mediated apoptosis. In this study we ask whether and how glycosylation of CD95 (Fas/APO-1), another death receptor, influences DISC formation and procaspase-8 activation at the CD95 DISC and thereby the onset of apoptosis. We concentrated on N-glycostructure since O-glycosylation of CD95 was not found. We applied different approaches to analyze the role of CD95 N-glycosylation on the signal transduction: in silico modeling of CD95 DISC, generation of CD95 glycosylation mutants (at N136 and N118), modulation of N-glycosylation by deoxymannojirimycin (DMM) and sialidase from Vibrio cholerae (VCN). We demonstrate that N-deglycosylation of CD95 does not block DISC formation and results only in the reduction of the procaspase-8 activation at the DISC. These findings are important for the better understanding of CD95 apoptosis regulation and reveal differences between apoptotic signaling pathways of the TRAIL and CD95 systems.	[Shatnyeva, Olga M.; Weber, Claudia E. M.; Pappa, Alexander; Krammer, Peter H.; Lavrik, Inna N.] German Canc Res Ctr, Div Immunogenet, D-6900 Heidelberg, Germany; [Kubarenko, Andriy V.; Weber, Alexander N. R.] German Canc Res Ctr, Jr Res Grp Toll Like Receptors & Canc, D-6900 Heidelberg, Germany; [Schwartz-Albiez, Reinhard] German Canc Res Ctr, Div Translat Immunol, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Shatnyeva, OM (corresponding author), German Canc Res Ctr, Div Immunogenet, D-6900 Heidelberg, Germany.	i.lavrik@dkfz.de	Lavrik, Inna N/C-1700-2009	Lavrik, Inna N/0000-0002-9324-309X; Weber, Alexander/0000-0002-8627-7056	Helmholtz Alliance on Systems Biology (SBCancer); Wilhelm Sander Stiftung; Helmholtz-Russia Joint Research Groups [2008-2 SFB 405]; Tumorzentrum Heidelberg/Mannheim	Helmholtz Alliance on Systems Biology (SBCancer); Wilhelm Sander Stiftung; Helmholtz-Russia Joint Research Groups; Tumorzentrum Heidelberg/Mannheim	Funding was provided by Helmholtz Alliance on Systems Biology (SBCancer), Wilhelm Sander Stiftung, Helmholtz-Russia Joint Research Groups-2008-2 SFB 405 and the Tumorzentrum Heidelberg/Mannheim. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AERTS JMFG, 1986, BIOCHEM BIOPH RES CO, V141, P452, DOI 10.1016/S0006-291X(86)80194-2; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Li Y, 2007, INT J BIOCHEM CELL B, V39, P1625, DOI 10.1016/j.biocel.2007.04.002; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; OEHM A, 1992, J BIOL CHEM, V267, P10709; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Powell LD., 2001, CURR PROTOC MOL BIOL; RALPH P, 1983, IMMUNOL LETT, V7, P17, DOI 10.1016/0165-2478(83)90049-4; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 2000, METHOD ENZYMOL, V322, P363; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schmitz I, 2002, BIOCHEM BIOPH RES CO, V297, P459, DOI 10.1016/S0006-291X(02)02242-8; Schneider U, 1977, Haematol Blood Transfus, V20, P265; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Strand S, 2004, ONCOGENE, V23, P3732, DOI 10.1038/sj.onc.1207387; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SVEDMYR E, 1975, P NATL ACAD SCI USA, V72, P1622, DOI 10.1073/pnas.72.4.1622; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920	56	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19927	10.1371/journal.pone.0019927	http://dx.doi.org/10.1371/journal.pone.0019927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625644	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200049
J	Ghilarov, D; Serebryakova, M; Shkundina, I; Severinov, K				Ghilarov, Dmitry; Serebryakova, Marina; Shkundina, Irina; Severinov, Konstantin			A Major Portion of DNA Gyrase Inhibitor Microcin B17 Undergoes an N,O-Peptidyl Shift during Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERED BISHETEROCYCLIC SITES; POSTTRANSLATIONAL MODIFICATIONS; ESCHERICHIA-COLI; BACTERIAL TOXIN; PEPTIDE; HETEROCYCLIZATION; AUTOPROTEOLYSIS; BIOSYNTHESIS; REPLICATION; SYNTHETASE	Microcin B17 (McB) is a 43-amino acid antibacterial peptide targeting the DNA gyrase. The McB precursor is ribosomally produced and then post-translationally modified by the Mcb-BCD synthase. Active mature McB contains eight oxazole and thiazole heterocycles. Here, we show that a major portion of mature McB contains an additional unusual modification, a backbone ester bond connecting McB residues 51 and 52. The modification results from an N -> O shift of the Ser(52) residue located immediately downstream of one of McBthiazole heterocycles. We speculate that the N, O-peptidyl shift undergone by Ser(52) is an intermediate of post-translational modification reactions catalyzed by the McbBCD synthase that normally lead to formation of McB heterocycles.	[Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Ghilarov, Dmitry; Serebryakova, Marina; Shkundina, Irina; Severinov, Konstantin] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Serebryakova, Marina] Inst Physicochem Med Fed Medicobiol Agcy, Moscow 119992, Russia; [Shkundina, Irina; Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Severinov, Konstantin] Waksman Inst Microbiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Dept Mol Biol & Biochem, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Ghilarov, Dmitry/N-4062-2015; Serebryakova, Marina/E-2986-2012	Serebryakova, Marina/0000-0002-5402-8215; Ghilarov, Dmitry/0000-0001-9325-3207	Russian Academy of Sciences Molecular and Cell Biology [02.740.11.0771]; Russian Foundation for Basic Research [09-04-00293-a]; Federal Program "Scientific and sicentific-pedagogical personnel of innovative Russia" [P1068]; Bortnik Foundation UMNIK	Russian Academy of Sciences Molecular and Cell Biology(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "Scientific and sicentific-pedagogical personnel of innovative Russia"; Bortnik Foundation UMNIK	This work was supported in part by the Russian Academy of Sciences Molecular and Cell Biology Program grant and Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2013," state contract 02.740.11.0771 (to K. S.), Russian Foundation for Basic Research grant 09-04-00293-a, and Federal Program "Scientific and sicentific-pedagogical personnel of innovative Russia 2009-2013," state contract P1068 (to I. S.).; Supported by the Bortnik Foundation UMNIK program.	Allali N, 2002, J BACTERIOL, V184, P3224, DOI 10.1128/JB.184.12.3224-3231.2002; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Drlica K, 2009, CURR TOP MED CHEM, V9, P981, DOI 10.2174/156802609789630947; Duquesne S, 2007, J MOL MICROB BIOTECH, V13, P200, DOI 10.1159/000104748; ELLIOTT DF, 1952, BIOCHEM J, V50, P542, DOI 10.1042/bj0500542; GENILLOUD O, 1989, J BACTERIOL, V171, P1126, DOI 10.1128/jb.171.2.1126-1135.1989; Gonzalez DJ, 2010, J BIOL CHEM, V285, P28220, DOI 10.1074/jbc.M110.118554; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; HERRERO M, 1986, J GEN MICROBIOL, V132, P393; Kelleher NL, 1999, BIOCHEMISTRY-US, V38, P15623, DOI 10.1021/bi9913698; Kelleher NL, 1998, J AM CHEM SOC, V120, P9716, DOI 10.1021/ja9822097; LAVINA M, 1986, J GEN MICROBIOL, V132, P1685; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; McIntosh JA, 2010, CHEMBIOCHEM, V11, P1413, DOI 10.1002/cbic.201000196; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Mitchell DA, 2009, J BIOL CHEM, V284, P13004, DOI 10.1074/jbc.M900802200; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Onaka H, 2005, MICROBIOL-SGM, V151, P3923, DOI 10.1099/mic.0.28420-0; Parks WM, 2007, BIOCHIMIE, V89, P500, DOI 10.1016/j.biochi.2006.12.005; Perler FB, 1997, CURR OPIN CHEM BIOL, V1, P292, DOI 10.1016/S1367-5931(97)80065-8; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Pierrat OA, 2005, BIOCHEMISTRY-US, V44, P4204, DOI 10.1021/bi0478751; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Roy RS, 1999, CHEM BIOL, V6, P305, DOI 10.1016/S1074-5521(99)80076-3; Saleh L, 2006, CHEM REC, V6, P183, DOI 10.1002/tcr.20082; Severinov K, 2007, MOL MICROBIOL, V65, P1380, DOI 10.1111/j.1365-2958.2007.05874.x; VIZAN JL, 1991, EMBO J, V10, P467, DOI 10.1002/j.1460-2075.1991.tb07969.x; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; YORGEY P, 1994, P NATL ACAD SCI USA, V91, P4519, DOI 10.1073/pnas.91.10.4519; Zamble DB, 2001, P NATL ACAD SCI USA, V98, P7712, DOI 10.1073/pnas.141225698	32	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26308	26318		10.1074/jbc.M111.241315	http://dx.doi.org/10.1074/jbc.M111.241315			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21628468	hybrid, Green Published			2022-12-25	WOS:000293078200007
J	Pedersen, JT; Ostergaard, J; Rozlosnik, N; Gammelgaard, B; Heegaard, NHH				Pedersen, Jeppe T.; Ostergaard, Jesper; Rozlosnik, Noemi; Gammelgaard, Bente; Heegaard, Niels H. H.			Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-beta Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER A-BETA; BINDING-SITE; CU-II; MOLECULAR-MECHANISM; HYDROGEN-PEROXIDE; COPPER(II) IONS; FIBRIL GROWTH; DISEASE; PROTEIN; COORDINATION	Cu(II) ions are implicated in the pathogenesis of Alzheimer disease by influencing the aggregation of the amyloid-beta (A beta) peptide. Elucidating the underlying Cu(II)-inducedA beta aggregation is paramount for understanding the role of Cu(II) in the pathology of Alzheimer disease. The aim of this study was to characterize the qualitative and quantitative influence of Cu(II) on the extracellular aggregation mechanism and aggregate morphology of A beta(1-40) using spectroscopic, microelectrophoretic, mass spectrometric, and ultrastructural techniques. We found that the Cu(II):A beta ratio in solution has a major influence on (i) the aggregation kinetics/mechanism of A beta, because three different kinetic scenarios were observed depending on the Cu(II):A beta ratio, (ii) the metal: peptide stoichiometry in the aggregates, which increased to 1.4 at supra-equimolar Cu(II):A beta ratio; and (iii) the morphology of the aggregates, which shifted from fibrillar to non-fibrillar at increasing Cu(II):A beta ratios. We observed dynamic morphological changes of the aggregates, and that the formation of spherical aggregates appeared to be a common morphological end point independent on the Cu(II) concentration. Experiments with A beta(1-42) were compatible with the conclusions for A beta(1-40) even though the low solubility of A beta(1-42) precluded examination under the same conditions as for the A beta(1-40). Experiments with A beta(1-16) and A beta(1-28) showed that other parts than the Cu(II)-binding His residues were important for Cu(II)-induced A beta aggregation. Based on this study we propose three mechanistic models for the Cu(II)-induced aggregation of A beta(1-40) depending on the Cu(II):A beta ratio, and identify key reaction steps that may be feasible targets for preventing Cu(II)-associated aggregation or toxicity in Alzheimer disease.	[Pedersen, Jeppe T.; Ostergaard, Jesper; Gammelgaard, Bente] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Rozlosnik, Noemi] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Heegaard, Niels H. H.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Statens Serum Institut	Ostergaard, J (corresponding author), Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Fac Pharmaceut Sci, Univ Pk2, DK-2100 Copenhagen, Denmark.	joe@farma.ku.dk; nhe@ssi.dk	Rozlosnik, Noemi/A-3090-2012; Gammelgaard, Bente/A-7826-2013; Ostergaard, Jesper/A-9922-2011; Pedersen, Jeppe Trudslev/A-2600-2011	Ostergaard, Jesper/0000-0003-3448-4237; Gammelgaard, Bente/0000-0002-9149-1014	Statens Serum Institut; Drug Research Academy, The Faculty of Pharmaceutical Sciences, University of Copenhagen	Statens Serum Institut; Drug Research Academy, The Faculty of Pharmaceutical Sciences, University of Copenhagen	This work was supported by the Statens Serum Institut and The Drug Research Academy, The Faculty of Pharmaceutical Sciences, University of Copenhagen.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Brzyska M, 2009, CHEMBIOCHEM, V10, P1045, DOI 10.1002/cbic.200800732; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Capanni C, 2004, CELL MOL LIFE SCI, V61, P982, DOI 10.1007/s00018-003-3447-3; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Dong J, 2007, P NATL ACAD SCI USA, V104, P13313, DOI 10.1073/pnas.0702669104; Dorlet P, 2009, ANGEW CHEM INT EDIT, V48, P9273, DOI 10.1002/anie.200904567; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; FRIEDEN C, 1985, ANNU REV BIOPHYS BIO, V14, P189, DOI 10.1146/annurev.bb.14.060185.001201; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Guilloreau L, 2006, J BIOL INORG CHEM, V11, P1024, DOI 10.1007/s00775-006-0154-1; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Jun SM, 2007, ANGEW CHEM INT EDIT, V46, P3959, DOI 10.1002/anie.200700318; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Karr JW, 2007, J AM CHEM SOC, V129, P3796, DOI 10.1021/ja068952d; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Karr JW, 2004, J AM CHEM SOC, V126, P13534, DOI 10.1021/ja0488028; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kowalik-Jankowska T, 2003, J INORG BIOCHEM, V95, P270, DOI 10.1016/S0162-0134(03)00128-4; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Lim KH, 2007, BIOCHEMISTRY-US, V46, P13523, DOI 10.1021/bi701112z; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Ostergaard J, 2006, ELECTROPHORESIS, V27, P2590, DOI 10.1002/elps.200600047; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Pedersen JT, 2011, ANGEW CHEM INT EDIT, V50, P2532, DOI 10.1002/anie.201006335; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHEN CL, 1993, BIOPHYS J, V65, P2383, DOI 10.1016/S0006-3495(93)81312-2; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Zou J, 2001, ANGEW CHEM INT EDIT, V40, P2274, DOI 10.1002/1521-3773(20010618)40:12<2274::AID-ANIE2274>3.0.CO;2-5	72	95	98	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26952	26963		10.1074/jbc.M111.220863	http://dx.doi.org/10.1074/jbc.M111.220863			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642429	Green Published, hybrid			2022-12-25	WOS:000293078200069
J	Gutierrez, DV; Mark, MD; Masseck, O; Maejima, T; Kuckelsberg, D; Hyde, RA; Krause, M; Kruse, W; Herlitze, S				Gutierrez, Davina V.; Mark, Melanie D.; Masseck, Olivia; Maejima, Takashi; Kuckelsberg, Denise; Hyde, Robert A.; Krause, Martin; Kruse, Wolfgang; Herlitze, Stefan			Optogenetic Control of Motor Coordination by G(i/o) Protein-coupled Vertebrate Rhodopsin in Cerebellar Purkinje Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(B) RECEPTORS; NEURONAL MICROCIRCUITS; OPTICAL-PROPERTIES; RAT CEREBELLUM; HUMAN BRAIN; ACTIVATION; LOCALIZATION; INHIBITION; ORGANIZATION; MODULATION	G protein-coupled receptors are involved in the modulation of complex neuronal networks in the brain. To investigate the impact of a cell-specific G(i/o) protein-mediated signaling pathway on brain function, we created a new optogenetic mouse model in which the G(i/o) protein-coupled receptor vertebrate rhodopsin can be cell-specifically expressed with the aid of Cre recombinase. Here we use this mouse model to study the functional impact of G(i/o) modulation in cerebellar Purkinje cells (PCs). We show that in vivo light activation of vertebrate rhodopsin specifically expressed in PCs reduces simple spike firing that is comparable with the reduction in firing observed for the activation of cerebellar G(i/o)-coupled GABA(B) receptors. Notably, the light exposure of the cerebellar vermis in freely moving mice changes the motor behavior. Thus, our studies directly demonstrate that spike modulation via G(i/o)-mediated signaling in cerebellar PCs affects motor coordination and show a new promising approach for studying the physiological function of G protein-coupled receptor-mediated signaling in a cell type-specific manner.	[Gutierrez, Davina V.; Hyde, Robert A.; Herlitze, Stefan] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Mark, Melanie D.; Masseck, Olivia; Maejima, Takashi; Kuckelsberg, Denise; Krause, Martin; Kruse, Wolfgang; Herlitze, Stefan] Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany	Case Western Reserve University; Ruhr University Bochum	Herlitze, S (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	Stefan.Herlitze@rub.de	Mark, Melanie/ABF-9102-2020	Mark, Melanie/0000-0002-2788-6003; Masseck, Olivia Andrea/0000-0002-1541-2388	National Institutes of Health [MH081127]; Deutsche Forschungsgemeinschaft [HE2471/8-1]; Japan Society for the Promotion of Science [R36MH086283]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081127, R36MH086283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH081127 (to S. H.). This work was also supported by Deutsche Forschungsgemeinschaft Grant HE2471/8-1, Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (to T. M.), and R36MH086283 (to D. G.).	Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bevilacqua F, 1999, APPL OPTICS, V38, P4939, DOI 10.1364/AO.38.004939; BILLARD JM, 1993, NEUROSCI RES, V16, P65, DOI 10.1016/0168-0102(93)90010-N; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; CURTIS DR, 1974, BRAIN RES, V70, P493, DOI 10.1016/0006-8993(74)90257-1; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Hausser M, 2004, J NEUROSCI, V24, P9215, DOI 10.1523/JNEUROSCI.3375-04.2004; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Ige AO, 2000, MOL BRAIN RES, V83, P72, DOI 10.1016/S0169-328X(00)00199-6; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; Joyal CC, 1996, BRAIN RES, V739, P1, DOI 10.1016/S0006-8993(96)00333-2; Kamikubo Y, 2007, J PHYSIOL-LONDON, V585, P549, DOI 10.1113/jphysiol.2007.141010; Kawaguchi S, 2000, NEURON, V27, P339, DOI 10.1016/S0896-6273(00)00041-6; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lalonde R, 2007, PROG NEUROBIOL, V81, P45, DOI 10.1016/j.pneurobio.2006.11.005; LeBeau FEN, 2005, TRENDS NEUROSCI, V28, P552, DOI 10.1016/j.tins.2005.08.005; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; LLINAS R, 1989, EUR J NEUROSCI, V1, P587, DOI 10.1111/j.1460-9568.1989.tb00365.x; Masseck OA, 2011, EXP PHYSIOL, V96, P51, DOI 10.1113/expphysiol.2010.055517; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; Morton SM, 2007, CEREBELLUM, V6, P79, DOI 10.1080/14734220601187741; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Pei Y, 2008, PHYSIOLOGY, V23, P313, DOI 10.1152/physiol.00025.2008; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Tabata T, 2005, J PHYSIOL-LONDON, V563, P443, DOI 10.1113/jphysiol.2004.081000; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Timmann D, 1998, EXP BRAIN RES, V119, P73, DOI 10.1007/s002210050321; Vigot R, 1997, NEUROSCI RES, V29, P151, DOI 10.1016/S0168-0102(97)00087-4; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang JY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055007	38	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25848	25858		10.1074/jbc.M111.253674	http://dx.doi.org/10.1074/jbc.M111.253674			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628464	Green Published, hybrid			2022-12-25	WOS:000293073000046
J	Hirai, H; Takai, R; Iwano, M; Nakai, M; Kondo, M; Takayama, S; Isogai, A; Che, FS				Hirai, Hiroyuki; Takai, Ryota; Iwano, Megumi; Nakai, Masaru; Kondo, Machiko; Takayama, Seiji; Isogai, Akira; Che, Fang-Sik			Glycosylation Regulates Specific Induction of Rice Immune Responses by Acidovorax avenae Flagellin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERSENSITIVE CELL-DEATH; PSEUDOMONAS-AERUGINOSA; INCOMPATIBLE STRAIN; ESCHERICHIA-COLI; INNATE IMMUNITY; AMINO-ACIDS; N-TERMINUS; PERCEPTION; RECEPTOR; IDENTIFICATION	Plants have a sensitive system that detects various pathogen-derived molecules to protect against infection. Flagellin, a main component of the bacterial flagellum, from the rice avirulent N1141 strain of the Gram-negative phytopathogenic bacterium Acidovorax avenae induces plant immune responses including H2O2 generation, whereas flagellin from the rice virulent K1 strain of A. avenae does not induce these immune responses. To clarify the molecular mechanism that leads to these differing responses between the K1 and N1141 flagellins, recombinant K1 and N1141 flagellins were generated using an Escherichia coli expression system. When cultured rice cells were treated with recombinant K1 or N1141 flagellin, both flagellins equally induced H2O2 generation, suggesting that post-translational modifications of the flagellins are involved in the specific induction of immune responses. Mass spectrometry analyses using glycosyltransferase-deficient mutants showed that 1,600- and 2,150-Da glycans were present on the flagellins from N1141 and K1, respectively. A deglycosylated K1 flagellin induced immune responses in the same manner as N1141 flagellin. Site-directed mutagenesis revealed that glycans were attached to four amino acid residues (Ser(178), Ser(183), Ser(212), and Thr(351)) in K1 flagellin. Among mutant K1 flagellins in which each glycan-attached amino acid residue was changed to alanine, S178A and S183A, K1 flagellin induced a strong immune response in cultured rice cells, indicating that the glycans at Ser(178) and Ser(183) in K1 flagellin prevent epitope recognition in rice.	[Hirai, Hiroyuki; Takai, Ryota; Kondo, Machiko; Che, Fang-Sik] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Shiga 5260829, Japan; [Iwano, Megumi; Nakai, Masaru; Takayama, Seiji; Isogai, Akira; Che, Fang-Sik] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Che, FS (corresponding author), Nagahama Inst Biosci & Technol, Grad Sch Biosci, 1266 Tamura, Shiga 5260829, Japan.	k_sai@nagahama-i-bio.ac.jp	Isogai, Akira/O-8897-2017	Isogai, Akira/0000-0001-8095-0441	Ministry of Education, Culture, Sports, Science and Technology of Japan [21380073]; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry [500107]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry	This work was supported in part by Grant-in-aid for Scientific Research (B) 21380073 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grant 500107 from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry.	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Berthiaume F, 2010, FEMS MICROBIOL LETT, V311, P176, DOI 10.1111/j.1574-6968.2010.02088.x; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Che FS, 2000, J BIOL CHEM, V275, P32347, DOI 10.1074/jbc.M004796200; Che FS, 1999, PLANT CELL PHYSIOL, V40, P1036, DOI 10.1093/oxfordjournals.pcp.a029485; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Iwano M, 2002, MOL PLANT PATHOL, V3, P1, DOI 10.1046/j.1464-6722.2001.00087.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kadota Ikuo, 1996, Annals of the Phytopathological Society of Japan, V62, P425, DOI 10.3186/jjphytopath.62.425; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Laquitaine L, 2006, MOL PLANT MICROBE IN, V19, P1103, DOI 10.1094/MPMI-19-1103; Logan SM, 2009, FEBS J, V276, P1014, DOI 10.1111/j.1742-4658.2008.06840.x; Qutyan M, 2010, J BACTERIOL, V192, P5972, DOI 10.1128/JB.00007-10; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schirm M, 2004, J BACTERIOL, V186, P6721, DOI 10.1128/JB.186.20.6721-6727.2004; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; SCHWACKE R, 1992, PLANTA, V187, P136, DOI 10.1007/BF00201635; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Silipo A, 2005, J BIOL CHEM, V280, P33660, DOI 10.1074/jbc.M506254200; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Tanaka N, 2003, MOL PLANT MICROBE IN, V16, P422, DOI 10.1094/MPMI.2003.16.5.422; Tanaka N., 2001, PLANT BIOTECHNOL-NAR, V18, P295; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Verma A, 2006, J BACTERIOL, V188, P4395, DOI 10.1128/JB.01642-05; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200	45	38	41	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25519	25530		10.1074/jbc.M111.254029	http://dx.doi.org/10.1074/jbc.M111.254029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628471	hybrid, Green Published			2022-12-25	WOS:000293073000014
J	Amankwah, EK; Wang, QG; Schildkraut, JM; Tsai, YY; Ramus, SJ; Fridley, BL; Beesley, J; Johnatty, SE; Webb, PM; Chenevix-Trench, G; Dale, LC; Lambrechts, D; Amant, F; Despierre, E; Vergote, I; Gayther, SA; Gentry-Maharaj, A; Menon, U; Chang-Claude, J; Wang-Gohrke, S; Anton-Culver, H; Ziogas, A; Dork, T; Durst, M; Antonenkova, N; Bogdanova, N; Brown, R; Flanagan, JM; Kaye, SB; Paul, J; Butzow, R; Nevanlinna, H; Campbell, I; Eccles, DM; Karlan, BY; Gross, J; Walsh, C; Pharoah, PDP; Song, HL; Kjaer, SK; Hogdall, E; Hogdall, C; Lundvall, L; Nedergaard, L; Kiemeney, LALM; Massuger, LFAG; van Altena, AM; Vermeulen, SHHM; Le, ND; Brooks-Wilson, A; Cook, LS; Phelan, CM; Cunningham, JM; Vachon, CM; Vierkant, RA; Iversen, ES; Berchuck, A; Goode, EL; Sellers, TA; Kelemen, LE				Amankwah, Ernest K.; Wang, Qinggang; Schildkraut, Joellen M.; Tsai, Ya-Yu; Ramus, Susan J.; Fridley, Brooke L.; Beesley, Jonathan; Johnatty, Sharon E.; Webb, Penelope M.; Chenevix-Trench, Georgia; Dale, Laura C.; Lambrechts, Diether; Amant, Frederic; Despierre, Evelyn; Vergote, Ignace; Gayther, Simon A.; Gentry-Maharaj, Aleksandra; Menon, Usha; Chang-Claude, Jenny; Wang-Gohrke, Shan; Anton-Culver, Hoda; Ziogas, Argyrios; Doerk, Thilo; Duerst, Matthias; Antonenkova, Natalia; Bogdanova, Natalia; Brown, Robert; Flanagan, James M.; Kaye, Stanley B.; Paul, James; Butzow, Ralf; Nevanlinna, Heli; Campbell, Ian; Eccles, Diana M.; Karlan, Beth Y.; Gross, Jenny; Walsh, Christine; Pharoah, Paul D. P.; Song, Honglin; Kjaer, Susanne Kruger; Hogdall, Estrid; Hogdall, Claus; Lundvall, Lene; Nedergaard, Lotte; Kiemeney, Lambertus A. L. M.; Massuger, Leon F. A. G.; van Altena, Anne M.; Vermeulen, Sita H. H. M.; Le, Nhu D.; Brooks-Wilson, Angela; Cook, Linda S.; Phelan, Catherine M.; Cunningham, Julie M.; Vachon, Celine M.; Vierkant, Robert A.; Iversen, Edwin S.; Berchuck, Andrew; Goode, Ellen L.; Sellers, Thomas A.; Kelemen, Linda E.		Australian Ovarian Canc Study Grp	Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENOME-WIDE ASSOCIATION; TGF-BETA; ORAL-CONTRACEPTIVES; EXPRESSION; DECORIN; RISK; TRENDS; INHIBITION; MORTALITY	Alterations in stromal tissue components can inhibit or promote epithelial tumorigenesis. Decorin (DCN) and lumican (LUM) show reduced stromal expression in serous epithelial ovarian cancer (sEOC). We hypothesized that common variants in these genes associate with risk. Associations with sEOC among Caucasians were estimated with odds ratios (OR) among 397 cases and 920 controls in two U. S.-based studies (discovery set), 436 cases and 1,098 controls in Australia (replication set 1) and a consortium of 15 studies comprising 1,668 cases and 4,249 controls (replication set 2). The discovery set and replication set 1 (833 cases and 2,013 controls) showed statistically homogeneous (P-heterogeneity >= 0.48) decreased risks of sEOC at four variants: DCN rs3138165, rs13312816 and rs516115, and LUM rs17018765 (OR = 0.6 to 0.9; P-trend = 0.001 to 0.03). Results from replication set 2 were statistically homogeneous (P-heterogeneity >= 0.13) and associated with increased risks at DCN rs3138165 and rs13312816, and LUM rs17018765: all ORs = 1.2; P-trend <= 0.02. The ORs at the four variants were statistically heterogeneous across all 18 studies (P-heterogeneity <= 0.03), which precluded combining. In post-hoc analyses, interactions were observed between each variant and recruitment period (P-interaction <= 0.003), age at diagnosis (P-interaction=0.04), and year of diagnosis (P-interaction=0.05) in the five studies with available information (1,044 cases, 2,469 controls). We conclude that variants in DCN and LUM are not directly associated with sEOC, and that confirmation of possible effect modification of the variants by non-genetic factors is required.	[Amankwah, Ernest K.; Wang, Qinggang; Dale, Laura C.; Cook, Linda S.; Kelemen, Linda E.] Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada; [Schildkraut, Joellen M.; Iversen, Edwin S.; Berchuck, Andrew] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Tsai, Ya-Yu; Phelan, Catherine M.; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Div Canc Prevent & Control, Tampa, FL USA; [Ramus, Susan J.; Gayther, Simon A.; Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, UCL EGA Inst Womens Hlth, Dept Gynaecol Oncol, London, England; [Fridley, Brooke L.; Vachon, Celine M.; Vierkant, Robert A.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Beesley, Jonathan; Johnatty, Sharon E.; Webb, Penelope M.; Chenevix-Trench, Georgia] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Campbell, Ian; Australian Ovarian Canc Study Grp] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Lambrechts, Diether] VIB, Louvain, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Louvain, Belgium; [Amant, Frederic; Despierre, Evelyn; Vergote, Ignace] Univ Hosp Leuven, Dept Obstet & Gynecol, Louvain, Belgium; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, Ulm, Germany; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Doerk, Thilo; Bogdanova, Natalia] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany; [Duerst, Matthias] Jena Univ Hosp, Dept Gynaecol, Jena, Germany; [Antonenkova, Natalia; Bogdanova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, BELARUS; [Brown, Robert; Flanagan, James M.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Epigenet Unit, London, England; [Kaye, Stanley B.] Inst Canc Res, Med Sect, Sutton, Surrey, England; [Paul, James] Univ Glasgow, Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Haartman Insitute, Helsinki, Finland; [Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Campbell, Ian] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Eccles, Diana M.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Karlan, Beth Y.; Gross, Jenny; Walsh, Christine] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Res Inst, Los Angeles, CA 90048 USA; [Pharoah, Paul D. P.; Song, Honglin] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge, England; [Kjaer, Susanne Kruger] Danish Canc Soc, Copenhagen, Denmark; [Kjaer, Susanne Kruger; Hogdall, Claus; Lundvall, Lene] Univ Copenhagen, Rigshosp, Gynecol Clin, DK-2100 Copenhagen, Denmark; [Hogdall, Estrid] Danish Canc Biobank, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Copenhagen, Denmark; [Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Kiemeney, Lambertus A. L. M.; Vermeulen, Sita H. H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Massuger, Leon F. A. G.; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands; [Brooks-Wilson, Angela] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Cook, Linda S.] Univ New Mexico, Div Epidemiol & Biostatist, Albuquerque, NM 87131 USA; [Cunningham, Julie M.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA; [Kelemen, Linda E.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Kelemen, Linda E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary; Duke University; H Lee Moffitt Cancer Center & Research Institute; University of London; University College London; Mayo Clinic; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of California System; University of California Irvine; Hannover Medical School; Friedrich Schiller University of Jena; Imperial College London; University of London; Institute of Cancer Research - UK; Beatson Oncology Centre; University of Glasgow; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Melbourne; Cedars Sinai Medical Center; University of Cambridge; Danish Cancer Society; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; British Columbia Cancer Agency; Simon Fraser University; University of New Mexico; Mayo Clinic; University of Calgary; University of Calgary	Amankwah, EK (corresponding author), Alberta Hlth Serv Canc Care, Dept Populat Hlth Res, Calgary, AB, Canada.	LKelemen@post.harvard.edu	Pharoah, Paul/V-6658-2019; van Altena, Anne M/B-9824-2016; Amant, Frédéric/W-7436-2019; Eccles, Diana/K-6327-2019; Dörk, Thilo/J-8620-2012; Verdrengh, Evelien/H-4571-2012; Webb, Penelope/D-5736-2013; Vermeulen, Sita H./L-4716-2015; Brooks-Wilson, Angela/E-9399-2012; Fridley, Brooke L/D-8315-2015; Vierkant, Robert/AAP-4927-2020; Kiemeney, Lambertus A./D-3357-2009; campbell, Ian G/F-6006-2011; Chenevix-Trench, Georgia/AAV-2014-2020; Menon, Usha/C-4716-2008; Massuger, Leon F.A.G./H-8072-2014; Ramus, Susan/AAG-8352-2019; Lester, Jenny/B-5933-2012; Bowtell, David/H-1007-2016; Lambrechts, Diether/AAJ-3167-2020; Bogdanova, Natalia V./Y-2205-2019; Johnatty, Sharon E/R-8890-2016	Pharoah, Paul/0000-0001-8494-732X; Amant, Frédéric/0000-0002-5452-4905; Eccles, Diana/0000-0002-9935-3169; Dörk, Thilo/0000-0002-9458-0282; Webb, Penelope/0000-0003-0733-5930; Vermeulen, Sita H./0000-0003-4913-8601; Brooks-Wilson, Angela/0000-0003-1009-6408; Fridley, Brooke L/0000-0001-7739-7956; Vierkant, Robert/0000-0001-6242-5221; Kiemeney, Lambertus A./0000-0002-2368-1326; Chenevix-Trench, Georgia/0000-0002-1878-2587; Menon, Usha/0000-0003-3708-1732; Ramus, Susan/0000-0003-0005-7798; Bowtell, David/0000-0001-9089-7525; Lambrechts, Diether/0000-0002-3429-302X; Johnatty, Sharon E/0000-0002-7888-1966; Kjaer, Susanne/0000-0002-8347-1398; Hogdall, Claus/0000-0002-5959-8874; Hogdall, Estrid/0000-0003-4689-5658; Brown, Robert/0000-0001-7960-5755; Paul, James/0000-0001-7367-5816; Flanagan, James/0000-0003-4955-1383; Beesley, Jonathan/0000-0003-1942-325X; Nevanlinna, Heli/0000-0002-0916-2976; Campbell, Ian/0000-0002-7773-4155	National Health and Medical Research Council, Australia [199600]; Cancer Council Tasmania, Australia; Cancer Foundation of Western Australia, Australia; National Cancer Plan - Action 29, Australia; Alberta Heritage Foundation for Medical Research, Canada; Worksafe BC, Canada; Canadian Institutes of Health Research, Canada; Michael Smith Foundation for Health Research, Canada; Mermaid 1, Denmark; Danish Cancer Society, Denmark; Helsinki University Central Hospital, Finland; Academy of Finland, Finland; Finnish Cancer Society, Finland; European Community, Germany [HEALTH-F2-2009-223175]; Federal Ministry of Education and Research, Germany; Programme of Clinical Biomedical Research, Germany [01 GB 9401]; University of Ulm, Germany [P. 685]; Radboud University Nijmegen Medical Centre, Netherlands; municipality and community health service of Nijmegen, Netherlands; Cancer Research UK, U.K.; Association for International Cancer Research, U.K.; St Andrews, U.K.; Lon V. Smith Foundation, U.K. [LVS-39420]; Eve Appeal, U.K.; OAK Foundation, U.K.; National Institute for Health Research Biomedical Research Centre, U.K.; Ovarian Cancer Research Fund, U.S.; National Institutes of Health, U.S. [R01-CA-61107, R01-CA-122443, R01-CA-76016, CA-58860, CA-92044, P50 CA83636]; Department of Defense, U.S. [W81XWH-06-1-0220, W81XWH-09-OCRP-CONDEV]; American Cancer Society California Division, U.S. [S10P-06-258-01-CCE]; Mayo Foundation, U.S.; L&S Milken Family Foundation, U.S.; NATIONAL CANCER INSTITUTE [R01CA061107, R25CA147832, P50CA083636, P50CA136393, R01CA076016, U01CA058860, R01CA122443, R01CA058860] Funding Source: NIH RePORTER; Cancer Research UK [13086] Funding Source: researchfish; Medical Research Council [G0801875] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0801875] Funding Source: UKRI	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Tasmania, Australia(Cancer Council Tasmania); Cancer Foundation of Western Australia, Australia; National Cancer Plan - Action 29, Australia; Alberta Heritage Foundation for Medical Research, Canada(Alberta Heritage Foundation for Medical Research); Worksafe BC, Canada; Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research, Canada(Michael Smith Foundation for Health Research); Mermaid 1, Denmark; Danish Cancer Society, Denmark(Danish Cancer Society); Helsinki University Central Hospital, Finland; Academy of Finland, Finland(Academy of Finland); Finnish Cancer Society, Finland; European Community, Germany(European Commission); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Programme of Clinical Biomedical Research, Germany; University of Ulm, Germany; Radboud University Nijmegen Medical Centre, Netherlands(Netherlands Government); municipality and community health service of Nijmegen, Netherlands(Netherlands Government); Cancer Research UK, U.K.(Cancer Research UK); Association for International Cancer Research, U.K.; St Andrews, U.K.; Lon V. Smith Foundation, U.K.; Eve Appeal, U.K.; OAK Foundation, U.K.; National Institute for Health Research Biomedical Research Centre, U.K.(National Institute for Health Research (NIHR)); Ovarian Cancer Research Fund, U.S.; National Institutes of Health, U.S.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense, U.S.(United States Department of Defense); American Cancer Society California Division, U.S.(American Cancer Society); Mayo Foundation, U.S.; L&S Milken Family Foundation, U.S.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Australia: National Health and Medical Research Council (199600), Cancer Council Tasmania, Cancer Foundation of Western Australia; Belgium: National Cancer Plan - Action 29; Canada: Alberta Heritage Foundation for Medical Research, Worksafe BC, Canadian Institutes of Health Research, Michael Smith Foundation for Health Research; Denmark: Mermaid 1, The Danish Cancer Society; Finland: Helsinki University Central Hospital Research Fund, Academy of Finland, the Finnish Cancer Society; Germany: European Community's Seventh Framework Programme (HEALTH-F2-2009-223175), Federal Ministry of Education and Research, Programme of Clinical Biomedical Research (01 GB 9401), University of Ulm (P. 685); Netherlands: Radboud University Nijmegen Medical Centre, the municipality and community health service of Nijmegen; U.K.: Cancer Research UK, Association for International Cancer Research, St Andrews, Lon V. Smith Foundation grant LVS-39420, Eve Appeal, OAK Foundation; National Institute for Health Research Biomedical Research Centre; U.S.: Ovarian Cancer Research Fund, National Institutes of Health (R01-CA-61107, R01-CA-122443, R01-CA-76016, CA-58860, CA-92044, P50 CA83636), Department of Defense (W81XWH-06-1-0220, W81XWH-09-OCRP-CONDEV), American Cancer Society California Division (S10P-06-258-01-CCE), Mayo Foundation, L&S Milken Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1994, LANCET, V344, P1250, DOI 10.1016/S0140-6736(94)90749-8; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beesley J, 2007, CANCER EPIDEM BIOMAR, V16, P2557, DOI 10.1158/1055-9965.EPI-07-0542; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; BISHOP JM, 1995, GENE DEV, V9, P1309, DOI 10.1101/gad.9.11.1309; Bray F, 2005, INT J CANCER, V113, P977, DOI 10.1002/ijc.20649; Bristow RE, 1999, CANCER, V85, P658, DOI 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gerstman B. Burt, 1996, Pharmacoepidemiology and Drug Safety, V5, P141, DOI 10.1002/(SICI)1099-1557(199605)5:3<141::AID-PDS221>3.0.CO;2-8; GERSTMAN BB, 1991, AM J PUBLIC HEALTH, V81, P90, DOI 10.2105/AJPH.81.1.90; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grazio D, 2008, EUR J GYNAECOL ONCOL, V29, P357; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Grisaru D, 2007, ONCOL REP, V18, P1347; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Koninger J, 2004, CLIN CANCER RES, V10, P4776, DOI 10.1158/1078-0432.CCR-1190-03; Leygue E, 2000, J PATHOL, V192, P313; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Massague J, 2000, GENE DEV, V14, P627; Matthews T J, 2009, NCHS Data Brief, P1; Merritt MA, 2008, INT J CANCER, V122, P170, DOI 10.1002/ijc.23017; Nash MA, 2002, CLIN CANCER RES, V8, P1754; *NAT CANC I, NAT CANC I SURV EP E; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; PIVER MS, 1991, SEMIN ONCOL, V18, P177; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; RISCH HA, 1994, AM J EPIDEMIOL, V140, P585, DOI 10.1093/oxfordjournals.aje.a117296; Rodriguez GC, 1998, J SOC GYNECOL INVEST, V5, P271, DOI 10.1016/S1071-5576(98)00017-3; Rodriguez GC, 2002, JNCI-J NATL CANCER I, V94, P50; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; SCAID DJ, 2010, HAPLO STATS; Sellers TA, 2005, CANCER EPIDEM BIOMAR, V14, P2536, DOI 10.1158/1055-9965.EPI-05-0142; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shridhar V, 2001, CANCER RES, V61, P5895; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Whiteman DC, 2003, CANCER EPIDEM BIOMAR, V12, P42; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P244, DOI 10.1080/03008200802147746	47	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19642	10.1371/journal.pone.0019642	http://dx.doi.org/10.1371/journal.pone.0019642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637745	Green Published, gold, Green Accepted			2022-12-25	WOS:000291052500009
J	Travasso, RDM; Poire, EC; Castro, M; Rodrguez-Manzaneque, JC; Hernandez-Machado, A				Travasso, Rui D. M.; Poire, Eugenia Corvera; Castro, Mario; Rodrguez-Manzaneque, Juan Carlos; Hernandez-Machado, A.			Tumor Angiogenesis and Vascular Patterning: A Mathematical Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; VEGF-A; NORMALIZATION; MECHANISMS; SIMULATION; SWITCH	Understanding tumor induced angiogenesis is a challenging problem with important consequences for diagnosis and treatment of cancer. Recently, strong evidences suggest the dual role of endothelial cells on the migrating tips and on the proliferating body of blood vessels, in consonance with further events behind lumen formation and vascular patterning. In this paper we present a multi-scale phase-field model that combines the benefits of continuum physics description and the capability of tracking individual cells. The model allows us to discuss the role of the endothelial cells' chemotactic response and proliferation rate as key factors that tailor the neovascular network. Importantly, we also test the predictions of our theoretical model against relevant experimental approaches in mice that displayed distinctive vascular patterns. The model reproduces the in vivo patterns of newly formed vascular networks, providing quantitative and qualitative results for branch density and vessel diameter on the order of the ones measured experimentally in mouse retinas. Our results highlight the ability of mathematical models to suggest relevant hypotheses with respect to the role of different parameters in this process, hence underlining the necessary collaboration between mathematical modeling, in vivo imaging and molecular biology techniques to improve current diagnostic and therapeutic tools.	[Travasso, Rui D. M.] Univ Coimbra, Dept Fis, Ctr Fis Computac, P-3000 Coimbra, Portugal; [Poire, Eugenia Corvera] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim & Fis, Mexico City 04510, DF, Mexico; [Castro, Mario] Univ Pontificia Comillas, GISC, Madrid, Spain; [Castro, Mario] Univ Pontificia Comillas, Escuela Tec Sup Ingn ICAI, Grp Dinam No Lineal DNL, Madrid, Spain; [Rodrguez-Manzaneque, Juan Carlos] Univ Granada, Pfizer, Andalusian Govt Ctr Genom & Oncol Res, GENYO, Granada, Spain; [Hernandez-Machado, A.] Univ Barcelona, Fac Fis, Dept ECM, E-08028 Barcelona, Spain	Universidade de Coimbra; Universidad Nacional Autonoma de Mexico; Comillas Pontifical University; Comillas Pontifical University; Pfizer; University of Granada; University of Barcelona	Travasso, RDM (corresponding author), Univ Coimbra, Dept Fis, Ctr Fis Computac, P-3000 Coimbra, Portugal.	rui@teor.fis.uc.pt	Hernandez-Machado, Aurora/H-7425-2012; Travasso, Rui/B-8342-2018; Hernandez-Machado, Aurora/N-3362-2019; Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; Poire, Eugenia Corvera/B-1119-2008; Poire, Eugenia Corvera/Y-6404-2019; Travasso, Rui/A-6774-2011; Castro, Mario/A-3585-2009	Hernandez-Machado, Aurora/0000-0002-0397-5255; Travasso, Rui/0000-0001-6078-0721; Hernandez-Machado, Aurora/0000-0002-0397-5255; Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Poire, Eugenia Corvera/0000-0002-4688-6922; Poire, Eugenia Corvera/0000-0002-4688-6922; Castro, Mario/0000-0003-3288-6144	Fundacao para a Ciencia e Tecnologia [PTDC/SAU-ENB/110354/2009]; Fundacao Calouste Gulbenkian; CONACyT [83149]; Instituto de Salud Carlos III [EMER07/055]; Spanish Ministry of Science and Innovation [FIS2009-12964-C05-02, FIS2009-12964-C05-03]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.mctes.pt), project PTDC/SAU-ENB/110354/2009; Fundacao Calouste Gulbenkian (http://www.gulbenkian.pt/), Estimulo a Investigacao Prize; CONACyT (http://www.conacyt.mx/), project 83149; Instituto de Salud Carlos III (http://www.isciii.es/), project EMER07/055; Spanish Ministry of Science and Innovation (http://www.micinn.es/), projects FIS2009-12964-C05-02 and FIS2009-12964-C05-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cai Y, 2009, ACTA MECH SINICA-PRC, V25, P889, DOI 10.1007/s10409-009-0301-3; Carmeliet P, 1999, CURR TOP MICROBIOL, V237, P133; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHAPLAIN MAJ, 2003, ANNU REV BIOMED ENG, V8, P233; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FERRARA N, 2008, OVERVIEW CLIN APPL V, P345; Feucht M, 1997, AM J PATHOL, V151, P1407; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gonzalez-Cinca R., 2004, ADV CONDENSED MATTER, P203; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jones EAV, 2006, PHYSIOLOGY, V21, P388, DOI 10.1152/physiol.00020.2006; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Markus M, 1999, MATH BIOSCI, V156, P191, DOI 10.1016/S0025-5564(98)10066-4; Mayer RJ, 2004, NEW ENGL J MED, V350, P2406, DOI 10.1056/NEJMe048098; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Painter KJ, 2009, J MATH BIOL, V58, P511, DOI 10.1007/s00285-008-0217-8; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Ropert S, 2006, TARGET ONCOL, V1, P239, DOI 10.1007/s11523-006-0027-0; Schugart RC, 2008, P NATL ACAD SCI USA, V105, P2628, DOI 10.1073/pnas.0711642105; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; STOKES CL, 1991, J CELL SCI, V99, P419; Tracqui P, 2005, CELL PROLIFERAT, V38, P119, DOI 10.1111/j.1365-2184.2005.00337.x; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971	41	82	83	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19989	10.1371/journal.pone.0019989	http://dx.doi.org/10.1371/journal.pone.0019989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637756	Green Submitted, gold, Green Published			2022-12-25	WOS:000291052500022
J	Sudhir, PR; Hsu, CL; Wang, MJ; Wang, YT; Chen, YJ; Sung, TY; Hsu, WL; Yang, UC; Chen, JY				Sudhir, Putty-Reddy; Hsu, Chia-Lang; Wang, Mei-Jung; Wang, Yi-Ting; Chen, Yu-Ju; Sung, Ting-Yi; Hsu, Wen-Lian; Yang, Ueng-Cheng; Chen, Jeou-Yuan			Phosphoproteomics Identifies Oncogenic Ras Signaling Targets and Their Involvement in Lung Adenocarcinomas	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; FUNCTIONAL PROTEOMICS; PHOSPHORYLATION; CANCER; PATHWAYS; MULTIPLE; KINASE; DIFFERENTIATION; TRANSDUCTION; MUTATIONS	Background: Ras is frequently mutated in a variety of human cancers, including lung cancer, leading to constitutive activation of MAPK signaling. Despite decades of research focused on the Ras oncogene, Ras-targeted phosphorylation events and signaling pathways have not been described on a proteome-wide scale. Methodology/Principal Findings: By functional phosphoproteomics, we studied the molecular mechanics of oncogenic Ras signaling using a pathway-based approach. We identified Ras-regulated phosphorylation events (n = 77) using label-free comparative proteomics analysis of immortalized human bronchial epithelial cells with and without the expression of oncogenic Ras. Many were newly identified as potential targets of the Ras signaling pathway. A majority (similar to 60%) of the Ras-targeted events consisted of a [pSer/Thr]-Pro motif, indicating the involvement of proline-directed kinases. By integrating the phosphorylated signatures into the Pathway Interaction Database, we further inferred Ras-regulated pathways, including MAPK signaling and other novel cascades, in governing diverse functions such as gene expression, apoptosis, cell growth, and RNA processing. Comparisons of Ras-regulated phosphorylation events, pathways, and related kinases in lung cancer-derived cells supported a role of oncogenic Ras signaling in lung adenocarcinoma A549 and H322 cells, but not in large cell carcinoma H1299 cells. Conclusions/Significance: This study reveals phosphorylation events, signaling networks, and molecular functions that are regulated by oncogenic Ras. The results observed in this study may aid to extend our knowledge on Ras signaling in lung cancer.	[Sudhir, Putty-Reddy; Wang, Mei-Jung; Chen, Jeou-Yuan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Hsu, Chia-Lang; Yang, Ueng-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Wang, Yi-Ting; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Chen, Jeou-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chen, Jeou-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Sudhir, PR (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	bmchen@ibms.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020; Chen, Joanne Jeou-Yuan/S-7022-2018; Hsu, Chia-Lang/O-1458-2013; Sung, Ting-Yi/AAQ-5413-2021; Chen, Yu-Ju/E-9481-2015	Hsu, Wen-Lian/0000-0001-7061-3513; Hsu, Chia-Lang/0000-0002-7447-8045; Sung, Ting-Yi/0000-0002-6028-0409; Chen, Yu-Ju/0000-0002-3178-6697	National Research Program on Genomic Medicine; Academia Sinica	National Research Program on Genomic Medicine; Academia Sinica(Academia Sinica - Taiwan)	The work was supported in part by the grant to JYC from National Research Program on Genomic Medicine and the post-doctoral fellowship to PRS from the Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Cutillas PR, 2007, MOL CELL PROTEOMICS, V6, P1560, DOI 10.1074/mcp.M700037-MCP200; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Lawlor K, 2009, J PROTEOME RES, V8, P1489, DOI 10.1021/pr8008572; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee JL, 2008, MOL CELL BIOL, V28, P5710, DOI 10.1128/MCB.00186-08; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lu XN, 2005, MOL CELL PROTEOMICS, V4, P1948, DOI 10.1074/mcp.M500138-MCP200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; PALMER RH, 1994, FEBS LETT, V356, P5, DOI 10.1016/0014-5793(94)01202-4; Persidis A, 1998, NAT BIOTECHNOL, V16, P1082, DOI 10.1038/3553; Popescu M, 2006, IEEE ACM T COMPUT BI, V3, P263, DOI 10.1109/TCBB.2006.37; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Schreiber TB, 2008, PROTEOMICS, V8, P4416, DOI 10.1002/pmic.200800132; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Tsou CC, 2010, MOL CELL PROTEOMICS, V9, P131, DOI 10.1074/mcp.M900177-MCP200; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wilbur WJ, 1996, COMPUT BIOL MED, V26, P209, DOI 10.1016/0010-4825(95)00055-0; WU H, 2009, COMPUTATIONAL STAT D, V54, P767; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zubarev RA, 2008, J PROTEOMICS, V71, P89, DOI 10.1016/j.jprot.2008.01.004	34	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20199	10.1371/journal.pone.0020199	http://dx.doi.org/10.1371/journal.pone.0020199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637843	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200039
J	Filali, H; Martin-Burriel, I; Harders, F; Varona, L; Lyahyai, J; Zaragoza, P; Pumarola, M; Badiola, JJ; Bossers, A; Bolea, R				Filali, Hicham; Martin-Burriel, Inmaculada; Harders, Frank; Varona, Luis; Lyahyai, Jaber; Zaragoza, Pilar; Pumarola, Marti; Badiola, Juan J.; Bossers, Alex; Bolea, Rosa			Gene Expression Profiling and Association with Prion-Related Lesions in the Medulla Oblongata of Symptomatic Natural Scrapie Animals	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; PANCREATITIS-ASSOCIATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; HUMAN SUBSTANTIA-NIGRA; GLUTATHIONE-PEROXIDASE; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; APOLIPOPROTEIN-E; PEYERS-PATCHES	The pathogenesis of natural scrapie and other prion diseases remains unclear. Examining transcriptome variations in infected versus control animals may highlight new genes potentially involved in some of the molecular mechanisms of prion-induced pathology. The aim of this work was to identify disease-associated alterations in the gene expression profiles of the caudal medulla oblongata (MO) in sheep presenting the symptomatic phase of natural scrapie. The gene expression patterns in the MO from 7 sheep that had been naturally infected with scrapie were compared with 6 controls using a Central Veterinary Institute (CVI) custom designed 4 x 44K microarray. The microarray consisted of a probe set on the previously sequenced ovine tissue library by CVI and was supplemented with all of the Ovis aries transcripts that are currently publicly available. Over 350 probe sets displayed greater than 2-fold changes in expression. We identified 148 genes from these probes, many of which encode proteins that are involved in the immune response, ion transport, cell adhesion, and transcription. Our results confirm previously published gene expression changes that were observed in murine models with induced scrapie. Moreover, we have identified new genes that exhibit differential expression in scrapie and could be involved in prion neuropathology. Finally, we have investigated the relationship between gene expression profiles and the appearance of the main scrapie-related lesions, including prion protein deposition, gliosis and spongiosis. In this context, the potential impacts of these gene expression changes in the MO on scrapie development are discussed.	[Filali, Hicham; Badiola, Juan J.; Bolea, Rosa] Univ Zaragoza, Ctr Invest Encefalopatias & Enfermedades Transmis, Fac Vet, Zaragoza, Spain; [Martin-Burriel, Inmaculada; Lyahyai, Jaber; Zaragoza, Pilar] Univ Zaragoza, Lab Genet Bioquim LAGENBIO, Fac Vet, Zaragoza, Spain; [Harders, Frank; Bossers, Alex] Cent Inst Anim Dis Control CIDC Lelystad, Lelystad, Netherlands; [Varona, Luis] Univ Zaragoza, Unidad Genet Cuantitat & Mejora Anim, Fac Vet, Zaragoza, Spain; [Pumarola, Marti] UAB IRTA, PRIOCAT Lab, CReSA, Barcelona, Spain	University of Zaragoza; University of Zaragoza; University of Zaragoza; IRTA	Filali, H (corresponding author), Univ Zaragoza, Ctr Invest Encefalopatias & Enfermedades Transmis, Fac Vet, Zaragoza, Spain.	rbolea@unizar.es	zaragoza, pilar/AAN-9479-2021; Bossers, Alex/AAA-6025-2021; Martin-Burriel, Inmaculada/K-3724-2014; Lyahyai, Jaber/C-4341-2011; Bossers, Alex/F-7757-2019; Varona Aguado, Luis/C-2744-2012; Filali, Hicham/D-1279-2014	Bossers, Alex/0000-0002-6586-717X; Martin-Burriel, Inmaculada/0000-0001-6016-4726; Bossers, Alex/0000-0002-6586-717X; Varona Aguado, Luis/0000-0001-6256-5478; Filali, Hicham/0000-0003-3352-740X; Pumarola Batlle, Marti/0000-0002-0935-7941	Spanish MCIIN [AGL2008-0256]; Ministerio de Asuntos Exteriores y de Cooperacion (MAEC/AECID); Dutch Ministry of Agriculture, Nature Management, and Fisheries (LNV)	Spanish MCIIN; Ministerio de Asuntos Exteriores y de Cooperacion (MAEC/AECID); Dutch Ministry of Agriculture, Nature Management, and Fisheries (LNV)	This work was performed as part of the AGL2008-0256 project, financed by the Spanish MCIIN. Hicham Filali was supported by doctoral grants from the Ministerio de Asuntos Exteriores y de Cooperacion (MAEC/AECID). Arrays and sequenced libraries were made available from projects at CVI supported by grants from the Dutch Ministry of Agriculture, Nature Management, and Fisheries (LNV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin C, 2004, J GEN VIROL, V85, P2103, DOI 10.1099/vir.0.80047-0; ARUSHANIAN EB, ZH NEVROL PSIKHIATR, V110, P100; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Basso M, 2004, PROTEOMICS, V4, P3943, DOI 10.1002/pmic.200400848; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bertipaglia I., 2007, V45, P29; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Bolea R, 2005, J VET DIAGN INVEST, V17, P467, DOI 10.1177/104063870501700511; BOLEA R, NEUROPATHOL APPL NEU, V36, P300; Bons N, 1999, P NATL ACAD SCI USA, V96, P4046, DOI 10.1073/pnas.96.7.4046; Booth S, 2004, BIOCHEM BIOPH RES CO, V325, P1339, DOI 10.1016/j.bbrc.2004.10.150; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Brown AR, 2004, NEUROPATH APPL NEURO, V30, P555, DOI 10.1111/j.1365-2990.2004.00565.x; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Brown DR, 2001, MED HYPOTHESES, V57, P555, DOI 10.1054/mehy.2001.1388; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Casellas J, 2008, ANIM GENET, V39, P89, DOI 10.1111/j.1365-2052.2007.01670.x; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Chesebro B, 1997, NAT MED, V3, P491, DOI 10.1038/nm0597-491; Choe LH, 2002, ELECTROPHORESIS, V23, P2242, DOI 10.1002/1522-2683(200207)23:14<2242::AID-ELPS2242>3.0.CO;2-F; Cosseddu GM, 2007, BRAIN RES, V1142, P217, DOI 10.1016/j.brainres.2007.01.033; Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006; Counts SE, 2008, CELL MOL LIFE SCI, V65, P1842, DOI 10.1007/s00018-008-8159-2; Counts SE, 2008, NEURODEGENER DIS, V5, P228, DOI 10.1159/000113710; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; Crawley JN, 2008, CELL MOL LIFE SCI, V65, P1836, DOI 10.1007/s00018-008-8158-3; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Dandoy-Dron F, 1998, J BIOL CHEM, V273, P7691, DOI 10.1074/jbc.273.13.7691; DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz C, 2005, J GEN VIROL, V86, P849, DOI 10.1099/vir.0.80412-0; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; DUGUID JR, 1990, NUCLEIC ACIDS RES, V18, P2789, DOI 10.1093/nar/18.9.2789; Duplan L, 2001, NEUROBIOL AGING, V22, P79, DOI 10.1016/S0197-4580(00)00182-2; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Fukuhara R, 2003, ZOOL SCI, V20, P861, DOI 10.2108/zsj.20.861; Garcia-Crespo David, 2005, BMC Vet Res, V1, P3, DOI 10.1186/1746-6148-1-3; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; GEORGSSON G, 1993, J COMP PATHOL, V108, P229, DOI 10.1016/S0021-9975(08)80287-3; Giese A, 2001, CURR TOP MICROBIOL, V253, P203; Giese A, 1998, BRAIN PATHOL, V8, P449; Goldmann W, 1999, J GEN VIROL, V80, P2275, DOI 10.1099/0022-1317-80-8-2275; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hanlon J, 2002, J COMP PATHOL, V127, P280, DOI 10.1053/jcpa.2002.0595; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Hochstrasser DF, 1997, FEBS LETT, V416, P161, DOI 10.1016/S0014-5793(97)01191-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG Y, TRENDS MOL MED, V16, P287; HUNTER N, 1994, ARCH VIROL, V137, P171, DOI 10.1007/BF01311184; Hur K, 2002, MECH AGEING DEV, V123, P1637, DOI 10.1016/S0047-6374(02)00099-4; Ishisaka R, 1999, CELL STRUCT FUNCT, V24, P465, DOI 10.1247/csf.24.465; Jin JH, 2006, MOL CELL PROTEOMICS, V5, P1193, DOI 10.1074/mcp.M500382-MCP200; Jones V, 1996, VET REC, V139, P360, DOI 10.1136/vr.139.15.360; Khaniya B, 2009, J TOXICOL ENV HEAL A, V72, P1008, DOI 10.1080/15287390903084199; Kim HC, 1999, BRAIN RES, V851, P76, DOI 10.1016/S0006-8993(99)02122-8; Kim JI, 2001, ANN NY ACAD SCI, V928, P182, DOI 10.1111/j.1749-6632.2001.tb05648.x; Kretzschmar HA, 1996, ARCH NEUROL-CHICAGO, V53, P913, DOI 10.1001/archneur.1996.00550090125018; LAPLANCHE JL, 1993, MAMM GENOME, V4, P463, DOI 10.1007/BF00296824; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li XM, 2004, PROTEIN SCI, V13, P2845, DOI 10.1110/ps.04937304; Liang Y, 2008, J NEURO-ONCOL, V86, P133, DOI 10.1007/s11060-007-9457-5; Ligios C, 2002, J COMP PATHOL, V127, P45, DOI 10.1053/jcpa.2002.0589; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Lyahyai J, 2010, ANIM BIOTECHNOL, V21, P1, DOI 10.1080/10495390903323851; Monleon E, 2004, J HISTOCHEM CYTOCHEM, V52, P145, DOI 10.1177/002215540405200201; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; ORELLE B, 1992, J CLIN INVEST, V90, P2284, DOI 10.1172/JCI116115; Palmiter R D, 1987, Experientia Suppl, V52, P63; Pappolla MA, 2002, J PINEAL RES, V32, P135, DOI 10.1034/j.1600-079x.2002.1o838.x; Parveen I, 2005, VET RES, V36, P665, DOI 10.1051/vetres:2005028; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riemer C, 2004, BIOCHEM BIOPH RES CO, V323, P556, DOI 10.1016/j.bbrc.2004.08.124; Serrano C, 2009, VET RES, V40, DOI 10.1051/vetres/2009024; Siso S, 2002, ACTA NEUROPATHOL, V103, P615, DOI 10.1007/s00401-001-0512-6; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Skretting G, 2004, BIOCHEM BIOPH RES CO, V316, P272, DOI 10.1016/j.bbrc.2004.02.040; Skretting G, 2006, GENE, V376, P116, DOI 10.1016/j.gene.2006.02.021; Spiropoulos J, 2007, NEUROPATH APPL NEURO, V33, P398, DOI 10.1111/j.1365-2990.2007.00800.x; Sun Y, 2005, NEUROSCI LETT, V380, P219, DOI 10.1016/j.neulet.2005.01.038; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Umehara F, 2004, NEUROLOGY, V62, P1604, DOI 10.1212/01.WNL.0000123116.96441.34; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas F, 2006, J VET INTERN MED, V20, P187, DOI 10.1892/0891-6640(2006)20[187:DACEOS]2.0.CO;2; Vidal E, 2009, J COMP PATHOL, V141, P135, DOI 10.1016/j.jcpa.2009.04.002; Vidal E, 2006, J VIROL METHODS, V136, P137, DOI 10.1016/j.jviromet.2006.05.008; WELLS GAH, 1995, VET REC, V136, P211, DOI 10.1136/vr.136.9.211; Werner CJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-8; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; WOLLMER MA, BIOCH BIOPHYS ACTA, V1801, P762; Xiang W, 2005, ANN NEUROL, V58, P242, DOI 10.1002/ana.20551; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; YANG X, J PSYCHOPHARMACOL; Zetzsche T, 2010, EXPERT REV MOL DIAGN, V10, P667, DOI 10.1586/ERM.10.48	104	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19909	10.1371/journal.pone.0019909	http://dx.doi.org/10.1371/journal.pone.0019909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629698	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800015
J	Skalamera, D; Ranall, MV; Wilson, BM; Leo, P; Purdon, AS; Hyde, C; Nourbakhsh, E; Grimmond, SM; Barry, SC; Gabrielli, B; Gonda, TJ				Skalamera, Dubravka; Ranall, Max V.; Wilson, Benjamin M.; Leo, Paul; Purdon, Amy S.; Hyde, Carolyn; Nourbakhsh, Ehsan; Grimmond, Sean M.; Barry, Simon C.; Gabrielli, Brian; Gonda, Thomas J.			A High-Throughput Platform for Lentiviral Overexpression Screening of the Human ORFeome	PLOS ONE			English	Article							OPEN READING FRAMES; CELL-CYCLE ARREST; FUNCTIONAL GENOMICS; UBIQUITIN CHAINS; PROTEIN-KINASES; GENE-EXPRESSION; IDENTIFICATION; NEK6; CLONING; VECTORS	In response to the growing need for functional analysis of the human genome, we have developed a platform for high-throughput functional screening of genes overexpressed from lentiviral vectors. Protein-coding human open reading frames (ORFs) from the Mammalian Gene Collection were transferred into lentiviral expression vector using the highly efficient Gateway recombination cloning. Target ORFs were inserted into the vector downstream of a constitutive promoter and upstream of an IRES controlled GFP reporter, so that their transfection, transduction and expression could be monitored by fluorescence. The expression plasmids and viral packaging plasmids were combined and transfected into 293T cells to produce virus, which was then used to transduce the screening cell line. We have optimised the transfection and transduction procedures so that they can be performed using robotic liquid handling systems in arrayed 96-well microplate, one-gene-per-well format, without the need to concentrate the viral supernatant. Since lentiviruses can infect both dividing and non-dividing cells, this system can be used to overexpress human ORFs in a broad spectrum of experimental contexts. We tested the platform in a 1990 gene pilot screen for genes that can increase proliferation of the non-tumorigenic mammary epithelial cell line MCF-10A after removal of growth factors. Transduced cells were labelled with the nucleoside analogue 5-ethynyl-2'-deoxyuridine (EdU) to detect cells progressing through S phase. Hits were identified using high-content imaging and statistical analysis and confirmed with vectors using two different promoters (CMV and EF1 alpha). The screen demonstrates the reliability, versatility and utility of our screening platform, and identifies novel cell cycle/proliferative activities for a number of genes.	[Skalamera, Dubravka; Ranall, Max V.; Wilson, Benjamin M.; Leo, Paul; Purdon, Amy S.; Hyde, Carolyn; Gabrielli, Brian; Gonda, Thomas J.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Nourbakhsh, Ehsan; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Barry, Simon C.] Univ Adelaide, Mol Immunol Lab, Discipline Paediat, Adelaide, SA, Australia; [Barry, Simon C.] Womens & Childrens Hosp, Womens & Childrens Hlth Res Inst, Adelaide, SA, Australia	University of Queensland; University of Queensland; University of Adelaide; Womens & Childrens Hospital Australia	Skalamera, D (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia.	d.skalamera@uq.edu.au	Grimmond, Sean/K-3246-2019; Gonda, Thomas J/A-3620-2012; Grimmond, Sean M/J-5304-2016; Leo, Paul J/B-3470-2011; barry, simon/Y-4529-2019; Gabrielli, Brian G/B-3655-2011; Leo, Paul/R-4464-2019	Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Leo, Paul J/0000-0001-8325-4134; barry, simon/0000-0002-0597-7609; Gabrielli, Brian G/0000-0003-3933-1651; Skalamera, Dubravka/0000-0002-5301-302X; Gonda, Thomas/0000-0002-8792-3021	National Health and Medical Research Council of Australia (NHMRC) [ID401608]; Australia Research Council (ARC) [LE0668241]; Australian Cancer Research Foundation (ACRF)	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council (ARC)(Australian Research Council); Australian Cancer Research Foundation (ACRF)	This work was supported by funding from the National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au/; grant ID401608), the Australia Research Council (ARC, http://www.arc.gov.au/; grant LE0668241) and the Australian Cancer Research Foundation (ACRF, http://www.acrf.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres DA, 2006, METHOD ENZYMOL, V407, P499, DOI 10.1016/S0076-6879(05)07040-0; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Blesch A, 2004, METHODS, V33, P164, DOI 10.1016/j.ymeth.2003.11.005; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Brown AL, 2006, J LEUKOCYTE BIOL, V80, P433, DOI 10.1189/jlb.0206112; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Chilov D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng115; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Crawford DF, 2001, J BIOL CHEM, V276, P37166, DOI 10.1074/jbc.M103414200; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011940; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIRKS W, 1993, GENE, V128, P247, DOI 10.1016/0378-1119(93)90569-O; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Forrest ARR, 2003, GENOME RES, V13, P1443, DOI 10.1101/gr.954803; Forrest ARR, 2003, GENOME RES, V13, P1366, DOI 10.1101/gr.1012403; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; Harada JN, 2005, GENOME RES, V15, P1136, DOI 10.1101/gr.3889305; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Jeon YJ, 2010, J BIOL CHEM, V285, P28126, DOI 10.1074/jbc.M110.137190; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Koenig-Hoffmann K, 2005, INT J CANCER, V113, P434, DOI 10.1002/ijc.20601; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Nassirpour R, 2010, MOL CANCER RES, V8, P717, DOI 10.1158/1541-7786.MCR-09-0291; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; Ranall MV, 2010, BIOTECHNIQUES, V48, P379, DOI 10.2144/000113410; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Temple G, 2006, HUM MOL GENET, V15, pR31, DOI 10.1093/hmg/ddl048; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wiemann S, 2004, GENOME RES, V14, P2136, DOI 10.1101/gr.2576704; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001	60	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20057	10.1371/journal.pone.0020057	http://dx.doi.org/10.1371/journal.pone.0020057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629697	Green Published, gold			2022-12-25	WOS:000291005800025
J	Su, WW; Chen, PYF; Hsiao, CH; Chen, HSL				Su, Wei-Wen; Chen, Phil Yeong-Fung; Hsiao, Ching-Hsi; Chen, Henry Shen-Lih			Primary Phacoemulsification and Intraocular Lens Implantation for Acute Primary Angle-Closure	PLOS ONE			English	Article							CATARACT-SURGERY; OCULAR BIOMETRY; LASER IRIDOTOMY; ASIAN EYES; GLAUCOMA; EXTRACTION; CONFIGURATION; RISE	Background: To investigate the effect of primary phacoemulsification on intraocular pressure (IOP) in patients with acute primary angle-closure (PAC) and coexisting cataract. Methodology: Sixteen eyes of 14 patients with acute PAC received phacoemulsification and intraocular lens implantation as initial management for medically uncontrolled IOP in a retrospective chart review. The effects on IOP, vision, anterior chamber depth (ACD), and number of antiglaucoma medications were evaluated. Principal Findings: The postoperative IOP was reduced in 16 eyes (100%). The mean +/- standard deviation preoperative IOP was 48.81 +/- 16.83 mm Hg, which decreased postoperatively to 16.46 +/- 10.67 mm Hg at 1 day, 9.43 +/- 3.03 mm Hg at 1 week, 9.49 +/- 2.14 mm Hg at 2 weeks, 10.78 +/- 3.56 mm Hg at 1 month, and 10.70 +/- 2.80 mm Hg at 3 months(p<0.001). The mean number of antiglaucoma medications decreased from 3.56 +/- 1.14 to 0.13 +/- 0.34 (p<0.001). The average preoperative ACD was 2.08 +/- 0.35 mm, which increased to 3.59 +/- 0.33 mm after surgery (p<0.001). Visual acuity (converted into logarithm of the minimum angle of resolution [logMAR]) improved from 1.14 +/- 0.71 to 0.73 +/- 0.53 (p=0.001). Conclusions: Primary phacoemulsification plus intraocular lens implantation lowered IOP, reduced the use of antiglaucoma medications, and improved vision in patients with acute PAC. This is a safe and effective method of IOP control and can be considered a first treatment option in managing patients with acute PAC and coexisting cataract.	[Su, Wei-Wen; Chen, Phil Yeong-Fung; Hsiao, Ching-Hsi; Chen, Henry Shen-Lih] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Su, WW (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan.	hslchen@yahoo.com.tw		Su, Wei-Wen/0000-0001-9682-9152				ALSBIRK PH, 1975, ACTA OPHTHALMOL, V53, P89; Aung T, 2001, AM J OPHTHALMOL, V131, P7, DOI 10.1016/S0002-9394(00)00621-8; Choong YF, 1999, EYE, V13, P613, DOI 10.1038/eye.1999.168; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Gunning FP, 1998, J CATARACT REFR SURG, V24, P1347, DOI 10.1016/S0886-3350(98)80227-7; Hu CC, 2008, ACTA OPHTHALMOL, V86, P440, DOI 10.1111/j.1600-0420.2007.01066.x; Imaizumi M, 2006, J CATARACT REFR SURG, V32, P85, DOI 10.1016/j.jcrs.2005.11.014; Jacobi PC, 2002, OPHTHALMOLOGY, V109, P1597, DOI 10.1016/S0161-6420(02)01123-5; Keenan TDL, 2009, J GLAUCOMA, V18, P201, DOI 10.1097/IJG.0b013e318181540a; Kurimoto Y, 1997, AM J OPHTHALMOL, V124, P775, DOI 10.1016/S0002-9394(14)71694-0; Lam DSC, 2008, OPHTHALMOLOGY, V115, P1134, DOI 10.1016/j.ophtha.2007.10.033; Lan YW, 2007, OPHTHALMOLOGICA, V221, P388, DOI 10.1159/000107498; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; MARKOWITZ SN, 1985, AM J OPHTHALMOL, V99, P400, DOI 10.1016/0002-9394(85)90005-4; Nolan W, 2006, BRIT J OPHTHALMOL, V90, P1, DOI 10.1136/bjo.2005.082040; Nolan WP, 2000, BRIT J OPHTHALMOL, V84, P1255, DOI 10.1136/bjo.84.11.1255; Nonaka A, 2006, OPHTHALMOLOGY, V113, P437, DOI 10.1016/j.ophtha.2005.11.018; PANEK WC, 1990, AM J OPHTHALMOL, V110, P185, DOI 10.1016/S0002-9394(14)76989-2; Ritch R, 1989, GLAUCOMAS, V1; Roberts TV, 2000, J CATARACT REFR SURG, V26, P1012, DOI 10.1016/S0886-3350(00)00358-8; Rosman M, 2002, OPHTHALMOLOGY, V109, P2227, DOI 10.1016/S0161-6420(02)01275-7; Tham CCY, 2009, OPHTHALMOLOGY, V116, P725, DOI 10.1016/j.ophtha.2008.12.054; TORNQUIST RAGNAR, 1953, ACTA OPHTHALMOL SUPPL, V39, P1; Yang CH, 1997, J CATARACT REFR SURG, V23, P1109, DOI 10.1016/S0886-3350(97)80089-2; Zhi ZM, 2003, AM J OPHTHALMOL, V135, P534, DOI 10.1016/S0002-9394(02)02108-6; Zhuo YH, 2009, J GLAUCOMA, V18, P646, DOI 10.1097/IJG.0b013e31819c4322	26	16	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20056	10.1371/journal.pone.0020056	http://dx.doi.org/10.1371/journal.pone.0020056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629644	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800024
J	Wang, HM; Pan, YL; Xue, B; Wang, XH; Zhao, F; Jia, J; Liang, XB; Wang, XM				Wang, Haomin; Pan, Yanli; Xue, Bing; Wang, Xinhong; Zhao, Feng; Jia, Jun; Liang, Xibin; Wang, Xiaomin			The Antioxidative Effect of Electro-Acupuncture in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; SUBSTANTIA-NIGRA; GLUTATHIONE-PEROXIDASE; BASAL GANGLIA; DOPAMINERGIC-NEURONS; TRANSECTED RATS; MESSENGER-RNA; ANIMAL-MODELS; MPTP; STIMULATION	Accumulating evidence indicates that oxidative stress plays a critical role in Parkinson's disease (PD). Our previous work has shown that 100 Hz electro-acupuncture (EA) stimulation at ZUSANLI (ST36) and SANYINJIAO (SP6) protects neurons in the substantia nigra pars compacta from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in male C57BL/6 mice, a model of PD. In the present study we administered 100 Hz EA stimulation at the two acupoints to MPTP-lesioned mice for 12 sessions starting from the day prior to the first MPTP injection. We found that in the striatum of MPTP treated mice 100 Hz EA stimulation effectively inhibited the production of hydrogen peroxide and malonaldehyde, and increased glutathione concentration and total superoxide dismutase activity through biochemical methods. However, it decreased glutathione peroxidase activity via biochemical analysis and did not affect the level of 1-methyl-4-phenylpyridinium in the striatum revealed by high performance liquid chromatography with ultraviolet detection. These data suggest that 100 Hz EA stimulation at ST36 and SP6 has antioxidative effects in the MPTP model of PD. This data, along with our previous work, indicates that 100 Hz EA stimulation at ST36 and SP6 protects the nigrostriatal system by multiple mechanisms including antioxidation and antiapoptosis, and suggests that EA stimulation is a promising therapy for treating PD.	[Wang, Haomin; Wang, Xinhong; Wang, Xiaomin] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Pan, Yanli] Beijing An Ding Hosp, Sci & Educ Off, Beijing, Peoples R China; [Xue, Bing] Capital Med Univ, Med Expt & Test Ctr, Beijing, Peoples R China; [Zhao, Feng] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Jia, Jun; Wang, Xiaomin] Capital Med Univ, Key Lab Neurodegenerat Disorders, Dept Physiol, Minist Educ, Beijing, Peoples R China; [Liang, Xibin] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Peking University; Capital Medical University; Capital Medical University; Capital Medical University; Stanford University	Wang, HM (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [30472245]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China (2011CB504100) and the National Natural Science Foundation of China (30472245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Andreassen OA, 2001, EXP NEUROL, V167, P189, DOI 10.1006/exnr.2000.7525; Ara J, 1998, P NATL ACAD SCI USA, V95, P7659, DOI 10.1073/pnas.95.13.7659; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; BRADBURY AJ, 1986, NEUROPHARMACOLOGY, V25, P939, DOI 10.1016/0028-3908(86)90025-0; Chen L, 1998, J Tradit Chin Med, V18, P23; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DOS SJG, 2008, PHYSIOL BEHAV, V93, P155; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Floor E, 1998, J NEUROCHEM, V70, P268; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; HERKENHAM M, 1991, NEUROSCIENCE, V40, P133, DOI 10.1016/0306-4522(91)90180-V; Hirsch EC, 2003, J NEURAL TRANSM-SUPP, P89, DOI 10.1007/978-3-7091-0643-3_6; Huang C, 2000, NEUROSCI LETT, V294, P159, DOI 10.1016/S0304-3940(00)01572-X; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kim ST, 2010, J PHYSIOL SCI, V60, P27, DOI 10.1007/s12576-009-0061-7; KISH SJ, 1985, NEUROSCI LETT, V58, P343, DOI 10.1016/0304-3940(85)90078-3; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Kung YY, 2006, AM J CHINESE MED, V34, P47, DOI 10.1142/S0192415X0600362X; Lee SH, 2002, NEUROSCI LETT, V332, P17, DOI 10.1016/S0304-3940(02)00900-X; Liang LP, 2007, J NEUROSCI, V27, P4326, DOI 10.1523/JNEUROSCI.0019-07.2007; Liang XB, 2003, NEUROREPORT, V14, P1177, DOI 10.1097/00001756-200306110-00015; Liang XB, 2002, MOL BRAIN RES, V108, P51, DOI 10.1016/S0169-328X(02)00513-2; Liu XY, 2004, EXP NEUROL, V189, P189, DOI 10.1016/j.expneurol.2004.05.028; Luo DZ, 2009, EUR J PHARMACOL, V617, P33, DOI 10.1016/j.ejphar.2009.06.015; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Moussaoui S, 2000, EXP NEUROL, V166, P235, DOI 10.1006/exnr.2000.7516; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Orth M, 2003, MOVEMENT DISORD, V18, P729, DOI 10.1002/mds.10447; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Rabinovic AD, 1998, J NEUROCHEM, V71, P2071; Ren Xiao-ming, 2008, J Tradit Chin Med, V28, P255; Rho SW, 2008, MOL CELLS, V25, P178; SAGGU H, 1989, J NEUROCHEM, V53, P692, DOI 10.1111/j.1471-4159.1989.tb11759.x; Schmidt N, 2001, J NEURAL TRANSM, V108, P1263, DOI 10.1007/s007020100004; SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H; Shulman LM, 2002, MOVEMENT DISORD, V17, P799, DOI 10.1002/mds.10134; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020; Zhang J, 2000, J NEUROPATH EXP NEUR, V59, P53, DOI 10.1093/jnen/59.1.53; Zhao LC, 2009, COMP BIOCHEM PHYS B, V152, P339, DOI 10.1016/j.cbpb.2008.12.014; Zhuang X, 2000, J Tradit Chin Med, V20, P265	53	59	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19790	10.1371/journal.pone.0019790	http://dx.doi.org/10.1371/journal.pone.0019790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625423	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200013
J	Lee, YJ; Savtchenko, R; Ostapchenko, VG; Makarava, N; Baskakov, IV				Lee, Young Jin; Savtchenko, Regina; Ostapchenko, Valeriy G.; Makarava, Natallia; Baskakov, Ilia V.			Molecular Structure of Amyloid Fibrils Controls the Relationship between Fibrillar Size and Toxicity	PLOS ONE			English	Article							PRION PROTEIN; PHYSICAL-PROPERTIES; DISEASE; PRP; NEURODEGENERATION; CLASSIFICATION; DEGENERATION; IMPAIRMENT; MECHANISMS; INSIGHTS	Background: According to the prevailing view, soluble oligomers or small fibrillar fragments are considered to be the most toxic species in prion diseases. To test this hypothesis, two conformationally different amyloid states were produced from the same highly pure recombinant full-length prion protein (rPrP). The cytotoxic potential of intact fibrils and fibrillar fragments generated by sonication from these two states was tested using cultured cells. Methodology/Principal Findings: For one amyloid state, fibril fragmentation was found to enhance its cytotoxic potential, whereas for another amyloid state formed within the same amino acid sequence, the fragmented fibrils were found to be substantially less toxic than the intact fibrils. Consistent with the previous studies, the toxic effects were more pronounced for cell cultures expressing normal isoform of the prion protein (PrPC) at high levels confirming that cytotoxicity was in part PrPC-dependent. Silencing of PrPC expression by small hairpin RNAs designed to silence expression of human PrPC (shRNA-PrPC) deminished the deleterious effects of the two amyloid states to a different extent, suggesting that the role of PrPC mediated and PrPC-independent mechanisms depends on the structure of the aggregates. Conclusions/Significance: This work provides a direct illustration that the relationship between an amyloid's physical dimension and its toxic potential is not unidirectional but is controlled by the molecular structure of prion protein (PrP) molecules within aggregated states. Depending on the structure, a decrease in size of amyloid fibrils can either enhance or abolish their cytotoxic effect. Regardless of the molecular structure or size of PrP aggregates, silencing of PrPC expression can be exploited to reduce their deleterious effects.	[Lee, Young Jin] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Lee, YJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	baskakov@umaryland.edu	Lee, Young Jin/AAF-6189-2019; Lee, Young Jin/K-9635-2019	Lee, Young Jin/0000-0002-2325-5271; Ostapchenko, Valeriy/0000-0002-3629-7702	National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS045585 to I.V.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BITAN G, 2002, P NATL ACAD SCI USA, P330; Blochberger TC, 1997, PROTEIN ENG, V10, P1465, DOI 10.1093/protein/10.12.1465; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Ermolayev V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000558; Ermolayev V, 2009, BIOPHYS J, V96, P3390, DOI 10.1016/j.bpj.2009.01.032; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krasemann S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013906; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Mabbott N, 2005, HAEMATOLOGICA, V90, P542; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Novitskaya V, 2007, J NEUROCHEM, V102, P398, DOI 10.1111/j.1471-4159.2007.04537.x; Ostapchenko VG, 2008, J MOL BIOL, V383, P1210, DOI 10.1016/j.jmb.2008.08.073; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; PARK JH, 2010, HIPPOCAMPUS IN PRESS; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Radford HE, 2010, CURR ISSUES MOL BIOL, V12, P119; RESENBERGER UK, 2011, EMBO J IN PRESS; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Siskova Z, 2010, AM J PATHOL, V177, P1411, DOI 10.2353/ajpath.2010.091037; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Thellung S, 2007, ANN NY ACAD SCI, V1096, P258, DOI 10.1196/annals.1397.092; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	50	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20244	10.1371/journal.pone.0020244	http://dx.doi.org/10.1371/journal.pone.0020244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625461	Green Published, gold, Green Submitted			2022-12-25	WOS:000290793400049
J	Tippett, E; Cheng, WJ; Westhorpe, C; Cameron, PU; Brew, BJ; Lewin, SR; Jaworowski, A; Crowe, SM				Tippett, Emma; Cheng, Wan-Jung; Westhorpe, Clare; Cameron, Paul U.; Brew, Bruce J.; Lewin, Sharon R.; Jaworowski, Anthony; Crowe, Suzanne M.			Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; ANTIINFLAMMATORY TYPE-2 MACROPHAGES; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD MONOCYTES; CYSTEINE-RICH FAMILY; TOLL-LIKE RECEPTORS; SOLUBLE CD163; ENDOTHELIAL-CELLS; MICROBIAL TRANSLOCATION; ACTIVATION MARKERS	CD163, a haptoglobin-hemoglobin (Hp-Hb) scavenger receptor, expressed by monocytes and macrophages, is important in resolution of inflammation. Age-related non-AIDS co-morbidities in HIV-infected individuals, particularly dementia and cardiovascular disease, result in part from effects of HIV-1 infection on monocyte and macrophage biology. CD163 coexpression on CD14+CD16++ monocytes has been proposed as a useful biomarker for HIV-1 disease progression and the presence of HIV associated dementia. Here we investigated CD163 expression on monocyte subsets ex vivo, on cultured macrophages, and soluble in plasma, in the setting of HIV-1 infection. Whole blood immunophenotyping revealed CD163 expression on CD14++CD16- monocytes but not on CD14+CD16++ monocytes (P = 0.004), supported by CD163 mRNA levels. Incubation with M-CSF induced CD163 protein expression on CD14+ CD16++ monocytes to the same extent as CD14++CD16- monocytes. CD163 expression on CD14++CD16- monocytes from HIV-infected subjects was significantly higher than from uninfected individuals, with a trend towards increased expression on CD14++CD16- monocytes (P = 0.019 and 0.069 respectively), which is accounted for by HIV-1 therapy including protease inhibitors. Shedding of CD163 was shown to predominantly occur from the CD14++CD16- subset after Ficoll isolation and LPS stimulation. Soluble CD163 concentration in plasma from HIV-1 infected donors was similar to HIV-1 uninfected donors. Monocyte CD163 expression in HIV-1 infected patients showed a complicated relationship with classical measures of disease progression. Our findings clarify technical issues regarding CD163 expression on monocyte subsets and further elucidates its role in HIV-associated inflammation by demonstrating that CD163 is readily lost from CD14++CD16- monocytes and induced in pro-inflammatory CD14+ CD16++ monocytes by M-CSF. Our data show that all monocyte subsets are potentially capable of differentiating into CD163-expressing anti-inflammatory macrophages given appropriate stimuli. Levels of CD163 expression on monocytes may be a potential biomarker reflecting efforts by the immune system to resolve immune activation and inflammation in HIV-infected individuals.	[Tippett, Emma; Cheng, Wan-Jung; Westhorpe, Clare; Cameron, Paul U.; Lewin, Sharon R.; Jaworowski, Anthony; Crowe, Suzanne M.] Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia; [Tippett, Emma; Lewin, Sharon R.; Jaworowski, Anthony; Crowe, Suzanne M.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cameron, Paul U.; Jaworowski, Anthony] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Brew, Bruce J.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia	Burnet Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; St Vincents Hospital Sydney	Tippett, E (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Virol, Melbourne, Vic, Australia.	crowe@burnet.edu.au	Lewin, Sharon/Z-3297-2019; Brew, Bruce/J-6513-2012	brew, bruce/0000-0003-0622-1392; Lewin, Sharon Ruth/0000-0002-0330-8241; Westhorpe, Clare/0000-0002-5789-0425; jaworowski, anthony/0000-0002-3844-805X; Cameron, Paul Urquhart/0000-0002-1906-6945	National Health and Medical Research Council [358399]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by National Health and Medical Research Council Program Grant 358399 to SRL and SMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2000, EUR J IMMUNOL, V30, P1872, DOI 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2; Ancuta P, 2006, J LEUKOCYTE BIOL, V80, P1156, DOI 10.1189/jlb.0206125; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bissel SJ, 2006, J NEUROIMMUNOL, V177, P85, DOI 10.1016/j.jneuroim.2006.04.017; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Bover LC, 2007, J IMMUNOL, V178, P8183, DOI 10.4049/jimmunol.178.12.8183; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Clerici M, 2000, ANN NY ACAD SCI, V917, P956; Crowe SM, 2010, J LEUKOCYTE BIOL, V87, P589, DOI 10.1189/jlb.0809580; Daly A, 2006, ALIMENT PHARM THER, V24, P553, DOI 10.1111/j.1365-2036.2006.03012.x; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Droste A, 1999, BIOCHEM BIOPH RES CO, V256, P110, DOI 10.1006/bbrc.1999.0294; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Fabriek BO, 2007, J NEUROIMMUNOL, V187, P179, DOI 10.1016/j.jneuroim.2007.04.016; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Frings W, 2002, FEBS LETT, V526, P93, DOI 10.1016/S0014-5793(02)03142-3; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Goldstein JI, 2003, ATHEROSCLEROSIS, V170, P325, DOI 10.1016/S0021-9150(03)00297-1; Goodale D, 2009, CYTOM PART B-CLIN CY, V76B, P107, DOI 10.1002/cyto.b.20449; Hamann W, 1995, INFLAMM RES, V44, P535, DOI 10.1007/BF01757358; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Hogger P, 1998, J IMMUNOL, V161, P1883; Jaworowski A, 2006, J INFECT DIS, V193, P693, DOI 10.1086/500367; Knudsen TB, 2007, SCAND J INFECT DIS, V39, P542, DOI 10.1080/00365540601113685; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kruger M, 1996, IMMUNOLOGY, V87, P162; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Maniecki MB, 2011, IMMUNOBIOLO IN PRESS; Matsushita N, 2002, CLIN EXP IMMUNOL, V130, P156, DOI 10.1046/j.1365-2249.2002.01963.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P29, DOI 10.1080/003655102762377466; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Moniuszko M, 2006, CLIN VACCINE IMMUNOL, V13, P704, DOI 10.1128/CVI.00417-05; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; MORGANELLI PM, 1988, J IMMUNOL, V140, P2296; MUSSON RA, 1984, SURV IMMUNOL RES, V3, P138; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Richens J, 2007, IMMUNOBIOLOGY, V212, P29, DOI 10.1016/j.imbio.2006.06.012; Roberts ES, 2004, J NEUROPATH EXP NEUR, V63, P1255, DOI 10.1093/jnen/63.12.1255; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Sanchez C, 1999, J IMMUNOL, V162, P5230; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2005, EUR J HAEMATOL, V74, P6, DOI 10.1111/j.1600-0609.2004.00318.x; Schaer DJ, 2007, ANTIOXID REDOX SIGN, V9, P991, DOI 10.1089/ars.2007.1576; SHEPHERD VL, 1982, J RETICULOENDOTH SOC, V32, P423; Souques F, 1997, J IMMUNOL METHODS, V204, P153, DOI 10.1016/S0022-1759(97)00039-2; Stec M, 2007, J LEUKOCYTE BIOL, V82, P594, DOI 10.1189/jlb.0207117; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Sulahian TH, 2004, J LEUKOCYTE BIOL, V76, P271, DOI 10.1189/jlb.1003523; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Weaver LK, 2007, J LEUKOCYTE BIOL, V81, P663, DOI 10.1189/jlb.0706428; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; Wenzel I, 1996, EUR J IMMUNOL, V26, P2758, DOI 10.1002/eji.1830261131; Williams L, 2002, J LEUKOCYTE BIOL, V72, P800; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Yearley JH, 2007, AIDS RES HUM RETROV, V23, P515, DOI 10.1089/aid.2006.0211; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZWADLOKLARWASSER G, 1990, INT ARCH ALLER A IMM, V91, P175, DOI 10.1159/000235111	73	73	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19968	10.1371/journal.pone.0019968	http://dx.doi.org/10.1371/journal.pone.0019968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625498	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400025
J	Chen, JH; Lu, ZJ; Cheng, D; Peng, S; Wang, HY				Chen, Jiahuan; Lu, Zhijuan; Cheng, De; Peng, Sha; Wang, Huayan			Isolation and Characterization of Porcine Amniotic Fluid-Derived Multipotent Stem Cells	PLOS ONE			English	Article							BONE-MARROW; DIFFERENTIATION; LINES; ISCHEMIA	The aim of this study was to isolate and characterize porcine amniotic fluid-derived multipotent stem cells (pAF-MSC). The porcine amniotic fluid (AF) from the amniotic cavity of pregnant gilts in the early stages of gestation (at E35) was collected and centrifuged for 5-10 min at 400 g to pellet cells. The primary culture of AF showed the multiple cell types, including the epithelial-like cells and fibroblast-like cells. By culturing in AMM medium for 6 to 8 days, the epithelial-like cells disappeared and the remaining cells presented the fibroblastoid morphology. The doubling time of pAF-MSCs was about 34.6 h, and the cells had been continually cultured over 60 passages in vitro. The flow cytometry results showed that pAF-MSCs were positive for CD44, CD117 and CD166, but negative for CD34, CD45 and CD54. Meanwhile, pAF-MSCs expressed ES cell markers, such as Oct4, Nanog, SSEA4, Tra-1-60 and Tra-1-81. The ratio of CD117(+)CD44(+) cells accounted for 98% of pAF-MSCs population. Three germ layer markers, including FGF5 (ectodermal marker), AFP (endodermal marker) and Bra (mesodermal marker), were detected in embryoid bodies derived from pAF-MSCs. Under the different induction conditions, the pAF-MSCs were capable of differentiating into neurocytes, adipocytes and beating cardiomyocytes. Furthermore, the pAF-MSCs didn't form teratoma when injected into immunodeficiency mice. These optimal features of pAF-MSCs provide an excellent alternative stem cell resource for potential cell therapy in regenerative medicine and transgenic animals.	[Chen, Jiahuan; Lu, Zhijuan; Cheng, De; Peng, Sha; Wang, Huayan] NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Lu, Zhijuan] Zhengzhou Senior High Sch, Zhemgzhou, Henan, Peoples R China	Northwest A&F University - China	Chen, JH (corresponding author), NW A&F Univ, Coll Vet Med, Dept Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	pengsha123@yahoo.com.cn; hhwang101@163.com			Chinese National Programs for Fundamental Research and Development ("973" Plan) [2009CB941002]	Chinese National Programs for Fundamental Research and Development ("973" Plan)(National Basic Research Program of China)	This work was supported by the Major Project of Chinese National Programs for Fundamental Research and Development ("973" Plan, 2009CB941002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chiavegato A, 2007, J MOL CELL CARDIOL, V42, P746, DOI 10.1016/j.yjmcc.2006.12.008; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; De Gemmis P, 2006, STEM CELLS DEV, V15, P719; EZASHI T, 2009, PNAS, P1; GOSDEN CM, 1983, BRIT MED BULL, V39, P348, DOI 10.1093/oxfordjournals.bmb.a071847; HOLM F, 2010, DRUG DISCOV TODAY TE, V5, P131; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Phermthai T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-79; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rehni AK, 2007, BEHAV BRAIN RES, V183, P95, DOI 10.1016/j.bbr.2007.05.028; Rho GJ, 2009, FRONT BIOSCI-LANDMRK, V14, P3942, DOI [10.2735/3503, 10.2741/3503]; Sartore S, 2005, EUR J CARDIO-THORAC, V28, P677, DOI 10.1016/j.ejcts.2005.07.019; STEELE MW, 1974, LANCET, V2, P1210; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003	29	57	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19964	10.1371/journal.pone.0019964	http://dx.doi.org/10.1371/journal.pone.0019964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625520	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200035
J	Dingle, KE; Griffiths, D; Didelot, X; Evans, J; Vaughan, A; Kachrimanidou, M; Stoesser, N; Jolley, KA; Golubchik, T; Harding, RM; Peto, TE; Fawley, W; Walker, AS; Wilcox, M; Crook, DW				Dingle, Kate E.; Griffiths, David; Didelot, Xavier; Evans, Jessica; Vaughan, Alison; Kachrimanidou, Melina; Stoesser, Nicole; Jolley, Keith A.; Golubchik, Tanya; Harding, Rosalind M.; Peto, Tim E.; Fawley, Warren; Walker, A. Sarah; Wilcox, Mark; Crook, Derrick W.			Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity	PLOS ONE			English	Article							TOXIN-B; INCREASED SPORULATION; HYPERVIRULENT STRAIN; SEQUENCE-ANALYSIS; PCR; EPIDEMIC; INFECTION; TCDC; MICROEVOLUTION; TRANSCRIPTION	Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains.	[Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Dingle, Kate E.; Griffiths, David; Evans, Jessica; Vaughan, Alison; Kachrimanidou, Melina; Stoesser, Nicole; Peto, Tim E.; Walker, A. Sarah; Crook, Derrick W.] John Radcliffe Hosp, Natl Inst Hlth Res, Oxford Biomed Res Ctr Programme, Oxford OX3 9DU, England; [Griffiths, David; Evans, Jessica; Vaughan, Alison; Kachrimanidou, Melina; Stoesser, Nicole; Peto, Tim E.; Walker, A. Sarah; Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Didelot, Xavier; Golubchik, Tanya] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Jolley, Keith A.; Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Fawley, Warren; Wilcox, Mark] Gen Infirm, Dept Microbiol, Old Med Sch, Leeds LS1 3EX, W Yorkshire, England; [Wilcox, Mark] Univ Leeds, Dept Microbiol, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Leeds General Infirmary; University of Leeds; University of Leeds	Dingle, KE (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	kate.dingle@ndcls.ox.ac.uk	Walker, Sarah/HDM-8717-2022; Stoesser, Nicole/H-3421-2019; Jolley, Keith/ABE-8587-2020; Didelot, Xavier/P-4282-2019; Golubchik, Tanya/B-4226-2018; Didelot, Xavier/H-1608-2013	Stoesser, Nicole/0000-0002-4508-7969; Jolley, Keith/0000-0002-0751-0287; Didelot, Xavier/0000-0003-1885-500X; Golubchik, Tanya/0000-0003-2765-9828; Didelot, Xavier/0000-0003-1885-500X; Kachrimanidou, Melina/0000-0001-9524-0047; peto, tim/0000-0003-3477-8307; Dingle, Kate/0000-0002-2303-5957	NIHR Biomedical Research Centre, Oxford, United Kingdom; Wellcome Trust; Medical Research Council [G0600719B, G0800778] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10279] Funding Source: researchfish; MRC [G0800778] Funding Source: UKRI	NIHR Biomedical Research Centre, Oxford, United Kingdom(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the NIHR Biomedical Research Centre, Oxford, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff of the Clinical Microbiology Laboratory and Infection Control, John Radcliffe Hospital, Oxford, and Infection Control Laboratory staff, Leeds General Infirmary, for their assistance throughout this work. This publication made use of the Clostridium difficile Multilocus Sequence Typing website, http://pubmlst.org/cdifficile/ which uses the Bacterial Isolate Genome Sequence Database system developed by Keith Jolley and sited at the Department of Zoology, University of Oxford [61]. The development of this site has been funded by the Wellcome Trust.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Albesa-Jove D, 2010, J MOL BIOL, V396, P1260, DOI 10.1016/j.jmb.2010.01.012; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belmares J, 2009, CLIN INFECT DIS, V49, P1141, DOI 10.1086/605638; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Burns K, 2010, J HOSP INFECT, V75, P287, DOI 10.1016/j.jhin.2010.03.025; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Freeman J, 2007, J ANTIMICROB CHEMOTH, V60, P83, DOI 10.1093/jac/dkm113; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; Govind R, 2006, J BACTERIOL, V188, P3716, DOI 10.1128/JB.188.10.3716-3720.2006; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammond GA, 1997, MICROB PATHOGENESIS, V22, P143, DOI 10.1006/mpat.1996.0100; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hensgens MP, 2009, EUROSURVEILLANCE, V14, P7; *HLTH PROT AG, 2009, CLOSTR DIFF RIB NETW; *HLTH PROT AG, 2005, COMMUN DIS REP CDR W, V15, P2; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuijper EJ, 2006, EMERG INFECT DIS, V12, P827; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Lemee L, 2005, MICROBIOL-SGM, V151, P3171, DOI 10.1099/mic.0.28155-0; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marsh JW, 2010, J CLIN MICROBIOL, V48, P412, DOI 10.1128/JCM.01315-09; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Pasanen T, 2011, CLIN MICROBIOL INFEC, V17, P166, DOI 10.1111/j.1469-0691.2010.03221.x; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pituch H, 2006, J MED MICROBIOL, V55, P207, DOI 10.1099/jmm.0.46213-0; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Soehn F, 1998, MOL GEN GENET, V258, P222, DOI 10.1007/s004380050726; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VONEICHELSTREIBER C, 1992, MOL GEN GENET, V233, P260, DOI 10.1007/BF00587587; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012	61	130	131	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19993	10.1371/journal.pone.0019993	http://dx.doi.org/10.1371/journal.pone.0019993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625511	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200037
J	Marais, S; Pepper, DJ; Schutz, C; Wilkinson, RJ; Meintjes, G				Marais, Suzaan; Pepper, Dominique J.; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme			Presentation and Outcome of Tuberculous Meningitis in a High HIV Prevalence Setting	PLOS ONE			English	Article							INFECTED PATIENTS; CRYPTOCOCCAL MENINGITIS; CEREBROSPINAL-FLUID; ADULTS	Background: Mycobacterium tuberculosis is a common, devastating cause of meningitis in HIV-infected persons. Due to international rollout programs, access to antiretroviral therapy (ART) is increasing globally. Starting patients with HIV-associated tuberculous meningitis (TBM) on ART during tuberculosis (TB) treatment may increase survival in these patients. We undertook this study to describe causes of meningitis at a secondary-level hospital in a high HIV/TB co-infection setting and to determine predictors of mortality in patients with TBM. Methods: A retrospective review of cerebrospinal fluid findings and clinical records over a six-month period (March 2009-August 2009). Definite, probable and possible TBM were diagnosed according to published case definitions. Results: TBM was diagnosed in 120/211 patients (57%) with meningitis. In 106 HIV-infected patients with TBM, six-month all-cause mortality was lower in those who received antiretroviral therapy (ART) during TB treatment; hazard ratio = 0.30 (95% CI = 0.08-0.82). Factors associated with inpatient mortality in HIV-infected patients were 1) low CD4(+) count at presentation; adjusted odds ratio (AOR) = 1.4 (95% confidence interval [CI] = 1.03-1.96) per 50 cells/mu L drop in CD4(+) count and, 2) higher British Medical Research Council TBM disease grade (2 or 3 versus 1); AOR = 4.8 (95% CI = 1.4515.87). Interpretation: Starting ART prior to or during TB treatment may be associated with lower mortality in patients with HIV-associated TBM. Advanced HIV and worse stage of TBM disease predict in-hospital mortality in patients presenting with TBM.	[Marais, Suzaan; Pepper, Dominique J.; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Marais, Suzaan; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme] GF Jooste Hosp, Infect Dis Unit, Cape Town, South Africa; [Marais, Suzaan; Schutz, Charlotte; Wilkinson, Robert J.; Meintjes, Graeme] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Pepper, Dominique J.] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA; [Wilkinson, Robert J.; Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Wilkinson, Robert J.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England	University of Cape Town; University of Cape Town; University of Mississippi; University of Mississippi Medical Center; Imperial College London; MRC National Institute for Medical Research	Marais, S (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	suzaanmarais@gmail.com	Marais, Suzaan/AAG-2750-2019; Schutz, Charlotte/G-6864-2016	Marais, Suzaan/0000-0002-8050-9610; Schutz, Charlotte/0000-0001-8329-6158; Meintjes, Graeme/0000-0003-1196-4414; Wilkinson, Robert/0000-0002-2753-1800	Perinatal HIV Research Unit, the US Agency for International Development; President's Emergency Plan for AIDS Relief; Wellcome Trust [WT 081667, 084323, 088316]; Fogarty International Center South Africa TB/AIDS [NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370, U2RTW007373 ICORTA]; European Union [SANTE/2005/105-061-102]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [U2RTW007373, U2RTW007370] Funding Source: NIH RePORTER	Perinatal HIV Research Unit, the US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Fogarty International Center South Africa TB/AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Perinatal HIV Research Unit, the US Agency for International Development, and the President's Emergency Plan for AIDS Relief (DJP, SM and CS); Wellcome Trust (RJW and GM, WT 081667, 084323 and 088316); a Fogarty International Center South Africa TB/AIDS Training Award (GM and DJP and CS, NIH/FIC 1U2RTW007373-01A1, 1U2RTW007370, U2RTW007373 ICORTA); a European Union Grant (RJW, SANTE/2005/105-061-102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekondi C, 2006, INT J INFECT DIS, V10, P387, DOI 10.1016/j.ijid.2005.07.004; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; Bogaerts J, 1999, J INFECTION, V39, P32, DOI 10.1016/S0163-4453(99)90099-3; Cecchini D, 2007, AIDS, V21, P373, DOI 10.1097/QAD.0b013e328012b84d; Croda MG, 2010, INT J INFECT DIS, V14, pE586, DOI 10.1016/j.ijid.2009.08.012; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; DUBE MP, 1992, AM J MED, V93, P520, DOI 10.1016/0002-9343(92)90579-Z; Gibbon CJ, 2008, S AFRICAN MED FORMUL, P301; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Heyderman RS, 1998, CLIN INFECT DIS, V26, P284, DOI 10.1086/516298; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Karande Sunil, 2005, Indian Journal of Pediatrics, V72, P755, DOI 10.1007/BF02734147; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; Marais S, 2010, TUBERCULOSIS, V90, P367, DOI 10.1016/j.tube.2010.08.006; MARSHALL G, 1948, LANCET, V254, P582; Medecins Sans Frontieres Western Cape Province Department of Health City of Cape Town Department of Health University of Cape Town Infectious Disease Epidemiology Unit, 2008, COMPR TB HIV SERV PR; Pepper DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-83; Pepper DJ, 2009, CLIN INFECT DIS, V48, pE96, DOI 10.1086/598988; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Puccioni-Sohler M, 2007, ARQ NEURO-PSIQUIAT, V65, P48, DOI 10.1590/S0004-282X2007000100011; *S AFR DEP HLTH HI, 2007, S AFR DEP HLTH HIV 1; Schutte CM, 2001, INFECTION, V29, P213, DOI 10.1007/s15010-001-1198-3; Subsai K, 2004, EUR J NEUROL, V11, P755, DOI 10.1111/j.1468-1331.2004.00879.x; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Torok ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001772; TOROK ME, 2010, CLIN INFECT IN PRESS; van der Weert EM, 2006, PEDIATR INFECT DIS J, V25, P65, DOI 10.1097/01.inf.0000183751.75880.f8; van Well Gijs T J, 2009, Pediatrics, V123, pe1, DOI 10.1542/peds.2008-1353; *WHO, 2010, WHO UN ACC SCAL PRIO	33	64	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20077	10.1371/journal.pone.0020077	http://dx.doi.org/10.1371/journal.pone.0020077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625509	Green Published, gold			2022-12-25	WOS:000290771200046
J	Gutenkunst, RN; Coombs, D; Starr, T; Dustin, ML; Goldstein, B				Gutenkunst, Ryan N.; Coombs, Daniel; Starr, Toby; Dustin, Michael L.; Goldstein, Byron			A Biophysical Model of Cell Adhesion Mediated by Immunoadhesin Drugs and Antibodies	PLOS ONE			English	Article							2-DIMENSIONAL DISSOCIATION-CONSTANT; FC-GAMMA-RIII; T-CELLS; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN-G; SHEAR-FLOW; RECEPTORS; CD2; AFFINITY; CYTOTOXICITY	A promising direction in drug development is to exploit the ability of natural killer cells to kill antibody-labeled target cells. Monoclonal antibodies and drugs designed to elicit this effect typically bind cell-surface epitopes that are overexpressed on target cells but also present on other cells. Thus it is important to understand adhesion of cells by antibodies and similar molecules. We present an equilibrium model of such adhesion, incorporating heterogeneity in target cell epitope density, nonspecific adhesion forces, and epitope immobility. We compare with experiments on the adhesion of Jurkat T cells to bilayers containing the relevant natural killer cell receptor, with adhesion mediated by the drug alefacept. We show that a model in which all target cell epitopes are mobile and available is inconsistent with the data, suggesting that more complex mechanisms are at work. We hypothesize that the immobile epitope fraction may change with cell adhesion, and we find that such a model is more consistent with the data, although discrepancies remain. We also quantitatively describe the parameter space in which binding occurs. Our model elaborates substantially on previous work, and our results offer guidance for the refinement of therapeutic immunoadhesins. Furthermore, our comparison with data from Jurkat T cells also points toward mechanisms relating epitope immobility to cell adhesion.	[Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Coombs, Daniel] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Coombs, Daniel] Univ British Columbia, Inst Appl Math, Vancouver, BC V5Z 1M9, Canada; [Starr, Toby; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Starr, Toby; Dustin, Michael L.] Skirball Inst Biomol Med, Program Mol Pathogenesis, New York, NY USA; [Goldstein, Byron] Los Alamos Natl Lab, Div Theoret, Theoret Biol & Biophys Grp, Los Alamos, NM USA	University of Arizona; University of British Columbia; University of British Columbia; New York University; United States Department of Energy (DOE); Los Alamos National Laboratory	Gutenkunst, RN (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	ryan.gutenkunst@arizona.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; Coombs, Daniel/0000-0002-8038-6278	Department of Energy [W-7405-ENG-36]; National Institutes of Health [R37-GM035556, R56-AI44931, P30-6M092391]; National Science and Engineering Research Council; Mathematics of Information Technology and Complex Systems National Centre of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems National Centre of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Energy through contract W-7405-ENG-36 and the National Institutes of Health through grants R37-GM035556 and R56-AI44931 and P30-6M092391. Further support was provided by the National Science and Engineering Research Council and the Mathematics of Information Technology and Complex Systems National Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CL, 1990, J IMMUNOL, V145, P196; Arnould L, 2006, BRIT J CANCER, V94, P259, DOI 10.1038/sj.bjc.6602930; Ashkenazi Avi, 1995, Methods (Orlando), V8, P104, DOI 10.1006/meth.1995.9996; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1981, CELL BIOPHYS, V3, P289, DOI 10.1007/BF02782629; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; BYRN RA, 1990, NATURE, V344, P667, DOI 10.1038/344667a0; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cooper JC, 2003, EUR J IMMUNOL, V33, P666, DOI 10.1002/eji.200323586; da Silva AJ, 2002, J IMMUNOL, V168, P4462, DOI 10.4049/jimmunol.168.9.4462; Dustin ML, 2007, J BIOL CHEM, V282, P34748, DOI 10.1074/jbc.M705616200; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; FEWTRELL C, 1980, J IMMUNOL, V125, P701; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Galon J, 1997, EUR J IMMUNOL, V27, P1928, DOI 10.1002/eji.1830270816; Ghetie MA, 1997, P NATL ACAD SCI USA, V94, P7509, DOI 10.1073/pnas.94.14.7509; HAMMER DA, 1989, CELL BIOPHYS, V14, P139, DOI 10.1007/BF02797131; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Jones E., 2001, SCIPY OPEN SOURCE SC; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Koon HB, 2006, LEUKEMIA RES, V30, P190, DOI 10.1016/j.leukres.2005.06.007; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; MAJEAU GR, 1994, J IMMUNOL, V152, P2753; Preithner S, 2006, MOL IMMUNOL, V43, P1183, DOI 10.1016/j.molimm.2005.07.010; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; SCALLON BJ, 1989, P NATL ACAD SCI USA, V86, P5079, DOI 10.1073/pnas.86.13.5079; Shao JY, 2005, ANN BIOMED ENG, V33, P483, DOI 10.1007/s10439-005-2504-5; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; WELLS AF, 1966, APPL MICROBIOL, V14, P271, DOI 10.1128/AEM.14.2.271-275.1966; WOFSY C, 1992, MATH BIOSCI, V112, P115, DOI 10.1016/0025-5564(92)90090-J; Zhu DM, 2006, ACS CHEM BIOL, V1, P649, DOI 10.1021/cb6002515; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19701	10.1371/journal.pone.0019701	http://dx.doi.org/10.1371/journal.pone.0019701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21629715	Green Submitted, Green Published, gold			2022-12-25	WOS:000290720200027
J	Carta, S; Tassi, S; Pettinati, I; Delfino, L; Dinarello, CA; Rubartelli, A				Carta, Sonia; Tassi, Sara; Pettinati, Ilaria; Delfino, Laura; Dinarello, Charles A.; Rubartelli, Anna			The Rate of Interleukin-1 beta Secretion in Different Myeloid Cells Varies with the Extent of Redox Response to Toll-like Receptor Triggering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SHOCK-PROTEIN 27; INFLAMMASOME ACTIVATION; THIOREDOXIN REDUCTASE; OXIDATIVE STRESS; IL-1-BETA; MONOCYTES; ATP; METABOLISM; EXPRESSION	Human myeloid cells activate the NLRP3 inflammasome and secrete interleukin (IL)-1 beta in response to various Toll-like receptor (TLR) ligands, but the rate of secretion is much higher in primary human monocytes than in cultured macrophages or THP-1 cells. The different myeloid cells also display different redox status under resting conditions and redox response to TLR activation. Resting monocytes display a balanced redox state, with low production of reactive oxygen species (ROS) and antioxidants. TLR engagement induces an effective redox response with increased ROS generation followed by a sustained antioxidant response, parallelled by efficient IL-1 beta secretion. Drugs blocking ROS production or the antioxidant response prevent the secretion of mature IL-1 beta but not the biosynthesis of pro-IL-1 beta, indicating that redox remodeling is responsible for IL-1 beta processing and release. Unlike monocytes, THP-1 cells and cultured macrophages have up-regulated antioxidant systems that buffer the oxidative hit provided by TLR triggering and suppress the consequent redox response. This aborted redox remodeling is paralleled by low efficiency IL-1 beta processing and secretion. High doses (5mM) of H2O2 overcome the high antioxidant capacity of THP-1 cells, restore an efficient redox response, and increase the rate of IL-1 beta secretion. Together these data indicate that a tightly controlled redox homeostasis in resting cells is a prerequisite for a robust redox response to TLR ligands, in turn necessary for the efficient inflammasome activation. Inflammasome activation by bacterial DNA is not modulated by redox responses, suggesting that redox-dependent regulation of IL-1 beta secretion is restricted to some inflammasomes including NLRP3 but excluding AIM-2.	[Carta, Sonia; Tassi, Sara; Pettinati, Ilaria; Delfino, Laura; Rubartelli, Anna] Natl Inst Canc Res, Cell Biol Unit, I-16132 Genoa, Italy; [Dinarello, Charles A.] Univ Colorado, Div Infect Dis, Dept Med, Aurora, CO 80045 USA	University of Genoa; IRCCS AOU San Martino IST; University of Colorado System; University of Colorado Anschutz Medical Campus	Rubartelli, A (corresponding author), Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	anna.rubartelli@istge.it	Dinarello, Charles/C-8524-2013; Rubartelli, Anna/AAA-1259-2021; carta, sonia/AAB-3799-2020	carta, sonia/0000-0002-1278-9761	Telethon, Italia [GGP09127]; Ministero Salute; Compagnia San Paolo	Telethon, Italia(Fondazione Telethon); Ministero Salute(Ministry of Health, Italy); Compagnia San Paolo(Compagnia di San Paolo)	The work was supported in part by grants from Telethon, Italia (GGP09127), Ministero Salute, and Compagnia San Paolo.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Carta S, 2009, J LEUKOCYTE BIOL, V86, P549, DOI 10.1189/jlb.1008598; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; HWANG C, 1991, PRODUCTION OF BIOLOGICALS FROM ANIMAL CELLS IN CULTURE, P548; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Ngai S, 2010, FEBS J, V277, P119, DOI 10.1111/j.1742-4658.2009.07458.x; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Powis G, 1998, CHEM-BIOL INTERACT, V112, P23, DOI 10.1016/S0009-2797(97)00148-8; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Tartier L, 2000, CELL DEATH DIFFER, V7, P1002, DOI 10.1038/sj.cdd.4400726; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Vene R, 2010, ANTIOXID REDOX SIGN, V13, P1145, DOI 10.1089/ars.2009.3078; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; You WJ, 2009, SHOCK, V32, P108, DOI 10.1097/SHK.0b013e318199165d; Zhang X, 2010, HYPERTENSION, V55, P1412, DOI 10.1161/HYPERTENSIONAHA.109.147066; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	46	71	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27069	27080		10.1074/jbc.M110.203398	http://dx.doi.org/10.1074/jbc.M110.203398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21628463	hybrid, Green Published			2022-12-25	WOS:000293268700002
J	Fernandez-Higuero, JA; Acebron, SP; Taneva, SG; del Castillo, U; Moro, F; Muga, A				Angel Fernandez-Higuero, Jose; Acebron, Sergio P.; Taneva, Stefka G.; del Castillo, Urko; Moro, Fernando; Muga, Arturo			Allosteric Communication between the Nucleotide Binding Domains of Caseinolytic Peptidase B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS CHAPERONE CLPB; PROTEIN-ACTIVATED ATPASE; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; AGGREGATED PROTEINS; SUBSTRATE-BINDING; COMMON MECHANISM; QUALITY CONTROL; CENTRAL PORE; HSP104	ClpB is a hexameric chaperone that solubilizes and reactivates protein aggregates in cooperation with the Hsp70/DnaK chaperone system. Each of the identical protein monomers contains two nucleotide binding domains (NBD), whose ATPase activity must be coupled to exert on the substrate the mechanical work required for its reactivation. However, how communication between these sites occurs is at present poorly understood. We have studied herein the affinity of each of the NBDs for nucleotides in WT ClpB and protein variants in which one or both sites are mutated to selectively impair nucleotide binding or hydrolysis. Our data show that the affinity of NBD2 for nucleotides (K-d = 3-7 mu M) is significantly higher than that of NBD1. Interestingly, the affinity of NBD1 depends on nucleotide binding to NBD2. Binding of ATP, but not ADP, to NBD2 increases the affinity of NBD1 (the Kd decreases from approximate to 160-300 to 50-60 mu M) for the corresponding nucleotide. Moreover, filling of the NBD2 ring with ATP allows the cooperative binding of this nucleotide and substrates to the NBD1 ring. Data also suggest that a minimum of four subunits cooperate to bind and reactivate two different aggregated protein substrates.	[Muga, Arturo] Univ Basque Country, Biophys Unit, Consejo Super Invest Cient, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain; Univ Basque Country, Fac Sci & Technol, Dept Biochem & Mol Biol, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Muga, A (corresponding author), Univ Basque Country, Biophys Unit, Consejo Super Invest Cient, Euskal Herriko Unibertsitatea, E-48080 Bilbao, Spain.	arturo.muga@ehu.es	Moro Pérez, Fernando/P-3891-2015; Muga, Arturo/N-1174-2014	Moro Pérez, Fernando/0000-0002-3568-3388; Muga, Arturo/0000-0003-0345-6882; del Castillo Rojo, Urko/0000-0002-4170-1749; Fernandez-Higuero, Jose Angel/0000-0002-4143-5532	Ministerio de Ciencia e Innovacion [BFU2007-64452, BFU2010-15443]; Universidad del Pais Vasco and Gobierno Vasco [IT-358-07]; Diputacion Foral de Bizkaia [DIPE08/18]; Ramon y Cajal	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad del Pais Vasco and Gobierno Vasco; Diputacion Foral de Bizkaia; Ramon y Cajal(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion Grants BFU2007-64452 and BFU2010-15443, Universidad del Pais Vasco and Gobierno Vasco Grant IT-358-07, and Diputacion Foral de Bizkaia Grant DIPE08/18.; Supported by a Ramon y Cajal contract.	Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beinker P, 2005, J BIOL CHEM, V280, P37965, DOI 10.1074/jbc.M506672200; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chesnokova LS, 2005, BIOCHEMISTRY-US, V44, P11224, DOI 10.1021/bi050787b; del Castillo U, 2010, FEBS LETT, V584, P929, DOI 10.1016/j.febslet.2010.01.029; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Farr CD, 1998, J BIOL CHEM, V273, P9744, DOI 10.1074/jbc.273.16.9744; Franzmann TM, 2011, J BIOL CHEM, V286, P17992, DOI 10.1074/jbc.M110.216176; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Kim KI, 2000, J MOL BIOL, V303, P655, DOI 10.1006/jmbi.2000.4165; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leskovar A, 2008, ARCH BIOCHEM BIOPHYS, V473, P16, DOI 10.1016/j.abb.2008.02.035; Li JZ, 2002, J MOL BIOL, V318, P1127, DOI 10.1016/S0022-2836(02)00188-2; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mogk A, 2004, CURR BIOL, V14, pR78, DOI 10.1016/j.cub.2003.12.051; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Neuwald AF, 1999, GENOME RES, V9, P27; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 2001, P NATL ACAD SCI USA, V98, P914, DOI 10.1073/pnas.031568098; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Taneva SG, 2010, BIOCHEMISTRY-US, V49, P1338, DOI 10.1021/bi901847q; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Werbeck ND, 2011, BIOCHEMISTRY-US, V50, P899, DOI 10.1021/bi1018286; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; WOO KM, 1992, J BIOL CHEM, V267, P20429; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Zietkiewicz S, 2010, BIOPOLYMERS, V93, P47, DOI 10.1002/bip.21294; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	56	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25547	25555		10.1074/jbc.M111.231365	http://dx.doi.org/10.1074/jbc.M111.231365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642426	Green Published, hybrid			2022-12-25	WOS:000293073000017
J	Begum, N; Hockman, S; Manganiello, VC				Begum, Najma; Hockman, Steven; Manganiello, Vincent C.			Phosphodiesterase 3A (PDE3A) Deletion Suppresses Proliferation of Cultured Murine Vascular Smooth Muscle Cells (VSMCs) via Inhibition of Mitogen-activated Protein Kinase (MAPK) Signaling and Alterations in Critical Cell Cycle Regulatory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE PHOSPHODIESTERASES; DIFFERENTIAL REGULATION; INSULIN REGULATION; MESANGIAL CELLS; GROWTH-FACTOR; NITRIC-OXIDE; CAMP; EXPRESSION; MIGRATION; ATHEROSCLEROSIS	Cyclic nucleotide phosphodiesterase 3 (PDE3) is an important regulator of cyclic adenosine monophosphate (cAMP) signaling within the cardiovascular system. In this study, we examined the role of PDE3A and PDE3B isoforms in regulation of growth of cultured vascular smooth muscle cells (VSMCs) and the mechanisms by which they may affect signaling pathways that mediate mitogen-induced VSMC proliferation. Serum-and PDGF-induced DNA synthesis in VSMCs grown from aortas of PDE3A-deficient (3A-KO) mice was markedly less than that in VSMCs from PDE3A wild type (3A-WT) and PDE3B-deficient (3B-KO) mice. The reduced growth response was accompanied by significantly less phosphorylation of extracellular signal-regulated kinase (ERK) in 3A-KO VSMCs, most likely due to a combination of greater site-specific inhibitory phosphorylation of Raf-1(Ser-259) by protein kinase A (PKA) and enhanced dephosphorylation of ERKs due to elevated mitogen-activated protein kinase phosphatase 1 (MKP-1). Furthermore, 3A-KO VSMCs, compared with 3A-WT, exhibited higher basal PKA activity and cAMP response element-binding protein (CREB) phosphorylation, higher levels of p53 and p53 phosphorylation, and elevated p21 protein together with lower levels of Cyclin-D1 and retinoblastoma (Rb) protein and Rb phosphorylation. Adenoviral overexpression of inactive CREB partially restored growth effects of serum in 3A-KO VSMCs. In contrast, exposure of 3A-WT VSMCs to VP16 CREB (active CREB) was associated with inhibition of serum-induced DNA synthesis similar to that in untreated 3A-KO VSMCs. Transfection of 3A-KO VSMCs with p53 siRNA reduced p21 and MKP-1 levels and completely restored growth without affecting amounts of Cyclin-D1 and Rb phosphorylation. We conclude that PDE3A regulates VSMC growth via two complementary pathways, i.e. PKA-catalyzed inhibitory phosphorylation of Raf-1 with resulting inhibition of MAPK signaling and PKA/CREB-mediated induction of p21, leading to G(0)/G(1) cell cycle arrest, as well as by increased accumulation of p53, which induces MKP-1, p21, and WIP1, leading to inhibition of G(1) to S cell cycle progression.	[Begum, Najma; Hockman, Steven; Manganiello, Vincent C.] NHLBI, Cardiovasc Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Begum, N (corresponding author), NHLBI, Cardiovasc Pulm Branch, NIH, 10 Ctr Dr,Bldg 10,Rm 5N322,MSC-1076, Bethesda, MD 20892 USA.	begumn@mail.nih.gov			National Institutes of Health through NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002540] Funding Source: NIH RePORTER	National Institutes of Health through NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health through the Intramural Research Program of the NHLBI.	Adler V, 1997, P NATL ACAD SCI USA, V94, P1686, DOI 10.1073/pnas.94.5.1686; Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Aoki M, 2001, DIABETOLOGIA, V44, P1034, DOI 10.1007/s001250100593; Begum N, 1998, AM J PHYSIOL-CELL PH, V275, pC42, DOI 10.1152/ajpcell.1998.275.1.C42; Begum N, 2002, DIABETES, V51, P2256, DOI 10.2337/diabetes.51.7.2256; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Cai Xinjiang, 2006, Expert Rev Cardiovasc Ther, V4, P789, DOI 10.1586/14779072.4.6.789; Cheng JF, 2004, AM J PHYSIOL-RENAL, V287, pF940, DOI 10.1152/ajprenal.00079.2004; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Ducommun B, 1991, Semin Cell Biol, V2, P233; Fukumoto S, 1999, CIRC RES, V85, P985; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Inoue Y, 2000, BRIT J PHARMACOL, V130, P231, DOI 10.1038/sj.bjp.0703287; Isenovic Esma R., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P172; Jacob A, 2004, AM J PHYSIOL-CELL PH, V287, pC1077, DOI 10.1152/ajpcell.00477.2003; Jacob A, 2002, AM J PHYSIOL-CELL PH, V283, pC704, DOI 10.1152/ajpcell.00110.2002; Kass DA, 2007, CARDIOVASC RES, V75, P303, DOI 10.1016/j.cardiores.2007.02.031; Koyama H, 2001, J CELL PHYSIOL, V186, P1; Kusari AB, 2000, MOL CELL BIOCHEM, V211, P27, DOI 10.1023/A:1007102428735; LAFONT A, 1995, CIRC RES, V76, P996, DOI 10.1161/01.RES.76.6.996; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lugnier C, 1999, J PHYSIOL PHARMACOL, V50, P639; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; MATOUSOVIC K, 1995, J CLIN INVEST, V96, P401, DOI 10.1172/JCI118049; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Morishita R, 2005, ATHEROSCLEROSIS SUPP, V6, P41, DOI 10.1016/j.atherosclerosissup.2005.09.007; Nelson PR, 1998, J VASC SURG, V27, P117, DOI 10.1016/S0741-5214(98)70298-8; Netherton SJ, 2005, MOL PHARMACOL, V67, P263, DOI 10.1124/mol.104.004853; Onishi T, 1997, J BONE MINER RES, V12, P1596, DOI 10.1359/jbmr.1997.12.10.1596; Osinski MT, 2001, MOL PHARMACOL, V59, P1044, DOI 10.1124/mol.59.5.1044; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Phillips PG, 2005, AM J PHYSIOL-LUNG C, V288, pL103, DOI 10.1152/ajplung.00095.2004; Plevin R, 1997, CELL SIGNAL, V9, P323, DOI 10.1016/S0898-6568(96)00193-3; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; SUN H, 1994, SCIENCE, V266, P285, DOI 10.1126/science.7939666; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yan C, 2007, CIRC RES, V100, P489, DOI 10.1161/01.RES.0000258451.44949.d7; Zhao H, 2008, EUR J PHARMACOL, V590, P29, DOI 10.1016/j.ejphar.2008.05.016	53	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26238	26249		10.1074/jbc.M110.214155	http://dx.doi.org/10.1074/jbc.M110.214155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21632535	Green Published, hybrid			2022-12-25	WOS:000293073000081
J	Verga Falzacappa, C; Mangialardo, C; Madaro, L; Ranieri, D; Lupoi, L; Stigliano, A; Torrisi, MR; Bouche, M; Toscano, V; Misiti, S				Verga Falzacappa, Cecilia; Mangialardo, Claudia; Madaro, Luca; Ranieri, Danilo; Lupoi, Lorenzo; Stigliano, Antonio; Torrisi, Maria Rosaria; Bouche, Marina; Toscano, Vincenzo; Misiti, Silvia			Thyroid Hormone T3 Counteracts STZ Induced Diabetes in Mouse	PLOS ONE			English	Article							BETA-CELL GROWTH; KINASE-B; ACTIVATION; SURVIVAL; MASS; APOPTOSIS; INSIGHTS; PATHWAY	This study intended to demonstrate that the thyroid hormone T3 counteracts the onset of a Streptozotocin (STZ) induced diabetes in wild type mice. To test our hypothesis diabetes has been induced in Balb/c male mice by multiple low dose Streptozotocin injection; and a group of mice was contemporaneously injected with T3. After 48 h mice were tested for glucose tolerance test, insulin serum levels and then sacrified. Whole pancreata were utilized for morphological and biochemical analyses, while protein extracts and RNA were utilized for expression analyses of specific molecules. The results showed that islets from T3 treated mice were comparable to age- and sex-matched control, untreated mice in number, shape, dimension, consistency, ultrastructure, insulin and glucagon levels, Tunel positivity and caspases activation, while all the cited parameters and molecules were altered by STZ alone. The T3-induced pro survival effect was associated with a strong increase in phosphorylated Akt. Moreover, T3 administration prevented the STZ-dependent alterations in glucose blood level, both during fasting and after glucose challenge, as well as in insulin serum level. In conclusion we demonstrated that T3 could act as a protective factor against STZ induced diabetes.	[Verga Falzacappa, Cecilia; Mangialardo, Claudia; Misiti, Silvia] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Verga Falzacappa, Cecilia; Toscano, Vincenzo] Fdn Studio Diabete Endocrinol & Metabol, DEM, Rome, Italy; [Madaro, Luca; Bouche, Marina] Univ Roma La Sapienza, Dipartimento Istol & Embriol Med, Rome, Italy; [Ranieri, Danilo; Stigliano, Antonio; Torrisi, Maria Rosaria; Toscano, Vincenzo] Univ Roma La Sapienza, Dipartimento Med Mol, Rome, Italy; [Lupoi, Lorenzo] Univ Cattolica Sacro Cuore, Stabilimento Utilizzaz Anim Lab, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Verga Falzacappa, C (corresponding author), Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy.	silvia.misiti@uniroma1.it	Madaro, Luca/ABE-4683-2021; Verga Falzacappa, Cecilia/C-5581-2017; Madaro, Luca/K-4629-2016; Stigliano, Antonio/AAN-2266-2020	Madaro, Luca/0000-0003-0839-5724; Verga Falzacappa, Cecilia/0000-0001-8957-4550; Madaro, Luca/0000-0003-0839-5724; STIGLIANO, Antonio/0000-0002-7143-0775; Bouche, Marina/0000-0002-0938-5360	Italian Ministry for University and Research [2006064322_004]; Sapienza University of Rome [C26F07MY89, C26A08EY99]; Association Francoise contre les Myopathies (AFM) [13951-2009]; Agenzia Spaziale Italiana (ASI); DEM; Fondazione per lo studio del Diabete; l'Endocrinologia ed il Metabolismo, Roma, Italy	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; Association Francoise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI)); DEM; Fondazione per lo studio del Diabete; l'Endocrinologia ed il Metabolismo, Roma, Italy	This work was supported by the Italian Ministry for University and Research (2006064322_004), by Sapienza University of Rome (C26F07MY89 and C26A08EY99), by Association Francoise contre les Myopathies (AFM, 13951-2009), and by Agenzia Spaziale Italiana (ASI). DEM, Fondazione per lo studio del Diabete, l'Endocrinologia ed il Metabolismo, Roma, Italy, supported CVF with a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237; Cao X, 2009, BIOCHEM J, V424, P201, DOI 10.1042/BJ20090643; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; FALZACAPPA CV, 2010, ISLETS, V2, P296; FALZACAPPA CV, 2006, J CELL PHYSIOL, V206, P309, DOI [10.1002/jcp.20460, DOI 10.1002/jcp.20460, DOI 10.1002/JCP.20460]; Furuya F, 2009, STEROIDS, V74, P628, DOI 10.1016/j.steroids.2008.10.009; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giannoukakis N, 2000, GENE THER, V7, P2015, DOI 10.1038/sj.gt.3301333; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; MIZRACHI EB, 2001, J CLIN INVEST, V108, P1631; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Ortega E, 2008, EUR J ENDOCRINOL, V158, P217, DOI 10.1530/EJE-07-0592; Pipeleers D, 2008, DIABETES OBES METAB, V10, P54, DOI 10.1111/j.1463-1326.2008.00941.x; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Verga Falzacappa C, 2007, J MOL ENDOCRINOL, V38, P221, DOI DOI 10.1677/JME.1.02166; Verga Falzacappa C, 2009, J CELL BIOCHEM, V106, P835, DOI 10.1002/jcb.22045; Webb P, 2004, EXPERT OPIN INV DRUG, V13, P489, DOI 10.1517/13543784.13.5.489; Zinke A, 2003, EXP CLIN ENDOCR DIAB, V111, P198, DOI 10.1055/s-2003-40463	34	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19839	10.1371/journal.pone.0019839	http://dx.doi.org/10.1371/journal.pone.0019839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637761	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500013
J	Champion, MD				Champion, Mia D.			Host-Pathogen O-Methyltransferase Similarity and Its Specific Presence in Highly Virulent Strains of Francisella tularensis Suggests Molecular Mimicry	PLOS ONE			English	Article							PROTEIN FAMILY; SEQUENCE; EVOLUTION; GENE; EPIDEMIOLOGY; ALIGNMENTS; TULAREMIA; MICE	Whole genome comparative studies of many bacterial pathogens have shown an overall high similarity of gene content (>95%) between phylogenetically distinct subspecies. In highly clonal species that share the bulk of their genomes subtle changes in gene content and small-scale polymorphisms, especially those that may alter gene expression and protein-protein interactions, are more likely to have a significant effect on the pathogen's biology. In order to better understand molecular attributes that may mediate the adaptation of virulence in infectious bacteria, a comparative study was done to further analyze the evolution of a gene encoding an o-methyltransferase that was previously identified as a candidate virulence factor due to its conservation specifically in highly pathogenic Francisella tularensis subsp. tularensis strains. The o-methyltransferase gene is located in the genomic neighborhood of a known pathogenicity island and predicted site of rearrangement. Distinct o-methyltransferase subtypes are present in different Francisella tularensis subspecies. Related protein families were identified in several host species as well as species of pathogenic bacteria that are otherwise very distant phylogenetically from Francisella, including species of Mycobacterium. A conserved sequence motif profile is present in the mammalian host and pathogen protein sequences, and sites of non-synonymous variation conserved in Francisella subspecies specific o-methyltransferases map proximally to the predicted active site of the orthologous human protein structure. Altogether, evidence suggests a role of the F. t. subsp. tularensis protein in a mechanism of molecular mimicry, similar perhaps to Legionella and Coxiella. These findings therefore provide insights into the evolution of niche-restriction and virulence in Francisella, and have broader implications regarding the molecular mechanisms that mediate host-pathogen relationships.				mchampion@tgen.org						BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; *BRENDA, 2011, BRENDA COMPR ENZ INF; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; CASALI N, 2009, HYPERVIRULENT MYCOBA; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Krzywinska E, 2005, MOL MICROBIOL, V56, P1262, DOI 10.1111/j.1365-2958.2005.04608.x; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; KuoLee R, 2007, INFECT IMMUN, V75, P1651, DOI 10.1128/IAI.01834-06; LAIGENG L, 1997, PNAS, V94, P5461; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; MORNER T, 2001, TULAREMIA; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; OLSUFJEV NG, 1982, J HYG EPIDEMIOL MICR, V26; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Plewniak F, 2000, BIOINFORMATICS, V16, P750, DOI 10.1093/bioinformatics/16.9.750; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; SCHMITT D, 1991, J BIOL CHEM, V266, P17416; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; SJOSTEDT A, 2005, FAMILY 17 FRANCISELL; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; *TBDB, 2011, TB DAT INT PLATF TUB; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20295	10.1371/journal.pone.0020295	http://dx.doi.org/10.1371/journal.pone.0020295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637805	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052200048
J	Griffiths, J; Barrero, JM; Taylor, J; Helliwell, CA; Gubler, F				Griffiths, Jayne; Barrero, Jose M.; Taylor, Jennifer; Helliwell, Chris A.; Gubler, Frank			ALTERED MERISTEM PROGRAM 1 Is involved in Development of Seed Dormancy in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID; GENE; ENCODES; AMP1; THALIANA; 8'-HYDROXYLASES; GERMINATION; PEPTIDASE; NETWORKS; MUTANTS	Mutants in the rice PLASTOCHRON 3 and maize VIVIPAROUS 8 genes have been shown to have reduced dormancy and ABA levels. In this study we used several mutants in the orthologous gene ALTERED MERISTEM PROGRAM 1 (AMP1) to determine its role in seed dormancy in Arabidopsis. Here we report that there are accession-specific effects of mutations in AMP1. In one accession, amp1 mutants produce seeds with higher dormancy, while those in two other accessions produce seeds of lower dormancy. These accession-specific effects of mutating AMP1 were shown to extend to ABA levels. We assayed global gene transcription differences in seeds of wild-type and mutant from two accessions demonstrating opposing phenotypes. The transcript changes observed indicate that the amp1 mutation shifts the seed transcriptome from a dormant into an after-ripened state. Specific changes in gene expression in the mutants give insight into the direct and indirect effects that may be contributing to the opposing dormancy phenotypes observed, and reveal a role for AMP1 in the acquisition and/or maintenance of seed dormancy in Arabidopsis.	[Griffiths, Jayne; Barrero, Jose M.; Taylor, Jennifer; Helliwell, Chris A.; Gubler, Frank] CSIRO, Div Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Griffiths, J (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.gubler@csiro.au	Barrero, Jose/X-5090-2019; Barrero, Jose M/B-4607-2009; Frank, Gubler/A-1291-2010; Helliwell, Chris/A-1469-2008; Taylor, Jennifer M/A-1686-2010	Barrero, Jose/0000-0001-7367-2199; Barrero, Jose M/0000-0001-7367-2199; Helliwell, Chris/0000-0001-5943-897X; Taylor, Jennifer M/0000-0003-4231-0181	CSIRO	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was supported by the CSIRO OCE postdoctoral fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero JM, 2010, PLANT J, V61, P611, DOI 10.1111/j.1365-313X.2009.04088.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Bethke P. C., 2007, Seed development, dormancy and germination, P153; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Cheng WH, 2009, PLANT MOL BIOL, V71, P61, DOI 10.1007/s11103-009-9509-7; Clark SE, 1996, DEVELOPMENT, V122, P1567; Evans MMS, 1997, PLANT J, V12, P769, DOI 10.1046/j.1365-313X.1997.12040769.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; GRIMM B, 1987, EUR J BIOCHEM, V167, P493, DOI 10.1111/j.1432-1033.1987.tb13364.x; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; Harari-Steinberg O, 2001, PLANT PHYSIOL, V127, P986, DOI 10.1104/pp.010270; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; HERZOG M, 1995, PLANT MOL BIOL, V27, P743, DOI 10.1007/BF00020227; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Kawakatsu T, 2009, PLANT J, V58, P1028, DOI 10.1111/j.1365-313X.2009.03841.x; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee BH, 2009, J MICROBIOL BIOTECHN, V19, P542, DOI 10.4014/jmb.0901.0082; Liang MX, 2006, PLANTA, V224, P1185, DOI 10.1007/s00425-006-0300-6; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mordhorst AP, 1998, GENETICS, V149, P549; Morris K, 2011, PLANT PHYSIOL, V155, P1851, DOI 10.1104/pp.110.169706; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Saibo NJM, 2007, PLANTA, V225, P831, DOI 10.1007/s00425-006-0395-9; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwartz SH, 2003, PLANT PHYSIOL, V131, P1591, DOI 10.1104/pp.102.017921; Suzuki M, 2008, CURR OPIN PLANT BIOL, V11, P548, DOI 10.1016/j.pbi.2008.06.015; Suzuki M, 2008, PLANT PHYSIOL, V146, P1193, DOI 10.1104/pp.107.114108; Teng S, 2008, PLANT J, V55, P372, DOI 10.1111/j.1365-313X.2008.03515.x; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903	42	22	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20408	10.1371/journal.pone.0020408	http://dx.doi.org/10.1371/journal.pone.0020408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637772	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200061
J	Qazi, H; Shi, ZD; Tarbell, JM				Qazi, Henry; Shi, Zhong-Dong; Tarbell, John M.			Fluid Shear Stress Regulates the Invasive Potential of Glioma Cells via Modulation of Migratory Activity and Matrix Metalloproteinase Expression	PLOS ONE			English	Article							INTERSTITIAL FLOW; VASCULAR NORMALIZATION; GROWTH-FACTOR; UP-REGULATION; COLLAGEN I; GLIOBLASTOMA; CONVECTION; MECHANISM; TUMORS; TISSUE	Background: Glioma cells are exposed to elevated interstitial fluid flow during the onset of angiogenesis, at the tumor periphery while invading normal parenchyma, within white matter tracts, and during vascular normalization therapy. Glioma cell lines that have been exposed to fluid flow forces in vivo have much lower invasive potentials than in vitro cell motility assays without flow would indicate. Methodology/Principal Findings: A 3D Modified Boyden chamber (Darcy flow through collagen/cell suspension) model was designed to mimic the fluid dynamic microenvironment to study the effects of fluid shear stress on the migratory activity of glioma cells. Novel methods for gel compaction and isolation of chemotactic migration from flow stimulation were utilized for three glioma cell lines: U87, CNS-1, and U251. All physiologic levels of fluid shear stress suppressed the migratory activity of U87 and CNS-1 cell lines. U251 motility remained unaltered within the 3D interstitial flow model. Matrix Metalloproteinase (MMP) inhibition experiments and assays demonstrated that the glioma cells depended on MMP activity to invade, and suppression in motility correlated with downregulation of MMP-1 and MMP-2 levels. This was confirmed by RT-PCR and with the aid of MMP-1 and MMP-2 shRNA constructs. Conclusions/Significance: Fluid shear stress in the tumor microenvironment may explain reduced glioma invasion through modulation of cell motility and MMP levels. The flow-induced migration trends were consistent with reported invasive potentials of implanted gliomas. The models developed for this study imply that flow-modulated motility involves mechanotransduction of fluid shear stress affecting MMP activation and expression. These models should be useful for the continued study of interstitial flow effects on processes that affect tumor progression.	[Qazi, Henry; Shi, Zhong-Dong; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Qazi, H (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu	Shi, Zhong-Dong/A-7212-2012		National Heart, Lung, and Blood Institute [RO1-HL-35549, RO1-HL-57093]; NIH/NCI [U54CA137788/U54CA132378]; NATIONAL CANCER INSTITUTE [U54CA137788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057093, R01HL035549] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute Grants RO1-HL-35549 and RO1-HL-57093. This study was also supported in part by the CCNY/MSKCC Partnership for Cancer Research NIH/NCI U54CA137788/U54CA132378.	AASLID R, 1990, ACT NEUR S, V51, P152; Annabi B, 2005, J NEUROCHEM, V94, P906, DOI 10.1111/j.1471-4159.2005.03256.x; Binder DK, 2002, J NEURO-ONCOL, V56, P149, DOI 10.1023/A:1014566604005; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; BRINKMAN HC, 1947, APPL SCI RES, V1, P27; Brockmann MA, 2003, NEUROSURGERY, V52, P1391, DOI 10.1227/01.NEU.0000064806.87785.AB; Camby I, 2005, BIOCHEM BIOPH RES CO, V335, P27, DOI 10.1016/j.bbrc.2005.07.037; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; CHICOINE MR, 1995, CANCER, V75, P2904, DOI 10.1002/1097-0142(19950615)75:12<2904::AID-CNCR2820751218>3.0.CO;2-2; CRAWFORD HC, 1994, INVAS METAST, V14, P234; Dafni H, 2002, CANCER RES, V62, P6731; Friedl P, 1997, CANCER RES, V57, P2061; Garanich JS, 2007, AM J PHYSIOL-HEART C, V292, pH3128, DOI 10.1152/ajpheart.00578.2006; Geer CP, 1997, J NEURO-ONCOL, V32, P193, DOI 10.1023/A:1005761031077; Girton TS, 2002, J BIOMECH ENG-T ASME, V124, P568, DOI 10.1115/1.1504099; HAUWER CD, 1997, BIOCH BIOPHYSICAL RE, V232, P267; HAUWER CD, 1998, J NEUROBIOL, V37, P373; Hegedus B, 2006, BIOPHYS J, V91, P2708, DOI 10.1529/biophysj.105.077834; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hetschko H, 2008, FEBS J, V275, P1925, DOI 10.1111/j.1742-4658.2008.06351.x; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hormigo A, 2007, CANCER CELL, V11, P6, DOI 10.1016/j.ccr.2006.12.008; Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053; ITO U, 1988, ACTA NEUROCHIR, V90, P35, DOI 10.1007/BF01541264; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karakiulakis G, 2007, J BIOL CHEM, V282, P908, DOI 10.1074/jbc.M602178200; KRUCZYNSKI A, 1995, INT J ONCOL, V6, P473; LONG DM, 1970, J NEUROSURG, V32, P127, DOI 10.3171/jns.1970.32.2.0127; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; McCready J, 2005, INT J CANCER, V117, P781, DOI 10.1002/ijc.21207; Mollica F, 2003, MICROVASC RES, V65, P56, DOI 10.1016/S0026-2862(02)00012-2; Mourad PD, 2005, SURG NEUROL, V63, P511, DOI 10.1016/j.surneu.2004.08.062; NAKAGAWA T, 1994, J NEUROSURG, V81, P69, DOI 10.3171/jns.1994.81.1.0069; Netti PA, 1996, MICROVASC RES, V52, P27, DOI 10.1006/mvre.1996.0041; Pedersen JA, 2007, J BIOMECH, V40, P1484, DOI 10.1016/j.jbiomech.2006.06.023; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sameshima T, 2000, CANCER LETT, V157, P177, DOI 10.1016/S0304-3835(00)00485-7; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Shi ZD, 2010, AM J PHYSIOL-HEART C, V298, pH127, DOI 10.1152/ajpheart.00732.2009; Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; SMITH DR, 1969, J NEUROSURG, V31, P50, DOI 10.3171/jns.1969.31.1.0050; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sun JX, 2001, CANCER RES, V61, P2276; Takano S, 1996, CANCER RES, V56, P2185; Wang S, 2000, ARTERIOSCL THROM VAS, V20, P2220, DOI 10.1161/01.ATV.20.10.2220; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yokota H, 2003, J BIOL CHEM, V278, P47275, DOI 10.1074/jbc.M304652200; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	56	77	79	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20348	10.1371/journal.pone.0020348	http://dx.doi.org/10.1371/journal.pone.0020348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637818	Green Published, gold			2022-12-25	WOS:000291052200055
J	Lengagne, R; Pommier, A; Caron, J; Douguet, L; Garcette, M; Kato, M; Avril, MF; Abastado, JP; Bercovici, N; Lucas, B; Prevost-Blondel, A				Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Kato, Masashi; Avril, Marie-Francoise; Abastado, Jean-Pierre; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle			T Cells Contribute to Tumor Progression by Favoring Pro-Tumoral Properties of Intra-Tumoral Myeloid Cells in a Mouse Model for Spontaneous Melanoma	PLOS ONE			English	Article							NF-KAPPA-B; SUPPRESSOR-CELLS; MACROPHAGE POLARIZATION; ADAPTIVE IMMUNITY; BEARING HOST; CANCER; ACTIVATION; DISTINCT; MICE; INFLAMMATION	Tumors affect myelopoeisis and induce the expansion of myeloid cells with immunosuppressive activity. In the MT/ret model of spontaneous metastatic melanoma, myeloid cells are the most abundant tumor infiltrating hematopoietic population and their proportion is highest in the most aggressive cutaneous metastasis. Our data suggest that the tumor microenvironment favors polarization of myeloid cells into type 2 cells characterized by F4/80 expression, a weak capacity to secrete IL-12 and a high production of arginase. Myeloid cells from tumor and spleen of MT/ret mice inhibit T cell proliferation and IFN gamma secretion. Interestingly, T cells play a role in type 2 polarization of myeloid cells. Indeed, intra-tumoral myeloid cells from MT/ret mice lacking T cells are not only less suppressive towards T cells than corresponding cells from wild-type MT/ret mice, but they also inhibit more efficiently melanoma cell proliferation. Thus, our data support the existence of a vicious circle, in which T cells may favor cancer development by establishing an environment that is likely to skew myeloid cell immunity toward a tumor promoting response that, in turn, suppresses immune effector cell functions.	[Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Avril, Marie-Francoise; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle] Inst Cochin, INSERM, U1016, Paris, France; [Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Avril, Marie-Francoise; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle] CNRS, UMR8104, Paris, France; [Lengagne, Renee; Pommier, Arnaud; Caron, Jonathan; Douguet, Laetitia; Garcette, Marylene; Avril, Marie-Francoise; Bercovici, Nadege; Lucas, Bruno; Prevost-Blondel, Armelle] Univ Paris 05, Paris, France; [Kato, Masashi] Chubu Univ, Unit Environm Hlth Sci, Aichi, Japan; [Avril, Marie-Francoise] Hop Cochin, APHP, Serv Dermatol, F-75674 Paris, France; [Abastado, Jean-Pierre] ASTAR, Singapore Immunol Network, BMSI, Singapore, Singapore	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Chubu University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Lengagne, R (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	armelle.blondel@inserm.fr	KATO, Masashi/I-7250-2014; bercovici, nadege/P-5239-2017; Prevost-Blondel, Armelle/N-7643-2017	Prevost-Blondel, Armelle/0000-0002-7268-5905; LUCAS, Bruno/0000-0002-0322-3977; Douguet, Laetitia/0000-0003-4319-491X	Canceropole IDF; Ligue contre le Cancer; CNRS	Canceropole IDF(Region Ile-de-France); Ligue contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by funding from Canceropole IDF, the "Ligue contre le Cancer" and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Boonman ZFHM, 2006, INVEST OPHTH VIS SCI, V47, P2959, DOI 10.1167/iovs.05-1427; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Daniel D, 2003, J EXP MED, V197, P1017, DOI 10.1084/jem.20021047; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Ibe S, 2001, J EXP MED, V194, P1549, DOI 10.1084/jem.194.11.1549; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Lengagne R, 2004, CANCER RES, V64, P1496, DOI 10.1158/0008-5472.CAN-03-2828; Lengagne R, 2008, J IMMUNOL, V180, P130, DOI 10.4049/jimmunol.180.1.130; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2004, EUR J CANCER, V40, P1660, DOI 10.1016/j.ejca.2004.03.016; Miselis NR, 2008, MOL CANCER THER, V7, P788, DOI 10.1158/1535-7163.MCT-07-0579; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nardin A, 2008, FRONT BIOSCI-LANDMRK, V13, P3494; Oosterling SJ, 2005, J PATHOL, V207, P147, DOI 10.1002/path.1830; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Soudja SM, 2010, CANCER RES, V70, P3515, DOI 10.1158/0008-5472.CAN-09-4354; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; WHITWORTH PW, 1990, CANCER METAST REV, V8, P319, DOI 10.1007/BF00052607; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20235	10.1371/journal.pone.0020235	http://dx.doi.org/10.1371/journal.pone.0020235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633700	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500045
J	Veiga, MI; Ferreira, PE; Jornhagen, L; Malmberg, M; Kone, A; Schmidt, BA; Petzold, M; Bjorkman, A; Nosten, F; Gil, JP				Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Jornhagen, Louise; Malmberg, Maja; Kone, Aminatou; Schmidt, Berit Aydin; Petzold, Max; Bjorkman, Anders; Nosten, Francois; Gil, Jose Pedro			Novel Polymorphisms in Plasmodium falciparum ABC Transporter Genes Are Associated with Major ACT Antimalarial Drug Resistance	PLOS ONE			English	Article							PFMDR1 COPY NUMBER; IN-VIVO SELECTION; ARTEMETHER-LUMEFANTRINE; SUBSTRATE-SPECIFICITY; ARTEMISININ RESISTANCE; CHLOROQUINE RESISTANCE; MEFLOQUINE RESISTANCE; COMBINATION THERAPY; MALARIA PARASITE; AMINO-ACIDS	Chemotherapy is a critical component of malaria control. However, the most deadly malaria pathogen, Plasmodium falciparum, has repeatedly mounted resistance against a series of antimalarial drugs used in the last decades. Southeast Asia is an epicenter of emerging antimalarial drug resistance, including recent resistance to the artemisinins, the core component of all recommended antimalarial combination therapies. Alterations in the parasitic membrane proteins Pgh-1, PfCRT and PfMRP1 are believed to be major contributors to resistance through decreasing intracellular drug accumulation. The pfcrt, pfmdr1 and pfmrp1 genes were sequenced from a set of P. falciparum field isolates from the Thai-Myanmar border. In vitro drug susceptibility to artemisinin, dihydroartemisinin, mefloquine and lumefantrine were assessed. Positive correlations were seen between the in vitro susceptibility responses to artemisinin and dihydroartemisinin and the responses to the arylamino-alcohol quinolines lumefantrine and mefloquine. The previously unstudied pfmdr1 F1226Y and pfmrp1 F1390I SNPs were associated significantly with artemisinin, mefloquine and lumefantrine in vitro susceptibility. A variation in pfmdr1 gene copy number was also associated with parasite drug susceptibility of artemisinin, mefloquine and lumefantrine. Our work unveils new candidate markers of P. falciparum multidrug resistance in vitro, while contributing to the understanding of subjacent genetic complexity, essential for future evidence-based drug policy decisions.	[Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Jornhagen, Louise; Malmberg, Maja; Kone, Aminatou; Schmidt, Berit Aydin; Bjorkman, Anders] Karolinska Inst, Malaria Res Lab, Dept Med, Stockholm, Sweden; [Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Gil, Jose Pedro] Univ Algarve, Drug Resistance & Pharmacogenet Grp, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Faro, Portugal; [Petzold, Max] Nord Sch Publ Hlth, Gothenburg, Sweden; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot Tak, Thailand; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Gil, Jose Pedro] Karolinska Inst, Div Pharmacogenet, Dept Physiol & Pharmacol, Stockholm, Sweden; [Gil, Jose Pedro] SUNY Binghamton, Lab Mol Anthropol & Hlth, Dept Anthropol, Binghamton, NY USA	Karolinska Institutet; Universidade do Algarve; Mahidol University; Mahidol University; University of Oxford; Karolinska Institutet; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Veiga, MI (corresponding author), Karolinska Inst, Malaria Res Lab, Dept Med, Stockholm, Sweden.	Isabel.veiga@ki.se	Veiga, Maria Isabel/H-9922-2018; Ferreira, Pedro/AAD-4309-2020; Nosten, Francois/AAC-5509-2019; Ferreira, Pedro/Q-6748-2016; Gil, José Pedro/AAB-6169-2020; Ferreira, Pedro/G-1717-2012; Ferreira, Pedro/HDO-1346-2022; Hua, QX/HGE-3640-2022; Pousao-Ferreira, Pedro/H-3689-2014; Malmberg, Maja/H-1890-2014	Veiga, Maria Isabel/0000-0002-2205-8102; Ferreira, Pedro/0000-0002-2682-7722; Nosten, Francois/0000-0002-7951-0745; Ferreira, Pedro/0000-0002-2682-7722; Ferreira, Pedro/0000-0002-2682-7722; Gil, Jose Pedro/0000-0002-6107-9379; Pousao-Ferreira, Pedro/0000-0001-6746-764X; Kone, Aminatou/0000-0001-7146-6439; Malmberg, Maja/0000-0002-4506-0408	Swedish Development Cooperation Agency-Department for Research Cooperation [SWE 2005-0017, SWE 2005-4596, SWE-2007-174, SWE-2005-4027]; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal-MCES [SFRH/BD/28393/2006, SFRH/BD/28368/2006]; Wellcome Trust of Great Britain	Swedish Development Cooperation Agency-Department for Research Cooperation; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal-MCES(Portuguese Foundation for Science and Technology); Wellcome Trust of Great Britain(Wellcome Trust)	This work was supported by project grants from Swedish Development Cooperation Agency-Department for Research Cooperation (SWE 2005-0017, SWE 2005-4596, SWE-2007-174 and SWE-2005-4027). MIV and PEF are recipients of PhD grants from Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal-MCES (ref. SFRH/BD/28393/2006 and ref. SFRH/BD/28368/2006, respectively). The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Tropical Medicine Research Unit, supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Cowman AF, 1995, AUST NZ J MED, V25, P837, DOI 10.1111/j.1445-5994.1995.tb02889.x; Dahlstrom S, 2009, J INFECT DIS, V200, P1456, DOI 10.1086/606009; Daoud R, 2001, J BIOL CHEM, V276, P12324, DOI 10.1074/jbc.M009782200; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Hastings IM, 2005, J INFECT DIS, V192, P1303, DOI 10.1086/432554; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Holmgren G, 2007, INFECT GENET EVOL, V7, P562, DOI 10.1016/j.meegid.2007.03.005; Imwong M, 2010, ANTIMICROB AGENTS CH, V54, P2886, DOI 10.1128/AAC.00032-10; Kavishe RA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-205; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Parquet V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-139; Peel SA, 2001, DRUG RESIST UPDATE, V4, P66, DOI 10.1054/drup.2001.0183; Picot S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-89; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rodrigues Coura J, 1987, Mem Inst Oswaldo Cruz, V82, P303; Rohrbach P, 2006, EMBO J, V25, P3000, DOI 10.1038/sj.emboj.7601203; Sanchez CP, 2010, INT J PARASITOL, V40, P1109, DOI 10.1016/j.ijpara.2010.04.001; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Uhlemann AC, 2005, J INFECT DIS, V192, P1830, DOI 10.1086/497337; Ursing J, 2006, J INFECT DIS, V194, P716, DOI 10.1086/506456; WHO, WORD MAL REP; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P3049, DOI 10.1128/AAC.00209-10; Zhang DW, 2006, DRUG METAB DISPOS, V34, P539, DOI 10.1124/dmd.105.007740; Zhang DW, 2004, BIOCHEMISTRY-US, V43, P9413, DOI 10.1021/bi0495230	44	68	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20212	10.1371/journal.pone.0020212	http://dx.doi.org/10.1371/journal.pone.0020212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633513	Green Submitted, gold, Green Published			2022-12-25	WOS:000291006500042
J	Friberg, IM; Lowe, A; Ralli, C; Bradley, JE; Jackson, JA				Friberg, Ida M.; Lowe, Ann; Ralli, Catriona; Bradley, Janette E.; Jackson, Joseph A.			Temporal Anomalies in Immunological Gene Expression in a Time Series of Wild Mice: Signature of an Epidemic?	PLOS ONE			English	Article							COWPOX VIRUS-INFECTION; WOOD MICE; HANTAVIRUS INFECTION; IMMUNE-RESPONSES; HOST IMMUNE; FIELD VOLE; POPULATION; PARASITES; DISEASE; DYNAMICS	Although the ecological importance of coinfection is increasingly recognized, analyses of microbial pathogen dynamics in wildlife usually focus on an ad hoc subset of the species present due to technological limitations on detection. Here we demonstrate the use of expression profiles for immunological genes (pattern recognition receptors, cytokines and transcription factors) as a means to identify, without preconception, the likelihood of important acute microbial infections in wildlife. Using a wood mouse population in the UK as a model we identified significant temporal clusters of individuals with extreme expression of immunological mediators across multiple loci, typical of an acute microbial infection. These clusters were circumstantially associated with demographic perturbation in the summertime wood mouse population. Animals in one cluster also had significantly higher individual macroparasite burdens than contemporaries with "normal" expression patterns. If the extreme transcriptional profiles observed are induced by an infectious agent then this implicates macroparasites as a possible player in mediating individual susceptibility or resilience to infection. The form of survey described here, combined with next generation nucleic acids sequencing methods for the broad detection of microbial infectious agents in individuals with anomalous immunological transcriptional profiles, could be a powerful tool for revealing unrecognized, ecologically important infectious agents circulating in wildlife populations.	[Friberg, Ida M.; Lowe, Ann; Ralli, Catriona; Bradley, Janette E.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Friberg, Ida M.; Jackson, Joseph A.] Aberystwyth Univ, IBERS, Aberystwyth, Ceredigion, Wales	University of Nottingham; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Friberg, IM (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	plximf@Nottingham.ac.uk		Jackson, Ida/0000-0002-3139-7384; Bradley, Janette/0000-0003-3973-7977	Natural Environment Research Council [NE/E015131/1]; European Commission; NERC [NE/E015131/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Commission(European CommissionEuropean Commission Joint Research Centre); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We acknowledge funding from the Natural Environment Research Council to JEB (NE/E015131/1) and the European Commission to IMF ( Marie Curie Early Stage Research Training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Alzhanova D, 2010, MICROBES INFECT, V12, P900, DOI 10.1016/j.micinf.2010.07.007; Behnke JM, 2005, J ANIM ECOL, V74, P982, DOI 10.1111/j.1365-2656.2005.00995.x; Bradley JE, 2008, PARASITOLOGY, V135, P807, DOI 10.1017/S0031182008000322; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Carslake D, 2005, J ANIM ECOL, V74, P647, DOI 10.1111/j.1365-2656.2005.00966.x; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; FLOWERDEW JR, 1972, J ANIM ECOL, V41, P553, DOI 10.2307/3195; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Guivier E, 2010, INFECT GENET EVOL, V10, P1208, DOI 10.1016/j.meegid.2010.07.022; GURNELL J, 1978, J ANIM ECOL, V47, P741, DOI 10.2307/3668; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Jackson JA, 2011, MOL ECOL, V20, P893, DOI 10.1111/j.1365-294X.2010.04907.x; Jackson JA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-16; Kallio ER, 2007, ECOLOGY, V88, P1911, DOI 10.1890/06-1620.1; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lonergan M, 2010, DIS AQUAT ORGAN, V88, P183, DOI 10.3354/dao02153; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; McKimmie CS, 2005, BIOCHEM BIOPH RES CO, V336, P925, DOI 10.1016/j.bbrc.2005.08.209; Montgomery WI, 1997, J ANIM ECOL, V66, P755, DOI 10.2307/5926; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Redpath SM, 2006, ECOL LETT, V9, P410, DOI 10.1111/j.1461-0248.2006.00895.x; ROWE FP, 1985, J APPL ECOL, V22, P55, DOI 10.2307/2403326; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stephan K, 2007, EUR J IMMUNOL, V37, P212, DOI 10.1002/eji.200636156; Stien A, 2002, J ANIM ECOL, V71, P937, DOI 10.1046/j.1365-2656.2002.00659.x; Telfer S, 2005, OIKOS, V109, P317, DOI 10.1111/j.0030-1299.2005.13734.x; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Thiriot A, 2009, MOL IMMUNOL, V46, P601, DOI 10.1016/j.molimm.2008.07.027; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILSON WL, 1993, MAMMAL REV, V23, P73, DOI 10.1111/j.1365-2907.1993.tb00418.x; Wittekindt NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013432	45	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20070	10.1371/journal.pone.0020070	http://dx.doi.org/10.1371/journal.pone.0020070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629775	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200031
J	Chowdhury, P; Pore, D; Mahata, N; Karmakar, P; Pal, A; Chakrabarti, MK				Chowdhury, Pinki; Pore, Debasis; Mahata, Nibedita; Karmakar, Poulomee; Pal, Amit; Chakrabarti, Manoj K.			Thermostable Direct Hemolysin Downregulates Human Colon Carcinoma Cell Proliferation with the Involvement of E-Cadherin, and beta-Catenin/Tcf-4 Signaling	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; HEAT-STABLE ENTEROTOXIN; PROTEIN-KINASE-C; VIBRIO-PARAHAEMOLYTICUS; EXTRACELLULAR CALCIUM; ESCHERICHIA-COLI; CACO-2 CELLS; IN-VITRO; CANCER; EXPRESSION	Background: Colon cancers are the frequent causes of cancer mortality worldwide. Recently bacterial toxins have received marked attention as promising approaches in the treatment of colon cancer. Thermostable direct hemolysin (TDH) secreted by Vibrio parahaemolyticus causes influx of extracellular calcium with the subsequent rise in intracellular calcium level in intestinal epithelial cells and it is known that calcium has antiproliferative activity against colon cancer. Key Results: In the present study it has been shown that TDH, a well-known traditional virulent factor inhibits proliferation of human colon carcinoma cells through the involvement of CaSR in its mechanism. TDH treatment does not induce DNA fragmentation, nor causes the release of lactate dehydrogenase. Therefore, apoptosis and cytotoxicity are not contributing to the TDH-mediated reduction of proliferation rate, and hence the reduction appears to be caused by decrease in cell proliferation. The elevation of E-cadherin, a cell adhesion molecule and suppression of beta-catenin, a proto-oncogene have been observed in presence of CaSR agonists whereas reverse effect has been seen in presence of CaSR antagonist as well as si-RNA in TDH treated cells. TDH also triggers a significant reduction of Cyclin-D and cdk2, two important cell cycle regulatory proteins along with an up regulation of cell cycle inhibitory protein p27(Kip1) in presence of CaSR agonists. Conclusion: Therefore TDH can downregulate colonic carcinoma cell proliferation and involves CaSR in its mechanism of action. The downregulation occurs mainly through the involvement of E-cadherin-beta-catenin mediated pathway and the inhibition of cell cycle regulators as well as upregulation of cell cycle inhibitors.	[Chowdhury, Pinki; Pore, Debasis; Mahata, Nibedita; Karmakar, Poulomee; Pal, Amit; Chakrabarti, Manoj K.] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chowdhury, P (corresponding author), Baylor Coll Med, Dept Med, Div Hematol & Oncol, Houston, TX 77030 USA.	mkc_niced@yahoo.co.in		/0000-0002-6026-1187; Chowdhury, Pinki/0000-0003-4100-0333	University Grants Commission, Government of India; Indian Council of Medical Research	University Grants Commission, Government of India(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The first author (PC) and fourth author (PK) are the recipients of the Senior Research Fellowship and Junior Research Fellowship of the University Grants Commission, Government of India, respectively. The second (DP) and third (NM) authors are the recipients of the Senior Research Fellowship of the Indian Council of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Arato-Ohshima T, 1999, INT J CANCER, V83, P387, DOI 10.1002/(SICI)1097-0215(19991029)83:3<387::AID-IJC15>3.0.CO;2-O; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhattacharya J, 1998, BBA-MOL CELL RES, V1403, P1, DOI 10.1016/S0167-4889(98)00026-3; BOYNTON AL, 1988, MINER ELECTROL METAB, V14, P86; BURAS RR, 1995, CELL PROLIFERAT, V28, P245, DOI 10.1111/j.1365-2184.1995.tb00067.x; Chakrabarty AM, 2003, J BACTERIOL, V185, P2683, DOI 10.1128/JB.185.9.2683-2686.2003; Chakrabarty S, 2003, CANCER RES, V63, P67; Chou TC, 1998, P NATL ACAD SCI USA, V95, P9642, DOI 10.1073/pnas.95.16.9642; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; DOUET JP, 1992, RES MICROBIOL, V143, P569, DOI 10.1016/0923-2508(92)90114-4; Fabbri A, 1999, INFECT IMMUN, V67, P1139, DOI 10.1128/IAI.67.3.1139-1148.1999; Ferlay J, 2001, CANC INCIDENCE MORTA; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gupta DD, 2005, TOXICOL APPL PHARM, V206, P9, DOI 10.1016/j.taap.2004.11.001; Hawk ET, 2002, SURG CLIN N AM, V82, P905, DOI 10.1016/S0039-6109(02)00046-4; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; HONDA T, 1992, CAN J MICROBIOL, V38, P1175, DOI 10.1139/m92-192; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; HULLA W, 1995, INT J CANCER, V62, P711, DOI 10.1002/ijc.2910620611; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kallay E, 1997, BIOCHEM BIOPH RES CO, V232, P80, DOI 10.1006/bbrc.1997.6225; Kwak JO, 2005, EXP MOL MED, V37, P457, DOI 10.1038/emm.2005.56; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lipkin M, 1999, ANN NY ACAD SCI, V889, P120, DOI 10.1111/j.1749-6632.1999.tb08729.x; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Pitari GM, 2003, P NATL ACAD SCI USA, V100, P2695, DOI 10.1073/pnas.0434905100; Punj V, 2004, ONCOGENE, V23, P2367, DOI 10.1038/sj.onc.1207376; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; Saha S, 2008, J APPL TOXICOL, V28, P475, DOI 10.1002/jat.1297; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sinha G, 2003, NAT MED, V9, P1229, DOI 10.1038/nm1003-1229a; Takahashi A, 2000, J MED MICROBIOL, V49, P801, DOI 10.1099/0022-1317-49-9-801; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Wang HM, 2001, J CELL PHYSIOL, V187, P188, DOI 10.1002/jcp.1068; Wargovich MJ, 2000, CARCINOGENESIS, V21, P1149, DOI 10.1093/carcin/21.6.1149; Whitfield JF, 2009, CANCER LETT, V275, P9, DOI 10.1016/j.canlet.2008.07.001; Yamada T, 2002, P NATL ACAD SCI USA, V99, P14098, DOI 10.1073/pnas.222539699	41	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20098	10.1371/journal.pone.0020098	http://dx.doi.org/10.1371/journal.pone.0020098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625458	Green Submitted, gold, Green Published			2022-12-25	WOS:000290793400039
J	Koettgen, M; Hofherr, A; Li, WZ; Chu, K; Cook, S; Montell, C; Watnick, T				Koettgen, Michael; Hofherr, Alexis; Li, Weizhe; Chu, Kristy; Cook, Stacey; Montell, Craig; Watnick, Terry			Drosophila Sperm Swim Backwards in the Female Reproductive Tract and Are Activated via TRPP2 Ion Channels	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; MALE-FERTILITY; CATION CHANNEL; MELANOGASTER; GENE; PROTEIN; PKD2; ACP36DE; STORAGE; MECHANISMS	Background: Sperm have but one purpose, to fertilize an egg. In various species including Drosophila melanogaster female sperm storage is a necessary step in the reproductive process. Amo is a homolog of the human transient receptor potential channel TRPP2 (also known as PKD2), which is mutated in autosomal dominant polycystic kidney disease. In flies Amo is required for sperm storage. Drosophila males with Amo mutations produce motile sperm that are transferred to the uterus but they do not reach the female storage organs. Therefore Amo appears to be a mediator of directed sperm motility in the female reproductive tract but the underlying mechanism is unknown. Methodology/Principal Findings: Amo exhibits a unique expression pattern during spermatogenesis. In spermatocytes, Amo is restricted to the endoplasmic reticulum (ER) whereas in mature sperm, Amo clusters at the distal tip of the sperm tail. Here we show that flagellar localization of Amo is required for sperm storage. This raised the question of how Amo at the rear end of sperm regulates forward movement into the storage organs. In order to address this question, we used in vivo imaging of dual labelled sperm to demonstrate that Drosophila sperm navigate backwards in the female reproductive tract. In addition, we show that sperm exhibit hyperactivation upon transfer to the uterus. Amo mutant sperm remain capable of reverse motility but fail to display hyperactivation and directed movement, suggesting that these functions are required for sperm storage in flies. Conclusions/Significance: Amo is part of a signalling complex at the leading edge of the sperm tail that modulates flagellar beating and that guides a backwards path into the storage organs. Our data support an evolutionarily conserved role for TRPP2 channels in cilia.	[Koettgen, Michael; Li, Weizhe; Chu, Kristy; Cook, Stacey; Watnick, Terry] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Koettgen, Michael; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Koettgen, Michael; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Koettgen, M (corresponding author), Univ Med Ctr Freiburg, Div Nephrol, Freiburg, Germany.	michael.koettgen@uniklinik-freiburg.de; twatnick@jhmi.edu	Li, Weizhe/G-6960-2012; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482; Kottgen, Michael/0000-0003-2406-5039; , Alexis/0000-0003-2842-6161	NIH [R01GM073704, RO1-EY08117, R01-EY10852]; PKD Foundation; DFG [KFO201]; German Federal and State Governments, Spemann Graduate School [GSC-4]; NATIONAL EYE INSTITUTE [R01EY008117, R01EY010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; DFG(German Research Foundation (DFG)); German Federal and State Governments, Spemann Graduate School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01GM073704 to TW, PKD Foundation Young Investigator Award and DFG KFO201 to MK, NIH RO1-EY08117 and NIH R01-EY10852 to CM. This study was supported in part by the Excellence Initiative of the German Federal and State Governments (GSC-4, Spemann Graduate School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila FW, 2009, P NATL ACAD SCI USA, V106, P15796, DOI 10.1073/pnas.0904029106; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Fraser LR, 2010, MOL REPROD DEV, V77, P197, DOI 10.1002/mrd.21124; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Hofherr A, 2011, ADV EXP MED BIOL, V704, P287, DOI 10.1007/978-94-007-0265-3_16; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Manier MK, 2010, SCIENCE, V328, P354, DOI 10.1126/science.1187096; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Neubaum DM, 1999, GENETICS, V153, P845; Neubaum DM, 1999, CURR TOP DEV BIOL, V41, P67; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Qazi MCB, 2003, J EXP BIOL, V206, P3521, DOI 10.1242/jeb.00585; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Venglarik CJ, 2004, J AM SOC NEPHROL, V15, P1168, DOI 10.1097/01.ASN.0000125616.42669.51; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Watnick TJ, 2003, CURR BIOL, V13, P2179, DOI 10.1016/S0960-9822(03)00913-8	36	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20031	10.1371/journal.pone.0020031	http://dx.doi.org/10.1371/journal.pone.0020031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625494	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400033
J	Pan, QM; Bai, YF; Wu, JG; Han, XG				Pan, Qingmin; Bai, Yongfei; Wu, Jianguo; Han, Xingguo			Hierarchical Plant Responses and Diversity Loss after Nitrogen Addition: Testing Three Functionally-Based Hypotheses in the Inner Mongolia Grassland	PLOS ONE			English	Article							SPECIES RICHNESS; SUCCESSIONAL GRASSLAND; COMPETITION; BIODIVERSITY; ALLOCATION; DEPOSITION; BIOMASS; AVAILABILITY; RESOURCES; LIGHT	Background: Numerous studies have shown that nitrogen (N) deposition decreases biodiversity in terrestrial ecosystems. To explain the N-induced species loss, three functionally based hypotheses have been proposed: the aboveground competition hypothesis, the belowground competition hypothesis, and the total competition hypothesis. However, none of them is supported sufficiently by field experiments. A main challenge to testing these hypotheses is to ascertain the role of shoot and root competition in controlling plant responses to N enrichment. Simultaneously examining both aboveground and belowground responses in natural ecosystems is logistically complex, and has rarely been done. Methodology/Principal Findings: In a two-year N addition experiment conducted in a natural grassland ecosystem, we investigated both above-and belowground responses of plants at the individual, species, and community levels. Plants differed significantly in their responses to N addition across the different organizational levels. The community-level species loss was mainly due to the loss of perennial grasses and forbs, while the relative abundance of plant species was dependent mainly on individual-level responses. Plasticity in biomass allocation was much smaller within a species than between species, providing a biological basis for explaining the functionally based species loss. All species increased biomass allocation to aboveground parts, but species with high belowground allocations were replaced by those with high aboveground allocations, indicating that the increased aboveground competition was the key process responsible for the observed diversity loss after N addition in this grassland ecosystem. Conclusions/Significance: Our findings shed new light on the validity of the three competing hypotheses concerning species loss in response to N enrichment. They also have important implications for predicting the future impacts of N deposition on the structure and functioning of terrestrial ecosystems. In addition, we have developed a new technique for ascertaining the roles of aboveground and belowground competition in determining plant responses to N fertilization.	[Pan, Qingmin; Bai, Yongfei; Han, Xingguo] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA; [Wu, Jianguo] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil SUCCES, Hohhot, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Inner Mongolia University	Pan, QM (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	pqm@ibcas.ac.cn	Wu, Jianguo/G-6267-2010; Han, Xingguo/K-7552-2016	Wu, Jianguo/0000-0002-1182-3024; Han, Xingguo/0000-0002-1836-975X	State Key Basic Research Development Program of China [2007CB106803]; Natural Science Foundation of China [30170670]; National Science Foundation [DEB-0618193]	State Key Basic Research Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from the State Key Basic Research Development Program of China (2007CB106803), Natural Science Foundation of China (30170670) and supported by National Science Foundation under grant no. DEB-0618193. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; BAZZAZ FA, PLANT RESOURCE ALLOC; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; Callaway JC, 2003, ECOL APPL, V13, P1626, DOI 10.1890/02-5144; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Fortunel C, 2009, PERSPECT PLANT ECOL, V11, P267, DOI 10.1016/j.ppees.2009.04.003; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Oksanen J, 1996, J ECOL, V84, P293, DOI 10.2307/2261364; OLFF H, 1992, OECOLOGIA, V89, P412, DOI 10.1007/BF00317420; Rajaniemi TK, 2003, J ECOL, V91, P407, DOI 10.1046/j.1365-2745.2003.00768.x; Rajaniemi TK, 2002, J ECOL, V90, P316, DOI 10.1046/j.1365-2745.2001.00662.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Robinson D, 1988, FUNCT ECOL, V2, P249, DOI 10.2307/2389701; Rubio G, 1999, NEW PHYTOL, V143, P539, DOI 10.1046/j.1469-8137.1999.00482.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Stevens MHH, 1999, ECOLOGY, V80, P455, DOI 10.1890/0012-9658(1999)080[0455:PDDSRA]2.0.CO;2; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; SULTAN SE, 1987, EVOL BIOL, V21, P127; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; TILMAN D, 1988; Tilman David, 1993, P13; WILSON SD, 1993, ECOLOGY, V74, P599, DOI 10.2307/1939319; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x	36	27	39	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20078	10.1371/journal.pone.0020078	http://dx.doi.org/10.1371/journal.pone.0020078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625503	Green Published, gold			2022-12-25	WOS:000290771200047
J	Yu, YP; Luo, JH				Yu, Y-P; Luo, J-H			Phosphorylation and interaction of myopodin by integrin-link kinase lead to suppression of cell growth and motility in prostate cancer cells	ONCOGENE			English	Article						myopodin; ILK; phosphorylation; tumor suppression; prostate cancer	LIVER-SPECIFIC ABLATION; BLADDER-CANCER; EXPRESSION; ILK; PROLIFERATION; ADHESION; PROTEIN; PARVIN; PINCH	Myopodin is a tumor-suppressor gene that suppresses growth of prostate and urothelial carcinomas. However, the mechanism of myopodin tumor-suppressor activity or signaling that leads to activation of myopodin remains unclear. In this report, we showed that the N-terminus of myopodin binds integrin-linked kinase (ILK) both in vivo and in vitro. An ILK interaction motif of 78 amino acids (amino acids 82-157) was identified in the N-terminus region of myopodin. Induction of ILK-dependent kinase activity by integrin alpha 7 led to phosphorylation of myopodin both in vivo and in vitro. Knocking down ILK dramatically reduced the inhibition of cell growth and motility mediated by myopodin. A mutant of myopodin lacking the ILK interaction motif is inactive in suppressing the growth and motility of PC3 cells. As a result, this study showed a novel and critical signaling pathway that leads to activation of myopodin. Oncogene (2011) 30, 4855-4863; doi:10.1038/onc.2011.200; published online 6 June 2011	[Yu, Y-P; Luo, J-H] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, YP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, BST S-416,3550 Terrace St, Pittsburgh, PA 15261 USA.	ypyu@pitt.edu			National Cancer Institute [R56 CA098249, RO1 CA098249]; American Cancer Society [RSG-08-137-01-CNE]; NATIONAL CANCER INSTITUTE [R56CA098249, R01CA098249] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Cancer Institute (R56 CA098249 and RO1 CA098249 to JHL) and American Cancer Society (RSG-08-137-01-CNE to YPY).	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Cebrian V, 2008, J PATHOL, V216, P111, DOI 10.1002/path.2390; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Donthamsetty S, 2010, TOXICOL SCI, V113, P358, DOI 10.1093/toxsci/kfp281; Gkretsi V, 2008, HEPATOLOGY, V48, P1932, DOI 10.1002/hep.22537; Han YC, 2010, CANCER RES, V70, P4375, DOI 10.1158/0008-5472.CAN-09-4403; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Jing L, 2004, AM J PATHOL, V164, P1799, DOI 10.1016/S0002-9440(10)63738-8; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lin F, 2001, AM J PATHOL, V159, P1603, DOI 10.1016/S0002-9440(10)63006-4; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Sanchez-Carbayo M, 2003, ONCOGENE, V22, P5298, DOI 10.1038/sj.onc.1206616; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Yamaji S, 2001, J CELL BIOL, V153, P1251, DOI 10.1083/jcb.153.6.1251; Yu YP, 2006, UROLOGY, V68, P578, DOI 10.1016/j.urology.2006.03.027; Yu YP, 2006, CANCER RES, V66, P7414, DOI 10.1158/0008-5472.CAN-06-0227	19	16	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2011	30	49					4855	4863		10.1038/onc.2011.200	http://dx.doi.org/10.1038/onc.2011.200			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21643011	Green Accepted			2022-12-25	WOS:000298346400002
J	Broer, A; Juelich, T; Vanslambrouck, JM; Tietze, N; Solomon, PS; Holst, J; Bailey, CG; Rasko, JEJ; Broer, S				Broeer, Angelika; Juelich, Torsten; Vanslambrouck, Jessica M.; Tietze, Nadine; Solomon, Peter S.; Holst, Jeff; Bailey, Charles G.; Rasko, John E. J.; Broeer, Stefan			Impaired Nutrient Signaling and Body Weight Control in a Na+ Neutral Amino Acid Cotransporter (Slc6a19)-deficient Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARTNUP DISORDER; MOLECULAR-CLONING; PLASMA-MEMBRANE; TRANSPORTER; B(0)AT1; MUTATIONS; COMPLEX; PROTEIN; SYSTEM; COLLECTRIN	Amino acid uptake in the intestine and kidney is mediated by a variety of amino acid transporters. To understand the role of epithelial neutral amino acid uptake in whole body homeostasis, we analyzed mice lacking the apical broad-spectrum neutral (0) amino acid transporter B(0)AT1 (Slc6a19). A general neutral aminoaciduria was observed similar to human Hartnup disorder which is caused by mutations in SLC6A19. Na+-dependent uptake of neutral amino acids into the intestine and renal brush-border membrane vesicles was abolished. No compensatory increase of peptide transport or other neutral amino acid transporters was detected. Mice lacking B(0)AT1 showed a reduced body weight. When adapted to a standard 20% protein diet, B(0)AT1-deficient mice lost body weight rapidly on diets containing 6 or 40% protein. Secretion of insulin in response to food ingestion after fasting was blunted. In the intestine, amino acid signaling to the mammalian target of rapamycin ( mTOR) pathway was reduced, whereas the GCN2/ATF4 stress response pathway was activated, indicating amino acid deprivation in epithelial cells. The results demonstrate that epithelial amino acid uptake is essential for optimal growth and body weight regulation.	[Broeer, Angelika; Juelich, Torsten; Tietze, Nadine; Solomon, Peter S.; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Vanslambrouck, Jessica M.; Holst, Jeff; Bailey, Charles G.; Rasko, John E. J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW 2050, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia	Australian National University; University of Sydney; Centenary Institute; University of Sydney	Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	Stefan.broer@anu.edu.au	Broer, Stefan/A-1286-2008; Solomon, Peter/C-9301-2009; Rasko, John EJ/F-5754-2013; Holst, Jeff/H-7634-2012	Broer, Stefan/0000-0002-8040-1634; Solomon, Peter/0000-0002-5130-7307; Holst, Jeff/0000-0002-0377-9318; Bailey, Charles/0000-0002-4725-7829; rasko, John/0000-0003-2975-807X	National Health and Medical Research Council [525415]; Australian Research Council [DP0877897]; University of Sydney Bridging [RIMS2009-02579]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Sydney Bridging(University of Sydney)	This work was supported by National Health and Medical Research Council Grant 525415, Australian Research Council Grant DP0877897, University of Sydney Bridging Grant RIMS2009-02579), and by an anonymous foundation.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Avissar NE, 2001, AM J PHYSIOL-CELL PH, V281, pC963, DOI 10.1152/ajpcell.2001.281.3.C963; Bailey CG, 2011, J CLIN INVEST, V121, P446, DOI 10.1172/JCI44474; BARON DN, 1956, LANCET, V271, P421; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Bohmer C, 2005, BIOCHEM J, V389, P745; Broer S, 2009, IUBMB LIFE, V61, P591, DOI 10.1002/iub.210; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; EVERS J, 1976, BIOCHIM BIOPHYS ACTA, V426, P598, DOI 10.1016/0005-2736(76)90124-3; FASS SJ, 1977, J BIOL CHEM, V252, P583; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Imai Y, 2010, CIRC J, V74, P405, DOI 10.1253/circj.CJ-10-0045; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2005, BIOCHEM J, V386, P417, DOI 10.1042/BJ20050100; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Li CH, 2004, J BIOL CHEM, V279, P13393, DOI 10.1074/jbc.M311502200; Lieberman M., 2009, BASIC MED BIOCH CLIN, P12; Matthews D. M., 1991, PROTEIN ABSORPTION; MATTHEWS DM, 1972, P NUTR SOC, V31, P171, DOI 10.1079/PNS19720033; Nassl A. M., 2011, AM J PHYSL IN PRESS; Oppedisano F, 2004, BBA-BIOMEMBRANES, V1667, P122, DOI 10.1016/j.bbamem.2004.09.007; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Quan H, 2004, MOL CELL BIOL, V24, P4166, DOI 10.1128/MCB.24.10.4166-4173.2004; Ray EC, 2003, J SURG RES, V115, P164, DOI 10.1016/S0022-4804(03)00225-7; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; SCRIVER CR, 1987, AM J HUM GENET, V40, P401; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Singer D, 2009, J BIOL CHEM, V284, P19953, DOI 10.1074/jbc.M109.011171; Son DO, 2004, BIOFACTORS, V21, P395, DOI 10.1002/biof.552210177; STEVENS BR, 1982, J MEMBRANE BIOL, V66, P213, DOI 10.1007/BF01868496; Symula DJ, 1997, MAMM GENOME, V8, P98, DOI 10.1007/s003359900366; Symula DJ, 1997, MAMM GENOME, V8, P102, DOI 10.1007/s003359900367; Vanslambrouck JM, 2010, BIOCHEM J, V428, P397, DOI 10.1042/BJ20091667	40	59	61	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26638	26651		10.1074/jbc.M111.241323	http://dx.doi.org/10.1074/jbc.M111.241323			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636576	hybrid, Green Published			2022-12-25	WOS:000293078200042
J	Miyashita, H; Maruyama, Y; Isshiki, H; Osawa, S; Ogura, T; Mio, K; Sato, C; Tomita, T; Iwatsubo, T				Miyashita, Hiroyuki; Maruyama, Yuusuke; Isshiki, Hayato; Osawa, Satoko; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara; Tomita, Taisuke; Iwatsubo, Takeshi			Three-dimensional Structure of the Signal Peptide Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEX; AUTOMATIC PARTICLE PICKUP; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; ENDOPLASMIC-RETICULUM; BETA-PEPTIDE; PRESENILIN 2; INHIBITORS; RECONSTRUCTION; IDENTIFICATION	Signal peptide peptidase (SPP) is an atypical aspartic protease that hydrolyzes peptide bonds within the transmembrane domain of substrates and is implicated in several biological and pathological functions. Here, we analyzed the structure of human SPP by electron microscopy and reconstructed the three-dimensional structure at a resolution of 22 angstrom. Enzymatically active SPP forms a slender, bullet-shaped homotetramer with dimensions of 85 x 85 x 130 angstrom. The SPP complex has four concaves on the rhombus-like sides, connected to a large chamber inside the molecule. Intriguingly, the N-terminal region of SPP is sufficient for the tetrameric assembly. Moreover, overexpression of the N-terminal region inhibited the formation of the endogenous SPP tetramer and the proteolytic activity within cells. These data suggest that the homotetramer is the functional unit of SPP and that its N-terminal region, which works as the structural scaffold, has a novel modulatory function for the intramembrane-cleaving activity of SPP.	[Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba 3058561, Japan; [Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tsukuba 3058561, Japan; [Miyashita, Hiroyuki; Isshiki, Hayato; Osawa, Satoko; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Agcy, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba 3058561, Japan.	ti-sato@aist.go.jp; taisuke@mol.f.u-tokyo.ac.jp	Ogura, Toshihiko/M-4089-2018; Mio, Kazuhiro/L-7488-2018; Tomita, Taisuke/L-5427-2015; Sato, Chikara/M-7183-2016	Mio, Kazuhiro/0000-0002-1655-8231; Tomita, Taisuke/0000-0002-0075-5943; Sato, Chikara/0000-0001-5543-4496	Japan Society for the Promotion of Science (JSPS); JST; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Core Research for Evolutional Science and Technology of JST, Japan; Grants-in-Aid for Scientific Research [23591263] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of JST, Japan(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported in part by grants-in-aid for young scientists (S) (to T. T.) from the Japan Society for the Promotion of Science (JSPS), by grants from the Strategic Japanese-Swiss Cooperative Program of the JST (to C. S.), by a grant-in-aid for scientific research on innovative areas, structural basis of cell-signaling complexes mediating signal perception, transduction and responses of a Ministry of Education, Culture, Sports, Science, and Technology (MEXT) (to C. S.), by the Targeted Proteins Research Program of the Japan Science and Technology Corporation (JST) (to T. T., T. I., C. S.), and by the Core Research for Evolutional Science and Technology of JST (to T. T. and T. I.), Japan.	Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Frank J, 2006, 3 DIMENSIONAL ELECT; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; HARAUZ G, 1986, OPTIK, V73, P146; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Sato T, 2008, J BIOL CHEM, V283, P33287, DOI 10.1074/jbc.M805670200; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; Shirotani K, 1999, NEUROSCI LETT, V262, P37, DOI 10.1016/S0304-3940(99)00037-3; Takasugi N, 2002, J BIOL CHEM, V277, P50198, DOI 10.1074/jbc.M205352200; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Urban S, 2008, CURR OPIN STRUC BIOL, V18, P432, DOI 10.1016/j.sbi.2008.03.005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	54	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26188	26197		10.1074/jbc.M111.260273	http://dx.doi.org/10.1074/jbc.M111.260273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636854	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000293073000076
J	Tavare, R; Sagoo, P; Varama, G; Tanriver, Y; Warely, A; Diebold, SS; Southworth, R; Schaeffter, T; Lechler, RI; Razavi, R; Lombardi, G; Mullen, GED				Tavare, Richard; Sagoo, Pervinder; Varama, Gopal; Tanriver, Yakup; Warely, Alice; Diebold, Sandra S.; Southworth, Richard; Schaeffter, Tobias; Lechler, Robert I.; Razavi, Reza; Lombardi, Giovanna; Mullen, Gregory E. D.			Monitoring of In Vivo Function of Superparamagnetic Iron Oxide Labelled Murine Dendritic Cells during Anti-Tumour Vaccination	PLOS ONE			English	Article							LYMPH-NODES; REPORTER GENE; TRANSPLANTATION; MIGRATION; TRACKING; SURVIVAL; PEPTIDE; HEART; MICE; MRI	Dendritic cells (DCs) generated in vitro to present tumour antigens have been injected in cancer patients to boost in vivo anti-tumour immune responses. This approach to cancer immunotherapy has had limited success. For anti-tumour therapy, delivery and subsequent migration of DCs to lymph nodes leading to effective stimulation of effector T cells is thought to be essential. The ability to non-invasively monitor the fate of adoptively transferred DCs in vivo using magnetic resonance imaging (MRI) is an important clinical tool to correlate their in vivo behavior with response to treatment. Previous reports of superparamagnetic iron oxides (SPIOs) labelling of different cell types, including DCs, have indicated varying detrimental effects on cell viability, migration, differentiation and immune function. Here we describe an optimised labelling procedure using a short incubation time and low concentration of clinically used SPIO Endorem to successfully track murine DC migration in vivo using MRI in a mouse tumour model. First, intracellular labelling of bone marrow derived DCs was monitored in vitro using electron microscopy and MRI relaxometry. Second, the in vitro characterisation of SPIO labelled DCs demonstrated that viability, phenotype and functions were comparable to unlabelled DCs. Third, ex vivo SPIO labelled DCs, when injected subcutaneously, allowed for the longitudinal monitoring by MR imaging of their migration in vivo. Fourth, the SPIO DCs induced the proliferation of adoptively transferred CD4(+) T cells but, most importantly, they primed cytotoxic CD8(+) T cell responses to protect against a B16-Ova tumour challenge. Finally, using anatomical information from the MR images, the immigration of DCs was confirmed by the increase in lymph node size post-DC injection. These results demonstrate that the SPIO labelling protocol developed in this study is not detrimental for DC function in vitro and in vivo has potential clinical application in monitoring therapeutic DCs in patients with cancer.	[Tavare, Richard; Varama, Gopal; Southworth, Richard; Schaeffter, Tobias; Razavi, Reza; Mullen, Gregory E. D.] Kings Coll London, St Thomas Hosp, Dept Imaging Chem & Biol, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Sagoo, Pervinder; Tanriver, Yakup; Lechler, Robert I.; Lombardi, Giovanna] Kings Coll London, Guys Hosp, MRC Ctr Transplantat, London WC2R 2LS, England; [Sagoo, Pervinder] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Warely, Alice] Kings Coll London, Ctr Ultrastructural Imaging, London WC2R 2LS, England; [Diebold, Sandra S.] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunol, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Tavare, R (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	giovanna.lombardi@kcl.ac.uk; greg.mullen@kcl.ac.uk	Tanriver, Yakup/AAU-7064-2020; Southworth, Richard/B-7855-2009; Schaeffter, Tobias/AAI-6826-2020; Southworth, Richard/S-1437-2019	Southworth, Richard/0000-0002-7904-8335; Schaeffter, Tobias/0000-0003-1310-2631; Southworth, Richard/0000-0002-7904-8335; Tavare, Richard/0000-0001-5150-5963; Sagoo, Pervinder/0000-0003-2568-9126; Tanriver, Yakup/0000-0002-4806-2548; Razavi, Reza/0000-0003-1065-3008	King's College London, Division of Imaging Sciences; MRC Centre of Transplantation; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; British Heart Foundation [RG/08/005/25303] Funding Source: researchfish; Medical Research Council [G0600698B] Funding Source: researchfish	King's College London, Division of Imaging Sciences; MRC Centre of Transplantation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support from King's College London, Division of Imaging Sciences, MRC Centre of Transplantation, The Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust and The British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2003, MAGN RESON MED, V49, P1006, DOI 10.1002/mrm.10465; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Chen IY, 2009, MOL IMAGING BIOL, V11, P178, DOI 10.1007/s11307-008-0182-z; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Dekaban GA, 2009, J IMMUNOTHER, V32, P240, DOI 10.1097/CJI.0b013e318197b2a0; Eggert AO, 2002, EUR J IMMUNOL, V32, P122, DOI 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO;2-C; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Janikashvili N, 2010, IMMUNOTHERAPY-UK, V2, P57, DOI 10.2217/IMT.09.78; Kuhlpeter R, 2007, RADIOLOGY, V245, P449, DOI 10.1148/radiol.2451061345; Long CM, 2009, CANCER RES, V69, P3180, DOI 10.1158/0008-5472.CAN-08-3691; MAKOWSKI MR, 2010, P ISMRM, V18; Manfredi AA, 2008, J IMMUNOL, V180, P2270, DOI 10.4049/jimmunol.180.4.2270; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rohani R, 2010, MOL IMAGING BIOL; Steitz J, 2006, CANCER GENE THER, V13, P318, DOI 10.1038/sj.cgt.7700894; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Toldbod HE, 2003, SCAND J IMMUNOL, V58, P43, DOI 10.1046/j.1365-3083.2003.01267.x; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; VARMA G, 2010, MAGN RESON MED; Verdijk P, 2007, INT J CANCER, V120, P978, DOI 10.1002/ijc.22385	22	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19662	10.1371/journal.pone.0019662	http://dx.doi.org/10.1371/journal.pone.0019662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637760	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500010
J	Shao, JZ; Zhang, YB; Yu, JL; Guo, L; Ding, Y				Shao, Jinzhen; Zhang, Yubo; Yu, Jianlan; Guo, Lin; Ding, Yi			Isolation of Thylakoid Membrane Complexes from Rice by a New Double-Strips BN/SDS-PAGE and Bioinformatics Prediction of Stromal Ridge Subunits Interaction	PLOS ONE			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; PHOTOSYSTEM-I; PROTEIN COMPLEXES; ARABIDOPSIS-THALIANA; MOLECULAR-DYNAMICS; PROTEOMIC APPROACH; ORYZA-SATIVA; MODEL; CHLOROPLAST; PHOSPHORYLATION	Thylakoid membrane complexes of rice (Oryza sativa L.) play crucial roles in growth and crop production. Understanding of protein interactions within the complex would provide new insights into photosynthesis. Here, a new "Double-Strips BN/SDS-PAGE" method was employed to separate thylakoid membrane complexes in order to increase the protein abundance on 2D-gels and to facilitate the identification of hydrophobic transmembrane proteins. A total of 58 protein spots could be observed and subunit constitution of these complexes exhibited on 2D-gels. The generality of this new approach was confirmed using thylakoid membrane from spinach (Spinacia oleracea) and pumpkin (Cucurita spp). Furthermore, the proteins separated from rice thylakoid membrane were identified by the mass spectrometry (MS). The stromal ridge proteins PsaD and PsaE were identified both in the holo-and core-PSI complexes of rice. Using molecular dynamics simulation to explore the recognition mechanism of these subunits, we showed that salt bridge interactions between residues R19 of PsaC and E168 of PasD as well as R75 of PsaC and E91 of PsaD played important roles in the stability of the complex. This stromal ridge subunits interaction was also supported by the subsequent analysis of the binding free energy, the intramolecular distances and the intramolecular energy.	[Shao, Jinzhen; Zhang, Yubo; Ding, Yi] Wuhan Univ, Coll Life Sci, Dept Genet, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Yu, Jianlan; Guo, Lin] Wuhan Univ, Coll Life Sci, Dept Biochem, Wuhan 430072, Peoples R China; [Shao, Jinzhen] Hubei Normal Univ, Coll Life Sci, Huangshi, Peoples R China	Wuhan University; Wuhan University; Hubei Normal University	Shao, JZ (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	yiding@whu.edu.cn	Zhang, Yubo/J-9659-2015	ZHANG, Yubo/0000-0002-7762-0027	973 Program of China [2007CB108705]; National Nature Science Foundation of China [30971740, 30821064]	973 Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The sources of funding are 973 Program of China [2007CB108705] and National Nature Science Foundation of China [30971740, 30821064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Andaluz S, 2006, PHOTOSYNTH RES, V89, P141, DOI 10.1007/s11120-006-9092-6; [Anonymous], 2010, R LANG ENV STAT COMP; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen X, 2007, PLANT SCI, V173, P397, DOI 10.1016/j.plantsci.2007.06.012; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; D'Amici GM, 2008, J PROTEOME RES, V7, P1326, DOI 10.1021/pr700613r; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Granvogl B, 2006, PROTEOMICS, V6, P3681, DOI 10.1002/pmic.200500924; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Komatsu S, 2005, PROTEOMICS, V5, P938, DOI 10.1002/pmic.200401040; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; Law RJ, 2005, J MOL GRAPH MODEL, V24, P157, DOI 10.1016/j.jmgm.2005.05.006; MOLL BA, 1987, PLANT PHYSIOL, V83, P428, DOI 10.1104/pp.83.2.428; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rexroth S, 2003, ELECTROPHORESIS, V24, P2814, DOI 10.1002/elps.200305543; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Sunderhaus Stephanie, 2007, Methods Mol Biol, V372, P315, DOI 10.1007/978-1-59745-365-3_23; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; Thidholm E, 2002, FEBS LETT, V513, P217, DOI 10.1016/S0014-5793(02)02314-1; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Venter H, 2002, BIOCHEM J, V363, P243, DOI 10.1042/0264-6021:3630243; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; ZANETTI G, 1987, EUR J BIOCHEM, V169, P143, DOI 10.1111/j.1432-1033.1987.tb13591.x; Zhang YB, 2010, J PHYS CHEM B, V114, P13839, DOI 10.1021/jp103547s; ZILBER AL, 1988, PLANT PHYSIOL, V88, P810, DOI 10.1104/pp.88.3.810	45	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20342	10.1371/journal.pone.0020342	http://dx.doi.org/10.1371/journal.pone.0020342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637806	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200054
J	Ferreira, RBR; Gill, N; Willing, BP; Antunes, LCM; Russell, SL; Croxen, MA; Finlay, BB				Ferreira, Rosana B. R.; Gill, Navkiran; Willing, Benjamin P.; Antunes, L. Caetano M.; Russell, Shannon L.; Croxen, Matthew A.; Finlay, B. Brett			The Intestinal Microbiota Plays a Role in Salmonella-Induced Colitis Independent of Pathogen Colonization	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; 16S RIBOSOMAL-RNA; CROHNS-DISEASE; GUT MICROBIOTA; DOUBLE-BLIND; TYPHIMURIUM INFECTION; CANDIDA-ALBICANS; GENETIC-CONTROL; MICE; METRONIDAZOLE	The intestinal microbiota is composed of hundreds of species of bacteria, fungi and protozoa and is critical for numerous biological processes, such as nutrient acquisition, vitamin production, and colonization resistance against bacterial pathogens. We studied the role of the intestinal microbiota on host resistance to Salmonella enterica serovar Typhimurium-induced colitis. Using multiple antibiotic treatments in 129S1/SvImJ mice, we showed that disruption of the intestinal microbiota alters host susceptibility to infection. Although all antibiotic treatments caused similar increases in pathogen colonization, the development of enterocolitis was seen only when streptomycin or vancomycin was used; no significant pathology was observed with the use of metronidazole. Interestingly, metronidazole-treated and infected C57BL/6 mice developed severe pathology. We hypothesized that the intestinal microbiota confers resistance to infectious colitis without affecting the ability of S. Typhimurium to colonize the intestine. Indeed, different antibiotic treatments caused distinct shifts in the intestinal microbiota prior to infection. Through fluorescence in situ hybridization, terminal restriction fragment length polymorphism, and real-time PCR, we showed that there is a strong correlation between the intestinal microbiota composition before infection and susceptibility to Salmonella-induced colitis. Members of the Bacteroidetes phylum were present at significantly higher levels in mice resistant to colitis. Further analysis revealed that Porphyromonadaceae levels were also increased in these mice. Conversely, there was a positive correlation between the abundance of Lactobacillus sp. and predisposition to colitis. Our data suggests that different members of the microbiota might be associated with S. Typhimurium colonization and colitis. Dissecting the mechanisms involved in resistance to infection and inflammation will be critical for the development of therapeutic and preventative measures against enteric pathogens.	[Ferreira, Rosana B. R.; Gill, Navkiran; Willing, Benjamin P.; Antunes, L. Caetano M.; Russell, Shannon L.; Croxen, Matthew A.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Russell, Shannon L.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Ferreira, RBR (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	bfinlay@interchange.ubc.ca	Martha Antunes, Luis Caetano/B-6864-2012; Willing, Benjamin/AAA-9650-2019; Ferreira, Rosana BR/A-3682-2019; Ferreira, Rosana/E-5169-2013; Antunes, Luis Caetano Martha/P-4988-2019	Martha Antunes, Luis Caetano/0000-0002-4933-2570; Ferreira, Rosana BR/0000-0002-7162-0026; Croxen, Matthew/0000-0002-9564-7952	Canadian Institutes of Health Research (CIHR); Canadian Crohn's and Colitis Foundation; Michael Smith Foundation for Heath Research; Michael Smith Foundation; National Science and Engineering Research Council (NSERC); Canadian Association of Gastroenterology/CIHR/Ferring Pharmaceuticals	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Crohn's and Colitis Foundation; Michael Smith Foundation for Heath Research(Michael Smith Foundation for Health Research); Michael Smith Foundation(Michael Smith Foundation for Health Research); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Association of Gastroenterology/CIHR/Ferring Pharmaceuticals(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Canadian Institutes of Health Research (CIHR) and the Canadian Crohn's and Colitis Foundation. R. B. R. Ferreira, N. Gill and L. C. M. Antunes are supported by postdoctoral fellowships from the CIHR. N. Gill is also supported by the Michael Smith Foundation for Heath Research. S. Russell is supported by a junior graduate studentship from the Michael Smith Foundation and a Canada Graduate Scholarship (CGS) from the National Science and Engineering Research Council (NSERC). M. A. Croxen is supported by a Canadian Association of Gastroenterology/CIHR/Ferring Pharmaceuticals postdoctoral fellowship. B. B. Finlay is the University of British Columbia Peter Wall Distinguished Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMBROSE NS, 1985, DIS COLON RECTUM, V28, P81, DOI 10.1007/BF02552649; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Begon M., 1996, ECOLOGY; BLICHFELDT P, 1978, SCAND J GASTROENTERO, V13, P123, DOI 10.3109/00365527809179816; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Damaskos D, 2008, BRIT J CLIN PHARMACO, V65, P453, DOI 10.1111/j.1365-2125.2008.03096.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gionchetti P, 2006, WORLD J GASTROENTERO, V12, P3306, DOI 10.3748/wjg.v12.i21.3306; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kibe R, 2007, MICROBIOL IMMUNOL, V51, P349, DOI 10.1111/j.1348-0421.2007.tb03916.x; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marteau P, 2006, GUT, V55, P842, DOI 10.1136/gut.2005.076604; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Pelissier MA, 2010, FEMS MICROBIOL ECOL, V73, P601, DOI 10.1111/j.1574-6941.2010.00916.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Petersen A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-245; Prantera C, 2002, GUT, V51, P405, DOI 10.1136/gut.51.3.405; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; URSING B, 1982, GASTROENTEROLOGY, V83, P550; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	45	113	119	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20338	10.1371/journal.pone.0020338	http://dx.doi.org/10.1371/journal.pone.0020338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633507	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500058
J	Dyce, PW; Liu, JH; Tayade, C; Kidder, GM; Betts, DH; Li, JL				Dyce, Paul W.; Liu, Jinghe; Tayade, Chandrakant; Kidder, Gerald M.; Betts, Dean H.; Li, Julang			In Vitro and In Vivo Germ Line Potential of Stem Cells Derived from Newborn Mouse Skin	PLOS ONE			English	Article							CHROMOSOME SYNAPSIS; GENE-EXPRESSION; PORCINE SKIN; OVARIAN STRUCTURES; FIG-ALPHA; DIFFERENTIATION; MEIOSIS; MICE; POPULATION; FOLLICLES	We previously reported that fetal porcine skin-derived stem cells were capable of differentiation into oocyte-like cells (OLCs). Here we report that newborn mice skin-derived stem cells are also capable of differentiating into early OLCs. Using stem cells from mice that are transgenic for Oct4 germline distal enhancer-GFP, germ cells resulting from their differentiation are expected to be GFP(+). After differentiation, some GFP(+) OLCs reached 40-45 mu M and expressed oocyte markers. Flow cytometric analysis revealed that similar to 0.3% of the freshly isolated skin cells were GFP(+). The GFP-positive cells increased to similar to 7% after differentiation, suggesting that the GFP(+) cells could be of in vivo origin, but are more likely induced upon being cultured in vitro. To study the in vivo germ cell potential of skin-derived cells, they were aggregated with newborn ovarian cells, and transplanted under the kidney capsule of ovariectomized mice. GFP(+) oocytes were identified within a subpopulation of follicles in the resulting growth. Our finding that early oocytes can be differentiated from mice skin-derived cells in defined medium may offer a new in vitro model to study germ cell formation and oogenesis.	[Dyce, Paul W.; Liu, Jinghe; Li, Julang] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Dyce, Paul W.; Kidder, Gerald M.; Betts, Dean H.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada; [Dyce, Paul W.; Kidder, Gerald M.; Betts, Dean H.] Childrens Hlth Res Inst, London, ON, Canada; [Tayade, Chandrakant] Queens Univ, Dept Anat & Cell Biol, Kingston, ON, Canada	University of Guelph; Western University (University of Western Ontario); Queens University - Canada	Dyce, PW (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	jli@uoguelph.ca	Betts, Dean H/B-7414-2015	Betts, Dean H/0000-0002-5528-9142; Dyce, Paul/0000-0002-4574-3321	Canadian Institutes for Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes for Health Research (CIHR), Natural Sciences and Engineering Research Council (NSERC), and the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA). Paul W. Dyce was supported by a Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and subsequently by a Postdoctoral Fellowship from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL M, 2009, J MOL ENDOCRINOL; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Epifano O, 2002, TRENDS ENDOCRIN MET, V13, P169, DOI 10.1016/S1043-2760(02)00576-3; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Guo W, 2009, CELL PROLIFERAT, V42, P49, DOI 10.1111/j.1365-2184.2008.00573.x; HEYTING C, 1988, CHROMOSOMA, V96, P325, DOI 10.1007/BF00286921; Klink A, 1997, MAMM GENOME, V8, P376, DOI 10.1007/s003359900638; KROEZE KL, 2009, J INVEST DERMATOL; KUES WA, 2004, BIOL REPROD; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Liang LF, 1997, DEVELOPMENT, V124, P4939; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Molyneaux KA, 2004, GENE EXPR PATTERNS, V4, P167, DOI 10.1016/j.modgep.2003.09.002; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pesce M, 1996, Int J Dev Biol, VSuppl 1, p229S; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Ratajczak MZ, 2007, LEUKEMIA, V21, P860, DOI 10.1038/sj.leu.2404630; Ratajczak MZ, 2008, J AUTOIMMUN, V30, P151, DOI 10.1016/j.jaut.2007.12.003; Redvers RP, 2006, P NATL ACAD SCI USA, V103, P13168, DOI 10.1073/pnas.0602579103; Sato S, 1995, DNA Res, V2, P89, DOI 10.1093/dnares/2.2.89; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tsai MS, 2006, BIOL REPROD, V74, P545, DOI 10.1095/biolreprod.105.046029; Weinbauer GF, 1997, ADV EXP MED BIOL, V424, P51; WICKRAMASINGHE D, 1991, DEV BIOL, V143, P162, DOI 10.1016/0012-1606(91)90063-9; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	44	59	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20339	10.1371/journal.pone.0020339	http://dx.doi.org/10.1371/journal.pone.0020339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629667	Green Published, gold			2022-12-25	WOS:000291005800043
J	Ding, Y; Zou, J; Li, ZL; Tian, JJ; Abdelalim, S; Du, F; She, RP; Wang, DS; Tan, C; Wang, HJ; Chen, WJ; Lv, DQ; Chang, LL				Ding, Ye; Zou, Jun; Li, Zhili; Tian, Jijing; Abdelalim, Saed; Du, Fang; She, Ruiping; Wang, Desheng; Tan, Cheng; Wang, Huijuan; Chen, Wenjuan; Lv, Dongqiang; Chang, Lingling			Study of Histopathological and Molecular Changes of Rat Kidney under Simulated Weightlessness and Resistance Training Protective Effect	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; HINDLIMB SUSPENSION; OXIDATIVE STRESS; PROTEIN-METABOLISM; SKELETAL RESPONSE; INDUCED APOPTOSIS; CYTOSOLIC CA2+; RENAL-FUNCTION; MODEL	To explore the effects of long-term weightlessness on the renal tissue, we used the two months tail suspension model to simulate microgravity and investigated the simulated microgravity on the renal morphological damages and related molecular mechanisms. The microscopic examination of tissue structure and ultrastructure was carried out for histopathological changes of renal tissue morphology. The immunohistochemistry, real-time PCR and Western blot were performed to explore the molecular mechanisms associated the observations. Hematoxylin and eosin (HE) staining showed severe pathological kidney lesions including glomerular atrophy, degeneration and necrosis of renal tubular epithelial cells in two months tail-suspended rats. Ultrastructural studies of the renal tubular epithelial cells demonstrated that basal laminas of renal tubules were rough and incrassate with mitochondria swelling and vacuolation. Cell apoptosis in kidney monitored by the expression of Bax/Bcl-2 and caspase-3 accompanied these pathological damages caused by long-term microgravity. Analysis of the HSP70 protein expression illustrated that overexpression of HSP70 might play a crucial role in inducing those pathological damages. Glucose regulated protein 78 (GRP78), one of the endoplasmic reticulum (ER) chaperones, was up-regulated significantly in the kidney of tail suspension rat, which implied that ER-stress was associated with apoptosis. Furthermore, CHOP and caspase-12 pathways were activated in ER-stress induced apoptosis. Resistance training not only reduced kidney cell apoptosis and expression of HSP70 protein, it also can attenuate the kidney impairment imposed by weightlessness. The appropriate optimization might be needed for the long term application for space exploration.	[Ding, Ye; Tian, Jijing; Du, Fang; She, Ruiping; Lv, Dongqiang; Chang, Lingling] China Agr Univ, Coll Vet Med, Minist Agr, Dept Vet Pathol,Key Lab Zoonosis, Beijing 100094, Peoples R China; [Zou, Jun; Abdelalim, Saed] China Agr Univ, Coll Vet Med, Natl Anim Protozoa Lab, Beijing 100094, Peoples R China; [Li, Zhili; Wang, Desheng; Tan, Cheng; Wang, Huijuan; Chen, Wenjuan] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Ding, Y (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Dept Vet Pathol,Key Lab Zoonosis, Beijing 100094, Peoples R China.	sheruiping@126.com	wang, huimin/HDM-8421-2022; El-Ashram, Saeed/AAC-6060-2021; wang, hui/GRS-4730-2022	El-Ashram, Saeed/0000-0003-0389-1980; 	Advanced Space Medico-Engineering Research Project of China [SJ200802]; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities [IRT0866]	Advanced Space Medico-Engineering Research Project of China; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities	This work was supported by Advanced Space Medico-Engineering Research Project of China, grant (NO. SJ200802), and the Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities (No. IRT0866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin KM, 1996, MED SCI SPORT EXER, V28, P1247, DOI 10.1097/00005768-199610000-00007; Brooks DP, 2000, J APPL PHYSIOL, V88, P1316, DOI 10.1152/jappl.2000.88.4.1316; CAMPBELL WW, 1995, AM J PHYSIOL-ENDOC M, V268, pE1143, DOI 10.1152/ajpendo.1995.268.6.E1143; Castaneda C, 2001, ANN INTERN MED, V135, P965, DOI 10.7326/0003-4819-135-11-200112040-00008; Ciftcioglu N, 2005, KIDNEY INT, V67, P483, DOI 10.1111/j.1523-1755.2005.67105.x; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Convertino VA, 2000, J APPL PHYSIOL, V89, P1737, DOI 10.1152/jappl.2000.89.5.1737; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; De Santo NG, 2005, J RENAL NUTR, V15, P183, DOI 10.1053/j.jrn.2004.09.011; Fluckey JD, 2002, ACTA PHYSIOL SCAND, V176, P293, DOI 10.1046/j.1365-201X.2002.01040.x; Gazenko O G, 1986, Probl Kosm Biol, V54, P1; GLOBUS RK, 1986, J BONE MINER RES, V1, P191; Grimm PC, 2003, J AM SOC NEPHROL, V14, P1662, DOI 10.1097/01.ASN.0000066143.02832.5E; Halet G, 1999, AM J PHYSIOL-HEART C, V276, pH1131, DOI 10.1152/ajpheart.1999.276.4.H1131; Inagi R, 2005, KIDNEY INT, V68, P2639, DOI 10.1111/j.1523-1755.2005.00736.x; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kijima K, 2004, TOXICOL APPL PHARM, V200, P103, DOI 10.1016/j.taap.2004.03.015; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; LINDERMAN JK, 1994, AM J PHYSIOL, V267, pR365, DOI 10.1152/ajpregu.1994.267.2.R365; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu T, 2008, POULTRY SCI, V87, P250, DOI 10.3382/ps.2007-00353; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyake Masao, 2003, Biol Sci Space, V17, P173; Morel JL, 1997, AM J PHYSIOL-HEART C, V273, pH2867, DOI 10.1152/ajpheart.1997.273.6.H2867; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NATOCHIN YV, 1991, AVIAT SPACE ENVIR MD, V62, P1037; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Perez MJ, 2005, J HEPATOL, V43, P324, DOI 10.1016/j.jhep.2005.02.028; Rall LC, 1996, ARTHRITIS RHEUM, V39, P1115, DOI 10.1002/art.1780390707; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; ROYLAND JE, 1994, LIFE SCI, V54, P545, DOI 10.1016/0024-3205(94)90005-1; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tesch PA, 1997, INT J SPORTS MED, V18, pS322, DOI 10.1055/s-2007-972744; Thomas GL, 1998, NEPHROL DIAL TRANSPL, V13, P2216, DOI 10.1093/ndt/13.9.2216; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turner R T, 1979, Physiologist, V22, pS73; Wade CE, 1998, AM J PHYSIOL-REG I, V275, pR1058; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Wimalawansa SM, 1999, J APPL PHYSIOL, V86, P1841, DOI 10.1152/jappl.1999.86.6.1841; WRONSKI TJ, 1987, AVIAT SPACE ENVIR MD, V58, P63; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zorbas Yan G., 2001, International Urology and Nephrology, V33, P423, DOI 10.1023/A:1019519403233	55	27	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20008	10.1371/journal.pone.0020008	http://dx.doi.org/10.1371/journal.pone.0020008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625440	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200023
J	Marconi, VC; Grandits, G; Okulicz, JF; Wortmann, G; Ganesan, A; Crum-Cianflone, N; Polis, M; Landrum, M; Dolan, MJ; Ahuja, SK; Agan, B; Kulkarni, H				Marconi, Vincent C.; Grandits, Greg; Okulicz, Jason F.; Wortmann, Glenn; Ganesan, Anuradha; Crum-Cianflone, Nancy; Polis, Michael; Landrum, Michael; Dolan, Matthew J.; Ahuja, Sunil K.; Agan, Brian; Kulkarni, Hemant		Infect Dis Clinical Res Program	Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS	PLOS ONE			English	Article							PROTEASE INHIBITOR THERAPY; TERM-FOLLOW-UP; HIV-1-INFECTED PATIENTS; CELL COUNT; RNA LEVEL; INTERMITTENT VIREMIA; DISEASE PROGRESSION; CLINICAL-OUTCOMES; LYMPHOCYTE COUNTS; PREDICTIVE VALUE	Background: The impact of viral load (VL) decay and cumulative VL on CD4 recovery and AIDS after highly-active antiretroviral therapy (HAART) is unknown. Methods and Findings: Three virologic kinetic parameters (first year and overall exponential VL decay constants, and first year VL slope) and cumulative VL during HAART were estimated for 2,278 patients who initiated HAART in the U. S. Military HIV Natural History Study. CD4 and VL trajectories were computed using linear and nonlinear Generalized Estimating Equations models. Multivariate Poisson and linear regression models were used to determine associations of VL parameters with CD4 recovery, adjusted for factors known to correlate with immune recovery. Cumulative VL higher than the sample median was independently associated with an increased risk of AIDS (relative risk 2.38, 95% confidence interval 1.56-3.62, p < 0.001). Among patients with VL suppression, first year VL decay and slope were independent predictors of early CD4 recovery (p = 0.001) and overall gain (p < 0.05). Despite VL suppression, those with slow decay during the first year of HAART as well as during the entire therapy period (overall), in general, gained less CD4 cells compared to the other subjects (133 vs. 195.4 cells/mu L; p = 0.001) even after adjusting for potential confounders. Conclusions: In a cohort with free access to healthcare, independent of established predictors of AIDS and CD4 recovery during HAART, cumulative VL and virologic decay patterns were associated with AIDS and distinct aspects of CD4 reconstitution.	[Marconi, Vincent C.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Marconi, Vincent C.; Grandits, Greg; Okulicz, Jason F.; Wortmann, Glenn; Ganesan, Anuradha; Crum-Cianflone, Nancy; Polis, Michael; Landrum, Michael; Agan, Brian] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Grandits, Greg] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Okulicz, Jason F.; Landrum, Michael] Brooke Army Med Ctr, San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX 78234 USA; [Wortmann, Glenn] Walter Reed Army Med Ctr, Infect Dis Serv, Washington, DC 20307 USA; [Ganesan, Anuradha] Natl Naval Med Ctr, Infect Dis Clin, Bethesda, MD USA; [Crum-Cianflone, Nancy] USN, Infect Dis Clin, San Diego Med Ctr, San Diego, CA 92152 USA; [Polis, Michael] NIAID, NIH, Bethesda, MD 20892 USA; [Dolan, Matthew J.] Wilford Hall USAF Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX 78236 USA; [Ahuja, Sunil K.; Kulkarni, Hemant] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX USA; [Ahuja, Sunil K.; Kulkarni, Hemant] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	Emory University; Uniformed Services University of the Health Sciences - USA; University of Minnesota System; University of Minnesota Twin Cities; San Antonio Military Medical Center; United States Department of Defense; United States Army; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Air Force; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Marconi, VC (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.	vcmarco@emory.edu; kulkarnih@uthscsa.edu	Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Kulkarni, Hemant/AEM-5750-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Polis, Michael/0000-0002-9151-2268; Agan, Brian/0000-0002-5114-1669	Infectious Disease Clinical Research Program [IDCRP-000-03]; Department of Defense through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health [Y1-AI-5072]; Veterans Administration Center on AIDS and HIV infection of the South Texas Veterans Health Care System; NIH [R37046326]; VA; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award; Doris Duke Distinguished Clinical Scientist Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072, R37AI046326] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program; Department of Defense through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Administration Center on AIDS and HIV infection of the South Texas Veterans Health Care System; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award(Burroughs Wellcome Fund); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-000-03) was provided by the Infectious Disease Clinical Research Program, a Department of Defense program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Inter-Agency Agreement Y1-AI-5072. This work was also supported by the Veterans Administration Center on AIDS and HIV infection of the South Texas Veterans Health Care System, and a MERIT (R37046326) award from the NIH to SKA. SKA is also supported by a VA MERIT award and is a recipient of the Elizabeth Glaser Scientist Award, the Burroughs Wellcome Clinical Scientist Award in Translational Research, and the Doris Duke Distinguished Clinical Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Anastos K, 2004, ANN INTERN MED, V140, P256, DOI 10.7326/0003-4819-140-4-200402170-00007; Anastos K, 2002, ARCH INTERN MED, V162, P1973, DOI 10.1001/archinte.162.17.1973; [Anonymous], 1993, JAMA, V269, P729; [Anonymous], [No title captured]; Babiker A, 2000, AIDS RES HUM RETROV, V16, P1123; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Breban R, 2006, LANCET, V367, P1285, DOI 10.1016/S0140-6736(06)68543-7; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; Casado JL, 1998, AIDS, V12, pF131, DOI 10.1097/00002030-199811000-00005; Choi AI, 2009, AIDS, V23, P2143, DOI 10.1097/QAD.0b013e3283313c91; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cole SR, 2010, AM J EPIDEMIOL, V171, P198, DOI 10.1093/aje/kwp347; Demeter LM, 2001, ANN INTERN MED, V135, P954, DOI 10.7326/0003-4819-135-11-200112040-00007; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Ghani AC, 2002, J ACQ IMMUN DEF SYND, V30, P167, DOI 10.1097/00042560-200206010-00005; Ghani AC, 2001, J ACQ IMMUN DEF SYND, V28, P226, DOI 10.1097/00042560-200111010-00004; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Guiguet M, 2009, LANCET ONCOL, V10, P1152, DOI 10.1016/S1470-2045(09)70282-7; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hulgan T, 2007, J INFECT DIS, V195, P425, DOI 10.1086/510536; Jacobson LP, 2002, AM J EPIDEMIOL, V155, P760, DOI 10.1093/aje/155.8.760; Journot V, 2001, CONTROL CLIN TRIALS, V22, P639, DOI 10.1016/S0197-2456(01)00158-1; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kim S, 2000, AIDS RES HUM RETROV, V16, P645, DOI 10.1089/088922200308873; Kitchen CM, 2001, CLIN INFECT DIS, V33, P466, DOI 10.1086/321900; Kousignian I, 2003, JAIDS-J ACQ IMM DEF, V34, P50, DOI 10.1097/00126334-200309010-00007; Kravcik S, 2001, HIV Clin Trials, V2, P160, DOI 10.1310/F45L-FDKK-Y48N-N2BT; Kuritzkes DR, 2007, J INFECT DIS, V195, P1169, DOI 10.1086/512619; Kuritzkes DR, 2000, J INFECT DIS, V181, P491, DOI 10.1086/315244; Le Moing V, 2002, J INFECT DIS, V185, P471, DOI 10.1086/338929; Lewden C, 2002, J INFECT DIS, V186, P710, DOI 10.1086/342047; LOVEDAY C, 1995, LANCET, V345, P820, DOI 10.1016/S0140-6736(95)92963-0; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maggiolo F, 2000, J ACQ IMMUN DEF SYND, V25, P36, DOI 10.1097/00126334-200009010-00005; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Notermans DW, 1998, AIDS, V12, P1483, DOI 10.1097/00002030-199812000-00010; PHILLIPS AN, 1994, BRIT MED J, V309, P309, DOI 10.1136/bmj.309.6950.309; Polis MA, 2001, LANCET, V358, P1760, DOI 10.1016/S0140-6736(01)06802-7; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sprout M, 2005, ANTIVIR THER, V10, P357; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Tomasoni LR, 2003, HIV CLIN TRIALS, V4, P311, DOI 10.1310/FGMF-Y0LY-DMX8-371V; Torti C, 2004, VIRAL IMMUNOL, V17, P279, DOI 10.1089/0882824041310630; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Weintrob AC, 2008, JAIDS-J ACQ IMM DEF, V49, P40, DOI 10.1097/QAI.0b013e31817bec05; Weintrob AC, 2009, JAIDS-J ACQ IMM DEF, V52, P574, DOI 10.1097/QAI.0b013e3181b98537; Weverling GJ, 1998, AIDS, V12, pF117, DOI 10.1097/00002030-199811000-00003; Wu HL, 2005, JAIDS-J ACQ IMM DEF, V39, P272, DOI 10.1097/01.qai.0000165907.04710.da; Wu HL, 1999, J INFECT DIS, V179, P799, DOI 10.1086/314670; Zoufaly A, 2009, J INFECT DIS, V200, P79, DOI 10.1086/599313	63	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e17956	10.1371/journal.pone.0017956	http://dx.doi.org/10.1371/journal.pone.0017956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625477	Green Published, gold, Green Submitted			2022-12-25	WOS:000290793400001
J	Grenz, A; Dalton, JH; Bauerle, JD; Badulak, A; Ridyard, D; Gandjeva, A; Aherne, CM; Brodsky, KS; Kim, JH; Tuder, RM; Eltzschig, HK				Grenz, Almut; Dalton, Julee H.; Bauerle, Jessica D.; Badulak, Alexander; Ridyard, Douglas; Gandjeva, Aneta; Aherne, Carol M.; Brodsky, Kelley S.; Kim, Jae-Hwan; Tuder, Rubin M.; Eltzschig, Holger K.			Partial Netrin-1 Deficiency Aggravates Acute Kidney Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; INDUCED VASCULAR LEAK; INDUCIBLE FACTOR-I; ACUTE LUNG INJURY; ADENOSINE RECEPTOR; ECTO-5'-NUCLEOTIDASE CD73; NUCLEOTIDE PHOSPHOHYDROLYSIS; ISCHEMIA/REPERFUSION INJURY; HIF-1-DEPENDENT REPRESSION	The netrin family of secreted proteins provides migrational cues in the developing central nervous system. Recently, netrins have also been shown to regulate diverse processes beyond their functions in the brain, incluing the ochrestration of inflammatory events. Particularly netrin-1 has been implicated in dampening hypoxia-induced inflammation. Here, we hypothesized an anti-inflammatory role of endogenous netrin-1 in acute kidney injury (AKI). As homozygous deletion of netrin-1 is lethal, we studied mice with partial netrin-1 deletion (Ntn-1(+/-) mice) as a genetic model. In fact, Ntn-1(+/-) mice showed attenuated Ntn-1 levels at baseline and following ischemic AKI. Functional studies of AKI induced by 30 min of renal ischemia and reperfusion revealed enhanced kidney dysfunction in Ntn-1(+/-) mice as assessed by measurements of glomerular filtration, urine flow rate, urine electrolytes, serum creatinine and creatinine clearance. Consistent with these findings, histological studies indicated a more severe degree kidney injury. Similarly, elevations of renal and systemic inflammatory markers were enhanced in mice with partial netrin-1 deficiency. Finally, treatment of Ntn-1(+/-) mice with exogenous netrin-1 restored a normal phenotype during AKI. Taking together, these studies implicate endogenous netrin-1 in attenuating renal inflammation during AKI.	[Grenz, Almut; Dalton, Julee H.; Bauerle, Jessica D.; Badulak, Alexander; Ridyard, Douglas; Aherne, Carol M.; Brodsky, Kelley S.; Kim, Jae-Hwan; Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Aurora, CO USA; [Gandjeva, Aneta; Tuder, Rubin M.] Univ Colorado Denver, Div Pulm Sci & Crit Care Med, Aurora, CO USA; [Kim, Jae-Hwan] Korea Univ, Coll Med, Dept Anesthesiol, Seoul 136705, South Korea	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Korea University; Korea University Medicine (KU Medicine)	Grenz, A (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Mucosal Inflammat Program, Anschutz Med Campus, Aurora, CO USA.	Almut.Grenz@ucdenver.edu; holger.eltzschig@ucdenver.edu		Aherne, Carol/0000-0001-5653-9003	United States National Institutes of Health [R01-HL0921, R01-DK083385, R01HL098294]; Foundation for Anesthesia Education and Research (FAER); American Society of Nephrology; DFG (Deutsche Forschungsgemeinschaft) [GR2121/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Anesthesia Education and Research (FAER); American Society of Nephrology; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present studies were supported by United States National Institutes of Health grant R01-HL0921, R01-DK083385 and R01HL098294 and Foundation for Anesthesia Education and Research (FAER) Grants to HKE, an American Society of Nephrology Medical Student Scholar grant and FAER grant to JDB, JHD and AB, and a DFG (Deutsche Forschungsgemeinschaft) Research Fellowship Grant (GR2121/1-1) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bove T, 2005, CIRCULATION, V111, P3230, DOI 10.1161/CIRCULATIONAHA.104.509141; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Eltzschig HK, 2009, EXPERT OPIN THER TAR, V13, P1267, DOI 10.1517/14728220903241666; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Grenz A, 2007, AM J PHYSIOL-RENAL, V292, pF475, DOI 10.1152/ajprenal.00275.2006; Guckelberger O, 2004, THROMB HAEMOSTASIS, V91, P576, DOI 10.1160/TH03-06-0373; Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Kim M, 2009, KIDNEY INT, V75, P809, DOI 10.1038/ki.2008.699; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Lu B, 2008, TRANSPLANTATION, V86, P1707, DOI 10.1097/TP.0b013e31819022bc; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mehta RL, 2005, J AM SOC NEPHROL, V16, P12, DOI 10.1681/ASN.2004110954; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; PARK SW, 2010, J PHARM EXP THER; Ramesh G, 2010, CLIN J AM SOC NEPHRO, V5, P395, DOI 10.2215/CJN.05140709; Reeves WB, 2008, AM J PHYSIOL-RENAL, V294, pF731, DOI 10.1152/ajprenal.00507.2007; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Wang WW, 2009, AM J PHYSIOL-RENAL, V296, pF723, DOI 10.1152/ajprenal.90686.2008; WEN J, FASEB J, V24, P740	61	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e14812	10.1371/journal.pone.0014812	http://dx.doi.org/10.1371/journal.pone.0014812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625583	gold, Green Published, Green Submitted			2022-12-25	WOS:000290771200001
J	Shan, XY; Margulies, KB				Shan, Xiaoyin; Margulies, Kenneth B.			Differential Regulation of PDE5 Expression in Left and Right Ventricles of Feline Hypertrophy Models	PLOS ONE			English	Article							PRESSURE-OVERLOAD; PULMONARY-HYPERTENSION; CYCLIC-GMP; PHOSPHODIESTERASE TYPE-5; CARDIAC-HYPERTROPHY; CHRONIC INHIBITION; HEART-FAILURE; IN-VIVO; SILDENAFIL; MYOCARDIUM	Background: Though long known to affect smooth muscle biology, recent studies indicate that phosphodiesterase 5 (PDE5) is also expressed in myocardium. Recognizing that the regulation of PDE5 in hypertrophy is not well understood, we assessed the response of PDE5 expression and the level of cGMP-dependent kinase I (cGKI) in the left and right ventricles of feline hypertrophy models. Methodology/Principal Findings: Using a cDNA library of feline aortic smooth muscle cells, we identified and cloned PDE5 cDNA for the first time in this species. The sequence shares 98% identity with its human orthologue at the amino acid level. E. coli expression of the cloned allele allowed selection of antibodies with appropriate specificity, facilitating the analysis of PDE5 expression in feline models created by selective proximal aortic (Ao) or pulmonary artery (PA) banding that resulted in hypertrophy of the left ventricle (LV) and right ventricle (RV), respectively. We demonstrated that PDE5 expression responded differentially with a decreased expression in the LV and an increased expression in the RV in the Ao-banded model. Similarly, in the PA-banded model, LV showed reduced expression while the RV expression was unaltered. In addition, the expression of cGKI was significantly decreased in the RV of Ao-banded group, correlating inversely with the increase in PDE5 expression. Conclusions/Significance: The differential regulation of PDE5 and cGKI expression suggests that the mechanisms involved in hypertrophy could be different in RV vs. LV. Reciprocal PDE5 and cGKI expression in the RV of Ao-banded model suggests functional significance for PDE5 up-regulation.	[Shan, Xiaoyin; Margulies, Kenneth B.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Shan, XY (corresponding author), Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA.	ken.margulies@uphs.upenn.edu			U. S. National Institutes of Health [R01 AG 17022]; NATIONAL INSTITUTE ON AGING [R01AG017022] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported through funds from the U. S. National Institutes of Health (R01 AG 17022). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen A, 2008, EUR J HEART FAIL, V10, P1158, DOI 10.1016/j.ejheart.2008.09.016; BAILEY BA, 1992, J MOL CELL CARDIOL, V24, P365, DOI 10.1016/0022-2828(92)93191-L; Bessay EP, 2008, J PHARMACOL EXP THER, V325, P62, DOI 10.1124/jpet.107.133405; Biel M, 1999, Rev Physiol Biochem Pharmacol, V135, P151, DOI 10.1007/BFb0033672; Corbin JD, 2004, INT J IMPOT RES, V16, pS4, DOI 10.1038/sj.ijir.3901205; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Furukawa T, 2006, J MOL CELL CARDIOL, V41, P753, DOI 10.1016/j.yjmcc.2006.07.021; Geng Y, 1998, J BIOL CHEM, V273, P27484, DOI 10.1074/jbc.273.42.27484; Hemnes AR, 2008, AM J PHYSIOL-LUNG C, V294, pL24, DOI 10.1152/ajplung.00245.2007; Ito M, 1996, CELL SIGNAL, V8, P575, DOI 10.1016/S0898-6568(96)00112-X; Itoh T, 2004, AM J RESP CRIT CARE, V169, P34, DOI 10.1164/rccm.200303-346OC; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Kuhn M, 2009, CARDIOVASC RES, V82, P4, DOI 10.1093/cvr/cvp057; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin CS, 2004, INT J IMPOT RES, V16, pS8, DOI 10.1038/sj.ijir.3901207; LOISELLE DS, 1979, AM J PHYSIOL, V237, pH90, DOI 10.1152/ajpheart.1979.237.1.H90; Lusche DF, 2005, EUR J PHARMACOL, V513, P9, DOI 10.1016/j.ejphar.2005.01.047; MOLLER G, PLOS ONE, V5; Murata T, 2010, ANTICANCER RES, V30, P355; Nagayama T, 2009, J MOL CELL CARDIOL, V46, P560, DOI 10.1016/j.yjmcc.2008.12.008; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Quaile MP, 2007, J MOL CELL CARDIOL, V43, P552, DOI 10.1016/j.yjmcc.2007.08.013; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Sanchez LS, 1998, PEDIATR RES, V43, P163, DOI 10.1203/00006450-199802000-00002; Schafer S, 2009, CARDIOVASC RES, V82, P30, DOI 10.1093/cvr/cvp002; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; Shan XY, 2008, BIOCHEMISTRY-US, V47, P10041, DOI 10.1021/bi800972z; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto Eiki, 2009, Expert Rev Clin Pharmacol, V2, P323, DOI 10.1586/ecp.09.20; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandeput F, 2009, J PHARMACOL EXP THER, V330, P884, DOI 10.1124/jpet.109.154468; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; WILLIAMS JF, 1982, J CLIN INVEST, V69, P309, DOI 10.1172/JCI110454; Xu HL, 2004, AM J PHYSIOL-HEART C, V287, pH2501, DOI 10.1152/ajpheart.00319.2004	40	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19922	10.1371/journal.pone.0019922	http://dx.doi.org/10.1371/journal.pone.0019922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625548	Green Submitted, Green Published, gold			2022-12-25	WOS:000290771200031
J	Sopko, N; Qin, YL; Finan, A; Dadabayev, A; Chigurupati, S; Qin, J; Penn, MS; Gupta, S				Sopko, Nikolai; Qin, Yilu; Finan, Amanda; Dadabayev, Alisher; Chigurupati, Sravanthi; Qin, Jun; Penn, Marc S.; Gupta, Sudhiranjan			Significance of Thymosin beta 4 and Implication of PINCH-1-ILK-alpha-Parvin (PIP) Complex in Human Dilated Cardiomyopathy	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; NF-KAPPA-B; CARDIAC-HYPERTROPHY; HEART-FAILURE; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; TARGETED ABLATION; PROTEIN-KINASE	Myocardial remodeling is a major contributor in the development of heart failure (HF) after myocardial infarction (MI). Integrin-linked kinase (ILK), LIM-only adaptor PINCH-1, and alpha-parvin are essential components of focal adhesions (FAs), which are highly expressed in the heart. ILK binds tightly to PINCH-1 and alpha-parvin, which regulates FA assembly and promotes cell survival via the activation of the kinase Akt. Mice lacking ILK, PINCH or alpha-parvin have been shown to develop severe defects in the heart, suggesting that these proteins play a critical role in heart function. Utilizing failing human heart tissues (dilated cardiomyopathy, DCM), we found a 2.27-fold (p < 0.001) enhanced expression of PINCH, 4 fold for alpha-parvin, and 10.5 fold (p < 0.001) for ILK as compared to non-failing (NF) counterparts. No significant enhancements were found for the PINCH isoform PINCH-2 and parvin isoform beta-parvin. Using a co-immunoprecipitation method, we also found that the PINCH-1-ILK-alpha-parvin (PIP) complex and Akt activation were significantly up-regulated. These observations were further corroborated with the mouse myocardial infarction (MI) and transaortic constriction (TAC) model. Thymosin beta4 (T beta 4), an effective cell penetrating peptide for treating MI, was found to further enhance the level of PIP components and Akt activation, while substantially suppressing NF-kappa B activation and collagen expression-the hallmarks of cardiac fibrosis. In the presence of an Akt inhibitor, wortmannin, we show that T beta 4 had a decreased effect in protecting the heart from MI. These data suggest that the PIP complex and activation of Akt play critical roles in HF development. T beta 4 treatment likely improves cardiac function by enhancing PIP mediated Akt activation and suppressing NF-kappa B activation and collagen-mediated fibrosis. These data provide significant insight into the role of the PIP-Akt pathway and its regulation by T beta 4 treatment in post-MI.	[Sopko, Nikolai; Finan, Amanda; Dadabayev, Alisher; Penn, Marc S.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Chigurupati, Sravanthi; Gupta, Sudhiranjan] Texas A&M Hlth Sci Ctr, Coll Med, Cardiovasc Res Inst, Div Cardiol,Dept Internal Med, Temple, TX USA; [Qin, Yilu; Qin, Jun; Gupta, Sudhiranjan] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cleveland Clinic Foundation	Sopko, N (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA.	sgupta@medicine.tamhsc.edu	Sopko, Nikolai/AAL-2036-2020	Sopko, Nikolai/0000-0003-4913-0570; Qin, Jun/0000-0002-2647-9270	American Heart Association [0835227N]; Texas A & M Health Science Center [R8000 R3536]; National Institutes of Health [R01HL58758]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Texas A & M Health Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by American Heart Association (National Scientist Development Grant (0835227N) and a start up fund from Texas A & M Health Science Center, Scott & White RGP Award (R8000 R3536) to Dr. S. Gupta, and National Institutes of Health grant to Dr. J. Qin (R01HL58758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASI M, 2011, EFFECT AMINOGUANIDIN; Ananthakrishnan R, 2005, MOL CELL BIOCHEM, V268, P103, DOI 10.1007/s11010-005-3699-3; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Chen H, 2005, LAB INVEST, V85, P1342, DOI 10.1038/labinvest.3700345; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Eke I, 2010, J CLIN INVEST, V120, P2516, DOI 10.1172/JCI41078; Fujiwara M, 2008, CIRC J, V72, P127, DOI 10.1253/circj.72.127; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Gao J, 2007, J MOL CELL CARDIOL, V43, P601, DOI 10.1016/j.yjmcc.2007.08.009; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Gupta S, 2005, J MOL MED, V83, P993, DOI 10.1007/s00109-005-0691-z; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Haq S, 2001, CIRCULATION, V103, P670; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Hausenloy DJ, 2004, CARDIOVASC RES, V63, P305, DOI 10.1016/j.cardiores.2004.04.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li YW, 2007, AM J PHYSIOL-HEART C, V292, pH946, DOI 10.1152/ajpheart.00361.2006; Liang XQ, 2009, CIRCULATION, V120, P568, DOI 10.1161/CIRCULATIONAHA.109.864686; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Peng X, 2006, J CLIN INVEST, V116, P217, DOI 10.1172/JCI24497; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Ruff D, 2010, ANN NY ACAD SCI, V1194, P223, DOI 10.1111/j.1749-6632.2010.05474.x; Sasaki T, 2007, PEDIATR INT, V49, P966, DOI 10.1111/j.1442-200X.2007.02491.x; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Sosne G, 2005, INVEST OPHTH VIS SCI, V46, P2388, DOI 10.1167/iovs.04-1368; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wu CY, 1999, J CELL SCI, V112, P4485; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Young D, 2008, J MOL BIOL, V381, P559, DOI 10.1016/j.jmb.2008.05.076	48	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20184	10.1371/journal.pone.0020184	http://dx.doi.org/10.1371/journal.pone.0020184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625516	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200052
J	Stemberger, S; Jamnig, A; Stefanova, N; Lepperdinger, G; Reindl, M; Wenning, GK				Stemberger, Sylvia; Jamnig, Angelika; Stefanova, Nadia; Lepperdinger, Guenter; Reindl, Markus; Wenning, Gregor K.			Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; MARROW STROMAL CELLS; ADULT BONE-MARROW; PARKINSONS-DISEASE; STRIATONIGRAL DEGENERATION; MICROGLIAL ACTIVATION; RAT MODEL; TARGETED OVEREXPRESSION; IN-VITRO; TRANSPLANTATION	Background: Mesenchymal stem cells (MSC) are currently strong candidates for cell-based therapies. They are well known for their differentiation potential and immunoregulatory properties and have been proven to be potentially effective in the treatment of a large variety of diseases, including neurodegenerative disorders. Currently there is no treatment that provides consistent long-term benefits for patients with multiple system atrophy (MSA), a fatal late onset alpha-synucleinopathy. Principally neuroprotective or regenerative strategies, including cell-based therapies, represent a powerful approach for treating MSA. In this study we investigated the efficacy of intravenously applied MSCs in terms of behavioural improvement, neuroprotection and modulation of neuroinflammation in the (PLP)-alpha synuclein (alpha SYN) MSA model. Methodology/Principal Findings: MSCs were intravenously applied in aged (PLP)-alpha SYN transgenic mice. Behavioural analyses, defining fine motor coordination and balance capabilities as well as stride length analysis, were performed to measure behavioural outcome. Neuroprotection was assessed by quantifying TH neurons in the substantia nigra pars compacta (SNc). MSC treatment on neuroinflammation was analysed by cytokine measurements (IL-1 alpha, IL-2, IL-4, IL-5, IL-6, IL-10, IL-17, GM-CSF, INF gamma, MCP-1, TGF-beta 1, TNF-alpha) in brain lysates together with immunohistochemistry for T-cells and microglia. Four weeks post MSC treatment we observed neuroprotection in the SNc, as well as downregulation of cytokines involved in neuroinflammation. However, there was no behavioural improvement after MSC application. Conclusions/Significance: To our knowledge this is the first experimental approach of MSC treatment in a transgenic MSA mouse model. Our data suggest that intravenously infused MSCs have a potent effect on immunomodulation and neuroprotection. Our data warrant further studies to elucidate the efficacy of systemically administered MSCs in transgenic MSA models.	[Stemberger, Sylvia; Stefanova, Nadia; Wenning, Gregor K.] Innsbruck Med Univ, Div Clin Neurobiol, Dept Neurol, Innsbruck, Austria; [Stemberger, Sylvia; Stefanova, Nadia; Reindl, Markus; Wenning, Gregor K.] Innsbruck Med Univ, Clin Dept Neurol, Innsbruck, Austria; [Jamnig, Angelika; Lepperdinger, Guenter] Austrian Acad Sci, Inst Biomed Aging Res, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Austrian Academy of Sciences	Stemberger, S (corresponding author), Innsbruck Med Univ, Div Clin Neurobiol, Dept Neurol, Innsbruck, Austria.	sylvia.stemberger@i-med.ac.at	Stefanova, Nadia/ABF-5664-2020; Reindl, Markus/ABE-5880-2020	Stefanova, Nadia/0000-0001-8188-639X; Lepperdinger, Gunter/0000-0002-4265-4489; Reindl, Markus/0000-0003-2817-1402; Wenning, Gregor/0000-0001-9077-1666	Austrian Research Foundation [FWF W1206]	Austrian Research Foundation(Austrian Science Fund (FWF))	This study was supported by the Austrian Research Foundation graduate program SPIN (FWF W1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; Bossolasco P, 2005, EXP NEUROL, V193, P312, DOI 10.1016/j.expneurol.2004.12.013; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Carter RJ, 1999, J NEUROSCI, V19, P3248; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Darlington PJ, 2010, ANN NEUROL, V68, P540, DOI 10.1002/ana.22065; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Ishizawa K, 2004, J NEUROPATH EXP NEUR, V63, P43, DOI 10.1093/jnen/63.1.43; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; Koellensperger M, 2009, J NEUROSCI RES, V87, P1679, DOI 10.1002/jnr.21972; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Lantos PL, 1998, J NEUROPATH EXP NEUR, V57, P1099, DOI 10.1097/00005072-199812000-00001; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Mayhew TM, 1996, J ANAT, V188, P1; Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745; Offen D, 2007, J NEURAL TRANSM-SUPP, P133; Ozawa T, 2006, ACTA NEUROPATHOL, V112, P531, DOI 10.1007/s00401-006-0109-1; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Park HJ, 2011, CELL TRANSPLANT, V20, P827, DOI 10.3727/096368910X540630; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Puschban Z, 2005, BRAIN RES BULL, V68, P54, DOI 10.1016/j.brainresbull.2005.08.025; Puschban Z, 2000, NEUROSCIENCE, V95, P377; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Stefanova N, 2010, MOVEMENT DISORD, V25, pS625; Stefanova N, 2008, EXP NEUROL, V210, P421, DOI 10.1016/j.expneurol.2007.11.022; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Stefanova N, 2009, EXP NEUROL, V219, P368, DOI 10.1016/j.expneurol.2009.05.016; Stemberger S, 2010, EXP NEUROL, V224, P459, DOI 10.1016/j.expneurol.2010.05.008; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; WENNING GK, 1994, BRAIN, V117, P835, DOI 10.1093/brain/117.4.835; Wenning GK, 1996, MOVEMENT DISORD, V11, P522, DOI 10.1002/mds.870110507; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Wenning GK, 2009, J NEUROL, V256, P1791, DOI 10.1007/s00415-009-5173-8; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Zhao H, 2004, CYTOKINE, V28, P1, DOI 10.1016/j.cyto.2004.05.004	58	67	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19808	10.1371/journal.pone.0019808	http://dx.doi.org/10.1371/journal.pone.0019808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625635	gold, Green Submitted, Green Published			2022-12-25	WOS:000290720200034
J	Chou, SW; Hwang, PS; Gomez, G; Fernando, CA; West, MC; Pollock, LM; Lin-Jones, J; Burnside, B; McDermott, BM				Chou, Shih-Wei; Hwang, Philsang; Gomez, Gustavo; Fernando, Carol A.; West, Megan C.; Pollock, Lana M.; Lin-Jones, Jennifer; Burnside, Beth; McDermott, Brian M., Jr.			Fascin 2b Is a Component of Stereocilia that Lengthens Actin-Based Protrusions	PLOS ONE			English	Article							HAIR CELL STEREOCILIA; BUNDLING PROTEIN; MOLECULAR TREADMILL; BIRD COCHLEA; INNER-EAR; IN-VIVO; ESPIN; EXPRESSION; FILAMENTS; BINDING	Stereocilia are actin-filled protrusions that permit mechanotransduction in the internal ear. To identify proteins that organize the cytoskeleton of stereocilia, we scrutinized the hair-cell transcriptome of zebrafish. One promising candidate encodes fascin 2b, a filamentous actin-bundling protein found in retinal photoreceptors. Immunolabeling of zebrafish hair cells and the use of transgenic zebrafish that expressed fascin 2b fused to green fluorescent protein demonstrated that fascin 2b localized to stereocilia specifically. When filamentous actin and recombinant fusion protein containing fascin 2b were combined in vitro to determine their dissociation constant, a K(d)approximate to 0.37 mu M was observed. Electron microscopy showed that fascin 2b-actin filament complexes formed parallel actin bundles in vitro. We demonstrated that expression of fascin 2b or espin, another actin-bundling protein, in COS-7 cells induced the formation of long filopodia. Coexpression showed synergism between these proteins through the formation of extra-long protrusions. Using phosphomutant fascin 2b proteins, which mimicked either a phosphorylated or a nonphosphorylated state, in COS-7 cells and in transgenic hair cells, we showed that both formation of long filopodia and localization of fascin 2b to stereocilia were dependent on serine 38. Overexpression of wild-type fascin 2b in hair cells was correlated with increased stereociliary length relative to controls. These findings indicate that fascin 2b plays a key role in shaping stereocilia.	[Chou, Shih-Wei; Hwang, Philsang; Gomez, Gustavo; Fernando, Carol A.; West, Megan C.; Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA; [Chou, Shih-Wei; Hwang, Philsang; West, Megan C.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Pollock, Lana M.; McDermott, Brian M., Jr.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [McDermott, Brian M., Jr.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Lin-Jones, Jennifer; Burnside, Beth] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of California System; University of California Berkeley	Chou, SW (corresponding author), Case Western Reserve Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Cleveland, OH 44106 USA.	bmm30@case.edu			March of Dimes Foundation [5-FY07-663]; Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health [DC009437, GM-08613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008613, T32GM008056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009437] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Center for Clinical Research and Technology at University Hospitals Case Medical Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by Basil O'Connor Starter Scholar Research Award Grant No. 5-FY07-663 from the March of Dimes Foundation (B. M. M.), the Center for Clinical Research and Technology at University Hospitals Case Medical Center (B. M. M.), and National Institutes of Health Grant DC009437 (B. M. M.). National Institutes of Health (NIH) Training Grant GM-08613 supports L. M. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Belyantseva IA, 2003, TRENDS MOL MED, V9, P458, DOI 10.1016/j.molmed.2003.09.008; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Chen B, 1999, MOL BIOL CELL, V10, P4327, DOI 10.1091/mbc.10.12.4327; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; Daudet N, 2002, CELL MOTIL CYTOSKEL, V53, P326, DOI 10.1002/cm.10092; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Eatock RA, 2003, CURR TOP DEV BIOL, V57, P389, DOI 10.1016/S0070-2153(03)57013-2; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Leong DT, 2007, BIOMATERIALS, V28, P203, DOI 10.1016/j.biomaterials.2006.09.011; Li HW, 2004, J COMP NEUROL, V468, P125, DOI 10.1002/cne.10944; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lin-Jones J, 2007, INVEST OPHTH VIS SCI, V48, P1380, DOI 10.1167/iovs.06-0763; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; McDermott BM, 2007, P NATL ACAD SCI USA, V104, P11820, DOI 10.1073/pnas.0704476104; McDermott BM, 2010, GENE EXPR PATTERNS, V10, P113, DOI 10.1016/j.gep.2010.01.001; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ono S, 1997, J BIOL CHEM, V272, P2527; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Rzadzinska A, 2005, CELL MOTIL CYTOSKEL, V62, P157, DOI 10.1002/cm.20094; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Sambrook J, 2001, MOL CLONING LAB MANU; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Sekerkova G, 2006, CELL MOL LIFE SCI, V63, P2329, DOI 10.1007/s00018-006-6148-x; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOBIN A, 1983, ACTA OTO-LARYNGOL, V96, P407, DOI 10.3109/00016488309132726; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; TILNEY LG, 1992, DEVELOPMENT, V116, P213; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vignjevic D, 2006, METHOD ENZYMOL, V406, P727, DOI 10.1016/S0076-6879(06)06057-5; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8	52	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e14807	10.1371/journal.pone.0014807	http://dx.doi.org/10.1371/journal.pone.0014807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21625653	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400002
J	McKinsey, EL; Parrish, JK; Irwin, AE; Niemeyer, BF; Kern, HB; Birks, DK; Jedlicka, P				McKinsey, E. L.; Parrish, J. K.; Irwin, A. E.; Niemeyer, B. F.; Kern, H. B.; Birks, D. K.; Jedlicka, P.			A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs	ONCOGENE			English	Article						microRNA; oncoprotein; Ewing; sarcoma; IGF	FACTOR-I-RECEPTOR; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; GROWTH; EXPRESSION; TUMOR; GENE; SUPPRESSES; GLIOMA	MicroRNAs (miRs) are a novel class of cellular bioactive molecules with critical functions in the regulation of gene expression in normal biology and disease. MiRs are frequently misexpressed in cancer, with potent biological consequences. However, relatively little is known about miRs in pediatric cancers, including sarcomas. Moreover, the mechanisms behind aberrant miR expression in cancer are poorly understood. Ewing sarcoma is an aggressive pediatric malignancy driven by EWS/Ets fusion oncoproteins, which are gain-of-function transcriptional regulators. We employed stable silencing of EWS/Fli1, the most common of the oncogenic fusions, and global miR profiling to identify EWS/Fli1-regulated miRs with oncogenesis-modifying roles in Ewing sarcoma. In this report, we characterize a group of miRs (100, 125b, 22, 221/222, 27a and 29a) strongly repressed by EWS/Fli1. Strikingly, all of these miRs have predicted targets in the insulin-like growth factor (IGF) signaling pathway, a pivotal driver of Ewing sarcoma oncogenesis. We demonstrate that miRs in this group negatively regulate the expression of multiple pro-oncogenic components of the IGF pathway, namely IGF-1, IGF-1 receptor, mammalian/mechanistic target of rapamycin and ribosomal protein S6 kinase A1. Consistent with tumor-suppressive functions, these miRs manifest growth inhibitory properties in Ewing sarcoma cells. Our studies thus uncover a novel oncogenic mechanism in Ewing sarcoma, involving post-transcriptional derepression of IGF signaling by the EWS/Fli1 fusion oncoprotein via miRs. This novel pathway may be amenable to innovative therapeutic targeting in Ewing sarcoma and other malignancies with activated IGF signaling. Oncogene (2011) 30, 4910-4920; doi:10.1038/onc.2011.197; published online 6 June 2011	[McKinsey, E. L.; Parrish, J. K.; Irwin, A. E.; Niemeyer, B. F.; Kern, H. B.; Jedlicka, P.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [Birks, D. K.] Univ Colorado, Dept Neurosurg, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Jedlicka, P (corresponding author), Univ Colorado, Dept Pathol, Anschutz Med Campus,POB 6511,MS 8104, Aurora, CO 80045 USA.	paul.jedlicka@ucdenver.edu		Niemeyer, Brian/0000-0002-2020-2238; Kern, Hanna/0000-0001-7505-7130	Alex's Lemonade Stand Foundation for Childhood Cancer; Boettcher Foundation; University of Colorado Cancer Center and School of Medicine; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation for Childhood Cancer; Boettcher Foundation; University of Colorado Cancer Center and School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank Steve Lessnick for Ewing sarcoma cell lines; James DeGregori and Yosef Refaeli for lentiviral and retroviral reagents; Lynne Bemis, Dawn Cochrane, Heide Ford, Jennifer Richer and Rajeev Vibhakar for helpful suggestions/discussions. Funding for this work was provided by Alex's Lemonade Stand Foundation for Childhood Cancer, the Boettcher Foundation's Webb-Waring Biomedical Research Program, and the University of Colorado Cancer Center and School of Medicine. These studies were inspired by the memory of Zeljko Nikolic.	Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benini S, 2004, INT J CANCER, V108, P358, DOI 10.1002/ijc.11576; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Huang L, 2011, INT J CANCER, V128, P1758, DOI 10.1002/ijc.25509; Im YH, 2000, CANCER RES, V60, P1536; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Jedlicka P, 2010, INT J CLIN EXP PATHO, V3, P338; Jedlicka P, 2009, AM J PATHOL, V174, P1280, DOI 10.2353/ajpath.2009.080409; Kim SY, 2009, ONCOLOGIST, V14, P83, DOI 10.1634/theoncologist.2008-0189; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li J, 2010, GYNECOL ONCOL, V119, P543, DOI 10.1016/j.ygyno.2010.08.034; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; Martins AS, 2006, CLIN CANCER RES, V12, P3532, DOI 10.1158/1078-0432.CCR-05-1778; Mateo-Lozano S, 2006, CLIN CANCER RES, V12, P6781, DOI 10.1158/1078-0432.CCR-06-0609; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Porter CC, 2008, BLOOD, V112, P4466, DOI 10.1182/blood-2008-03-146571; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Schmidt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003713; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Scotlandi K, 1996, CANCER RES, V56, P4570; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi L, 2010, BRAIN RES, V1312, P120, DOI 10.1016/j.brainres.2009.11.056; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Silvany RE, 2000, ONCOGENE, V19, P4523, DOI 10.1038/sj.onc.1203811; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Ting Y, 2010, BIOCHEM BIOPH RES CO, V394, P606, DOI 10.1016/j.bbrc.2010.03.030; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toretsky JA, 1999, CANCER RES, V59, P5745; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Yang L, 2010, BIOCHEM BIOPH RES CO, V402, P129, DOI 10.1016/j.bbrc.2010.09.129; YEE D, 1990, J CLIN INVEST, V86, P1806, DOI 10.1172/JCI114910; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang CZ, 2009, INT J ONCOL, V34, P1653, DOI 10.3892/ijo_00000296; Zhang J, 2010, BRIT J CANCER, V103, P1215, DOI 10.1038/sj.bjc.6605895; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhou X, 2010, LAB INVEST, V90, P144, DOI 10.1038/labinvest.2009.126	96	67	73	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	49					4910	4920		10.1038/onc.2011.197	http://dx.doi.org/10.1038/onc.2011.197			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21643012	Green Accepted			2022-12-25	WOS:000298346400007
J	Bachmeier, B; Fichtner, I; Killian, PH; Kronski, E; Pfeffer, U; Efferth, T				Bachmeier, Beatrice; Fichtner, Iduna; Killian, Peter H.; Kronski, Emanuel; Pfeffer, Ulrich; Efferth, Thomas			Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; DENSITY-DEPENDENT REGULATION; MATRIX-METALLOPROTEINASE; TUMOR-CELLS; IN-VIVO; TIMP EXPRESSION; POOR-PROGNOSIS; TNF-ALPHA; GENE; ARTEMISININ	Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinically used as anti-malarial agent, has recently revealed remarkable anti-tumor activity offering a role as novel candidate for cancer chemotherapy. We analyzed the anti-tumor effects of artesunate in metastasizing breast carcinoma in vitro and in vivo. Unlike as expected, artesunate induced resistance in highly metastatic human breast cancer cells MDA-MB-231. Likewise acquired resistance led to abolishment of apoptosis and cytotoxicity in pre-treated MDA-MB-231 cells. In contrast, artesunate was more cytotoxic towards the less tumorigenic MDA-MB-468 cells without showing resistance. Unraveling the underlying molecular mechanisms, we found that resistance was induced due to activation of the tumor progression related transcription factors NFkB and AP-1. Thereby transcription, expression and activity of the matrix-degrading enzyme MMP-1, whose function is correlated with increased invasion and metastasis, was up-regulated upon acquisition of resistance. Additionally, activation of the apoptosis-related factor NF kappa B lead to increased expression of ant-apoptotic bcl2 and reduced expression of pro-apoptotic bax. Application of artesunate in vivo in a model of xenografted breast cancer showed, that tumors growth was not efficiently abolished as compared to the control drug doxorubicin. Taken together our in vitro and in vivo results correlate well showing for the first time that artesunate induces resistance in highly metastatic breast tumors.	[Bachmeier, Beatrice; Killian, Peter H.; Kronski, Emanuel] Univ Munich, Dept Clin Chem & Clin Biochem, Munich, Germany; [Bachmeier, Beatrice; Pfeffer, Ulrich] Adv Biotechnol Ctr, Genoa, Italy; [Fichtner, Iduna] Max Delbruck Ctr Mol Med, Dept Expt Pharmacol, Berlin, Germany; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, Mainz, Germany	University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johannes Gutenberg University of Mainz	Bachmeier, B (corresponding author), Univ Munich, Dept Clin Chem & Clin Biochem, Munich, Germany.	efferth@uni-mainz.de	Pfeffer, Ulrich/J-7064-2016	Pfeffer, Ulrich/0000-0003-0872-4671; Efferth, Thomas/0000-0002-3096-3292; Bachmeier, Beatrice/0000-0002-3592-7354				Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Bachmeier BE, 2005, THROMB HAEMOSTASIS, V93, P761, DOI 10.1160/TH04-09-0601; Bachmeier BE, 2005, EXP CELL RES, V305, P83, DOI 10.1016/j.yexcr.2004.12.019; Bachmeier BE, 2000, BIOL CHEM, V381, P509, DOI 10.1515/BC.2000.065; Bachmeier BE, 2007, CELL PHYSIOL BIOCHEM, V19, P137, DOI 10.1159/000099202; Becker M, 2005, MOL CANCER THER, V4, P151; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Berger TG, 2005, ONCOL REP, V14, P1599; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chen H, 2009, ANTI-CANCER DRUG, V20, P131, DOI 10.1097/CAD.0b013e3283212ade; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; DU JH, CANC CHEMOTHER PHARM, V65, P895; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Efferth T, 2005, IN VIVO, V19, P225; Efferth T, 2004, BIOCHEM PHARMACOL, V68, P3, DOI 10.1016/j.bcp.2004.03.003; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; Efferth T, 1996, ARZNEIMITTEL-FORSCH, V46, P196; Efferth T, 2001, INT J ONCOL, V18, P767; El-Deiry Wafik S., 1997, Current Opinion in Oncology, V9, P79; Hernandez-Vargas H, 2007, BREAST CANCER RES TR, V102, P157, DOI 10.1007/s10549-006-9322-9; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Katsman A, 2009, CURR PHARM DESIGN, V15, P792, DOI 10.2174/138161209787582156; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970; Li WD, 2006, INT IMMUNOPHARMACOL, V6, P1243, DOI 10.1016/j.intimp.2006.03.004; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Murray GI, 1998, J PATHOL, V185, P256; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perona R, 2007, CLIN TRANSL ONCOL, V9, P625, DOI 10.1007/s12094-007-0115-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell JS, 2002, CANCER RES, V62, P2318; Sertel S, 2010, CHEM-BIOL INTERACT, V185, P42, DOI 10.1016/j.cbi.2010.02.002; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yang JM, 2003, MOL CANCER RES, V1, P420; ZHANG RD, 1991, INVAS METAST, V11, P204; Zhang Zhu-Yi, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P134	53	63	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20550	10.1371/journal.pone.0020550	http://dx.doi.org/10.1371/journal.pone.0020550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637790	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200078
J	Barrey, E; Saint-Auret, G; Bonnamy, B; Damas, D; Boyer, O; Gidrol, X				Barrey, Eric; Saint-Auret, Gaelle; Bonnamy, Blandine; Damas, Dominique; Boyer, Orane; Gidrol, Xavier			Pre-microRNA and Mature microRNA in Human Mitochondria	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRANSFER-RNA IMPORT; DIFFERENTIAL EXPRESSION; PROTEIN IMPORT; CANCER-CELLS; IDENTIFICATION; TARGETS; PROLIFERATION; TRANSCRIPTION; CARCINOMA	Background: Because of the central functions of the mitochondria in providing metabolic energy and initiating apoptosis on one hand and the role that microRNA (miRNA) play in gene expression, we hypothesized that some miRNA could be present in the mitochondria for post-transcriptomic regulation by RNA interference. We intend to identify miRNA localized in the mitochondria isolated from human skeletal primary muscular cells. Methodology/Principal Findings: To investigate the potential origin of mitochondrial miRNA, we in-silico searched for microRNA candidates in the mtDNA. Twenty five human pre-miRNA and 33 miRNA aligments (E-value<0.1) were found in the reference mitochondrial sequence and some of the best candidates were chosen for a co-localization test. In situ hybridization of pre-mir-302a, pre-let-7b and mir-365, using specific labelled locked nucleic acids and confocal microscopy, demonstrated that these miRNA were localized in mitochondria of human myoblasts. Total RNA was extracted from enriched mitochondria isolated by an immunomagnetic method from a culture of human myotubes. The detection of 742 human miRNA (miRBase) were monitored by RT-qPCR at three increasing mtRNA inputs. Forty six miRNA were significantly expressed (2(nd) derivative method Cp>35) for the smallest RNA input concentration and 204 miRNA for the maximum RNA input concentration. In silico analysis predicted 80 putative miRNA target sites in the mitochondrial genome (E-value<0.05). Conclusions/Significance: The present study experimentally demonstrated for the first time the presence of pre-miRNA and miRNA in the human mitochondria isolated from skeletal muscular cells. A set of miRNA were significantly detected in mitochondria fraction. The origin of these pre-miRNA and miRNA should be further investigate to determine if they are imported from the cytosol and/or if they are partially processed in the mitochondria.	[Barrey, Eric; Bonnamy, Blandine; Damas, Dominique; Boyer, Orane] INSERM, U902, Unite Biol Integrat Adaptat Exercice, Genopole Evry, France; [Barrey, Eric; Saint-Auret, Gaelle; Gidrol, Xavier] CEA, Direct Sci Vivant, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA	Barrey, E (corresponding author), INSERM, U902, Unite Biol Integrat Adaptat Exercice, Genopole Evry, France.	eric.barrey@inserm.fr; xavier.gidrol@cea.fr		Gidrol, Xavier/0000-0002-4233-3749	Genopole d'Evry (ATIGE); "Institut National de la Sante et de la Recherche Medicale" (INSERM); "Commissariat a l'Energie Atomique" (CEA); "Institut de la Recherche Agronomique" (INRA)	Genopole d'Evry (ATIGE); "Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Commissariat a l'Energie Atomique" (CEA)(French Atomic Energy Commission); "Institut de la Recherche Agronomique" (INRA)	This study was supported jointly by the Genopole d'Evry (ATIGE), the "Institut National de la Sante et de la Recherche Medicale" (INSERM), "Commissariat a l'Energie Atomique" (CEA) and the "Institut de la Recherche Agronomique" (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Aude-Garcia C, 2010, BIOCHEM J, V430, P237, DOI 10.1042/BJ20100131; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Cannino G, 2004, NEUROSCIENCE, V128, P91, DOI 10.1016/j.neuroscience.2004.06.018; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen H, 2010, SCI CHINA LIFE SCI, V53, P101, DOI 10.1007/s11427-010-0002-y; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chinnery PF, 1999, J MED GENET, V36, P425; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P70, DOI 10.1016/j.bbrc.2010.09.115; Mokranjac Dejana, 2007, Methods Mol Biol, V372, P277, DOI 10.1007/978-1-59745-365-3_20; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; SHARP MGF, 1992, J PATHOL, V168, P163, DOI 10.1002/path.1711680203; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Tetzlaff MT, 2007, ENDOCR PATHOL, V18, P163, DOI 10.1007/s12022-007-0023-7; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666	54	196	209	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20220	10.1371/journal.pone.0020220	http://dx.doi.org/10.1371/journal.pone.0020220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637849	Green Published, gold			2022-12-25	WOS:000291052200040
J	Liang, CW; Zhang, XW; Chi, XY; Guan, XY; Li, YX; Qin, S; Shao, HB				Liang, Chengwei; Zhang, Xiaowen; Chi, Xiaoyuan; Guan, Xiangyu; Li, Youxun; Qin, Song; Shao, Hong Bo			Serine/Threonine Protein Kinase SpkG Is a Candidate for High Salt Resistance in the Unicellular Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP PCC-6803; SIGNAL-TRANSDUCTION; GENES; STRESS; EXPRESSION; BACTERIA; COMPETENCE; PERCEPTION; SYSTEMS; XANTHUS	Background: Seven serine/threonine kinase genes have been predicted in unicellular cyanobacterium Synechocystis sp. PCC6803. SpkA and SpkB were shown to be required for cell motility and SpkE has no kinase activity. There is no report whether the other four STKs are involved in stress-mediated signaling in Synechocystis PCC6803. Methodology/Principal Findings: In this paper, we examined differential expression of the other four serine/threonine kinases, SpkC, SpkD, SpkF and SpkG, at seven different stress conditions. The transcriptional level was up-regulated of spkG and down-regulated of spkC under high salt stress condition. Two spk deletion mutants, Delta spkC and Delta spkG, were constructed and their growth characteristic were examined compared to the wild strain. The wild strain and Delta spkC mutant were not affected under high salt stress conditions. In contrast, growth of spkG mutant was completely impaired. To further confirm the function of spkG, we also examined the effect of mutation of spkG on the expression of salt stress-inducible genes. We compared genome-wide patterns of transcription between wild-type Synechocystis sp. PCC6803 and cells with a mutation in the SpkG with DNA microarray analysis. Conclusion: In this study, we first study the spkG gene as sensor of high salt signal. We consider that SpkG play essential roles in Synechocystis sp. for sensing the high salt signal directly, rather than mediating signals among other kinases. Our microarray experiment may help select relatively significant genes for further research on mechanisms of signal transduction of Synechocystis sp. PCC6803 under high salt stress.	[Liang, Chengwei] Qingdao Univ Sci & Technol, Qingdao, Peoples R China; [Liang, Chengwei; Zhang, Xiaowen; Chi, Xiaoyuan; Li, Youxun; Qin, Song] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Zhang, Xiaowen] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Guan, Xiangyu] Ocean Univ China, Qingdao, Peoples R China; [Shao, Hong Bo] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China	Qingdao University of Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ocean University of China; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Liang, CW (corresponding author), Qingdao Univ Sci & Technol, Qingdao, Peoples R China.	sqin@yic.ac.cn			Chinese Academy of Sciences [KZCX2-YW-209]; National Natural Science Foundation of China [40876082, 31000135]; International Innovation Partnership Program; Open Foundation of Chemical Engineering Subject, Qingdao University of Science and Technology	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Innovation Partnership Program; Open Foundation of Chemical Engineering Subject, Qingdao University of Science and Technology	This work is supported by the Key Innovative Project of Chinese Academy of Sciences (KZCX2-YW-209), National Natural Science Foundation of China (40876082 and 31000135), International Innovation Partnership Program, "Typical environmental process and effects on resources," and Open Foundation of Chemical Engineering Subject, Qingdao University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Hagemann M, 2011, FEMS MICROBIOL REV, V35, P87, DOI 10.1111/j.1574-6976.2010.00234.x; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; Kamei A, 2003, CURR MICROBIOL, V46, P296, DOI 10.1007/s00284-002-3887-2; Kamei A, 2002, DNA RES, V9, P71, DOI 10.1093/dnares/9.3.71; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Kim D, 2001, MICROBIOL-SGM, V147, P1197, DOI 10.1099/00221287-147-5-1197; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; MANN NH, 1994, MICROBIOL-SGM, V140, P3207, DOI 10.1099/13500872-140-12-3207; Marin K, 2003, P NATL ACAD SCI USA, V100, P9061, DOI 10.1073/pnas.1532302100; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nadvornik R, 1999, J BACTERIOL, V181, P15; Nariya H, 2005, MOL MICROBIOL, V56, P1314, DOI 10.1111/j.1365-2958.2005.04619.x; Neu JM, 2002, MOL MICROBIOL, V44, P417, DOI 10.1046/j.1365-2958.2002.02879.x; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Pandhal Jagroop, 2009, Saline Syst, V5, P8, DOI 10.1186/1746-1448-5-8; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Shao HB, 2008, BIOESSAYS, V30, P634, DOI 10.1002/bies.20770; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; WYLIE JL, 1995, J BACTERIOL, V177, P3021, DOI 10.1128/jb.177.11.3021-3026.1995; Zhang XW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-395	31	28	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e18718	10.1371/journal.pone.0018718	http://dx.doi.org/10.1371/journal.pone.0018718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637338	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200008
J	Niehage, C; Steenblock, C; Pursche, T; Bornhauser, M; Corbeil, D; Hoflack, B				Niehage, Christian; Steenblock, Charlotte; Pursche, Theresia; Bornhaeuser, Martin; Corbeil, Denis; Hoflack, Bernard			The Cell Surface Proteome of Human Mesenchymal Stromal Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTEINS; EMBRYONIC STEM-CELLS; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; MONOLAYER CULTURES; PROGENITOR-CELL; DENDRITIC CELLS; RECEPTOR CD97; LIGAND CD55	Background: Multipotent human mesenchymal stromal cells (hMSCs) are considered as promising biological tools for regenerative medicine. Their antibody-based isolation relies on the identification of reliable cell surface markers. Methodology/Principal Findings: To obtain a comprehensive view of the cell surface proteome of bone marrow-derived hMSCs, we have developed an analytical pipeline relying on cell surface biotinylation of intact cells using cell impermeable, cleavable sulfo-NHS-SS-biotin to enrich the plasma membrane proteins and mass spectrometry for identification with extremely high confidence. Among the 888 proteins identified, we found approximate to 200 bona fide plasma membrane proteins including 33 cell adhesion molecules and 26 signaling receptors. In total 41 CD markers including 5 novel ones (CD97, CD112, CD239, CD276, and CD316) were identified. The CD markers are distributed homogenously within plastic-adherent hMSC populations and their expression is modulated during the process of adipogenesis or osteogenesis. Moreover, our in silico analysis revealed a significant difference between the cell surface proteome of hMSCs and that of human embryonic stem cells reported previously. Conclusions/Significance: Collectively, our analytical methods not only provide a basis for further studies of mechanisms maintaining the multipotency of hMSCs within their niches and triggering their differentiation after signaling, but also a toolbox for a refined antibody-based identification of hMSC populations from different tissues and their isolation for therapeutic intervention.	[Niehage, Christian; Steenblock, Charlotte; Pursche, Theresia; Corbeil, Denis; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany; [Bornhaeuser, Martin] Univ Hosp Dresden, Dept Hematol & Oncol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Niehage, C (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	Corbeil, Denis/AFL-1008-2022; Steenblock, Charlotte/C-9038-2018; Corbeil, Denis/L-2340-2019; HOFLACK, Bernard/AAZ-6668-2020; Corbeil, Denis/A-6519-2010	Corbeil, Denis/0000-0003-1181-3659; Steenblock, Charlotte/0000-0002-9635-4860	Deutsche Forschungsgemeinschaft [TRR 83, SFB655 B2, SFB655 B3, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1]; Bundesministerium fur Bildung und Forschung [0313815B]; Dresden University of Technology [HWP-1207]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Dresden University of Technology	This work was supported in part by grants from Deutsche Forschungsgemeinschaft (TRR 83)(BH), SFB655 B2 (MB), SFB655 B3 (DC), HO 2584/2-1 (BH), HO 2584/1-1 (BH), HO 2584/6-1 (BH), HO 2584/8-1 (BH), Bundesministerium fur Bildung und Forschung (0313815B, BH) and Dresden University of Technology (HWP-1207, BH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Crop M, 2009, TRANSPL INT, V22, P365, DOI 10.1111/j.1432-2277.2008.00786.x; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Freund D, 2010, CYTOTHERAPY, V12, P131, DOI 10.3109/14653240903476438; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gregory C. A., 2005, SCI STKE, ppe37; Gu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015795; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002; Kettner S, 2007, MOL CELL BIOL, V27, P7718, DOI 10.1128/MCB.00180-07; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee HJ, 2009, ARTHRITIS RHEUM-US, V60, P2325, DOI 10.1002/art.24786; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Liu F, 2008, J BONE MINER METAB, V26, P312, DOI 10.1007/s00774-007-0842-0; Liu Y, 2005, ONCOL REP, V14, P1413; LURIA EA, 1971, TRANSFUSION, V11, P345, DOI 10.1111/j.1537-2995.1971.tb04426.x; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Pal R, 2009, J TISSUE ENG REGEN M, V3, P163, DOI 10.1002/term.143; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pozzobon M, 2009, STEM CELLS DEV, V18, P497, DOI 10.1089/scd.2008.0003; Qiu HB, 2008, J PROTEOME RES, V7, P1904, DOI 10.1021/pr700651b; Rabilloud T, 2009, ELECTROPHORESIS, V30, pS174, DOI 10.1002/elps.200900050; Roche S, 2009, PROTEOMICS, V9, P223, DOI 10.1002/pmic.200800035; Salasznyk RM, 2005, STEM CELLS DEV, V14, P354, DOI 10.1089/scd.2005.14.354; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Santos TM, 2010, TRANSPL P, V42, P563, DOI 10.1016/j.transproceed.2010.01.032; Schindler J, 2006, J NEURAL TRANSM, V113, P995, DOI 10.1007/s00702-006-0508-4; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; van Pel M, 2008, HAEMATOL-HEMATOL J, V93, P1137, DOI 10.3324/haematol.12838; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wang ZY, 2004, BLOOD, V103, P100, DOI 10.1182/blood-2003-04-1063; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128; Zhang AX, 2007, MOL CELL BIOCHEM, V304, P167, DOI 10.1007/s11010-007-9497-3; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	56	77	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20399	10.1371/journal.pone.0020399	http://dx.doi.org/10.1371/journal.pone.0020399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637820	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200060
J	Stepanow, S; Reichwald, K; Huse, K; Gausmann, U; Nebel, A; Rosenstiel, P; Wabitsch, M; Fischer-Posovszky, P; Platzer, M				Stepanow, Stefanie; Reichwald, Kathrin; Huse, Klaus; Gausmann, Ulrike; Nebel, Almut; Rosenstiel, Philip; Wabitsch, Martin; Fischer-Posovszky, Pamela; Platzer, Matthias			Allele-Specific, Age-Dependent and BMI-Associated DNA Methylation of Human MCHR1	PLOS ONE			English	Article							CPG ISLANDS; GENE-EXPRESSION; SEQUENCE; GENOTYPE; EPIGENETICS; STRATEGIES; OBESITY; GENOME	Background: Melanin-concentrating hormone receptor 1 (MCHR1) plays a significant role in regulation of energy balance, food intake, physical activity and body weight in humans and rodents. Several association studies for human obesity showed contrary results concerning the SNPs rs133072 (G/A) and rs133073 (T/C), which localize to the first exon of MCHR1. The variations constitute two main haplotypes (GT, AC). Both SNPs affect CpG dinucleotides, whereby each haplotype contains a potential methylation site at one of the two SNP positions. In addition, 15 CpGs in close vicinity of these SNPs constitute a weak CpG island. Here, we studied whether DNA methylation in this sequence context may contribute to population-and age-specific effects of MCHR1 alleles in obesity. Principal Findings: We analyzed DNA methylation of a 315 bp region of MCHR1 encompassing rs133072 and rs133073 and the CpG island in blood samples of 49 individuals by bisulfite sequencing. The AC haplotype shows a significantly higher methylation level than the GT haplotype. This allele-specific methylation is age-dependent. In young individuals (20-30 years) the difference in DNA methylation between haplotypes is significant; whereas in individuals older than 60 years it is not detectable. Interestingly, the GT allele shows a decrease in methylation status with increasing BMI, whereas the methylation of the AC allele is not associated with this phenotype. Heterozygous lymphoblastoid cell lines show the same pattern of allele-specific DNA methylation. The cell line, which exhibits the highest difference in methylation levels between both haplotypes, also shows allele-specific transcription of MCHR1, which can be abolished by treatment with the DNA methylase inhibitor 5-aza-2'-deoxycytidine. Conclusions: We show that DNA methylation at MCHR1 is allele-specific, age-dependent, BMI-associated and affects transcription. Conceivably, this epigenetic regulation contributes to the age-and/or population specific effects reported for MCHR1 in several human obesity studies.	[Stepanow, Stefanie; Reichwald, Kathrin; Huse, Klaus; Gausmann, Ulrike; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Nebel, Almut; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Wabitsch, Martin; Fischer-Posovszky, Pamela] Univ Ulm, Dept Pediat & Adolescent Med, Ulm, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Kiel; Ulm University	Stepanow, S (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.	stepanow@fli-leibniz.de	Gausmann, Ulrike/H-2595-2012; Rosenstiel, Philip/A-5137-2009; Nebel, Almut/E-4196-2010	Gausmann, Ulrike/0000-0002-2147-960X; Rosenstiel, Philip/0000-0002-9692-8828; Fischer-Posovszky, Pamela/0000-0003-3402-9840; Huse, Klaus/0000-0003-3854-1884	Leibniz Graduate School for Aging and Age-Related Diseases - LGSA	Leibniz Graduate School for Aging and Age-Related Diseases - LGSA	Funding was provided by the Leibniz Graduate School for Aging and Age-Related Diseases - LGSA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2003, ENDOCRINOLOGY, V144, P3943, DOI 10.1210/en.2003-0149; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell CG, 2005, DIABETES, V54, P3049, DOI 10.2337/diabetes.54.10.3049; Bennett-Baker PE, 2003, GENETICS, V165, P2055; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Bradley RL, 2000, DIABETES, V49, P1073, DOI 10.2337/diabetes.49.7.1073; Bradley RL, 2002, AM J PHYSIOL-ENDOC M, V283, pE584, DOI 10.1152/ajpendo.00161.2002; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gibson WT, 2004, OBES RES, V12, P743, DOI 10.1038/oby.2004.89; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gravina S, 2010, PFLUG ARCH EUR J PHY, V459, P247, DOI 10.1007/s00424-009-0730-7; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Luthin DR, 2007, LIFE SCI, V81, P423, DOI 10.1016/j.lfs.2007.05.029; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rutanen J, 2007, OBESITY, V15, P2902, DOI 10.1038/oby.2007.345; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Takai Daiya, 2003, In Silico Biology, V3, P235; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wermter AK, 2005, EUR J ENDOCRINOL, V152, P851, DOI 10.1530/eje.1.01917; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zakharova IS, 2009, CHROMOSOMA, V118, P279, DOI 10.1007/s00412-009-0206-8; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	57	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e17711	10.1371/journal.pone.0017711	http://dx.doi.org/10.1371/journal.pone.0017711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637341	Green Published, gold			2022-12-25	WOS:000291052200004
J	Zheng, XD; Guo, JB; Xu, LP; Li, HL; Zhang, DW; Zhang, K; Sun, F; Wen, TY; Liu, SG; Pang, H				Zheng, Xiangdong; Guo, Jiubiao; Xu, Lipeng; Li, Honglei; Zhang, Dongwei; Zhang, Kai; Sun, Fei; Wen, Tingyi; Liu, Siguo; Pang, Hai			Crystal Structure of a Novel Esterase Rv0045c from Mycobacterium tuberculosis	PLOS ONE			English	Article							AUTOMATED STRUCTURE SOLUTION; ALPHA/BETA-HYDROLASE FOLD; DENSITY MODIFICATION; GENOME SEQUENCE; PROTEINS; DATABASE; DOCKING; ENZYME; FAMILY; SERVER	There are at least 250 enzymes in Mycobacterium tuberculosis (M. tuberculosis) involved in lipid metabolism. Some of the enzymes are required for bacterial survival and full virulence. The esterase Rv0045c shares little amino acid sequence similarity with other members of the esterase/lipase family. Here, we report the 3D structure of Rv0045c. Our studies demonstrated that Rv0045c is a novel member of alpha/beta hydrolase fold family. The structure of esterase Rv0045c contains two distinct domains: the alpha/beta fold domain and the cap domain. The active site of esterase Rv0045c is highly conserved and comprised of two residues: Ser154 and His309. We proposed that Rv0045c probably employs two kinds of enzymatic mechanisms when hydrolyzing C-O ester bonds within substrates. The structure provides insight into the hydrolysis mechanism of the C-O ester bond, and will be helpful in understanding the ester/lipid metabolism in M. tuberculosis.	[Zheng, Xiangdong; Guo, Jiubiao; Xu, Lipeng; Li, Honglei; Pang, Hai] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Zheng, Xiangdong; Guo, Jiubiao; Liu, Siguo] Chinese Acad Agr, Harbin Vet Res Inst, Harbin, Peoples R China; [Zhang, Dongwei] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Zhang, Kai; Sun, Fei] Chinese Acad Sci, Inst Biophys, Beijing 100080, Peoples R China; [Wen, Tingyi] Chinese Acad Sci, Inst Microbiol, Dept Ind Microbiol & Biotechnol, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of British Columbia; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zheng, XD (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	siguo_liu@yahoo.com.cn; pangh@xtal.tsinghua.edu.cn	Zhang, Dongwei/AAS-8384-2020; Sun, Fei/C-4190-2015; Wen, Tingyi/M-6095-2014; Zheng, Xiangdong/AAL-4774-2021	Zhang, Dongwei/0000-0002-7793-1482; Sun, Fei/0000-0002-0351-5144; Wen, Tingyi/0000-0003-2583-7088; Guo, Jiubiao/0000-0003-2716-1712; Zhang, Kai/0000-0001-8617-2855	Foundation of State Key Laboratory of Veterinary Biotechnology [SKLVBF2009]; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program [2008ZX09401-05]; National Natural Science Foundation of China [30770439]; Major State Basic Research Development Program of China [2006CB504400]; Tsinghua-Yue-Yuen Medical Sciences Fund [20240000551]	Foundation of State Key Laboratory of Veterinary Biotechnology; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Tsinghua-Yue-Yuen Medical Sciences Fund	This work was financially supported by the Foundation of State Key Laboratory of Veterinary Biotechnology (SKLVBF2009), Harbin Veterinary Research Institute (HVRI), the National Drug Discovery Program (Grant 2008ZX09401-05), the National Natural Science Foundation of China (No. 30770439), the 973 Project of the Major State Basic Research Development Program of China (No. 2006CB504400) and the Tsinghua-Yue-Yuen Medical Sciences Fund (20240000551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin X, 1998, NUCLEIC ACIDS RES, V26, P226, DOI 10.1093/nar/26.1.226; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; Habe H, 2003, BIOCHEM BIOPH RES CO, V303, P631, DOI 10.1016/S0006-291X(03)00375-9; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hubbard TJP, 1998, ACTA CRYSTALLOGR D, V54, P1147, DOI 10.1107/S0907444998009172; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; McCulloch KM, 2010, BIOCHEMISTRY-US, V49, P1226, DOI 10.1021/bi901812p; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MURRAY PR, 2005, MED MICROBIOLOGY; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nardini M, 1999, J BIOL CHEM, V274, P14579, DOI 10.1074/jbc.274.21.14579; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Orengo CA, 1998, ACTA CRYSTALLOGR D, V54, P1155, DOI 10.1107/S0907444998007501; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Ryan KJ., 2004, SHERRIS MED MICROBIO; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041	28	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20506	10.1371/journal.pone.0020506	http://dx.doi.org/10.1371/journal.pone.0020506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637775	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200072
J	Chen, CC; Fernald, RD				Chen, Chun-Chun; Fernald, Russell D.			Visual Information Alone Changes Behavior and Physiology during Social Interactions in a Cichlid Fish (Astatotilapia burtoni)	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; BRAIN SEROTONERGIC ACTIVITY; STRESS COPING STRATEGIES; CHARR SALVELINUS-ALPINUS; JUVENILE RAINBOW-TROUT; MESSENGER-RNA; HAPLOCHROMIS-BURTONI; XIPHOPHORUS-HELLERI; ANOLIS-CAROLINENSIS; AGGRESSIVE-BEHAVIOR	Social behavior can influence physiological systems dramatically yet the sensory cues responsible are not well understood. Behavior of male African cichlid fish, Astatotilapia burtoni, in their natural habitat suggests that visual cues from conspecifics contribute significantly to regulation of social behavior. Using a novel paradigm, we asked whether visual cues alone from a larger conspecific male could influence behavior, reproductive physiology and the physiological stress response of a smaller male. Here we show that just seeing a larger, threatening male through a clear barrier can suppress dominant behavior of a smaller male for up to 7 days. Smaller dominant males being "attacked'' visually by larger dominant males through a clear barrier also showed physiological changes for up to 3 days, including up-regulation of reproductive-and stress-related gene expression levels and lowered plasma 11-ketotestesterone concentrations as compared to control animals. The smaller males modified their appearance to match that of non-dominant males when exposed to a larger male but they maintained a physiological phenotype similar to that of a dominant male. After 7 days, reproductive-and stress-related gene expression, circulating hormone levels, and gonad size in the smaller males showed no difference from the control group suggesting that the smaller male habituated to the visual intruder. However, the smaller male continued to display subordinate behaviors and assumed the appearance of a subordinate male for a full week despite his dominant male physiology. These data suggest that seeing a larger male alone can regulate the behavior of a smaller male but that ongoing reproductive inhibition depends on additional sensory cues. Perhaps, while experiencing visual social stressors, the smaller male uses an opportunistic strategy, acting like a subordinate male while maintaining the physiology of a dominant male.	[Chen, Chun-Chun; Fernald, Russell D.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Fernald, Russell D.] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Chen, CC (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27706 USA.	chunchun.cc@gmail.com			National Institute of Neurological Disorder and Stroke [NS34950]; Lucille P. Markey Biomedical Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034950, R56NS034950, R01NS034950] Funding Source: NIH RePORTER	National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lucille P. Markey Biomedical Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Neurological Disorder and Stroke (NS34950) to RDF and Lucille P. Markey Biomedical Research Fellowship to CCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday DD, 2003, J FISH BIOL, V62, P486, DOI 10.1046/j.1095-8649.2003.00033.x; Albeck DS, 1997, J NEUROSCI, V17, P4895; ALBONETTI ME, 1994, BEHAV BRAIN RES, V62, P187, DOI 10.1016/0166-4328(94)90027-2; Au TM, 2006, BEHAV BRAIN RES, V170, P342, DOI 10.1016/j.bbr.2006.02.027; Bale TL, 2005, HORM BEHAV, V48, P1, DOI 10.1016/j.yhbeh.2005.01.009; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bass AH, 2001, BRAIN BEHAV EVOLUT, V57, P293, DOI 10.1159/000047247; Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016; BLANCHARD DC, 2002, HORMONES BRAIN BEHAV, V1, P735; BUTLER PD, 1990, J NEUROSCI, V10, P176; Chen CC, 2008, GEN COMP ENDOCR, V157, P148, DOI 10.1016/j.ygcen.2008.04.003; Clement TS, 2005, HORM BEHAV, V47, P336, DOI 10.1016/j.yhbeh.2004.11.014; Consten D, 2001, BIOL REPROD, V64, P1063, DOI 10.1095/biolreprod64.4.1063; Cruz EMV, 2007, HORM BEHAV, V51, P611, DOI 10.1016/j.yhbeh.2007.02.010; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; Doyon C, 2005, J ENDOCRINOL, V186, P123, DOI 10.1677/joe.1.06142; Dzieweczynski TL, 2006, GEN COMP ENDOCR, V147, P184, DOI 10.1016/j.ygcen.2005.12.023; Earley RL, 2003, NATURWISSENSCHAFTEN, V90, P226, DOI 10.1007/s00114-003-0415-6; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; FERNALD R D, 1977, Environmental Biology of Fishes, V2, P299, DOI 10.1007/BF00005997; Fernald RD, 2002, NOVART FDN SYMP, V244, P169; FERNALD RD, 1985, VISION RES, V25, P155, DOI 10.1016/0042-6989(85)90108-7; Flik G, 2006, GEN COMP ENDOCR, V146, P36, DOI 10.1016/j.ygcen.2005.11.005; Fox HE, 1997, J NEUROSCI, V17, P6463; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P7794, DOI 10.1073/pnas.90.16.7794; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; Godwin J, 2000, BRAIN BEHAV EVOLUT, V55, P77, DOI 10.1159/000006643; Goncalves D, 2007, HORM BEHAV, V51, P534, DOI 10.1016/j.yhbeh.2007.02.003; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Hofmann HA, 1999, P NATL ACAD SCI USA, V96, P14171, DOI 10.1073/pnas.96.24.14171; Hofmann HA, 2000, J NEUROSCI, V20, P4740, DOI 10.1523/JNEUROSCI.20-12-04740.2000; Hoglund E, 2002, J EXP BIOL, V205, P2535; Hoglund E, 2001, PHYSIOL BEHAV, V74, P381, DOI 10.1016/S0031-9384(01)00571-6; Huising M, 2004, J MOL ENDOCRINOL, V32, P627, DOI 10.1677/jme.0.0320627; KINDLER PM, 1991, HORM BEHAV, V25, P410, DOI 10.1016/0018-506X(91)90011-6; Korzan WJ, 2007, BRAIN BEHAV EVOLUT, V70, P257, DOI 10.1159/000105489; Korzan WJ, 2007, BEHAV BRAIN RES, V183, P31, DOI 10.1016/j.bbr.2007.05.021; Korzan WJ, 2000, BRAIN RES, V870, P170, DOI 10.1016/S0006-8993(00)02420-3; Korzan WJ, 2000, HORM BEHAV, V38, P193, DOI 10.1006/hbeh.2000.1619; Lowry CA, 2006, GEN COMP ENDOCR, V146, P19, DOI 10.1016/j.ygcen.2005.12.006; Maruska KP, 2010, HORM BEHAV, V58, P230, DOI 10.1016/j.yhbeh.2010.03.011; Meerlo P, 1997, PSYCHONEUROENDOCRINO, V22, P155, DOI 10.1016/S0306-4530(96)00047-9; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Oliveira RF, 2001, HORM BEHAV, V39, P157, DOI 10.1006/hbeh.2001.1643; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366; Overli O, 2002, HORM BEHAV, V42, P53, DOI 10.1006/hbeh.2002.1796; Parikh VN, 2006, J ENDOCRINOL, V190, P183, DOI 10.1677/joe.1.06755; Parikh VN, 2006, BEHAV BRAIN RES, V166, P291, DOI 10.1016/j.bbr.2005.07.011; Remage-Healey L, 2006, HORM BEHAV, V50, P432, DOI 10.1016/j.yhbeh.2006.05.007; Rosenthal GG, 2000, J BIOSCIENCES, V25, P285, DOI 10.1007/BF02703937; Schiml PA, 2000, HORM BEHAV, V37, P212, DOI 10.1006/hbeh.2000.1575; Schjolden J, 2005, PHYSIOL BIOCHEM ZOOL, V78, P715, DOI 10.1086/432153; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; Semsar K, 2003, J NEUROSCI, V23, P4386; Semsar K, 2001, HORM BEHAV, V40, P21, DOI 10.1006/hbeh.2001.1663; SUMMERS CH, 1994, HORM BEHAV, V28, P29, DOI 10.1006/hbeh.1994.1003; Summers CH, 2005, J COMP PHYSIOL A, V191, P241, DOI 10.1007/s00359-004-0554-z; Thompson RR, 2004, HORM BEHAV, V46, P646, DOI 10.1016/j.yhbeh.2004.06.008; Thompson RR, 2004, BEHAV NEUROSCI, V118, P620, DOI 10.1037/0735-7044.118.3.620; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Volpato GL, 2003, BRAZ J MED BIOL RES, V36, P1659, DOI 10.1590/S0100-879X2003001200007; WHITE SA, 1993, J NEUROSCI, V13, P434; White SA, 2002, J EXP BIOL, V205, P2567; WHITE SA, 1995, P NATL ACAD SCI USA, V92, P8363, DOI 10.1073/pnas.92.18.8363; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	68	37	39	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20313	10.1371/journal.pone.0020313	http://dx.doi.org/10.1371/journal.pone.0020313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633515	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500054
J	Montero-Pau, J; Serra, M				Montero-Pau, Javier; Serra, Manuel			Life-Cycle Switching and Coexistence of Species with No Niche Differentiation	PLOS ONE			English	Article							SEXUAL REPRODUCTION; INDUCTION; ALLOCATION; DIAPAUSE; SIMILARITY; DIVERGENCE; ROTIFERS; COMPLEX; GROWTH	The increasing evidence of coexistence of cryptic species with no recognized niche differentiation has called attention to mechanisms reducing competition that are not based on niche-differentiation. Only sex-based mechanisms have been shown to create the negative feedback needed for stable coexistence of competitors with completely overlapping niches. Here we show that density-dependent sexual and diapause investment can mediate coexistence of facultative sexual species having identical niches. We modelled the dynamics of two competing cyclical parthenogens with species-specific density-dependent sexual and diapause investment and either equal or different competitive abilities. We show that investment in sexual reproduction creates an opportunity for other species to invade and become established. This may happen even if the invading species is an inferior competitor. Our results suggests a previously unnoticed mechanism for species coexistence and can be extended to other facultative sexual species and species investing in diapause where similar density-dependent life-history switches could act to promote coexistence.	[Montero-Pau, Javier; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat Biol Evolutiva, Valencia, Spain	University of Valencia	Montero-Pau, J (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat Biol Evolutiva, Valencia, Spain.	javier.montero@uv.es	Montero-Pau, Javier/H-6711-2015; Serra, Manuel/H-7817-2015	Montero-Pau, Javier/0000-0002-0864-8157; Serra, Manuel/0000-0003-1731-1529	USA National Science Foundation [EF-0412674]; Spanish Ministerio de Ciencia e Innovacion [CGL2009-07364]; Spanish Ministerio de Ciencia y Tecnologia [BES2004-5248]	USA National Science Foundation(National Science Foundation (NSF)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the USA National Science Foundation (EF-0412674) (http://www.nsf.gov), the Spanish Ministerio de Ciencia e Innovacion (CGL2009-07364) (http://www.micinn.es), and by a fellowship to JMP by the Spanish Ministerio de Ciencia y Tecnologia (BES2004-5248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAN S, 1994, HYDROBIOLOGIA, V293, P185, DOI 10.1007/BF00229940; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Ciros-Perez J, 2002, OECOLOGIA, V131, P35, DOI 10.1007/s00442-001-0856-6; Coelho FF, 2005, REV BIOL TROP, V53, P369; DEMEESTER L, 2004, EVOLUTION MOL ECOSYS; Garcia-Roger EM, 2009, LIMNOL OCEANOGR, V54, P1845, DOI 10.4319/lo.2009.54.6.1845; Gomez A, 2002, EVOLUTION, V56, P1431; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Kubanek J, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P453; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Roff Derek A., 1992; Schroder T, 2005, HYDROBIOLOGIA, V546, P291, DOI 10.1007/s10750-005-4235-x; Serra M, 1999, J EVOLUTION BIOL, V12, P263; Serra M, 2005, J PLANKTON RES, V27, P37, DOI 10.1093/plankt/fbh148; Serra M, 2004, EVOLUTION MOL ECOSYS; Serra M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P281, DOI 10.1007/978-90-481-2770-2_14; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; SNELL TW, 1988, J EXP MAR BIOL ECOL, V124, P73, DOI 10.1016/0022-0981(88)90112-8; Stelzer CP, 2006, LIMNOL OCEANOGR, V51, P125, DOI 10.4319/lo.2006.51.1.0125; Takada T, 1996, J THEOR BIOL, V182, P179, DOI 10.1006/jtbi.1996.0153; Wellborn GA, 2004, FRESHWATER BIOL, V49, P1, DOI 10.1046/j.1365-2426.2003.01160.x; Zadereev E, 2007, AQUAT ECOL, V41, P255, DOI 10.1007/s10452-006-9062-2; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhang DY, 1998, J THEOR BIOL, V193, P465, DOI 10.1006/jtbi.1998.0712	30	29	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20314	10.1371/journal.pone.0020314	http://dx.doi.org/10.1371/journal.pone.0020314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625466	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400054
J	Storm, P; Aits, S; Puthia, MK; Urbano, A; Northen, T; Powers, S; Bowen, B; Chao, Y; Reindl, W; Lee, DY; Sullivan, NL; Zhang, J; Trulsson, M; Yang, H; Watson, JD; Svanborg, C				Storm, P.; Aits, S.; Puthia, M. K.; Urbano, A.; Northen, T.; Powers, S.; Bowen, B.; Chao, Y.; Reindl, W.; Lee, D. Y.; Sullivan, N. L.; Zhang, J.; Trulsson, M.; Yang, H.; Watson, J. D.; Svanborg, C.			Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis	ONCOGENE			English	Article						HAMLET; metabolism; c-Myc; glycolysis	APOPTOSIS-LIKE MECHANISM; HUMAN ALPHA-LACTALBUMIN; ENERGY-METABOLISM; GLUCOSE-METABOLISM; PYRUVATE-KINASE; TUMOR-CELLS; HYPOXIA; GROWTH; 3-BROMOPYRUVATE; INHIBITION	HAMLET is the first member of a new family of tumoricidal protein-lipid complexes that kill cancer cells broadly, while sparing healthy, differentiated cells. Many and diverse tumor cell types are sensitive to the lethal effect, suggesting that HAMLET identifies and activates conserved death pathways in cancer cells. Here, we investigated the molecular basis for the difference in sensitivity between cancer cells and healthy cells. Using a combination of small-hairpin RNA (shRNA) inhibition, proteomic and metabolomic technology, we identified the c-Myc oncogene as one essential determinant of HAMLET sensitivity. Increased c-Myc expression levels promoted sensitivity to HAMLET and shRNA knockdown of c-Myc suppressed the lethal response, suggesting that oncogenic transformation with c-Myc creates a HAMLET-sensitive phenotype. Furthermore, HAMLET sensitivity was modified by the glycolytic state of tumor cells. Glucose deprivation sensitized tumor cells to HAMLET-induced cell death and in the shRNA screen, hexokinase 1 (HK1), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 and hypoxia-inducible factor 1 alpha modified HAMLET sensitivity. HK1 was shown to bind HAMLET in a protein array containing similar to 8000 targets, and HK activity decreased within 15min of HAMLET treatment, before morphological signs of tumor cell death. In parallel, HAMLET triggered rapid metabolic paralysis in carcinoma cells. Tumor cells were also shown to contain large amounts of oleic acid and its derivatives already after 15 min. The results identify HAMLET as a novel anti-cancer agent that kills tumor cells by exploiting unifying features of cancer cells such as oncogene addiction or the Warburg effect. Oncogene (2011) 30, 4765-4779; doi: 10.1038/onc.2011.196; published online 6 June 2011	[Storm, P.; Aits, S.; Trulsson, M.; Svanborg, C.] Lund Univ, Dept Lab Med, Div Microbiol Immunol & Glycobiol, S-22362 Lund, Sweden; [Puthia, M. K.; Urbano, A.; Chao, Y.; Yang, H.] ASTAR, Inst Biomed Sci, Singapore Immunol Network SIgN, Singapore, Singapore; [Northen, T.; Bowen, B.; Reindl, W.; Lee, D. Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Powers, S.; Sullivan, N. L.; Zhang, J.; Watson, J. D.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Lund University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cold Spring Harbor Laboratory	Svanborg, C (corresponding author), Lund Univ, Dept Microbiol Immunol & Glycobiol MIG, Inst Lab Med, Solvegatan 23, S-22362 Lund, Sweden.	catharina.svanborg@med.lu.se	Northen, Trent/K-3139-2012; Aits, Sonja/D-1496-2011	Aits, Sonja/0000-0002-1321-0678; Northen, Trent/0000-0001-8404-3259; Storm, Petter/0000-0002-7655-3731; Chao, Yinxia/0000-0003-1185-3511; Powers, Scott/0000-0003-2769-1932; Puthia, Manoj/0000-0001-6048-7234	Sharon D Lund foundation; American Cancer Society; Swedish Cancer Society; Swedish Medical Research Council; Medical Faculty (Lund University); Soderberg Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Swedish Society for Medical Research; Network of Excellence: EuroPathoGenomics; Crafoord Foundation; Osterlund Foundation; US Department of Energy at Berkeley Lab [DE-AC02-05CH11231]; National Institutes of Health, National Cancer Institute [U54 CA 112970]; California Breast Cancer Research Program [15IB-0063]; NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER	Sharon D Lund foundation; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty (Lund University); Soderberg Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Swedish Society for Medical Research; Network of Excellence: EuroPathoGenomics; Crafoord Foundation; Osterlund Foundation; US Department of Energy at Berkeley Lab(United States Department of Energy (DOE)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Sharon D Lund foundation grant and the American Cancer Society, the Swedish Cancer Society, the Swedish Medical Research Council, the Medical Faculty (Lund University), the Soderberg Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the HJ Forssman Foundation for Medical Research, the Royal Physiographic Society, the Swedish Society for Medical Research, the Network of Excellence: EuroPathoGenomics, the Crafoord Foundation, the Osterlund Foundation, the US Department of Energy Low Dose SFA Program at Berkeley Lab [DE-AC02-05CH11231], the National Institutes of Health, National Cancer Institute grant U54 CA 112970 and the California Breast Cancer Research Program [15IB-0063].	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Baran R, 2009, CURR OPIN MICROBIOL, V12, P547, DOI 10.1016/j.mib.2009.07.004; Brest P, 2007, CANCER RES, V67, P11327, DOI 10.1158/0008-5472.CAN-07-1153; Brummelkamp TR, 2003, NAT REV CANCER, V3, P781, DOI 10.1038/nrc1191; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coleman MC, 2008, FREE RADICAL BIO MED, V44, P322, DOI 10.1016/j.freeradbiomed.2007.08.032; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Dang CV, 1999, MOL CELL BIOL, V19, P1; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; LI Y, 1984, P NATL ACAD SCI-BIOL, V81, P6808, DOI 10.1073/pnas.81.21.6808; Mathupala SP, 1997, J BIOENERG BIOMEMBR, V29, P339, DOI 10.1023/A:1022494613613; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; THOMAS DB, 1975, CELL, V5, P37, DOI 10.1016/0092-8674(75)90089-6; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WATSON PH, 1991, CANCER RES, V51, P3996; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	52	35	36	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	48					4765	4779		10.1038/onc.2011.196	http://dx.doi.org/10.1038/onc.2011.196			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	863AH	21643007	Green Accepted			2022-12-25	WOS:000298134700001
J	Vazquez, V; Liang, XW; Horndahl, JK; Ganesh, VK; Smeds, E; Foster, TJ; Hook, M				Vazquez, Vanessa; Liang, Xiaowen; Horndahl, Jenny K.; Ganesh, Vannakambadi K.; Smeds, Emanuel; Foster, Timothy J.; Hook, Magnus			Fibrinogen Is a Ligand for the Staphylococcus aureus Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMM) Bone Sialoprotein-binding Protein (Bbp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUMPING FACTOR-B; ESCHERICHIA-COLI; EXPRESSION; CHAIN; CLFB; ADHERENCE; FAMILY; LOCK; DOCK; SDRG	Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) are bacterial surface proteins mediating adherence of the microbes to components of the extracellular matrix of the host. On Staphylococci, the MSCRAMMs often have multiple ligands. Consequently, we hypothesized that the Staphylococcus aureus MSCRAMM bone sialoprotein-binding protein (Bbp) might recognize host molecules other than the identified bone protein. A ligand screen revealed that Bbp binds human fibrinogen (Fg) but not Fg from other mammals. We have characterized the interaction between Bbp and Fg. The binding site for Bbp was mapped to residues 561-575 in the Fg A alpha chain using recombinant Fg chains and truncation mutants in Far Western blots and solid-phase binding assays. Surface plasmon resonance was used to determine the affinity of Bbp for Fg. The interaction of Bbp with Fg peptides corresponding to the mapped residues was further characterized using isothermal titration calorimetry. In addition, Bbp expressed on the surface of bacteria mediated adherence to immobilized Fg A alpha. Also, Bbp interferes with thrombin-induced Fg coagulation. Together these data demonstrate that human Fg is a ligand for Bbp and that Bbp can manipulate the biology of the Fg ligand in the host.	[Vazquez, Vanessa; Liang, Xiaowen; Horndahl, Jenny K.; Ganesh, Vannakambadi K.; Smeds, Emanuel; Hook, Magnus] Texas A&M Univ Syst Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, Houston, TX 77030 USA; [Vazquez, Vanessa] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Foster, Timothy J.] Trinity Coll Dublin, Dept Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Trinity College Dublin	Hook, M (corresponding author), Texas A&M Univ Syst Hlth Sci Ctr, Ctr Infect & Inflammatory Dis, Inst Biosci & Technol, 2121 W Holcombe Blvd,Ste 603, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu	Sarathy, Vanessa V./U-7803-2019	Sarathy, Vanessa V./0000-0002-1262-2101; Liang, Xiaowen/0000-0002-6174-2951	Science Foundation Ireland; National Institutes of Health [AI 20624]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Science Foundation Ireland.; Supported by Grant AI 20624 from the National Institutes of Health. To whom correspondence should be addressed: Center for Infectious and Inflammatory Diseases, Texas A&M University System Health Science Center, Institute of Biosciences and Technology, 2121 West Holcombe Blvd., Ste. 603, Houston, TX 77030. Tel.: 713-677-7551; Fax: 713-677-7576; E-mail: mhook@ibt.tamhsc.edu.	BOLYARD MG, 1989, BLOOD, V73, P1202; BOLYARD MG, 1988, GENE, V66, P183, DOI 10.1016/0378-1119(88)90355-1; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 1999, ACTA CRYSTALLOGR D, V55, P554, DOI 10.1107/S0907444998012426; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LORD ST, 1985, DNA-J MOLEC CELL BIO, V4, P33, DOI 10.1089/dna.1985.4.33; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863	27	63	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29797	29805		10.1074/jbc.M110.214981	http://dx.doi.org/10.1074/jbc.M110.214981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21642438	Green Published, hybrid			2022-12-25	WOS:000294046600039
J	Johansen, C; Riis, JL; Gedebjerg, A; Kragballe, K; Iversen, L				Johansen, Claus; Riis, Jette L.; Gedebjerg, Anne; Kragballe, Knud; Iversen, Lars			Tumor Necrosis Factor alpha-Mediated Induction of Interleukin 17C in Human Keratinocytes Is Controlled by Nuclear Factor kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LESIONAL PSORIATIC SKIN; IL-17 CYTOKINE FAMILY; TRANSCRIPTION FACTORS; ATOPIC-DERMATITIS; SIGNALING PATHWAY; KEY ROLE; ACTIVATION; P65; PHOSPHORYLATION; RECEPTORS	IL-17C is a member of the IL-17 family of cytokines. The expression of IL-17C has been demonstrated to be strongly induced by TNF alpha in human keratinocytes, and recently the level of IL-17C was found to be increased in the inflammatory skin disease psoriasis. However, little is known about the molecular mechanisms involved in the regulation of IL-17C. Here, we show that pretreatment of cultured human keratinocytes with the inhibitor of kappa B kinase 2 inhibitor, SC-514, resulted in a significant reduction in both IL-17C mRNA and protein expression, indicating the significance of this pathway in the regulation of IL-17C. NF-kappa B binding sites were identified upstream from the IL-17C gene, and by electrophoretic mobility shift assay NF-kappa B was shown to bind to all three identified binding sites. Moreover, NF-kappa B binding to these sites was inducible by TNF alpha Supershift analysis revealed binding of the NF-kappa B subunits p65 and p50 to all three NF-kappa B binding sites. To determine the contribution of NF-kappa B in IL-17C expression, we conducted luciferase gene reporter experiments and demonstrated that a 3204-bp promoter fragment of IL-17C containing three putative NF-kappa B binding sites was strongly activated by TNF alpha. Interestingly, mutations of the three NF-kappa B binding sites revealed that one specific NF-kappa B binding site was crucial for the TNF alpha-mediated IL-17C induction because mutation of this specific site completely abolished TNF alpha-induced IL-17C promoter activation. We conclude that the activation of NF-kappa B (p65/p50) is crucial for the TNF alpha-induced stimulation of IL-17C expression in human keratinocytes.	[Johansen, Claus; Riis, Jette L.; Gedebjerg, Anne; Kragballe, Knud; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus C, Denmark	Aarhus University	Johansen, C (corresponding author), Aarhus Univ Hosp, Dept Dermatol, PP Oerumsgade 11, DK-8000 Aarhus C, Denmark.	claus.johansen@ki.au.dk		Iversen, Lars/0000-0003-1816-4508; Johansen, Claus/0000-0002-5665-5212; Johansen, Claus/0000-0003-0240-5127				Abeyama K, 2000, J CLIN INVEST, V105, P1751, DOI 10.1172/JCI9745; Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Dajee M, 2006, J INVEST DERMATOL, V126, P1792, DOI 10.1038/sj.jid.5700307; Danning CL, 2000, ARTHRITIS RHEUM-US, V43, P1244, DOI 10.1002/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Huber MA, 2002, J BIOL CHEM, V277, P1268, DOI 10.1074/jbc.M109358200; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Johansen C, 2005, J INVEST DERMATOL, V124, P1284, DOI 10.1111/j.0022-202X.2005.23749.x; Johansen C, 2010, BRIT J DERMATOL, V163, P1194, DOI 10.1111/j.1365-2133.2010.10036.x; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Johansen C, 2000, J INVEST DERMATOL, V114, P1174, DOI 10.1046/j.1523-1747.2000.00003.x; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Nakagami H, 2006, CURR PHARM BIOTECHNO, V7, P95, DOI 10.2174/138920106776597702; Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Solt LA, 2009, J BIOL CHEM, V284, P27596, DOI 10.1074/jbc.M109.047563; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	42	41	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25487	25494		10.1074/jbc.M111.240671	http://dx.doi.org/10.1074/jbc.M111.240671			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628458	Green Published, hybrid			2022-12-25	WOS:000293073000011
J	Majerle, A; Pristovsek, P; Mancek-Keber, M; Jerala, R				Majerle, Andreja; Pristovsek, Primoz; Mancek-Keber, Mateja; Jerala, Roman			Interaction of the HIV-1 gp120 Viral Protein V3 Loop with Bacterial Lipopolysaccharide A PATTERN RECOGNITION INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRINCIPAL NEUTRALIZING DETERMINANT; ENVELOPE GLYCOPROTEIN; ALTERNATIVE CONFORMATIONS; STRUCTURAL ELEMENTS; CORECEPTOR BINDING; FLUORESCENT-PROBE; PEPTIDE REVEALS; NMR STRUCTURE; LIPID-A	HIV-1 represents an elusive target for therapeutic compounds due to its high rate of mutation. Targeting structural patterns instead of a constantly changing specific three-dimensional structure may represent an approach that is less sensitive to viral mutations. The V3 loop of gp120 of HIV-1, which is responsible for binding of viral gp120 to CCR5 or CXCR4 coreceptors, has already been identified as an effective target for the inhibition of viral entry. The peptide derived from the V3 loop of gp120 specifically interacts with the lipid A moiety of LPS, as does the full gp120 protein. NMR analysis of V3 in complex with LPS shows formation of an amphipathic turn. The interaction between LPS and V3 relies on the structural pattern, comprising a combination of hydrophobic and charge interactions, similar to the interaction between antimicrobial peptides and LPS. LPS inhibited binding of gp120 to the surface of target T cells. Nonendotoxic LPS antagonists inhibited viral infection, demonstrating the possibility for the development of an inhibitor of HIV-1 attachment to T cells based on the recognition of a conserved structural pattern.	[Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Majerle, Andreja; Mancek-Keber, Mateja; Jerala, Roman] Excellent NMR Future Innovat Sustainable Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Hajdrihova Ulica 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si		Pristovsek, Primoz/0000-0002-2304-1791	Slovenian Research Agency; Excellent NMR(right arrow)Future Innovation for Sustainable Technologies Centre of Excellence, Ljubljana, Slovenia	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Excellent NMR(right arrow)Future Innovation for Sustainable Technologies Centre of Excellence, Ljubljana, Slovenia	This work was supported by the Slovenian Research Agency and Excellent NMR -> Future Innovation for Sustainable Technologies Centre of Excellence, Ljubljana, Slovenia.	Andrianov AM, 2007, J BIOMOL STRUCT DYN, V24, P597, DOI 10.1080/07391102.2007.10507149; Basmaciogullari S, 2002, J VIROL, V76, P10791, DOI 10.1128/JVI.76.21.10791-10800.2002; BATINIC D, 1992, J BIOL CHEM, V267, P6664; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Bjorndal A, 1997, J VIROL, V71, P7478; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Cole AM, 2003, FEBS LETT, V535, P195, DOI 10.1016/S0014-5793(02)03860-7; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; Del Prete GQ, 2010, J VIROL, V84, P8777, DOI 10.1128/JVI.00333-10; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; FREED EO, 1991, J VIROL, V65, P190, DOI 10.1128/JVI.65.1.190-194.1991; Geng MY, 2003, ANTIVIR RES, V59, P127, DOI 10.1016/S0166-3542(03)00068-8; Genois N, 2000, J LEUKOCYTE BIOL, V68, P854; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; HARROP HA, 1994, AIDS, V8, P183, DOI 10.1097/00002030-199402000-00005; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; Japelj B, 2005, J BIOL CHEM, V280, P16955, DOI 10.1074/jbc.M500266200; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Mancek-Keber M, 2006, FASEB J, V20, P1836, DOI 10.1096/fj.06-5862com; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Melendez Johana, 2001, Cellular and Molecular Biology Online Papers, V47, pOL51; Mor A, 2009, BIOCHEMISTRY-US, V48, P3288, DOI 10.1021/bi802308n; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Pristovsek P, 2005, J MED CHEM, V48, P1666, DOI 10.1021/jm049217k; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Seydel U, 2005, FEBS J, V272, P327, DOI 10.1111/j.1742-4658.2004.04471.x; Sharon M, 2003, STRUCTURE, V11, P225, DOI 10.1016/S0969-2126(03)00011-X; Sharpe S, 2004, J AM CHEM SOC, V126, P4979, DOI 10.1021/ja0392162; Simard S, 2008, CLIN IMMUNOL, V127, P198, DOI 10.1016/j.clim.2008.01.007; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Tugarinov V, 2000, STRUCT FOLD DES, V8, P385, DOI 10.1016/S0969-2126(00)00119-2; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; Verani A, 2002, J IMMUNOL, V168, P6388, DOI 10.4049/jimmunol.168.12.6388; Wood SJ, 2004, COMB CHEM HIGH T SCR, V7, P239; Wu G, 2000, J BIOL CHEM, V275, P36645, DOI 10.1074/jbc.M005369200; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wuthrich K, 1986, NMR PROTEINS NUCL AC	60	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26228	26237		10.1074/jbc.M111.220434	http://dx.doi.org/10.1074/jbc.M111.220434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636577	Green Published, hybrid			2022-12-25	WOS:000293073000080
J	Ouda, R; Onomoto, K; Takahasi, K; Edwards, MR; Kato, H; Yoneyama, M; Fujita, T				Ouda, Ryota; Onomoto, Koji; Takahasi, Kiyohiro; Edwards, Michael R.; Kato, Hiroki; Yoneyama, Mitsutoshi; Fujita, Takashi			Retinoic Acid-inducible Gene I-inducible miR-23b Inhibits Infections by Minor Group Rhinoviruses through Down-regulation of the Very Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; HEPATITIS-C VIRUS; RIG-I; RNA; EXPRESSION; PROTEINS; ASTHMA; STAT1; EXACERBATIONS	In mammals, viral infections are detected by innate immune receptors, including Toll-like receptor and retinoic acid inducible gene I (RIG-I)-like receptor (RLR), which activate the type I interferon (IFN) system. IFN essentially activates genes encoding antiviral proteins that inhibit various steps of viral replication as well as facilitate the subsequent activation of acquired immune responses. In this study, we investigated the expression of non-coding RNA upon viral infection or RLR activation. Using a microarray, we identified several microRNAs (miRNA) specifically induced to express by RLR signaling. As suggested by Bioinformatics (miRBase Target Data base), one of the RLR-inducible miRNAs, miR-23b, actually knocked down the expression of very low density lipoprotein receptor (VLDLR) and LDLR-related protein 5 (LRP5). Transfection of miR-23b specifically inhibited infection of rhinovirus 1B (RV1B), which utilizes the low density lipoprotein receptor (LDLR) family for viral entry. Conversely, introduction of anti-miRNA-23b enhanced the viral yield. Knockdown experiments using small interfering RNA (siRNA) revealed that VLDLR, but not LRP5, is critical for an efficient infection by RV1B. Furthermore, experiments with the transfection of infectious viral RNA revealed that miR-23b did not affect post-entry viral replication. Our results strongly suggest that RIG-I signaling results in the inhibitions of infections of RV1B through the miR-23b-mediated down-regulation of its receptor VLDLR.	[Ouda, Ryota; Onomoto, Koji; Takahasi, Kiyohiro; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan; [Ouda, Ryota; Fujita, Takashi] Kyoto Univ, Mol Cell Biol Lab, Grad Sch Biostudies, Kyoto 6068507, Japan; [Takahasi, Kiyohiro] Kyoto Univ, Inst Innovat NanoBio Drug Discovery & Dev, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Chiba 2608673, Japan; [Yoneyama, Mitsutoshi] PRESTO Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Edwards, Michael R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, London SW7 2AZ, England; [Edwards, Michael R.] MRC, London SE1 9RT, England; [Edwards, Michael R.] Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England; [Edwards, Michael R.] Ctr Resp Infect, London SW7 2AZ, England	Kyoto University; Kyoto University; Kyoto University; Chiba University; Japan Science & Technology Agency (JST); Imperial College London; University of London; King's College London	Fujita, T (corresponding author), Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017; Ouda, Ryota/P-9681-2019	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Edwards, Michael Robert/0000-0001-6837-0532	Ministry of Education, Science, Sports and Culture in Japan; Ministry of Health, Labor, and Welfare; PRESTO Japan Science and Technology Agency; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nippon Boehringer Ingelheim; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [MRC-Asthma UK Centre] Funding Source: researchfish	Ministry of Education, Science, Sports and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); PRESTO Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Nippon Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This work was supported in part by a Grant-in-aid from the Ministry of Education, Science, Sports and Culture in Japan, the Ministry of Health, Labor, and Welfare, the PRESTO Japan Science and Technology Agency, the Uehara Memorial Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Nippon Boehringer Ingelheim.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grunberg K, 2000, CLIN EXP ALLERGY, V30, P1015; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lehtonen A, 1997, J IMMUNOL, V159, P794; Marlovits TC, 1998, J VIROL, V72, P10246, DOI 10.1128/JVI.72.12.10246-10250.1998; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nizet S, 2005, J VIROL, V79, P14730, DOI 10.1128/JVI.79.23.14730-14736.2005; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okun VM, 2001, J BIOL CHEM, V276, P1057, DOI 10.1074/jbc.M008039200; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Savolainen Carita, 2003, Paediatr Respir Rev, V4, P91, DOI 10.1016/S1526-0542(03)00030-7; Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Vaucheret H, 2001, J CELL SCI, V114, P3083; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wu AJ, 1997, J CELL PHYSIOL, V173, P110, DOI 10.1002/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	43	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26210	U901		10.1074/jbc.M111.229856	http://dx.doi.org/10.1074/jbc.M111.229856			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21642441	hybrid, Green Published			2022-12-25	WOS:000293073000078
J	Wakabayashi, H; Griffiths, AE; Fay, PJ				Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.			Increasing Hydrophobicity or Disulfide Bridging at the Factor VIII A1 and C2 Domain Interface Enhances Procofactor Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT DISSOCIATION; A1/A3-C1-C2 DIMER; COFACTOR ACTIVITY; CHARGED RESIDUES; CA2+ BINDING; MUTATIONS; ASSOCIATION; CHAINS; PH	Factor VIII (FVIII) consists of a heavy (A1A2B domains) and light chain (A3C1C2 domains), whereas the contiguous A1A2 domains are separate subunits in the cofactor, FVIIIa. FVIII x-ray structures show close contacts between A1 and C2 domains. To explore the role of this region in FVIII(a) stability, we generated a variant containing a disulfide bond between A1 and C2 domains by mutating Arg-121 and Leu-2302 to Cys (R121C/L2302C) and a second variant with a bulkier hydrophobic group (A108I) to better occupy a cavity between A1 and C2 domains. Disulfide bonding in the R121C/L2302C variant was >90% efficient as judged by Western blots. Binding affinity between the A108I A1 and A3C1C2 subunits was increased similar to 3.7-fold in the variant as compared with WT as judged by changes in fluorescence of acrylodan-labeled A1 subunits. FVIII thermal and chemical stability were monitored following rates of loss of FVIII activity at 57 C or in guanidinium by factor Xa generation assays. The rate of decay of FVIIIa activity was monitored at 23 C following activation by thrombin. Both R121C/L2302C and A108I variants showed up to similar to 4-fold increases in thermal stability but minimal improvements in chemical stability. The purified A1 subunit of A108I reconstituted with the A3C1C2 subunit showed an similar to 4.6-fold increase in thermal stability, whereas reconstitution of the variant A1 with a truncated A3C1 subunit showed similar stability values as compared with WTA1. Together, these results suggest that altering contacts at this A1-C2 junction by covalent modification or increasing hydrophobicity increases inter-chain affinity and functionally enhances FVIII stability.	[Wakabayashi, Hironao; Griffiths, Amy E.; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Sch Med, Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199, HL76213]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076213, R01HL038199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38199 and HL76213 (to P. J. F.). Preliminary accounts of portions of this work were presented at the 22nd Congress of the International Society on Thrombosis and Hemostasis, July 13, 2009, Boston, MA and the 51st Annual Meeting of the American Society of Hematology, December 5, 2009, New Orleans, LA.	Ansong C, 2005, BIOCHEMISTRY-US, V44, P8850, DOI 10.1021/bi050145o; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Hakeos WH, 2002, THROMB HAEMOSTASIS, V88, P781, DOI 10.1055/s-0037-1613302; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pipe SW, 2001, BLOOD, V97, P685, DOI 10.1182/blood.V97.3.685; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2006, BBA-PROTEINS PROTEOM, V1764, P1094, DOI 10.1016/j.bbapap.2006.04.004; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906	26	10	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25748	25755		10.1074/jbc.M111.241109	http://dx.doi.org/10.1074/jbc.M111.241109			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628455	Green Published, hybrid			2022-12-25	WOS:000293073000036
J	Wong, CYA; Wuriyanghan, H; Xie, Y; Lin, MF; Abel, PW; Tu, YP				Wong, Chuu-Yun A.; Wuriyanghan, Hada; Xie, Yan; Lin, Ming-Fong; Abel, Peter W.; Tu, Yaping			Epigenetic Regulation of Phosphatidylinositol 3,4,5-Triphosphate-dependent Rac Exchanger 1 Gene Expression in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; BETA-GAMMA-SUBUNITS; P-REX1; ACTIVATION; MIGRATION; PROMOTER; PROTEIN; SP1; TRANSCRIPTION; TARGET	Aberrant up-regulation of P-Rex1 expression plays important roles in cancer progression and metastasis. The present study investigated the regulatory mechanism underlying P-Rex1 gene expression in prostate cancer cells. We showed that P-Rex1 expression was much higher in metastatic prostate cancer cells than in prostate epithelial cells and non-metastatic prostate cancer cells. Histone deacetylase (HDAC) inhibitors or silence of endogenous HDAC1 and HDAC2 markedly elevated P-Rex1 transcription in non-metastatic prostate cancer cells, whereas overexpression of recombinant HDAC1 in metastatic prostate cancer cells suppressed P-Rex1 expression. HDAC inhibitor trichostatin A (TSA) also significantly increased P-Rex1 promoter activity and caused acetylated histones to accumulate and associate with the P-Rex1 promoter. One Sp1 site, essential for basal promoter activity, was identified as critical for the TSA effect. TSA treatment did not alter the DNA-binding activity of Sp1 toward the P-Rex1 promoter; however, it facilitated the dissociation of the repressive HDAC1 and HDAC2 from the Sp1 binding region. Interestingly, HDAC1 association with Sp1 and with the P-Rex1 promoter were much weaker in metastatic prostate cancer PC-3 cells than in non-metastatic prostate cancer cells, and HDAC inhibitors only had very modest stimulatory effects on P-Rex1 promoter activity and P-Rex1 expression in PC-3 cells. Altogether, our studies demonstrate that HDACs could regulate P-Rex1 gene transcription by interaction with Sp1 and by region-specific changes in histone acetylation within the P-Rex1 promoter. Disassociation of HDACs from Sp1 on the P-Rex1 promoter may contribute to aberrant up-regulation of P-Rex1 in cancer.	[Wong, Chuu-Yun A.; Wuriyanghan, Hada; Xie, Yan; Abel, Peter W.; Tu, Yaping] Creighton Univ, Dept Pharmacol, Sch Med, Omaha, NE 68178 USA; [Lin, Ming-Fong] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68131 USA	Creighton University; University of Nebraska System; University of Nebraska Medical Center	Tu, YP (corresponding author), 2500 Calif Plaza, Omaha, NE 68178 USA.	yapingtu@creighton.edu		Abel, Peter/0000-0002-6588-1676	National Institutes of Health [CA125661, CA88184]; U.S. Dept. of Defense [W81XWH-07-1-0189]; NATIONAL CANCER INSTITUTE [R01CA125661, R01CA088184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA125661 (to Y. T.) and CA88184 (to M. F. L.). This work was also supported by the U.S. Dept. of Defense Prostate Cancer Research Program (Grant W81XWH-07-1-0189 to Y. T.).	Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Camarero N, 2003, NUCLEIC ACIDS RES, V31, P1693, DOI 10.1093/nar/gkg262; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Jackson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011962; Kang JE, 2005, CELL PHYSIOL BIOCHEM, V16, P23, DOI 10.1159/000087728; Knight-Krajewski S, 2004, ONCOGENE, V23, P5513, DOI 10.1038/sj.onc.1207708; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Murillo H, 2006, GENE CHROMOSOME CANC, V45, P702, DOI 10.1002/gcc.20333; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sellak H, 2002, CIRC RES, V90, P405, DOI 10.1161/hh0402.105898; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VanLint C, 1996, GENE EXPRESSION, V5, P245; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wolff D. W., 2011, INT J CANC IN PRESS; Wolffe AP, 1997, NATURE, V387, P16, DOI 10.1038/387016a0; Xie Y, 2007, MOL PHARMACOL, V72, P73, DOI 10.1124/mol.107.033894; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251	37	21	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25813	25822		10.1074/jbc.M110.211292	http://dx.doi.org/10.1074/jbc.M110.211292			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636851	Green Published, hybrid			2022-12-25	WOS:000293073000043
J	Berrich, M; Kieda, C; Grillon, C; Monteil, M; Lamerant, N; Gavard, J; Boulouis, HJ; Haddad, N				Berrich, Moez; Kieda, Claudine; Grillon, Catherine; Monteil, Martine; Lamerant, Nathalie; Gavard, Julie; Boulouis, Henri Jean; Haddad, Nadia			Differential Effects of Bartonella henselae on Human and Feline Macro- and Micro-Vascular Endothelial Cells	PLOS ONE			English	Article							CAT-SCRATCH DISEASE; MOLECULAR EPIDEMIOLOGY; BACILLARY ANGIOMATOSIS; PROLIFERATION; INFECTION; EXPRESSION; HETEROGENEITY; ANGIOGENESIS; INDUCTION; DIVERSITY	Bartonella henselae, a zoonotic agent, induces tumors of endothelial cells (ECs), namely bacillary angiomatosis and peliosis in immunosuppressed humans but not in cats. In vitro studies on ECs represent to date the only way to explore the interactions between Bartonella henselae and vascular endothelium. However, no comparative study of the interactions between Bartonella henselae and human (incidental host) ECs vs feline (reservoir host) ECs has been carried out because of the absence of any available feline endothelial cell lines. To this purpose, we have developed nine feline EC lines which allowed comparing the effects of Bartonella strains on human and feline micro-vascular ECs representative of the infection development sites such as skin, versus macro-vascular ECs, such as umbilical vein. Our model revealed intrinsic differences between human (Human Skin Microvascular ECs -HSkMEC and Human Umbilical Vein ECs - iHUVEC) and feline ECs susceptibility to Bartonella henselae infection. While no effect was observed on the feline ECs upon Bartonella henselae infection, the human ones displayed accelerated angiogenesis and wound healing. Noticeable differences were demonstrated between human micro-and macro-vasculature derived ECs both in terms of pseudotube formation and healing. Interestingly, Bartonella henselae effects on human ECs were also elicited by soluble factors. Neither Bartonella henselae-infected Human Skin Microvascular ECs clinically involved in bacillary angiomatosis, nor feline ECs increased cAMP production, as opposed to HUVEC. Bartonella henselae could stimulate the activation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) in homologous cellular systems and trigger VEGF production by HSkMECs only, but not iHUVEC or any feline ECs tested. These results may explain the decreased pathogenic potential of Bartonella henselae infection for cats as compared to humans and strongly suggest that an autocrine secretion of VEGF by human skin endothelial cells might induce their growth and ultimately lead to bacillary angiomatosis formation.	[Berrich, Moez; Monteil, Martine; Boulouis, Henri Jean; Haddad, Nadia] Univ Paris Est, Ecole Natl Vet Alfort, Unite Mixte Rech Biol Mol & Immunol Parasitaires, Maisons Alfort, France; [Kieda, Claudine; Grillon, Catherine; Lamerant, Nathalie] CNRS, Ctr Biophys Mol, Unite Propre Rech 4301, Orleans, France; [Gavard, Julie] Univ Paris 05, CNRS, Inst Cochin, INSERM,U1016, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Berrich, M (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, Unite Mixte Rech Biol Mol & Immunol Parasitaires, Maisons Alfort, France.	hjboulouis@vet-alfort.fr	Kieda, Claudine/U-1361-2019; Gavard, Julie/I-5487-2012; Grillon, Catherine/I-4974-2016; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Grillon, Catherine/0000-0001-5019-7831; Gavard, Julie/0000-0003-3107-2026	CNRS; Conseil Regional du Centre; Canceropole GO; Ligue Contre le Cancer (call Ile-de-France); Direction Generale de l'Enseignement et de la Recherche (Ministere de l'Agriculture, de l'Alimentation, de la Peche et des Affaires rurales)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional du Centre(Region Centre-Val de Loire); Canceropole GO; Ligue Contre le Cancer (call Ile-de-France); Direction Generale de l'Enseignement et de la Recherche (Ministere de l'Agriculture, de l'Alimentation, de la Peche et des Affaires rurales)	The authors gratefully acknowledge financial support from the CNRS, the Conseil Regional du Centre, the Canceropole GO, the Ligue Contre le Cancer (call Ile-de-France) and the Direction Generale de l'Enseignement et de la Recherche (Ministere de l'Agriculture, de l'Alimentation, de la Peche et des Affaires rurales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; BIZOUARNE N, 1993, BIOL CELL, V79, P27, DOI 10.1016/0248-4900(93)90259-H; BIZOUARNE N, 1993, BIOL CELL, V79, P209, DOI 10.1016/0248-4900(93)90139-6; Bouchouicha R, 2009, EMERG INFECT DIS, V15, P813, DOI 10.3201/eid1505.080995; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Breitschwerdt EB, 2008, VET IMMUNOL IMMUNOP, V123, P167, DOI 10.1016/j.vetimm.2008.01.025; Buchmann AU, 2010, VET PATHOL, V47, P163, DOI 10.1177/0300985809354347; Buchmann AU, 2010, J CLIN MICROBIOL, V48, P3295, DOI 10.1128/JCM.00750-10; CARREAU A, 2011, J CELL MOL MED; Cerimele F, 2003, AM J PATHOL, V163, P1321, DOI 10.1016/S0002-9440(10)63491-8; Chang CC, 2002, J INFECT DIS, V186, P1733, DOI 10.1086/345764; CHANG CC, 2010, VET MICROBIOL; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chomel BB, 2009, VET RES, V40, DOI 10.1051/vetres/2009011; CONLEY T, 1994, J LAB CLIN MED, V124, P521; Conway EM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-207; Fournier PE, 2002, J CLIN MICROBIOL, V40, P3620, DOI 10.1128/JCM.40.10.3620-3624.2002; Guptill L, 2010, VET CLIN N AM-SMALL, V40, P1073, DOI 10.1016/j.cvsm.2010.07.009; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; Kieda C, 2002, ENDOTHELIUM-J ENDOTH, V9, P247, DOI 10.1080/10623320214736; Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603; KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; LEBOIT PE, 1989, AM J SURG PATHOL, V13, P909, DOI 10.1097/00000478-198911000-00001; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315; McCord AM, 2005, INFECT IMMUN, V73, P5735, DOI 10.1128/IAI.73.9.5735-5742.2005; McCord AM, 2007, DNA CELL BIOL, V26, P657, DOI 10.1089/dna.2007.0592; McCord AM, 2006, INFECT IMMUN, V74, P5185, DOI 10.1128/IAI.00622-06; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; Palmari J, 1996, ANAL CELL PATHOL, V11, P13; Pries A. R., 2006, V176, P1; Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018; Red-Horse K, 2006, J CLIN INVEST, V116, P2585, DOI 10.1172/JCI30058; REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992; Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Riess T, 2007, INFECT IMMUN, V75, P35, DOI 10.1128/IAI.00963-06; Sander A, 1998, SCAND J INFECT DIS, V30, P387, DOI 10.1080/00365549850160693; Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x; SCHEIDEGGER F, 2010, CELL MICROBIOL; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Woestyn S, 2004, J CLIN MICROBIOL, V42, P1420, DOI 10.1128/JCM.42.4.1420-1427.2004; Yager JA, 2010, VET DERMATOL; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20204	10.1371/journal.pone.0020204	http://dx.doi.org/10.1371/journal.pone.0020204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637717	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500041
J	Swevers, L; Liu, JS; Huvenne, H; Smagghe, G				Swevers, Luc; Liu, Jisheng; Huvenne, Hanneke; Smagghe, Guy			Search for Limiting Factors in the RNAi Pathway in Silkmoth Tissues and the Bm5 Cell Line: The RNA-Binding Proteins R2D2 and Translin	PLOS ONE			English	Article							BOMBYX-MORI; DROSOPHILA; INTERFERENCE; SILKWORM; GENOME; EXPRESSION; SEQUENCE; GENES; METAMORPHOSIS; MECHANISMS	RNA interference (RNAi), an RNA-dependent gene silencing process that is initiated by double-stranded RNA (dsRNA) molecules, has been applied with variable success in lepidopteran insects, in contrast to the high efficiency achieved in the coleopteran Tribolium castaneum. To gain insight into the factors that determine the efficiency of RNAi, a survey was carried out to check the expression of factors that constitute the machinery of the small interfering RNA (siRNA) and microRNA (miRNA) pathways in different tissues and stages of the silkmoth, Bombyx mori. It was found that the dsRNA-binding protein R2D2, an essential component in the siRNA pathway in Drosophila, was expressed at minimal levels in silkmoth tissues. The silkmoth-derived Bm5 cell line was also deficient in expression of mRNA encoding full-length BmTranslin, an RNA-binding factor that has been shown to stimulate the efficiency of RNAi. However, despite the lack of expression of the RNA-binding proteins, silencing of a luciferase reporter gene was observed by co-transfection of luc dsRNA using a lipophilic reagent. In contrast, gene silencing was not detected when the cells were soaked in culture medium supplemented with dsRNA. The introduction of an expression construct for Tribolium R2D2 (TcR2D2) did not influence the potency of luc dsRNA to silence the luciferase reporter. Immunostaining experiments further showed that both TcR2D2 and BmTranslin accumulated at defined locations within the cytoplasm of transfected cells. Our results offer a first evaluation of the expression of the RNAi machinery in silkmoth tissues and Bm5 cells and provide evidence for a functional RNAi response to intracellular dsRNA in the absence of R2D2 and Translin. The failure of TcR2D2 to stimulate the intracellular RNAi pathway in Bombyx cells is discussed.	[Swevers, Luc] Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece; [Liu, Jisheng; Huvenne, Hanneke; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium	National Centre of Scientific Research "Demokritos"; Ghent University	Swevers, L (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biol, Athens, Greece.	swevers@bio.demokritos.gr; guy.smagghe@ugent.be	Smagghe, Guy/AAE-8914-2019	Smagghe, Guy/0000-0001-8334-3313; Liu, Jisheng/0000-0003-0857-4298	Research Council of Ghent University (BOF-UGent); Fund for Scientific Research-Flanders (FWO-Vlaanderen), Brussels, Belgium [F 6/12]; General Secretariat for Research and Technology; Hellenic Republic Ministry of National Education and Religious Affairs, in Greece; University of Ghent in Belgium; Chinese Academy of Sciences (CSC); Research Council of Ghent University	Research Council of Ghent University (BOF-UGent)(Ghent University); Fund for Scientific Research-Flanders (FWO-Vlaanderen), Brussels, Belgium(FWO); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); Hellenic Republic Ministry of National Education and Religious Affairs, in Greece; University of Ghent in Belgium; Chinese Academy of Sciences (CSC)(Chinese Academy of Sciences); Research Council of Ghent University(Ghent University)	The authors acknowledge support by the Research Council of Ghent University (BOF-UGent) (www.ugent.be), the Fund for Scientific Research-Flanders (FWO-Vlaanderen F 6/12, Brussels, Belgium) (www.fwo.be) and the General Secretariat for Research and Technology, Hellenic Republic Ministry of National Education and Religious Affairs, in Greece (Aristeia program) (www.gsrt.gr). Luc Swevers acknowledges the support by a scholarship for foreign researcher, special research fund, University of Ghent in Belgium (www.ugent.be). Jisheng Liu is the recipient of a doctoral grant from the Chinese Academy of Sciences (CSC) (cas.cn) and is supported by the Research Council of Ghent University (www.ugent.be). Hanneke Huvenne is a postdoctoral research fellow from the IWT-Vlaanderen (Brussel) (www.iwt.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck M, 2003, VIROLOGY, V314, P521, DOI 10.1016/S0042-6822(03)00463-X; Belles X, 2010, ANNU REV ENTOMOL, V55, P111, DOI 10.1146/annurev-ento-112408-085301; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Claussen M, 2006, GENETICS, V174, P1337, DOI 10.1534/genetics.106.063016; Consortium ISG., 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI DOI 10.1016/J.IBMB.2008.11.004; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Eliahoo E, 2010, NUCLEIC ACIDS RES, V38, P2975, DOI 10.1093/nar/gkp1230; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; Farrell PJ, 2000, PROTEINS, V41, P144, DOI 10.1002/1097-0134(20001001)41:1<144::AID-PROT160>3.3.CO;2-8; Georgomanolis T, 2009, INSECT BIOCHEM MOLEC, V39, P892, DOI 10.1016/j.ibmb.2009.10.006; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; Gupta GD, 2008, FEBS J, V275, P4235, DOI 10.1111/j.1742-4658.2008.06571.x; HANNAN GN, 2009, ECDYSONE STRUCTURES, P205; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Johnson JA, 2010, INSECT BIOCHEM MOLEC, V40, P394, DOI 10.1016/j.ibmb.2010.03.005; JOHNSON R, 1992, VIROLOGY, V190, P815, DOI 10.1016/0042-6822(92)90919-G; Kalidas S, 2008, MECH DEVELOP, V125, P475, DOI 10.1016/j.mod.2008.01.006; Kemp C, 2009, CURR OPIN IMMUNOL, V21, P3, DOI 10.1016/j.coi.2009.01.007; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Labropoulou V, 2008, CELL MICROBIOL, V10, P2118, DOI 10.1111/j.1462-5822.2008.01195.x; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Machado E, 2007, INSECT BIOCHEM MOLEC, V37, P876, DOI 10.1016/j.ibmb.2007.04.003; Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Posnien N., 2009, COLD SPRING HARB PRO; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Soin T, 2010, PEST MANAG SCI, V66, P1215, DOI 10.1002/ps.1998; Swevers L, 2004, FASEB J, V18, P134, DOI 10.1096/fj.03-0627fje; Swevers L, 1999, INSECT BIOCHEM MOLEC, V29, P955, DOI 10.1016/S0965-1748(99)00059-4; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tatsuke T, 2010, CELL MOL BIOL LETT, V15, P118, DOI 10.2478/s11658-009-0038-9; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; van Rij RP, 2009, TRENDS MICROBIOL, V17, P163, DOI 10.1016/j.tim.2009.01.003; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yu XM, 2009, GENOMICS, V94, P438, DOI 10.1016/j.ygeno.2009.08.007; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018	59	42	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20250	10.1371/journal.pone.0020250	http://dx.doi.org/10.1371/journal.pone.0020250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637842	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200043
J	Beck, EJ; Mandalia, S; Lo, G; Sharott, P; Youle, M; Anderson, J; Baily, G; Brettle, R; Fisher, M; Gompels, M; Kinghorn, G; Johnson, M; McCarron, B; Pozniak, A; Tang, A; Walsh, J; White, D; Williams, I; Gazzard, B				Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Sharott, Peter; Youle, Mike; Anderson, Jane; Baily, Guy; Brettle, Ray; Fisher, Martin; Gompels, Mark; Kinghorn, George; Johnson, Margaret; McCarron, Brendan; Pozniak, Anton; Tang, Alan; Walsh, John; White, David; Williams, Ian; Gazzard, Brian		NPMS-HHC Steering Grp	Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; HIV-INFECTION; SOUTH-AFRICA; POPULATION	Aim: Calculate time to first-line treatment failure, annual cost and cost-effectiveness of NNRTI versus PIboosted first-line HAART regimens in the UK, 1996-2006. Background: Population costs for HIV services are increasing in the UK and interventions need to be effective and efficient to reduce or stabilize costs. 2NRTIs + NNRTI regimens are cost-effective regimens for first-line HAART, but these regimens have not been compared with first-line PI(boosted) regimens. Methods: Times to first-line treatment failure and annual costs were calculated for first-line HAART regimens by CD4 count when starting HAART (2006 UK prices). Cost-effectiveness of 2NRTIs+NNRTI versus 2NRTIs+PI(boosted) regimens was calculated for four CD4 strata. Results: 55% of 5,541 people living with HIV (PLHIV) started HAART with CD4 count <= 200 cells/mm(3), many of whom were Black Africans. Annual treatment cost decreased as CD4 count increased; most marked differences were observed between starting HAART with CD4 <= 200 cells/mm3 compared with CD4 count >200 cells/mm3. 2NRTI+PI(boosted) and 2NRTI+NNRTI regimens were the most effective regimens across the four CD4 strata; 2NRTI+NNRTI was cost-saving or cost-effective compared with 2NRTI + PI(boosted) regimens. Conclusion: To ensure more effective and efficient provision of HIV services, 2NRTI+NNRTI should be started as first-line HAART regimen at CD4 counts <= 350 cell/mm3, unless specific contra-indications exist. This will increase the number of PLHIV receiving HAART and will initially increase population costs of providing HIV services. However, starting PLHIV earlier on cost-effective regimens will maintain them in better health and use fewer health or social services, thereby generating fewer treatment and care costs, enabling them to remain socially and economically active members of society. This does raise a number of ethical issues, which will have to be acknowledged and addressed, especially in countries with limited resources.	[Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Youle, Mike; Gazzard, Brian] NPMS HHC Coordinating & Analyt Ctr, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Sharott, Peter] London Procurement Programme, London Specialised Commissioning Grp, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Anderson, Jane] Homerton Univ Hosp NHS Fdn Trust, London, England; [Baily, Guy] London Hosp, London E1 1BB, England; [Baily, Guy] Barts Hosp, London, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Fisher, Martin] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [Kinghorn, George] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [McCarron, Brendan] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Beck, Eduard J.; Mandalia, Sundhiya; Lo, Gary; Pozniak, Anton; Gazzard, Brian] Chelsea & Westminster Hosp, London, England; [Tang, Alan] Royal Berkshire Hosp, Reading, Berks, England; [Walsh, John] St Marys Hosp, London, England; [White, David] Birmingham Heartsland Hosp, Birmingham, W Midlands, England; [Williams, Ian] Mortimer Market Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; Queen Mary University London; University of Brighton; Southmead Hospital; University of Sheffield; James Cook University Hospital; Imperial College London; Royal Berkshire Hospital; Imperial College London	Beck, EJ (corresponding author), NPMS HHC Coordinating & Analyt Ctr, London, England.	becke@unaids.org	Kinghorn, George/AAO-1425-2021; Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Kinghorn, George/0000-0001-6608-5076	Tibotec	Tibotec	During 2008/2009, the NPMS-HHC was financially supported through a non-restrictive grant from Tibotec, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 1999, AIDS, V13, P2157, DOI 10.1097/00002030-199910220-00020; Beck EJ, 1998, PHARMACOECONOMICS, V14, P639, DOI 10.2165/00019053-199814060-00005; Beck EJ, 2004, AIDS, V18, P2411; Beck EJ, 2003, BRIT J SEX MED, V27, P21; BECK EJ, 2010, 18 INT AIDS C VIENN; BECK EJ, 2003, BRIT J SEX MED, V27, P19; BECK EJ, 2008, USE COST HIV SERVICE; BECK EJ, 2006, HIV PANDEMIC LOCAL G, P769; BECK EJ, 2008, DECADE HAART, P45; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Crum-Cianflone NF, 2010, JAIDS-J ACQ IMM DEF, V54, P248, DOI 10.1097/QAI.0b013e3181c8ef22; Ford N, 2009, NEW ENGL J MED, V360, P1808, DOI 10.1056/NEJMp0902820; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Geng EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014098; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; *INSIGHT COMM AD B, 2010, COMM STAT START TRIA; John A, 2010, MED CARE, V48, P1071; Josefsson L, 2010, CURR OPIN INFECT DIS, V23, P628, DOI 10.1097/QCO.0b013e32833ff1d0; Krentz HB, 2008, HIV MED, V9, P721, DOI 10.1111/j.1468-1293.2008.00613.x; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mandalia S, 2002, HIV Med, V3, P254, DOI 10.1046/j.1468-1293.2002.00110.x; Mandalia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015677; NEATON JD, 2009, STRATEGIC TIMING ANT; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; THAKKAR B, 1998, SUGI 23 MARCH 22 25; *UNAIDS PEPFAR, 2007, P WORKSH 15 17 MAY 2; Wagner B, 2010, LANCET, V376, P953, DOI 10.1016/S0140-6736(10)61442-0; WHO, 2010, ANT THER HIV INF AD; Wood E, 2003, AIDS, V17, P711, DOI 10.1097/00002030-200303280-00009	36	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20200	10.1371/journal.pone.0020200	http://dx.doi.org/10.1371/journal.pone.0020200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633514	Green Published, Green Accepted, gold			2022-12-25	WOS:000291006500041
J	Cheng, L; Yang, ZH; Wang, XH; Jiao, YY; Xie, XY; Lin, J; Zhang, H; Han, JQ; Jiang, K; Ye, QN				Cheng, Long; Yang, Zhihong; Wang, Xiaohui; Jiao, Yuanyuan; Xie, Xiangyang; Lin, Jing; Zhang, Hao; Han, Juqiang; Jiang, Kai; Ye, Qinong			Suppression of Estrogen Receptor Transcriptional Activity by Connective Tissue Growth Factor	PLOS ONE			English	Article							ALPHA-ASSOCIATED PROTEIN; BREAST-CANCER CELLS; CCN FAMILY; CROSS-TALK; EXPRESSION; CYR61; CTGF; MEMBRANE; ACTS; BETA	Secreted growth factors have been shown to stimulate the transcriptional activity of estrogen receptors (ER) that are responsible for many biological processes. However, whether these growth factors physically interact with ER remains unclear. Here, we show for the first time that connective tissue growth factor (CTGF) physically and functionally associates with ER. CTGF interacted with ER both in vitro and in vivo. CTGF interacted with ER DNA-binding domain. ER interaction region in CTGF was mapped to the thrombospondin type I repeat, a cell attachment motif. Overexpression of CTGF inhibited ER transcriptional activity as well as the expression of estrogen-responsive genes, including pS2 and cathepsin D. Reduction of endogenous CTGF with CTGF small interfering RNA enhanced ER transcriptional activity. The interaction between CTGF and ER is required for the repression of estrogen-responsive transcription by CTGF. Moreover, CTGF reduced ER protein expression, whereas the CTGF mutant that did not repress ER transcriptional activity also did not alter ER protein levels. The results suggested the transcriptional regulation of estrogen signaling through interaction between CTGF and ER, and thus may provide a novel mechanism by which cross-talk between secreted growth factor and ER signaling pathways occurs.	[Cheng, Long; Yang, Zhihong; Wang, Xiaohui; Jiao, Yuanyuan; Xie, Xiangyang; Zhang, Hao; Han, Juqiang; Jiang, Kai; Ye, Qinong] Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China; [Lin, Jing] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Clin Lab, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Cheng, L (corresponding author), Beijing Inst Biotechnol, Dept Med Mol Biol, Beijing, Peoples R China.	yeqn66@yahoo.com	jiao, jen/L-2076-2013	Cheng, Long/0000-0002-4752-1298; Jiang, Kai/0000-0002-8507-1945	Major State Basic Research Development Program [2011CB504202, 2007CB914603]; National Natural Science Foundation [30972594, 30800205, 81072173, 30625035]; National Key Technologies RD Program [2009ZX09301-002]; Medicine and Health Research Foundation [06J021]	Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Medicine and Health Research Foundation	This work was supported by Major State Basic Research Development Program (2011CB504202 and 2007CB914603), National Natural Science Foundation (30972594, 30800205, 81072173 and 30625035), the National Key Technologies R&D Program for New Drugs (2009ZX09301-002), and Medicine and Health Research Foundation of PLA People's Liberation Army (06J021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Chang CC, 2006, JNCI-J NATL CANCER I, V98, P984, DOI 10.1093/jnci/djj242; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Ding LH, 2003, NUCLEIC ACIDS RES, V31, P5266, DOI 10.1093/nar/gkg731; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Farooqui M, 2006, MOL CANCER THER, V5, P611, DOI 10.1158/1535-7163.MCT-05-0016; Ford CE, 2009, P NATL ACAD SCI USA, V106, P3919, DOI 10.1073/pnas.0809516106; Gobinet J, 2001, BIOCHEMISTRY-US, V40, P15369, DOI 10.1021/bi011384o; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Han JQ, 2006, NUCLEIC ACIDS RES, V34, P3095, DOI 10.1093/nar/gkl389; Hanstein B, 2004, EUR J ENDOCRINOL, V150, P243, DOI 10.1530/eje.0.1500243; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; Jacob J, 2006, MOL CELL ENDOCRINOL, V246, P34, DOI 10.1016/j.mce.2005.11.015; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Lichtner RB, 2003, BIOMED PHARMACOTHER, V57, P447, DOI 10.1016/j.biopha.2003.09.006; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875; Loven MA, 2004, MOL ENDOCRINOL, V18, P2649, DOI 10.1210/me.2003-0195; Loven MA, 2003, MOL ENDOCRINOL, V17, P67, DOI 10.1210/me.2002-0280; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; PIETRAS RJ, 1980, BIOCHEM J, V191, P743, DOI 10.1042/bj1910743; Qin X, 2008, CELL MOL LIFE SCI, V65, P2752, DOI 10.1007/s00018-008-8273-1; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie D, 2001, CANCER RES, V61, P8917; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	48	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20028	10.1371/journal.pone.0020028	http://dx.doi.org/10.1371/journal.pone.0020028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629692	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005800022
J	Gupta, N; Singh, S; Maturu, VN; Sharma, YP; Gill, KD				Gupta, Nidhi; Singh, Surjit; Maturu, V. Nagarjuna; Sharma, Yash Paul; Gill, Kiran Dip			Paraoxonase 1 (PON1) Polymorphisms, Haplotypes and Activity in Predicting CAD Risk in North-West Indian Punjabis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HUMAN-SERUM PARAOXONASE; DEPENDENT DIABETES-MELLITUS; ARTERY-DISEASE; GLN-ARG192 POLYMORPHISM; PROMOTER POLYMORPHISMS; GENETIC-POLYMORPHISM; PESTICIDE EXPOSURE; VASCULAR-DISEASE; ATHEROSCLEROSIS	Background: Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) and hydrolyzes the oxidized form, therefore preventing the development of atherosclerosis. The polymorphisms of PON1 gene are known to affect the PON1 activity and thereby coronary artery disease (CAD) risk. As studies are lacking in North-West Indian Punjabi's, a distinct ethnic group with high incidence of CAD, we determined PON1 activity, genotypes and haplotypes in this population and correlated them with the risk of CAD. Methodology/Principal Findings: 350 angiographically proven (>= 70% stenosis) CAD patients and 300 healthy controls were investigated. PON1 activity was determined towards paraoxon (Paraoxonase; PONase) and phenylacetate (Arylesterase; AREase) substrates. In addition, genotyping was carried out by using multiplex PCR, allele specific oligonucleotide -PCR and PCR-RFLP methods and haplotyping was determined by PHASE software. The serum PONase and AREase activities were significantly lower in CAD patients as compared to the controls. All studied polymorphisms except L55M had significant effect on PONase activity. However AREase activity was not affected by them. In a logistic regression model, after adjustment for the conventional risk factors for CAD, QR (OR: 2.73 (1.57-4.72)) and RR (OR, 16.24 (6.41-41.14)) genotypes of Q192R polymorphism and GG (OR: 2.07 (1.02-4.21)) genotype of -162A/G polymorphism had significantly higher CAD risk. Haplotypes L-T-G-Q-C (OR: 3.25 (1.72-6.16)) and L-T-G-R-G (OR: 2.82 (1.01-7.80)) were also significantly associated with CAD. Conclusions: In conclusion this study shows that CAD patients had lower PONase and AREase activities as compared to the controls. The coding Q192R polymorphism, promoter -162A/G polymorphism and L-T-G-Q-C and L-T-G-R-G haplotypes are all independently associated with CAD.	[Gupta, Nidhi; Gill, Kiran Dip] PGIMER, Dept Biochem, Chandigarh, India; [Singh, Surjit; Maturu, V. Nagarjuna] PGIMER, Dept Internal Med, Chandigarh, India; [Sharma, Yash Paul] PGIMER, Dept Cardiol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Gupta, N (corresponding author), PGIMER, Dept Biochem, Chandigarh, India.	kdgill2002@yahoo.co.in		Maturu, Venkata Nagarjuna/0000-0002-3679-9497	Council of Scientific and Industrial Research - University Grants Commission (CSIR-UGC)	Council of Scientific and Industrial Research - University Grants Commission (CSIR-UGC)(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research - University Grants Commission (CSIR-UGC), provided research fellowship to NG. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Antikainen M, 1996, J CLIN INVEST, V98, P883, DOI 10.1172/JCI118869; Arca M, 2002, EUR J CLIN INVEST, V32, P9, DOI 10.1046/j.1365-2362.2002.00935.x; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P1673, DOI 10.1289/ehp.7005; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Brophy VH, 2001, PHARMACOGENETICS, V11, P77, DOI 10.1097/00008571-200102000-00009; CAMBIEN F, 2001, GENOTYPE PHENOTYPE, P31; Cao HB, 1999, J LIPID RES, V40, P133; Daly AK, 1996, METHOD ENZYMOL, V272, P199, DOI 10.1016/S0076-6879(96)72024-4; Davies HG, 1996, NAT GENET, V14, P334, DOI 10.1038/ng1196-334; Deakin S, 2003, BIOCHEM J, V372, P643, DOI 10.1042/BJ20021670; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Enas E A, 1998, Indian Heart J, V50, P105; Enas E A, 1996, Indian Heart J, V48, P343; FURLONG CE, 1991, BIOCHEMISTRY-US, V30, P10133, DOI 10.1021/bi00106a009; Furlong CE, 2006, PHARMACOGENET GENOM, V16, P183; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; GARIN MCB, 1994, BIOCHEM J, V304, P549, DOI 10.1042/bj3040549; Gordon D, 2002, HUM HERED, V54, P22, DOI 10.1159/000066696; Gouedard C, 2003, MOL PHARMACOL, V63, P945, DOI 10.1124/mol.63.4.945; HEGELE RA, 1995, ARTERIOSCL THROM VAS, V15, P89, DOI 10.1161/01.ATV.15.1.89; Hernandez AF, 2003, HUM EXP TOXICOL, V22, P565, DOI 10.1191/0960327103ht400oa; James RW, 2000, DIABETES, V49, P1390, DOI 10.2337/diabetes.49.8.1390; Janus ED, 1996, CIRCULATION, V94, P2671, DOI 10.1161/01.CIR.94.11.2671; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Jarvik GP, 2003, ARTERIOSCL THROM VAS, V23, P1465, DOI 10.1161/01.ATV.0000081635.96290.D3; Ko YL, 1998, ATHEROSCLEROSIS, V141, P259, DOI 10.1016/S0021-9150(98)00179-8; Leviev I, 2000, ARTERIOSCL THROM VAS, V20, P516, DOI 10.1161/01.ATV.20.2.516; Leviev N, 2001, J MOL MED, V79, P457, DOI 10.1007/s001090100240; Mackness B, 2000, EUR J CLIN INVEST, V30, P4; Mackness B, 1998, ATHEROSCLEROSIS, V139, P341, DOI 10.1016/S0021-9150(98)00095-1; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 2002, CURR OPIN LIPIDOL, V13, P357, DOI 10.1097/00041433-200208000-00002; Mackness B, 1997, BRIT J PHARMACOL, V122, P265, DOI 10.1038/sj.bjp.0701390; MACKNESS MI, 1991, ATHEROSCLEROSIS, V86, P193, DOI 10.1016/0021-9150(91)90215-O; Mackness MI, 2000, CURR OPIN LIPIDOL, V11, P383, DOI 10.1097/00041433-200008000-00007; MCELVEEN J, 1986, CLIN CHEM, V32, P671; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; Najafi M, 2009, THROMB RES, V123, P503, DOI 10.1016/j.thromres.2008.03.004; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Nevin DN, 1996, ARTERIOSCL THROM VAS, V16, P1243, DOI 10.1161/01.ATV.16.10.1243; Ombres D, 1998, ARTERIOSCL THROM VAS, V18, P1611, DOI 10.1161/01.ATV.18.10.1611; Richter RJ, 2010, ADV EXP MED BIOL, V660, P29, DOI 10.1007/978-1-60761-350-3_4; Richter RJ, 2008, CIRC-CARDIOVASC GENE, V1, P147, DOI 10.1161/CIRCGENETICS.108.811638; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Rompler H, 2006, NAT PROTOC, V1, P720, DOI 10.1038/nprot.2006.84; ROSE HA, 1970, CENSUS REPORT, V1, P55; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; SAIKAWA Y, 1995, BIOCHEMISTRY-US, V34, P9951, DOI 10.1021/bi00031a018; Sanghera DK, 1997, ARTERIOSCL THROM VAS, V17, P1067, DOI 10.1161/01.ATV.17.6.1067; Schmidt H, 1998, STROKE, V29, P2043, DOI 10.1161/01.STR.29.10.2043; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Singh S, 1999, INDIAN J MED RES, V110, P133; Singh S, 2007, INDIAN J MED RES, V125, P783; SORENSON RC, 1995, P NATL ACAD SCI USA, V92, P7187, DOI 10.1073/pnas.92.16.7187; Suehiro T, 2000, ATHEROSCLEROSIS, V150, P295, DOI 10.1016/S0021-9150(99)00379-2; Suehiro T, 1996, INT J CARDIOL, V57, P69, DOI 10.1016/S0167-5273(96)02779-9; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Zama T, 1997, ARTERIOSCL THROM VAS, V17, P3565, DOI 10.1161/01.ATV.17.12.3565	62	61	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e17805	10.1371/journal.pone.0017805	http://dx.doi.org/10.1371/journal.pone.0017805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629682	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800001
J	Kolligs, FT; Crispin, A; Munte, A; Wagner, A; Mansmann, U; Goke, B				Kolligs, Frank T.; Crispin, Alexander; Munte, Axel; Wagner, Andreas; Mansmann, Ulrich; Goeke, Burkhard			Risk of Advanced Colorectal Neoplasia According to Age and Gender	PLOS ONE			English	Article							FECAL OCCULT-BLOOD; SOCIETY-TASK-FORCE; ASYMPTOMATIC ADULTS; CANCER STATISTICS; COLONIC NEOPLASIA; ADVANCED ADENOMAS; AMERICAN-COLLEGE; COLONOSCOPY; PREVENTION; SURVEILLANCE	Background: Colorectal cancer (CRC) is one of the leading causes of cancer related morbidity and death. Despite the fact that the mean age at diagnosis of CRC is lower in men, screening by colonoscopy or fecal occult blood test (FOBT) is initiated at same age in both genders. The prevalence of the common CRC precursor lesion, advanced adenoma, is well documented only in the screening population. The purpose of this study was to assess the risk of advanced adenoma at ages below screening age. Methods and Findings: We analyzed data from a census of 625,918 outpatient colonoscopies performed in adults in Bavaria between 2006 and 2008. A logistic regression model to determine gender-and age-specific risk of advanced neoplasia was developed. Advanced neoplasia was found in 16,740 women (4.6%) and 22,684 men (8.6%). Male sex was associated with an overall increased risk of advanced neoplasia (odds ratio 1.95; 95% confidence interval, CI, 1.91 to 2.00). At any age and in any indication group, more colonoscopies were needed in women than in men to detect advanced adenoma or cancer. At age 75 14.8 (95% CI, 14.4-15.2) screening, 18.2 (95% CI, 17.7-18.7) diagnostic, and 7.9 (95% CI, 7.6-8.2) colonoscopies to follow up on a positive FOBT (FOBT colonoscopies) were needed to find advanced adenoma in women. At age 50 39.0 (95% CI, 38.0-40.0) diagnostic, and 16.3 (95% CI, 15.7-16.9) FOBT colonoscopies were needed. Comparable numbers were reached 20 and 10 years earlier in men than in women, respectively. Conclusions: At any age and independent of the indication for colonoscopy, men are at higher risk of having advanced neoplasia diagnosed upon colonoscopy than women. This suggests that starting screening earlier in life in men than in women might result in a relevant increase in the detection of asymptomatic preneoplastic and neoplastic colonic lesions.	[Kolligs, Frank T.; Wagner, Andreas; Goeke, Burkhard] Univ Munich, Dept Med 2, Munich, Germany; [Crispin, Alexander; Mansmann, Ulrich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Munte, Axel] Bavarian Assoc Compulsory Hlth Insurance Phys, Munich, Germany	University of Munich; University of Munich	Kolligs, FT (corresponding author), Univ Munich, Dept Med 2, Munich, Germany.	fkolligs@med.uni-muenchen.de			Munich Center of Health Sciences	Munich Center of Health Sciences	The support by the LMUinnovativ project Munich Center of Health Sciences, subproject II (evidence-based prevention and modeling of chronic diseases) is gratefully acknowledged.	Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2010, GASTROENTEROLOGY, V138, P870, DOI 10.1053/j.gastro.2009.10.054; Crispin A, 2009, ENDOSCOPY, V41, P1018, DOI 10.1055/s-0029-1215214; Gellad ZF, 2010, AM J GASTROENTEROL, V105, P1746, DOI 10.1038/ajg.2010.107; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones RM, 2010, CANCER EPIDEM BIOMAR, V19, P2821, DOI 10.1158/1055-9965.EPI-10-0695; Kahi CJ, 2008, GASTROENTEROLOGY, V135, P380, DOI 10.1053/j.gastro.2008.06.026; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman D, 2005, AM J GASTROENTEROL, V100, P2756, DOI 10.1111/j.1572-0241.2005.00352.x; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansmann U, 2008, DTSCH ARZTEBL INT, V105, P434, DOI 10.3238/arztebl.2008.0434; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nguyen SP, 2009, CLIN GASTROENTEROL H, V7, P676, DOI 10.1016/j.cgh.2009.01.008; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schmiegel W, 2008, Z GASTROENTEROL, V46, P799, DOI 10.1055/s-2008-1027726; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Strul H, 2006, AM J GASTROENTEROL, V101, P255, DOI 10.1111/j.1572-0241.2006.00430.x; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	31	63	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20076	10.1371/journal.pone.0020076	http://dx.doi.org/10.1371/journal.pone.0020076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629650	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800026
J	Verdino, P; Witherden, DA; Podshivalova, K; Rieder, SE; Havran, WL; Wilson, IA				Verdino, Petra; Witherden, Deborah A.; Podshivalova, Katie; Rieder, Stephanie E.; Havran, Wendy L.; Wilson, Ian A.			cDNA Sequence and Fab Crystal Structure of HL4E10, a Hamster IgG Lambda Light Chain Antibody Stimulatory for gamma delta T Cells	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; ANTIGEN RECOGNITION; SIGNAL PEPTIDES; PREDICTION; JAML; GENE; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISM; EXPRESSION	Hamsters are widely used to generate monoclonal antibodies against mouse, rat, and human antigens, but sequence and structural information for hamster immunoglobulins is sparse. To our knowledge, only three hamster IgG sequences have been published, all of which use kappa light chains, and no three-dimensional structure of a hamster antibody has been reported. We generated antibody HL4E10 as a probe to identify novel costimulatory molecules on the surface of gamma delta T cells which lack the traditional alpha beta T cell co-receptors CD4, CD8, and the costimulatory molecule CD28. HL4E10 binding to gamma delta T cell, surface-expressed, Junctional Adhesion Molecule-Like (JAML) protein leads to potent costimulation via activation of MAP kinase pathways and cytokine production, resulting in cell proliferation. The cDNA sequence of HL4E10 is the first example of a hamster lambda light chain and only the second known complete hamster heavy chain sequence. The crystal structure of the HL4E10 Fab at 2.95 angstrom resolution reveals a rigid combining site with pockets faceted by solvent-exposed tyrosine residues, which are structurally optimized for JAML binding. The characterization of HL4E10 thus comprises a valuable addition to the spartan database of hamster immunoglobulin genes and structures. As the HL4E10 antibody is uniquely costimulatory for gamma delta T cells, humanized versions thereof may be of clinical relevance in treating gamma delta T cell dysfunction-associated diseases, such as chronic non-healing wounds and cancer.	[Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Witherden, Deborah A.; Podshivalova, Katie; Rieder, Stephanie E.; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Verdino, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Podshivalova, Katie/K-7401-2019		NIH [AI042266, CA58896, AI064811]; Skaggs Institute; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R01AI064811, R37AI042266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Erwin-Schrodinger Fellowship J2313 of the Austrian Science Fund (P.V.), by NIH grants AI042266 and CA58896 (I.A.W.), AI064811 (W.L.H.) and the Skaggs Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEGRE ML, 1995, J IMMUNOL, V155, P1544; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boismenu R, 1998, CLIN IMMUNOL IMMUNOP, V86, P121, DOI 10.1006/clin.1997.4468; Born WK, 2006, CURR OPIN IMMUNOL, V18, P31, DOI 10.1016/j.coi.2005.11.007; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; COLLINS M, 1995, IMMUNOGENETICS, V42, P225, DOI 10.1007/BF00191230; Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez A, 2008, J CLASSIF, V25, P43, DOI 10.1007/s00357-008-9004-x; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Greve B, 2004, J IMMUNOL, V173, P157, DOI 10.4049/jimmunol.173.1.157; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jameson J, 2003, CURR OPIN IMMUNOL, V15, P349, DOI 10.1016/S0952-7915(03)00045-1; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kabelitz D, 2000, INT ARCH ALLERGY IMM, V122, P1, DOI 10.1159/000024353; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Konigshofer Y, 2006, CURR OPIN IMMUNOL, V18, P527, DOI 10.1016/j.coi.2006.07.008; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEGENDRE NM, 1993, PRACTICAL GUIDE PROT; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mallender WD, 1995, MOL IMMUNOL, V32, P1093, DOI 10.1016/0161-5890(95)00082-8; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; Martin ACR, 1996, J MOL BIOL, V263, P800, DOI 10.1006/jmbi.1996.0617; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCGUIRE KL, 1985, NUCLEIC ACIDS RES, V13, P5611, DOI 10.1093/nar/13.15.5611; Mozdzanowski J, 1998, ANAL BIOCHEM, V260, P183, DOI 10.1006/abio.1998.2690; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; SANCHEZMADRID F, 1983, J IMMUNOL, V130, P309; Sharp LL, 2005, CRIT REV IMMUNOL, V25, P1, DOI 10.1615/CritRevImmunol.v25.i1.10; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tsunasawa S, 1998, J BIOCHEM, V124, P778, DOI 10.1093/oxfordjournals.jbchem.a022179; Verdino P, 2011, STRUCTURE, V19, P80, DOI 10.1016/j.str.2010.10.007; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Werner WE, 2005, ANAL BIOCHEM, V342, P120, DOI 10.1016/j.ab.2005.04.012; WHITTERS MJ, 1995, IMMUNOGENETICS, V42, P227, DOI 10.1007/BF00191231; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Witherden DA, 2010, SCIENCE, V329, P1205, DOI 10.1126/science.1192698; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	63	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19828	10.1371/journal.pone.0019828	http://dx.doi.org/10.1371/journal.pone.0019828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629689	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800012
J	Balk, L; Hylland, K; Hansson, T; Berntssen, MHG; Beyer, J; Jonsson, G; Melbye, A; Grung, M; Torstensen, BE; Borseth, JF; Skarphedinsdottir, H; Klungsoyr, J				Balk, Lennart; Hylland, Ketil; Hansson, Tomas; Berntssen, Marc H. G.; Beyer, Jonny; Jonsson, Grete; Melbye, Alf; Grung, Merete; Torstensen, Bente E.; Borseth, Jan Fredrik; Skarphedinsdottir, Halldora; Klungsoyr, Jarle			Biomarkers in Natural Fish Populations Indicate Adverse Biological Effects of Offshore Oil Production	PLOS ONE			English	Article							COD GADUS-MORHUA; PIKE ESOX-LUCIUS; PERCH PERCA-FLUVIATILIS; DNA ADDUCT FORMATION; SALMON SALMO-SALAR; NORTH-SEA-OIL; ATLANTIC COD; VITAMIN-E; LIPID-COMPOSITION; FUNDULUS-HETEROCLITUS	Background: Despite the growing awareness of the necessity of a sustainable development, the global economy continues to depend largely on the consumption of non-renewable energy resources. One such energy resource is fossil oil extracted from the seabed at offshore oil platforms. This type of oil production causes continuous environmental pollution from drilling waste, discharge of large amounts of produced water, and accidental spills. Methods and principal findings: Samples from natural populations of haddock (Melanogrammus aeglefinus) and Atlantic cod (Gadus morhua) in two North Sea areas with extensive oil production were investigated. Exposure to and uptake of polycyclic aromatic hydrocarbons (PAHs) were demonstrated, and biomarker analyses revealed adverse biological effects, including induction of biotransformation enzymes, oxidative stress, altered fatty acid composition, and genotoxicity. Genotoxicity was reflected by a hepatic DNA adduct pattern typical for exposure to a mixture of PAHs. Control material was collected from a North Sea area without oil production and from remote Icelandic waters. The difference between the two control areas indicates significant background pollution in the North Sea. Conclusion: It is most remarkable to obtain biomarker responses in natural fish populations in the open sea that are similar to the biomarker responses in fish from highly polluted areas close to a point source. Risk assessment of various threats to the marine fish populations in the North Sea, such as overfishing, global warming, and eutrophication, should also take into account the ecologically relevant impact of offshore oil production.	[Balk, Lennart; Hansson, Tomas; Skarphedinsdottir, Halldora] Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden; [Hylland, Ketil] Univ Oslo, Dept Biol, Oslo, Norway; [Hylland, Ketil; Grung, Merete] Norwegian Inst Water Res NIVA, Oslo, Norway; [Berntssen, Marc H. G.; Torstensen, Bente E.] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Beyer, Jonny; Borseth, Jan Fredrik] Int Res Inst Stavanger IRIS, Stavanger, Norway; [Beyer, Jonny] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway; [Jonsson, Grete] Stavanger Univ Hosp, Dept Med Biochem, Stavanger, Norway; [Melbye, Alf] SINTEF Mat & Chem, Trondheim, Norway; [Klungsoyr, Jarle] Inst Marine Res IMR, Bergen, Norway	Stockholm University; University of Oslo; Norwegian Institute for Water Research (NIVA); Universitetet i Stavanger; Stavanger University Hospital; SINTEF; Institute of Marine Research - Norway	Balk, L (corresponding author), Stockholm Univ, Dept Appl Environm Sci ITM, S-10691 Stockholm, Sweden.	lennart.balk@itm.su.se; tomas.hansson@itm.su.se	Beyer, Jonny/E-8001-2011; Berntssen, Marc/O-9406-2018	Beyer, Jonny/0000-0003-2229-3185	Norwegian Research Council; Norwegian Ministry of Fisheries; Norwegian Oil Industry Association	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Ministry of Fisheries; Norwegian Oil Industry Association	The study was supported by the Norwegian Research Council, the Norwegian Ministry of Fisheries, and the Norwegian Oil Industry Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas E, 2000, AQUAT TOXICOL, V51, P241, DOI 10.1016/S0166-445X(00)00108-9; Aas E, 2000, BIOMARKERS, V5, P9, DOI 10.1080/135475000230505; Aas E, 2003, BIOMARKERS, V8, P445, DOI 10.1080/1354750032000158439; BALK L, 1984, TOXICOL APPL PHARM, V74, P430, DOI 10.1016/0041-008X(84)90296-5; BEACH AC, 1992, CARCINOGENESIS, V13, P1053, DOI 10.1093/carcin/13.7.1053; BELL JG, 1985, BRIT J NUTR, V53, P149, DOI 10.1079/BJN19850019; Beyer J, 2010, ENVIRON TOXICOL PHAR, V30, P224, DOI 10.1016/j.etap.2010.08.004; Bohne-Kjersem A, 2009, MAR ENVIRON RES, V68, P268, DOI 10.1016/j.marenvres.2009.06.016; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; BRIDGES B A, 1990, Mutation Research, V239, P143, DOI 10.1016/0165-1110(90)90002-S; Brigelius-Flohe R, 2010, MOL NUTR FOOD RES, V54, P583, DOI 10.1002/mnfr.201000091; Brigelius-Flohe R, 2010, MOL NUTR FOOD RES, V54, P581, DOI [10.1002/mnfr.201090018, 10.1002/mnfr.201000091]; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; BURTON GW, 1994, P NUTR SOC, V53, P251, DOI 10.1079/PNS19940030; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; DEY I, 1993, P NATL ACAD SCI USA, V90, P7498, DOI 10.1073/pnas.90.16.7498; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DUNN BP, 1987, CANCER RES, V47, P6543; Ericson G, 1999, AQUAT TOXICOL, V45, P181, DOI 10.1016/S0166-445X(98)00100-3; Ericson G, 2000, MUTAT RES-FUND MOL M, V454, P11, DOI 10.1016/S0027-5107(00)00092-0; Ericson G, 1999, MUTAT RES-FUND MOL M, V427, P135, DOI 10.1016/S0027-5107(99)00088-3; Ericson G, 1998, CAN J FISH AQUAT SCI, V55, P815, DOI 10.1139/cjfas-55-4-815; EXLER J, 1975, J AM OIL CHEM SOC, V52, P154, DOI 10.1007/BF02557948; Falch E, 2006, J FOOD COMPOS ANAL, V19, P727, DOI 10.1016/j.jfca.2005.12.004; Falch E, 2006, PROCESS BIOCHEM, V41, P666, DOI 10.1016/j.procbio.2005.08.015; Farkas T, 2001, AQUAC RES, V32, P645, DOI 10.1046/j.1365-2109.2001.00600.x; Farmen E, 2010, MAR POLLUT BULL, V60, P1092, DOI 10.1016/j.marpolbul.2010.01.015; Farmer PB, 1999, MUTAT RES-FUND MOL M, V424, P275, DOI 10.1016/S0027-5107(99)00025-1; French BL, 1996, AQUAT TOXICOL, V36, P1, DOI 10.1016/S0166-445X(96)00812-0; Gamble SC, 1997, J CHEM TECHNOL BIOT, V68, P123; GOKSOYR A, 1991, COMP BIOCHEM PHYS C, V100, P157, DOI 10.1016/0742-8413(91)90144-I; Grim JM, 2010, J EXP BIOL, V213, P445, DOI 10.1242/jeb.036939; Grung M, 2009, J TOXICOL ENV HEAL A, V72, P254, DOI 10.1080/15287390802539210; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Holth TF, 2009, ENVIRON SCI TECHNOL, V43, P3329, DOI 10.1021/es803479p; Hylland K, 2006, J TOXICOL ENV HEAL A, V69, P125, DOI 10.1080/15287390500259392; Jonsson G, 2003, J ENVIRON MONITOR, V5, P513, DOI 10.1039/b300903n; JOSEPHY PD, 1997, MOL TOXICOLOGY, P97; KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0; Knijn R.J., 1993, ICES COOP RES REP, V194, P268; KURELEC B, 1993, MAR ENVIRON RES, V35, P341, DOI 10.1016/0141-1136(93)90101-5; LEACH JJ, 1973, TOXICOL APPL PHARM, V25, P430; LIE O, 1986, AQUACULTURE, V59, P187, DOI 10.1016/0044-8486(86)90003-7; LIE O, 1994, FISH PHYSIOL BIOCHEM, V13, P241, DOI 10.1007/BF00004362; LIEHR JG, 1986, P NATL ACAD SCI USA, V83, P5301, DOI 10.1073/pnas.83.14.5301; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCKEE MJ, 1983, AQUAT TOXICOL, V3, P103, DOI 10.1016/0166-445X(83)90032-2; Meier S, 2007, COMP BIOCHEM PHYS C, V145, P420, DOI 10.1016/j.cbpc.2007.01.012; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Neff J.M., 2002, BIOACCUMULATION MARI, P241; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126; REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543; REICHERT WL, 1994, NMFSNWFSC14 NOAA NTI; Rilfors L, 2002, COLLOID SURFACE B, V26, P112, DOI 10.1016/S0927-7765(01)00310-1; RUUS A, 2003, 86903 SFT NIVA; SANTOS J, 1993, AQUACULTURE, V110, P173; Shugart L. R., 1995, AQUATIC TOXICOLOGY E, P405; STAGG RM, 1996, PRODUCED WATER, V2, P195; STEIN JE, 1993, MAR ENVIRON RES, V35, P95, DOI 10.1016/0141-1136(93)90020-Z; Sturve J, 2006, AQUAT TOXICOL, V78, pS73, DOI 10.1016/j.aquatox.2006.02.019; Sundt RC, 2009, MAR POLLUT BULL, V58, P1382, DOI 10.1016/j.marpolbul.2009.04.016; The National Academy Press, 2003, OIL SEA; Torstensen BE, 2004, AQUACULT NUTR, V10, P175, DOI 10.1111/j.1365-2095.2004.00289.x; VARANASI U, 1989, CANCER RES, V49, P1171; VARANASI U, 1989, CRC UNISCIENCE SERIE, P93; Willett KL, 2001, TOXICOL APPL PHARM, V177, P264, DOI 10.1006/taap.2001.9296; WURGLER FE, 1992, MUTAGENESIS, V7, P321, DOI 10.1093/mutage/7.5.321; 2001, SURVEY INFORM CUTTIN, P54	70	54	56	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19735	10.1371/journal.pone.0019735	http://dx.doi.org/10.1371/journal.pone.0019735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625421	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200011
J	Tamura, R; Nishida, H; Eifuku, S; Nagao, K; Fushiki, H; Watanabe, Y; Ono, T				Tamura, Ryoi; Nishida, Hiroshi; Eifuku, Satoshi; Nagao, Kaoru; Fushiki, Hiroaki; Watanabe, Yukio; Ono, Taketoshi			Short-Term Synaptic Plasticity in the Dentate Gyrus of Monkeys	PLOS ONE			English	Article							URETHANE-ANESTHETIZED RATS; PAIRED-PULSE DEPRESSION; FREELY MOVING RATS; HIPPOCAMPAL-FORMATION; MEMORY; POTENTIATION; INHIBITION; FACILITATION; CELLS	The hippocampus plays an important role in learning and memory. Synaptic plasticity in the hippocampus, short-term and long-term, is postulated to be a neural substrate of memory trace. Paired-pulse stimulation is a standard technique for evaluating a form of short-term synaptic plasticity in rodents. However, evidence is lacking for paired-pulse responses in the primate hippocampus. In the present study, we recorded paired-pulse responses in the dentate gyrus of monkeys while stimulating to the medial part of the perforant path at several inter-pulse intervals (IPIs) using low and high stimulus intensities. When the stimulus intensity was low, the first pulse produced early strong depression (at IPIs of 10-30 ms) and late slight depression (at IPIs of 100-1000 ms) of field excitatory postsynaptic potentials (fEPSPs) generated by the second pulse, interposing no depression IPIs (50-70 ms). When the stimulus intensity was high, fEPSPs generated by the second pulse were depressed by the first pulse at all IPIs except for the longest one (2000 ms). Population spikes (PSs) generated by the second pulse were completely blocked or strongly depressed at shorter IPIs (10-100 or 200 ms, respectively), while no depression or slight facilitation occurred at longer IPIs (500-2000 ms). Administration of diazepam slightly increased fEPSPs, while it decreased PSs produced by the first pulse. It also enhanced the facilitation of PSs produced by the second stimulation at longer IPIs. The present results, in comparison with previous studies using rodents, indicate that paired-pulse responses of fEPSPs in the monkey are basically similar to those of rodents, although paired-pulse responses of PSs in the monkey are more delayed than those in rodents and have a different sensitivity to diazepam.	[Tamura, Ryoi; Nishida, Hiroshi; Eifuku, Satoshi; Nagao, Kaoru] Toyama Univ, Dept Integrat Neurosci, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan	University of Toyama	Tamura, R (corresponding author), Toyama Univ, Dept Integrat Neurosci, Grad Sch Med & Pharmaceut Sci Res, Toyama 930, Japan.	rtamura@med.u-toyama.ac.jp			Japan Society for the Promotion of Science [20500356]; Japan Chemical Industry Association, Long-range Research Initiative [2004NT01]; Grants-in-Aid for Scientific Research [23500465] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Chemical Industry Association, Long-range Research Initiative; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (C); Grant number: 20500356, and Japan Chemical Industry Association, Long-range Research Initiative; Grant number: 2004NT01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMEC RE, 1981, EPILEPSIA, V22, P205; ALBERTSON TE, 1989, EXP NEUROL, V106, P142, DOI 10.1016/0014-4886(89)90087-3; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; BAKST I, 1985, J COMP NEUROL, V236, P423, DOI 10.1002/cne.902360402; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bliss TVP, 2007, HIPPOCAMPUS BOOK, P343; Bronzino JD, 1997, ANN BIOMED ENG, V25, P870, DOI 10.1007/BF02684171; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; JOY RM, 1993, BRAIN RES, V604, P273, DOI 10.1016/0006-8993(93)90379-2; Krug M, 1998, EUR J PHARMACOL, V356, P179, DOI 10.1016/S0014-2999(98)00544-5; Kusama T., 1970, STEREOTAXIC ATLAS BR; LOMO T, 1971, EXP BRAIN RES, V12, P18; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; PITKANEN A, 1993, J COMP NEUROL, V331, P37, DOI 10.1002/cne.903310104; RALL T W, 1990, P345; Ribak CE, 2000, J COMP NEUROL, V428, P240, DOI 10.1002/1096-9861(20001211)428:2<240::AID-CNE4>3.0.CO;2-Q; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tamura R, 2011, HIPPOCAMPUS, V21, P565, DOI 10.1002/hipo.20773; TUFF LP, 1983, BRAIN RES, V277, P79, DOI 10.1016/0006-8993(83)90909-5; URUNO K, 1995, BRAIN RES, V695, P163, DOI 10.1016/0006-8993(95)00652-7; Wilson CL, 1998, EPILEPSY RES, V31, P211, DOI 10.1016/S0920-1211(98)00063-1; Yamaguchi H, 2001, J PHARMACOL EXP THER, V298, P354; Zappone CA, 2004, J NEUROSCI, V24, P853, DOI 10.1523/JNEUROSCI.1619-03.2004; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20006	10.1371/journal.pone.0020006	http://dx.doi.org/10.1371/journal.pone.0020006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625444	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400029
J	Beaudrot, L; Du, YJ; Kassim, AR; Rejmanek, M; Harrison, RD				Beaudrot, Lydia; Du, Yanjun; Kassim, Abdul Rahman; Rejmanek, Marcel; Harrison, Rhett D.			Do Epigeal Termite Mounds Increase the Diversity of Plant Habitats in a Tropical Rain Forest in Peninsular Malaysia?	PLOS ONE			English	Article							BUILDING TERMITES; BETA-DIVERSITY; TRADE-OFFS; HETEROGENEITY; MECHANISMS; ASSOCIATIONS; PERFORMANCE; NUTRIENTS; COMMUNITY; ISOPTERA	The extent to which environmental heterogeneity can account for tree species coexistence in diverse ecosystems, such as tropical rainforests, is hotly debated, although the importance of spatial variability in contributing to species co-existence is well recognized. Termites contribute to the micro-topographical and nutrient spatial heterogeneity of tropical forests. We therefore investigated whether epigeal termite mounds could contribute to the coexistence of plant species within a 50 ha plot at Pasoh Forest Reserve, Malaysia. Overall, stem density was significantly higher on mounds than in their immediate surroundings, but tree species diversity was significantly lower. Canonical correspondence analysis showed that location on or off mounds significantly influenced species distribution when stems were characterized by basal area. Like studies of termite mounds in other ecosystems, our results suggest that epigeal termite mounds provide a specific microhabitat for the enhanced growth and survival of certain species in these species-rich tropical forests. However, the extent to which epigeal termite mounds facilitate species coexistence warrants further investigation.	[Beaudrot, Lydia; Rejmanek, Marcel] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Beaudrot, Lydia; Du, Yanjun; Kassim, Abdul Rahman; Harrison, Rhett D.] Ctr Trop Forest Sci, Int Field Biol Course 2008, Pasoh Forest Reserve, Malaysia; [Du, Yanjun] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Kassim, Abdul Rahman] Forest Res Inst Malaysia, Selangor, Malaysia; [Rejmanek, Marcel] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Harrison, Rhett D.] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China	University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Botany, CAS; Institute Penyelidikan Perhutanan Malaysia; University of California System; University of California Davis; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Beaudrot, L (corresponding author), Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA.	rharrison@xtbg.org.cn	; Beaudrot, L./M-6936-2017	Harrison, Rhett/0000-0001-9055-3546; Beaudrot, L./0000-0001-8135-7519	Center for Tropical Forest Science - Arnold Arboretum Pasoh Field course; Forest Research Institute of Malaysia; Center for Tropical Forest Science; Arnold Arboretum	Center for Tropical Forest Science - Arnold Arboretum Pasoh Field course; Forest Research Institute of Malaysia; Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Arnold Arboretum	The Center for Tropical Forest Science - Arnold Arboretum Pasoh Field course supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Forest Research Institute of Malaysia, the Center for Tropical Forest Science, and the Arnold Arboretum for supporting the 2008 International CTFS-AA Field Biology Course and providing the opportunity to study in the Pasoh Forest Reserve. We thank Shawn Cheng, Mark Grote, and John Harting for their help on the project and Alison Marklein for assistance with R code. We thank Cori Boyko, Ryan Boyko, John Chau, Katie Feilen, Ben Janes, Andrew Latimer, Andy Marshall, Casey Peters, and Jens Stevens for discussion and feedback on earlier drafts. We would also like to thank Gary Paoli and three anonymous reviewers whose comments on earlier versions greatly improved the manuscript.	ABE T, 1979, Japanese Journal of Ecology, V29, P337; ABE T, 1978, Kontyu, V46, P273; ABE T, 1978, MALAYSIAN NATURALIST, V30, P235; Adzmi Y, 2010, J TROP FOR SCI, V22, P21; Baillie IC, 2006, J TROP ECOL, V22, P543, DOI 10.1017/S026646740600352X; Baltzer JL, 2007, J BIOGEOGR, V34, P1916, DOI 10.1111/j.1365-2699.2007.01739.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Baraloto C, 2010, BIOTROPICA, V42, P420, DOI 10.1111/j.1744-7429.2009.00620.x; BIGNELL DE, 1995, INSECT SOC, V42, P57, DOI 10.1007/BF01245699; Blomqvist MM, 2000, OIKOS, V90, P582, DOI 10.1034/j.1600-0706.2000.900316.x; BURSLEM D.F.R.P., 1996, ECOLOGY TROPICAL FOR, P211; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; COVENTRY RJ, 1988, AUST J SOIL RES, V26, P375, DOI 10.1071/SR9880375; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; HOBBS RJ, 1985, OECOLOGIA, V67, P342, DOI 10.1007/BF00384939; Holt JA, 2000, TERMITES EVOLUTION S; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KANG BT, 1978, PLANT SOIL, V50, P241, DOI 10.1007/BF02107175; Kitajima K., 2008, TROPICAL FOREST COMM, P160; KOCHUMMEN K M, 1990, Journal of Tropical Forest Science, V3, P1; Lee K. E., 1971, TERMITES AND SOILS; Leps J, 2003, MULTIVARIATE ANAL EC; MCCOMIE LD, 1993, J SOIL SCI, V44, P427, DOI 10.1111/j.1365-2389.1993.tb00465.x; Moe SR, 2009, PLANT ECOL, V202, P31, DOI 10.1007/s11258-009-9575-6; NYE PH, 1955, J SOIL SCI, V6, P73, DOI 10.1111/j.1365-2389.1955.tb00831.x; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; PENDLETON ROBERT L., 1942, JOUR AMER SOC AGRON, V34, P340; Potts MD, 2002, ECOLOGY, V83, P2782, DOI 10.1890/0012-9658(2002)083[2782:HPITRF]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; Rogers LKR, 1999, INSECT SOC, V46, P366, DOI 10.1007/s000400050158; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; SALICK J, 1983, BIOTROPICA, V15, P1, DOI 10.2307/2387990; Sileshi GW, 2010, J VEG SCI, V21, P923, DOI 10.1111/j.1654-1103.2010.01197.x; SPAIN AV, 1988, J ECOL, V76, P181, DOI 10.2307/2260462; Takamura K, 2001, J TROP ECOL, V17, P541, DOI 10.1017/S0266467401001407; THO YP, 1982, STUDIES TAXONOMY BIO; Tilman D., 1982, Monographs in Population Biology, pi; Traore S, 2008, PLANT ECOL, V198, P285, DOI 10.1007/s11258-008-9404-3; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Veenendaal EM, 1996, J ECOL, V84, P83, DOI 10.2307/2261702; WATSON JP, 1977, J SOIL SCI, V28, P664, DOI 10.1111/j.1365-2389.1977.tb02273.x; Wood T.G., 1978, International Biological Programme, P245; WOOD TG, 1996, AGR ZOOLOGY REV, P117; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zimmermann JK, 2008, TROPICAL FOREST COMM, P98	48	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19777	10.1371/journal.pone.0019777	http://dx.doi.org/10.1371/journal.pone.0019777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625558	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200022
J	Del Porto, P; Cifani, N; Guarnieri, S; Di Domenico, EG; Mariggio, MA; Spadaro, F; Guglietta, S; Anile, M; Venuta, F; Quattrucci, S; Ascenzioni, F				Del Porto, Paola; Cifani, Noemi; Guarnieri, Simone; Di Domenico, Enea Gino; Mariggio, Maria A.; Spadaro, Francesca; Guglietta, Silvia; Anile, Marco; Venuta, Federico; Quattrucci, Serena; Ascenzioni, Fiorentina			Dysfunctional CFTR Alters the Bactericidal Activity of Human Macrophages against Pseudomonas aeruginosa	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; SUSCEPTIBILITY; IDENTIFICATION; LOCALIZATION; INFLAMMATION; NEUTROPHILS; INFECTION; CELLS	Chronic inflammation of the lung, as a consequence of persistent bacterial infections by several opportunistic pathogens represents the main cause of mortality and morbidity in cystic fibrosis (CF) patients. Mechanisms leading to increased susceptibility to bacterial infections in CF are not completely known, although the involvement of cystic fibrosis transmembrane conductance regulator (CFTR) in microbicidal functions of macrophages is emerging. Tissue macrophages differentiate in situ from infiltrating monocytes, additionally, mature macrophages from different tissues, although having a number of common activities, exhibit variation in some molecular and cellular functions. In order to highlight possible intrinsic macrophage defects due to CFTR dysfunction, we have focused our attention on in vitro differentiated macrophages from human peripheral blood monocytes. Here we report on the contribution of CFTR in the bactericidal activity against Pseudomonas aeruginosa of monocyte derived human macrophages. At first, by real time PCR, immunofluorescence and patch clamp recordings we demonstrated that CFTR is expressed and is mainly localized to surface plasma membranes of human monocyte derived macrophages (MDM) where it acts as a cAMP-dependent chloride channel. Next, we evaluated the bactericidal activity of P. aeruginosa infected macrophages from healthy donors and CF patients by antibiotic protection assays. Our results demonstrate that control and CF macrophages do not differ in the phagocytic activity when infected with P. aeruginosa. Rather, although a reduction of intracellular live bacteria was detected in both non-CF and CF cells, the percentage of surviving bacteria was significantly higher in CF cells. These findings further support the role of CFTR in the fundamental functions of innate immune cells including eradication of bacterial infections by macrophages.	[Del Porto, Paola; Cifani, Noemi; Di Domenico, Enea Gino; Guglietta, Silvia; Ascenzioni, Fiorentina] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Guarnieri, Simone; Mariggio, Maria A.] Univ Gabriele Annunzio, Dept Neurosci & Imaging, Ctr Excellence Ageing CeSI, Chieti, Italy; [Spadaro, Francesca] Ist Super Sanita, Dept Cell Biol & Neurosci, Unit Expt Immunotherapy, I-00161 Rome, Italy; [Anile, Marco; Venuta, Federico] Univ Roma La Sapienza, Policlin Umberto I, Dept Thorac Surg, Rome, Italy; [Quattrucci, Serena] Univ Roma La Sapienza, Dept Pediat, Ctr Riferimento Fibrosi Cist Reg Lazio, Rome, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome	Del Porto, P (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy.	delporto@uniroma1.it	Spadaro, Francesca/M-7512-2017; Di Domenico, Enea Gino/I-2542-2019; Del Porto, Paola/AAU-2550-2020; Mariggiò, Maria Addolorata/T-9047-2017; Guarnieri, Simone/AAA-5921-2020; Guglietta, Silvia/A-3918-2012	Spadaro, Francesca/0000-0002-6610-350X; Di Domenico, Enea Gino/0000-0001-6295-6006; Mariggiò, Maria Addolorata/0000-0001-5306-7143; Mariggio, Maria Addolorata/0000-0002-3508-8706; Del Porto, Paola/0000-0003-4802-8910; Guarnieri, Simone/0000-0002-2916-2965; Venuta, Federico/0000-0001-9296-877X; Guglietta, Silvia/0000-0001-9998-5716	Italian Foundation for Cystic Fibrosis Research [FFC 14/2007, FFC 21/2009]; Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma 'La Sapienza'	Italian Foundation for Cystic Fibrosis Research; Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma 'La Sapienza'(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by the Italian Foundation for Cystic Fibrosis Research (grants FFC 14/2007 and FFC 21/2009 adopted by Delegazione FFC di Latina e Lega Italiana Fibrosi Cistica Onlus-Associazione Laziale Onlus'') to P. D. P and by the Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma 'La Sapienza' to F. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auriche C, 2010, GENE THER, V17, P1341, DOI 10.1038/gt.2010.89; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Deriy LV, 2009, J BIOL CHEM, V284, P35926, DOI 10.1074/jbc.M109.057372; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Dormer RL, 2001, PFLUG ARCH EUR J PHY, V443, pS117; Haggie PM, 2009, AM J PHYSIOL-LUNG C, V296, pL859, DOI 10.1152/ajplung.00018.2009; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; MATSUI H, 1998, SCIENCE, V95, P1005; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Nixon GM, 2002, ARCH DIS CHILD, V87, P306, DOI 10.1136/adc.87.4.306; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Painter RG, 2008, J LEUKOCYTE BIOL, V83, P1345, DOI 10.1189/jlb.0907658; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822; RIORDAN JR, 1989, SCIENCE, V245, P1066; Saiman L, 1999, J CLIN MICROBIOL, V37, P2987, DOI 10.1128/JCM.37.9.2987-2991.1999; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Swanson J, 2006, NAT CELL BIOL, V8, P908, DOI 10.1038/ncb0906-908; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Zhang Y, 2010, J IMMUNOL, V184, P5104, DOI 10.4049/jimmunol.0902851	33	113	121	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19970	10.1371/journal.pone.0019970	http://dx.doi.org/10.1371/journal.pone.0019970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625641	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200051
J	Pursall, ER; Rolff, J				Pursall, E. Rhiannon; Rolff, Jens			Immune Responses Accelerate Ageing: Proof-of-Principle in an Insect Model	PLOS ONE			English	Article							LIFE-SPAN; INNATE IMMUNITY; INFLAMMATION; DISEASES; ACTIVATION; RESISTANCE; LONGEVITY; MORTALITY; ORIGINS; PROTEIN	The pathology of many of the world's most important infectious diseases is caused by the immune response. Additionally age-related disease is often attributed to inflammatory responses. Consequently a reduction in infections and hence inflammation early in life has been hypothesized to explain the rise in lifespan in industrialized societies. Here we demonstrate experimentally for the first time that eliciting an immune response early in life accelerates ageing. We use the beetle Tenebrio molitor as an inflammation model. We provide a proof of principle for the effects of early infection on morbidity late in life and demonstrate a long-lasting cost of immunopathology. Along with presenting a proof-of-principle study, we discuss a mechanism for the apparently counter-adaptive persistence of immunopathology in natural populations. If immunopathology from early immune response only becomes costly later in life, natural selection on reducing self-harm would be relaxed, which could explain the presence of immune self-harm in nature.	[Pursall, E. Rhiannon] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Birmingham; University of Sheffield	Pursall, ER (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	r.pursall@bham.ac.uk; jor@sheffield.ac.uk		Rolff, Jens/0000-0002-1529-5409	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council (BBSRC) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armitage SAO, 2003, J EVOLUTION BIOL, V16, P1038, DOI 10.1046/j.1420-9101.2003.00551.x; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bengtsson T, 2003, INT J EPIDEMIOL, V32, P286, DOI 10.1093/ije/dyg061; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; BRODERICK N, INSECT INFECT IMMUNI; Catalano R, 2006, INT J EPIDEMIOL, V35, P1264, DOI 10.1093/ije/dyl108; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Licastro Federico, 2005, Immun Ageing, V2, P8; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 1997, NEW ENGL J MED, V337, P423; RYERSE JS, 1979, TISSUE CELL, V11, P533, DOI 10.1016/0040-8166(79)90061-2; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sherratt TN, 2010, J ANIM ECOL, V79, P1034, DOI 10.1111/j.1365-2656.2010.01719.x; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; THOMPSON JJW, 2002, THESIS U SHEFFIELD S; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wigglesworth V. B., 1965, PRINCIPLES INSECT PH	42	27	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19972	10.1371/journal.pone.0019972	http://dx.doi.org/10.1371/journal.pone.0019972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625631	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200052
J	Aziz, MH; Shen, H; Maki, CG				Aziz, M. H.; Shen, H.; Maki, C. G.			Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3	ONCOGENE			English	Article						p53; Nutlin; resistance	TUMOR-CELLS; MUTANT P53; OVARIAN-CANCER; APOPTOSIS; MDM2; THERAPY; PATHWAY; PROTEIN; GENE; CHEMOSENSITIVITY	Wild-type p53 is a stress-responsive tumor suppressor and potent growth inhibitor. Genotoxic stresses (for example, ionizing and ultraviolet radiation or chemotherapeutic drug treatment) can activate p53, but also induce mutations in the P53 gene, and thus select for p53-mutated cells. Nutlin-3a (Nutlin) is pre-clinical drug that activates p53 in a non-genotoxic manner. Nutlin occupies the p53-binding pocket of murine double minute 2 (MDM2), activating p53 by blocking the p53-MDM2 interaction. Because Nutlin neither binds p53 directly nor introduces DNA damage, we hypothesized Nutlin would not induce P53 mutations, and, therefore, not select for p53-mutated cells. To test this, populations of SJSA-1 (p53 wild-type) cancer cells were expanded that survived repeated Nutlin exposures, and individual clones were isolated. Group 1 clones were resistant to Nutlin-induced apoptosis, but still underwent growth arrest. Surprisingly, while some Group 1 clones retained wild-type p53, others acquired a heterozygous p53 mutation. Apoptosis resistance in Group 1 clones was associated with decreased PUMA induction and decreased caspase 3/7 activation. Group 2 clones were resistant to both apoptosis and growth arrest induced by Nutlin. Group 2 clones had acquired mutations in the p53-DNA-binding domain and expressed only mutant p53s that were induced by Nutlin treatment, but were unable to bind the P21 and PUMA gene promoters, and unable to activate transcription. These results demonstrate that non-genotoxic p53 activation (for example, by Nutlin treatment) can lead to the acquisition of somatic mutations in p53 and select for p53-mutated cells. These findings have implications for the potential clinical use of Nutlin and other small molecule MDM2 antagonists. Oncogene (2011) 30, 4678-4686; doi:10.1038/onc.2011.185; published online 6 June 2011	[Aziz, M. H.; Shen, H.; Maki, C. G.] Rush Univ, Dept Anat & Cell Biol, Med Ctr, Chicago, IL 60612 USA	Rush University	Maki, CG (corresponding author), Rush Univ, Dept Anat & Cell Biol, Med Ctr, 1653 W Congress Pkwy,Jelke 1306,900 S Paulina,AcF, Chicago, IL 60612 USA.	Carl_Maki@rush.edu			National Cancer Institute [1RO1CA137598-01A1]; NATIONAL CANCER INSTITUTE [R01CA137598] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grant 1RO1CA137598-01A1 to CGM.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Blagosklonny MV, 2005, CELL DEATH DIFFER, V12, P592, DOI 10.1038/sj.cdd.4401610; Blagosklonny MV, 2002, NAT REV CANCER, V2, P221, DOI 10.1038/nrc743; Brown L, 2007, CRIT REV EUKAR GENE, V17, P73, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.50; Christiansen DH, 2001, J CLIN ONCOL, V19, P1405, DOI 10.1200/JCO.2001.19.5.1405; DeBenedetti VMG, 1996, CANCER EPIDEM BIOMAR, V5, P93; Drakos E, 2007, CLIN CANCER RES, V13, P3380, DOI 10.1158/1078-0432.CCR-06-2581; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Gaitonde SV, 2000, ONCOGENE, V19, P4042, DOI 10.1038/sj.onc.1203756; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Leonard DGB, 2002, CLIN CANCER RES, V8, P973; Lovric MM, 2010, ONCOGENE, V29, P5048, DOI 10.1038/onc.2010.242; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Mayelzadeh F, 2007, ONCOGENE, V26, P2955, DOI 10.1038/sj.onc.1210110; McDermott U, 2005, CANCER RES, V65, P8951, DOI 10.1158/0008-5472.CAN-05-0961; Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Pietenpol JA, 1996, P NATL ACAD SCI USA, V93, P8390, DOI 10.1073/pnas.93.16.8390; Pinyol M, 2000, AM J PATHOL, V156, P1987, DOI 10.1016/S0002-9440(10)65071-7; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Vaseva AV, 2009, CELL CYCLE, V8, P1711, DOI 10.4161/cc.8.11.8596; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wu GS, 1996, CLIN CANCER RES, V2, P623; Wu GS, 2002, ONCOGENE, V21, P1, DOI 10.1038/sj.onc.1205020	36	96	96	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	46					4678	4686		10.1038/onc.2011.185	http://dx.doi.org/10.1038/onc.2011.185			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	851EV	21643018	Green Accepted			2022-12-25	WOS:000297252100007
J	Cheng, F; Cappai, R; Ciccotosto, GD; Svensson, G; Multhaup, G; Fransson, LA; Mani, K				Cheng, Fang; Cappai, Roberto; Ciccotosto, Giuseppe D.; Svensson, Gabriel; Multhaup, Gerd; Fransson, Lars-Ake; Mani, Katrin			Suppression of Amyloid beta A11 Antibody Immunoreactivity by Vitamin C POSSIBLE ROLE OF HEPARAN SULFATE OLIGOSACCHARIDES DERIVED FROM GLYPICAN-1 BY ASCORBATE-INDUCED, NITRIC OXIDE (NO)-CATALYZED DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYPICAN-1 HEPARAN-SULFATE; PRECURSOR PROTEIN APP; INSOLUBLE MEMBRANE COMPARTMENT; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; DEPENDENT AUTOCLEAVAGE; MULTIVESICULAR BODIES; RECYCLING GLYPICAN-1; NEURITE OUTGROWTH	Amyloid beta (A beta) is generated from the copper- and heparan sulfate (HS)-binding amyloid precursor protein (APP) by proteolytic processing. APP supports S-nitrosylation of the HS proteoglycan glypican-1 (Gpc-1). In the presence of ascorbate, there is NO-catalyzed release of anhydromannose (anMan)-containing oligosaccharides from Gpc-1-nitrosothiol. We investigated whether these oligosaccharides interact with A beta during APP processing and plaque formation. anMan immunoreactivity was detected in amyloid plaques of Alzheimer (AD) and APP transgenic (Tg2576) mouse brains by immunofluorescence microscopy. APP/APP degradation products detected by antibodies to the C terminus of APP, but not A beta oligomers detected by the anti-A beta A11 antibody, colocalized with anMan immunoreactivity in Tg2576 fibroblasts. A50-55-kDa anionic, sodium dodecyl sulfate-stable, anMan- and A beta-immunoreactive species was obtained from Tg2576 fibroblasts using immunoprecipitation with anti-APP (C terminus). anMan-containing HS oligo- and disaccharide preparations modulated or suppressed A11 immunoreactivity and oligomerization of A beta 42 peptide in an in vitro assay. A11 immunoreactivity increased in Tg2576 fibroblasts when Gpc-1 autoprocessing was inhibited by 3-beta[2(diethylamino) ethoxy] androst-5-en-17-one (U18666A) and decreased when Gpc-1 autoprocessing was stimulated by ascorbate. Neither overexpression of Gpc-1 in Tg2576 fibroblasts nor addition of copper ion and NO donor to hippocampal slices from 3xTg-AD mice affected A11 immunoreactivity levels. However, A11 immunoreactivity was greatly suppressed by the subsequent addition of ascorbate. We speculate that temporary interaction between the A beta domain and small, anMan-containing oligosaccharides may preclude formation of toxic A beta oligomers. A portion of the oligosaccharides are co-secreted with the A beta peptides and deposited in plaques. These results support the notion that an inadequate supply of vitamin C could contribute to late onset AD in humans.	[Cheng, Fang; Svensson, Gabriel; Fransson, Lars-Ake; Mani, Katrin] Lund Univ, Glycobiol Grp, Div Neurosci, Dept Expt Med Sci,Biomed Ctr A13, SE-22184 Lund, Sweden; [Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Multhaup, Gerd] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany	Lund University; University of Melbourne; University of Melbourne; Free University of Berlin	Fransson, LA (corresponding author), Lund Univ, Glycobiol Grp, Div Neurosci, Dept Expt Med Sci,Biomed Ctr A13, BMC A13, SE-22184 Lund, Sweden.	Lars-Ake.Fransson@med.lu.se; katrin.mani@med.lu.se	Cappai, Roberto/B-3347-2010	Cappai, Roberto/0000-0002-9505-8496; Mani, Katrin/0000-0002-1821-0634	Swedish Science Council (VR-M); Bergvall Foundation; Crafoord Foundation; Hedborg Foundation; Kock Foundation; Segerfalk Foundation; Zoega Foundation; Osterlund Foundation; Medical Faculty of Lund University; National Health and Medical Research Council of Australia; Deutsche Forschungsgemeinschaft	Swedish Science Council (VR-M); Bergvall Foundation; Crafoord Foundation; Hedborg Foundation; Kock Foundation; Segerfalk Foundation; Zoega Foundation; Osterlund Foundation; Medical Faculty of Lund University; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Swedish Science Council (VR-M); the Bergvall, Crafoord, Hedborg, Kock, Segerfalk, Zoega, and Osterlund Foundations; and the Medical Faculty of Lund University (to L.-A.F. and K. M.) and in part by the National Health and Medical Research Council of Australia (to R. C.) and the Deutsche Forschungsgemeinschaft (to G. M.).	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Burns M, 2003, J NEUROSCI, V23, P5645; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Cappai R, 2005, J BIOL CHEM, V280, P13913, DOI 10.1074/jbc.M409179200; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Cheng F, 2006, J NEUROCHEM, V98, P1445, DOI 10.1111/j.1471-4159.2006.03981.x; Davis W, 2008, CURR ALZHEIMER RES, V5, P448, DOI 10.2174/156720508785908900; Ding K, 2002, J BIOL CHEM, V277, P33353, DOI 10.1074/jbc.M203383200; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; FRANSSON LA, 1990, BIOCHEM J, V269, P381, DOI 10.1042/bj2690381; Fransson LA, 2004, CELL MOL LIFE SCI, V61, P1016, DOI 10.1007/s00018-004-3445-0; FRANSSON LA, 1980, EUR J BIOCHEM, V106, P59; Fransson LA, 2007, TRENDS MOL MED, V13, P143, DOI 10.1016/j.molmed.2007.02.005; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lofgren K, 2008, EUR J NEUROSCI, V28, P964, DOI 10.1111/j.1460-9568.2008.06386.x; Mani K, 2000, GLYCOBIOLOGY, V10, P577, DOI 10.1093/glycob/10.6.577; Mani K, 2004, J BIOL CHEM, V279, P12918, DOI 10.1074/jbc.M313678200; Mani K, 2003, J BIOL CHEM, V278, P38956, DOI 10.1074/jbc.M300394200; Mani K, 2007, J BIOL CHEM, V282, P21934, DOI 10.1074/jbc.M701200200; Mani K, 2006, GLYCOBIOLOGY, V16, P1251, DOI 10.1093/glycob/cwl045; Mani K, 2006, GLYCOBIOLOGY, V16, P711, DOI 10.1093/glycob/cwj121; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Multhaup G, 2006, NEURODEGENER DIS, V3, P270, DOI 10.1159/000095266; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; PEJLER G, 1988, J BIOL CHEM, V263, P5197; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SMALL DH, 1994, J NEUROSCI, V14, P2117; SNOW AD, 1994, AM J PATHOL, V144, P337; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1988, AM J PATHOL, V133, P456; Spector R, 2009, J NEUROCHEM, V111, P315, DOI 10.1111/j.1471-4159.2009.06326.x; Svensson G, 2009, GLYCOCONJUGATE J, V26, P1247, DOI 10.1007/s10719-009-9243-z; Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; van Horssen J, 2001, ACTA NEUROPATHOL, V102, P604; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilhelmus MMM, 2007, MOL NEUROBIOL, V35, P203, DOI 10.1007/s12035-007-0029-7; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6	80	29	30	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27559	27572		10.1074/jbc.M111.243345	http://dx.doi.org/10.1074/jbc.M111.243345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21642435	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000293268700050
J	Chien, CD; Kirilyuk, A; Li, JV; Zhang, WT; Lahusen, T; Schmidt, MO; Oh, AS; Wellstein, A; Riegel, AT				Chien, Christopher D.; Kirilyuk, Alexander; Li, Jordan V.; Zhang, Wentao; Lahusen, Tyler; Schmidt, Marcel O.; Oh, Annabell S.; Wellstein, Anton; Riegel, Anna T.			Role of the Nuclear Receptor Coactivator AIB1-Delta 4 Splice Variant in the Control of Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER METASTASIS; TYROSINE PHOSPHORYLATION; AIB1; IMPORT; ESTROGEN; ACTIVATION; EXPRESSION; PROTEIN; LOCALIZATION; HORMONE	The oncogene amplified in breast cancer 1 (AIB1) is a nuclear receptor coactivator that plays a major role in the progression of various cancers. We previously identified a splice variant of AIB1 called AIB1-Delta 4 that is overexpressed in breast cancer. Using mass spectrometry, we define the translation initiation of AIB1-Delta 4 at Met(224) of the full-length AIB1 sequence and have raised an antibody to a peptide representing the acetylated N terminus. We show that AIB1-Delta 4 is predominantly localized in the cytoplasm, although leptomycin B nuclear export inhibition demonstrates that AIB1-Delta 4 can enter and traffic through the nucleus. Our data indicate an import mechanism enhanced by other coactivators such as p300/CBP. Wereport that the endogenously and exogenously expressed AIB1-Delta 4 is recruited as efficiently as full-length AIB1 to estrogen-response elements of genes, and it enhances estrogen-dependent transcription more effectively than AIB1. Expression of an N-terminal AIB1 protein fragment, which is lost in the AIB1-Delta 4 isoform, potentiates AIB1 as a coactivator. This suggests a model whereby the transcriptional activity of AIB1 is squelched by a repressive mechanism utilizing the N-terminal domain and that the increased coactivator function of AIB1-Delta 4 is due to the loss of this inhibitory domain. Finally, we show, using Scorpion primer technology, that AIB1-Delta 4 expression is correlated with metastatic capability of human cancer cell lines.	[Riegel, Anna T.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Canc Ctr, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Dept Pharmacol, Lombardi Canc Ctr, Washington, DC 20007 USA	Georgetown University; Georgetown University	Riegel, AT (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Canc Ctr, Washington, DC 20007 USA.	ariege01@georgetown.edu	Schmidt, Marcel/AAV-8054-2021	Schmidt, Marcel/0000-0002-3991-2766; Kirilyuk, Alexander/0000-0001-6403-8882; Wellstein, Anton/0000-0002-0570-4950; Oh, Annabell S./0000-0002-0676-1164	National Institutes of Health, NCI [R01 CA113477, P30-CA051008]; Department of Defense [BC083320]; Center of Excellence [W81XWH-06-10590]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA113477, T32CA009686] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA113477 from NCI (to A. T. R.). This work was also supported by Department of Defense Breast Cancer Research Program Grant BC083320 (to C. D. C.) and Center of Excellence Grant W81XWH-06-10590 (to V. C. Jordan, A. W., and A. T. R.).; Mass spectrometric analysis was performed in the Proteomics and Metabolomics Shared Resource, and microscopy was performed in the Microscopy and Imaging Shared Resource, which are supported in part by National Institutes of Health NCI Grant P30-CA051008. We also thank Geoffrey Storchan for help with chromatin immunoprecipitation experimental design.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cai D, 2010, CANCER RES, V70, P6477, DOI 10.1158/0008-5472.CAN-10-0005; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; DRIESSEN HPC, 1985, CRIT REV BIOCHEM MOL, V18, P281, DOI 10.3109/10409238509086784; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Hanover JA, 2009, J BIOL CHEM, V284, P12593, DOI 10.1074/jbc.R800076200; Harigopal M, 2009, BREAST CANCER RES TR, V115, P77, DOI 10.1007/s10549-008-0063-9; Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Li C., 2011, ONCOGENE IN PRESS; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Lodrini M, 2008, NUCLEIC ACIDS RES, V36, P1847, DOI 10.1093/nar/gkn029; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nakles RE, 2011, MOL ENDOCRINOL, V25, P549, DOI 10.1210/me.2010-0114; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Qutob MS, 2002, MOL CELL BIOL, V22, P6611, DOI 10.1128/MCB.22.18.6611-6626.2002; Reiter R, 2004, ONCOGENE, V23, P403, DOI 10.1038/sj.onc.1207202; Reiter R, 2001, J BIOL CHEM, V276, P39736, DOI 10.1074/jbc.M104744200; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; SUNDSTROM SA, 1989, J BIOL CHEM, V264, P16941; Taveau M, 2002, ANAL BIOCHEM, V305, P227, DOI 10.1006/abio.2002.5664; Thelwell N, 2000, NUCLEIC ACIDS RES, V28, P3752, DOI 10.1093/nar/28.19.3752; Thompson ME, 2010, FEBS J, V277, P3072, DOI 10.1111/j.1742-4658.2010.07733.x; Thorat MA, 2008, HISTOPATHOLOGY, V53, P634, DOI 10.1111/j.1365-2559.2008.03155.x; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yeung PL, 2006, BIOCHEM BIOPH RES CO, V348, P13, DOI 10.1016/j.bbrc.2006.06.163; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367	61	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26813	26827		10.1074/jbc.M110.216200	http://dx.doi.org/10.1074/jbc.M110.216200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636853	Green Published, hybrid			2022-12-25	WOS:000293078200057
J	Shen, XK; Fang, JP; Lv, XF; Pei, ZC; Wang, Y; Jiang, SS; Ding, K				Shen, Xiaokun; Fang, Jianping; Lv, Xiaofen; Pei, Zhicao; Wang, Ying; Jiang, Songshan; Ding, Kan			Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT HEPARINS; CANCER-ASSOCIATED THROMBOSIS; SULFATE PROTEOGLYCANS; ENDOTHELIAL-CELLS; VENOUS THROMBOEMBOLISM; TUMOR ANGIOGENESIS; TUBE FORMATION; BREAST-CANCER; GROWTH; METASTASIS	Heparin, which has been used as an anticoagulant drug for decades, inhibits angiogenesis, whereas thrombin promotes tumor-associated angiogenesis. However, the mechanisms underlying the regulation of angiogenesis by heparin and thrombin are not well understood. Here, we show that microRNA-10b (miR-10b) is down-regulated by heparin and up-regulated by thrombin in human microvascular endothelial cells (HMEC-1). Overexpression of miR-10b induces HMEC-1 cell migration, tube formation, and angiogenesis, and down-regulates homeobox D10 (HoxD10) expression via direct binding of miR-10b to the putative 3 ' UTR of HoxD10. In addition, HMEC-1 cell migration and tube formation are induced by HoxD10 knockdown, whereas angiogenesis is arrested when HoxD10 expression is increased after anti-miR-10b or heparin treatments. Furthermore, expression of miR-10b and its transcription factor Twist are up-regulated by thrombin, whereas HoxD10 expression is impaired by thrombin. Using quartz crystal microbalance analysis, we show that heparin binds to thrombin, thereby inhibiting thrombin-induced expression of Twist and miR-10b. However, the expression of miR-10b is not attenuated by heparin any more after thrombin expression is silenced by its siRNA. Interestingly, we find that heparin attenuates miR-10b expression and induces HoxD10 expression in vivo to inhibit angiogenesis and impair the growth of MDA-MB-231 tumor xenografts. These results provide insight into the molecular mechanism by which heparin and thrombin regulate angiogenesis.	[Shen, Xiaokun; Fang, Jianping; Lv, Xiaofen; Wang, Ying; Jiang, Songshan; Ding, Kan] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 200031, Peoples R China; [Pei, Zhicao] NW A&F Univ, Coll Sci, Yangling, Shanxi, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Jiang, Songshan] Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Northwest A&F University - China; Sun Yat Sen University; Sun Yat Sen University	Jiang, SS (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 200031, Peoples R China.	jiangssh@mail.sysu.edu.cn; kding@mail.shcnc.ac.cn		Ding, Kan/0000-0002-8140-9259	National Natural Science Foundation of China [30770484]; Chinese Academy of Sciences, China; Chinese Academy of Sciences, China ( to K. D.), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09301-001, 2009ZX09501-011, 2009ZX09103-071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences, China(Chinese Academy of Sciences); Chinese Academy of Sciences, China ( to K. D.), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"(Chinese Academy of Sciences)	This work was supported National Natural Science Foundation of China Grant 30770484, "100 Talents Project" of Chinese Academy of Sciences, China ( to K. D.), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grants 2009ZX09301-001, 2009ZX09501-011, and 2009ZX09103-071.	Agorogiannis EI, 2002, LANCET, V359, P1440, DOI 10.1016/S0140-6736(02)08385-X; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; BARSHAVIT R, 1989, J CLIN INVEST, V84, P1096, DOI 10.1172/JCI114272; Bick RL, 2003, NEW ENGL J MED, V349, P109, DOI 10.1056/NEJMp030086; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Castelli R, 2004, VASC MED, V9, P205, DOI 10.1191/1358863x04vm566ra; Chai GL, 2010, CANCER SCI, V101, P1997, DOI 10.1111/j.1349-7006.2010.01616.x; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Collen A, 2000, CANCER RES, V60, P6196; Costantini V, 1998, BLOOD COAGUL FIBRIN, V9, P79, DOI 10.1097/00001721-199801000-00010; Daly ME, 2003, JNCI-J NATL CANCER I, V95, P1660, DOI 10.1093/jnci/djg101; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Fu Y, 2009, BIOCHEMISTRY-US, V48, P11655, DOI 10.1021/bi901265z; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Hasan J, 2005, CLIN CANCER RES, V11, P8172, DOI 10.1158/1078-0432.CCR-05-0452; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Khorana AA, 2010, THROMB RES, V125, P490, DOI 10.1016/j.thromres.2009.12.023; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Laubli H, 2009, CANCER INVEST, V27, P474, DOI 10.1080/07357900802647136; Lee AYY, 2007, THROMB RES, V120, pS121, DOI 10.1016/S0049-3848(07)70140-8; Li G, 2010, CANCER LETT, V299, P29, DOI 10.1016/j.canlet.2010.07.021; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Marchetti M, 2008, THROMB RES, V121, P637, DOI 10.1016/j.thromres.2007.06.015; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Mousa SA, 2004, CARDIOVASC DRUG REV, V22, P121; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Qiu H, 2010, J BIOL CHEM, V285, P32638, DOI 10.1074/jbc.M110.105544; Rodrigues CA, 2010, J THROMB THROMBOLYS, V30, P67, DOI 10.1007/s11239-010-0441-0; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; SHIBATA S, 1993, CLIN IMMUNOL IMMUNOP, V67, P264, DOI 10.1006/clin.1993.1074; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Snyder KM, 2008, SEMIN THROMB HEMOST, V34, P734, DOI 10.1055/s-0029-1145255; Solari V, 2010, BRIT J CANCER, V103, P593, DOI 10.1038/sj.bjc.6605808; Soncin F, 1997, J BIOL CHEM, V272, P9818; Tan HX, 2010, MED ONCOL, V27, P654, DOI 10.1007/s12032-009-9264-2; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zacharski LR, 2002, CANCER LETT, V186, P1, DOI 10.1016/S0304-3835(02)00258-6; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	58	62	69	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26616	26627		10.1074/jbc.M111.224212	http://dx.doi.org/10.1074/jbc.M111.224212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642433	hybrid, Green Published			2022-12-25	WOS:000293078200040
J	Trindade, J; Loyola, RD				Trindade-Filho, Joaquim; Loyola, Rafael Dias			Performance and Consistency of Indicator Groups in Two Biodiversity Hotspots	PLOS ONE			English	Article							RESERVE SELECTION; CONSERVATION; SURROGATE; DIVERSITY; AREAS; VERTEBRATES; FUTURE; TAXA	Background: In a world limited by data availability and limited funds for conservation, scientists and practitioners must use indicator groups to define spatial conservation priorities. Several studies have evaluated the effectiveness of indicator groups, but still little is known about the consistency in performance of these groups in different regions, which would allow their a priori selection. Methodology/Principal Findings: We systematically examined the effectiveness and the consistency of nine indicator groups in representing mammal species in two top-ranked Biodiversity Hotspots (BH): the Brazilian Cerrado and the Atlantic Forest. To test for group effectiveness we first found the best sets of sites able to maximize the representation of each indicator group in the BH and then calculated the average representation of different target species by the indicator groups in the BH. We considered consistent indicator groups whose representation of target species was not statistically different between BH. We called effective those groups that outperformed the target-species representation achieved by random sets of species. Effective indicator groups required the selection of less than 2% of the BH area for representing target species. Restricted-range species were the most effective indicators for the representation of all mammal diversity as well as target species. It was also the only group with high consistency. Conclusions/Significance: We show that several indicator groups could be applied as shortcuts for representing mammal species in the Cerrado and the Atlantic Forest to develop conservation plans, however, only restricted-range species consistently held as the most effective indicator group for such a task. This group is of particular importance in conservation planning as it captures high diversity of endemic and endangered species.	[Trindade-Filho, Joaquim] Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [Loyola, Rafael Dias] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Trindade, J (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil.	avispa@gmail.com	Filho, Joaquim Trindade/AAP-1545-2021; Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; TRINDADE FILHO, JOAQUIM/0000-0001-5429-3193	CNPq [475886/2009-7, 563621/2010-9]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	R.D.L. research is funded by CNPq (projects # 475886/2009-7 and # 563621/2010-9). J.T.-F. was supported by a CAPES master scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bani L, 2006, CONSERV BIOL, V20, P512, DOI 10.1111/j.1523-1739.2006.00331.x; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; Carbayo F, 2011, TRENDS ECOL EVOL, V26, P154, DOI 10.1016/j.tree.2011.01.004; Chiarucci A, 2007, BIODIVERS CONSERV, V16, P525, DOI 10.1007/s10531-006-6733-1; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; de Carvalho RA, 2010, NAT CONSERVACAO, V8, P171, DOI 10.4322/natcon.00802011; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dobrovolski R, 2011, BIODIVERS CONSERV, V20, P2445, DOI 10.1007/s10531-011-9997-z; Faith D. P., 1996, Biodiversity Letters, V3, P18, DOI 10.2307/2999706; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; Diniz JAF, 2009, NAT CONSERVACAO, V7, P100; FLYNN DFB, 2008, ECOL LETT, V11, P1; Grantham HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011430; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Jenkins CN, 2010, BIOL CONSERV, V143, P992, DOI 10.1016/j.biocon.2010.01.014; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kubota U, 2007, GLOBAL ECOL BIOGEOGR, V16, P632, DOI 10.1111/j.1466-8238.2007.00319.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Larsen FW, 2009, DIVERS DISTRIB, V15, P70, DOI 10.1111/j.1472-4642.2008.00507.x; Lawler JJ, 2008, ANIM CONSERV, V11, P270, DOI 10.1111/j.1469-1795.2008.00176.x; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loucks C, 2008, J BIOGEOGR, V35, P1337, DOI 10.1111/j.1365-2699.2008.01899.x; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Loyola Rafael D., 2009, Open Ecology Journal, V2, P29, DOI 10.2174/1874213000902010029; Loyola RD, 2009, BIODIVERS CONSERV, V18, P2017, DOI 10.1007/s10531-008-9570-6; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Mace Georgina M., 2006, P17; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pinto MP, 2008, DIVERS DISTRIB, V14, P78, DOI 10.1111/j.1472-4642.2007.00421.x; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Rylands AB, 2005, CONSERV BIOL, V19, P612, DOI 10.1111/j.1523-1739.2005.00711.x; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Schmit JP, 2005, BIOL CONSERV, V121, P99, DOI 10.1016/j.biocon.2004.04.013; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Trakhtenbrot A, 2005, ECOL APPL, V15, P335, DOI 10.1890/04-0077; UNDERHILL LG, 1994, BIOL CONSERV, V70, P85, DOI 10.1016/0006-3207(94)90302-6; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004	57	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19746	10.1371/journal.pone.0019746	http://dx.doi.org/10.1371/journal.pone.0019746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637330	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200013
J	Xue, W; Cojocaru, RI; Dudley, VJ; Brooks, M; Swaroop, A; Sarthy, VP				Xue, Wei; Cojocaru, Radu I.; Dudley, V. Joseph; Brooks, Matthew; Swaroop, Anand; Sarthy, Vijay P.			Ciliary Neurotrophic Factor Induces Genes Associated with Inflammation and Gliosis in the Retina: A Gene Profiling Study of Flow-Sorted, Muller Cells	PLOS ONE			English	Article							INTRACELLULAR SIGNALING PATHWAYS; FACTOR PREVENTS DEGENERATION; AAV-MEDIATED DELIVERY; GANGLION-CELLS; PHOTORECEPTOR DEGENERATION; ANIMAL-MODELS; TYROSINE PHOSPHORYLATION; MOUSE PHOTORECEPTORS; ROD PHOTORECEPTORS; PIGMENT EPITHELIUM	Background: Ciliary neurotrophic factor (CNTF), a member of the interleukin-6 cytokine family, has been implicated in the development, differentiation and survival of retinal neurons. The mechanisms of CNTF action as well as its cellular targets in the retina are poorly understood. It has been postulated that some of the biological effects of CNTF are mediated through its action via retinal glial cells; however, molecular changes in retinal glia induced by CNTF have not been elucidated. We have, therefore, examined gene expression dynamics of purified Muller (glial) cells exposed to CNTF in vivo. Methodology/Principal Findings: Muller cells were flow-sorted from mgfap-egfp transgenic mice one or three days after intravitreal injection of CNTF. Microarray analysis using RNA from purified Muller cells showed differential expression of almost 1,000 transcripts with two-to seventeen-fold change in response to CNTF. A comparison of transcriptional profiles from Muller cells at one or three days after CNTF treatment showed an increase in the number of transcribed genes as well as a change in the expression pattern. Ingenuity Pathway Analysis showed that the differentially regulated genes belong to distinct functional types such as cytokines, growth factors, G-protein coupled receptors, transporters and ion channels. Interestingly, many genes induced by CNTF were also highly expressed in reactive Muller cells from mice with inherited or experimentally induced retinal degeneration. Further analysis of gene profiles revealed 20-30% overlap in the transcription pattern among Muller cells, astrocytes and the RPE. Conclusions/Significance: Our studies provide novel molecular insights into biological functions of Muller glial cells in mediating cytokine response. We suggest that CNTF remodels the gene expression profile of Muller cells leading to induction of networks associated with transcription, cell cycle regulation and inflammatory response. CNTF also appears to function as an inducer of gliosis in the retina.	[Xue, Wei; Dudley, V. Joseph; Sarthy, Vijay P.] Northwestern Univ, Dept Ophthalmol, Feinberg Med Sch, Chicago, IL 60611 USA; [Cojocaru, Radu I.; Brooks, Matthew; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Xue, W (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Med Sch, Chicago, IL 60611 USA.	vjsarthy@northwestern.edu		Swaroop, Anand/0000-0002-1975-1141	NIH [EY019325]; National Eye Institute; NATIONAL EYE INSTITUTE [R01EY019325, ZIAEY000450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY019325 (VS), unrestricted funds from Research to Prevent Blindness and intramural program of the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Biber K, 2006, CURR DRUG TARGETS, V7, P29, DOI 10.2174/138945006775270196; Bok D, 2002, EXP EYE RES, V74, P719, DOI 10.1006/exer.2002.1176; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cayouette M, 1997, HUM GENE THER, V8, P423, DOI 10.1089/hum.1997.8.4-423; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Chun MH, 2000, BRAIN RES, V868, P358, DOI 10.1016/S0006-8993(00)02305-2; Cui Q, 2000, NEUROREPORT, V11, P3999, DOI 10.1097/00001756-200012180-00019; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Do Rhee K, 2010, ADV EXP MED BIOL, V664, P647, DOI 10.1007/978-1-4419-1399-9_74; DRAGER UC, 1984, J NEUROSCI, V4, P2025; Escartin C, 2007, J NEUROSCI, V27, P7094, DOI 10.1523/JNEUROSCI.0174-07.2007; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Gallagher D, 2007, J NEUROSCI, V27, P9664, DOI 10.1523/JNEUROSCI.0608-07.2007; Green ES, 2001, MOL THER, V3, P507, DOI 10.1006/mthe.2001.0289; HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Howard M, 1994, GUIDEBOOK CYTOKINES; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kirsch M, 1997, J NEUROCHEM, V68, P979; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Lau D, 2000, INVEST OPHTH VIS SCI, V41, P3622; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEWIS GP, 1992, J NEUROSCI, V12, P3968; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; LO AC, 1995, EXP NEUROL, V134, P49, DOI 10.1006/exnr.1995.1035; Machida S, 2001, INVEST OPHTH VIS SCI, V42, P1087; MacLennan AJ, 1996, J NEUROSCI, V16, P621; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Ogilvie JM, 2000, EXP NEUROL, V161, P676, DOI 10.1006/exnr.1999.7291; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Pease ME, 2009, INVEST OPHTH VIS SCI, V50, P2194, DOI 10.1167/iovs.08-3013; Peterson WM, 2000, J NEUROSCI, V20, P4081; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rhee KD, 2004, J NEUROSCI, V24, P9779, DOI 10.1523/JNEUROSCI.1785-04.2004; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sarthy V., 2001, PERSP VIS R; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Schnitzer J., 1988, Progress in Retinal Research, V7, P209, DOI 10.1016/0278-4327(88)90009-0; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Servidei T, 1998, J BIOL CHEM, V273, P6233, DOI 10.1074/jbc.273.11.6233; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wahlin KJ, 2001, EXP EYE RES, V73, P693, DOI 10.1006/exer.2001.1078; Walsh N, 2001, EXP EYE RES, V72, P495, DOI 10.1006/exer.2000.0984; Wang Y, 2002, CURR EYE RES, V24, P305, DOI 10.1076/ceyr.24.4.305.8408; WEN R, 1995, J NEUROSCI, V15, P7377; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Whiteley SJO, 2001, EXP EYE RES, V73, P557, DOI 10.1006/exer.2001.1066; WINTER CG, 1995, P NATL ACAD SCI USA, V92, P5865, DOI 10.1073/pnas.92.13.5865; YI Y, 2006, NAT NEUROSCI, V9, P843; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	89	40	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20326	10.1371/journal.pone.0020326	http://dx.doi.org/10.1371/journal.pone.0020326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637858	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200052
J	Plessis, A; Cournol, R; Effroy, D; Perez, VS; Botran, L; Kraepiel, Y; Frey, A; Sotta, B; Cornic, G; Leung, J; Giraudat, J; Marion-Poll, A; North, HM				Plessis, Anne; Cournol, Raphael; Effroy, Delphine; Perez, Viridiana Silva; Botran, Lucy; Kraepiel, Yvan; Frey, Anne; Sotta, Bruno; Cornic, Gabriel; Leung, Jeffrey; Giraudat, Jerome; Marion-Poll, Annie; North, Helen M.			New ABA-Hypersensitive Arabidopsis Mutants Are Affected in Loci Mediating Responses to Water Deficit and Dickeya dadantii Infection	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; CIS-ACTING ELEMENTS; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; DROUGHT; GENE; STRESS; PROTEIN; PLANT; 8'-HYDROXYLASE	On water deficit, abscisic acid (ABA) induces stomata closure to reduce water loss by transpiration. To identify Arabidopsis thaliana mutants which transpire less on drought, infrared thermal imaging of leaf temperature has been used to screen for suppressors of an ABA-deficient mutant (aba3-1) cold-leaf phenotype. Three novel mutants, called hot ABA-deficiency suppressor (has), have been identified with hot-leaf phenotypes in the absence of the aba3 mutation. The defective genes imparted no apparent modification to ABA production on water deficit, were inherited recessively and enhanced ABA responses indicating that the proteins encoded are negative regulators of ABA signalling. All three mutants showed ABA-hypersensitive stomata closure and inhibition of root elongation with little modification of growth and development in non-stressed conditions. The has2 mutant also exhibited increased germination inhibition by ABA, while ABA-inducible gene expression was not modified on dehydration, indicating the mutated gene affects early ABA-signalling responses that do not modify transcript levels. In contrast, weak ABA-hypersensitivity relative to mutant developmental phenotypes suggests that HAS3 regulates drought responses by both ABA-dependent and independent pathways. has1 mutant phenotypes were only apparent on stress or ABA treatments, and included reduced water loss on rapid dehydration. The HAS1 locus thus has the required characteristics for a targeted approach to improving resistance to water deficit. In contrast to has2, has1 exhibited only minor changes in susceptibility to Dickeya dadantii despite similar ABA-hypersensitivity, indicating that crosstalk between ABA responses to this pathogen and drought stress can occur through more than one point in the signalling pathway.	[Plessis, Anne; Cournol, Raphael; Effroy, Delphine; Perez, Viridiana Silva; Botran, Lucy; Frey, Anne; Marion-Poll, Annie; North, Helen M.] AgroParisTech, INRA, Inst Jean Pierre Bourgin, UMR1318, Versailles, France; [Kraepiel, Yvan] Univ Paris 06, Lab Interact Plantes Pathogenes, UMR217, AgroParisTech,INRA, Paris, France; [Sotta, Bruno] Univ Paris 06, Lab Physiol Cellulaire & Mol Plantes UR5, Paris, France; [Cornic, Gabriel] Univ Paris Sud, CNRS, Lab Ecol Systemat & Evolut, UMR8079,IFR 87, Orsay, France; [Leung, Jeffrey; Giraudat, Jerome] CNRS, Inst Sci Vegetal, UPR2355, Gif Sur Yvette, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Plessis, A (corresponding author), INRA, UMR Genet Divers & Ecophysiol Cereales 1095, Clermont Ferrand, France.	helen.north@versailles.inra.fr	Silva-Perez, Viridiana/AAF-9472-2019; North, Helen/AAD-4964-2020; Kraepiel, Yvan/D-5056-2017	Silva-Perez, Viridiana/0000-0001-5653-1802; North, Helen/0000-0002-5749-2603; Kraepiel, Yvan/0000-0003-4043-5896	Genoplante and ANR-Genoplante [AF 2001 073, GNP05037G]; Ministere de l'Enseignement et de la Recherche; la Fondation Etchebes, France; Mexican Secretaria de Educacion Publica	Genoplante and ANR-Genoplante(French National Research Agency (ANR)); Ministere de l'Enseignement et de la Recherche; la Fondation Etchebes, France; Mexican Secretaria de Educacion Publica	This work was supported by the Genoplante and ANR-Genoplante programs (grant number AF 2001 073 and GNP05037G); the Ministere de l'Enseignement et de la Recherche (Doctoral fellowship to A.P.) and la Fondation Etchebes, France and the Mexican Secretaria de Educacion Publica (Master fellowship to V.S.-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/J.1364-3703.2007.00437.X, 10.1111/j.1364-3703.2007.00437.x]; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Beaudoin N, 2000, PLANT CELL, V12, P1103, DOI 10.1105/tpc.12.7.1103; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; DETORRESZABALA M, 2009, PLANT J, V59, P375, DOI DOI 10.1111/J.1365-313X.2009.03875.X; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Macquet A, 2007, PLANT CELL, V19, P3990, DOI 10.1105/tpc.107.050179; Marin E, 1997, PLANT PHYSIOL BIOCH, V35, P369; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; Mosher S, 2010, PLANT PHYSIOL, V152, P1901, DOI 10.1104/pp.109.152603; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; North HM, 2005, PLANT SCI, V169, P115, DOI 10.1016/j.plantsci.2005.03.002; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Okamoto M, 2009, PLANT PHYSIOL, V149, P825, DOI 10.1104/pp.108.130823; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Steber CM, 1998, GENETICS, V149, P509; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang YB, 2004, J EXP BOT, V55, P1187, DOI 10.1093/jxb/erh135; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; YAMAGUCHISHINOZAKI K, 1992, NUCLEIC ACIDS RES, V20, P6737, DOI 10.1093/nar/20.24.6737; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296	63	25	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20243	10.1371/journal.pone.0020243	http://dx.doi.org/10.1371/journal.pone.0020243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633512	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500047
J	Costanzo, MS; Brown, KM; Hartl, DL				Costanzo, Marna S.; Brown, Kyle M.; Hartl, Daniel L.			Fitness Trade-Offs in the Evolution of Dihydrofolate Reductase and Drug Resistance in Plasmodium falciparum	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; CHLORPROGUANIL-DAPSONE; SULFADOXINE-PYRIMETHAMINE; AFRICAN CHILDREN; MALARIA; CYCLOGUANIL; MUTATIONS; ALLELES; CHLORCYCLOGUANIL; WR99210	Background: Patterns of emerging drug resistance reflect the underlying adaptive landscapes for specific drugs. In Plasmodium falciparum, the parasite that causes the most serious form of malaria, antifolate drugs inhibit the function of essential enzymes in the folate pathway. However, a handful of mutations in the gene coding for one such enzyme, dihydrofolate reductase, confer drug resistance. Understanding how evolution proceeds from drug susceptibility to drug resistance is critical if new antifolate treatments are to have sustained usefulness. Methodology/Principal Findings: We use a transgenic yeast expression system to build on previous studies that described the adaptive landscape for the antifolate drug pyrimethamine, and we describe the most likely evolutionary trajectories for the evolution of drug resistance to the antifolate chlorcycloguanil. We find that the adaptive landscape for chlorcycloguanil is multi-peaked, not all highly resistant alleles are equally accessible by evolution, and there are both commonalities and differences in adaptive landscapes for chlorcycloguanil and pyrimethamine. Conclusions/Significance: Our findings suggest that cross-resistance between drugs targeting the same enzyme reflect the fitness landscapes associated with each particular drug and the position of the genotype on both landscapes. The possible public health implications of these findings are discussed.	[Costanzo, Marna S.; Brown, Kyle M.; Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Costanzo, MS (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	marna.costanzo@gmail.com			NIH [GM079536]; Harvey Fellowship; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvey Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grant GM079536 to DLH, a Harvey Fellowship to MSC, and a National Science Foundation graduate research fellowship to KMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 2010, R LANG ENV STAT COMP; Brown KM, 2010, MOL BIOL EVOL, V27, P2682, DOI 10.1093/molbev/msq160; Chusacultanachai S, 2002, MOL BIOCHEM PARASIT, V120, P61, DOI 10.1016/S0166-6851(01)00440-6; CLYDE D. F., 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene, V54, P597, DOI 10.1016/0035-9203(60)90038-9; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; DePristo MA, 2007, MOL BIOL EVOL, V24, P1608, DOI 10.1093/molbev/msm118; Ferlan JT, 2001, MOL BIOCHEM PARASIT, V113, P139, DOI 10.1016/S0166-6851(01)00207-9; FERONE R, 1969, MOL PHARMACOL, V5, P49; FERONE R, 1977, B WORLD HEALTH ORGAN, V55, P291; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Hankins EG, 2001, MOL BIOCHEM PARASIT, V117, P91, DOI 10.1016/S0166-6851(01)00335-8; Hastings MD, 2002, P NATL ACAD SCI USA, V99, P13137, DOI 10.1073/pnas.182295999; Hunt SY, 2005, MOL BIOCHEM PARASIT, V139, P25, DOI 10.1016/j.molbiopara.2004.09.005; Kompis IM, 2005, CHEM REV, V105, P593, DOI 10.1021/cr0301144; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Malisa AL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-190; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; Nzila A, 2006, J ANTIMICROB CHEMOTH, V57, P1043, DOI 10.1093/jac/dkl104; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila-Mounda A, 1998, ANTIMICROB AGENTS CH, V42, P164, DOI 10.1128/AAC.42.1.164; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; Rastelli G, 2000, BIOORGAN MED CHEM, V8, P1117, DOI 10.1016/S0968-0896(00)00022-5; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; Sirawaraporn W, 1997, P NATL ACAD SCI USA, V94, P1124, DOI 10.1073/pnas.94.4.1124; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; THOMPSON PE, 1968, J PARASITOL, V54, P588, DOI 10.2307/3277088; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilairatana P, 1997, ANN TROP MED PARASIT, V91, P125, DOI 10.1080/00034989761454; Wooden JM, 1997, MOL BIOCHEM PARASIT, V85, P25, DOI 10.1016/S0166-6851(96)02808-3; [No title captured]; [No title captured]	36	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19636	10.1371/journal.pone.0019636	http://dx.doi.org/10.1371/journal.pone.0019636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625425	gold, Green Submitted, Green Published			2022-12-25	WOS:000291005200007
J	Bettus, G; Ranjeva, JP; Wendling, F; Benar, CG; Confort-Gouny, S; Regis, J; Chauvel, P; Cozzone, PJ; Lemieux, L; Bartolomei, F; Guye, M				Bettus, Gaelle; Ranjeva, Jean-Philippe; Wendling, Fabrice; Benar, Christian G.; Confort-Gouny, Sylviane; Regis, Jean; Chauvel, Patrick; Cozzone, Patrick J.; Lemieux, Louis; Bartolomei, Fabrice; Guye, Maxime			Interictal Functional Connectivity of Human Epileptic Networks Assessed by Intracerebral EEG and BOLD Signal Fluctuations	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MONKEY VISUAL-CORTEX; EPILEPTOGENIC NETWORKS; FIELD POTENTIALS; FMRI; MRI; ABNORMALITIES; OSCILLATIONS; CORRELATE; SPIKES	In this study, we aimed to demonstrate whether spontaneous fluctuations in the blood oxygen level dependent (BOLD) signal derived from resting state functional magnetic resonance imaging (fMRI) reflect spontaneous neuronal activity in pathological brain regions as well as in regions spared by epileptiform discharges. This is a crucial issue as coherent fluctuations of fMRI signals between remote brain areas are now widely used to define functional connectivity in physiology and in pathophysiology. We quantified functional connectivity using non-linear measures of cross-correlation between signals obtained from intracerebral EEG (iEEG) and resting-state functional MRI (fMRI) in 5 patients suffering from intractable temporal lobe epilepsy (TLE). Functional connectivity was quantified with both modalities in areas exhibiting different electrophysiological states (epileptic and non affected regions) during the interictal period. Functional connectivity as measured from the iEEG signal was higher in regions affected by electrical epileptiform abnormalities relative to non-affected areas, whereas an opposite pattern was found for functional connectivity measured from the BOLD signal. Significant negative correlations were found between the functional connectivities of iEEG and BOLD signal when considering all pairs of signals (theta, alpha, beta and broadband) and when considering pairs of signals in regions spared by epileptiform discharges (in broadband signal). This suggests differential effects of epileptic phenomena on electrophysiological and hemodynamic signals and/or an alteration of the neurovascular coupling secondary to pathological plasticity in TLE even in regions spared by epileptiform discharges. In addition, indices of directionality calculated from both modalities were consistent showing that the epileptogenic regions exert a significant influence onto the non epileptic areas during the interictal period. This study shows that functional connectivity measured by iEEG and BOLD signals give complementary but sometimes inconsistent information in TLE.	[Bettus, Gaelle; Ranjeva, Jean-Philippe; Confort-Gouny, Sylviane; Cozzone, Patrick J.; Guye, Maxime] CNRS, UMR 6612, CRMBM, Marseille, France; [Bettus, Gaelle; Benar, Christian G.; Regis, Jean; Chauvel, Patrick; Bartolomei, Fabrice] INSERM, U751, Lab Neurophysiol & Neuropsychol, F-13258 Marseille, France; [Bettus, Gaelle; Ranjeva, Jean-Philippe; Benar, Christian G.; Confort-Gouny, Sylviane; Regis, Jean; Chauvel, Patrick; Cozzone, Patrick J.; Bartolomei, Fabrice; Guye, Maxime] Univ Mediterranee Aix Marseille II, Fac Med, Marseille, France; [Regis, Jean; Chauvel, Patrick; Cozzone, Patrick J.; Bartolomei, Fabrice; Guye, Maxime] Assistance Publ Hop Marseille, Marseille, France; [Wendling, Fabrice] INSERM, U642, Rennes, France; [Lemieux, Louis] UCL, Dept Clin & Expt Epilepsy, UCL Inst Neurol, London, England; [Lemieux, Louis] Natl Soc Epilepsy, MRI Unit, Bucksburn, Aberdeen, Scotland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London	Bettus, G (corresponding author), CNRS, UMR 6612, CRMBM, Marseille, France.	fabrice.bartolomei@mail.ap-hm.fr	WENDLING, Fabrice/P-9574-2019; Wendling, Fabrice/F-8924-2013	WENDLING, Fabrice/0000-0003-2428-9665; Lemieux, Louis/0000-0003-3036-7412; Chauvel, Patrick/0000-0003-2161-6077; Ranjeva, Jean-Philippe/0000-0001-8073-102X	CNRS; INSERM; Agence Nationale de la Recherche (ANR, CONNECTEPI); ADEREM; Region 'Provence Alpes-Cote d'Azur' and Deltamed; Medical Research Council (MRC) [G0301067]; Medical Research Council [G0301067] Funding Source: researchfish; MRC [G0301067] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (ANR, CONNECTEPI)(French National Research Agency (ANR)); ADEREM; Region 'Provence Alpes-Cote d'Azur' and Deltamed(Region Provence-Alpes-Cote d'Azur); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by CNRS, INSERM, Agence Nationale de la Recherche (ANR, CONNECTEPI) and ADEREM. GB is funded by a PhD research grant delivered by the Region 'Provence Alpes-Cote d'Azur' and Deltamed. This work was also partly funded through a grant from the Medical Research Council (MRC grant number G0301067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; BANCAUD JTJ, 1965, STEREOELECTOENCEPHAL; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2002, EPILEPSIA, V43, P1001, DOI 10.1046/j.1528-1157.2002.48501.x; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Benar CG, 2006, NEUROIMAGE, V30, P1161, DOI 10.1016/j.neuroimage.2005.11.008; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2010, J NEUROL NEUROSUR PS, V81, P1147, DOI 10.1136/jnnp.2009.191460; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bourien J, 2005, CLIN NEUROPHYSIOL, V116, P443, DOI 10.1016/j.clinph.2004.08.010; Carmichael DW, 2010, NEUROIMAGE, V49, P379, DOI 10.1016/j.neuroimage.2009.07.062; Chassoux F, 2004, BRAIN, V127, P164, DOI 10.1093/brain/awh014; CHAUVEL P, 1987, REV NEUROL, V143, P443; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; Ekstrom A, 2010, BRAIN RES REV, V62, P233, DOI 10.1016/j.brainresrev.2009.12.004; Ekstrom A, 2009, J NEUROPHYSIOL, V101, P2668, DOI 10.1152/jn.91252.2008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Guye M, 2005, NEUROIMAGE, V26, P1174, DOI 10.1016/j.neuroimage.2005.03.023; Guye M, 2002, EPILEPSIA, V43, P1197, DOI 10.1046/j.1528-1157.2002.05102.x; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Lachaux JP, 2007, HUM BRAIN MAPP, V28, P1368, DOI 10.1002/hbm.20352; Lemieux L, 2008, HUM BRAIN MAPP, V29, P329, DOI 10.1002/hbm.20389; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LIAO W, 2010, HUM BRAIN MAPP; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Logothetis NK, 2009, NEUROIMAGE, V45, P1080, DOI 10.1016/j.neuroimage.2009.01.010; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Ojemann GA, 2010, BRAIN, V133, P46, DOI 10.1093/brain/awp227; Pereira FRS, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-66; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Rodrigo S, 2008, EPILEPSIA, V49, P1367, DOI 10.1111/j.1528-1167.2008.01607.x; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; TALAIRACH J, 1974, NEUROCHIRURGIE, V20, P1; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Vulliemoz S, 2011, NEUROIMAGE, V54, P182, DOI 10.1016/j.neuroimage.2010.08.004; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; Wendling F, 2001, NEUROPHYSIOL CLIN, V31, P139, DOI 10.1016/S0987-7053(01)00255-6; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Yogarajah M, 2008, NEUROIMAGE, V40, P1755, DOI 10.1016/j.neuroimage.2007.12.046; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	60	82	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20071	10.1371/journal.pone.0020071	http://dx.doi.org/10.1371/journal.pone.0020071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625517	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200044
J	Kumar, S; Pioszak, A; Zhang, CH; Swaminathan, K; Xu, HE				Kumar, Shiva; Pioszak, Augen; Zhang, Chenghai; Swaminathan, Kunchithapadam; Xu, H. Eric			Crystal Structure of the PAC1R Extracellular Domain Unifies a Consensus Fold for Hormone Recognition by Class B G-Protein Coupled Receptors	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; HYPOTHALAMIC POLYPEPTIDE; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; PITUITARY-GLAND; BINDING-SITES; PACAP; PEPTIDE; VIP	Pituitary adenylate cyclase activating polypeptide (PACAP) is a member of the PACAP/glucagon family of peptide hormones, which controls many physiological functions in the immune, nervous, endocrine, and muscular systems. It activates adenylate cyclase by binding to its receptor, PAC1R, a member of class B G-protein coupled receptors (GPCR). Crystal structures of a number of Class B GPCR extracellular domains (ECD) bound to their respective peptide hormones have revealed a consensus mechanism of hormone binding. However, the mechanism of how PACAP binds to its receptor remains controversial as an NMR structure of the PAC1R ECD/PACAP complex reveals a different topology of the ECD and a distinct mode of ligand recognition. Here we report a 1.9 angstrom crystal structure of the PAC1R ECD, which adopts the same fold as commonly observed for other members of Class B GPCR. Binding studies and cell-based assays with alanine-scanned peptides and mutated receptor support a model that PAC1R uses the same conserved fold of Class B GPCR ECD for PACAP binding, thus unifying the consensus mechanism of hormone binding for this family of receptors.	[Kumar, Shiva; Pioszak, Augen; Zhang, Chenghai; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA; [Kumar, Shiva; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Van Andel Institute; National University of Singapore	Kumar, S (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA.	dbsks@nus.edu.sg; eric.xu@vai.org	Xu, H. Eric/ABD-7487-2021	Xu, H. Eric/0000-0002-6829-8144	Jay and Betty Van Andel foundation; National Institute of Health [GM08743]; Ministry of Education, Singapore and Biomedical Research Council; National University of Singapore; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Office of Science of the U. S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM008743] Funding Source: NIH RePORTER	Jay and Betty Van Andel foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Singapore and Biomedical Research Council(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Office of Science of the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the Jay and Betty Van Andel foundation (HEX, AP and KS), National Institute of Health grant GM08743 (HEX and AP), grants from Ministry of Education, Singapore and Biomedical Research Council (KS) and a research scholarship from National University of Singapore (KS). We thank J. S. Brunzelle for assistance in data collection at the beamlines of sector 21 (LS-CAT), which is partly funded by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). Use of the Advanced Photon Source was supported by the Office of Science of the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2008, ANN NY ACAD SCI, V1144, P28, DOI 10.1196/annals.1418.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BUSCAIL L, 1990, FEBS LETT, V262, P77, DOI 10.1016/0014-5793(90)80158-F; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; CAUVIN A, 1990, PEPTIDES, V11, P773, DOI 10.1016/0196-9781(90)90194-A; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; Dickinson T, 1999, TRENDS PHARMACOL SCI, V20, P324, DOI 10.1016/S0165-6147(99)01340-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GOTTSCHALL PE, 1990, ENDOCRINOLOGY, V127, P272, DOI 10.1210/endo-127-1-272; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; LAM HC, 1990, EUR J BIOCHEM, V193, P725, DOI 10.1111/j.1432-1033.1990.tb19392.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Martinez C, 2006, ANN NY ACAD SCI, V1070, P405, DOI 10.1196/annals.1317.053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rawlings SR, 1996, ENDOCR REV, V17, P4, DOI 10.1210/er.17.1.4; Reglodi D, 2006, ANN NY ACAD SCI, V1070, P518, DOI 10.1196/annals.1317.072; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; ROBBERECHT P, 1984, FEBS LETT, V166, P277, DOI 10.1016/0014-5793(84)80095-2; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; STOFFEL M, 1994, GENOMICS, V23, P697, DOI 10.1006/geno.1994.1560; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	43	48	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19682	10.1371/journal.pone.0019682	http://dx.doi.org/10.1371/journal.pone.0019682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625560	Green Submitted, Green Published, gold			2022-12-25	WOS:000290771200014
J	Lu, Y; Malmhall, C; Sjostrand, M; Radinger, M; O'Neil, SE; Lotvall, J; Bossios, A				Lu, You; Malmhall, Carina; Sjostrand, Margareta; Radinger, Madeleine; O'Neil, Serena E.; Lotvall, Jan; Bossios, Apostolos			Expansion of CD4(+)CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and ROR gamma t Cells in Allergic Inflammation, Local Lung Distribution and Chemokine Gene Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; TOLERANCE INDUCTION; TGF-BETA; DIFFERENTIATION; TREG; RECRUITMENT; MECHANISMS; DEPLETION; RESPONSES; CONTAINS	Allergic asthma is associated with airway eosinophilia, which is regulated by different T-effector cells. T cells express transcription factors T-bet, GATA-3, ROR gamma t and Foxp3, representing Th1, Th2, Th17 and Treg cells respectively. No study has directly determined the relative presence of each of these T cell subsets concomitantly in a model of allergic airway inflammation. In this study we determined the degree of expansion of these T cell subsets, in the lungs of allergen challenged mice. Cell proliferation was determined by incorporation of 5-bromo-2'-deoxyuridine (BrdU) together with 7-aminoactnomycin (7-AAD). The immunohistochemical localisation of T cells in the lung microenvironments was also quantified. Local expression of cytokines, chemokines and receptor genes was measured using real-time RT-PCR array analysis in tissue sections isolated by laser microdissection and pressure catapulting technology. Allergen exposure increased the numbers of T-bet(+), GATA-3(+), ROR gamma t(+) and Foxp3(+) cells in CD4(+)CD25(+) and CD4(+)CD25(-) T cells, with the greatest expansion of GATA-3(+) cells. The majority of CD4(+)CD25(+) T-bet(+), GATA-3(+), ROR gamma t(+) and Foxp3(+) cells had incorporated BrdU and underwent proliferation during allergen exposure. Allergen exposure led to the accumulation of T-bet(+), GATA-3(+) and Foxp3(+) cells in peribronchial and alveolar tissue, GATA-3(+) and Foxp3(+) cells in perivascular tissue, and ROR gamma t(+) cells in alveolar tissue. A total of 28 cytokines, chemokines and receptor genes were altered more than 3 fold upon allergen exposure, with expression of half of the genes claimed in all three microenvironments. Our study shows that allergen exposure affects all T effector cells in lung, with a dominant of Th2 cells, but with different local cell distribution, probably due to a distinguished local inflammatory milieu.	[Lu, You; Malmhall, Carina; Sjostrand, Margareta; Radinger, Madeleine; O'Neil, Serena E.; Lotvall, Jan; Bossios, Apostolos] Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Lu, Y (corresponding author), Univ Gothenburg, Dept Internal Med, Krefting Res Ctr, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden.	apostolos.bossios@gu.se	Bossios, Apostolos/ABH-8262-2020	Bossios, Apostolos/0000-0002-0494-2690; Radinger, Madeleine/0000-0002-0652-7378; Lotvall, Jan/0000-0001-9195-9249	Swedish Heart-Lung Foundation [20070575]; Sahlgrenska University Hospital Foundation, Gothenburg, Sweden; Herman Krefting Foundation Against Asthma/Allergy	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sahlgrenska University Hospital Foundation, Gothenburg, Sweden; Herman Krefting Foundation Against Asthma/Allergy	The work was supported by a grant from the Swedish Heart-Lung Foundation (project no. 20070575) and Sahlgrenska University Hospital Foundation, Gothenburg, Sweden. Prof. Jan Lotvall is funded by the Herman Krefting Foundation Against Asthma/Allergy. The sponsors played no role in the study design, conduct, collection, analysis, interpretation, review, or approval of the manuscript.	Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boudousquie C, 2009, CLIN EXP ALLERGY, V39, P1415, DOI 10.1111/j.1365-2222.2009.03314.x; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brusko TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007980; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Herve MGD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011784; Eriksson U, 2005, J IMMUNOL, V175, P2715, DOI 10.4049/jimmunol.175.4.2715; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; FOWELL D, 1993, J EXP MED, V177, P627, DOI 10.1084/jem.177.3.627; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kearley J, 2007, J EXP MED, V204, P1289, DOI 10.1084/jem.20062093; Laan M, 1999, J IMMUNOL, V162, P2347; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Lu Y, 2010, SCAND J IMMUNOL, V71, P176, DOI 10.1111/j.1365-3083.2009.02363.x; Mahnke K, 2007, INT J CANCER, V120, P2723, DOI 10.1002/ijc.22617; Malmhall C, 2007, ALLERGY, V62, P1007, DOI 10.1111/j.1398-9995.2007.01420.x; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Radinger M, 2011, IMMUNOLOGY, V132, P144, DOI 10.1111/j.1365-2567.2010.03349.x; ROSSETTI CA, 2010, RES VET SCI; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samitas K, 2011, EUR RESPIR J, V37, P331, DOI 10.1183/09031936.00017810; Saoudi A, 1996, J EXP MED, V184, P2393, DOI 10.1084/jem.184.6.2393; Schmidt-Weber C. B., 2008, V94, P1, DOI 10.1159/000154844; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Sun JB, 2006, J IMMUNOL, V177, P7634, DOI 10.4049/jimmunol.177.11.7634; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P4, DOI 10.1111/j.1365-2222.2005.02139.x; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008; Yamashita N, 2006, J ALLERGY CLIN IMMUN, V117, P1040, DOI 10.1016/j.jaci.2006.01.009; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhao LL, 2008, SCAND J IMMUNOL, V67, P480, DOI 10.1111/j.1365-3083.2008.02098.x; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	47	11	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19889	10.1371/journal.pone.0019889	http://dx.doi.org/10.1371/journal.pone.0019889			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625544	gold, Green Published, Green Submitted			2022-12-25	WOS:000290771200029
J	Rhodin, MHJ; Dinman, JD				Rhodin, Michael H. J.; Dinman, Jonathan D.			An Extensive Network of Information Flow through the B1b/c Intersubunit Bridge of the Yeast Ribosome	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DIAMOND-BLACKFAN ANEMIA; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PEPTIDYL TRANSFERASE CENTER; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; PROTEIN L11; EUKARYOTIC RIBOSOME; VIRUS PROPAGATION	Yeast ribosomal proteins L11 and S18 form a dynamic intersubunit interaction called the B1b/c bridge. Recent high resolution images of the ribosome have enabled targeting of specific residues in this bridge to address how distantly separated regions within the large and small subunits of the ribosome communicate with each other. Mutations were generated in the L11 side of the B1b/c bridge with a particular focus on disrupting the opposing charge motifs that have previously been proposed to be involved in subunit ratcheting. Mutants had wide-ranging effects on cellular viability and translational fidelity, with the most pronounced phenotypes corresponding to amino acid changes resulting in alterations of local charge properties. Chemical protection studies of selected mutants revealed rRNA structural changes in both the large and small subunits. In the large subunit rRNA, structural changes mapped to Helices 39, 80, 82, 83, 84, and the peptidyltransferase center. In the small subunit rRNA, structural changes were identified in helices 30 and 42, located between S18 and the decoding center. The rRNA structural changes correlated with charge-specific alterations to the L11 side of the B1b/c bridge. These analyses underscore the importance of the opposing charge mechanism in mediating B1b/c bridge interactions and suggest an extensive network of information exchange between distinct regions of the large and small subunits.	[Rhodin, Michael H. J.; Dinman, Jonathan D.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Rhodin, MHJ (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dinman@umd.edu		Dinman, Jonathan/0000-0002-2402-9698	National Institutes of Health [R01 GM058859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant to JDD from the National Institutes of Health (R01 GM058859). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Besseova I, 2010, NUCLEIC ACIDS RES, V38, P6247, DOI 10.1093/nar/gkq414; Breinig F, 2002, CELL, V108, P395, DOI 10.1016/S0092-8674(02)00634-7; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CLARE J, 1985, P NATL ACAD SCI USA, V82, P2829, DOI 10.1073/pnas.82.9.2829; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2010, J BIOL CHEM, V285, P12587, DOI 10.1074/jbc.M109.056259; DeLano W., 2006, PYMOL MOL GRAPHICS S; DINMAN JD, 1992, J VIROL, V66, P3669, DOI 10.1128/JVI.66.6.3669-3676.1992; DINMAN JD, 1995, YEAST, V11, P1115, DOI 10.1002/yea.320111202; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; Dinman Jonathan D, 2005, Int J Biomed Sci, V1, P2; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; ICHO T, 1988, J BIOL CHEM, V263, P1467; Jacobs JL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh157; Kiparisov S, 2005, MOL GENET GENOMICS, V274, P235, DOI 10.1007/s00438-005-0020-9; Liao PY, 2011, NUCLEIC ACIDS RES, V39, P300, DOI 10.1093/nar/gkq761; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P6175, DOI 10.1093/nar/gkn642; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; OHTAKE Y, 1995, MOL CELL BIOL, V15, P2772; Petrov AN, 2008, NUCLEIC ACIDS RES, V36, P6187, DOI 10.1093/nar/gkn643; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Quarello P, 2010, HAEMATOL-HEMATOL J, V95, P206, DOI 10.3324/haematol.2009.011783; Rakauskaite R, 2008, NUCLEIC ACIDS RES, V36, P1497, DOI 10.1093/nar/gkm1179; Rhodin MHJ, 2010, NUCLEIC ACIDS RES, V38, P8377, DOI 10.1093/nar/gkq711; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sergiev PV, 2005, J MOL BIOL, V353, P116, DOI 10.1016/j.jmb.2005.08.006; Shasmal M, 2010, BIOCHEM BIOPH RES CO, V399, P192, DOI 10.1016/j.bbrc.2010.07.053; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	53	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20048	10.1371/journal.pone.0020048	http://dx.doi.org/10.1371/journal.pone.0020048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625514	Green Submitted, gold, Green Published			2022-12-25	WOS:000290771200043
J	Srivastava, A; Gangnard, S; Dechavanne, S; Amirat, F; Bentley, AL; Bentley, GA; Gamain, B				Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Amirat, Farroudja; Bentley, Anita Lewit; Bentley, Graham A.; Gamain, Benoit			Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; FALCIPARUM-INFECTED ERYTHROCYTES; CROSS-REACTIVE ANTIBODIES; PLASMODIUM-FALCIPARUM; VAR GENE; MEMBRANE PROTEIN-1; PARASITE ADHESION; PLACENTAL MALARIA; IMMUNOGLOBULIN-G; HIGH-LEVEL	Var2CSA, a key molecule linked with pregnancy-associated malaria (PAM), causes sequestration of Plasmodium falciparum infected erythrocytes (PEs) in the placenta by adhesion to chondroitin sulfate A (CSA). Var2CSA possesses a 300 kDa extracellular region composed of six Duffy-binding like (DBL) domains and a cysteine-rich interdomain region (CIDRpam) module. Although initial studies implicated several individual var2CSA DBL domains as important for adhesion of PEs to CSA, new studies revealed that these individual domains lack both the affinity and specificity displayed by the full-length extracellular region. Indeed, recent evidence suggests the presence of a single CSA-binding site formed by a higher-order domain organization rather than several independent binding sites located on the different domains. Here, we search for the minimal binding region within var2CSA that maintains high affinity and specificity for CSA binding, a characteristic feature of the full-length extracellular region. Accordingly, truncated recombinant var2CSA proteins comprising different domain combinations were expressed and their binding characteristics assessed against different sulfated glycosaminoglycans (GAGs). Our results indicate that the smallest region within var2CSA with similar binding properties to those of the full-length var2CSA is DBL1X-3X. We also demonstrate that inhibitory antibodies raised in rabbit against the full-length DBL1X-6e target principally DBL3X and, to a lesser extent, DBL5e. Taken together, our results indicate that efforts should focus on the DBL1X-3X region for developing vaccine and therapeutic strategies aimed at combating PAM.	[Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Amirat, Farroudja; Bentley, Anita Lewit; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, F-75015 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Amirat, Farroudja; Bentley, Anita Lewit; Bentley, Graham A.] CNRS, URA2185, F-75015 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Gamain, Benoit] INSERM, U665, F-75739 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Gamain, Benoit] Inst Natl Transfus Sanguine, F-75739 Paris, France; [Srivastava, Anand; Gangnard, Stephane; Dechavanne, Sebastien; Gamain, Benoit] Univ Paris Diderot, UMR S665, F-75739 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Srivastava, A (corresponding author), Inst Pasteur, Unite Immunol Struct, F-75015 Paris, France.	benoit.gamain@inserm.fr	Dechavanne, Sebastien/AAL-8108-2021; SRIVASTAVA, ANAND/C-9609-2012; Srivastava, Anand/AAD-2166-2019; Srivastava, Anand/AFY-2073-2022; Gamain, Benoit/N-9985-2017	SRIVASTAVA, ANAND/0000-0002-2031-4643; Srivastava, Anand/0000-0002-2031-4643; Gamain, Benoit/0000-0002-8255-2145; Dechavanne, Sebastien/0000-0001-9400-1976	Institut National de la Sante et de la Recherche Medicale; Sanofi-Aventis; European Community [201222]; Fondation pour la Recherche Medicale (FRM)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Sanofi-Aventis(Sanofi-Aventis); European Community(European Commission); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by an ATIP-AVENIR grant from the Institut National de la Sante et de la Recherche Medicale and Sanofi-Aventis (BG). The research leading to these results has received funding from the European Community's Seventh Framework Programme Grant ([FP7/2007-2013]) ( to GAB and BG) under Grant agreement 201222. AS was supported by a grant from the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2008, INFECT IMMUN, V76, P1791, DOI 10.1128/IAI.01470-07; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Avril M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016622; Avril M, 2010, INFECT IMMUN, V78, P2248, DOI 10.1128/IAI.00410-09; Badaut C, 2007, MOL BIOCHEM PARASIT, V151, P89, DOI 10.1016/j.molbiopara.2006.10.010; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fernandez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012558; Fernandez P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-170; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gangnard S, 2010, MOL BIOCHEM PARASIT, V173, P115, DOI 10.1016/j.molbiopara.2010.05.014; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Magistrado PA, 2011, VACCINE, V29, P437, DOI 10.1016/j.vaccine.2010.10.080; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	45	50	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20270	10.1371/journal.pone.0020270	http://dx.doi.org/10.1371/journal.pone.0020270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625526	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200056
J	Alalade, E; Denny, K; Potter, G; Steffens, D; Wang, LH				Alalade, Emmanuel; Denny, Kevin; Potter, Guy; Steffens, David; Wang, Lihong			Altered Cerebellar-Cerebral Functional Connectivity in Geriatric Depression	PLOS ONE			English	Article							BLOOD-FLOW ABNORMALITIES; MAJOR DEPRESSION; HYPOTHALAMO-CEREBELLAR; RHESUS-MONKEY; UNIPOLAR DEPRESSION; FASTIGIAL NUCLEUS; CINGULATE CORTEX; EXERCISE; PROJECTIONS; AMYGDALA	Although volumetric and activation changes in the cerebellum have frequently been reported in studies on major depression, its role in the neural mechanism of depression remains unclear. To understand how the cerebellum may relate to affective and cognitive dysfunction in depression, we investigated the resting-state functional connectivity between cerebellar regions and the cerebral cortex in samples of patients with geriatric depression (n = 11) and healthy controls (n = 18). Seed-based connectivity analyses were conducted using seeds from cerebellum regions previously identified as being involved in the executive, default-mode, affective- limbic, and motor networks. The results revealed that, compared with controls, individuals with depression show reduced functional connectivity between several cerebellum seed regions, specifically those in the executive and affective- limbic networks with the ventromedial prefrontal cortex (vmPFC) and increased functional connectivity between the motor-related cerebellum seed regions with the putamen and motor cortex. We further investigated whether the altered functional connectivity in depressed patients was associated with cognitive function and severity of depression. A positive correlation was found between the Crus II-vmPFC connectivity and performance on the Hopkins Verbal Learning Test-Revised delayed memory recall. Additionally, the vermis-posterior cinglate cortex (PCC) connectivity was positively correlated with depression severity. Our results suggest that cerebellum-vmPFC coupling may be related to cognitive function whereas cerebellum-PCC coupling may be related to emotion processing in geriatric depression.	[Alalade, Emmanuel] Morehouse Sch Med, Atlanta, GA 30310 USA; [Denny, Kevin; Wang, Lihong] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Potter, Guy; Steffens, David; Wang, Lihong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA	Morehouse School of Medicine; Duke University; Duke University	Alalade, E (corresponding author), Morehouse Sch Med, Atlanta, GA 30310 USA.	lihong.wang@duke.edu	Wang, Lihong/D-8960-2011		Paul B. Beeson Career Developmental Awards [K23-AG028982]; National Alliance for Research in Schizophrenia and Depression Young Investigator Award; Duke Silvio O. Conte Center for the Neuroscience of Depression [P50-MH60451]; NIMH [K24 MH70027, K23 MH087741]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087741, P50MH060451, K24MH070027, R25MH071544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028982] Funding Source: NIH RePORTER	Paul B. Beeson Career Developmental Awards; National Alliance for Research in Schizophrenia and Depression Young Investigator Award; Duke Silvio O. Conte Center for the Neuroscience of Depression; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Paul B. Beeson Career Developmental Awards (K23-AG028982), a National Alliance for Research in Schizophrenia and Depression Young Investigator Award (LW), and the Duke Silvio O. Conte Center for the Neuroscience of Depression (P50-MH60451). DC is supported by a NIMH Mid-Career Development Award (K24 MH70027). GP is supported by NIMH Career Development Award (K23 MH087741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREZIK JA, 1984, NEUROSCIENCE, V11, P497, DOI 10.1016/0306-4522(84)90040-X; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; BLUMENTHAL JA, 1989, J GERONTOL, V44, pM147, DOI 10.1093/geronj/44.5.M147; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DelBello MP, 1999, NEUROPSYCHOPHARMACOL, V21, P63, DOI 10.1016/S0893-133X(99)00026-3; Di Francescomarino S, 2009, SPORTS MED, V39, P797, DOI 10.2165/11317750-000000000-00000; DIETRICHS E, 1984, ANAT EMBRYOL, V170, P313, DOI 10.1007/BF00318735; DIETRICHS E, 1984, BRAIN RES, V296, P225, DOI 10.1016/0006-8993(84)90060-X; DOLAN RJ, 1992, J NEUROL NEUROSUR PS, V55, P768, DOI 10.1136/jnnp.55.9.768; Escalona P.R., 1993, DEPRESSION, V1, P156, DOI DOI 10.1002/DEPR.3050010307; Etkin A, 2010, ANXIETY DISORDERS TH, P192; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Frodl TS, 2008, ARCH GEN PSYCHIAT, V65, P1156, DOI 10.1001/archpsyc.65.10.1156; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; HAINES DE, 1984, BRAIN BEHAV EVOLUT, V24, P198, DOI 10.1159/000121317; HEATH RG, 1974, EXP NEUROL, V45, P268, DOI 10.1016/0014-4886(74)90118-6; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Kimbrell TA, 2002, BIOL PSYCHIAT, V51, P237, DOI 10.1016/S0006-3223(01)01216-1; Konarski JZ, 2005, J PSYCHIATR NEUROSCI, V30, P178; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LAYNE C, 1980, J CLIN PSYCHOL, V36, P647, DOI 10.1002/1097-4679(198007)36:3<647::AID-JCLP2270360306>3.0.CO;2-9; Liotti M, 2002, AM J PSYCHIAT, V159, P1830, DOI 10.1176/appi.ajp.159.11.1830; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Ma Qiang, 2008, Neurosci Bull, V24, P265, DOI 10.1007/s12264-008-0402-1; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2003, NEUROPSYCHOLOGIA, V41, P203, DOI 10.1016/S0028-3932(02)00150-1; Pillay SS, 1997, BIOL PSYCHIAT, V42, P79, DOI 10.1016/S0006-3223(96)00335-6; QVIST H, 1989, ANAT EMBRYOL, V179, P471, DOI 10.1007/BF00319590; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; SCHMAHMANN JD, 1995, NEUROSCI LETT, V199, P175, DOI 10.1016/0304-3940(95)12056-A; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2000, J NEUROLINGUIST, V13, P189, DOI 10.1016/S0911-6044(00)00011-7; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; SHAH SA, 1992, ACTA PSYCHIAT SCAND, V85, P474, DOI 10.1111/j.1600-0447.1992.tb03214.x; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; STOODLEY CJ, 2011, CEREBELLUM, V11, P352, DOI DOI 10.1007/S12311-011-0260-7; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; VILENSKY JA, 1981, BRAIN RES, V205, P391, DOI 10.1016/0006-8993(81)90348-6; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wolf SA, 2011, BRAIN BEHAV IMMUN, V25, P971, DOI 10.1016/j.bbi.2010.10.014; Worsley KJ, 2001, FUNCTIONAL MRI INTRO	57	104	108	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20035	10.1371/journal.pone.0020035	http://dx.doi.org/10.1371/journal.pone.0020035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637831	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052200028
J	Annala, M; Laurila, K; Lahdesmaki, H; Nykter, M				Annala, Matti; Laurila, Kirsti; Lahdesmaki, Harri; Nykter, Matti			A Linear Model for Transcription Factor Binding Affinity Prediction in Protein Binding Microarrays	PLOS ONE			English	Article							UNIVERSAL DNA MICROARRAYS; IN-VIVO; SITES; SPECIFICITIES; SELECTION; COMPACT; TARGETS; DESIGN	Protein binding microarrays (PBM) are a high throughput technology used to characterize protein-DNA binding. The arrays measure a protein's affinity toward thousands of double-stranded DNA sequences at once, producing a comprehensive binding specificity catalog. We present a linear model for predicting the binding affinity of a protein toward DNA sequences based on PBM data. Our model represents the measured intensity of an individual probe as a sum of the binding affinity contributions of the probe's subsequences. These subsequences characterize a DNA binding motif and can be used to predict the intensity of protein binding against arbitrary DNA sequences. Our method was the best performer in the Dialogue for Reverse Engineering Assessments and Methods 5 (DREAM5) transcription factor/DNA motif recognition challenge. For the DREAM5 bonus challenge, we also developed an approach for the identification of transcription factors based on their PBM binding profiles. Our approach for TF identification achieved the best performance in the bonus challenge.	[Annala, Matti; Laurila, Kirsti; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Sch Sci & Technol, Helsinki, Finland; [Lahdesmaki, Harri; Nykter, Matti] Turku Univ, Turku Ctr Biotechnol, Turku, Finland	Tampere University; Aalto University; University of Turku	Annala, M (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	matti.annala@tut.fi		Nykter, Matti/0000-0001-6956-2843	Academy of Finland [122973, 132877, 134290, 135320, 213462]; EU; Tekes Finland; Tampere Doctoral Programme in Information Science and Engineering (TISE); Otto A. Malm Foundation	Academy of Finland(Academy of Finland); EU(European Commission); Tekes Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Tampere Doctoral Programme in Information Science and Engineering (TISE); Otto A. Malm Foundation	This work was supported by the Academy of Finland (projects 122973, 132877, 134290, 135320, 213462), EU ERASysBio ERA-NET, the Tekes Finland Distinguished Professor programme, the Tampere Doctoral Programme in Information Science and Engineering (TISE), and the Otto A. Malm Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1007/BF00993379; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mintseris J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-429; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nykter M, 2009, ANN NY ACAD SCI, V1158, P205, DOI 10.1111/j.1749-6632.2008.03758.x; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Philippakis AA, 2008, J COMPUT BIOL, V15, P655, DOI 10.1089/cmb.2007.0114; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rocke DM, 2001, J COMPUT BIOL, V8, P557, DOI 10.1089/106652701753307485; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316	42	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20059	10.1371/journal.pone.0020059	http://dx.doi.org/10.1371/journal.pone.0020059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637853	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200031
J	Bejjanki, VR; Clayards, M; Knill, DC; Aslin, RN				Bejjanki, Vikranth Rao; Clayards, Meghan; Knill, David C.; Aslin, Richard N.			Cue Integration in Categorical Tasks: Insights from Audio-Visual Speech Perception	PLOS ONE			English	Article							BAYESIAN INTEGRATION; INFORMATION; INFANTS; FUSION; MODEL; INFERENCE; TEXTURE; SIGNALS; HEARING; SENSES	Previous cue integration studies have examined continuous perceptual dimensions (e. g., size) and have shown that human cue integration is well described by a normative model in which cues are weighted in proportion to their sensory reliability, as estimated from single-cue performance. However, this normative model may not be applicable to categorical perceptual dimensions (e. g., phonemes). In tasks defined over categorical perceptual dimensions, optimal cue weights should depend not only on the sensory variance affecting the perception of each cue but also on the environmental variance inherent in each task-relevant category. Here, we present a computational and experimental investigation of cue integration in a categorical audio-visual (articulatory) speech perception task. Our results show that human performance during audio-visual phonemic labeling is qualitatively consistent with the behavior of a Bayes-optimal observer. Specifically, we show that the participants in our task are sensitive, on a trial-by-trial basis, to the sensory uncertainty associated with the auditory and visual cues, during phonemic categorization. In addition, we show that while sensory uncertainty is a significant factor in determining cue weights, it is not the only one and participants' performance is consistent with an optimal model in which environmental, within category variability also plays a role in determining cue weights. Furthermore, we show that in our task, the sensory variability affecting the visual modality during cue-combination is not well estimated from single-cue performance, but can be estimated from multi-cue performance. The findings and computational principles described here represent a principled first step towards characterizing the mechanisms underlying human cue integration in categorical tasks.	[Bejjanki, Vikranth Rao; Clayards, Meghan; Knill, David C.; Aslin, Richard N.] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Bejjanki, VR (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	vrao@bcs.rochester.edu			MURI from the Office of Naval Research, Department of Defense [N00014-07-1-0937]	MURI from the Office of Naval Research, Department of Defense(United States Department of Defense)	This work was supported by MURI grant N00014-07-1-0937 from the Office of Naval Research, Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Banks MS, 1998, VISION RES, V38, P187, DOI 10.1016/S0042-6989(97)00179-X; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Clayards M, 2008, COGNITION, V108, P804, DOI 10.1016/j.cognition.2008.04.004; COHEN MM, 1990, BEHAV RES METH INSTR, V22, P260, DOI 10.3758/BF03203157; Desjardins RN, 2004, DEV PSYCHOBIOL, V45, P187, DOI 10.1002/dev.20033; Desjardins RN, 1997, J EXP CHILD PSYCHOL, V66, P85, DOI 10.1006/jecp.1997.2379; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Holt LL, 2006, J ACOUST SOC AM, V119, P3059, DOI 10.1121/1.2188377; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jacobs RA, 2002, TRENDS COGN SCI, V6, P345, DOI 10.1016/S1364-6613(02)01948-4; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Knill DC, 2007, J VISION, V7, DOI 10.1167/7.7.5; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; MASSARO DW, 1983, J EXP PSYCHOL HUMAN, V9, P753, DOI 10.1037/0096-1523.9.5.753; MASSARO DW, 1993, J PHONETICS, V21, P445, DOI 10.1016/S0095-4470(19)30230-X; MASSARO DW, 1984, CHILD DEV, V55, P1777, DOI 10.2307/1129925; MASSARO DW, SPEECH PERCEPTION EA; MASSARO DW, PERCEIVING TALKING F; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Papoulis Athanasios, PROBABILITY RANDOM V; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Remez RE, 2001, PSYCHOL SCI, V12, P24, DOI 10.1111/1467-9280.00305; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Ross LA, 2007, CEREB CORTEX, V17, P1147, DOI 10.1093/cercor/bhl024; Schwartz JL, 2006, J ACOUST SOC AM, V120, P1795, DOI 10.1121/1.2258814; Schwartz JL, 2010, J ACOUST SOC AM, V127, P1584, DOI 10.1121/1.3293001; Sekiyama K, 1997, PERCEPT PSYCHOPHYS, V59, P73, DOI 10.3758/BF03206849; Sekiyama K, 2008, DEVELOPMENTAL SCI, V11, P306, DOI 10.1111/j.1467-7687.2008.00677.x; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; SWANSON WH, 1992, PERCEPT PSYCHOPHYS, V51, P409, DOI 10.3758/BF03211637; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Wallace MT, 2004, EXP BRAIN RES, V158, P252, DOI 10.1007/s00221-004-1899-9; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	48	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19812	10.1371/journal.pone.0019812	http://dx.doi.org/10.1371/journal.pone.0019812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637344	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200016
J	Woodwark, C; Bateman, A				Woodwark, Cara; Bateman, Alex			The Characterisation of Three Types of Genes that Overlie Copy Number Variable Regions	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; TRANSCRIPTION FACTORS; HUMAN GENOME; EVOLUTION; MICRORNAS; EXPRESSION; TARGETS; DATABASE; TRANSLATION; SHAPES	Background: Due to the increased accuracy of Copy Number Variable region (CNV) break point mapping, it is now possible to say with a reasonable degree of confidence whether a gene (i) falls entirely within a CNV; (ii) overlaps the CNV or (iii) actually contains the CNV. We classify these as type I, II and III CNV genes respectively. Principal Findings: Here we show that although type I genes vary in copy number along with the CNV, most of these type I genes have the same expression levels as wild type copy numbers of the gene. These genes must, therefore, be under homeostatic dosage compensation control. Looking into possible mechanisms for the regulation of gene expression we found that type I genes have a significant paucity of genes regulated by miRNAs and are not significantly enriched for monoallelically expressed genes. Type III genes, on the other hand, have a significant excess of genes regulated by miRNAs and are enriched for genes that are monoallelically expressed. Significance: Many diseases and genomic disorders are associated with CNVs so a better understanding of the different ways genes are associated with normal CNVs will help focus on candidate genes in genome wide association studies.	[Woodwark, Cara; Bateman, Alex] Wellcome Trust Sanger Inst, Cambridge, England	Wellcome Trust Sanger Institute	Woodwark, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	cara@sanger.ac.uk	Bateman, Alex/E-6518-2011; Bateman, Alex/H-2861-2019	Bateman, Alex/0000-0002-6982-4660	Wellcome Trust [WT077044/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [grant number WT077044/Z/05/Z] http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Necsulea A, 2009, TRENDS GENET, V25, P519, DOI 10.1016/j.tig.2009.10.001; Ohno S., 1970, EVOLUTION GENE DUPLI; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Patthy L, 2003, GENETICA, V118, P217, DOI 10.1023/A:1024182432483; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruault M, 2008, TRENDS GENET, V24, P574, DOI 10.1016/j.tig.2008.08.008; Schuster-Bockler B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009474; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	35	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e14814	10.1371/journal.pone.0014814	http://dx.doi.org/10.1371/journal.pone.0014814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637334	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200001
J	Zeiser, E; Frokjaer-Jensen, C; Jorgensen, E; Ahringer, J				Zeiser, Eva; Frokjaer-Jensen, Christian; Jorgensen, Erik; Ahringer, Julie			MosSCI and Gateway Compatible Plasmid Toolkit for Constitutive and Inducible Expression of Transgenes in the C. elegans Germline	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; REQUIREMENTS; VERSION	Here we describe a toolkit for the production of fluorescently tagged proteins in the C. elegans germline and early embryo using Mos1-mediated single copy insertion (MosSCI) transformation. We have generated promoter and 3'UTR fusions to sequences of different fluorescent proteins yielding constructs for germline expression that are compatible with MosSCI MultiSite Gateway vectors. These vectors allow tagged transgene constructs to be inserted as single copies into known sites in the C. elegans genome using MosSCI. We also show that two C. elegans heat shock promoters (Phsp-16.2 and Phsp-16.41) can be used to induce transgene expression in the germline when inserted via MosSCI transformation. This flexible set of new vectors, available to the research community in a plasmid repository, should facilitate research focused on the C. elegans germline and early embryo.	[Zeiser, Eva; Ahringer, Julie] Univ Cambridge, Gurdon Inst, Cambridge, England; [Zeiser, Eva; Ahringer, Julie] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Frokjaer-Jensen, Christian] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Frokjaer-Jensen, Christian] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Frokjaer-Jensen, Christian; Jorgensen, Erik] Univ Utah, Dept Biol, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	University of Cambridge; University of Cambridge; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Zeiser, E (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	ja219@cam.ac.uk	Frøkjær-Jensen, Christian/ABB-4637-2020	Ahringer, Julie/0000-0002-7074-4051; Frokjaer-Jensen, Christian/0000-0002-3178-0906	Lundbeck Foundation; National Institutes of Health [NIH/NIGMS1R01GM095817-01]; Wellcome Trust [054523]; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CF-J is funded by a fellowship from the Lundbeck Foundation (http://www.lundbeckfonden.dk/en/index.asp). This work was supported by the National Institutes of Health (http://www.nih.gov/) (NIH/NIGMS1R01GM095817-01) to EMJ, and a Wellcome Trust (http://www.wellcome.ac.uk/) Senior Research Fellowship (054523) and core funding from the Wellcome Trust and Cancer Research UK (http://www.cancerresearchuk.org/) to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Bazopoulou D, 2009, GENETICA, V137, P39, DOI 10.1007/s10709-009-9361-3; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Kelly WG, 1997, GENETICS, V146, P227; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; OKKEMA PG, 1993, GENETICS, V135, P385; Praitis V, 2001, GENETICS, V157, P1217; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082	15	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20082	10.1371/journal.pone.0020082	http://dx.doi.org/10.1371/journal.pone.0020082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637852	Green Published, gold			2022-12-25	WOS:000291052200032
J	Stevenson, L; Allen, WL; Proutski, I; Stewart, G; Johnston, L; McCloskey, K; Wilson, PM; Longley, DB; Johnston, PG				Stevenson, Leanne; Allen, Wendy L.; Proutski, Irina; Stewart, Gail; Johnston, Louise; McCloskey, Karen; Wilson, Peter M.; Longley, Daniel B.; Johnston, Patrick G.			Calbindin 2 (CALB2) Regulates 5-Fluorouracil Sensitivity in Colorectal Cancer by Modulating the Intrinsic Apoptotic Pathway	PLOS ONE			English	Article							MULTICENTER RANDOMIZED-TRIAL; CELL-DEATH; 1ST-LINE TREATMENT; GENE-EXPRESSION; CALRETININ; FLUOROURACIL; IRINOTECAN; LOCALIZATION; MESOTHELIOMA; CHEMOTHERAPY	The role of the calcium binding protein, Calbindin 2 (CALB2), in regulating the response of colorectal cancer (CRC) cells to 5-Fluorouracil (5-FU) was investigated. Real-time RT-PCR and Western blot analysis revealed that CALB2 mRNA and protein expression were down-regulated in p53 wild-type and p53 null isogenic HCT116 CRC cell lines following 48 h and 72 h 5-FU treatment. Moreover, 5-FU-induced apoptosis was significantly reduced in HCT116 and LS174T CRC cell lines in which CALB2 expression had been silenced. Further investigation revealed that CALB2 translocated to the mitochondria following 5-FU treatment and that 5-FU-induced loss of mitochondrial membrane potential (Delta psi(m)) was abrogated in CALB2-silenced cells. Furthermore, CALB2 silencing decreased 5-FU-induced cytochrome c and smac release from the mitochondria and also decreased 5-FU-induced activation of caspases 9 and 3/7. Of note, co-silencing of XIAP overcame 5-FU resistance in CALB2-silenced cells. Collectively, these results suggest that following 5-FU treatment in CRC cell lines, CALB2 is involved in apoptosis induction through the intrinsic mitochondrial pathway. This indicates that CALB2 may be an important mediator of 5-FU-induced cell death. Moreover, down-regulation of CALB2 in response to 5-FU may represent an intrinsic mechanism of resistance to this anti-cancer drug.	[Stevenson, Leanne; Allen, Wendy L.; Proutski, Irina; Stewart, Gail; Johnston, Louise; McCloskey, Karen; Wilson, Peter M.; Longley, Daniel B.; Johnston, Patrick G.] Queens Univ Belfast, Drug Resistance Grp, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Stevenson, L (corresponding author), Queens Univ Belfast, Drug Resistance Grp, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	s.stevenson@qub.ac.uk		Moore, Wendy/0000-0003-0732-4123; McCloskey, Karen/0000-0002-9135-9013	Cancer Research UK [C212/A7402]; Research and Development Office Northern Ireland, Department of Health, Social Services and Public Safety [RRG/3261/05, RRG 6.42]	Cancer Research UK(Cancer Research UK); Research and Development Office Northern Ireland, Department of Health, Social Services and Public Safety	Funding was received from Cancer Research UK (C212/A7402); and Research and Development Office Northern Ireland, Department of Health, Social Services and Public Safety (RRG/3261/05, RRG 6.42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertschy S, 1998, HISTOCHEM CELL BIOL, V109, P59; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Caponigro F, 2005, CURR OPIN ONCOL, V17, P212, DOI 10.1097/01.cco.0000159623.68506.cf; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Chu AY, 2005, MODERN PATHOL, V18, P105, DOI 10.1038/modpathol.3800259; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; D'Orlando C, 2002, BRAIN RES, V945, P181, DOI 10.1016/S0006-8993(02)02753-1; D'Orlando C, 2001, BRAIN RES, V909, P145, DOI 10.1016/S0006-8993(01)02671-3; Doglioni C, 1996, AM J SURG PATHOL, V20, P1037, DOI 10.1097/00000478-199609000-00001; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; Gotzos V, 1996, ANTICANCER RES, V16, P3491; Gotzos V, 1999, AM J SURG PATHOL, V23, P701, DOI 10.1097/00000478-199906000-00010; Hack NJ, 2000, J NEUROSCI, V20; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Johnston PG, 2001, ANTI-CANCER DRUG, V12, P639, DOI 10.1097/00001813-200109000-00001; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuznicki J, 1996, BBA-MOL CELL RES, V1313, P194, DOI 10.1016/0167-4889(96)00089-4; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Longley DB, 2002, CANCER RES, V62, P2644; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Schurmans S, 1997, P NATL ACAD SCI USA, V94, P10415, DOI 10.1073/pnas.94.19.10415; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366; Wu Y, 2009, CANCER BIOL THER, V8, P146, DOI 10.4161/cbt.8.2.7087; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20276	10.1371/journal.pone.0020276	http://dx.doi.org/10.1371/journal.pone.0020276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629658	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800040
J	Gentilucci, M; Campione, GC				Gentilucci, Maurizio; Campione, Giovanna Cristina			Do Postures of Distal Effectors Affect the Control of Actions of Other Distal Effectors? Evidence for a System of Interactions between Hand and Mouth	PLOS ONE			English	Article							AREA F5; LANGUAGE; REPRESENTATION; GESTURE; SPEECH; COMMUNICATION; PREMOTOR; CORTEX; MONKEY	The present study aimed at determining whether, in healthy humans, postures assumed by distal effectors affect the control of the successive grasp executed with other distal effectors. In experiments 1 and 2, participants reached different objects with their head and grasped them with their mouth, after assuming different hand postures. The postures could be implicitly associated with interactions with large or small objects. The kinematics of lip shaping during grasp varied congruently with the hand posture, i.e. it was larger or smaller when it could be associated with the grasping of large or small objects, respectively. In experiments 3 and 4, participants reached and grasped different objects with their hand, after assuming the postures of mouth aperture or closure (experiment 3) and the postures of toe extension or flexion (experiment 4). The mouth postures affected the kinematics of finger shaping during grasp, that is larger finger shaping corresponded with opened mouth and smaller finger shaping with closed mouth. In contrast, the foot postures did not influence the hand grasp kinematics. Finally, in experiment 5 participants reached-grasped different objects with their hand while pronouncing opened and closed vowels, as verified by the analysis of their vocal spectra. Open and closed vowels induced larger and smaller finger shaping, respectively. In all experiments postures of the distal effectors induced no effect, or only unspecific effects on the kinematics of the reach proximal/axial component. The data from the present study support the hypothesis that there exists a system involved in establishing interactions between movements and postures of hand and mouth. This system might have been used to transfer a repertoire of hand gestures to mouth articulation postures during language evolution and, in modern humans, it may have evolved a system controlling the interactions existing between speech and gestures.	[Gentilucci, Maurizio; Campione, Giovanna Cristina] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gentilucci, Maurizio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Gentilucci, M (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	maurizio.gentilucci@unipr.it		Campione, Giovanna Cristina/0000-0003-0410-5400	MIUR (Ministero dell'Istruzione, dell'Universita e delle Ricerca); IIT ( Istituto Italiano di Tecnologia)	MIUR (Ministero dell'Istruzione, dell'Universita e delle Ricerca)(Ministry of Education, Universities and Research (MIUR)); IIT ( Istituto Italiano di Tecnologia)	The study was supported by grants MIUR (Ministero dell'Istruzione, dell'Universita e delle Ricerca) and IIT ( Istituto Italiano di Tecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Armstrong D. F., 1999, ORIGINAL SIGNS GESTU; Armstrong D. F., 1995, GESTURE NATURE LANGU; Baldissera FG, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-70; Barbieri F, 2007, EXP BRAIN RES, V180, P421, DOI 10.1007/s00221-007-0869-4; Barbieri F, 2009, BRAIN LANG, V110, P1, DOI 10.1016/j.bandl.2009.01.002; Bernardis P, 2006, NEUROPSYCHOLOGIA, V44, P178, DOI 10.1016/j.neuropsychologia.2005.05.007; Browman C., 1995, MIND MOTION EXPLORAT, P175; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; CORBALLIS MC, 1992, COGNITION, V44, P197, DOI 10.1016/0010-0277(92)90001-X; Corballis MC, 2002, HAND MOUTH ORIGINS L; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Donald M., 1991, ORIGINS MODERN MIND; GENTILUCCI M, 1994, EXP BRAIN RES, V99, P483; Gentilucci M, 2002, NEUROPSYCHOLOGIA, V40, P1139, DOI 10.1016/S0028-3932(01)00233-0; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2008, J PHYSIOL-PARIS, V102, P21, DOI 10.1016/j.jphysparis.2008.03.002; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gentilucci M, 2006, J COGNITIVE NEUROSCI, V18, P1059, DOI 10.1162/jocn.2006.18.7.1059; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; GIVON Talmy, 1995, FUNCTIONALISM GRAMMA; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; LEONI FA, 2002, MANUALE FONETICA; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paget R, 1930, HUMAN SPEECH; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Ruben RJ, 2005, ACTA OTO-LARYNGOL, V125, P464, DOI 10.1080/00016480510026287; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	34	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19793	10.1371/journal.pone.0019793	http://dx.doi.org/10.1371/journal.pone.0019793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625428	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005200014
J	Stewart, JL; Maloof, JN; Nemhauser, JL				Stewart, Jodi L.; Maloof, Julin N.; Nemhauser, Jennifer L.			PIF Genes Mediate the Effect of Sucrose on Seedling Growth Dynamics	PLOS ONE			English	Article							LIGHT-SIGNAL-TRANSDUCTION; HYPOCOTYL ELONGATION; TRANSCRIPTION FACTOR; BLUE-LIGHT; ARABIDOPSIS; PHYTOCHROME; GIBBERELLIN; DEGRADATION; GERMINATION; PROTEIN	As photoautotrophs, plants can use both the form and amount of fixed carbon as a measure of the light environment. In this study, we used a variety of approaches to elucidate the role of exogenous sucrose in modifying seedling growth dynamics. In addition to its known effects on germination, high-resolution temporal analysis revealed that sucrose could extend the number of days plants exhibited rapid hypocotyl elongation, leading to dramatic increases in ultimate seedling height. In addition, sucrose changed the timing of daily growth maxima, demonstrating that diel growth dynamics are more plastic than previously suspected. Sucrose-dependent growth promotion required function of multiple phytochrome-interacting factors (PIFs), and overexpression of PIF5 led to growth dynamics similar to plants exposed to sucrose. Consistent with this result, sucrose was found to increase levels of PIF5 protein. PIFs have well-established roles as integrators of response to light levels, time of day and phytohormone signaling. Our findings strongly suggest that carbon availability can modify the known photomorphogenetic signaling network.	[Stewart, Jodi L.; Nemhauser, Jennifer L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Maloof, Julin N.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis	Stewart, JL (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jn7@uw.edu		Maloof, Julin/0000-0002-9623-2599	National Science Foundation [IOS-0820854, IOS-0919021]; Seattle Chapter of the Achievement Rewards for College Scientists Foundation; University of Washington	National Science Foundation(National Science Foundation (NSF)); Seattle Chapter of the Achievement Rewards for College Scientists Foundation; University of Washington(University of Washington)	JLS is supported by the National Science Foundation Graduate Research Fellowship Program and the Seattle Chapter of the Achievement Rewards for College Scientists Foundation. Funding for the Maloof Lab was provided by National Science Foundation grant IOS-0820854. Funding for the Nemhauser Lab was provided by the University of Washington Royalty Research Fund and National Science Foundation grant IOS-0919021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; CHENG CL, 1992, P NATL ACAD SCI USA, V89, P1861, DOI 10.1073/pnas.89.5.1861; Chory J, 2010, PLANT J, V61, P982, DOI 10.1111/j.1365-313X.2009.04105.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Dekkers BJW, 2004, PLANTA, V218, P579, DOI 10.1007/s00425-003-1154-9; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Dijkwel PP, 1996, PLANT PHYSIOL, V110, P455, DOI 10.1104/pp.110.2.455; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; KAZAMA H, 1973, PLANT CELL PHYSIOL, V14, P449; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kurata T, 1998, PLANT PHYSIOL, V118, P793, DOI 10.1104/pp.118.3.793; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Monte E, 2007, J EXP BOT, V58, P3125, DOI 10.1093/jxb/erm186; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Oh E, 2004, PLANT CELL, V16, P3045, DOI 10.1105/tpc.104.025163; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2006, PLANT J, V47, P124, DOI 10.1111/j.1365-313X.2006.02773.x; Parks BM, 1998, PLANT PHYSIOL, V118, P609, DOI 10.1104/pp.118.2.609; Parks BM, 2001, CURR OPIN PLANT BIOL, V4, P436, DOI 10.1016/S1369-5266(00)00197-7; Penfield S, 2010, PLANT MOL BIOL, V73, P89, DOI 10.1007/s11103-009-9571-1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piskurewicz U, 2009, EMBO J, V28, P2259, DOI 10.1038/emboj.2009.170; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078; Zhang YQ, 2010, J PLANT PHYSIOL, V167, P1130, DOI 10.1016/j.jplph.2010.03.007; [No title captured]	51	82	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19894	10.1371/journal.pone.0019894	http://dx.doi.org/10.1371/journal.pone.0019894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625438	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200019
J	Chang, CH; Chang, TY; Chang, YJ; Huang, KL; Chin, SC; Ryu, SJ; Yang, TC; Lee, TH				Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Chin, Shy Chyi; Ryu, Shan Jin; Yang, Tao Chieh; Lee, Tsong Hai			The Role of Perfusion Computed Tomography in the Prediction of Cerebral Hyperperfusion Syndrome	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CAROTID-ARTERY STENOSIS; CT PERFUSION; ACUTE STROKE; BLOOD-FLOW; INTRACRANIAL HEMORRHAGE; QUANTITATIVE ASSESSMENT; ISCHEMIC-STROKE; DYNAMIC CT; ENDARTERECTOMY	Background: Hyperperfusion syndrome (HPS) following carotid angioplasty with stenting (CAS) is associated with significant morbidity and mortality. At present, there are no reliable parameters to predict HPS. The aim of this study was to clarify whether perfusion computed tomography (CT) is a feasible and reliable tool in predicting HPS after CAS. Methodology/Principal Findings: We performed a retrospective case-control study of 54 patients (11 HPS patients and 43 non-HPS) with unilateral severe stenosis of the carotid artery who underwent CAS. We compared the prevalence of vascular risk factors and perfusion CT parameters including regional cerebral blood volume (rCBV), regional cerebral blood flow (rCBF), and time to peak (TTP) within seven days prior to CAS. Demographic information, risk factors for atherosclerosis, and perfusion CT parameters were evaluated by multivariable logistic regression analysis. The rCBV index was calculated as [(ipsilateral rCBV - contralateral rCBV)/contralateral rCBV], and indices of rCBF and TTP were similarly calculated. We found that eleven patients had HPS, including five with intracranial hemorrhages (ICHs) of whom three died. After a comparison with non-HPS control subjects, independent predictors of HPS included the severity of ipsilateral carotid artery stenosis, 3-hour mean systolic blood pressure (3 h SBP) after CAS, pre-stenting rCBV index > 0.15 and TTP index > 0.22. Conclusions/Significance: The combination of severe ipsilateral carotid stenosis, 3 h SBP after CAS, rCBV index and TTP index provides a potential screening tool for predicting HPS in patients with unilateral carotid stenosis receiving CAS. In addition, adequate management of post-stenting blood pressure is the most important treatable factor in preventing HPS in these high risk patients.	[Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Ryu, Shan Jin; Lee, Tsong Hai] Chang Gung Univ, Stroke Ctr, Tao Yuan, Taiwan; [Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Ryu, Shan Jin; Lee, Tsong Hai] Chang Gung Univ, Linkou Med Ctr, Gung Mem Hosp, Dept Neurol, Tao Yuan, Taiwan; [Chang, Chien Hung; Chang, Ting Yu; Chang, Yeu Jhy; Huang, Kuo Lun; Ryu, Shan Jin; Lee, Tsong Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chin, Shy Chyi] Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan; [Yang, Tao Chieh] Chang Gung Univ, Linkou Med Ctr, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, CH (corresponding author), Chang Gung Univ, Stroke Ctr, Tao Yuan, Taiwan.	thlee@adm.cgmh.org.tw	Lee, Tsong Hai/C-1235-2011	Chang, Ting-Yu/0000-0003-4642-7352	Chang Gung Memorial Hospital [CMRPG 35073]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant from the Medical Research Project, Chang Gung Memorial Hospital (CMRPG 35073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Chebl A, 2004, J AM COLL CARDIOL, V43, P1596, DOI 10.1016/j.jacc.2003.12.039; BERNSTEIN M, 1984, NEUROSURGERY, V15, P50, DOI 10.1227/00006123-198407000-00010; CAPLAN LR, 1978, STROKE, V9, P457, DOI 10.1161/01.STR.9.5.457; Ernst T, 1999, MAGN RESON IMAGING, V17, P349, DOI 10.1016/S0730-725X(98)00171-4; Ferguson GG, 1999, STROKE, V30, P1751, DOI 10.1161/01.STR.30.9.1751; Firlik AD, 1997, STROKE, V28, P2208, DOI 10.1161/01.STR.28.11.2208; GIBBS JM, 1984, LANCET, V1, P310; Gillard JH, 2000, NEUROL RES, V22, P457; Golledge J, 2000, STROKE, V31, P1439, DOI 10.1161/01.STR.31.6.1439; Hobson R W 2nd, 1997, Cardiovasc Surg, V5, P457, DOI 10.1016/S0967-2109(97)00048-3; Howell M, 2002, J ENDOVASC THER, V9, P810, DOI 10.1583/1545-1550(2002)009<0810:COPSBP>2.0.CO;2; Jain R, 2004, RADIOLOGY, V231, P906, DOI 10.1148/radiol.2313030093; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Kluytmans M, 1998, RADIOLOGY, V209, P675, DOI 10.1148/radiology.209.3.9844658; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Lu J, 2005, CHINESE MED J-PEKING, V118, P1812; Malek AM, 2000, STROKE, V31, P3029, DOI 10.1161/01.STR.31.12.3029; Markus HS, 2004, J NEUROL NEUROSUR PS, V75, P353, DOI 10.1136/jnnp.2003.025825; McCabe DJH, 1999, STROKE, V30, P2483, DOI 10.1161/01.STR.30.11.2483; Meyers PM, 2000, NEUROSURGERY, V47, P335, DOI 10.1097/00006123-200008000-00013; Morrish W, 2000, AM J NEURORADIOL, V21, P1911; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; NORRVING B, 1982, STROKE, V13, P155, DOI 10.1161/01.STR.13.2.155; Ouriel K, 1999, J VASC SURG, V29, P82, DOI 10.1016/S0741-5214(99)70362-9; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Qureshi AI, 2002, STROKE, V33, P1916, DOI 10.1161/01.STR.0000019423.08947.43; Reichenbach JR, 1999, AM J NEURORADIOL, V20, P1842; Roberts HC, 2000, AM J NEURORADIOL, V21, P421; SAKAI F, 1985, J CEREBR BLOOD F MET, V5, P207, DOI 10.1038/jcbfm.1985.27; Sanelli PC, 2004, ACAD RADIOL, V11, P1085, DOI 10.1016/j.acra.2004.07.002; Soinne L, 2003, STROKE, V34, P1655, DOI 10.1161/01.STR.0000075605.36068.D9; Spetzler R F, 1978, Clin Neurosurg, V25, P651; Tomandl BF, 2003, RADIOGRAPHICS, V23, P565, DOI 10.1148/rg.233025036; Trojanowska A, 2006, J NEURORADIOLOGY, V33, P169, DOI 10.1016/S0150-9861(06)77255-8; Tseng YC, 2009, J COMPUT ASSIST TOMO, V33, P540, DOI 10.1097/RCT.0b013e318188ad99; Waaijer A, 2007, RADIOLOGY, V245, P541, DOI 10.1148/radiol.2451061493	37	13	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19886	10.1371/journal.pone.0019886	http://dx.doi.org/10.1371/journal.pone.0019886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625479	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400018
J	Laoong-u-thai, Y; Zhao, BP; Phongdara, A; Yang, JZ				Laoong-u-thai, Yanisa; Zhao, Baoping; Phongdara, Amornrat; Yang, Jinzeng			Molecular Characterizations of a Novel Putative DNA-Binding Protein LvDBP23 in Marine Shrimp L. vannamei Tissues and Molting Stages	PLOS ONE			English	Article							EXPRESSION PATTERNS; GLYCINE-RICH; MUSCLE; REGION	Background: Litopenaeus Vannamei, well known as pacific white shrimp, is the most popular shrimp in the world shrimp market. Identification and characterization of shrimp muscle regulatory genes are not only important for shrimp genetic improvement, but also facilitate comparative genomic tools for understanding of muscle development and regeneration. Methodology/Principal Findings: A novel mRNA encoding for a putative DNA-binding protein LvDBP23 was identified from Litopenaeus vannamei abdominal muscle cDNA library. The LvDBP23 cDNA contains 639 nucleotides of protein-coding sequence with deduced 212 amino acids of predicted molecular mass 23.32 kDa with glycine-rich domain at amino acid position 94-130. The mRNA sequence is successfully used for producing LvDBP23 recombinant protein in sf9 insect cell expression system. The expression of LvDBP23 mRNA is presented in abdominal muscle and swimming leg muscle, as well as other tissues including intestine, lymphoid and gill. The mRNA expression has the highest level in abdominal muscle in all tested tissues. LVDBP23 transcript during the molt cycle is highly expressed in the intermolt stage. In vitro nucleic acid-binding assays reveal that LvDBP23 protein can bind to both ssDNA and dsDNA, indicating its possible role of regulation of gene transcription. Conclusions/Significance: We are the first to report a DNA-binding protein identified from the abdominal muscle tissue of marine shrimp L. Vannamei. Its high-level specific expression during the intermot stage suggests its role in the regulation of muscle buildup during the growth phase of shrimp molt cycle.	[Laoong-u-thai, Yanisa; Zhao, Baoping; Yang, Jinzeng] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Laoong-u-thai, Yanisa] Burapha Univ, Fac Engn, Dept Chem Engn, Chon Buri, Thailand; [Phongdara, Amornrat] Prince Songkla Univ, Ctr Genom & Bioinformat Res, Hat Yai, Thailand; [Yang, Jinzeng] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China	University of Hawaii System; University of Hawaii Manoa; Burapha University; Prince of Songkla University; Huazhong Agricultural University	Laoong-u-thai, Y (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	pamornra@yahoo.com; Jinzeng@hawaii.edu			USDA-CSREES-TSTAR [2008-34135-19343]; National Research Council of Thailand; National Research University Project of Thailand; Office of the Higher Education Commission [SCI540527M]	USDA-CSREES-TSTAR(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Research University Project of Thailand; Office of the Higher Education Commission	The USDA-CSREES-TSTAR programs (Award # 2008-34135-19343), National Research Council of Thailand, The National Research University Project of Thailand and Office of the Higher Education Commission (Grant # SCI540527M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Cesar JRO, 2007, MOL REPROD DEV, V74, P554, DOI 10.1002/mrd.20605; Cesar JRO, 2008, ANIMAL, P1; Cesar JRD, 2006, AQUACULTURE, V261, P688, DOI 10.1016/j.aquaculture.2006.08.003; ELHAJ AJ, 1987, J EXP BIOL, V127, P413; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Laoong-U-Thai Y, 2009, INT J BIOL SCI, V5, P205; Li F, 2005, MOL CELL BIOL, V25, P8913, DOI 10.1128/MCB.25.20.8913-8924.2005; Li ZC, 2010, MOL REPROD DEV, V77, P990, DOI 10.1002/mrd.21252; Li ZC, 2010, MOL REPROD DEV, V77, P76, DOI 10.1002/mrd.21111; Lin L, 1996, MOL CELL BIOL, V16, P2248; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mykles D.L., 1985, Progress in Clinical and Biological Research, V180, P141; MYKLES DL, 1990, J CRUSTACEAN BIOL, V10, P577, DOI 10.2307/1548402; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; Wyban J, 2009, P SPEC SESS SUST SHR, P12; Zhang Shuli, 2009, Weishengwu Xuebao, V49, P453	21	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19959	10.1371/journal.pone.0019959	http://dx.doi.org/10.1371/journal.pone.0019959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625495	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400024
J	Lugt, BV; Beck, ZT; Fuhlbrigge, RC; Hacohen, N; Campbell, JJ; Boes, M				Lugt, Bryan Vander; Beck, Zachary T.; Fuhlbrigge, Robert C.; Hacohen, Nir; Campbell, James J.; Boes, Marianne			TGF-beta Suppresses beta-Catenin-Dependent Tolerogenic Activation Program in Dendritic Cells	PLOS ONE			English	Article							LANGERHANS CELLS; MATURATION; RESPONSES; ADHESION; DISRUPTION; RECEPTORS; TOLERANCE; IMMATURE; IMMUNITY	The mechanisms that underlie the critical dendritic cell (DC) function in maintainance of peripheral immune tolerance are incompletely understood, although the beta-catenin signaling pathway is critical for this role. The molecular details by which beta-catenin signaling is regulated in DCs are unknown. Mechanical disruption of murine bone marrow-derived DC (BMDC) clusters activates DCs while maintaining their tolerogenic potential and this activation is associated with beta-catenin signaling, providing a useful model with which to explore tolerance-associated beta-catenin signaling in DCs. In this report, we demonstrate novel molecular features of the signaling events that control DC activation in response to mechanical stimulation. Non-canonical beta-catenin signaling is an essential component of this tolerogenic activation and is modulated by adhesion molecules, including integrins. This unique beta-catenin-dependent signaling pathway is constitutively active at low levels, suggesting that mechanical stimulation is not necessarily required for induction of this unique activation program. We additionally find that the immunomodulatory cytokine TGF-beta antagonizes beta-catenin in DCs, thereby selectively suppressing signaling associated with tolerogenic DC activation while having no impact on LPS-induced, beta-cateninin-dependent immunogenic activation. These findings provide new molecular insight into the regulation of a critical signaling pathway for DC function in peripheral immune tolerance.	[Lugt, Bryan Vander; Beck, Zachary T.; Fuhlbrigge, Robert C.; Campbell, James J.; Boes, Marianne] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Hacohen, Nir] Broad Inst Harvard & MIT, Cambridge, MA USA; [Boes, Marianne] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat Immunol, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Lugt, BV (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jcampbell@rics.bwh.harvard.edu; mboes@umcutrecht.nl		Boes, Marianne/0000-0003-2590-1692	National Institutes of Health (NIH) [RO1-AR052810, R01-AI046784, R03-AI083796]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046784, R03AI083796, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052810] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors received funding from the National Institutes of Health, NIH RO1-AR052810 (to MB and RF) and R01-AI046784 & R03-AI083796 (to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Fu CM, 2010, IMMUNOL RES, V46, P72, DOI 10.1007/s12026-009-8126-5; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Geissmann F, 1999, J IMMUNOL, V162, P4567; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kel JM, 2010, J IMMUNOL, V185, P3248, DOI 10.4049/jimmunol.1000981; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Sato K, 2000, J IMMUNOL, V164, P2285, DOI 10.4049/jimmunol.164.5.2285; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; van den Broek M, 2007, IMMUNITY, V27, P544, DOI 10.1016/j.immuni.2007.10.004	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20099	10.1371/journal.pone.0020099	http://dx.doi.org/10.1371/journal.pone.0020099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625453	gold, Green Published, Green Submitted			2022-12-25	WOS:000290793400040
J	Kupakuwana, GV; Crill, JE; McPike, MP; Borer, PN				Kupakuwana, Gillian V.; Crill, James E., II; McPike, Mark P.; Borer, Philip N.			Acyclic Identification of Aptamers for Human alpha-Thrombin Using Over-Represented Libraries and Deep Sequencing	PLOS ONE			English	Article							IN-VITRO SELECTION; BINDING DNA APTAMERS; CAPILLARY-ELECTROPHORESIS; EQUILIBRIUM MIXTURES; AUTOMATED SELECTION; RNA APTAMERS; NON-SELEX; LIGANDS; MOLECULES; DIAGNOSTICS	Background: Aptamers are oligonucleotides that bind proteins and other targets with high affinity and selectivity. Twenty years ago elements of natural selection were adapted to in vitro selection in order to distinguish aptamers among randomized sequence libraries. The primary bottleneck in traditional aptamer discovery is multiple cycles of in vitro evolution. Methodology/Principal Findings: We show that over-representation of sequences in aptamer libraries and deep sequencing enables acyclic identification of aptamers. We demonstrated this by isolating a known family of aptamers for human alpha-thrombin. Aptamers were found within a library containing an average of 56,000 copies of each possible randomized 15mer segment. The high affinity sequences were counted many times above the background in 2-6 million reads. Clustering analysis of sequences with more than 10 counts distinguished two sequence motifs with candidates at high abundance. Motif I contained the previously observed consensus 15mer, Thb1 (46,000 counts), and related variants with mostly G/T substitutions; secondary analysis showed that affinity for thrombin correlated with abundance (K-d=12 nM for Thb1). The signal-to-noise ratio for this experiment was roughly 10,000: 1 for Thb1. Motif II was unrelated to Thb1 with the leading candidate (29,000 counts) being a novel aptamer against hexose sugars in the storage and elution buffers for Concanavilin A (K-d = 0.5 mM for alpha-methyl-mannoside); ConA was used to immobilize alpha-thrombin. Conclusions/Significance: Over-representation together with deep sequencing can dramatically shorten the discovery process, distinguish aptamers having a wide range of affinity for the target, allow an exhaustive search of the sequence space within a simplified library, reduce the quantity of the target required, eliminate cycling artifacts, and should allow multiplexing of sequencing experiments and targets.	[Kupakuwana, Gillian V.; Borer, Philip N.] Syracuse Univ, Grad Program Struct Biol Biochem & Biophys, Syracuse, NY 13244 USA; [Crill, James E., II; McPike, Mark P.; Borer, Philip N.] AptaMatrix Inc, Syracuse, NY USA; [Borer, Philip N.] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA	Syracuse University; Syracuse University	Kupakuwana, GV (corresponding author), Syracuse Univ, Grad Program Struct Biol Biochem & Biophys, Syracuse, NY 13244 USA.	pnborer@syr.edu			National Institutes of Health [R43, R44 AI075739, F31 GM086129]; New York State Office of Science, Technology and Academic Research [TTIP C060056]; Syracuse Center of Excellence in Environmental and Energy Systems [EPA X-83232501]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI075739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM086129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Science, Technology and Academic Research; Syracuse Center of Excellence in Environmental and Energy Systems; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (R43, R44 AI075739) to AptaMatrix, Inc., an NIH pre-doctoral fellowship (F31 GM086129) to GVK, a grant from the New York State Office of Science, Technology and Academic Research to Syracuse University (TTIP C060056), and from the Syracuse Center of Excellence in Environmental and Energy Systems to SU (EPA X-83232501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNIE JG, 2008, T ROY SOC TROP MED H, V102, pS55; Berezovski M, 2006, J AM CHEM SOC, V128, P1410, DOI 10.1021/ja056943j; Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Berezovski MV, 2006, NAT PROTOC, V1, P1359, DOI 10.1038/nprot.2006.200; Biesecker G, 1999, IMMUNOPHARMACOLOGY, V42, P219, DOI 10.1016/S0162-3109(99)00020-X; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Boese BJ, 2007, NUCLEIC ACIDS RES, V35, P6378, DOI 10.1093/nar/gkm708; BORER PN, 2009, Patent No. 2009151688; BORER PN, 2010, PITTCON M PITTSB C A, P1430; Chen F, 2007, BIOCHEM BIOPH RES CO, V357, P743, DOI 10.1016/j.bbrc.2007.04.007; Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107; Cox JC, 2001, BIOORGAN MED CHEM, V9, P2525, DOI 10.1016/S0968-0896(01)00028-1; Cox JC, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf107; Cox JC, 2002, COMB CHEM HIGH T SCR, V5, P289; Davis JP, 1996, METHOD ENZYMOL, V267, P302; Deterding RR, 2010, AM J RESP CRIT CARE, V181, pA6722; Drabovich A, 2005, J AM CHEM SOC, V127, P11224, DOI 10.1021/ja0530016; Eaton BE, 1997, BIOORGAN MED CHEM, V5, P1087, DOI 10.1016/S0968-0896(97)00044-8; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fitzwater T, 1996, METHOD ENZYMOL, V267, P275; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Golden MC, 2000, J BIOTECHNOL, V81, P167, DOI 10.1016/S0168-1656(00)00290-X; Hicke BJ, 2006, J NUCL MED, V47, P668; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kelly JA, 1996, J MOL BIOL, V256, P417, DOI 10.1006/jmbi.1996.0097; Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030; KUPAKUWANA GV, THESIS SYRACUSE U; KUPAKUWANA GV, 2010, BIOPHYS SOC M, pB276; Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106; Marshall KA, 2000, METHOD ENZYMOL, V318, P193; Mendonsa SD, 2004, ANAL CHEM, V76, P5387, DOI 10.1021/ac049857v; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Niles JC, 2006, ACS CHEM BIOL, V1, P515, DOI 10.1021/cb6002527; Nitsche A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-48; Padmanabhan K, 1996, ACTA CRYSTALLOGR D, V52, P272, DOI 10.1107/S0907444995013977; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Pandana H, 2008, IEEE SENS J, V8, P661, DOI 10.1109/JSEN.2008.922725; Platt M, 2009, INTEGR BIOL-UK, V1, P116, DOI 10.1039/b814892a; Potyrailo RA, 1998, ANAL CHEM, V70, P3419, DOI 10.1021/ac9802325; SILVERMAN SK, 2007, FUNCTIONAL NUCL ACID; Stojanovic MN, 2001, J AM CHEM SOC, V123, P4928, DOI 10.1021/ja0038171; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Xu Y, 2009, ANAL CHEM, V81, P7436, DOI 10.1021/ac9012072; Yang Q, 1998, P NATL ACAD SCI USA, V95, P5462, DOI 10.1073/pnas.95.10.5462; Zimmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009169	47	40	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19395	10.1371/journal.pone.0019395	http://dx.doi.org/10.1371/journal.pone.0019395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625587	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200007
J	Cioaca, D; Ghenea, S; Spiridon, LN; Marin, M; Petrescu, AJ; Petrescu, SM				Cioaca, Daniela; Ghenea, Simona; Spiridon, Laurentiu N.; Marin, Marioara; Petrescu, Andrei-Jose; Petrescu, Stefana M.			C-Terminus Glycans with Critical Functional Role in the Maturation of Secretory Glycoproteins	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; N-GLYCOSYLATION SITES; NEGATIVE OCULOCUTANEOUS ALBINISM; ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; LINKED OLIGOSACCHARIDES; TYROSINASE ACTIVITY; SERVER; TRANSPORT	The N-glycans of membrane glycoproteins are mainly exposed to the extracellular space. Human tyrosinase is a transmembrane glycoprotein with six or seven bulky N-glycans exposed towards the lumen of subcellular organelles. The central active site region of human tyrosinase is modeled here within less than 2.5 angstrom accuracy starting from Streptomyces castaneoglobisporus tyrosinase. The model accounts for the last five C-terminus glycosylation sites of which four are occupied and indicates that these cluster in two pairs - one in close vicinity to the active site and the other on the opposite side. We have analyzed and compared the roles of all tyrosinase N-glycans during tyrosinase processing with a special focus on the proximal to the active site N-glycans, s6:N337 and s7:N371, versus s3:N161 and s4:N230 which decorate the opposite side of the domain. To this end, we have constructed mutants of human tyrosinase in which its seven N-glycosylation sites were deleted. Ablation of the s6:N337 and s7:N371 sites arrests the post-translational productive folding process resulting in terminally misfolded mutants subjected to degradation through the mannosidase driven ERAD pathway. In contrast, single mutants of the other five N-glycans located either opposite to the active site or into the N-terminus Cys1 extension of tyrosinase are temperature-sensitive mutants and recover enzymatic activity at the permissive temperature of 31 degrees C. Sites s3 and s4 display selective calreticulin binding properties. The C-terminus sites s7 and s6 are critical for the endoplasmic reticulum retention and intracellular disposal. Results herein suggest that individual N-glycan location is critical for the stability, regional folding control and secretion of human tyrosinase and explains some tyrosinase gene missense mutations associated with oculocutaneous albinism type I.	[Cioaca, Daniela; Ghenea, Simona; Spiridon, Laurentiu N.; Marin, Marioara; Petrescu, Andrei-Jose; Petrescu, Stefana M.] Acad Romana, Dept Mol Cell Biol, Inst Biochem, Bucharest, Romania	Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Nicolae Simionescu Institute of Cellular Biology & Pathology	Cioaca, D (corresponding author), Acad Romana, Dept Mol Cell Biol, Inst Biochem, Bucharest, Romania.	ap@biochim.ro; Stefana.Petrescu@biochim.ro	Spiridon, Laurentiu N/A-3352-2017; Chiritoiu, Mari/Q-3983-2017; Petrescu, Stefana M/I-9240-2012; Petrescu, Stefana/AAJ-9505-2021; Petrescu, Andrei-Jose J/G-4576-2016	Spiridon, Laurentiu N/0000-0003-3080-1610; Chiritoiu, Mari/0000-0003-2064-2003; Petrescu, Stefana M/0000-0002-4047-0811; Petrescu, Stefana/0000-0002-4047-0811; Petrescu, Andrei-Jose J/0000-0002-4478-3946; Ghenea, Simona/0000-0002-5566-0335	Institute of Biochemistry; CNCSIS [ID 1171 - 1018/2008, ID 249 - 168/2007]; European Social Fund [POSDRU/89/1.5/S/60746]	Institute of Biochemistry; CNCSIS(Consiliul National al Cercetarii Stiintifice (CNCS)); European Social Fund(European Social Fund (ESF))	This work was supported by the Romanian Academy projects 1 and 3 of the Institute of Biochemistry and CNCSIS Grants ID 1171 - 1018/2008 and ID 249 - 168/2007. Simona Ghenea also acknowledges the postdoctoral program POSDRU/89/1.5/S/60746, from European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Branza-Nichita N, 1999, BIOCHEM BIOPH RES CO, V261, P720, DOI 10.1006/bbrc.1999.1030; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Furumura M, 1998, BIOCHEM BIOPH RES CO, V242, P579, DOI 10.1006/bbrc.1997.8007; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gupta G, 2009, GLYCOCONJUGATE J, V26, P691, DOI 10.1007/s10719-008-9213-x; Halaban R, 2001, J BIOL CHEM, V276, P11933, DOI 10.1074/jbc.M008703200; Hanganu Andrei, 2009, Romanian Journal of Biochemistry, V46, P123; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; JACOBSON SG, 1984, DOC OPHTHALMOL, V56, P337, DOI 10.1007/BF00155678; Kamada A, 2004, J BIOL CHEM, V279, P21533, DOI 10.1074/jbc.M401403200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Miyazaki Satoshi, 2002, Journal of Structural and Functional Genomics, V2, P37, DOI 10.1023/A:1014418700858; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Negroiu G, 1999, CELL MOL BIOL, V45, P1001; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; OETTING WS, 1991, J INVEST DERMATOL, V97, P15, DOI 10.1111/1523-1747.ep12477808; Olivares C, 2003, J BIOL CHEM, V278, P15735, DOI 10.1074/jbc.M300658200; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Petrescu SM, 1997, J BIOL CHEM, V272, P15796, DOI 10.1074/jbc.272.25.15796; Petrescu SM, 2000, BIOCHEMISTRY-US, V39, P5229, DOI 10.1021/bi000107z; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Popescu CI, 2005, J BIOL CHEM, V280, P13833, DOI 10.1074/jbc.M413087200; Popescu CI, 2006, J BIOL CHEM, V281, P21682, DOI 10.1074/jbc.M603841200; Potter BA, 2004, MOL BIOL CELL, V15, P1407, DOI 10.1091/mbc.E03-08-0550; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rogers KA, 2006, IMMUNOLOGY, V118, P88, DOI 10.1111/j.1365-2567.2006.02345.x; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Tang BL, 1995, EUR J CELL BIOL, V68, P398; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	59	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19979	10.1371/journal.pone.0019979	http://dx.doi.org/10.1371/journal.pone.0019979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625599	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200054
J	Sanders, J; Haag, JD; Samuelson, DJ				Sanders, Jennifer; Haag, Jill D.; Samuelson, David J.			Physical Confirmation and Mapping of Overlapping Rat Mammary Carcinoma Susceptibility QTLs, Mcs2 and Mcs6	PLOS ONE			English	Article							BREAST-CANCER RISK; GROWTH-FACTOR-I; CIRCULATING LEVELS; IGF-I; BINDING-PROTEIN; POLYMORPHISMS; SUPPRESSOR; EXPRESSION; GENES; LOCI	Only a portion of the estimated heritability of breast cancer susceptibility has been explained by individual loci. Comparative genetic approaches that first use an experimental organism to map susceptibility QTLs are unbiased methods to identify human orthologs to target in human population-based genetic association studies. Here, overlapping rat mammary carcinoma susceptibility (Mcs) predicted QTLs, Mcs6 and Mcs2, were physically confirmed and mapped to identify the human orthologous region. To physically confirm Mcs6 and Mcs2, congenic lines were established using the Wistar-Furth (WF) rat strain, which is susceptible to developing mammary carcinomas, as the recipient (genetic background) and either Wistar-Kyoto (WKy, Mcs6) or Copenhagen (COP, Mcs2), which are resistant, as donor strains. By comparing Mcs phenotypes of WF. WKy congenic lines with distinct segments of WKy chromosome 7 we physically confirmed and mapped Mcs6 to similar to 33 Mb between markers D7Rat171 and gUwm64-3. The predicted Mcs2 QTL was also physically confirmed using segments of COP chromosome 7 introgressed into a susceptible WF background. The Mcs6 and Mcs2 overlapping genomic regions contain multiple annotated genes, but none have a clear or well established link to breast cancer susceptibility. Igf1 and Socs2 are two of multiple potential candidate genes in Mcs6. The human genomic region orthologous to rat Mcs6 is on chromosome 12 from base positions 71,270,266 to 105,502,699. This region has not shown a genome-wide significant association to breast cancer risk in pun studies of breast cancer susceptibility.	[Sanders, Jennifer; Samuelson, David J.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Haag, Jill D.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Samuelson, David J.] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Samuelson, David J.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Louisville, KY 40292 USA; [Samuelson, David J.] Univ Louisville, Sch Med, Ctr Environm Genom & Integrat Biol, Louisville, KY 40292 USA	University of Louisville; University of Wisconsin System; University of Wisconsin Madison; University of Louisville; University of Louisville; University of Louisville	Sanders, J (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	david.samuelson@louisville.edu			National Institutes of Health [CA137052, CA077494, ES014443]; University of Louisville; NATIONAL CANCER INSTITUTE [R01CA077494, R01CA137052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES014443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants CA137052, CA077494, and ES014443. J.S. was supported by the University of Louisville Integrated Programs in Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Aldave AJ, 2010, INVEST OPHTH VIS SCI, V51, P4006, DOI 10.1167/iovs.09-4067; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Cleveland RJ, 2006, CARCINOGENESIS, V27, P758, DOI 10.1093/carcin/bgi294; Datta B, 2009, BBA-REV CANCER, V1796, P281, DOI 10.1016/j.bbcan.2009.08.002; Farabegoli F, 2005, J CLIN PATHOL, V58, P1046, DOI 10.1136/jcp.2004.024919; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gu FY, 2010, CANCER EPIDEM BIOMAR, V19, P2877, DOI 10.1158/1055-9965.EPI-10-0507; Haffner MC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-136; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Lan H, 2001, GENETICS, V157, P331; Leung KC, 2003, P NATL ACAD SCI USA, V100, P1016, DOI 10.1073/pnas.0337600100; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Neuhausen SL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2414; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; PEYRAT JP, 1990, J STEROID BIOCHEM, V37, P823, DOI 10.1016/0960-0760(90)90426-L; Quan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014727; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Russo J, 2000, J MAMMARY GLAND BIOL, V5, P187, DOI 10.1023/A:1026443305758; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; Samuelson DJ, 2003, CARCINOGENESIS, V24, P1455, DOI 10.1093/carcin/bgg112; Sasi W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-178; Shepel LA, 1998, GENETICS, V149, P289; Shull James D, 2007, Breast Dis, V28, P69; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thompson TC, 2010, YONSEI MED J, V51, P479, DOI 10.3349/ymj.2010.51.4.479; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Valladares A, 2006, CANCER GENET CYTOGEN, V170, P147, DOI 10.1016/j.cancergencyto.2006.06.002	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19891	10.1371/journal.pone.0019891	http://dx.doi.org/10.1371/journal.pone.0019891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625632	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200044
J	Stuken, A; Orr, RJS; Kellmann, R; Murray, SA; Neilan, BA; Jakobsen, KS				Stuken, Anke; Orr, Russell J. S.; Kellmann, Ralf; Murray, Shauna A.; Neilan, Brett A.; Jakobsen, Kjetill S.			Discovery of Nuclear-Encoded Genes for the Neurotoxin Saxitoxin in Dinoflagellates	PLOS ONE			English	Article							PARALYTIC SHELLFISH TOXIN; GYMNODINIUM-CATENATUM DINOPHYCEAE; ALEXANDRIUM-TAMARENSE; PHYLOGENETIC ANALYSES; SIGNAL PEPTIDES; PURIFICATION; BACTERIA; PROTEIN; CYANOBACTERIA; BIOSYNTHESIS	Saxitoxin is a potent neurotoxin that occurs in aquatic environments worldwide. Ingestion of vector species can lead to paralytic shellfish poisoning, a severe human illness that may lead to paralysis and death. In freshwaters, the toxin is produced by prokaryotic cyanobacteria; in marine waters, it is associated with eukaryotic dinoflagellates. However, several studies suggest that saxitoxin is not produced by dinoflagellates themselves, but by co-cultured bacteria. Here, we show that genes required for saxitoxin synthesis are encoded in the nuclear genomes of dinoflagellates. We sequenced >1.2x10(6) mRNA transcripts from the two saxitoxin-producing dinoflagellate strains Alexandrium fundyense CCMP1719 and A. minutum CCMP113 using high-throughput sequencing technology. In addition, we used in silico transcriptome analyses, RACE, qPCR and conventional PCR coupled with Sanger sequencing. These approaches successfully identified genes required for saxitoxin-synthesis in the two transcriptomes. We focused on sxtA, the unique starting gene of saxitoxin synthesis, and show that the dinoflagellate transcripts of sxtA have the same domain structure as the cyanobacterial sxtA genes. But, in contrast to the bacterial homologs, the dinoflagellate transcripts are monocistronic, have a higher GC content, occur in multiple copies, contain typical dinoflagellate spliced-leader sequences and eukaryotic polyA-tails. Further, we investigated 28 saxitoxin-producing and non-producing dinoflagellate strains from six different genera for the presence of genomic sxtA homologs. Our results show very good agreement between the presence of sxtA and saxitoxin-synthesis, except in three strains of A. tamarense, for which we amplified sxtA, but did not detect the toxin. Our work opens for possibilities to develop molecular tools to detect saxitoxin-producing dinoflagellates in the environment.	[Stuken, Anke; Orr, Russell J. S.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway; [Kellmann, Ralf] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Murray, Shauna A.; Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Murray, Shauna A.; Neilan, Brett A.] Univ New S Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia; [Murray, Shauna A.; Neilan, Brett A.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo; University of Bergen; University of New South Wales Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; University of Oslo	Stuken, A (corresponding author), Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway.	k.s.jakobsen@bio.uio.no	Murray, Shauna/K-5781-2015; Neilan, Brett A/I-5767-2012	Murray, Shauna/0000-0001-7096-1307; Neilan, Brett A/0000-0001-6113-772X; Stuken, Anke/0000-0002-7553-9524	ARC [LP0776759]; Research Council of Norway [186292/V40]	ARC(Australian Research Council); Research Council of Norway(Research Council of Norway)	SM and BAN are fellows of the Australian Research Council and were supported by ARC project LP0776759. This project was supported by a grant (186292/V40) from the Research Council of Norway to KSJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALAM M, 1973, TOXICON, V11, P65, DOI 10.1016/0041-0101(73)90154-2; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baker TR, 2003, TOXICON, V41, P339, DOI 10.1016/S0041-0101(02)00314-8; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; CAVALIERE R, 2008, THESIS U NEW S WALES; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Doblin MA, 1999, J EXP MAR BIOL ECOL, V236, P33, DOI 10.1016/S0022-0981(98)00193-2; Erdner DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-88; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; Hallegraeff G. M., 1995, MANUAL HARMFUL MARIN, V33, P1; Harlow LD, 2007, PHYCOLOGIA, V46, P46, DOI 10.2216/06-28.1; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Ho AYT, 2006, AQUAT MICROB ECOL, V42, P41, DOI 10.3354/ame042041; Hoagland P, 2006, ECOLOGY HARMFUL ALGA; Hold GL, 2001, FEMS MICROBIOL ECOL, V36, P223, DOI 10.1111/j.1574-6941.2001.tb00843.x; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Hsiao YY, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/138538; Prol MJ, 2009, CAN J MICROBIOL, V55, P943, DOI [10.1139/W09-047, 10.1139/w09-047]; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KELLMANN R, 2005, THESIS U NEW S WALES; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kellmann R, 2010, MAR DRUGS, V8, P1011, DOI 10.3390/md8041011; KUMAR S, BIOINFORMAT IN PRESS; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LE QH, 1997, MOL GEN GENET, V225, P10; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; LIN S, 2006, J PHYCOL, V42, P3; Maddison WP, 1992, MACCLADE; Martins CA, 2003, APPL ENVIRON MICROB, V69, P5693, DOI 10.1128/AEM.69.9.5693-5698.2003; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Negri A, 2003, J PHYCOL, V39, P663, DOI 10.1046/j.1529-8817.2003.02131.x; ORR RJS, HARMFUL ALG IN PRESS; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Plumley FG, 2001, J PHYCOL, V37, P926; Sako Y, 2001, J PHYCOL, V37, P1044, DOI 10.1046/j.1529-8817.2001.00119.x; SATO S, 1998, PURIFICATION FLUORES, P465; SCHANTZ EJ, 1966, BIOCHEMISTRY-US, V5, P1191, DOI 10.1021/bi00868a011; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Shimizu Y, 1996, ANNU REV MICROBIOL, V50, P431, DOI 10.1146/annurev.micro.50.1.431; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stein LD, 2004, NATURE, V431, P915, DOI 10.1038/431915a; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Stuken A, 2010, MICROBIOL-SGM, V156, P2438, DOI 10.1099/mic.0.036988-0; Taroncher-Oldenburg G, 1999, NAT TOXINS, V7, P207, DOI 10.1002/1522-7189(200009/10)7:5<207::AID-NT61>3.0.CO;2-Q; Taroncher-Oldenburg G, 2000, APPL ENVIRON MICROB, V66, P2105, DOI 10.1128/AEM.66.5.2105-2112.2000; Uribe P, 2008, MAR BIOTECHNOL, V10, P692, DOI 10.1007/s10126-008-9107-8; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185; Worden AZ, 2010, CURR OPIN MICROBIOL, V13, P652, DOI 10.1016/j.mib.2010.08.001; Yang I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-248; Yoshida T, 2002, FISHERIES SCI, V68, P634, DOI 10.1046/j.1444-2906.2002.00471.x; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003	65	141	146	9	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e20096	10.1371/journal.pone.0020096	http://dx.doi.org/10.1371/journal.pone.0020096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625593	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200064
J	Vaira, V; Faversani, A; Dohi, T; Montorsi, M; Augello, C; Gatti, S; Coggi, G; Altieri, DC; Bosari, S				Vaira, V.; Faversani, A.; Dohi, T.; Montorsi, M.; Augello, C.; Gatti, S.; Coggi, G.; Altieri, D. C.; Bosari, S.			miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression	ONCOGENE			English	Article						miR-296; Scribble; cell plasticity; tumor progression; metastases	COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN CANCERS; LEADING-EDGE; MICRORNAS; CARCINOMA; TUMORIGENESIS; EXPRESSION; MIGRATION; PROTEINS; INVASION	The expression of small, non-coding RNA or microRNAs (miR), is frequently deregulated in human cancer, but how these pathways affect disease progression is still largely elusive. Here, we report on a miR, miR-296, which is progressively lost during tumor progression and correlates with metastatic disease in colorectal, breast, lung, gastric, parathyroid, liver and bile ducts cancers. Functionally, miR-296 controls a global cell motility gene signature in epithelial cells by transcriptionally repressing the cell polarity-cell plasticity module, Scribble (Scrib). In turn, loss of miR-296 causes aberrantly increased and mislocalized Scrib in human tumors, resulting in exaggerated random cell migration and tumor cell invasiveness. Re-expression of miR-296 in MDA-MB231 cells inhibits tumor growth in vivo. Finally, miR-296 or Scrib levels predict tumor relapse in hepatocellular carcinoma patients. These data identify miR-296 as a global repressor of tumorigenicity and uncover a previously unexplored exploitation of Scrib in tumor progression in humans. Oncogene (2012) 31, 27-38; doi: 10.1038/onc.2011.209; published online 6 June 2011	[Vaira, V.; Faversani, A.; Augello, C.; Coggi, G.; Bosari, S.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Pathol, I-20132 Milan, Italy; [Faversani, A.; Augello, C.; Coggi, G.; Bosari, S.] Univ Milan, Sch Med, Div Pathol, Dept Med Surg & Dent, Milan, Italy; [Dohi, T.; Altieri, D. C.] Wistar Inst Canc Ctr, Prostate Canc Discovery & Dev Program, Philadelphia, PA USA; [Montorsi, M.] Univ Milan, Sch Med, Ist Clin Humanitas IRCCS, Div Gen Surg 3, Rozzano, Italy; [Gatti, S.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Surg Res Ctr, I-20132 Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; The Wistar Institute; IRCCS Humanitas Research Hospital; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Bosari, S (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Pathol, Via F Sforza 35, I-20132 Milan, Italy.	silvano.bosari@unimi.it	Bosari, Silvano/K-7744-2016; Vaira, Valentina/K-6499-2016; Faversani, Alice/K-6509-2016; Gatti, Stefano/AAE-3281-2022; Gatti, Stefano/M-1780-2015; Montorsi, Marco/GYD-3896-2022	Bosari, Silvano/0000-0002-9744-6951; Vaira, Valentina/0000-0003-4416-6216; Faversani, Alice/0000-0002-0970-6208; Gatti, Stefano/0000-0003-2209-4338; Gatti, Stefano/0000-0003-2209-4338; Montorsi, Marco/0000-0002-3887-3451	Doctorate School of Molecular Medicine at Universita degli Studi di Milano; Fondazione Invernizzi; Fondazione Berlucchi; National Institutes of Health [HL54131, CA140043, CA78810, CA118005]; NATIONAL CANCER INSTITUTE [R01CA078810, R01CA118005, P01CA140043] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER	Doctorate School of Molecular Medicine at Universita degli Studi di Milano; Fondazione Invernizzi; Fondazione Berlucchi; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Riccardo Ghidoni, Michele Samaja and Massimo Locati for availability of laboratory equipment and reagents, Patrizia Doi and Delfina Tosi for technical help. AF is supported by a fellowship of the Doctorate School of Molecular Medicine at Universita degli Studi di Milano. This work was supported by grants from the Fondazione Invernizzi (to GC), Fondazione Berlucchi (to SB), and from National Institutes of Health grants HL54131, CA140043, CA78810 and CA118005 (to DCA).	Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Bahri S, 2010, DEVELOPMENT, V137, P2023, DOI 10.1242/dev.045088; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Kamei Y, 2007, HUM PATHOL, V38, P1273, DOI 10.1016/j.humpath.2007.01.026; Kim SW, 2007, GENE CHROMOSOME CANC, V46, P1, DOI 10.1002/gcc.20384; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Romagnoli S, 2009, AM J PATHOL, V174, P762, DOI 10.2353/ajpath.2009.080721; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wei JJ, 2011, CLIN CANCER RES, V17, P1297, DOI 10.1158/1078-0432.CCR-10-0993; Woo HG, 2009, CANCER RES, V69, P4059, DOI 10.1158/0008-5472.CAN-09-0164; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yang HS, 2009, CLIN CANCER RES, V15, P5744, DOI 10.1158/1078-0432.CCR-09-0385; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhuo OY, 2010, ONCOL RES, V18, P593, DOI 10.3727/096504010X12767359114045	39	65	68	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	1					27	38		10.1038/onc.2011.209	http://dx.doi.org/10.1038/onc.2011.209			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21643016	Green Accepted			2022-12-25	WOS:000299176200003
J	Zhang, B; Qian, D; Ma, HH; Jin, R; Yang, PX; Cai, MY; Liu, YH; Liao, YJ; Deng, HX; Mai, SJ; Zhang, H; Zeng, YX; Lin, MC; Kung, HF; Xie, D; Huang, JJ				Zhang, B.; Qian, D.; Ma, H-H; Jin, R.; Yang, P-X; Cai, M-Y; Liu, Y-H; Liao, Y-J; Deng, H-X; Mai, S-J; Zhang, H.; Zeng, Y-X; Lin, M. C.; Kung, H-F; Xie, D.; Huang, J-J			Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation	ONCOGENE			English	Article						anthracyclines; telomere dysfunction; PinX1; telomerase; cancer	SENSITIZES CANCER-CELLS; REVERSE-TRANSCRIPTASE; MAMMALIAN TELOMERES; DNA-DAMAGE; IN-VIVO; THERAPEUTICS; TRAFFICKING; BIOGENESIS; SHELTERIN; SUBUNIT	Telomere maintenance is essential for cancer growth. Induction of telomere dysfunction, for example, by inhibition of telomeric proteins or telomerase, has been shown to strongly enhance cancer cells' sensitivity to chemotherapies. However, it is not clear whether modulations of telomere maintenance constitute cancer cellular responses to chemotherapies. Furthermore, the manner in which anti-cancer drugs affect telomere function remains unknown. In this study, we show that anthracyclines, a class of anti-cancer drugs widely used in clinical cancer treatments, have an active role in triggering telomere dysfunction specifically in telomerase-positive cancer cells. Anthracyclines interrupt telomere maintenance by telomerase through the down-regulation of PinX1, a protein factor responsible for targeting telomerase onto telomeres, thereby inhibiting telomerase association with telomeres. We further demonstrate that anthracyclines downregulate PinX1 by inducing this protein degradation through the ubiquitin-proteasome-dependent pathway. Our data not only reveal a novel action for anthracyclines as telomerase functional inhibitors but also provide a clue for the development of novel anti-cancer drugs based on telomerase/telomere targeting, which is actively investigated by many current studies. Oncogene (2012) 31, 1-12; doi: 10.1038/onc.2011.214; published online 6 June 2011	[Zhang, B.; Qian, D.; Cai, M-Y; Liao, Y-J; Deng, H-X; Mai, S-J; Zeng, Y-X; Kung, H-F; Xie, D.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Ma, H-H; Jin, R.; Yang, P-X; Zhang, H.; Huang, J-J] Beijing Inst Biotechnol, Lab Tumor & Mol Biol, Beijing 100850, Peoples R China; [Liu, Y-H] Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Lin, M. C.; Kung, H-F] Chinese Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chinese University of Hong Kong	Xie, D (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Room 634,651 Dongfeng Rd E, Guangzhou 510060, Guangdong, Peoples R China.	hkung@cuhk.edu.hk; xied@mail.sysu.edu.cn; huangjun_j@yahoo.com	LIAO, YIJI/Z-4902-2019; mai, sj/HGE-8908-2022	LIAO, YIJI/0000-0002-0849-4573; 	Chinese NSFC [30901769, 30771074]; Guangdong National Science Foundation [9451008901002371]; China Postdoctoral Science Foundation [20090450900]; National Basic Research Program (973 program) of China [2010CB912802, 2010CB529404]	Chinese NSFC(National Natural Science Foundation of China (NSFC)); Guangdong National Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Basic Research Program (973 program) of China(National Basic Research Program of China)	This work is supported by grants from the Chinese NSFC (30901769), Guangdong National Science Foundation (9451008901002371) and the China Postdoctoral Science Foundation (20090450900) to B Zhang, and also partially by grants from the National Basic Research Program (973 program) of China (No. 2010CB912802) to H-F Kung and (No. 2010CB529404) to J-J Huang, the Chinese NSFC (30771074) to H Zhang.	Akiyama Y, 2004, ONCOL REP, V11, P871; Autexier C, 1996, TRENDS BIOCHEM SCI, V21, P387, DOI 10.1016/S0968-0004(96)90128-0; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Chang Q, 2004, INT J CANCER, V109, P309, DOI 10.1002/ijc.11689; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Collins K, 2006, NAT REV MOL CELL BIO, V7, P484, DOI 10.1038/nrm1961; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Hawkins GA, 2004, PROSTATE, V60, P298, DOI 10.1002/pros.20075; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Laurent G, 2001, BLOOD, V98, P913, DOI 10.1182/blood.V98.4.913; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nakamura M, 2005, HUM GENE THER, V16, P859, DOI 10.1089/hum.2005.16.859; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Small GW, 2003, J PHARMACOL EXP THER, V307, P861, DOI 10.1124/jpet.103.055806; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Uziel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009132; Wang C, 2010, EUR J CELL BIOL, V89, P748, DOI 10.1016/j.ejcb.2010.05.005; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhang B, 2009, CANCER RES, V69, P75, DOI 10.1158/0008-5472.CAN-08-1393; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	35	32	32	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	1					1	12		10.1038/onc.2011.214	http://dx.doi.org/10.1038/onc.2011.214			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21643006				2022-12-25	WOS:000299176200001
J	Lee, HW; Dominy, BN; Cao, WG				Lee, Hyun-Wook; Dominy, Brian N.; Cao, Weiguo			New Family of Deamination Repair Enzymes in Uracil-DNA Glycosylase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DEOXYINOSINE; RECOGNITION; IDENTIFICATION; MUTAGENESIS; MUTATIONS; XANTHINE; BINDING	DNA glycosylases play a major role in the repair of deaminated DNA damage. Previous investigations identified five families within the uracil-DNA glycosylase (UDG) superfamily. All enzymes within the superfamily studied thus far exhibit uracil-DNA glycosylase activity. Here we identify a new class of DNA glycosylases in the UDG superfamily that lacks UDG activity. Instead, these enzymes act as hypoxanthine-DNA glycosylases in vitro and in vivo. Molecular modeling and structure-guided mutational analysis allowed us to identify a unique catalytic center in this class of DNA glycosylases. Based on unprecedented biochemical properties and phylogenetic analysis, we propose this new class of DNA repair glycosylases that exists in bacteria, archaea, and eukaryotes as family 6 and designate it as the hypoxanthine-DNA glycosylase family. This study demonstrates the structural evolvability that underlies substrate specificity and catalytic flexibility in the evolution of enzymatic function.	[Lee, Hyun-Wook; Cao, Weiguo] Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Clemson, SC 29634 USA; [Dominy, Brian N.] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, WG (corresponding author), Clemson Univ, Dept Biochem & Genet, S Carolina Expt Stn, Rm 219 Biosyst Res Complex,51 New Cherry St, Clemson, SC 29634 USA.	wgc@clemson.edu	Dominy, Brian/AAA-4541-2020	Dominy, Brian/0000-0002-5635-2879	National Institutes of Health [GM090141]; Cooperative State Research, Education, and Extension Service/United States Department of Agriculture [SC-1700274, 5905]; United States Department of Defense [W81XWH-10-1-0385]; National Science Foundation [MCB-0953783]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cooperative State Research, Education, and Extension Service/United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Defense(United States Department of Defense); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090141 (to W. C.). This work was also supported by Cooperative State Research, Education, and Extension Service/United States Department of Agriculture Grant SC-1700274 (Technical Contribution Number 5905), United States Department of Defense Grant W81XWH-10-1-0385 (to W. C.), and National Science Foundation Grant MCB-0953783 (to B. N. D.).	Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; CASEGREEN SC, 1994, NUCLEIC ACIDS RES, V22, P131, DOI 10.1093/nar/22.2.131; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Josephy PD, 2000, MUTAT RES-FUND MOL M, V455, P71, DOI 10.1016/S0027-5107(00)00063-4; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Lee HW, 2010, J BIOL CHEM, V285, P41483, DOI 10.1074/jbc.M110.150003; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maiti A, 2008, P NATL ACAD SCI USA, V105, P8890, DOI 10.1073/pnas.0711061105; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Mi RJ, 2009, J MOL BIOL, V385, P761, DOI 10.1016/j.jmb.2008.09.038; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Sambrook J., 2001, MOL CLONING LAB MANU; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schouten KA, 1999, MUTAT RES-DNA REPAIR, V435, P245, DOI 10.1016/S0921-8777(99)00049-X; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918	27	41	46	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31282	31287		10.1074/jbc.M111.249524	http://dx.doi.org/10.1074/jbc.M111.249524			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21642431	Green Published, hybrid			2022-12-25	WOS:000294487500023
J	Reiss, K; Cornelsen, I; Husmann, M; Gimpl, G; Bhakdi, S				Reiss, Karina; Cornelsen, Isabell; Husmann, Matthias; Gimpl, Gerald; Bhakdi, Sucharit			Unsaturated Fatty Acids Drive Disintegrin and Metalloproteinase (ADAM)-dependent Cell Adhesion, Proliferation, and Migration by Modulating Membrane Fluidity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; L-SELECTIN; ADAM17; ALPHA; ACTIVATION; RECEPTOR; CADHERIN; SURFACE; ATHEROSCLEROSIS; PATHOGENESIS	The disintegrin-metalloproteinases ADAM10 and ADAM17 mediate the release of several cell signaling molecules and cell adhesion molecules such as vascular endothelial cadherin or L-selectin affecting endothelial permeability and leukocyte transmigration. Dysregulation of ADAM activity may contribute to the pathogenesis of vascular diseases, but the mechanisms underlying the control of ADAM functions are still incompletely understood. Atherosclerosis is characterized by lipid plaque formation and local accumulation of unsaturated free fatty acids (FFA). Here, we show that unsaturated FFA increase ADAM-mediated substrate cleavage. We demonstrate that these alterations are not due to genuine changes in enzyme activity, but correlate with changes in membrane fluidity as revealed by measurement of 1,6-diphenyl-1,3,5-hexatriene fluorescence anisotropy and fluorescence recovery after photobleaching analyses. ELISA and immunoblot experiments conducted with granulocytes, endothelial cells, and keratinocytes revealed rapid increase of ectodomain shedding of ADAM10 and ADAM17 substrates upon membrane fluidization. Large amounts of unsaturated FFA may be liberated from cholesteryl esters in LDL that is entrapped in atherosclerotic lesions. Incubation of cells with thus modified LDL resulted in rapid cleavage of ADAM substrates with corresponding functional consequences on cell proliferation, cell migration, and endothelial permeability, events of high significance in atherogenesis. We propose that FFA represent critical regulators of ADAM function that may assume relevance in many biological settings through their influence on mobility of enzyme and substrate in lipid bilayers.	[Reiss, Karina] Univ Kiel, Dept Dermatol, D-24098 Kiel, Germany; [Cornelsen, Isabell; Husmann, Matthias; Bhakdi, Sucharit] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, D-55131 Mainz, Germany; [Gimpl, Gerald] Johannes Gutenberg Univ Mainz, Dept Biochem, D-55128 Mainz, Germany	University of Kiel; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Reiss, K (corresponding author), Univ Kiel, Dept Dermatol, Olshaussenstr 40, D-24098 Kiel, Germany.	kreiss@dermatology.uni-kiel.de; sbhakdi@uni-mainz.de	Gimpl, Gerald/R-3722-2019; Reiss, Karina/B-3175-2010	Gimpl, Gerald/0000-0002-5703-1989	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 490]; Cluster of Excellence "Inflammation at Interfaces";  [CRC877]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; 	This work was supported by the Deutsche Forschungsgemeinschaft Sonderforschungsbereich Grant 490 (to S. B. and M. H.), Grant CRC877 (to K. R.), and by the Cluster of Excellence "Inflammation at Interfaces" (to K. R.).	BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carrie I, 2009, CURR PHARM DESIGN, V15, P4173, DOI 10.2174/138161209789909764; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Gimpl G, 2000, EUR J BIOCHEM, V267, P2483, DOI 10.1046/j.1432-1327.2000.01280.x; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Leskovjan AC, 2010, ANAL CHEM, V82, P2711, DOI 10.1021/ac1002728; Li Y, 2006, BLOOD, V108, P2275, DOI 10.1182/blood-2006-02-005827; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Maretzky T, 2008, J INVEST DERMATOL, V128, P1737, DOI 10.1038/sj.jid.5701242; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; MERRILL AR, 1987, BIOCHIM BIOPHYS ACTA, V896, P89, DOI 10.1016/0005-2736(87)90359-2; Muller WE, 1998, AMYLOID, V5, P10, DOI 10.3109/13506129809007284; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Nogueira AC, 2008, SHOCK, V29, P342, DOI 10.1097/SHK.0b013e31815abbc6; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; SEIFERT PS, 1990, J EXP MED, V172, P547, DOI 10.1084/jem.172.2.547; Suriyaphol P, 2002, CIRCULATION, V106, P2581, DOI 10.1161/01.CIR.0000038366.11851.D0; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Valeva A, 2004, J BIOL CHEM, V279, P25143, DOI 10.1074/jbc.M313913200; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Yang XG, 2010, J LIPID RES, V51, P957, DOI 10.1194/jlr.M002287	41	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26931	26942		10.1074/jbc.M111.243485	http://dx.doi.org/10.1074/jbc.M111.243485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642425	Green Published, hybrid			2022-12-25	WOS:000293078200067
J	Liu, R; Shi, Y; Yang, HJ; Wang, L; Zhang, S; Xia, YY; Wong, JLJ; Feng, ZW				Liu, Rui; Shi, Yu; Yang, Hai Jie; Wang, Lei; Zhang, Si; Xia, Yin Yan; Wong, Jing Lin Jack; Feng, Zhi Wei			Neural Cell Adhesion Molecule Potentiates the Growth of Murine Melanoma via beta-Catenin Signaling by Association with Fibroblast Growth Factor Receptor and Glycogen Synthase Kinase-3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; TUMOR-GROWTH; PHOSPHATIDYLINOSITOL 3-KINASE; NEURITE OUTGROWTH; FGF-RECEPTOR; EXON 3; C-FOS; NCAM; EXPRESSION; WNT	The neural cell adhesion molecule (NCAM) was recently shown to be involved in the progression of various tumors with diverse effects. We previously demonstrated that NCAM potentiates the cellular invasion and metastasis of melanoma. Here we further report that the growth of melanoma is obviously retarded when the expression of NCAM is silenced. We found that the proliferation of murine B16F0 melanoma cells, their colony formation on soft agar, and growth of transplanted melanoma in vivo are clearly inhibited by the introduction of NCAM siRNA. Interestingly, change of NCAM expression level is shown to regulate the activity of Wnt signaling molecule, beta-catenin, markedly. This novel machinery requires the function of FGF receptor and glycogen synthase kinase-3 beta but is independent of the Wnt receptors, MAPK-Erk and PI3K/Akt pathways. In addition, NCAM is found to form a functional complex with beta-catenin, FGF receptor, and glycogen synthase kinase-3 beta. Moreover, up-regulation of NCAM140 and NCAM180 appears more potent than NCAM120 in activation of beta-catenin, suggesting that the intracellular domain of NCAM is required for facilitating the beta-catenin signaling. Furthermore, the melanoma cells also exhibit distinct differentiation phenotypes with the NCAM silencing. Our findings reveal a novel regulatory role of NCAM in the progression of melanoma that might serve as a new therapeutic target for the treatment of melanoma.	[Shi, Yu; Yang, Hai Jie; Wang, Lei; Zhang, Si; Xia, Yin Yan; Wong, Jing Lin Jack; Feng, Zhi Wei] Nanyang Technol Univ, Sch Biol Sci, Genom & Genet Div, Singapore 637551, Singapore; [Liu, Rui] Xi An Jiao Tong Univ, Sch Med, Xian 710061, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Xi'an Jiaotong University	Feng, ZW (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Genom & Genet Div, 60 Nanyang Dr, Singapore 637551, Singapore.	zwfeng@ntu.edu.sg	Liu, Rui/H-1813-2011					Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO;2-D; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Berezin V, 2010, ADV EXP MED BIOL, V663, P337, DOI 10.1007/978-1-4419-1170-4_21; Blaheta RA, 2002, CELL COMMUN ADHES, V9, P131, DOI 10.1080/15419060214520; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Chamberlain AJ, 2003, J AM ACAD DERMATOL, V48, P694, DOI 10.1067/mjd.2003.216; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Cohen C, 2002, CLIN CANCER RES, V8, P3728; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; DENTON KJ, 1992, J PATHOL, V167, P187, DOI 10.1002/path.1711670205; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Ely SA, 2002, AM J PATHOL, V160, P1293, DOI 10.1016/S0002-9440(10)62556-4; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Geertsen R, 1999, INT J CANCER, V83, P135, DOI 10.1002/(SICI)1097-0215(19990924)83:1<135::AID-IJC23>3.0.CO;2-2; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Huerta S, 2001, SURGERY, V130, P834, DOI 10.1067/msy.2001.116415; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Klehr M, 2009, J IMMUNOTHER, V32, P442, DOI 10.1097/CJI.0b013e31819f8b69; Kolkova K, 2005, J NEUROCHEM, V92, P886, DOI 10.1111/j.1471-4159.2004.02919.x; Kolkova K, 2000, J NEUROSCI, V20, P2238; Larue L, 2003, PIGM CELL RES, V16, P312, DOI 10.1034/j.1600-0749.2003.00050.x; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Li G, 2001, CANCER RES, V61, P3819; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lutz RJ, 2009, MABS-AUSTIN, V1, P548, DOI 10.4161/mabs.1.6.10029; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; Meier F, 2006, INT J CANCER, V119, P549, DOI 10.1002/ijc.21880; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Miyahara R, 2001, J SURG ONCOL, V77, P49, DOI 10.1002/jso.1065; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOOY CM, 1995, HUM PATHOL, V26, P1185, DOI 10.1016/0046-8177(95)90191-4; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Pollock PM, 2002, MELANOMA RES, V12, P183, DOI 10.1097/00008390-200204000-00013; Reifenberger J, 2002, INT J CANCER, V100, P549, DOI 10.1002/ijc.10512; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Satyamoorthy K, 2003, CANCER RES, V63, P756; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; Shi Y, 2011, INT J BIOCHEM CELL B, V43, P682, DOI 10.1016/j.biocel.2011.01.016; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takahashi Y, 2008, INT J CANCER, V123, P2315, DOI 10.1002/ijc.23812; Takahashi Y, 2006, J CONTROL RELEASE, V116, P90, DOI 10.1016/j.jconrel.2006.09.002; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Kilsdonk JWJ, 2008, CANCER RES, V68, P3671, DOI 10.1158/0008-5472.CAN-07-5767; VANWOERT MH, 1971, J INVEST DERMATOL, V56, P343, DOI 10.1111/1523-1747.ep12261194; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Xie SH, 1997, CANCER RES, V57, P2295; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474; Zecchini S, 2010, ADV EXP MED BIOL, V663, P319, DOI 10.1007/978-1-4419-1170-4_20; Zhang S, 2010, NEUROCHEM INT, V56, P919, DOI 10.1016/j.neuint.2010.03.023	85	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26127	26137		10.1074/jbc.M111.237297	http://dx.doi.org/10.1074/jbc.M111.237297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628472	Green Published, hybrid			2022-12-25	WOS:000293073000070
J	Das, D; Cherbuin, N; Tan, XY; Anstey, KJ; Easteal, S				Das, Debjani; Cherbuin, Nicolas; Tan, Xiaoyun; Anstey, Kaarin J.; Easteal, Simon			DRD4-exonIII-VNTR Moderates the Effect of Childhood Adversities on Emotional Resilience in Young-Adults	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; DOPAMINE-RECEPTOR D4; SCALE CD-RISC; BEHAVIORAL ACTIVATION; PARENTING QUALITY; GENE; DRD4; ASSOCIATION; INHIBITION; ANXIETY	Most individuals successfully maintain psychological well-being even when exposed to trauma or adversity. Emotional resilience or the ability to thrive in the face of adversity is determined by complex interactions between genetic makeup, previous exposure to stress, personality, coping style, availability of social support, etc. Recent studies have demonstrated that childhood trauma diminishes resilience in adults and affects mental health. The Dopamine receptor D4 (DRD4) exon III variable number tandem repeat (VNTR) polymorphism was reported to moderate the impact of adverse childhood environment on behaviour, mood and other health-related outcomes. In this study we investigated whether DRD4-exIII-VNTR genotype moderates the effect of childhood adversities (CA) on resilience. In a representative population sample (n = 1148) aged 30-34 years, we observed an interactive effect of DRD4 genotype and CA (beta = 0.132; p = 0.003) on resilience despite no main effect of the genotype when effects of age, gender and education were controlled for. The 7-repeat allele appears to protect against the adverse effect of CA since the decline in resilience associated with increased adversity was evident only in individuals without the 7-repeat allele. Resilience was also significantly associated with approach-/avoidance-related personality measures (behavioural inhibition/activation system; BIS/BAS) measures and an interactive effect of DRD4-exIII-VNTR genotype and CA on BAS was observed. Hence it is possible that approach-related personality traits could be mediating the effect of the DRD4 gene and childhood environment interaction on resilience such that when stressors are present, the 7-repeat allele influences the development of personality in a way that provides protection against adverse outcomes.	[Das, Debjani; Tan, Xiaoyun; Easteal, Simon] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cherbuin, Nicolas; Anstey, Kaarin J.] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Das, D (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	debjani.das@anu.edu.au	Das, Debjani/A-8162-2008; Anstey, Kaarin/A-3852-2008; Cherbuin, Nicolas/A-8515-2008	Anstey, Kaarin/0000-0002-9706-9316; Cherbuin, Nicolas/0000-0001-6481-0748; Easteal, Simon/0000-0002-0462-502X	NHMRC of Australia Unit [973302]; NHMRC Capacity Building [418020]; NHMRC [471501, 366756]	NHMRC of Australia Unit(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Capacity Building(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by NHMRC of Australia Unit Grant No. 973302. DD is funded by NHMRC Capacity Building Grant No. 418020 in Population Health Research. NC is funded by NHMRC Research Fellowship No. 471501. KA is funded by NHMRC Research Fellowship No. 366756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTEY KJ, 2011, INT J EPIDEMIOL 0224; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Campbell-Sills L, 2004, PSYCHOL ASSESSMENT, V16, P244, DOI 10.1037/1040-3590.16.3.244; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chipman P, 2007, AM J MED GENET B, V144B, P561, DOI 10.1002/ajmg.b.30480; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Das D, 2011, AM J MED GENET B, V156B, P346, DOI 10.1002/ajmg.b.31169; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Engels WR, 2009, GENETICS, V183, P1431, DOI 10.1534/genetics.109.108977; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; FOWLES DC, 1988, PSYCHOPHYSIOLOGY, V25, P373, DOI 10.1111/j.1469-8986.1988.tb01873.x; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Haglund MEM, 2007, DEV PSYCHOPATHOL, V19, P889, DOI 10.1017/S0954579407000430; Jorm A., 1992, INT J METH PSYCH RES, V2, P31; Jorm AF, 2003, AUST NZ J PUBL HEAL, V27, P434, DOI 10.1111/j.1467-842X.2003.tb00423.x; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Karairmak O, 2010, PSYCHIAT RES, V179, P350, DOI 10.1016/j.psychres.2009.09.012; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; Khoshouei MS, 2009, INT J TEST, V9, P60, DOI 10.1080/15305050902733471; Leone L, 2001, EUR J PERSONALITY, V15, P373, DOI 10.1002/per.415; Li T, 1997, MOL PSYCHIATR, V2, P413, DOI 10.1038/sj.mp.4000310; NEUGEBAUER R, 1990, J CLIN EPIDEMIOL, V43, P1337, DOI 10.1016/0895-4356(90)90100-4; Propper C, 2007, DEV PSYCHOBIOL, V49, P619, DOI 10.1002/dev.20249; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Scott J, 2010, ARCH GEN PSYCHIAT, V67, P111, DOI 10.1001/archgenpsychiatry.2009.188; Sheese BE, 2007, DEV PSYCHOPATHOL, V19, P1039, DOI 10.1017/S0954579407000521; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Singh K., 2010, J PSYCHOL, V1, P23, DOI [10.1080/09764224.2010.11885442, DOI 10.1080/09764224.2010.11885442]; Stein DJ, 2009, CNS SPECTRUMS, V14, P41, DOI 10.1017/S1092852900027280; Strobel A, 2003, NEUROPSYCHOBIOLOGY, V47, P52, DOI 10.1159/000068876; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854	40	23	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20177	10.1371/journal.pone.0020177	http://dx.doi.org/10.1371/journal.pone.0020177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769XV	21637770	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500037
J	Leu, HB; Chung, CM; Lin, SJ; Jong, YS; Pan, WH; Chen, JW				Leu, Hsin-Bang; Chung, Chia-Min; Lin, Shing-Jong; Jong, Yuh-Shiun; Pan, Wen-Harn; Chen, Jaw-Wen			Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; INSULIN-RESISTANCE; APM1 GENE; CARDIOVASCULAR RISK; BLOOD-PRESSURE; POPULATION; PROGRAM; LOCUS	Objective: Cardiovascular risk increases with the presence of both metabolic syndrome (MetS) and hypertension (HTN). Although the adiponectin (ADIPOQ) gene has been reported to be involved in MetS, its association with HTN remained undetermined. This study aimed to investigate the association of ADIPOQ gene with the phenotypes of HTN and MetS. Methods: A total of 962 participants from 302 families from the Taiwan young-onset hypertension genetic study were enrolled. Plasma adiponectin were measured, and association analysis was conducted by using GEE regression-based method. Another study, of 1448 unrelated participants, was conducted to replicate the association between ADIPOQ gene and variable phenotypes of MetS with or without HTN. Results: Among 962 subjects from family samples, the lowest plasma adiponectin value was observed in MetS with HTN component (9.3 +/- 0.47 mu g/ml) compared with hypertensives (13.4 +/- 0.74 mu g/ml) or MetS without HTN (11.9 +/- 0.60 mu g/ml, P<0.05). The SNP rs1501299 (G276T) in ADIPOQ gene was found associated with the presence of HTN in MetS (odds ratio for GG+GT vs. TT = 2.46; 95% CI: 1.14-5.3, p = 0.02), but not rs2241766 (T45G). No association of ADIPOQ gene with HTN alone or MetS without HTN was observed. The significant association of the SNP rs1501299 (G276T) with the phenotype of presence of HTN in MetS was confirmed (odds ratio for GG+GT vs. TT = 2.15; 95% CI: 1.1-4.3) in the replication study. Conclusions: ADIPOQ genetic variants were selectively and specifically associated with the concomitant presence of MetS and HTN, suggesting potential genetic linkage between MetS and HTN.	[Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Leu, Hsin-Bang; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Leu, Hsin-Bang; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Chung, Chia-Min] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biochem Sci, Taipei 115, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Jong, Yuh-Shiun] Tao Yuan Gen Hosp, Dept Hlth, Tao Yuan, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Leu, HB (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	pan@ibms.sinica.edu.tw; jwchen@vghtpe.gov.tw			Taipei Veterans General Hospital [V96ER2-014, V97C1-125]; National Science Council [97HDP004, 97HDP004-2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This study was partially supported by grants V96ER2-014 and V97C1-125 from the Taipei Veterans General Hospital and grants of 97HDP004 and 97HDP004-2 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Austin MA, 2004, DIABETES, V53, P1166, DOI 10.2337/diabetes.53.4.1166; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chen W, 1999, AM J EPIDEMIOL, V150, P667; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; Filippi E, 2004, EUR J HUM GENET, V12, P199, DOI 10.1038/sj.ejhg.5201120; Furuhashi M, 2005, HYPERTENS RES, V28, P141, DOI 10.1291/hypres.28.141; Gable DR, 2006, ATHEROSCLEROSIS, V188, P231, DOI 10.1016/j.atherosclerosis.2006.02.010; Gu HF, 2004, DIABETES, V53, pS31, DOI 10.2337/diabetes.53.2007.S31; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Iacobellis G, 2006, OBESITY, V14, P368, DOI 10.1038/oby.2006.48; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lin HF, 2005, DIABETOLOGIA, V48, P2006, DOI 10.1007/s00125-005-1892-2; Mancia G, 2007, HYPERTENSION, V49, P40, DOI 10.1161/01.HYP.0000251933.22091.24; Menzaghi C, 2004, PHYSIOL GENOMICS, V19, P170, DOI 10.1152/physiolgenomics.00122.2004; Mohammadzadeh G, 2009, SCAND J CLIN LAB INV, V69, P764, DOI 10.3109/00365510903137237; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Ohashi K, 2004, J AM COLL CARDIOL, V43, P1195, DOI 10.1016/j.jacc.2003.10.049; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Pan WH, 2005, ASIA PAC J CLIN NUTR, V14, P203; Pan WH, 2000, HUM GENET, V107, P210, DOI 10.1007/s004390000365; Qi L, 2005, DIABETES, V54, P1607, DOI 10.2337/diabetes.54.5.1607; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rutter MK, 2005, DIABETES, V54, P3252, DOI 10.2337/diabetes.54.11.3252; Schillaci G, 2004, J AM COLL CARDIOL, V43, P1817, DOI 10.1016/j.jacc.2003.12.049; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Yang WS, 2006, J MOL MED, V84, P112, DOI 10.1007/s00109-005-0011-7; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	34	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19999	10.1371/journal.pone.0019999	http://dx.doi.org/10.1371/journal.pone.0019999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637762	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500023
J	Liandris, E; Gazouli, M; Andreadou, M; Sechi, LA; Rosu, V; Ikonomopoulos, J				Liandris, Emmanouil; Gazouli, Maria; Andreadou, Margarita; Sechi, Leonardo A.; Rosu, Valentina; Ikonomopoulos, John			Detection of Pathogenic Mycobacteria Based on Functionalized Quantum Dots Coupled with Immunomagnetic Separation	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; EXTRAPULMONARY DISSEMINATION; TUBERCULOSIS; DNA	Mycobacteria have always proven difficult to identify due to their low growth rate and fastidious nature. Therefore molecular biology and more recently nanotechnology, have been exploited from early on for the detection of these pathogens. Here we present the first stage of development of an assay incorporating cadmium selenide quantum dots (QDs) for the detection of mycobacterial surface antigens. The principle of the assay is the separation of bacterial cells using magnetic beads coupled with genus-specific polyclonal antibodies and monoclonal antibodies for heparin-binding hemagglutinin. These complexes are then tagged with anti-mouse biotinylated antibody and finally streptavidin-conjugated QDs which leads to the detection of a fluorescent signal. For the evaluation of performance, the method under study was applied on Mycobacterium bovis BCG and Mycobacterium tuberculosis ( positive controls), as well as E. coli and Salmonella spp. that constituted the negative controls. The direct observation of the latter category of samples did not reveal fluorescence as opposed to the mycobacteria mentioned above. The minimum detection limit of the assay was defined to 10(4) bacteria/ml, which could be further decreased by a 1 log when fluorescence was measured with a spectrofluorometer. The method described here can be easily adjusted for any other protein target of either the pathogen or the host, and once fully developed it will be directly applicable on clinical samples.	[Liandris, Emmanouil; Andreadou, Margarita; Ikonomopoulos, John] Agr Univ Athens, Dept Anim Sci & Aquaculture, Athens, Greece; [Gazouli, Maria] Univ Athens, Sch Med, Biol Lab, GR-11527 Athens, Greece; [Sechi, Leonardo A.; Rosu, Valentina] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy	Agricultural University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University of Sassari	Liandris, E (corresponding author), Agr Univ Athens, Dept Anim Sci & Aquaculture, Athens, Greece.	ikonomop@aua.gr	Liandris, Emmanouil/AAJ-9737-2021; Gazouli, Maria/W-6245-2019; Sechi, Leonardo Antonio/Y-3109-2018; Liandris, Emmanouil/K-1762-2014; Gazouli, Maria/I-2572-2018	Gazouli, Maria/0000-0002-3295-6811; Liandris, Emmanouil/0000-0003-0918-6633; Gazouli, Maria/0000-0002-3295-6811; sechi, leonardo antonio/0000-0003-0566-2049	European Union [LSHB-CT-2007-036812]	European Union(European Commission)	This work was performed within the context of the NANOMYC project that is supported by the European Union (LSHB-CT-2007-036812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branen JR, 2007, J FOOD PROTECT, V70, P841, DOI 10.4315/0362-028X-70.4.841; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Gazouli M, 2010, J CLIN MICROBIOL, V48, P2830, DOI 10.1128/JCM.00185-10; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Liandris E, 2009, J MICROBIOL METH, V78, P260, DOI 10.1016/j.mimet.2009.06.009; Lin PL, 2008, J MED PRIMATOL, V37, P44, DOI 10.1111/j.1600-0684.2007.00261.x; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Pfyffer GE, 2003, MANUAL CLIN MICROBIO, P532; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Serrano-Moreno BA, 2008, ZOONOSES PUBLIC HLTH, V55, P258, DOI 10.1111/j.1863-2378.2008.01125.x; Shin AR, 2006, CLIN VACCINE IMMUNOL, V13, P869, DOI 10.1128/CVI.00103-06; Valanne A, 2005, J VIROL METHODS, V129, P83, DOI 10.1016/j.jviromet.2005.05.012; Zhu L, 2004, APPL ENVIRON MICROB, V70, P597, DOI 10.1128/AEM.70.1.597-598.2004	15	42	47	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20026	10.1371/journal.pone.0020026	http://dx.doi.org/10.1371/journal.pone.0020026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637746	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052500026
J	Corjon, S; Gonzalez, G; Henning, P; Grichine, A; Lindholm, L; Boulanger, P; Fender, P; Hong, SS				Corjon, Stephanie; Gonzalez, Gaelle; Henning, Petra; Grichine, Alexei; Lindholm, Leif; Boulanger, Pierre; Fender, Pascal; Hong, Saw-See			Cell Entry and Trafficking of Human Adenovirus Bound to Blood Factor X Is Determined by the Fiber Serotype and Not Hexon: Heparan Sulfate Interaction	PLOS ONE			English	Article							TARGETED GENE DELIVERY; NUCLEAR-PORE COMPLEX; VIRUS-LIKE PARTICLES; COXSACKIE B VIRUSES; BETULINIC ACID DSB; PENTON BASE; BINDING SITE; INTRACELLULAR TRAFFICKING; VECTOR TRANSDUCTION; TYPE-5 VECTORS	Human adenovirus serotype 5 (HAdV5)-based vectors administered intravenously accumulate in the liver as the result of their direct binding to blood coagulation factor X (FX) and subsequent interaction of the FX-HAdV5 complex with heparan sulfate proteoglycan (HSPG) at the surface of liver cells. Intriguingly, the serotype 35 fiber-pseudotyped vector HAdV5F35 has liver transduction efficiencies 4-logs lower than HAdV5, even though both vectors carry the same hexon capsomeres. In order to reconcile this apparent paradox, we investigated the possible role of other viral capsid proteins on the FX/HSPG-mediated cellular uptake of HAdV5-based vectors. Using CAR-and CD46-negative CHO cells varying in HSPG expression, we confirmed that FX bound to serotype 5 hexon protein and to HAdV5 and HAdV5F35 virions via its Gla-domain, and enhanced the binding of both vectors to surface-immobilized hypersulfated heparin and cellular HSPG. Using penton mutants, we found that the positive effect of FX on HAdV5 binding to HSPG and cell transduction did not depend on the penton base RGD and fiber shaft KKTK motifs. However, we found that FX had no enhancing effect on the HAdV5F35-mediated cell transduction, but a negative effect which did not involve the cell attachment or endocytic step, but the intracellular trafficking and nuclear import of the FX-HAdV5F35 complex. By cellular imaging, HAdV5F35 particles were observed to accumulate in the late endosomal compartment, and were released in significant amounts into the extracellular medium via exocytosis. We showed that the stability of serotype 5 hexon: FX interaction was higher at low pH compared to neutral pH, which could account for the retention of FX-HAdV5F35 complexes in the late endosomes. Our results suggested that, despite the high affinity interaction of hexon capsomeres to FX and cell surface HSPG, the adenoviral fiber acted as the dominant determinant of the internalization and trafficking pathway of HAdV5-based vectors.	[Corjon, Stephanie; Gonzalez, Gaelle; Boulanger, Pierre; Hong, Saw-See] Univ Lyon 1, INRA, UMR 754, F-69365 Lyon, France; [Henning, Petra] Univ Goteborg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Grichine, Alexei] UJF, INSERM, CRI, Inst Albert Bonniot,U823, La Tronche, France; [Lindholm, Leif] Got A Gene AB, Kullavik, Sweden; [Fender, Pascal] UJF, EMBL, CNRS, UMI 3265,Unit Virus Host Interact, Grenoble, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Corjon, S (corresponding author), Univ Lyon 1, INRA, UMR 754, F-69365 Lyon, France.	pfender@embl.fr; saw-see.hong@univ-lyon1.fr	Grichine, Alexei/P-8377-2019; Hong, Saw See/M-9818-2017; Boulanger, Pierre/AFV-2750-2022; Grichine, Alexei/M-3923-2013	Grichine, Alexei/0000-0002-7335-9706; Hong, Saw See/0000-0001-8871-0901; Grichine, Alexei/0000-0002-7335-9706; Fender, Pascal/0000-0002-6698-3367; Henning, Petra/0000-0002-9330-6265	French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM) [TG0801, TG0901]; French Agency for AIDS Research (ANRS, DendrAde); University of Lyon-1; Centre National de la Recherche Scientifique [FRE-3011]; Region Rhone-Alpes; ANRS; Contrat d'Interface HCL-INSERM	French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM); French Agency for AIDS Research (ANRS, DendrAde)(ANRSFrench National Research Agency (ANR)); University of Lyon-1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); ANRS(ANRSFrench National Research Agency (ANR)); Contrat d'Interface HCL-INSERM	The work in France (Lyon and Grenoble) was supported by the French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM contracts TG0801 and TG0901), the French Agency for AIDS Research (ANRS, DendrAde contract 2007-2008), the University of Lyon-1 and the Centre National de la Recherche Scientifique (FRE-3011), and the Region Rhone-Alpes (Cluster 10-Infectiology). SC was the recipient of an ANRS fellowship, and GG of a VLM fellowship. SSH is the recipient of a Contrat d'Interface HCL-INSERM (2008-2012). The funders in France had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work in Sweden for the construction of the chimeric adenoviral vector was supported by Got-a-Gene AB, and potential financial competing interests exist.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Chiu CY, 2001, J VIROL, V75, P5375, DOI 10.1128/JVI.75.11.5375-5380.2001; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Colin M, 2005, MOL THER, V11, P224, DOI 10.1016/j.ymthe.2004.10.007; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; DaFonseca S, 2007, ANTIVIR THER, V12, P1185; DaFonseca S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-162; Darr S, 2009, J GEN VIROL, V90, P2849, DOI 10.1099/vir.0.014514-0; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; DEFER C, 1990, J VIROL, V64, P3661, DOI 10.1128/JVI.64.8.3661-3673.1990; Devaux P, 1996, J GEN VIROL, V77, P1477, DOI 10.1099/0022-1317-77-7-1477; Di Paolo NC, 2007, J VIROL, V81, P12249, DOI 10.1128/JVI.01584-07; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2008, VIROLOGY, V371, P155, DOI 10.1016/j.virol.2007.09.026; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; Gaden F, 2004, J VIROL, V78, P7227, DOI 10.1128/JVI.78.13.7227-7247.2004; Gaden F, 2002, AM J RESP CELL MOL, V27, P628, DOI 10.1165/rcmb.4841; GAGGAR A, 2003, NAT MED, V8, P746; Ganesh S, 2009, HUM GENE THER, V20, P1201, DOI 10.1089/hum.2009.045; Granio O, 2010, HUM GENE THER, V21, P251, DOI 10.1089/hum.2009.056; Granio O, 2009, J VIROL, V83, P6048, DOI 10.1128/JVI.00012-09; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Greig JA, 2009, MOL THER, V17, P1683, DOI 10.1038/mt.2009.152; Henning P, 2005, GENE THER, V12, P211, DOI 10.1038/sj.gt.3302408; Henning P, 2002, HUM GENE THER, V13, P1427, DOI 10.1089/10430340260185067; Henning P, 2006, J GEN VIROL, V87, P3151, DOI 10.1099/vir.0.81992-0; Hong SS, 2003, MOL THER, V7, P692, DOI 10.1016/S1525-0016(03)00067-4; Huang S, 1996, J VIROL, V70, P4502, DOI 10.1128/JVI.70.7.4502-4508.1996; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Karayan L, 1997, J VIROL, V71, P8678, DOI 10.1128/JVI.71.11.8678-8689.1997; KARAYAN L, 1994, VIROLOGY, V202, P782, DOI 10.1006/viro.1994.1400; Kawakami Y, 2003, CANCER RES, V63, P1262; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Leopold PL, 2000, HUM GENE THER, V11, P151, DOI 10.1089/10430340050016238; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; Magnusson MK, 2001, J VIROL, V75, P7280, DOI 10.1128/JVI.75.16.7280-7289.2001; MAGNUSSON MK, 2007, CANCER GENE THER, V14, P1; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Meier O, 2003, J GENE MED, V5, P451, DOI 10.1002/jgm.409; Mitraki A, 2006, ADV PROTEIN CHEM, V73, P97, DOI 10.1016/S0065-3233(06)73004-2; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; Molinier-Frenkel V, 2000, J VIROL, V74, P7678, DOI 10.1128/JVI.74.16.7678-7682.2000; Molinier-Frenkel V, 2003, J BIOL CHEM, V278, P37175, DOI 10.1074/jbc.M303496200; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Murakami S, 2007, GENE THER, V14, P1525, DOI 10.1038/sj.gt.3303019; Myhre S, 2007, GENE THER, V14, P376, DOI 10.1038/sj.gt.3302875; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Parker AL, 2008, CURR OPIN MOL THER, V10, P439; Parker AL, 2007, J VIROL, V81, P3627, DOI 10.1128/JVI.02786-06; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Parker AL, 2009, J VIROL, V83, P479, DOI 10.1128/JVI.01878-08; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Rogee S, 2010, GENE THER, V17, P880, DOI 10.1038/gt.2010.37; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Sakurai F, 2008, BIOL PHARM BULL, V31, P1819, DOI 10.1248/bpb.31.1819; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; Stevenson SC, 1997, J VIROL, V71, P4782, DOI 10.1128/JVI.71.6.4782-4790.1997; THERY C, 2006, CURR PROTOCOLS CEL S, V30; Tomko RP, 2000, EXP CELL RES, V255, P47, DOI 10.1006/excr.1999.4761; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Toyoda E, 2008, INT J ONCOL, V33, P1141, DOI 10.3892/ijo_00000103; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Uil TG, 2009, J GENE MED, V11, P990, DOI 10.1002/jgm.1395; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Venkateswarlu D, 2002, BIOPHYS J, V82, P1190, DOI 10.1016/S0006-3495(02)75476-3; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Vives RR, 2004, VIROLOGY, V321, P332, DOI 10.1016/j.virol.2004.01.015; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Von Seggern DJ, 2000, J VIROL, V74, P354, DOI 10.1128/JVI.74.1.354-362.2000; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waddington SN, 2007, J VIROL, V81, P9568, DOI 10.1128/JVI.00663-07; WANG H, 2010, NAT MED         1212; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Waszak P, 2007, MOL THER, V15, P2008, DOI 10.1038/sj.mt.6300254; Wickham TJ, 1995, GENE THER, V2, P750; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004; Zabner J, 1999, J VIROL, V73, P8689, DOI 10.1128/JVI.73.10.8689-8695.1999	105	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e18205	10.1371/journal.pone.0018205	http://dx.doi.org/10.1371/journal.pone.0018205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637339	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000291052200007
J	Haas, JD; Nistala, K; Petermann, F; Saran, N; Chennupati, V; Schmitz, S; Korn, T; Wedderburn, LR; Forster, R; Krueger, A; Prinz, I				Haas, Jan D.; Nistala, Kiran; Petermann, Franziska; Saran, Namita; Chennupati, Vijaykumar; Schmitz, Susanne; Korn, Thomas; Wedderburn, Lucy R.; Foerster, Reinhold; Krueger, Andreas; Prinz, Immo			Expression of miRNAs miR-133b and miR-206 in the Il17a/f Locus Is Co-Regulated with IL-17 Production in alpha beta and gamma delta T Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; MICRORNAS; DIFFERENTIATION; CYTOKINE; INTERLEUKIN-17; REGENERATION; COEXPRESSION; REGULATORS; PLASTICITY; ARTHRITIS	Differentiation of T helper 17 cells (Th17) is a multistep process that involves the cytokines IL-6, TGF-beta, and IL-23 as well as IL-1 beta, IL-21, and TNF-alpha. Thereby, robust induction of the capacity to produce IL-17 involves epigenetic modifications of the syntenic Il17a/f locus. Using inbred mouse strains, we identified co-regulation of gene transcription at the Il17a/f locus with the nearby microRNAs miR-133b and miR-206 that are clustered approximately 45 kb upstream of Il17a/f. Expression of these microRNAs was specific for Th17 as compared to other CD4(+) T cell subsets and this was equally valid for in vitro polarized and ex vivo derived cells. From all factors analyzed, IL-23 was the most important cytokine for the in vitro induction of miR-133b and miR-206 in naive CD4(+) T cells of wild type mice. However, analysis of IL-23R deficient mice revealed that IL-23R signaling was not essential for the induction of miR-133b and miR-206. Importantly, we found a similar co-regulation in CCR6(+) and other gamma delta T cell subsets that are predisposed to production of IL-17. Taken together, we discovered a novel feature of T cell differentiation towards an IL-17-producing phenotype that is shared between alpha beta and gamma delta T cells. Notably, the specific co-regulation of miR-133b and miR-206 with the Il17a/f locus also extended to human Th17 cells. This qualifies expression of miR-133b and miR-206 in T cells as novel biomarkers for Th17-type immune reactions.	[Haas, Jan D.; Saran, Namita; Chennupati, Vijaykumar; Schmitz, Susanne; Foerster, Reinhold; Krueger, Andreas; Prinz, Immo] Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany; [Nistala, Kiran; Wedderburn, Lucy R.] UCL, Rheumatol Unit, Inst Child Hlth, London, England; [Petermann, Franziska; Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-8000 Munich, Germany	Hannover Medical School; University of London; University College London; Technical University of Munich	Haas, JD (corresponding author), Hannover Med Sch, Inst Immunol, D-3000 Hannover, Germany.	prinz.immo@mh-hannover.de	Prinz, Immo/A-3026-2010; Korn, Thomas/AAE-6960-2019; Krueger, Andreas/M-9769-2019; Förster, Reinhold/D-6770-2011; Krueger, Andreas/B-9427-2009	Prinz, Immo/0000-0002-8789-9578; Korn, Thomas/0000-0002-3633-0955; Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334; Wedderburn, Lucy/0000-0002-7495-1429; Forster, Reinhold/0000-0001-6190-7923	German Research Foundation (DFG) [KR2320/2-1, EXC62, SFB621-A14]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, www.dfg.de; Emmy-Noether Program, KR2320/2-1 and EXC62, "Rebirth," A. K.; and SFB621-A14, I.P.). Open Access Publication supported by the DFG. JH, VC and NS are scholars of the Hannover Biomedical Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; INOSE H, 2009, P NATL ACAD SCI US; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KUCHEN S, 2010, IMMUNITY; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu SP, 2009, CELL TRANSPLANT, V18, P1039, DOI 10.3727/096368909X471224; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; MISSIAGLIA E, 2010, BR J CANC; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Purmann A, 2007, GENOMICS, V89, P580, DOI 10.1016/j.ygeno.2007.01.010; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022	49	40	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20171	10.1371/journal.pone.0020171	http://dx.doi.org/10.1371/journal.pone.0020171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637854	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200036
J	Li, ZD; Wen, JK; Lin, YN; Wang, SH; Xue, P; Zhang, ZP; Zhou, Y; Wang, X; Sui, L; Bi, LJ; Zhang, XE				Li, Zhongdao; Wen, Jikai; Lin, Yaning; Wang, Shihua; Xue, Peng; Zhang, Zhiping; Zhou, Ying; Wang, Xiao; Sui, Li; Bi, Li-Jun; Zhang, Xian-En			A Sir2-Like Protein Participates in Mycobacterial NHEJ	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; YEAST; TUBERCULOSIS; LIGASE; KU; COMPLEXES; MECHANISM	In eukaryotic cells, repair of DNA double-strand breaks (DSBs) by the nonhomologous end-joining (NHEJ) pathway is critical for genome stability. In contrast to the complex eukaryotic repair system, bacterial NHEJ apparatus consists of only two proteins, Ku and a multifunctional DNA ligase (LigD), whose functional mechanism has not been fully clarified. We show here for the first time that Sir2 is involved in the mycobacterial NHEJ repair pathway. Here, using tandem affinity purification (TAP) screening, we have identified an NAD-dependent deacetylase in mycobacteria which is a homologue of the eukaryotic Sir2 protein and interacts directly with Ku. Results from an in vitro glutathione S-transferase (GST) pull-down assay suggest that Sir2 interacts directly with LigD. Plasmid-based end-joining assays revealed that the efficiency of DSB repair in a sir2 deletion mutant was reduced 2-fold. Moreover, the Delta sir2 strain was about 10-fold more sensitive to ionizing radiation (IR) in the stationary phase than the wild-type. Our results suggest that Sir2 may function closely together with Ku and LigD in the nonhomologous end-joining pathway in mycobacteria.	[Li, Zhongdao; Zhang, Zhiping; Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Li, Zhongdao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wen, Jikai] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Lin, Yaning; Wang, Shihua] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Xue, Peng; Zhou, Ying; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol & Prote Platform, Beijing 100080, Peoples R China; [Wang, Xiao; Sui, Li] China Inst Atom Energy, Dept Nucl Phys, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Birmingham; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Biophysics, CAS; China Institute of Atomic Energy	Li, ZD (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	blj@sun5.ibp.ac.cn; x.zhang@wh.iov.cn	wen, jikai/AAV-9818-2021; ZHANG, Xian-En/AAJ-5579-2021	wen, jikai/0000-0002-4010-4416; 	National Protein Research Fund [2009CB825402, 2009CB522605, 2006CB910902]; Chinese Academy of Sciences [KSCX2-YW-R-164, KSCX1-YW-R-63]; National Natural Science Foundation of China [30970590]; Chinese Ministry of Health [2008ZX10003-005]	National Protein Research Fund; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Health	This work was supported by the National Protein Research Fund (Grant No: 2009CB825402, 2009CB522605 and 2006CB910902), the Chinese Academy of Sciences (Grant No: KSCX2-YW-R-164 and KSCX1-YW-R-63), the National Natural Science Foundation of China (Grant No: 30970590) and the Key Project Specialized for Infectious Diseases from the Chinese Ministry of Health (2008ZX10003-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniukwu J, 2008, GENE DEV, V22, P512, DOI 10.1101/gad.1631908; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Della M, 2004, SCIENCE, V306, P683, DOI 10.1126/science.1099824; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; Pitcher RS, 2007, ANNU REV MICROBIOL, V61, P259, DOI 10.1146/annurev.micro.61.080706.093354; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Pitcher RS, 2007, J MOL BIOL, V366, P391, DOI 10.1016/j.jmb.2006.10.046; Pitcher RS, 2005, J MOL BIOL, V351, P531, DOI 10.1016/j.jmb.2005.06.038; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Weller GR, 2002, SCIENCE, V297, P1686, DOI 10.1126/science.1074584; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3	30	17	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20045	10.1371/journal.pone.0020045	http://dx.doi.org/10.1371/journal.pone.0020045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637345	gold, Green Published			2022-12-25	WOS:000291052200029
J	Monnich, M; Kuriger, Z; Print, CG; Horsfield, JA				Moennich, Maren; Kuriger, Zoe; Print, Cristin G.; Horsfield, Julia A.			A Zebrafish Model of Roberts Syndrome Reveals That Esco2 Depletion Interferes with Development by Disrupting the Cell Cycle	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; DROSOPHILA NIPPED-B; GENE-EXPRESSION; DNA-REPLICATION; SC PHOCOMELIA; HUMAN HOMOLOG; C-MYC; ESTABLISHMENT; ACETYLATION	The human developmental diseases Cornelia de Lange Syndrome (CdLS) and Roberts Syndrome (RBS) are both caused by mutations in proteins responsible for sister chromatid cohesion. Cohesion is mediated by a multi-subunit complex called cohesin, which is loaded onto chromosomes by NIPBL. Once on chromosomes, cohesin binding is stabilized in S phase upon acetylation by ESCO2. CdLS is caused by heterozygous mutations in NIPBL or cohesin subunits SMC1A and SMC3, and RBS is caused by homozygous mutations in ESCO2. The genetic cause of both CdLS and RBS reside within the chromosome cohesion apparatus, and therefore they are collectively known as "cohesinopathies". However, the two syndromes have distinct phenotypes, with differences not explained by their shared ontology. In this study, we have used the zebrafish model to distinguish between developmental pathways downstream of cohesin itself, or its acetylase ESCO2. Esco2 depleted zebrafish embryos exhibit features that resemble RBS, including mitotic defects, craniofacial abnormalities and limb truncations. A microarray analysis of Esco2-depleted embryos revealed that different subsets of genes are regulated downstream of Esco2 when compared with cohesin subunit Rad21. Genes downstream of Rad21 showed significant enrichment for transcriptional regulators, while Esco2-regulated genes were more likely to be involved the cell cycle or apoptosis. RNA in situ hybridization showed that runx1, which is spatiotemporally regulated by cohesin, is expressed normally in Esco2-depleted embryos. Furthermore, myca, which is downregulated in rad21 mutants, is upregulated in Esco2-depleted embryos. High levels of cell death contributed to the morphology of Esco2-depleted embryos without affecting specific developmental pathways. We propose that cell proliferation defects and apoptosis could be the primary cause of the features of RBS. Our results show that mutations in different elements of the cohesion apparatus have distinct developmental outcomes, and provide insight into why CdLS and RBS are distinct diseases.	[Moennich, Maren; Kuriger, Zoe; Horsfield, Julia A.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Print, Cristin G.] Univ Auckland, Sch Biomed Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand	University of Otago; University of Auckland; University of Auckland	Monnich, M (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand.	julia.horsfield@otago.ac.nz	Horsfield, Julia A/B-5091-2012	Horsfield, Julia A/0000-0002-9536-7790; Print, Cristin/0000-0001-8345-7812	Marsden Fund of New Zealand [UOO-037]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by grant # UOO-037 from the Marsden Fund of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We gratefully acknowledge CureKids, the KD Kirkby Trust and Lottery Health NZ for their support of the Otago Zebrafish Facility.	Ball AR, 2008, BIOESSAYS, V30, P5, DOI 10.1002/bies.20691; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Craig JM, 2005, CHROMOSOMA, V114, P252, DOI 10.1007/s00412-005-0010-z; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Dorsett D, 2010, CURR BIOL, V20, pR886, DOI 10.1016/j.cub.2010.09.036; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Dorsett D, 2009, ANN NY ACAD SCI, V1151, P22, DOI 10.1111/j.1749-6632.2008.03450.x; Furthauer M., 2001, R01RR15402 NIH; Galloway JL, 2009, NATURE, V460, P400, DOI 10.1038/nature08117; Gause M, 2008, CHROMOSOMA, V117, P51, DOI 10.1007/s00412-007-0125-5; Gause M, 2010, MOL CELL BIOL, V30, P4940, DOI 10.1128/MCB.00642-10; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; HERRMANN J, 1977, EUR J PEDIATR, V125, P117, DOI 10.1007/BF00489985; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kawauchi S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000650; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Liu JL, 2010, ADV EXP MED BIOL, V685, P111; Misulovin Z, 2008, CHROMOSOMA, V117, P89, DOI 10.1007/s00412-007-0129-1; Monnich M, 2009, GENE EXPR PATTERNS, V9, P586, DOI 10.1016/j.gep.2009.08.004; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2010, CURR BIOL, V20, P1787, DOI 10.1016/j.cub.2010.09.006; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Schulz S, 2008, PRENATAL DIAG, V28, P42, DOI 10.1002/pd.1904; Seitan VC, 2006, PLOS BIOL, V4, P1411, DOI 10.1371/journal.pbio.0040242; SHEPARD J, 2004, CELLULAR DEV BIOL, P109; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vega H, 2010, J MED GENET, V47, P30, DOI 10.1136/jmg.2009.068395; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	70	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20051	10.1371/journal.pone.0020051	http://dx.doi.org/10.1371/journal.pone.0020051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637801	Green Published, gold			2022-12-25	WOS:000291052200030
J	Southcombe, J; Tannetta, D; Redman, C; Sargent, I				Southcombe, Jennifer; Tannetta, Dionne; Redman, Christopher; Sargent, Ian			The Immunomodulatory Role of Syncytiotrophoblast Microvesicles	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ALKALINE-PHOSPHATASE; RECEPTOR EXPRESSION; NORMAL-PREGNANCY; HUMAN PLACENTA; PREECLAMPSIA; EXOSOMES; MICROPARTICLES; ANGIOGENESIS; CIRCULATION	Immune adaptation is a critical component of successful pregnancy. Of primary importance is the modification of cytokine production upon immune activation. With the discovery that normal pregnancy itself is a pro-inflammatory state, it was recognised that the classical Th1/Th2 cytokine paradigm, with a shift towards 'type 2' cytokine production (important for antibody production), and away from 'type 1' immunity (associated with cell mediated immunity and graft rejection), is too simplistic. It is now generally agreed that both arms of cytokine immunity are activated, but with a bias towards 'type 2' immunity. Many factors are released from the placenta that can influence the maternal cytokine balance. Here we focus on syncytiotrophoblast microvesicles (STBM) which are shed from the placenta into the maternal circulation. We show that STBM can bind to monocytes and B cells and induce cytokine release (TNF alpha, MIP-1 alpha, IL-1 alpha, IL-1 beta, IL-6, IL-8). Other cytokines are down-modulated, such as IP-10 which is associated with 'type 1' immunity. Therefore STBM may aid the 'type 2' skewed nature of normal pregnancy. We also observed that PBMC from third trimester normal pregnant women produce more TNF alpha and IL-6 in response to STBM than PBMC from non-pregnant women, confirming that maternal immune cells are primed by pregnancy, possibly through their interaction with STBM.	[Southcombe, Jennifer; Tannetta, Dionne; Redman, Christopher; Sargent, Ian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Southcombe, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	jen.southcombe@obs-gyn.ox.ac.uk		Southcombe, Jennifer/0000-0003-0699-650X	Wellcome Trust [GR079862MA]; Department of Health's National Institute for Health Research Biomedical Research Centres	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	This study was supported by a grant from the Wellcome Trust (http://www.wellcome.ac.uk), Ref GR079862MA, and by the Oxford Partnership Comprehensive Biomedical Research Centre (http://www.oxfordbrc.org) with funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; ARKWRIGHT PD, 1994, GLYCOBIOLOGY, V4, P39, DOI 10.1093/glycob/4.1.39; Atay S, 2011, AM J REPROD IMMUNOL, V65, P65, DOI 10.1111/j.1600-0897.2010.00880.x; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chaouat G, 2004, INT ARCH ALLERGY IMM, V134, P93, DOI 10.1159/000074300; CHAOUAT G, 1987, J REPROD IMMUNOL, V10, P179, DOI 10.1016/0165-0378(87)90085-4; Chaouat G, 2010, AM J REPROD IMMUNOL, V63, P624, DOI 10.1111/j.1600-0897.2010.00832.x; Christen U, 2004, AUTOIMMUNITY, V37, P273, DOI 10.1080/08916930410001713124; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DAVIES JO, 1985, J ROY SOC MED, V78, P899, DOI 10.1177/014107688507801104; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; EATON BM, 1994, BBA-BIOMEMBRANES, V1193, P85, DOI 10.1016/0005-2736(94)90336-0; Gercel-Taylor C, 2002, J REPROD IMMUNOL, V56, P29, DOI 10.1016/S0165-0378(02)00025-6; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Gupta AK, 2005, J REPROD IMMUNOL, V68, P15, DOI 10.1016/j.jri.2005.05.003; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; KRAUS TA, 2010, AM J REPROD IMMUNOL; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Montagnana M, 2008, GYNECOL ENDOCRINOL, V24, P113, DOI 10.1080/09513590801895575; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sacks GP, 2003, CLIN EXP IMMUNOL, V131, P490, DOI 10.1046/j.1365-2249.2003.02082.x; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Scarpellini F, 2009, HUM REPROD, V24, P2703, DOI 10.1093/humrep/dep240; SCHALL TJ, 1993, J EXP MED, V177, P1821, DOI 10.1084/jem.177.6.1821; SMARASON AK, 1993, BRIT J OBSTET GYNAEC, V100, P943, DOI 10.1111/j.1471-0528.1993.tb15114.x; SMITH NC, 1974, NATURE, V252, P302, DOI 10.1038/252302b0; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wurfel W, 2010, HUM REPROD, V25, P2151, DOI 10.1093/humrep/deq106	40	118	124	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20245	10.1371/journal.pone.0020245	http://dx.doi.org/10.1371/journal.pone.0020245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633494	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500048
J	Eloe, EA; Fadrosh, DW; Novotny, M; Allen, LZ; Kim, M; Lombardo, MJ; Yee-Greenbaum, J; Yooseph, S; Allen, EE; Lasken, R; Williamson, SJ; Bartlett, DH				Eloe, Emiley A.; Fadrosh, Douglas W.; Novotny, Mark; Allen, Lisa Zeigler; Kim, Maria; Lombardo, Mary-Jane; Yee-Greenbaum, Joyclyn; Yooseph, Shibu; Allen, Eric E.; Lasken, Roger; Williamson, Shannon J.; Bartlett, Douglas H.			Going Deeper: Metagenome of a Hadopelagic Microbial Community	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; NORTH-ATLANTIC; BATHYPELAGIC PLANKTON; FAMILIES DATABASE; SUBTROPICAL GYRE; MARINE-BACTERIA; GENOME SEQUENCE; ORGANIC-MATTER; SARGASSO SEA; LIFE-STYLES	The paucity of sequence data from pelagic deep-ocean microbial assemblages has severely restricted molecular exploration of the largest biome on Earth. In this study, an analysis is presented of a large-scale 454-pyrosequencing metagenomic dataset from a hadopelagic environment from 6,000 m depth within the Puerto Rico Trench (PRT). A total of 145 Mbp of assembled sequence data was generated and compared to two pelagic deep ocean metagenomes and two representative surface seawater datasets from the Sargasso Sea. In a number of instances, all three deep metagenomes displayed similar trends, but were most magnified in the PRT, including enrichment in functions for two-component signal transduction mechanisms and transcriptional regulation. Overrepresented transporters in the PRT metagenome included outer membrane porins, diverse cation transporters, and di- and tri-carboxylate transporters that matched well with the prevailing catabolic processes such as butanoate, glyoxylate and dicarboxylate metabolism. A surprisingly high abundance of sulfatases for the degradation of sulfated polysaccharides were also present in the PRT. The most dramatic adaptational feature of the PRT microbes appears to be heavy metal resistance, as reflected in the large numbers of transporters present for their removal. As a complement to the metagenome approach, single-cell genomic techniques were utilized to generate partial whole-genome sequence data from four uncultivated cells from members of the dominant phyla within the PRT, Alphaproteobacteria, Gammaproteobacteria, Bacteroidetes and Planctomycetes. The single-cell sequence data provided genomic context for many of the highly abundant functional attributes identified from the PRT metagenome, as well as recruiting heavily the PRT metagenomic sequence data compared to 172 available reference marine genomes. Through these multifaceted sequence approaches, new insights have been provided into the unique functional attributes present in microbes residing in a deeper layer of the ocean far removed from the more productive sun-drenched zones above.	[Eloe, Emiley A.; Allen, Eric E.; Bartlett, Douglas H.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Fadrosh, Douglas W.; Novotny, Mark; Allen, Lisa Zeigler; Lombardo, Mary-Jane; Yee-Greenbaum, Joyclyn; Yooseph, Shibu; Lasken, Roger] J Craig Venter Inst, La Jolla, CA USA; [Kim, Maria; Williamson, Shannon J.] J Craig Venter Inst, Rockville, MD USA; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute; J. Craig Venter Institute; University of California System; University of California San Diego	Eloe, EA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	dbartlett@ucsd.edu	Eloe-Fadrosh, Emiley/AAP-8019-2021	Yooseph, Shibu/0000-0001-5581-5002	NSF [EF-0801793, EF-0827051]; NAI/APS Lewis and Clark Fund for Exploration and Field Research in Astrobiology	NSF(National Science Foundation (NSF)); NAI/APS Lewis and Clark Fund for Exploration and Field Research in Astrobiology	This work was supported by NSF grants EF-0801793 and EF-0827051 to D.H.B. and a NAI/APS Lewis and Clark Fund for Exploration and Field Research in Astrobiology to E.A.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Badger JH, 2006, J BACTERIOL, V188, P6841, DOI 10.1128/JB.00111-06; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Bochdansky AB, 2010, P NATL ACAD SCI USA, V107, P8287, DOI 10.1073/pnas.0913744107; Campanaro S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-122; CHI E, 1995, MOL MICROBIOL, V17, P713, DOI 10.1111/j.1365-2958.1995.mmi_17040713.x; COALE KH, 1988, LIMNOL OCEANOGR, V33, P1084, DOI 10.4319/lo.1988.33.5.1084; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GEORGE RY, 1979, AMBIO SPECIAL REPORT, V6, P51; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gophna U, 2005, GENE, V355, P48, DOI 10.1016/j.gene.2005.05.028; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; HEBEL D, 1986, J PLANKTON RES, V8, P819, DOI 10.1093/plankt/8.4.819; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Huang S, 2009, GEOCHIM COSMOCHIM AC, V73, P65, DOI 10.1016/j.gca.2008.08.023; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joyce TM, 1999, DEEP-SEA RES PT II, V46, P245, DOI 10.1016/S0967-0645(98)00102-7; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Lauro FM, 2008, EXTREMOPHILES, V12, P15, DOI 10.1007/s00792-006-0059-5; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Martin-Cuadrado AB, 2009, APPL ENVIRON MICROB, V75, P7436, DOI 10.1128/AEM.01283-09; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Moffett JW, 2007, DEEP-SEA RES PT I, V54, P586, DOI 10.1016/j.dsr.2006.12.013; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagata T, 2010, DEEP-SEA RES PT II, V57, P1519, DOI 10.1016/j.dsr2.2010.02.019; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Oh HM, 2009, J BACTERIOL, V191, P7144, DOI 10.1128/JB.01191-09; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Teira E, 2006, LIMNOL OCEANOGR, V51, P60, DOI 10.4319/lo.2006.51.1.0060; Thrash JC, 2010, J BACTERIOL, V192, P2938, DOI 10.1128/JB.00208-10; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang FP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001937; Wecker P, 2010, MICROB BIOTECHNOL, V3, P583, DOI 10.1111/j.1751-7915.2010.00183.x; Welch TJ, 1996, J BACTERIOL, V178, P5027, DOI 10.1128/jb.178.16.5027-5031.1996; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woebken D, 2007, ISME J, V1, P419, DOI 10.1038/ismej.2007.63; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; YAYANOS AA, 1982, REV SCI INSTRUM, V53, P704, DOI 10.1063/1.1137011; Yoon JH, 2004, INT J SYST EVOL MICR, V54, P1829, DOI 10.1099/ijs.0.63156-0; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zeng YX, 2009, POLAR BIOL, V32, P1447, DOI 10.1007/s00300-009-0641-2	84	69	70	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20388	10.1371/journal.pone.0020388	http://dx.doi.org/10.1371/journal.pone.0020388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629664	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800046
J	Hoefling, M; Lima, N; Haenni, D; Seidel, CAM; Schuler, B; Grubmuller, H				Hoefling, Martin; Lima, Nicola; Haenni, Dominik; Seidel, Claus A. M.; Schuler, Benjamin; Grubmueller, Helmut			Structural Heterogeneity and Quantitative FRET Efficiency Distributions of Polyprolines through a Hybrid Atomistic Simulation and Monte Carlo Approach	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE FRET; FLUORESCENCE ANISOTROPY; DYNAMICS SIMULATIONS; ORGANIC-MOLECULES; PROTEIN; CONFORMATIONS; REVEALS; PROLINE; SPECTROSCOPY	Forster Resonance Energy Transfer (FRET) experiments probe molecular distances via distance dependent energy transfer from an excited donor dye to an acceptor dye. Single molecule experiments not only probe average distances, but also distance distributions or even fluctuations, and thus provide a powerful tool to study biomolecular structure and dynamics. However, the measured energy transfer efficiency depends not only on the distance between the dyes, but also on their mutual orientation, which is typically inaccessible to experiments. Thus, assumptions on the orientation distributions and averages are usually made, limiting the accuracy of the distance distributions extracted from FRET experiments. Here, we demonstrate that by combining single molecule FRET experiments with the mutual dye orientation statistics obtained from Molecular Dynamics (MD) simulations, improved estimates of distances and distributions are obtained. From the simulated time-dependent mutual orientations, FRET efficiencies are calculated and the full statistics of individual photon absorption, energy transfer, and photon emission events is obtained from subsequent Monte Carlo (MC) simulations of the FRET kinetics. All recorded emission events are collected to bursts from which efficiency distributions are calculated in close resemblance to the actual FRET experiment, taking shot noise fully into account. Using polyproline chains with attached Alexa 488 and Alexa 594 dyes as a test system, we demonstrate the feasibility of this approach by direct comparison to experimental data. We identified cis-isomers and different static local environments as sources of the experimentally observed heterogeneity. Reconstructions of distance distributions from experimental data at different levels of theory demonstrate how the respective underlying assumptions and approximations affect the obtained accuracy. Our results show that dye fluctuations obtained from MD simulations, combined with MC single photon kinetics, provide a versatile tool to improve the accuracy of distance distributions that can be extracted from measured single molecule FRET efficiencies.	[Hoefling, Martin; Lima, Nicola; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Theoret & Computat Biophys Dept, Gottingen, Germany; [Haenni, Dominik; Schuler, Benjamin] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Seidel, Claus A. M.] Univ Dusseldorf, Inst Mol Phys Chem MPC, Dusseldorf, Germany	Max Planck Society; University of Zurich; Heinrich Heine University Dusseldorf	Hoefling, M (corresponding author), Max Planck Inst Biophys Chem, Theoret & Computat Biophys Dept, Gottingen, Germany.	hgrubmu@gwdg.de	Schuler, Benjamin/E-7342-2011; Hoefling, Martin/A-7495-2011; Seidel, Claus A.M./A-3682-2012	Schuler, Benjamin/0000-0002-5970-4251; Seidel, Claus A.M./0000-0002-5171-149X; Haenni, Dominik/0000-0002-2166-7109	German Israeli Foundation [1000.89.9/2008]; Elite Network of Bavaria; Swiss National Science Foundation; Volkswagen Stiftung	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Elite Network of Bavaria; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Volkswagen Stiftung(Volkswagen)	This work has been supported by the German Israeli Foundation grant (Agreement No. 1000.89.9/2008) (to MH), Elite Network of Bavaria (International Doctorate Program NanoBioTechnology) (to MH), the Swiss National Science Foundation (to BS) and the Volkswagen Stiftung (to HG, CS and BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERGER A, 1954, J AM CHEM SOC, V76, P5552, DOI 10.1021/ja01650a082; Berglund AJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068101; Best RB, 2007, P NATL ACAD SCI USA, V104, P18964, DOI 10.1073/pnas.0709567104; Braslavsky SE, 2008, PHOTOCH PHOTOBIO SCI, V7, P1444, DOI 10.1039/b810620g; Brune R, 2007, PROC SPIE, V6633, DOI 10.1117/12.727853; Brunger AT, 2011, J STRUCT BIOL, V173, P497, DOI 10.1016/j.jsb.2010.09.004; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CARLSON HA, 1993, J COMPUT CHEM, V14, P1240, DOI 10.1002/jcc.540141013; Corry B, 2008, BIOPHYS J, V95, P2711, DOI 10.1529/biophysj.107.126243; Corry B, 2006, BIOPHYS J, V91, P1032, DOI 10.1529/biophysj.106.080713; COWNAN PM, 1955, NATURE, V176, P501; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Fiori N, 2010, BIOPHYS J, V98, P2265, DOI 10.1016/j.bpj.2010.02.008; Dolghih E, 2009, J PHYS CHEM A, V113, P4639, DOI 10.1021/jp811395r; Doose S, 2007, P NATL ACAD SCI USA, V104, P17400, DOI 10.1073/pnas.0705605104; DORMAN DE, 1973, MACROMOLECULES, V6, P80, DOI 10.1021/ma60031a013; Duser MG, 2008, J BIOL CHEM, V283, P33602, DOI 10.1074/jbc.M805170200; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Feoktistov V., 2006, SEARCH SOLUTIONS; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FRISCH MJ, 2004, GAUSSIAN 03 B 04; Gopich I, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1812746; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Gopich IV, 2003, J PHYS CHEM B, V107, P5058, DOI 10.1021/jp027481o; GOPICH IV, 2010, J PHYS CHEM B; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HARRINGTON WF, 1958, BIOCHIM BIOPHYS ACTA, V27, P24, DOI 10.1016/0006-3002(58)90289-0; HENRY ER, 1987, P NATL ACAD SCI USA, V84, P6142, DOI 10.1073/pnas.84.17.6142; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hillger F, 2008, ANGEW CHEM INT EDIT, V47, P6184, DOI 10.1002/anie.200800298; HOFFMANN A, PHYS CHEM C IN PRESS; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Kalinin S, 2008, J PHYS CHEM B, V112, P8361, DOI 10.1021/jp711942q; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Krueger BP, 1998, J PHYS CHEM B, V102, P9603, DOI 10.1021/jp983589l; LAKOWICZ CDG, 2006, REV FLUORESCENCE ANN; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Moradi M, 2009, P NATL ACAD SCI USA, V106, P20746, DOI 10.1073/pnas.0906500106; Neubauer H, 2007, J AM CHEM SOC, V129, P12746, DOI 10.1021/ja0722574; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Ranjit S, 2009, J PHYS CHEM B, V113, P7861, DOI 10.1021/jp810842u; RINDERMANN JJ, 2011, J AM CHEM SOC, V13, P1857; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Rusinova E, 2002, ANAL BIOCHEM, V308, P18, DOI 10.1016/S0003-2697(02)00325-1; Saito M, 2008, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2006, P607, DOI 10.1007/978-3-540-74496-2_36; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; Santoso Y, 2010, CHEMPHYSCHEM, V11, P2209, DOI 10.1002/cphc.201000129; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Schroder GF, 2004, COMPUT PHYS COMMUN, V158, P150, DOI 10.1016/j.cpc.2004.02.001; Schroder GF, 2003, J CHEM PHYS, V119, P9920, DOI 10.1063/1.1616511; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; Schuetz P, 2010, J PHYS CHEM B, V114, P15227, DOI 10.1021/jp1053698; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Schuler Benjamin, 2007, V350, P115; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; Sindbert S, 2011, J AM CHEM SOC, V133, P2463, DOI 10.1021/ja105725e; SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; SPEELMAN AL, 2011, J PHYS CH A IN PRESS; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Torella JP, 2010, BIOPHYS J, V98, p591A, DOI 10.1016/j.bpj.2009.12.3213; Unruh JR, 2009, J PHYS CHEM B, V113, P14381, DOI 10.1021/jp903302k; Uphoff S, 2010, NAT METHODS, V7, P831, DOI [10.1038/NMETH.1502, 10.1038/nmeth.1502]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Oort B, 2009, CHEM PHYS, V357, P113, DOI 10.1016/j.chemphys.2008.10.052; VanBeek DB, 2007, BIOPHYS J, V92, P4168, DOI 10.1529/biophysj.106.092650; VENKATACHALAM CM, 1975, BIOPOLYMERS, V14, P1121, DOI 10.1002/bip.1975.360140602; Widengren J, 2006, ANAL CHEM, V78, P2039, DOI 10.1021/ac0522759; Wozniak AK, 2005, RNA, V11, P1545, DOI 10.1261/rna.2950605; Wozniak AK, 2008, P NATL ACAD SCI USA, V105, P18337, DOI 10.1073/pnas.0800977105; Yefimova S, 2008, J APPL SPECTROSC+, V75, P658, DOI 10.1007/s10812-008-9108-4; Zagrovic B, 2005, P NATL ACAD SCI USA, V102, P11698, DOI 10.1073/pnas.0409693102	88	88	88	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19791	10.1371/journal.pone.0019791	http://dx.doi.org/10.1371/journal.pone.0019791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629703	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800009
J	Margalida, A; Colomer, MA; Sanuy, D				Margalida, Antoni; Angels Colomer, Ma; Sanuy, Delfi			Can Wild Ungulate Carcasses Provide Enough Biomass to Maintain Avian Scavenger Populations? An Empirical Assessment Using a Bio-Inspired Computational Model	PLOS ONE			English	Article							VULTURE AEGYPIUS-MONACHUS; GYPAETUS-BARBATUS; BEARDED VULTURE; FOOD PREFERENCES; DIET; DICLOFENAC; SYSTEM; LEAD; CONSERVATION; ECOSYSTEMS	Background: The reduction in the amount of food available for European avian scavengers as a consequence of restrictive public health policies is a concern for managers and conservationists. Since 2002, the application of several sanitary regulations has limited the availability of feeding resources provided by domestic carcasses, but theoretical studies assessing whether the availability of food resources provided by wild ungulates are enough to cover energetic requirements are lacking. Methodology/Findings: We assessed food provided by a wild ungulate population in two areas of NE Spain inhabited by three vulture species and developed a P System computational model to assess the effects of the carrion resources provided on their population dynamics. We compared the real population trend with to a hypothetical scenario in which only food provided by wild ungulates was available. Simulation testing of the model suggests that wild ungulates constitute an important food resource in the Pyrenees and the vulture population inhabiting this area could grow if only the food provided by wild ungulates would be available. On the contrary, in the Pre-Pyrenees there is insufficient food to cover the energy requirements of avian scavenger guilds, declining sharply if biomass from domestic animals would not be available. Conclusions/Significance: Our results suggest that public health legislation can modify scavenger population trends if a large number of domestic ungulate carcasses disappear from the mountains. In this case, food provided by wild ungulates could be not enough and supplementary feeding could be necessary if other alternative food resources are not available (i.e. the reintroduction of wild ungulates), preferably in European Mediterranean scenarios sharing similar and socioeconomic conditions where there are low densities of wild ungulates. Managers should anticipate the conservation actions required by assessing food availability and the possible scenarios in order to make the most suitable decisions.	[Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert Lleida, Spain; [Margalida, Antoni] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Angels Colomer, Ma] Univ Lleida, Dept Math, Lleida, Spain; [Sanuy, Delfi] Univ Lleida, Dept Anim Prod, Lleida, Spain	Fundacion para la Conservacion del Quebranthuesos (FCQ); University of Bern; Universitat de Lleida; Universitat de Lleida	Margalida, A (corresponding author), Bearded Vulture Study & Protect Grp, El Pont De Suert Lleida, Spain.	margalida@inf.entorno.es	sanuy, delfi/ABC-4266-2020; castells, delfi sanuy/B-8414-2011; Margalida, Antoni/AAG-5337-2020; Cugat, Maria Angeles Colomer/O-2909-2015; Margalida, Antoni/A-2723-2011; Margalida, Antoni/A-2723-2011	castells, delfi sanuy/0000-0002-2533-7588; Cugat, Maria Angeles Colomer/0000-0003-4469-9178; Margalida, Antoni/0000-0002-0576-3993; Margalida, Antoni/0000-0002-7383-671X; Margalida, Antoni/0000-0002-3904-6212	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya; Ministerio de Medio Ambiente	Departament of Medi Ambient i Habitatge of Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Medio Ambiente(Spanish Government)	AM was supported by the Departament of Medi Ambient i Habitatge of Generalitat de Catalunya and Ministerio de Medio Ambiente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colomer MA, 2011, ECOL MODEL, V222, P33, DOI 10.1016/j.ecolmodel.2010.09.012; Arlettaz R, 1996, NOS OISEAUX, V43, P369; Blanco G, 2009, ANIM CONSERV, V12, P571, DOI 10.1111/j.1469-1795.2009.00283.x; Blazquez M., 2009, MUNIBE S, P308; Bousquet F, 2004, ECOL MODEL, V176, P313, DOI 10.1016/j.ecolmodel.2004.01.011; Cardona M, 2010, LECT NOTES COMPUT SC, V5957, P182, DOI 10.1007/978-3-642-11467-0_14; Cardona M, 2009, LECT NOTES COMPUT SC, V5391, P137; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar J.A., 2009, MUNIBE S, V29; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; FERRER C, 2008, PASTOS PIRINEO, P37; Fillat F, 2006, PASTOS, V33, P171; Gangoso L, 2009, ENVIRON POLLUT, V157, P569, DOI 10.1016/j.envpol.2008.09.015; GARCIA D, 2009, MUNIBE CIENCIAS NA S, V29, P116; Garcia-Gonzalez R, 2002, P 42 M SPAN SOC STUD, P245; Garcia-Martinez A, 2009, ANIMAL, V3, P152, DOI 10.1017/S1751731108003297; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Green RE, 2006, J APPL ECOL, V43, P949, DOI 10.1111/j.1365-2664.2006.01225.x; Green RE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004022; Hernandez M, 2008, ECOTOXICOLOGY, V17, P264, DOI 10.1007/s10646-008-0193-1; Hernandez M, 2009, ENVIRON RES, V109, P837, DOI 10.1016/j.envres.2009.05.001; Hernandez M, 2009, EUR J WILDLIFE RES, V55, P415, DOI 10.1007/s10344-009-0255-6; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Kleijnen JPC, 1998, HANDBOOK OF SIMULATION, P173, DOI 10.1002/9780470172445.ch6; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lambertucci SA, 2010, ENVIRON SCI TECHNOL, V44, P7759, DOI 10.1021/es102667c; Lemus JA, 2009, P ROY SOC B-BIOL SCI, V276, P2307, DOI 10.1098/rspb.2009.0071; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Margalida A, 2007, J WILDLIFE MANAGE, V71, P1621, DOI 10.2193/2006-049; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Margalida A, 2009, IBIS, V151, P235; Mateo-Tomas P, 2010, EUR J WILDLIFE RES, V56, P519, DOI 10.1007/s10344-009-0341-9; Moreno-Opo R, 2010, WILDLIFE BIOL, V16, P25, DOI 10.2981/09-037; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; Pun G., 2010, OXFORD HDB MEMBRANE; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Romero-Campero FJ, 2008, ARTIF LIFE, V14, P95, DOI 10.1162/artl.2008.14.1.95; Ruiz-Olmo J., 1995, ELS GRANS MAMIFERS C; Sanchez-Zapata JA, 2010, BIRD STUDY, V57, P352, DOI 10.1080/00063651003674946; Tella JL, 2001, NATURE, V410, P408, DOI 10.1038/35068717; Telleria JL, 2009, BIRD STUDY, V57, P352; THIBAULT JC, 1993, IBIS, V135, P42, DOI 10.1111/j.1474-919X.1993.tb02808.x; Thiollay JM, 2007, ORYX, V41, P322, DOI 10.1017/S0030605307000809; Xirouchakis Stavros, 2001, Ardeola, V48, P183	53	67	69	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20248	10.1371/journal.pone.0020248	http://dx.doi.org/10.1371/journal.pone.0020248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629647	Green Published, gold			2022-12-25	WOS:000291005800036
J	Tuya, F; Vanderklift, MA; Wernberg, T; Thomsen, MS				Tuya, Fernando; Vanderklift, Mathew A.; Wernberg, Thomas; Thomsen, Mads S.			Gradients in the Number of Species at Reef-Seagrass Ecotones Explained by Gradients in Abundance	PLOS ONE			English	Article							EDGE; PATTERNS; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; MACROALGAE; GASTROPODS; DISPERSAL; LANDSCAPE; SPILLOVER	Gradients in the composition and diversity (e. g. number of species) of faunal assemblages are common at ecotones between juxtaposed habitats. Patterns in the number of species, however, can be confounded by patterns in abundance of individuals, because more species tend to be found wherever there are more individuals. We tested whether proximity to reefs influenced patterns in the composition and diversity ('species density' = number of species per area and 'species richness' = number of species per number of individuals) of prosobranch gastropods in meadows of two seagrasses with different physiognomy: Posidonia and Amphibolis. A change in the species composition was observed from reef-seagrass edges towards the interiors of Amphibolis, but not in Posidonia meadows. Similarly, the abundance of gastropods and species density was higher at edges relative to interiors of Amphibolis meadows, but not in Posidonia meadows. However, species richness was not affected by proximity to reefs in either type of seagrass meadow. The higher number of species at the reef-Amphibolis edge was therefore a consequence of higher abundance, rather than species richness per se. These results suggest that patterns in the composition and diversity of fauna with proximity to adjacent habitats, and the underlying processes that they reflect, likely depend on the physiognomy of the habitat.	[Tuya, Fernando] Univ Las Palmas Gran Canaria, Marine Sci Fac, Ctr Biodiversidad & Gest Ambiental, Las Palmas Gran Canaria, Canary Islands, Spain; [Tuya, Fernando] Edith Cowan Univ, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Vanderklift, Mathew A.] CSIRO Marine & Atmospher Res, Wembley, WA, Australia; [Wernberg, Thomas; Thomsen, Mads S.] Univ Western Australia, Oceans Inst, Sch Plant Biol, Crawley, WA, Australia; [Wernberg, Thomas] Australian Inst Marine Sci, Crawley, WA, Australia	Universidad de Las Palmas de Gran Canaria; Edith Cowan University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Australian Institute of Marine Science	Tuya, F (corresponding author), Univ Las Palmas Gran Canaria, Marine Sci Fac, Ctr Biodiversidad & Gest Ambiental, Las Palmas Gran Canaria, Canary Islands, Spain.	f.tuya@ecu.edu.au	Wernberg, Thomas/B-4172-2010; Thomsen, Mads/B-1204-2011; Vanderklift, Mathew A/B-1003-2008	Wernberg, Thomas/0000-0003-1185-9745; Vanderklift, Mathew A/0000-0002-5170-7546	Spanish MCINN; Ramon y Cajal; ECU; Strategic Research Funds for the Marine Environment	Spanish MCINN(Spanish Government); Ramon y Cajal(Spanish Government); ECU; Strategic Research Funds for the Marine Environment	FT was supported by a postdoctoral research fellowship within the Spanish MCINN framework "Plan de Formacion y Perfeccionamiento" and the "Ramon y Cajal" program during writing. This work was funded by an ECU "Faculty Small Grant" and the Strategic Research Funds for the Marine Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Baker J, 2002, ECOLOGY, V83, P3048, DOI 10.1890/0012-9658(2002)083[3048:TEEAES]2.0.CO;2; Barros F, 2001, ESTUAR COAST SHELF S, V52, P191, DOI 10.1006/ecss.2000.0734; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; COLWELL RK, 2000, ESTIMATES STAT ESTIM; Dangerfield JM, 2003, AUSTRAL ECOL, V28, P227, DOI 10.1046/j.1442-9993.2003.01240.x; Denys C, 2002, OECOLOGIA, V130, P315, DOI 10.1007/s004420100796; Doropoulos C, 2009, ESTUAR COAST SHELF S, V83, P13, DOI 10.1016/j.ecss.2009.03.011; Dutoit T, 2007, ACTA OECOL, V31, P127, DOI 10.1016/j.actao.2006.03.010; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P215, DOI 10.1016/0022-0981(90)90186-G; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jernakoff P, 1998, AQUAT BOT, V60, P359, DOI 10.1016/S0304-3770(97)00100-9; Jorgensen NM, 2003, HYDROBIOLOGIA, V503, P69, DOI 10.1023/B:HYDR.0000008491.89382.e5; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; Lahti DC, 2001, BIOL CONSERV, V99, P365, DOI 10.1016/S0006-3207(00)00222-6; Lavery PS, 2002, MAR ECOL PROG SER, V236, P99, DOI 10.3354/meps236099; Magura T, 2002, FOREST ECOL MANAG, V157, P23, DOI 10.1016/S0378-1127(00)00654-X; Miller LP, 2007, J MAR BIOL ASSOC UK, V87, P735, DOI 10.1017/S0025315407055221; ODUM E P, 1971, P574; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; SERGEEV V N, 1988, Transactions of the Royal Society of South Australia, V112, P97; Talley DM., 2006, CONNECTIVITY CONSERV, P97, DOI DOI 10.1017/CBO9780511754821.006; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Tuya F, 2008, ESTUAR COAST SHELF S, V78, P774, DOI 10.1016/j.ecss.2008.02.017; Tuya F, 2010, MAR ECOL PROG SER, V405, P175, DOI 10.3354/meps08516; Tuya F, 2009, J MOLLUS STUD, V75, P27, DOI 10.1093/mollus/eyn032; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Valentine JF, 2008, ECOL APPL, V18, P1501, DOI 10.1890/07-1720.1; Van Elven BR, 2004, MAR ECOL PROG SER, V276, P71, DOI 10.3354/meps276071; Vanderklift MA, 2007, MAR ECOL PROG SER, V340, P235, DOI 10.3354/meps340235; Walker S, 2003, J VEG SCI, V14, P579, DOI 10.1111/j.1654-1103.2003.tb02185.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wernberg T, 2006, OECOLOGIA, V147, P692, DOI 10.1007/s00442-005-0318-7; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20190	10.1371/journal.pone.0020190	http://dx.doi.org/10.1371/journal.pone.0020190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629654	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005800032
J	Khoo, MLM; Tao, H; Meedeniya, ACB; Mackay-Sim, A; Ma, DDF				Khoo, Melissa L. M.; Tao, Helen; Meedeniya, Adrian C. B.; Mackay-Sim, Alan; Ma, David D. F.			Transplantation of Neuronal-Primed Human Bone Marrow Mesenchymal Stem Cells in Hemiparkinsonian Rodents	PLOS ONE			English	Article							OLFACTORY ENSHEATHING CELLS; CENTRAL-NERVOUS-SYSTEM; STROMAL CELLS; PARKINSONS-DISEASE; RAT MODEL; IN-VITRO; DOPAMINERGIC-NEURONS; PROGENITOR CELLS; ADULT-RAT; NEUROECTODERMAL DIFFERENTIATION	Bone marrow-derived human mesenchymal stem cells (hMSCs) have shown promise in in vitro neuronal differentiation and in cellular therapy for neurodegenerative disorders, including Parkinson' disease. However, the effects of intracerebral transplantation are not well defined, and studies do not agreed on the optimal neuronal differentiation method. Here, we investigated three growth factor-based neuronal differentiation procedures (using FGF-2/EGF/PDGF/SHH/FGF-8/GDNF), and found all to be capable of eliciting an immature neural phenotype, in terms of cell morphology and gene/protein expression. The neuronal-priming (FGF-2/EGF) method induced neurosphere-like formation and the highest NES and NR4A2 expression by hMSCs. Transplantation of undifferentiated and neuronal-primed hMSCs into the striatum and substantia nigra of 6-OHDA-lesioned hemiparkinsonian rats revealed transient graft survival of 7 days, despite the reported immunosuppressive properties of MSCs and cyclosporine-immunosuppression of rats. Neither differentiation of hMSCs nor induction of host neurogenesis was observed at injection sites, and hMSCs continued producing mesodermal fibronectin. Strategies for improving engraftment and differentiation post-transplantation, such as prior in vitro neuronal-priming, nigral and striatal grafting, and co-transplantation of olfactory ensheathing cells that promote neural regeneration, were unable to provide advantages. Innate inflammatory responses (Iba-1-positive microglia/macrophage and GFAP-positive astrocyte activation and accumulation) were detected around grafts within 7 days. Our findings indicate that growth factor-based methods allow hMSC differentiation toward immature neuronal-like cells, and contrary to previous reports, only transient survival and engraftment of hMSCs occurs following transplantation in immunosuppressed hemiparkinsonian rats. In addition, suppression of host innate inflammatory responses may be a key factor for improving hMSC survival and engraftment.	[Khoo, Melissa L. M.; Tao, Helen; Ma, David D. F.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Khoo, Melissa L. M.; Tao, Helen; Ma, David D. F.] Univ New S Wales, Sydney, NSW, Australia; [Meedeniya, Adrian C. B.; Mackay-Sim, Alan] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Natl Ctr Adult Stem Cell Res, Brisbane, Qld 4111, Australia	University of New South Wales Sydney; Griffith University	Khoo, MLM (corresponding author), St Vincents Ctr Appl Med Res, Sydney, NSW, Australia.	d.ma@amr.org.au	Mackay-Sim, Alan/C-3431-2008	Mackay-Sim, Alan/0000-0003-4446-5371	St Vincent's Clinic Foundation; SVH Haematology Research Fund; New South Wales Ministry for Science and Medical Research; Australian Department of Health and Ageing; Australian Government; UNSW; HCC & Arrow Bone Marrow Transplant Foundation	St Vincent's Clinic Foundation; SVH Haematology Research Fund; New South Wales Ministry for Science and Medical Research; Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Government(Australian GovernmentCGIAR); UNSW; HCC & Arrow Bone Marrow Transplant Foundation	This study was supported by the St Vincent's Clinic Foundation, SVH Haematology Research Fund, the New South Wales Ministry for Science and Medical Research, and a grant to AMS from the Australian Department of Health and Ageing. MLMK is the recipient of the Australian Government Postgraduate Award, and the UNSW, and HCC & Arrow Bone Marrow Transplant Foundation scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AK, 2004, NEUROBIOL DIS, V16, P516, DOI 10.1016/j.nbd.2004.04.014; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; Barker RA, 2000, J NEUROSCI, V20, P3415, DOI 10.1523/JNEUROSCI.20-09-03415.2000; Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Bertani N, 2005, J CELL SCI, V118, P3925, DOI 10.1242/jcs.02511; Bianco JI, 2004, GLIA, V45, P111, DOI 10.1002/glia.10298; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839; BOREL JF, 1977, IMMUNOLOGY, V32, P1017; Boruch AV, 2001, GLIA, V33, P225, DOI 10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.3.CO;2-P; Bouchez G, 2008, NEUROCHEM INT, V52, P1332, DOI 10.1016/j.neuint.2008.02.003; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Camp DM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-17; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dewar D, 2007, ACTA NEUROCHIR, V149, P407, DOI 10.1007/s00701-007-1121-5; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Greco SJ, 2007, J IMMUNOL, V179, P3342, DOI 10.4049/jimmunol.179.5.3342; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Guo L, 2005, BIOMED ENVIRON SCI, V18, P36; Hayase M, 2009, J CEREBR BLOOD F MET, V29, P1409, DOI 10.1038/jcbfm.2009.62; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jiang YH, 2003, P NATL ACAD SCI USA, V100, P11854, DOI 10.1073/pnas.1834196100; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johansson S, 2005, BRAIN, V128, P2961, DOI 10.1093/brain/awh644; Kan I, 2007, NEUROSCI LETT, V419, P28, DOI 10.1016/j.neulet.2007.03.070; Kan I, 2007, J LIPID RES, V48, P513, DOI 10.1194/jlr.C600022-JLR200; Khoo MLM, 2008, STEM CELLS DEV, V17, P883, DOI 10.1089/scd.2007.0185; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kramer BC, 2006, BIOCHEM BIOPH RES CO, V343, P1045, DOI 10.1016/j.bbrc.2006.02.191; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Larsson LC, 2001, EXP NEUROL, V172, P100, DOI 10.1006/exnr.2001.7738; Larsson LC, 1999, TRANSPLANTATION, V68, P1153, DOI 10.1097/00007890-199910270-00016; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Mackay-Sim Alan, 2005, Keio Journal of Medicine, V54, P8; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RAMONCUETO A, 1992, NEUROSCIENCE, V47, P213, DOI 10.1016/0306-4522(92)90134-N; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Ruitenberg MJ, 2006, J NEUROTRAUM, V23, P468, DOI 10.1089/neu.2006.23.468; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Schulz TC, 2004, STEM CELLS, V22, P1218, DOI 10.1634/stemcells.2004-0114; Shetty P, 2009, CELL BIOL INT, V33, P830, DOI 10.1016/j.cellbi.2009.05.002; Shukla S, 2009, J NEUROCHEM, V109, P436, DOI 10.1111/j.1471-4159.2009.05983.x; Singhal S, 2008, STEM CELLS, V26, P1074, DOI 10.1634/stemcells.2007-0898; SMANN P, 2004, CELL TISSUE RES, V318, P149; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; STROMBERG I, 1986, NEUROSCI LETT, V71, P271, DOI 10.1016/0304-3940(86)90632-4; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Suon S, 2004, STEM CELLS DEV, V13, P625, DOI 10.1089/scd.2004.13.625; Suon S, 2006, BRAIN RES, V1106, P46, DOI 10.1016/j.brainres.2006.05.109; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Tao H, 2005, DEV GROWTH DIFFER, V47, P423; Teng X, 2008, J NEUROSCI RES, V86, P3140, DOI 10.1002/jnr.21767; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; WALLGREN AC, 1995, TRANSPLANTATION, V60, P594, DOI 10.1097/00007890-199509270-00013; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4	87	67	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19025	10.1371/journal.pone.0019025	http://dx.doi.org/10.1371/journal.pone.0019025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625433	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200001
J	Breuer, S; Schievink, SI; Schulte, A; Blankenfeldt, W; Fackler, OT; Geyer, M				Breuer, Sebastian; Schievink, Simone I.; Schulte, Antje; Blankenfeldt, Wulf; Fackler, Oliver T.; Geyer, Matthias			Molecular Design, Functional Characterization and Structural Basis of a Protein Inhibitor Against the HIV-1 Pathogenicity Factor Nef	PLOS ONE			English	Article							I DOWN-REGULATION; HIGH-AFFINITY; SH3 DOMAIN; CRYSTAL-STRUCTURE; BINDING SURFACE; SUBUNIT-H; CD4; PEPTIDE; ENTRY; SPECIFICITY	Increased spread of HIV-1 and rapid emergence of drug resistance warrants development of novel antiviral strategies. Nef, a critical viral pathogenicity factor that interacts with host cell factors but lacks enzymatic activity, is not targeted by current antiviral measures. Here we inhibit Nef function by simultaneously blocking several highly conserved protein interaction surfaces. This strategy, referred to as "wrapping Nef'', is based on structure-function analyses that led to the identification of four target sites: (i) SH3 domain interaction, (ii) interference with protein transport processes, (iii) CD4 binding and (iv) targeting to lipid membranes. Screening combinations of Nef-interacting domains, we developed a series of small Nef interacting proteins (NIs) composed of an SH3 domain optimized for binding to Nef, fused to a sequence motif of the CD4 cytoplasmic tail and combined with a prenylation signal for membrane association. NIs bind to Nef in the low nM affinity range, associate with Nef in human cells and specifically interfere with key biological activities of Nef. Structure determination of the Nef-inhibitor complex reveals the molecular basis for binding specificity. These results establish Nef-NI interfaces as promising leads for the development of potent Nef inhibitors.	[Breuer, Sebastian; Schulte, Antje; Blankenfeldt, Wulf] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany; [Schievink, Simone I.; Fackler, Oliver T.] Univ Klinikum Heidelberg, Dept Infektiol, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Breuer, S (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	oliver.fackler@med.uni-heidelberg.de; matthias.geyer@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668; Fackler, Oliver Till/0000-0003-2982-4209; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft [GE-976/1, FA-378/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft to MG (GE-976/1) and OTF (FA-378/4). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dikeakos JD, 2010, MOL BIOL CELL, V21, P3279, DOI 10.1091/mbc.E10-05-0470; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Geyer M, 2002, MOL BIOL CELL, V13, P2045, DOI 10.1091/mbc.02-02-0026; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hiipakka M, 2001, VIROLOGY, V286, P152, DOI 10.1006/viro.2001.0973; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; Homann S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-6; Jere A, 2010, MICROBES INFECT, V12, P65, DOI 10.1016/j.micinf.2009.09.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keppler OT, 2005, J VIROL, V79, P1655, DOI 10.1128/JVI.79.3.1655-1665.2005; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEIDIG KP, 1995, J BIOMOL NMR, V6, P255, DOI 10.1007/BF00197807; Olszewski A, 2004, P NATL ACAD SCI USA, V101, P14079, DOI 10.1073/pnas.0406040101; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sauter D, 2010, CELL, V141, P392, DOI 10.1016/j.cell.2010.04.022; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Szilluweit R, 2009, BIOPHYS J, V96, P3242, DOI 10.1016/j.bpj.2008.12.3947; Vollmuth F, 2010, ANGEW CHEM INT EDIT, V49, P6768, DOI 10.1002/anie.201002724; Yamamoto T, 2009, AIDS, V23, P2265, DOI 10.1097/QAD.0b013e328332817c; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066	62	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20033	10.1371/journal.pone.0020033	http://dx.doi.org/10.1371/journal.pone.0020033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625496	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400034
J	Pressler, H; Sissung, TM; Venzon, D; Price, DK; Figg, WD				Pressler, Heather; Sissung, Tristan M.; Venzon, David; Price, Douglas K.; Figg, William D.			Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; ANDROGEN; CARCINOMA; TRANSPORTERS; PROLIFERATION; POLYMORPHISMS; TESTOSTERONE	The organic anion transporting polypeptide (OATP) family of transporters has been implicated in prostate cancer disease progression probably by transporting hormones or drugs. In this study, we aimed to elucidate the expression, frequency, and relevance of OATPs as a biomarker in hormone-dependent cancers. We completed a study examining SLCO1B3, SLCO1B1 and SLCO2B1 mRNA expression in 381 primary, independent patient samples representing 21 cancers and normal tissues. From a separate cohort, protein expression of OATP1B3 was examined in prostate, colon, and bladder tissue. Based on expression frequency, SLCO2B1 was lower in liver cancer (P = 0.04) which also trended lower with decreasing differentiation (P = 0.004) and lower magnitude in pancreatic cancer (P = 0.05). SLCO2B1 also had a higher frequency in thyroid cancer (67%) than normal (0%) and expression increased with stage (P = 0.04). SLCO1B3 was expressed in 52% of cancerous prostate samples and increased SLCO1B3 expression trended with higher Gleason score (P = 0.03). SLCO1B3 expression was also higher in testicular cancer (P = 0.02). SLCO1B1 expression was lower in liver cancer (P = 0.04) which trended lower with liver cancer grade (P = 0.0004) and higher with colon cancer grade (P = 0.05). Protein expression of OATP1B3 was examined in normal and cancerous prostate, colon, and bladder tissue samples from an independent cohort. The results were similar to the transcription data, but showed distinct localization. OATPs correlate to differentiation in certain hormone-dependent cancers, thus may be useful as biomarkers for assessing clinical treatment and stage of disease.	[Pressler, Heather; Price, Douglas K.; Figg, William D.] NCI, Mol Pharmacol Sect, Bethesda, MD 20892 USA; [Sissung, Tristan M.; Figg, William D.] NCI, Clin Pharmacol Program, Med Oncol Branch, Bethesda, MD 20892 USA; [Venzon, David] NCI, Biostat & Data Management Sect, Bethesda, MD 20892 USA; [Pressler, Heather] Johns Hopkins Univ, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Pressler, H (corresponding author), NCI, Mol Pharmacol Sect, Bethesda, MD 20892 USA.	wdfigg@helix.nih.gov	Figg, William D/M-2411-2016		National Institutes of Health, National Cancer Institute, Bethesda, MD; National Science Foundation; Department of Defense [PC094258]; NATIONAL CANCER INSTITUTE [ZIABC010547, ZIDSC007202, ZIABC010453] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Bethesda, MD www.nih.gov. Stipend support was provided for Ms. Pressler by the National Science Foundation www.nsf.gov and Department of Defense Prostate Cancer Research Training Award #PC094258 www.grants.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baker SD, 2009, CLIN PHARMACOL THER, V85, P155, DOI 10.1038/clpt.2008.95; Blechet C, 2007, VIRCHOWS ARCH, V450, P433, DOI 10.1007/s00428-007-0379-6; Ferlin A, 2010, ENDOCR-RELAT CANCER, V17, P17, DOI 10.1677/ERC-09-0176; FRANKE RM, J CLINONCOL, V28, P4562; Giron RA, 2009, FEBS J, V276, P5598, DOI 10.1111/j.1742-4658.2009.07253.x; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hamada A, 2008, CLIN CANCER RES, V14, P3312, DOI 10.1158/1078-0432.CCR-07-4118; Ieiri I, 2009, EXPERT OPIN DRUG MET, V5, P703, DOI 10.1517/17425250902976854; Imada S, 1997, EUR UROL, V31, P360; JUSTENHOVEN C, 2010, BREAST CANC RES TREA; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Melvin WS, 1997, SURGERY, V121, P392, DOI 10.1016/S0039-6060(97)90308-1; Miyamoto H, 2007, J NATL CANCER I, V99, P558, DOI 10.1093/jnci/djk113; Sharifi N, 2008, BJU INT, V102, P617, DOI 10.1111/j.1464-410X.2008.07629.x; Sherman ME, 2007, GYNECOL ONCOL, V107, P431, DOI 10.1016/j.ygyno.2007.07.061; SISSUNG TM, MOL BIOTECHNOL, V44, P152; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Smith NF, 2005, CANCER BIOL THER, V4, P815, DOI 10.4161/cbt.4.8.1867; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; WRIGHT JL, 2011, CANC EPIDEMIOL BIOMA; YANG M, 2010, J CLIN ONCOLOG UNPUB	21	79	82	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20372	10.1371/journal.pone.0020372	http://dx.doi.org/10.1371/journal.pone.0020372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625523	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200057
J	Ye, L; Wen, ZY; Dong, K; Wang, X; Bu, ZG; Zhang, HZ; Compans, RW; Yang, CL				Ye, Ling; Wen, Zhiyuan; Dong, Ke; Wang, Xi; Bu, Zhigao; Zhang, Huizhong; Compans, Richard W.; Yang, Chinglai			Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; DEFICIENCY SYNDROME AIDS; CYTOPLASMIC DOMAIN; GP41 EPITOPE; GLYCOPROTEIN GP41; SURFACE-ANTIGEN; INFLUENZA-VIRUS; MEMBRANE; GP120	Several conserved neutralizing epitopes have been identified in the HIV Env protein and among these, the MPER of gp41 has received great attention and is widely recognized as a promising target. However, little success has been achieved in eliciting MPER-specific HIV neutralizing antibodies by a number of different vaccine strategies. We investigated the ability of HA/gp41 chimeric protein-based vaccines, which were designed to enhance the exposure of the MPER in its native conformation, to induce MPER-specific HIV neutralizing antibodies. In characterization of the HA/gp41 chimeric protein, we found that by mutating an unpaired Cys residue (Cys-14) in its HA1 subunit to a Ser residue, the modified chimeric protein HA-C14S/gp41 showed increased reactivity to a conformation-sensitive monoclonal antibody against HA and formed more stable trimers in VLPs. On the other hand, HA-C14S/gp41 and HA/gp41 chimeric proteins expressed on the cell surfaces exhibited similar reactivity to monoclonal antibodies 2F5 and 4E10. Immunization of guinea pigs using the HA-C14S/gp41 DNA or VLP vaccines induced antibodies against the HIV gp41 as well as to a peptide corresponding to a segment of MPER at higher levels than immunization by standard HIV VLPs. Further, sera from vaccinated guinea pigs were found to exhibit HIV neutralizing activities. Moreover, sera from guinea pigs vaccinated by HA-C14S/gp41 DNA and VLP vaccines but not the standard HIV VLPs, were found to neutralize HIV pseudovirions containing a SIV-4E10 chimeric Env protein. The virus neutralization could be blocked by a MPER-specific peptide, thus demonstrating induction of MPER-specific HIV neutralizing antibodies by this novel vaccine strategy. These results show that induction of MPER-specific HIV neutralizing antibodies can be achieved through a rationally designed vaccine strategy.	[Ye, Ling; Wen, Zhiyuan; Dong, Ke; Wang, Xi; Compans, Richard W.; Yang, Chinglai] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ye, Ling; Wen, Zhiyuan; Dong, Ke; Wang, Xi; Compans, Richard W.; Yang, Chinglai] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Wen, Zhiyuan; Bu, Zhigao] Harbin Vet Res Inst, Minist Agr, Key Lab Vet Publ Hlth, Harbin, Peoples R China; [Dong, Ke; Wang, Xi; Zhang, Huizhong] Fourth Mil Med Univ, Tangdu Hosp, Cent Lab, Xian 710032, Peoples R China	Emory University; Emory University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Air Force Military Medical University	Ye, L (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	yling@emory.edu; chyang@emory.edu	Compans, Richard W/I-4087-2013; Yang, Chinglai/D-1409-2014; Wen, Zhiyuan/AAT-1639-2020	Compans, Richard W/0000-0003-2360-335X; Yang, Chinglai/0000-0002-9308-7760; Wen, Zhiyuan/0000-0003-3112-0243	National Institutes of Health [AI077446]; Emory University Global Health Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Global Health Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant AI077446 and by funding from the Emory University Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Belshe RB, 1998, AIDS, V12, P2407, DOI 10.1097/00002030-199818000-00009; Bu ZG, 2004, VIROLOGY, V328, P62, DOI 10.1016/j.virol.2004.06.041; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Cohen J, 2003, SCIENCE, V300, P28; Connor RI, 1998, J VIROL, V72, P1552, DOI 10.1128/JVI.72.2.1552-1576.1998; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Earl PL, 2001, J VIROL, V75, P645, DOI 10.1128/JVI.75.2.645-653.2001; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Graham BS, 1998, J INFECT DIS, V177, P310, DOI 10.1086/514209; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2008, J VIROL, V82, P2367, DOI 10.1128/JVI.02161-07; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hinz A, 2009, VIROLOGY, V390, P221, DOI 10.1016/j.virol.2009.05.015; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Miedema F, 2008, AIDS, V22, P1699, DOI 10.1097/QAD.0b013e3283021a61; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MUSTER T, 1995, J VIROL, V69, P6678, DOI 10.1128/JVI.69.11.6678-6686.1995; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; VanCott TC, 1999, J VIROL, V73, P4640, DOI 10.1128/JVI.73.6.4640-4650.1999; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Vzorov AN, 1996, VIROLOGY, V221, P22, DOI 10.1006/viro.1996.0349; Vzorov AN, 2000, J VIROL, V74, P8219, DOI 10.1128/JVI.74.18.8219-8225.2000; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wen ZY, 2009, ANTIVIR RES, V84, P215, DOI 10.1016/j.antiviral.2009.09.005; WRIN T, 1994, AIDS, V8, P1622, DOI 10.1097/00002030-199411000-00017; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; YAMSHCHIKOV GV, 1995, VIROLOGY, V214, P50, DOI 10.1006/viro.1995.9955; Yao QZ, 2000, AIDS RES HUM RETROV, V16, P227, DOI 10.1089/088922200309322; Ye L, 2004, J VIROL, V78, P13409, DOI 10.1128/JVI.78.24.13409-13419.2004; Ye L, 2006, VIROLOGY, V352, P74, DOI 10.1016/j.virol.2006.04.012; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	56	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e14813	10.1371/journal.pone.0014813	http://dx.doi.org/10.1371/journal.pone.0014813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625584	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200002
J	Climent, N; Guerra, S; Garcia, F; Rovira, C; Miralles, L; Gomez, CE; Pique, N; Gil, C; Gatell, JM; Esteban, M; Gallart, T				Climent, Nuria; Guerra, Susana; Garcia, Felipe; Rovira, Cristina; Miralles, Laia; Elena Gomez, Carmen; Pique, Nuria; Gil, Cristina; Maria Gatell, Jose; Esteban, Mariano; Gallart, Teresa			Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8(+) T Cell Responses in HIV-1-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POXVIRUS VECTORS MVA; TEST-OF-CONCEPT; GENE-EXPRESSION; CANDIDATE VACCINE; IMMUNE-RESPONSES; INTERFERON-ALPHA; DOUBLE-BLIND; ANKARA MVA; INFECTION	Currently, MVA virus vectors carrying HIV-1 genes are being developed as HIV-1/AIDS prophylactic/therapeutic vaccines. Nevertheless, little is known about the impact of these vectors on human dendritic cells (DC) and their capacity to present HIV-1 antigens to human HIV-specific T cells. This study aimed to characterize the interaction of MVA and MVA expressing the HIV-1 genes Env-Gag-Pol-Nef of clade B (referred to as MVA-B) in human monocyte-derived dendritic cells (MDDC) and the subsequent processes of HIV-1 antigen presentation and activation of memory HIV-1-specific T lymphocytes. For these purposes, we performed ex vivo assays with MDDC and autologous lymphocytes from asymptomatic HIV-infected patients. Infection of MDDC with MVA-B or MVA, at the optimal dose of 0.3 PFU/MDDC, induced by itself a moderate degree of maturation of MDDC, involving secretion of cytokines and chemokines (IL1-ra, IL-7, TNF-alpha, IL-6, IL-12, IL-15, IL-8, MCP-1, MIP-1 alpha, MIP-1 beta, RANTES, IP-10, MIG, and IFN-alpha). MDDC infected with MVA or MVA-B and following a period of 48 h or 72 h of maturation were able to migrate toward CCL19 or CCL21 chemokine gradients. MVA-B infection induced apoptosis of the infected cells and the resulting apoptotic bodies were engulfed by the uninfected MDDC, which cross-presented HIV-1 antigens to autologous CD8(+) T lymphocytes. MVA-B-infected MDDC co-cultured with autologous T lymphocytes induced a highly functional HIV-specific CD8(+) T cell response including proliferation, secretion of IFN-gamma, IL-2, TNF-alpha, MIP-1 beta, MIP-1 alpha, RANTES and IL-6, and strong cytotoxic activity against autologous HIV-1-infected CD4(+) T lymphocytes. These results evidence the adjuvant role of the vector itself (MVA) and support the clinical development of prophylactic and therapeutic anti-HIV vaccines based on MVA-B.	[Climent, Nuria; Rovira, Cristina; Miralles, Laia; Gallart, Teresa] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Climent, Nuria; Garcia, Felipe; Rovira, Cristina; Miralles, Laia; Gil, Cristina; Maria Gatell, Jose; Gallart, Teresa] IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Climent, Nuria; Garcia, Felipe; Rovira, Cristina; Miralles, Laia; Gil, Cristina; Maria Gatell, Jose; Gallart, Teresa] Catalonian Ctr HIV Vaccines HIVACAT, Barcelona, Spain; [Guerra, Susana; Elena Gomez, Carmen; Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Garcia, Felipe; Gil, Cristina; Maria Gatell, Jose] Hosp Clin Barcelona, Infect Dis & AIDS Unit, Barcelona, Spain; [Pique, Nuria] Univ Barcelona, Fac Pharm, Dept Microbiol & Parasitol, E-08007 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Climent, N (corresponding author), Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain.	nucliment@yahoo.es	Gomez, Carmen Elena/K-1940-2014; , Felipe/F-4242-2014; Esteban, Mariano/ABG-5375-2020; guerra, susana/K-5972-2014; Climent, Núria/AAF-8161-2021	Gomez, Carmen Elena/0000-0002-5414-7935; , Felipe/0000-0001-7658-5832; Esteban, Mariano/0000-0003-0846-2827; guerra, susana/0000-0001-9067-2991; Climent, Núria/0000-0002-0791-656X; Miralles, Laia/0000-0002-0754-5607; Gil, Cristina/0000-0002-2692-8814; Pique, Nuria/0000-0002-7308-030X	Spanish Ministry of Health, RIS-Spanish Cooperative Network on AIDS Research [FIS 2006-1259, FIS 200980145, FIS 2009-11078]; Spanish Ministry of Education and Science [BIO2004-03954, SAF2005-05566, SAF2008-02036, SAF2008-04395]; Spanish Foundation for AIDS Research (FIPSE) [36344/02, 36536/05, 36551/06, 36750/08]; Fundacion Botin; EU [QLRT-PL-1999-01321, QLK2-CT-2002-01867]; Spanish Ministry of Health; Abbott Laboratories; Boehringer Ingelheim; Bristol Myers Squibb; GlaxoSmithKline; Merck Sharp; Dohme and Roche;  [MuNanoVac-EU-STREP-037200]	Spanish Ministry of Health, RIS-Spanish Cooperative Network on AIDS Research; Spanish Ministry of Education and Science(Spanish Government); Spanish Foundation for AIDS Research (FIPSE); Fundacion Botin; EU(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Abbott Laboratories(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp; Dohme and Roche; 	This work was supported by grants from the Spanish Ministry of Health (FIS 2006-1259, RIS-Spanish Cooperative Network on AIDS Research, FIS 200980145 and FIS 2009-11078), the Spanish Ministry of Education and Science (BIO2004-03954, SAF2005-05566, SAF2008-02036 and SAF2008-04395), the Spanish Foundation for AIDS Research (FIPSE 36344/02, 36536/05, 36551/06 and 36750/08), Fundacion Botin, the EU (EuroVac QLRT-PL-1999-01321 and QLK2-CT-2002-01867), MuNanoVac-EU-STREP-037200. FIPSE is a non-profit Foundation including: Spanish Ministry of Health, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme and Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2000, AM J RESP CRIT CARE, V162, P1466, DOI 10.1164/ajrccm.162.4.2003130; Aline F, 2007, MICROBES INFECT, V9, P536, DOI 10.1016/j.micinf.2007.01.021; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barat C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-30; Barouch DH, 2001, J VIROL, V75, P5151, DOI 10.1128/JVI.75.11.5151-5158.2001; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brandler S, 2010, J VIROL, V84, P5314, DOI 10.1128/JVI.02329-09; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carreno BM, 2009, IMMUNOL CELL BIOL, V87, P167, DOI 10.1038/icb.2008.80; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; DeVico AL, 2004, NAT REV MICROBIOL, V2, P401, DOI 10.1038/nrmicro878; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Garcia F, 2005, J INFECT DIS, V191, P1680, DOI 10.1086/429340; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Greiner S, 2006, CLIN EXP IMMUNOL, V146, P344, DOI 10.1111/j.1365-2249.2006.03177.x; Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018; Guerra S, 2004, J VIROL, V78, P5820, DOI 10.1128/JVI.78.11.5820-5834.2004; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Humrich JY, 2007, EUR J IMMUNOL, V37, P954, DOI 10.1002/eji.200636230; Jenne L, 2001, TRENDS IMMUNOL, V22, P102, DOI 10.1016/S1471-4906(00)01813-5; Johnson LA, 2010, CURR NEUROL NEUROSCI, V10, P259, DOI 10.1007/s11910-010-0111-9; Karpov AV, 2001, EUR J MED RES, V6, P507; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kim HJ, 2010, VACCINE, V28, P2877, DOI 10.1016/j.vaccine.2010.01.061; Koff WC, 2010, NATURE, V464, P161, DOI 10.1038/464161a; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lapenta C, 2003, J EXP MED, V198, P361, DOI 10.1084/jem.20021924; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Liu JY, 2007, VACCINE, V25, P2951, DOI 10.1016/j.vaccine.2006.05.081; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2003, NAT MED, V9, P874, DOI 10.1038/nm0703-874; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Promadej-Lanier N, 2010, JAIDS-J ACQ IMM DEF, V53, P574, DOI 10.1097/QAI.0b013e3181d3521f; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saini M, 2009, BLOOD, V113, P5793, DOI 10.1182/blood-2008-12-192252; Stylianou E, 2002, CLIN EXP IMMUNOL, V130, P279, DOI 10.1046/j.1365-2249.2002.01980.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tovey MG, 2008, BIOL CHEM, V389, P541, DOI 10.1515/BC.2008.051; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Wang Y, 2009, J IMMUNOL, V183, P3324, DOI 10.4049/jimmunol.0803985; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhang R, 2010, CYTOKINE, V50, P195, DOI 10.1016/j.cyto.2010.02.017; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	86	32	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19644	10.1371/journal.pone.0019644	http://dx.doi.org/10.1371/journal.pone.0019644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21625608	Green Published, Green Submitted, gold			2022-12-25	WOS:000290720200022
J	Hamill, KJ; Hopkinson, SB; Jonkman, MF; Jones, JCR				Hamill, Kevin J.; Hopkinson, Susan B.; Jonkman, Marcel F.; Jones, Jonathan C. R.			Type XVII Collagen Regulates Lamellipod Stability, Cell Motility, and Signaling to Rac1 by Targeting Bullous Pemphigoid Antigen 1e to alpha 6 beta 4 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-4 INTEGRIN; ALPHA-3-BETA-1 INTEGRIN; MIGRATION; HEMIDESMOSOME; ADHESION; SUBUNIT; STABILIZATION; PROTEIN; BP180; COMPONENTS	Rac1 activity, polarity, lamellipodial dynamics, and directed motility are defective in keratinocytes exhibiting deficiency in beta 4 integrin or knockdown of the plakin protein Bullous Pemphigoid Antigen 1e (BPAG1e). The activity of Rac, formation of stable lamellipodia, and directed migration are restored in beta 4 integrin-deficient cells by inducing expression of a truncated form of beta 4 integrin, which lacks binding sites for BPAG1e and plectin. In these same cells, BPAG1e, the truncated beta 4 integrin, and type XVII collagen (Col XVII), a transmembrane BPAG1e-binding protein, but not plectin, colocalize along the substratum-attached surface. This finding suggested to us that Col XVII mediates the association of BPAG1e and alpha 6 beta 4 integrin containing the truncated beta 4 subunit and supports directed migration. To test these possibilities, we knocked down Col XVII expression in keratinocytes expressing both full-length and truncated beta 4 integrin proteins. Col XVII-knockdown keratinocytes exhibit a loss in BPAG1e-alpha 6 beta 4 integrin interaction, a reduction in lamellipodial stability, an impairment in directional motility, and a decrease in Rac1 activity. These defects are rescued by a mutant Col XVII protein truncated at its carboxyl terminus. In summary, our results suggest that in motile cells Col XVII recruits BPAG1e to alpha 6 beta 4 integrin and is necessary for activation of signaling pathways, motile behavior, and lamellipodial stability.	[Hamill, Kevin J.; Hopkinson, Susan B.; Jones, Jonathan C. R.] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jonkman, Marcel F.] Univ Groningen, Dept Dermatol, Univ Med Ctr Groningen, NL-9713 G2 Groningen, Netherlands	Northwestern University; Feinberg School of Medicine; University of Groningen	Jones, JCR (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Hamill, Kevin/F-8983-2012; Jones, Jonathan C R/T-9467-2017; Hamill, Kevin/ABF-9727-2020; Jonkman, Marcel F./H-4647-2011	Jones, Jonathan C R/0000-0002-1496-4922; Hamill, Kevin/0000-0002-7852-1944; 	National Institutes of Health [R01 AR054184]; Dermatology Foundation; Vlinderkind (the Butterfly Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; Vlinderkind (the Butterfly Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR054184 (to J. C. R. J.). This work was also supported by a Dermatology Foundation research grant (to K. J. H.).; Supported by Vlinderkind (the Butterfly Foundation).	Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hamill KJ, 2009, MOL BIOL CELL, V20, P2954, DOI 10.1091/mbc.E09-01-0051; Harlow E., 1988, ANTIBODIES LAB MANUA; HASHIMOTO T, 1993, J INVEST DERMATOL, V100, P310, DOI 10.1111/1523-1747.ep12469916; Herold-Mende C, 2001, CELL TISSUE RES, V306, P399, DOI 10.1007/s004410100462; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Hopkinson SB, 1998, J INVEST DERMATOL, V111, P1015, DOI 10.1046/j.1523-1747.1998.00452.x; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; Hopkinson SB, 2000, MOL BIOL CELL, V11, P277, DOI 10.1091/mbc.11.1.277; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Jonkman MF, 2002, J INVEST DERMATOL, V119, P1275, DOI 10.1046/j.1523-1747.2002.19609.x; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; KLATTE DH, 1994, J INVEST DERMATOL, V102, P39, DOI 10.1111/1523-1747.ep12371728; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Mainiero F, 2000, IMMUNITY, V12, P7, DOI 10.1016/S1074-7613(00)80154-5; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Niessen CM, 1997, J CELL SCI, V110, P1705; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Parikka M, 2006, EXP CELL RES, V312, P1431, DOI 10.1016/j.yexcr.2006.01.015; Parikka M, 2003, J HISTOCHEM CYTOCHEM, V51, P921, DOI 10.1177/002215540305100707; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Qiao HJ, 2009, J INVEST DERMATOL, V129, P2288, DOI 10.1038/jid.2009.20; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; RIDDELLE KS, 1991, J CELL BIOL, V112, P159, DOI 10.1083/jcb.112.1.159; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Tsuruta D, 2003, J BIOL CHEM, V278, P38707, DOI 10.1074/jbc.M301637200; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; Werner ME, 2007, J BIOL CHEM, V282, P5560, DOI 10.1074/jbc.M603669200; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	53	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26768	26780		10.1074/jbc.M110.203646	http://dx.doi.org/10.1074/jbc.M110.203646			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642434	Green Published, hybrid			2022-12-25	WOS:000293078200053
J	Yamamoto, H; Kokame, K; Okuda, T; Nakajo, Y; Yanamoto, H; Miyata, T				Yamamoto, Hitomi; Kokame, Koichi; Okuda, Tomohiko; Nakajo, Yukako; Yanamoto, Hiroji; Miyata, Toshiyuki			NDRG4 Protein-deficient Mice Exhibit Spatial Learning Deficits and Vulnerabilities to Cerebral Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWNSTREAM REGULATED GENE-2; CENTRAL-NERVOUS-SYSTEM; QT INTERVAL DURATION; NEUROTROPHIC FACTOR; NDRG1-DEFICIENT MICE; COMMON VARIANTS; BRAIN; CELLS; EXPRESSION; RAT	The N-myc downstream-regulated gene (NDRG) family consists of four related proteins, NDRG1-NDRG4, in mammals. We previously generated NDRG1-deficient mice that were unable to maintain myelin sheaths in peripheral nerves. This condition was consistent with human hereditary motor and sensory neuropathy, Charcot-Marie-Tooth disease type 4D, caused by a nonsense mutation of NDRG1. In contrast, the effects of genetic defects of the other NDRG members remain unknown. In this study, we focused on NDRG4, which is specifically expressed in the brain and heart. In situ mRNA hybridization on the brain revealed that NDRG4 was expressed in neurons of various areas. We generated NDRG4-deficient mice that were born normally with the expected Mendelian frequency. Immunochemical analysis demonstrated that the cortex of the NDRG4-deficient mice contained decreased levels of brain-derived neurotrophic factor (BDNF) and normal levels of glial cell line-derived neurotrophic factor, NGF, neurotrophin-3, and TGF-beta 1. Consistent with BDNF reduction, NDRG4-deficient mice had impaired spatial learning and memory but normal motor function in the Morris water maze test. When temporary focal ischemia of the brain was induced, the sizes of the infarct lesions were larger, and the neurological deficits were more severe in NDRG4-deficient mice compared with the control mice. These findings indicate that NDRG4 contributes to the maintenance of intracerebral BDNF levels within the normal range, which is necessary for the preservation of spatial learning and the resistance to neuronal cell death caused by ischemic stress.	[Yamamoto, Hitomi; Kokame, Koichi; Okuda, Tomohiko; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka 5658565, Japan; [Nakajo, Yukako; Yanamoto, Hiroji] Natl Cerebral & Cardiovasc Ctr, Lab Neurol & Neurosurg, Osaka 5658565, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Kokame, K (corresponding author), 5-7-1 Fujishirodai, Osaka 5658565, Japan.	kame@ri.ncvc.go.jp; hyanamot@res.ncvc.go.jp	yanamoto, hiroji/ABB-3923-2020; Yanamoto, Hiroji/ABF-7320-2020	Kokame, Koichi/0000-0002-9654-6299	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan; from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan.	Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Burchfield JG, 2004, J BIOL CHEM, V279, P18623, DOI 10.1074/jbc.M401504200; Choi SC, 2003, FEBS LETT, V553, P413, DOI 10.1016/S0014-5793(03)01030-5; Drogemuller C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011258; Dupays L, 2009, DEV BIOL, V333, P121, DOI 10.1016/j.ydbio.2009.06.025; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P163, DOI 10.1016/j.nmd.2006.10.002; Endres M, 2000, J CEREBR BLOOD F MET, V20, P139, DOI 10.1097/00004647-200001000-00018; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kitowska A, 2010, ACTA BIOCHIM POL, V57, P15; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kolarow R, 2007, J NEUROSCI, V27, P10350, DOI 10.1523/JNEUROSCI.0692-07.2007; Lin H, 2002, CIRCULATION, V105, P1962, DOI 10.1161/01.CIR.0000015365.49180.05; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nishimoto S, 2003, EUR J BIOCHEM, V270, P2521, DOI 10.1046/j.1432-1033.2003.03626.x; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Santhanam AVR, 2010, STROKE, V41, P350, DOI 10.1161/STROKEAHA.109.564492; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schilling SH, 2009, J BIOL CHEM, V284, P25160, DOI 10.1074/jbc.M109.012484; Takagi T, 1998, DEVELOPMENT, V125, P21; Takahashi K, 2005, INT J NEUROPSYCHOPH, V8, P381, DOI 10.1017/S1461145705005134; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamamoto H, 2003, EXP NEUROL, V182, P261, DOI 10.1016/S0014-4886(03)00116-X; Yanamoto H, 2004, BRAIN RES, V1019, P178, DOI 10.1016/j.brainres.2004.05.105; Yanamoto H, 2001, STROKE, V32, P232, DOI 10.1161/01.STR.32.1.232; Yanamoto H, 2000, BRAIN RES, V859, P240, DOI 10.1016/S0006-8993(00)01966-1; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	42	59	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26158	26165		10.1074/jbc.M111.256446	http://dx.doi.org/10.1074/jbc.M111.256446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21636852	Green Published, hybrid			2022-12-25	WOS:000293073000073
J	Albershardt, TC; Salerni, BL; Soderquist, RS; Bates, DJP; Pletnev, AA; Kisselev, AF; Eastman, A				Albershardt, Tina C.; Salerni, Bethany L.; Soderquist, Ryan S.; Bates, Darcy J. P.; Pletnev, Alexandre A.; Kisselev, Alexei F.; Eastman, Alan			Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; BCL-2 PROTEINS; CYTOCHROME-C; ER STRESS; APOPTOSIS; BAX; RESISTANCE; SENSITIVITY; INHIBITORS; RELEASE	BH3 mimetics are small molecules designed or discovered to mimic the binding of BH3-only proteins to the hydrophobic groove of antiapoptotic BCL2 proteins. The selectivity of these molecules for BCL2, BCL-XL, or MCL1 has been established in vitro; whether they inhibit these proteins in cells has not been rigorously investigated. In this study, we used a panel of leukemia cell lines to assess the ability of seven putative BH3 mimetics to inhibit antiapoptotic proteins in a cell-based system. We show that ABT-737 is the only BH3 mimetic that inhibits BCL2 as assessed by displacement of BAD and BIM from BCL2. The other six BH3 mimetics activate the endoplasmic reticulum stress response inducing ATF4, ATF3, and NOXA, which can then bind to and inhibit MCL1. In most cancer cells, inhibition of one antiapoptotic protein does not acutely induce apoptosis. However, by combining two BH3 mimetics, one that inhibits BCL2 and one that induces NOXA, apoptosis is induced within 6 h in a BAX/BAK-dependent manner. Because MCL1 is a major mechanism of resistance to ABT-737, these results suggest a novel strategy to overcome this resistance. Our findings highlight a novel signaling pathway through which many BH3 mimetics inhibit MCL1 and suggest the potential use of these agents as adjuvants in combination with various chemotherapy strategies.	[Eastman, Alan] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Lebanon, NH 03756 USA; [Pletnev, Alexandre A.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Eastman, A (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Rubin Bldg,Level 6, Lebanon, NH 03756 USA.	alan.r.eastman@dartmouth.edu			National Institutes of Health [CA50224, T32 09658]; Cancer Center [CA23108]; NATIONAL CANCER INSTITUTE [P30CA023108, T32CA009658, R01CA050224, R55CA050224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA50224 (to A. E.). This work was also supported by Cancer Center Support Grant CA23108 to the Norris Cotton Cancer Center and National Institutes of Health Training Grant T32 09658 (to B. L. S., R. S. S., and D. J. P. B.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Altun M, 2005, CANCER RES, V65, P7896, DOI 10.1158/0008-5472.CAN-05-0506; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Ganju N, 2003, CELL DEATH DIFFER, V10, P652, DOI 10.1038/sj.cdd.4401234; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salerni BL, 2010, MOL CANCER THER, V9, P791, DOI 10.1158/1535-7163.MCT-10-0028; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	38	88	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24882	24895		10.1074/jbc.M111.255828	http://dx.doi.org/10.1074/jbc.M111.255828			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21628457	Green Published, hybrid			2022-12-25	WOS:000292547900038
J	Suda, M; Takei, Y; Aoyama, Y; Narita, K; Sakurai, N; Fukuda, M; Mikuni, M				Suda, Masashi; Takei, Yuichi; Aoyama, Yoshiyuki; Narita, Kosuke; Sakurai, Noriko; Fukuda, Masato; Mikuni, Masahiko			Autistic Traits and Brain Activation during Face-to-Face Conversations in Typically Developed Adults	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; SPECTRUM QUOTIENT AQ; SOCIAL BRAIN; ASPERGER-SYNDROME; CHILDHOOD AUTISM; PERCEPTION; REACTIVITY; DISORDERS; FLUENCY	Background: Autism spectrum disorders (ASD) are characterized by impaired social interaction and communication, restricted interests, and repetitive behaviours. The severity of these characteristics is posited to lie on a continuum that extends into the general population. Brain substrates underlying ASD have been investigated through functional neuroimaging studies using functional magnetic resonance imaging (fMRI). However, fMRI has methodological constraints for studying brain mechanisms during social interactions (for example, noise, lying on a gantry during the procedure, etc.). In this study, we investigated whether variations in autism spectrum traits are associated with changes in patterns of brain activation in typically developed adults. We used near-infrared spectroscopy (NIRS), a recently developed functional neuroimaging technique that uses near-infrared light, to monitor brain activation in a natural setting that is suitable for studying brain functions during social interactions. Methodology: We monitored regional cerebral blood volume changes using a 52-channel NIRS apparatus over the prefrontal cortex (PFC) and superior temporal sulcus (STS), 2 areas implicated in social cognition and the pathology of ASD, in 28 typically developed participants (14 male and 14 female) during face-to-face conversations. This task was designed to resemble a realistic social situation. We examined the correlations of these changes with autistic traits assessed using the Autism-Spectrum Quotient (AQ). Principal Findings: Both the PFC and STS were significantly activated during face-to-face conversations. AQ scores were negatively correlated with regional cerebral blood volume increases in the left STS during face-to-face conversations, especially in males. Conclusions: Our results demonstrate successful monitoring of brain function during realistic social interactions by NIRS as well as lesser brain activation in the left STS during face-to-face conversations in typically developed participants with higher levels of autistic traits.	[Suda, Masashi; Takei, Yuichi; Aoyama, Yoshiyuki; Narita, Kosuke; Sakurai, Noriko; Fukuda, Masato; Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Gunma, Japan	Gunma University	Suda, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Gunma, Japan.	fkdpsy@med.gunma-u.ac.jp	Takei, Yuichi/AAS-2278-2021		Gunma University; Hitachi Group (Advanced Research Laboratory, Hitachi Ltd, and the Research and Developmental Center, Hitachi Medical Corporation); Grants-in-Aid for Scientific Research [23390286] Funding Source: KAKEN	Gunma University; Hitachi Group (Advanced Research Laboratory, Hitachi Ltd, and the Research and Developmental Center, Hitachi Medical Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Gunma University (Drs. Fukuda and Mikuni) and the Hitachi Group (Advanced Research Laboratory, Hitachi Ltd, and the Research and Developmental Center, Hitachi Medical Corporation) have had an official contract for a collaborative study of the clinical application of near-infrared spectroscopy in psychiatric disorders since 2002. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ardila A, 2008, BRAIN COGNITION, V68, P92, DOI 10.1016/j.bandc.2008.03.003; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 2003, ESSENTIAL DIFFERENCE; Baron-Cohen Simon, 1995, MINDBLINDNESS ESSAY; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Boddaert N, 2003, AM J PSYCHIAT, V160, P2057, DOI 10.1176/appi.ajp.160.11.2057; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Dawson G, 2007, J AUTISM DEV DISORD, V37, P523, DOI 10.1007/s10803-006-0182-2; Frith U, 1991, AUTISM ASPERGERS SYN; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Grinter EJ, 2009, J AUTISM DEV DISORD, V39, P1278, DOI 10.1007/s10803-009-0740-5; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Levitt JG, 2003, BIOL PSYCHIAT, V54, P1355, DOI 10.1016/S0006-3223(03)00688-7; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Meresse IG, 2005, ANN NEUROL, V58, P466, DOI 10.1002/ana.20597; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pelphrey KA, 2005, BRAIN, V128, P1038, DOI 10.1093/brain/awh404; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Suda M, 2008, NEUROSCI RES, V60, P319, DOI 10.1016/j.neures.2007.12.001; Suda M, 2010, J PSYCHIATR RES, V44, P547, DOI 10.1016/j.jpsychires.2009.11.005; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Uehara T, 2007, EAT WEIGHT DISORD-ST, V12, P183, DOI 10.1007/BF03327596; VONDEMHAGEN EA, 2010, CEREB CORTEX; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Williams JHG, 2005, NEUROIMAGE, V25, P133, DOI 10.1016/j.neuroimage.2004.10.047	41	31	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20021	10.1371/journal.pone.0020021	http://dx.doi.org/10.1371/journal.pone.0020021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21637754	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500025
J	Klein, D; Weisshardt, P; Kleff, V; Jastrow, H; Jakob, HG; Ergun, S				Klein, Diana; Weisshardt, Philip; Kleff, Veronika; Jastrow, Holger; Jakob, Heinz Guenther; Erguen, Sueleyman			Vascular Wall-Resident CD44+Multipotent Stem Cells Give Rise to Pericytes and Smooth Muscle Cells and Contribute to New Vessel Maturation	PLOS ONE			English	Article							PERIVASCULAR PROGENITOR CELLS; MESENCHYMAL STROMAL CELLS; ENDOTHELIAL-CELLS; GROWTH-FACTOR; ANGIOGENESIS; CANCER	Here, we identify CD44(+)CD90(+)CD73(-)CD34(-)CD45(-) cells within the adult human arterial adventitia with properties of multipotency which were named vascular wall-resident multipotent stem cells (VW-MPSCs). VW-MPSCs exhibit typical mesenchymal stem cell characteristics including cell surface markers in immunostaining and flow cytometric analyses, and differentiation into adipocytes, chondrocytes and osteocytes under culture conditions. Particularly, TGF beta 1 stimulation up-regulates smooth muscle cell markers in VW-MPSCs. Using fluorescent cell labelling and co-localisation studies we show that VW-MPSCs differentiate to pericytes/smooth muscle cells which cover the wall of newly formed endothelial capillary-like structures in vitro. Co-implantation of EGFP-labelled VW-MPSCs and human umbilical vein endothelial cells into SCID mice subcutaneously via Matrigel results in new vessels formation which were covered by pericyte-or smooth muscle-like cells generated from implanted VW-MPSCs. Our results suggest that VW-MPSCs are of relevance for vascular morphogenesis, repair and self-renewal of vascular wall cells and for local capacity of neovascularization in disease processes.	[Klein, Diana; Weisshardt, Philip; Kleff, Veronika; Jastrow, Holger; Erguen, Sueleyman] Univ Hosp Essen, Inst Anat, Essen, N Rhine Westpha, Germany; [Jakob, Heinz Guenther] Univ Hosp Essen, Clin Thorax & Cardiovasc Surg, Essen, N Rhine Westpha, Germany	University of Duisburg Essen; University of Duisburg Essen	Klein, D (corresponding author), Univ Hosp Essen, Inst Anat, Essen, N Rhine Westpha, Germany.	Diana.Klein@uk-essen.de	Klein, Diana/AAB-5251-2020; Klein, Diana/ABC-7916-2020	Klein, Diana/0000-0002-1770-443X; Klein, Diana/0000-0002-1770-443X	Stem Cell Network North Rhine-Westphalia	Stem Cell Network North Rhine-Westphalia	The work was supported by Stem Cell Network North Rhine-Westphalia (D. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2005, HYPERTENSION, V45, P321, DOI 10.1161/01.HYP.0000154789.28695.ea; Alajati A, 2008, NAT METHODS, V5, P439, DOI 10.1038/NMETH.1198; Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Campagnolo P, 2010, CIRCULATION, V121, P1735, DOI 10.1161/CIRCULATIONAHA.109.899252; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Covas DT, 2005, EXP CELL RES, V309, P340, DOI 10.1016/j.yexcr.2005.06.005; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Erguen S, 2008, STEM CELL REV, V4, P169, DOI 10.1007/s12015-008-9028-y; Ergun S, 2007, THROMB HAEMOSTASIS, V98, P930, DOI 10.1160/TH07-04-0318; Ergun S, 2006, CANCER LETT, V238, P180, DOI 10.1016/j.canlet.2005.06.033; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Howson KM, 2005, AM J PHYSIOL-CELL PH, V289, pC1396, DOI 10.1152/ajpcell.00168.2005; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Invernici G, 2007, AM J PATHOL, V170, P1879, DOI 10.2353/ajpath.2007.060646; Kano MR, 2009, CANCER SCI, V100, P173, DOI 10.1111/j.1349-7006.2008.01003.x; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Klein D, 2010, HISTOL HISTOPATHOL, V25, P681, DOI 10.14670/HH-25.681; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; LENNON DP, 2006, CULTURE CELLS TISSUE, P23; Liu JY, 2008, CARDIOVASC RES, V79, P24, DOI 10.1093/cvr/cvn059; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Pasquinelli G, 2007, STEM CELLS, V25, P1627, DOI 10.1634/stemcells.2006-0731; Passman JN, 2008, P NATL ACAD SCI USA, V105, P9349, DOI 10.1073/pnas.0711382105; Potta SP, 2009, HYPERTENSION, V53, P196, DOI 10.1161/HYPERTENSIONAHA.108.121863; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Sainz J, 2006, ARTERIOSCL THROM VAS, V26, P281, DOI 10.1161/01.ATV.0000197793.83391.91; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315	42	127	129	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20540	10.1371/journal.pone.0020540	http://dx.doi.org/10.1371/journal.pone.0020540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637782	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052200077
J	Roberts, MG; Nishiura, H				Roberts, Michael George; Nishiura, Hiroshi			Early Estimation of the Reproduction Number in the Presence of Imported Cases: Pandemic Influenza H1N1-2009 in New Zealand	PLOS ONE			English	Article							DEPENDENT BRANCHING-PROCESSES; SERIAL INTERVAL; H1N1; AGE; GROWTH; VIRUS; MODEL; TIME; RATES	We analyse data from the early epidemic of H1N1-2009 in New Zealand, and estimate the reproduction number R. We employ a renewal process which accounts for imported cases, illustrate some technical pitfalls, and propose a novel estimation method to address these pitfalls. Explicitly accounting for the infection-age distribution of imported cases and for the delay in transmission dynamics due to international travel, R was estimated to be 1: 25 (95% confidence interval: 1: 07,1: 47). Hence we show that a previous study, which did not account for these factors, overestimated R. Our approach also permitted us to examine the infection-age at which secondary transmission occurs as a function of calendar time, demonstrating the downward bias during the beginning of the epidemic. These technical issues may compromise the usefulness of a well-known estimator of R - the inverse of the moment-generating function of the generation time given the intrinsic growth rate. Explicit modelling of the infection-age distribution among imported cases and the examination of the time dependency of the generation time play key roles in avoiding a biased estimate of R, especially when one only has data covering a short time interval during the early growth phase of the epidemic.	[Roberts, Michael George] Massey Univ, Ctr Math Biol, Inst Informat & Math Sci, Auckland, New Zealand; [Roberts, Michael George] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Nishiura, Hiroshi] Univ Utrecht, Utrecht, Netherlands	Massey University; Massey University; Japan Science & Technology Agency (JST); Utrecht University	Roberts, MG (corresponding author), Massey Univ, Ctr Math Biol, Inst Informat & Math Sci, Auckland, New Zealand.	m.g.roberts@massey.ac.nz		Nishiura, Hiroshi/0000-0003-0941-8537	Health Research Council [10/754]; Japan Science and Technology Agency, Saitama, Japan	Health Research Council; Japan Science and Technology Agency, Saitama, Japan(Japan Science & Technology Agency (JST))	MGR wishes to acknowledge funding from the Health Research Council under contract number 10/754 (www.hrc.govt.nz/index.html). HN receives support from the Japan Science and Technology Agency, Saitama, Japan, through the PRESTO programme (www.jst.go.jp/kisoken/presto/index_e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey N. T. J., 1964, ELEMENTS STOCHASTIC; Boelle P., 2009, EUROSURVEILLANCE, V14; DEMETRIUS L, 1977, P NATL ACAD SCI USA, V74, P384, DOI 10.1073/pnas.74.1.384; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; GREY DR, 1976, J APPL PROBAB, V13, P138, DOI 10.2307/3212674; Griffin JT, 2011, BIOSTATISTICS, V12, P303, DOI 10.1093/biostatistics/kxq058; Hahne S, 2009, EUROSURVEILLANCE, V14, P2; JAGERS P, 1968, THEOR PROBAB APPL+, V13, P225, DOI 10.1137/1113027; Kelly HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011341; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Keyfitz BL, 1997, MATH COMPUT MODEL, V26, P1, DOI 10.1016/S0895-7177(97)00165-9; Lipsitch M, 2004, AM J EPIDEMIOL, V160, P517, DOI 10.1093/aje/kwh256; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Miller JC, 2010, J THEOR BIOL, V262, P107, DOI 10.1016/j.jtbi.2009.08.007; Mukherjee P, 2010, EMERG INFECT DIS, V16, P21, DOI 10.3201/eid1601.091376; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nishiura H, 2010, EUROSURVEILLANCE, V15, P19; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2010, MATH BIOSCI ENG, V7, P851, DOI 10.3934/mbe.2010.7.851; Nishiura H, 2010, J TRAVEL MED, V17, P269, DOI 10.1111/j.1708-8305.2010.00418.x; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Nishiura H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006852; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Paine S, 2010, EUROSURVEILLANCE, V15, P9; PARTHASARATHY PR, 1991, INT J MATH ED SCI TE, V22, P317; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Roberts MG, 2007, J R SOC INTERFACE, V4, P325, DOI 10.1098/rsif.2006.0176; Roberts MG, 2007, J R SOC INTERFACE, V4, P949, DOI 10.1098/rsif.2007.1031; Roberts MG, 2006, MATH POPUL STUD, V13, P205, DOI 10.1080/08898480600950473; Tomba GS, 2010, MATH BIOSCI, V223, P24, DOI 10.1016/j.mbs.2009.10.004; TULJAPURKAR SD, 1982, J MATH BIOL, V13, P325, DOI 10.1007/BF00276067; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	40	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e17835	10.1371/journal.pone.0017835	http://dx.doi.org/10.1371/journal.pone.0017835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637342	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052200005
J	Scarcelli, N; Barnaud, A; Eiserhardt, W; Treier, UA; Seveno, M; d'Anfray, A; Vigouroux, Y; Pintaud, JC				Scarcelli, Nora; Barnaud, Adeline; Eiserhardt, Wolf; Treier, Urs A.; Seveno, Marie; d'Anfray, Amelie; Vigouroux, Yves; Pintaud, Jean-Christophe			A Set of 100 Chloroplast DNA Primer Pairs to Study Population Genetics and Phylogeny in Monocotyledons	PLOS ONE			English	Article							NONCODING REGIONS; GENOME SEQUENCES; MOLECULAR PHYLOGENY; UNIVERSAL PRIMERS; INVERTED REPEAT; EVOLUTION; GRASSES; POACEAE; RBCL; ORCHIDACEAE	Chloroplast DNA sequences are of great interest for population genetics and phylogenetic studies. However, only a small set of markers are commonly used. Most of them have been designed for amplification in a large range of Angiosperms and are located in the Large Single Copy (LSC). Here we developed a new set of 100 primer pairs optimized for amplification in Monocotyledons. Primer pairs amplify coding (exon) and non-coding regions (intron and intergenic spacer). They span the different chloroplast regions: 72 are located in the LSC, 13 in the Small Single Copy (SSC) and 15 in the Inverted Repeat region (IR). Amplification and sequencing were tested in 13 species of Monocotyledons: Dioscorea abyssinica, D. praehensilis, D. rotundata, D. dumetorum, D. bulbifera, Trichopus sempervirens (Dioscoreaceae), Phoenix canariensis, P. dactylifera, Astrocaryum scopatum, A. murumuru, Ceroxylon echinulatum (Arecaceae), Digitaria excilis and Pennisetum glaucum (Poaceae). The diversity found in Dioscorea, Digitaria and Pennisetum mainly corresponded to Single Nucleotide Polymorphism (SNP) while the diversity found in Arecaceae also comprises Variable Number Tandem Repeat (VNTR). We observed that the most variable loci (rps15-ycf1, rpl32-ccsA, ndhF-rpl32, ndhG-ndhI and ccsA) are located in the SSC. Through the analysis of the genetic structure of a wild-cultivated species complex in Dioscorea, we demonstrated that this new set of primers is of great interest for population genetics and we anticipate that it will also be useful for phylogeny and bar-coding studies.	[Scarcelli, Nora; Barnaud, Adeline; Seveno, Marie; d'Anfray, Amelie; Vigouroux, Yves; Pintaud, Jean-Christophe] IRD, UMR Diversite Adaptat & Dev Plantes DIADE, Montpellier, France; [Eiserhardt, Wolf; Treier, Urs A.] Aarhus Univ, Dept Biol Sci, Ecoinformat & Biodivers Grp, Aarhus, Denmark	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Aarhus University	Scarcelli, N (corresponding author), IRD, UMR Diversite Adaptat & Dev Plantes DIADE, Montpellier, France.	nora.scarcelli@ird.fr	Eiserhardt, Wolf L./D-7677-2011; Treier, Urs/A-1913-2012; vigouroux, Yves/A-9056-2011	Eiserhardt, Wolf L./0000-0002-8136-5233; Treier, Urs/0000-0003-4027-739X; vigouroux, Yves/0000-0002-8361-6040; Scarcelli, Nora/0000-0003-4382-9583; barnaud, adeline/0000-0001-9896-1210; d'Anfray, Amelie/0000-0003-2284-4004	EU [212631]; IRD	EU(European Commission); IRD	This study was funded by EU Seventh Framework Programme as part of the project FP7-PALMS (grant agreement 212631) and by annual research budget of IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; Barrett CF, 2009, SYST BOT, V34, P496, DOI 10.1600/036364409789271245; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Caddick LR, 2002, BOT J LINN SOC, V138, P123, DOI 10.1046/j.1095-8339.2002.138002123.x; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Cameron KM, 2006, CLADISTICS, V22, P239, DOI 10.1111/j.1096-0031.2006.00102.x; Chair H, 2005, GENOME, V48, P674, DOI 10.1139/G05-018; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, ANN BOT-LONDON, V104, P387, DOI 10.1093/aob/mcp067; Couvreur TLP, 2007, SYST BOT, V32, P519, DOI 10.1600/036364407782250526; Cozzolino S, 2003, J MOL EVOL, V57, pS41, DOI 10.1007/s00239-003-0006-3; Cozzolino S, 2003, MOL ECOL, V12, P2783, DOI 10.1046/j.1365-294X.2003.01958.x; Crisp MD, 2010, MOL PHYLOGENET EVOL, V54, P512, DOI 10.1016/j.ympev.2009.09.020; DUVALL MR, 1993, ANN MO BOT GARD, V80, P607, DOI 10.2307/2399849; Ebert D, 2009, MOL ECOL RESOUR, V9, P777, DOI 10.1111/j.1755-0998.2008.02320.x; Espindola A, 2010, BOT J LINN SOC, V163, P14, DOI 10.1111/j.1095-8339.2010.01049.x; EXCOFFIER L, 1994, GENETICS, V136, P343; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Goremykin V, 1996, MOL BIOL EVOL, V13, P383, DOI 10.1093/oxfordjournals.molbev.a025597; Graham Sean W., 2006, Aliso, V22, P3; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Heinze B, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-4; Hinchliff CE, 2009, AM J BOT, V96, P1487, DOI 10.3732/ajb.0800252; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Kennedy AH, 2010, SYST BOT, V35, P64, DOI 10.1600/036364410790862489; Kim KJ, 2005, MOL CELLS, V19, P104; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Ohi-Toma T, 2010, SYST BOT, V35, P244, DOI 10.1600/036364410791638315; OLMSTEAD RG, 1993, PLANT MOL BIOL, V22, P1191, DOI 10.1007/BF00028992; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Pintaud J. -C., 2008, P296; Pintaud Jean-Christophe, 2010, P267; Provan J, 2004, MOL ECOL NOTES, V4, P262, DOI 10.1111/j.1471-8286.2004.00636.x; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Roncal Julissa, 2010, P245; Rozen S, 2000, BIOINFORMATICS METHO; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Scarcelli N, 2006, MOL ECOL, V15, P2421, DOI 10.1111/j.1365-294X.2006.02958.x; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Smith CI, 2008, P ROY SOC B-BIOL SCI, V275, P249, DOI 10.1098/rspb.2007.1405; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Sun GL, 2009, BIOCHEM SYST ECOL, V37, P67, DOI 10.1016/j.bse.2008.12.002; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura MN, 2004, J PLANT RES, V117, P109, DOI 10.1007/s10265-003-0133-3; TERAUCHI R, 1992, THEOR APPL GENET, V83, P743, DOI 10.1007/BF00226693; Trenel P, 2007, MOL PHYLOGENET EVOL, V45, P272, DOI 10.1016/j.ympev.2007.03.018; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Yang JB, 2010, TAXON, V59, P1102, DOI 10.1002/tax.594010; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zeng CX, 2010, MOL PHYLOGENET EVOL, V56, P821, DOI 10.1016/j.ympev.2010.03.041; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	70	79	83	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19954	10.1371/journal.pone.0019954	http://dx.doi.org/10.1371/journal.pone.0019954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637837	Green Published, gold			2022-12-25	WOS:000291052200023
J	Yang, Q; Kapoula, Z				Yang, Qing; Kapoula, Zoi			Distinct Control of Initiation and Metrics of Memory-Guided Saccades and Vergence by the FEF: A TMS Study	PLOS ONE			English	Article							FRONTAL EYE FIELD; TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; CORTICAL CONTROL; AREA; MOVEMENT; NEURONS; CHILDREN; FEEDBACK; LATENCY	Background: The initiation of memory guided saccades is known to be controlled by the frontal eye field (FEF). Recent physiological studies showed the existence of an area close to FEF that controls also vergence initiation and execution. This study is to explore the effect of transcranial magnetic simulation (TMS) over FEF on the control of memory-guided saccade-vergence eye movements. Methodology/Principal Findings: Subjects had to make an eye movement in dark towards a target flashed 1 sec earlier (memory delay); the location of the target relative to fixation point was such as to require either a vergence along the median plane, or a saccade, or a saccade with vergence; trials were interleaved. Single pulse TMS was applied on the left or right FEF; it was delivered at 100 ms after the end of memory delay, i.e. extinction of fixation LED that was the "go" signal. Twelve healthy subjects participated in the study. TMS of left or right FEF prolonged the latency of all types of eye movements; the increase varied from 21 to 56 ms and was particularly strong for the divergence movements. This indicates that FEF is involved in the initiation of all types of memory guided movement in the 3D space. TMS of the FEF also altered the accuracy but only for leftward saccades combined with either convergence or divergence; intrasaccadic vergence also increased after TMS of the FEF. Conclusions/Significance: The results suggest anisotropy in the quality of space memory and are discussed in the context of other known perceptual motor anisotropies.	[Yang, Qing; Kapoula, Zoi] Hop Europeen Georges Pompidou, CNRS, UMR 8194, IRIS Grp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Yang, Q (corresponding author), Hop Europeen Georges Pompidou, CNRS, UMR 8194, IRIS Grp, Paris, France.	qing.yang@egp.aphp.fr						Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Busettini C, 2005, J NEUROPHYSIOL, V94, P2312, DOI 10.1152/jn.01337.2004; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191, DOI 10.1152/jn.1999.81.5.2191; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Evdokimidis I, 2001, COGNITIVE BRAIN RES, V12, P89, DOI 10.1016/S0926-6410(01)00037-4; Ferraina S, 2000, J NEUROPHYSIOL, V83, P625, DOI 10.1152/jn.2000.83.1.625; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Hausmann M, 2002, NEUROPSYCHOLOGIA, V40, P808, DOI 10.1016/S0028-3932(01)00179-8; JAMPEL RS, 1960, J COMP NEUROL, V115, P371, DOI 10.1002/cne.901150306; Kapoula Z, 2005, ANN NY ACAD SCI, V1039, P184, DOI 10.1196/annals.1325.018; Kapoula Z., 2008, J EYE MOVEMENT RES, V2, P1; Koch G, 2005, NEUROIMAGE, V24, P34, DOI 10.1016/j.neuroimage.2004.09.042; KROMMENHOEK KP, 1994, EXP BRAIN RES, V102, P95, DOI 10.1007/BF00232442; Kumar AN, 2005, ANN NY ACAD SCI, V1039, P466, DOI 10.1196/annals.1325.046; Kurkin S, 2003, ANN NY ACAD SCI, V1004, P262, DOI 10.1196/annals.1303.023; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MURI RM, 1991, EXP BRAIN RES, V86, P219; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Narayanan NS, 2005, NEUROPSYCHOLOGY, V19, P223, DOI 10.1037/0894-4105.19.2.223; Nyffeler T, 2004, EUR J NEUROSCI, V20, P2240, DOI 10.1111/j.1460-9568.2004.03667.x; OHTSUKA K, 1989, OPHTHALMOLOGICA, V198, P53, DOI 10.1159/000309959; OHTSUKA K, 1988, OPHTHALMOLOGICA, V197, P85, DOI 10.1159/000309925; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1993, EXP BRAIN RES, V95, P166; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; RIVAUD S, 1994, EXP BRAIN RES, V102, P110; Ro T, 2002, J CLIN EXP NEUROPSYC, V24, P930, DOI 10.1076/jcen.24.7.930.8385; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; TAKAGI M, 1995, VISION RES, V35, P3373, DOI 10.1016/0042-6989(95)00073-N; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Vernet M, 2008, INVEST OPHTH VIS SCI, V49, P230, DOI 10.1167/iovs.07-0854; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Yang Q, 2003, J VISION, V3, P554, DOI 10.1167/3.8.3; Yang Q, 2004, INVEST OPHTH VIS SCI, V45, P2231, DOI 10.1167/iovs.03-1291; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e20322	10.1371/journal.pone.0020322	http://dx.doi.org/10.1371/journal.pone.0020322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637804	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052200051
J	Krell, D; Assoku, M; Galloway, M; Mulholland, P; Tomlinson, I; Bardella, C				Krell, Daniel; Assoku, Mawuelikem; Galloway, Malcolm; Mulholland, Paul; Tomlinson, Ian; Bardella, Chiara			Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma	PLOS ONE			English	Article							NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; HELA-CELLS; GLIOMAS; 2-HYDROXYGLUTARATE; DIFFERENTIATION; SENSITIVITY; LEUKEMIA; ALPHA	Isocitrate dehydrogenases (IDHs) catalyse oxidative decarboxylation of isocitrate to a-ketoglutarate (a-KG). IDH1 functions in the cytosol and peroxisomes, whereas IDH2 and IDH3 are both localized in the mitochondria. Heterozygous somatic mutations in IDH1 occur at codon 132 in 70% of grade II-III gliomas and secondary glioblastomas (GBMs), and in 5% of primary GBMs. Mutations in IDH2 at codon 172 are present in grade II-III gliomas at a low frequency. IDH1 and IDH2 mutations cause both loss of normal enzyme function and gain-of-function, causing reduction of a-KG to D-2-hydroxyglutarate (D-2HG) which accumulates. Excess hydroxyglutarate (2HG) can also be caused by germline mutations in D-and L-2-hydroxyglutarate dehydrogenases (D2HGDH and L2HGDH). If loss of IDH function is critical for tumourigenesis, we might expect some tumours to acquire somatic IDH3 mutations. Alternatively, if 2HG accumulation is critical, some tumours might acquire somatic D2HGDH or L2HGDH mutations. We therefore screened 47 glioblastoma samples looking for changes in these genes. Although IDH1 R132H was identified in 12% of samples, no mutations were identified in any of the other genes. This suggests that mutations in IDH3, D2HGDH and L2HGDH do not occur at an appreciable frequency in GBM. One explanation is simply that mono-allelic IDH1 and IDH2 mutations occur more frequently by chance than the bi-allelic mutations expected at IDH3, D2HGDH and L2HGDH. Alternatively, both loss of IDH function and 2HG accumulation might be required for tumourigenesis, and only IDH1 and IDH2 mutations have these dual effects.	[Krell, Daniel; Assoku, Mawuelikem; Tomlinson, Ian; Bardella, Chiara] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England; [Krell, Daniel; Assoku, Mawuelikem; Mulholland, Paul] Univ Coll London Hosp, Dept Med Oncol, London, England; [Galloway, Malcolm] Royal Free Hosp, Dept Cellular Pathol, London NW3 2QG, England	University of Oxford; Wellcome Centre for Human Genetics; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Krell, D (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford, England.	chiara.bardella@well.ox.ac.uk	bardella, chiara/AAG-6272-2021	Mulholland, Paul/0000-0002-7926-824X; Bardella, Chiara/0000-0002-7780-2541	Oxford Comprehensive Biomedical Core (BRC); charity Mothers and Daughters; University College London Hospitals, Experimental Cancer Medicine Centre; Wellcome Trust [075491/Z/04]	Oxford Comprehensive Biomedical Core (BRC); charity Mothers and Daughters; University College London Hospitals, Experimental Cancer Medicine Centre; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Oxford Comprehensive Biomedical Core (BRC), the charity Mothers and Daughters, the University College London Hospitals, Experimental Cancer Medicine Centre, and a core centre grant from the Wellcome Trust (075491/Z/04). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; HASELBECK RJ, 1993, J BIOL CHEM, V268, P12116; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kil IS, 2007, FREE RADICAL BIO MED, V43, P1197, DOI 10.1016/j.freeradbiomed.2007.07.009; KLOOSTERHOF NK, 2010, LANCET ONCOL; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Lee SH, 2004, INT J RADIAT BIOL, V80, P635, DOI 10.1080/09553000400007680; Lee SM, 2009, FREE RADICAL RES, V43, P165, DOI 10.1080/10715760802653661; Minard KI, 1999, J BIOL CHEM, V274, P3402, DOI 10.1074/jbc.274.6.3402; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang ES, 2009, BIOCHIMIE, V91, P1020, DOI 10.1016/j.biochi.2009.05.008; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	24	59	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19868	10.1371/journal.pone.0019868	http://dx.doi.org/10.1371/journal.pone.0019868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625441	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005200018
J	Moncini, S; Salvi, A; Zuccotti, P; Viero, G; Quattrone, A; Barlati, S; De Petro, G; Venturin, M; Riva, P				Moncini, Silvia; Salvi, Alessandro; Zuccotti, Paola; Viero, Gabriella; Quattrone, Alessandro; Barlati, Sergio; De Petro, Giuseppina; Venturin, Marco; Riva, Paola			Role of miR-103 and miR-107 in Regulation of CDK5R1 Expression and in Cellular Migration	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL-SPECIFIC ACTIVATOR; MICRORNA EXPRESSION; NEURITE OUTGROWTH; MESSENGER-RNA; TAU-PROTEIN; MOUSE MODEL; GENES; P35; PRECURSOR	CDK5R1 encodes p35, a specific activator of the serine/threonine kinase CDK5, which plays crucial roles in CNS development and maintenance. CDK5 activity strongly depends on p35 levels and p35/CDK5 misregulation is deleterious for correct CNS function, suggesting that a tightly controlled regulation of CDK5R1 expression is needed for proper CDK5 activity. Accordingly, CDK5R1 expression was demonstrated to be controlled at both transcriptional and post-transcriptional levels, but a possible regulation through microRNAs (miRNAs) has never been investigated. We predicted, within the large CDK5R1 3'UTR several miRNA target sites. Among them, we selected for functional studies miR-103 and miR-107, whose expression has shown a strong inverse correlation with p35 levels in different cell lines. A significant reduction of CDK5R1 mRNA and p35 levels was observed after transfection of SK-N-BE neuroblastoma cells with the miR-103 or miR-107 precursor (pre-miR-103 or pre-miR-107). Conversely, p35 levels significantly increased following transfection of the corresponding antagonists (anti-miR-103 or anti-miR-107). Moreover, the level of CDK5R1 transcript shifts from the polysomal to the subpolysomal mRNA fraction after transfection with pre-miR-107 and, conversely, from the subpolysomal to the polysolmal mRNA fraction after transfection with anti-miR-107, suggesting a direct action on translation efficiency. We demonstrate, by means of luciferase assays, that miR-103 and miR-107 are able to directly interact with the CDK5R1 3'-UTR, in correspondence of a specific target site. Finally, miR-103 and miR-107 overexpression, as well as CDK5R1 silencing, caused a reduction in SK-N-BE migration ability, indicating that these miRNAs affect neuronal migration by modulating CDK5R1 expression. These findings indicate that miR-103 and miR-107 regulate CDK5R1 expression, allowing us to hypothesize that a miRNA-mediated mechanism may influence CDK5 activity and the associated molecular pathways.	[Moncini, Silvia; Zuccotti, Paola; Venturin, Marco; Riva, Paola] Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy; [Salvi, Alessandro; Barlati, Sergio; De Petro, Giuseppina] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Biol & Genet, Brescia, Italy; [Viero, Gabriella; Quattrone, Alessandro] Univ Trento, CIBIO, Trento, Italy; [Viero, Gabriella] CNR, Inst Biophys, Trento, Italy	University of Milan; University of Brescia; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Moncini, S (corresponding author), Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy.	paola.riva@unimi.it	Venturin, Marco/J-8735-2017; Riva, Paola/K-7871-2016; Salvi, Alessandro/AAB-7896-2019; Viero, Gabriella/G-2096-2012; De Petro, Giuseppina/C-2719-2011	Venturin, Marco/0000-0002-5871-9689; Riva, Paola/0000-0001-6481-8467; Salvi, Alessandro/0000-0001-6993-1565; Viero, Gabriella/0000-0002-6755-285X; De Petro, Giuseppina/0000-0001-9306-0851; Quattrone, Alessandro/0000-0003-3333-7630	Italian Ministry of the University and Research [2007MWCEAL_003]; Italian Found in Basic Research (FIRB) [RBFR0895DC]; MIUR, University of Brescia	Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Found in Basic Research (FIRB); MIUR, University of Brescia(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Italian Ministry of the University and Research by means of the following grants: Research Project of National Interest (PRIN contract number 2007MWCEAL_003 to PR, http://prin.miur.it/), Italian Found in Basic Research (FIRB contract number RBFR0895DC to MV, http://firb.miur.it/) and by local MIUR funds of the University of Brescia (to GDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bai Y, 2006, BBA-MOL CELL RES, V1763, P1076, DOI 10.1016/j.bbamcr.2006.08.009; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Humbert S, 2000, J CELL SCI, V113, P975; Jeong YG, 2003, NEUROSCIENCE, V118, P323, DOI 10.1016/S0306-4522(03)00002-2; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kuss AW, 2008, CURR NEUROL NEUROSCI, V8, P190, DOI 10.1007/s11910-008-0031-0; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI X, 2010, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934.2010.01194.X; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Moncini S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-111; Namgung U, 2004, MOL CELL NEUROSCI, V25, P422, DOI 10.1016/j.mcn.2003.11.005; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Paglini G, 2001, EMBO REP, V2, P1139, DOI 10.1093/embo-reports/kve250; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Szaro BG, 2010, TRENDS NEUROSCI, V33, P27, DOI 10.1016/j.tins.2009.10.002; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; UCHIDA T, 1994, FEBS LETT, V355, P35, DOI 10.1016/0014-5793(94)01163-X; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Venturin M, 2006, NEUROGENETICS, V7, P59, DOI 10.1007/s10048-005-0026-9; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Weishaupt JH, 2003, CELL TISSUE RES, V312, P1, DOI 10.1007/s00441-003-0703-7; Westmark PR, 2006, NEUROBIOL AGING, V27, P787, DOI 10.1016/j.neurobiolaging.2006.03.003; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang CX, 2009, CURR OPIN MOL THER, V11, P641; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	57	82	87	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20038	10.1371/journal.pone.0020038	http://dx.doi.org/10.1371/journal.pone.0020038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625387	Green Published, Green Submitted, gold			2022-12-25	WOS:000291005200026
J	Genovesio, A; Giardini, MA; Kwon, YJ; Dossin, FD; Choi, SY; Kim, NY; Kim, HC; Jung, SY; Schenkman, S; Almeida, IC; Emans, N; Freitas, LH				Genovesio, Auguste; Giardini, Miriam A.; Kwon, Yong-Jun; Dossin, Fernando de Macedo; Choi, Seo Yeon; Kim, Nam Youl; Kim, Hi Chul; Jung, Sung Yong; Schenkman, Sergio; Almeida, Igor C.; Emans, Neil; Freitas-Junior, Lucio H.			Visual Genome-Wide RNAi Screening to Identify Human Host Factors Required for Trypanosoma cruzi Infection	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; CHAGAS-DISEASE; MAMMALIAN-CELLS; SURFACE PROTEIN; GENE-EXPRESSION; E-CADHERIN; INVASION; RECEPTOR; BINDING; CA2+	The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a neglected tropical infection that affects millions of people in the Americas. Current chemotherapy relies on only two drugs that have limited efficacy and considerable side effects. Therefore, the development of new and more effective drugs is of paramount importance. Although some host cellular factors that play a role in T. cruzi infection have been uncovered, the molecular requirements for intracellular parasite growth and persistence are still not well understood. To further study these host-parasite interactions and identify human host factors required for T. cruzi infection, we performed a genome-wide RNAi screen using cellular microarrays of a printed siRNA library that spanned the whole human genome. The screening was reproduced 6 times and a customized algorithm was used to select as hits those genes whose silencing visually impaired parasite infection. The 162 strongest hits were subjected to a secondary screening and subsequently validated in two different cell lines. Among the fourteen hits confirmed, we recognized some cellular membrane proteins that might function as cell receptors for parasite entry and others that may be related to calcium release triggered by parasites during cell invasion. In addition, two of the hits are related to the TGF-beta signaling pathway, whose inhibition is already known to diminish levels of T. cruzi infection. This study represents a significant step toward unveiling the key molecular requirements for host cell invasion and revealing new potential targets for antiparasitic therapy.	[Genovesio, Auguste] Inst Pasteur Korea, Image Min Grp, Songnam, Gyeonggi Do, South Korea; [Giardini, Miriam A.; Dossin, Fernando de Macedo; Freitas-Junior, Lucio H.] Inst Pasteur Korea, Ctr Neglected Dis Drug Discovery, Songnam, Gyeonggi Do, South Korea; [Kwon, Yong-Jun; Choi, Seo Yeon; Kim, Nam Youl; Kim, Hi Chul; Jung, Sung Yong] Inst Pasteur Korea, Discovery Biol Grp, Songnam, Gyeonggi Do, South Korea; [Kwon, Yong-Jun] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Kwon, Yong-Jun] Yonsei Univ, Natl Res Lab, Seoul 120749, South Korea; [Schenkman, Sergio] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Emans, Neil] CSIR Biosci, Synthet Biol ERA, High Throughput Biol Grp, Pretoria, South Africa	Institut Pasteur Korea; Institut Pasteur Korea; Institut Pasteur Korea; Yonsei University; Yonsei University; Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas El Paso; Council for Scientific & Industrial Research (CSIR) - South Africa	Genovesio, A (corresponding author), Inst Pasteur Korea, Image Min Grp, Songnam, Gyeonggi Do, South Korea.	neiljemans@gmail.com; freitasjunior@ip-korea.org	Freitas-Junior, Lucio H/C-8677-2011; Schenkman, Sergio/A-9227-2013; Giardini, Miriam/GWM-6512-2022; Almeida, Igor C./AAF-9409-2019; Emans, Neil/H-4299-2011; Dossin, Fernando/D-1503-2011; GENOVESIO, Auguste/I-1656-2017	Freitas-Junior, Lucio H/0000-0002-8904-7897; Schenkman, Sergio/0000-0001-9353-8480; Almeida, Igor C./0000-0002-2443-8213; Giardini, Miriam A./0000-0002-6510-2409; Genovesio, Auguste/0000-0003-1877-5595	Korean Government (MEST) [K204EA000001-09E0100-00110]; FAPESP; CNPq (Brazil); NIH [2S06GM00812, 1R01AI070655, 5G12RR008124-16A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070655] Funding Source: NIH RePORTER	Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Korea Research Foundation Grant provided by the Korean Government (MEST) (project number K204EA000001-09E0100-00110). S.S. was supported by FAPESP and CNPq (Brazil). I.C.A. was supported by the NIH grants 2S06GM00812, 1R01AI070655 and 5G12RR008124-16A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Burleigh BA, 1998, CURR OPIN MICROBIOL, V1, P461, DOI 10.1016/S1369-5274(98)80066-0; Buscaglia CA, 2003, MICROBES INFECT, V5, P419, DOI 10.1016/S1286-4579(03)00050-9; Caler EV, 2000, INFECT IMMUN, V68, P6602, DOI 10.1128/IAI.68.12.6602-6610.2000; Campbell DA, 2004, CURR MOL MED, V4, P549, DOI 10.2174/1566524043360249; Castro JA, 2006, HUM EXP TOXICOL, V25, P471, DOI 10.1191/0960327106het653oa; Claser C, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-68; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Costales JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-252; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Docampo R, 1996, PARASITOL TODAY, V12, P61, DOI 10.1016/0169-4758(96)80656-9; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Erfle H, 2005, METHOD ENZYMOL, V404, P1, DOI 10.1016/S0076-6879(05)04001-2; Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Erfle Holger, 2007, Methods Mol Biol, V360, P155; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Hauck CR, 2002, MED MICROBIOL IMMUN, V191, P55, DOI 10.1007/s00430-002-0119-0; Imai K, 2005, MICROBIOL IMMUNOL, V49, P623, DOI 10.1111/j.1348-0421.2005.tb03654.x; Kleshchenko YY, 2004, INFECT IMMUN, V72, P6717, DOI 10.1128/IAI.72.11.6717-6721.2004; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Alves MJM, 2009, MEM I OSWALDO CRUZ, V104, P76, DOI 10.1590/S0074-02762009000900013; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Miles MA, 2009, PARASITOLOGY, V136, P1509, DOI 10.1017/S0031182009990977; MING M, 1995, CELL, V82, P287, DOI 10.1016/0092-8674(95)90316-X; MORENO SNJ, 1994, J EXP MED, V180, P1535, DOI 10.1084/jem.180.4.1535; Nde PN, 2006, INFECT IMMUN, V74, P1643, DOI 10.1128/IAI.74.3.1643-1648.2006; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2; OUAISSI MA, 1984, NATURE, V308, P380, DOI 10.1038/308380a0; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Shigihara T, 2008, PARASITOL RES, V102, P715, DOI 10.1007/s00436-007-0819-x; Simmons KJ, 2006, FEBS LETT, V580, P2365, DOI 10.1016/j.febslet.2006.03.054; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Soler AP, 2001, HUM PATHOL, V32, P149, DOI 10.1053/hupa.2001.21562; TARDIEUX I, 1994, J EXP MED, V179, P1017, DOI 10.1084/jem.179.3.1017; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; VELGE P, 1988, PARASITOLOGY, V97, P255, DOI 10.1017/S0031182000058467; VILLALTA F, 1993, MOL BIOCHEM PARASIT, V61, P217, DOI 10.1016/0166-6851(93)90068-9; Villalta F, 2008, FRONT BIOSCI-LANDMRK, V13, P3714, DOI 10.2741/2961; Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	60	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19733	10.1371/journal.pone.0019733	http://dx.doi.org/10.1371/journal.pone.0019733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625474	gold, Green Published, Green Submitted			2022-12-25	WOS:000290793400009
J	Zvi, A; Rotem, S; Bar-Haim, E; Cohen, O; Shafferman, A				Zvi, Anat; Rotem, Shahar; Bar-Haim, Erez; Cohen, Ofer; Shafferman, Avigdor			Whole-Genome Immunoinformatic Analysis of F. tularensis: Predicted CTL Epitopes Clustered in Hotspots Are Prone to Elicit a T-Cell Response	PLOS ONE			English	Article							VACCINE DEVELOPMENT; HIV ENVELOPE; IDENTIFICATION; TULAREMIA; REGIONS; PROTEIN; CANDIDATES; PEPTIDES; ANTIGENS; VIRUS	The cellular arm of the immune response plays a central role in the defense against intracellular pathogens, such as F. tularensis. To date, whole genome immunoinformatic analyses were limited either to relatively small genomes (e.g. viral) or to preselected subsets of proteins in complex pathogens. Here we present, for the first time, an unbiased bacterial global immunoinformatic screen of the 1740 proteins of F. tularensis subs. holarctica (LVS), aiming at identification of immunogenic peptides eliciting a CTL response. The very large number of predicted MHC class I binders (about 100,000, IC(50) of 1000 nM or less) required the design of a strategy for further down selection of CTL candidates. The approach developed focused on mapping clusters rich in overlapping predicted epitopes, and ranking these "hotspot'' regions according to the density of putative binding epitopes. Limited by the experimental load, we selected to screen a library of 1240 putative MHC binders derived from 104 top-ranking highly dense clusters. Peptides were tested for their ability to stimulate IFN gamma secretion from splenocytes isolated from LVS vaccinated C57BL/6 mice. The majority of the clusters contained one or more CTL responder peptides and altogether 127 novel epitopes were identified, of which 82 are non-redundant. Accordingly, the level of success in identification of positive CTL responders was 17-25 fold higher than that found for a randomly selected library of 500 predicted MHC binders (IC(50) of 500 nM or less). Most proteins (ca. 2/3) harboring the highly dense hotspots are membrane-associated. The approach for enrichment of true positive CTL epitopes described in this study, which allowed for over 50% increase in the dataset of known T-cell epitopes of F. tularensis, could be applied in immunoinformatic analyses of many other complex pathogen genomes.	[Zvi, Anat; Rotem, Shahar; Bar-Haim, Erez; Cohen, Ofer; Shafferman, Avigdor] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Zvi, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	avigdor@iibr.gov.il	Bar-Haim, Erez/AAA-6444-2020	Bar-Haim, Erez/0000-0003-3435-8599	IIBR	IIBR	The study was funded by the IIBR research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambini S, 2009, DRUG DISCOV TODAY, V14, P252, DOI 10.1016/j.drudis.2008.12.007; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140; Chakravarti DN, 2000, VACCINE, V19, P601, DOI 10.1016/S0264-410X(00)00256-5; Chitlaru T, 2009, FUTURE MICROBIOL, V4, P983, DOI [10.2217/fmb.09.73, 10.2217/FMB.09.73]; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan W, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P213, DOI 10.1007/978-90-481-9054-6_23; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Davies V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006948; Ginodi I, 2008, BIOINFORMATICS, V24, P477, DOI 10.1093/bioinformatics/btm616; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hepburn MJ, 2008, EXPERT REV ANTI-INFE, V6, P231, DOI 10.1586/14787210.6.2.231; Huster KM, 2006, CURR OPIN IMMUNOL, V18, P458, DOI 10.1016/j.coi.2006.05.008; Kim SK, 2001, CURR OPIN IMMUNOL, V13, P429, DOI 10.1016/S0952-7915(00)00237-5; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lucchiari-Hartz M, 2003, P NATL ACAD SCI USA, V100, P7755, DOI 10.1073/pnas.1232228100; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2006, TRENDS BIOTECHNOL, V24, P537, DOI 10.1016/j.tibtech.2006.10.001; Lundegaard Claus, 2010, Immunome Res, V6 Suppl 2, pS3, DOI 10.1186/1745-7580-6-S2-S3; Lundegaard C, 2010, IMMUNOLOGY, V130, P309, DOI 10.1111/j.1365-2567.2010.03300.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mann BJ, 2009, EXPERT REV VACCINES, V8, P877, DOI [10.1586/erv.09.51, 10.1586/ERV.09.51]; McMurry JA, 2007, CURR MOL MED, V7, P351, DOI 10.2174/156652407780831584; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; McMurry Julie A, 2007, Med Health R I, V90, P311; Moise L, 2008, HUM VACCINES, V4, P219, DOI 10.4161/hv.4.3.5394; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Schmid BV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-184; Seder RA, 2000, NATURE, V406, P793, DOI 10.1038/35021239; SETTE A, 1994, J IMMUNOL, V153, P5586; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Shafferman A, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P295, DOI 10.1007/978-90-481-9054-6_32; Shankar P, 1996, IMMUNOL LETT, V52, P23, DOI 10.1016/0165-2478(96)02574-6; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Surman S, 2001, P NATL ACAD SCI USA, V98, P4587, DOI 10.1073/pnas.071063898; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Valmori D, 2007, CLIN IMMUNOL, V122, P163, DOI 10.1016/j.clim.2006.09.005; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002; Zvi A, 2010, CHALLENGE OF HIGHLY PATHOGENIC MICROORGANISMS: MECHANISMS OF VIRULENCE AND NOVEL MEDICAL COUNTERMEASURES, P229, DOI 10.1007/978-90-481-9054-6_25	57	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20050	10.1371/journal.pone.0020050	http://dx.doi.org/10.1371/journal.pone.0020050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625462	Green Submitted, gold, Green Published			2022-12-25	WOS:000290793400037
J	Bell, SL; Chiang, AN; Brodsky, JL				Bell, Samantha L.; Chiang, Annette N.; Brodsky, Jeffrey L.			Expression of a Malarial Hsp70 Improves Defects in Chaperone-Dependent Activities in ssa1 Mutant Yeast	PLOS ONE			English	Article							SHOCK-PROTEIN COMPLEMENTS; PLASMODIUM-FALCIPARUM; MOLECULAR CHAPERONES; IMMUNOSUPPRESSANT DEOXYSPERGUALIN; FUNCTIONAL INTERACTION; TRANSLOCATION; PARASITE; HEAT-SHOCK-PROTEIN-70; DEGRADATION; HSC70	Plasmodium falciparum causes the most virulent form of malaria and encodes a large number of molecular chaperones. Because the parasite encounters radically different environments during its lifecycle, many members of this chaperone ensemble may be essential for P. falciparum survival. Therefore, Plasmodium chaperones represent novel therapeutic targets, but to establish the mechanism of action of any developed therapeutics, it is critical to ascertain the functions of these chaperones. To this end, we report the development of a yeast expression system for PfHsp70-1, a P. falciparum cytoplasmic chaperone. We found that PfHsp70-1 repairs mutant growth phenotypes in yeast strains lacking the two primary cytosolic Hsp70s, SSA1 and SSA2, and in strains harboring a temperature sensitive SSA1 allele. PfHsp70-1 also supported chaperone-dependent processes such as protein translocation and ER associated degradation, and ameliorated the toxic effects of oxidative stress. By introducing engineered forms of PfHsp70-1 into the mutant strains, we discovered that rescue requires PfHsp70-1 ATPase activity. Together, we conclude that yeast can be co-opted to rapidly uncover specific cellular activities mediated by malarial chaperones.	[Bell, Samantha L.; Chiang, Annette N.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bell, SL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Bell, Samantha L./AAZ-3080-2021	Bell, Samantha L./0000-0002-5453-3203	National Institutes of Health [GM75061]; Howard Hughes Medical Institute; Chancellor's Undergraduate Research Fellowship; University of Pittsburgh; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chancellor's Undergraduate Research Fellowship; University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grant GM75061 (http://www.nih.gov/), a Howard Hughes Medical Institute Undergraduate Research Fellowship (to the Department of Biological Sciences at the University of Pittsburgh; http://www.hhmi.org/grants/institutions/colleges.html), a Chancellor's Undergraduate Research Fellowship and the Horowitz Fellowship (University of Pittsburgh, http://www.pitt.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Agarwal M, 2003, PLANT MOL BIOL, V51, P543, DOI 10.1023/A:1022324920316; ANG D, 1991, J BIOL CHEM, V266, P24233; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Baxter BK, 1998, CURR GENET, V33, P412, DOI 10.1007/s002940050354; Becker J, 1996, MOL CELL BIOL, V16, P4378; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; BOTHA M, 2011, CELL STRESS IN PRESS; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Brodsky JL, 1999, BIOCHEM PHARMACOL, V57, P877, DOI 10.1016/S0006-2952(98)00376-1; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chiang AN, 2009, BIOORGAN MED CHEM, V17, P1527, DOI 10.1016/j.bmc.2009.01.024; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hundley HA, 2005, SCIENCE, V308, P1032, DOI 10.1126/science.1109247; HUNT NH, 1990, BLOOD CELLS, V16, P499; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; LEE YRJ, 1994, PLANT CELL, V6, P1889, DOI 10.1105/tpc.6.12.1889; Leng CH, 1998, PROTEIN SCI, V7, P1186, DOI 10.1002/pro.5560070513; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McClellan AJ, 2000, GENETICS, V156, P501; Midorikawa Y, 1998, CHEMOTHERAPY, V44, P409, DOI 10.1159/000007152; Misra G, 2009, BIOPHYS CHEM, V142, P55, DOI 10.1016/j.bpc.2009.03.006; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munder T, 1999, APPL MICROBIOL BIOT, V52, P311, DOI 10.1007/s002530051525; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; NELSON RJ, 1992, GENETICS, V131, P277; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Ramya TNC, 2007, J BIOL CHEM, V282, P6388, DOI 10.1074/jbc.M610251200; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHIRMER EC, 1994, PLANT CELL, V6, P1899, DOI 10.1105/tpc.6.12.1899; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; SHARMA YD, 1992, COMP BIOCHEM PHYS B, V102, P437, DOI 10.1016/0305-0491(92)90033-N; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; SIKORSKI RS, 1989, GENETICS, V122, P19; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; STONE DE, 1990, MOL CELL BIOL, V10, P1622, DOI 10.1128/MCB.10.4.1622; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonkin CJ, 2006, CURR OPIN MICROBIOL, V9, P381, DOI 10.1016/j.mib.2006.06.015; Toovey S, 2009, TRAVEL MED INFECT DI, V7, P2, DOI 10.1016/j.tmaid.2008.12.004; Tutar Y, 2006, GENETICS, V172, P851, DOI 10.1534/genetics.105.048926; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Wright CM, 2007, GENETICS, V175, P1649, DOI 10.1534/genetics.106.066274; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	71	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20047	10.1371/journal.pone.0020047	http://dx.doi.org/10.1371/journal.pone.0020047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625512	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000290771200042
J	Gal-Mor, O; Elhadad, D; Deng, WY; Rahav, G; Finlay, BB				Gal-Mor, Ohad; Elhadad, Dana; Deng, Wanyin; Rahav, Galia; Finlay, Brett B.			The Salmonella enterica PhoP Directly Activates the Horizontally Acquired SPI-2 Gene sseL and Is Functionally Different from a S. bongori Ortholog	PLOS ONE			English	Article							III SECRETION SYSTEM; HELIX TRANSCRIPTION FACTORS; ESCHERICHIA-COLI K-12; PATHOGENICITY ISLAND-2; 2-COMPONENT SYSTEM; MOLECULAR CHARACTERIZATION; HOST-CELLS; SEROVAR TYPHIMURIUM; SSRA-SSRB; VIRULENCE	To establish a successful infection within the host, a pathogen must closely regulate multiple virulence traits to ensure their accurate temporal and spatial expression. As a highly adapted intracellular pathogen, Salmonella enterica has acquired during its evolution various virulence genes via numerous lateral transfer events, including the acquisition of the Salmonella Pathogenicity Island 2 (SPI-2) and its associated effectors. Beneficial use of horizontally acquired genes requires that their expression is effectively coordinated with the already existing virulence programs and the regulatory set-up in the bacterium. As an example for such a mechanism, we show here that the ancestral PhoPQ system of Salmonella enterica is able to regulate directly the SPI-2 effector gene sseL (encoding a secreted deubiquitinase) in an SsrB-independent manner and that PhoP plays a part in a feed-forward regulatory loop, which fine-tunes the cellular level of SseL. Additionally, we demonstrate the presence of conserved cis regulatory elements in the promoter region of sseL and show direct binding of purified PhoP to this region. Interestingly, in contrast to the S. enterica PhoP, an ortholog regulator from a S. bongori SARC 12 strain was found to be impaired in promoting transcription of sseL and other genes from the PhoP regulon. These findings have led to the identification of a previously uncharacterized residue in the DNA-binding domain of PhoP, which is required for the transcriptional activation of PhoP regulated genes in Salmonella spp. Collectively our data demonstrate an interesting interface between the acquired SsrB regulon and the ancestral PhoPQ regulatory circuit, provide novel insights into the function of PhoP, and highlight a mechanism of regulatory integration of horizontally acquired genes into the virulence network of Salmonella enterica.	[Gal-Mor, Ohad; Elhadad, Dana; Rahav, Galia] Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel; [Gal-Mor, Ohad; Deng, Wanyin; Finlay, Brett B.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Elhadad, Dana; Rahav, Galia] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; University of British Columbia; Tel Aviv University; Sackler Faculty of Medicine	Gal-Mor, O (corresponding author), Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel.	Ohad.Gal-Mor@sheba.health.gov.il	Gal-Mor, Ohad/U-5025-2017	Gal-Mor, Ohad/0000-0002-2540-6790	Michael Smith Foundation for Health Research (MSFHR); Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Ferring Pharmaceuticals; European Community [PF7/2007-2013, 249241]; Israeli Ministry of Health; CIHR; Howard Hughes Medical Institute	Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Ferring Pharmaceuticals(Canadian Institutes of Health Research (CIHR)); European Community(European Commission); Israeli Ministry of Health; CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	OG was supported by postdoctoral fellowships from the Michael Smith Foundation for Health Research (MSFHR) and the Canadian Association of Gastroenterology/Canadian Institutes of Health Research/Ferring Pharmaceuticals. Research in OG's laboratory is supported by grants from the European Community's Seventh Framework Program (PF7/2007-2013) under grant agreement no. 249241 and from the Chief Scientist of the Israeli Ministry of Health. Work in BBF's laboratory was supported by grants from CIHR and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Boyd EF, 1996, APPL ENVIRON MICROB, V62, P804, DOI 10.1128/AEM.62.3.804-808.1996; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Coombes BK, 2007, INFECT IMMUN, V75, P574, DOI 10.1128/IAI.00985-06; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ehrbar Kristin, 2005, Infection Genetics and Evolution, V5, P1; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunn JS, 1998, MICROB PATHOGENESIS, V25, P77, DOI 10.1006/mpat.1998.0217; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; KASAHARA M, 1992, J BACTERIOL, V174, P492, DOI 10.1128/jb.174.2.492-498.1992; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; KONG W, 2008, J BIOL CHEM; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miller JH, 1972, EXPT MOL BIOL; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Munson GP, 2000, MOL MICROBIOL, V36, P1391, DOI 10.1046/j.1365-2958.2000.01957.x; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; SCHEERENGROOT EP, 1994, J BACTERIOL, V176, P6418, DOI 10.1128/JB.176.21.6418-6426.1994; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Xu X, 2010, INFECT IMMUN, V78, P49, DOI 10.1128/IAI.00931-09; Yamamoto K, 2002, MOL MICROBIOL, V45, P423, DOI 10.1046/j.1365-2958.2002.03017.x; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	61	11	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20024	10.1371/journal.pone.0020024	http://dx.doi.org/10.1371/journal.pone.0020024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625519	Green Submitted, gold, Green Published			2022-12-25	WOS:000290771200041
J	Gao, XC; Zhou, CJ; Zhou, ZR; Zhang, YH; Zheng, XM; Song, AX; Hu, HY				Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Zhang, Yu-Hang; Zheng, Xue-Ming; Song, Ai-Xin; Hu, Hong-Yu			Co-Chaperone HSJ1a Dually Regulates the Proteasomal Degradation of Ataxin-3	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; UBIQUITIN-DEPENDENT DEGRADATION; MACHADO-JOSEPH-DISEASE; NITRIC-OXIDE SYNTHASE; HSP70 ATPASE ACTIVITY; MOLECULAR CHAPERONES; J-DOMAIN; CHIP; AGGREGATION; LIGASE	Homo sapiens J domain protein (HSJ1) is a J-domain containing co-chaperone that is known to stimulate ATPase activity of HSP70 chaperone, while it also harbors two ubiquitin (Ub)-interacting motifs (UIMs) that may bind with ubiquitinated substrates and potentially function in protein degradation. We studied the effects of HSJ1a on the protein levels of both normal and the disease-related polyQ-expanded forms of ataxin-3 (Atx3) in cells. The results demonstrate that the N-terminal J-domain and the C-terminal UIM domain of HSJ1a exert opposite functions in regulating the protein level of cellular overexpressed Atx3. This dual regulation is dependent on the binding of the J-domain with HSP70, and the UIM domain with polyUb chains. The J-domain down-regulates the protein level of Atx3 through HSP70 mediated proteasomal degradation, while the UIM domain may alleviate this process via maintaining the ubiquitinated Atx3. We propose that cochaperone HSJ1a orchestrates the balance of substrates in stressed cells in a Yin-Yang manner.	[Gao, Xue-Chao; Zhou, Chen-Jie; Zhou, Zi-Ren; Zhang, Yu-Hang; Zheng, Xue-Ming; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gao, XC (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	hyhu@sibs.ac.cn	Hu, Hong-Yu/AAQ-2633-2020; Chou, Steven Ziren/M-1995-2014		National Basic Research Program of China [2006CB910305]; Sino Swiss Science and Technology Cooperation Program [GJHZ0909]; National Natural Science Foundation of China [30670431, 10979070]	National Basic Research Program of China(National Basic Research Program of China); Sino Swiss Science and Technology Cooperation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (2006CB910305), the Sino Swiss Science and Technology Cooperation Program (GJHZ0909), and the National Natural Science Foundation of China (30670431 and 10979070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chai YH, 1999, J NEUROSCI, V19, P10338; CHEETHAM ME, 1992, BIOCHEM J, V284, P469, DOI 10.1042/bj2840469; CHEETHAM ME, 1994, EUR J BIOCHEM, V226, P99, DOI 10.1111/j.1432-1033.1994.tb20030.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fei EK, 2007, BIOCHEM BIOPH RES CO, V357, P487, DOI 10.1016/j.bbrc.2007.03.160; Gao XC, 2008, ACTA BIOCH BIOPH SIN, V40, P612, DOI 10.1111/j.1745-7270.2008.00441.x; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; HABERHAUSEN G, 1995, J NEUROL SCI, V132, P71, DOI 10.1016/0022-510X(95)90927-I; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Malgaroli A, 2006, CURR OPIN NEUROBIOL, V16, P270, DOI 10.1016/j.conb.2006.05.009; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schnaider T, 2000, LIFE SCI, V67, P1455, DOI 10.1016/S0024-3205(00)00735-9; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; SONG AX, PLOS ONE, V5; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; Westhoff B, 2005, CURR BIOL, V15, P1058, DOI 10.1016/j.cub.2005.04.058; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; ZIJLSTRA MP, EUR J NEUROSCI	58	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19763	10.1371/journal.pone.0019763	http://dx.doi.org/10.1371/journal.pone.0019763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625540	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200020
J	Wacklin, P; Makivuokko, H; Alakulppi, N; Nikkila, J; Tenkanen, H; Rabina, J; Partanen, J; Aranko, K; Matto, J				Wacklin, Pirjo; Makivuokko, Harri; Alakulppi, Noora; Nikkila, Janne; Tenkanen, Heli; Rabina, Jarkko; Partanen, Jukka; Aranko, Kari; Matto, Jaana			Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA; BLOOD-GROUP; FECAL MICROBIOTA; CROHNS-DISEASE; SUSCEPTIBILITY; IMPACT; PCR; PHENOTYPE; INFECTION	Intestinal microbiota plays an important role in human health, and its composition is determined by several factors, such as diet and host genotype. However, thus far it has remained unknown which host genes are determinants for the microbiota composition. We studied the diversity and abundance of dominant bacteria and bifidobacteria from the faecal samples of 71 healthy individuals. In this cohort, 14 were non-secretor individuals and the remainders were secretors. The secretor status is defined by the expression of the ABH and Lewis histo-blood group antigens in the intestinal mucus and other secretions. It is determined by fucosyltransferase 2 enzyme, encoded by the FUT2 gene. Non-functional enzyme resulting from a nonsense mutation in the FUT2 gene leads to the non-secretor phenotype. PCR-DGGE and qPCR methods were applied for the intestinal microbiota analysis. Principal component analysis of bifidobacterial DGGE profiles showed that the samples of non-secretor individuals formed a separate cluster within the secretor samples. Moreover, bifidobacterial diversity (p < 0.0001), richness (p < 0.0003), and abundance (p < 0.05) were significantly reduced in the samples from the nonsecretor individuals as compared with those from the secretor individuals. The non-secretor individuals lacked, or were rarely colonized by, several genotypes related to B. bifidum, B. adolescentis and B. catenulatum/pseudocatenulatum. In contrast to bifidobacteria, several bacterial genotypes were more common and the richness (p < 0.04) of dominant bacteria as detected by PCR-DGGE was higher in the non-secretor individuals than in the secretor individuals. We showed that the diversity and composition of the human bifidobacterial population is strongly associated with the histo-blood group ABH secretor/non-secretor status, which consequently appears to be one of the host genetic determinants for the composition of the intestinal microbiota. This association can be explained by the difference between the secretor and non-secretor individuals in their expression of ABH and Lewis glycan epitopes in the mucosa.	[Wacklin, Pirjo; Makivuokko, Harri; Alakulppi, Noora; Nikkila, Janne; Tenkanen, Heli; Rabina, Jarkko; Partanen, Jukka; Aranko, Kari; Matto, Jaana] Finnish Red Cross Blood Serv, Helsinki, Finland		Wacklin, P (corresponding author), Finnish Red Cross Blood Serv, Helsinki, Finland.	pirjo.wacklin@bts.redcross.fi	Partanen, Jukka/B-7207-2014; Alakulppi, Noora/D-7839-2015	Partanen, Jukka/0000-0001-6681-4734; Alakulppi, Noora/0000-0002-2292-9342				Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Boesten RJ, 2008, J CLIN GASTROENTEROL, V42, pS163, DOI 10.1097/MCG.0b013e31817dbd62; Brenner DM, 2009, REV GASTROENTEROL DI, V9, P7; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Chouraqui JP, 2004, J PEDIATR GASTR NUTR, V38, P288, DOI 10.1097/00005176-200403000-00011; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Hurd EA, 2004, INFECT IMMUN, V72, P4279, DOI 10.1128/IAI.72.7.4279-4281.2004; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; KINANE DF, 1982, BRIT MED J, V285, P7, DOI 10.1136/bmj.285.6334.7; Kirjavainen PV, 2009, CLIN VACCINE IMMUNOL, V16, P29, DOI 10.1128/CVI.00323-08; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Larsson MM, 2006, J INFECT DIS, V194, P1422, DOI 10.1086/508430; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Macfarlane GT, 2009, CURR PHARM DESIGN, V15, P1528, DOI 10.2174/138161209788168146; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Matto J, 2005, FEMS IMMUNOL MED MIC, V43, P213, DOI 10.1016/j.femsim.2004.08.009; Matto J, 2004, J APPL MICROBIOL, V97, P459, DOI 10.1111/j.1365-2672.2004.02340.x; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Morrow AL, 2010, FASEB J, V24; Moulds JM, 1996, TRANSFUSION, V36, P362, DOI 10.1046/j.1537-2995.1996.36496226154.x; Nubel U, 1996, J BACTERIOL, V178, P5636; RAJILICSTOJANOV.M, 2007, THESIS WAGENINGENUNI; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Silva LM, 2010, GLYCOCONJUGATE J, V27, P61, DOI 10.1007/s10719-009-9255-8; THORN SM, 1989, FEMS MICROBIOL IMMUN, V47, P401; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, FRONT BIOSCI-LANDMRK, V14, P4673, DOI 10.2741/3559; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	46	181	193	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e20113	10.1371/journal.pone.0020113	http://dx.doi.org/10.1371/journal.pone.0020113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625510	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200049
J	Guryanova, OA; Drazba, JA; Frolova, EI; Chumakov, PM				Guryanova, Olga A.; Drazba, Judith A.; Frolova, Elena I.; Chumakov, Peter M.			Actin Cytoskeleton Remodeling by the Alternatively Spliced Isoform of PDLIM4/RIL Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-LIM PROTEIN; 20S PROTEASOMAL DEGRADATION; KLF6 TUMOR-SUPPRESSOR; ALPHA-ACTININ; DOMAIN PROTEIN; QUINONE OXIDOREDUCTASE-1; ORNITHINE-DECARBOXYLASE; CAENORHABDITIS-ELEGANS; ENDOTHELIAL-CELLS; HEART DEVELOPMENT	RIL (product of PDLIM4 gene) is an actin-associated protein that has previously been shown to stimulate actin bundling by interacting with actin-cross-linking protein alpha-actinin-1 and increasing its affinity to filamentous actin. Here, we report that the alternatively spliced isoform of RIL, denoted here as RILaltCterm, functions as a dominant-negative modulator of RIL-mediated actin reorganization. RILaltCterm is regulated at the level of protein stability, and this protein isoform accumulates particularly in response to oxidative stress. We show that the alternative C-terminal segment of RILaltCterm has a disordered structure that directs the protein to rapid degradation in the core 20 S proteasomes. Such degradation is ubiquitin-independent and can be blocked by binding to NAD(P) H quinone oxidoreductase NQO1, a detoxifying enzyme induced by prolonged exposure to oxidative stress. We show that either overexpression of RILaltCterm or its stabilization by stresses counteracts the effects produced by full-length RIL on organization of actin cytoskeleton and cell motility. Taken together, the data suggest a mechanism for fine-tuning actin cytoskeleton rearrangement in response to stresses.	[Guryanova, Olga A.; Drazba, Judith A.; Chumakov, Peter M.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Guryanova, Olga A.; Frolova, Elena I.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Chumakov, Peter M.] VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Chumakov, Peter M.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Cleveland Clinic Foundation; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Novosibirsk State University	Chumakov, PM (corresponding author), 9500 Euclid Ave,Mail Code NE20, Cleveland, OH 44195 USA.	chumakp@ccf.org	Chumakov, Peter M/E-7731-2014	Chumakov, Peter/0000-0002-8078-2908; Guryanova, Olga/0000-0002-6514-8466	National Institutes of Health [R01 CA104903, AG025276]; Howard Hughes Medical Institute [55005603]; Russian Foundation for Basic Research [08-04-00686a, 11-04-01210]; Government of Russian Federation [11.G34.31.0034]; Russian Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA104903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Government of Russian Federation; Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA104903 and AG025276 (to P. M. C.). This work was also supported by Howard Hughes Medical Institute Grant 55005603 (to P. M. C.), Russian Foundation for Basic Research Grants 08-04-00686a (to P. M. C.) and 11-04-01210 (to E. I. F.), a grant from the Russian Academy of Sciences Program on Molecular and Cellular Biology (to P. M. C.), and Government of Russian Federation Grant 11.G34.31.0034 (to P. M. C.).	Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Au YH, 2004, STRUCTURE, V12, P611, DOI 10.1016/j.str.2004.02.019; Bashirova AA, 1998, GENE, V210, P239, DOI 10.1016/S0378-1119(98)00080-8; Bauer K, 2000, BLOOD, V96, P4236; Begleiter A, 2004, METHOD ENZYMOL, V382, P320; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Benna C, 2009, CELL TISSUE RES, V337, P463, DOI 10.1007/s00441-009-0813-y; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Bordone L, 2002, J BIOL CHEM, V277, P26673, DOI 10.1074/jbc.M112037200; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; Fu SL, 2000, ONCOGENE, V19, P3537, DOI 10.1038/sj.onc.1203691; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Gonzalez-Juarrero M, 2009, AM J RESP CELL MOL, V40, P398, DOI 10.1165/rcmb.2008-0248OC; Gur'ianova O A, 2006, Mol Biol (Mosk), V40, P448; Guy PM, 1999, MOL BIOL CELL, V10, P1973, DOI 10.1091/mbc.10.6.1973; Han HF, 2009, MOL BIOL CELL, V20, P2361, DOI 10.1091/mbc.E08-06-0584; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; He ML, 2009, PROSTATE, V69, P1643, DOI 10.1002/pros.21013; Herrick S, 2010, MOL CELL NEUROSCI, V43, P188, DOI 10.1016/j.mcn.2009.10.009; Huang CQ, 2003, J BIOL CHEM, V278, P7360, DOI 10.1074/jbc.M211875200; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Kesari A, 2008, AM J PATHOL, V173, P1476, DOI 10.2353/ajpath.2008.080098; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Klaavuniemi T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-22; Kotaka M, 2000, J CELL BIOCHEM, V78, P558, DOI 10.1002/1097-4644(20000915)78:4<558::AID-JCB5>3.0.CO;2-I; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; Mazurek N, 2005, CANCER RES, V65, P10767, DOI 10.1158/0008-5472.CAN-04-3333; McKeown CR, 2006, DEV DYNAM, V235, P530, DOI 10.1002/dvdy.20633; Mills JC, 2001, P NATL ACAD SCI USA, V98, P13687, DOI 10.1073/pnas.231332398; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Nakagawa N, 2000, BIOCHEM BIOPH RES CO, V272, P505, DOI 10.1006/bbrc.2000.2787; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Pomies P, 1999, J BIOL CHEM, V274, P29242, DOI 10.1074/jbc.274.41.29242; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schulz TW, 2004, J NEUROSCI, V24, P8584, DOI 10.1523/JNEUROSCI.2100-04.2004; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Szpirer C, 1996, MAMM GENOME, V7, P701, DOI 10.1007/s003359900211; Talalay P, 2004, METHOD ENZYMOL, V382, P355; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; Thurau M, 2009, J VIROL, V83, P598, DOI 10.1128/JVI.00629-08; Torrado M, 2004, INVEST OPHTH VIS SCI, V45, P3955, DOI 10.1167/iovs.04-0721; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009; Yamazaki T, 2010, CARDIOVASC RES, V86, P374, DOI 10.1093/cvr/cvq023; Yea S, 2008, GASTROENTEROLOGY, V134, P1521, DOI 10.1053/j.gastro.2008.02.015; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	79	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26849	26859		10.1074/jbc.M111.241554	http://dx.doi.org/10.1074/jbc.M111.241554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21636573	hybrid, Green Published			2022-12-25	WOS:000293078200060
J	Storbeck, S; Saha, S; Krausze, J; Klink, BU; Heinz, DW; Layer, G				Storbeck, Sonja; Saha, Sayantan; Krausze, Joern; Klink, Bjoern U.; Heinz, Dirk W.; Layer, Gunhild			Crystal Structure of the Heme d(1) Biosynthesis Enzyme NirE in Complex with Its Substrate Reveals New Insights into the Catalytic Mechanism of S-Adenosyl-L-methionine-dependent Uroporphyrinogen III Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSG GENE ENCODES; ESCHERICHIA-COLI; TETRAPYRROLE BIOSYNTHESIS; MULTIFUNCTIONAL PROTEIN; SIROHEME BIOSYNTHESIS; C-METHYLTRANSFERASE; SYNTHASE; PURIFICATION; METHYLASE; VITAMIN-B12	During the biosynthesis of heme d(1), the essential cofactor of cytochrome cd(1) nitrite reductase, the NirE protein catalyzes the methylation of uroporphyrinogen III to precorrin-2 using S-adenosyl- L-methionine (SAM) as the methyl group donor. The crystal structure of Pseudomonas aeruginosa NirE in complex with its substrate uroporphyrinogen III and the reaction by-product S-adenosyl-L-homocysteine (SAH) was solved to 2.0 angstrom resolution. This represents the first enzyme-substrate complex structure for a SAM-dependent uroporphyrinogen III methyltransferase. The large substrate binds on top of the SAH in a "puckered" conformation in which the two pyrrole rings facing each other point into the same direction either upward or downward. Three arginine residues, a histidine, and a methionine are involved in the coordination of uroporphyrinogen III. Through site-directed mutagenesis of the nirE gene and biochemical characterization of the corresponding NirE variants the amino acid residues Arg-111, Glu-114, and Arg-149 were identified to be involved in NirE catalysis. Based on our structural and biochemical findings, we propose a potential catalytic mechanism for NirE in which the methyl transfer reaction is initiated by an arginine catalyzed proton abstraction from the C-20 position of the substrate.	[Storbeck, Sonja; Layer, Gunhild] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Saha, Sayantan; Krausze, Joern; Klink, Bjoern U.; Heinz, Dirk W.] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Klink, Bjoern U.] Duke Univ, Med Ctr, Durham, NC 27705 USA	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Duke University	Layer, G (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	g.layer@tu-braunschweig.de			Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie;  [FOR 1220]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); 	This work was supported by grants from the Deutsche Forschungsgemeinschaft Emmy-Noether Program (to G. L.) and FOR 1220 (to D. W. H.) and by the Fonds der Chemischen Industrie (to G. L. and D. W. H.).	Aiyar A, 1996, Methods Mol Biol, V57, P177; Anderson PJ, 2001, GENE, V281, P63, DOI 10.1016/S0378-1119(01)00820-4; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; BLANCHE F, 1991, J BACTERIOL, V173, P4637, DOI 10.1128/jb.173.15.4637-4645.1991; BRUNT RD, 1989, J CHEM SOC CHEM COMM, P428, DOI 10.1039/c39890000428; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan J, 2006, PROTEIN EXPRES PURIF, V46, P40, DOI 10.1016/j.pep.2005.07.010; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Layer G, 2010, PROTEIN SCI, V19, P1137, DOI 10.1002/pro.405; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; LEEPER FJ, 1985, NAT PROD REP, V2, P561, DOI 10.1039/np9850200561; Leustek T, 1997, J BIOL CHEM, V272, P2744, DOI 10.1074/jbc.272.5.2744; Lobo SAL, 2009, BIOCHEM J, V420, P317, DOI 10.1042/BJ20090151; MASCARO L, 1977, J AM CHEM SOC, V99, P273, DOI 10.1021/ja00443a062; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Minor W, 2002, ACTA PHYS POL A, V101, P613, DOI 10.12693/APhysPolA.101.613; Montange RK, 2010, J MOL BIOL, V396, P761, DOI 10.1016/j.jmb.2009.12.007; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Rehse PH, 2005, ACTA CRYSTALLOGR D, V61, P913, DOI 10.1107/S0907444905008838; ROBIN C, 1991, J BACTERIOL, V173, P4893, DOI 10.1128/jb.173.15.4893-4896.1991; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schubert HL, 2008, BIOCHEMISTRY-US, V47, P8648, DOI 10.1021/bi800635y; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SCOTT AI, 1989, J CHEM SOC CHEM COMM, P522, DOI 10.1039/c39890000522; SPENCER JB, 1993, FEBS LETT, V335, P57, DOI 10.1016/0014-5793(93)80438-Z; Storbeck S, 2009, FEBS J, V276, P5973, DOI 10.1111/j.1742-4658.2009.07306.x; Stroupe ME, 2003, NAT STRUCT BIOL, V10, P1064, DOI 10.1038/nsb1007; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WARREN MJ, 1994, CIBA F SYMP, V180, P26; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; WARREN MJ, 1994, BIOCHEM J, V302, P837, DOI 10.1042/bj3020837; WARREN MJ, 1990, J AM CHEM SOC, V112, P5343, DOI 10.1021/ja00169a048; Woodcock SC, 1998, BIOCHEM J, V330, P121; Zajicek RS, 2009, FEBS J, V276, P6399, DOI 10.1111/j.1742-4658.2009.07354.x; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	43	25	26	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26754	26767		10.1074/jbc.M111.239855	http://dx.doi.org/10.1074/jbc.M111.239855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21632530	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000293078200052
J	Taschner, M; Bhogaraju, S; Vetter, M; Morawetz, M; Lorentzen, E				Taschner, Michael; Bhogaraju, Sagar; Vetter, Melanie; Morawetz, Michaela; Lorentzen, Esben			Biochemical Mapping of Interactions within the Intraflagellar Transport (IFT) B Core Complex IFT52 BINDS DIRECTLY TO FOUR OTHER IFT-B SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT INTERMEDIATE CHAIN; CAENORHABDITIS-ELEGANS; CHLAMYDOMONAS-REINHARDTII; CYTOPLASMIC DYNEIN; PROTEIN SEQUENCES; DISEASE GENE; CILIA; PREDICTION; PARTICLES; COMPONENT	Cilia and flagella are complex structures emanating from the surface of most eukaroytic cells and serve important functions including motility, signaling, and sensory reception. A process called intraflagellar transport (IFT) is of central importance to ciliary assembly and maintenance. The IFT complex is required for this transport and consists of two distinct multisubunit sub-complexes, IFT-A and IFT-B. Despite the importance of the IFT complex, little is known about its overall architecture. This paper presents a biochemical dissection of the molecular interactions within the IFT-B core complex. Two stable subcomplexes consisting of IFT88/70/52/46 and IFT81/74/27/25 were recombinantly co-expressed and purified. We identify a novel interaction between IFT70/52 and map the interaction domains between IFT52 and the other subunits within the IFT88/70/52/46 complex. Additionally, we show that IFT52 binds directly to the IFT81/74/27/25 complex, indicating that it could mediate the interaction between the two subcomplexes. Our data lead to an improved architectural map for the IFT-B core complex with new interactions as well as domain resolution mapping for several subunits.	[Taschner, Michael; Bhogaraju, Sagar; Vetter, Melanie; Morawetz, Michaela; Lorentzen, Esben] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Max Planck Society	Lorentzen, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	lorentze@biochem.mpg.de	Lorentzen, Esben/AAX-8077-2020	Bhogaraju, Sagar/0000-0001-9998-5927; Lorentzen, Esben/0000-0001-6493-7220; Vetter, Melanie/0000-0003-1777-2376; Taschner, Michael/0000-0002-8881-3705; Taschner, Michael/0000-0002-3789-5077	Austrian Science Fund [J 3148-B12]	Austrian Science Fund(Austrian Science Fund (FWF))	Recipient of an Erwin-Schroedinger-stipend granted by the Austrian Science Fund J 3148-B12.	Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beatson S, 2004, TRENDS BIOCHEM SCI, V29, P396, DOI 10.1016/j.tibs.2004.06.002; Behal RH, 2009, METHOD CELL BIOL, V93, P179, DOI 10.1016/S0091-679X(08)93010-7; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Brazelton WJ, 2001, CURR BIOL, V11, P1591, DOI 10.1016/S0960-9822(01)00485-7; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Fan ZC, 2010, MOL BIOL CELL, V21, P2696, DOI 10.1091/mbc.E10-03-0191; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Fribourg S, 2001, J MOL BIOL, V306, P363, DOI 10.1006/jmbi.2000.4376; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goodenough UW, 1989, CURR OPIN CELL BIOL, V1, P58, DOI 10.1016/S0955-0674(89)80037-7; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Lucker BF, 2010, J BIOL CHEM, V285, P21508, DOI 10.1074/jbc.M110.106997; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Pozsgai E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-233; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schafer JC, 2006, J CELL SCI, V119, P4088, DOI 10.1242/jcs.03187; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195	40	55	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26344	26352		10.1074/jbc.M111.254920	http://dx.doi.org/10.1074/jbc.M111.254920			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21642430	Green Published, hybrid			2022-12-25	WOS:000293078200011
J	Ryu, YS; Lee, Y; Lee, KW; Hwang, CY; Maeng, JS; Kim, JH; Seo, YS; You, KH; Song, B; Kwon, KS				Ryu, Yeung Sook; Lee, Younglang; Lee, Keun Woo; Hwang, Chae Young; Maeng, Jin-Soo; Kim, Jeong-Hoon; Seo, Yeon-Soo; You, Kwan-Hee; Song, Byeongwoon; Kwon, Ki-Sun			TRIM32 Protein Sensitizes Cells to Tumor Necrosis Factor (TNF alpha)-induced Apoptosis via Its RING Domain-dependent E3 Ligase Activity against X-linked Inhibitor of Apoptosis (XIAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DYSTROPHY TYPE 2H; COILED-COIL PROTEIN; UBIQUITIN LIGASE; ANTIVIRAL ACTIVITY; CASPASE ACTIVITY; OPITZ-SYNDROME; GENE; FINGER; IAP	TRIM32, which belongs to the tripartite motif (TRIM) protein family, has the RING finger, B-box, and coiled-coil domain structures common to this protein family, along with an additional NHL domain at the C terminus. TRIM32 reportedly functions as an E3 ligase for actin, a protein inhibitor of activated STAT y (PIASy), dysbindin, and c-Myc, and it has been associated with diseases such as muscular dystrophy and epithelial carcinogenesis. Here, we identify a new substrate of TRIM32 and propose a mechanism through which TRIM32 might regulate apoptosis. Our overexpression and knockdown experiments demonstrate that TRIM32 sensitizes cells to TNF alpha-induced apoptosis. The RING domain is necessary for this pro-apoptotic function of TRM32 as well as being responsible for its E3 ligase activity. TRIM32 colocalizes and directly interacts with X-linked inhibitor of apoptosis (XIAP), a well known cancer therapeutic target, through its coiled-coil and NHL domains. TRIM32 overexpression enhances XIAP ubiquitination and subsequent proteasome-mediated degradation, whereas TRIM32 knockdown has the opposite effect, indicating that XIAP is a substrate of TRIM32. In vitro reconstitution assay reveals that XIAP is directly ubiquitinated by TRIM32. Our novel results collectively suggest that TRIM32 sensitizes TNF alpha-induced apoptosis by antagonizing XIAP, an anti-apoptotic downstream effector of TNF alpha signaling. This function may be associated with TRIM32-mediated tumor suppressive mechanism.	[Ryu, Yeung Sook; Lee, Younglang; Lee, Keun Woo; Hwang, Chae Young; Maeng, Jin-Soo; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, Taejon 305806, South Korea; [Kim, Jeong-Hoon; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [You, Kwan-Hee] Chungnam Natl Univ, Sch Biol Sci, Taejon 305764, South Korea; [Song, Byeongwoon] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Emory University	Kwon, KS (corresponding author), Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Lab Cell Signaling, 52 Oun Dong, Taejon 305333, South Korea.	kwonks@kribb.re.kr	Seo, Yeonsoo/C-1605-2011		Korea Research Council of Fundamental Science and Technology (KRCF); National Research Foundation (NRF) of Korea [20110002141, 2010-0014635]	Korea Research Council of Fundamental Science and Technology (KRCF); National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported by grants from the Korea Research Council of Fundamental Science and Technology (KRCF) and the National Research Foundation (NRF) of Korea (Grants 20110002141 and 2010-0014635) (to K. S. K.).	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Dal Zotto L, 1998, HUM MOL GENET, V7, P489, DOI 10.1093/hmg/7.3.489; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Frank DJ, 2002, DEVELOPMENT, V129, P399; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hasegawa N, 1996, BIOCHEM BIOPH RES CO, V225, P627, DOI 10.1006/bbrc.1996.1221; Horn EJ, 2004, CARCINOGENESIS, V25, P157, DOI 10.1093/carcin/bgh003; Ikeda K, 2000, FEBS LETT, V472, P9, DOI 10.1016/S0014-5793(00)01421-6; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Kim JH, 2004, NUCLEIC ACIDS RES, V32, P2287, DOI 10.1093/nar/gkh534; Kimura F, 2003, J BIOL CHEM, V278, P25046, DOI 10.1074/jbc.M303438200; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Lee SS, 2009, EXP CELL RES, V315, P1313, DOI 10.1016/j.yexcr.2008.11.021; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Li JL, 2001, ENDOCRINOLOGY, V142, P370, DOI 10.1210/en.142.1.370; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Shyu HW, 2003, EXP CELL RES, V287, P301, DOI 10.1016/S0014-4827(03)00110-1; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Takahata M, 2008, MOL IMMUNOL, V45, P2045, DOI 10.1016/j.molimm.2007.10.023; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; ZETTERQVIST O, 1976, BIOCHEM BIOPH RES CO, V70, P696, DOI 10.1016/0006-291X(76)90648-3; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	61	47	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25729	25738		10.1074/jbc.M111.241893	http://dx.doi.org/10.1074/jbc.M111.241893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21628460	Green Published, hybrid			2022-12-25	WOS:000293073000034
J	Tamura, T; Cormier, JH; Hebert, DN				Tamura, Taku; Cormier, James H.; Hebert, Daniel N.			Characterization of Early EDEM1 Protein Maturation Events and Their Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; RETICULUM-ASSOCIATED DEGRADATION; CELL RECEPTOR-CD3 COMPLEX; N-LINKED GLYCANS; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; INFLUENZA HEMAGGLUTININ; SIGNAL SEQUENCES; MEMBRANE	The endoplasmic reticulum (ER) quality control factor EDEM1 associates with a number of ER proteins and ER-associated degradation (ERAD) substrates; however, an understanding of its role in ERAD is unclear. The early maturation events for EDEM1 including signal sequence cleavage and glycosylation were analyzed, and their relationship to the function of EDEM1 was determined. EDEM1 has five N-linked glycosylation sites with the most C-terminal site recognized poorly cotranslationally, resulting in the accumulation of EDEM1 containing four or five glycans. The fifth site was modified post-translationally when bypassed cotranslationally. Signal sequence cleavage of EDEM1 was found to be a slow and inefficient process. Signal sequence cleavage produced a soluble form of EDEM1 that efficiently associated with the oxidoreductase ERdj5 and most effectively accelerated the turnover of a soluble ERAD substrate. In contrast, a type-II membrane form of EDEM1 was generated when the signal sequence was uncleaved, creating an N-terminal transmembrane segment. The membrane form of EDEM1 efficiently associated with the ER membrane protein SEL1L and accelerated the turnover of a membrane-associated ERAD substrate. Together, these results demonstrated that signal sequence cleavage functionally regulated the association of EDEM1-soluble and membrane-integrated isoforms with distinct ERAD machinery and substrates.	[Tamura, Taku; Cormier, James H.; Hebert, Daniel N.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Cormier, James H.; Hebert, Daniel N.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hebert, DN (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, 710 N Pleasant St, Amherst, MA 01003 USA.	dhebert@biochem.umass.edu		Tamura, Taku/0000-0001-6074-9273	National Institutes of Health [CA79864, GM086874]; The Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [R01CA079864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA79864 and GM086874 (United States Public Health; to D. N. H.). This work was also supported by The Uehara Memorial Foundation (to T. T.).	Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bonfanti R, 2009, DIABETES CARE, V32, P123, DOI 10.2337/dc08-0783; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Kosmaoglou M, 2009, J CELL SCI, V122, P4465, DOI 10.1242/jcs.055228; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; NICCHITTA CV, 1995, J CELL BIOL, V129, P957, DOI 10.1083/jcb.129.4.957; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Rane NS, 2010, J CELL BIOL, V188, P515, DOI 10.1083/jcb.200911115; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Svedine S, 2004, J CELL SCI, V117, P2937, DOI 10.1242/jcs.01154; Termine DJ, 2009, J CELL SCI, V122, P976, DOI 10.1242/jcs.037291; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WADA I, 1995, J BIOL CHEM, V270, P20298, DOI 10.1074/jbc.270.35.20298; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Zuber C, 2007, P NATL ACAD SCI USA, V104, P4407, DOI 10.1073/pnas.0700154104	59	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24906	24915		10.1074/jbc.M111.243998	http://dx.doi.org/10.1074/jbc.M111.243998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21632540	Green Published, hybrid			2022-12-25	WOS:000292547900040
J	Zhang, XY; Zhang, Q; Wang, DH				Zhang, Xue-Ying; Zhang, Qiang; Wang, De-Hua			Litter Size Variation in Hypothalamic Gene Expression Determines Adult Metabolic Phenotype in Brandt's Voles (Lasiopodomys brandtii)	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; HIGH-FAT DIET; MATERNAL OBESITY; BODY-WEIGHT; MALE RATS; LEPTIN RESISTANCE; ENERGY-BALANCE; FOOD-INTAKE; GROWTH; THERMOGENESIS	Background: Early postnatal environments may have long-term and potentially irreversible consequences on hypothalamic neurons involved in energy homeostasis. Litter size is an important life history trait and negatively correlated with milk intake in small mammals, and thus has been regarded as a naturally varying feature of the early developmental environment. Here we investigated the long-term effects of litter size on metabolic phenotype and hypothalamic neuropeptide mRNA expression involved in the regulation of energy homeostasis, using the offspring reared from large (10-12) and small (3-4) litter sizes, of Brandt's voles (Lasiopodomys brandtii), a rodent species from Inner Mongolia grassland in China. Methodology/Principal Findings: Hypothalamic leptin signaling and neuropeptides were measured by Real-Time PCR. We showed that offspring reared from small litters were heavier at weaning and also in adulthood than offspring from large litters, accompanied by increased food intake during development. There were no significant differences in serum leptin levels or leptin receptor (OB-Rb) mRNA in the hypothalamus at weaning or in adulthood, however, hypothalamic suppressor of cytokine signaling 3 (SOCS3) mRNA in adulthood increased in small litters compared to that in large litters. As a result, the agouti-related peptide (AgRP) mRNA increased in the offspring from small litters. Conclusions/Significance: These findings support our hypothesis that natural litter size has a permanent effect on offspring metabolic phenotype and hypothalamic neuropeptide expression, and suggest central leptin resistance and the resultant increase in AgRP expression may be a fundamental mechanism underlying hyperphagia and the increased risk of overweight in pups of small litters. Thus, we conclude that litter size may be an important and central determinant of metabolic fitness in adulthood.	[Zhang, Xue-Ying; Zhang, Qiang; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Zhang, Qiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	wangdh@ioz.ac.cn			National Natural Science Foundation of China [30900175]; Key Project of the National Eleventh-Five Year Research Program of China [2009BAI83B01]; National Science and Technology Ministry [2007BC109103]; Chinese Academy of Sciences [KSCX2-EW-N-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Eleventh-Five Year Research Program of China; National Science and Technology Ministry; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (30900175) and Key Project of the National Eleventh-Five Year Research Program of China (2009BAI83B01) to XYZ, the National Science and Technology Ministry (2007BC109103) and Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-N-005) to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBERT R, 1980, J NUTR, V110, P649, DOI 10.1093/jn/110.4.649; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; CAMERON GN, 1973, J MAMMAL, V54, P489, DOI 10.2307/1379133; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cerf ME, 2010, INT J DEV NEUROSCI, V28, P625, DOI 10.1016/j.ijdevneu.2010.07.226; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Cottrell EC, 2007, P NUTR SOC, V66, P198, DOI 10.1017/S0029665107005447; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; FAUST IM, 1980, J NUTR, V110, P2027, DOI 10.1093/jn/110.10.2027; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Passos MCF, 2009, BRIT J NUTR, V101, P250, DOI 10.1017/S0007114508006521; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HELDMAIER G, 1982, INT J BIOMETEOROL, V26, P339, DOI 10.1007/BF02219505; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hytinantti TK, 2001, ARCH DIS CHILD-FETAL, V85, pF123, DOI 10.1136/fn.85.2.F123; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Klieverik LP, 2009, ENDOCRINOLOGY, V150, P5639, DOI 10.1210/en.2009-0297; Koskela E, 1998, OECOLOGIA, V115, P379, DOI 10.1007/s004420050531; Li XS, 2005, HORM BEHAV, V48, P321, DOI 10.1016/j.yhbeh.2005.04.004; Liu H, 2003, J MAMMAL, V84, P1410, DOI 10.1644/BRG-030; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Patterson CM, 2010, ENDOCRINOLOGY, V151, P4270, DOI 10.1210/en.2010-0401; Pereira-Toste F, 2009, HORM METAB RES, V41, P874, DOI 10.1055/s-0029-1234070; Remmers F, 2008, BRIT J NUTR, V99, P1149, DOI 10.1017/S0007114507843546; Rodrigues AL, 2011, J NUTR BIOCHEM, V22, P109, DOI 10.1016/j.jnutbio.2009.11.013; Rodel HG, 2010, PHYSIOL BEHAV, V99, P644, DOI 10.1016/j.physbeh.2010.01.032; RYAN V, 1975, DEV PSYCHOBIOL, V8, P363, DOI 10.1002/dev.420080410; Schmidt I, 2000, PHYSIOL GENOMICS, V3, P113, DOI 10.1152/physiolgenomics.2000.3.2.113; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SMITH TJ, 1982, P NATL ACAD SCI-BIOL, V79, P7537, DOI 10.1073/pnas.79.23.7537; Stockley P, 2002, P NATL ACAD SCI USA, V99, P12932, DOI 10.1073/pnas.192125999; Stofkova A, 2009, Endocr Regul, V43, P99; Tang GB, 2009, AM J PHYSIOL-REG I, V297, pR1293, DOI 10.1152/ajpregu.00185.2009; Toste FP, 2006, BRIT J NUTR, V95, P830, DOI 10.1079/BJN20061726; Trevenzoli IH, 2010, HORM METAB RES, V42, P483, DOI 10.1055/s-0030-1249103; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Varma A, 2004, AM J PHYSIOL-ENDOC M, V287, pE1132, DOI 10.1152/ajpendo.00228.2004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wang Jianmei, 2006, Acta Theriologica Sinica, V26, P84; Wang ZW, 2000, BIOCHEM BIOPH RES CO, V277, P20, DOI 10.1006/bbrc.2000.3615; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Xiao XQ, 2007, ENDOCRINOLOGY, V148, P4150, DOI 10.1210/en.2007-0373; Zhang XY, 2008, J COMP PHYSIOL B, V178, P637, DOI 10.1007/s00360-008-0255-y; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao ZJ, 2005, PHYSIOL BEHAV, V85, P143, DOI 10.1016/j.physbeh.2005.03.014	57	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19913	10.1371/journal.pone.0019913	http://dx.doi.org/10.1371/journal.pone.0019913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637839	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200020
J	Westmuckett, AD; Thacker, KM; Moore, KL				Westmuckett, Andrew D.; Thacker, Kelly M.; Moore, Kevin L.			Tyrosine Sulfation of Native Mouse Psgl-1 Is Required for Optimal Leukocyte Rolling on P-Selectin In Vivo	PLOS ONE			English	Article							GLYCOPROTEIN LIGAND-1; MONOCLONAL-ANTIBODY; DEFICIENT MICE; ATHEROSCLEROSIS; RECRUITMENT; NEUTROPHILS; BINDING; VENULES; MECHANISMS; PROTEINS	Background: We recently demonstrated that tyrosine sulfation is an important contributor to monocyte recruitment and retention in a mouse model of atherosclerosis. P-selectin glycoprotein ligand-1 (Psgl-1) is tyrosine-sulfated in mouse monocyte/macrophages and its interaction with P-selectin is important in monocyte recruitment in atherosclerosis. However, whether tyrosine sulfation is required for the P-selectin binding function of mouse Psgl-1 is unknown. Here we test the function of native Psgl-1 expressed in leukocytes lacking endogenous tyrosylprotein sulfotransferase (TPST) activity. Methodology/Principal Findings: Psgl-1 function was assessed by examining P-selectin dependent leukocyte rolling in post-capillary venules of C57BL6 mice transplanted with hematopoietic progenitors from wild type (WT -> B6) or Tpst1;Tpst2 double knockout mice (Tpst DKO -> B6) which lack TPST activity. We observed that rolling flux fractions were lower and leukocyte rolling velocities were higher in Tpst DKO -> B6 venules compared to WT -> B6 venules. Similar results were observed on immobilized P-selectin in vitro. Finally, Tpst DKO leukocytes bound less P-selectin than wild type leukocytes despite equivalent surface expression of Psgl-1. Conclusions/Significance: These findings provide direct and convincing evidence that tyrosine sulfation is required for optimal function of mouse Psgl-1 in vivo and suggests that tyrosine sulfation of Psgl-1 contributes to the development of atherosclerosis.	[Westmuckett, Andrew D.; Thacker, Kelly M.; Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Westmuckett, AD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA.	Andrew-Westmuckett@omrf.org			National Institutes of Health [HD056022]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institutes of Health to KLM (HD056022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Borges E, 1997, BLOOD, V90, P1934, DOI 10.1182/blood.V90.5.1934; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Kawar ZS, 2008, GLYCOBIOLOGY, V18, P441, DOI 10.1093/glycob/cwn020; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIPOWSKY HH, 1978, MICROVASC RES, V15, P93, DOI 10.1016/0026-2862(78)90009-2; Long DS, 2004, P NATL ACAD SCI USA, V101, P10060, DOI 10.1073/pnas.0402937101; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Ridger VC, 2005, AM J PATHOL, V166, P945, DOI 10.1016/S0002-9440(10)62314-0; ROSA P, 1992, J BIOL CHEM, V267, P12227; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SCHMIDSCHONBEIN GW, 1980, BLOOD, V56, P866; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; Sperandio M, 2006, METHOD ENZYMOL, V416, P346, DOI 10.1016/S0076-6879(06)16023-1; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Westmuckett AD, 2009, ARTERIOSCL THROM VAS, V29, P1730, DOI 10.1161/ATVBAHA.109.192963; Xia LJ, 2003, BLOOD, V101, P552, DOI 10.1182/blood-2001-11-0036; Yang J, 1996, BLOOD, V87, P4176, DOI 10.1182/blood.V87.10.4176.bloodjournal87104176; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	38	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20406	10.1371/journal.pone.0020406	http://dx.doi.org/10.1371/journal.pone.0020406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633705	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500061
J	Zang, LS; Liu, TX; Wan, FH				Zang, Lian-Sheng; Liu, Tong-Xian; Wan, Fang-Hao			Reevaluation of the Value of Autoparasitoids in Biological Control	PLOS ONE			English	Article							TABACI GENNADIUS HOMOPTERA; ENCARSIA-TRICOLOR; APHELINIDAE HYMENOPTERA; SEX DETERMINATION; HOST SELECTION; MALE EGGS; PARASITOIDS; ALEYRODIDAE; BEMISIA; HYPERPARASITISM	Autoparasitoids with the capacity of consuming primary parasitoids that share the same hosts to produce males are analogous to intraguild predators. The use of autoparasitoids in biological control programs is a controversial matter because there is little evidence to support the view that autoparasitoids do not disrupt and at times may promote suppression of insect pests in combination with primary parasitoids. We found that Encarsia sophia, a facultative autoparasitoid, preferred to use heterospecific hosts as secondary hosts for producing males. The autoparasitoids mated with males originated from heterospecifics may parasitize more hosts than those mated with males from conspecifics. Provided with an adequate number of males, the autoparasitoids killed more hosts than En. formosa, a commonly used parasitoid for biological control of whiteflies. This study supports the view that autoparasitoids in combination with primary parasitoids do not disrupt pest management and may enhance such programs. The demonstrated preference of an autoparasitoid for heterospecifics and improved performance of males from heterospecifics observed in this study suggests these criteria should be considered in strategies that endeavor to mass-produce and utilize autoparasitoids in the future.	[Zang, Lian-Sheng] Jilin Agr Univ, Inst Biol Control, Changchun, Peoples R China; [Liu, Tong-Xian] NW A&F Univ, Key Lab Appl Entomol, Yangling, Shaanxi, Peoples R China; [Zang, Lian-Sheng; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Jilin Agricultural University; Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zang, LS (corresponding author), Jilin Agr Univ, Inst Biol Control, Changchun, Peoples R China.	txliu@nwsuaf.edu.cn; wanfangh@public3.bta.net.cn			National Natural Science Foundation of China [30930062, 31071735]; National Basic Research and Development Program of China [2009CB119200]; Northwest AF University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China); Northwest AF University	The research was partially supported by the National Natural Science Foundation of China (30930062 and 31071735) (provided partial support to the first author's research), the National Basic Research and Development Program of China (2009CB119200) (provided partial support the salary for LSZ and FHW) and Northwest A&F University (provided partial salary to TXL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony B, 2004, BIOL CONTROL, V30, P546, DOI 10.1016/j.biocontrol.2004.01.018; Antony B, 2003, ENVIRON ENTOMOL, V32, P584, DOI 10.1603/0046-225X-32.3.584; AVILLA J, 1991, ENTOMOL EXP APPL, V59, P219, DOI 10.1007/BF00189364; Bernal JS, 2001, BIOL CONTROL, V20, P210, DOI 10.1006/bcon.2000.0905; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; Briggs CJ, 2001, THEOR POPUL BIOL, V60, P33, DOI 10.1006/tpbi.2001.1529; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; CLARKE SR, 1989, CAN ENTOMOL, V121, P853, DOI 10.4039/Ent121853-10; DOWELL RV, 1979, ENVIRON ENTOMOL, V8, P595, DOI 10.1093/ee/8.4.595; EHLER LE, 1979, ENVIRON ENTOMOL, V8, P829, DOI 10.1093/ee/8.5.829; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; GERLING D, 1985, ENTOMOPHAGA, V30, P163, DOI 10.1007/BF02372249; Heinz KM, 1996, BIOL CONTROL, V6, P384, DOI 10.1006/bcon.1996.0049; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huang Y, 2009, BIOCONTROL, V54, P411, DOI 10.1007/s10526-008-9189-2; Hunter MS, 2002, ECOLOGY, V83, P1459, DOI 10.1890/0012-9658(2002)083[1459:DAADHS]2.0.CO;2; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Hunter MS, 1998, ENTOMOL EXP APPL, V89, P249, DOI 10.1023/A:1003555607725; HUNTER MS, 1989, ENTOMOPHAGA, V34, P265, DOI 10.1007/BF02372675; KENNETT CE, 1966, HILGARDIA, V37, P255, DOI 10.3733/hilg.v37n09p255; Loomans A. J. M., 2002, Bulletin OILB/SROP, V25, P143; Mills NJ, 1996, J APPL ECOL, V33, P1379, DOI 10.2307/2404778; NGUYEN R, 1983, Environmental Entomology, V12, P878; NGUYEN R, 1987, ANN ENTOMOL SOC AM, V80, P713, DOI 10.1093/aesa/80.6.713; Parkes GT, 2001, AUST J ENTOMOL, V40, P74, DOI 10.1046/j.1440-6055.2001.00208.x; Pedata PA, 1996, ENTOMOL EXP APPL, V81, P207, DOI 10.1007/BF00192146; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; *SAS I, 2006, SAS STAT VERS 9 1; THOMPSON CR, 1987, ENVIRON ENTOMOL, V16, P140, DOI 10.1093/ee/16.1.140; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; Walter GH, 2006, ENTOMOL EXP APPL, V118, P97, DOI 10.1111/j.1570-7458.2006.00373.x; WALTER GH, 1983, BIOL J LINN SOC, V19, P63, DOI 10.1111/j.1095-8312.1983.tb00777.x; West SA, 2000, ECOL LETT, V3, P294, DOI 10.1046/j.1461-0248.2000.00153.x; WILK BM, 1981, ENTOMOPHAGA, V26, P313, DOI 10.1007/BF02371881; WILLIAMS JR, 1972, B ENTOMOL RES, V61, P463, DOI 10.1017/S0007485300047337; WILLIAMS JR, 1977, ENTOMOPHAGA, V22, P345, DOI 10.1007/BF02373258; WILLIAMS T, 1995, BIOL CONTROL, V5, P209, DOI 10.1006/bcon.1995.1026; WILLIAMS T, 1991, ECOL ENTOMOL, V16, P377, DOI 10.1111/j.1365-2311.1991.tb00230.x; Williams T, 1996, BIOCONTROL SCI TECHN, V6, P603, DOI 10.1080/09583159631244; YU DS, 1990, ECOL ENTOMOL, V15, P469, DOI 10.1111/j.1365-2311.1990.tb00830.x; Zang LS, 2008, ENTOMOL EXP APPL, V127, P55, DOI 10.1111/j.1570-7458.2008.00667.x; Zang LS, 2010, ENVIRON ENTOMOL, V39, P912, DOI 10.1603/EN09266; Zang LS, 2009, BIOCONTROL SCI TECHN, V19, P573, DOI 10.1080/09583150902912673; ZANG LS, 2011, INSECT SCI IN PRESS	45	20	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20324	10.1371/journal.pone.0020324	http://dx.doi.org/10.1371/journal.pone.0020324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633501	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500056
J	Zhang, XL; Upreti, C; Stanton, PK				Zhang, Xiao-lei; Upreti, Chirag; Stanton, Patric K.			G beta gamma and the C Terminus of SNAP-25 Are Necessary for Long-Term Depression of Transmitter Release	PLOS ONE			English	Article							SCHAFFER COLLATERAL-CA1 SYNAPSES; MEDIATE PRESYNAPTIC INHIBITION; SYNAPTIC DEPRESSION; CALCIUM-CHANNELS; CA2+ CHANNELS; NITRIC-OXIDE; VESICLE POOL; HIPPOCAMPAL SYNAPSES; ADENYLATE-CYCLASE; AMPA RECEPTORS	Background: Short-term presynaptic inhibition mediated by G protein-coupled receptors involves a direct interaction between G proteins and the vesicle release machinery. Recent studies implicate the C terminus of the vesicle-associated protein SNAP-25 as a molecular binding target of G beta gamma that transiently reduces vesicular release. However, it is not known whether SNAP-25 is a target for molecular modifications expressing long-term changes in transmitter release probability. Methodology/Principal Findings: This study utilized two-photon laser scanning microscopy for real-time imaging of action potential-evoked [Ca(2+)] increases, in single Schaffer collateral presynaptic release sites in in vitro hippocampal slices, plus simultaneous recording of Schaffer collateral-evoked synaptic potentials. We used electroporation to infuse small peptides through CA3 cell bodies into presynaptic Schaffer collateral terminals to selectively study the presynaptic effect of scavenging the G-protein G beta gamma. We demonstrate here that the C terminus of SNAP-25 is necessary for expression of LTD, but not long-term potentiation (LTP), of synaptic strength. Using type A botulinum toxin (BoNT/A) to enzymatically cleave the 9 amino acid C-terminus of SNAP-25 eliminated the ability of low frequency synaptic stimulation to induce LTD, but not LTP, even if release probability was restored to pre-BoNT/A levels by elevating extracellular [Ca(2+)]. Presynaptic electroporation infusion of the 14-amino acid C-terminus of SNAP-25 (Ct-SNAP-25), to scavenge G beta gamma, reduced both the transient presynaptic inhibition produced by the group II metabotropic glutamate receptor stimulation, and LTD. Furthermore, presynaptic infusion of mSIRK, a second, structurally distinct G beta gamma scavenging peptide, also blocked the induction of LTD. While G beta gamma binds directly to and inhibit voltage-dependent Ca(2+) channels, imaging of presynaptic [Ca(2+)] with Mg-Green revealed that low-frequency stimulation only transiently reduced presynaptic Ca(2+) influx, an effect not altered by infusion of Ct-SNAP-25. Conclusions/Significance: The C-terminus of SNAP-25, which links synaptotagmin I to the SNARE complex, is a binding target for G beta gamma necessary for both transient transmitter-mediated presynaptic inhibition, and the induction of presynaptic LTD.	[Zhang, Xiao-lei; Upreti, Chirag; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Stanton, Patric K.] New York Med Coll, Dept Neurol, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Zhang, XL (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	patric_stanton@nymc.edu			NIH [NS44421]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS044421, R01NS044421] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH grant #NS44421 to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bailey CP, 2008, LEARN MEMORY, V15, P261, DOI 10.1101/lm.810208; Bailey CP, 2003, EUR J NEUROSCI, V17, P903, DOI 10.1046/j.1460-9568.2003.02507.x; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BINZ T, 1994, J BIOL CHEM, V269, P1617; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Braunewell KH, 2001, REV NEUROSCIENCE, V12, P121; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen XK, 2005, NAT NEUROSCI, V8, P1160, DOI 10.1038/nn1529; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gage AT, 1997, HIPPOCAMPUS, V7, P286; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; IZUMI Y, 1993, NEUROREPORT, V4, P1131; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; LAU CG, J NEUROSCI, V30, P242; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Nagy G, 2005, MOL BIOL CELL, V16, P5675, DOI 10.1091/mbc.E05-07-0595; Nicholls RE, 2006, P NATL ACAD SCI USA, V103, P6380, DOI 10.1073/pnas.0601267103; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Photowala H, 2006, P NATL ACAD SCI USA, V103, P4281, DOI 10.1073/pnas.0600509103; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Reyes M, 1996, J NEUROSCI, V16, P5951; Reyes-Harde M, 1999, J NEUROPHYSIOL, V82, P1569, DOI 10.1152/jn.1999.82.3.1569; Santschi L, 1999, J NEUROPHYSIOL, V82, P1577, DOI 10.1152/jn.1999.82.3.1577; Santschi LA, 2006, J NEUROBIOL, V66, P205, DOI 10.1002/neu.20213; Seagar M, 1999, PHILOS T ROY SOC B, V354, P289, DOI 10.1098/rstb.1999.0380; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stanton PK, 2005, EUR J NEUROSCI, V22, P2451, DOI 10.1111/j.1460-9568.2005.04437.x; Stanton PK, 2003, J NEUROSCI, V23, P5936; Stanton PK, 1996, J NEUROPHYSIOL, V76, P2097, DOI 10.1152/jn.1996.76.3.2097; Stanton PK, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0002.2001; Stephens GJ, 2005, J PHYSIOL-LONDON, V563, P765, DOI 10.1113/jphysiol.2004.080192; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Yoon EJ, 2007, MOL PHARMACOL, V72, P1210, DOI 10.1124/mol.107.039446; Young SM, 2005, P NATL ACAD SCI USA, V102, P2614, DOI 10.1073/pnas.0409656102; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zhang Y, 2008, J NEUROSCI, V28, P14176, DOI 10.1523/JNEUROSCI.1350-08.2008; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721	64	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20500	10.1371/journal.pone.0020500	http://dx.doi.org/10.1371/journal.pone.0020500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21633701	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500066
J	Hernandez, R; Cabalceta, C; Saravia-Otten, P; Chaves, A; Gutierrez, JM; Rucavado, A				Hernandez, Rosario; Cabalceta, Carmen; Saravia-Otten, Patricia; Chaves, Alessandra; Maria Gutierrez, Jose; Rucavado, Alexandra			Poor Regenerative Outcome after Skeletal Muscle Necrosis Induced by Bothrops asper Venom: Alterations in Microvasculature and Nerves	PLOS ONE			English	Article							LOCAL TISSUE-DAMAGE; SNAKE-VENOM; HEMORRHAGIC METALLOPROTEINASES; PHOSPHOLIPASES A(2); IN-VITRO; APOPTOSIS; MECHANISMS; PATHOLOGY; MYOTOXIN; NEUROTOXINS	Background: Viperid snakebite envenoming is characterized by prominent local tissue damage, including muscle necrosis. A frequent outcome of such local pathology is deficient skeletal muscle regeneration, which causes muscle dysfunction, muscle loss and fibrosis, thus provoking permanent sequelae that greatly affect the quality of life of patients. The causes of such poor regenerative outcome of skeletal muscle after viperid snakebites are not fully understood. Methodology/Principal Findings: A murine model of muscle necrosis and regeneration was adapted to study the effects of the venom and isolated toxins of Bothrops asper, the medically most important snake in Central America. Gastrocnemius muscle was injected with either B. asper venom, a myotoxic phospholipase A(2) (Mtx), a hemorrhagic metalloproteinase (SVMP), or saline solution. At various time intervals, during one month, tissue samples were collected and analyzed by histology, and by immunocytochemical and immunohistochemical techniques aimed at detecting muscle fibers, collagen, endothelial cells, myoblasts, myotubes, macrophages, TUNEL-positive nuclei, and axons. A successful regenerative response was observed in muscle injected with Mtx, which induces myonecrosis but does not affect the microvasculature. In contrast, poor regeneration, with fibrosis and atrophic fibers, occurred when muscle was injected with venom or SVMP, both of which provoke necrosis, microvascular damage leading to hemorrhage, and poor axonal regeneration. Conclusions/Significance: The deficient skeletal muscle regeneration after injection of B. asper venom is likely to depend on the widespread damage to the microvasculature, which affects the removal of necrotic debris by phagocytes, and the provision of nutrients and oxygen required for regeneration. In addition, deficient axonal regeneration is likely to contribute to the poor regenerative outcome in this model.	[Hernandez, Rosario; Saravia-Otten, Patricia] Univ San Carlos, Fac Ciencias Quim & Farm, Finca San Isidro, Guatemala; [Hernandez, Rosario; Cabalceta, Carmen; Chaves, Alessandra; Maria Gutierrez, Jose; Rucavado, Alexandra] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica	Universidad de San Carlos de Guatemala; Universidad Costa Rica	Hernandez, R (corresponding author), Univ San Carlos, Fac Ciencias Quim & Farm, Finca San Isidro, Guatemala.	alexandra.rucavado@ucr.ac.cr	Rucavado, Alexandra/AGY-1867-2022; Gutiérrez, José/GSJ-1846-2022	Gutierrez, Jose Maria/0000-0001-8385-3081	NeTropica [2-N-2008]; Vicerrectoria de Investigacion, Universidad de Costa Rica [741-A7-604]	NeTropica; Vicerrectoria de Investigacion, Universidad de Costa Rica	This study was supported by NeTropica (grant 2-N-2008), by Vicerrectoria de Investigacion, Universidad de Costa Rica (project 741-A7-604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1; ARCE V, 1991, INT J EXP PATHOL, V72, P211; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; CANTINI M, 1995, J NEUROPATH EXP NEUR, V54, P121, DOI 10.1097/00005072-199501000-00014; Cantini M, 2002, NEUROL SCI, V23, P189, DOI 10.1007/s100720200060; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Cintra-Francischinelli M, 2009, CELL MOL LIFE SCI, V66, P1718, DOI 10.1007/s00018-009-9053-2; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018; Fan H.W., 1995, HDB CLIN TOXICOLOGY, P667; Franca FOS, 2003, ANIMAIS PECONHENTOS, P72; Gallacci M, 2010, TOXICON, V55, P1, DOI 10.1016/j.toxicon.2009.10.025; Grounds MD, 1999, CURR OPIN NEUROL, V12, P535, DOI 10.1097/00019052-199910000-00007; GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1; Gutierrez J.M, 1997, VENOM PHOSPHOLIPASE, P321; Gutierrez J. M., 2003, ANIMAIS PECONHENTOS, P310, DOI DOI 10.1590/S0036-46652003000600009; Gutierrez J.M., 2010, HDB VENOMS TOXINS RE, P491; GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; GUTIERREZ JM, 1995, EXP MOL PATHOL, V62, P28, DOI 10.1006/exmp.1995.1004; GUTIERREZ JM, 1984, TOXICON, V22, P719, DOI 10.1016/0041-0101(84)90155-7; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Hamza L, 2010, TOXICON, V56, P381, DOI 10.1016/j.toxicon.2010.04.001; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HELUANY NF, 1992, TOXICON, V30, P1203, DOI 10.1016/0041-0101(92)90436-9; Kalhovde JM, 2005, J PHYSIOL-LONDON, V562, P847, DOI 10.1113/jphysiol.2004.073684; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Gutierrez JM, 2010, TOXICON, V55, P166, DOI 10.1016/j.toxicon.2009.08.006; Gutierrez JM, 2009, TOXICON, V54, P958, DOI 10.1016/j.toxicon.2009.01.038; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6; Otero-Patino R, 2009, TOXICON, V54, P998, DOI 10.1016/j.toxicon.2009.07.001; Queiroz LD, 2002, TOXICON, V40, P1483, DOI 10.1016/S0041-0101(02)00166-6; QUEIROZ LS, 1984, TOXICON, V22, P339, DOI 10.1016/0041-0101(84)90077-1; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Rucavado A, 1998, INT J EXP PATHOL, V79, P245; Salvini TF, 2001, TOXICON, V39, P641, DOI 10.1016/S0041-0101(00)00188-4; Sandri M, 1998, LAB INVEST, V78, P1005; Santo Neto H., 2005, Toxicon, V46, P814, DOI 10.1016/j.toxicon.2005.08.013; Schiaffino S., 2008, SKELETAL MUSCLE REPA; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Siu PM, 2009, FRONT BIOSCI-LANDMRK, V14, P432, DOI 10.2741/3253; Slater Clarke R., 2008, V3, P303; Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; Tidball James G., 2008, V3, P243; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; Warrell D.A., 1996, ENVENOMINGS THEIR TR, P63; Warrell D.A., 2004, VENOMOUS REPTILES W, P709; WHO, 2007, RAB ENV NEGL PUBL HL	60	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19834	10.1371/journal.pone.0019834	http://dx.doi.org/10.1371/journal.pone.0019834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629691	gold, Green Published			2022-12-25	WOS:000291005800013
J	Buldu, JM; Bajo, R; Maestu, F; Castellanos, N; Leyva, I; Gil, P; Sendina-Nadal, I; Almendral, JA; Nevado, A; del-Pozo, F; Boccaletti, S				Buldu, Javier M.; Bajo, Ricardo; Maestu, Fernando; Castellanos, Nazareth; Leyva, Inmaculada; Gil, Pablo; Sendina-Nadal, Irene; Almendral, Juan A.; Nevado, Angel; del-Pozo, Francisco; Boccaletti, Stefano			Reorganization of Functional Networks in Mild Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMER-DISEASE; MEMORY TASK; CONNECTIVITY; ATTENTION	Whether the balance between integration and segregation of information in the brain is damaged in Mild Cognitive Impairment (MCI) subjects is still a matter of debate. Here we characterize the functional network architecture of MCI subjects by means of complex networks analysis. Magnetoencephalograms (MEG) time series obtained during a memory task were evaluated by synchronization likelihood (SL), to quantify the statistical dependence between MEG signals and to obtain the functional networks. Graphs from MCI subjects show an enhancement of the strength of connections, together with an increase in the outreach parameter, suggesting that memory processing in MCI subjects is associated with higher energy expenditure and a tendency toward random structure, which breaks the balance between integration and segregation. All features are reproduced by an evolutionary network model that simulates the degenerative process of a healthy functional network to that associated with MCI. Due to the high rate of conversion from MCI to Alzheimer Disease (AD), these results show that the analysis of functional networks could be an appropriate tool for the early detection of both MCI and AD.	[Buldu, Javier M.; Leyva, Inmaculada; Sendina-Nadal, Irene; Almendral, Juan A.] Univ Rey Juan Carlos, Complex Syst Grp, Fuenlabrada, Spain; [Buldu, Javier M.; Leyva, Inmaculada; Sendina-Nadal, Irene; Almendral, Juan A.] Ctr Biomed Technol, Lab Biol Networks, Madrid, Spain; [Bajo, Ricardo; Maestu, Fernando; Castellanos, Nazareth; Nevado, Angel; del-Pozo, Francisco] Politecn Madrid, Ctr Biomed Technol, Cognit & Computat Neurosci Lab, Madrid, Spain; [Bajo, Ricardo; Maestu, Fernando; Castellanos, Nazareth; Nevado, Angel; del-Pozo, Francisco] Complutense Univ Madrid UPM UCM, Madrid, Spain; [Gil, Pablo] Hosp Clin San Carlos, Memory Unit, Madrid, Spain; [Boccaletti, Stefano] Ctr Biomed Technol, Computat Syst Biol Grp, Madrid, Spain; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Florence, Italy	Universidad Rey Juan Carlos; Universidad Politecnica de Madrid; Complutense University of Madrid; Hospital Clinico San Carlos; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Buldu, JM (corresponding author), Univ Rey Juan Carlos, Complex Syst Grp, Fuenlabrada, Spain.	javier.buldu@urjc.es	Castellanos, Nazareth/AAA-8812-2020; Buldu, Javier/N-5422-2014; Almendral, Juan/ABC-8025-2021; Boccaletti, Stefano/U-7603-2019; Maestu, Fernando/E-3213-2012; maestu, fernando/M-7480-2019; Buldu, Javier Martin/R-8167-2018; Nevado, Angel/O-1861-2013; Leyva, I./M-1820-2013; Nevado, Angel/H-8619-2015; Sendiña-Nadal, Irene/M-3083-2013; Bajo, Ricardo/AAA-5541-2019; POZO GUERRERO, FRANCISCO DEL/H-6668-2015	Buldu, Javier/0000-0002-9345-599X; Almendral, Juan/0000-0003-1100-7446; Boccaletti, Stefano/0000-0002-5758-7012; Maestu, Fernando/0000-0002-3195-0071; maestu, fernando/0000-0002-3195-0071; Leyva, I./0000-0001-9634-5385; Nevado, Angel/0000-0002-1660-8294; Sendiña-Nadal, Irene/0000-0003-0432-235X; POZO GUERRERO, FRANCISCO DEL/0000-0001-9919-9125; Bajo, Ricardo/0000-0003-0646-2962; Castellanos, Nazareth/0000-0002-3508-7316	Obra Social Caja Madrid; Spanish Ministry of ST [FIS2009-07072, PSI2009-14415-C03-01]; Community of Madrid [S2009ESP-1691]	Obra Social Caja Madrid; Spanish Ministry of ST; Community of Madrid(Comunidad de Madrid)	This work was supported by MADRI.B project, Obra Social Caja Madrid, by the Spanish Ministry of S&T [FIS2009-07072, PSI2009-14415-C03-01] and by the Community of Madrid under the R&D Program of activities MODELICO-CM [S2009ESP-1691]. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Ahnert SE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016101; Babiloni C, 2006, BRAIN RES BULL, V69, P63, DOI 10.1016/j.brainresbull.2005.10.013; Bajo R, 2010, J ALZHEIMERS DIS, V22, P183, DOI 10.3233/JAD-2010-100177; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; DETOLEDOMORRELL L, 1991, ARCH NEUROL-CHICAGO, V48, P605, DOI 10.1001/archneur.1991.00530180061018; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dijkstra E. W., 1959, NUMER MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Maestu F, 2001, NEUROREPORT, V12, P3917, DOI 10.1097/00001756-200112210-00013; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rubinov M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-55; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	38	87	89	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e19584	10.1371/journal.pone.0019584	http://dx.doi.org/10.1371/journal.pone.0019584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21625430	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005200004
J	Ren, TY; He, WX; Porsov, E				Ren, Tianying; He, Wenxuan; Porsov, Edward			Localization of the Cochlear Amplifier in Living Sensitive Ears	PLOS ONE			English	Article							BASILAR-MEMBRANE VIBRATION; HAIR-BUNDLE MOVEMENTS; MECHANICAL AMPLIFICATION; PRESTIN; PROPAGATION; ADAPTATION; CHANNELS; REGION; MODEL	Background: To detect soft sounds, the mammalian cochlea increases its sensitivity by amplifying incoming sounds up to one thousand times. Although the cochlear amplifier is thought to be a local cellular process at an area basal to the response peak on the spiral basilar membrane, its location has not been demonstrated experimentally. Methodology and Principal Findings: Using a sensitive laser interferometer to measure sub-nanometer vibrations at two locations along the basilar membrane in sensitive gerbil cochleae, here we show that the cochlea can boost soft sound-induced vibrations as much as 50 dB/mm at an area proximal to the response peak on the basilar membrane. The observed amplification works maximally at low sound levels and at frequencies immediately below the peak-response frequency of the measured apical location. The amplification decreases more than 65 dB/mm as sound levels increases. Conclusions and Significance: We conclude that the cochlea amplifier resides at a small longitudinal region basal to the response peak in the sensitive cochlea. These data provides critical information for advancing our knowledge on cochlear mechanisms responsible for the remarkable hearing sensitivity, frequency selectivity and dynamic range.	[Ren, Tianying; He, Wenxuan; Porsov, Edward] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol & Head & Neck Surg, Portland, OR 97201 USA; [Ren, Tianying] Xi An Jiao Tong Univ, Sch Med, Dept Physiol, Xian 710049, Shaanxi, Peoples R China	Oregon Health & Science University; Xi'an Jiaotong University	Ren, TY (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol & Head & Neck Surg, Portland, OR 97201 USA.	rent@ohsu.edu			National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) [DC04554]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004554] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/) grant DC04554. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; COOPER NP, 1992, HEARING RES, V63, P191, DOI 10.1016/0378-5955(92)90084-Z; Cooper NP, 1999, J ACOUST SOC AM, V106, pL59, DOI 10.1121/1.428147; DALLOS P, 1992, J NEUROSCI, V12, P4575; Dallos P, 2006, J PHYSIOL-LONDON, V576, P37, DOI 10.1113/jphysiol.2006.114652; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; DEBOER E, 1983, J ACOUST SOC AM, V73, P577, DOI 10.1121/1.389004; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; He DZZ, 2003, J NEUROSCI, V23, P9089; He WX, 2008, P NATL ACAD SCI USA, V105, P2729, DOI 10.1073/pnas.0708103105; He WX, 2007, HEARING RES, V228, P112, DOI 10.1016/j.heares.2007.01.026; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; Hudspeth AJ, 2000, P NATL ACAD SCI USA, V97, P11765, DOI 10.1073/pnas.97.22.11765; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; KHANNA SM, 1986, HEARING RES, V23, P37, DOI 10.1016/0378-5955(86)90174-7; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; NEELY ST, 1986, J ACOUST SOC AM, V79, P1472, DOI 10.1121/1.393674; NUTTALL AL, 1991, HEARING RES, V51, P203, DOI 10.1016/0378-5955(91)90037-A; PETERSON LC, 1950, J ACOUST SOC AM, V22, P369, DOI 10.1121/1.1906615; Ren TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1226; Ren TY, 2004, NAT NEUROSCI, V7, P333, DOI 10.1038/nn1216; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Ren TY, 2001, HEARING RES, V151, P48, DOI 10.1016/S0378-5955(00)00211-2; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Rhode WS, 2000, J ACOUST SOC AM, V107, P3317, DOI 10.1121/1.429404; Ricci AJ, 2002, J NEUROSCI, V22, P44, DOI 10.1523/JNEUROSCI.22-01-00044.2002; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; RUGGERO MA, 1991, HEARING RES, V51, P215, DOI 10.1016/0378-5955(91)90038-B; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; von Bekesy G, 1970, Nature, V225, P1207, DOI 10.1038/2251207a0; von Bekesy G, 1960, EXPT HEARING; Zheng J, 2002, AUDIOL NEURO-OTOL, V7, P9, DOI 10.1159/000046855; ZWISLOCKI J, 1953, J ACOUST SOC AM, V25, P986, DOI 10.1121/1.1907231; ZWISLOCKI J, 2002, AUDITORY SOUND TRANS	37	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20149	10.1371/journal.pone.0020149	http://dx.doi.org/10.1371/journal.pone.0020149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629790	Green Published, gold			2022-12-25	WOS:000291005200038
J	Xu, J; Lan, L; Bogard, N; Mattione, C; Cohen, RS				Xu, Jiang; Lan, Lan; Bogard, Nicholas; Mattione, Cristin; Cohen, Robert S.			Rab11 Is Required for Epithelial Cell Viability, Terminal Differentiation, and Suppression of Tumor-Like Growth in the Drosophila Egg Chamber	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; SOMATIC STEM-CELLS; FOLLICLE CELLS; CADHERIN TRAFFICKING; OOCYTE SPECIFICATION; ADHERENS JUNCTIONS; EXOCYST COMPONENTS; POLARITY; OOGENESIS; OVARY	Background: The Drosophila egg chamber provides an excellent system in which to study the specification and differentiation of epithelial cell fates because all of the steps, starting with the division of the corresponding stem cells, called follicle stem cells, have been well described and occur many times over in a single ovary. Methodology/Principal Findings: Here we investigate the role of the small Rab11 GTPase in follicle stem cells (FSCs) and in their differentiating daughters, which include main body epithelial cells, stalk cells and polar cells. We show that rab11-null FSCs maintain their ability to self renew, even though previous studies have shown that FSC self renewal is dependent on maintenance of E-cadherin-based intercellular junctions, which in many cell types, including Drosophila germline stem cells, requires Rab11. We also show that rab11-null FSCs give rise to normal numbers of cells that enter polar, stalk, and epithelial cell differentiation pathways, but that none of the cells complete their differentiation programs and that the epithelial cells undergo premature programmed cell death. Finally we show, through the induction of rab11-null clones at later points in the differentiation program, that Rab11 suppresses tumor-like growth of epithelial cells. Thus, rab11-null epithelial cells arrest differentiation early, assume an aberrant cell morphology, delaminate from the epithelium, and invade the neighboring germline cyst. These phenotypes are associated with defects in E-cadherin localization and a general loss of cell polarity. Conclusions/Significance: While previous studies have revealed tumor suppressor or tumor suppressor-like activity for regulators of endocytosis, our study is the first to identify such activity for regulators of endocytic recycling. Our studies also support the recently emerging view that distinct mechanisms regulate junction stability and plasticity in different tissues.	[Xu, Jiang; Lan, Lan; Bogard, Nicholas; Mattione, Cristin; Cohen, Robert S.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Xu, J (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	rcohen@ku.edu	LAN, LAN/N-8872-2018; Tsai, Yu-Chen/B-5852-2008	Bogard, Nicholas/0000-0001-9231-9382; Xu, Jiang/0000-0002-6933-5453	National Institutes of Health [P20 RR15563, R01 GM068022]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P20 RR15563 and R01 GM068022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2005, DROSOPHILA LAB HDB, pxxviii; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bai JW, 2002, DEVELOPMENT, V129, P5377, DOI 10.1242/dev.00115; Besse F, 2003, DEVELOPMENT, V130, P1017, DOI 10.1242/dev.00313; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Dollar G, 2002, DEVELOPMENT, V129, P517; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; Grammont M, 2001, DEVELOPMENT, V128, P2243; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Jankovics F, 2001, GENETICS, V158, P1177; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Larkin MK, 1996, DEVELOPMENT, V122, P3639; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; McGregor JR, 2002, DEVELOPMENT, V129, P705; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nystul T, 2010, GENETICS, V184, P503, DOI 10.1534/genetics.109.109538; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Tan LH, 2001, DEVELOPMENT, V128, P1159; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Vachias C, 2010, DEVELOPMENT, V137, P2703, DOI 10.1242/dev.052183; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20180	10.1371/journal.pone.0020180	http://dx.doi.org/10.1371/journal.pone.0020180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21629779	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005200042
J	Carmo, CR; Lyons-Lewis, J; Seckl, MJ; Costa-Pereira, AP				Carmo, Catarina R.; Lyons-Lewis, Janet; Seckl, Michael J.; Costa-Pereira, Ana P.			A Novel Requirement for Janus Kinases as Mediators of Drug Resistance Induced by Fibroblast Growth Factor-2 in Human Cancer Cells	PLOS ONE			English	Article							BCL-X-L; LUNG-CANCER; INTERFERON-GAMMA; DEPENDENT PATHWAY; POOR-PROGNOSIS; APOPTOSIS; CYTOKINES; STAT3; ACTIVATION; PREDICTOR	The development of resistance to chemotherapy is a major cause of cancer-related death. Elucidating the mechanisms of drug resistance should thus lead to novel therapeutic strategies. Fibroblast growth factor (FGF)-2 signaling induces the assembly of a multi-protein complex that provides tumor cells with the molecular machinery necessary for drug resistance. This complex, which involves protein kinase C (PKC) epsilon, v-raf murine sarcoma viral oncogene homolog B1 (B-RAF) and p70 S6 kinase beta (S6K2), enhances the selective translation of anti-apoptotic proteins such as B-cell leukaemia/lymphoma-2 (BCL-2) and inhibitors of apoptosis protein (IAP) family members and these are able to protect multiple cancer cell types from chemotherapy-induced cell death. The Janus kinases (JAKs) are most noted for their critical roles in mediating cytokine signaling and immune responses. Here, we show that JAKs have novel functions that support their consideration as new targets in therapies aimed at reducing drug resistance. As an example, we show that the Janus kinase TYK2 is phosphorylated downstream of FGF-2 signaling and required for the full phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. Moreover, TYK2 is necessary for the induction of key anti-apoptotic proteins, such as BCL-2 and myeloid cell leukemia sequence (MCL) 1, and for the promotion of cell survival upon FGF-2. Silencing JAK1, JAK2 or TYK2 using RNA interference (RNAi) inhibits FGF2-mediated proliferation and results in the sensitization of tumor cells to chemotherapy-induced killing. These effects are independent of activation of signal transducer and activator of transcription (STAT) 1, STAT3 and STAT5A/B, the normal targets of JAK signaling. Instead, TYK2 associates with the other kinases previously implicated in FGF-2-mediated drug resistance. In light of these findings we hypothesize that TYK2 and other JAKs are important modulators of FGF-2-driven cell survival and that inhibitors of these kinases will likely improve the effectiveness of other cancer therapies.	[Carmo, Catarina R.; Lyons-Lewis, Janet; Seckl, Michael J.; Costa-Pereira, Ana P.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Carmo, CR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp Campus, London, England.	a.costa-pereira@imperial.ac.uk	Costa-Pereira, Ana/AAE-8192-2020	Ramos do Carmo, Catarina/0000-0001-9717-6667	Cancer Treatment and Research Trust; Department of Health funded Experimental Cancer Medicine Centre; Cancer Research UK	Cancer Treatment and Research Trust; Department of Health funded Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK)	Cancer Treatment and Research Trust funded this work. MJS and JLL are also supported by a Department of Health funded Experimental Cancer Medicine Centre Grant, and APC-P and MJS by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; Chen E, 2010, CANCER CELL, V18, P524, DOI 10.1016/j.ccr.2010.10.013; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Graeven U, 1999, J CANCER RES CLIN, V125, P577, DOI 10.1007/s004320050319; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kerr IM, 2003, FEBS LETT, V546, P1, DOI 10.1016/S0014-5793(03)00411-3; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Krejci P, 2008, J CELL SCI, V121, P272, DOI 10.1242/jcs.017160; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Packham G, 1998, GENE DEV, V12, P2475, DOI 10.1101/gad.12.16.2475; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Pardo OE, 2001, ONCOGENE, V20, P7658, DOI 10.1038/sj.onc.1204994; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ruotsalainen T, 2002, CANCER EPIDEM BIOMAR, V11, P1492; Sakai I, 1997, J BIOL CHEM, V272, P12350, DOI 10.1074/jbc.272.19.12350; Salven P, 1999, BLOOD, V94, P3334, DOI 10.1182/blood.V94.10.3334.422k18_3334_3339; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Simma O, 2009, CANCER RES, V69, P203, DOI 10.1158/0008-5472.CAN-08-1705; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; Verma A, 2003, CANCER METAST REV, V22, P423, DOI 10.1023/A:1023805715476; Watling D, 2008, P NATL ACAD SCI USA, V105, P6051, DOI 10.1073/pnas.0710814105; Wilks AF, 2008, SEMIN CELL DEV BIOL, V19, P319, DOI 10.1016/j.semcdb.2008.07.020; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	36	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19861	10.1371/journal.pone.0019861	http://dx.doi.org/10.1371/journal.pone.0019861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625473	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400015
J	Inoshita, T; Martin, JR; Marion-Poll, F; Ferveur, JF				Inoshita, Tsuyoshi; Martin, Jean-Rene; Marion-Poll, Frederic; Ferveur, Jean-Francois			Peripheral, Central and Behavioral Responses to the Cuticular Pheromone Bouquet in Drosophila melanogaster Males	PLOS ONE			English	Article							CIS-VACCENYL ACETATE; COURTSHIP BEHAVIOR; SEX-PHEROMONE; BITTER TASTE; BRAIN; HYDROCARBONS; NEURONS; FLY; BIOLUMINESCENCE; INHIBITION	Pheromonal communication is crucial with regard to mate choice in many animals including insects. Drosophila melanogaster flies produce a pheromonal bouquet with many cuticular hydrocarbons some of which diverge between the sexes and differently affect male courtship behavior. Cuticular pheromones have a relatively high weight and are thought to be - mostly but not only - detected by gustatory contact. However, the response of the peripheral and central gustatory systems to these substances remains poorly explored. We measured the effect induced by pheromonal cuticular mixtures on (i) the electrophysiological response of peripheral gustatory receptor neurons, (ii) the calcium variation in brain centers receiving these gustatory inputs and (iii) the behavioral reaction induced in control males and in mutant desat1 males, which show abnormal pheromone production and perception. While male and female pheromones induced inhibitory-like effects on taste receptor neurons, the contact of male pheromones on male fore-tarsi elicits a long-lasting response of higher intensity in the dedicated gustatory brain center. We found that the behavior of control males was more strongly inhibited by male pheromones than by female pheromones, but this difference disappeared in anosmic males. Mutant desat1 males showed an increased sensitivity of their peripheral gustatory neurons to contact pheromones and a behavioral incapacity to discriminate sex pheromones. Together our data indicate that cuticular hydrocarbons induce long-lasting inhibitory effects on the relevant taste pathway which may interact with the olfactory pathway to modulate pheromonal perception.	[Inoshita, Tsuyoshi; Ferveur, Jean-Francois] Univ Bourgogne, INRA, Ctr Sci Gout & Alimentat, UMR 6265,CNRS,UMR 1324, Dijon, France; [Martin, Jean-Rene] CNRS, Inst Neurobiol Alfred Fessard, Lab Neurobiol & Dev, Unite Propre Rech 3294, Gif Sur Yvette, France; [Marion-Poll, Frederic] Univ Paris 06, INRA, UMR 1272, Versailles, France; [Marion-Poll, Frederic] AgroParisTech, Dept Sci Vie & Sante, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; AgroParisTech	Inoshita, T (corresponding author), Univ Bourgogne, INRA, Ctr Sci Gout & Alimentat, UMR 6265,CNRS,UMR 1324, Dijon, France.	jean-francois.ferveur@u-bourgogne.fr	Frederic, Marion-Poll/I-1358-2019	Frederic, Marion-Poll/0000-0001-6824-0180	CNRS; Burgundy Regional Council; ANR (INSAVEL); ANR (Drosaequorin); Ministry of Agriculture	CNRS(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); ANR (INSAVEL)(French National Research Agency (ANR)); ANR (Drosaequorin)(French National Research Agency (ANR)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by the CNRS, Burgundy Regional Council, and ANR (INSAVEL) to J-FF and TI, by the CNRS and ANR (Drosaequorin) to J-RM, and by the Ministry of Agriculture to FM-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ANTONY C, 1982, J INSECT PHYSIOL, V28, P873, DOI 10.1016/0022-1910(82)90101-9; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; FUJISHIRO N, 1984, J INSECT PHYSIOL, V30, P317, DOI 10.1016/0022-1910(84)90133-1; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Houot B, 2010, GENETICS, V185, P1297, DOI 10.1534/genetics.110.117226; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1989, CR ACAD SCI II, V309, P1551; KIMURA K, 1986, J EXP ZOOL, V239, P393, DOI 10.1002/jez.1402390310; Koganezawa M, 2010, CURR BIOL, V20, P1, DOI 10.1016/j.cub.2009.11.038; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lacaille F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000661; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Martin JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000275; Martin JR, 2008, J NEUROGENET, V22, P285, DOI 10.1080/01677060802298517; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Rybak F, 2002, P ROY SOC B-BIOL SCI, V269, P695, DOI 10.1098/rspb.2001.1919; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Siwicki KK, 2003, BEHAV PROCESS, V64, P225, DOI 10.1016/S0376-6357(03)00137-2; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; van der Goes van Naters W, 2007, CURR BIOL, V17, P606, DOI DOI 10.1016/J.CUB.2007.02.043; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	44	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e19770	10.1371/journal.pone.0019770	http://dx.doi.org/10.1371/journal.pone.0019770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625481	Green Published, Green Submitted, gold			2022-12-25	WOS:000290793400010
J	Ramirez-Lazaro, MJ; Lario, S; Casalots, A; Sanfeliu, E; Boix, L; Garcia-Iglesias, P; Sanchez-Delgado, J; Montserrat, A; Bella-Cueto, MR; Gallach, M; Sanfeliu, I; Segura, F; Calvet, X				Jose Ramirez-Lazaro, Maria; Lario, Sergio; Casalots, Alex; Sanfeliu, Esther; Boix, Loreto; Garcia-Iglesias, Pilar; Sanchez-Delgado, Jordi; Montserrat, Antonia; Rosa Bella-Cueto, Maria; Gallach, Marta; Sanfeliu, Isabel; Segura, Ferran; Calvet, Xavier			Real-Time PCR Improves Helicobacter pylori Detection in Patients with Peptic Ulcer Bleeding	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIBIOTIC-TREATMENT; BREATH TEST; UREASE TEST; INFECTION; DIAGNOSIS; TESTS; PREVALENCE; DISEASE; STOOL	Background and Aims: Histological and rapid urease tests to detect H. pylori in biopsy specimens obtained during peptic ulcer bleeding episodes (PUB) often produce false-negative results. We aimed to examine whether immunohistochemistry and real-time PCR can improve the sensitivity of these biopsies. Patients and Methods: We selected 52 histology-negative formalin-fixed paraffin-embedded biopsy specimens obtained during PUB episodes. Additional tests showed 10 were true negatives and 42 were false negatives. We also selected 17 histology-positive biopsy specimens obtained during PUB to use as controls. We performed immunohistochemistry staining and real-time PCR for 16S rRNA, ureA, and 23S rRNA for H. pylori genes on all specimens. Results: All controls were positive for H. pylori on all PCR assays and immunohistochemical staining. Regarding the 52 initially negative biopsies, all PCR tests were significantly more sensitive than immunohistochemical staining (p < 0.01). Sensitivity and specificity were 55% and 80% for 16S rRNA PCR, 43% and 90% for ureA PCR, 41% and 80% for 23S rRNA PCR, and 7% and 100% for immunohistochemical staining, respectively. Combined analysis of PCR assays for two genes were significantly more sensitive than ureA or 23S rRNA PCR tests alone (p < 0.05) and marginally better than 16S rRNA PCR alone. The best combination was 16S rRNA+ureA, with a sensitivity of 64% and a specificity of 80%. Conclusions: Real-time PCR improves the detection of H. pylori infection in histology-negative formalin-fixed paraffin-embedded biopsy samples obtained during PUB episodes. The low reported prevalence of H. pylori in PUB may be due to the failure of conventional tests to detect infection.	[Jose Ramirez-Lazaro, Maria; Lario, Sergio; Garcia-Iglesias, Pilar; Sanchez-Delgado, Jordi; Montserrat, Antonia; Gallach, Marta; Calvet, Xavier] Univ Autonoma Barcelona, Digest Dis Dept, Hosp Sabadell, Inst Univ Parc Tauli,Dept Med, Sabadell, Spain; [Jose Ramirez-Lazaro, Maria; Lario, Sergio; Boix, Loreto; Sanchez-Delgado, Jordi; Montserrat, Antonia; Calvet, Xavier] Inst Salud Carlos III, IBERehd, Barcelona, Spain; [Boix, Loreto] Hosp Clin Barcelona, Liver Unit, BCLC Grp, Barcelona, Spain; [Casalots, Alex; Sanfeliu, Esther; Rosa Bella-Cueto, Maria] Hosp Sabadell, Dept Pathol, Sabadell, Spain; [Sanfeliu, Isabel; Segura, Ferran] Univ Autonoma Barcelona, Dept Infect Dis, Hosp Sabadell, Inst Univ Parc Tauli,Dept Med, Sabadell, Spain; [Sanfeliu, Isabel; Segura, Ferran] Spanish Network Res Infect Dis REIPI RD06 0018, Seville, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Ramirez-Lazaro, MJ (corresponding author), Univ Autonoma Barcelona, Digest Dis Dept, Hosp Sabadell, Inst Univ Parc Tauli,Dept Med, Sabadell, Spain.	xcalvet@tauli.cat	Calvet, Xavier/H-3288-2019; Lario, Sergio/G-1173-2016	Calvet, Xavier/0000-0002-6278-9663; Ramirez-Lazaro, Maria Jose/0000-0003-0534-6070; Sanfeliu Torres, Esther/0000-0002-7974-3346; Bella-Cueto, Maria Rosa/0000-0002-5144-0490; Calvet, Xavier/0000-0002-4413-4209; Lario, Sergio/0000-0001-9294-1585; Ramirez Lazaro, Maria Jose/0000-0002-7044-6126	Instituto de Salud Carlos III [PI 05/1157, PI 05/0664]; Societat Catalana de Digestologia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Societat Catalana de Digestologia	This study was supported by grants from the Instituto de Salud Carlos III (PI 05/1157 and PI 05/0664) and the Societat Catalana de Digestologia. Maria Jose Ramirez-Lazaro, Sergio Lario and Loreto Boix are CIBERehd staff researchers. CIBERehd is funded by the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo T, 2004, HELICOBACTER, V9, P249, DOI 10.1111/j.1083-4389.2004.00219.x; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Biswas B, 2006, FDA IND STAT WORKSH; Brullet E, 2009, GASTROENTEROLOGY, V136, pA43; Calvet X, 2010, CLIN INFECT DIS, V50, P323, DOI 10.1086/649860; Calvet X, 2009, CLIN INFECT DIS, V48, P1385, DOI 10.1086/598198; Castillo-Rojas G, 2002, EUR J GASTROEN HEPAT, V14, P1113, DOI 10.1097/00042737-200210000-00012; Castro-Fernandez M, 2004, REV ESP ENFERM DIG, V96, P395; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Ciesielska U, 2002, FOLIA HISTOCHEM CYTO, V40, P129; de Argila CM, 2001, MED CLIN-BARCELONA, V117, P386, DOI 10.1016/S0025-7753(01)72122-7; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fantry GT, 1999, AM J GASTROENTEROL, V94, P1421, DOI 10.1111/j.1572-0241.1999.01421.x; Genta RM, 2010, AM J SURG PATHOL, V34, pE25, DOI 10.1097/PAS.0b013e3181e51067; Gisbert JP, 2007, HELICOBACTER, V12, P231, DOI 10.1111/j.1523-5378.2007.00492.x; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P848, DOI 10.1111/j.1572-0241.2006.00528.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P617, DOI 10.1111/j.1365-2036.2004.01898.x; Gisbert JP, 2004, ALIMENT PHARM THER, V19, P923, DOI 10.1111/j.1365-2036.2004.01932.x; Gisbert JP, 2003, SCAND J GASTROENTERO, V38, P2, DOI 10.1080/00365521.2003.11800649; Gisbert JP, 2001, SCAND J GASTROENTERO, V36, P717, DOI 10.1080/003655201300191978; Graham DY, 2003, AM J GASTROENTEROL, V98, P1005, DOI 10.1111/j.1572-0241.2003.07426.x; Guell M, 2006, ALIMENT PHARM THER, V23, P53, DOI 10.1111/j.1365-2036.2006.02726.x; Hayat M, 1999, GUT, V45, pA77; He QA, 2002, J CLIN MICROBIOL, V40, P3720, DOI 10.1128/JCM.40.10.3720-3728.2002; Houghton J, 2002, GASTROINTEST ENDOSC, V55, P11, DOI 10.1067/mge.2002.120391; Hung LCT, 2005, GASTROENTEROLOGY, V128, P1845, DOI 10.1053/j.gastro.2005.03.026; Kobayashi D, 2002, J MED MICROBIOL, V51, P305, DOI 10.1099/0022-1317-51-4-305; LAGE AP, 1995, J CLIN MICROBIOL, V33, P2752, DOI 10.1128/JCM.33.10.2752-2756.1995; Lanas A, 2010, MED CLIN-BARCELONA, V135, P608, DOI 10.1016/j.medcli.2010.07.002; Lascols C, 2003, J CLIN MICROBIOL, V41, P4573, DOI 10.1128/JCM.41.10.4573-4577.2003; Lee JM, 2000, AM J GASTROENTEROL, V95, P1166, DOI 10.1111/j.1572-0241.2000.02004.x; Leung WK, 1998, AM J GASTROENTEROL, V93, P1914, DOI 10.1111/j.1572-0241.1998.00457.x; Lin HJ, 2005, WORLD J GASTROENTERO, V11, P382, DOI 10.3748/wjg.v11.i3.382; Lo CC, 2005, WORLD J GASTROENTERO, V11, P3909; Pilotto A, 1997, DIGEST DIS SCI, V42, P586, DOI 10.1023/A:1018807412030; Raderer M, 2006, GUT, V55, P616, DOI 10.1136/gut.2005.083022; Resti M, 2009, CLIN THER, V31, P1266, DOI 10.1016/j.clinthera.2009.06.010; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Schabereiter-Gurtner C, 2004, J CLIN MICROBIOL, V42, P4512, DOI 10.1128/JCM.42.10.4512-4518.2004; Scholte GHA, 1997, DIAGN MOL PATHOL, V6, P238, DOI 10.1097/00019606-199708000-00008; Sotoudehmanesh Rasoul, 2005, Indian J Gastroenterol, V24, P59; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tankovic J, 2007, GASTROEN CLIN BIOL, V31, P792, DOI 10.1016/S0399-8320(07)73967-2; WEISS J, 1994, J CLIN MICROBIOL, V32, P1663, DOI 10.1128/JCM.32.7.1663-1668.1994; Wu CY, 1999, SCAND J GASTROENTERO, V34, P234, DOI 10.1080/00365529950173618	45	39	40	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20009	10.1371/journal.pone.0020009	http://dx.doi.org/10.1371/journal.pone.0020009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21625499	gold, Green Submitted, Green Published			2022-12-25	WOS:000290793400030
J	Geissler, R; Scholze, H; Hahn, S; Streubel, J; Bonas, U; Behrens, SE; Boch, J				Geissler, Rene; Scholze, Heidi; Hahn, Simone; Streubel, Jana; Bonas, Ulla; Behrens, Sven-Erik; Boch, Jens			Transcriptional Activators of Human Genes with Programmable DNA-Specificity	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; DOUBLE-STRAND BREAKS; TAL EFFECTORS; III EFFECTORS; RESTRICTION ENZYMES; BINDING SPECIFICITY; BACTERIAL-BLIGHT; C-TERMINUS; ONE-POT; RECOGNITION	TAL (transcription activator-like) effectors are translocated by Xanthomonas bacteria into plant cells where they activate transcription of target genes. DNA target sequence recognition occurs in a unique mode involving a central domain of tandem repeats. Each repeat recognizes a single base pair in a contiguous DNA sequence and a pair of adjacent hypervariable amino acid residues per repeat specifies which base is bound. Rearranging the repeats allows the design of novel TAL proteins with predictable DNA-recognition specificities. TAL protein-based transcriptional activation in plant cells is mediated by a C-terminal activation domain (AD). Here, we created synthetic TAL proteins with designed repeat compositions using a novel modular cloning strategy termed "Golden TAL Technology". Newly programmed TAL proteins were not only functional in plant cells, but also in human cells and activated targeted expression of exogenous as well as endogenous genes. Transcriptional activation in different human cell lines was markedly improved by replacing the TAL-AD with the VP16-AD of herpes simplex virus. The creation of TAL proteins with potentially any desired DNA-recognition specificity allows their versatile use in biotechnology.	[Geissler, Rene; Behrens, Sven-Erik] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Sect Microbial Biotechnol, Halle, Saale, Germany; [Scholze, Heidi; Hahn, Simone; Streubel, Jana; Bonas, Ulla; Boch, Jens] Univ Halle Wittenberg, Dept Genet, Inst Biol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Geissler, R (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Sect Microbial Biotechnol, Halle, Saale, Germany.	sven.behrens@biochemtech.uni-halle.de; jens.boch@genetik.uni-halle.de		Streubel, Jana/0000-0001-8155-511X	Deutsche Forschungsgemeinschaft [SPP 1212, SFB 648, BE 1885/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SPP 1212 to J.B. and U.B., SFB 648 to U.B. and S.-E.B.; BE 1885/6 to S.-E.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Kay S, 2005, MOL PLANT MICROBE IN, V18, P838, DOI 10.1094/MPMI-18-0838; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; MILLER JC, 2010, NAT BIOTECHNOL, DOI DOI 10.1038/NBT.1755; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Park KS, 2005, BIOTECHNOL PROGR, V21, P664, DOI 10.1021/bp049658x; Prinz M, 2010, TRENDS MOL MED, V16, P379, DOI 10.1016/j.molmed.2010.06.001; Reik A, 2007, BIOTECHNOL BIOENG, V97, P1180, DOI 10.1002/bit.21304; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2010, NEW PHYTOL, V187, P1048, DOI 10.1111/j.1469-8137.2010.03217.x; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Scholze H, 2010, VIRULENCE, V1, P428, DOI 10.4161/viru.1.5.12863; Schornack S, 2005, MOL PLANT MICROBE IN, V18, P1215, DOI 10.1094/MPMI-18-1215; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008; White FF, 2009, PLANT PHYSIOL, V150, P1677, DOI 10.1104/pp.109.139360; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824; Zhu WG, 1999, PLANT CELL, V11, P1665, DOI 10.1105/tpc.11.9.1665	38	113	203	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19509	10.1371/journal.pone.0019509	http://dx.doi.org/10.1371/journal.pone.0019509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625585	gold, Green Published, Green Submitted			2022-12-25	WOS:000290771200008
J	Giuliani, M; Fleury, M; Vernochet, A; Ketroussi, F; Clay, D; Azzarone, B; Lataillade, JJ; Durrbach, A				Giuliani, Massimo; Fleury, Maud; Vernochet, Amelia; Ketroussi, Farah; Clay, Denis; Azzarone, Bruno; Lataillade, Jean Jacques; Durrbach, Antoine			Long-Lasting Inhibitory Effects of Fetal Liver Mesenchymal Stem Cells on T-Lymphocyte Proliferation	PLOS ONE			English	Article							MARROW STROMAL CELLS; HLA-G; IN-VITRO; EXPRESSION; DIFFERENTIATION; BLOOD; IDENTIFICATION; TRANSCRIPTS; SUPPRESSION; SURVIVAL	Human bone marrow mesenchymal stem cells (BM-MSC) are multipotent progenitor cells that have transient immunomodulatory properties on Natural Killer (NK) cells, Dendritic Cells (DC), and T cells. This study compared the use of MSC isolated from bone marrow and fetal liver (FL-MSC) to determine which displayed the most efficient immunosuppressive effects on T cell activation. Although both types of MSC exhibit similar phenotype profile, FL-MSC displays a much more extended in vitro life-span and immunomodulatory properties. When co-cultured with CD3/CD28-stimulated T cells, both BM-MSC and FL-MSC affected T cell proliferation by inhibiting their entry into the cell cycle, by inducing the down-regulation of phospho-retinoblastoma (pRb), cyclins A and D1, as well as up-regulating p27(kip1) expression. The T cell inhibition by MSC was not due to the soluble HLA-G5 isoform, but to the surface expression of HLA-G1, as shown by the need of cell-cell contact and by the use of neutralizing anti-HLA-G antibodies. To note, in a HLA-G-mediated fashion, MSC facilitated the expansion of a CD4(low)/CD8(low) T subset that had decreased secretion of IFN-gamma, and an induced secretion of the immunomodulatory cytokine IL-10. Because of their longer lasting in vitro immunosuppressive properties, mainly mediated by HLA-G, and their more efficient induction of IL-10 production and T cell apoptosis, fetal liver MSC could be considered a new tool for MSC therapy to prevent allograft rejection.	[Giuliani, Massimo; Vernochet, Amelia; Ketroussi, Farah; Azzarone, Bruno; Durrbach, Antoine] Hop Paul Brousse, INSERM, U1014, Villejuif, France; [Fleury, Maud] Hop Paul Brousse, INSERM, U602, Villejuif, France; [Vernochet, Amelia; Ketroussi, Farah; Azzarone, Bruno; Durrbach, Antoine] Univ Paris 11, Serv Nephrol, Le Kremlin Bicetre, France; [Clay, Denis] Hop Paul Brousse, IFR89, Villejuif, France; [Lataillade, Jean Jacques] Hop Percy, Lab Therapie Cellulaire, CTSA, Clamart, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Giuliani, M (corresponding author), Hop Paul Brousse, INSERM, U1014, Villejuif, France.	giulianimas@hotmail.com	Azzarone, Bruno/AAH-9251-2019	Azzarone, Bruno/0000-0002-5962-3849	NRB-Vaincre le Cancer; DIM Stem-Pole; Institut Francilien de Recherche en Nephrologie et Transplantation (IFRNT)	NRB-Vaincre le Cancer; DIM Stem-Pole; Institut Francilien de Recherche en Nephrologie et Transplantation (IFRNT)	This work was supported by grants from the NRB-Vaincre le Cancer, DIM Stem-Pole, and Institut Francilien de Recherche en Nephrologie et Transplantation (IFRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Anker PSI, 2003, HAEMATOLOGICA, V88, P845; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carosella ED, 2003, ADV IMMUNOL, V81, P199, DOI 10.1016/S0065-2776(03)81006-4; Carosella ED, 2008, HUM IMMUNOL, V69, P700, DOI 10.1016/j.humimm.2008.08.280; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2007, STEM CELLS, V25, P2025, DOI 10.1634/stemcells.2006-0548; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hayflick L, 1985, Clin Geriatr Med, V1, P15; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x; Le Rond S, 2004, EUR J IMMUNOL, V34, P649, DOI 10.1002/eji.200324266; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mikhelson V. M., 2010, Radiatsionnaya Biologiya Radioekologiya, V50, P269; Naji A, 2007, BLOOD, V110, P3936, DOI 10.1182/blood-2007-04-083139; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nasef A, 2007, GENE EXPRESSION, V13, P217; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ramasamy R, 2008, CELL IMMUNOL, V251, P131, DOI 10.1016/j.cellimm.2008.04.009; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Rizzo R, 2008, CYTOTHERAPY, V10, P364, DOI 10.1080/14653240802105299; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Rouas-Freiss N, 2005, INT J CANCER, V117, P114, DOI 10.1002/ijc.21151; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Yao YQ, 2005, J IMMUNOL, V175, P8379, DOI 10.4049/jimmunol.175.12.8379; Zhou HP, 2006, TRANSPL P, V38, P3046, DOI 10.1016/j.transproceed.2006.10.002	45	68	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19988	10.1371/journal.pone.0019988	http://dx.doi.org/10.1371/journal.pone.0019988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21625521	Green Published, Green Submitted, gold			2022-12-25	WOS:000290771200036
J	Chang, YJ; Yeh, ML; Li, YC; Hsu, CY; Lin, CC; Hsu, MS; Chiu, WT				Chang, Ying-Jui; Yeh, Min-Li; Li, Yu-Chuan; Hsu, Chien-Yeh; Lin, Chao-Cheng; Hsu, Meng-Shiuan; Chiu, Wen-Ta			Predicting Hospital-Acquired Infections by Scoring System with Simple Parameters	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; ADMINISTRATIVE CODING DATA; TRAUMATIC BRAIN-INJURY; NOSOCOMIAL INFECTIONS; RISK-FACTORS; SURVEILLANCE; PREVENTION; MORTALITY; COSTS	Background: Hospital-acquired infections (HAI) are associated with increased attributable morbidity, mortality, prolonged hospitalization, and economic costs. A simple, reliable prediction model for HAI has great clinical relevance. The objective of this study is to develop a scoring system to predict HAI that was derived from Logistic Regression (LR) and validated by Artificial Neural Networks (ANN) simultaneously. Methodology/Principal Findings: A total of 476 patients from all the 806 HAI inpatients were included for the study between 2004 and 2005. A sample of 1,376 non-HAI inpatients was randomly drawn from all the admitted patients in the same period of time as the control group. External validation of 2,500 patients was abstracted from another academic teaching center. Sixteen variables were extracted from the Electronic Health Records (EHR) and fed into ANN and LR models. With stepwise selection, the following seven variables were identified by LR models as statistically significant: Foley catheterization, central venous catheterization, arterial line, nasogastric tube, hemodialysis, stress ulcer prophylaxes and systemic glucocorticosteroids. Both ANN and LR models displayed excellent discrimination (area under the receiver operating characteristic curve [AUC]: 0.964 versus 0.969, p = 0.507) to identify infection in internal validation. During external validation, high AUC was obtained from both models (AUC: 0.850 versus 0.870, p = 0.447). The scoring system also performed extremely well in the internal (AUC: 0.965) and external (AUC: 0.871) validations. Conclusions: We developed a scoring system to predict HAI with simple parameters validated with ANN and LR models. Armed with this scoring system, infectious disease specialists can more efficiently identify patients at high risk for HAI during hospitalization. Further, using parameters either by observation of medical devices used or data obtained from EHR also provided good prediction outcome that can be utilized in different clinical settings.	[Chang, Ying-Jui; Yeh, Min-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Ying-Jui] Far Eastern Mem Hosp, Dept Dermatol, New Taipei, Taiwan; [Yeh, Min-Li] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan; [Li, Yu-Chuan] Taipei Med Univ, Dept Dermatol, Wan Fang Hosp, Taipei, Taiwan; [Li, Yu-Chuan; Hsu, Chien-Yeh] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, CECR, Taipei, Taiwan; [Lin, Chao-Cheng] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Meng-Shiuan] Far Eastern Mem Hosp, Infect Dis Sect, Dept Internal Med, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jack@tmu.edu.tw; cyhsu@tmu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657				Archibald LK, 2007, BENNETT BRACHMANS HO, P483; Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Chong Chee-Fah, 2003, AMIA Annu Symp Proc, P160; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Department of Health EY Taiwan, 2010, EL MED REC; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Escolano S, 2000, STAT MED, V19, P3465, DOI 10.1002/1097-0258(20001230)19:24&lt;3465::AID-SIM658&gt;3.0.CO;2-6; Ferrer M, 1999, ANN INTERN MED, V130, P991, DOI 10.7326/0003-4819-130-12-199906150-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Goldstein Melissa M, 2010, Perspect Health Inf Manag, V7; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kamp-Hopmans TEM, 2003, INFECT CONT HOSP EP, V24, P584, DOI 10.1086/502258; Kostadima E, 2006, EUR RESPIR J, V27, P437, DOI 10.1183/09031936.06.00127405; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lin CC, 2008, COMPUT METH PROG BIO, V91, P91, DOI 10.1016/j.cmpb.2008.02.004; Mahieu LM, 2001, J HOSP INFECT, V47, P223, DOI 10.1053/jhin.2000.0852; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Shang J S, 2000, Health Care Manag Sci, V3, P287, DOI 10.1023/A:1019018129822; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Teramoto S, 2006, EUR RESPIR J, V27, P436, DOI 10.1183/09031936.06.00113405; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Wilson JS, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-47; Woeltje KF, 2010, CRIT CARE MED, V38, pS399, DOI 10.1097/CCM.0b013e3181e6d11d	42	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23137	10.1371/journal.pone.0023137	http://dx.doi.org/10.1371/journal.pone.0023137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887234	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000008
J	Wang, D; Li, YP; Lee, SG; Wang, L; Fan, JH; Zhang, G; Wu, J; Ji, Y; Li, SL				Wang, Dong; Li, Yanping; Lee, Simin Gharib; Wang, Lei; Fan, Jinhui; Zhang, Gong; Wu, Jiang; Ji, Yong; Li, Songlin			Ethnic Differences in Body Composition and Obesity Related Risk Factors: Study in Chinese and White Males Living in China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; MASS INDEX; WAIST CIRCUMFERENCE; METABOLIC-DISORDERS; INSULIN-RESISTANCE; FAT; PREVALENCE; ASIA; POPULATION	The purpose of this cross-sectional observational study was to identify ethnic differences in body composition and obesity-related risk factors between Chinese and white males living in China. 115 Chinese and 114 white male pilots aged 28-63 years were recruited. Fasting body weight, height and blood pressure were measured following standard procedures. Whole-body and segmental body composition were measured using an 8-contact electrode bioimpedance analysis (BIA) system. Fasting serum glucose, fasting plasma total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, and triglycerides (TG) were assessed using automatic biochemistry analyzer. After adjusting for age and body mass index (BMI), Chinese males had significantly higher percentage of body fat (PBF) both with respect to whole body (Chinese: 23.7% +/- 0.2% vs. Whites: 22.4% +/- 0.2%) and the trunk area (Chinese: 25.0% +/- 0.3% vs. Whites: 23.2% +/- 0.3%) compared to their white counterparts. At all BMIs, Chinese males had significantly higher fasting glucose levels (Chinese: 5.7 +/- 1.0 mmol/L vs. Whites: 5.2 +/- 1.0 mmol/L) but lower high-density lipoprotein levels (Chinese: 0.8 +/- 1.0 mmol/L vs. Whites: 1.0 +/- 1.0 mmol/L) than white males. In addition, a marginally significantly higher diastolic blood pressure was found among Chinese men than that among white men (Chinese: 80 +/- 1.0 mmHg vs. Whites: 77 +/- 1.0 mmHg). Chinese males had more body fat and a greater degree of central fat deposition pattern than that seen in white males in the present study. Furthermore, data on blood pressure, fasting glucose and blood lipids suggest that Chinese men may be more prone to obesity-related risk factors than white men.	[Wang, Dong; Wang, Lei; Fan, Jinhui; Zhang, Gong; Wu, Jiang; Ji, Yong; Li, Songlin] Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China; [Wang, Dong] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Yanping] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Lee, Simin Gharib] Tsinghua Univ, Beijing 100084, Peoples R China	Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Tsinghua University	Wang, D (corresponding author), Civil Aviat Adm China, Civil Aviat Med Ctr, Beijing, Peoples R China.	wangdong621@live.cn; lsonglin@yahoo.com	Li, Yanping/H-6437-2011; Palmer, Cheryl/H-4074-2011; Wang, Dong D./AAU-2951-2021	Li, Yanping/0000-0002-0412-2748; Wang, Dong D./0000-0002-0897-3048; Sanders, Paul/0000-0002-2915-5714; Palmer, Cheryl/0000-0001-6088-9161; Gillespie, George/0000-0001-6436-9542	Civil Aviation Administration of China [200 000 RMB]; NATIONAL CANCER INSTITUTE [R01CA127620, R01CA109748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199] Funding Source: NIH RePORTER	Civil Aviation Administration of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Civil Aviation Administration of China, grant number 200 000 RMB; (http://www.caac.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; *AM HEART ASS, 2002, HEART DIS STROK STAT; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Bell AC, 2001, INT J OBESITY, V25, P1079, DOI 10.1038/sj.ijo.0801651; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chang CJ, 2000, INT J OBESITY, V24, P1699, DOI 10.1038/sj.ijo.0801457; Cheng TO, 2009, INT J CARDIOL, V135, P385, DOI 10.1016/j.ijcard.2007.11.080; Chumlea WC, 2002, INT J OBESITY, V26, P1596, DOI 10.1038/sj.ijo.0802167; *CIV AV ADM CHIN, 2001, STAND MED CHECK CERT; Cooperative Meta-analysis Group of China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Deurenberg P, 2003, EUR J CLIN NUTR, V57, P405, DOI 10.1038/sj.ejcn.1601569; Deurenberg P, 1997, Asia Pac J Clin Nutr, V6, P102; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Du SM, 2010, BIOMED ENVIRON SCI, V23, P92, DOI 10.1016/S0895-3988(10)60037-2; ESTON R, 1994, BRIT J SPORT MED, V28, P9, DOI 10.1136/bjsm.28.1.9; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; James WPT, 2004, COMP QUANTIFICATION, P497; JIANG ZM, 1991, WORLD J SURG, V15, P95, DOI 10.1007/BF01658974; JIN J, 2008, ZHONG GUO YUN DONG Y, V27, P463; Lee CMY, 2007, ASIA PAC J CLIN NUTR, V16, P187; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rush EC, 2007, INT J OBESITY, V31, P1232, DOI 10.1038/sj.ijo.0803576; Rush EC, 2009, BRIT J NUTR, V102, P632, DOI 10.1017/S0007114508207221; SLUYTER JD, 2009, OBESITY, V18, P183; Vikram NK, 2003, NUTRITION, V19, P503, DOI 10.1016/S0899-9007(02)01083-3; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Weng X, 2006, EUR J CLIN NUTR, V60, P931, DOI 10.1038/sj.ejcn.1602396; WHO, 2004, LANCET, V363, P902; World Economic Forum, 2010, GLOB RISKS 2010 GLOB; World Health Organization, 2021, OB OV FACT SHEETS; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhao D, 2007, AM J CARDIOL, V100, P835, DOI 10.1016/j.amjcard.2007.03.103	44	69	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2011	6	5							e19835	10.1371/journal.pone.0019835	http://dx.doi.org/10.1371/journal.pone.0019835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766HI	21602932	Green Published, gold, Green Submitted			2022-12-25	WOS:000290771200026
J	Zheng, BW; Zhang, QM; Gao, J; Han, HM; Li, M; Zhang, JR; Qi, JX; Yan, JH; Gao, GF				Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Zhang, Jingren; Qi, Jianxun; Yan, Jinghua; Gao, George F.			Insight into the Interaction of Metal Ions with TroA from Streptococcus suis	PLOS ONE			English	Article							TREPONEMA-PALLIDUM TROA; TRANSPORT PROTEIN ZNUA; ZINC-BINDING PROTEIN; CRYSTAL-STRUCTURE; ABC TRANSPORTERS; IRON TRANSPORT; MANGANESE; VIRULENCE; REVEALS; PSAA	Background: The scavenging ability of sufficient divalent metal ions is pivotal for pathogenic bacteria to survive in the host. ATP-binding cassette (ABC)-type metal transporters provide a considerable amount of different transition metals for bacterial growth. TroA is a substrate binding protein for uptake of multiple metal ions. However, the function and structure of the TroA homologue from the epidemic Streptococcus suis isolates (SsTroA) have not been characterized. Methodology/Principal Findings: Here we determined the crystal structure of SsTroA from a highly pathogenic streptococcal toxic shock syndrome (STSS)-causing Streptococcus suis in complex with zinc. Inductively coupled plasma mass spectrometry (ICP-MS) analysis revealed that apo-SsTroA binds Zn2+ and Mn2+. Both metals bind to SsTroA with nanomolar affinity and stabilize the protein against thermal unfolding. Zn2+ and Mn2+ induce distinct conformational changes in SsTroA compared with the apo form as confirmed by both circular dichroism (CD) and nuclear magnetic resonance (NMR) spectra. NMR data also revealed that Zn2+/Mn2+ bind to SsTroA in either the same site or an adjacent region. Finally, we found that the folding of the metal-bound protein is more compact than the corresponding apoprotein. Conclusions/Significance: Our findings reveal a mechanism for uptake of metal ions in S. suis and this mechanism provides a reasonable explanation as to how SsTroA operates in metal transport.	[Zheng, Beiwen; Zhang, Qiangmin; Gao, Jia; Han, Huiming; Li, Ming; Qi, Jianxun; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Zheng, Beiwen; Han, Huiming; Gao, George F.] Chinese Acad Sci, Coll Life Sci, Grad Univ, Beijing, Peoples R China; [Gao, Jia] Guangxi Univ, Key Lab, Minist Educ Microbial & Plant Genet Engn, Nanning, Guangxi, Peoples R China; [Zhang, Jingren] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi University; Tsinghua University; Chinese Academy of Sciences	Zheng, BW (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	gaof@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021; Georgieva, Angelina/AAC-4823-2021	Georgieva, Angelina/0000-0003-0731-7775	Ministry of Science and Technology (MOST) [2011CB504003, 2006BAD06A04]; National Natural Science Fundation of China (NSFC) [30728014]; NSFC Innovative Research Group [81021003]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Natural Science Fundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC Innovative Research Group	The work was supported by grants from the Ministry of Science and Technology (MOST, Project 973 Grant No. 2011CB504003; National Key Technology R&D Program 2006BAD06A04); J.Z. and G. F. G. have a joint grant by National Natural Science Fundation of China (NSFC, Grant No. 30728014). G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2008, INFECT IMMUN, V76, P1590, DOI 10.1128/IAI.00987-07; Aranda J, 2009, MICROBIOL-SGM, V155, P1580, DOI 10.1099/mic.0.026278-0; Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; BLANCO DR, 1995, J BACTERIOL, V177, P3556, DOI 10.1128/jb.177.12.3556-3562.1995; BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2; Chandra BR, 2007, J MOL BIOL, V367, P970, DOI 10.1016/j.jmb.2007.01.041; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Feng YJ, 2008, J BACTERIOL, V190, P7567, DOI 10.1128/JB.01532-07; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GARIEPY J, 1985, BIOCHEMISTRY-US, V24, P544, DOI 10.1021/bi00323a045; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hazlett KRO, 2003, J BIOL CHEM, V278, P20687, DOI 10.1074/jbc.M300781200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Kamen DE, 2001, PROTEIN SCI, V10, P2123, DOI 10.1110/ps.19801; LANGFORD P, 1991, FEMS MICROBIOL LETT, V77, P347, DOI 10.1016/0378-1097(91)90578-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Ma Y, 2009, PHILOS T R SOC B, V364, P2725, DOI 10.1098/rstb.2009.0093; McEwan AG, 2009, MOL MICROBIOL, V72, P812, DOI 10.1111/j.1365-2958.2009.06700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; PERCH B, 1968, ACTA PATHOL MIC SC, V74, P69; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rajam G, 2008, CRIT REV MICROBIOL, V34, P131, DOI [10.1080/10408410802275352, 10.1080/10408410802275352 ]; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V748, P99, DOI 10.1016/0167-4838(83)90032-8; Rukhman V, 2005, J MOL BIOL, V348, P961, DOI 10.1016/j.jmb.2005.03.006; Sambrook J, 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	66	100	100	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19510	10.1371/journal.pone.0019510	http://dx.doi.org/10.1371/journal.pone.0019510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21611125	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200010
J	Chang, YT; Wu, CC; Shyr, YM; Chen, TC; Hwang, TL; Yeh, TS; Chang, KP; Liu, HP; Liu, YL; Tsai, MH; Chang, YS; Yu, JS				Chang, Ya-Ting; Wu, Chih-Ching; Shyr, Yi-Ming; Chen, Tse-Ching; Hwang, Tsann-Long; Yeh, Ta-Sen; Chang, Kai-Ping; Liu, Hao-Ping; Liu, Yu-Ling; Tsai, Ming-Hung; Chang, Yu-Sun; Yu, Jau-Song			Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CLINICAL-SIGNIFICANCE; PROTEOMIC ANALYSIS; NKG2D LIGANDS; CELL LINES; EXPRESSION; PROTEIN; BIOMARKERS; INDICATOR; DIAGNOSIS	Background: To discover novel markers for improving the efficacy of pancreatic cancer (PC) diagnosis, the secretome of two PC cell lines (BxPC-3 and MIA PaCa-2) was profiled. UL16 binding protein 2 (ULBP2), one of the proteins identified in the PC cell secretome, was selected for evaluation as a biomarker for PC detection because its mRNA level was also found to be significantly elevated in PC tissues. Methods: ULBP2 expression in PC tissues from 67 patients was studied by immunohistochemistry. ULBP2 serum levels in 154 PC patients and 142 healthy controls were measured by bead-based immunoassay, and the efficacy of serum ULBP2 for PC detection was compared with the widely used serological PC marker carbohydrate antigen 19-9 (CA 19-9). Results: Immunohistochemical analyses revealed an elevated expression of ULPB2 in PC tissues compared with adjacent non-cancerous tissues. Meanwhile, the serum levels of ULBP2 among all PC patients (n = 154) and in early-stage cancer patients were significantly higher than those in healthy controls (p < 0.0001). The combination of ULBP2 and CA 19-9 outperformed each marker alone in distinguishing PC patients from healthy individuals. Importantly, an analysis of the area under receiver operating characteristic curves showed that ULBP2 was superior to CA 19-9 in discriminating patients with early-stage PC from healthy controls. Conclusions: Collectively, our results indicate that ULBP2 may represent a novel and useful serum biomarker for pancreatic cancer primary screening.	[Chang, Ya-Ting; Tsai, Ming-Hung; Yu, Jau-Song] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Chih-Ching; Liu, Hao-Ping; Liu, Yu-Ling; Chang, Yu-Sun; Yu, Jau-Song] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Shyr, Yi-Ming] Taipei Vet Gen Hosp, Dept Surg, Div Gen & Transplantat Surg, Taipei, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Anat Pathol, Tao Yuan, Taiwan; [Hwang, Tsann-Long; Yeh, Ta-Sen] Chang Gung Mem Hosp, Dept Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Head & Neck Surg, Tao Yuan, Taiwan; [Yu, Jau-Song] Chang Gung Univ, Dept Cell & Mol Biol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, YT (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	luckywu@mail.cgu.edu.tw; yusong@mail.cgu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657	Taiwan National Science Council [NSC 96-2320-B-182-031-MY3]; Department of Health [DOH-99-TD-C-111-006]; Ministry of Education [EMRPD180241, EMRPD180091]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Ministry of Education	This study was supported by the grants from the Taiwan National Science Council (NSC 96-2320-B-182-031-MY3), Department of Health (DOH-99-TD-C-111-006), and Ministry of Education (EMRPD180241 and EMRPD180091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan M, 2001, TUMORI, V87, P337, DOI 10.1177/030089160108700513; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chang ST, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-105; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; *DEP HLTH, 2009, STAND DEATH RAT LEAD; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guo JH, 2009, CANCER SCI, V100, P2292, DOI 10.1111/j.1349-7006.2009.01324.x; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hoimes CJ, 2009, J PANCREAS, V10, P352; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Katz MH, 2005, PANCREATOLOGY, V5, P576, DOI 10.1159/000087500; Lee MX, 2009, J PANCREAS, V10, P104; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Maccalli C, 2007, CLIN CANCER RES, V13, P7459, DOI 10.1158/1078-0432.CCR-07-1166; MAGNANI JL, 1983, CANCER RES, V43, P5489; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Melle C, 2007, CLIN CHEM, V53, P629, DOI 10.1373/clinchem.2006.079194; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Oto A, 2006, CURR PROBL DIAGN RAD, V35, P199, DOI 10.1067/j.cpradiol.2006.06.001; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Pende D, 2002, CANCER RES, V62, P6178; Pliarchopoulou K, 2009, CANCER TREAT REV, V35, P431, DOI 10.1016/j.ctrv.2009.02.005; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; RAVN V, 1993, PATHOL RES PRACT, V189, P1015; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; TEMPERO MA, 1987, CANCER RES, V47, P5501; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Watson NFS, 2006, INT J CANCER, V118, P1445, DOI 10.1002/ijc.21510; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu CC, 2008, PROTEOM CLIN APPL, V2, P1586, DOI 10.1002/prca.200800080; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	41	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20029	10.1371/journal.pone.0020029	http://dx.doi.org/10.1371/journal.pone.0020029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21887234	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400031
J	Sun, YC; Yin, J; Cao, HF; Li, CY; Kang, L; Ge, F				Sun, Yucheng; Yin, Jin; Cao, Haifeng; Li, Chuanyou; Kang, Le; Ge, Feng			Elevated CO2 Influences Nematode-Induced Defense Responses of Tomato Genotypes Differing in the JA Pathway	PLOS ONE			English	Article							ATMOSPHERIC CO2; CARBON-DIOXIDE; SIGNALING PATHWAY; NATURAL ENEMIES; JASMONIC ACID; ROOT; RESISTANCE; HERBIVORY; COSTS; BIOSYNTHESIS	Rising atmospheric CO2 concentrations can affect the induced defense of plants against chewing herbivores but little is known about whether elevated CO2 can change the induced defense of plants against parasitic nematodes. This study examined the interactions between the root-knot nematode Meloidogyne incognita and three isogenic tomato (Lycopersicon esculentum) genotypes grown under ambient (390 ppm) and elevated (750 ppm) CO2 in growth chambers. In a previous study with open-top chambers in the field, we reported that elevated CO2 increased the number of nematode-induced root galls in a JA-defense-dominated genotype but not in a wild-type or JA-defense-recessive genotype. In the current study, we tested the hypothesis that elevated CO2 will favor the salicylic acid (SA)-pathway defense but repress the jasmonic acid (JA)-pathway defense of plants against plant-parasitic nematodes. Our data showed that elevated CO2 reduced the JA-pathway defense against M. incognita in the wild-type and in a genotype in which defense is dominated by the JA pathway (a JA-defense-dominated genotype) but up-regulated the SA-pathway defense in the wild type and in a JA-defense-recessive genotype (jasmonate-deficient mutant). Our results suggest that, in terms of defense genes, secondary metabolites, and volatile organic compounds, induced defense of nematode-infected plants could be affected by elevated CO2, and that CO2-induced changes of plant resistance may lead to genotype-specific responses of plants to nematodes under elevated CO2. The changes in resistance against nematodes, however, were small relative to those reported for chewing insects.	[Sun, Yucheng; Yin, Jin; Cao, Haifeng; Kang, Le; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China; [Li, Chuanyou] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Sun, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest & Rodent, Beijing, Peoples R China.	gef@ioz.ac.cn	Kang, Le/ABD-1116-2022; Li, Chuanyou/ABF-4143-2020; Jiang, Xingyu/U-3976-2018	Kang, Le/0000-0003-4262-2329; Jiang, Xingyu/0000-0002-5008-4703; Sun, Yi/0000-0002-1746-0404; Sun, Yucheng/0000-0003-2353-0218	National Basic Research Program of China (973 Program) [2009CB119200]; National Nature Science Fund of China [30970510, 31000854, 30921063]; Chinese Academy of Science [KSCX3-YW-N-005, 2010-Biols-CAS-0102]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB119200), the National Nature Science Fund of China (No. 30970510, 31000854 and 30921063) and the Innovation Program of Chinese Academy of Science (KSCX3-YW-N-005, 2010-Biols-CAS-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Ayres E, 2008, SOIL BIOL BIOCHEM, V40, P978, DOI 10.1016/j.soilbio.2007.11.018; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bidart-Bouzat MG, 2005, OECOLOGIA, V145, P415, DOI 10.1007/s00442-005-0158-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; [陈法军 Chen Fajun], 2004, [昆虫知识, Entomological  Knowledge], V41, P279; Cooper WR, 2005, J CHEM ECOL, V31, P1953, DOI 10.1007/s10886-005-6070-y; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hamilton JG, 2001, ECOL LETT, V4, P86, DOI 10.1046/j.1461-0248.2001.00192.x; Hartley SE, 2000, GLOBAL CHANGE BIOL, V6, P497, DOI 10.1046/j.1365-2486.2000.00333.x; HOWE GA, 2007, ANNU REV PLANT BIOL, V17, P41; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kujala TS, 2000, J AGR FOOD CHEM, V48, P5338, DOI 10.1021/jf000523q; Lau JA, 2009, OECOLOGIA, V161, P401, DOI 10.1007/s00442-009-1384-z; Li CR, 2002, PLANT CELL ENVIRON, V25, P369, DOI 10.1046/j.0016-8025.2001.00818.x; Li CY, 2003, PLANT CELL, V15, P1646, DOI 10.1105/tpc.012237; Li CY, 2002, PLANT PHYSIOL, V130, P494, DOI 10.1104/pp.005314; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Loreto F, 2001, GLOBAL CHANGE BIOL, V7, P709, DOI 10.1046/j.1354-1013.2001.00442.x; Melillo MT, 2006, NEW PHYTOL, V170, P501, DOI 10.1111/j.1469-8137.2006.001724.x; Niklaus PA, 2003, GLOBAL CHANGE BIOL, V9, P585, DOI 10.1046/j.1365-2486.2003.00614.x; Soriano IR, 2004, J CHEM ECOL, V30, P1885, DOI 10.1023/B:JOEC.0000045584.56515.11; Stevens MT, 2007, EVOL ECOL, V21, P829, DOI 10.1007/s10682-006-9154-4; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Sun YC, 2010, AGR ECOSYST ENVIRON, V135, P140, DOI 10.1016/j.agee.2009.09.011; TERRILL TH, 1992, J SCI FOOD AGR, V58, P321, DOI 10.1002/jsfa.2740580306; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; Vasyukova N. I., 2003, Doklady Akademii Nauk, V391, P419; Vuorinen T, 2004, PLANT PHYSIOL, V135, P1984, DOI 10.1104/pp.104.047084; Vuorinen T, 2004, ATMOS ENVIRON, V38, P675, DOI 10.1016/j.atmosenv.2003.10.029; Williamson VM, 1998, ANNU REV PHYTOPATHOL, V36, P277, DOI 10.1146/annurev.phyto.36.1.277; Yeates GW, 2003, BIOL FERT SOILS, V38, P319, DOI 10.1007/s00374-003-0659-5; Yin J, 2009, AGR ECOSYST ENVIRON, V132, P267, DOI 10.1016/j.agee.2009.04.010; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P5129, DOI 10.1073/pnas.0800568105; Zavala JA, 2009, OECOLOGIA, V161, P35, DOI 10.1007/s00442-009-1360-7	42	61	63	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e19751	10.1371/journal.pone.0019751	http://dx.doi.org/10.1371/journal.pone.0019751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21629688	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800007
J	Wang, DY; Olman, MA; Stewart, J; Tipps, R; Huang, P; Sanders, PW; Toline, E; Prayson, RA; Lee, J; Weil, RJ; Palmer, CA; Gillespie, GY; Liu, WM; Pieper, RO; Guan, JL; Gladson, CL				Wang, Dongyan; Olman, Mitchell A.; Stewart, Jerry, Jr.; Tipps, Russell; Huang, Ping; Sanders, Paul W.; Toline, Eric; Prayson, Richard A.; Lee, Jeongwu; Weil, Robert J.; Palmer, Cheryl A.; Gillespie, G. Yancey; Liu, Wei Michael; Pieper, Russell O.; Guan, Jun-Lin; Gladson, Candece L.			Downregulation of FIP200 Induces Apoptosis of Glioblastoma Cells and Microvascular Endothelial Cells by Enhancing Pyk2 Activity	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HUMAN BREAST-CANCER; ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; TYROSINE KINASE; CYCLE PROGRESSION; INTERACTING PROTEIN; HUMAN NEUTROPHILS; MAMMALIAN-CELLS; SRC KINASE	The expression of focal adhesion kinase family interacting protein of 200-kDa (FIP200) in normal brain is limited to some neurons and glial cells. On immunohistochemical analysis of biopsies of glioblastoma tumors, we detected FIP200 in the tumor cells, tumor-associated endothelial cells, and occasional glial cells. Human glioblastoma tumor cell lines and immortalized human astrocytes cultured in complete media also expressed FIP200 as did primary human brain microvessel endothelial cells (MvEC), which proliferate in culture and resemble reactive endothelial cells. Downregulation of endogenous expression of FIP200 using small interfering RNA resulted in induction of apoptosis in the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC. It has been shown by other investigators using cells from other tissues that FIP200 can interact directly with, and inhibit, proline-rich tyrosine kinase 2 (Pyk2) and focal adhesion kinase (FAK). In the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC, we found that downregulation of FIP200 increased the activity of Pyk2 without increasing its expression, but did not affect the activity or expression of FAK. Coimmunoprecipitation and colocalization studies indicated that the endogenous FIP200 was largely associated with Pyk2, rather than FAK, in the glioblastoma tumor cells and brain MvEC. Moreover, the pro-apoptotic effect of FIP200 downregulation was inhibited significantly by a TAT-Pyk2-fusion protein containing the Pyk2 autophosphorylation site in these cells. In summary, downregulation of endogenous FIP200 protein in glioblastoma tumor cells, astrocytes, and brain MvECs promotes apoptosis, most likely due to the removal of a direct interaction of FIP200 with Pyk2 that inhibits Pyk2 activation, suggesting that FIP200 expression may be required for the survival of all three cell types found in glioblastoma tumors.	[Wang, Dongyan; Stewart, Jerry, Jr.; Toline, Eric; Palmer, Cheryl A.; Liu, Wei Michael; Gladson, Candece L.] Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA; [Olman, Mitchell A.] Univ Alabama Birmingham, Dept Med, Div Pulm Crit Care, Birmingham, AL 35294 USA; [Sanders, Paul W.] Univ Alabama Birmingham, Dept Nephrol, Birmingham, AL 35294 USA; [Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Tipps, Russell; Huang, Ping; Liu, Wei Michael; Gladson, Candece L.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA; [Lee, Jeongwu] Cleveland Clin, Dept Stem Cell & Regenerat Med, Cleveland, OH 44106 USA; [Prayson, Richard A.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Weil, Robert J.; Gladson, Candece L.] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA; [Pieper, Russell O.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Guan, Jun-Lin] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Wang, DY (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Neuropathol, Birmingham, AL 35294 USA.	gladsoc@ccf.org	Li, Yanping/H-6437-2011; Palmer, Cheryl/H-4074-2011; Wang, Dong D./AAU-2951-2021	Li, Yanping/0000-0002-0412-2748; Wang, Dong D./0000-0002-0897-3048; Sanders, Paul/0000-0002-2915-5714; Palmer, Cheryl/0000-0001-6088-9161; Gillespie, George/0000-0001-6436-9542	National Institutes of Health [DK46199, HL58655, CA109748, CA127620]; Melvin Burkhardt chair in Neurosurgical Oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA127620, R01CA109748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melvin Burkhardt chair in Neurosurgical Oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK46199 to PWS, HL58655 to MAO, CA109748 and CA127620 to CLG, and the Melvin Burkhardt chair in Neurosurgical Oncology and the Karen Colina Wilson research endowment within the Brain Tumor and Neuro-Oncology Center at the Cleveland Clinic for support of RJW. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Avdi NJ, 2001, J BIOL CHEM, V276, P2189, DOI 10.1074/jbc.M007527200; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chano T, 2002, GENE, V291, P29, DOI 10.1016/S0378-1119(02)00585-1; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chauhan D, 1999, ONCOGENE, V18, P6733, DOI 10.1038/sj.onc.1203082; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Dahiya R, 1998, INT J ONCOL, V12, P811; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gutenberg A, 2004, ACTA NEUROPATHOL, V108, P224, DOI 10.1007/s00401-004-0886-3; Han HS, 2003, J EXP MED, V197, P63, DOI 10.1084/jem.20021638; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kurenova E, 2004, MOL CELL BIOL, V24, P4361, DOI 10.1128/MCB.24.10.4361-4371.2004; Kuwabara K, 2004, ENDOCRINOLOGY, V145, P3324, DOI 10.1210/en.2003-1433; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Lipinski CA, 2003, MOL CANCER RES, V1, P323; Lulo J, 2009, BIOCHEM BIOPH RES CO, V383, P347, DOI 10.1016/j.bbrc.2009.04.011; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Melendez J, 2004, J BIOL CHEM, V279, P53516, DOI 10.1074/jbc.M408475200; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Ramachandra M, 2002, CANCER RES, V62, P6045; Rege TA, 2009, J CELL PHYSIOL, V218, P94, DOI 10.1002/jcp.21570; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stettner AR, 2005, CANCER RES, V65, P5535, DOI 10.1158/0008-5472.CAN-04-3688; The WHO, 2020, CLASSIFICATION TUMOU; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang DY, 2000, J CELL SCI, V113, P4221; Wang Q, 2003, J CELL BIOL, V160, P565, DOI 10.1083/jcb.200207036; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Ying WZ, 2008, AM J PHYSIOL-RENAL, V295, pF406, DOI 10.1152/ajprenal.90294.2008; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	69	71	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e19629	10.1371/journal.pone.0019629	http://dx.doi.org/10.1371/journal.pone.0019629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21602932	Green Published, gold			2022-12-25	WOS:000290558500017
